PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Assmann, A; Schmidt, V; Lepke, C; Sugimura, Y; Assmann, AK; Barth, M; Lichtenberg, A; Akhyari, P				Assmann, Alexander; Schmidt, Vera; Lepke, Caroline; Sugimura, Yukiharu; Assmann, Anna Kathrin; Barth, Mareike; Lichtenberg, Artur; Akhyari, Payam			Degeneration of biological heart valve grafts in a rat model of superoxide dismutase-3 deficiency	FASEB JOURNAL			English	Article						aortic valve graft; calcification; graft degeneration; oxidative stress; superoxide dismutase-3	VENTRICULAR HYPERTROPHY; ARTERIAL-HYPERTENSION; MISSENSE MUTATION; OXIDATIVE STRESS; NITRIC-OXIDE; PROTECTION; SYSTEM; RISK	While oxidative stress is known as key element in the pathogenesis of atherosclerosis and calcific aortic valve disease, its role in the degeneration of biological cardiovascular grafts has not been clarified yet. Therefore, the present study aimed to examine the impact of oxidative stress on the degeneration of biological cardiovascular allografts in a standardized chronic implantation model realized in rats exhibiting superoxide dismutase 3 deficiency (SOD3((-))). Rats with SOD3 loss-of-function mutation (n = 24) underwent infrarenal implantation of cryopreserved valved aortic conduits, while SOD3-competent recipients served as controls (n = 28). After a follow-up period of 4 or 12 weeks, comparative analyses addressed degenerative processes, hemodynamics, and evaluation of the oxidative stress model. SOD3((-)) rats presented decreased circulating SOD activity (p = .0079). After 12 weeks, 58% of the implant valves in SOD3((-)) rats showed regurgitation (vs. 31% in controls, p = .2377). Intima hyperplasia and chondro-osteogenic transformation contributed to progressive graft calcification (p = .0024). At 12 weeks, hydroxyapatite deposition (p = .0198) and the gene expression of runt-related transcription factor-2 (Runx2) (p = .0093) were significantly enhanced in group SOD3((-)). This study provides the first in vivo evidence that impaired systemic antioxidant activity contributes to biological cardiovascular graft degeneration.	[Assmann, Alexander; Schmidt, Vera; Lepke, Caroline; Sugimura, Yukiharu; Assmann, Anna Kathrin; Barth, Mareike; Lichtenberg, Artur; Akhyari, Payam] Heinrich Heine Univ, Med Fac, Dept Cardiac Surg, Dusseldorf, Germany; [Assmann, Alexander; Schmidt, Vera; Lepke, Caroline; Sugimura, Yukiharu; Assmann, Anna Kathrin; Barth, Mareike; Lichtenberg, Artur; Akhyari, Payam] Heinrich Heine Univ, Med Fac, Res Grp Expt Surg, Dusseldorf, Germany; [Lichtenberg, Artur] Heinrich Heine Univ, Med Fac, CARID Cardiovasc Res Inst Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Lichtenberg, A (corresponding author), Heinrich Heine Univ, Dept Cardiac Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	artur.lichtenberg@med.uni-duesseldorf.de	Barth, Mareike/AAB-2975-2020	Barth, Mareike/0000-0002-6118-6799	S. Bunnenberg Foundation; Projekt DEAL	S. Bunnenberg Foundation; Projekt DEAL	The authors gratefully acknowledge technical support by Gisela Muller. The generous support of the S. Bunnenberg Foundation to the Cardiovascular Research Facilities at Heinrich Heine University is greatly appreciated. Open Access funding enabled and organized by Projekt DEAL.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Assmann A, 2014, J CARDIOVASC PHARM, V64, P332, DOI 10.1097/FJC.0000000000000123; Assmann A, 2014, BIOMATERIALS, V35, P7416, DOI 10.1016/j.biomaterials.2014.05.034; Assmann A, 2013, BIOMATERIALS, V34, P6015, DOI 10.1016/j.biomaterials.2013.04.037; Assmann A, 2012, J SURG RES, V176, P367, DOI 10.1016/j.jss.2011.10.009; Assmann Anna Kathrin, 2021, J Cardiovasc Pharmacol, V79, pe103, DOI 10.1097/FJC.0000000000001150; Beyer AM, 2014, AM J PHYSIOL-HEART C, V306, pH339, DOI 10.1152/ajpheart.00619.2012; Branchetti E, 2013, ARTERIOSCL THROM VAS, V33, pE66, DOI 10.1161/ATVBAHA.112.300177; Butany J, 2005, J CLIN PATHOL, V58, P113, DOI 10.1136/jcp.2004.020271; Carlsson LM, 1996, P NATL ACAD SCI USA, V93, P5219, DOI 10.1073/pnas.93.11.5219; Chen YB, 2021, ARTERIOSCL THROM VAS, V41, P20, DOI 10.1161/ATVBAHA.120.313791; Christian AJ, 2014, BIOMATERIALS, V35, P2097, DOI 10.1016/j.biomaterials.2013.11.045; Chu Y, 2005, CIRCULATION, V112, P1047, DOI 10.1161/CIRCULATIONAHA.104.531251; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; FOLZ RJ, 1994, HUM MOL GENET, V3, P2251, DOI 10.1093/hmg/3.12.2251; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; Guglielmo M, 2022, EUR RADIOL, V32, P6017, DOI 10.1007/s00330-022-08747-x; Guo HP, 2020, FREE RADICAL BIO MED, V152, P787, DOI 10.1016/j.freeradbiomed.2020.01.023; Iida S, 2006, AM J PHYSIOL-HEART C, V291, pH914, DOI 10.1152/ajpheart.00080.2006; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; KARLSSON K, 1988, BIOCHEM J, V255, P223; Laukkanen MO., 2018, ENCY SIGNALING MOL, P5232; Lee S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005648; Legare JF, 2000, CIRCULATION, V102, P75; Lund DD, 2009, AM J PHYSIOL-HEART C, V296, pH1920, DOI 10.1152/ajpheart.01342.2008; MARKLUND SL, 1984, J CLIN INVEST, V74, P1398, DOI 10.1172/JCI111550; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Munakata H, 2013, CIRC J, V77, P2295, DOI 10.1253/circj.CJ-12-1439; Nalluri N, 2018, J INTERV CARDIOL, V31, P661, DOI 10.1111/joic.12520; Pinto A, 2016, EUR J CARDIO-THORAC, V50, P1035, DOI 10.1093/ejcts/ezw216; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Tjang YS, 2007, EUR J CARDIO-THORAC, V32, P469, DOI 10.1016/j.ejcts.2007.06.012; Volpe M, 2002, J AM SOC NEPHROL, V13, pS173, DOI 10.1097/01.ASN.0000032549.36050.78; Wolin MS, 2006, HYPERTENSION, V48, P368, DOI 10.1161/01.HYP.0000237667.46006.f4; Xu DC, 2011, HYPERTENSION, V58, P303, DOI 10.1161/HYPERTENSIONAHA.110.166819; Yamada H, 2000, NEPHRON, V84, P218, DOI 10.1159/000045580; Zhang B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00622	41	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22591	10.1096/fj.202200727RR	http://dx.doi.org/10.1096/fj.202200727RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J1FE	36251410	hybrid			2022-12-28	WOS:000868790700001
J	Ji, Z; Wang, J; Yang, S; Tao, SJ; Shen, CQ; Wei, HX; Li, Q; Jin, PS				Ji, Zhe; Wang, Jian; Yang, Shuai; Tao, Shengjun; Shen, Caiqi; Wei, Hanxiao; Li, Qiang; Jin, Peisheng			Graphene oxide accelerates diabetic wound repair by inhibiting apoptosis of Ad-MSCs via Linc00324/miR-7977/STK4 pathway	FASEB JOURNAL			English	Article						adipose-derived mesenchymal stem cells; diabetic wound; graphene oxide; Linc00324; miR-7977	CELL; PROLIFERATION; MIGRATION	Many studies have shown that graphene oxide (GO) promotes proliferation and differentiation of a variety of stem cells. However, its effect on adipose-derived mesenchymal stem cell (Ad-MSCs) apoptosis is still unclear. Apoptosis is a significant factor affecting stem cell-based treatment of diabetic wounds. Therefore, we explored the effect of GO on Ad-MSC apoptosis and diabetic wound healing. In this study, qRT-PCR was used to detect Ad-MSC expression of LncRNAs, miRNAs, and mRNAs under high-glucose environment. RNA immunoprecipitation (RIP), RNA pull-down, and luciferase assays were used to detect interactions of specific lncRNAs, miRNAs, and mRNAs. The effects of GO on Ad-MSC apoptosis were explored by flow cytometry, TUNEL assay, and Western blot. A diabetic wound model was used to explore the function of Linc00324 on Ad-MSC reparative properties in vivo. As a result, GO inhibited high glucose-induced apoptosis in Ad-MSCs, and Linc00324 contributed to the anti-apoptotic effect of GO. RIP and RNA pull-down confirmed that Linc00324 directly interacted with miR-7977, functioning as a miRNA sponge to regulate expression of the miR-7977 target gene STK4 (MST1) and downstream signaling pathways. In addition, GO reduced the apoptosis of Ad-MSCs in wounds and promoted wound healing. Taken together, these findings suggest GO may be a superior auxiliary material for Ad-MSCs to facilitate diabetic wound healing via the Linc00324/miR-7977/STK4 pathway.	[Ji, Zhe; Wang, Jian; Yang, Shuai; Tao, Shengjun; Shen, Caiqi; Wei, Hanxiao; Li, Qiang; Jin, Peisheng] Xuzhou Med Univ, Dept Plast Surg, Affiliated Hosp, Huaihai West Rd, Xuzhou, Jiangsu, Peoples R China; [Jin, Peisheng] Xuzhou Med Univ, Jiangsu Ctr Collaborat & Innovat Canc, Xuzhou, Jiangsu, Peoples R China; [Jin, Peisheng] Xuzhou Med Univ, Jiangsu Canc Biotherapy Inst, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Li, Q; Jin, PS (corresponding author), Xuzhou Med Univ, Dept Plast Surg, Affiliated Hosp, Huaihai West Rd, Xuzhou, Jiangsu, Peoples R China.	fallin1983@163.com; 100000401006@xzhmu.edu.cn	Zhe, Ji/GLR-4104-2022		National Natural Science Foundation of China [82072819]; National Natural Science Foundation of Jiangsu Province [BK20201155]; China Postdoctoral Science Foundation [2019T120462]; Jiangsu Postdoctoral Science Foundation [2019K155]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX20_2456, KYCX20_2480]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This study was supported by grants from the National Natural Science Foundation of China (82072819), the National Natural Science Foundation of Jiangsu Province (BK20201155), China Postdoctoral Science Foundation (2019T120462), Jiangsu Postdoctoral Science Foundation (2019K155), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX20_2456, KYCX20_2480).	Ali T, 2020, ELIFE, V9, DOI 10.7554/eLife.60583; Barman PK, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00528; Chen LY, 2020, J CELL BIOCHEM, V121, P3382, DOI 10.1002/jcb.29612; Cheng YH, 2022, COLLOID SURFACE B, V209, DOI 10.1016/j.colsurfb.2021.112150; Choe G, 2019, NANOSCALE, V11, P23275, DOI 10.1039/c9nr07643c; Conlon TM, 2020, NATURE, V588, P151, DOI 10.1038/s41586-020-2882-8; Dekoninck S, 2019, NAT CELL BIOL, V21, P18, DOI 10.1038/s41556-018-0237-6; Dhoke NR, 2020, MOL THER, V28, P1314, DOI 10.1016/j.ymthe.2020.02.014; Dong XJ, 2020, PROSTAG LEUKOTR ESS, V161, DOI 10.1016/j.plefa.2020.102179; Fu C, 2019, ARTIF CELL NANOMED B, V47, P1867, DOI 10.1080/21691401.2019.1613422; Garcia-Alegria E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25917; Guo F, 2020, CELL CYCLE, V19, P1997, DOI 10.1080/15384101.2020.1783481; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Horiguchi H, 2016, HAEMATOLOGICA, V101, P437, DOI 10.3324/haematol.2015.134932; Huang RY, 2019, BIOMATER SCI-UK, V7, P4248, DOI 10.1039/c9bm00939f; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kim JH, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00259; Kim J, 2013, J BIOMED MATER RES A, V101, P3520, DOI 10.1002/jbm.a.34659; Kim TH, 2013, BIOMATERIALS, V34, P8660, DOI 10.1016/j.biomaterials.2013.07.101; Kovanecz I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164044; Lasocka I, 2019, INT J NANOMED, V14, P2281, DOI 10.2147/IJN.S190928; Li B, 2020, J MOL ENDOCRINOL, V65, P69, DOI 10.1530/JME-19-0242; Li Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0615-9; Lou D, 2020, BIOACT MATER, V5, P667, DOI 10.1016/j.bioactmat.2020.04.018; Moradi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58099-z; Ni X, 2019, EUR REV MED PHARMACO, V23, P10740, DOI 10.26355/eurrev_201912_19775; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Nyambat B, 2018, J MATER CHEM B, V6, P979, DOI 10.1039/c7tb02480k; Peng XZ, 2020, J CELL MOL MED, V24, P304, DOI 10.1111/jcmm.14728; Ren CX, 2018, ADV SCI, V5, DOI 10.1002/advs.201700595; Sekula-Stryjewska M, 2021, MAT SCI ENG C-MATER, V119, DOI 10.1016/j.msec.2020.111614; Turunen SP, 2019, CELL DEATH DIFFER, V26, P2577, DOI 10.1038/s41418-019-0321-x; Tyc KM, 2021, LAB INVEST, V101, P503, DOI 10.1038/s41374-020-00498-x; Tyeb S, 2020, BIOMACROMOLECULES, V21, P294, DOI 10.1021/acs.biomac.9b01355; Wear-Maggitti K, 2004, ANN PLAS SURG, V52, P519, DOI 10.1097/01.sap.0000122857.49274.8c; Wu SK, 2020, J CELL PHYSIOL, V235, P339, DOI 10.1002/jcp.28973; Xie MY, 2018, J CELL MOL MED, V22, P3595, DOI 10.1111/jcmm.13639; Xu SJ, 2011, ANAL CHEM, V83, P3817, DOI 10.1021/ac200237j; Yan HL, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0047-y; Yoshida M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213220; Yu XY, 2019, IUBMB LIFE, V71, P1611, DOI 10.1002/iub.2102; Zambrano-Andazol I, 2020, MAT SCI ENG C-MATER, V114, DOI 10.1016/j.msec.2020.111075; Zhang YX, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.432; Zhu JY, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07302-5	44	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22623	10.1096/fj.202201079RR	http://dx.doi.org/10.1096/fj.202201079RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5M0HV	36269304				2022-12-28	WOS:000870788800001
J	Azad, A; Campbell, KR; Zhabyeyev, P; Oudit, GY; Moore, RB; Murray, AG				Azad, Abul K.; Campbell, Kieran R.; Zhabyeyev, Pavel; Oudit, Gavin Y.; Moore, Ronald B.; Murray, Allan G.			Loss of apelin blocks the emergence of sprouting angiogenesis in experimental tumors	FASEB JOURNAL			English	Article						angiogenesis inhibitors; apelin; endothelial cells; gene expression profiling; neoplasm; neovascularization; single-cell analysis; vascular endothelial growth factor receptor-2	ENDOTHELIAL-CELL HETEROGENEITY; CANCER; VEGF; HYPOXIA; PROGRESSION; VESSELS; NORMALIZATION; METASTASIS; INHIBITION; INVASION	Angiogenesis inhibitor drugs targeting vascular endothelial growth factor (VEGF) signaling to the endothelial cell (EC) are used to treat various cancer types. However, primary or secondary resistance to therapy is common. Clinical and pre-clinical studies suggest that alternative pro-angiogenic factors are upregulated after VEGF pathway inhibition. Therefore, identification of alternative pro-angiogenic pathway(s) is critical for the development of more effective anti-angiogenic therapy. Here we study the role of apelin as a pro-angiogenic G-protein-coupled receptor ligand in tumor growth and angiogenesis. We found that loss of apelin in mice delayed the primary tumor growth of Lewis lung carcinoma 1 and B16F10 melanoma when combined with the VEGF receptor tyrosine kinase inhibitor, sunitinib. Targeting apelin in combination with sunitinib markedly reduced the tumor vessel density, and decreased microvessel remodeling. Apelin loss reduced angiogenic sprouting and tip cell marker gene expression in comparison to the sunitinib-alone-treated mice. Single-cell RNA sequencing of tumor EC demonstrated that the loss of apelin prevented EC tip cell differentiation. Thus, apelin is a potent pro-angiogenic cue that supports initiation of tumor neovascularization. Together, our data suggest that targeting apelin may be useful as adjuvant therapy in combination with VEGF signaling inhibition to inhibit the growth of advanced tumors.	[Azad, Abul K.; Zhabyeyev, Pavel; Oudit, Gavin Y.; Murray, Allan G.] Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada; [Campbell, Kieran R.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Campbell, Kieran R.] Univ Toronto, Dept Mol Genet & Stat Sci, Toronto, ON, Canada; [Zhabyeyev, Pavel; Oudit, Gavin Y.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022		Canadian Institutes of Health Research [PJT175257]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating award from the Canadian Institutes of Health Research (PJT175257) to Allan G. Murray.	Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Bennewith KL, 2004, CANCER RES, V64, P6183, DOI 10.1158/0008-5472.CAN-04-0289; Berta J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85162-0; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Frisch A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114179; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goveia J, 2020, CANCER CELL, V37, P21, DOI 10.1016/j.ccell.2019.12.001; Harford-Wright E, 2017, BRAIN, V140, P2939, DOI 10.1093/brain/awx253; Hawkins R, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07154-z; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kahn BM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136655; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2013, ANGIOGENESIS, V16, P723, DOI 10.1007/s10456-013-9349-6; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerbel RS, 2015, CANCER J, V21, P274, DOI 10.1097/PPO.0000000000000134; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Lugano R, 2020, CELL MOL LIFE SCI, V77, P1745, DOI 10.1007/s00018-019-03351-7; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Martin JD, 2019, ANNU REV PHYSIOL, V81, P505, DOI 10.1146/annurev-physiol-020518-114700; Mastrella G, 2019, CANCER RES, V79, P2298, DOI 10.1158/0008-5472.CAN-18-0881; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Motzer RJ, 2020, CANCER CELL, V38, P803, DOI 10.1016/j.ccell.2020.10.011; Neelakantan D, 2019, MOL CANCER RES, V17, P1378, DOI 10.1158/1541-7786.MCR-18-0989; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Podgorska M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101513; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Sorli SC, 2007, ONCOGENE, V26, P7692, DOI 10.1038/sj.onc.1210573; Stuhler V, 2021, EXPERT OPIN BIOL TH, V21, P1215, DOI 10.1080/14712598.2021.1890713; Tolkach Y, 2019, BRIT J CANCER, V120, P633, DOI 10.1038/s41416-019-0396-7; Uribesalgo I, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809266; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Wu FTH, 2019, BRIT J CANCER, V120, P196, DOI 10.1038/s41416-018-0297-1; Yamagishi A, 2019, INT J BIOL SCI, V15, P1546, DOI 10.7150/ijbs.33423; Zhao H, 2018, CELL REP, V25, P1241, DOI 10.1016/j.celrep.2018.10.015; Zhao Q, 2018, CANCER RES, V78, P2370, DOI 10.1158/0008-5472.CAN-17-2728	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22560	10.1096/fj.202200616RR	http://dx.doi.org/10.1096/fj.202200616RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1NF	36165236				2022-12-28	WOS:000859931700001
J	Francis, M; Ahmad, A; Bodgi, L; Azzam, P; Youssef, T; Abou Daher, A; Eid, AA; Fornoni, A; Pollack, A; Marples, B; Zeidan, YH				Francis, Marina; Ahmad, Anis; Bodgi, Larry; Azzam, Patrick; Youssef, Tarek; Abou Daher, Alaa; Eid, Assaad A.; Fornoni, Alessia; Pollack, Alan; Marples, Brian; Zeidan, Youssef H.			SMPDL3b modulates radiation-induced DNA damage response in renal podocytes	FASEB JOURNAL			English	Article						nuclear sphingolipids; ATM nuclear shuttling; DNA damage response; double-strand breaks; radiation nephropathy; radiation podocytopathy; SMPDL3b; sphingolipids	DOUBLE-STRAND BREAKS; HISTONE H2AX; ATM KINASE; PROTEIN; P53; SPHINGOLIPIDS; IMPACT; REPAIR; PHOSPHORYLATION; THERAPY	The kidneys are radiosensitive and dose-limiting organs for radiotherapy (RT) targeting abdominal and paraspinal tumors. Excessive radiation doses to the kidneys ultimately lead to radiation nephropathy. Our prior work unmasked a novel role for the lipid-modifying enzyme, sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b), in regulating the response of renal podocytes to radiation injury. In this study, we investigated the role of SMPDL3b in DNA double-strand breaks (DSBs) repair in vitro and in vivo. We assessed the kinetics of DSBs recognition and repair along with the ATM pathway and nuclear sphingolipid metabolism in wild-type (WT) and SMPDL3b overexpressing (OE) human podocytes. We also assessed the extent of DNA damage repair in SMPDL3b knock-down (KD) human podocytes, and C57BL6 WT and podocyte-specific SMPDL3b-knock out (KO) mice after radiation injury. We found that SMPDL3b overexpression enhanced DSBs recognition and repair through modulating ATM nuclear shuttling. OE podocytes were protected against radiation-induced apoptosis by increasing the phosphorylation of p53 at serine 15 and attenuating subsequent caspase-3 cleavage. SMPDL3b overexpression prevented radiation-induced alterations in nuclear ceramide-1-phosphate (C1P) and ceramide levels. Interestingly, exogenous C1P pretreatment radiosensitized OE podocytes by delaying ATM nuclear foci formation and DSBs repair. On the other hand, SMPDL3b knock-down, in vitro and in vivo, induced a significant delay in DSBs repair. Additionally, increased activation of apoptosis was induced in podocytes of SMPDL3b-KO mice compared to WT mice at 24h post-irradiation. Together, our results unravel a novel role for SMPDL3b in radiation-induced DNA damage response. The current work suggests that SMPDL3b modulates nuclear sphingolipid metabolism, ATM nuclear shuttling, and DSBs repair.	[Francis, Marina; Azzam, Patrick; Youssef, Tarek; Abou Daher, Alaa; Eid, Assaad A.; Zeidan, Youssef H.] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Ahmad, Anis; Pollack, Alan] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Dept Radiat Oncol, Miami, FL 33136 USA; [Bodgi, Larry; Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Beirut, Lebanon; [Fornoni, Alessia] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL USA; [Fornoni, Alessia] Univ Miami, Dept Med, Katz Family Div Nephrol & Hypertens, Miami, FL USA; [Marples, Brian] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA	American University of Beirut; University of Miami; American University of Beirut; University of Miami; University of Miami; University of Rochester	Zeidan, YH (corresponding author), Amer Univ Beirut, Dept Radiat Oncol, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.	yz09@aub.edu.lb		Eid, Assaad/0000-0002-3603-0960; Francis, Marina/0000-0001-7264-8111; Bodgi, Larry/0000-0003-1067-9435	National Institutes of Health [1R01CA227493]; Live Like Bella, Florida Department of Health [9LA08]; Medical Practice Plan; American University of Beirut; Sylvester Cancer Center Award [PG011608, PG014020]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Live Like Bella, Florida Department of Health; Medical Practice Plan; American University of Beirut; Sylvester Cancer Center Award	National Institutes of Health, Grant/Award Number: 1R01CA227493; Live Like Bella, Florida Department of Health, Grant/Award Number: 9LA08; Medical Practice Plan, American University of Beirut; Sylvester Cancer Center Award, Grant/Award Number: PG011608 and PG014020	Abou Daher A, 2020, FASEB J, V34, P7915, DOI 10.1096/fj.201902179R; Ahmad A, 2017, FASEB J, V31, P771, DOI 10.1096/fj.201600618R; Albi E., 2006, RECENT RES DEV BIOPH, V37, P211; Azzam P, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.732528; BALDWIN JN, 1962, CALIF MED, V97, P359; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Basic-Jukic N, 2013, CURR PHARM DESIGN, V19, P6046; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Bodgi L, 2016, INT J RADIAT BIOL, V92, P117, DOI 10.3109/09553002.2016.1135260; Bodgi L, 2013, J THEOR BIOL, V333, P135, DOI 10.1016/j.jtbi.2013.05.020; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carroll Brittany, 2015, Advances in Biological Regulation, V58, P38, DOI 10.1016/j.jbior.2014.11.001; CASSADY JR, 1995, INT J RADIAT ONCOL, V31, P1249, DOI 10.1016/0360-3016(94)00428-N; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Combemale P, 2022, MOL NEUROBIOL, V59, P556, DOI 10.1007/s12035-021-02615-3; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Edeani A., 2016, AM SOC NEPHROLOGY; Edsall DL, 1906, J AMER MED ASSOC, V47, P1425; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Ferlazzo ML, 2018, MOL NEUROBIOL, V55, P4973, DOI 10.1007/s12035-017-0648-6; Ferlazzo ML, 2014, MOL NEUROBIOL, V49, P1200, DOI 10.1007/s12035-013-8591-7; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Francis M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124481; Hankins JL, 2013, J BIOL CHEM, V288, P19726, DOI 10.1074/jbc.M113.481622; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; KASTAN MB, 1991, CANCER RES, V51, P6304; Klaus R, 2021, RADIAT ONCOL, V16, DOI 10.1186/s13014-021-01764-y; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Ledeen RW, 2008, J LIPID RES, V49, P1176, DOI 10.1194/jlr.R800009-JLR200; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Mallela SK, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158517; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00127; Mitrofanova A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10584-4; Negritto M, 2010, NAT ED, V3, P26; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Ouenzar F, 2016, TRANSL CANCER RES, V5, pS742, DOI 10.21037/tcr.2016.10.61; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pereira S, 2018, INT J RADIAT ONCOL, V100, P353, DOI 10.1016/j.ijrobp.2017.10.029; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saha GB, 2012, PHYS RADIOBIOLOGY NU; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider G, 2013, MOL CANCER RES, V11, P793, DOI 10.1158/1541-7786.MCR-12-0600; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; STEPHENS LC, 1995, INT J RADIAT ONCOL, V31, P865, DOI 10.1016/0360-3016(94)00437-4; Suzuki K, 2001, RADIAT RES, V155, P248, DOI 10.1667/0033-7587(2001)155[0248:RISLGA]2.0.CO;2; Tomassoni ML, 1999, BIOCHEM BIOPH RES CO, V258, P476, DOI 10.1006/bbrc.1999.0659; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zhao H, 2008, CELL CYCLE, V7, P3048, DOI 10.4161/cc.7.19.6750	64	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22545	10.1096/fj.202100186RR	http://dx.doi.org/10.1096/fj.202100186RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1XJ	36094323				2022-12-28	WOS:000853121100001
J	Kazi, S; Castaneda, JM; Savolainen, A; Xu, YD; Liu, N; Qiao, HY; Ramirez-Solis, R; Nozawa, K; Yu, ZF; Matzuk, MM; Prunskaite-Hyyrylainen, R				Kazi, Samina; Castaneda, Julio M.; Savolainen, Audrey; Xu, Yiding; Liu, Ning; Qiao, Huanyu; Ramirez-Solis, Ramiro; Nozawa, Kaori; Yu, Zhifeng; Matzuk, Martin M.; Prunskaite-Hyyrylainen, Renata			MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice	FASEB JOURNAL			English	Article						diplotene; liquid-liquid phase separation; male infertility; pachytene; subnuclear; XY body	DOUBLE-STRAND BREAKS; CELL NUCLEAR ANTIGEN; XY BODY; CROSSING-OVER; CHROMOSOME INACTIVATION; MOUSE SPERMATOCYTES; WILD-TYPE; PROTEIN; EXPRESSION; MEIOSIS	Meiosis has a principal role in sexual reproduction to generate haploid gametes in both sexes. During meiosis, the cell nucleus hosts a dynamic environment where some genes are transcriptionally activated, and some are inactivated at the same time. This becomes possible through subnuclear compartmentalization. The sex body, sequestering X and Y chromosomes during male meiosis and creating an environment for the meiotic sex chromosome inactivation (MSCI) is one of the best known and studied subnuclear compartments. Herein, we show that MRNIP forms droplet-like accumulations that fuse together to create a distinct subnuclear compartment that partially overlaps with the sex body chromatin during diplotene. We demonstrate that Mrnip(-/-) spermatocytes have impaired DNA double-strand break (DSB) repair, they display reduced sex body formation and defective MSCI. We show that Mrnip(-/-) undergoes critical meiocyte loss at the diplotene stage. Furthermore, we determine that DNA DSBs (induced by SPO11) and synapsis initiation (facilitated by SYCP1) precede Mrnip expression in testes. Altogether, our findings indicate that in addition to an emerging role in DNA DSB repair, MRNIP has an essential function in spermatogenesis during meiosis I by forming drop-like accumulations interacting with the sex body.	[Kazi, Samina; Savolainen, Audrey; Prunskaite-Hyyrylainen, Renata] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, FI-90220 Oulu, Finland; [Castaneda, Julio M.] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Xu, Yiding; Liu, Ning; Qiao, Huanyu] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA; [Ramirez-Solis, Ramiro] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Nozawa, Kaori; Yu, Zhifeng; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA; [Yu, Zhifeng; Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX USA	University of Oulu; Osaka University; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Baylor College of Medicine	Prunskaite-Hyyrylainen, R (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7A, FI-90220 Oulu, Finland.	renata.prunskaite@oulu.fi		Kazi, Samina/0000-0003-4476-1007	Academy of Finland (AKA) [285151, 336449]; Bill and Melinda Gates Foundation (GF) [INV-001902]; HHS | National Institutes of Health (NIH) [R00 HD082375, R01 GM135549]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD088412, P01HD087157]; HHS | NIH | National Cancer Institute (NCI) [NCI-CA125123]; MEXT | Japan Society for the Promotion of Science (JSPS) [JP18K14715, JP20K15804]; Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Academy of Finland (AKA)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Bill and Melinda Gates Foundation (GF); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Cancer Institute (NCI); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Academy of Finland (AKA), Grant/Award Number: 285151 and 336449; Bill and Melinda Gates Foundation (GF), Grant/Award Number: INV-001902; HHS | National Institutes of Health (NIH), Grant/Award Number: R00 HD082375 and R01 GM135549; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD088412 and P01HD087157; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: NCI--CA125123; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18K14715 and JP20K15804; Oulun Yliopisto (University of Oulu); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse)	Abe H, 2020, CURR BIOL, V30, P408, DOI 10.1016/j.cub.2019.11.064; Alavattam KG, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04075-3; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bennett LG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5974; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Inselman A, 2003, CYTOGENET GENOME RES, V103, P277, DOI 10.1159/000076813; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; James RD, 2002, CHROMOSOME RES, V10, P549, DOI 10.1023/A:1020910601858; Jarvis S, 2005, HUM REPROD, V20, P108, DOI 10.1093/humrep/deh565; Jiang HW, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007300; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kulkarni DS, 2020, NATURE, V586, P623, DOI 10.1038/s41586-020-2645-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pD458, DOI 10.1093/nar/gkaa937; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Lin M, 2021, BIOCHEM BIOPH RES CO, V550, P127, DOI 10.1016/j.bbrc.2021.02.143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Makino Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42578-z; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Oura S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008954; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Peterson SE, 2011, METHODS MOL BIOL, V767, P191, DOI 10.1007/978-1-61779-201-4_14; Piovesan D, 2021, NUCLEIC ACIDS RES, V49, pD361, DOI 10.1093/nar/gkaa1058; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Plug AW, 1998, J CELL SCI, V111, P413; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Prunskaite-Hyyrylainen R, 2016, HUM MOL GENET, V25, P1059, DOI 10.1093/hmg/ddv621; Prunskaite-Hyyrylainen R, 2014, FASEB J, V28, P1568, DOI 10.1096/fj.13-233247; Qiao HY, 2018, MOL CELL, V72, P211, DOI 10.1016/j.molcel.2018.08.031; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; RICHLER C, 1994, MOL BIOL CELL, V5, P1341, DOI 10.1091/mbc.5.12.1341; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Staples CJ, 2016, CELL REP, V16, P2565, DOI 10.1016/j.celrep.2016.07.087; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2015, ANNU REV GENET, V49, P395, DOI 10.1146/annurev-genet-112414-055145; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; Vernet N, 2016, HUM MOL GENET, V25, P5300, DOI 10.1093/hmg/ddw344; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang YL, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30303-w; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu YD, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.674203; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	80	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22479	10.1096/fj.202101168RR	http://dx.doi.org/10.1096/fj.202101168RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3M2JG	35920200	Green Published			2022-12-28	WOS:000835283400001
J	Dwyer, LJ; Stowe, AM; Doyle, K; Popovich, P; Engler-Chiurazzi, E; LeGuern, C; Buckwalter, MS; Poznansky, MC; Sirbulescu, RF				Dwyer, Liam J.; Stowe, Ann M.; Doyle, Kristian; Popovich, Phillip; Engler-Chiurazzi, Elizabeth; LeGuern, Christian; Buckwalter, Marion S.; Poznansky, Mark C.; Sirbulescu, Ruxandra F.			The 2022 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, March 30, 2022	FASEB JOURNAL			English	Article							MACROPHAGES		[Dwyer, Liam J.; Poznansky, Mark C.; Sirbulescu, Ruxandra F.] Harvard Med Sch, Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Dept Med, 149 13th St, Boston, MA 02129 USA; [Stowe, Ann M.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Doyle, Kristian] Univ Arizona, Dept Neurol, Tucson, AZ USA; [Popovich, Phillip] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA; [Engler-Chiurazzi, Elizabeth] Tulane Univ, Sch Med, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA; [LeGuern, Christian] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Transplantat, Boston, MA 02129 USA; [Buckwalter, Marion S.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA USA; [Sirbulescu, Ruxandra F.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Kentucky; University of Arizona; University System of Ohio; Ohio State University; Tulane University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Poznansky, MC; Sirbulescu, RF (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Dept Med, 149 13th St, Boston, MA 02129 USA.	mpoznansky@mgh.harvard.edu; rsirbulescu@mgh.harvard.edu		Dwyer, Liam/0000-0001-5908-5959; Buckwalter, Marion/0000-0003-2807-2447	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01NS096091]; Leducq Foundation	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Leducq Foundation(Leducq Foundation)	We are grateful to Phoebe Ingram at the Vaccine and Immunotherapy Center and to Ying Zhu at FASEB for help with organizing the conference. The work presented by K.P. Doyle was supported by the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; R01NS096091) and the Leducq Foundation.	Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Deng SP, 2007, J IMMUNOL, V178, P6028, DOI 10.4049/jimmunol.178.10.6028; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Drag LL, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01897-9; Fu Q, 2021, AM J TRANSPLANT, V21, P3847, DOI 10.1111/ajt.16772; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Li Y, 2020, NATURE, V587, P613, DOI 10.1038/s41586-020-2795-6; Ortega SB, 2020, P NATL ACAD SCI USA, V117, P4983, DOI 10.1073/pnas.1913292117; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Zbesko JC, 2021, BRAIN BEHAV IMMUN, V91, P578, DOI 10.1016/j.bbi.2020.09.014; Zbesko JC, 2018, NEUROBIOL DIS, V112, P63, DOI 10.1016/j.nbd.2018.01.007	12	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22459	10.1096/fj.202201027	http://dx.doi.org/10.1096/fj.202201027			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3B1OO	35857314				2022-12-28	WOS:000827717800001
J	Mei, SQ; Li, L; Zhou, XJ; Xue, C; Livingston, MJ; Wei, QQ; Dai, B; Mao, ZG; Changlin,; Dong, Z				Mei, Shuqin; Li, Lin; Zhou, Xiangjun; Xue, Cheng; Livingston, Man J.; Wei, Qingqing; Dai, Bing; Mao, Zhiguo; Mei, Changlin; Dong, Zheng			Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1	FASEB JOURNAL			English	Article						diabetic kidney disease; fibrosis; HIF-1; high glucose	ACTIVATION; APOPTOSIS; PREVENTS; PATHWAY; INJURY; MODELS	Diabetes may prevent kidney repair and sensitize the kidney to fibrosis or scar formation. To test this possibility, we examined renal fibrosis induced by unilateral ureteral obstruction (UUO) in diabetic mouse models. Indeed, UUO induced significantly more renal fibrosis in both Akita and STZ-induced diabetic mice than in nondiabetic mice. The diabetic mice also had more apoptosis and interstitial macrophage infiltration during UUO. In vitro, hypoxia induced higher expression of the fibrosis marker protein fibronectin in high glucose-conditioned renal tubular cells than in normal glucose cells. Mechanistically, hypoxia induced significantly more hypoxia-inducible factor-1 alpha (HIF-1 alpha) in high glucose cells than in normal glucose cells. Inhibition of HIF-1 attenuated the expression of fibronectin induced by hypoxia in high-glucose cells. Consistently, UUO induced significantly higher HIF-1 alpha expression along with fibrosis in diabetic mice kidneys than in nondiabetic kidneys. The increased expression of fibrosis induced by UUO in diabetic mice was diminished in proximal tubule-HIF-1 alpha-knockout mice. Together, these results indicate that diabetes sensitizes kidney tissues and cells to fibrogenesis probably by enhancing HIF-1 activation.	[Mei, Shuqin; Li, Lin; Xue, Cheng; Dai, Bing; Mao, Zhiguo; Mei, Changlin] Naval Med Univ, Affiliated Hosp 2, Dept Nephrol, Shanghai 200003, Peoples R China; [Mei, Shuqin; Livingston, Man J.; Wei, Qingqing; Dong, Zheng] Augusta Univ, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA 21245 USA; [Mei, Shuqin; Livingston, Man J.; Wei, Qingqing; Dong, Zheng] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Zhou, Xiangjun] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Peoples R China	Naval Medical University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wuhan University	Changlin, (corresponding author), Naval Med Univ, Affiliated Hosp 2, Dept Nephrol, Shanghai 200003, Peoples R China.; Dong, Z (corresponding author), Augusta Univ, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA 21245 USA.	chlmei1954@126.com; zdong@augusta.edu		Livingston, Man/0000-0001-8638-0902	Department of Veterans Affairs of USA [1TK6BX005236, I01 BX000319]; National Institutes of Health of USA [5R01DK058831, 5R01DK087843]; National Natural Science Foundation of China (NSFC) [81873595, 81800681]; Shanghai Municipal Key Clinical Specialty [shslczdzk02503]	Department of Veterans Affairs of USA(US Department of Veterans Affairs); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Key Clinical Specialty	Department of Veterans Affairs of USA, Grant/Award Number: 1TK6BX005236 and I01 BX000319; National Institutes of Health of USA, Grant/Award Number: 5R01DK058831 and 5R01DK087843; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81873595 and 81800681; Shanghai Municipal Key Clinical Specialty, Grant/Award Number: shslczdzk02503	Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Bohuslavova R, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0200-8; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brownfoot FC, 2015, MOL CELL ENDOCRINOL, V413, P202, DOI 10.1016/j.mce.2015.06.033; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; DeFronzo RA, 2021, NAT REV NEPHROL, V17, P319, DOI 10.1038/s41581-021-00393-8; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Ekberg NR, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2936962; Gutierrez OM, 2022, AM J KIDNEY DIS, V79, P849, DOI 10.1053/j.ajkd.2021.09.018; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Ma ZW, 2020, J CLIN INVEST, V130, P5011, DOI 10.1172/JCI135536; Matoba K, 2013, KIDNEY INT, V84, P545, DOI 10.1038/ki.2013.130; Mei SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22171; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Na JI, 2015, AM J TRANSL RES, V7, P751; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nayak BK, 2016, DIABETES, V65, P1387, DOI 10.2337/db15-0519; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Oshima M, 2021, NAT REV NEPHROL, V17, P740, DOI 10.1038/s41581-021-00462-y; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Peng JP, 2012, J PHARMACOL EXP THER, V340, P176, DOI 10.1124/jpet.111.187427; Qi CY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8637138; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sugahara M, 2020, KIDNEY360, V1, P1021, DOI 10.34067/KID.0001302020; Wei QQ, 2018, J CLIN INVEST, V128, P5448, DOI 10.1172/JCI121859; Wei QQ, 2016, J AM SOC NEPHROL, V27, P2784, DOI 10.1681/ASN.2015080870; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007	32	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22477	10.1096/fj.202200845R	http://dx.doi.org/10.1096/fj.202200845R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3E5YY	35881071				2022-12-28	WOS:000830060500001
J	Sanz, FJ; Solana-Manrique, C; Lilao-Garzon, J; Brito-Casillas, Y; Munoz-Descalzo, S; Paricio, N				Sanz, Francisco Jose; Solana-Manrique, Cristina; Lilao-Garzon, Joaquin; Brito-Casillas, Yeray; Munoz-Descalzo, Silvia; Paricio, Nuria			Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila	FASEB JOURNAL			English	Article						drosophila; high fat; sugar diet; mouse model; neurodegeneration; Parkinson's disease; type 2 diabetes mellitus	OXIDATIVE STRESS; DJ-1 MUTANTS; IN-VIVO; MODEL; DYSFUNCTION; HOMEOSTASIS; PATHWAY; OBESITY; CELLS	Parkinson's disease (PD) is the second most common neurodegenerative disease. Diabetes mellitus (DM) is a metabolic disease characterized by high levels of glucose in blood. Recent epidemiological studies have highlighted the link between both diseases; it is even considered that DM might be a risk factor for PD. To further investigate the likely relation of these diseases, we have used a Drosophila PD model based on inactivation of the DJ-1 beta gene (ortholog of human DJ-1), and diet-induced Drosophila and mouse type 2 DM (T2DM) models, together with human neuron-like cells. T2DM models were obtained by feeding flies with a high sugar-containing medium, and mice with a high fat diet. Our results showed that both fly models exhibit common phenotypes such as alterations in carbohydrate homeostasis, mitochondrial dysfunction or motor defects, among others. In addition, we demonstrated that T2DM might be a risk factor of developing PD since our diet-induced fly and mouse T2DM models present DA neuron dysfunction, a hallmark of PD. We also confirmed that neurodegeneration is caused by increased glucose levels, which has detrimental effects in human neuron-like cells by triggering apoptosis and leading to cell death. Besides, the observed phenotypes were exacerbated in DJ-1 beta mutants cultured in the high sugar medium, indicating that DJ-1 might have a role in carbohydrate homeostasis. Finally, we have confirmed that metformin, an antidiabetic drug, is a potential candidate for PD treatment and that it could prevent PD onset in T2DM model flies. This result supports antidiabetic compounds as promising PD therapeutics.	[Sanz, Francisco Jose; Solana-Manrique, Cristina; Paricio, Nuria] Univ Valencia, Fac CC Biol, Dept Genet, Dr Moliner 50, E-46100 Burjassot, Spain; [Sanz, Francisco Jose; Solana-Manrique, Cristina; Paricio, Nuria] Univ Valencia, Inst Univ Biotecnol & Biomed BIOTECMED, Burjassot, Spain; [Lilao-Garzon, Joaquin; Brito-Casillas, Yeray; Munoz-Descalzo, Silvia] Univ Las Palmas Gran Canaria ULPGC, Inst Univ Invest Biomed & Sanitarias IUIBS, Las Palmas Gran Canaria, Spain	University of Valencia; University of Valencia; Universidad de Las Palmas de Gran Canaria	Paricio, N (corresponding author), Univ Valencia, Fac CC Biol, Dept Genet, Dr Moliner 50, E-46100 Burjassot, Spain.	nuria.paricio@uv.es	Brito Casillas, Yeray/U-6954-2018; Paricio, Nuria/K-2184-2014	Brito Casillas, Yeray/0000-0002-0707-7444; Munoz-Descalzo, Silvia/0000-0003-0939-7721; Paricio, Nuria/0000-0001-7193-2532	University of Valencia (Programa de Acciones Especiales de Investigacion) [UV-INV-AE-1553209]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ULPGC; ULPGC predoctoral program; ACIISI [CEI2019-02]; Programa de Ayudas a la Investigacion de la ULPGC; ACIISI; FEDER Funds [ProID2020010013]; ProjektDEAL	University of Valencia (Programa de Acciones Especiales de Investigacion); Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ULPGC; ULPGC predoctoral program; ACIISI; Programa de Ayudas a la Investigacion de la ULPGC; ACIISI; FEDER Funds(European Commission); ProjektDEAL	We are grateful to Dr. Jongkyeong Chung and the Bloomington Drosophila Stock Center for providing fly stocks. Research at the NP lab is supported by the University of Valencia (Programa de Acciones Especiales de Investigacion, UV-INV-AE-1553209). SMD is supported by the "Viera y Clavijo" Program from the Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI) and the ULPGC and JLG by the ULPGC predoctoral program. Research at the SMD lab is supported by the ACIISI (CEI2019-02), Programa de Ayudas a la Investigacion de la ULPGC, and ACIISI co-funded by FEDER Funds (ProID2020010013). Open access funding enabled and organized by ProjektDEAL.	Afentou N, 2019, MOV DISORD CLIN PRAC, V6, P282, DOI 10.1002/mdc3.12755; Alvarez-Rendon JP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1417528; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anandhan A, 2017, BRAIN RES BULL, V133, P12, DOI 10.1016/j.brainresbull.2017.03.009; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Ashcroft FM, 2017, CELL METAB, V26, P17, DOI 10.1016/j.cmet.2017.05.014; Athauda D, 2016, PARKINSONISM RELAT D, V32, P1, DOI 10.1016/j.parkreldis.2016.07.019; Bandres-Ciga S, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2020.104782; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Cao J, 2014, GENETICS, V197, P175, DOI 10.1534/genetics.113.160663; Casani S, 2013, FREE RADICAL BIO MED, V61, P151, DOI 10.1016/j.freeradbiomed.2013.03.021; Chai C, 2013, CURR GENOMICS, V14, P486, DOI 10.2174/1389202914666131210195808; Cheong JLY, 2020, J PARKINSON DIS, V10, P775, DOI 10.3233/JPD-191900; Cho SJ, 2019, BIOMOL THER, V27, P85, DOI 10.4062/biomolther.2018.202; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Figlewicz DP, 1996, BRAIN RES, V736, P54, DOI 10.1016/S0006-8993(96)00727-5; Fiory F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00868; Foray V, 2012, PHYSIOL ENTOMOL, V37, P295, DOI 10.1111/j.1365-3032.2012.00831.x; Galikova M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071896; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gonzalez-Rodriguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0; Graham P, 2017, CURR TOP DEV BIOL, V121, P397, DOI 10.1016/bs.ctdb.2016.07.011; Han J, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.591161; Hassan A, 2020, CUREUS, V12, DOI 10.7759/cureus.9853; Hong CT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030740; Jain D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138535; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Jang Y, 2017, EXP NEUROBIOL, V26, P104, DOI 10.5607/en.2017.26.2.104; Sanz FJ, 2017, FREE RADICAL BIO MED, V108, P683, DOI 10.1016/j.freeradbiomed.2017.04.364; Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001; Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821; Lavara-Culebras E, 2010, GENE, V462, P26, DOI 10.1016/j.gene.2010.04.009; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liguori F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011295; Lilao-Garzon J, 2021, ADV EXP MED BIOL, V1307, P553, DOI 10.1007/5584_2020_536; Lu M, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw047; Maiti P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0099-z; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018292; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mencke P, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020347; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Molina-Mateo D, 2017, BBA-MOL BASIS DIS, V1863, P2882, DOI 10.1016/j.bbadis.2017.07.013; Mor DE, 2020, P NATL ACAD SCI USA, V117, P26438, DOI 10.1073/pnas.2009838117; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Munoz-Soriano V, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/520640; Murillo-Maldonado JM, 2011, DIABETES, V60, P1632, DOI 10.2337/db10-1288; Navarro JA, 2014, J NEUROCHEM, V131, P369, DOI 10.1111/jnc.12818; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Paudel YN, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104593; Renaud J, 2018, NEUROBIOL AGING, V69, P117, DOI 10.1016/j.neurobiolaging.2018.05.010; Renaud J, 2014, NEUROTOX RES, V25, P110, DOI 10.1007/s12640-013-9439-7; Requejo-Aguilar R, 2015, BIOCHEM J, V467, P303, DOI 10.1042/BJ20141025; Rocha KMA., 2021, RES SOC DEV, V10, DOI [10.33448/rsd-v10i1.11673, DOI 10.33448/RSD-V10I1.11673]; Rose SJ, 2017, MOVEMENT DISORD, V32, P1694, DOI 10.1002/mds.27169; Sanz FJ., 2021, NEUROTHERAPEUTICS, V2021, P1; Sharma T, 2021, NEUROSCI LETT, V749, DOI 10.1016/j.neulet.2021.135754; Solana-Manrique Cristina, 2022, Cells, V11, DOI 10.3390/cells11030331; Solana-Manrique C, 2020, FREE RADICAL BIO MED, V158, P137, DOI 10.1016/j.freeradbiomed.2020.06.036; Sonninen TM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71329-8; Standl E, 2019, EUR J PREV CARDIOL, V26, P7, DOI 10.1177/2047487319881021; Strobbe D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00068; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teleman AA, 2012, EXP CLIN ENDOCR DIAB, V120, P184, DOI 10.1055/s-0032-1304566; Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y; Wu R, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.54; Xiong YL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00228; Yasugi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01754-9; Zhang XL, 2019, BRAIN RES BULL, V146, P228, DOI 10.1016/j.brainresbull.2019.01.007; Zhang Y, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2021-002337	73	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22432	10.1096/fj.202200286R	http://dx.doi.org/10.1096/fj.202200286R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2M8OV	35766235	Green Published			2022-12-28	WOS:000817953200001
J	Baxter, M; Poolman, T; Cunningham, P; Hunter, L; Voronkov, M; Kitchen, GB; Goosey, L; Begley, N; Kay, D; Hespe, A; Maidstone, R; Loudon, ASI; Ray, DW				Baxter, Matthew; Poolman, Toryn; Cunningham, Peter; Hunter, Louise; Voronkov, Maria; Kitchen, Gareth B.; Goosey, Laurence; Begley, Nicola; Kay, Danielle; Hespe, Abby; Maidstone, Robert; Loudon, Andrew S., I; Ray, David W.			Circadian clock function does not require the histone methyltransferase MLL3	FASEB JOURNAL			English	Article						circadian; clock; epigenetics; histone; inflammation; KMT2C; methyltransferase; MLL3	H3K4 MONOMETHYLATION; TRANSCRIPTION; ALPHA; ACETYLATION; MACROPHAGES; ENHANCERS; PROTEINS; ROLES	The circadian clock controls the physiological function of tissues through the regulation of thousands of genes in a cell-type-specific manner. The core cellular circadian clock is a transcription-translation negative feedback loop, which can recruit epigenetic regulators to facilitate temporal control of gene expression. Histone methyltransferase, mixed lineage leukemia gene 3 (MLL3) was reported to be required for the maintenance of circadian oscillations in cultured cells. Here, we test the role of MLL3 in circadian organization in whole animals. Using mice expressing catalytically inactive MLL3, we show that MLL3 methyltransferase activity is in fact not required for circadian oscillations in vitro in a range of tissues, nor for the maintenance of circadian behavioral rhythms in vivo. In contrast to a previous report, loss of MLL3-dependent methylation did not affect the global levels of H3K4 methylation in liver, indicating substantial compensation from other methyltransferases. Furthermore, we found little evidence of genomic repositioning of H3K4me3 marks. We did, however, observe repositioning of H3K4me1 from intronic regions to intergenic regions and gene promoters; however, there were no changes in H3K4me1 mark abundance around core circadian clock genes. Output functions of the circadian clock, such as control of inflammation, were largely intact in MLL3-methyltransferase-deficient mice, although some gene-specific changes were observed, with sexually dimorphic loss of circadian regulation of specific cytokines. Taken together, these observations indicate that MLL3-directed histone methylation is not essential for core circadian clock function; however, it may influence the inflammatory response.	[Baxter, Matthew; Poolman, Toryn; Voronkov, Maria; Kay, Danielle; Hespe, Abby; Maidstone, Robert; Ray, David W.] John Radcliffe Hosp, NHIR Oxford Biomed Res Ctr, Oxford, England; [Baxter, Matthew; Poolman, Toryn; Voronkov, Maria; Kay, Danielle; Hespe, Abby; Maidstone, Robert; Ray, David W.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Cunningham, Peter; Hunter, Louise; Kitchen, Gareth B.; Goosey, Laurence; Begley, Nicola; Loudon, Andrew S., I] Univ Manchester, Ctr Biol Timing, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Oxford; University of Oxford; University of Manchester	Baxter, M; Ray, DW (corresponding author), John Radcliffe Hosp, NHIR Oxford Biomed Res Ctr, Oxford, England.	matthew.baxter@cardiov.ox.ac.uk; david.ray@ocdem.ox.ac.uk	Maidstone, Robert/GOH-0414-2022	Maidstone, Robert/0000-0002-3482-3246; Hunter, Ann Louise/0000-0002-3874-4852; Loudon, Andrew/0000-0003-3648-445X; Kitchen, Gareth/0000-0001-5070-3183; Baxter, Matthew/0000-0002-3612-2574; Poolman, Toryn/0000-0002-7427-6603	Wellcome Trust [107849/Z/15/Z, 107851/Z/15/2]	Wellcome Trust(Wellcome Trust)	Wellcome Trust, Grant/Award Number: 107849/Z/15/Z and 107851/Z/15/2	Baxter M, 2020, IMMUNOLOGY, V161, P261, DOI 10.1111/imm.13166; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caratti G, 2018, J CLIN INVEST, V128, P4454, DOI 10.1172/JCI96138; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cunningham PS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29983; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hunter AL, 2020, P NATL ACAD SCI USA, V117, P25869, DOI 10.1073/pnas.2005330117; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kitchen GB, 2021, FASEB J, V35, DOI 10.1096/fj.202100044RRR; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kwapis JL., 2018, NAT COMMUN, V91, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee S, 2009, PROG MOL BIOL TRANSL, V87, P343, DOI 10.1016/S1877-1173(09)87010-5; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Quagliarini F, 2019, MOL CELL, V76, P531, DOI 10.1016/j.molcel.2019.10.007; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rickels R, 2020, GENE DEV, V34, P1493, DOI 10.1101/gad.339762.120; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Stratmann M, 2012, MOL CELL, V48, P277, DOI 10.1016/j.molcel.2012.08.012; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094; Zhong YB, 2018, NUCLEIC ACIDS RES, V46, P3382, DOI 10.1093/nar/gky101	47	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22356	10.1096/fj.202200368R	http://dx.doi.org/10.1096/fj.202200368R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2C9IA	35704036	hybrid, Green Published			2022-12-28	WOS:000811171300001
J	Gao, S; Li, N; Wang, Y; Lin, ZJ; Zhu, YJ; Xu, JM; Zhang, Q; Zhu, CH; Zhou, YM; Zhou, J; Shen, X				Gao, Shuang; Li, Na; Wang, Yanuo; Lin, Zhongjing; Zhu, Yanji; Xu, Jianmin; Zhang, Qiong; Zhu, Caihong; Zhou, Yingming; Zhou, Jia; Shen, Xi			Inhibition of vascular endothelial growth factor alleviates neovascular retinopathy with regulated neurotrophic/proinflammatory cytokines through the modulation of DBI-TSPO signaling	FASEB JOURNAL			English	Article						diazepam binding inhibitor; microglial cell; Muller cell; translocator protein (18 kDa); vascular endothelial growth factor	PROLIFERATIVE DIABETIC-RETINOPATHY; OXYGEN-INDUCED RETINOPATHY; PROTEIN 18 KDA; MULLER CELLS; RETINAL NEURONS; MOUSE MODEL; MICROGLIA; VEGF; EXPRESSION; GLIA	Diazepam binding inhibitor (DBI)-translocator protein (18kDa) (TSPO) signaling in the retina was reported to possess coordinated macroglia-microglia interactions. We investigated DBI-TSPO signaling and its correlation with vascular endothelial growth factor (VEGF), neurotrophic or inflammatory cytokines in neovascular retinopathy, and under hypoxic conditions. The vitreous expression of DBI, VEGF, nerve growth factor (NGF), and interleukin-1beta (IL-1 beta) were examined in proliferative diabetic retinopathy (PDR) patients with or without anti-VEGF therapy and nondiabetic controls. Retinal DBI-TSPO signaling and the effect of the anti-VEGF agent were evaluated in a mouse model of oxygen-induced retinopathy (OIR). Interactions between Muller cell-derived VEGF and DBI, as well as cocultured microglial cells under hypoxic conditions, were studied, using Western blot, real-time RT-PCR, enzyme-linked immunosorbent assay (ELISA), flow cytometry, and immunofluorescent labeling. Results showed that vitreous levels of DBI, VEGF, NGF, and IL-1 beta were significantly higher in PDR patients compared with controls, which further changed after anti-VEGF therapy. A statistical association was found between vitreous DBI and VEGF, NGF, IL-1 beta, and age. The application of the anti-VEGF agent in the OIR model induced retinal expression of DBI and NGF, and attenuated inflammation and microglial cell activation. Inhibition of Muller cell-derived VEGF could increase its DBI expression under hypoxic conditions, while the DBI-TSPO signaling pathway is essential for anti-VEGF agents exerting anti-inflammatory and neuroprotective effects, as well as limiting inflammatory magnitude, promoting its neurotrophin production and anti-inflammatory (M2) polarization in microglial cells. These findings suggest the beneficial effect of anti-VEGF therapy on inflammation and neurotrophy of retinal glial cells through modulation of the DBI-TSPO signaling pathway.	[Gao, Shuang; Li, Na; Wang, Yanuo; Zhu, Yanji; Xu, Jianmin; Zhang, Qiong; Zhu, Caihong; Zhou, Yingming; Shen, Xi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Ophthalmol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China; [Lin, Zhongjing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Zhou, Jia] Shanghai Jiao Tong Univ, Sch Med, LuWan Branch, Dept Ophthalmol,Ruijin Hosp, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Ophthalmol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.; Zhou, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, LuWan Branch, Dept Ophthalmol,Ruijin Hosp, Shanghai 200025, Peoples R China.	irench@163.com; carl_shen2005@126.com			National Nature Science Foundation of China [81970805]; Science and Technology Commission of Shanghai Municipality [18411964900]; Shanghai Municipal Health Commission [201840193]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Health Commission	This work was supported by the National Nature Science Foundation of China [grant number 81970805]; Science and Technology Commission of Shanghai Municipality [grant number 18411964900]; and Shanghai Municipal Health Commission [grant number 201840193].	AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Akkoyun I, 2012, ACTA OPHTHALMOL, V90, P564, DOI 10.1111/j.1755-3768.2010.01963.x; Altmann C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010110; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Arroba AI, 2014, ADV EXP MED BIOL, V801, P373, DOI 10.1007/978-1-4614-3209-8_47; Boss JD, 2017, INVEST OPHTH VIS SCI, V58, P5594, DOI 10.1167/iovs.17-21973; Bravo-San Pedro JM, 2019, AUTOPHAGY, V15, P2036, DOI 10.1080/15548627.2019.1662585; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bromberg-White JL, 2013, INVEST OPHTH VIS SCI, V54, P6472, DOI 10.1167/iovs.13-12518; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; Coughlin BA, 2017, VISION RES, V139, P93, DOI 10.1016/j.visres.2017.03.013; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gallina D, 2015, EXP NEUROL, V273, P114, DOI 10.1016/j.expneurol.2015.08.007; Garcia TB, 2017, CYTOKINE GROWTH F R, V34, P43, DOI 10.1016/j.cytogfr.2016.11.005; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Martinez-Zapata MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008721.pub2; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Lanfray D, 2013, DIABETES, V62, P801, DOI 10.2337/db11-0785; Li N, 2019, EXP EYE RES, V187, DOI 10.1016/j.exer.2019.107743; Liu XL, 2010, INVEST OPHTH VIS SCI, V51, P3749, DOI 10.1167/iovs.09-4226; Mages K, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1424-5; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pardue MT, 2018, PROG RETIN EYE RES, V65, P50, DOI 10.1016/j.preteyeres.2018.02.002; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Porcu P, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12351; Portillo JAC, 2017, DIABETES, V66, P483, DOI 10.2337/db16-0051; Rivera JC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3940241; Rocco ML, 2017, GRAEF ARCH CLIN EXP, V255, P567, DOI 10.1007/s00417-016-3567-8; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0422-5; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1931, DOI 10.1097/IAE.0000000000000723; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Ting DSW, 2017, LANCET, V389, P2165, DOI 10.1016/S0140-6736(17)31194-7; Tonon MC, 2020, PHARMACOL THERAPEUT, V208, DOI 10.1016/j.pharmthera.2019.06.008; Tuisku J, 2019, EUR J NUCL MED MOL I, V46, P2329, DOI 10.1007/s00259-019-04403-7; VanGuilder HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016271; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Veiga S, 2007, GLIA, V55, P1426, DOI 10.1002/glia.20558; Wang J, 2016, MOL VIS, V22, P254; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang MH, 2014, ADV EXP MED BIOL, V801, P333, DOI 10.1007/978-1-4614-3209-8_42; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22367	10.1096/fj.202101294RRR	http://dx.doi.org/10.1096/fj.202101294RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1SE	35639422				2022-12-28	WOS:000803156600001
J	Richter, B; Kapanadze, T; Weingartner, N; Walter, S; Vogt, I; Grund, A; Schmitz, J; Brasen, JH; Limbourg, FP; Haffner, D; Leifheit-Nestler, M				Richter, Beatrice; Kapanadze, Tamar; Weingaertner, Nina; Walter, Stefanie; Vogt, Isabel; Grund, Andrea; Schmitz, Jessica; Braesen, Jan Hinrich; Limbourg, Florian P.; Haffner, Dieter; Leifheit-Nestler, Maren			High phosphate-induced progressive proximal tubular injury is associated with the activation of Stat3/Kim-1 signaling pathway and macrophage recruitment	FASEB JOURNAL			English	Article						fibroblast growth factor 23; inflammation; macrophages; parathyroid hormone; phosphate; proximal tubular injury; STAT3	DIETARY PHOSPHORUS INTAKE; GROWTH-FACTOR 23; KIDNEY INJURY; SERUM PHOSPHATE; FACTOR RECEPTOR; FOOD-ADDITIVES; HEALTH IMPACT; RENAL-DISEASE; MORTALITY; MOLECULE-1	Dietary phosphate intake in the Western population greatly exceeds the recommended dietary allowance and is linked to enhanced cardiovascular and all-cause mortality. It is unclear whether a chronic high phosphate diet (HPD) causes kidney injury in healthy individuals. Here, we show that feeding a 2% HPD in C57BL/6N mice for one up to six months resulted in hyperphosphatemia, hyperphosphaturia, increased plasma levels of fibroblast growth factor (FGF) 23, and parathyroid hormone (PTH) compared to mice on a 0.8% phosphate diet. Kidney injury was already noted after two months of HPD characterized by loss of proximal tubular (PT) cell polarity, flattened epithelia, disruption of brush border membranes, vacuolization, increased PT cell proliferation, marked interstitial mononuclear infiltration, and progressive accumulation of collagen fibers. HPD increased Stat3 activation and Kim-1 expression in PT epithelial cells and enhanced renal synthesis of chemokines recruiting monocytes and macrophages as well as macrophage related factors. Enhanced recruitment of F4/80(+) macrophages around injured PT lesions was timely associated with increased Kim-1 synthesis, tubular MCP-1 expression, and degree of PT injury score. Likewise, tubulointerstitial fibrosis was associated with activation of Stat3/Kim-1 signaling pathway. The stimulation of human proximal tubular cells with high phosphate activated Stat3 signaling and induced HAVCR1 and CCL2 expression. We conclude that high phosphate results in progressive proximal tubular injury, indicating that high dietary phosphate intake may affect kidney health and therefore represents an underestimated health problem for the general population.	[Richter, Beatrice; Weingaertner, Nina; Walter, Stefanie; Vogt, Isabel; Grund, Andrea; Haffner, Dieter; Leifheit-Nestler, Maren] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Pediat Res Ctr, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Kapanadze, Tamar; Limbourg, Florian P.] Hannover Med Sch, Dept Nephrol & Hypertens, Hannover, Germany; [Kapanadze, Tamar; Limbourg, Florian P.] Hannover Med Sch, Vasc Med Res, Hannover, Germany; [Schmitz, Jessica; Braesen, Jan Hinrich] Hannover Med Sch, Inst Pathol, Nephropathol Unit, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Leifheit-Nestler, M (corresponding author), Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Pediat Res Ctr, Carl Neuberg Str 1, D-30625 Hannover, Germany.	leifheit-nestler.maren@mh-hannover.de		Richter, Beatrice/0000-0002-3550-8571; Brasen, Jan Hinrich/0000-0002-2863-3067; Haffner, Dieter/0000-0002-9601-7813; Limbourg, Florian/0000-0002-8313-7226	Deutsche Forschungsgemeinschaft (DFG) [Li948-7/1]; Hannover Medical School	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hannover Medical School	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: Li948-7/1; Hannover Medical School, Grant/Award Number: HilF/LifeScience Stiftung Munchen	Ajay AK, 2014, J AM SOC NEPHROL, V25, P105, DOI 10.1681/ASN.2013020161; Alderson HV, 2016, CLIN J AM SOC NEPHRO, V11, P2141, DOI 10.2215/CJN.02670316; Amdur RL, 2016, CLIN J AM SOC NEPHRO, V11, P1546, DOI 10.2215/CJN.13121215; [Anonymous], 2021, PROP MAX LEV ADD PHO; Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bhatraju PK, 2018, J AM SOC NEPHROL, V29, P2713, DOI [10.1681/ASN.2018070719, 10.1681/asn.2018070719]; Bon N, 2018, MOL METAB, V11, P197, DOI 10.1016/j.molmet.2018.02.007; Bon N, 2018, J BIOL CHEM, V293, P2102, DOI 10.1074/jbc.M117.807339; Bozic M, 2022, NEPHROL DIAL TRANSPL, V37, P663, DOI 10.1093/ndt/gfab184; Calvo MS, 2019, AM J KIDNEY DIS, V73, P542, DOI 10.1053/j.ajkd.2018.11.004; Calvo MS, 2014, ADV NUTR, V5, P104, DOI 10.3945/an.113.004861; Calvo MS, 2013, AM J CLIN NUTR, V98, P6, DOI 10.3945/ajcn.112.053934; Campos-Obando N, 2017, J BONE MINER RES, V32, P1182, DOI 10.1002/jbmr.3094; Chang AR, 2017, ANNU REV NUTR, V37, P321, DOI 10.1146/annurev-nutr-071816-064607; Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Czaya B, 2022, ELIFE, V11, DOI 10.7554/eLife.74782; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Di Iorio BR, 2013, NEPHROL DIAL TRANSPL, V28, P632, DOI 10.1093/ndt/gfs477; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Erem S, 2018, HISTOCHEM CELL BIOL, V150, P711, DOI 10.1007/s00418-018-1711-8; Esquinas P, 2021, CLIN KIDNEY J, V14, P847, DOI 10.1093/ckj/sfaa009; Fan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep39324; Finch JL, 2013, KIDNEY INT, V84, P1145, DOI 10.1038/ki.2013.213; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Francis C, 2019, KIDNEY INT, V96, P1346, DOI 10.1016/j.kint.2019.07.026; Grabner A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02068-6; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2015, J CLIN ENDOCR METAB, V100, P4264, DOI 10.1210/jc.2015-2279; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Hu MC, 2020, NEPHROL DIAL TRANSPL, V35, P411, DOI 10.1093/ndt/gfz156; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Huttunen MM, 2007, J BONE MINER RES, V22, P83, DOI 10.1359/JBMR.061009; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Institute of Medicine (US) Standing Committee on the scientific evaluation of dietary reference intakes, 1997, DIETARY REFERENCE IN; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Krick S, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00236-2018; Kuro-O Makoto, 2021, Clin Sci (Lond), V135, P1915, DOI 10.1042/CS20201453; Lopes AA, 2012, AM J KIDNEY DIS, V60, P90, DOI 10.1053/j.ajkd.2011.12.025; Mancini FR, 2018, CLIN NUTR, V37, P1625, DOI 10.1016/j.clnu.2017.07.025; Manghat P, 2010, OSTEOPOROSIS INT, V21, P1853, DOI 10.1007/s00198-009-1142-4; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Munoz-Castaneda JR, 2017, FASEB J, V31, P3858, DOI 10.1096/fj.201700006R; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Pace J, 2019, AM J PHYSIOL-RENAL, V316, pF1151, DOI 10.1152/ajprenal.00034.2019; Peng XG, 2015, J IMMUNOL, V195, P2797, DOI 10.4049/jimmunol.1403209; Peri-Okonny P, 2019, CIRCULATION, V139, P1422, DOI 10.1161/CIRCULATIONAHA.118.037550; Santamaria R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32065-2; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shiizaki K, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145693; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Smith ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02709-w; Sullivan CM, 2007, J RENAL NUTR, V17, P350, DOI 10.1053/j.jrn.2007.05.008; Takashi Y, 2020, J ENDOCRINOL INVEST, V43, P877, DOI 10.1007/s40618-020-01205-9; Tian L, 2017, CELL PHYSIOL BIOCHEM, V41, P769, DOI 10.1159/000458737; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Ugrica M, 2021, NEPHROL DIAL TRANSPL, V36, P1183, DOI 10.1093/ndt/gfab015; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Vorland CJ, 2017, CURR OSTEOPOROS REP, V15, P473, DOI 10.1007/s11914-017-0398-4; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674	68	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22407	10.1096/fj.202200167RR	http://dx.doi.org/10.1096/fj.202200167RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6GV	35713543				2022-12-28	WOS:000812326100001
J	Chen, JY; Wang, J; Hart, DA; Ahmed, AS; Ackermann, PW				Chen, Junyu; Wang, Jin; Hart, David A.; Ahmed, Aisha S.; Ackermann, Paul W.			Complement factor D as a predictor of Achilles tendon healing and long-term patient outcomes	FASEB JOURNAL			English	Article						Achilles tendon rupture; complement factor D; mass spectrometry; patient-reported; functional outcome; predictive biomarker; prognostic	EXPRESSION; MICRODIALYSIS; REPAIR; SECRETION; TISSUE; CELL	Dense connective tissue healing, such as tendon, is protracted leading to highly variable and unsatisfactory patient outcomes. Biomarkers prognostic of long-term clinical outcomes is, however, unknown. The present study was designed to investigate the proteomic profile of healing, identify potential biomarkers, and assess their association with the patient's long-term outcomes after ATR. Quantitative mass spectrometry analysis demonstrated 1423 proteins in healing and contralateral healthy Achilles tendons of 28 ATR patients. Comparing healing at 2 weeks and healthy protein profiles, we identified 821 overlapping, 390 upregulated, and 17 downregulated proteins. Upregulated proteins are related mainly to extracellular matrix organization and metabolism, while downregulated pathways were associated with exocytosis in immune modulation and thrombosis formation. Further proteomic profiling in relation to validated patient outcomes revealed the downregulated pro-inflammatory complement factor D (CFD) as the most reliable predictive biomarker of successful tendon healing. Our finding showed a comprehensive proteomic landscape and bioinformatics on human connective tissue, indicating subtype-specific and shared biological processes and proteins in healing and healthy Achilles tendons, as well as in tendons related to good and poor patient outcomes. Inflammatory protein CFD and serpin family B member 1 were finally identified as potential predictive biomarkers of effective healing outcomes when combined the proteomic profiles with a validated clinical database. Following the future elucidation of the mechanisms associated with the identified biomarkers as predictors of good outcomes, our findings could lead to improved prognostic accuracy and development of targeted treatments, thus improving the long-term healing outcomes for all patients.	[Chen, Junyu; Ahmed, Aisha S.; Ackermann, Paul W.] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Wang, Jin] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Key Lab Tumor Mol Diag & Individualized Med Zheji, Hangzhou, Peoples R China; [Wang, Jin] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	Karolinska Institutet; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Xi'an Jiaotong University; University of Calgary	Chen, JY; Ackermann, PW (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	junyu.chen@ki.se; paul.ackermann@ki.se			Swedish National Centre for Sports Research [2019-0079, 2020-0019]; Swedish Rheumatism Association [R-931941, R-940565]; King Gustav V Foundation [FAI-2018-0524, FAI-2019-0611]; Swedish Research Council [2017-00202, SLL20180348]	Swedish National Centre for Sports Research; Swedish Rheumatism Association; King Gustav V Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Swedish National Centre for Sports Research (2019-0079; 2020-0019), Swedish Rheumatism Association (R-931941; R-940565), and King Gustav V Foundation (FAI-2018-0524; FAI-2019-0611) to ASA. The Swedish Research Council (2017-00202) and the regional agreement on medical training and clinical research (ALF; SLL20180348) to PWA.	Ackermann PW, 2013, KNEE SURG SPORT TR A, V21, P1801, DOI 10.1007/s00167-012-2197-x; Alim MA, 2018, KNEE SURG SPORT TR A, V26, P2021, DOI 10.1007/s00167-017-4621-8; Alim MA., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2016-000114, DOI 10.1136/BMJSEM-2016-000114]; BALKE N, 1995, FEBS LETT, V371, P300, DOI 10.1016/0014-5793(95)00926-Z; Baraldo M, 2021, FASEB J, V35, DOI 10.1096/fj.202101054RR; Barratt J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.712572; Benarafa C, 2011, J LEUKOCYTE BIOL, V90, P21, DOI 10.1189/jlb.0810461; Bennet D, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.461; Bostick GP, 2010, J ORTHOP SPORT PHYS, V40, P345, DOI 10.2519/jospt.2010.3204; Dams OC, 2020, KNEE SURG SPORT TR A, V28, P3330, DOI 10.1007/s00167-020-05924-7; de la Pena A, 2000, ADV DRUG DELIVER REV, V45, P189, DOI 10.1016/S0169-409X(00)00106-X; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Ezure T, 2019, BIOFACTORS, V45, P556, DOI 10.1002/biof.1512; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Greve K, 2012, SCAND J MED SCI SPOR, V22, pE55, DOI 10.1111/j.1600-0838.2012.01475.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hajian-Tilaki KO, 2011, MED ONCOL, V28, P1296, DOI 10.1007/s12032-010-9629-6; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006; Justet C, 2015, CELL TISSUE RES, V362, P557, DOI 10.1007/s00441-015-2223-7; Karki RG, 2019, J MED CHEM, V62, P4656, DOI 10.1021/acs.jmedchem.9b00271; Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]; Li JP, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-019-0252-7; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lopez-Perez SJ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0117-3; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; O'Brien EJO, 2012, INT J EXP PATHOL, V93, P319, DOI 10.1111/j.1365-2613.2012.00829.x; Olesen JL, 2006, SCAND J RHEUMATOL, V35, P312, DOI 10.1080/03009740600556373; Olsson N, 2014, AM J SPORT MED, V42, P1448, DOI 10.1177/0363546514527409; Pillitteri D, 2007, PLATELETS, V18, P119, DOI 10.1080/09537100600800792; Qu FN, 2019, NAT REV RHEUMATOL, V15, P167, DOI 10.1038/s41584-018-0151-0; Qu FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01955-w; Sato N, 2016, J PROTEOME RES, V15, P4709, DOI 10.1021/acs.jproteome.6b00806; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svedman S, 2018, AM J SPORT MED, V46, P2929, DOI 10.1177/0363546518793655; Uchiyama K, 2012, AM J PHYSIOL-GASTR L, V302, pG1163, DOI 10.1152/ajpgi.00292.2011; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wang C, 2019, J BONE JOINT SURG AM, V101, P2226, DOI 10.2106/JBJS.18.01483; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Wang Y, 2021, J PERIODONTOL, V92, P863, DOI 10.1002/JPER.20-0397; Zhou HJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015275	44	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22365	10.1096/fj.202200200RR	http://dx.doi.org/10.1096/fj.202200200RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9AI	35596679				2022-12-28	WOS:000798204000001
J	Li, PP; Liu, ZY; Wang, JP; Bi, XL; Xiao, Y; Qiao, RF; Zhou, XC; Guo, SW; Wan, PF; Chang, M; Hong, GD; Liu, ZS; Ming, X; Gao, JG; Fu, XL				Li, Peipei; Liu, Ziyi; Wang, Jinpeng; Bi, Xiuli; Xiao, Yu; Qiao, Ruifeng; Zhou, Xuanchen; Guo, Siwei; Wan, Peifeng; Chang, Miao; Hong, Guodong; Liu, Zhangsuo; Ming, Xia; Gao, Jiangang; Fu, Xiaolong			Gstm1/Gstt1 is essential for reducing cisplatin ototoxicity in CBA/CaJ mice	FASEB JOURNAL			English	Article						cisplatin; Gstm1; Gstt1; hair cells; hearing	GLUTATHIONE-S-TRANSFERASE; OUTER HAIR CELL; GENE POLYMORPHISMS; NULL GENOTYPES; RISK-FACTORS; NRF2 TARGET; GSTM1; GSTT1; INDUCTION; EXPRESSION	Cisplatin is a widely used chemotherapeutic agent. However, its clinical utility is limited because of cisplatin-induced ototoxicity. Glutathione S-transferase (GST) was found to play a vital role in reducing cisplatin ototoxicity in mice. Deletion polymorphisms of GSTM1 and GSTT1, members of the GST family, are common in humans and are presumed to be associated with cisplatin-induced hearing impairment. However, the specific roles of GSTM1 and GSTT1 in cisplatin ototoxicity are not completely clear. Here, under cisplatin treatment, simultaneous deletion of Gstm1 and Gstt1 lead to a more profound hearing loss in CBA/CaJ mice (Gstm1/Gstt1-DKO) than in wild-type mice. The Gstm1/Gstt1-DKO mice, in which phase II detoxification genes were upregulated, exhibited more severe oxidative stress and higher outer hair cell apoptosis in the cochleae than the control mice. Thus, our study revealed that Gstm1 and Gstt1 protect auditory hair cells from cisplatin-induced ototoxicity in the CBA/CaJ mice, and genetic screening for GSTM1 and GSTT1 polymorphisms could help determine a standard cisplatin dose for cancer patients undergoing chemotherapy.	[Li, Peipei; Liu, Zhangsuo] Zhengzhou Univ, Dept Integrated Tradit & Western Nephrol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Li, Peipei; Liu, Zhangsuo] Zhengzhou Univ, Affiliated Hosp 1, Henan Prov Res Ctr Kidney Dis, Zhengzhou, Peoples R China; [Liu, Ziyi; Bi, Xiuli; Qiao, Ruifeng; Chang, Miao; Gao, Jiangang; Fu, Xiaolong] Shandong First Med Univ, Shandong Prov Hosp, Jinan, Peoples R China; [Wang, Jinpeng] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistant Biol Shandong Prov, Jinan, Peoples R China; [Xiao, Yu; Guo, Siwei; Wan, Peifeng] Shandong Univ, Sch Life Sci, Qingdao, Peoples R China; [Zhou, Xuanchen; Ming, Xia; Fu, Xiaolong] Shandong First Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Shandong Prov Hosp, Jinan, Peoples R China; [Hong, Guodong; Fu, Xiaolong] Southeast Univ, Zhongda Hosp,Jiangsu Prov High Tech Key Lab Biome, Sch Life Sci & Technol,Dept Otolaryngol Head & Ne, Adv Inst Life & Hlth,State Key Lab Bioelect, Nanjing, Peoples R China	Zhengzhou University; Zhengzhou University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong Normal University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Southeast University - China	Gao, JG; Fu, XL (corresponding author), Shandong First Med Univ, Shandong Prov Hosp, Jinan, Peoples R China.	jggao@sdfmu.edu.cn; fuxiaolongshifan@163.com	Liu, ziyi/HHM-8313-2022; Zhou, Xuanchen/GXG-0014-2022		National Science Foundation of China [82171162, 81900937]; National Key R&D Program of China [2019YFA0111400]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	National Science Foundation of China, Grant/Award Number: 82171162 and 81900937; National Key R&D Program of China, Grant/Award Number: 2019YFA0111400	Atmaca N, 2014, FOOD CHEM TOXICOL, V70, P191, DOI 10.1016/j.fct.2014.05.011; Barahmani N, 2009, NEURO-ONCOLOGY, V11, P292, DOI 10.1215/15228517-2008-089; Bates DE, 2002, ANN PHARMACOTHER, V36, P446, DOI 10.1345/aph.1A216; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; BOARD PG, 1981, AM J HUM GENET, V33, P36; Budai B, 2020, J MOL MED, V98, P963, DOI 10.1007/s00109-020-01921-y; Casares C, 2012, EUR ARCH OTO-RHINO-L, V269, P2455, DOI 10.1007/s00405-012-2029-0; Chang J, 2013, AM J PHYSIOL-RENAL, V304, pF348, DOI 10.1152/ajprenal.00568.2012; Chanhom N, 2020, BIOMED REP, V12, P153, DOI 10.3892/br.2020.1275; CLERICI WJ, 1995, HEARING RES, V84, P30, DOI 10.1016/0378-5955(95)00010-2; da Silva Claudio Nunes, 2015, J Bras Nefrol, V37, P248, DOI 10.5935/0101-2800.20150038; Ding B, 2014, EUR J OBSTET GYN R B, V183, P114, DOI 10.1016/j.ejogrb.2014.10.032; Dinh CT, 2015, OTOL NEUROTOL, V36, P1566, DOI 10.1097/MAO.0000000000000849; Fuciarelli M, 2009, ARCH TOXICOL, V83, P115, DOI 10.1007/s00204-008-0334-6; Fuertes MA, 2003, CHEM REV, V103, P645, DOI 10.1021/cr020010d; Goncalves MS, 2013, J LARYNGOL OTOL, V127, P536, DOI 10.1017/S0022215113000947; Gronau S, 2003, OTOLARYNG HEAD NECK, V128, P674, DOI 10.1016/S0194-5998(03)00176-1; Hasan S, 2015, TUMOR BIOL, V36, P5195, DOI 10.1007/s13277-015-3175-y; Henderson CJ, 2011, DRUG METAB REV, V43, P152, DOI 10.3109/03602532.2011.562900; Honkura Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19329; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; IKEDA K, 1993, ACTA OTO-LARYNGOL, V113, P137, DOI 10.3109/00016489309135781; Im GJ, 2015, HEARING RES, V330, P113, DOI 10.1016/j.heares.2015.08.004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Josephy PD., 2010, HUM GENOMICS PROTEOM, V2010, P876940, DOI [10.4061/2010/876940, DOI 10.4061/2010/876940]; Kalcioglu MT, 2005, EUR ARCH OTO-RHINO-L, V262, P856, DOI 10.1007/s00405-004-0909-7; Kim SJ, 2015, TOXICOL APPL PHARM, V288, P192, DOI 10.1016/j.taap.2015.07.014; Klis SFL, 2000, NEUROREPORT, V11, P623, DOI 10.1097/00001756-200002280-00037; Knight TR, 2007, TOXICOL SCI, V100, P513, DOI 10.1093/toxsci/kfm233; Konig-Greger D, 2004, OTOLARYNG HEAD NECK, V130, P718, DOI 10.1016/j.otohns.2003.10.011; Kruger M, 2015, CLIN ORAL INVEST, V19, P1791, DOI 10.1007/s00784-015-1400-0; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; LaPensee EW, 2009, CARCINOGENESIS, V30, P1298, DOI 10.1093/carcin/bgp120; Li SL, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0792-3; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Masood N, 2013, ASIAN PAC J CANCER P, V14, P3535, DOI 10.7314/APJCP.2013.14.6.3535; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Monteiro TP, 2012, J CLIN PHARM THER, V37, P712, DOI 10.1111/j.1365-2710.2012.01368.x; Mukherjea D, 2011, EXPERT OPIN DRUG DIS, V6, P491, DOI 10.1517/17460441.2011.562887; Mukherjea D, 2011, ANTIOXID REDOX SIGN, V14, P999, DOI 10.1089/ars.2010.3497; Mukherjea D, 2008, J NEUROSCI, V28, P13056, DOI 10.1523/JNEUROSCI.1307-08.2008; Nho JH, 2018, TOX RESEARCH, V34, P133, DOI 10.5487/TR.2018.34.2.133; Oldenburg J, 2007, J CLIN ONCOL, V25, P708, DOI 10.1200/JCO.2006.08.9599; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Park HJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12073-0; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Polimanti R, 2013, GENE, V512, P102, DOI 10.1016/j.gene.2012.09.113; Rosell Rafael, 2003, Cancer Control, V10, P297; RUEDI L, 1952, LARYNGOSCOPE, V62, P333; Rybak LP, 2009, TOHOKU J EXP MED, V219, P177, DOI 10.1620/tjem.219.177; Saitou Marie, 2015, Asian Pac J Cancer Prev, V16, P355; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Simic T, 2006, AMINO ACIDS, V30, P495, DOI 10.1007/s00726-006-0329-7; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; SRIVASTAVA PK, 1993, BIOCHEM J, V294, P159, DOI 10.1042/bj2940159; Sweeney C, 2000, CANCER EPIDEM BIOMAR, V9, P449; Teitz T, 2018, J EXP MED, V215, P1187, DOI 10.1084/jem.20172246; Truong MT, 2007, INT J PEDIATR OTORHI, V71, P1631, DOI 10.1016/j.ijporl.2007.06.021; Tsukasaki N, 2000, HEARING RES, V149, P189, DOI 10.1016/S0378-5955(00)00182-9; van Ruijven MWM, 2005, HEARING RES, V205, P241, DOI 10.1016/j.heares.2005.03.023; van Ruijven MWM, 2004, HEARING RES, V197, P44, DOI 10.1016/j.heares.2004.07.014; Wang XJ, 2014, GENE, V533, P48, DOI 10.1016/j.gene.2013.10.004; Watanabe KI, 2002, ANTICANCER RES, V22, P4081; WIENCKE JK, 1995, CANCER EPIDEM BIOMAR, V4, P253; Wisnovsky SP, 2013, CHEM BIOL, V20, P1323, DOI 10.1016/j.chembiol.2013.08.010; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Zou W, 2013, ENVIRON SCI TECHNOL, V47, P12434, DOI 10.1021/es401791s	71	0	0	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22373	10.1096/fj.202200324R	http://dx.doi.org/10.1096/fj.202200324R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4IL	35621716				2022-12-28	WOS:000800621000001
J	Haider, P; Kral-Pointner, JB; Salzmann, M; Moik, F; Bleichert, S; Schrottmaier, WC; Kaun, C; Brekalo, M; Fischer, MB; Speidl, WS; Hengstenberg, C; Podesser, BK; Huber, K; Pabinger, I; Knapp, S; Brombacher, F; Brostjan, C; Ay, C; Wojta, J; Hohensinner, PJ				Haider, Patrick; Kral-Pointner, Julia B.; Salzmann, Manuel; Moik, Florian; Bleichert, Sonja; Schrottmaier, Waltraud C.; Kaun, Christoph; Brekalo, Mira; Fischer, Michael B.; Speidl, Walter S.; Hengstenberg, Christian; Podesser, Bruno K.; Huber, Kurt; Pabinger, Ingrid; Knapp, Sylvia; Brombacher, Frank; Brostjan, Christine; Ay, Cihan; Wojta, Johann; Hohensinner, Philipp J.			Interleukin-4 receptor alpha signaling regulates monocyte homeostasis	FASEB JOURNAL			English	Article						homeostasis; immunity; innate; interleukin-4; monocytes; receptors; signal transduction	VENOUS THROMBOEMBOLISM; UNIQUE FUNCTIONS; MACROPHAGES; ACTIVATION; IL-4; CANCER; MICE; SURVIVAL	Interleukin-4 (IL-4) and its receptors (IL-4R) promote the proliferation and polarization of macrophages. However, it is unknown if IL-4R also influences monocyte homeostasis and if steady state IL-4 levels are sufficient to affect monocytes. Employing full IL-4 receptor alpha knockout mice (IL-4R alpha(-/-)) and mice with a myeloid-specific deletion of IL-4R alpha (IL-4R alpha(f/f) LysM(cre)), we show that IL-4 acts as a homeostatic factor regulating circulating monocyte numbers. In the absence of IL-4R alpha, murine monocytes in blood were reduced by 50% without altering monocytopoiesis in the bone marrow. This reduction was accompanied by a decrease in monocyte-derived inflammatory cytokines in the plasma. RNA sequencing analysis and immunohistochemical staining of splenic monocytes revealed changes in mRNA and protein levels of anti-apoptotic factors including BIRC6 in IL-4R alpha(-/-) knockout animals. Furthermore, assessment of monocyte lifespan in vivo measuring BrdU(+) cells revealed that the lifespan of circulating monocytes was reduced by 55% in IL-4R alpha(-/-) mice, whereas subcutaneously applied IL-4 prolonged it by 75%. Treatment of human monocytes with IL-4 reduced the amount of dying monocytes in vitro. Furthermore, IL-4 stimulation reduced the phosphorylation of proteins involved in the apoptosis pathway, including the phosphorylation of the NF kappa Bp65 protein. In a cohort of human patients, serum IL-4 levels were significantly associated with monocyte counts. In a sterile peritonitis model, reduced monocyte counts resulted in an attenuated recruitment of monocytes upon inflammatory stimulation in IL-4R alpha(f/f) LysM(cre) mice without changes in overall migratory function. Thus, we identified a homeostatic role of IL-4R alpha in regulating the lifespan of monocytes in vivo.	[Haider, Patrick; Kral-Pointner, Julia B.; Salzmann, Manuel; Kaun, Christoph; Brekalo, Mira; Speidl, Walter S.; Hengstenberg, Christian; Wojta, Johann; Hohensinner, Philipp J.] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Kral-Pointner, Julia B.; Podesser, Bruno K.; Wojta, Johann; Hohensinner, Philipp J.] Ludwig Boltzmann Inst Cardiovasc Res, Vienna, Austria; [Moik, Florian; Pabinger, Ingrid; Ay, Cihan] Med Univ Vienna, Comprehens Canc Ctr, Dept Internal Med 1, Div Haematol & Haemostaseol, Vienna, Austria; [Bleichert, Sonja; Brostjan, Christine] Med Univ Vienna, Dept Gen Surg, Vis Vasc Surg, Vienna, Austria; [Schrottmaier, Waltraud C.] Med Univ Vienna, Inst Vasc Biol & Thrombosis Res, Vienna, Austria; [Fischer, Michael B.] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Fischer, Michael B.] Danube Univ Krems, Dept Biomed Res, Krems, Austria; [Podesser, Bruno K.; Hohensinner, Philipp J.] Med Univ Vienna, Ctr Biomed Res, Vienna, Austria; [Huber, Kurt] Wilhelminenhosp, Dept Med Cardiol & Intens Care Med 3, Vienna, Austria; [Huber, Kurt] Sigmund Freud Univ, Med Fac, Vienna, Austria; [Knapp, Sylvia] Med Univ Vienna, Dept Internal Med 1, Lab Infect Biol, Vienna, Austria; [Brombacher, Frank] Int Ctr Genet & Biotechnol Cape Town Component, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Cape Town, South Africa; [Wojta, Johann] Med Univ Vienna, Core Facil, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Danube University Krems; Medical University of Vienna; Wilhelminenspital; Medical University of Vienna; University of Cape Town; University of Cape Town; Medical University of Vienna	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	johann.wojta@meduniwien.ac.at	Schrottmaier, Waltraud Cornelia/ADY-2164-2022	Schrottmaier, Waltraud Cornelia/0000-0003-0550-4120; Salzmann, Manuel/0000-0001-5477-3533; Brostjan, Christine/0000-0003-1462-5397	Austrian Science Fund (FWF) [SFB54]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (FWF), Grant/Award Number: SFB54	Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Bitton A, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2938; Celik MO, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133093; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Dalmasso AP, 2014, J BIOL CHEM, V289, P838, DOI 10.1074/jbc.M113.455766; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ensembl, 2018, MM10 MUR REF GEN DOW; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Gencode, 2019, MUR GEN ANN DOWNL GE; Genome Aggregation Database (gnomAD), 2021, MORPHEUS; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haider P, 2020, ARTERIOSCL THROM VAS, V40, P2265, DOI 10.1161/ATVBAHA.120.314883; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hohensinner PJ, 2021, BIOCHEM PHARMACOL, V190, DOI 10.1016/j.bcp.2021.114634; Hohensinner PJ, 2021, HAEMATOLOGICA, V106, P454, DOI 10.3324/haematol.2019.220210; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Irvine KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86914; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Mohrs M, 1999, J IMMUNOL, V162, P7302; PRENDIVILLE J, 1993, EUR J CANCER, V29A, P1700, DOI 10.1016/0959-8049(93)90108-R; Punnonen J, 1997, J ALLERGY CLIN IMMUN, V100, P792, DOI 10.1016/S0091-6749(97)70276-8; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Ranasinghe C., 2018, ENCY SIGNALING MOL, P2549; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reinhart R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0754-z; Reitter EM, 2014, CLIN EXP IMMUNOL, V177, P253, DOI 10.1111/cei.12308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thaler B, 2019, BLOOD, V134, P561, DOI 10.1182/blood.2018850420; Uzonna JE, 1998, J IMMUNOL, V161, P5507; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956	41	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22532	10.1096/fj.202101672RR	http://dx.doi.org/10.1096/fj.202101672RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H4LR	36063138	hybrid, Green Published			2022-12-28	WOS:000849852400001
J	Tantengco, OAG; Richardson, LS; Radnaa, E; Kammala, AK; Kim, S; Medina, PMB; Han, A; Menon, R				Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Radnaa, Enkhtuya; Kammala, Ananth Kumar; Kim, Sungjin; Medina, Paul Mark B.; Han, Arum; Menon, Ramkumar			Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip	FASEB JOURNAL			English	Article						microfluidics; mycoplasma; organ-on-a-chip; pregnancy; preterm birth; Ureaplasma parvum infection of the maternal uterine tract	PRETERM PREMATURE RUPTURE; INTRAUTERINE INFECTION; MEMBRANES; PREGNANCY; BIRTH; TERM; CHORIOAMNIONITIS; INFLAMMATION; ASSOCIATION; PARTURITION	Genital mycoplasmas can break the cervical barrier and cause intraamniotic infection and preterm birth. This study developed a six-chamber vagina-cervix-decidua-organ-on-a-chip (VCD-OOC) that recapitulates the female reproductive tract during pregnancy with culture chambers populated by vaginal epithelial cells, cervical epithelial and stromal cells, and decidual cells. Cells cultured in VCD-OOC were characterized by morphology and immunostaining for cell-specific markers. We transferred the media from the decidual cell chamber of the VCD-OOC to decidual cell chamber in feto-maternal interface organ-on-a-chip (FMi-OOC), which contains the fetal membrane layers. An ascending Ureaplasma parvum infection was created in VCD-OOC. U. parvum was monitored for 48 h post-infection with their cytotoxicity (LDH assay) and inflammatory effects (multiplex cytokine assay) in the cells tested. An ascending U. parvum infection model of PTB was developed using CD-1 mice. The cell morphology and expression of cell-specific markers in the VCD-OOC mimicked those seen in lower genital tract tissues. U. parvum reached the cervical epithelial cells and decidua within 48 h and did not cause cell death in VCD-OOC or FMi-OOC cells. U. parvum infection promoted minimal inflammation, while the combination of U. parvum and LPS promoted massive inflammation in the VCD-OOC and FMi-OOC cells. In the animal model, U. parvum vaginal inoculation of low-dose U. parvum did not result in PTB, and even a high dose had only some effects on PTB (20%). However, intra-amniotic injection of U. parvum resulted in 67% PTB. We report the colonization of U. parvum in various cell types; however, inconsistent, and low-grade inflammation across multiple cell types suggests poor immunogenicity induced by U. parvum.	[Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Radnaa, Enkhtuya; Kammala, Ananth Kumar; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Basic Sci & Translat Res, Galveston, TX 77555 USA; [Tantengco, Ourlad Alzeus G.; Medina, Paul Mark B.] Univ Philippines Manila, Coll Med, Dept Biochem & Mol Biol, Biol Models Lab, Manila, Philippines; [Kim, Sungjin; Han, Arum] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Han, Arum] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Han, Arum] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	University of Texas System; University of Texas Medical Branch Galveston; University of the Philippines System; University of the Philippines Manila; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Han, A (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	arum.han@ece.tamu.edu; ra2menon@utmb.edu	; Han, Arum/C-7078-2013	Radnaa, Enkhtuya/0000-0001-8142-8137; Richardson, Lauren/0000-0001-8392-2833; Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Menon, Ramkumar/0000-0001-9213-6105; Medina, Paul Mark/0000-0001-6116-1818; Han, Arum/0000-0002-9223-8301	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD100729]	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: 1R01HD100729	AVERBUCH B, 1995, EUR J OBSTET GYN R B, V62, P25, DOI 10.1016/0301-2115(95)02176-8; De Tomasi JB, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7693183; Bosquet EG, 2006, GYNECOL OBSTET INVES, V61, P119, DOI 10.1159/000089457; Caballero A, 2019, J WOMENS HEALTH, V28, P606, DOI 10.1089/jwh.2018.7043; Cappelletti M, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001385; CHAMBERS S, 1991, EUR J OBSTET GYN R B, V38, P103, DOI 10.1016/0028-2243(91)90185-N; Chen X., 2021, FRONT ONCOL, V11, P2258; Cunha GKP, 2022, BJOG-INT J OBSTET GY, V129, P1174, DOI [10.1111/1471-0528.17076, 10.1111/1471-0528.16949]; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Dolgushin I I, 2004, Zh Mikrobiol Epidemiol Immunobiol, P43; Dubicke A, 2016, REPROD SCI, V23, P595, DOI 10.1177/1933719115616497; Dubicke A, 2010, J REPROD IMMUNOL, V84, P176, DOI 10.1016/j.jri.2009.12.004; Edwards VL., 2021, BIORXIV; Frew L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103434; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Gordon J, 2019, CELL TISSUE RES, V376, P443, DOI 10.1007/s00441-018-02983-8; Gravina FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111307; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; Hein M, 2001, AM J OBSTET GYNECOL, V185, P586, DOI 10.1067/mob.2001.116685; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; HIRSCH E, 1995, AM J OBSTET GYNECOL, V172, P1598, DOI 10.1016/0002-9378(95)90503-0; Iwahashi M, 2003, J CLIN ENDOCR METAB, V88, P2231, DOI 10.1210/jc.2002-021213; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky Marian, 2009, Acta Medica (Hradec Kralove), V52, P117; Khorsandi D, 2019, INT J GYNECOL CANCER, V29, pA154, DOI 10.1136/ijgc-2019-ESGO.220; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Lohmussaar K, 2021, CELL STEM CELL, V28, P1380, DOI 10.1016/j.stem.2021.03.012; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; MITCHELL BF, 1984, AM J OBSTET GYNECOL, V148, P303, DOI 10.1016/S0002-9378(84)80073-3; Motomura K, 2020, MBIO, V11, DOI 10.1128/mBio.00797-20; Myers DA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.105049; Myers KM, 2015, J BIOMECH, V48, P1511, DOI 10.1016/j.jbiomech.2015.02.065; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Namba F, 2010, PEDIATR RES, V67, P166, DOI 10.1203/PDR.0b013e3181c6e58e; Noda-Nicolau NM, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.859732; Noda-Nicolau NM, 2018, J REPROD IMMUNOL, V126, P60, DOI 10.1016/j.jri.2018.02.007; Nott J.P., 2016, T RES ANAT, V2, P1, DOI DOI 10.1016/j.tria.2016.02.001; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Pavlidis I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14089-y; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Radnaa E, 2022, BIOL REPROD, V106, P568, DOI 10.1093/biolre/ioab231; Radnaa E, 2021, LAB CHIP, V21, P1956, DOI 10.1039/d0lc01323d; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Richardson L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00715; Richardson LS, 2020, LAB CHIP, V20, P4486, DOI 10.1039/d0lc00875c; Richardson LS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay1486; ROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1086, DOI 10.1016/S0002-9378(12)80043-3; Sheller-Miller S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd3865; Spencer NR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260370; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Suff N, 2018, AM J PATHOL, V188, P2164, DOI 10.1016/j.ajpath.2018.06.016; Tantengco OAG, 2021, BIOL REPROD, V105, P1562, DOI 10.1093/biolre/ioab181; Tantengco Ourlad Alzeus G, 2021, Front Glob Womens Health, V2, P777643, DOI 10.3389/fgwh.2021.777643; Tantengco OAG, 2022, REPRODUCTION, V163, P1, DOI 10.1530/REP-21-0308; Tantengco OAG, 2021, BIOL REPROD, V105, P204, DOI 10.1093/biolre/ioab058; Tantengco OAG, 2021, FASEB J, V35, DOI 10.1096/fj.202002590RRR; Tantengco OAG, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13370; Tantengco OAG, 2020, MED HYPOTHESES, V145, DOI 10.1016/j.mehy.2020.110336; Vink J, 2018, BEST PRACT RES CL OB, V52, P88, DOI 10.1016/j.bpobgyn.2018.03.007; Vink J, 2017, SEMIN PERINATOL, V41, P427, DOI 10.1053/j.semperi.2017.07.014; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Wittmaack A, 2019, J WOMENS HEALTH, V28, P1538, DOI 10.1089/jwh.2018.7457; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Xiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14584; Yellon SM, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03156; Yoshida K, 2019, INTERFACE FOCUS, V9, DOI 10.1098/rsfs.2019.0026; Yu SX, 2022, BIOSENS BIOELECTRON, V204, DOI 10.1016/j.bios.2022.114040	69	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22551	10.1096/fj.202200872R	http://dx.doi.org/10.1096/fj.202200872R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4O3AR	36106554				2022-12-28	WOS:000854575800001
J	van Beurden, AW; Schoonderwoerd, RA; Tersteeg, MMH; Gutierrez, PD; Michel, S; Blommers, R; Rohling, JHT; Meijer, JH				van Beurden, Anouk W.; Schoonderwoerd, Robin A.; Tersteeg, Mayke M. H.; Gutierrez, Pablo de Torres; Michel, Stephan; Blommers, Ruben; Rohling, Jos H. T.; Meijer, Johanna H.			Single cell model for re-entrainment to a shifted light cycle	FASEB JOURNAL			English	Article						entrainment; PER2; phase shift; retinohypothalamic tract; suprachiasmatic nucleus	SUPRACHIASMATIC NUCLEUS; MOUSE; EXPRESSION; CLOCK; TIME; RAT; OSCILLATIONS; ORGANIZATION; MECHANISM; MPER2	Our daily 24-h rhythm is synchronized to the external light-dark cycle resulting from the Earth's daily rotation. In the mammalian brain, the suprachiasmatic nucleus (SCN) serves as the master clock and receives light-mediated input via the retinohypothalamic tract. Abrupt changes in the timing of the light-dark cycle (e.g., due to jet lag) cause a phase shift in the circadian rhythms in the SCN. Here, we investigated the effects of a 6-h delay in the light-dark cycle on PERIOD2::LUCIFERASE expression at the single-cell level in mouse SCN organotypic explants. The ensemble pattern in phase shift response obtained from individual neurons in the anterior and central SCN revealed a bimodal distribution; specifically, neurons in the ventrolateral SCN responded with a rapid phase shift, while neurons in the dorsal SCN generally did not respond to the shift in the light-dark cycle. We also stimulated the hypothalamic tract in acute SCN slices to simulate light-mediated input to the SCN; interestingly, we found similarities between the distribution and fraction of rapid shifting neurons (in response to the delay) and neurons that were excited in response to electrical stimulation. These results suggest that a subpopulation of neurons in the ventral SCN that have an excitatory response to light input, shift their clock more readily than dorsal located neurons, and initiate the SCN's entrainment to the new light-dark cycle. Thus, we propose that light-excited neurons in the anterior and central SCN play an important role in the organism's ability to adjust to changes in the external light-dark cycle.	[van Beurden, Anouk W.; Schoonderwoerd, Robin A.; Tersteeg, Mayke M. H.; Gutierrez, Pablo de Torres; Michel, Stephan; Blommers, Ruben; Rohling, Jos H. T.; Meijer, Johanna H.] Leiden Univ Med Ctr, Dept Cell & Chem Biol, POB 9600, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC)	Meijer, JH (corresponding author), Leiden Univ Med Ctr, Dept Cell & Chem Biol, POB 9600, NL-2300 RC Leiden, Netherlands.	j.h.meijerk@lumc.nl		de Torres Gutierrez, Pablo/0000-0002-8387-1885; van Beurden, Anouk/0000-0002-0551-0347	EC | European Research Council (ERC) [834513]	EC | European Research Council (ERC)	EC | European Research Council (ERC), Grant/Award Number: 834513	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Brenna A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01178-6; Buijink MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168954; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Colwell CS, 2001, EUR J NEUROSCI, V13, P1420, DOI 10.1046/j.0953-816x.2001.01517.x; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hastings MH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010013; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Irwin RP, 2009, EUR J NEUROSCI, V30, P1462, DOI 10.1111/j.1460-9568.2009.06944.x; Lokshin M, 2015, J BIOL RHYTHM, V30, P251, DOI 10.1177/0748730415584058; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Michel S, 2013, EUR J NEUROSCI, V37, P964, DOI 10.1111/ejn.12109; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Plano SA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00558; Quintero JE, 2003, J NEUROSCI, V23, P8070; Rohling JHT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025437; Schoonderwoerd RA, 2022, FASEB J, V36, DOI 10.1096/fj.202200477R; SHIBATA S, 1993, BRAIN RES, V615, P95, DOI 10.1016/0006-8993(93)91118-C; Sonoda T, 2020, SCIENCE, V368, P527, DOI 10.1126/science.aay3152; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	37	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22518	10.1096/fj.202200478R	http://dx.doi.org/10.1096/fj.202200478R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4G6YV	36057093	Green Published			2022-12-28	WOS:000849340200001
J	Daniele, LL; Han, JYS; Samuels, IS; Komirisetty, R; Mehta, N; McCord, JL; Yu, MZ; Wang, YK; Boesze-Battaglia, K; Bell, BA; Du, JH; Peachey, NS; Philp, NJ				Daniele, Lauren L.; Han, John Y. S.; Samuels, Ivy S.; Komirisetty, Ravikiran; Mehta, Nikhil; McCord, Jessica L.; Yu, Minzhong; Wang, Yekai; Boesze-Battaglia, Kathleen; Bell, Brent A.; Du, Jianhai; Peachey, Neal S.; Philp, Nancy J.			Glucose uptake by GLUT1 in photoreceptors is essential for outer segment renewal and rod photoreceptor survival	FASEB JOURNAL			English	Article						glucose depervation; GLUT1; photoreceptors; retina; rhodopsin; Slc2a1	TARGETED DISRUPTION; PROLINE OXIDASE; HOMEOBOX GENE; CONE DEATH; CELL FATE; METABOLISM; RHODOPSIN; RETINA; EXPRESSION; PIGMENT	Photoreceptors consume glucose supplied by the choriocapillaris to support phototransduction and outer segment (OS) renewal. Reduced glucose supply underlies photoreceptor cell death in inherited retinal degeneration and age-related retinal disease. We have previously shown that restricting glucose transport into the outer retina by conditional deletion of Slc2a1 encoding GLUT1 resulted in photoreceptor loss and impaired OS renewal. However, retinal neurons, glia, and the retinal pigment epithelium play specialized, synergistic roles in metabolite supply and exchange, and the cell-specific map of glucose uptake and utilization in the retina is incomplete. In these studies, we conditionally deleted Slc2a1 in a pan-retinal or rod-specific manner to better understand how glucose is utilized in the retina. Using non-invasive ocular imaging, electroretinography, and histochemical and biochemical analyses we show that genetic deletion of Slc2a1 from retinal neurons and Muller glia results in reduced OS growth and progressive rod but not cone photoreceptor cell death. Rhodopsin levels were severely decreased even at postnatal day 20 when OS length was relatively normal. Arrestin levels were not changed suggesting that glucose uptake is required to synthesize membrane glycoproteins. Rod-specific deletion of Slc2a1 resulted in similar changes in OS length and rod photoreceptor cell death. These studies demonstrate that glucose is an essential carbon source for rod photoreceptor cell OS maintenance and viability.	[Daniele, Lauren L.; Han, John Y. S.; Komirisetty, Ravikiran; Mehta, Nikhil; McCord, Jessica L.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA; [Samuels, Ivy S.; Yu, Minzhong; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Samuels, Ivy S.; Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Yu, Minzhong; Peachey, Neal S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26506 USA; [Wang, Yekai; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Boesze-Battaglia, Kathleen] Univ Penn, Dept Basic & Translat Sci, Penn Dent Med, Philadelphia, PA 19104 USA; [Bell, Brent A.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	Jefferson University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; West Virginia University; West Virginia University; University of Pennsylvania; University of Pennsylvania	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA.	nancy.philp@jefferson.edu	Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Philp, Nancy/0000-0001-7028-0448; Yu, Minzhong/0000-0002-3115-8930; Samuels, Ivy/0000-0003-1351-031X; Daniele, Lauren/0000-0002-9397-0342	HHS \ NIH \ National Eye Institute (NEI) [R01EY026525, R01EY12042, R01EY031324, R01EY032462, P30EY025585]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [T32AA007463]; Research to Prevent Blindness; U.S. Department of Veterans Affairs (VA) [I01BX002340, IK6-BX005233, I01BX005844]	HHS \ NIH \ National Eye Institute (NEI); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY026525(NJPandKBB), R01EY12042, R01EY031324, R01EY032462 and P30EY025585; HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: T32AA007463(JH); Research to Prevent Blindness (NSP); U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX002340(NSP), IK6-BX005233(ISS) and I01BX005844(NSP)	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; AMES A, 1992, J NEUROSCI, V12, P4234; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Bell BA, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.05.012; Bell BA, 2015, EXP EYE RES, V135, P192, DOI 10.1016/j.exer.2015.04.009; Bell BA, 2014, EXP EYE RES, V127, P280, DOI 10.1016/j.exer.2014.01.001; Bonezzi PJ, 2018, CURR EYE RES, V43, P666, DOI 10.1080/02713683.2018.1433859; Botta S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96560; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Cunnane SC, 2020, NAT REV DRUG DISCOV, V19, P609, DOI 10.1038/s41573-020-0072-x; Daniele LL, 2011, VISION RES, V51, P447, DOI 10.1016/j.visres.2010.12.017; Daum JM, 2017, ELIFE, V6, DOI 10.7554/eLife.31437; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; Fadl BR, 2020, MOL VIS, V26, P705; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Guo MC, 2022, FEBS J, V289, P2337, DOI 10.1111/febs.16177; Han JYS, 2020, FASEB J, V34, P5401, DOI 10.1096/fj.201902961R; Hancock CN, 2016, AMINO ACIDS, V48, P859, DOI 10.1007/s00726-015-2134-7; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; He JZ, 2021, FASEB J, V35, DOI 10.1096/fj.202101121R; Holoman NC, 2021, J NEUROSCI, V41, P3275, DOI 10.1523/JNEUROSCI.2010-20.2021; Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903; Hsieh PN, 2019, ENDOCR REV, V40, P137, DOI 10.1210/er.2018-00151; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hurley JB, 2021, ANNU REV VIS SCI, V7, P665, DOI 10.1146/annurev-vision-100419-115156; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Koch SF, 2015, J CLIN INVEST, V125, P3704, DOI 10.1172/JCI82462; KOWALOFF EM, 1977, P NATL ACAD SCI USA, V74, P5368, DOI 10.1073/pnas.74.12.5368; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li B, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101672; McCann MR, 2021, METABOLITES, V11, DOI 10.3390/metabo11010051; Mehmel M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061616; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Murray AR, 2015, HUM MOL GENET, V24, P2709, DOI 10.1093/hmg/ddv031; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64487-2; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0712-9; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0296-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Salinas RY, 2017, J CELL BIOL, V216, P1489, DOI 10.1083/jcb.201608081; Samson M, 2009, DEV DYNAM, V238, P3218, DOI 10.1002/dvdy.22138; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen WY, 2021, GLIA, V69, P1966, DOI 10.1002/glia.24005; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Shin BC, 2018, J NEUROSCI, V38, P9579, DOI 10.1523/JNEUROSCI.0503-18.2018; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Trachsel-Moncho L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0855-8; Tran DH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012673; TURCO SJ, 1982, J BIOL CHEM, V257, P8674; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Viegas FO, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.656000; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719; Wang L, 1997, ACTA PHYSIOL SCAND, V160, P75, DOI 10.1046/j.1365-201X.1997.00131.x; Wang LX, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0305-9; Wang W, 2019, CELL REP, V28, P1323, DOI 10.1016/j.celrep.2019.06.093; Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022; Watanabe T, 1999, BIOCHEM BIOPH RES CO, V256, P505, DOI 10.1006/bbrc.1999.0369; Weh E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2638-2; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Winkler BS, 2000, INVEST OPHTH VIS SCI, V41, P3183; Xue YL, 2021, ELIFE, V10, DOI 10.7554/eLife.66240; Yam M, 2019, J BIOL CHEM, V294, P10278, DOI 10.1074/jbc.RA119.007983; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Yu C, 2020, TRENDS NEUROSCI, V43, P433, DOI 10.1016/j.tins.2020.03.012; Zhang R, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03103-7; Zhang Y, 2019, J MOL CELL BIOL, V11, P1, DOI 10.1093/jmcb/mjy052	93	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22428	10.1096/fj.202200369R	http://dx.doi.org/10.1096/fj.202200369R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2O2WK	35766190	hybrid, Green Published			2022-12-28	WOS:000818924600001
J	Lai, F; Wang, JJ; Tang, H; Huang, P; Liu, J; He, G; Zhou, M; Tao, X; Tang, KL				Lai, Fan; Wang, Jingjing; Tang, Hong; Huang, Pan; Liu, Juan; He, Gang; Zhou, Mei; Tao, Xu; Tang, Kanglai			VEGF promotes tendon regeneration of aged rats by inhibiting adipogenic differentiation of tendon stem/progenitor cells and promoting vascularization	FASEB JOURNAL			English	Article						adipogenesis; tendon regeneration; tendon stem; progenitor cells; VEGF	STEM-CELLS; EXTRACELLULAR-MATRIX; ADIPOSE-TISSUE; SCAR FORMATION; IN-VITRO; OSTEOPONTIN; EXPRESSION; IDENTIFICATION; REJUVENATION; ANGIOGENESIS	Studies have shown that the stem cell microenvironment is a key factor for stem cell maintenance or differentiation. In this study, we compared the expression of 23 cytokines such as IL-6, IL-10, and TNF alpha between young and aged rats during patellar tendon repair by cytokine microarray, and found that significant difference between IL-10, G-CSF, and VEGF at 3, 7, or 14 days post-operatively. The effects of these factors on adipogenic differentiation of TPSCs were examined through western blot and oil red O experiments. It was shown that VEGF had an inhibitive effect on the adipogenic differentiation of TPSCs. SPP-1 was figured out as our target by RNA sequencing and confirmed by western blot in vitro. Further in vivo studies showed that adipocyte accumulation was also decreased in the tendons of aged rats after injection of VEGF and the histological score and biomechanical property were also improved via targeting SPP-1. Furthermore, histochemical results showed that vascularization of the injury sites was significantly elevated. In conclusion, VEGF not only plays an important role in decreasing adipocyte accumulation but also improves vascularization of the tendon during aged tendon healing. We believe active regulation of VEGF may improve the treatment of age-related tendon diseases and tendon injuries.	[Lai, Fan; Tang, Hong; Huang, Pan; Liu, Juan; He, Gang; Zhou, Mei; Tao, Xu; Tang, Kanglai] Army Med Univ, Southwest Hosp, Dept Sports Med Ctr, Chongqing 400038, Peoples R China; [Wang, Jingjing] Army Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China	Army Medical University; Army Medical University	Tao, X; Tang, KL (corresponding author), Army Med Univ, Southwest Hosp, Dept Sports Med Ctr, Chongqing 400038, Peoples R China.	taoux@hotmail.com; tangkanglai@tmmu.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GRS-7509-2022; wang, jing/GVT-8700-2022; WANG, JINGYI/GSJ-1241-2022	Lai, Fan/0000-0002-2638-5960	Leading Talents in Scientific and Technological Innovation for the National 10 000 Talents Program [4139Z2B1]; National key innovation team foundation [4174DH]; National Natural Science Foundation of China (NSFC) [81772330]; Research innovation group on sports injury repair and reconstruction foundation [CSTC2020JCYJ-CXTTX0004]	Leading Talents in Scientific and Technological Innovation for the National 10 000 Talents Program; National key innovation team foundation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research innovation group on sports injury repair and reconstruction foundation	Leading Talents in Scientific and Technological Innovation for the National 10 000 Talents Program, Grant/Award Number: 4139Z2B1; National key innovation team foundation, Grant/Award Number: 4174DH; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772330; Research innovation group on sports injury repair and reconstruction foundation, Grant/Award Number: CSTC2020JCYJ-CXTTX0004	Ahmed IM, 1998, J ORTHOPAED RES, V16, P591, DOI 10.1002/jor.1100160511; Albers IS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0885-2; Bentley K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0522; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bian XT, 2019, J CELL MOL MED, V23, P7406, DOI 10.1111/jcmm.14604; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chen Y, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-017-0058-9; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; D'Alimonte I, 2011, J BIOL REG HOMEOS AG, V25, P57; Dallaudiere B, 2013, EUR J RADIOL, V82, pE823, DOI 10.1016/j.ejrad.2013.06.012; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Galatz LM, 2015, J ORTHOP RES, V33, P823, DOI 10.1002/jor.22853; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Han WF, 2017, ACTA BIOCH BIOPH SIN, V49, P1015, DOI 10.1093/abbs/gmx104; Huang Y, 2020, J CELL BIOCHEM, V121, P2343, DOI 10.1002/jcb.29457; Jiang DP, 2018, ADV CLIN EXP MED, V27, P1625, DOI 10.17219/acem/75503; Jiang DP, 2014, CELL BIOCHEM BIOPHYS, V70, P967, DOI 10.1007/s12013-014-0004-7; Jurets A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148333; Khouri RK, 2018, PLAST RECONSTR SURG, V142, P1248, DOI 10.1097/PRS.0000000000004952; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Kraus A, 2018, PLAST RECONSTR SURG, V142, P1240, DOI 10.1097/PRS.0000000000004920; Lai F, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04838-w; Lai F, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02720-y; LAU DCW, 1990, INT J OBESITY, V14, P153; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Li QM, 2017, EXP THER MED, V13, P449, DOI 10.3892/etm.2017.4019; Lin DS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.510; Lu Y, 2020, EUR J PHARMACOL, V866, DOI 10.1016/j.ejphar.2019.172822; Lui PPY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0097-y; Ming N., 2012, BIOMATERIALS, V34, P2024; Moreno-Viedma V, 2018, OBES RES CLIN PRACT, V12, P277, DOI 10.1016/j.orcp.2018.02.006; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Stoll C, 2011, BIOMATERIALS, V32, P4806, DOI 10.1016/j.biomaterials.2011.03.026; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tempfer H, 2018, CELL PHYSIOL BIOCHEM, V46, P1148, DOI 10.1159/000489057; Tempfer H, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00330; Teunis T, 2014, J SHOULDER ELB SURG, V23, P1913, DOI 10.1016/j.jse.2014.08.001; Wang MX, 2019, HORM METAB RES, V51, P741, DOI 10.1055/a-0926-3991; Wang YJ, 2019, J CELL MOL MED, V23, P7535, DOI 10.1111/jcmm.14622; Wang YJ, 2019, J CELL MOL MED, V23, P5475, DOI 10.1111/jcmm.14430; Yin HY, 2020, BIOMATERIALS, V236, DOI 10.1016/j.biomaterials.2020.119802; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130454; Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088; Zhang JY, 2010, AM J SPORT MED, V38, P2477, DOI 10.1177/0363546510376750; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang MZ, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01918-x; Zhang W, 2017, J RECEPT SIG TRANSD, V37, P217, DOI 10.1080/10799893.2016.1212375	52	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22433	10.1096/fj.202200213R	http://dx.doi.org/10.1096/fj.202200213R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3C7GT	35867348				2022-12-28	WOS:000828789000001
J	Elia, I; Realini, G; Di Mauro, V; Borghi, S; Bottoni, L; Tornambe, S; Vitiello, L; Weiss, SJ; Chiariello, M; Tamburrini, A; Oliviero, S; Neri, F; Orlandini, M; Galvagni, F				Elia, Ines; Realini, Giulia; Di Mauro, Vittoria; Borghi, Sara; Bottoni, Laura; Tornambe, Salvatore; Vitiello, Libero; Weiss, Stephen J.; Chiariello, Mario; Tamburrini, Annalaura; Oliviero, Salvatore; Neri, Francesco; Orlandini, Maurizio; Galvagni, Federico			SNAI1 is upregulated during muscle regeneration and represses FGF21 and ATF3 expression by directly binding their promoters	FASEB JOURNAL			English	Article						E box; endoplasmic reticulum stress; gene silencing; microarray analysis; muscle regeneration; myoblast differentiation; promoter; skeletal muscle; transcription	GROWTH-FACTOR 21; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ER STRESS; CELLS; MACROPHAGES; MYOD; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION	During skeletal myogenesis, the zinc-finger transcription factors SNAI1 and SNAI2, are expressed in proliferating myoblasts and regulate the transition to terminally differentiated myotubes while repressing pro-differentiation genes. Here, we demonstrate that SNAI1 is upregulated in vivo during the early phase of muscle regeneration induced by bupivacaine injury. Using shRNA-mediated gene silencing in C2C12 myoblasts and whole-transcriptome microarray analysis, we identified a collection of genes belonging to the endoplasmic reticulum (ER) stress pathway whose expression, induced by myogenic differentiation, was upregulated in absence of SNAI1. Among these, key ER stress genes, such as Atf3, Ddit3/Chop, Hspa5/Bip, and Fgf21, a myokine involved in muscle differentiation, were strongly upregulated. Furthermore, by promoter mutant analysis and Chromatin immune precipitation assay, we demonstrated that SNAI1 represses Fgf21 and Atf3 in proliferating myoblasts by directly binding to multiple E boxes in their respective promoter regions. Together, these data describe a new regulatory mechanism of myogenic differentiation involving the direct repressive action of SNAI1 on ER stress and Fgf21 expression, ultimately contributing to maintaining the proliferative and undifferentiated state of myoblasts.	[Elia, Ines; Realini, Giulia; Bottoni, Laura; Tornambe, Salvatore; Orlandini, Maurizio; Galvagni, Federico] Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy; [Di Mauro, Vittoria] IRCCS Humanitas Res Hosp, Rozzano, Italy; [Borghi, Sara] NYU Grossman Sch Med, Dept Pathol, New York, NY USA; [Vitiello, Libero] Univ Padua, Dept Biol, Padua, Italy; [Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Med Genet, Inst Life Sci, Ann Arbor, MI 48109 USA; [Chiariello, Mario] Consiglio Nazl Ric CNR, Ist Fisiol Clin IFC, Siena, Italy; [Chiariello, Mario] Ist Studio Prevenz & Rete Oncol ISPRO, Core Res Lab CRL, Siena, Italy; [Tamburrini, Annalaura; Oliviero, Salvatore; Neri, Francesco] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy; [Tamburrini, Annalaura; Oliviero, Salvatore] IRCCS, IIGM Italian Inst Genom Med, Candiolo, Italy; [Di Mauro, Vittoria] CNR, Inst Genet & Biomed Res IRGB, Milan Unit, Via Fantoli 16-15, I-20138 Milan, Italy; [Borghi, Sara] NYU Langone Hlth, Immune Monitoring Lab, 550 First Ave, New York, NY 10016 USA	University of Siena; University of Padua; University of Michigan System; University of Michigan; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); NYU Langone Medical Center	Galvagni, F (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy.	federico.galvagni@unisi.it	Chiariello, Mario/O-3642-2014	Chiariello, Mario/0000-0001-8434-5177; DI MAURO, VITTORIA/0000-0002-4707-4264	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Anselmi F, 2012, ANGIOGENESIS, V15, P187, DOI 10.1007/s10456-012-9252-6; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Contreras O, 2021, CELL SIGNAL, V84, DOI 10.1016/j.cellsig.2021.110036; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Correra RM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32941-x; Edagawa M, 2014, J BIOL CHEM, V289, P21544, DOI 10.1074/jbc.M114.558890; El Haddad M, 2017, CELL MOL LIFE SCI, V74, P1923, DOI 10.1007/s00018-016-2445-1; Galvagni F, 2002, J BIOL CHEM, V277, P19106, DOI 10.1074/jbc.M109642200; Galvagni F, 2000, J BIOL CHEM, V275, P3168, DOI 10.1074/jbc.275.5.3168; Galvagni F, 2015, STEM CELLS, V33, P742, DOI 10.1002/stem.1898; Guardiola O, 2017, JOVE-J VIS EXP, DOI 10.3791/54515; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; He SQ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143737; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Kleger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014599; Ku HC, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00556; Lee NKL, 2011, AM J PHYSIOL-ENDOC M, V301, pE172, DOI 10.1152/ajpendo.00094.2011; Leshem Y, 2000, J CELL PHYSIOL, V184, P101, DOI 10.1002/(SICI)1097-4652(200007)184:1<101::AID-JCP11>3.0.CO;2-D; Li HS, 2020, J BONE MINER RES, V35, P738, DOI 10.1002/jbmr.3932; Li HT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02677-9; Liu XY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1648715; Liu XY, 2017, J CELL PHYSIOL, V232, P1893, DOI 10.1002/jcp.25735; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; McLennan IS, 1996, J ANAT, V188, P17; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Morville T, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122737; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Shan TZ, 2017, J CELL PHYSIOL, V232, P2964, DOI 10.1002/jcp.25730; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sun H, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.625287; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan YY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.670435; Wan XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807874; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yu YH, 2016, INT IMMUNOPHARMACOL, V38, P144, DOI 10.1016/j.intimp.2016.05.026; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou SM, 2018, MUSCLE NERVE, V58, P573, DOI 10.1002/mus.26195; Zink W, 2002, ANESTHESIOLOGY, V97, P710, DOI 10.1097/00000542-200209000-00026	62	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22401	10.1096/fj.202200215R	http://dx.doi.org/10.1096/fj.202200215R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2G2XC	35726676				2022-12-28	WOS:000813460800001
J	Wang, XG; Yin, YX; Qian, W; Peng, C; Shen, SN; Wang, TT; Zhao, SL				Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting; Zhao, Shuli			Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4/TXNIP-NLRP3-GSDMD pathway in ovarian cancer	FASEB JOURNAL			English	Article						citric acid; metabolite; ovarian cancer; pyroptosis	CELL-DEATH; CITRATE; GLUTATHIONE; ACTIVATION; AUTOPHAGY; CASPASES; CLEAVAGE; BIOLOGY; GSDMD	Malignant tumors display profound changes in cellular metabolism, yet how these altered metabolites affect the development and growth of tumors is not fully understood. Here, we used metabolomics to analyze the metabolic profile differences in ovarian cancer and found that citric acid (CA) is the most significantly downregulated metabolite. Recently, CA has been reported to inhibit the growth of a variety of tumor cells, but whether it is involved in pyroptosis of ovarian cancer and its potential molecular mechanisms still remains to be further investigated. Here, we demonstrated that CA inhibits the growth of ovarian cancer cells in a dose-dependent manner. RNA-seq analysis revealed that CA significantly promoted the expression of thioredoxin interacting protein (TXNIP) and caspase-4 (CASP4). Morphologic examination by transmission electron microscopy indicated that CA-treated ovarian cancer cells exhibited typical pyroptosis characteristics. Further mechanistic analyses showed that CA facilitates pyroptosis via the CASP4/TXNIP-NLRP3-Gesdermin-d (GSDMD) pathway in ovarian cancer. This study elucidated that CA induces ovarian cancer cell death through classical and non-classical pyroptosis pathways, which may be beneficial as an ovarian cancer therapy.	[Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting] Nanjing Univ, Med Sch, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Wang, Xiaogang; Yin, Yuxin; Qian, Wei; Peng, Chen; Shen, Sunan; Wang, Tingting] Nanjing Univ, Med Sch, Div Immunol, Jiangsu Key Lab Mol Med, Nanjing, Peoples R China; [Zhao, Shuli] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Wang, TT (corresponding author), Nanjing Univ, Med Sch, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China.; Zhao, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Nanjing, Peoples R China.	wangtt@nju.edu.cn; shulizhao79@163.com		Wang, Xiaogang/0000-0002-3412-6651	National Natural Science Foundation of China [82072648, 81772542, 81872114]; Natural Science Foundation of Jiangsu Province [BK20211508, 20190134]; Fundamental Research Funds for the Central Universities [021414380500]; Jiangsu Provincial Special Program of Medical Science [BE2019617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Provincial Special Program of Medical Science	This work is supported by grants from the National Natural Science Foundation of China (82072648, 81772542, and 81872114), the Natural Science Foundation of Jiangsu Province (BK20211508 and 20190134), the Fundamental Research Funds for the Central Universities (021414380500), and the Jiangsu Provincial Special Program of Medical Science (BE2019617).	Abdel-Salam OME, 2014, J MED FOOD, V17, P588, DOI 10.1089/jmf.2013.0065; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Bucay AH, 2011, CLIN RES HEPATOL GAS, V35, P241, DOI 10.1016/j.clinre.2010.12.011; Bucay AH, 2009, MED HYPOTHESES, V73, P271, DOI 10.1016/j.mehy.2009.03.018; Cao M, 2012, ANAL SCI, V28, P451, DOI 10.2116/analsci.28.451; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Costello LC, 1999, PROSTATE, V38, P237, DOI 10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO;2-O; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fan XR, 2021, LIFE SCI, V275, DOI 10.1016/j.lfs.2021.119355; Fuhler GM, 2017, TRENDS MOL MED, V23, P3, DOI 10.1016/j.molmed.2016.12.001; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Heo MJ, 2019, GUT, V68, P708, DOI 10.1136/gutjnl-2017-315123; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Icard P, 2018, CANCER RES, V78, P5176, DOI 10.1158/0008-5472.CAN-18-1666; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jeong YM, 2009, PHARMAZIE, V64, P829, DOI 10.1691/ph.2009.9622; Jia YF, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101534; Kruspig B, 2012, CELL MOL LIFE SCI, V69, P4229, DOI 10.1007/s00018-012-1166-3; Li N, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.623489; Lu YF, 2011, ANTICANCER RES, V31, P797; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mycielska ME, 2015, CURR MOL MED, V15, P884, DOI 10.2174/1566524016666151123104855; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Qiao LQ, 2019, FASEB J, V33, P12760, DOI 10.1096/fj.201900483RR; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Ren JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04626-4; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shenoy N, 2018, CANCER CELL, V34, P700, DOI 10.1016/j.ccell.2018.07.014; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Toohey JI, 2008, CANCER LETT, V263, P164, DOI 10.1016/j.canlet.2008.02.002; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang L, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.635774; Wang YP, 2020, J BIOL CHEM, V295, P11938, DOI 10.1074/jbc.REV119.007624; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Zhang L, 2012, CLIN BIOCHEM, V45, P1064, DOI 10.1016/j.clinbiochem.2012.05.012; Zhang RJ, 2020, J AGR FOOD CHEM, V68, P1326, DOI 10.1021/acs.jafc.9b07908	47	1	1	8	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22362	10.1096/fj.202101993RR	http://dx.doi.org/10.1096/fj.202101993RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1L7YE	35608902				2022-12-28	WOS:000799499800001
J	Shao, R; Liao, XM; Lan, YW; Zhang, H; Jiao, L; Du, QY; Han, D; Ai, QH; Mai, KS; Wan, M				Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Han, Dong; Ai, Qinghui; Mai, Kangsen; Wan, Min			Vitamin D regulates insulin pathway and glucose metabolism in zebrafish (Danio rerio)	FASEB JOURNAL			English	Article						1; 25(OH)(2)D-3; diabetes; glucose homeostasis; hyperglycemia; insulin; insulin receptor; vitamin D-3	GLYCOGEN-SYNTHESIS; MUSCLE; RESISTANCE; TRANSPORT; STIMULATION; EXPRESSION; RECEPTORS; LIVER; LEADS	1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3], the most active vitamin D (VD) metabolite, is a steroid hormone playing an important role in many physiological functions in addition to maintaining mineral homeostasis. In this study, we explored the mechanism that the VD regulated insulin pathway and glucose metabolism in zebrafish in vitro and in vivo. Our results show that 1,25(OH)(2)D-3 significantly enhances the expression of insulin receptor a (insra), insulin receptor substrate 1 (irs1) and glucose transporter 2 (glut2), and promotes glycolysis and glycogenesis, while suppressing gluconeogenesis in zebrafish liver cell line (ZFL) under the condition of high glucose (20 mM), instead of the normal glucose (10 mM). Moreover, consistent results were obtained from the zebrafish fed with VD3-deficient diet, as well as the cyp2r1(-/-) zebrafish, in which endogenous VD metabolism is blocked. Furthermore, results from dual-luciferase reporting system exhibited that 1,25(OH)(2)D-3 directly activated the transcription of insra, rather than insrb in zebrafish by binding to vitamin D response element (VDRE) located at -181 to -167 bp in the promoter region of insra. Importantly, the 1,25(OH)(2)D-3 treatment significantly alleviated the symptoms of hyperglycemia in diabetic zebrafish. In conclusion, our study demonstrated that VD activates VDRE located in the promoter area of insra in zebrafish to promote insulin/insra signaling pathway, thereby contributing to the maintenance of glucose homeostasis.	[Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Ai, Qinghui; Mai, Kangsen; Wan, Min] Ocean Univ China, Coll Fisheries, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China; [Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Ai, Qinghui; Mai, Kangsen; Wan, Min] Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China; [Han, Dong] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Ai, Qinghui; Mai, Kangsen; Wan, Min] Pilot Natl Lab Marine Sci & Technol, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Qingdao National Laboratory for Marine Science & Technology	Wan, M (corresponding author), Ocean Univ China, Coll Fisheries, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China.; Wan, M (corresponding author), Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China.	Wanmin@ouc.edu.cn		Shao, Rui/0000-0002-1774-6461	National Natural Science Foundation of China (NSFC) [31972802]; National Key R&D Program of China [2018YFD0900400]; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong) [ZR2019MC041]; Fundamental Research Funds for the Central Universities [202161026]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972802; National Key R&D Program of China, Grant/Award Number: 2018YFD0900400; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong):, Grant/Award Number: ZR2019MC041; Fundamental Research Funds for the Central Universities, Grant/Award Number: 202161026	Alcaraz-Perez F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-81; Barbarawi M, 2020, J CLIN ENDOCR METAB, V105, P2857, DOI 10.1210/clinem/dgaa335; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Colotta F, 2017, J AUTOIMMUN, V85, P78, DOI 10.1016/j.jaut.2017.07.007; Contreras-Bolivar V, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103491; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Gong YL, 2018, GEN COMP ENDOCR, V269, P33, DOI 10.1016/j.ygcen.2018.08.012; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li SL, 2018, FISH PHYSIOL BIOCHEM, V44, P1185, DOI 10.1007/s10695-018-0508-y; Liao XM, 2022, J INNATE IMMUN, V14, P229, DOI 10.1159/000519183; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Melguizo-Rodriguez L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030830; Merz KE, 2020, COMPR PHYSIOL, V10, P785, DOI 10.1002/cphy.c190029; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Morro M, 2020, DIABETES, V69, P927, DOI 10.2337/db19-0757; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Nozaki Y, 2020, P NATL ACAD SCI USA, V117, P8166, DOI 10.1073/pnas.1921694117; Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339; Peng XY, 2017, CELL REP, V19, P1444, DOI 10.1016/j.celrep.2017.04.066; Pittas AG, 2019, NEW ENGL J MED, V381, P520, DOI 10.1056/NEJMoa1900906; Polakof S, 2016, COMP BIOCHEM PHYS B, V199, P43, DOI 10.1016/j.cbpb.2015.11.001; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Roder PV, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.6; Salehpour A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.652061; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sassi F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111656; Shao R, 2022, BRIT J NUTR, V128, P2083, DOI 10.1017/S0007114522000125; Singh A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41009-3; Tai K, 2008, NUTRITION, V24, P279, DOI 10.1016/j.nut.2007.11.006; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Toyoshima Y, 2008, ENDOCRINOLOGY, V149, P5996, DOI 10.1210/en.2008-0329; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wei Z, 2018, CELL, V173, P1135, DOI 10.1016/j.cell.2018.04.013; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Yang BY, 2018, AM J PHYSIOL-ENDOC M, V315, pE38, DOI 10.1152/ajpendo.00227.2017; Yang BY, 2017, SCI BULL, V62, P486, DOI 10.1016/j.scib.2017.03.001; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zheng JS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003394	50	1	1	23	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22330	10.1096/fj.202200334RR	http://dx.doi.org/10.1096/fj.202200334RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U6CL	35474468				2022-12-28	WOS:000787737000001
J	Shi, HK; Tsai, KHY; Ma, DC; Wang, XS; Desai, R; Parungao, RJ; Hunt, NJ; Cheng, YY; Zhang, H; Xu, Y; Simanainen, U; Tan, Q; Cooper, MS; Handelsman, DJ; Maitz, PK; Wang, YW				Shi, Huaikai; Tsai, Kevin H-Y; Ma, Duncan; Wang, Xiaosuo; Desai, Reena; Parungao, Roxanne J.; Hunt, Nicholas J.; Cheng, Yuen Yee; Zhang, Hao; Xu, Ye; Simanainen, Ulla; Tan, Qian; Cooper, Mark S.; Handelsman, David J.; Maitz, Peter K.; Wang, Yiwei			Controlled dual release of dihydrotestosterone and flutamide from polycaprolactone electrospun scaffolds accelerate burn wound healing	FASEB JOURNAL			English	Article						androgens; burn injury; controlled drug delivery; flutamine; PCL scaffold; wound healing	KERATINOCYTE GROWTH-FACTOR; ANDROGEN RECEPTOR; CELLS	Wound healing is a complex process involving multiple independent and overlapping sequential physiological mechanisms. In addition to cutaneous injury, a severe burn stimulates physiological derangements that induce a systemic hypermetabolic response resulting in impaired wound healing. Topical application of the anti-androgen drug, flutamide accelerates cutaneous wound healing, whereas paradoxically systemic dihydrotestosterone (DHT) improves burn wound healing. We developed and characterized a PCL scaffold that is capable of controlled release of androgen (DHT) and anti-androgen (F) individually or together. This study aims to investigate whether local modification of androgen actions has an impact on burn injury wound healing. In a full-thickness burn wound healing, mouse model, DHT/F-scaffold showed a significantly faster wound healing compared with F-scaffold or DHT-scaffold. Histology analysis confirmed that DHT/F-scaffold exhibited higher re-epithelization, cell proliferation, angiogenesis, and collagen deposition. Dual release of DHT and F from PCL scaffolds promoted cell proliferation of human keratinocytes and alters the keratinocyte cell cycle. Lastly, no adverse effects on androgen-dependent organs, spleen and liver were observed. In conclusion, we demonstrated DHT plus F load PCL scaffolds accelerated burn wound healing when loading alone did not. These findings point to a complex role of androgens in burn wound healing and open novel therapeutic avenues for treating severe burn patients.	[Shi, Huaikai; Ma, Duncan; Parungao, Roxanne J.; Maitz, Peter K.; Wang, Yiwei] Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia; [Shi, Huaikai; Cheng, Yuen Yee] Concord Hosp, Asbestos Dis Res Inst, Sydney, NSW, Australia; [Tsai, Kevin H-Y; Cooper, Mark S.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Adrenal Steroids Lab, Sydney, NSW, Australia; [Wang, Xiaosuo] Univ Sydney, Bosch Mass Spectrometry Facil, Sydney, NSW, Australia; [Desai, Reena; Simanainen, Ulla; Handelsman, David J.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Dept Androl, Sydney, NSW, Australia; [Hunt, Nicholas J.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Biogerontol Grp, Sydney, NSW, Australia; [Hunt, Nicholas J.] Univ Sydney, Sydney Nano Inst, Sydney, NSW, Australia; [Hunt, Nicholas J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Zhang, Hao; Xu, Ye; Tan, Qian] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Burns & Plast Surg, Affiliated Hosp,Med Sch, Nanjing, Peoples R China; [Maitz, Peter K.] Concord Repatriat Gen Hosp, Burns Unit, Concord, Australia; [Wang, Yiwei] Nanjing Univ Chinese Med, Jiangsu Prov Engn Res Ctr TCM External Medicat De, Nanjing, Peoples R China	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; Nanjing University; Concord Repatriation General Hospital; Nanjing University of Chinese Medicine	Wang, YW (corresponding author), Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia.	yiweiwang@anzac.edu.au	Maitz, Peter/GQI-2475-2022; Ekanayake, Kanchana/P-8817-2016; Tsai, Kevin/GQR-1990-2022; Research Institute, ANZAC/CAE-9030-2022	SHI, HUAIKAI/0000-0002-8269-2981	Australian National Health and Medical Research Council (NHMRC) [1100296]; National Science Foundation of China [82172217]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Australian National Health and Medical Research Council (NHMRC) Project Grant (1100296), National Science Foundation of China (82172217)	Ahn CS, 2012, BURNS, V38, P967, DOI 10.1016/j.burns.2012.05.016; Ashcroft GS, 2003, WOUND REPAIR REGEN, V11, P468, DOI 10.1046/j.1524-475X.2003.11614.x; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Baranoski Sharon, 2005, Home Healthc Nurse, V23, P307, DOI 10.1097/00004045-200505000-00009; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Chong C, 2013, BURNS TRAUMA, V1, DOI 10.4103/2321-3868.118935; Gilliver SC, 2009, J PATHOL, V217, P73, DOI 10.1002/path.2444; Gilliver SC, 2008, ENDOCRINOLOGY, V149, P5747, DOI 10.1210/en.2008-0355; Gilliver SC, 2007, LAB INVEST, V87, P871, DOI 10.1038/labinvest.3700627; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2016, J BURN CARE RES, V37, P86, DOI 10.1097/BCR.0000000000000265; Kumtornrut C, 2019, J DERMATOL SCI, V93, P150, DOI 10.1016/j.jdermsci.2019.01.007; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Planz B, 1998, J UROLOGY, V160, P1850, DOI 10.1016/S0022-5347(01)62431-5; Planz B, 2001, J UROLOGY, V166, P678, DOI 10.1016/S0022-5347(05)66042-9; Shi HK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176231; Toraldo G, 2012, WOUND REPAIR REGEN, V20, P61, DOI 10.1111/j.1524-475X.2011.00757.x; Wang YW, 2016, WOUND REPAIR REGEN, V24, P478, DOI 10.1111/wrr.12420; Wolverton SE., 1995, CURR PROBL DERMATOL, V7, P6, DOI DOI 10.1016/S1040-0486(09)80019-7	21	0	0	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22310	10.1096/fj.202101803R	http://dx.doi.org/10.1096/fj.202101803R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0I4HN	35394674	Green Published			2022-12-28	WOS:000779382300001
J	Teegala, LR; Elshoweikh, Y; Gudneppanavar, R; Thodeti, S; Pokhrel, S; Southard, E; Thodeti, CK; Paruchuri, S				Teegala, Lakshminarayan Reddy; Elshoweikh, Yasmine; Gudneppanavar, Ravindra; Thodeti, Sathwika; Pokhrel, Sabita; Southard, Erik; Thodeti, Charles K.; Paruchuri, Sailaja			Protein Kinase C alpha and beta compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation	FASEB JOURNAL			English	Article						asthma; KIT; MC; P38 MAPK; PKC; proliferation; SCF; viability	PKC-EPSILON; RECEPTOR; EFFECTOR; ACTIVATION; MIGRATION; SURVIVAL; ISOFORMS; INNATE; IGE; INHIBITION	Mast cells (MCs) develop from hematopoietic progenitors and differentiate into mature MCs that reside within connective or mucosal tissues. Though the number of MCs in tissues usually remains constant, inflammation and asthma disturb this homeostasis, leading to proliferation of MCs. Understanding the signaling events behind this proliferative response could lead to the development of novel strategies for better management of allergic diseases. MC survival, proliferation, differentiation, and migration are all maintained by a MC growth factor, stem cell factor (SCF) via its receptor, KIT. Here, we explored how protein kinase C (PKC) redundancy influences MC proliferation in bone marrow-derived MC (BMMC). We found that SCF activates PKC alpha and PKC beta isoforms, which in turn modulates KIT phosphorylation and internalization. Further, PKC alpha and PKC beta activate p38 mitogen activated protein kinase (MAPK), and this axis subsequently regulates SCF-induced MC cell proliferation. To ascertain the individual roles of PKC alpha and PKC beta, we knocked down either PKC alpha or PKC beta or both via short hairpin RNA (shRNA) and analyzed KIT phosphorylation, p38 MAPK phosphorylation, and MC viability and proliferation. To our surprise, downregulation of neither PKC alpha nor PKC beta affected MC viability and proliferation. In contrast, blocking both PKC alpha and PKC beta significantly attenuated SCF-induced cell viability and proliferation, suggesting that PKC alpha and PKC beta compensate for each other downstream of SCF signaling to enhance MC viability and proliferation. Our results not only suggest that PKC classical isoforms are novel therapeutic targets for SCF/MC-mediated inflammatory and allergic diseases, but they also emphasize the importance of inhibiting both PKC alpha and beta isoforms simultaneously to prevent MC proliferation.	[Teegala, Lakshminarayan Reddy; Elshoweikh, Yasmine; Gudneppanavar, Ravindra; Thodeti, Sathwika; Pokhrel, Sabita; Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Teegala, Lakshminarayan Reddy; Southard, Erik; Thodeti, Charles K.; Paruchuri, Sailaja] Univ Toledo, Dept Physiol & Pharmacol, Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA; [Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Toledo; Northeast Ohio Medical University (NEOMED)	Paruchuri, S (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA.	Sailaja.Paruchuri@UToledo.edu	Teegala, Lakshminarayan/ABB-5531-2021	Teegala, Lakshminarayan/0000-0001-7725-8294	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R01AI144115]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL148585]	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01AI144115; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL148585; James Foght support	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bell KS, 2015, IMMUNOL LETT, V168, P31, DOI 10.1016/j.imlet.2015.09.001; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Chang EY, 1997, J IMMUNOL, V159, P2624; Da Silva CA, 2006, FUND CLIN PHARMACOL, V20, P21, DOI 10.1111/j.1472-8206.2005.00390.x; Fehrenbach K, 2009, J IMMUNOL, V182, P7897, DOI 10.4049/jimmunol.0801773; Feuser K, 2011, MOL IMMUNOL, V48, P546, DOI 10.1016/j.molimm.2010.10.010; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gombedza F, 2017, FASEB J, V31, P1556, DOI 10.1096/fj.201601045R; Grimbaldeston MA, 2006, CURR OPIN IMMUNOL, V18, P751, DOI 10.1016/j.coi.2006.09.011; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jensen Bettina M., 2007, Inflammation & Allergy Drug Targets, V6, P57, DOI 10.2174/187152807780077255; Kondeti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071536; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lessmann E, 2006, INT IMMUNOL, V18, P767, DOI 10.1093/intimm/dxl012; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Mani M, 2009, BLOOD, V114, P2900, DOI 10.1182/blood-2009-01-200733; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; RAZIN E, 1994, P NATL ACAD SCI USA, V91, P7722, DOI 10.1073/pnas.91.16.7722; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; SHEFFER AL, 1995, INT ARCH ALLERGY IMM, V107, P11, DOI 10.1159/000236917; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Tkaczyk C, 2006, IMMUNOL ALLERGY CLIN, V26, P427, DOI 10.1016/j.iac.2006.05.011; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Zeidman R, 1999, INT J CANCER, V81, P494, DOI 10.1002/(SICI)1097-0215(19990505)81:3<494::AID-IJC26>3.0.CO;2-L	41	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22273	10.1096/fj.202101838RRR	http://dx.doi.org/10.1096/fj.202101838RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0K2TQ	35349200	Green Published			2022-12-28	WOS:000780645900001
J	Zhang, YH; Wang, CY; Sun, MM; Jin, YT; Braz, CU; Khatib, H; Hacker, TA; Liss, M; Gotthardt, M; Granzier, H; Ge, Y; Guo, W				Zhang, Yanghai; Wang, Chunyan; Sun, Mingming; Jin, Yutong; Braz, Camila Urbano; Khatib, Hasan; Hacker, Timothy A.; Liss, Martin; Gotthardt, Michael; Granzier, Henk; Ge, Ying; Guo, Wei			RBM20 phosphorylation and its role in nucleocytoplasmic transport and cardiac pathogenesis	FASEB JOURNAL			English	Article						cardiomyopathy; phosphorylation; pre-mRNA splicing; protein condensates; protein trafficking; RNA-binding motif 20 (RBM20)	RNA-BINDING-PROTEINS; SR PROTEINS; MASH SUITE; GENE; TITIN; MUTATIONS; EXPRESSION; CARDIOMYOPATHY; IDENTIFICATION; QUANTIFICATION	Arginine-serine (RS) domain(s) in splicing factors are critical for protein-protein interaction in pre-mRNA splicing. Phosphorylation of RS domain is important for splicing control and nucleocytoplasmic transport in the cell. RNA-binding motif 20 (RBM20) is a splicing factor primarily expressed in the heart. A previous study using phospho-antibody against RS domain showed that RS domain can be phosphorylated. However, its actual phosphorylation sites and function have not been characterized. Using middle-down mass spectrometry, we identified 16 phosphorylation sites, two of which (S638 and S640 in rats, or S637 and S639 in mice) were located in the RSRSP stretch in the RS domain. Mutations on S638 and S640 regulated splicing, promoted nucleocytoplasmic transport and protein-RNA condensates. Phosphomimetic mutations on S638 and S640 indicated that phosphorylation was not the major cause for RBM20 nucleocytoplasmic transport and condensation in vitro. We generated a S637A knock-in (KI) mouse model (Rbm20(S637A)) and observed the reduced RBM20 phosphorylation. The KI mice exhibited aberrant gene splicing, protein condensates, and a dilated cardiomyopathy (DCM)-like phenotype. Transcriptomic profiling demonstrated that KI mice had altered expression and splicing of genes involving cardiac dysfunction, protein localization, and condensation. Our in vitro data showed that phosphorylation was not a direct cause for nucleocytoplasmic transport and protein condensation. Subsequently, the in vivo results reveal that RBM20 mutations led to cardiac pathogenesis. However, the role of phosphorylation in vivo needs further investigation.	[Zhang, Yanghai; Wang, Chunyan; Braz, Camila Urbano; Khatib, Hasan; Guo, Wei] Univ Wisconsin, Dept Anim & Dairy Sci, 1933 Observ Dr, Madison, WI 53706 USA; [Sun, Mingming; Guo, Wei] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Jin, Yutong; Ge, Ying] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Hacker, Timothy A.] Univ Wisconsin, Sch Med & Publ Hlth, Div Cardiovasc Med, Dept Med, Madison, WI 53706 USA; [Liss, Martin; Gotthardt, Michael] Max Delbrueck Ctr Mol Med Helmholtz Assoc, Neuromuscular & Cardiovasc Cell Biol, Berlin, Germany; [Gotthardt, Michael] Charite, Berlin, Germany; [Granzier, Henk] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Ge, Ying] Univ Wisconsin, Sch Med & Publ & Lealth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Ge, Ying] Univ Wisconsin, Sch Med & Publ Hlth, Human Prote Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wyoming; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Arizona; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Guo, W (corresponding author), Univ Wisconsin, Dept Anim & Dairy Sci, 1933 Observ Dr, Madison, WI 53706 USA.	wguo2@wisc.edu	Gotthardt, Michael/ABE-8274-2021; Wang, Chunyan/CAH-1092-2022	Gotthardt, Michael/0000-0003-1788-3172; Wang, Chunyan/0000-0002-6430-413X	NIH NHLBI [HL148733, NICHD HD101870, NIGMS P20GM103432]; American Heart Association Foundation [16BGIA27790136, 19TPA3480072]; Wisconsin Alumni Research Foundation [AAH4884]; University of Wisconsin Foundation [AAH5964]; NIH [HL109810, HL096971, S10OD018475, R35HL144998]	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Foundation(American Heart Association); Wisconsin Alumni Research Foundation; University of Wisconsin Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH NHLBI HL148733, NICHD HD101870, and NIGMS P20GM103432; the American Heart Association Foundation 16BGIA27790136 and 19TPA3480072; the Wisconsin Alumni Research Foundation (AAH4884); and the University of Wisconsin Foundation (AAH5964); YG would like to acknowledge NIH R01 grants, HL109810 and HL096971 and the high-end instrument grant S10OD018475 and HG would like to acknowledge R35HL144998	Ayache J, 2015, MOL BIOL CELL, V26, P2579, DOI 10.1091/mbc.E15-03-0136; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Brody MJ, 2016, AM J PHYSIOL-HEART C, V310, pH269, DOI 10.1152/ajpheart.00717.2014; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cai WX, 2019, CIRC RES, V125, P936, DOI 10.1161/CIRCRESAHA.119.315305; Cai WX, 2016, MOL CELL PROTEOMICS, V15, P703, DOI 10.1074/mcp.O115.054387; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Filippello A, 2013, FEBS LETT, V587, P2989, DOI 10.1016/j.febslet.2013.07.018; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Guner H, 2014, J AM SOC MASS SPECTR, V25, P464, DOI 10.1007/s13361-013-0789-4; Guo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084281; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ihara K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74800-8; Jin YT, 2019, MABS-AUSTIN, V11, P106, DOI 10.1080/19420862.2018.1525253; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Li SJ, 2013, NUCLEIC ACIDS RES, V41, P2659, DOI 10.1093/nar/gks1362; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin ZQ, 2019, MOL CELL PROTEOMICS, V18, P594, DOI 10.1074/mcp.TIR118.001086; Liu XW, 2013, J PROTEOME RES, V12, P5830, DOI 10.1021/pr400849y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Luo Y, 2018, BIOCHEMISTRY-US, V57, P2424, DOI 10.1021/acs.biochem.7b01162; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Methawasin M, 2014, CIRCULATION, V129, P1924, DOI 10.1161/CIRCULATIONAHA.113.005610; Millat G, 2011, EUR J MED GENET, V54, pE570, DOI 10.1016/j.ejmg.2011.07.005; Monaco I, 2019, J ELECTROCARDIOL, V53, P40, DOI 10.1016/j.jelectrocard.2018.12.015; Murayama R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26624-w; Pantou MP, 2018, CARDIOLOGY, V141, P150, DOI 10.1159/000494453; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Rampersaud E, 2011, PROG PEDIATR CARDIOL, V31, P39, DOI 10.1016/j.ppedcard.2010.11.008; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Refaat MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/j.hrthm.2011.10.016; Rexiati M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010018; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider JW, 2020, NAT MED, V26, P1788, DOI 10.1038/s41591-020-1087-x; Serrano P, 2016, J MOL BIOL, V428, P2430, DOI 10.1016/j.jmb.2016.04.009; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Wang CY, 2022, J MOL CELL CARDIOL, V165, P115, DOI 10.1016/j.yjmcc.2022.01.004; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wickham H, 2016, PROGRAMMING GGPLOT2, DOI 10.1007/978-3-319-24277-4_12; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zhu CQ, 2017, METHODSX, V4, P320, DOI 10.1016/j.mex.2017.09.007; Zhu CQ, 2017, BBA-MOL BASIS DIS, V1863, P2363, DOI 10.1016/j.bbadis.2017.06.023; Zhu CQ, 2017, BBA-MOL BASIS DIS, V1863, P2056, DOI 10.1016/j.bbadis.2016.11.008; Zhu CQ, 2015, J MOL CELL BIOL, V7, P88, DOI 10.1093/jmcb/mjv002; Zografos TA, 2013, ARRHYTH ELECTROPHYSI, V2, P109, DOI 10.15420/aer.2013.2.2.109	64	3	3	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22302	10.1096/fj.202101811RR	http://dx.doi.org/10.1096/fj.202101811RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0I4HL	35394688	Green Published, Green Accepted			2022-12-28	WOS:000779382100001
J	Liao, YJ; Peng, XJ; Li, XZ; Wu, DK; Qiu, SF; Tang, XM; Zhang, DS				Liao, Yingjun; Peng, Xiongjun; Li, Xiaozhou; Wu, Dengke; Qiu, Shuangfa; Tang, Xianming; Zhang, Dongshan			CircRNA_45478 promotes ischemic AKI by targeting the miR-190a-5p/PHLPP1 axis	FASEB JOURNAL			English	Article						AKI; apoptosis; circular RNA; miR-190a-5p; PHLPP1	RENAL FIBROSIS; SEPTIC AKI; INHIBITION; ACTIVATION; APOPTOSIS; BIOMARKER; PATHWAY; UUO	A few studies suggested that circular RNAs were involved in the development of ischemic acute kidney injury (AKI). However, the function and regulation mechanism of circRNA_45478 in ischemic AKI remains unknown. In the present study, ischemic injury induced the expressions of circRNA_45478 in mouse proximal tubule-derived cell lines (BUMPT cells) and kidneys of C57BL/6 mice. Functionally, circRNA_45478 mediated I/R-induced apoptosis in BUMPT cells. Mechanistically, circRNA_45478 upregulated the expression of Pleckstrin homology (PH) domain leucine-rich repeat protein phosphatase 1 (PHLPP1) via sponging of microRNA (miR)-190a-5p. Finally, inhibition of circRNA_45478 significantly alleviated the progression of ischemic AKI through regulation of the miR-190a-5p/PHLPP1 pathway. Taken together, our data showed that circRNA_45478/miR-190a-5p/PHLPP1 axis mediated the progression of ischemic AKI.	[Liao, Yingjun; Li, Xiaozhou; Wu, Dengke; Qiu, Shuangfa; Tang, Xianming; Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410011, Hunan, Peoples R China; [Liao, Yingjun; Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China; [Peng, Xiongjun] Cent South Univ, Xiangya Hosp 2, Dept Med Equipment, Changsha, Peoples R China; [Li, Xiaozhou; Wu, Dengke; Qiu, Shuangfa; Tang, Xianming; Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Emergency Med & Difficult Dis Inst, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University	Tang, XM; Zhang, DS (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410011, Hunan, Peoples R China.	txm750916@csu.edu.cn; dongshanzhang@csu.edit.cn			Changsha Science and Technology Bureau project [kq1907144, kq2014242, kq2001039]; Department of Science and Technology of Hunan Province project of International Cooperation and Exchanges [2020WK2009]; China Hunan Provincial Science and Technology Department (HSTD) [2021sk4004]; Key Project of Hunan Provincial Science and Technology Innovation [2020SK1014]; National Natural Science Foundation of China (NSFC) [81870475, 81570646, 81770951]; Natural Science Foundation of Hunan Province [2021JJ30959]	Changsha Science and Technology Bureau project; Department of Science and Technology of Hunan Province project of International Cooperation and Exchanges; China Hunan Provincial Science and Technology Department (HSTD); Key Project of Hunan Provincial Science and Technology Innovation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	Changsha Science and Technology Bureau project, Grant/Award Number: kq1907144, kq2014242 and kq2001039; Department of Science and Technology of Hunan Province project of International Cooperation and Exchanges, Grant/Award Number: 2020WK2009; China Hunan Provincial Science and Technology Department (HSTD), Grant/Award Number: 2021sk4004; Key Project of Hunan Provincial Science and Technology Innovation, Grant/Award Number: 2020SK1014; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870475, 81570646 and 81770951; Natural Science Foundation of Hunan Province, Grant/Award Number: 2021JJ30959	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Ai K, 2022, MOL THER-NUCL ACIDS, V28, P77, DOI 10.1016/j.omtn.2022.02.015; Altesha MA, 2019, J CELL PHYSIOL, V234, P5588, DOI 10.1002/jcp.27384; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Chen X, 2019, THERANOSTICS, V9, P588, DOI 10.7150/thno.29678; Cheng ZA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11162-4; Fu LY, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118707; Garikipati VNS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11777-7; Ge YN, 2019, MOL THER-NUCL ACIDS, V17, P741, DOI 10.1016/j.omtn.2019.07.007; Gomes BC, 2020, CAN J KIDNEY HEALTH, V7, DOI 10.1177/2054358120934215; Han SJ, 2019, KIDNEY RES CLIN PRAC, V38, P427, DOI 10.23876/j.krcp.19.062; Hosohata K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111448; Huang T, 2022, INT IMMUNOPHARMACOL, V106, DOI 10.1016/j.intimp.2022.108614; Kerins MJ, 2018, ANTIOXID REDOX SIGN, V29, P1756, DOI 10.1089/ars.2017.7176; Lei M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1135-7; Li PL, 2020, MOL THER-NUCL ACIDS, V20, P879, DOI 10.1016/j.omtn.2020.05.016; Li Q, 2015, TUMOR BIOL, V36, P2007, DOI 10.1007/s13277-014-2807-y; Li XZ, 2022, EBIOMEDICINE, V76, DOI 10.1016/j.ebiom.2022.103859; Li XZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18304-z; Li YX, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/8709298; Liu J, 2022, APOPTOSIS, V27, P531, DOI 10.1007/s10495-022-01730-3; Liu XB, 2018, MOL THER-NUCL ACIDS, V10, P142, DOI 10.1016/j.omtn.2017.12.001; Mathur A, 2021, MOL CELL BIOCHEM, V476, P3681, DOI 10.1007/s11010-021-04177-3; Mathur A, 2018, FREE RADICAL BIO MED, V120, P414, DOI 10.1016/j.freeradbiomed.2018.04.550; Meng FH, 2022, RENAL FAILURE, V44, P672, DOI 10.1080/0886022X.2022.2032746; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Sun CC, 2017, MOL THER-NUCL ACIDS, V9, P100, DOI 10.1016/j.omtn.2017.08.015; Wang SH, 2020, CLIN BREAST CANCER, V20, P422, DOI 10.1016/j.clbc.2020.04.006; Xiao Y, 2022, FASEB J, V36, DOI 10.1096/fj.202200064RR; Xie YX, 2021, MOL THER-NUCL ACIDS, V23, P76, DOI 10.1016/j.omtn.2020.09.028; Xu X, 2019, FASEB J, V33, P4513, DOI 10.1096/fj.201801515R; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Yi L, 2021, AGING-US, V13, P12780, DOI 10.18632/aging.202947; Zhang MJ, 2020, J CELL MOL MED, V24, P4612, DOI 10.1111/jcmm.15123; Zhang P, 2020, MOL THER-NUCL ACIDS, V19, P1027, DOI 10.1016/j.omtn.2019.12.037	36	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22633	10.1096/fj.202201070R	http://dx.doi.org/10.1096/fj.202201070R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5U5DY	36315192				2022-12-28	WOS:000876568600001
J	Matsunaga, Y; Tamura, Y; Takahashi, K; Kitaoka, Y; Takahashi, Y; Hoshino, D; Kadoguchi, T; Hatta, H				Matsunaga, Yutaka; Tamura, Yuki; Takahashi, Kenya; Kitaoka, Yu; Takahashi, Yumiko; Hoshino, Daisuke; Kadoguchi, Tomoyasu; Hatta, Hideo			Branched-chain amino acid supplementation suppresses the detraining-induced reduction of mitochondrial content in mouse skeletal muscle	FASEB JOURNAL			English	Article						branched-chain amino acid; detraining; mitochondria; mitochondrial biogenesis; mitophagy; skeletal muscle	PROTEIN-SYNTHESIS; EXERCISE; ENDURANCE; ADAPTATIONS; LEUCINE; GLYCOGEN; INCREASES; AUTOPHAGY; PGC-1-ALPHA; BIOGENESIS	Exercise training enhances oxidative capacity whereas detraining reduces mitochondrial content in skeletal muscle. The strategy to suppress the detraining-induced reduction of mitochondrial content has not been fully elucidated. As previous studies reported that branched-chain amino acid (BCAA) ingestion increased mitochondrial content in skeletal muscle, we evaluated whether BCAA supplementation could suppress the detraining-induced reduction of mitochondrial content. Six-week-old male Institute of Cancer Research (ICR) mice were randomly divided into four groups as follows: control (Con), endurance training (Tr), detraining (DeTr), and detraining with BCAA supplementation (DeTr + BCAA). Mice in Tr, DeTr, and DeTr + BCAA performed treadmill running exercises [20-30 m/min, 60 min, 5 times/week, 4 weeks]. Then, mice in DeTr and DeTr + BCAA were administered with water or BCAA [0.6 mg/g of body weight, twice daily] for 2 weeks of detraining. In whole skeletal muscle, mitochondrial enzyme activities and protein content were decreased after 2 weeks of detraining, but the reduction was suppressed by BCAA supplementation. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) protein content, a master regulator of mitochondrial biogenesis, was decreased by detraining irrespective of BCAA ingestion. Regarding mitochondrial degradation, BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3), a mitophagy-related protein, was significantly higher in the Tr group than in the DeTr + BCAA group, but not different from in the DeTr group. With respect to mitochondrial quality, BCAA ingestion did not affect oxygen consumption rate (OCR) and reactive oxygen species (ROS) production in isolated mitochondria. Our findings suggest that BCAA ingestion suppresses the detraining-induced reduction of mitochondrial content partly through inhibiting mitophagy.	[Matsunaga, Yutaka; Tamura, Yuki; Takahashi, Kenya; Kitaoka, Yu; Takahashi, Yumiko; Hoshino, Daisuke; Kadoguchi, Tomoyasu; Hatta, Hideo] Univ Tokyo, Dept Sports Sci, Tokyo, Japan; [Tamura, Yuki] Nippon Sport Sci Univ, Grad Sch Hlth & Sport Sci, Tokyo, Japan; [Kitaoka, Yu] Kanagawa Univ, Dept Human Sci, Yokohama, Kanagawa, Japan; [Hoshino, Daisuke] Univ Electrocommun, Dept Engn Sci, Tokyo, Japan	University of Tokyo; Nippon Sport Science University; Kanagawa University; University of Electro-Communications - Japan	Matsunaga, Y (corresponding author), Univ Tokyo, Dept Sports Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	y_matsunaga@idaten.c.u-tokyo.ac.jp		Kadoguchi, Tomoyasu/0000-0001-6336-5160; Takahashi, Yumiko/0000-0002-4762-0982; Kitaoka, Yu/0000-0001-6932-2735	Kozuki Foundation; Japan Society for the Promotion of Science [19K24310]	Kozuki Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Kozuki Foundation research grant program; Japan Society for the Promotion of Science, Grant/Award Number: 19K24310	Anthony JC, 2000, J NUTR, V130, P2413; Bartolome A, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00441-17; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Blocquiaux S, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110860; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chesley A, 1996, AM J PHYSIOL-ENDOC M, V270, pE328, DOI 10.1152/ajpendo.1996.270.2.E328; COYLE EF, 1985, J APPL PHYSIOL, V59, P853, DOI 10.1152/jappl.1985.59.3.853; COYLE EF, 1986, J APPL PHYSIOL, V60, P95, DOI 10.1152/jappl.1986.60.1.95; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Guan YT, 2019, EXERC SPORT SCI REV, V47, P151, DOI 10.1249/JES.0000000000000192; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Iwanaka N, 2010, J APPL PHYSIOL, V108, P274, DOI 10.1152/japplphysiol.00420.2009; Jackman SR, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00390; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Karlsson HKR, 2004, AM J PHYSIOL-ENDOC M, V287, pE1, DOI 10.1152/ajpendo.00430.2003; Kitaoka Y, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13998; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacLean D. A., 1994, American Journal of Physiology, V267, pE1010; Macleod KF, 2020, ANNU REV CANC BIOL, V4, P41, DOI 10.1146/annurev-cancerbio-030419-033405; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; MARTIN WH, 1986, J AM COLL CARDIOL, V7, P982, DOI 10.1016/S0735-1097(86)80215-7; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Moberg M, 2016, AM J PHYSIOL-CELL PH, V310, pC874, DOI 10.1152/ajpcell.00374.2015; Moyzis AG, 2015, AM J PHYSIOL-HEART C, V308, pH183, DOI 10.1152/ajpheart.00708.2014; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Ogasawara R, 2013, J APPL PHYSIOL, V114, P934, DOI 10.1152/japplphysiol.01161.2012; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Putti R, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00426; Rivera ME, 2022, ENDOCRINE, V76, P18, DOI 10.1007/s12020-021-02939-z; Sanchez AMJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060542; Sanchez AMJ, 2018, BIOCHEM BIOPH RES CO, V499, P493, DOI 10.1016/j.bbrc.2018.03.176; Shimomura Y., 2012, J PHYS FITNESS SPORT, V1, P219, DOI [10.7600/jpfsm.1.219, DOI 10.7600/JPFSM.1.219]; Skein M, 2012, EUR J APPL PHYSIOL, V112, P2859, DOI 10.1007/s00421-011-2253-0; Stancliffe RA., 2012, THESIS U TENNESSEE K; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Tamai Y, 2021, BIOMED PHARMACOTHER, V135, DOI 10.1016/j.biopha.2020.111181; Tamura Y, 2020, AM J PHYSIOL-CELL PH, V319, pC1029, DOI 10.1152/ajpcell.00494.2019; Tamura Y, 2015, J PHYSIOL-LONDON, V593, P2707, DOI 10.1113/JP270093; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Tomiya S, 2019, AM J PHYSIOL-REG I, V317, pR649, DOI 10.1152/ajpregu.00118.2019; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, pE361, DOI 10.1152/ajpendo.00292.2010; Wakabayashi Y, 2020, AM J PHYSIOL-REG I, V318, pR677, DOI 10.1152/ajpregu.00089.2019; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamashita SI, 2021, J CELL PHYSIOL, V236, P7612, DOI 10.1002/jcp.30404; Zhang FY, 2016, EBIOMEDICINE, V13, P157, DOI 10.1016/j.ebiom.2016.10.013; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhong YZ, 2019, NUTRITION, V60, P217, DOI 10.1016/j.nut.2018.09.032	66	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22628	10.1096/fj.202200588R	http://dx.doi.org/10.1096/fj.202200588R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5W1LP	36322028				2022-12-28	WOS:000877683500001
J	Filiberto, AC; Ladd, Z; Leroy, V; Su, G; Elder, CT; Pruitt, EY; Hensley, SE; Lu, GY; Hartman, JB; Zarrinpar, A; Sharma, AK; Upchurch, GR				Filiberto, Amanda C.; Ladd, Zachary; Leroy, Victoria; Su, Gang; Elder, Craig T.; Pruitt, Eric Y.; Hensley, Sara E.; Lu, Guanyi; Hartman, Joseph B.; Zarrinpar, Ali; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.			Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms	FASEB JOURNAL			English	Article						abdominal aortic aneurysms; ferroptosis; formyl peptide receptor 2; HMGB1; macrophages; resolvin D1	RESOLVING LIPID MEDIATORS; PROTEIN-COUPLED RECEPTOR; OXIDATIVE STRESS; D1; MECHANISMS; LIGAND; RESPONSES; MODEL	Abdominal aortic aneurysm (AAA) formation is characterized by inflammation, leukocyte infiltration, and vascular remodeling. Resolvin D1 (RvD1) is derived from omega-3 polyunsaturated fatty acids and is involved in the resolution phase of chronic inflammatory diseases. The aim of this study was to decipher the protective role of RvD1 via formyl peptide receptor 2 (FPR2) receptor signaling in attenuating abdominal aortic aneurysms (AAA). The elastase-treatment model of AAA in C57BL/6 (WT) mice and human AAA tissue was used to confirm our hypotheses. Elastase-treated FPR2(-/-) mice had a significant increase in aortic diameter, proinflammatory cytokine production, immune cell infiltration (macrophages and neutrophils), elastic fiber disruption, and decrease in smooth muscle cell alpha-actin expression compared to elastase-treated WT mice. RvD1 treatment attenuated AAA formation, aortic inflammation, and vascular remodeling in WT mice, but not in FPR2(-/-) mice. Importantly, human AAA tissue demonstrated significantly decreased FPR2 mRNA expression compared to non-aneurysm human aortas. Mechanistically, RvD1/FPR2 signaling mitigated p47(phox) phosphorylation and prevented hallmarks of ferroptosis, such as lipid peroxidation and Nrf2 translocation, thereby attenuating HMGB1 secretion. Collectively, this study demonstrates RvD1-mediated immunomodulation of FPR2 signaling on macrophages to mitigate ferroptosis and HMGB1 release, leading to resolution of aortic inflammation and remodeling during AAA pathogenesis.	[Filiberto, Amanda C.; Ladd, Zachary; Leroy, Victoria; Su, Gang; Elder, Craig T.; Pruitt, Eric Y.; Hensley, Sara E.; Lu, Guanyi; Hartman, Joseph B.; Zarrinpar, Ali; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.] Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Upchurch, GR (corresponding author), Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA.	gib.upchurch@surgery.ufl.edu		Leroy, Victoria/0000-0002-1025-1888; Sharma, Ashish/0000-0002-1234-6039	American College of Surgeons (ACS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL153341, HL138931]	American College of Surgeons (ACS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	American College of Surgeons (ACS); HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL153341 and HL138931	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Arnardottir H, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142883; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Chakraborty A, 2022, J MOL CELL CARDIOL, V163, P67, DOI 10.1016/j.yjmcc.2021.09.010; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Elder CT, 2021, FASEB J, V35, DOI 10.1096/fj.202100484R; Fashandi AZ, 2018, SURGERY, V163, P397, DOI 10.1016/j.surg.2017.10.003; Fredman G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00205; Gerlach BD, 2020, CELL DEATH DIFFER, V27, P525, DOI 10.1038/s41418-019-0370-1; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Honkanen Petri, 2014, Surg Neurol Int, V5, P74, DOI 10.4103/2152-7806.132960; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuivaniemi H, 2015, EXPERT REV CARDIOVAS, V13, P975, DOI 10.1586/14779072.2015.1074861; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Liu GJ, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01918-x; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Martensson J, 2021, J INNATE IMMUN, V13, P242, DOI 10.1159/000514887; Maschalidi S, 2022, NATURE, V606, P776, DOI 10.1038/s41586-022-04754-6; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Meital LT, 2017, PROSTAG LEUKOTR ESS, V118, P1, DOI 10.1016/j.plefa.2017.02.001; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Piechota-Polanczyk Aleksandra, 2015, Front Cardiovasc Med, V2, P19, DOI 10.3389/fcvm.2015.00019; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Ramon S, 2014, EUR J IMMUNOL, V44, P357, DOI 10.1002/eji.201343316; Rymut N, 2020, FASEB J, V34, P597, DOI 10.1096/fj.201902126R; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Sekheri M, 2020, P NATL ACAD SCI USA, V117, P7971, DOI 10.1073/pnas.1920193117; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Shannon AH, 2020, J SURG RES, V251, P239, DOI 10.1016/j.jss.2020.01.028; Sharma AK, 2016, ARTERIOSCL THROM VAS, V36, P908, DOI 10.1161/ATVBAHA.116.307373; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Halade GV, 2022, EBIOMEDICINE, V79, DOI 10.1016/j.ebiom.2022.103992; Vinchi F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00094; Wales KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112816; Wiernicki B, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31218-2; Yang Y, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04775-z; Zhang Y, 2022, BIOMED PHARMACOTHER, V145, DOI 10.1016/j.biopha.2021.112423	53	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22579	10.1096/fj.202201114R	http://dx.doi.org/10.1096/fj.202201114R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6KZ	36183323				2022-12-28	WOS:000862995400001
J	Kaufman, PD; Huang, S; Pederson, T				Kaufman, Paul D.; Huang, Sui; Pederson, Thoru			The nuclear bodies conference: Hubs of genomic activity, June 24-28, Western Shore, Nova Scotia, Canada	FASEB JOURNAL			English	Editorial Material						genome coordination; nucleus organization		This conference brought together leaders in the investigation of various bodies that populate the nucleus, a field that complements research on chromosome biology. These nuclear bodies had been receiving increasing attention as hubs of genome activity and the new findings reported at the conference strongly confirmed and significantly expanded this principle.	[Kaufman, Paul D.] Univ Massachusetts, Chan Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Huang, Sui] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Pederson, Thoru] Univ Massachusetts, Chan Sch Med, Dept Biochem & Mol Biotechnol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Chan Sch Med, Dept Biochem & Mol Biotechnol, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu		Kaufman, Paul/0000-0003-3089-313X	National Institutes of Health [R13 CA271711-01]; Keith R. Porter Endowment for Cell Biology; Nikon; New England Biolabs; Ionis Pharmaceuticals; FASEB; Company of Biologists; ChromaTech	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keith R. Porter Endowment for Cell Biology; Nikon; New England Biolabs; Ionis Pharmaceuticals; FASEB; Company of Biologists; ChromaTech	National Institutes of Health, Grant/Award Number: R13 CA271711-01; Keith R. Porter Endowment for Cell Biology; Nikon; New England Biolabs; Ionis Pharmaceuticals; FASEB; Company of Biologists; ChromaTech		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22588	10.1096/fj.202201455R	http://dx.doi.org/10.1096/fj.202201455R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5R1XF	36287614				2022-12-28	WOS:000874310000001
J	Deng, ZH; Zhong, J; Jiang, HL; Jeong, HW; Chen, JW; Shu, YH; Tan, M; Adams, RH; Xie, KP; Chen, Q; Liu, Y				Deng, Zhao-hua; Zhong, Jing; Jiang, Hai-lin; Jeong, Hyun-Woo; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Adams, Ralf H.; Xie, Ke-ping; Chen, Qi; Liu, Yang			Antipsychotic drugs induce vascular defects in hematopoietic organs	FASEB JOURNAL			English	Article						antipsychotic agents; bone marrow; haloperidol; hematopoietic stem cell; stem cell microenvironment; vascular endothelial cell; VEGF	ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; VEGF; NICHE; LIVER; RECONSTITUTION; ANGIOGENESIS; HALOPERIDOL; EFFICACY; SAFETY	Antipsychotic agents are clinically utilized to treat schizophrenia and other mental disorders. These drugs induce neurological and metabolic side effects, but their influence on blood vessels remains largely unknown. Here, we show that haloperidol, one of the most frequently prescribed antipsychotic agents, induces vascular defects in bone marrow. Acute haloperidol treatment results in vascular dilation that is specific to hematopoietic organs. This vessel dilation is associated with disruption of hematopoiesis and hematopoietic stem/progenitor cells (HSPCs), both of which are reversible after haloperidol withdrawal. Mechanistically, haloperidol treatment blocked the secretion of vascular endothelial growth factor A (VEGF-A) from HSPCs. Genetic blockade of VEGF-A secretion from hematopoietic cells or inhibition of VEGFR2 in endothelial cells result in similar vessel dilation in bone marrow during regeneration after irradiation and transplantation. Conversely, VEGF-A gain of function rescues the bone marrow vascular defects induced by haloperidol treatment and irradiation. Our work reveals an unknown effect of antipsychotic agents on the vasculature and hematopoiesis with potential implications for drug application in clinic.	[Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol,Ctr Cell Lineage & Dev, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, GIBH HKU Guangdong Hong Kong Stem Cell & Regenera, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, GIBH CUHK Joint Res Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] China New Zealand Joint Lab Biomed & Hlth, Guangzhou, Peoples R China; [Zhong, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Hai-lin; Xie, Ke-ping; Liu, Yang] South China Univ Technol, Sch Med, Dept Pathol, Guangzhou 510006, Peoples R China; [Jiang, Hai-lin; Xie, Ke-ping; Liu, Yang] South China Univ Technol, Sch Med, Ctr Pancreat Canc Res, Guangzhou 510006, Peoples R China; [Jeong, Hyun-Woo; Adams, Ralf H.; Chen, Qi; Liu, Yang] Univ Munster, Fac Med, Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Chen, Jian-wei] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Biomed Sci Coll, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, NHC Key Lab Biotechnol Drugs, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Key Lab Rare & Uncommon Dis Shandong Prov, Jinan, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South China University of Technology; South China University of Technology; Max Planck Society; University of Munster; Anhui University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, Y (corresponding author), South China Univ Technol, Sch Med, Dept Pathol, Guangzhou 510006, Peoples R China.; Liu, Y (corresponding author), South China Univ Technol, Sch Med, Ctr Pancreat Canc Res, Guangzhou 510006, Peoples R China.; Chen, Q (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Ctr Cell Lineage & Dev, Guangzhou 510530, Peoples R China.	chen_qi@gibh.ac.cn; yangl005@scut.edu.cn		Jeong, Hyun-Woo/0000-0002-6976-6739; Chen, Qi/0000-0001-8485-6540	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences [1103792101]; European Research Council [AdG 786672]; Leducq Foundation; Max Planck Society, Germany; Science and Techonology Planning Project of Guangdong Province, China [2020B1212060052]; South China University of Technology (SCUT); University of Muenster, Germany; Christiane Nuesslein-Volhard Foundation, Germany	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences; European Research Council(European Research Council (ERC)European Commission); Leducq Foundation(Leducq Foundation); Max Planck Society, Germany(Max Planck Society); Science and Techonology Planning Project of Guangdong Province, China; South China University of Technology (SCUT); University of Muenster, Germany; Christiane Nuesslein-Volhard Foundation, Germany	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Grant/Award Number: 1103792101; Christiane Nuesslein-Volhard Foundation, Germany; European Research Council, Grant/Award Number: AdG 786672, PROVEC; Leducq Foundation; Max Planck Society, Germany; Science and Techonology Planning Project of Guangdong Province, China, Grant/Award Number: 2020B1212060052; South China University of Technology (SCUT); University of Muenster, Germany	ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; [Anonymous], 2012, CLIN RES INFORM DRUG; Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379; Ban Thomas A, 2007, Neuropsychiatr Dis Treat, V3, P495; Batsivari A, 2020, NAT CELL BIOL, V22, P7, DOI 10.1038/s41556-019-0444-9; Beach SR, 2020, GEN HOSP PSYCHIAT, V67, P42, DOI 10.1016/j.genhosppsych.2020.08.008; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bourne JA, 2001, CNS DRUG REV, V7, P399; Casey DE, 1996, J CLIN PSYCHIAT, V57, P40; Chen Q, 2019, CELL STEM CELL, V25, P768, DOI 10.1016/j.stem.2019.10.006; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Comazzetto S, 2021, DEV CELL, V56, P1848, DOI 10.1016/j.devcel.2021.05.018; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Cristina C, 2005, ENDOCRINOLOGY, V146, P2952, DOI 10.1210/en.2004-1445; de Araujo AN, 2012, DRUG HEALTHC PATIENT, V4, P173, DOI 10.2147/DHPS.S37429; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dold M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009831.pub2; Duarte D, 2018, CELL STEM CELL, V22, P64, DOI 10.1016/j.stem.2017.11.006; Fang ST, 2020, BLOOD, V136, P1871, DOI 10.1182/blood.2020005699; Fielding C, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28175-1; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hall R L, 2003, Expert Opin Drug Saf, V2, P395, DOI 10.1517/eods.2.4.395.21419; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hoyer FF, 2020, CIRCULATION, V142, P244, DOI 10.1161/CIRCULATIONAHA.120.046038; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Jozwiak-Bebenista M, 2018, PHARMACOL REP, V70, P1032, DOI 10.1016/j.pharep.2018.05.005; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; King DJ, 1998, J PSYCHOPHARMACOL, V12, P283, DOI 10.1177/026988119801200309; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Lee YJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20200882; Liu Y, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28775-x; Liu Y, 2021, BLOOD, V138, P2051, DOI 10.1182/blood.2020010419; MALHOTRA AK, 1993, DRUG SAFETY, V9, P429, DOI 10.2165/00002018-199309060-00005; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Maryanovich M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031344; Paik DT, 2020, CIRCULATION, V142, P1848, DOI 10.1161/CIRCULATIONAHA.119.041433; Pani L, 2007, EUR PSYCHIAT, V22, P267, DOI 10.1016/j.eurpsy.2007.02.005; Pillai A, 2006, SCHIZOPHR RES, V87, P48, DOI 10.1016/j.schres.2006.06.017; Pimkin M, 2014, GENOME RES, V24, P1932, DOI 10.1101/gr.164178.113; Pinho S, 2019, NAT REV MOL CELL BIO, V20, P303, DOI 10.1038/s41580-019-0103-9; Poller WC, 2020, CIRC RES, V126, P1061, DOI 10.1161/CIRCRESAHA.120.315895; Rohde David, 2022, Nat Cardiovasc Res, V1, P28, DOI 10.1038/s44161-021-00002-8; Schloss MJ, 2022, NAT IMMUNOL, V23, P605, DOI 10.1038/s41590-022-01165-7; Shao Lijian, 2021, Blood, V137, P775, DOI 10.1182/blood.2019004415; Stroup TS, 2018, WORLD PSYCHIATRY, V17, P341, DOI 10.1002/wps.20567; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang XQ, 2012, HEPATOLOGY, V56, P1557, DOI 10.1002/hep.25820; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521; Zhu FF, 2019, P NATL ACAD SCI USA, V116, P18416, DOI 10.1073/pnas.1906251116	56	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22538	10.1096/fj.202200862R	http://dx.doi.org/10.1096/fj.202200862R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H7GU	36065631	hybrid			2022-12-28	WOS:000850045500001
J	Zha, LF; Wang, JL; Cheng, X				Zha, Ling-Feng; Wang, Jing-Lin; Cheng, Xiang			The effects of RNA methylation on immune cells development and function	FASEB JOURNAL			English	Review						epigenetics; immune cells; methylation; modification; RNA	MESSENGER-RNA; BIOLOGICAL FUNCTIONS; M(6)A MODIFICATION; METHYLTRANSFERASE; N-6-METHYLADENOSINE; TRANSLATION; NUCLEAR; RECOGNITION; COMPLEX; DEMETHYLATION	Among the more than 170 known RNA modifications, methylation modification is the most frequent and well-studied. Depending on where the methylation occurs, RNA methylation can be classified as N-6-methyladenosine, N-1-methyladenosine, 5-methylcytosine, N-7-methylguanosine, and others. The methylation of RNA is constantly and dynamically modified in the complex microenvironment by methyltransferases, demethylases, and methylation reading proteins. These changes affect the proliferation and differentiation of immune cells as well as their effector activities by affecting RNA location, activity, stability, and translation efficiency. This review outlines how diverse RNA methylation alterations affect immune cell development and biological activity, as well as the role of RNA methylation in health and disease, to provide a molecular basis for future immunotherapies.	[Zha, Ling-Feng; Wang, Jing-Lin; Cheng, Xiang] Huazhong Univ Sci & Technol, Hubei Key Lab Biol Targeted Therapy, Tongji Med Coll,Union Hosp,Dept Cardiol, Hubei Prov Engn Res Ctr Immunol Diag & Therapy Ca, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Hubei Key Lab Biol Targeted Therapy, Tongji Med Coll,Union Hosp,Dept Cardiol, Hubei Prov Engn Res Ctr Immunol Diag & Therapy Ca, Wuhan 430022, Peoples R China.	nathancx@hust.edu.cn			National Natural Science Foundation of China [82200319]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China for Ling Feng Zha (No. 82200319) funded this study.	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alexandrov A, 2005, RNA, V11, P821, DOI 10.1261/rna.2030705; Anderson NR, 2021, CANCER RES, V81, P1201, DOI 10.1158/0008-5472.CAN-20-2990; Bakos O, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0398-7; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Berulava T, 2020, EUR J HEART FAIL, V22, P54, DOI 10.1002/ejhf.1672; Chelmicki T, 2021, NATURE, V591, P312, DOI 10.1038/s41586-020-03135-1; Chen X, 2019, NAT CELL BIOL, V21, P978, DOI 10.1038/s41556-019-0361-y; Chen YB, 2021, AUTOPHAGY, V17, P457, DOI 10.1080/15548627.2020.1720431; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Cooley S, 2018, BLOOD, V131, P1053, DOI 10.1182/blood-2017-08-752170; Courtney DG, 2019, CELL HOST MICROBE, V26, P217, DOI 10.1016/j.chom.2019.07.005; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Doring Y, 2020, CIRC RES, V126, P787, DOI 10.1161/CIRCRESAHA.119.316142; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dong LH, 2021, CANCER CELL, V39, P945, DOI 10.1016/j.ccell.2021.04.016; Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Du J, 2020, DEV CELL, V55, P737, DOI 10.1016/j.devcel.2020.10.023; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Galloway A, 2021, NUCLEIC ACIDS RES, V49, P6722, DOI 10.1093/nar/gkab465; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Geng QS, 2021, CANCER MANAG RES, V13, P7989, DOI 10.2147/CMAR.S331549; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gonatopoulos-Pournatzis T, 2014, BIOCHEM J, V457, P231, DOI 10.1042/BJ20131214; Grenov AC, 2021, J EXP MED, V218, DOI 10.1084/jem.20210360; Gu XF, 2020, CELL SIGNAL, V69, DOI 10.1016/j.cellsig.2020.109553; Guo GQ, 2021, MOL THER-NUCL ACIDS, V26, P575, DOI 10.1016/j.omtn.2021.08.020; Guo GQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00430; Guo M, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106800; Guy MP, 2014, RNA BIOL, V11, P1608, DOI 10.1080/15476286.2015.1008360; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huang ZD, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.657547; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li XY, 2017, MOL CELL, V68, P993, DOI 10.1016/j.molcel.2017.10.019; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Lin JY, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/2830565; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu JD, 2021, NATURE, V591, P322, DOI 10.1038/s41586-021-03313-9; Liu J, 2019, IMMUNITY, V50, P600, DOI 10.1016/j.immuni.2019.01.021; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu J, 2019, TRENDS CELL BIOL, V29, P487, DOI 10.1016/j.tcb.2019.02.008; Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu Y, 2021, CELL METAB, V33, P1221, DOI 10.1016/j.cmet.2021.04.001; Liu YH, 2019, AM J PHYSIOL-CELL PH, V317, pC762, DOI 10.1152/ajpcell.00212.2019; Luo Q, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5735279; Luo Q, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8193895; Luo Q, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1298; Luo YH, 2016, CIRC RES, V118, P944, DOI 10.1161/CIRCRESAHA.115.307674; Ma SB, 2021, J EXP MED, V218, DOI 10.1084/jem.20210279; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; Mathlin J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134684; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Mo XB, 2019, J NEUROL, V266, P2699, DOI 10.1007/s00415-019-09476-w; Mo XB, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00299; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Murphy AJ, 2021, NAT REV IMMUNOL, V21, P669, DOI 10.1038/s41577-021-00580-5; Nachtergaele S, 2018, ANNU REV GENET, V52, P349, DOI 10.1146/annurev-genet-120417-031522; Nair L, 2021, MOL CELL, V81, P3949, DOI 10.1016/j.molcel.2021.07.037; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Ounap K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075686; Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605; Pan JF, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.657466; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Qin XP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00689; Qiu WN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21904-y; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Roundtree IA, 2016, TRENDS GENET, V32, P320, DOI 10.1016/j.tig.2016.03.006; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Schiff D, 2019, NEURO-ONCOLOGY, V21, P837, DOI 10.1093/neuonc/noz033; Seijkens TTP, 2018, J AM COLL CARDIOL, V71, P527, DOI 10.1016/j.jacc.2017.11.055; Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shulman Z, 2020, NAT IMMUNOL, V21, P501, DOI 10.1038/s41590-020-0650-4; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Song DD, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.659628; Song H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25803-0; Song HW, 2019, AUTOPHAGY, V15, P1419, DOI 10.1080/15548627.2019.1586246; Sreejit G, 2020, CIRCULATION, V141, P1080, DOI 10.1161/CIRCULATIONAHA.119.043833; Su R, 2022, NAT CELL BIOL, V24, P205, DOI 10.1038/s41556-021-00835-2; Sun T, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108613; Tong JY, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd4742; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; Uddin MB, 2020, THERANOSTICS, V10, P3164, DOI 10.7150/thno.41687; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Vilela R, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00014-18; Waku T, 2016, J CELL SCI, V129, P2382, DOI 10.1242/jcs.183723; Wang BB, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.692130; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang JH, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/3120391; Wang N, 2017, BIOCHEM BIOPH RES CO, V493, P94, DOI 10.1016/j.bbrc.2017.09.069; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang YN, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.591629; Wei JB, 2022, SCIENCE, V376, P968, DOI 10.1126/science.abe9582; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wiener D, 2021, NAT REV GENET, V22, P119, DOI 10.1038/s41576-020-00295-8; Wu R, 2019, CELL RES, V29, P23, DOI 10.1038/s41422-018-0113-8; Xu WQ, 2021, NATURE, V591, P317, DOI 10.1038/s41586-021-03210-1; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Yang Y, 2019, MOL CELL, V75, P1188, DOI 10.1016/j.molcel.2019.06.033; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yao YP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21594-6; Yin HL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21514-8; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zhang CY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00922; Zhang GQ, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28547-7; Zhang LS, 2019, MOL CELL, V74, P1304, DOI 10.1016/j.molcel.2019.03.036; Zhang XQ, 2021, J CELL MOL MED, V25, P3634, DOI 10.1111/jcmm.16469; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhao YS, 2019, TRANSL ONCOL, V12, P1323, DOI 10.1016/j.tranon.2019.06.007; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830; Zheng Z, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107819; Zhou J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg0470; Zhou KI, 2018, NAT CELL BIOL, V20, P230, DOI 10.1038/s41556-018-0046-y; Zhou MJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.794754; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152; Zhu YY, 2019, J EXP MED, V216, P1664, DOI 10.1084/jem.20190337	138	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22552	10.1096/fj.202200716R	http://dx.doi.org/10.1096/fj.202200716R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N7UF	36111987				2022-12-28	WOS:000854221000001
J	Assis, AD; Chiarotto, GB; da Silva, NS; Simoes, GF; Oliveira, ALR				Assis, Alex Dias; Chiarotto, Gabriela Bortolanca; da Silva, Natalia Scanavachia; Simoes, Gustavo Ferreira; Rodrigues Oliveira, Alexandre Leite			Pregabalin synchronizes the regeneration of nerve and muscle fibers optimizing the gait recovery of MDX dystrophic mice	FASEB JOURNAL			English	Article						DMD; MDX; nervous injury; nervous system; pregabalin therapy	DUCHENNE MUSCULAR-DYSTROPHY; SPINAL-CORD-INJURY; AXONAL REGENERATION; NEUROPATHIC PAIN; PURKINJE-CELLS; MESSENGER-RNA; EXPRESSION; GABAPENTIN; SUBUNIT; BINDING	Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder induced by mutations in the dystrophin gene, leading to a degeneration of muscle fibers, triggering retrograde immunomodulatory, and degenerative events in the central nervous system. Thus, neuroprotective drugs such as pregabalin (PGB) can improve motor function by modulating plasticity, together with anti-inflammatory effects. The present work aimed to study the effects of PGB on axonal regeneration after axotomy in dystrophic and non-dystrophic mice. For that, MDX and C57BL/10 mouse strains were subjected to peripheral nerve damage and were treated with PGB (30 mg/kg/day, i.p.) for 28 consecutive days. The treatment was carried out in mice as soon as they completed 5 weeks of life, 1 week before the lesion, corresponding to the peak period of muscle degeneration in the MDX strain. Six-week-old mice were submitted to unilateral sciatic nerve crush and were sacrificed in the 9th week of age. The ipsi and contralateral sciatic nerves were processed for immunohistochemistry and qRT-PCR, evaluating the expression of proteins and gene transcripts related to neuronal and Schwann cell activity. Cranial tibial muscles were dissected for evaluation of neuromuscular junctions using alpha-bungarotoxin, and the myelinated axons of the sciatic nerve were analyzed by morphometry. The recovery of motor function was monitored throughout the treatment through tests of forced locomotion (rotarod) and spontaneous walking track test (Catwalk system). The results show that treatment with PGB reduced the retrograde cyclic effects of muscle degeneration/regeneration on the nervous system. This fact was confirmed after peripheral nerve injury, showing better adaptation and response of neurons and glia for rapid axonal regeneration, with efficient muscle targeting and regain of function. No side effects of PGB treatment were observed, and the expression of pro-regenerative proteins in neurons and Schwann cells was upregulated. Morphometry of the axons was in line with the preservation of motor endplates, resulting in enhanced performance of dystrophic animals. Overall, the present data indicate that pregabalin is protective and enhances regeneration of the SNP during the development of DMD, improving motor function, which can, in turn, be translated to the clinic.	[Assis, Alex Dias; Chiarotto, Gabriela Bortolanca; da Silva, Natalia Scanavachia; Simoes, Gustavo Ferreira; Rodrigues Oliveira, Alexandre Leite] Univ Campinas UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz,Rua Monteiro Lobato 255, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Oliveira, ALR (corresponding author), Univ Campinas UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz,Rua Monteiro Lobato 255, BR-13083970 Campinas, SP, Brazil.	alroliv@unicamp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/05006-0, 2015/14385-7]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303085/20170-7, 446609/2014-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: 2018/05006-0 and 2015/14385-7; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 303085/20170-7 and 446609/2014-5	Assis AD, 2021, MOL CELL NEUROSCI, V114, DOI 10.1016/j.mcn.2021.103632; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bian F, 2006, BRAIN RES, V1075, P68, DOI 10.1016/j.brainres.2005.12.084; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Burns DP, 2019, J PHYSIOL-LONDON, V597, P831, DOI 10.1113/JP277443; Caudal D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230083; Celik M, 2015, INT J NEUROSCI, V125, P845, DOI 10.3109/00207454.2014.978976; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; Cullheim S, 2002, BRAIN RES REV, V40, P309, DOI 10.1016/S0165-0173(02)00213-8; Cunningham MO, 2004, EUR J NEUROSCI, V20, P1566, DOI 10.1111/j.1460-9568.2004.03625.x; Daneshdoust D, 2017, NEUROSCIENCE, V344, P148, DOI 10.1016/j.neuroscience.2016.12.037; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Dooley DJ, 2000, J PHARMACOL EXP THER, V295, P1086; Fink K, 2002, NEUROPHARMACOLOGY, V42, P229, DOI 10.1016/S0028-3908(01)00172-1; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Haastert-Talini K., 2017, MODERN CONCEPTS PERI, P127; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Joshi I, 2006, EUR J PHARMACOL, V553, P82, DOI 10.1016/j.ejphar.2006.09.019; Krishnan VS, 2020, MOL CELL NEUROSCI, V105, DOI 10.1016/j.mcn.2020.103484; Kueh SLL, 2008, CLIN EXP PHARMACOL P, V35, P207, DOI 10.1111/j.1440-1681.2007.04816.x; Kueh SLL, 2011, NEUROBIOL DIS, V43, P558, DOI 10.1016/j.nbd.2011.05.002; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; Kwak D., 2020, INT J ENV RES PUBLIC, V17, P1; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Li M, 2005, ACTA PHARMACOL SIN, V26, P192, DOI 10.1111/j.1745-7254.2005.00522.x; LINDA H, 1992, EXP BRAIN RES, V91, P284; LU X, 1994, BRAIN RES, V652, P174, DOI 10.1016/0006-8993(94)90335-2; MAYHEW TM, 1984, J ANAT, V139, P45; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Meymandi MS, 2017, INFLAMMOPHARMACOLOGY, V25, P237, DOI 10.1007/s10787-017-0325-4; MIRA JC, 1979, J ANAT, V129, P77; NAGEL A, 1990, MUSCLE NERVE, V13, P742, DOI 10.1002/mus.880130813; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Patel AM, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0535-1; Pearce JMS, 2005, EUR NEUROL, V54, P46, DOI 10.1159/000087386; Personius KE, 2005, MUSCLE NERVE, V32, P656, DOI 10.1002/mus.20405; Piehl F, 1998, EXP BRAIN RES, V119, P191, DOI 10.1007/s002210050333; RASMINSKY M, 1978, BRAIN RES, V143, P71, DOI 10.1016/0006-8993(78)90753-9; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; Krishnan VS, 2020, MOL CELL NEUROSCI, V108, DOI 10.1016/j.mcn.2020.103549; Schopf CL., 2021, P NATL ACAD SCI USA, V118, P1; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Silva GAA, 2014, BRAIN BEHAV, V4, P925, DOI 10.1002/brb3.276; Simoes GF, 2010, NEUROPATH APPL NEURO, V36, P55, DOI 10.1111/j.1365-2990.2009.01033.x; Simoes GF, 2014, BRAIN BEHAV, V4, P738, DOI 10.1002/brb3.250; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Stay TL, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.040840; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Sun CM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080837; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.01.013; Tedeschi A, 2016, NEURON, V92, P419, DOI 10.1016/j.neuron.2016.09.026; Tierney M, 2016, MUSCLE NERVE, V54, P763, DOI 10.1002/mus.25115; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Venugopal V., 2021, DUCHENNE MUSCULAR DY; Vidal CJ, 2013, CHEM-BIOL INTERACT, V203, P330, DOI 10.1016/j.cbi.2012.08.001; XIN L, 1990, BRAIN RES, V510, P144, DOI 10.1016/0006-8993(90)90741-S; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x	65	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22511	10.1096/fj.202200411RR	http://dx.doi.org/10.1096/fj.202200411RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X8TC	35998000				2022-12-28	WOS:000843305900001
J	Deng, DJ; Wang, X; Yue, KY; Wang, YM; Jin, QW				Deng, Da-Jie; Wang, Xi; Yue, Kai-Ye; Wang, Yamei; Jin, Quan-Wen			Analysis of the potential role of fission yeast PP2A in spindle assembly checkpoint inactivation	FASEB JOURNAL			English	Article						fission yeast; PP2A; spindle checkpoint inactivation	PROTEIN PHOSPHATASE 1; MITOTIC EXIT; REGULATORY SUBUNITS; AAA-ATPASE; PROMOTES; COMPLEX; CDC20; APC/C; KINETOCHORES; MPS1	As a surveillance mechanism, the activated spindle assembly checkpoint (SAC) potently inhibits the E3 ubiquitin ligase APC/C (anaphase-promoting complex/cyclosome) to ensure accurate chromosome segregation. Although the protein phosphatase 2A (PP2A) has been proposed to be both, directly and indirectly, involved in spindle assembly checkpoint inactivation in mammalian cells, whether it is similarly operating in the fission yeast Schizosaccharomycer pombe has never been demonstrated. Here, we investigated whether fission yeast PP2A is involved in SAC silencing by following the rate of cyclin B (Cdc13) destruction at SPBs during the recovery phase in nda3-KM311 cells released from the inhibition of APC/C by the activated spindle checkpoint. The timing of the SAC inactivation is only slightly delayed when two B56 regulatory subunits (Par1 and Par2) of fission yeast PP2A are absent. Overproduction of individual PP2A subunits either globally in the nda3-KM311 arrest-and-release system or locally in the synthetic spindle checkpoint activation system only slightly suppresses the SAC silencing defects in PP1 deletion (dis2 Delta) cells. Our study thus demonstrates that the fission yeast PP2A is not a key regulator actively involved in SAC inactivation.	[Deng, Da-Jie; Wang, Xi; Yue, Kai-Ye; Wang, Yamei; Jin, Quan-Wen] Xiamen Univ, Fac Med & Life Sci, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China	Xiamen University	Wang, YM; Jin, QW (corresponding author), Xiamen Univ, Fac Med & Life Sci, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.	jinquanwen@xmu.edu.cn		Jin, Quan-wen/0000-0001-6146-6910	National Natural Science Foundation of China [31871362, 31671411]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31871362 and 31671411; National Natural Science Foundation of China, Grant/Award Number: 31871362 and 31671411	Alfieri C, 2018, NATURE, V559, P274, DOI 10.1038/s41586-018-0281-1; Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Amin P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219766; Aravamudhan P, 2015, NAT CELL BIOL, V17, P868, DOI 10.1038/ncb3179; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bokros M, 2016, CELL REP, V14, P1074, DOI 10.1016/j.celrep.2016.01.007; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen C, 2019, CURR BIOL, V29, P104, DOI 10.1016/j.cub.2018.11.054; Chen YH, 2017, J CELL SCI, V130, P1003, DOI 10.1242/jcs.198457; Cordeiro MH, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002020; Cullati SN, 2020, MOL CELL, V82, P2006, DOI 10.1016/j.molcel.2022.03.005; Espert A, 2014, J CELL BIOL, V206, P833, DOI 10.1083/jcb.201406109; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujimitsu K, 2020, EMBO REP, V21, DOI 10.15252/embr.201948503; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hayward D, 2019, J CELL BIOL, V218, P3188, DOI 10.1083/jcb.201905026; Hein JB, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012081; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Jiang W, 2000, GENETICS, V154, P1025; Jin FZ, 2013, P NATL ACAD SCI USA, V110, P21036, DOI 10.1073/pnas.1307595111; Kapanidou M, 2017, TRENDS BIOCHEM SCI, V42, P193, DOI 10.1016/j.tibs.2016.12.001; Kim T, 2017, GENE DEV, V31, P1089, DOI 10.1101/gad.302067.117; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Labit H, 2012, EMBO J, V31, P3351, DOI 10.1038/emboj.2012.168; Lee SJ, 2017, J CELL SCI, V130, P1760, DOI 10.1242/jcs.201608; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mao YJ, 2011, ANAL BIOCHEM, V415, P21, DOI 10.1016/j.ab.2011.04.004; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moura M, 2017, ELIFE, V6, DOI 10.7554/eLife.25366; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Rossio V, 2013, J CELL SCI, V126, P4396, DOI 10.1242/jcs.127365; Ruggiero A, 2020, CURR BIOL, V30, P335, DOI 10.1016/j.cub.2019.11.054; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Sewart K, 2017, CURR BIOL, V27, P1213, DOI 10.1016/j.cub.2017.03.007; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; Sivakumar S, 2016, ELIFE, V5, DOI 10.7554/eLife.12902; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tange Y, 2008, GENETICS, V179, P785, DOI 10.1534/genetics.107.081695; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Trautmann S, 2004, DEV CELL, V7, P755, DOI 10.1016/j.devcel.2004.10.006; Vagnarelli P, 2021, SEMIN CELL DEV BIOL, V117, P140, DOI 10.1016/j.semcdb.2021.03.010; Vanoosthuyse V, 2009, MOL BIOL CELL, V20, P5096, DOI 10.1091/mbc.E09-09-0762; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wang YM, 2012, MOL BIOL CELL, V23, P3348, DOI 10.1091/mbc.E11-12-1020; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yuan I, 2017, CURR BIOL, V27, P137, DOI 10.1016/j.cub.2016.11.014; Zhang G, 2014, J CELL SCI, V127, P871, DOI 10.1242/jcs.139725	83	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22524	10.1096/fj.202101884R	http://dx.doi.org/10.1096/fj.202101884R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Z1YW	36006032				2022-12-28	WOS:000844217200001
J	Yue, YY; Wang, YC; Liao, ZX; Hu, FY; Liu, QY; Dong, J; Zhong, M; Chen, MH; Pan, YM; Zhong, H; Shang, J				Yue, Yun-yun; Wang, Yi-chuan; Liao, Zi-xian; Hu, Fang-yuan; Liu, Qiu-yan; Dong, Jing; Zhong, Min; Chen, Ming-han; Pan, Yu-min; Zhong, Hui; Shang, Jing			Peripheral benzodiazepine receptor TSPO needs to be reconsidered before using as a drug target for a pigmentary disorder	FASEB JOURNAL			English	Article						drug target; melanogenesis; Ro5-4864; TSPO; zebrafish	L-TYROSINE; TRANSLOCATOR; BINDING; LIGAND; STEROIDOGENESIS; MELANOGENESIS; CHOLESTEROL; REGULATORS; DISEASE; MOUSE	The peripheral benzodiazepine receptor (TSPO/PBR) is highly conserved among different species but with perplexing biochemical functions. Multiple ligands of TSPO show commendable regulatory activities in lots of biological functions, such as neuro-protection, cholesterol transport, and so on. These researches support that TSPO may be a potential target for disease treatment and drug development. Previous studies have shown that its ligands benzodiazepines show a satisfactory effect on melanogenic promotion. However, the potential application of TSPO in drug development for pigmentary disorder needs further investigation. In this study, we confirmed the melanogenesis induction of TSPO ligand, Ro5-4864 in mouse melanoma cell lines, human skin tissue, and zebrafish embryos by inducing melanin synthesis and melanosome transport. Molecular genetics and pharmacological studies showed that TSPO deficiency did not affect melanin production in B16F10 cells and zebrafish embryos, nor did it affect the melanin promotion effect of Ro5-4864. Whether or not TSPO exists, the expression of lots of melanogenesis-related proteins, such as TYR, TRP-1, DCT, Mlph, and Rab27 was upregulated with the Ro5-4864 administration. These results indicated that Ro5-4864 induces melanogenesis in a TSPO-independent manner, which is inconsistent with previous research. This research is a reminder that we need to be very careful during target validation in drug development.	[Yue, Yun-yun; Wang, Yi-chuan; Liao, Zi-xian; Hu, Fang-yuan; Liu, Qiu-yan; Dong, Jing; Zhong, Min; Chen, Ming-han; Zhong, Hui; Shang, Jing] China Pharmaceut Univ, Sch Tradit Chinese Pharm, 639 Longmian Rd, Nanjing 210009, Jiangsu, Peoples R China; [Pan, Yu-min] Guangxi Normal Univ, Sch Chem & Pharm, Guilin, Peoples R China; [Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Peoples R China; [Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Peoples R China; [Shang, Jing] Natl Inst Food & Drug Control, NMPA Key Lab Res & Evaluat Cosmet, Beijing, Peoples R China	China Pharmaceutical University; Guangxi Normal University; China Pharmaceutical University; China Pharmaceutical University; National Institute of Food & Drug Control - China	Zhong, H; Shang, J (corresponding author), China Pharmaceut Univ, Sch Tradit Chinese Pharm, 639 Longmian Rd, Nanjing 210009, Jiangsu, Peoples R China.	cpuzhonghui@126.com; shangjing21cn@cpu.edu.cn			college of Life Science and Technology of China Pharmaceutical University; National Natural Science Foundation of China [81874331]	college of Life Science and Technology of China Pharmaceutical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We express our gratitude to Professor Ming Ding from the college of Life Science and Technology of China Pharmaceutical University for their support of proteomic experiments and analysis in this research. In addition, we appreciate Professor Yibei Xiao from the School of Pharmacy of China Pharmaceutical University for their support of prokaryotic expression and purification of TSPO protein. Thanks for their help on experiments and useful advice. This work was supported by the National Natural Science Foundation of China (No. 81874331).	Alamri A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061387; Allen JR, 2020, PIGM CELL MELANOMA R, V33, P416, DOI 10.1111/pcmr.12836; Arbo BD, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100943; Bonsack F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061694; Cooper CD, 2017, DEV DYNAM, V246, P889, DOI 10.1002/dvdy.24550; Costa B, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.114015; Costa B, 2016, ACS CHEM NEUROSCI, V7, P1041, DOI 10.1021/acschemneuro.6b00149; Denora N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122640; Dixon T, 2021, BIOPHYS J, V120, P158, DOI 10.1016/j.bpj.2020.11.015; Fan JJ, 2018, ENDOCRINOLOGY, V159, P1130, DOI 10.1210/en.2017-03065; Fu Y, 2020, NEURO-ONCOLOGY, V22, P240, DOI 10.1093/neuonc/noz183; Georges E., 2021, J BIOCHEM, V170, P239; Germelli L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063115; Gut P, 2015, TRENDS ENDOCRIN MET, V26, P349, DOI 10.1016/j.tem.2015.04.001; Jaipuria G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14893; Kim T, 2021, J ENZYM INHIB MED CH, V36, P831, DOI 10.1080/14756366.2021.1900158; Lacapere JJ, 2020, TRENDS PHARMACOL SCI, V41, P110, DOI 10.1016/j.tips.2019.11.005; Li F, 2015, SCIENCE, V350, DOI 10.1126/science.aab2595; Li F, 2015, PHARMACOL RES, V99, P404, DOI 10.1016/j.phrs.2015.03.022; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li YC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102457; Liu L, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091344; Lv JP, 2019, INT J BIOCHEM CELL B, V116, DOI 10.1016/j.biocel.2019.105620; Ma BJ, 2018, MOL PAIN, V14, DOI 10.1177/1744806917748019; Ma L, 2016, BRAIN RES BULL, V121, P192, DOI 10.1016/j.brainresbull.2016.02.001; MATTHEW E, 1981, P NATL ACAD SCI-BIOL, V78, P3935, DOI 10.1073/pnas.78.6.3935; Meng Y, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109588; Middleton RJ, 2015, BIOCHEM SOC T, V43, P553, DOI 10.1042/BST20150039; Midzak A, 2015, BIOCHEM SOC T, V43, P572, DOI 10.1042/BST20150061; Moosmann B, 2019, DRUG TEST ANAL, V11, P541, DOI 10.1002/dta.2561; Ohbayashi Norihiko, 2020, F1000Res, V9, DOI 10.12688/f1000research.24625.1; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Scarf AM, 2009, J MED CHEM, V52, P581, DOI 10.1021/jm8011678; Selvaraj V, 2016, J ENDOCRINOL, V231, pR1, DOI 10.1530/JOE-16-0241; Shang C, 2020, BEHAV BRAIN RES, V379, DOI 10.1016/j.bbr.2019.112320; Shi Y, 2022, NAT NEUROSCI, V25, P317, DOI 10.1038/s41593-022-01013-9; SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Vibert L, 2017, PIGM CELL MELANOMA R, V30, P219, DOI 10.1111/pcmr.12568; Werry EL, 2015, BIOCHEM SOC T, V43, P531, DOI 10.1042/BST20150015; Xie Q, 2021, PHOTODIAGN PHOTODYN, V34, DOI 10.1016/j.pdpdt.2021.102209; Yao RM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00986; Zhou SQ, 2021, BIOCHEM BIOPHYS REP, V26, DOI 10.1016/j.bbrep.2021.100949	49	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22454	10.1096/fj.202101746RR	http://dx.doi.org/10.1096/fj.202101746RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X9JD	35839067				2022-12-28	WOS:000825512200001
J	Zhang, LC; Wang, LF; Xiang, SY; Hu, YY; Zhao, SY; Liao, Y; Zhu, ZF; Wu, XY				Zhang, Lichao; Wang, Lifu; Xiang, Suoyu; Hu, Yunyi; Zhao, Siyu; Liao, Yao; Zhu, Zifeng; Wu, Xiaoying			CRISPR/Cas9-mediated gene knockout of Sj16 in Schistosoma japonicum eggs upregulates the host-to-egg immune response	FASEB JOURNAL			English	Article						CRISPR/Cas9; IL-1 beta; Schistosoma japonicum; Sj16; T-cell immunity	IFN-GAMMA; CELLS; INFLAMMATION; PROTEIN; RSJ16; SUPPRESSION; IL-1-BETA; WORMS; IL-4	Schistosomiasis is an important, neglected tropical disease. Schistosoma japonicum can evade host attacks by regulating the host's immunity, causing continuous infection. However, interactions between the host's immune system and S. japonicum are unclear. Our previous research found that the Sj16 protein isolated from S. japonicum has an anti-inflammatory effect in the host. However, the role of Sj16 in the regulation of host immunity in S. japonicum infection is not clear. Here, we applied the CRISPR/Cas9 technique to knockout Sj16 in S. japonicum eggs and investigated the effect of Sj16 in regulating host immunity. We found egg viability decreased after Sj16 knockout. In addition, we found granulomatous inflammation increased, the T-cell immune response enhanced and the immune microenvironment changed in mice model injected with Sj16-knockout eggs by tail vein. These findings suggested that S. japonicum could regulate host immunity through Sj16 to evade the host immune attack and cause continuous infection. In addition, we confirmed the application of CRISPR/Cas9-mediated gene reprogramming for functional genomics in S. japonicum.	[Zhang, Lichao; Wang, Lifu; Xiang, Suoyu; Hu, Yunyi; Zhao, Siyu; Liao, Yao; Zhu, Zifeng; Wu, Xiaoying] Sun Yat Sen Univ, Dept Parasitol Zhongshan, Sch Med, Guangzhou, Peoples R China; [Zhang, Lichao; Xiang, Suoyu; Hu, Yunyi; Zhao, Siyu; Liao, Yao; Zhu, Zifeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Peoples R China; [Zhang, Lichao; Xiang, Suoyu; Hu, Yunyi; Zhao, Siyu; Liao, Yao; Zhu, Zifeng] Pmvincial Engn Technol Res Ctr Biol Vector Contro, Guangzhou, Peoples R China; [Wang, Lifu] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou Key Lab Clin Rapid Diag & Early Warning, Guangzhou, Peoples R China; [Wu, Xiaoying] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 3, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Wu, XY (corresponding author), Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 3, Guangzhou, Peoples R China.	wuxy227@mail.sysu.edu.cn			National Natural Science Foundation of China (NSFC) [81871682, 81902081]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2020A1515011573]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81871682 and 81902081; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2020A1515011573	Anders HJ, 2016, J AM SOC NEPHROL, V27, P2564, DOI 10.1681/ASN.2016020177; Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Barnett R, 2018, LANCET, V392, P2431, DOI 10.1016/S0140-6736(18)33008-3; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Campanati A, 2014, ARCH DERMATOL RES, V306, P915, DOI 10.1007/s00403-014-1493-3; Chen DH, 2016, IMMUNOLOGY, V149, P25, DOI 10.1111/imm.12623; Cheng YL, 2008, PARASITOL RES, V102, P1129, DOI 10.1007/s00436-008-0880-0; Cui J, 2014, HUM VACC IMMUNOTHER, V10, P3270, DOI 10.4161/21645515.2014.979640; Degboe Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00003; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dong BL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006237; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Gao YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082480; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Hosokawa I, 2016, INFLAMMATION, V39, P1520, DOI 10.1007/s10753-016-0386-3; Hu SM, 2012, J PARASITOL, V98, P274, DOI 10.1645/GE-2692.1; Hu SM, 2009, INT J PARASITOL, V39, P191, DOI 10.1016/j.ijpara.2008.06.017; Ittiprasert W, 2019, ELIFE, V8, DOI 10.7554/eLife.41337; Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kogan-Sakin I, 2009, CARCINOGENESIS, V30, P698, DOI 10.1093/carcin/bgp043; Kong DL, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3729-8; Li XH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003925; Liu X, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00732-19; Lu LX, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1010596; Lu LX, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008909; Lu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08689-1; Lundy SK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00039; Mahnke K, 2005, CURR TOP MICROBIOL, V293, P133, DOI 10.1007/3-540-27702-1_7; Masamba P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137216; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Santana JB, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.605235; Schwartz C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02492; Shen J, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3697-z; Sun X, 2010, PARASITE IMMUNOL, V32, P739, DOI 10.1111/j.1365-3024.2010.01240.x; Sun XJ, 2012, PARASITE IMMUNOL, V34, P430, DOI 10.1111/j.1365-3024.2012.01377.x; Sun X, 2012, PARASITOL RES, V110, P2429, DOI 10.1007/s00436-011-2782-9; Tallima H, 2009, CYTOKINE, V48, P239, DOI 10.1016/j.cyto.2009.07.581; Uchiyama R, 2017, J IMMUNOL, V199, P1122, DOI 10.4049/jimmunol.1601373; Vennervald BJ, 2004, CURR OPIN INFECT DIS, V17, P439, DOI 10.1097/00001432-200410000-00009; Wang JP, 2020, SCIENCE, V369, P1649, DOI 10.1126/science.abb7699; Wang LF, 2021, BIOENG TRANSL MED, V6, DOI 10.1002/btm2.10219; Wang LF, 2017, THERANOSTICS, V7, P3446, DOI 10.7150/thno.20359; WARREN KS, 1975, AM J PATHOL, V80, P279; Wendt G, 2020, SCIENCE, V369, P1644, DOI 10.1126/science.abb7709; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Xie H, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.617461; You H, 2021, FASEB J, V35, DOI 10.1096/fj.202001745RR; Zhang AP, 2020, CELL IMMUNOL, V352, DOI 10.1016/j.cellimm.2020.104113; Zhang YM, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-05006-8; Zhang YX, 2012, EUR J IMMUNOL, V42, P1523, DOI 10.1002/eji.201141933; Zheng B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00061; Zhou S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005094	55	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22615	10.1096/fj.202200600RR	http://dx.doi.org/10.1096/fj.202200600RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5M6JH	36273308				2022-12-28	WOS:000871204600001
J	Katagiri, W; Yokomizo, S; Ishizuka, T; Yamashita, K; Kopp, T; Roessing, M; Sato, A; Iwasaki, T; Sato, H; Fukuda, T; Monaco, H; Manganiello, S; Nomura, S; Ng, MR; Feil, S; Ogawa, E; Fukumura, D; Atochin, DN; Choi, HS; Kashiwagi, S				Katagiri, Wataru; Yokomizo, Shinya; Ishizuka, Takanobu; Yamashita, Keiko; Kopp, Timo; Roessing, Malte; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki; Fukuda, Takeshi; Monaco, Hailey; Manganiello, Sophia; Nomura, Shinsuke; Ng, Mei Rosa; Feil, Susanne; Ogawa, Emiyu; Fukumura, Dai; Atochin, Dmitriy N.; Choi, Hak Soo; Kashiwagi, Satoshi			Dual near-infrared II laser modulates the cellular redox state of T cells and augments the efficacy of cancer immunotherapy	FASEB JOURNAL			English	Article						immunotherapy; multispectral near-infrared II laser; photobiomodulation; T cell exhaustion; tumor microenvironment	TUMOR-INFILTRATING LYMPHOCYTES; CYTOCHROME-C-OXIDASE; BIPHASIC DOSE-RESPONSE; NITRIC-OXIDE; STANDARDIZED METHOD; MULTIPLE ROLES; SOLID TUMORS; ACTIVATION; THERAPY; MECHANISMS	Immunotherapy, including immune checkpoint inhibitors, has revolutionized cancer treatment, but only a minor fraction of patients shows durable responses. A new approach to overcome this limitation is yet to be identified. Recently, we have shown that photobiomodulation (PBM) with near-infrared (NIR) light in the NIR-II window reduces oxidative stress and supports the proliferation of CD8(+) T cells, suggesting that PBM with NIR-II light could augment anti-cancer immunity. Here, we report a novel approach to support tumor-infiltrating CD8(+) T cells upon PBM with NIR-II laser with high tissue penetration depth. Brief treatments of a murine model of breast cancer with dual 1064 and 1270 nm lasers reduced the expression of the programmed cell death protein 1 (PD-1) in CD8(+) T cells in a syngeneic mouse model of breast cancer. The direct effect of the NIR-II laser treatment on T cells was confirmed by the enhanced tumor growth delay by the adoptive transfer of laser-treated CD8(+) T cells ex vivo against a model tumor antigen. We further demonstrated that specific NIR-II laser parameters augmented the effect of the immune checkpoint inhibitor on tumor growth. PBM with NIR-II light augments the efficacy of cancer immunotherapy by supporting CD8(+) T cells. Unlike the current immunotherapy with risks of undesirable drug-drug interactions and severe adverse events, the laser is safe and low-cost. It can be broadly combined with other therapy without modification to achieve clinical significance. In addition, our study established a path to develop a novel laser-based therapy to treat cancer effectively.	[Katagiri, Wataru; Yokomizo, Shinya; Fukuda, Takeshi; Monaco, Hailey; Manganiello, Sophia; Nomura, Shinsuke; Choi, Hak Soo; Kashiwagi, Satoshi] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA; [Katagiri, Wataru] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa, Japan; [Yokomizo, Shinya] Tokyo Metropolitan Univ, Dept Radiol Sci, Arakawa, Japan; [Ishizuka, Takanobu; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki] Terumo Co Ltd, Biores Ctr, Tokyo, Japan; [Ishizuka, Takanobu; Yamashita, Keiko; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki] Terumo Co Ltd, Corp R&D Ctr, Tokyo, Japan; [Kopp, Timo; Roessing, Malte; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem IFIB, Tubingen, Germany; [Nomura, Shinsuke] Univ Miyazaki Hosp, Fac Med, Dept Surg, Miyazaki, Japan; [Ng, Mei Rosa; Fukumura, Dai] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Charlestown, MA 02129 USA; [Ogawa, Emiyu] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Keio University; Tokyo Metropolitan University; Terumo Corporation; Terumo Corporation; Eberhard Karls University of Tubingen; University of Miyazaki; Harvard University; Massachusetts General Hospital; Kitasato University; Harvard University; Massachusetts General Hospital	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA.	skashiwagi@mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019		CMI, Inc.; Deutsche Forschungsgemeinschaft (DFG) [335549539 - GRK 2381]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R01AI105131, R21AI144103]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS096237]; Japan Business Federation; Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Reinhard Frank-Stiftung; Terumo Corporation; Keio University (Keio)	CMI, Inc.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); Japan Business Federation; Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Reinhard Frank-Stiftung; Terumo Corporation; Keio University (Keio)	CMI, Inc., Grant/Award Number: Study abroad scholarship; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 335549539 - GRK 2381; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01AI105131 and R21AI144103; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS096237; Japan Business Federation; Keio University (Keio); Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Reinhard Frank-Stiftung; Terumo Corporation	Ager EI, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv017; BOELENS R, 1983, BIOCHIM BIOPHYS ACTA, V724, P176, DOI 10.1016/0005-2728(83)90136-6; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Frossi B, 2008, MOL IMMUNOL, V45, P58, DOI 10.1016/j.molimm.2007.05.008; Fu GT, 2017, J EXP MED, V214, P1453, DOI 10.1084/jem.20161120; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Gomes-Santos IL, 2021, CANCER IMMUNOL RES, V9, P765, DOI 10.1158/2326-6066.CIR-20-0499; Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002; Halle S, 2016, IMMUNITY, V44, P233, DOI 10.1016/j.immuni.2016.01.010; Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161; Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162; Hu S, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800066; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Incio J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag0945; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Karu T, 2010, PHOTOMED LASER SURG, V28, P159, DOI 10.1089/pho.2010.2789; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Kashiwagi S, 2020, FASEB J, V34, P3485, DOI 10.1096/fj.201902164R; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Katagiri W, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.3.036003; Khan I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10581; Kimizuka Y, 2018, J IMMUNOL, V201, P3587, DOI 10.4049/jimmunol.1701687; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Lee JH, 2012, QUANT IMAGING MED SU, V2, P266, DOI 10.3978/j.issn.2223-4292.2012.12.04; Mellman I, 2016, CANCER IMMUNOL RES, V4, P279, DOI 10.1158/2326-6066.CIR-16-0045; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Murray T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00573; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Owens EA, 2016, ACCOUNTS CHEM RES, V49, P1731, DOI 10.1021/acs.accounts.6b00239; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sanderson TH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25184-3; Sanderson TH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21869-x; Sarti P., 2012, INT J CELL BIOL, V2012; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Sawada J, 2021, AM J PATHOL, V191, P396, DOI 10.1016/j.ajpath.2020.10.009; Scheffel MJ, 2016, CANCER RES, V76, P6006, DOI 10.1158/0008-5472.CAN-16-0587; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Stael Simon, 2022, Methods Mol Biol, V2447, P127, DOI 10.1007/978-1-0716-2079-3_11; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang HY, 2016, IMMUNITY, V44, P782, DOI 10.1016/j.immuni.2016.01.015; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Weinberg F, 2019, CANCERS, V11, DOI 10.3390/cancers11081191; Wilkinson RW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01082; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	66	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22521	10.1096/fj.202200033R	http://dx.doi.org/10.1096/fj.202200033R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4F6SB	36052742				2022-12-28	WOS:000848638600001
J	Cavalu, S; Sharaf, H; Saber, S; Youssef, ME; Abdelhamid, AM; Mourad, AAE; Ibrahim, S; Allam, S; Elgharabawy, RM; El-Ahwany, E; Amin, NA; Shata, A; Eldegla, M; Atef, M; Aboraya, M; Mohamed, M; Anz, N; Abd Elmotelb, D; Gabr, F; Elzablawy, D; Hamada, M; Yehia, A; Osama, D; Mohammed, OA				Cavalu, Simona; Sharaf, Hossam; Saber, Sameh; Youssef, Mahmoud E.; Abdelhamid, Amir Mohamed; Mourad, Ahmed A. E.; Ibrahim, Samar; Allam, Shady; Elgharabawy, Rehab Mohamed; El-Ahwany, Eman; Amin, Noha A.; Shata, Ahmed; Eldegla, Mai; Atef, Marina; Aboraya, Maii; Mohamed, Mayar; Anz, Niera; Abd Elmotelb, Dina; Gabr, Fayrouz; Elzablawy, Dalia; Hamada, Menna; Yehia, Amr; Osama, Dalia; Mohammed, Osama A.			Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-kappa B, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis	FASEB JOURNAL			English	Article						ambroxol hydrochloride; HO-1; NF-kappa B; Nrf2; oxidative stress; ulcerative colitis	FREE-RADICAL PRODUCTION; ESCHERICHIA-COLI; HEME OXYGENASE-1; INFLAMMATORY RESPONSE; LUNG INJURY; MODEL; HYDROCHLORIDE; ACTIVATION; EXPRESSION; PROTECTION	Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology that increases the risk of developing colorectal cancer and imposes a lifelong healthcare burden on millions of patients worldwide. Current treatment strategies are associated with significant risks and have been shown to be fairly effective. Hence, discovering new therapies that have better efficacy and safety profiles than currently exploited therapeutic strategies is challenging. It has been well delineated that NF-kappa B/Nrf2 crosstalk is a chief player in the interplay between oxidative stress and inflammation. Ambroxol hydrochloride, a mucolytic agent, has shown antioxidant and anti-inflammatory activity in humans and animals and has not yet been examined for the management of UC. Therefore, our approach was to investigate whether ambroxol could be effective to combat UC using the common acetic acid rat model. Interestingly, a high dose of oral ambroxol (200 mg/kg/day) reasonably improved the microscopic and macroscopic features of the injured colon. This was linked to low disease activity and a reduction in the colonic weight/length ratio. In the context of that, ambroxol boosted Nrf2 activity and upregulated HO-1 and catalase to augment the antioxidant defense against oxidative damage. Besides, ambroxol inactivated NF-kappa B signaling and its consequent target pro-inflammatory mediators, IL-6 and TNF-alpha. In contrast, IL-10 is upregulated. Consistent with these results, myeloperoxidase activity is suppressed. Moreover, ambroxol decreased the susceptibility of the injured colon to apoptosis. To conclude, our findings highlight the potential application of ambroxol to modify the progression of UC by its anti-inflammatory, antioxidant, and antiapoptotic properties.	[Cavalu, Simona] Univ Oradea, Fac Med & Pharm, P Ta 1 Decembrie 10, Oradea 410087, Romania; [Sharaf, Hossam; Eldegla, Mai; Atef, Marina; Aboraya, Maii; Mohamed, Mayar; Anz, Niera; Abd Elmotelb, Dina; Gabr, Fayrouz; Elzablawy, Dalia; Hamada, Menna; Yehia, Amr; Osama, Dalia] Delta Univ Sci & Technol, Fac Pharm, Dept Biochem, Gamasa, Egypt; [Saber, Sameh; Youssef, Mahmoud E.; Abdelhamid, Amir Mohamed] Delta Univ Sci & Technol, Fac Pharm, Dept Pharmacol, Gamasa, Egypt; [Mourad, Ahmed A. E.] Port Said Univ, Fac Pharm, Dept Pharmacol & Toxicol, Port Said, Egypt; [Ibrahim, Samar] Ahram Canadian Univ, Fac Pharm, Dept Pharm Practice, Giza, Egypt; [Allam, Shady] Menoufia Univ, Fac Pharm, Dept Pharmacol & Toxicol, Menoufia, Egypt; [Elgharabawy, Rehab Mohamed] Tanta Univ, Fac Pharm, Pharmacol & Toxicol Dept, Tanta, Egypt; [El-Ahwany, Eman] Theodor Bilharz Res Inst, Dept Immunol, Giza, Egypt; [Amin, Noha A.] Theodor Bilharz Res Inst, Dept Haematol, Giza, Egypt; [Shata, Ahmed] Mansoura Univ, Fac Med, Dept Clin Pharmacol, Mansoura, Egypt; [Shata, Ahmed] Delta Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Gamasa, Egypt; [Mohammed, Osama A.] Ain Shams Univ, Fac Med, Dept Clin Pharmacol, Cairo, Egypt; [Mohammed, Osama A.] Bisha Univ, Fac Med, Dept Clin Pharmacol, Bisha, Saudi Arabia	University of Oradea; Delta University for Science & Technology; Delta University for Science & Technology; Egyptian Knowledge Bank (EKB); Port Said University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Tanta University; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Egyptian Knowledge Bank (EKB); Mansoura University; Delta University for Science & Technology; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Bisha	Cavalu, S (corresponding author), Univ Oradea, Fac Med & Pharm, P Ta 1 Decembrie 10, Oradea 410087, Romania.	simona.cavalu@gmail.com	CAVALU, SIMONA/AAV-5882-2021; Abdelhamid, Amir Mohamed/ABG-3588-2020	CAVALU, SIMONA/0000-0001-7810-8925; Abdelhamid, Amir Mohamed/0000-0002-8630-2872				Abdelhamid AM, 2021, LIFE SCI, V286, DOI 10.1016/j.lfs.2021.120070; Al-Horani R, 2022, NAT REV DRUG DISCOV, V21, P15, DOI 10.1038/d41573-021-00194-5; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; ARENA/OLAW, 2002, I AN CAR US COMM GUI, V2nd; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bishr A, 2019, CAN J PHYSIOL PHARM, V97, P55, DOI 10.1139/cjpp-2018-0528; Cao DW, 2019, EUR REV MED PHARMACO, V23, P5004, DOI 10.26355/eurrev_201906_18092; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Davinelli S, 2022, MOLECULES, V27, DOI 10.3390/molecules27020502; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dulai PS, 2014, GUT, V63, P1843, DOI 10.1136/gutjnl-2014-307126; El-Rous MA, 2021, INFLAMMOPHARMACOLOGY, V29, P1169, DOI 10.1007/s10787-021-00818-7; Fumery M, 2018, CLIN GASTROENTEROL H, V16, P343, DOI 10.1016/j.cgh.2017.06.016; Glorieux C, 2015, FREE RADICAL BIO MED, V87, P84, DOI 10.1016/j.freeradbiomed.2015.06.017; Hafez MM, 2009, APPL BIOCHEM BIOTECH, V158, P97, DOI 10.1007/s12010-008-8312-2; Haque S E, 2005, Indian J Physiol Pharmacol, V49, P57; Hartmann RM, 2012, DIGEST DIS SCI, V57, P2038, DOI 10.1007/s10620-012-2134-3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He XQ, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S7-002; Hiemstra S, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10857-x; Iwamoto M, 1996, J PATHOL, V180, P152; Jairath V, 2020, LANCET GASTROENTEROL, V5, P2, DOI 10.1016/S2468-1253(19)30358-9; Jang YY, 2003, PHARMACOL TOXICOL, V92, P173, DOI 10.1034/j.1600-0773.2003.920407.x; Jensen SR, 2015, INT J MED MICROBIOL, V305, P925, DOI 10.1016/j.ijmm.2015.10.002; Ji XQ, 2014, WORLD J GASTROENTERO, V20, P13501, DOI 10.3748/wjg.v20.i37.13501; Joshi SV, 2011, INDIAN J PHARMACOL, V43, P656, DOI 10.4103/0253-7613.89821; Kanauchi Y, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-021-04154-2; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; KEYSE SM, 1987, J BIOL CHEM, V262, P14821; Khalil R, 2020, TOXICOL APPL PHARM, V407, DOI 10.1016/j.taap.2020.115246; Lee CS, 2002, PHARMACOL TOXICOL, V91, P140, DOI 10.1034/j.1600-0773.2002.910309.x; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Maines MD, 1999, J PHARMACOL EXP THER, V291, P911; Malerba M, 2008, EXPERT OPIN DRUG MET, V4, P1119, DOI 10.1517/17425255.4.8.1119 ; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; Mei Y, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02969; Nandi A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9613090; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Petersen AM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-171; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Saber S, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112029; Saber S, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14040341; Saber S, 2021, LIFE SCI, V270, DOI 10.1016/j.lfs.2021.119123; Saber S, 2020, CANCER CHEMOTH PHARM, V85, P331, DOI 10.1007/s00280-020-04033-z; Saber S, 2019, ARCH BIOCHEM BIOPHYS, V671, P185, DOI 10.1016/j.abb.2019.07.014; Seidelin JB, 2009, SCAND J GASTROENTERO, V44, P1429, DOI 10.3109/00365520903301212; Silveira CRA, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1252-3; Albert-Garay JS, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05284-x; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Stetinova V, 2004, CLIN EXP MED, V4, P152, DOI 10.1007/s10238-004-0050-3; Stetinova V, 2009, GEN PHYSIOL BIOPHYS, V28, P309, DOI 10.4149/gpb_2009_03_309; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; Sunkari S, 2019, INT IMMUNOPHARMACOL, V71, P301, DOI 10.1016/j.intimp.2019.03.035; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Wang R, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.670159; Wang XD, 2001, GENE DEV, V15, P2922; Weiser T, 2008, CNS NEUROSCI THER, V14, P17, DOI 10.1111/j.1527-3458.2007.00032.x; Wu G, 2004, J CARD FAIL, V10, P519, DOI 10.1016/j.cardfail.2004.02.002; Yang SY, 2017, STEM CELL REP, V8, P728, DOI 10.1016/j.stemcr.2017.01.011; Youssef ME, 2022, ENVIRON SCI POLLUT R, V29, P25723, DOI 10.1007/s11356-021-17831-6; Youssef ME, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.719984; Zhao JM, 2017, ACTA CHIR BELG, V117, P232, DOI 10.1080/00015458.2017.1287395	67	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9								10.1096/fj.202200749R	http://dx.doi.org/10.1096/fj.202200749R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2QD	35947115				2022-12-28	WOS:000838762200001
J	Dawson, NJ; Scott, GR				Dawson, Neal J.; Scott, Graham R.			Adaptive increases in respiratory capacity and O-2 affinity of subsarcolemmal mitochondria from skeletal muscle of high-altitude deer mice	FASEB JOURNAL			English	Article						bioenergetics; biological evolution; high-altitude hypoxia; muscle mitochondria; reactive oxygen species	CYTOCHROME-C-OXIDASE; THERMOGENIC CAPACITY; HYPOXIA ACCLIMATION; EVOLVED CHANGES; PHENOTYPE; EXERCISE; POPULATIONS; ENERGY; FLIGHT; PERFORMANCE	Aerobic energy demands have led to the evolution of complex mitochondrial reticula in highly oxidative muscles, but the extent to which metabolic challenges can be met with adaptive changes in physiology of specific mitochondrial fractions remains unresolved. We examined mitochondrial mechanisms supporting adaptive increases in aerobic performance in deer mice (Peromyscus maniculatus) adapted to the hypoxic environment at high altitude. High-altitude and low-altitude mice were born and raised in captivity, and exposed as adults to normoxia or hypobaric hypoxia (12 kPa O-2 for 6-8 weeks). Subsarcolemmal and intermyofibrillar mitochondria were isolated from the gastrocnemius, and a comprehensive substrate titration protocol was used to examine mitochondrial physiology and O-2 kinetics by high-resolution respirometry and fluorometry. High-altitude mice had greater yield, respiratory capacity for oxidative phosphorylation, and O-2 affinity (lower P-50) of subsarcolemmal mitochondria compared to low-altitude mice across environments, but there were no species difference in these traits in intermyofibrillar mitochondria. High-altitude mice also had greater capacities of complex II relative to complexes I + II and higher succinate dehydrogenase activities in both mitochondrial fractions. Exposure to chronic hypoxia reduced reactive oxygen species (ROS) emission in high-altitude mice but not in low-altitude mice. Our findings suggest that functional changes in subsarcolemmal mitochondria contribute to improving aerobic performance in hypoxia in high-altitude deer mice. Therefore, physiological variation in specific mitochondrial fractions can help overcome the metabolic challenges of life at high altitude.	[Dawson, Neal J.; Scott, Graham R.] McMaster Univ, Dept Biol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Dawson, Neal J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	McMaster University; University of Glasgow	Scott, GR (corresponding author), McMaster Univ, Dept Biol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	scottg2@mcmaster.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-05707]	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/ Award Number: RGPIN-2018-05707	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; BARRE H, 1989, American Journal of Physiology, V256, pR1192; Battersby BJ, 1998, J EXP BIOL, V201, P2455; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bundgaard A, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.174391; Cano I, 2013, RESP PHYSIOL NEUROBI, V189, P477, DOI 10.1016/j.resp.2013.08.020; Cardinale DA, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13110; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; Cheviron ZA, 2013, J EXP BIOL, V216, P1160, DOI 10.1242/jeb.075598; Cheviron ZA, 2012, P NATL ACAD SCI USA, V109, P8635, DOI 10.1073/pnas.1120523109; Chicco AJ, 2018, J BIOL CHEM, V293, P6659, DOI 10.1074/jbc.RA117.000470; Chung DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16598-6; Chung DJ., 2022, J PHYSL, V600, p547; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; D'Hulst G, 2017, J APPL PHYSIOL, V122, P406, DOI 10.1152/japplphysiol.00264.2016; Dawson NJ, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13030; Dawson NJ, 2020, ELIFE, V9, DOI 10.7554/eLife.56259; Du SNN, 2016, J EXP BIOL, V219, P1130, DOI 10.1242/jeb.132860; Fasching M., 2013, MITOCHONDR PHYSL NET, V14, P1; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GAYESKI T E J, 1988, American Journal of Physiology, V254, pH1179; Glancy B, 2021, PHYSIOL REV, V101, P1561, DOI 10.1152/physrev.00040.2020; Glancy B, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.541040; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; Gnaiger E, 1998, BBA-BIOENERGETICS, V1365, P249, DOI 10.1016/S0005-2728(98)00076-0; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E, 2000, LIFE IN THE COLD, P431; Gnaiger E., 2010, MITOCHONDR PHYSL NET, V2, P1; HAYES JP, 1989, PHYSIOL ZOOL, V62, P732, DOI 10.1086/physzool.62.3.30157924; Hickey AJR, 2012, J COMP PHYSIOL B, V182, P91, DOI 10.1007/s00360-011-0599-6; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Horscroft JA, 2017, P NATL ACAD SCI USA, V114, P6382, DOI 10.1073/pnas.1700527114; Ivy CM, 2017, ACTA PHYSIOL, V221, P266, DOI 10.1111/apha.12912; Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206; KAYSER B, 1991, J APPL PHYSIOL, V70, P1938, DOI 10.1152/jappl.1991.70.5.1938; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Larsen FJ, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13463; Lau DS, 2017, AM J PHYSIOL-REG I, V312, pR400, DOI 10.1152/ajpregu.00365.2016; Lau GY, 2017, MOL BIOL EVOL, V34, P2153, DOI 10.1093/molbev/msx179; Lui MA, 2015, AM J PHYSIOL-REG I, V308, pR779, DOI 10.1152/ajpregu.00362.2014; Lyons SA, 2021, AM J PHYSIOL-REG I, V320, pR735, DOI 10.1152/ajpregu.00266.2020; Mahalingam S, 2020, J PHYSIOL-LONDON, V598, P5411, DOI 10.1113/JP280298; Mahalingam S, 2017, J PHYSIOL-LONDON, V595, P4785, DOI 10.1113/JP274130; McClelland GB, 1998, P NATL ACAD SCI USA, V95, P10288, DOI 10.1073/pnas.95.17.10288; McClelland GB, 2019, ANNU REV PHYSIOL, V81, P561, DOI 10.1146/annurev-physiol-021317-121527; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.12916; Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142; Murray AJ, 2016, J PHYSIOL-LONDON, V594, P1137, DOI 10.1113/JP270079; Murray AJ, 2014, BIOESSAYS, V36, P721, DOI 10.1002/bies.201400042; Natarajan C, 2015, MOL BIOL EVOL, V32, P978, DOI 10.1093/molbev/msu403; Nikel KE, 2018, COMP BIOCHEM PHYS B, V224, P98, DOI 10.1016/j.cbpb.2017.11.009; Reguera DP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020443; Robertson CE, 2021, J EXP BIOL, V224, DOI 10.1242/jeb.235218; Schiffer TA, 2016, AM J PHYSIOL-CELL PH, V311, pC452, DOI 10.1152/ajpcell.00099.2016; Scott GR, 2018, INTEGR COMP BIOL, V58, P506, DOI 10.1093/icb/icy056; Scott GR, 2015, MOL BIOL EVOL, V32, P1962, DOI 10.1093/molbev/msv076; Scott GR, 2009, P R SOC B, V276, P3645, DOI 10.1098/rspb.2009.0947; Scott GR, 2009, AM J PHYSIOL-REG I, V297, pR1066, DOI 10.1152/ajpregu.00241.2009; Smith KA, 2017, REDOX BIOL, V13, P228, DOI 10.1016/j.redox.2017.05.020; SNYDER LRG, 1982, RESP PHYSIOL, V48, P89, DOI 10.1016/0034-5687(82)90052-4; Tate KB, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2750; Tate KB, 2017, J EXP BIOL, V220, P3616, DOI 10.1242/jeb.164491; WARDLAW GM, 1984, AM J PHYSIOL, V247, pR911, DOI 10.1152/ajpregu.1984.247.5.R911	67	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22391	10.1096/fj.202200219R	http://dx.doi.org/10.1096/fj.202200219R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1V6QD	35661419	Green Accepted			2022-12-28	WOS:000806211000001
J	Wu, ZXE; Kruger, MC; Cooper, GJS; Sequeira, IR; McGill, AT; Poppitt, SD; Fraser, K				Wu, Zhanxuan E.; Kruger, Marlena C.; Cooper, Garth J. S.; Sequeira, Ivana R.; McGill, Anne-Thea; Poppitt, Sally D.; Fraser, Karl			Dissecting the relationship between plasma and tissue metabolome in a cohort of women with obesity: Analysis of subcutaneous and visceral adipose, muscle, and liver	FASEB JOURNAL			English	Article						biomarkers; clinical metabolomics; liquid chromatography-mass spectrometry; tissue metabolomics	AMINO-ACID-METABOLISM; MASS-SPECTROMETRY; REGIONAL DIFFERENCES; INSULIN-RESISTANCE; FAT-CONTENT; LC-MS; DIACYLGLYCEROL; VALIDATION; CERAMIDES; MECHANISM	Untargeted metabolomics of blood samples has become widely applied to study metabolic alterations underpinning disease and to identify biomarkers. However, understanding the relevance of a blood metabolite marker can be challenging if it is unknown whether it reflects the concentration in relevant tissues. To explore this field, metabolomic and lipidomic profiles of plasma, four sites of adipose tissues (ATs) from peripheral or central depot, two sites of muscle tissue, and liver tissue from a group of nondiabetic women with obesity who were scheduled to undergo bariatric surgery (n = 21) or other upper GI surgery (n = 5), were measured by liquid chromatography coupled with mass spectrometry. Relationships between plasma and tissue profiles were examined using Pearson correlation analysis subject to Benjamini-Hochberg correction. Plasma metabolites and lipids showed the highest number of significantly positive correlations with their corresponding concentrations in liver tissue, including lipid species of ceramide, mono- and di-hexosylceramide, sphingomyelin, phosphatidylcholine (PC), phosphatidylethanolamine (PE), lysophosphatidylethanolamine, dimethyl phosphatidylethanolamine, ether-linked PC, ether-linked PE, free fatty acid, cholesteryl ester, diacylglycerol and triacylglycerol, and polar metabolites linked to several metabolic functions and gut microbial metabolism. Plasma also showed significantly positive correlations with muscle for several phospholipid species and polar metabolites linked to metabolic functions and gut microbial metabolism, and with AT for several triacylglycerol species. In conclusion, plasma metabolomic and lipidomic profiles were reflective more of the liver profile than any of the muscle or AT sites examined in the present study. Our findings highlighted the importance of taking into consideration the metabolomic relationship of various tissues with plasma when postulating plasma metabolites marker to underlying mechanisms occurring in a specific tissue.	[Wu, Zhanxuan E.; Fraser, Karl] AgResearch Limited, Food Chem & Struct, Palmerston North 4442, New Zealand; [Wu, Zhanxuan E.; Kruger, Marlena C.] Massey Univ, Sch Hlth Sci, Palmerston North, New Zealand; [Wu, Zhanxuan E.; Sequeira, Ivana R.; Poppitt, Sally D.; Fraser, Karl] High Value Nutr Natl Sci Challenge, Auckland, New Zealand; [Kruger, Marlena C.; Poppitt, Sally D.; Fraser, Karl] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Cooper, Garth J. S.; Sequeira, Ivana R.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Cooper, Garth J. S.; Poppitt, Sally D.] Univ Auckland, Dept Med, Auckland, New Zealand; [Cooper, Garth J. S.] Univ Manchester, Ctr Adv Discovery & Expt Therapeut, Sch Med Sci, Manchester, Lancs, England; [Sequeira, Ivana R.; McGill, Anne-Thea; Poppitt, Sally D.] Univ Auckland, Sch Biol Sci, Human Nutr Unit, Auckland, New Zealand; [McGill, Anne-Thea] Southern Cross Univ, Sch Hlth & Iuman Sci, Lismore, NSW, Australia	Massey University; Massey University; University of Auckland; University of Auckland; University of Manchester; University of Auckland; Southern Cross University	Wu, ZXE; Fraser, K (corresponding author), AgResearch Limited, Food Chem & Struct, Palmerston North 4442, New Zealand.	Emily.Wu@agresearch.co.nz; karl.fraser@agresearch.co.nz			New Zealand Ministry for Business, Innovation and Employment (MBIE) through the High Value Nutrition National Science Challenge [3710040]; New Zealand Health Research Council (HRC) [08/190C]	New Zealand Ministry for Business, Innovation and Employment (MBIE) through the High Value Nutrition National Science Challenge; New Zealand Health Research Council (HRC)(Health Research Council of New Zealand)	This study was funded by the New Zealand Ministry for Business, Innovation and Employment (MBIE, grant no. 3710040) through the High Value Nutrition National Science Challenge and New Zealand Health Research Council (HRC, grant no.08/190C). We thank Dr. Heike Schwendel (AgResearch) for technical assistance and guidance with the LC-MS instrumental analysis.	Al-Sari N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228521; Bagheri M, 2018, J PROTEOME RES, V17, P1452, DOI 10.1021/acs.jproteome.7b00802; Belanger C, 2006, STEROIDS, V71, P674, DOI 10.1016/j.steroids.2006.04.008; Carter TC, 2016, METABOLISM, V65, P1399, DOI 10.1016/j.metabol.2016.06.007; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; deBlaauw I, 1996, AM J PHYSIOL-GASTR L, V270, pG298, DOI 10.1152/ajpgi.1996.270.2.G298; Elffers TW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185403; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gao XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12254-1; Gika H, 2011, BIOANALYSIS, V3, P1647, DOI [10.4155/BIO.11.122, 10.4155/bio.11.122]; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Gruzdeva O, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0856-8; Guasch-Ferre M, 2016, DIABETES CARE, V39, P833, DOI 10.2337/dc15-2251; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hellmuth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074927; Hong X., 2020, BMC MED, V18, P1; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Janeiro MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101398; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Jove M, 2014, FASEB J, V28, P1071, DOI 10.1096/fj.13-234419; Jung YS, 2015, BIOL PHARM BULL, V38, P971, DOI 10.1248/bpb.b15-00244; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim SH, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0127-7; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; LI JB, 1979, AM J PHYSIOL, V236, pE222, DOI 10.1152/ajpendo.1979.236.3.E222; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Mayo R, 2018, HEPATOL COMMUN, V2, P807, DOI 10.1002/hep4.1188; McGranaghan P, 2020, BIOMARKERS, V25, P101, DOI 10.1080/1354750X.2020.1716073; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mendez Sanchez N., 2017, BILIRUBIN BIOMARKER, P281; Naz S, 2014, BIOANALYSIS, V6, P1657, DOI 10.4155/bio.14.119; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Oresic M, 2013, DIABETOLOGIA, V56, P2266, DOI 10.1007/s00125-013-2981-2; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rangel-Huerta OD, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1553-y; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Ruiz-Canela M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005705; Sam S, 2018, HORM MOL BIOL CLIN I, V33, DOI 10.1515/hmbci-2018-0014; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schleinitz D, 2020, EUR J HUM GENET, V28, P1714, DOI 10.1038/s41431-020-0681-1; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Soeters MR, 2009, CLIN SCI, V116, P585, DOI 10.1042/CS20080433; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Sui J, 2019, EXP THER MED, V18, P3603, DOI 10.3892/etm.2019.7981; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Teft WA, 2017, MOL PHARMACEUT, V14, P310, DOI 10.1021/acs.molpharmaceut.6b00937; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Walker CG, 2015, BRIT J NUTR, V114, P756, DOI 10.1017/S0007114515002251; Walker GE, 2007, OBESITY, V15, P1933, DOI 10.1038/oby.2007.231; Wigger L, 2017, CELL REP, V18, P2269, DOI 10.1016/j.celrep.2017.02.019; Wu ZXE, 2021, INT J OBESITY, V45, P1844, DOI 10.1038/s41366-021-00854-x; Wu ZXE, 2019, METABOLITES, V9, DOI 10.3390/metabo9070124; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132; Yin XY, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.10.046	68	0	0	12	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22371	10.1096/fj.202101812R	http://dx.doi.org/10.1096/fj.202101812R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2C8PX	35704337				2022-12-28	WOS:000811124200001
J	Wu, Z; Hu, T; Chen, WQ; Cheng, Y; Wang, MS; Jia, RY; Zhu, DK; Liu, MF; Zhao, XX; Yang, Q; Wu, Y; Zhang, SQ; Huang, J; Mao, S; Ou, XM; Gao, Q; Sun, D; Cheng, AC; Chen, S				Wu, Zhen; Hu, Tao; Chen, Weiqiong; Cheng, Yao; Wang, Mingshu; Jia, Renyong; Zhu, Dekang; Liu, Mafeng; Zhao, Xinxin; Yang, Qiao; Wu, Ying; Zhang, Shaqiu; Huang, Juan; Mao, Sai; Ou, Xumin; Gao, Qun; Sun, Di; Cheng, Anchun; Chen, Shun			The autophagy-related degradation of MDA5 by Tembusu virus nonstructural 2B disrupts IFN beta production	FASEB JOURNAL			English	Article						autophagy; IFN beta; immune evasion; NS2B; Tembusu virus	NS2B COFACTOR; DENGUE; PROTEIN	Duck Tembusu virus (TMUV) is a serious avian pathogen causing a decline in egg production, but the mechanism of the virus that breaks through the innate immune system is poorly understood. Here, we show that TMUV inhibits poly(I:C)-induced interferon (IFN) production. Because poly(I:C) transfection can specifically activate the MDA5 pathway in duck primary cells, we found that infection with TMUV can specifically target MDA5 and lead to its degradation. MDA5 downregulation could be blocked by the autophagy inhibitor 3-methyladenine (3-MA) but not a proteasome inhibitor, strongly implicating MDA5 degradation as an autophagy-related degradation pathway. Pretreatment with 3-MA enhanced the expression of MDA5 and inhibited TMUV replication. To screen TMUV proteins that degraded MDA5, the TMUV replicon and MDA5-Flag were cotransfected into cells, and the western blot analysis showed that nonstructural 2B (NS2B) can degrade MDA5 in a dose-dependent manner. Dual-luciferase assays indicate that NS2B alone inhibits MDA5- or poly(I:C)-mediated IFN production. NS2B binds MDA5 in the presence of 3-MA. The deletion of the amino acids of NS2B from residues 51 to 92 (hydrophilic area) restored the expression of MDA5 and relieved the MDA5-mediated IFN beta production inhibition by NS2B, indicating that the hydrophilic area of NS2B is important for its interaction with host innate immunity.	[Wu, Zhen; Hu, Tao; Chen, Weiqiong; Cheng, Yao; Wang, Mingshu; Jia, Renyong; Liu, Mafeng; Zhao, Xinxin; Yang, Qiao; Wu, Ying; Zhang, Shaqiu; Huang, Juan; Mao, Sai; Ou, Xumin; Gao, Qun; Sun, Di; Cheng, Anchun; Chen, Shun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China; [Wang, Mingshu; Jia, Renyong; Zhu, Dekang; Liu, Mafeng; Zhao, Xinxin; Yang, Qiao; Wu, Ying; Zhang, Shaqiu; Huang, Juan; Mao, Sai; Ou, Xumin; Gao, Qun; Sun, Di; Cheng, Anchun; Chen, Shun] Sichuan Agr Univ, Coll Vet Med, Res Ctr Avian Dis, Chengdu, Peoples R China; [Wang, Mingshu; Jia, Renyong; Zhu, Dekang; Liu, Mafeng; Zhao, Xinxin; Yang, Qiao; Wu, Ying; Zhang, Shaqiu; Huang, Juan; Mao, Sai; Ou, Xumin; Gao, Qun; Sun, Di; Cheng, Anchun; Chen, Shun] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Cheng, AC; Chen, S (corresponding author), Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China.	chenganchun@vip.163.com; shunchen@sicau.edu.cn		Wu, Zhen/0000-0002-7081-6430	China Agricultural System [CARS-42-17]; Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System [SCCXTD-2020-18]	China Agricultural System; Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System	China Agricultural System, Grant/Award Number: CARS-42-17; Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System, Grant/Award Number: SCCXTD-2020-18	Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37; Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Avia M, 2019, EMBO REP, V20, DOI 10.15252/embr.201948766; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chappell KJ, 2008, J GEN VIROL, V89, P1010, DOI 10.1099/vir.0.83447-0; Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047; Chen SL, 2014, ARCH VIROL, V159, P1099, DOI 10.1007/s00705-013-1931-0; Chen S, 2018, ANTIVIR RES, V157, P120, DOI 10.1016/j.antiviral.2018.06.016; Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291; Cheng YQ, 2019, J IMMUNOL, V203, P1930, DOI 10.4049/jimmunol.1900293; Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; He Y, 2019, VIROLOGY, V533, P86, DOI 10.1016/j.virol.2019.05.003; Hou PP, 2021, CELL RES, V31, P62, DOI 10.1038/s41422-020-0362-1; Hu ZQ, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010022; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Khumthong R, 2002, J BIOCHEM MOL BIOL, V35, P206; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Patkar CG, 2009, ANTIMICROB AGENTS CH, V53, P4103, DOI 10.1128/AAC.00074-09; Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang J, 2016, J IMMUNOL, V197, P4704, DOI 10.4049/jimmunol.1502317; Wu Z, 2019, J IMMUNOL, V203, P3374, DOI 10.4049/jimmunol.1900956; Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zhang R, 2017, J VIROL, V91, DOI [10.1128/JVI.01148-17, 10.1128/jvi.01148-17]; Zhang W, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.671471; Zhang W, 2020, J VIROL, V94, DOI 10.1128/JVI.01850-19	35	1	1	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22417	10.1096/fj.202101916RRR	http://dx.doi.org/10.1096/fj.202101916RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6PG	35713934				2022-12-28	WOS:000812348400001
J	Yang, Z; Li, TL; Xian, JZ; Chen, J; Huang, Y; Zhang, Q; Lin, XF; Lu, HY; Lin, YB				Yang, Zhe; Li, Tengling; Xian, Jianzhong; Chen, Jia; Huang, Yin; Zhang, Qin; Lin, Xiufang; Lu, Hongyun; Lin, Yubi			SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2 alpha signaling pathway in arrhythmogenic cardiomyopathy	FASEB JOURNAL			English	Article						arrhythmogenic cardiomyopathy; fibrosis; HIF-2 alpha; inflammation; SGLT2 inhibitor	RIGHT-VENTRICULAR CARDIOMYOPATHY; HEART-FAILURE; TRANSFORMING GROWTH-FACTOR-BETA-1; CARDIOVASCULAR OUTCOMES; MUTUAL ANTAGONISM; EMPAGLIFLOZIN; MACROPHAGES; ACTIVATION; MECHANISMS; EXPRESSION	Excessive cardiac fibrosis and inflammation aberrantly contribute to the progressive pathogenesis of arrhythmogenic cardiomyopathy (ACM). Whether sodium-glucose cotransporter-2 inhibitor (SGLT2i), as a new hypoglycemic drug, benefits ACM remains unclear. Cardiomyocyte-specific Dsg2 exon-11 knockout and wild-type (WT) littermate mice were used as the animal model of ACM and controls, respectively. Mice were administered by gavage with either SGLT2i dapagliflozin (DAPA, 1 mg/kg/day) or vehicle alone for 8 weeks. HL-1 cells were treated with DAPA to identify the molecular mechanism in vitro. All mice presented normal glucose homeostasis. DAPA not only significantly ameliorated cardiac dysfunction, adverse remodeling, and ventricular dilation in ACM but also attenuated ACM-associated cardiac fibrofatty replacement, as demonstrated by the echocardiography and histopathological examination. The protein expressions of HIF-2 alpha and HIF-1 alpha were decreased and increased respectively in cardiac tissue of ACM, which were compromised after DAPA treatment. Additionally, NF-kappa B P65 and I kappa B phosphorylation, as well as fibrosis indicators (including TGF-beta, alpha-SMA, Collagen I, and Collagen III) were increased in ACM. However, these trends were markedly suppressed by DAPA treatment. Consistent with these results in vitro, DAPA alleviated the I kappa B phosphorylation and NF-kappa B p65 transcriptional activity in DSG2-knockdown HL-1 cells. Interestingly, the elective HIF-2 alpha inhibitor PT2399 almost completely blunted the DAPA-mediated downregulation of indicators concerning cardiac fibrosis and inflammation. SGLT2i attenuated the ACM-associated cardiac dysfunction and adverse remodeling in a glucose-independent manner by suppressing cardiac fibrosis and inflammation via reverting the HIF-2 alpha signaling pathway, suggesting that SGLT2i is a novel and available therapy for ACM.	[Yang, Zhe; Lu, Hongyun] Jinan Univ, Zhuhai Peoples Hosp, Dept Endocrinol & Metab, Zhuhai Hosp, Jinan, Peoples R China; [Yang, Zhe; Lin, Yubi] Guangdong Med Univ, Dongguan Affiliated Hosp 1, Dongguan 523710, Peoples R China; [Li, Tengling; Xian, Jianzhong; Huang, Yin; Zhang, Qin; Lin, Xiufang] Sun Yat Sen Univ, Affiliated Hosp 5, Guangdong Prov Key Lab Biomed Imaging, Zhuhai, Peoples R China; [Li, Tengling; Xian, Jianzhong; Huang, Yin; Zhang, Qin; Lin, Xiufang] Sun Yat Sen Univ, Affiliated Hosp 5, Guangdong Prov Engn Res Ctr Mol Imaging, Zhuhai, Peoples R China; [Chen, Jia] Second Peoples Hosp Guangdong Prov, Dept Cardiol 2, Guangzhou, Peoples R China	Jinan University; University of Jinan; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University	Lin, YB (corresponding author), Guangdong Med Univ, Dongguan Affiliated Hosp 1, Dongguan 523710, Peoples R China.; Lu, HY (corresponding author), Jinan Univ, Zhuhai Hosp, Dept Endocrinol & Metab, Zhuhai 519000, Guangdong, Peoples R China.	luhongyun2013@163.com; linyubi88@qq.com			Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [Grant2020A1515010123, 2021A1515010695]; Science Project of the Second People's Hospital of Guangdong Province [TQ2019-005]; Medical Science and Technology Research Project of Guangdong Province [A2020069]	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Science Project of the Second People's Hospital of Guangdong Province; Medical Science and Technology Research Project of Guangdong Province	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: Grant2020A1515010123 and 2021A1515010695; The Science Project of the Second People's Hospital of Guangdong Province, Grant/Award Number: TQ2019-005; The Medical Science and Technology Research Project of Guangdong Province, Grant/Award Number: A2020069	Asimaki A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008008; Austin KM, 2019, NAT REV CARDIOL, V16, P519, DOI 10.1038/s41569-019-0200-7; Ban JJ, 2014, HYPOXIA, V2, P171, DOI 10.2147/HP.S68771; Campian ME, 2010, EUR J NUCL MED MOL I, V37, P2079, DOI 10.1007/s00259-010-1525-y; Chelko SP, 2019, CIRCULATION, V140, P1491, DOI 10.1161/CIRCULATIONAHA.119.040676; Chen L, 2019, INT J CARDIOL, V274, P263, DOI 10.1016/j.ijcard.2018.06.105; Corrado D, 2017, CIRC RES, V121, P784, DOI 10.1161/CIRCRESAHA.117.309345; Corrado D, 2017, NEW ENGL J MED, V376, P1489, DOI 10.1056/NEJMc1701400; Elliott PM, 2019, EUR J HEART FAIL, V21, P955, DOI 10.1002/ejhf.1534; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; GENG YJ, 1994, EXP CELL RES, V214, P418, DOI 10.1006/excr.1994.1275; Hamilton RM, 2009, PACE, V32, pS44, DOI 10.1111/j.1540-8159.2009.02384.x; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ishizuka S, 2016, INFLAMM RES, V65, P439, DOI 10.1007/s00011-016-0926-1; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kamezaki M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22229-5; Kang S, 2020, CAN J CARDIOL, V36, P543, DOI 10.1016/j.cjca.2019.08.033; Kapitsinou PP, 2014, J CLIN INVEST, V124, P2396, DOI 10.1172/JCI69073; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kong KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11829-2; Kosiborod M, 2017, CIRCULATION, V136, P249, DOI 10.1161/CIRCULATIONAHA.117.029190; Kosiborod MN, 2020, CIRCULATION, V141, P90, DOI 10.1161/CIRCULATIONAHA.119.044138; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee HC, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0849-6; Lee TM, 2017, FREE RADICAL BIO MED, V104, P298, DOI 10.1016/j.freeradbiomed.2017.01.035; Li CG, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0816-2; Li GM, 2002, J THORAC CARDIOV SUR, V123, P89, DOI 10.1067/mtc.2002.118275; Lin YB, 2018, J ELECTROCARDIOL, V51, P837, DOI 10.1016/j.jelectrocard.2018.06.012; Lin YB, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0580-2; Lin YB, 2017, CARDIOLOGY, V138, P41, DOI 10.1159/000462962; Lubos N, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0803-5; Maeda S, 2013, DIABETES-METAB RES, V29, P406, DOI 10.1002/dmrr.2407; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nilsson LM, 2019, AM J PHYSIOL-RENAL, V316, pF1078, DOI 10.1152/ajprenal.00615.2018; Oh CM, 2019, KOREAN CIRC J, V49, P1183, DOI 10.4070/kcj.2019.0180; Ojima A, 2015, HORM METAB RES, V47, P686, DOI 10.1055/s-0034-1395609; Packer M, 2020, JACC-BASIC TRANSL SC, V5, P961, DOI 10.1016/j.jacbts.2020.05.006; Packer M, 2021, AM J KIDNEY DIS, V77, P280, DOI 10.1053/j.ajkd.2020.04.016; Packer M, 2018, DIABETES OBES METAB, V20, P1361, DOI 10.1111/dom.13229; Padron-Barthe L, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0640-3; Petrie MC, 2020, JAMA-J AM MED ASSOC, V323, P1353, DOI 10.1001/jama.2020.1906; Pfister M, 2011, CLIN PHARMACOL THER, V89, P621, DOI 10.1038/clpt.2011.16; Rubart M, 2018, CARDIOVASC RES, V114, P389, DOI 10.1093/cvr/cvx163; Tabib A, 2003, CIRCULATION, V108, P3000, DOI 10.1161/01.CIR.0000108396.65446.21; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; THIENE G, 1991, EUR HEART J, V12, P22, DOI 10.1093/eurheartj/12.suppl_D.22; Verma S, 2018, DIABETOLOGIA, V61, P2108, DOI 10.1007/s00125-018-4670-7; Wang Y, 2019, J BIOL CHEM, V294, P12779, DOI 10.1074/jbc.RA119.007834; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Ye YM, 2018, CARDIOVASC DRUG THER, V32, P553, DOI 10.1007/s10557-018-6837-3; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Zannad F, 2020, LANCET, V396, P819, DOI 10.1016/S0140-6736(20)31824-9; Zelniker TA, 2020, J AM COLL CARDIOL, V75, P422, DOI 10.1016/j.jacc.2019.11.031; Zhang YZ, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01312-8; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	65	2	2	13	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22410	10.1096/fj.202200243R	http://dx.doi.org/10.1096/fj.202200243R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6PF	35713937	hybrid			2022-12-28	WOS:000812348300001
J	Zeng, ZJ; Huang, HH; Zhang, JM; Liu, YY; Zhong, WS; Chen, WM; Lu, Y; Qiao, YJ; Zhao, HJ; Meng, XJ; Zou, F; Cai, SX; Dong, HM				Zeng, Zhaojin; Huang, Haohua; Zhang, Jinming; Liu, Yuanyuan; Zhong, Wenshan; Chen, Weimou; Lu, Ye; Qiao, Yujie; Zhao, Haijin; Meng, Xiaojing; Zou, Fei; Cai, Shaoxi; Dong, Hangming			HDM induce airway epithelial cell ferroptosis and promote inflammation by activating ferritinophagy in asthma	FASEB JOURNAL			English	Article						asthma; autophagy; ferroptosis; inflammation; iron; oxidative stress	AUTOPHAGY; DEATH; BIOMARKERS; ALLERGENS; DAMAGE; MODEL	Asthma is a disease characterized by airway epithelial barrier destruction, chronic airway inflammation, and airway remodeling. Repeated damage to airway epithelial cells by allergens in the environment plays an important role in the pathophysiology of asthma. Ferroptosis is a novel form of regulated cell death mediated by lipid peroxidation in association with free iron-mediated Fenton reactions. In this study, we explored the contribution of ferroptosis to house dust mite (HDM)-induced asthma models. Our in vivo and in vitro models showed labile iron accumulation and enhanced lipid peroxidation with concomitant nonapoptotic cell death upon HDM exposure. Treatment with ferroptosis inhibitors deferoxamine (DFO) and ferrostatin-1 (Fer-1) illuminated the role of ferroptosis and related damage-associated molecular patterns in HDM-treated airway epithelial cells. Furthermore, DFO and Fer-1 reduced HDM-induced airway inflammation in model mice. Mechanistically, NCOA4-mediated ferritin-selective autophagy (ferritinophagy) was initiated during ferritin degradation in response to HDM exposure. Together, these data suggest that ferroptosis plays an important role in HDM-induced asthma and that ferroptosis may be a potential treatment target for HDM-induced asthma.	[Zeng, Zhaojin; Huang, Haohua; Zhang, Jinming; Liu, Yuanyuan; Zhong, Wenshan; Chen, Weimou; Lu, Ye; Qiao, Yujie; Zhao, Haijin; Cai, Shaoxi; Dong, Hangming] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Guangzhou, Peoples R China; [Meng, Xiaojing; Zou, Fei] Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China	Cai, SX; Dong, HM (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Guangzhou, Peoples R China.	hxkc@smu.edu.cn; dhm@smu.edu.cn	liu, yuanyuan/GWZ-5838-2022		National Natural Science Foundation of China [81870058, 81970032, 82170032]; Natural Science Foundation of Guangdong Province [2017A030313849]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China, Grant/Award Number: 81870058, 81970032 and 82170032; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2017A030313849	Ali MK, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01340-2019; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V111, P408, DOI 10.1067/mai.2003.16; Bibi H, 2014, REDOX BIOL, V2, P814, DOI 10.1016/j.redox.2014.06.009; Chen CA, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03362-4; Chen YR, 2020, IMMUNOL LETT, V225, P9, DOI 10.1016/j.imlet.2020.06.005; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dorscheid DR, 2001, AM J RESP CRIT CARE, V164, P1939, DOI 10.1164/ajrccm.164.10.2103013; Du JJ, 2016, REGEN BIOMATER, V3, P223, DOI 10.1093/rb/rbw023; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hu ZX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2256-z; Hur GY, 2008, J ALLERGY CLIN IMMUN, V122, P774, DOI 10.1016/j.jaci.2008.07.034; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lambrecht BN, 2013, CELL RES, V23, P588, DOI 10.1038/cr.2013.26; Lee KS, 2003, J ALLERGY CLIN IMMUN, V111, P1278, DOI 10.1067/mai.2003.1501; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x; Liu JN, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.38; Liu MX, 2021, J INFLAMM RES, V14, P3891, DOI 10.2147/JIR.S322724; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Palikhe NS, 2011, ALLERGY ASTHMA IMMUN, V3, P21, DOI 10.4168/aair.2011.3.1.21; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Poon A, 2012, AUTOPHAGY, V8, P694, DOI 10.4161/auto.19315; Sharma Anita, 2003, Indian Journal of Pediatrics, V70, P715, DOI 10.1007/BF02724313; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Song Y, 2019, ONCOL LETT, V18, P2159, DOI 10.3892/ol.2019.10568; Sun YT, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110108; Tang WF, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10918; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a; Xu MY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2299-1; Yang YN, 2020, AGING-US, V12, P9085, DOI 10.18632/aging.103176; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7; Zhao JM, 2020, P NATL ACAD SCI USA, V117, P14376, DOI 10.1073/pnas.1921618117; Zhou BR, 2020, SEMIN CANCER BIOL, V66, P89, DOI 10.1016/j.semcancer.2019.03.002; Zhuang J, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109925	48	1	1	12	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22359	10.1096/fj.202101977RR	http://dx.doi.org/10.1096/fj.202101977RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N3IJ	35621121	hybrid			2022-12-28	WOS:000800552500001
J	Howlader, MA; Demina, EP; Samarani, S; Guo, TL; Caillon, A; Ahmad, A; Pshezhetsky, AV; Cairo, CW				Howlader, Md Amran; Demina, Ekaterina P.; Samarani, Suzanne; Guo, Tianlin; Caillon, Antoine; Ahmad, Ali; Pshezhetsky, Alexey, V; Cairo, Christopher W.			The Janus-like role of neuraminidase isoenzymes in inflammation	FASEB JOURNAL			English	Article						inflammation; leukocytes; neuraminidase; sialic acid; sialidase	INDUCED CYTOKINE PRODUCTION; AIR POUCH MODEL; IN-VIVO; SELECTIVE INHIBITORS; HUMAN MONOCYTES; CELL-MIGRATION; SIALIDASE; EXPRESSION; LIPOPOLYSACCHARIDE; DIFFERENTIATION	The processes of activation, extravasation, and migration of immune cells to a site are early and essential steps in the induction of an acute inflammatory response. These events are an essential part of the inflammatory cascade, which involves multiple regulatory steps. Using a murine air pouch model of inflammation with LPS as an inflammation inducer, we demonstrate that isoenzymes of the neuraminidase family (NEU1, 3, and 4) play essential roles in these processes by acting as positive or negative regulators of leukocyte infiltration. In genetically knocked-out (KO) mice for different NEU genes (Neu1 KO, Neu3 KO, Neu4 KO, and Neu3/4 double KO mice) with LPS-induced air pouch inflammation, leukocytes at the site of inflammation were counted, and the inflamed tissue was analyzed using immunohistochemistry. Our data show that leukocyte recruitment was decreased in NEU1- and NEU3-deficient mice, while it was increased in NEU4-deficient animals. Consistent with these results, systemic as well as pouch exudate levels of pro-inflammatory cytokines were reduced in Neu1 and increased in Neu4 KO mice. Pharmacological inhibitors specific for NEU1, NEU3, and NEU4 isoforms also affected leukocyte recruitment. Together our data demonstrate that NEU isoenzymes have distinct-and even opposing-effects on leukocyte recruitment, and therefore warrant further investigation to determine their mechanisms and importance as regulators of the inflammatory cascade.	[Howlader, Md Amran; Guo, Tianlin; Cairo, Christopher W.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Demina, Ekaterina P.; Caillon, Antoine; Pshezhetsky, Alexey, V] Univ Montreal, Div Med Genet, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Samarani, Suzanne; Ahmad, Ali] Univ Montreal, Dept Microbiol Infect Dis & Immunol, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Pshezhetsky, Alexey, V] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	University of Alberta; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.; Pshezhetsky, AV (corresponding author), Univ Montreal, Div Med Genet, St Justine Hosp Res Ctr, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca; ccairo@ualberta.ca	; Cairo, Christopher/B-5355-2009	Caillon, Antoine/0000-0003-0803-569X; Cairo, Christopher/0000-0003-3363-8708; Howlader, Md Amran/0000-0002-1872-3480; A, Pshezhetsky/0000-0002-6612-1062	GlycoNet student travel grant; GlycoNet collaborative team grant (CD-2); GlycoNet collaborative team grant (ID-01); Canadian Institutes of Health Research [PJT-148863]	GlycoNet student travel grant; GlycoNet collaborative team grant (CD-2); GlycoNet collaborative team grant (ID-01); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a GlycoNet student travel grant (MAH), GlycoNet collaborative team grants (CD-2: CWC and AVP; ID-01: CWC, AVP, and AA), and the Canadian Institutes of Health Research (Grant PJT-148863, CWC and AVP)	Albohy A, 2013, ACS MED CHEM LETT, V4, P532, DOI 10.1021/ml400080t; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; Diab A, 1999, INFECT IMMUN, V67, P2590, DOI 10.1128/IAI.67.5.2590-2601.1999; Feng CG, 2013, J IMMUNOL, V191, P4828, DOI 10.4049/jimmunol.1202673; Feng CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032359; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Guo TL, 2018, J MED CHEM, V61, P11261, DOI 10.1021/acs.jmedchem.8b04111; Guo TL, 2018, J MED CHEM, V61, P1990, DOI 10.1021/acs.jmedchem.7b01574; Howlader MA, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00791; Jia F, 2016, BBA-MOL CELL BIOL L, V1861, P1170, DOI 10.1016/j.bbalip.2016.06.013; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kho I, 2020, MOL GENET METAB, V129, pS88, DOI 10.1016/j.ymgme.2019.11.220; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LINDBERG B, 1981, CARBOHYD RES, V97, P105, DOI 10.1016/S0008-6215(00)80528-5; Lotfi N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01265; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XF, 2017, FASEB J, V31, P3467, DOI 10.1096/fj.201601299R; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Quinn MT, 2001, IMMUNOLOGY, V104, P185, DOI 10.1046/j.1365-2567.2001.01300.x; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Sherry B, 1998, MOL MED, V4, P648, DOI 10.1007/BF03401925; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Sieve I, 2018, VASC PHARMACOL, V103, P16, DOI 10.1016/j.vph.2018.01.005; SIN YM, 1986, ANN RHEUM DIS, V45, P873, DOI 10.1136/ard.45.10.873; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; Tessier PA, 1997, J IMMUNOL, V159, P3595; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; Wu XD, 2010, BBA-MOL BASIS DIS, V1802, P259, DOI 10.1016/j.bbadis.2009.10.008; Zen K, 2007, J MOL BIOL, V374, P54, DOI 10.1016/j.jmb.2007.09.014; Zhang Y, 2013, J MED CHEM, V56, P2948, DOI 10.1021/jm301892f	55	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22285	10.1096/fj.202101218R	http://dx.doi.org/10.1096/fj.202101218R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E4ZB	35363389	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000776689300001
J	Zhu, MY; Wang, H; Ding, YL; Yang, YY; Xu, Z; Shi, L; Zhang, NX				Zhu, Mengying; Wang, Hui; Ding, Yiluan; Yang, Yuanyuan; Xu, Zhuo; Shi, Li; Zhang, Naixia			Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1	FASEB JOURNAL			English	Article						COH29; cyclin D1; deubiquitinase; inhibitor; USP2	CANCER-CELL GROWTH; PATHWAY; TARGET; DEGRADATION; METASTASIS; STABILIZES; MECHANISMS; DISCOVERY; DISTINCT; ARREST	USP2 contributes to the quality control of multiple oncogenic proteins including cyclin D1, Mdm2, Aurora-A, etc., and it is a potential target for anti-cancer drug development. However, currently only a few inhibitors with moderate inhibition activities against USP2 have been discovered. USP2-targeted active compounds with either new scaffolds or enhanced activities are in need. Here in this study, Ub-AMC hydrolysis assay-based screening against similar to 4000 commercially available drugs and drug candidates was performed to identify USP2-targeted inhibitors. COH29, which was originally developed as an anti-cancer agent by blocking the function of human ribonucleotide reductase (RNR, IC50 = 16 mu M), was found to exhibit an inhibition activity against USP2 with the IC50 value at 2.02 +/- 0.16 mu M. The following conducted biophysical and biochemical experiments demonstrated that COH29 could specifically interact with USP2 and inhibit its enzymatic activity in a noncompetitive inhibition mode (K-i = 1.73 +/- 0.14 mu M). Since COH29 shows similar inhibitory potencies against RNR (RRM2) and USP2, USP2 inhibition-dependent cellular consequences of COH29 are expected. The results of cellular assays confirmed that the application of COH29 could downregulate the level of cyclin D1 by enhancing its degradation via ubiquitin-proteasome system (UPS), and the modulation effect of COH29 on cyclin D1 is independent of RRM2. Since cyclin D1 acts as an oncogenic driver in human cancer, our findings suggest that USP2 might be a promising therapeutic target for cyclin D1-addicted cancers, and COH29 could serve as a starting compound for high selectivity inhibitor development against USP2.	[Zhu, Mengying; Wang, Hui; Ding, Yiluan; Yang, Yuanyuan; Xu, Zhuo; Shi, Li; Zhang, Naixia] Chinese Acad Sci, Analyt Res Ctr Organ & Biol Mol, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China; [Zhu, Mengying; Xu, Zhuo; Zhang, Naixia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, L; Zhang, NX (corresponding author), Chinese Acad Sci, Analyt Res Ctr Organ & Biol Mol, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	shili@simm.ac.cn; nxzhang@simm.ac.cn		Zhang, Naixia/0000-0003-4824-5819; Shi, Li/0000-0003-2013-5511	National Natural Science Foundation of China (NSFC) [21977105, 32000890, 32171220, 22107111]; Shanghai Municipal Science and Technology Major Project	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 21977105, 32000890, 32171220 and 22107111; Shanghai Municipal Science and Technology Major Project	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Ande SR, 2009, EUR J PHARMACOL, V625, P199, DOI 10.1016/j.ejphar.2009.08.042; Castaneda CA, 2016, STRUCTURE, V24, P423, DOI 10.1016/j.str.2016.01.007; Chen MC, 2015, MOL PHARMACOL, V87, P996, DOI 10.1124/mol.114.094987; Cheng J, 2019, BBA-REV CANCER, V1872, DOI 10.1016/j.bbcan.2019.188312; Chuang SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21476-w; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; Davis MI, 2016, J BIOL CHEM, V291, P24628, DOI 10.1074/jbc.M116.738567; Fang Y, 2017, CANCER METAST REV, V36, P669, DOI 10.1007/s10555-017-9702-0; Fricker LD, 2020, ANNU REV PHARMACOL, V60, P457, DOI 10.1146/annurev-pharmtox-010919-023603; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; He JB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1512-6; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Kim JC, 2018, AM J CANCER RES, V8, P1823; Kitamura H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031209; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kwasna D, 2018, MOL CELL, V70, P150, DOI 10.1016/j.molcel.2018.02.023; Lee JT, 2010, CELL CYCLE, V9, P857, DOI 10.4161/cc.9.5.11175; Li WY, 2020, GENE DEV, V34, P1310, DOI 10.1101/gad.339804.120; Liu Z, 2013, ONCOGENE, V32, P1660, DOI 10.1038/onc.2012.188; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Magiera K, 2017, CELL CHEM BIOL, V24, P458, DOI 10.1016/j.chembiol.2017.03.002; Mazzu YZ, 2019, CLIN CANCER RES, V25, P4480, DOI 10.1158/1078-0432.CCR-18-4046; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pozhidaeva A, 2019, DNA REPAIR, V76, P30, DOI 10.1016/j.dnarep.2019.02.005; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Raasi Shahri, 2005, V301, P47; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Ruiz EJ, 2021, ELIFE, V10, DOI [10.7554/eLife.71596, 10.7554/eLife.71596.sa1, 10.7554/eLife.71596.sa2]; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tedesco AC, 2004, J MAGN MAGN MATER, V272, P2404, DOI 10.1016/j.jmmm.2003.12.375; Tomala MD, 2018, EUR J MED CHEM, V150, P261, DOI 10.1016/j.ejmech.2018.03.009; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang H, 2021, FEBS J, V288, P1325, DOI 10.1111/febs.15461; Wang XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0208-z; Wertz IE, 2019, CELL CHEM BIOL, V26, P156, DOI 10.1016/j.chembiol.2018.10.022; Yang GF, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02160-y; Yang YY, 2019, PROTEIN SCI, V28, P1606, DOI 10.1002/pro.3675; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003; Zhao Y, 2018, CELL REP, V22, P2442, DOI 10.1016/j.celrep.2018.02.007; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	55	0	0	8	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22329	10.1096/fj.202101914RR	http://dx.doi.org/10.1096/fj.202101914RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U8DF	35476303				2022-12-28	WOS:000787876900001
J	Shiraishi, Y; Adachi, T; Cacicedo, JM; Ido, Y				Shiraishi, Yasunaga; Adachi, Takeshi; Cacicedo, Jose M.; Ido, Yasuo			Development of a high-yield, high-quality purification process for adeno-associated virus vectors that can be used in vivo without ultracentrifugation: Application to a lung endothelial cell-targeted adeno-associated virus	FASEB JOURNAL			English	Article						adeno-associated virus; capsid modification; inflammation; purification method	HIGH-EFFICIENCY TRANSDUCTION; GENE-TRANSFER; NEXT-GENERATION; VIRAL VECTORS; AAV VECTORS; EFFICACY; SEROTYPE; SAFETY; TITER	Recombinant adeno-associated viruses (rAAVs) are useful vectors for expressing genes of interest in vivo because of their low immunogenicity and long-term gene expression. Various mutations have been introduced in recent years and have enabled high-efficacy, stabilized, and organ-oriented transduction. Our purpose for using rAAV is to express our target gene in the mouse lung to investigate pulmonary artery hypertension. We constructed a self-complementary AAV having mutant capsids with the ESGHGYF insert, which directs the vectors to lung endothelial cells. However, when this mutant virus was purified from the producing cells by the conventional method using an ultracentrifuge, it resulted in a low yield. In addition, the purification method using an ultracentrifuge is tedious and labor-intensive. Therefore, we aimed to develop a simple, high-quality method for obtaining enough lung-targeted rAAV. First, we modified amino acids (T491V and Y730F) of the capsid to stabilize the rAAV from degradation, and we optimized culture conditions. Next, we noticed that many rAAVs were released from the cells into the culture medium. We, therefore, improved our purification method by purifying from the culture medium without the ultracentrifugation step. Purification without ultracentrifugation had the problem that impurities were mixed in, causing inflammation. However, by performing PEG precipitation and chloroform extraction twice, we were able to purify rAAV that caused only as little inflammation as that obtained by the ultracentrifuge method. Sufficient rAAV was obtained and can now be administered to a rat as well as mice from a single dish: 1.50 x 10(13) +/- 3.58 x 10(12) vector genome from one phi 150 mm dish (mean +/- SEM).	[Shiraishi, Yasunaga] Natl Def Med Coll, Res Inst, Div Environm Med, Saitama, Japan; [Shiraishi, Yasunaga; Adachi, Takeshi; Ido, Yasuo] Natl Def Med Coll, Dept Internal Med, Div Cardiovasc Med, Saitama, Japan; [Cacicedo, Jose M.] ALPCO Diagnost, Dept Res & Dev, Salem, NH USA; [Ido, Yasuo] Boston Univ, Sch Med, Dept Med, Boston, MA USA	National Defense Medical College - Japan; National Defense Medical College - Japan; Boston University	Shiraishi, Y; Ido, Y (corresponding author), Natl Def Med Coll, Dept Internal Med, Div Cardiovasc Med, Tokorozawa, Saitama 3598513, Japan.	sirayasu10@hotmail.com; yido@bu.edu		Shiraishi, Yasunaga/0000-0001-5901-4026	MEXT | Japan Society for the Promotion of Science (JSPS) [JP18K08120, JP20K17204]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18K08120 and JP20K17204	Aslanidi GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059142; Atkinson EM., 2003, METHODS GENERATING H; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Benskey MJ, 2016, HUM GENE THER METHOD, V27, P32, DOI 10.1089/hgtb.2015.117; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Buning H, 2019, MOL THER-METH CLIN D, V12, P248, DOI 10.1016/j.omtm.2019.01.008; Cacicedo JM, 2011, INVEST OPHTH VIS SCI, V52, P3630, DOI 10.1167/iovs.10-5784; Clark K Reed, 2002, Kidney Int, V61, pS9; Davidoff AM, 2004, J VIROL METHODS, V121, P209, DOI 10.1016/j.jviromet.2004.07.001; Ding W, 2006, MOL THER, V13, P671, DOI 10.1016/j.ymthe.2005.12.002; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Gama-Norton L, 2011, HUM GENE THER, V22, P1269, DOI 10.1089/hum.2010.143; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Guo P, 2013, BIOENGINEERED, V4, P103, DOI 10.4161/bioe.22293; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Itagaki K, 2021, ANTIOXID REDOX SIGN, V35, P1273, DOI 10.1089/ars.2021.0052; Kimura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49624-w; Korbelin J, 2016, MOL THER, V24, P1050, DOI 10.1038/mt.2016.62; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Michailidis E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16882-5; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Piras BA, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.15; Rego M., 2018, BIORXIV, DOI [10.1101/488585, DOI 10.1101/488585]; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sakamoto S., 2018, METHOD MANUFACTURING; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Shiraishi Y, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030471; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Verdera HC, 2020, MOL THER, V28, P723, DOI 10.1016/j.ymthe.2019.12.010; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22653	10.1096/fj.202200840RR	http://dx.doi.org/10.1096/fj.202200840RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SV	36374251				2022-12-28	WOS:000883025800001
J	Villani, R; Sangineto, M; Pontrelli, P; Bellanti, F; Bukke, VN; Moola, A; Gesualdo, L; Vendemiale, G; Grandaliano, G; Stallone, G; Serviddio, G				Villani, Rosanna; Sangineto, Moris; Pontrelli, Paola; Bellanti, Francesco; Bukke, Vidyasagar N.; Moola, Archana; Gesualdo, Loreto; Vendemiale, Gianluigi; Grandaliano, Giuseppe; Stallone, Giovanni; Serviddio, Gaetano			Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells	FASEB JOURNAL			English	Article						direct antiviral agents; HCV; hepatitis; metabolism; mitochondria	DNA; SIGNATURE	Hepatitis C virus (HCV) adopts several immune evasion mechanisms such as interfering with innate immunity or promoting T-cell exhaustion. However, the recent direct-antiviral agents (DAAs) rapidly eliminate the virus, and the repercussions in terms of immune system balance are unknown. Here we compared the PBMCs transcriptomic profile of patients with HCV chronic infection at baseline (T0) and 12 weeks after the end of the therapy (SVR12) with DAAs. 3862 genes were differently modulated, identifying oxidative phosphorylation as the top canonical pathway differentially activated. Therefore, we dissected PBMCs bioenergetic profile by analyzing mitochondrial respiration and glycolysis at 4 timepoints: T0, 4 weeks of therapy, end of therapy (EoT), and SVR12. Maximal and reserve respiratory capacity considerably increased at EoT, persisting until SVR12. Notably, over time a significant increase was observed in respiratory chain (RC) complexes protein levels and the enzymatic activity of complexes I, II, and IV. Mitochondrial-DNA integrity improved over time, and the expression of mitochondrial biogenesis key regulators such as TFAM, Nrf-1, and PPARGC1A significantly increased at SVR12; hence, RC complexes synthesis and mitochondrial respiration were supported after treatment. HCV clearance with DAAS profoundly changed PBMCs bioenergetic profile, suggesting the immunometabolism study as a new approach to the understanding of viral immune evasion mechanisms and host adaptations during infections and therapies.	[Villani, Rosanna; Sangineto, Moris; Bukke, Vidyasagar N.; Moola, Archana; Serviddio, Gaetano] Univ Foggia, Dept Med & Surg Sci, Liver Unit, CURE Univ Ctr Liver Dis Res & Treatment, Foggia, Italy; [Pontrelli, Paola] Univ Bari Aldo Moro, Fac Med, Dept Emergency & Organ Transplantat, Expt Biol, Bari, Italy; [Bellanti, Francesco; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Internal Med, Foggia, Italy; [Gesualdo, Loreto; Grandaliano, Giuseppe] Aldo Moro Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, Bari, Italy; [Stallone, Giovanni] Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Foggia, Italy; [Stallone, Giovanni] Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Viale Luigi Pinto,1, I-71100 Foggia, Italy	University of Foggia; Universita degli Studi di Bari Aldo Moro; University of Foggia; Universita degli Studi di Bari Aldo Moro; University of Foggia; University of Foggia	Stallone, G (corresponding author), Univ Foggia, Dept Med & Surg Sci, Nephrol Dialysis & Transplantat Unit, Viale Luigi Pinto,1, I-71100 Foggia, Italy.	trial.epatologia@unifg.it						Aregay A, 2019, J HEPATOL, V71, P889, DOI 10.1016/j.jhep.2019.06.025; Gokhale NS, 2014, FUTURE VIROL, V9, P1061, DOI 10.2217/FVL.14.89; Gureev AP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00435; H-gM B., 2022, FASEB J, V36, P3217; Huang MH, 2014, ACTA PHARM SIN B, V4, P241, DOI 10.1016/j.apsb.2014.06.010; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jones N, 2015, CLIN EXP IMMUNOL, V182, P69, DOI 10.1111/cei.12662; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Liu HM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/548390; Medeiros TC, 2019, AUTOPHAGY, V15, P178, DOI 10.1080/15548627.2018.1532263; Pawar T, 2018, MITOCHONDRION, V40, P16, DOI 10.1016/j.mito.2017.09.002; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pontrelli P, 2019, NEPHROL DIAL TRANSPL, V34, P157, DOI 10.1093/ndt/gfy206; Rascio F, 2015, J PATHOL, V237, P72, DOI 10.1002/path.4553; Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569; Sangineto M, 2021, MED CLIN-BARCELONA, V156, P317, DOI 10.1016/j.medcli.2020.04.050; Sangineto M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020652; Schooley Robert T, 2014, Top Antivir Med, V21, P148; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Urbanowicz A, 2019, ARCH IMMUNOL THER EX, V67, P79, DOI 10.1007/s00005-018-0532-8; Villani R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93251-3; Villani R, 2021, INTERN EMERG MED, V16, P1239, DOI 10.1007/s11739-020-02628-1; Wang W, 2016, METHODS MOL BIOL, V1351, P27, DOI 10.1007/978-1-4939-3040-1_3; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	25	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22650	10.1096/fj.202200629R	http://dx.doi.org/10.1096/fj.202200629R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1KV	36394523				2022-12-28	WOS:000887950200001
J	Szczepanski, HE; Flannigan, KL; Mainoli, B; Alston, L; Baruta, GM; Lee, JW; Venu, VKP; Shearer, J; Dufour, A; Hirota, SA				Szczepanski, Holly E.; Flannigan, Kyle L.; Mainoli, Barbara; Alston, Laurie; Baruta, Grace M.; Lee, Joshua W.; Venu, Vivek Krishna Pulakazhi; Shearer, Jane; Dufour, Antoine; Hirota, Simon A.			NR4A1 modulates intestinal smooth muscle cell phenotype and dampens inflammation-associated intestinal remodeling	FASEB JOURNAL			English	Article						Crohn's disease; fibrostenosis; inflammation; smooth muscle	NUCLEAR RECEPTOR NUR77; CROHNS-DISEASE; ORPHAN RECEPTOR; SAMP1/YITFC MOUSE; SPONTANEOUS MODEL; PROLIFERATION; MECHANISMS; FIBROSIS; COMPLICATIONS; TRANSCRIPTION	Stricture formation is a common complication of Crohn's disease (CD), driven by enhanced deposition of extracellular matrix (ECM) and expansion of the intestinal smooth muscle layers. Nuclear receptor subfamily 4 group A member 1 (NR4A1) is an orphan nuclear receptor that exhibits anti-proliferative effects in smooth muscle cells (SMCs). We hypothesized that NR4A1 regulates intestinal SMC proliferation and muscle thickening in the context of inflammation. Intestinal SMCs isolated from Nr4a1(+/+) and Nr4a1(-/-) littermates were subjected to shotgun proteomic analysis, proliferation, and bioenergetic assays. Proliferation was assessed in the presence and absence of NR4A1 agonists, cytosporone-B (Csn-B) and 6-mercaptopurine (6-MP). In vivo, we compared colonic smooth muscle thickening in Nr4a1(+/+) and Nr4a1(-/-) mice using the chronic dextran sulfate sodium (DSS) model of colitis. Second, SAMP1/YitFc mice (a model of spontaneous ileitis) were treated with Csn-B and small intestinal smooth muscle thickening was assessed. SMCs isolated from Nr4a1(-/-) mice exhibited increased abundance of proteins related to cell proliferation, metabolism, and ECM production, whereas Nr4a1(+/+) SMCs highly expressed proteins related to the regulation of the actin cytoskeleton and contractile processes. SMCs isolated from Nr4a1(-/-) mice exhibited increased proliferation and alterations in cellular metabolism, whereas activation of NR4A1 attenuated proliferation. In vivo, Nr4a1(-/-) mice exhibited increased colonic smooth muscle thickness following repeated cycles of DSS. Activating NR4A1 with Csn-B, in the context of established inflammation, reduced ileal smooth muscle thickening in SAMP1/YitFc mice. Targeting NR4A1 may provide a novel approach to regulate intestinal SMC phenotype, limiting excessive proliferation that contributes to stricture development in CD.	[Szczepanski, Holly E.; Flannigan, Kyle L.; Mainoli, Barbara; Alston, Laurie; Baruta, Grace M.; Lee, Joshua W.; Venu, Vivek Krishna Pulakazhi; Dufour, Antoine; Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW,Hlth Sci Room 1845, Calgary, AB T2N 4N1, Canada; [Szczepanski, Holly E.; Flannigan, Kyle L.; Mainoli, Barbara; Alston, Laurie; Baruta, Grace M.; Lee, Joshua W.; Venu, Vivek Krishna Pulakazhi; Shearer, Jane; Dufour, Antoine; Hirota, Simon A.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Mainoli, Barbara; Shearer, Jane; Dufour, Antoine] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Shearer, Jane; Hirota, Simon A.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Dufour, Antoine] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Hirota, Simon A.] Univ Calgary, Dept Immunol Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Hirota, SA (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW,Hlth Sci Room 1845, Calgary, AB T2N 4N1, Canada.	shirota@ucalgary.ca		Hirota, Simon/0000-0001-5782-1481	Crohn's and Colitis Canada (Crohn et Colite Canada); Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) [376341]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [DGECR-2019-00112]	Crohn's and Colitis Canada (Crohn et Colite Canada); Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Crohn's and Colitis Canada (Crohn et Colite Canada); Gouvernement du Canada | Canadian Institutes of Health Research (IRSC), Grant/Award Number: #376341; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: DGECR-2019-00112	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Andersson E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186142; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bai TR, 2000, AM J RESP CRIT CARE, V162, P663, DOI 10.1164/ajrccm.162.2.9907151; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bonafiglia QA, 2018, AM J PHYSIOL-CELL PH, V315, pC722, DOI 10.1152/ajpcell.00216.2018; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Chen WQ, 2017, J CROHNS COLITIS, V11, P92, DOI 10.1093/ecco-jcc/jjw126; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cui ML, 2016, HYPERTENSION, V67, P153, DOI 10.1161/HYPERTENSIONAHA.115.06114; Curciarello R, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00126; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Flynn RS, 2011, INFLAMM BOWEL DIS, V17, P193, DOI 10.1002/ibd.21351; Ginnan R, 2012, BIOCHEM J, V444, P105, DOI 10.1042/BJ20120152; Hamanaka RB, 2018, AM J RESP CELL MOL, V58, P585, DOI 10.1165/rcmb.2017-0186OC; Hamers AAJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133598; Hazelgrove KB, 2009, AM J PHYSIOL-GASTR L, V296, pG1230, DOI 10.1152/ajpgi.90508.2008; Herring JA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111373; Hiwatashi N, 2018, LARYNGOSCOPE, V128, pE425, DOI 10.1002/lary.27361; Huo Y, 2014, BIOCHEM PHARMACOL, V92, P590, DOI 10.1016/j.bcp.2014.09.021; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Koenis DS, 2018, CELL REP, V24, P2127, DOI 10.1016/j.celrep.2018.07.065; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Latella G, 2015, SCAND J GASTROENTERO, V50, P53, DOI 10.3109/00365521.2014.968863; Lawrance IC, 2017, J CROHNS COLITIS, V11, P1491, DOI 10.1016/j.crohns.2014.09.008; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; Li C, 2014, INFLAMM BOWEL DIS, V20, P1250, DOI 10.1097/MIB.0000000000000043; Li J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182679; Liebmann M, 2018, P NATL ACAD SCI USA, V115, pE8017, DOI 10.1073/pnas.1721049115; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin XF, 2004, J CELL SCI, V117, P5609, DOI 10.1242/jcs.01474; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2014, AM J RESP CELL MOL, V50, P379, DOI 10.1165/rcmb.2013-0198OC; Lobo SB, 2007, J ANAT, V211, P819, DOI 10.1111/j.1469-7580.2007.00820.x; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Martinez-Fierro ML, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017208; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Nair DG, 2011, AM J PHYSIOL-GASTR L, V300, pG903, DOI 10.1152/ajpgi.00528.2010; Nie XW, 2016, VASC PHARMACOL, V87, P230, DOI 10.1016/j.vph.2016.11.002; Niu GM, 2015, FASEB J, V29, P131, DOI 10.1096/fj.14-257550; Ouyang Q, 2016, P NATL ACAD SCI USA, V113, pE5598, DOI 10.1073/pnas.1609221113; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Parhamifar Ladan, 2013, Methods Mol Biol, V948, P13, DOI 10.1007/978-1-62703-140-0_2; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoepfer AM, 2012, DIGESTION, V86, P23, DOI 10.1159/000341961; Scirocco A, 2016, J CELL PHYSIOL, V231, P295, DOI 10.1002/jcp.25105; Severi C, 2014, EUR J HISTOCHEM, V58, P307, DOI 10.4081/ejh.2014.2457; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Sokol H, 2014, CURR OPIN GASTROEN, V30, P378, DOI 10.1097/MOG.0000000000000078; Stanzel RDP, 2010, AM J PHYSIOL-CELL PH, V299, pC805, DOI 10.1152/ajpcell.00086.2010; Stenmark KR, 2018, CARDIOVASC RES, V114, P551, DOI 10.1093/cvr/cvy004; Thia KT, 2010, GASTROENTEROLOGY, V139, P1147, DOI 10.1053/j.gastro.2010.06.070; Venu VKP, 2021, AM J PHYSIOL-GASTR L, V321, pG280, DOI 10.1152/ajpgi.00338.2019; Wang LY, 2010, MOL CELL BIOCHEM, V341, P159, DOI 10.1007/s11010-010-0447-0; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Yao LM, 2012, CARCINOGENESIS, V33, P301, DOI 10.1093/carcin/bgr287; Yoon K, 2011, CARCINOGENESIS, V32, P836, DOI 10.1093/carcin/bgr040; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zeng XL, 2018, CELL PHYSIOL BIOCHEM, V46, P1078, DOI 10.1159/000488838; Zhang L, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9363461; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	74	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22609	10.1096/fj.202101817RR	http://dx.doi.org/10.1096/fj.202101817RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5I8YD	36250380				2022-12-28	WOS:000868634500001
J	Cui, C; Zang, N; Song, J; Guo, XH; He, Q; Hu, HQ; Yang, MM; Wang, YQ; Yang, JW; Zou, Y; Gao, J; Wang, LS; Wang, C; Liu, FQ; He, FL; Hou, XG; Chen, L				Cui, Chen; Zang, Nan; Song, Jia; Guo, Xinghong; He, Qin; Hu, Huiqing; Yang, Mengmeng; Wang, Yuanqi; Yang, Jingwen; Zou, Ying; Gao, Jing; Wang, Lingshu; Wang, Chuan; Liu, Fuqiang; He, Falian; Hou, Xinguo; Chen, Li			Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424-5p	FASEB JOURNAL			English	Article						diabetic kidney disease; exosomes; mesenchymal stem cells; miR-424-5p; YAP1	PLASTICITY; FIBROSIS	Diabetic kidney disease (DKD) is well-acknowledged as one of the most common complications in diabetes mellitus. Recent studies have demonstrated the promising role of mesenchymal stem cell-derived exosomes (MSC-exos) as a cell-free treatment strategy for DKD. The present study sought to investigate the therapeutic potential and the underlying mechanisms of MSC-exos in DKD. The authentication of MSC-exos was validated by western blot, transmission electron microscope (TEM), and nanosight tracking analysis (NTA). Apoptosis was detected by western blot, TUNEL staining, and flow cytometry. Epithelial-to-mesenchymal transition (EMT) was evaluated by western blot and immunofluorescence. The relationship between miR-424-5p and Yes-associated protein 1 (YAP1) was revealed by dual luciferase reporter assay. We observed that MSC-exos could attenuate DKD by decreasing cell apoptosis and inhibiting epithelial-to-mesenchymal transition (EMT) in diabetic kidneys in db/db mice. Besides, we documented that MSC-exos could reverse high glucose-induced apoptosis and EMT in HK2 cells. Interestingly, miR-424-5p derived from MSC-exos could inhibit YAP1 activation in HK2 cells, resulting in alleviation of high glucose-induced cell apoptosis and EMT. Our study provides novel insights into MSC-exos-mediated protective effect in DKD. MSC-exos could inhibit high glucose-induced apoptosis and EMT through miR-424-5p targeting of YAP1.	[Cui, Chen; Zang, Nan; Song, Jia; Guo, Xinghong; He, Qin; Hu, Huiqing; Yang, Mengmeng; Wang, Yuanqi; Yang, Jingwen; Zou, Ying; Gao, Jing; Wang, Lingshu; Wang, Chuan; Liu, Fuqiang; Hou, Xinguo; Chen, Li] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Endocrinol, Jinan, Peoples R China; [Wang, Lingshu; Wang, Chuan; Liu, Fuqiang; Hou, Xinguo; Chen, Li] Shandong Univ, Inst Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Lingshu; Wang, Chuan; Liu, Fuqiang; Hou, Xinguo; Chen, Li] Shandong Prov Med & Hlth, Key Lab Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Lingshu; Wang, Chuan; Liu, Fuqiang; Hou, Xinguo; Chen, Li] Jinan Clin Res Ctr Endocrine & Metab Dis, Jinan, Peoples R China; [He, Falian; Chen, Li] Nuolai Biomed Technol Co Ltd, Tai An, Shandong, Peoples R China; [Hou, Xinguo] Shandong Univ, Dept Endocrinol, Hosp 2, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University	Hou, XG; Chen, L (corresponding author), Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China.	houxinguo@sdu.edu.cn; chenli3@email.sdu.edu.cn			Taishan Industry Leading Talent Project of Shandong Province; National Natural Science Foundation of China [82070800]	Taishan Industry Leading Talent Project of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Taishan Industry Leading Talent Project of Shandong Province and National Natural Science Foundation of China (82070800).	Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Anders HJ, 2018, NAT REV NEPHROL, V14, P361, DOI 10.1038/s41581-018-0001-y; Andrzejewska A, 2019, STEM CELLS, V37, P855, DOI 10.1002/stem.3016; Chen JC, 2020, DIABETES, V69, P2446, DOI 10.2337/db20-0579; Chen L, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/8035853; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Duan YR, 2020, J BIOL CHEM, V295, P12868, DOI 10.1074/jbc.RA120.012522; Elahi FM, 2020, STEM CELLS, V38, P15, DOI 10.1002/stem.3061; Guo F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-19; Herrmann IK, 2021, NAT NANOTECHNOL, V16, P748, DOI 10.1038/s41565-021-00931-2; Hu J, 2013, KIDNEY INT, V84, P521, DOI 10.1038/ki.2013.114; Isaac R, 2021, CELL METAB, V33, P1744, DOI 10.1016/j.cmet.2021.08.006; Jin J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1177-1; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lee Seung Eun, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0268-5; Li DL, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02064-0; Liu MY, 2021, GASTROENTEROLOGY, V160, P1771, DOI 10.1053/j.gastro.2020.12.077; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45523; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lytvyn Y, 2020, ENDOCR REV, V41, P202, DOI 10.1210/endrev/bnz010; Molitch ME, 2015, KIDNEY INT, V87, P20, DOI 10.1038/ki.2014.128; Nagaishi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34842; Persson F, 2018, KIDNEY INT SUPPL, V8, P2, DOI 10.1016/j.kisu.2017.10.003; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Srivastava SP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/125469; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Ti DD, 2016, SCI CHINA LIFE SCI, V59, P1305, DOI 10.1007/s11427-016-0240-4; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Wang GF, 2019, J CELL PHYSIOL, V234, P11646, DOI 10.1002/jcp.27822; Wang JM, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111918; Wang Y, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02148-5; Wang Y, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.671566; Wang YH, 2021, DIABETES RES CLIN PR, V173, DOI 10.1016/j.diabres.2021.108702; Wong JS, 2016, AM J PHYSIOL-RENAL, V311, pF241, DOI 10.1152/ajprenal.00500.2015; Xiang E, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01852-y; Xie QX, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02011-z; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Yang TT, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154258; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhao M, 2021, ACS NANO, V15, P1519, DOI 10.1021/acsnano.0c08947; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194	43	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22517	10.1096/fj.202200488R	http://dx.doi.org/10.1096/fj.202200488R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4D1KB	36036527				2022-12-28	WOS:000846904200001
J	Guo, X; Zhang, Y; Liu, C; Ren, LL; Gao, S; Bi, J; Liang, J; Wang, P				Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Liang, Jia; Wang, Peng			Intranasal administration of beta-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						B3galt2; ischemic stroke; NLRP3 inflammasome; oxidative stress; TGF-beta 1	CEREBRAL-ARTERY OCCLUSION; NF-KAPPA-B; DRUG-DELIVERY; BRAIN; MECHANISMS; PATHWAYS; INJURY; MICE	Ischemic stroke is one of the major causes of morbidity and mortality. The beta-1, 3-galactosyltransferase 2 (B3galt2), a member of beta-1, 3-galactosyltransferase family, is playing a vital role in the pathological process of cerebral ischemic injury, but its underlying mechanisms remain unclear. In the present study, we examined the involvement of oxidative stress and NLRP3 inflammasome activation in the neuroprotective effect of B3galt2. Cerebral ischemia/reperfusion (I/R) injury was simulated in a mouse middle cerebral artery occlusion (MCAO) model. Recombinant human B3galt2 (rh-B3galt2) was administered intranasally 1 h post MCAO, and TGF-beta 1-siRNA was administered intracerebroventricularly 24 h before MCAO. Outcome measures included brain infarct volume, neurological function, blood-brain barrier (BBB) permeability, neuronal apoptosis, oxidative stress, and the inflammatory response. First, we found that rh-B3galt2 significantly alleviated brain infarct volume and BBB permeability, improved neurological function, and attenuated I/R-induced neuron apoptosis and oxidative stress. Furthermore, rh-B3galt2 attenuated pro-inflammatory cytokines, NF-kappa B, IL-6, TNF-alpha, and IL-1 beta, and inhibited NLRP3 inflammasome activation. Finally, inhibition of TGF-beta 1 by TGF-beta 1-siRNA abolished the anti-oxidative and anti-inflammatory effects of rh-B3galt2 in mice after I/R. Collectively, our study demonstrated that rh-B3galt2 exerts neuroprotective effects by regulating cerebral ischemia-induced oxidative stress and NLRP3 inflammasome, which is mainly dependent on the heightening of the TGF-beta 1 pathway. Thus, B3galt2 might be considered a new therapeutic target for ischemic stroke treatment.	[Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Wang, Peng] Jinzhou Med Univ, Dept Neurobiol, Jinzhou 121001, Liaoning, Peoples R China; [Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Wang, Peng] Jinzhou Med Univ, Key Lab Neurodegenerat Dis Liaoning Prov, Jinzhou, Peoples R China; [Liang, Jia] Jinzhou Med Univ, Inst Life Sci, Jinzhou 121001, Liaoning, Peoples R China	Jinzhou Medical University; Jinzhou Medical University; Jinzhou Medical University	Wang, P (corresponding author), Jinzhou Med Univ, Dept Neurobiol, Jinzhou 121001, Liaoning, Peoples R China.; Liang, J (corresponding author), Jinzhou Med Univ, Inst Life Sci, Jinzhou 121001, Liaoning, Peoples R China.	liangjia@jzmu.edu.cn; wangpeng@jzmu.edu.cn			National Natural Science Foundation of China (NSFC) [81971231]; Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation) [2022--MS--391]; educational department of Liaoning province [JYTQN2020011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation); educational department of Liaoning province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81971231; Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation), Grant/Award Number: 2022--MS--391; Scientific research project from the educational department of Liaoning province, Grant/Award Number: JYTQN2020011	Alishahi M, 2019, INT J STROKE, V14, P574, DOI 10.1177/1747493019841242; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Angata K, 2006, METHOD ENZYMOL, V417, P25, DOI 10.1016/S0076-6879(06)17003-2; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen HY, 2020, CHEM-BIOL INTERACT, V331, DOI 10.1016/j.cbi.2020.109249; Cherait A, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.585082; Feng YS, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00155; Feng ZH, 2019, J CEREBR BLOOD F MET, V39, P97, DOI 10.1177/0271678X17725211; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Franke M, 2021, BRAIN BEHAV IMMUN, V92, P221, DOI 10.1016/j.bbi.2020.12.009; Gamdzyk M, 2020, MOL NEUROBIOL, V57, P2600, DOI 10.1007/s12035-020-01904-7; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jia MJ, 2021, BRAIN RES BULL, V169, P104, DOI 10.1016/j.brainresbull.2021.01.010; Kaur H, 2019, NEUROPHARMACOLOGY, V158, DOI 10.1016/j.neuropharm.2019.107727; Khatri V, 2021, FASEB J, V35, DOI 10.1096/fj.202002622R; Kozlovskaya L, 2014, J CONTROL RELEASE, V189, P133, DOI 10.1016/j.jconrel.2014.06.053; Kroes RA, 2010, P NATL ACAD SCI USA, V107, P12646, DOI 10.1073/pnas.0909862107; Li LZ, 2020, CNS NEUROSCI THER, V26, P288, DOI 10.1111/cns.13291; Lyu JX, 2021, CNS NEUROSCI THER, V27, P515, DOI 10.1111/cns.13620; Mao LL, 2021, TRANSL STROKE RES, V12, P711, DOI 10.1007/s12975-021-00912-6; Marsh JD, 2010, J AM COLL CARDIOL, V56, P683, DOI 10.1016/j.jacc.2009.12.072; McGonigal R, 2019, J NEUROSCI, V39, P63, DOI 10.1523/JNEUROSCI.2095-18.2018; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Moll T, 2020, BRAIN, V143, P1332, DOI 10.1093/brain/awz358; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Okada T, 2019, MOL NEUROBIOL, V56, P8203, DOI 10.1007/s12035-019-01668-9; Orellana-Urzua S, 2020, CURR PHARM DESIGN, V26, P4246, DOI 10.2174/1381612826666200708133912; Pardeshi CV, 2013, EXPERT OPIN DRUG DEL, V10, P957, DOI 10.1517/17425247.2013.790887; Pu HJ, 2021, J CEREBR BLOOD F MET, V41, P2870, DOI 10.1177/0271678X211028680; Rodriguez R, 2005, J NEUROSCI METH, V147, P22, DOI 10.1016/j.jneumeth.2005.02.013; Ruegsegger GN, 2019, FASEB J, V33, P4458, DOI 10.1096/fj.201802043R; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi XD, 2017, J CEREBR BLOOD F MET, V37, P1447, DOI 10.1177/0271678X16656201; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Wang P, 2021, J CEREBR BLOOD F MET, V41, P641, DOI 10.1177/0271678X20926787; Xu QX, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02137-8; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Yang X, 2021, NEUROCHEM INT, V144, DOI 10.1016/j.neuint.2021.104976; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014; Yu YH, 2018, INT J BIOL MACROMOL, V116, P537, DOI 10.1016/j.ijbiomac.2018.04.113; Zhang L, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04363-7; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792	46	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22542	10.1096/fj.202200456RR	http://dx.doi.org/10.1096/fj.202200456RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4L5YD	36094000				2022-12-28	WOS:000852705800001
J	Khokhlatchev, AV; Sharma, A; Deering, TG; Shaw, JJP; Costa-Pinheiro, P; Golla, U; Annageldiyev, C; Cabot, MC; Conaway, MR; Tan, SF; Ung, J; Feith, DJ; Loughran, TP; Claxton, DF; Fox, TE; Kester, M				Khokhlatchev, Andrei, V; Sharma, Arati; Deering, Tye G.; Shaw, Jeremy J. P.; Costa-Pinheiro, Pedro; Golla, Upendarrao; Annageldiyev, Charyguly; Cabot, Myles C.; Conaway, Mark R.; Tan, Su-Fern; Ung, Johnson; Feith, David J.; Loughran, Thomas P., Jr.; Claxton, David F.; Fox, Todd E.; Kester, Mark			Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia	FASEB JOURNAL			English	Article						cell death; ceramides; cytarabine; drug resistance; leukemia; myeloid; acute; models; animal; recurrence; signal transduction; standard of care; venetoclax	LONG-CHAIN CERAMIDES; HUMAN BREAST; RESISTANCE; AUTOPHAGY	Despite several new therapeutic options for acute myeloid leukemia (AML), disease relapse remains a significant challenge. We have previously demonstrated that augmenting ceramides can counter various drug-resistance mechanisms, leading to enhanced cell death in cancer cells and extended survival in animal models. Using a nanoscale delivery system for ceramide (ceramide nanoliposomes, CNL), we investigated the effect of CNL within a standard of care venetoclax/cytarabine (Ara-C) regimen. We demonstrate that CNL augmented the efficacy of venetoclax/cytarabine in in vitro, ex vivo, and in vivo models of AML. CNL treatment induced non-apoptotic cytotoxicity, and augmented cell death induced by Ara-C and venetoclax. Mechanistically, CNL reduced both venetoclax (Mcl-1) and cytarabine (Chk1) drug-resistant signaling pathways. Moreover, venetoclax and Ara-C augmented the generation of endogenous pro-death ceramide species, which was intensified with CNL. Taken together, CNL has the potential to be utilized as an adjuvant therapy to improve outcomes, potentially extending survival, in patients with AML.	[Khokhlatchev, Andrei, V; Deering, Tye G.; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA; [Sharma, Arati; Golla, Upendarrao; Annageldiyev, Charyguly; Claxton, David F.] Penn State Univ, Div Hematol & Oncol, Coll Med, Dept Med, Hershey, PA USA; [Sharma, Arati] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA; [Sharma, Arati; Golla, Upendarrao; Annageldiyev, Charyguly; Claxton, David F.] Penn State Univ, Penn State Canc Inst, Coll Med, Hershey, PA USA; [Shaw, Jeremy J. P.; Costa-Pinheiro, Pedro] Univ Virginia, Dept Expt Pathol, Charlottesville, VA USA; [Cabot, Myles C.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA; [Cabot, Myles C.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Conaway, Mark R.] Univ Virginia, Sch Med, Publ Hlth Sci, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Ung, Johnson; Feith, David J.; Loughran, Thomas P., Jr.] Univ Virginia, Sch Med, Dept Med, Div Hematol & Oncol, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Feith, David J.; Loughran, Thomas P., Jr.; Kester, Mark] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Ung, Johnson] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Kester, Mark] NanoSTAR Inst, Charlottesville, VA USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Fox, TE (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	tfox@virginia.edu	Golla, Upendar Rao/D-5933-2017	Golla, Upendar Rao/0000-0003-0519-7087; Ung, Johnson/0000-0002-3275-0530	HHS | NIH | National Cancer Institute (NCI) [P01-CA171983, F99CA245802, P30-CA044579, F31-CA271809]	HHS | NIH | National Cancer Institute (NCI)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: P01-CA171983, F99CA245802, P30-CA044579 and F31-CA271809	Alhoshani A, 2020, ONCOTARGETS THER, V13, P13357, DOI 10.2147/OTT.S281519; Annageldiyev C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00393; Annageldiyev C, 2020, HAEMATOLOGICA, V105, P687, DOI 10.3324/haematol.2018.212886; Anroedh S, 2018, J LIPID RES, V59, P1729, DOI 10.1194/jlr.P081281; Barth BM, 2019, BLOOD ADV, V3, P2598, DOI 10.1182/bloodadvances.2018021295; Bose P, 2017, LEUKEMIA LYMPHOMA, V58, P2026, DOI 10.1080/10428194.2017.1283032; Cingolani F, 2016, CHEM PHYS LIPIDS, V197, P25, DOI 10.1016/j.chemphyslip.2015.07.026; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; David L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9704; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; DiNardo CD, 2020, BLOOD, V135, P791, DOI 10.1182/blood.2019003988; DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Jayappa KD, 2017, BLOOD ADV, V1, P933, DOI 10.1182/bloodadvances.2016004176; Kantarjian H, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00425-3; Kao LP, 2019, J LIPID RES, V60, P1590, DOI 10.1194/jlr.RA119000251; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Lewis AC, 2022, BLOOD, V139, P3737, DOI 10.1182/blood.2021013277; Liu FB, 2022, EXP HEMATOL, V105, P39, DOI 10.1016/j.exphem.2021.10.006; Liu K, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01304-w; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Montgomery D.C., 2005, DESIGN ANAL EXPT, V6th; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Ricci C, 2006, BBA-BIOMEMBRANES, V1758, P2121, DOI 10.1016/j.bbamem.2006.06.016; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Shaw JJP, 2020, MOL CANCER THER, V19, P2621, DOI 10.1158/1535-7163.MCT-20-0182; Sheridan M, 2021, CANCERS, V13, DOI 10.3390/cancers13102475; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Stefanko A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168781; Stiban J, 2015, BBA-BIOMEMBRANES, V1848, P561, DOI 10.1016/j.bbamem.2014.11.018; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Tippetts TS, 2018, J LIPID RES, V59, P1549, DOI 10.1194/jlr.C088377; Vincelette ND, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40218-0; Wang Z, 2017, ONCOTARGET, V8, P104022, DOI 10.18632/oncotarget.21955; Wei AH, 2020, BLOOD, V135, P2137, DOI 10.1182/blood.2020004856; Yamada Osamu, 2013, JAKSTAT, V2, pe25256, DOI 10.4161/jkst.25256; Yamamoto JF, 2008, CANCER CAUSE CONTROL, V19, P379, DOI 10.1007/s10552-007-9097-2; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zheng Shuyu, 2022, Genomics Proteomics Bioinformatics, V20, P587, DOI 10.1016/j.gpb.2022.01.004; Zhou FJ, 2021, J CANCER, V12, P6727, DOI 10.7150/jca.60208	45	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22514	10.1096/fj.202200765R	http://dx.doi.org/10.1096/fj.202200765R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N0XZ	36106439	hybrid, Green Published			2022-12-28	WOS:000853744300001
J	Shen, BB; Mei, M; Ai, SM; Liao, XH; Li, N; Xiang, S; Wen, CL; Tao, Y; Dai, HZ				Shen, Bingbing; Mei, Mei; Ai, Shanmu; Liao, Xiaohui; Li, Ning; Xiang, Sha; Wen, Chaolin; Tao, Yang; Dai, Huanzi			TRPC6 inhibits renal tubular epithelial cell pyroptosis through regulating zinc influx and alleviates renal ischemia-reperfusion injury	FASEB JOURNAL			English	Article						A20; pyroptosis; renal ischemia; reperfusion injury; TRPC6		Canonical transient receptor potential-6 (TRPC6) has been reported to be involved in cell damage after ischemia/reperfusion (I/R) injury in target organs. While the effect and of TRPC6 on pyroptosis in renal I/R injury remain unclear. In our study, we first established the renal I/R mouse model and oxygen-glucose deprivation and re-oxygenation (OGD/R) cell model, and investigated the impacts of TRPC6 on the pyroptosis-related proteins using CCK-8, western blot, ELISA, and immunofluorescence probes. Besides, we also explored the mechanism of TRPC6 in pyroptosis of renal tubular epithelial cells through A20 knockdown or overexpression and zinc chloride (ZnCl2) or a zinc ion chelator (TPEN) treatment. Our results indicated that I/R injury could cause downregulation of TRPC6 both in vivo and in vitro. In the I/R injury murine model, TRPC6 inhibition exacerbated tissue damage and upregulated NLRP3, ASC, caspase-1, IL-18, and IL-1 beta, which could be alleviated by the administration of ZnCl2. In the OGD/R cell model, inhibitor of TRPC6 (SAR7334) reduced zinc ion influx, aggravated cell death and upregulated pyroptosis-related protein. The pyroptosis phenotype also could be alleviated by ZnCl2 and intensified by TPEN. Overexpression of A20 reduced the expression of pyroptosis-related protein, increased cell viability in the sh-TRPC6 and TPEN-treated OGD/R cell models, while A20 deficiency impaired the protective effect of zinc ion. Therefore, our results indicate that TRPC6 could promote zinc ion influx in renal tubular epithelial cells, thereby upregulating intracellular A20, inhibiting the activation of inflammasome NLRP3, and ultimately attenuating renal I/R injury.	[Shen, Bingbing; Li, Ning; Xiang, Sha; Wen, Chaolin] Chongqing Univ Cent Hosp, Chongqing Emergency Med Ctr, Chongqing Key Lab Emergency Med, Dept Nephrol, Chongqing, Peoples R China; [Shen, Bingbing] Army Med Univ, Hosp 1, Dept Nephrol, Chongqing, Peoples R China; [Mei, Mei] Peoples Hosp Shapingba Dist, Dept Nephrol, Chongqing, Peoples R China; [Ai, Shanmu] Chongqing Univ Cent Hosp, Chongqing Emergency Med Ctr, Chongqing Key Lab Emergency Med, Dept Emergency, Chongqing, Peoples R China; [Liao, Xiaohui] Chongqing Univ, Affiliated Cent Hosp, Dept Nephrol, Chongqing, Peoples R China; [Tao, Yang] Chongqing Univ Cent Hosp, Chongqing Emergency Med Ctr, Dept Crit Care Med, Chongqing Key Lab Emergency Med, Chongqing, Peoples R China; [Dai, Huanzi] Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing, Peoples R China	Army Medical University; Chongqing University; Army Medical University	Tao, Y (corresponding author), Chongqing Univ Cent Hosp, Chongqing Emergency Med Ctr, Dept Crit Care Med, Chongqing Key Lab Emergency Med, Chongqing, Peoples R China.; Dai, HZ (corresponding author), Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing, Peoples R China.	taoyang805148@163.com; dhz084426@163.com			Chongqing Municipal Natural Science Foundation [cstc2020jcyj-msxmX1085, cstc2020jcyj-msxmX0013]; National Natural Science Foundation of China [81873604]; Discipline Construction Foundation of Chongqing University Central Hospital [XKJS201907]; Chongqing University Central Hospital Scientific Research Foundation [2021KYQD1113]	Chongqing Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Discipline Construction Foundation of Chongqing University Central Hospital; Chongqing University Central Hospital Scientific Research Foundation	This work supported by the Chongqing Municipal Natural Science Foundation (No. cstc2020jcyj-msxmX1085, cstc2020jcyj-msxmX0013), National Natural Science Foundation of China (81873604), Discipline Construction Foundation of Chongqing University Central Hospital (XKJS201907), Chongqing University Central Hospital Scientific Research Foundation (2021KYQD1113).	Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Chen QZ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2360-0; Chen XL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2157-1; Chen YY, 2022, PART FIBRE TOXICOL, V19, DOI 10.1186/s12989-021-00443-w; Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7; Du LP, 2019, J MOL CELL CARDIOL, V132, P136, DOI 10.1016/j.yjmcc.2019.05.011; Gammoh NZ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060624; Gan XP, 2016, BIOSENS BIOELECTRON, V86, P393, DOI 10.1016/j.bios.2016.06.087; Gibon J, 2011, BBA-BIOMEMBRANES, V1808, P2807, DOI 10.1016/j.bbamem.2011.08.013; Hayashi K, 2021, J NEUROSURG, V134, P992, DOI 10.3171/2020.1.JNS192047; Hou X, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.698975; Jain PP, 2021, AM J PHYSIOL-LUNG C, V321, pL1161, DOI 10.1152/ajplung.00159.2021; Jardin I, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118828; Jurcau A, 2021, J INTEGR NEUROSCI, V20, P727, DOI 10.31083/j.jin2003078; Kim EY, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040856; Li CG, 2021, ACTA BIOCH BIOPH SIN, V53, P131, DOI 10.1093/abbs/gmaa155; Liu H, 2020, FASEB J, V34, P835, DOI 10.1096/fj.201901816R; Liu H, 2021, J CELL MOL MED, V25, P5060, DOI 10.1111/jcmm.16483; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Miao NJ, 2019, KIDNEY INT, V96, P1105, DOI 10.1016/j.kint.2019.04.035; Nakamura H, 2019, J DERMATOL SCI, V95, P62, DOI 10.1016/j.jdermsci.2019.07.004; Nie CQ, 2021, LIFE SCI, V272, DOI 10.1016/j.lfs.2021.119248; Perera M, 2021, CONTRAST MEDIA MOL I, V2021, DOI 10.1155/2021/6686803; Polichnowski AJ, 2020, AM J PHYSIOL-RENAL, V318, pF1086, DOI 10.1152/ajprenal.00590.2019; Qin ZQ, 2019, AGING-US, V11, P9295, DOI 10.18632/aging.102348; Qiu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9743280; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Sakaguchi R, 2020, FREE RADICAL BIO MED, V146, P36, DOI 10.1016/j.freeradbiomed.2019.10.415; Shen BB, 2019, MOL THER-NUCL ACIDS, V17, P701, DOI 10.1016/j.omtn.2019.06.025; Shen BB, 2016, MED SCI MONITOR, V22, P633, DOI 10.12659/MSM.897353; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Skrypnyk NI, 2013, JOVE-J VIS EXP, DOI 10.3791/50495; Staruschenko A, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0960-9; Summersgill H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.547; Tajima T, 2019, KIDNEY INT, V95, P1120, DOI 10.1016/j.kint.2018.11.034; Tang TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0378-3; Tirpe AA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246140; Wang HB, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107497; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241	39	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22527	10.1096/fj.202200109RR	http://dx.doi.org/10.1096/fj.202200109RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4D1JX	36036542				2022-12-28	WOS:000846903800001
J	Thomas, ACQ; Brown, A; Hatt, AA; Manta, K; Costa-Parke, A; Kamal, M; Joanisse, S; McGlory, C; Phillips, SM; Kumbhare, D; Parise, G				Thomas, Aaron C. Q.; Brown, Alex; Hatt, Aidan A.; Manta, Katherine; Costa-Parke, Anamaria; Kamal, Michael; Joanisse, Sophie; McGlory, Chris; Phillips, Stuart M.; Kumbhare, Dinesh; Parise, Gianni			Short-term aerobic conditioning prior to resistance training augments muscle hypertrophy and satellite cell content in healthy young men and women	FASEB JOURNAL			English	Article						aerobic conditioning; aerobic training; capillarization; muscle stem cells; resistance training; responder; satellite cells; single-leg cycling	HUMAN SKELETAL-MUSCLE; MYONUCLEAR ADDITION; STEM-CELLS; EXERCISE; CAPILLARIZATION; ACTIVATION; GROWTH; EXPANSION; DYNAMICS; STRENGTH	Factors influencing inter-individual variability of responses to resistance training (RT) remain to be fully elucidated. We have proposed the importance of capillarization in skeletal muscle for the satellite cell (SC) response to RT-induced muscle hypertrophy, and hypothesized that aerobic conditioning (AC) would augment RT-induced adaptations. Fourteen healthy young (22 +/- 2 years) men and women underwent AC via 6 weeks of unilateral cycling followed by 10 weeks of bilateral RT to investigate how AC alters SC content, activity, and muscle hypertrophy following RT. Muscle biopsies were taken at baseline (unilateral), post AC (bilateral), and post RT (bilateral) in the aerobically conditioned (AC + RT) and unconditioned (RT) legs. Immunofluorescence was used to determine muscle capillarization, fiber size, SC content, and activity. Type I and type II fiber cross-sectional area (CSA) increased following RT, and when legs were analyzed independently, AC + RT increased type I, type II, and mixed-fiber CSA, where the RT leg tended to increase type II (p = .05), but not type I or mixed-fiber CSA. SC content, activation, and differentiation increased with RT, where type I total and quiescent SC content was greater in AC + RT compared to the RT leg. Those with the greatest capillary-to-fiber perimeter exchange index before RT had the greatest change in CSA following RT and a significant relationship was observed between type II fiber capillarization and the change in type II-fiber CSA with RT (r = 0.35). This study demonstrates that AC prior to RT can augment RT-induced muscle adaptions and that these differences are associated with increases in capillarization.	[Thomas, Aaron C. Q.; Brown, Alex; Hatt, Aidan A.; Manta, Katherine; Costa-Parke, Anamaria; Kamal, Michael; Joanisse, Sophie; Phillips, Stuart M.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Joanisse, Sophie] Manchester Metropolitan Univ, Dept Sport & Exercise Sci, Musculoskeletal Sci & Sport Med Res Ctr, Fac Sci & Engn, Manchester, Lancs, England; [Joanisse, Sophie] Manchester Metropolitan Univ Inst Sport, Manchester, Lancs, England; [McGlory, Chris] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [McGlory, Chris] Queens Univ, Dept Med, Kingston, ON, Canada; [Kumbhare, Dinesh] Toronto Rehabil Inst, Toronto, ON, Canada	McMaster University; Manchester Metropolitan University; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Joanisse, Sophie/0000-0001-9983-9401	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05633]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada, Grant/ Award Number: RGPIN--2016--05633	Abbiss CR, 2011, J APPL PHYSIOL, V110, P1248, DOI 10.1152/japplphysiol.01247.2010; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Blaauw B, 2014, J MUSCLE RES CELL M, V35, P3, DOI 10.1007/s10974-014-9376-y; Burns KJ, 2014, EUR J APPL PHYSIOL, V114, P961, DOI 10.1007/s00421-014-2830-0; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Damas F, 2018, EUR J APPL PHYSIOL, V118, P2607, DOI 10.1007/s00421-018-3984-y; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Dinulovic I, 2017, ADV EXP MED BIOL, V1041, P141, DOI 10.1007/978-3-319-69194-7_8; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Elmer SJ, 2012, MED SCI SPORT EXER, V44, P1504, DOI 10.1249/MSS.0b013e31824fb8bd; Fukada S, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118742; Gliemann L, 2016, EUR J APPL PHYSIOL, V116, P1443, DOI 10.1007/s00421-016-3419-6; Hepple RT, 1997, CAN J APPL PHYSIOL, V22, P11, DOI 10.1139/h97-002; Hiscock N, 2003, AM J PHYSIOL-HEART C, V285, pH1759, DOI 10.1152/ajpheart.00150.2003; Hoier B, 2012, J PHYSIOL-LONDON, V590, P595, DOI 10.1113/jphysiol.2011.216135; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; Holloway TM, 2018, MED SCI SPORT EXER, V50, P36, DOI 10.1249/MSS.0000000000001409; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Knuiman P, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0055-9; Kostrominova TY, 2011, MICROSC RES TECHNIQ, V74, P18, DOI 10.1002/jemt.20865; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lundberg TR, 2013, J APPL PHYSIOL, V114, P81, DOI 10.1152/japplphysiol.01013.2012; MacInnis MJ, 2017, APPL PHYSIOL NUTR ME, V42, P563, DOI 10.1139/apnm-2016-0645; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Morton RW, 2019, J PHYSIOL-LONDON, V597, P4601, DOI 10.1113/JP278056; Murach KA, 2018, PHYSIOLOGY, V33, P26, DOI 10.1152/physiol.00019.2017; Nederveen JP, 2015, ACTA PHYSIOL, V215, P177, DOI 10.1111/apha.12601; Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155; Nederveen JP, 2017, AM J PHYSIOL-REG I, V312, pR85, DOI 10.1152/ajpregu.00221.2016; Nederveen JP, 2016, J CACHEXIA SARCOPENI, V7, P547, DOI 10.1002/jcsm.12105; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Snijders T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13278; Snijders T, 2017, J CACHEXIA SARCOPENI, V8, P267, DOI 10.1002/jcsm.12137; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; West DWD, 2010, J APPL PHYSIOL, V108, P60, DOI 10.1152/japplphysiol.01147.2009; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153	48	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22500	10.1096/fj.202200398RR	http://dx.doi.org/10.1096/fj.202200398RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0JH	35971745				2022-12-28	WOS:000840655900001
J	Suresh, V; Dash, P; Suklabaidya, S; Murmu, KC; Sasmal, PK; Jogdand, GM; Parida, D; Sethi, M; Das, B; Mohapatra, D; Saha, S; Prasad, P; Satoskar, A; Senapati, S				Suresh, Voddu; Dash, Pujarini; Suklabaidya, Sujit; Murmu, Krushna Chandra; Sasmal, Prakash K.; Jogdand, Gajendra M.; Parida, Deepti; Sethi, Manisha; Das, Biswajit; Mohapatra, Debasish; Saha, Subha; Prasad, Punit; Satoskar, Abhay; Senapati, Shantibhusan			MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis	FASEB JOURNAL			English	Article						apCAFs; apoptosis; CAFs; fibrosis; pancreatic stellate cells; stromal cells; Treg	MIGRATION INHIBITORY FACTOR; CANCER-ASSOCIATED FIBROBLASTS; PROMOTES CELL-SURVIVAL; MESENCHYMAL STEM-CELLS; FACTOR EXPRESSION; P53; ACTIVATION; SECRETION; GAMMA	The presence of activated pancreatic stellate cells (PSCs) in the pancreatic ductal adenocarcinoma (PDAC) microenvironment plays a significant role in cancer progression. Macrophage migration inhibitory factor (MIF) is overexpressed in PDAC tissues and expressed by both cancer and stromal cells. The pathophysiological role of MIF in PDAC-associated fibroblasts or PSCs is yet to be elucidated. Here we report that the PSCs of mouse or cancer-associated fibroblast cells (CAFs) of human expresses MIF and its receptors, whose expression gets upregulated upon LPS or TNF-alpha stimulation. In vitro functional experiments showed that MIF significantly conferred a survival advantage to CAFs/PSCs upon growth factor deprivation. Genetic or pharmacological inhibition of MIF also corroborated these findings. Further, co-injection of mouse pancreatic cancer cells with PSCs isolated from Mif(-/-) or Mif(+/+) mice confirmed the pro-survival effect of MIF in PSCs and also demonstrated the pro-tumorigenic role of MIF expressed by CAFs in vivo. Differential gene expression analysis and in vitro mechanistic studies indicated that MIF expressed by activated CAFs/PSCs confers a survival advantage to these cells by suppression of interferon pathway induced p53 dependent apoptosis.	[Suresh, Voddu; Dash, Pujarini; Suklabaidya, Sujit; Parida, Deepti; Sethi, Manisha; Das, Biswajit; Mohapatra, Debasish; Senapati, Shantibhusan] Inst Life Sci, Dept Canc Biol, Tumor Microenvironm & Anim Models Lab, Nalco Sq, Bhubaneswar 751023, India; [Suresh, Voddu; Murmu, Krushna Chandra; Parida, Deepti; Sethi, Manisha; Saha, Subha] Reg Ctr Biotechnol, Faridabad, India; [Murmu, Krushna Chandra; Saha, Subha; Prasad, Punit] Inst Life Sci, Epigenet & Chromatin Biol Unit, Bhubaneswar, India; [Sasmal, Prakash K.] All India Inst Med Sci, Dept Gen Surg, Bhubaneswar, India; [Jogdand, Gajendra M.] Inst Life Sci, Infect Dis Biol, Bhubaneswar, India; [Mohapatra, Debasish] Kalinga Inst Ind Technol, Bhubaneswar, India; [Satoskar, Abhay] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Kalinga Institute of Industrial Technology (KIIT); University System of Ohio; Ohio State University	Senapati, S (corresponding author), Inst Life Sci, Dept Canc Biol, Tumor Microenvironm & Anim Models Lab, Nalco Sq, Bhubaneswar 751023, India.	senapati@ils.res.in	Jogdand, Gajendra/HGB-4028-2022; Jogdand, Gajendra/HGD-5901-2022	DAS, BISWAJIT/0000-0002-5657-5626; Suresh, Voddu/0000-0001-8533-9465; Jogdand, Gajendra/0000-0002-3515-5454	DST | Science and Engineering Research Board (SERB) [EMR/2016/006214]	DST | Science and Engineering Research Board (SERB)	DST | Science and Engineering Research Board (SERB), Grant/Award Number: EMR/2016/006214	Baumert JT, 2006, WORLD J GASTROENTERO, V12, P896, DOI 10.3748/wjg.v12.i6.896; Cao WG, 2006, HUM REPROD, V21, P421, DOI 10.1093/humrep/dei315; Choi S, 2012, J IMMUNOL, V189, P3905, DOI 10.4049/jimmunol.1102152; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Djurec M, 2018, P NATL ACAD SCI USA, V115, pE1147, DOI 10.1073/pnas.1717802115; Du W, 2013, ONCOGENE, V32, P1469, DOI 10.1038/onc.2012.143; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Fitzner B, 2007, CELL SIGNAL, V19, P782, DOI 10.1016/j.cellsig.2006.10.002; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Gomes AO, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00906; Harryvan TJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111989; Hirokawa J, 1998, J BIOCHEM, V123, P733; Huang H., 2021, SSRN ELECT J, V53, DOI [10.2139/ssrn.3790948, DOI 10.2139/SSRN.3790948]; Kato T, 2018, CLIN CANCER RES, V24, P4820, DOI 10.1158/1078-0432.CCR-18-0205; Lan HY, 1997, MOL MED, V3, P136, DOI 10.1007/BF03401805; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nallanthighal S, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00086; Ndlovu R, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00482; Neuzillet C, 2019, J PATHOL, V248, P51, DOI 10.1002/path.5224; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Poltavets V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00431; Pyle ME, 2003, J ENDOCRINOL, V176, P103, DOI 10.1677/joe.0.1760103; Rice EK, 2003, NEPHROLOGY, V8, P156, DOI 10.1046/j.1440-1797.2003.00152.x; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Sewell-Loftin MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13006-x; Suklabaidya S, 2018, LAB INVEST, V98, P27, DOI 10.1038/labinvest.2017.127; Suklabaidya S, 2016, ONCOTARGET, V7, P41825, DOI 10.18632/oncotarget.9729; Sun QQ, 2018, THERANOSTICS, V8, P5072, DOI 10.7150/thno.26546; Suresh V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51947-7; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanese K, 2015, J INVEST DERMATOL, V135, P2775, DOI 10.1038/jid.2015.204; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Venning FA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00224; Vonlaufen A, 2007, GASTROENTEROLOGY, V133, P1293, DOI 10.1053/j.gastro.2007.06.062; Vonlaufen Alain, 2014, World J Gastrointest Pathophysiol, V5, P82, DOI 10.4291/wjgp.v5.i2.82; Walker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103028; Wang D, 2018, ONCOL REP, V40, P2628, DOI 10.3892/or.2018.6703; Xia WZ, 2018, INT J MOL MED, V41, P1127, DOI 10.3892/ijmm.2017.3282; Xia WZ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0076-3; Xia WZ, 2015, MOL CELL BIOCHEM, V404, P11, DOI 10.1007/s11010-015-2361-y; Yao Y, 2016, STEM CELL REP, V7, P249, DOI 10.1016/j.stemcr.2016.07.003	44	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22449	10.1096/fj.202101953R	http://dx.doi.org/10.1096/fj.202101953R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X9IS	35839070				2022-12-28	WOS:000825511100001
J	Yao, C; Cao, YQ; Wang, D; Lv, YH; Liu, Y; Gu, XS; Wang, YJ; Wang, XH; Yu, B				Yao, Chun; Cao, Yuqi; Wang, Dong; Lv, Yehua; Liu, Yan; Gu, Xiaosong; Wang, Yongjun; Wang, Xuhua; Yu, Bin			Single-cell sequencing reveals microglia induced angiogenesis by specific subsets of endothelial cells following spinal cord injury	FASEB JOURNAL			English	Article						cell-cell interaction; microglia; single-cell RNA sequencing; spinal cord injury; vascular endothelial cell	AXONAL GROWTH; RECONSTRUCTION; OSTEOPONTIN; MECHANISMS; VEGF	Spinal cord injury (SCI) results in dynamic alterations of the microenvironment at the lesion site, which inevitably leads to neuronal degeneration and functional impairment. The destruction of the spinal vascular system leads to a significant deterioration of the milieu, which exacerbates inflammatory response and deprives cells of nutrient support in the lesion. Limited endogenous angiogenesis occurs after SCI, but the cellular events at the lesion site during this process are unclear so far. Here, we performed single-cell RNA sequencing (scRNA-seq) on spinal cord tissues of rats at different time points after SCI. After clustering and cell-type identification, we focused on vascular endothelial cells (ECs), which play a pivotal role in angiogenesis, and drew the cellular and molecular atlas for angiogenesis after SCI. We found that microglia and macrophages promote endogenous angiogenesis by regulating EC subsets through SPP1 and IGF signaling pathways. Our results indicate that immune cells promote angiogenesis by regulating specific subsets of vascular ECs, which provides new clues for exploring SCI intervention.	[Yao, Chun; Cao, Yuqi; Wang, Dong; Lv, Yehua; Liu, Yan; Gu, Xiaosong; Wang, Yongjun; Yu, Bin] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong 226001, Peoples R China; [Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China; [Wang, Xuhua] Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain Machine In, Sch Brain Sci & Brain Med, NHC & CAMS Key Lab Med Neurobiol, Hangzhou, Peoples R China	Nantong University; Nantong University; Zhejiang University	Wang, YJ; Yu, B (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong 226001, Peoples R China.; Wang, XH (corresponding author), Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain Machine In, Sch Brain Sci & Brain Med, NHC & CAMS Key Lab Med Neurobiol, Hangzhou, Peoples R China.	wyjbs@ntu.edu.cn; xhw@zju.edu.cn; yubin@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Key R&D Program of China [2020YFA0113600, 2017YFA0104701]; National Natural Science Foundation of China [32130060]; Natural Science Foundation of Jiangsu Province [BK20202013]; Jiangsu Provincial Key Medical Center and Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Key Medical Center and Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key R&D Program of China, Grant/Award Number: 2020YFA0113600 and 2017YFA0104701; National Natural Science Foundation of China, Grant/Award Number: 32130060; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20202013; Jiangsu Provincial Key Medical Center and Priority Academic Program Development of Jiangsu Higher Education Institutions	Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blum JA, 2021, NAT NEUROSCI, V24, P572, DOI 10.1038/s41593-020-00795-0; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chen WQ, 2019, J CELL COMMUN SIGNAL, V13, P291, DOI 10.1007/s12079-019-00511-z; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Delile J, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.173807; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Fan BY, 2018, CELL TRANSPLANT, V27, P853, DOI 10.1177/0963689718755778; Feng W, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00165; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Haggerty AE, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aaa9d8; Hakim R, 2021, J NEUROSCI, V41, P8441, DOI 10.1523/JNEUROSCI.0860-21.2021; Halder SK, 2018, ANGIOGENESIS, V21, P251, DOI 10.1007/s10456-017-9593-2; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Jin LY, 2021, J NEUROTRAUM, V38, P1203, DOI 10.1089/neu.2020.7413; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobak D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13056-x; Kumar H, 2020, J NEUROSCI, V40, P1943, DOI 10.1523/JNEUROSCI.2035-19.2020; Li HB, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118572; Liu YY, 2017, NEURON, V95, P817, DOI 10.1016/j.neuron.2017.07.037; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Milich Lindsay M, 2021, J Exp Med, V218, DOI 10.1084/jem.20210040; Nakanishi T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1338-2; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Ni SF, 2019, MOL THER, V27, P2134, DOI 10.1016/j.ymthe.2019.08.009; Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3; Ntranos V, 2019, NAT METHODS, V16, P163, DOI 10.1038/s41592-018-0303-9; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Pagano PJ, 2006, CIRC RES, V98, P1453, DOI 10.1161/01.RES.0000231258.23378.a6; Parker MW, 2012, BIOCHEMISTRY-US, V51, P9437, DOI 10.1021/bi3012143; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Rocha LA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00164; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Yamazaki Y, 2021, NEURON, V109, DOI 10.1016/j.neuron.2020.11.019; Yao L, 2021, J NEUROIMMUNOL, V351, DOI 10.1016/j.jneuroim.2020.577458; Yu B, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00287; Yu WH, 2017, CELL, V171, P849, DOI 10.1016/j.cell.2017.10.005; Zhang D, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10700; Zhu Y, 2015, NEUROBIOL DIS, V74, P114, DOI 10.1016/j.nbd.2014.10.024	60	3	3	12	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22393	10.1096/fj.202200337R	http://dx.doi.org/10.1096/fj.202200337R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2C0YH	35699080	Green Submitted			2022-12-28	WOS:000810603700001
J	Guo, YL; Peng, Q; Hao, LY; Ji, JM; Zhang, ZQ; Xue, Y; Liu, YW; Gao, YT; Li, CG; Shi, XL				Guo, Yinglin; Peng, Qing; Hao, Liyuan; Ji, Jingmin; Zhang, Zhiqin; Xue, Yu; Liu, Yiwei; Gao, Yuting; Li, Caige; Shi, Xinli			Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma	FASEB JOURNAL			English	Article						bile acids; dihydroartemisinin; farnesoid X receptor; hepatocellular carcinoma; YAP1	X-RECEPTOR; BILE-ACID; NUCLEAR RECEPTOR; OBETICHOLIC ACID; LIVER-INJURY; CANCER; IDENTIFICATION; METABOLISM; SENESCENCE; PROTECTS	Loss of FXR, one of bile acid receptors, enlarged livers. Yes-associated protein 1 (YAP1), a dominant oncogene, promotes hepatocellular carcinoma (HCC). However, the relationship between FXR and YAP1 was unspecified in bile acid homeostasis in HCC. Here, we used TIMER2.0, the Cancer Genome Atlas (TCGA) Database, and Kaplan-Meier Plotter Database and discovered that FXR was positively correlated with better prognosis in liver cancer patients. Our previous research showed that dihydroartemisinin (DHA) inhibited cell proliferation in HepG2 and HepG22215 cells. However, the relationship of YAP1 and the bile acid receptor FXR remains elusive during DHA treatment. Furthermore, we showed that DHA improved FXR and reduced YAP1 in the liver cancer cells and mice. Additionally, the expression of nucleus protein FXR was enhanced in Yap1(LKO) mice with liver cancer. DHA promoted the expression level of whole and nuclear protein FXR independent of YAP1 in Yap1(LKO) mice with liver cancer. DHA declined cholesterol 7 alpha-hydroxylase, but not sterol 27-hydroxylase, and depressed cholic acid and chenodeoxycholic acid of liver tissue in Yap1(LKO) mice with liver cancer. Generally, our results suggested that DHA improved FXR and declined YAP1 to suppress bile acid metabolism. Thus, we suggested that FXR acted as a potential therapeutic target in HCC.	[Guo, Yinglin; Peng, Qing; Hao, Liyuan; Ji, Jingmin; Zhang, Zhiqin; Xue, Yu; Liu, Yiwei; Gao, Yuting; Li, Caige; Shi, Xinli] Hebei Univ Chinese Med, Dept Pathobiol & Immunol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China	Hebei University of Chinese Medicine	Shi, XL (corresponding author), Hebei Univ Chinese Med, Dept Pathobiol & Immunol, 3 Xingyuan Rd, Shijiazhuang 050200, Hebei, Peoples R China.	sxlsunshine@sina.com		Shi, Xinli/0000-0003-1164-1156	National Natural Science Foundation of China [81873112]; Science and Technology Project of Hebei Education Department [ZD2022120]; Scientific and technological capability improvement project of Hebei University of Chinese Medicine [KTZ2019002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Hebei Education Department; Scientific and technological capability improvement project of Hebei University of Chinese Medicine	The study was supported by National Natural Science Foundation of China (81873112), Science and Technology Project of Hebei Education Department (ZD2022120), and Scientific and technological capability improvement project of Hebei University of Chinese Medicine (KTZ2019002).	Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Attia YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12629-4; Bai H., 2015, FASEB J, V29, DOI [10.1096/fasebj.29.1_supplement.45.4, DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.45.4]; Bergmann J, 2017, HEPATOLOGY, V65, P89, DOI 10.1002/hep.28874; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bhargava P, 2020, J CLIN INVEST, V130, P3467, DOI 10.1172/JCI129401; Bray F, 2020, CA-CANCER J CLIN, V70, P313, DOI 10.3322/caac.21609; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Cariello M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11549-7; Cox AG, 2016, NAT CELL BIOL, V18, P886, DOI 10.1038/ncb3389; Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274; Deuschle U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043044; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gulfo J, 2020, J HEPATOL, V73, P1131, DOI 10.1016/j.jhep.2020.05.007; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Hao LY, 2021, ONCOL LETT, V22, DOI 10.3892/ol.2021.12914; He JL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0427-9; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Huang TE, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.599067; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ibar C, 2020, DEV CELL, V54, P256, DOI 10.1016/j.devcel.2020.06.025; Ji SY, 2019, DEV CELL, V48, P460, DOI 10.1016/j.devcel.2018.12.021; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146; Kim DH, 2019, FASEB J, V33, P11109, DOI 10.1096/fj.201900325R; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Li SH, 2020, MOL CELL BIOCHEM, V475, P79, DOI 10.1007/s11010-020-03861-0; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Lozano E, 2014, MOL CANCER RES, V12, P91, DOI 10.1158/1541-7786.MCR-13-0503; Lv B, 2018, CELL PHYSIOL BIOCHEM, V48, P158, DOI 10.1159/000491715; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Out C, 2011, HEPATOLOGY, V53, P2075, DOI 10.1002/hep.24286; Peng ZS, 2019, J BIOL CHEM, V294, P8529, DOI 10.1074/jbc.RA118.004361; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Rowen RJ., 2002, BREAKTHROUGHS PREVEN; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Shi XL, 2019, PHYTOTHER RES, V33, P1413, DOI 10.1002/ptr.6332; Sun LL, 2021, NAT REV GASTRO HEPAT, V18, P335, DOI 10.1038/s41575-020-00404-2; Takahashi S, 2017, TOXICOL SCI, V158, P334, DOI 10.1093/toxsci/kfx094; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Trauner M, 2019, HEPATOLOGY, V70, P788, DOI 10.1002/hep.30509; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wen M, 2021, PHYTOTHER RES, V35, P3799, DOI 10.1002/ptr.7086; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956; Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yang ZX, 2010, HEPATOL INT, V4, P741, DOI 10.1007/s12072-010-9202-6; Ye C, 2021, PHYTOTHER RES, V35, P3406, DOI 10.1002/ptr.7062; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zou J, 2019, BMB REP, V52, P520, DOI 10.5483/BMBRep.2019.52.8.058	67	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22361	10.1096/fj.202200171R	http://dx.doi.org/10.1096/fj.202200171R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AV	35616366				2022-12-28	WOS:000800258400001
J	Farmer, JP; Mistry, SN; Laughton, CA; Holliday, ND				Farmer, James P.; Mistry, Shailesh N.; Laughton, Charles A.; Holliday, Nicholas D.			Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators	FASEB JOURNAL			English	Article						beta 2-Adrenoceptor; Allosteric modulators; Biosensors; CXCR2; GPCRs; Prostanoid receptor EP2	SYNTHETIC PEPTIDES; BINDING-SITE; ANTAGONISTS; SELECTIVITY; KINETICS; GUIDE; G(S)	G protein-coupled receptors (GPCRs) are widely therapeutically targeted, and recent advances in allosteric modulator development at these receptors offer further potential for exploitation. Intracellular allosteric modulators (IAM) represent a class of ligands that bind to the receptor-effector interface (e.g., G protein) and inhibit agonist responses noncompetitively. This potentially offers greater selectivity between receptor subtypes compared to classical orthosteric ligands. However, while examples of IAM ligands are well described, a more general methodology for assessing compound interactions at the IAM site is lacking. Here, fluorescent labeled peptides based on the G alpha peptide C terminus are developed as novel binding and activation biosensors for the GPCR-IAM site. In TR-FRET binding studies, unlabeled peptides derived from the G alpha s subunit were first characterized for their ability to positively modulate agonist affinity at the beta(2)-adrenoceptor. On this basis, a tetramethylrhodamine (TMR) labeled tracer was synthesized based on the 19 amino acid G alpha s peptide (TMR-G alpha s19cha18, where cha = cyclohexylalanine). Using NanoBRET technology to detect binding, TMR-G alpha s19cha18 was recruited to Gs coupled beta(2)-adrenoceptor and EP2 receptors in an agonist-dependent manner, but not the Gi-coupled CXCR2 receptor. Moreover, NanoBRET competition binding assays using TMR-G alpha s19cha18 enabled direct assessment of the affinity of unlabeled ligands for beta(2)-adrenoceptor IAM site. Thus, the NanoBRET platform using fluorescent-labeled G protein peptide mimetics offers novel potential for medium-throughput screens to identify IAMs, applicable across GPCRs coupled to a G protein class. Using the same platform, Gs peptide biosensors also represent useful tools to probe orthosteric agonist efficacy and the dynamics of receptor activation.	[Farmer, James P.; Holliday, Nicholas D.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Med Sch, Nottingham NG7 2UH, England; [Farmer, James P.] Univ Birmingham, Ctr Membrane Prot & Receptors, Nottingham, England; [Farmer, James P.] Univ Nottingham, Nottingham, England; [Mistry, Shailesh N.; Laughton, Charles A.] Univ Nottingham, Sch Pharm, Nottingham, England; [Holliday, Nicholas D.] Biocity, Excellerate Biosci, Nottingham, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Farmer, JP; Holliday, ND (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Med Sch, Nottingham NG7 2UH, England.	mbyjf3@nottingham.ac.uk; mbzndh@nottingham.ac.uk		Holliday, Nicholas/0000-0002-2900-828X; Farmer, James/0000-0002-4224-9299	British Pharmacological Society AJ Clark studentship	British Pharmacological Society AJ Clark studentship	This work was funded by The British Pharmacological Society AJ Clark studentship. The authors would like to thank Dr Desislava Nesheva for supplying CXCR2 cell membranes and Dr Nicola Dijon for providing initial EP2 constructs.	A.Kaur, 2020, bioRxiv, DOI 10.1101/2020.08.05.237982; Agasid MT, 2021, J AM CHEM SOC, V143, P4085, DOI 10.1021/jacs.0c11837; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2011, J MED CHEM, V54, P6874, DOI 10.1021/jm2008562; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dijon NC, 2021, METHODS MOL BIOL, V2268, P249, DOI 10.1007/978-1-0716-1221-7_17; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Gilchrist Annette, 2002, Sci STKE, V2002, ppl1, DOI 10.1126/stke.2002.118.pl1; Gonsiorek W, 2007, J PHARMACOL EXP THER, V322, P477, DOI 10.1124/jpet.106.118927; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hoare SRJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67844-3; Jiang CX, 2020, ACS CHEM NEUROSCI, V11, P1436, DOI 10.1021/acschemneuro.0c00078; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kim K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017201118; Liu XY, 2017, NATURE, V548, P480, DOI 10.1038/nature23652; Lu HF, 2018, J MED CHEM, V61, P2518, DOI 10.1021/acs.jmedchem.7b01854; Mannes M, 2021, ANGEW CHEM INT EDIT, V60, P10247, DOI 10.1002/anie.202100180; Mazzoni MR, 2000, MOL PHARMACOL, V58, P226, DOI 10.1124/mol.58.1.226; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Qu CX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1268; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Soave M, 2020, BRIT J PHARMACOL, V177, P978, DOI 10.1111/bph.14953; Stoddart LA, 2018, TRENDS PHARMACOL SCI, V39, P136, DOI 10.1016/j.tips.2017.10.006; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Stott LA, 2016, BIOCHEM PHARMACOL, V101, P1, DOI 10.1016/j.bcp.2015.10.011; Sykes DA, 2019, MOL CELL ENDOCRINOL, V485, P9, DOI 10.1016/j.mce.2019.01.018; Sykes DA, 2018, METHODS MOL BIOL, V1824, P177, DOI 10.1007/978-1-4939-8630-9_10; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010	44	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22576	10.1096/fj.202201024R	http://dx.doi.org/10.1096/fj.202201024R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6NY	36183332	Green Published			2022-12-28	WOS:000863003200001
J	Tian, HM; Xu, FF; Zhao, FF; Pan, NC; Lu, SD; Jia, X; Zhou, YJ				Tian, Haimeng; Xu, Feifan; Zhao, Feifei; Pan, Nachuan; Lu, Sidan; Jia, Xin; Zhou, Yajun			Early-immediate gene Egr1 is associated with TGF beta 1 regulation of epigenetic reader Bromodomain-containing protein 4 via the canonical Smad3 signaling in hepatic stellate cells in vitro and in vivo	FASEB JOURNAL			English	Article						bromodomain containing protein 4; early growth response-1; hepatic stellate cells; liver fibrosis; transforming growth factor beta-1	GROWTH-FACTOR-BETA; CATENIN PATHWAY; EXPRESSION; LEPTIN; BRD4; INHIBITION; CONTRIBUTES; MECHANISMS; FIBROSIS	Upon chronic damage to the liver, multiple cytokines stimulate hepatic stellate cells (HSCs), causing the alterations of gene expression profiles and thus leading to HSC activation, a key step in liver fibrogenesis. Activated HSCs are the dominant contributors to liver fibrosis. Bromodomain containing protein 4 (BrD4), an important epigenetic reader, was demonstrated to concentrate on hundreds of enhancers associated with genes involved in multiple profibrotic pathways, thereby directing HSC activation and the fibrotic responses. The present studies were designed to examine the effect of transforming growth factor beta-1 (TGF beta 1), the most potent pro-fibrotic cytokine, on BrD4 expression in HSCs and, if so, elucidated the underlying mechanisms in vitro and in vivo. The experiments employed the heterogeneous TGF beta 1 knockout (TGF beta 1(+/-)) mice, gene knockdown in vivo, and a model of thioacetamide (TAA)-induced liver injury. The results revealed that TGF beta 1 enhanced BrD4 expression in HSCs, which was mediated, at least, by Smad3 signaling and early-immediate gene Egr1 (early growth response-1). TGF beta 1-induced Smad3 signaling increased Egr1 expression and promoted Egr1 binding to BrD4 promoter at a site around -111 bp, promoting BrD4 expression. Egr1 knockdown reduced BrD4 expression in HSCs in a mouse model of TAA-induced liver injury and lessened liver fibrosis. Double fluorescence staining demonstrated a strong increase in BrD4 expression in activated HSCs in fibrotic areas of the human livers, paralleling the upregulation of p-Smad3 and Egr1. This research suggested novel molecular events underlying the roles of the master pro-fibrotic cytokine TGF beta 1 in HSC activation and liver fibrogenesis.	[Tian, Haimeng; Zhao, Feifei; Lu, Sidan; Jia, Xin; Zhou, Yajun] Nantong Univ, Med Sch, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China; [Xu, Feifan] Shanghai Univ, Dept Clin Lab, Affiliated Nantong Hosp, Peoples Hosp Nantong 6, Nantong, Peoples R China; [Pan, Nachuan] Western Univ, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada	Nantong University; Shanghai University; Western University (University of Western Ontario)	Zhou, YJ (corresponding author), Nantong Univ, Med Sch, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China.	zhouyajun@ntu.edu.cn			National Natural Science Foundation of China (NSFC) [81873577]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81873577	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Cai XB, 2018, J CELL MOL MED, V22, P5050, DOI 10.1111/jcmm.13787; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cheng FY, 2020, FASEB J, V34, P5578, DOI 10.1096/fj.201903021RR; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419; Ding N, 2015, P NATL ACAD SCI USA, V112, P15713, DOI 10.1073/pnas.1522163112; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357; Honda H, 2002, HEPATOLOGY, V36, P12, DOI 10.1053/jhep.2002.33684; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25754; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Pritchard MT, 2010, AM J PATHOL, V176, P2743, DOI 10.2353/ajpath.2010.091186; Qian JJ, 2012, PHARMACOL RES, V66, P219, DOI 10.1016/j.phrs.2012.06.003; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Senoo H, 2017, ANAT SCI INT, V92, P387, DOI 10.1007/s12565-017-0395-9; Shah R, 2013, ALCOHOL CLIN EXP RES, V37, P1838, DOI 10.1111/acer.12167; Stratton Matthew S, 2017, F1000Res, V6, DOI 10.12688/f1000research.11339.1; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114; Zhou Q, 2014, BBA-MOL BASIS DIS, V1842, P2367, DOI 10.1016/j.bbadis.2014.10.001; Zhou YJ, 2010, MOL CELL ENDOCRINOL, V323, P193, DOI 10.1016/j.mce.2010.03.005; Zhu XF, 2020, J PATHOL, V252, P423, DOI 10.1002/path.5536	35	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22605	10.1096/fj.202201263R	http://dx.doi.org/10.1096/fj.202201263R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0WP	36250963				2022-12-28	WOS:000868768200001
J	Zong, BB; Wang, YJ; Wang, JY; Zhang, P; Kan, GH; Li, MY; Feng, J; Wang, YF; Chen, XP; Jin, R; Ge, Q				Zong, Beibei; Wang, Yujia; Wang, Jingyi; Zhang, Peng; Kan, Guanghan; Li, Mingyang; Feng, Juan; Wang, Yifan; Chen, Xiaoping; Jin, Rong; Ge, Qing			Effects of long-term simulated microgravity on liver metabolism in rhesus macaques	FASEB JOURNAL			English	Article						dysbiosis; head-down bed rest; lipid metabolism; liver; rhesus macaques	BED-REST; PHYSICAL INACTIVITY; INSULIN-RESISTANCE; NONHUMAN-PRIMATES; ACID; SPACEFLIGHT; MICROBIOTA; SPACE; IRON; PROMOTES	The liver is an essential multifunctional organ and constantly communicates with nearly all the tissues in the body. Spaceflight or simulated microgravity has a significant impact on the livers of rodent models, including lipid accumulation and inflammatory cell infiltration. Whether similar liver lipotoxicity could occur in humans is not known, even though altered circulating cholesterol profile has been reported in astronauts. Using a 42-day head-down bed rest (HDBR) model in rhesus macaques, the present study investigated whether simulated microgravity alters the liver of non-human primates at the transcriptome and metabolome levels. Its association with stress and intestinal changes was also explored. Compared to the controls, the HDBR monkeys showed mild liver injury, elevated ANGPTL3 level in the plasma, and accumulation of fat vacuoles and inflammatory cells in the liver. Altered transcriptome signatures with up-regulation of genes in lipid metabolisms and down-regulation of genes in innate immune defense were also found in HDBR group-derived liver samples. The metabolic profiling of the liver revealed mildly disturbed fatty acid metabolism in the liver of HDBR monkeys. The intestinal dysbiosis, its associated endotoxemia and changes in the composition of bile acids, and elevated stress hormone in HDBR monkeys may contribute to the altered lipid metabolisms in the liver. These data indicate that liver metabolic functions and gut-liver axis should be closely monitored in prolonged spaceflight to facilitate strategy design to improve and maintain metabolic homeostasis.	[Zong, Beibei; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China; [Wang, Yujia; Wang, Jingyi; Wang, Yifan; Jin, Rong; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Immunol, NHC Key Lab Med Immunol, Beijing, Peoples R China; [Zhang, Peng; Kan, Guanghan; Chen, Xiaoping] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Mingyang] Capital Med Univ, Beijing Friendship Hosp, Immunol Res Ctr, Beijing Clin Res Inst, Beijing, Peoples R China; [Feng, Juan] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Minist Educ, Beijing, Peoples R China; [Chen, Xiaoping] China Astronauts Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Zong, Beibei; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China	Peking University; Peking University; Capital Medical University; Peking University; Peking University	Jin, R; Ge, Q (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	jinrong@bjmu.edu.cn; qingge@bjmu.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; Li, Mingyang/HGF-2294-2022; WANG, JINGYI/GSJ-1241-2022	Li, Mingyang/0000-0003-1446-6381; 	Beijing Natural Science Foundation [7202079]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; National Natural Science Foundation of China [32070897, 31872734, 31671244, 31872733, 32071178]; Open Funding Project of National Key Laboratory of Human Factors Engineering [6142222200105]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of National Key Laboratory of Human Factors Engineering	Beijing Natural Science Foundation, Grant/Award Number: 7202079; Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Grant/Award Number: 81621001; National Natural Science Foundation of China, Grant/Award Number: 32070897, 31872734, 31671244, 31872733 and 32071178; the Open Funding Project of National Key Laboratory of Human Factors Engineering, Grant/Award Number: 6142222200105	Afarideh M, 2015, ENDOCR PRACT, V21, P711, DOI 10.4158/EP14442.OR; Anselm V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081763; Austermann K, 2021, J NUTR, V151, P1527, DOI 10.1093/jn/nxab036; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Barcelos RP, 2016, MINI-REV MED CHEM, V16, P12, DOI 10.2174/1389557515666150722102613; Beheshti A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55869-2; Belozerova I N, 2003, Neurosci Behav Physiol, V33, P735, DOI 10.1023/A:1024429311622; Bergouignan A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010027; Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; Blaber EA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102062; Bonnefoy J, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.830662; Brooks NE, 2014, INT J MED SCI, V11, P1248, DOI 10.7150/ijms.9694; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cavey T, 2017, EXP PHYSIOL, V102, P291, DOI 10.1113/EP086188; Chen Y, 2017, INFLAMMATION, V40, P589, DOI 10.1007/s10753-016-0506-0; Choi SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58898-4; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; Coker RH, 2014, J GERONTOL A-BIOL, V69, P363, DOI [10.1093/gerona/glt100, 10.1093/gerona/glu123]; Cox LA, 2017, ILAR J, V58, P235, DOI 10.1093/ilar/ilx025; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; da Silveira WA, 2020, CELL, V183, P1185, DOI 10.1016/j.cell.2020.11.002; Davies KAB, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819888824; Desai RI, 2021, LIFE SCI SPACE RES, V30, P9, DOI 10.1016/j.lssr.2021.03.008; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Fianchi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126485; Foley MH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017709118; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Havel PJ, 2017, ILAR J, V58, P251, DOI 10.1093/ilar/ilx031; Hess AL, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0597-3; Jiang P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0724-4; Jiang S, 2019, J DRUG TARGET, V27, P876, DOI 10.1080/1061186X.2019.1566342; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Jomura R, 2022, BBA-BIOMEMBRANES, V1864, DOI 10.1016/j.bbamem.2021.183840; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kalra S., 2021, MED SCI BASEL, V9, P39; Kersten S, 2019, CURR OPIN LIPIDOL, V30, P205, DOI 10.1097/MOL.0000000000000600; Kim YK, 2021, J CLIN MED, V10, DOI 10.3390/jcm10173819; Koenig SC, 2004, AVIAT SPACE ENVIR MD, V75, P7; Kuehnast T, 2022, MICROBIOME, V10, DOI 10.1186/s40168-021-01222-7; Le Roux E, 2022, J PHYSIOL-LONDON, V600, P1037, DOI 10.1113/JP281064; Li BG, 2019, CELL REP, V26, P2720, DOI 10.1016/j.celrep.2019.02.015; Li R, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00343-5; Liu C, 2021, FASEB J, V35, DOI 10.1096/fj.202100939R; Liu ZZ, 2020, GUT MICROBES, V11, DOI 10.1080/19490976.2019.1710091; Lu Y, 2020, J CLIN INVEST, V130, P3791, DOI 10.1172/JCI134485; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Markin A, 1998, ACTA ASTRONAUT, V42, P247, DOI 10.1016/S0094-5765(98)00121-0; Mazzucco S, 2010, J CLIN ENDOCR METAB, V95, P2508, DOI 10.1210/jc.2009-2561; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Moore ST, 2003, J VESTIBUL RES-EQUIL, V13, P377; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Nay K, 2020, FASEB J, V34, P14920, DOI 10.1096/fj.202001199RR; Pecaut MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174174; Rada P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03003-w; Rahimi L, 2020, DIABET METAB SYND OB, V13, P1133, DOI 10.2147/DMSO.S247379; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ridola Lorenzo, 2022, J Hepatol, V77, P262, DOI 10.1016/j.jhep.2022.01.003; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Rojas IY, 2021, OBESITY, V29, P337, DOI 10.1002/oby.23065; Rudwill F, 2015, LIVER INT, V35, P1700, DOI 10.1111/liv.12743; Saxena R, 1999, HEPATOLOGY, V30, P1339, DOI 10.1002/hep.510300607; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Song JW, 2020, CELL METAB, V32, P188, DOI 10.1016/j.cmet.2020.06.016; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Vacca M, 2020, NAT METAB, V2, P514, DOI 10.1038/s42255-020-0214-9; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; Visekruna A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.703218; Voorhies AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46303-8; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2214-9; Wang XP, 2020, FASEB J, V34, P15180, DOI 10.1096/fj.202001246RR; Wang XC, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/6620289; Wang YF, 2019, FASEB J, V33, P10140, DOI 10.1096/fj.201900238RR; Ward K, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.573581; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077401; Xu Z, 2017, BONE, V94, P152, DOI 10.1016/j.bone.2016.09.023; Yang JC, 2018, BONE, V114, P235, DOI 10.1016/j.bone.2018.06.012; Zhang P., 2022, JCSM RAPID COMMUNICA, V5, P212; Zhang X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0459-y; Zhang Y, 2021, BIOL PHARM BULL, V44, P162, DOI 10.1248/bpb.b20-00299; Zhou KJ, 2015, J PROTEOME RES, V14, P4844, DOI 10.1021/acs.jproteome.5b00676; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465	85	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22536	10.1096/fj.202200544RR	http://dx.doi.org/10.1096/fj.202200544RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5BN	36070186				2022-12-28	WOS:000850592300001
J	Zhao, J; Chen, J; Zhu, W; Qi, XM; Wu, YG				Zhao, Jing; Chen, Juan; Zhu, Wei; Qi, Xiang-ming; Wu, Yong-gui			Exosomal miR-7002-5p derived from highglucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b	FASEB JOURNAL			English	Article						Atg9b; autophagy; exosomes; macrophages; tubular epithelial cells		Macrophage infiltration plays an important role in the progression of diabetic nephropathy (DN). Previously, we demonstrated that highglucose-stimulated macrophage-derived exosomes (HG-exo) induces proliferation and extracellular matrix accumulation in glomerular mesangial cells, but its effect on tubular cells is unclear. This study aimed to explore the role of HG-exo on renal tubular injury in DN. The results show that HG-exo could induce dysfunction, autophagy inhibition, and inflammation in mouse tubular epithelial cell (mTEC) and C57 mouse kidney. Moreover, miR-7002-5p was differentially expressed in HG-exo based on miRNAs sequencing and bioinformatics analysis. A dual-luciferase reporter assay confirmed that Atg9b was the direct target gene of miR-7002-5p. Further experimentation showed that miR-7002-5p inhibition in vivo and vitro reserves HG-exo effects. These results demonstrated that HG-exo carries excessive miR-7002-5p and inhibits autophagy through targeting Atg9b; this process then induces renal tubular dysfunction and inflammation. In conclusion, our study clarifies the important role of macrophage-derived exosomes in DN and is expected to provide new insight on DN prevention and treatment.	[Zhao, Jing; Chen, Juan; Zhu, Wei; Qi, Xiang-ming; Wu, Yong-gui] Anhui Med Univ, Dept Nephropathy, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Wu, Yong-gui] Anhui Med Univ, Ctr Sci Res, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Qi, XM; Wu, YG (corresponding author), Anhui Med Univ, Dept Nephropathy, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.	qxm119@126.com; wuyonggui@medmail.com.cn			National Natural Science Foundation of China [81770722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by National Natural Science Foundation of China (grant no. 81770722).	Chen SJ, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12763; Cole JB, 2020, NAT REV NEPHROL, V16, P377, DOI 10.1038/s41581-020-0278-5; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Fan Z, 2018, IMMUNOL INVEST, V47, P303, DOI 10.1080/08820139.2018.1428199; Fan Z, 2018, INT IMMUNOPHARMACOL, V58, P145, DOI 10.1016/j.intimp.2018.03.019; Fu J, 2019, J AM SOC NEPHROL, V30, P533, DOI 10.1681/ASN.2018090896; Gao C, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00175-y; Gluhovschi C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4626125; Javier PH., 2021, HYPERTENSION, V77, P960; Jia YL, 2017, ONCOTARGET, V8, P41717, DOI 10.18632/oncotarget.16684; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Li Z, 2021, CANCER MANAG RES, V13, P25, DOI 10.2147/CMAR.S272140; Liang WJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13187; Ma ZW, 2020, J CLIN INVEST, V130, P5011, DOI 10.1172/JCI135536; Maeda S, 2020, NAT STRUCT MOL BIOL, V27, P1194, DOI 10.1038/s41594-020-00520-2; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Panfoli I, 2020, EXPERT REV PROTEOMIC, V17, P735, DOI 10.1080/14789450.2020.1866993; Peng L, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-021-02696-w; Robert CL., 2018, CURR PHARM DESIGN, V24, P2241; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Selby NM, 2020, DIABETES OBES METAB, V22, P3, DOI 10.1111/dom.14007; Suzuki C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010155; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Van JAD, 2017, J AM SOC NEPHROL, V28, P1050, DOI 10.1681/ASN.2016091018; Wang N, 2017, THERANOSTICS, V7, P2325, DOI 10.7150/thno.18225; Wang X, 2017, DIABETES, V66, P494, DOI 10.2337/db16-0773; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Yang C, 2021, AUTOPHAGY, V17, P2325, DOI 10.1080/15548627.2020.1824694; Zeng HX, 2020, INFLAMM RES, V69, P1215, DOI 10.1007/s00011-020-01411-4; Zhu M, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106551; Zhu QJ, 2019, FASEB J, V33, P9279, DOI 10.1096/fj.201802427RRR	35	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22501	10.1096/fj.202200550RR	http://dx.doi.org/10.1096/fj.202200550RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0VK	35971776				2022-12-28	WOS:000840688400001
J	Andresen, B; de Marees, M; Schiffer, T; Bloch, W; Suhr, F				Andresen, Bernhard; de Marees, Markus; Schiffer, Thorsten; Bloch, Wilhelm; Suhr, Frank			Skeletal muscle fiber type-specific expressions of mechanosensors integrin-linked kinase, talin, and vinculin and their modulation by loading and environmental conditions in humans	FASEB JOURNAL			English	Article						exercise; humans; hypoxia; mechanical loading; skeletal muscle	RESISTANCE EXERCISE; SPRINT INTERVAL; GENE-EXPRESSION; ADAPTATIONS; HYPOXIA; TIME; COSTAMERES; REGULATORS; GROWTH; TENDON	Mechanosensors control muscle integrity as demonstrated in mice. However, no information is available in human muscle about the distribution of mechanosensors and their adaptations to mechanical loading and environmental conditions (hypoxia). Here, we hypothesized that mechanosensors show fiber-type-specific distributions and that loading and environmental conditions specifically regulate mechanosensors. We randomly subjected 28 healthy males to one of the following groups (n = 7 each) consisting of nine loading sessions within 3 weeks: normoxia moderate (NM), normoxia intensive (NI), hypoxia moderate (HM), and hypoxia intensive (HI). We took six biopsies: pre (T0), 4 h (T1), and 24 h (T2) after the third as well as 4 h (T3), 24 h (T4), and 72 h (T5) after the ninth training session. We analyzed subjects' maximal oxygen consumption (V?O(2)max), maximal power output (Pmax), muscle fiber types and cross-sectional areas (CSA), fiber-type-specific integrin-linked kinase (ILK) localizations as well as ILK, vinculin and talin protein and gene expressions in dependence on loading and environmental conditions. V?O(2)max increased upon NM and HM, Pmax upon all interventions. Fiber types did not change, whereas CSA increased upon NI and HI, but decreased upon HM. ILK showed a type 2-specific fiber type localization. ILK, vinculin, and talin protein and gene expressions differed depending on loading and environmental conditions. Our data demonstrate that mechanosensors show fiber type-specific distributions and that exercise intensities rather than environmental variables influence their profiles in human muscles. These data are the first of their kind in human muscle and indicate that mechanosensors manage the mechanosensing at a fiber-type-specific resolution and that the intensity of mechanical stimulation has a major impact.	[Andresen, Bernhard; Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [de Marees, Markus] Ruhr Univ Bochum, Inst Sports Med & Sports Nutr, Bochum, Germany; [Schiffer, Thorsten] Outpatient Clin Sports Traumatol & Publ Hlth Cons, Cologne, Germany; [Suhr, Frank] Katholieke Univ Leuven, Dept Movement Sci, Biomed Sci Grp, Exercise Physiol Res Grp, Tervuursevest 101 Bus 1500, B-3001 Leuven, Belgium	German Sport University Cologne; Ruhr University Bochum; KU Leuven	Suhr, F (corresponding author), Katholieke Univ Leuven, Dept Movement Sci, Biomed Sci Grp, Exercise Physiol Res Grp, Tervuursevest 101 Bus 1500, B-3001 Leuven, Belgium.	frank.suhr@kuleuven.be		Suhr, Frank/0000-0002-9013-3944	Federal Institute of Sport Sciences (BISp) [IIA-070114/13-14]	Federal Institute of Sport Sciences (BISp)	We thank the participants for their contribution to this project. The Federal Institute of Sport Sciences (BISp) granted the project to Frank Suhr (project number IIA-070114/13-14).	BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chopard A, 2005, FASEB J, V19, P1722, DOI 10.1096/fj.04-3336fje; Clanton TL, 2001, J APPL PHYSIOL, V90, P2476, DOI 10.1152/jappl.2001.90.6.2476; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Diman A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600031; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Friedmann-Bette B, 2012, J APPL PHYSIOL, V112, P289, DOI 10.1152/japplphysiol.00959.2011; Gehlert S, 2015, PFLUG ARCH EUR J PHY, V467, P1343, DOI 10.1007/s00424-014-1579-y; Gehlert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049326; Gehlert S, 2012, EUR J APPL PHYSIOL, V112, P2393, DOI 10.1007/s00421-011-2209-4; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Greiwe L, 2016, ACTA PHYSIOL, V217, P61, DOI 10.1111/apha.12633; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Hessel AL, 2020, JOVE-J VIS EXP, DOI 10.3791/61598; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; HOPPELER H, 1990, EXPERIENTIA, V46, P1185, DOI 10.1007/BF01936933; Jacobs RA, 2016, J PHYSIOL-LONDON, V594, P1151, DOI 10.1113/JP271118; Kruger M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00076; Laforet P, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0815-2; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundby C, 2017, ACTA PHYSIOL, V220, P218, DOI 10.1111/apha.12827; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mathes S, 2019, CELL MOL LIFE SCI, V76, P2987, DOI 10.1007/s00018-019-03026-3; Muller AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00449; Pingel J, 2017, J MUSCLE RES CELL M, V38, P317, DOI 10.1007/s10974-017-9489-1; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SHEAR CR, 1985, J CELL BIOL, V101, P240, DOI 10.1083/jcb.101.1.240; SIMONEAU JA, 1985, EUR J APPL PHYSIOL O, V54, P250, DOI 10.1007/BF00426141; Strasser B, 2018, FRONT BIOSCI-LANDMRK, V23, P1505, DOI 10.2741/4657; Suhr F, 2007, J APPL PHYSIOL, V103, P474, DOI 10.1152/japplphysiol.01160.2006; Suhr Frank, 2019, Cell Physiol Biochem, V52, P633, DOI 10.33594/000000045; Suhr F, 2015, METHODS MOL BIOL, P115, DOI 10.1007/978-1-4939-2703-6_8; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Wackerhage H, 2019, J APPL PHYSIOL, V126, P30, DOI 10.1152/japplphysiol.00685.2018; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906	47	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22458	10.1096/fj.202101377RR	http://dx.doi.org/10.1096/fj.202101377RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3C6WO	35867073				2022-12-28	WOS:000828762200001
J	Zhang, Z; Deng, KP; Kang, ZQ; Wang, F; Fan, YX				Zhang, Zhen; Deng, Kaiping; Kang, Ziqi; Wang, Feng; Fan, Yixuan			MicroRNA profiling reveals miR-145-5p inhibits goat myoblast differentiation by targeting the coding domain sequence of USP13	FASEB JOURNAL			English	Article						differentiation; goat primary myoblast; miR-145-5p; USP13	MUSCLE-SPECIFIC MICRORNAS; SKELETAL-MUSCLE; CELL-CYCLE; PROLIFERATION; MECHANISMS; PROGRESSION; EXPRESSION; GROWTH; SITES	MicroRNAs (miRNAs) are evolutionarily conserved endogenous small non-coding RNAs that play critical roles in skeletal muscle development. In this study, we identified putative miRNAs that were differentially expressed in the longissimus dorsi muscle between fetus (75 days of pregnancy) and lamb (1 day of age). We detected 1208 miRNAs, 313 of which were differentially expressed. In particular, we found that miR-145-5p was differentially and highly expressed in lamb skeletal muscle. In addition, our results demonstrated that overexpression of miR-145-5p inhibited the differentiation and apoptosis of goat primary myoblasts (GPMs), whereas knockdown of miR-145-5p had the opposite effect. The coding domain sequence (CDS) of ubiquitin-specific peptidase 13 (USP13) was predicted and validated as a target of miR-145-5p. We also demonstrated that the influence as a key regulator of GPMs differentiation is primarily mediated by targeting and inhibiting USP13. Taken together, these results revealed a novel pathway in skeletal muscle development in which miR-145-5p targets CDS region of USP13 to regulate differentiation and apoptosis of GPMs.	[Zhang, Zhen; Deng, Kaiping; Kang, Ziqi; Wang, Feng; Fan, Yixuan] Nanjing Agr Univ, Inst Sheep & Goat Sci, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Wang, F; Fan, YX (corresponding author), Nanjing Agr Univ, Inst Sheep & Goat Sci, Nanjing 210095, Peoples R China.	caeet@njau.edu.cn; fanyixuan@njau.edu.cn		Zhang, Zhen/0000-0002-4186-9744	National Key R&D program of China [2021YFD1200902]; Jiangsu Agricultural Industry Technology System [JATS [2020]400]; National Natural Science Foundation of China [32102520]; Natural Science Foundation of Jiangsu Province [BK20210403]	National Key R&D program of China; Jiangsu Agricultural Industry Technology System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the National Key R&D program of China (2021YFD1200902), Jiangsu Agricultural Industry Technology System (no. JATS [2020]400), the National Natural Science Foundation of China (no. 32102520), and the Natural Science Foundation of Jiangsu Province (no. BK20210403). M.A. El-Samahy, as a new researcher, revised the manuscript.	Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brien P, 2013, STEM CELLS, V31, P1597, DOI 10.1002/stem.1399; Brummer A, 2014, BIOESSAYS, V36, P617, DOI 10.1002/bies.201300104; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cheng C, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10228; Deng K., 2021, MOL THER NUCL ACIDS, P2634; Deng KP, 2021, EXP CELL RES, V401, DOI 10.1016/j.yexcr.2021.112524; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Esposito M, 2020, ONCOGENE, V39, P6009, DOI 10.1038/s41388-020-01396-8; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Guo JZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165764; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; He ML, 2022, GENES-BASEL, V13, DOI 10.3390/genes13030520; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Huang JM, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111089; Kadkhoda S, 2022, PATHOL RES PRACT, V231, DOI 10.1016/j.prp.2022.153780; Kwon J, 2022, ONCOGENE, V41, P1974, DOI 10.1038/s41388-022-02224-x; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Lee JH, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00284-z; Li YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15752; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Ling YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22262-4; Liu XG, 2021, NEUROSCIENCE, V460, P161, DOI 10.1016/j.neuroscience.2021.02.004; Liu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050001; Luo HM, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.628339; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Pajalunga D, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102753; Qu Z, 2019, CANCER MANAG RES, V11, P9175, DOI 10.2147/CMAR.S186829; Raza SHA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030295; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Shen XM, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03419-y; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Silva WJ, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13278; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Velayutham N, 2019, PEDIATR CARDIOL, V40, P1345, DOI 10.1007/s00246-019-02163-7; Wang J, 2018, GENE, V668, P107, DOI 10.1016/j.gene.2018.05.039; Wang JY, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1039-z; Wang S, 2021, LIFE SCI, V282, DOI 10.1016/j.lfs.2021.119820; Wang X, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101332; Wang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096857; Wei B, 2020, EXP THER MED, V19, P1915, DOI 10.3892/etm.2020.8427; Weston AD, 2003, J CELL SCI, V116, P2885, DOI 10.1242/jcs.00525; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wu Y, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108831; Xu M, 2020, J CELL PHYSIOL, V235, P87, DOI 10.1002/jcp.28986; Xu WX, 2019, AM J TRANSL RES, V11, P6739; Yin HD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093274; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zeinali T, 2019, BIOMED PHARMACOTHER, V109, P195, DOI 10.1016/j.biopha.2018.10.037; Zhang Z, 2022, FASEB J, V36, DOI 10.1096/fj.202101317R; Zheng LF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9530951	56	3	3	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22370	10.1096/fj.202200246R	http://dx.doi.org/10.1096/fj.202200246R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1P9AU	35635726				2022-12-28	WOS:000802295100001
J	Dawson, NJ; Millet, C; Selman, C; Metcalfe, NB				Dawson, Neal J.; Millet, Caroline; Selman, Colin; Metcalfe, Neil B.			Inter-individual variation in mitochondrial phosphorylation efficiency predicts growth rates in ectotherms at high temperatures	FASEB JOURNAL			English	Article						ATP; O; brown trout; climate change; global warming; liver; muscle	OXIDATIVE STRESS; THERMAL TOLERANCE; HYDROGEN-PEROXIDE; FISH; DETOXIFICATION; MUSCLE; OXYGEN; PHYSIOLOGY; LIVER; WATER	There is increasing evidence that aquatic ectotherms are especially vulnerable to global warming since their metabolic demands increase with ambient temperature while water-oxygen content decreases. The possible role of shrinking aerobic scope in limiting performance has been much discussed; however, less attention has been given to whether tissue-level changes in the efficiency of oxygen usage occur at elevated temperatures. Here, we show that this varies widely among individuals, with consequences for performance. We examined the inter-individual variation in growth rate and mitochondrial function from white muscle and liver of brown trout (Salmo trutta) acclimated to either high (19.5 degrees C) or near-optimal temperature (12 degrees C). Liver (but not muscle) mitochondria showed a positive relationship between growth rate and maximal oxidative phosphorylation at both temperatures, and a negative relationship between growth rate and ROS release. There was a positive correlation in both tissues between individual mitochondrial phosphorylation efficiency and growth rate, but only at 19.5 degrees C. In this representative of aquatic ectotherms, an individual's liver mitochondrial efficiency thus seems to dictate its capacity to grow at elevated temperatures. This suggests that individual heterogeneity in cellular function may cause variation in the thermal limits of aquatic ectotherms and could adversely affect wild populations in warming environments.	[Dawson, Neal J.; Millet, Caroline; Selman, Colin; Metcalfe, Neil B.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Dawson, NJ (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland.	neal.dawson@gmail.com			UKRI | Natural Environment Research Council (NERC) [NE/R001510/1]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [PDF-488166-2016]	UKRI | Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	UKRI | Natural Environment Research Council (NERC), Grant/Award Number: NE/R001510/1; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: PDF-488166-2016	ACETO A, 1994, FREE RADICAL RES, V21, P285, DOI 10.3109/10715769409056581; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Auer SK, 2015, FUNCT ECOL, V29, P479, DOI 10.1111/1365-2435.12396; Bermejo-Nogales A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122889; Blier PU, 2014, CAN J ZOOL, V92, P591, DOI 10.1139/cjz-2013-0183; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brusle Jacques, 1996, P76; Chung DJ, 2018, INTEGR COMP BIOL, V58, P578, DOI 10.1093/icb/icy013; Comte L, 2017, NAT CLIM CHANGE, V7, P718, DOI 10.1038/NCLIMATE3382; Crespo M, 2016, ENVIRON SCI POLLUT R, V23, P19229, DOI 10.1007/s11356-016-7146-7; Dawson NJ, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13030; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; Fangue NA, 2009, J EXP BIOL, V212, P514, DOI 10.1242/jeb.024034; Gerber L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78519-4; Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211; Gregory TR, 1998, CAN J FISH AQUAT SCI, V55, P1583, DOI 10.1139/cjfas-55-7-1583; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; HARRIS KR, 1980, J CHEM SOC FARAD T 1, V76, P377, DOI 10.1039/f19807600377; Iftikar FI, 2014, J EXP BIOL, V217, P2348, DOI 10.1242/jeb.098798; Jutfelt F, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.169615; Koch RE, 2021, TRENDS ECOL EVOL, V36, P321, DOI 10.1016/j.tree.2020.12.006; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lenartova V, 1997, BIOMARKERS, V2, P247, DOI 10.1080/135475097231625; Little AG, 2020, J FISH BIOL, V97, P328, DOI 10.1111/jfb.14402; McKenzie DJ, 2021, REV AQUACULT, V13, P138, DOI 10.1111/raq.12467; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Monserrat JM, 2008, COMP BIOCHEM PHYS C, V148, P287, DOI 10.1016/j.cbpc.2008.06.011; Ohlberger J, 2013, FUNCT ECOL, V27, P991, DOI 10.1111/1365-2435.12098; Pascual P, 2003, CHEM-BIOL INTERACT, V145, P191, DOI 10.1016/S0009-2797(03)00002-4; Portner HO, 2017, J EXP BIOL, V220, P2685, DOI 10.1242/jeb.134585; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996; Salin K, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1466; Salin K, 2018, FUNCT ECOL, V32, P2149, DOI 10.1111/1365-2435.13125; Salin K, 2016, PHYSIOL BIOCHEM ZOOL, V89, P511, DOI 10.1086/688769; Salin K, 2016, J EXP BIOL, V219, P1356, DOI 10.1242/jeb.133025; Secor SM, 2016, COMPR PHYSIOL, V6, P773, DOI 10.1002/cphy.c150013; Seebacher F, 2015, NAT CLIM CHANGE, V5, P61, DOI 10.1038/NCLIMATE2457; Shama LNS, 2016, EVOL APPL, V9, P1096, DOI 10.1111/eva.12370; Siscar R, 2014, SCI TOTAL ENVIRON, V466, P898, DOI 10.1016/j.scitotenv.2013.07.081; Speers-Roesch B, 2016, FUNCT ECOL, V30, P842, DOI 10.1111/1365-2435.12652; Sylvie G, 2012, PHYSIOL BIOCHEM ZOOL, V85, P415, DOI 10.1086/666364; Thoral Elisa, 2021, Biol Lett, V17, P20200759, DOI 10.1098/rsbl.2020.0759; Verberk WCEP, 2021, BIOL REV, V96, P247, DOI 10.1111/brv.12653; Wang L, 2006, COMP BIOCHEM PHYS C, V144, P216, DOI 10.1016/j.cbpc.2006.08.009; Zavorka L, 2021, FUNCT ECOL, V35, P1960, DOI 10.1111/1365-2435.13860	51	0	0	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22333	10.1096/fj.202101806RR	http://dx.doi.org/10.1096/fj.202101806RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0W6OR	35486025	Green Accepted			2022-12-28	WOS:000789143900001
J	El Kharbili, M; Aviszus, K; Sasse, SK; Zhao, XY; Serban, KA; Majka, SM; Gerber, AN; Gally, F				El Kharbili, Manale; Aviszus, Katja; Sasse, Sarah K.; Zhao, Xiaoyun; Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne			Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor gamma	FASEB JOURNAL			English	Article						FABP5; macrophage polarization; PPAR gamma; resolution of inflammation	OBSTRUCTIVE PULMONARY-DISEASE; PPAR-GAMMA; GENE-EXPRESSION; INDUCED SPUTUM; POLARIZATION; INFLAMMATION; DEFICIENCY; RESOLUTION; AGONIST; SYSTEM	Resolution of inflammation is an active process that is tightly regulated to achieve repair and tissue homeostasis. In the absence of resolution, persistent inflammation underlies the pathogenesis of chronic lung disease such as chronic obstructive pulmonary disease (COPD) with recurrent exacerbations. Over the course of inflammation, macrophage programming transitions from pro-inflammatory to pro-resolving, which is in part regulated by the nuclear receptor Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma). Our previous work demonstrated an association between Fatty Acid Binding Protein 5 (FABP5) expression and PPAR gamma activity in peripheral blood mononuclear cells of healthy and COPD patients. However, a role for FABP5 in macrophage programming has not been examined. Here, using a combination of in vitro and in vivo approaches, we demonstrate that FABP5 is necessary for PPAR gamma activation. In turn, PPAR gamma acts directly to increase FABP5 expression in primary human alveolar macrophages. We further illustrate that lack of FABP5 expression promotes a pro-inflammatory macrophage programming with increased secretion of pro-inflammatory cytokines and increased chromatin accessibility for pro-inflammatory transcription factors (e.g., NF-kappa B and MAPK). And finally, real-time cell metabolic analysis using the Seahorse technology shows an inhibition of oxidative phosphorylation in FABP5-deficient macrophages. Taken together, our data indicate that FABP5 and PPAR gamma reciprocally regulate each other's expression and function, consistent with a novel positive feedback loop between the two factors that mediates macrophage pro-resolving programming. Our studies highlight the importance of defining targets and regulatory mechanisms that control the resolution of inflammation and may serve to inform novel interventional strategies directed towards COPD.	[El Kharbili, Manale; Aviszus, Katja; Zhao, Xiaoyun; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne] Natl Jewish Hlth, Dept Immunol & Genom Med, 1400 Jackson St,Room K827, Denver, CO 80206 USA; [Sasse, Sarah K.; Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne] Univ Colorado, Dept Med, Aurora, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Gally, F (corresponding author), Natl Jewish Hlth, Dept Immunol & Genom Med, 1400 Jackson St,Room K827, Denver, CO 80206 USA.	gallyf@njhealth.org			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL141264]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL141264	Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Auwerx J, 1999, CELL, V97, P161; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Bewley MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163139; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; de Groot LES, 2019, AM J PHYSIOL-LUNG C, V316, pL369, DOI 10.1152/ajplung.00456.2018; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Eapen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13888-x; Ferroni P, 2013, CURR VASC PHARMACOL, V11, P338, DOI 10.2174/1570161111311030008; Frankenberger M, 2004, CLIN EXP IMMUNOL, V138, P507, DOI 10.1111/j.1365-2249.2004.02637.x; Gally F, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144294; Gally F, 2013, AM J PHYSIOL-LUNG C, V305, pL64, DOI 10.1152/ajplung.00276.2012; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Gupta A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101147; Helledie T, 2000, J LIPID RES, V41, P1740; Hertzel AV, 1998, MOL CELL BIOCHEM, V188, P33; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kapellos TS, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2349045; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lakshmi SP, 2017, INT J CHRONIC OBSTR, V12, P2141, DOI 10.2147/COPD.S121416; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Liu PS, 2019, METHODS MOL BIOL, V1862, P173, DOI 10.1007/978-1-4939-8769-6_13; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Rao DM, 2019, J INNATE IMMUN, V11, P469, DOI 10.1159/000496405; Rao DM, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0227-8; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rubin JD, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02153-7; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; Tripodi IJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23051136; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yoon YS, 2015, MUCOSAL IMMUNOL, V8, P1031, DOI 10.1038/mi.2014.130; Zimmerman AW, 2001, BIOCHEM J, V360, P159, DOI 10.1042/0264-6021:3600159	51	0	0	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22300	10.1096/fj.202200128R	http://dx.doi.org/10.1096/fj.202200128R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O7OA	35436029	hybrid, Green Published			2022-12-28	WOS:000783712500001
J	Zhang, Y; Chang, HM; Zhu, H; Leung, PCK				Zhang, Yu; Chang, Hsun-Ming; Zhu, Hua; Leung, Peter C. K.			BMP2 suppresses the production of pentraxin 3 in human endometrial stromal and decidual stromal cells	FASEB JOURNAL			English	Article						BMP2; decidual stromal cells; decidualization; endometrial stromal cell; PTX3	GROWTH-DIFFERENTIATION FACTOR-8; SIGNALING PATHWAY; LONG PENTRAXIN-3; INNATE IMMUNITY; DOWN-REGULATION; EXPRESSION; PREGNANCY; PTX3; STEROIDOGENESIS; TISSUE	Bone morphogenetic protein 2 (BMP2) has been shown to act as a critical regulator in the processes of embryo implantation and endometrial decidualization. The expression and production of pentraxin 3 (PTX3) is essential for successful pregnancy, and aberrant production of PTX3 is involved in the pathogenesis of several vascular complications during pregnancy. Studies have shown that several transforming growth factor beta superfamily members, including BMP2, can regulate female reproductive function by modulating the expression of PTX3 in human granulosa cells. However, to date, whether BMP2 can regulate the production of PTX3 during endometrial decidualization remains to be elucidated. In this study, we aimed to explore the effect of BMP2 on the expression and production of PTX3 and the underlying molecular mechanisms using immortalized human endometrial stromal cells (I-HESCs) and human decidual stromal cells (HDSCs). We demonstrated that treatment with exogenous BMP2 significantly suppressed PTX3 production by decreasing the mRNA level of PTX3 in both I-HESCs and HDSCs. The results also showed that BMP2 activated SMAD signaling by inducing an increase in the protein levels of phosphorylated SMAD1/5/8, and this effect could be abolished by pretreatment with the ALK2/3 inhibitor DMH-1 but not with the ALK1/4/7 inhibitor SB431542. Additionally, combined knockdown of ALK2 and ALK3 completely reversed the BMP2-induced suppressive effect on PTX3 expression, while concomitant knockdown of SMAD1 and SMAD5 or knockdown of SMAD4 completely reversed the BMP2-induced suppressive effect on PTX3 expression. Taken together, these results indicate that BMP2 suppressed PTX3 production by decreasing PTX expression, which is mediated by a canonical ALK2/3-mediated SMAD1/5-SMAD4-dependent signaling pathway. Our findings suggest that BMP2 may potentially regulate the process of endometrial decidualization by suppressing the production of PTX3 in humans.	[Zhang, Yu] Hangzhou Med Coll, Sch Nursing, 8 Yikang St, Hangzhou 311399, Peoples R China; [Zhang, Yu; Chang, Hsun-Ming; Zhu, Hua; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Chang, Hsun-Ming] China Med Univ Hosp, Reprod Med Ctr, Dept Obstet & Gynecol, Taichung, Taiwan	Hangzhou Medical College; University of British Columbia; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhang, Y (corresponding author), Hangzhou Med Coll, Sch Nursing, 8 Yikang St, Hangzhou 311399, Peoples R China.; Zhang, Y; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	zhangy@hmc.edu.cn; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	CARE program at the BC Women's Hospital	CARE program at the BC Women's Hospital	We thank the patients and staff of the CARE program at the BC Women's Hospital and Health Centre for providing placental samples used in this study.	Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Cetin I, 2006, AM J OBSTET GYNECOL, V194, P1347, DOI 10.1016/j.ajog.2005.11.018; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2016, FERTIL STERIL, V105, P520, DOI 10.1016/j.fertnstert.2015.10.034; Chang HM, 2015, MOL CELL ENDOCRINOL, V404, P82, DOI 10.1016/j.mce.2015.01.036; Chang HM, 2015, J CLIN ENDOCR METAB, V100, pE365, DOI 10.1210/jc.2014-2496; Chang HM, 2014, J CLIN ENDOCR METAB, V99, pE1922, DOI 10.1210/jc.2014-1223; Colmenares-Mejia CC, 2020, HYPERTENS RES, V43, P884, DOI 10.1038/s41440-020-0434-0; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; Hamed S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2606-3; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Larsson A, 2011, INFLAMMATION, V34, P448, DOI 10.1007/s10753-010-9252-x; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li H, 2018, ENDOCRINOLOGY, V159, P1644, DOI 10.1210/en.2017-03127; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liu C, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110485; Luo J, 2020, FASEB J, V34, P15462, DOI 10.1096/fj.202000508R; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Popovici RM, 2008, ENDOCRINOLOGY, V149, P1136, DOI 10.1210/en.2007-1302; Rovere-Querini P, 2006, OBSTET GYNECOL, V108, P148, DOI 10.1097/01.AOG.0000224607.46622.bc; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Susperregui ARG, 2011, MOL ENDOCRINOL, V25, P1006, DOI 10.1210/me.2010-0515; Todoric J, 2013, EUR J CLIN INVEST, V43, P341, DOI 10.1111/eci.12051; Tranguch S, 2007, BIOL REPROD, V77, P425, DOI 10.1095/biolreprod.107.062414; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; You JL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.607332; Yu N, 2021, TAIWAN J OBSTET GYNE, V60, P816, DOI 10.1016/j.tjog.2021.07.006; Zeybek S, 2019, BALK J MED GENET, V22, P21, DOI 10.2478/bjmg-2019-0002; Zhang Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.573028; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1; Zhou P, 2012, INFLAMM RES, V61, P1005, DOI 10.1007/s00011-012-0507-x	34	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22319	10.1096/fj.202200081RR	http://dx.doi.org/10.1096/fj.202200081RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3EM	35429060				2022-12-28	WOS:000782725200001
J	Huang, HC; Shi, MX; Qi, CY; Tian, Q; Li, HD; Liu, MM; Li, MS; Liu, Q				Huang, Huachen; Shi, Mengxuan; Qi, Caiyun; Tian, Qi; Li, Handong; Liu, Mingming; Li, Minshu; Liu, Qiang			Sphingosine-1-phosphate receptor modulation improves neurogenesis and functional recovery after stroke	FASEB JOURNAL			English	Article						immune modulation; inflammation; ischemic stroke; neurogenesis; S1PR	NEURAL STEM-CELLS; SPHINGOSINE 1-PHOSPHATE; SUBVENTRICULAR ZONE; ISCHEMIC-STROKE; FINGOLIMOD; NEURONS; BRAIN; MICE; PROLIFERATION; GENERATION	Cerebral ischemia activates neural progenitors that participate in brain remodeling following acute injury. Sphingosine-1-phosphate receptor (S1PR) signaling governs cell proliferation and mobilization, yet its potential impact on neural progenitors and stroke recovery remains poorly understood. The goal of this study was to investigate the impact of S1PR modulation on post-stroke neurogenesis and functional recovery, using a S1PR modulator BAF312. Mice were subjected to 60 min middle cerebral artery occlusion (MCAO) and received BAF312 starting from day 3 after MCAO until the end of experiment. BAF312 facilitated motor function recovery in MCAO mice until day 14 after surgery. Flow cytometry analysis revealed that BAF312 treatment led to an increase of type A cells in subventricular zone (SVZ), but not other progenitor cell subsets in MCAO mice. We found an increase of BrdU incorporation in SVZ DCX+ cells from MCAO mice receiving BAF312 and augmented proliferation of DCX+ cells in cultured neurospheres isolated from SVZ tissues. Notably, a S1PR1 antagonist W146 abolished BAF312-induced increase of SVZ type A cells from MCAO mice and proliferation of DCX+ cells in cultured neurospheres. Additionally, the benefit of BAF312 to improve neurogenesis and stroke recovery remains in Rag2(-/-) mice lacking of T and B cells. Our results demonstrate that S1PR modulation improves neurogenesis and functional recovery following brain ischemia.	[Huang, Huachen; Shi, Mengxuan; Qi, Caiyun; Tian, Qi; Li, Handong; Liu, Mingming; Li, Minshu; Liu, Qiang] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University	Liu, Q (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	qliu@tmu.edu.cn	Liu, Qiang/HHZ-3181-2022					Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Behrangi N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010024; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Bobinger T, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3214350; Bobinger T, 2019, STROKE, V50, P3246, DOI 10.1161/STROKEAHA.119.027134; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceanga M, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.700297; Chatzikonstantinou S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113217; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Dillen Y, 2020, TRANSL STROKE RES, V11, P60, DOI 10.1007/s12975-019-00717-8; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gentile A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0686-4; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Healy LM, 2016, CURR DRUG TARGETS, V17, P1841, DOI 10.2174/1389450116666151001112710; Huang HC, 2019, STROKE, V50, P1021, DOI 10.1161/STROKEAHA.118.024287; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Huttner HB, 2014, NAT NEUROSCI, V17, P801, DOI 10.1038/nn.3706; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Jin WN, 2018, STROKE, V49, P1471, DOI 10.1161/STROKEAHA.118.020203; Kestner RI, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00280; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Li ZG, 2020, J EXP MED, V217, DOI 10.1084/jem.20200213; Liang HX, 2019, P NATL ACAD SCI USA, V116, P13621, DOI 10.1073/pnas.1811825116; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Lourbopoulos A, 2017, J CEREBR BLOOD F MET, V37, P2084, DOI 10.1177/0271678X16660986; Lucaciu A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176242; Lucaciu A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061515; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Palma-Tortosa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16109-7; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scott LJ, 2020, CNS DRUGS, V34, P1191, DOI 10.1007/s40263-020-00771-z; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Thompson A, 2020, NAT REV NEUROL, V16, P589, DOI 10.1038/s41582-020-00421-4; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhang RL, 2016, J CEREBR BLOOD F MET, V36, P2034, DOI 10.1177/0271678X16674487	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22616	10.1096/fj.202200533RR	http://dx.doi.org/10.1096/fj.202200533RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1OR	36394527				2022-12-28	WOS:000887960200001
J	Lee, YJ; Jeon, HY; Lee, AJ; Kim, M; Ha, KS				Lee, Yeon-Ju; Jeon, Hye-Yoon; Lee, Ah-Jun; Kim, Minsoo; Ha, Kwon-Soo			Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy	FASEB JOURNAL			English	Article						diabetic retinopathy; dopamine; hyperglycemic memory; microvascular dysfunction; mitochondrial dysfunction	MITOCHONDRIAL FISSION; TRANSGLUTAMINASE 2; OXIDATIVE STRESS; METABOLIC MEMORY; VASCULAR LEAKAGE; C-PEPTIDE; PERMEABILITY; P66(SHC)	Dopamine is a neurotransmitter that mediates visual function in the retina and diabetic retinopathy (DR) is the most common microvascular complication of diabetes and the leading cause of blindness; however, the role of dopamine in retinal vascular dysfunction in DR remains unclear. Here, we report a mechanism of hyperglycemic memory (HGM)-induced retinal microvascular dysfunction and the protective effect of dopamine against the HGM-induced retinal microvascular leakage and abnormalities. We found that HGM induced persistent oxidative stress, mitochondrial membrane potential collapse and fission, and adherens junction disassembly and subsequent vascular leakage after blood glucose normalization in the mouse retinas. These persistent hyperglycemic stresses were inhibited by dopamine treatment in human retinal endothelial cells and by intravitreal injection of levodopa in the retinas of HGM mice. Moreover, levodopa supplementation ameliorated HGM-induced pericyte degeneration, acellular capillary and pericyte ghost generation, and endothelial apoptosis in the mouse retinas. Our findings suggest that dopamine alleviates HGM-induced retinal microvascular leakage and abnormalities by inhibiting persistent oxidative stress and mitochondrial dysfunction.	[Lee, Yeon-Ju; Jeon, Hye-Yoon; Lee, Ah-Jun; Ha, Kwon-Soo] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon, South Korea; [Kim, Minsoo] Kangwon Natl Univ, Dept Anesthesiol & Pain Med, Sch Med, Chunchon, South Korea	Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr			National Research Foundation of Korea (NRF) [2020R1A5A8019180, 2021R1A2C2091794]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2020R1A5A8019180 and 2021R1A2C2091794	Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Chesler K, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.4.8; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Devi SM, 2020, ACTA NEUROL BELG, V120, P257, DOI 10.1007/s13760-020-01274-w; Di Lisa F, 2017, BRIT J PHARMACOL, V174, P1690, DOI 10.1111/bph.13478; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Jeon HY, 2022, BIOCHIP J, V16, P111, DOI 10.1007/s13206-022-00057-0; Jeon HY, 2019, FASEB J, V33, P750, DOI 10.1096/fj.201800723R; Kim D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071662; Kim MK, 2018, INVEST OPHTH VIS SCI, V59, P572, DOI 10.1167/iovs.17-22692; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kowluru RA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63527-1; Kowluru RA, 2019, DIABETES, V68, P241, DOI 10.2337/dbi18-0016; Kowluru RA, 2017, VISION RES, V139, P30, DOI 10.1016/j.visres.2017.02.011; Lahouaoui H, 2016, MOL VIS, V22, P959; Lee JY, 2019, FASEB J, V33, P12655, DOI 10.1096/fj.201901358RR; Lee YJ, 2018, FASEB J, V32, P6089, DOI 10.1096/fj.201800014RR; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Motz CT, 2020, DIABETES, V69, P1518, DOI 10.2337/db19-0869; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Popova E, 2014, J COMP PHYSIOL A, V200, P333, DOI 10.1007/s00359-014-0906-2; Semeraro F, 2019, DIABETES METAB, V45, P517, DOI 10.1016/j.diabet.2019.04.002; Seo JA, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114052; Simo R, 2018, DIABETOLOGIA, V61, P1902, DOI 10.1007/s00125-018-4692-1; Simo-Servat O, 2019, OPHTHALMIC RES, V62, P211, DOI 10.1159/000499541; Sinha S, 2009, J CELL SCI, V122, P3385, DOI 10.1242/jcs.053124; Wang W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061816; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006	39	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22643	10.1096/fj.202200865R	http://dx.doi.org/10.1096/fj.202200865R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6UC	36331561				2022-12-28	WOS:000878733500001
J	Romero, JR; Inostroza-Nieves, Y; Pulido-Perez, P; Lopez, P; Wohlgemuth, JG; Dlott, JS; Snyder, LM; Alper, SL; Rivera, A				Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo; Wohlgemuth, Jay G.; Dlott, Jeffrey S.; Snyder, L. Michael; Alper, Seth L.; Rivera, Alicia			Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via Na+/Mg2+ exchange	FASEB JOURNAL			English	Article							GARDOS CHANNEL ACTIVITY; TRANSGENIC MOUSE MODEL; PROTEIN-KINASE-C; CELL-DISEASE; MG2+ EFFLUX; RED-CELLS; PLASMA; RECEPTOR; DEFICIENCY; ACTIVATION	Painful crises in sickle cell disease (SCD) are associated with increased plasma cytokines levels, including endothelin-1 (ET-1). Reduced red cell magnesium content, mediated in part by increased Na+/Mg2+ exchanger (NME) activity, contributes to erythrocyte K+ loss, dehydration and sickling in SCD. However, the relationship between ET-1 and the NME in SCD has remained unexamined. We observed increased NME activity in sickle red cells incubated in the presence of 500 nM ET-1. Deoxygenation of sickle red cells, in contrast, led to decreased red cell NME activity and cellular dehydration that was reversed by the NME inhibitor, imipramine. Increased NME activity in sickle red cells was significantly blocked by pre-incubation with 100 nM BQ788, a selective blocker of ET-1 type B receptors. These results suggest an important role for ET-1 and for cellular magnesium homeostasis in SCD. Consistent with these results, we observed increased NME activity in sickle red cells of three mouse models of sickle cell disease greater than that in red cells of C57BL/J6 mice. In vivo treatment of BERK sickle transgenic mice with ET-1 receptor antagonists reduced red cell NME activity. Our results suggest that ET-1 receptor blockade may be a promising therapeutic approach to control erythrocyte volume and magnesium homeostasis in SCD and may thus attenuate or retard the associated chronic inflammatory and vascular complications of SCD.	[Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Romero, Jose R.; Inostroza-Nieves, Yaritza; Pulido-Perez, Patricia; Lopez, Pablo; Alper, Seth L.; Rivera, Alicia] Harvard Med Sch, Dept Med, Boston, MA USA; [Inostroza-Nieves, Yaritza] San Juan Bautista Sch Med, Dept Biochem & Pharmacol, Caguas, PR USA; [Wohlgemuth, Jay G.; Dlott, Jeffrey S.; Snyder, L. Michael] Quest Diagnost, Secaucus, NJ USA; [Alper, Seth L.; Rivera, Alicia] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA USA; [Alper, Seth L.; Rivera, Alicia] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA USA; [Rivera, Alicia] Boston Childrens Hosp, Div Lab Med, Boston, MA USA; [Rivera, Alicia] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Rivera, A (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave Bldg RN 380A, Boston, MA 02215 USA.	arivera3@bidmc.harvard.edu		Romero, Jose Ricardo/0000-0001-8225-0772	National Heart, Lung, and Blood Institute [HL67699, HL090632, HL096518]; National Institute of Diabetes and Digestive and Kidney Diseases [DK064841]; Quest Diagnostics	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Quest Diagnostics	National Heart, Lung, and Blood Institute, Grant/Award Number: HL67699, HL090632 and HL096518; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK064841; Quest Diagnostics	Ahmed S, 2021, DEV COMP IMMUNOL, V125, DOI 10.1016/j.dci.2021.104230; Altura BM, 2014, INT J CLIN EXP MED, V7, P1; Altura RA, 2002, J PEDIATR-US, V140, P565, DOI 10.1067/mpd.2002.122644; Angerio Allan D, 2003, Crit Care Nurs Q, V26, P225; Arjona FJ, 2019, PFLUG ARCH EUR J PHY, V471, P845, DOI 10.1007/s00424-018-2234-9; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Bourantas KL, 1998, EUR J HAEMATOL, V61, P49; Brailoiu E, 2018, NEUROSCIENCE, V377, P105, DOI 10.1016/j.neuroscience.2018.02.039; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Chadebech P, 2020, CYTOKINE, V136, DOI 10.1016/j.cyto.2020.155259; Croizat H, 1999, AM J HEMATOL, V60, P105, DOI 10.1002/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO;2-Z; De Franceschi L, 2000, BRIT J HAEMATOL, V108, P284; DeFranceschi L, 1996, BLOOD, V88, P2738, DOI 10.1182/blood.V88.7.2738.bloodjournal8872738; Durpes MC, 2010, BLOOD CELL MOL DIS, V44, P219, DOI 10.1016/j.bcmd.2010.02.001; Ebel H, 2004, BBA-BIOMEMBRANES, V1667, P132, DOI 10.1016/j.bbamem.2004.09.008; Ebel H, 2004, BBA-BIOMEMBRANES, V1664, P150, DOI 10.1016/j.bbamem.2004.05.004; Ergul S, 2004, AM J HEMATOL, V76, P245, DOI 10.1002/ajh.20107; Feillet-Coudray C, 2006, EUR J NUTR, V45, P171, DOI 10.1007/s00394-005-0579-2; Feillet-Coudray C, 2004, METABOLISM, V53, P660, DOI 10.1016/j.metabol.2003.12.014; FERAY JC, 1988, N-S ARCH PHARMACOL, V338, P332; FERAY JC, 1986, BIOCHIM BIOPHYS ACTA, V856, P76, DOI 10.1016/0005-2736(86)90012-X; Ferre S, 2010, BBA-MOL BASIS DIS, V1802, P952, DOI 10.1016/j.bbadis.2010.06.016; Ferreira A, 2004, J CELL PHYSIOL, V199, P434, DOI 10.1002/jcp.10463; Ferreira A, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.861644; Ferri C, 1997, CLIN SCI, V93, P35, DOI 10.1042/cs0930035; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Geisness AC, 2022, HAEMATOLOGICA, V107, P1438, DOI 10.3324/haematol.2021.278666; Ginzburg YZ, 2007, AM J HEMATOL, V82, P911, DOI 10.1002/ajh.20941; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; GUNTHER T, 1993, MINER ELECTROL METAB, V19, P259; Hankins JS, 2008, BRIT J HAEMATOL, V140, P80, DOI 10.1111/j.1365-2141.2007.06884.x; JIMENEZ JS, 1995, MOL CELL BIOCHEM, V152, P1; Kalish BT, 2015, HAEMATOLOGICA, V100, P870, DOI 10.3324/haematol.2015.124586; Kaul DK, 2006, AM J PHYSIOL-HEART C, V291, pH167, DOI 10.1152/ajpheart.01096.2005; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; KURANTSINMILLS J, 1987, J LAB CLIN MED, V109, P486; LEHMANN H, 1963, BRIT MED J, P1158; Libien J, 2005, MOL BRAIN RES, V136, P104, DOI 10.1016/j.molbrainres.2005.01.005; LUDI H, 1987, J PHYSIOL-LONDON, V390, P367; Maier JA, 2021, SEMIN CELL DEV BIOL, V115, P37, DOI 10.1016/j.semcdb.2020.11.002; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Moslehi N, 2012, J RES MED SCI, V17, P607; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Nielsen FH, 2018, J INFLAMM RES, V11, P25, DOI 10.2147/JIR.S136742; Oh SO, 1997, J LAB CLIN MED, V130, P191, DOI 10.1016/S0022-2143(97)90095-0; ORTIZ OE, 1990, J PHYSIOL-LONDON, V427, P211, DOI 10.1113/jphysiol.1990.sp018168; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pedrosa AM, 2020, BRIT J HAEMATOL, V190, pE39, DOI 10.1111/bjh.16693; PHELAN M, 1995, J CLIN INVEST, V96, P1145, DOI 10.1172/JCI118102; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Prado GN, 2013, FASEB J, V27, P4619, DOI 10.1096/fj.13-228577; Rab MAE, 2019, JOVE-J VIS EXP, DOI 10.3791/60213; Rivera A, 2005, BLOOD, V105, P382, DOI 10.1182/blood-2003-11-3755; Rivera A, 2002, BLOOD, V99, P357, DOI 10.1182/blood.V99.1.357; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; Romero JR, 2004, BLOOD, V103, P2384, DOI 10.1182/blood-2003-01-0237; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; SALTER KJ, 1995, EXP PHYSIOL, V80, P815, DOI 10.1113/expphysiol.1995.sp003889; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Shmukler BE, 2019, BLOOD CELL MOL DIS, V79, DOI 10.1016/j.bcmd.2019.102346; Sponder G, 2013, MAGNESIUM RES, V26, P176, DOI 10.1684/mrh.2014.0351; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Touyz RM, 2003, J HYPERTENS, V21, P337, DOI 10.1097/00004872-200302000-00025; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; XU W, 1994, J MEMBRANE BIOL, V141, P277; Yousif OO, 2018, BIOL TRACE ELEM RES, V186, P295, DOI 10.1007/s12011-018-1307-0	74	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22638	10.1096/fj.202201339R	http://dx.doi.org/10.1096/fj.202201339R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6TX	36331552				2022-12-28	WOS:000878733000001
J	Jo, S; Centeio, R; Park, J; Ousingsawat, J; Jeon, DK; Talbi, K; Schreiber, R; Ryu, K; Kahlenberg, K; Somoza, V; Delpiano, L; Gray, MA; Amaral, MD; Railean, V; Beekman, JM; Rodenburg, LW; Namkung, W; Kunzelmann, K				Jo, Sungwoo; Centeio, Raquel; Park, Jinhong; Ousingsawat, Jiraporn; Jeon, Dong-Kyu; Talbi, Khaoula; Schreiber, Rainer; Ryu, Kunhi; Kahlenberg, Kristin; Somoza, Veronika; Delpiano, Livia; Gray, Michael A.; Amaral, Margarida D.; Railean, Violeta; Beekman, Jeffrey M.; Rodenburg, Lisa W.; Namkung, Wan; Kunzelmann, Karl			The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion	FASEB JOURNAL			English	Article						airways; asthma; Cl- secretion; cystic fibrosis; pH regulation; S9-A13	TRANSMEMBRANE CONDUCTANCE REGULATOR; FUNCTIONAL-CHARACTERIZATION; CL-/HCO3-EXCHANGE; EPITHELIAL-CELLS; CL-TRANSPORT; CFTR; CHANNEL; EXPRESSION; DAMAGE; HCO3	The solute carrier 26 family member A9 (SLC26A9) is an epithelial anion transporter that is assumed to contribute to airway chloride secretion and surface hydration. Whether SLC26A9 or CFTR is responsible for airway Cl- transport under basal conditions is still unclear, due to the lack of a specific inhibitor for SLC26A9. In the present study, we report a novel potent and specific inhibitor for SLC26A9, identified by screening of a drug-like molecule library and subsequent chemical modifications. The most potent compound S9-A13 inhibited SLC26A9 with an IC50 of 90.9 +/- 13.4 nM. S9-A13 did not inhibit other members of the SLC26 family and had no effects on Cl- channels such as CFTR, TMEM16A, or VRAC. S9-A13 inhibited SLC26A9 Cl- currents in cells that lack expression of CFTR. It also inhibited proton secretion by HGT-1 human gastric cells. In contrast, S9-A13 had minimal effects on ion transport in human airway epithelia and mouse trachea, despite clear expression of SLC26A9 in the apical membrane of ciliated cells. In both tissues, basal and stimulated Cl- secretion was due to CFTR, while acidification of airway surface liquid by S9-A13 suggests a role of SLC26A9 for airway bicarbonate secretion.	[Jo, Sungwoo; Park, Jinhong; Jeon, Dong-Kyu; Ryu, Kunhi; Namkung, Wan] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Centeio, Raquel; Ousingsawat, Jiraporn; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Physiol Inst, Univ St 31, D-93053 Regensburg, Germany; [Talbi, Khaoula; Kahlenberg, Kristin; Somoza, Veronika] Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany; [Delpiano, Livia; Gray, Michael A.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Amaral, Margarida D.; Railean, Violeta] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Beekman, Jeffrey M.; Rodenburg, Lisa W.] Univ Utrecht, Univ Med Ctr, Regenerat Med Utrecht, Utrecht, Netherlands	Yonsei University; University of Regensburg; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich; Newcastle University - UK; BIOISI; Universidade de Lisboa; Utrecht University; Utrecht University Medical Center	Kunzelmann, K (corresponding author), Univ Regensburg, Physiol Inst, Univ St 31, D-93053 Regensburg, Germany.; Namkung, W (corresponding author), Yonsei Univ, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, 85 Songdogwahak Ro, Incheon 21983, South Korea.	wnamkung@yonsei.ac.kr; karl.kunzelmann@ur.de	Amaral, Margarida/E-5748-2012; Somoza, Veronika/D-4141-2013	Amaral, Margarida/0000-0002-0828-8630; Somoza, Veronika/0000-0003-2456-9245; Delpiano, Livia/0000-0002-2319-4456	Deutsche Forschungsgemeinschaft (DFG) [DFG KU756/14-1]; Gilead Sciences (Gilead); UK CF-Trust [SRC013]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gilead Sciences (Gilead)(Gilead Sciences); UK CF-Trust	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DFG KU756/14-1; Gilead Sciences (Gilead), Grant/Award Number: Mucus in CF; UK CF-Trust, Grant/Award Number: SRC013	ALBAZZAZ FJ, 1994, AM J PHYSIOL, V267, pL193, DOI 10.1152/ajplung.1994.267.2.L193; Avella M, 2011, J CELL PHYSIOL, V226, P212, DOI 10.1002/jcp.22328; BALLARD ST, 1994, AM J PHYSIOL, V267, pL79, DOI 10.1152/ajplung.1994.267.1.L79; Benedetto R, 2020, PFLUG ARCH EUR J PHY, V472, P1507, DOI 10.1007/s00424-020-02440-y; Bertrand CA, 2017, AM J PHYSIOL-LUNG C, V312, pL912, DOI 10.1152/ajplung.00178.2016; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Besteman SB, 2022, J INFECT DIS, V226, P258, DOI 10.1093/infdis/jiac114; Cabrita I, 2021, AM J RESP CELL MOL, V64, P50, DOI 10.1165/rcmb.2019-0442OC; Centeio R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105133; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen AP, 2012, HUM MUTAT, V33, P1275, DOI 10.1002/humu.22107; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; El Khouri E, 2014, INT J BIOCHEM CELL B, V52, P58, DOI 10.1016/j.biocel.2014.02.001; Holik AK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115881; Ishibashi K, 2008, AM J PHYSIOL-REG I, V294, pR1729, DOI 10.1152/ajpregu.00758.2007; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Lam ATN, 2020, J CLIN INVEST, V130, P272, DOI 10.1172/JCI129833; Larsen MB, 2021, AM J PHYSIOL-LUNG C, V321, pL1147, DOI 10.1152/ajplung.00563.2020; Liu XM, 2015, PFLUG ARCH EUR J PHY, V467, P1261, DOI 10.1007/s00424-014-1543-x; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Miller MR, 2015, J PEDIATR-US, V166, P1152, DOI 10.1016/j.jpeds.2015.01.044; Needham PG, 2021, BIOCHEM J, V478, P4203, DOI 10.1042/BCJ20210644; Ousingsawat J, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23062998; Ousingsawat J, 2012, J CELL PHYSIOL, V227, P2323, DOI 10.1002/jcp.22967; Park J, 2019, J ALLERGY CLIN IMMUN, V144, P1425, DOI 10.1016/j.jaci.2019.07.016; Pinto MC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222313064; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Rakonczay Z, 2008, J CELL PHYSIOL, V214, P442, DOI 10.1002/jcp.21220; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Saint-Criq V, 2019, JOVE-J VIS EXP, DOI 10.3791/59815; Salomon JJ, 2016, AM J PHYSIOL-LUNG C, V310, pL593, DOI 10.1152/ajplung.00321.2015; Sato Y, 2019, J BIOL CHEM, V294, P18269, DOI 10.1074/jbc.RA119.010192; Schreiber R, 2008, PFLUG ARCH EUR J PHY, V457, P431, DOI 10.1007/s00424-008-0543-0; Simao S, 2013, LIFE SCI, V93, P435, DOI 10.1016/j.lfs.2013.07.026; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Strug LJ, 2016, HUM MOL GENET, V25, P4590, DOI 10.1093/hmg/ddw290; Sun L, 2012, NAT GENET, V44, P562, DOI 10.1038/ng.2221; Walter JD, 2019, ELIFE, V8, DOI 10.7554/eLife.46986; Wang XF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-7; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105	47	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22534	10.1096/fj.202200313RR	http://dx.doi.org/10.1096/fj.202200313RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A5VB	36183361	Green Published			2022-12-28	WOS:000862954000001
J	Nie, Y; Fan, HL; Li, JH; Lei, XJ; Zhang, TC; Wang, YF; Mao, ZZ; Tao, KS; Song, WJ				Nie, Ye; Fan, Hanlu; Li, Jianhui; Lei, Xinjun; Zhang, Tianchen; Wang, Yanfang; Mao, Zhenzhen; Tao, Kaishan; Song, Wenjie			Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; immune cell; prognosis; tertiary lymphoid structure; tertiary lymphoid structure formation	T-CELLS; IMMUNOTHERAPY; INFILTRATION; PROGNOSIS; SURVIVAL; CANCERS; CLUSTER; STAGE	The prognostic value of immune cells in tertiary lymphoid structures (TLSs) remains unclear in hepatocellular carcinoma (HCC). Here, 59 of 145 patients had TLSs in training set, 48 of 120 patients had TLSs in testing set. Immunohistochemistry (IHC) were used to label CD3+ T cells, CD20+ B cells, CD8+ T cells, CD208+ dendritic cells, and CD21+ follicular dendritic cells in TLSs. High CD20+, CD208+, and CD8+ cell densities were favorable prognostic factors for overall survival (OS). High CD3+, CD20+, CD208+, and CD8+ cell densities were significantly associated with reduced early recurrence. TLSs were divided into three grades (A, B, and C) based on immune cell density. Patients with grade C or B had significantly improved OS. Patients with grade C had the lowest recurrence rate, followed by those with grade B, while patients with grade A had the highest recurrence rate. The stromal, immune, and ESTIMATE scores derived from the ESTIMATE package were significantly higher and tumor purity was significantly lower in patients with TLSs. Patients with TLSs had significantly higher relative numbers of memory B cells, plasma cells, CD8+ T cells, NK cells, and dendritic cells and lower relative numbers of Treg cells, macrophages, and M2 macrophages according to the CIBERSORT assessment. Bioinformatics analysis and experiments confirmed that KLRK1 and GZMA expression are associated TLSs formation and can predict TLSs existence. Grade B and grade C were favorable prognostic factors for OS and recurrence and could represent immune-active tumors.	[Nie, Ye; Fan, Hanlu; Wang, Yanfang; Mao, Zhenzhen; Tao, Kaishan; Song, Wenjie] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Li, Jianhui] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China; [Lei, Xinjun] Ctr Hosp Weinan Shaanxi, Dept Gen Surg, Weinan, Peoples R China; [Zhang, Tianchen] Xian Med Univ, Dept Gen Surg, Affiliated Hosp 1, Xian, Peoples R China; [Wang, Yanfang; Mao, Zhenzhen] Xian Med Univ, Xian, Peoples R China	Air Force Military Medical University; Anhui Medical University; Xi'an Medical University; Xi'an Medical University	Tao, KS; Song, WJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China.	taokaishan0686@163.com; songvvenjie1230123@163.com		Li, Jianhui/0000-0002-7946-0768	National Natural Science Foundation of China [81672716]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81672716).	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Arulraj T, 2021, J IMMUNOL, V206, P1436, DOI 10.4049/jimmunol.2001355; Bin Seow DY, 2020, BREAST CANCER RES TR, V180, P369, DOI 10.1007/s10549-020-05548-y; Blanchard L, 2021, ANGIOGENESIS, V24, P719, DOI 10.1007/s10456-021-09792-8; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Calderaro J, 2017, J HEPATOL, V67, P727, DOI 10.1016/j.jhep.2017.05.014; Colbeck EJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01830; Cui YF, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01591-1; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Engelhard VH, 2018, J IMMUNOL, V200, P432, DOI 10.4049/jimmunol.1701269; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fujita M, 2020, EBIOMEDICINE, V53, DOI 10.1016/j.ebiom.2020.102659; He WT, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00980; Heinemann J, 2019, METHODS MOL BIOL, V1859, P275, DOI 10.1007/978-1-4939-8757-3_16; Gunderson AJ, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1900635; Kaseb AO, 2019, CANCER IMMUNOL RES, V7, P1390, DOI 10.1158/2326-6066.CIR-18-0605; Li H, 2020, AGING-US, V12, P3451, DOI 10.18632/aging.102821; Li W, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2019.1672495; Lin ZY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78560-3; Liu ZQ, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-020-02697-y; Longo V, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100698; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Moreno-Cubero E, 2016, WORLD J GASTROENTERO, V22, P6469, DOI 10.3748/wjg.v22.i28.6469; Mori T, 2021, CANCER SCI, V112, P1746, DOI 10.1111/cas.14888; Munguia-Fuentes R, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.587809; Nie Y, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.706915; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Poggi A, 2007, ANN NY ACAD SCI, V1109, P47, DOI 10.1196/annals.1398.007; Qin M, 2021, ONCOL LETT, V22, DOI 10.3892/ol.2021.13097; Raskov H, 2021, BRIT J CANCER, V124, P359, DOI 10.1038/s41416-020-01048-4; Reading JL, 2018, IMMUNOL REV, V283, P194, DOI 10.1111/imr.12657; Sakimura C, 2017, J SURG RES, V215, P74, DOI 10.1016/j.jss.2017.03.033; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Shimizu K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01450; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Singh L, 2021, CANCER IMMUNOL IMMUN, V70, P1291, DOI 10.1007/s00262-020-02773-8; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Wang J, 2018, J CLIN GASTROENTEROL, V52, P437, DOI 10.1097/MCG.0000000000000859; Yoon HH, 2019, CLIN CANCER RES, V25, P125, DOI 10.1158/1078-0432.CCR-18-1984; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang Y, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110562; Zhong C, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.589680; Zhu J, 2020, J GASTROINTEST ONCOL, V11, P1364, DOI 10.21037/jgo-20-556; Ziogas IA, 2021, ONCOLOGIST, V26, pE1036, DOI 10.1002/onco.13638	44	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22586	10.1096/fj.202200269RR	http://dx.doi.org/10.1096/fj.202200269RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0CF	36190431	hybrid			2022-12-28	WOS:000863244100001
J	She, XD; Zhang, PY; Shi, DM; Peng, JW; Wang, Q; Meng, XJ; Jiang, Y; Calderone, R; Bellanti, JA; Liu, WD; Li, DM				She, Xiaodong; Zhang, Pengyi; Shi, Dongmei; Peng, Jingwen; Wang, Qiong; Meng, Xiangjing; Jiang, Yong; Calderone, Richard; Bellanti, Joseph A.; Liu, Weida; Li, Dongmei			The mitochondrial complex I proteins of Candida albicans moderate phagocytosis and the production of pro-inflammatory cytokines in murine macrophages and dendritic cells	FASEB JOURNAL			English	Article						C; albicans mitochondrial; cell wall; CI subunit proteins; cytokines of dendritic cells; mannan-MAPK signaling; phagocytosis	GLUCAN EXPOSURE; STRESS; PHOSPHOLIPOMANNAN; SACCHAROMYCES; RECOGNITION; ACTIVATION; TRANSPORT; VIRULENCE; INTEGRITY; DATABASE	Loss of respiratory functions impairs Candida albicans colonization of host tissues and virulence in a murine model of candidiasis. Furthermore, it is known that respiratory inhibitors decrease mannan synthesis and glucan exposure and thereby promotes phagocytosis. To understand the impact of respiratory proteins of C. albicans on host innate immunity, we characterized cell wall defects in three mitochondrial complex I (CI) null mutants (nuo1 Delta, nuo2 Delta and ndh51 Delta) and in one CI regulator mutant (goa1 Delta), and we studied the corresponding effects of these mutants on phagocytosis, neutrophil killing and cytokine production by dendritic cells (DCs). We find that reductions of phosphopeptidomannan (PPM) in goa1 Delta, nuo1 Delta and phospholipomannan (PLM) in nuo2 Delta lead to reductions of IL-2, IL-4, and IL-10 but increase of TNF-alpha in infected DCs. While PPM loss is a consequence of a reduced phospho-Cek1/2 MAPK that failed to promote phagocytosis and IL-22 production in goa1 Delta and nuo1 Delta, a 30% glucan reduction and a defective Mek1 MAPK response in ndh51 Delta lead to only minor changes in phagocytosis and cytokine production. Glucan exposure and PLM abundance seem to remain sufficient to opsonize neutrophil killing perhaps via humoral immunity. The diversity of immune phenotypes in these mutants possessing divergent cell wall defects is further supported by their transcriptional profiles in each infected murine macrophage scenario. Since metabolic processes, oxidative stress-induced senescence, and apoptosis are differently affected in these scenarios, we speculate that during the early stages of infection, host immune cells coordinate their bioactivities based upon a mixture of signals generated during host-fungi interactions.	[She, Xiaodong; Shi, Dongmei; Peng, Jingwen; Wang, Qiong; Liu, Weida] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [She, Xiaodong; Zhang, Pengyi; Jiang, Yong; Calderone, Richard; Bellanti, Joseph A.; Li, Dongmei] Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, 3900 Reservoir Rd NW, Washington, DC 20057 USA; [She, Xiaodong; Liu, Weida] Jiangsu Key Lab Mol Biol Skin Dis & STIs, Nanjing, Peoples R China; [Zhang, Pengyi] Shandong Sport Univ, Sport Sci Res Ctr, Jinan, Peoples R China; [Shi, Dongmei] Jining 1 Peoples Hosp, Dept Dermatol, Jining, Peoples R China; [Meng, Xiangjing] Shandong Acad Pharmaceut Sci, Jinan, Peoples R China; [Jiang, Yong] Tianjin Med Univ, Dept Dermatol, Hosp 2, Tianjin, Peoples R China; [Liu, Weida] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Nanjing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Georgetown University; Shandong Sport University; Tianjin Medical University; Nanjing Medical University	Li, DM (corresponding author), Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, 3900 Reservoir Rd NW, Washington, DC 20057 USA.; Liu, WD (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Nanjing 210029, Peoples R China.	liumycology@126.com; dl33@georgetown.edu		She, Xiaodong/0000-0002-8719-0462	National Natural Science Foundation of Jiangsu Province, China [BK20191137]; Natural Science Foundation of Shandong Province, China [ZR2020MC018]; Shandong Province Higher Education Science and Technology Project [J18KA123]; Shandong Province Higher Education Youth Innovation Talent Introduction Program; Scientific and Technological Innovation Project of Medicine and Health of Chinese Academy of Medical Sciences [2016-I2M-3-021]	National Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Shandong Province Higher Education Science and Technology Project; Shandong Province Higher Education Youth Innovation Talent Introduction Program; Scientific and Technological Innovation Project of Medicine and Health of Chinese Academy of Medical Sciences	This study was supported by funding from the National Natural Science Foundation of Jiangsu Province, China (BK20191137) to Xiaodong She; from the Natural Science Foundation of Shandong Province, China (ZR2020MC018), Shandong Province Higher Education Science and Technology Project (J18KA123), and Shandong Province Higher Education Youth Innovation Talent Introduction Program to Pengyi Zhang; and from the Scientific and Technological Innovation Project of Medicine and Health of Chinese Academy of Medical Sciences (2016-I2M-3-021) to Dr. Weida Liu.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calderone R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov027; Courjol F, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv116; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Duvenage L, 2019, MBIO, V10, DOI [10.1128/mBio.02535-18, 10.1128/mbio.02535-18]; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Feng YH, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.855651; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Garcia R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06001-9; Graus MS, 2018, CELL REP, V24, P2432, DOI 10.1016/j.celrep.2018.07.088; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Hara-Kaonga B, 2007, J MICROBIOL METH, V69, P37, DOI 10.1016/j.mimet.2006.11.017; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Hopke A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005644; Huang XH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006414; Ingelsson B, 2018, P NATL ACAD SCI USA, V115, pE478, DOI 10.1073/pnas.1711950115; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; Kumamoto CA, 2016, CELL HOST MICROBE, V19, P750, DOI 10.1016/j.chom.2016.05.018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Li DM, 2016, CURR GENET, V62, P87, DOI 10.1007/s00294-015-0518-6; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; Li DM, 2011, EUKARYOT CELL, V10, P672, DOI 10.1128/EC.00303-10; Loreto ES., 2017, IMMUNOTHERAPY MYTHS, DOI [10.5772/66164, DOI 10.5772/66164]; Losse J, 2010, J IMMUNOL, V184, P912, DOI 10.4049/jimmunol.0901702; McDonough JA, 2002, FUNGAL GENET BIOL, V36, P117, DOI 10.1016/S1087-1845(02)00007-5; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Santambrogio L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01033; Sexton DJ, 2021, CLIN INFECT DIS, V73, P1142, DOI 10.1093/cid/ciab327; She XD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.559975; She XD, 2018, MITOCHONDRION, V38, P48, DOI 10.1016/j.mito.2017.08.003; She XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147175; She XD, 2015, CELL MICROBIOL, V17, P1350, DOI 10.1111/cmi.12438; She XD, 2013, CELL MICROBIOL, V15, P1572, DOI 10.1111/cmi.12135; Shi DM, 2019, LIFE SCI, V222, P183, DOI 10.1016/j.lfs.2019.03.009; Skalnikova HK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122697; Stalhberger T, 2014, J BIOL CHEM, V289, P12647, DOI 10.1074/jbc.M113.547034; Sun N, 2019, MBIO, V10, DOI 10.1128/mBio.00300-19; Trinel PA, 2002, J BIOL CHEM, V277, P37260, DOI 10.1074/jbc.M202295200; Trinel PA, 2002, INFECT IMMUN, V70, P5274, DOI 10.1128/IAI.70.9.5274-5278.2002; Underhill D, 2008, INFLAMM BOWEL DIS, V14, P1147, DOI 10.1002/ibd.20402; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West L, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478743; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Zhang PY, 2018, FUNGAL GENET BIOL, V111, P73, DOI 10.1016/j.fgb.2017.11.002; Zhou YJ, 2021, APPL MICROBIOL BIOT, V105, P2485, DOI 10.1007/s00253-021-11187-0; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	69	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22575	10.1096/fj.202200275RRR	http://dx.doi.org/10.1096/fj.202200275RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5D7JB	36208290	hybrid			2022-12-28	WOS:000865111900001
J	Kim, JY; Manna, D; Etscheid, M; Leergaard, TB; Kanse, SM				Kim, Jeong Yeon; Manna, Dipankar; Etscheid, Michael; Leergaard, Trygve B.; Kanse, Sandip M.			Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models	FASEB JOURNAL			English	Article						bleeding; brain; FSAP; HABP2; hemorrhage; ischemic stroke; protease; thrombectomy; thrombolysis; tPA	MARBURG-I POLYMORPHISM; PLASMINOGEN-ACTIVATOR; RECANALIZATION; THROMBOSIS; BLOOD	The outcome of ischemic stroke can be improved by further refinements of thrombolysis and reperfusion strategies. Factor VII activating protease (FSAP) is a circulating serine protease that could be important in this context. Its levels are raised in patients as well as mice after stroke and a single nucleotide polymorphism (SNP) in the coding sequence, which results in an inactive enzyme, is linked to an increased risk of stroke. In vitro, FSAP cleaves fibrinogen to promote fibrinolysis, activates protease-activated receptors, and decreases the cellular cytotoxicity of histones. Based on these facts, we hypothesized that FSAP can be used as a treatment for ischemic stroke. A combination of tissue plasminogen activator (tPA), a thrombolytic drug, and recombinant serine protease domain of FSAP (FSAP-SPD) improved regional cerebral perfusion and neurological outcome and reduced infarct size in a mouse model of thromboembolic stroke. FSAP-SPD also improved stroke outcomes and diminished the negative consequences of co-treatment with tPA in the transient middle cerebral artery occlusion model of stroke without altering cerebral perfusion. The inactive MI-isoform of FSAP had no impact in either model. FSAP enhanced the lysis of blood clots in vitro, but in the tail transection model of hemostasis, FSAP-SPD treatment provoked a faster clotting time indicating that it also has pro-coagulant actions. Thus, apart from enhancing thrombolysis, FSAP has multiple effects on stroke progression and represents a promising novel therapeutic strategy in the treatment of ischemic stroke.	[Kim, Jeong Yeon; Manna, Dipankar; Leergaard, Trygve B.; Kanse, Sandip M.] Univ Oslo, Dept Mol Med, Inst Basic Med Sci, Sognsvannsveien 9, N-0172 Oslo, Norway; [Etscheid, Michael] Paul Ehrlich Inst, Div Hematol Transfus Med, Langen, Germany	University of Oslo; Paul Ehrlich Institute	Kanse, SM (corresponding author), Univ Oslo, Dept Mol Med, Inst Basic Med Sci, Sognsvannsveien 9, N-0172 Oslo, Norway.	sandip.kanse@medisin.uio.no		Kanse, Sandip/0000-0003-0782-9957	Research Council of Norway [251239]; Scientia Fellow/Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Research Council of Norway(Research Council of Norway); Scientia Fellow/Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Research Council of Norway, Grant/ Award Number: 251239; Scientia Fellow/ Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Artunc F, 2022, PFLUG ARCH EUR J PHY, V474, P217, DOI 10.1007/s00424-021-02639-7; Berge-Seidl S, 2022, ACS CHEM BIOL, V17, P2631, DOI 10.1021/acschembio.2c00538; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Byskov K, 2020, FASEB J, V34, P1079, DOI 10.1096/fj.201801986RR; Campbell BCV, 2020, LANCET, V396, P129, DOI 10.1016/S0140-6736(20)31179-X; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Cheng YC, 2016, STROKE, V47, P307, DOI 10.1161/STROKEAHA.115.011328; de Lizarrondo SM, 2017, CIRCULATION, V136, P646, DOI 10.1161/CIRCULATIONAHA.117.027290; Desilles JP, 2015, STROKE, V46, P3241, DOI 10.1161/STROKEAHA.115.010721; du Sert NP, 2020, EXP PHYSIOL, V105, P1459, DOI 10.1113/EP088870; de Rueda ME, 2015, STROKE, V46, P2517, DOI 10.1161/STROKEAHA.114.008598; Etscheid M, 2012, THROMB RES, V130, P935, DOI 10.1016/j.thromres.2012.07.023; Etscheid M, 2000, BIOL CHEM, V381, P1223, DOI 10.1515/BC.2000.150; Etscheid M, 2018, BBA-MOL BASIS DIS, V1864, P3397, DOI 10.1016/j.bbadis.2018.07.030; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Garantziotis S, 2019, MATRIX BIOL, V78-79, P1, DOI 10.1016/j.matbio.2019.02.002; Grasso S, 2018, THROMB RES, V161, P36, DOI 10.1016/j.thromres.2017.11.012; Griffin JH, 2018, BLOOD, V132, P159, DOI 10.1182/blood-2018-02-769026; Griffin JH, 2016, ARTERIOSCL THROM VAS, V36, P2143, DOI 10.1161/ATVBAHA.116.308038; Hanson E, 2012, J THROMB HAEMOST, V10, P848, DOI 10.1111/j.1538-7836.2012.04692.x; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Joshi AU, 2015, EUR J NEUROSCI, V41, P963, DOI 10.1111/ejn.12830; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Kanse SM, 2012, ARTERIOSCL THROM VAS, V32, P427, DOI 10.1161/ATVBAHA.111.238394; Kara E, 2017, THROMB HAEMOSTASIS, V117, P1750, DOI 10.1160/TH17-02-0081; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Li D, 2020, PHLEBOLOGY, V35, P345, DOI 10.1177/0268355519881604; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Maroney SA, 2011, ARTERIOSCL THROM VAS, V31, P821, DOI 10.1161/ATVBAHA.110.220293; Marsman G, 2017, BLOOD ADV, V1, P2491, DOI 10.1182/bloodadvances.2017010959; Mei T, 2019, BIOMATERIALS, V215, DOI 10.1016/j.biomaterials.2019.05.020; Murao A, 2021, APOPTOSIS, V26, P152, DOI 10.1007/s10495-021-01663-3; Nielsen NV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55531-x; Park JY, 2014, STROKE, V45, P2480, DOI 10.1161/STROKEAHA.114.006297; Ramasubramanian B, 2022, FASEB J, V36, DOI 10.1096/fj.202200303RR; Romisch J, 2002, BIOL CHEM, V383, P1119, DOI 10.1515/BC.2002.121; Rut W, 2019, THROMB RES, V182, P124, DOI 10.1016/j.thromres.2019.08.016; Staessens S, 2021, PLATELETS, V32, P331, DOI 10.1080/09537104.2020.1748586; Stephan F, 2011, CRIT CARE, V15, DOI 10.1186/cc10131; Stoll G, 2019, NAT REV NEUROL, V15, P473, DOI 10.1038/s41582-019-0221-1; Subramaniam S, 2015, THROMB HAEMOSTASIS, V113, P870, DOI 10.1160/TH14-06-0519; Thiebaut AM, 2018, LANCET NEUROL, V17, P1121, DOI 10.1016/S1474-4422(18)30323-5; Tian DS, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-021-00802-1; Trompet S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/424759; Vivien D, 2017, REV NEUROL-FRANCE, V173, P566, DOI 10.1016/j.neurol.2017.07.003; Wang JA, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1425-0; Waqas M, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105557; Willeit J, 2003, CIRCULATION, V107, P667, DOI 10.1161/01.CIR.0000055189.18831.B1; Wygrecka M, 2007, J BIOL CHEM, V282, P21671, DOI 10.1074/jbc.M610748200; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Zhang J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.08	53	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22564	10.1096/fj.202200828R	http://dx.doi.org/10.1096/fj.202200828R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1ID	36165219	Green Published, Green Submitted			2022-12-28	WOS:000859918300001
J	Iacopucci, APM; Pereira, PD; Pereira, DA; Calmasini, FB; Pittala, V; Reis, LO; Burnett, AL; Costa, FF; Silva, FH				Magrini Iacopucci, Ana Paula; Pereira, Pamela da Silva; Pereira, Dalila Andrade; Calmasini, Fabiano Beraldi; Pittala, Valeria; Reis, Leonardo Oliveira; Burnett, Arthur L.; Costa, Fernando Ferreira; Silva, Fabio Henrique			Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation: Implication for priapism in sickle cell disease	FASEB JOURNAL			English	Article						anemia; cGMP; erectile dysfunction; heme oxygenase; nitric oxide; oxidative stress; PDE5	NITRIC-OXIDE; HEME OXYGENASE-1; CARBON-MONOXIDE; NADPH OXIDASE; EXCESS ADENOSINE; CYCLASE; CONTRIBUTES; HAPTOGLOBIN; ACTIVATION; INHIBITORS	Patients with sickle cell disease (SCD) display priapism. Clinical studies have shown a strong positive correlation between priapism and high levels of intravascular hemolysis in men with SCD. However, there are no experimental studies that show that intravascular hemolysis promotes alterations in erectile function. Therefore, we aimed to evaluate the corpus cavernosum smooth muscle relaxant function in a murine model that displays intravascular hemolysis induced by phenylhydrazine (PHZ), as well as the role of intravascular hemolysis in increasing the stress oxidative in the penis. Corpus cavernosum strips were dissected free and placed in organ baths. Acetylcholine and electrical field stimulation (EFS)-induced corpus cavernosum relaxations in vitro were obtained. Increased corpus cavernosum relaxant responses to acetylcholine and EFS were observed in the PHZ group. Protein expression of heme oxygenase-1 increased in the corpus cavernosum of the PHZ group, but PDE5 protein expression was not modified. Preincubation with the heme oxygenase inhibitor 1 J completely reversed the increased relaxant responses to acetylcholine and EFS in PHZ mice. Protein expression of NADPH oxidase subunit gp91phox, 3-nitrotyrosine, and 4-hydroxynonenal increased in the corpus cavernosum of the PHZ group, suggesting a state of oxidative stress. Basal cGMP production was lower in the PHZ group. Our results show that intravascular hemolysis promotes increased corpus cavernosum smooth muscle relaxation associated with increased HO-1 expression, as well as increased oxidative stress associated with upregulation of gp91phox expression. Moreover, our study supports clinical studies that point to a strong positive correlation between priapism and high levels of intravascular hemolysis in men with SCD.	[Magrini Iacopucci, Ana Paula; Pereira, Dalila Andrade; Calmasini, Fabiano Beraldi; Silva, Fabio Henrique] Sao Francisco Univ Med Sch, Lab Multidisciplinary Res, Rua Sao Francisco 218, BR-2916900 Braganca Paulista, SP, Brazil; [Pereira, Pamela da Silva; Costa, Fernando Ferreira] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, Brazil; [Pittala, Valeria] Univ Catania, Dept Drug & Hlth Sci, Catania, Italy; [Reis, Leonardo Oliveira] Pontifical Catholic Univ Campinas, UroSci, Campinas, SP, Brazil; [Burnett, Arthur L.] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA	Universidade Estadual de Campinas; University of Catania; Pontificia Universidade Catolica de Campinas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Silva, FH (corresponding author), Sao Francisco Univ Med Sch, Lab Multidisciplinary Res, Rua Sao Francisco 218, BR-2916900 Braganca Paulista, SP, Brazil.	fabiohsilva87@gmail.com			Sao Paulo Research Foundation [2019/18886-1, 2017/08122-9]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Sao Paulo Research Foundation, Grant/Award Number: 2019/18886-1 and 2017/08122-9	Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; Belcher JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196455; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bivalacqua TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068028; Bivalacqua TJ, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.050; Carson CC, 2005, BJU INT, V96, P257, DOI 10.1111/j.1464-410X.2005.05614.x; Cita KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154866; Gbotosho OT, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.561917; Hanson MS, 2011, BRIT J HAEMATOL, V154, P502, DOI 10.1111/j.1365-2141.2011.08738.x; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Lagoda G, 2013, J UROLOGY, V189, P762, DOI 10.1016/j.juro.2012.08.198; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Musicki B, 2018, ANDROLOGY-US, V6, P184, DOI 10.1111/andr.12442; Musicki B, 2021, J CELL PHYSIOL, V236, P3073, DOI 10.1002/jcp.30075; Musicki B, 2012, J SEX MED, V9, P1980, DOI 10.1111/j.1743-6109.2012.02798.x; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Ning C, 2014, FASEB J, V28, P2725, DOI 10.1096/fj.13-247833; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Nunes KP, 2015, J PHARMACOL EXP THER, V353, P330, DOI 10.1124/jpet.114.220970; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Salerno L, 2019, EUR J MED CHEM, V167, P439, DOI 10.1016/j.ejmech.2019.02.027; Salerno L, 2018, EUR J MED CHEM, V148, P54, DOI 10.1016/j.ejmech.2018.02.007; Salonia A, 2014, EUR UROL, V65, P480, DOI 10.1016/j.eururo.2013.11.008; Schaer CA, 2016, AM J RESP CRIT CARE, V193, P1111, DOI 10.1164/rccm.201510-2058OC; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291; Silva FH, 2016, J PHARMACOL EXP THER, V359, P230, DOI 10.1124/jpet.116.235473; Silva FH, 2018, J PHARMACOL EXP THER, V367, P194, DOI 10.1124/jpet.118.249581; Sopko NA, 2015, J SEX MED, V12, P1878, DOI 10.1111/jsm.12976; Sorrenti V, 2012, CHEM BIOL DRUG DES, V80, P876, DOI 10.1111/cbdd.12015; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Teixeira CE, 2007, J PHARMACOL EXP THER, V322, P1093, DOI 10.1124/jpet.107.124594; Ushiyama M, 2004, HYPERTENS RES, V27, P253, DOI 10.1291/hypres.27.253; Vendrame F, 2018, J CLIN LIPIDOL, V12, P1532, DOI 10.1016/j.jacl.2018.08.002; Wang R, 1997, BRIT J PHARMACOL, V121, P927, DOI 10.1038/sj.bjp.0701222	39	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22535	10.1096/fj.202200867R	http://dx.doi.org/10.1096/fj.202200867R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5AY	36070139				2022-12-28	WOS:000850590800001
J	Buscetta, M; Cristaldi, M; Cimino, M; La Mensa, A; Dino, P; Bucchieri, F; Rappa, F; Amato, S; Aronica, TS; Pace, E; Bertani, A; Cipollina, C				Buscetta, Marco; Cristaldi, Marta; Cimino, Maura; La Mensa, Agnese; Dino, Paola; Bucchieri, Fabio; Rappa, Francesca; Amato, Santina; Aronica, Tommaso Silvano; Pace, Elisabetta; Bertani, Alessandro; Cipollina, Chiara			Cigarette smoke promotes inflammasome-independent activation of caspase-1 and-4 leading to gasdermin D cleavage in human macrophages	FASEB JOURNAL			English	Article						alveolar macrophages; caspase; cigarette smoke; inflammasome; lung	NF-KAPPA-B; NLRP3 INFLAMMASOME	Mechanisms and consequences of gasdermin D (GSDMD) activation in cigarette smoke (CS)-associated inflammation and lung disease are unknown. GSDMD is a downstream effector of caspase-1, -8, and -4. Upon cleavage, GSDMD generates pores into cell membranes. Different degrees of GSDMD activation are associated with a range of physiological outputs ranging from cell hyperactivation to pyroptosis. We have previously reported that in human monocyte-derived macrophages CS extract (CSE) inhibits the NLRP3 inflammasome and shifts the response to lipopolysaccharide (LPS) towards the TLR4-TRIF axis leading to activation of caspase-8, which, in turn, activates caspase-1. In the present work, we investigated whether other ASC-dependent inflammasomes could be involved in caspase activation by CSE and whether caspase activation led to GSDMD cleavage and other downstream effects. Presented results demonstrate that CSE promoted ASC-independent activation of caspase-1 leading to GSDMD cleavage and increased cell permeability, in the absence of cell death. GSDMD cleavage was strongly enhanced upon stimulation with LPS+CSE, suggesting a synergistic effect between the two stimuli. Noteworthy, CSE promoted LPS internalization leading to caspase-4 activation, thus contributing to increased GSDMD cleavage. Caspase-dependent GSDMD cleavage was associated with mitochondrial superoxide generation. Increased cleaved GSDMD was found in lung macrophages of smokers compared to ex-smokers and non-smoking controls. Our findings revealed that ASC-independent activation of caspase-1, -4, and -8 and GSDMD cleavage upon exposure to CS may contribute to macrophage dysfunction and feed the chronic inflammation observed in the smokers' lung.	[Buscetta, Marco; Cristaldi, Marta; Cimino, Maura; La Mensa, Agnese; Dino, Paola; Cipollina, Chiara] Fdn RiMED, Via Bandiera 11, I-90133 Palermo, Italy; [La Mensa, Agnese; Dino, Paola; Bucchieri, Fabio; Rappa, Francesca] Univ Palermo, Dept Biomed Neumsci & Adv Diagnost BiND, Palermo, Italy; [Amato, Santina; Aronica, Tommaso Silvano] Azienda Rilievo Nazl Alta Specializzaz Osped ARNA, Palermo, Italy; [Pace, Elisabetta; Cipollina, Chiara] CNR, Ist Farmacol Traslaz IFT, Palermo, Italy; [Bertani, Alessandro] IRCCS ISMETT UPMC Italy, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Cipollina, C (corresponding author), Fdn RiMED, Via Bandiera 11, I-90133 Palermo, Italy.	ccipollina@fondazionerimed.com		rappa, francesca/0000-0001-6610-5268; La Mensa, Agnese/0000-0002-9344-2881	PO FESR Regione Siciliana [G78I18000930007]; Sicilian Region [G77B17000110001]	PO FESR Regione Siciliana; Sicilian Region	PO FESR Regione Siciliana, Grant/ Award Number: G78I18000930007; Sicilian Region, Grant/Award Number: G77B17000110001	Aghapour M, 2018, AM J RESP CELL MOL, V58, P157, DOI 10.1165/rcmb.2017-0200TR; Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, pL895, DOI 10.1152/ajplung.00180.2014; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Buscetta M, 2020, FASEB J, V34, P1819, DOI 10.1096/fj.201901239R; Chan AH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190314; Chen L, 2016, AM J RESP CELL MOL, V55, P815, DOI 10.1165/rcmb.2016-0051OC; Cipollina C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37625; de Torre-Minguela C, 2021, FASEB J, V35, DOI 10.1096/fj.202100085R; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Duffney PF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232102; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Han S, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0485-6; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Jiang C, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/123845; Kelesidis T, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019324; Le YQ, 2020, J CELL MOL MED, V24, P1319, DOI 10.1111/jcmm.14789; Lieberman J, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav1447; Lugg ST, 2022, THORAX, V77, P94, DOI 10.1136/thoraxjnl-2020-216296; Ma YM, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.720049; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Markelic I, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-11164-1; Nguyen JMK, 2021, AM J PHYSIOL-LUNG C, V320, pL1, DOI 10.1152/ajplung.00367.2020; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Orning P, 2021, J LEUKOCYTE BIOL, V109, P121, DOI 10.1002/JLB.3MR0420-305R; Pace E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033601; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pinkerton JW, 2017, MOL IMMUNOL, V86, P44, DOI 10.1016/j.molimm.2017.01.014; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Sanders KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36163-z; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Will Y., 2018, MITOCHONDRIAL DYSFUN; Yang H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00484; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	44	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22525	10.1096/fj.202200837R	http://dx.doi.org/10.1096/fj.202200837R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Y9JP	36004615				2022-12-28	WOS:000844039000001
J	Matsukawa, T; Yin, MM; Baslan, T; Chung, YJ; Cao, DC; Bertoli, R; Zhu, YLJ; Walker, RL; Freeland, A; Knudsen, E; Lowe, SW; Meltzer, PS; Aplan, PD				Matsukawa, Toshihiro; Yin, Mianmian; Baslan, Timour; Chung, Yang Jo; Cao, Dengchao; Bertoli, Ryan; Zhu, Yuelin J.; Walker, Robert L.; Freeland, Amy; Knudsen, Erik; Lowe, Scott W.; Meltzer, Paul S.; Aplan, Peter D.			Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context	FASEB JOURNAL			English	Article						B-cell precursor acute lymphoblastic leukemia; bone marrow failure; DNA stress; Mcm2; tumor suppressor gene	ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BETHESDA PROPOSALS; SOMATIC MUTATIONS; BCOR; CLASSIFICATION; IDENTIFICATION; INSTABILITY; DEFICIENCY; NEOPLASMS	Minichromosome maintenance proteins (Mcm2-7) form a hexameric complex that unwinds DNA ahead of a replicative fork. The deficiency of Mcm proteins leads to replicative stress and consequent genomic instability. Mice with a germline insertion of a Cre cassette into the 3 ' UTR of the Mcm2 gene (designated Mcm2(Cre)) have decreased Mcm2 expression and invariably develop precursor T-cell lymphoblastic leukemia/lymphoma (pre-T LBL), due to 100-1000 kb deletions involving important tumor suppressor genes. To determine whether mice that were protected from pre-T LBL would develop non-T-cell malignancies, we used two approaches. Mice engrafted with Mcm2(Cre/Cre) Lin(-)Sca-1(+)Kit(+) hematopoietic stem/progenitor cells did not develop hematologic malignancy; however, these mice died of hematopoietic stem cell failure by 6 months of age. Placing the Mcm2(Cre) allele onto an athymic nu/nu background completely prevented pre-T LBL and extended survival of these mice three-fold (median 296.5 vs. 80.5 days). Ultimately, most Mcm2(Cre/Cre);nu/nu mice developed B-cell precursor acute lymphoblastic leukemia (BCP-ALL). We identified recurrent deletions of 100-1000 kb that involved genes known or suspected to be involved in BCP-ALL, including Pax5, Nf1, Ikzf3, and Bcor. Moreover, whole-exome sequencing identified recurrent mutations of genes known to be involved in BCP-ALL progression, such as Jak1/Jak3, Ptpn11, and Kras. These findings demonstrate that an Mcm2(Cre/Cre) hypomorph can induce hematopoietic dysfunction via hematopoietic stem cell failure as well as a "deletor" phenotype affecting known or suspected tumor suppressor genes.	[Matsukawa, Toshihiro; Yin, Mianmian; Chung, Yang Jo; Cao, Dengchao; Bertoli, Ryan; Zhu, Yuelin J.; Walker, Robert L.; Meltzer, Paul S.; Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, 37 Room 6002,37 Convent Dr, Bethesda, MD 20892 USA; [Baslan, Timour; Lowe, Scott W.] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA; [Freeland, Amy; Knudsen, Erik] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, New York, NY USA; [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Howard Hughes Medical Institute	Aplan, PD (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, 37 Room 6002,37 Convent Dr, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov		Matsukawa, Toshihiro/0000-0003-2371-3778; Cao, Dengchao/0000-0001-9808-991X	HHS | NIH | National Cancer Institute (NCI) [SC0130378, SC010379]; Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation; Uehara Memorial Foundation	HHS | NIH | National Cancer Institute (NCI); Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: SC0130378 and SC010379; Memorial Sloan-Kettering Cancer Center (MSK); Naito Foundation; Uehara Memorial Foundation	Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Bagley BN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003034; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Beauchamp EM, 2021, BLOOD CANCER DISCOV, V2, P500, DOI 10.1158/2643-3230.BCD-20-0224; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Chervinsky DS, 2001, CANCER RES, V61, P6382; Chervinsky DS, 2001, LEUKEMIA, V15, P141, DOI 10.1038/sj.leu.2401997; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Damm F, 2013, BLOOD, V122, P3169, DOI 10.1182/blood-2012-11-469619; EATON GJ, 1976, TRANSPLANTATION, V22, P217, DOI 10.1097/00007890-197609000-00001; Gough SM, 2017, BLOOD ADV, V1, P1749, DOI 10.1182/bloodadvances.2017009837; Gough SM, 2014, CANCER DISCOV, V4, P564, DOI 10.1158/2159-8290.CD-13-0419; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Jallades L, 2017, HAEMATOLOGICA, V102, P1758, DOI 10.3324/haematol.2016.160192; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; KAUSHIK A, 1995, EUR J IMMUNOL, V25, P631, DOI 10.1002/eji.1830250249; Kawabata T, 2011, MAMM GENOME, V22, P506, DOI 10.1007/s00335-011-9333-7; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Matsukawa T, 2020, STEM CELLS, V38, P1366, DOI 10.1002/stem.3263; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Rusiniak ME, 2012, ONCOGENE, V31, P4034, DOI 10.1038/onc.2011.566; SCHEIFF JM, 1978, ANAT EMBRYOL, V153, P115, DOI 10.1007/BF00343368; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Szadvari I, 2016, PHYSIOL RES, V65, pS441, DOI 10.33549/physiolres.933526; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wong TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02858-0; Xiang ZF, 2008, BLOOD, V111, P4809, DOI 10.1182/blood-2007-05-090308; Yin MM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131434; Yin MM, 2019, BLOOD, V133, P2610, DOI 10.1182/blood.2018864173; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	51	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22430	10.1096/fj.202200061RR	http://dx.doi.org/10.1096/fj.202200061RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3M2QF	35920299	Green Accepted			2022-12-28	WOS:000835302700001
J	Yao, XL; El-Samahy, MA; Li, XD; Bao, YJ; Guo, JH; Yang, F; Wang, ZB; Li, K; Zhang, YL; Wang, F				Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng			LncRNA-412.25 activates the LIF/STAT3 signaling pathway in ovarian granulosa cells of Hu sheep by sponging miR-346	FASEB JOURNAL			English	Article						apoptosis; granulosa cells; Hu sheep; lncRNA-412; 25; miR-346	LEUKEMIA INHIBITORY FACTOR; LITTER SIZE; ATRETIC FOLLICLES; STROMAL CELLS; BONE-MARROW; PROLIFERATION; APOPTOSIS; DIFFERENTIATION; EXPRESSION; PROMOTES	Although long non-coding RNAs (lncRNAs) are reported to regulate follicular development and reproductive disease pathogenesis, the underlying mechanisms have not been elucidated. In this study, lncRNA expression profiling of different-sized healthy follicles from Hu sheep with different prolificacy revealed 50 613 lncRNAs. Numerous lncRNAs were differentially expressed among different comparison groups. This study characterized one novel transcript, lncRNA-412.25 (from healthy follicles with a diameter of >5 mm), which was predominantly expressed in the high prolificacy group and localized to the cytoplasm of granulosa cells (GCs). LncRNA-412.25 knockdown promoted and inhibited Hu sheep GC apoptosis and proliferation, respectively. Interestingly, lncRNA-412.25 could directly bind to miR-346, which can target the gene of leukemia inhibitory factor (LIF). Knockdown of lncRNA-412.25 promoted GC apoptosis by downregulating LIF expression, where this effect was attenuated by miR-346. Moreover, the miR-346 inhibitor mitigated the lncRNA-412.25 knockdown-induced downregulation of phosphorylated protein of signal transducer and activator of transcription 3 (STAT3), which was validated using immunofluorescence analysis. Our results demonstrated that lncRNA-412.25 regulates GC proliferation and apoptosis in Hu sheep by binding to miR-346 and then activating the LIF/STAT3 pathway. These findings provide novel insights into the mechanisms underlying prolificacy in sheep.	[Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Hu Sheep Acad, Nanjing 210095, Peoples R China; [Yao, Xiaolei; El-Samahy, Mohamed AbdFatah; Li, Xiaodan; Bao, Yongjin; Guo, Jiahe; Yang, Fan; Wang, Zhibo; Li, Kang; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Peoples R China; [El-Samahy, Mohamed AbdFatah] Minist Agr, ARC, Anim Prod Res Inst, Giza, Egypt	Nanjing Agricultural University; Nanjing Agricultural University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Ministry of Agriculture & Land Reclamation - Egypt	Wang, F (corresponding author), Nanjing Agr Univ, Hu Sheep Acad, Nanjing 210095, Peoples R China.	caeet@njau.edu.cn	Wang, Zhibo/GSD-3371-2022		National Natural Science Foundation of China [31872357, 32002174]; Jiangsu Planned Projects for Postdoctoral Research Funds [2021K254B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Planned Projects for Postdoctoral Research Funds	National Natural Science Foundation of China, Grant/Award Number: 31872357 and 32002174; Jiangsu Planned Projects for Postdoctoral Research Funds, Grant/Award Number: 2021K254B	Bai N, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0838-8; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen XW, 2020, OPEN LIFE SCI, V15, P423, DOI 10.1515/biol-2020-0039; Chen YF, 2021, LIFE SCI, V277, DOI 10.1016/j.lfs.2021.119076; Chen Y, 2019, MOL CELL ENDOCRINOL, V490, P15, DOI 10.1016/j.mce.2019.03.009; Chu MX, 2007, J ANIM SCI, V85, P598, DOI 10.2527/jas.2006-324; Chu MX, 2011, MOL BIOL REP, V38, P4071, DOI 10.1007/s11033-010-0526-z; Du X, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0864-x; Ernst EH, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00078; Feng X, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171350; Gao XX, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194606; Ghosh S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030251; HARESIGN W, 1985, LIVEST PROD SCI, V13, P3, DOI 10.1016/0301-6226(85)90075-2; Huang X, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0392-4; Ilha GF, 2015, REPRODUCTION, V150, P395, DOI 10.1530/REP-15-0026; Kawazoe T, 2020, MOL CANCER RES, V18, P1876, DOI 10.1158/1541-7786.MCR-20-0186; La YF, 2019, PEERJ, V7, DOI 10.7717/peerj.6938; Lan YY, 2020, STEM CELLS, V38, P340, DOI 10.1002/stem.3130; Lass A, 2001, FERTIL STERIL, V76, P1091, DOI 10.1016/S0015-0282(01)02878-3; Li H, 2018, J CELL PHYSIOL, V233, P4643, DOI 10.1002/jcp.26230; Li L, 2021, ARCH MED SCI, V17, P785, DOI 10.5114/aoms.2019.89254; Lin HC, 2009, MOL BIOL REP, V36, P1833, DOI 10.1007/s11033-008-9387-0; Ling YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183163; Liu AJ, 2021, REPROD DOMEST ANIM, V56, P604, DOI 10.1111/rda.13898; Liu GL, 2020, MOL THER-NUCL ACIDS, V20, P205, DOI 10.1016/j.omtn.2020.02.007; Lu CL, 2005, CHINESE SCI BULL, V50, P2665, DOI 10.1360/982005-983; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Matsushita K, 2014, J CELL BIOCHEM, V115, P1262, DOI 10.1002/jcb.24777; Miao XY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01049; Miao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep39398; Miao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep35299; MOOR RM, 1978, J ENDOCRINOL, V77, P309, DOI 10.1677/joe.0.0770309; Murphy MJ, 2016, ENDOCRINOLOGY, V157, P4378, DOI 10.1210/en.2016-1283; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Perks CM, 2003, HUM REPROD, V18, P2672, DOI 10.1093/humrep/deg496; Robker RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101182; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shabbir S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85245-y; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Spotter A, 2005, J ANIM SCI, V83, P2264; Subramani E, 2013, FERTIL STERIL, V100, pS297, DOI 10.1016/j.fertnstert.2013.07.1052; Sun XY, 2003, PROG BIOCHEM BIOPHYS, V30, P180; Taylor DH, 2015, MOL REPROD DEV, V82, P932, DOI 10.1002/mrd.22581; Thompson LH, 2010, CELL CYCLE, V9, P4213, DOI 10.4161/cc.9.20.13543; Wang JC, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109551; Wang TS, 2015, BIOL OPEN, V4, P893, DOI 10.1242/bio.011890; Yang M, 2017, CELL PHYSIOL BIOCHEM, V44, P293, DOI 10.1159/000484885; Yao XL, 2021, MOL THER-NUCL ACIDS, V24, P223, DOI 10.1016/j.omtn.2021.02.030; Yao XL, 2020, REPROD FERT DEVELOP, V32, P335, DOI 10.1071/RD18442; Yao XL, 2018, THERIOGENOLOGY, V114, P70, DOI 10.1016/j.theriogenology.2018.03.014; Yao XL, 2017, THERIOGENOLOGY, V102, P162, DOI 10.1016/j.theriogenology.2017.08.002; Yao XL, 2017, THERIOGENOLOGY, V95, P54, DOI 10.1016/j.theriogenology.2017.02.018; Yu H, 2019, PHARMAZIE, V74, P243, DOI 10.1691/ph.2019.8881; Yuan XL, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060295; Yuan ZH, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110958; Yue GH, 1996, ANIM REPROD SCI, V44, P223, DOI 10.1016/0378-4320(96)01562-X; Zhang L, 2019, J CELL PHYSIOL, V234, P4754, DOI 10.1002/jcp.27272; Zheng J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020157; Zhu HL, 2020, GENOMICS, V112, P3597, DOI 10.1016/j.ygeno.2020.04.011; Zhu WY, 2017, ONCOTARGET, V8, P65218, DOI 10.18632/oncotarget.18060	62	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22467	10.1096/fj.202200632R	http://dx.doi.org/10.1096/fj.202200632R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5KX	35929417				2022-12-28	WOS:000836187400001
J	Gao, XX; Lin, S; Jiang, PY; Ye, MY; Chen, W; Hu, CX; Chen, YH				Gao, Xing-Xing; Lin, Shuai; Jiang, Pei-Ying; Ye, Meng-Ying; Chen, Wei; Hu, Chuan-Xiang; Chen, Yuan-Hua			Gestational cholestasis induced intrauterine growth restriction through triggering IRE1 alpha-mediated apoptosis of placental trophoblast cells	FASEB JOURNAL			English	Article						apoptosis; gestational cholestasis; intrauterine growth restriction (IUGR); IRE1 alpha; placental insufficiency	ENDOPLASMIC-RETICULUM STRESS; INTRAHEPATIC CHOLESTASIS; PREGNANCY; INFLAMMATION; INHIBITION; ACTIVATION	Epidemiological and animal experimental studies suggest an association between gestational cholestasis and intrauterine growth restriction (IUGR). Here, we explored the mechanism through which gestational cholestasis induced IUGR. To establish gestational cholestasis model, pregnant mice were subcutaneously injected with 17 alpha-Ethynylestradiol (E2) on gestational day 13 (GD13)-GD17. Some pregnant mice were intraperitoneally injected with 4 mu 8C on GD13-GD17. The results found that the apoptosis of trophoblast cells was elevated in placentas of mice with gestational cholestasis and in deoxycholic acid (DCA)-treated human trophoblast cell lines and primary mouse trophoblast cells. Correspondingly, the levels of placental cleaved caspase-3 and Bax were increased, while placental Bcl2 level was decreased in mice with gestational cholestasis and in DCA-treated trophoblast cells. Further analysis found that placental IRE1 alpha pathway was activated in mice with gestational cholestasis and in DCA-treated trophoblast cells. Interestingly, 4 mu 8C, an IRE1 alpha RNase inhibitor, significantly inhibited caspase-3 activity and apoptosis of trophoblast cells in vivo and in vitro. Importantly, 4 mu 8C rescued gestational cholestasis-induced placental insufficiency and IUGR. Furthermore, a case-control study demonstrated that placental IRE1 alpha and caspase-3 pathways were activated in cholestasis cases. Our results provide evidence that gestational cholestasis induces placental insufficiency and IUGR may be via triggering IRE1 alpha-mediated apoptosis of placental trophoblast cells.	[Gao, Xing-Xing; Lin, Shuai; Jiang, Pei-Ying; Ye, Meng-Ying; Chen, Wei; Hu, Chuan-Xiang; Chen, Yuan-Hua] Anhui Med Univ, Sch Basic Med Sci, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Chen, Yuan-Hua] Anhui Med Univ, Key Lab Environm Toxicol, Anhui Higher Educ Inst, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, YH (corresponding author), Anhui Med Univ, Sch Basic Med Sci, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	yuanhuach@126.com			National Natural Science Foundation of China [82173559]; Key Research and Development Projects of Anhui Province [202104j07020035]; Key Projects of Anhui Provincial Natural Science Research in Colleges and Universities [KJ2020A0146, KJ2019A0224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Projects of Anhui Province; Key Projects of Anhui Provincial Natural Science Research in Colleges and Universities	The authors thank Prof. De-Xiang Xu for assistance in reviewing the data. This study was supported by the National Natural Science Foundation of China (82173559 to YHC), Key Research and Development Projects of Anhui Province (202104j07020035 to YHC), and the Key Projects of Anhui Provincial Natural Science Research in Colleges and Universities (KJ2020A0146 to SL, KJ2019A0224 to YHC).	Aplin JD, 2020, NAT REV ENDOCRINOL, V16, P479, DOI 10.1038/s41574-020-0372-6; Barapatre N., 2021, PLACENTA, V109, P19; Berends LM, 2018, DIABETOLOGIA, V61, P2225, DOI 10.1007/s00125-018-4694-z; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Chen W, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7419249; Chen YH, 2020, J STEROID BIOCHEM, V203, DOI 10.1016/j.jsbmb.2020.105733; Chen YH, 2016, J IMMUNOL, V197, P4762, DOI 10.4049/jimmunol.1601331; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Dasgupta D, 2020, GASTROENTEROLOGY, V159, P1487, DOI 10.1053/j.gastro.2020.06.031; Freitag N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02791-5; Frissen M, 2021, HEPATOLOGY, V73, P1836, DOI 10.1002/hep.31494; Gao XX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73378-5; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Gijbels E, 2021, LIVER INT, V41, P656, DOI 10.1111/liv.14800; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hoftiezer L, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.12.023; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Hourihan JM, 2016, MOL CELL, V63, P553, DOI 10.1016/j.molcel.2016.07.019; Huo XF, 2011, AM J PHYSIOL-GASTR L, V301, pG278, DOI 10.1152/ajpgi.00092.2011; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jiang WY, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00051; Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008; Kennedy LM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01869-3; Lammert F, 2000, J HEPATOL, V33, P1012, DOI 10.1016/S0168-8278(00)80139-7; Lewkowitz AK, 2019, AM J OBST GYNEC MFM, V1, P64, DOI 10.1016/j.ajogmf.2019.02.005; Li L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66138-y; Liu HJ, 2021, J MATERN-FETAL NEO M, V34, P1356, DOI 10.1080/14767058.2019.1636371; Liu XY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2746521; Manna LB, 2019, BJOG-INT J OBSTET GY, V126, P1633, DOI 10.1111/1471-0528.15926; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; Mottino AD, 2002, HEPATOLOGY, V35, P1409, DOI 10.1053/jhep.2002.33327; Ovadia C, 2019, LANCET, V393, P899, DOI 10.1016/S0140-6736(18)31877-4; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Paules C, 2019, ULTRASOUND OBST GYN, V53, P615, DOI 10.1002/uog.20103; Pavlovic N, 2020, ELIFE, V9, DOI 10.7554/eLife.55865; Pennington KA, 2012, JOVE-J VIS EXP, DOI 10.3791/3202; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Raguema N, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00098; REYES H, 1993, SEMIN LIVER DIS, V13, P289, DOI 10.1055/s-2007-1007357; Schwartz N, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.033; Selvaratnam RJ, 2021, JAMA-J AM MED ASSOC, V326, P145, DOI 10.1001/jama.2021.8608; Shemer EAW, 2015, J HEPATOL, V63, P456, DOI 10.1016/j.jhep.2015.03.010; Smith DD, 2020, CLIN OBSTET GYNECOL, V63, P134, DOI 10.1097/GRF.0000000000000495; Song XL, 2014, HEPATOLOGY, V60, P1993, DOI 10.1002/hep.27171; Sreekantha S, 2020, FASEB J, V34, P16073, DOI 10.1096/fj.202000985RR; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Vasavan T, 2021, J HEPATOL, V74, P1087, DOI 10.1016/j.jhep.2020.11.038; Wu J, 2016, CELL PHYSIOL BIOCHEM, V38, P847, DOI 10.1159/000443039; Yao F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25744-7; You L, 2021, ARCH TOXICOL, V95, P1899, DOI 10.1007/s00204-021-03030-2; Yule CS, 2021, AM J PERINAT, V38, P414, DOI 10.1055/s-0040-1717076; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083281; Zhang YY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9186	58	0	0	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22388	10.1096/fj.202101844RR	http://dx.doi.org/10.1096/fj.202101844RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1GY	35639049				2022-12-28	WOS:000803127400001
J	Miller, JD; Ackerman, MS; Laspra, B; Polino, C; Huffaker, JS				Miller, Jon D.; Ackerman, Mark S.; Laspra, Belen; Polino, Carmelo; Huffaker, Jordan S.			Public attitude toward Covid-19 vaccination: The influence of education, partisanship, biological literacy, and coronavirus understanding	FASEB JOURNAL			English	Article							CONSEQUENCES; IDEOLOGY	The Covid-19 pandemic posed new issues about vaccination and contagious diseases that had not been the focus of public policy debate in the United States since the tuberculosis pandemic of the late 19th century and the early 20th century. Using a national address-based probability sample of American adults in 2020 and a structural equation model, this analysis seeks to understand the role of education, age, gender, race, education, partisanship, religious fundamentalism, biological literacy, and understanding of the coronavirus to predict individual intention concerning taking the Covid-19 vaccine. Given the substantial changes in the United States since the tuberculosis pandemic, it is important to understand the factors that drive acceptance and hesitancy about Covid-19 vaccination. We find that education, biological literacy, and understanding of the coronavirus were strong positive predictors of willingness to be vaccinated and religious fundamentalism and conservative partisanship were strong negative predictors of intent to vaccinate. These results should be encouraging to the scientific community.	[Miller, Jon D.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48106 USA; [Ackerman, Mark S.] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; [Ackerman, Mark S.; Huffaker, Jordan S.] Univ Michigan, Coll Engn, Ann Arbor, MI 48109 USA; [Laspra, Belen; Polino, Carmelo] Univ Oviedo, Dept Philosophy, Asturias, Spain; [Polino, Carmelo] Ctr Redes, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oviedo	Miller, JD (corresponding author), Univ Michigan, Inst Social Res, Ann Arbor, MI 48106 USA.	jondmiller@umich.edu	Polino, Carmelo/GYE-1760-2022	Polino, Carmelo/0000-0003-1789-8024; Miller, Jon D./0000-0001-8714-0126	University of Michigan [NNX16AC66A]; National Aeronautics and Space Administration (NASA) [NNX16AC66A]	University of Michigan(University of Michigan System); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	The 2020 Scientific Literacy Study was supported by a cooperative agreement (NNX16AC66A) between the University of Michigan and the National Aeronautics and Space Administration (NASA) to study the development and distribution of civic scientific literacy in the United States and the factors that contribute to adult scientific understanding. All findings and conclusions are the responsibility of the authors and do not necessarily reflect the views of NASA or its staff	Abramowitz A, 2018, GREAT ALIGNMENT, DOI DOI 10.2307/J.CTVHRCZH3; Burns J.M., 1963, DEADLOCK DEMOCRACY 4; Campbell Angus., 1960, AM VOTER; Conis E, 2017, ENVIRON HIST-US, V22, P696, DOI 10.1093/envhis/emx086; Converse PE, 2006, CRIT REV, V18, P1, DOI 10.1080/08913810608443650; COSTNER HL, 1965, AM SOCIOL REV, V30, P341, DOI 10.2307/2090715; Dube E, 2021, ANNU REV PUBL HEALTH, V42, P175, DOI 10.1146/annurev-publhealth-090419-102240; Hayduk L. A., 1987, STRUCTURAL EQUATION; Hochschild J.L., 2015, DO FACTS MATTER INFO; Hofstadter Richard, 1962, ANTIINTELLECTUALISM; Iyengar S, 2019, ANNU REV POLIT SCI, V22, P129, DOI 10.1146/annurev-polisci-051117-073034; Iyengar S, 2015, AM J POLIT SCI, V59, P690, DOI 10.1111/ajps.12152; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Joreskog, 1993, NEW FEATURE LISREL 8; Kricorian K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256122; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Mason L, 2018, PUBLIC OPIN QUART, V82, P280, DOI 10.1093/poq/nfy005; Mason L, 2016, PUBLIC OPIN QUART, V80, P351, DOI 10.1093/poq/nfw001; Mason Lilliana, 2018, UNCIVIL AGREEMENT PO, DOI DOI 10.7208/CHICAGO/9780226524689.001.0001; Merkley E, 2021, NAT HUM BEHAV, V5, P706, DOI 10.1038/s41562-021-01112-w; Millennials, 2021, PEW RES CTR; Miller J.D., 2001, BIOMEDICAL COMMUNICA; Miller J.D., 1983, AM PEOPLE SCI POLICY; Miller J.D., 1987, COMMUNICATING SCI PU, P14; Miller J.D., 2010, SCI ED AM CORE COMPO, P241; Miller J.D., 2010, BUILDING EVIDENCE BA, P225; MILLER JD, 1983, DAEDALUS, V112, P29; Miller JD, 1998, PUBLIC UNDERST SCI, V7, P203, DOI 10.1088/0963-6625/7/3/001; Miller JD, 2020, INFORM SOC, V37, P82, DOI 10.1080/01972243.2020.1870022; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Nikolovski J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251963; Pew Research Center, 2019, TRUST DISTR AM; Piltch-Loeb R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251095; Price D, 2021, SOC SCI-BASEL, V10, DOI 10.3390/socsci10110442; Uribe FAR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256731; Schulmeister PM., 2020, PUBLIC OPINION MONIT; Stecula DA, 2020, HARV KENNEDY SCH HKS, DOI [10.37016/mr-2020-007, DOI 10.37016/MR-2020-007]; Whitehead AL., 2020, TAKING AM BACK GOD C; Wilcox Clyde, 2006, ONWARD CHRISTIAN SOL	39	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22382	10.1096/fj.202200730	http://dx.doi.org/10.1096/fj.202200730			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1U6US	35657606	Green Published			2022-12-28	WOS:000805545800001
J	Short, WD; Steen, E; Kaul, A; Wang, XY; Olutoye, OO; Vangapandu, HV; Templeman, N; Blum, AJ; Moles, CM; Narmoneva, DA; Crombleholme, TM; Butte, MJ; Bollyky, PL; Keswani, SG; Balaji, S				Short, Walker D.; Steen, Emily; Kaul, Aditya; Wang, Xinyi; Olutoye, Oluyinka O., II; Vangapandu, Hima V.; Templeman, Natalie; Blum, Alexander J.; Moles, Chad M.; Narmoneva, Daria A.; Crombleholme, Timothy M.; Butte, Manish J.; Bollyky, Paul L.; Keswani, Sundeep G.; Balaji, Swathi			IL-10 promotes endothelial progenitor cell infiltration and wound healing via STAT3	FASEB JOURNAL			English	Article						angiogenesis; diabetes; endothelial progenitor cells; IL-10; VEGF; wound healing	POSTNATAL NEOVASCULARIZATION; ADULT VASCULOGENESIS; VESSEL FORMATION; GENE-EXPRESSION; SERUM-LEVELS; VEGF; INTERLEUKIN-10; MOBILIZATION; PROLIFERATION; ANGIOGENESIS	Endothelial progenitor cells (EPCs) contribute to de novo angiogenesis, tissue regeneration, and remodeling. Interleukin 10 (IL-10), an anti-inflammatory cytokine that primarily signals via STAT3, has been shown to drive EPC recruitment to injured tissues. Our previous work demonstrated that overexpression of IL-10 in dermal wounds promotes regenerative tissue repair via STAT3-dependent regulation of fibroblast-specific hyaluronan synthesis. However, IL-10's role and specific mode of action on EPC recruitment, particularly in dermal wound healing and neovascularization in both normal and diabetic wounds, remain to be defined. Therefore, inducible skin-specific STAT3 knockdown mice were studied to determine IL-10's impact on EPCs, dermal wound neovascularization and healing, and whether it is STAT3-dependent. We show that IL-10 overexpression significantly elevated EPC counts in the granulating wound bed, which was associated with robust capillary lumen density and enhanced re-epithelialization of both control and diabetic (db/db) wounds at day 7. We noted increased VEGF and high C-X-C motif chemokine 12 (CXCL12) levels in wounds and a favorable CXCL12 gradient at day 3 that may support EPC mobilization and infiltration from bone marrow to wounds, an effect that was abrogated in STAT3 knockdown wounds. These findings were supported in vitro. IL-10 promoted VEGF and CXCL12 synthesis in primary murine dermal fibroblasts, with blunted VEGF expression upon blocking CXCL12 in the media by antibody binding. IL-10-conditioned fibroblast media also significantly promoted endothelial sprouting and network formation. In conclusion, these studies demonstrate that overexpression of IL-10 in dermal wounds recruits EPCs and leads to increased vascular structures and faster re-epithelialization.	[Short, Walker D.; Steen, Emily; Kaul, Aditya; Wang, Xinyi; Olutoye, Oluyinka O., II; Vangapandu, Hima V.; Templeman, Natalie; Blum, Alexander J.; Moles, Chad M.; Keswani, Sundeep G.; Balaji, Swathi] Texas Childrens Hosp, Dept Surg, Div Pediat Surg, C-450-05 1102 Bates Ave, Houston, TX 77030 USA; [Short, Walker D.; Steen, Emily; Kaul, Aditya; Wang, Xinyi; Olutoye, Oluyinka O., II; Vangapandu, Hima V.; Templeman, Natalie; Blum, Alexander J.; Moles, Chad M.; Keswani, Sundeep G.; Balaji, Swathi] Baylor Coll Med, Houston, TX 77030 USA; [Narmoneva, Daria A.] Univ Cincinnati, Coll Engn & Appl Sci, Dept Biomed Chem & Environm Engn, Biomed Engn, Cincinnati, OH USA; [Crombleholme, Timothy M.] Univ Connecticut, Sch Med, Connecticut Childrens Hosp, Div Pediat Gen Thorac & Fetal Surg, Farmington, CT USA; [Crombleholme, Timothy M.] Fetal Care Ctr Dallas, Dallas, TX USA; [Butte, Manish J.] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90024 USA; [Butte, Manish J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90024 USA; [Bollyky, Paul L.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis, Stanford, CA 94305 USA	Baylor College of Medicine; Baylor College of Medicine; University System of Ohio; University of Cincinnati; University of Connecticut; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University	Balaji, S (corresponding author), Texas Childrens Hosp, Dept Surg, Div Pediat Surg, C-450-05 1102 Bates Ave, Houston, TX 77030 USA.; Balaji, S (corresponding author), Baylor Coll Med, Feigin Ctr, C-450-05 1102 Bates Ave, Houston, TX 77030 USA.	balaji@bcm.edu			NIGMS [1R01GM111808NIH]; Wound Healing Society Foundation; Gulf Coast Consortia; John S. Dunn Foundation Collaborative Research Award	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wound Healing Society Foundation; Gulf Coast Consortia; John S. Dunn Foundation Collaborative Research Award	NIGMS, Grant/Award Number: 1R01GM111808NIH; Wound Healing Society Foundation, Grant/Award Number: 3M Award; Gulf Coast Consortia, Grant/Award Number: John S. Dunn Foundation Collaborative Research Award	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balaji S, 2017, FASEB J, V31, P868, DOI 10.1096/fj.201600856R; Balaji S, 2013, ADV WOUND CARE, V2, P283, DOI 10.1089/wound.2012.0398; Balaji S, 2012, WOUND REPAIR REGEN, V20, P15, DOI 10.1111/j.1524-475X.2011.00750.x; Bauer SM, 2005, J VASC SURG, V41, P699, DOI 10.1016/j.jvs.2005.01.015; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; Carmeliet P, 2000, NATURE, V408, P43, DOI 10.1038/35040684; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Cho H, 2016, WOUND REPAIR REGEN, V24, P829, DOI 10.1111/wrr.12453; Cho H, 2012, ACTA BIOMATER, V8, P154, DOI 10.1016/j.actbio.2011.08.029; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Desouza CV, 2011, DIABETES, V60, P1286, DOI 10.2337/db10-0875; Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018; Eming SA, 2007, AM J PATHOL, V170, P188, DOI 10.2353/ajpath.2007.060370; Emontzpohl C, 2015, INT J CARDIOL, V181, P284, DOI 10.1016/j.ijcard.2014.11.226; Evrard SM, 2012, J THROMB HAEMOST, V10, P670, DOI 10.1111/j.1538-7836.2012.04644.x; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Frykberg RG, 2015, ADV WOUND CARE, V4, P560, DOI 10.1089/wound.2015.0635; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Georgescu A, 2011, EUR J PHARMACOL, V669, P1, DOI 10.1016/j.ejphar.2011.07.035; Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x; Grieb G, 2012, SURGERY, V151, P268, DOI 10.1016/j.surg.2010.10.008; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heeschen C, 2003, CIRCULATION, V107, P524, DOI 10.1161/01.CIR.0000048183.37648.1A; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Keswani SG, 2004, WOUND REPAIR REGEN, V12, P497, DOI 10.1111/j.1067-1927.2004.12501.x; Kieran I, 2013, WOUND REPAIR REGEN, V21, P428, DOI 10.1111/wrr.12043; Kim KA, 2012, ARCH PHARM RES, V35, P223, DOI 10.1007/s12272-012-0203-y; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Matias MAT, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-39; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Moroguchi A, 2004, EUR SURG RES, V36, P39, DOI 10.1159/000075073; Morris LM, 2010, WOUND REPAIR REGEN, V18, P383, DOI 10.1111/j.1524-475X.2010.00596.x; Muraoka N, 2005, BIRTH DEFECTS RES A, V73, P956, DOI 10.1002/bdra.20191; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Patel J, 2017, CIRCULATION, V135, P786, DOI 10.1161/CIRCULATIONAHA.116.024754; Pawlus MR, 2014, ONCOGENE, V33, P1670, DOI 10.1038/onc.2013.115; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILLIPS TJ, 1994, J INVEST DERMATOL, V102, pS38, DOI 10.1111/1523-1747.ep12388556; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Ribatti D, 2001, MECH DEVELOP, V100, P157, DOI 10.1016/S0925-4773(00)00522-0; Rosti V, 2007, HAEMATOLOGICA, V92, P1291, DOI 10.3324/haematol.11455; Sengupta N, 2010, INVEST OPHTH VIS SCI, V51, P2697, DOI 10.1167/iovs.09-4137; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang Y, 2016, GRAEF ARCH CLIN EXP, V254, P1957, DOI 10.1007/s00417-016-3427-6; Yamamoto T, 2001, BIOCHEM BIOPH RES CO, V281, P200, DOI 10.1006/bbrc.2001.4321; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Zhou XC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0911-3	77	1	1	9	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22298	10.1096/fj.201901024RR	http://dx.doi.org/10.1096/fj.201901024RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1W9IB	35670763				2022-12-28	WOS:000807079400001
J	Nishinaka, A; Tanaka, M; Aoshima, K; Kuriyama, A; Sasaki, T; Otsu, W; Yasuda, H; Nakamura, S; Shimazawa, M; Hara, H				Nishinaka, Anri; Tanaka, Miruto; Aoshima, Kota; Kuriyama, Aika; Sasaki, Takahiro; Otsu, Wataru; Yasuda, Hiroto; Nakamura, Shinsuke; Shimazawa, Masamitsu; Hara, Hideaki			The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma	FASEB JOURNAL			English	Article						cornea; intraocular pressure; neovascular glaucoma; retina; vascular endothelial growth factor	CORNEAL ENDOTHELIUM; MECHANISMS; THICKNESS; DISEASES; FIBROSIS; CELLS; MMP-9	Neovascular glaucoma (NVG) is caused by the formation of new blood vessels in the angle, iris, and cornea in retinal ischemic disease, such as proliferative diabetic retinopathy (PDR) and retinal vein occlusion (RVO), which can reduce the visual acuity. However, the pathophysiological symptoms of NVG are still not well understood because there is no model for the formation of NVG in the angle, iris, and cornea. The aim of this study was to investigate the involvement of NVG during ischemic disease, in a murine model of retinal ischemia. We evaluated the changes of the intraocular pressure (IOP) and pathological symptoms in the anterior eye segment and retina in this model, and the changes in the RNA or protein expression of vascular endothelial growth factor (VEGF) and fibrosis-related factors were analyzed in the retina and cornea by quantitative real-time polymerase chain reaction or western blot, respectively. Furthermore, we examined the changes in IOP after intravitreal injection of an anti-VEGF antibody. First, NVG formed in the retinal ischemic murine model, and the IOP was elevated in mice with NVG formation. Interestingly, VEGF expression was decreased in the retina but increased in the cornea in the murine model of NVG. On the other hand, fibrosis-related factors were increased in the retina and also significantly increased in the cornea in NVG. Moreover, the administration of anti-VEGF antibody immediately after vessel occlusion suppressed the increase in IOP, but administration at 7 days after vessel occlusion accelerated the increase in IOP. These findings suggest that the formation of NVG may be correlated with the pathological symptoms of retinal ischemic disease, via changes in VEGF and fibrosis-related factor expression.	[Nishinaka, Anri; Tanaka, Miruto; Aoshima, Kota; Kuriyama, Aika; Sasaki, Takahiro; Yasuda, Hiroto; Nakamura, Shinsuke; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan; [Otsu, Wataru; Shimazawa, Masamitsu] Gifu Pharmaceut Univ, Dept Biomed Res Lab, Gifu, Japan	Gifu Pharmaceutical University; Gifu Pharmaceutical University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	hidehara@gifu-pu.ac.jp		Otsu, Wataru/0000-0002-5930-1954				Abdelfattah NS, 2015, INT J OPHTHALMOL-CHI, V8, P182, DOI 10.3980/j.issn.2222-3959.2015.01.32; Ajvazi Halil, 2015, Rom J Ophthalmol, V59, P154; Al-Bahlal A, 2017, INDIAN J OPHTHALMOL, V65, P969, DOI 10.4103/ijo.IJO_33_17; Barac I Ramona, 2015, Rom J Ophthalmol, V59, P24; Behzadian MA, 2001, INVEST OPHTH VIS SCI, V42, P853; BUSTED N, 1981, BRIT J OPHTHALMOL, V65, P687, DOI 10.1136/bjo.65.10.687; Cai D, 2014, AM J PATHOL, V184, P2662, DOI 10.1016/j.ajpath.2014.06.016; CASHWELL LF, 1988, SOUTHERN MED J, V81, P1364, DOI 10.1097/00007611-198811000-00008; Cunha-Vaz J, 2017, DEV OPHTHALMOL, V58, P11, DOI 10.1159/000455265; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Fujimoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161332; Fuma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43509; Havens SJ, 2016, DEV OPHTHALMOL, V55, P196, DOI 10.1159/000431196; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Kim M, 2015, SURV OPHTHALMOL, V60, P524, DOI 10.1016/j.survophthal.2015.04.003; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023322; Nebbioso M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/580373; Nishinaka A, 2021, FASEB J, V35, DOI 10.1096/fj.202001740RR; Nishinaka A, 2018, INVEST OPHTH VIS SCI, V59, P4701, DOI 10.1167/iovs.18-23994; Pease ME, 2011, INVEST OPHTH VIS SCI, V52, P858, DOI 10.1167/iovs.10-5556; Rodrigues Gustavo B, 2016, Int J Retina Vitreous, V2, P26; Rong AJ, 2019, AM J OPHTHALMOL, V204, P62, DOI 10.1016/j.ajo.2019.02.038; Rosenberg ME, 2000, INVEST OPHTH VIS SCI, V41, P2915; Simha A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007920.pub3; Torricelli AAM, 2016, EXP EYE RES, V142, P110, DOI 10.1016/j.exer.2014.09.012; Tsui I, 2011, RETINA-J RET VIT DIS, V31, P105, DOI 10.1097/IAE.0b013e3181e36c6d; Tuuminen R, 2014, EYE, V28, P1095, DOI 10.1038/eye.2014.137; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	32	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22323	10.1096/fj.202101917R	http://dx.doi.org/10.1096/fj.202101917R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0W6GN	35485981				2022-12-28	WOS:000789122700001
J	Moran, AL; Carter, SP; Kaylor, JJ; Jiang, ZC; Broekman, S; Dillon, ET; Sanchez, AG; Minhas, SK; van Wijk, E; Radu, RA; Travis, GH; Carey, M; Blacque, OE; Kennedy, BN				Moran, Ailis L.; Carter, Stephen P.; Kaylor, Joanna J.; Jiang, Zhichun; Broekman, Sanne; Dillon, Eugene T.; Sanchez, Alicia Gomez; Minhas, Sajal K.; van Wijk, Erwin; Radu, Roxana A.; Travis, Gabriel H.; Carey, Michelle; Blacque, Oliver E.; Kennedy, Breandan N.			Dawn and dusk peaks of outer segment phagocytosis, and visual cycle function require Rab28	FASEB JOURNAL			English	Article						bisretinoids; cilia; ciliopathy; cone-rod dystrophy; outer segment; phagocytosis; Rab28; retinoids; visual cycle; zebrafish	COMPUTATIONAL PLATFORM; CONE PHOTORECEPTOR; ROD; GENE; RPE; MUTATIONS; CYTOSCAPE; IDENTIFICATION; FLUOROPHORE; PHAGOSOMES	RAB28 is a farnesylated, ciliary G-protein. Patient variants in RAB28 are causative of autosomal recessive cone-rod dystrophy (CRD), an inherited human blindness. In rodent and zebrafish models, the absence of Rab28 results in diminished dawn, photoreceptor, outer segment phagocytosis (OSP). Here, we demonstrate that Rab28 is also required for dusk peaks of OSP, but not for basal OSP levels. This study further elucidated the molecular mechanisms by which Rab28 controls OSP and inherited blindness. Proteomic profiling identified factors whose expression in the eye or whose expression at dawn and dusk peaks of OSP is dysregulated by loss of Rab28. Notably, transgenic overexpression of Rab28, solely in zebrafish cones, rescues the OSP defect in rab28 KO fish, suggesting rab28 gene replacement in cone photoreceptors is sufficient to regulate Rab28-OSP. Rab28 loss also perturbs function of the visual cycle as retinoid levels of 11-cRAL, 11cRP, and atRP are significantly reduced in larval and adult rab28 KO retinae (p < .05). These data give further understanding on the molecular mechanisms of RAB28-associated CRD, highlighting roles of Rab28 in both peaks of OSP, in vitamin A metabolism and in retinoid recycling.	[Moran, Ailis L.; Carter, Stephen P.; Blacque, Oliver E.; Kennedy, Breandan N.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Moran, Ailis L.; Carter, Stephen P.; Dillon, Eugene T.; Sanchez, Alicia Gomez; Blacque, Oliver E.; Kennedy, Breandan N.] Univ Coll Dublin, UCD Conway Inst, Dublin, Ireland; [Kaylor, Joanna J.; Jiang, Zhichun; Radu, Roxana A.; Travis, Gabriel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Broekman, Sanne; van Wijk, Erwin] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Nijmegen, Netherlands; [Broekman, Sanne; van Wijk, Erwin] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Sanchez, Alicia Gomez] Univ Complutense Madrid, Fac Opt & Optometry, Ocupharm Diagnost Grp Res, Madrid, Spain; [Minhas, Sajal K.; Carey, Michelle] Univ Coll Dublin, UCD Sch Math & Stat, Dublin, Ireland; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	University College Dublin; University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Radboud University Nijmegen; Radboud University Nijmegen; Complutense University of Madrid; University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kennedy, BN (corresponding author), Univ Coll Dublin, F062 UCD Conway Inst, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Van Wijk, Erwin/0000-0002-5702-3460; Moran, Ailis/0000-0002-8706-9777; Kennedy, Breandan/0000-0001-7991-4689; Radu, Roxana/0000-0002-5064-6403; Carter, Stephen/0000-0002-0562-8783	Irish Research Council [EPS2019/526]; Science Foundation Ireland [18/CRT/6049, 20/FFP-P/8538]; European Union [734907, 101007931]; Research to Prevent Blindness, Inc. (RPB, New York)	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission); Research to Prevent Blindness, Inc. (RPB, New York)(Research to Prevent Blindness (RPB))	This project received funding from: the Irish Research Council grant EPS2019/526. This publication has emanated from research supported in part by grants from Science Foundation Ireland under grant numbers 18/CRT/6049 and 20/FFP-P/8538. The European Union's Horizon 2020 Research and Innovation Programme under grant agreement numbers 734907 (3DNEONET) and 101007931 (CRYSTAL<SUP>3</SUP>). A UCLA Stein Eye Institute, unrestricted grant from Research to Prevent Blindness, Inc. (RPB, New York).	Akella JS, 2020, ELIFE, V9, DOI 10.7554/eLife.50580; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Angueyra JM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00110; BASINGER S, 1976, SCIENCE, V194, P1074, DOI 10.1126/science.1086510; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bujakowska KM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028274; Carter SP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00136; Carter SP, 2019, CURR OPIN CELL BIOL, V59, P133, DOI 10.1016/j.ceb.2019.04.007; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Scortecci JF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26161-7; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gomez Sanchez A., 2021, OPEN RES EUROPE, V1, P92; Guadagno NA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080909; Hu KP, 2019, BIOMED CIRC SYST C; Iarossi G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010381; Inana G, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1434-6; Jensen VL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006469; Jespersgaard C, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.29; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khan M, 2020, KLIN MONATSBL AUGENH, V237, P267, DOI 10.1055/a-1057-9939; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1978, INVEST OPHTH VIS SCI, V17, P1189; Lee GI, 2017, OPHTHALMIC GENET, V38, P587, DOI 10.1080/13816810.2017.1301965; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Lewis TR, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0177-9; Li LJ, 2015, CYTOSKELETON, V72, P447, DOI 10.1002/cm.21255; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lorach H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29631-z; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Milicevic N, 2021, FASEB J, V35, DOI 10.1096/fj.202100293RR; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2014, ADV EXP MED BIOL, V801, P77, DOI 10.1007/978-1-4614-3209-8_10; Quint WH, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02185-z; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Riveiro-Alvarez R, 2015, JAMA OPHTHALMOL, V133, P133, DOI 10.1001/jamaophthalmol.2014.4266; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Salinas RY, 2017, J CELL BIOL, V216, P1489, DOI 10.1083/jcb.201608081; Shadrach KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067983; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P27043, DOI 10.1073/pnas.1913518117; Hoang T, 2020, SCIENCE, V370, P934, DOI 10.1126/science.abb8598; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Villanueva-Mendoza C, 2021, GENES-BASEL, V12, DOI 10.3390/genes12111824; Ward R, 2020, J BIOL CHEM, V295, P6482, DOI 10.1074/jbc.RA119.011374; Ying GX, 2018, J BIOL CHEM, V293, P17546, DOI 10.1074/jbc.RA118.005484; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1970, INVEST OPHTH VISUAL, V9, P524; Yu C, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232439; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	65	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22309	10.1096/fj.202101897R	http://dx.doi.org/10.1096/fj.202101897R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KU	35471581	Green Published			2022-12-28	WOS:000787349300001
J	Qian, LL; Ji, JJ; Jiang, Y; Guo, JQ; Wu, Y; Yang, ZW; Ma, GS; Yao, YY				Qian, Ling Lin; Ji, Jing Jing; Jiang, Yu; Guo, Jia Qi; Wu, Ya; Yang, Ziwei; Ma, Gen Shan; Yao, Yu Yu			Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through beta-catenin/Foxo1/TLR4 signaling	FASEB JOURNAL			English	Article							CELL-DEATH; INFLAMMATION; SUPPRESSES; ACTIVATION; INHIBITOR; APOPTOSIS; PATHWAY	Non-alcoholic fatty liver disease (NAFLD) is a public health challenge and an increasing cause of chronic liver disease worldwide. However, the underlying molecular mechanism remains unclear. The aim of this study was to determine the precise role of serpina3c in the process of NAFLD. Male Apoe(-/-)/serpina3c(-/-) double knockout (DKO) and Apoe(-/-) mice were fed a high-fat diet (HFD) for 12 weeks. Several markers of steatosis and inflammation were evaluated. In vitro cell models induced by palmitic acid (PA) treatment were used to evaluate the beneficial effect of serpina3c on necroptosis and the underlying molecular mechanism. Compared with Apoe(-/-) mice, DKO mice exhibited a significantly exacerbated hepatic steatosis, increased hepatic triglyceride content and expression of genes involved in lipid metabolism (SREBP1c and SCD1), promoted hepatic inflammation and fibrosis, promoted necroptosis by increasing expression of receptor-interacting protein 3 (RIP3), phosphorylated mixed lineage kinase domain-like (MLKL) and high mobility group box 1 (HMGB1). Notably, serpina3c deficiency increased beta-catenin, Foxo1, and Toll-like receptor 4 (TLR4) protein expression. In vitro , serpina3c knockdown promoted necroptosis and lipid droplet formation under condition of lipotoxicity. However, these phenomena were reversed by the overexpression of serpina3c. Mechanistically, downregulation of serpina3c expression promoted Foxo1 and beta-catenin colocalized in the nucleus under condition of lipotoxicity, consequently upregulating the expression of TLR4. Conversely, disruption of Foxo1-beta/catenin by Foxo1 and beta-catenin inhibitors decreased TLR4 expression and ameliorated hepatic necroptosis in vitro. This study highlights a novel mechanism that serpina3c modulates NAFLD development by inhibiting necroptosis via beta-catenin/Foxo1/TLR4.	[Qian, Ling Lin; Ji, Jing Jing; Jiang, Yu; Guo, Jia Qi; Wu, Ya; Yang, Ziwei; Ma, Gen Shan; Yao, Yu Yu] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China	Yao, YY (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China.	yaoyuyunj@hotmail.com	Guo, Jiaqi/GSO-0702-2022		National Natural Science Foundation of China (NSFC) [81770452]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	We would like to thank Bing Li for reviewing the draft. This work was supported by the National Natural Science Foundation of China (NSFC) 81770452.	Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Choi Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100961; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Farrell G, 2019, HEPATOLOGY, V69, P2241, DOI 10.1002/hep.30333; Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020; Harrison Stephen A, 2020, J Hepatol, V72, P816, DOI 10.1016/j.jhep.2019.11.024; He YC, 2020, CARDIOVASC DIAGN THE, V10, P107, DOI 10.21037/cdt.2019.12.08; Ji JJ, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109745; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2; Lee T, 2019, MOL CELL ENDOCRINOL, V486, P96, DOI 10.1016/j.mce.2019.03.001; Li B, 2019, HUM GENE THER, V30, P339, DOI 10.1089/hum.2018.084; Li CY, 2021, CELL DEATH DIFFER, V28, P1705, DOI 10.1038/s41418-020-00695-7; Lindenmeyer CC, 2018, CLIN LIVER DIS, V22, P11, DOI 10.1016/j.cld.2017.08.003; Majdi A, 2020, J HEPATOL, V72, P627, DOI 10.1016/j.jhep.2019.11.008; Mendez-Sanchez N, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.184; Ming M, 2012, J BIOL CHEM, V287, P22683, DOI 10.1074/jbc.M112.342089; Mularczyk M, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111560; Noureddin Mazen, 2018, Curr Hepatol Rep, V17, P350, DOI 10.1007/s11901-018-0425-7; Qian Ling-Lin, 2021, Clin Sci (Lond), V135, P447, DOI 10.1042/CS20201235; Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931; Shojaie L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249682; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wilson RB, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105208; Wree A, 2019, SEMIN LIVER DIS, V39, P275, DOI 10.1055/s-0039-1685515; Wu XQ, 2020, J HEPATOL, V73, P617, DOI 10.1016/j.jhep.2020.03.023; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zang SF, 2016, CLIN EXP PHARMACOL P, V43, P13, DOI 10.1111/1440-1681.12499; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang YZ, 2018, ATHEROSCLEROSIS, V274, P128, DOI 10.1016/j.atherosclerosis.2018.04.031; Zheng XL, 2017, INVEST OPHTH VIS SCI, V58, P2874, DOI 10.1167/iovs.17-21544; Zhou T, 2014, INVEST OPHTH VIS SCI, V55, P4863, DOI 10.1167/iovs.14-14023	40	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22316	10.1096/fj.202101345RRR	http://dx.doi.org/10.1096/fj.202101345RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3EU	35429042				2022-12-28	WOS:000782726000001
J	Van den Bergh, G; Van den Branden, A; Opdebeeck, B; Fransen, P; Neven, E; De Meyer, G; D'Haese, PC; Verhulst, A				Van den Bergh, Geoffrey; Van den Branden, Astrid; Opdebeeck, Britt; Fransen, Paul; Neven, Ellen; De Meyer, Guido; D'Haese, Patrick C.; Verhulst, Anja			Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats	FASEB JOURNAL			English	Article						endothelium; medial calcific sclerosis; nitric oxide; vascular calcification; vascular stiffness	NITRIC-OXIDE SYNTHASE; VASCULAR CALCIFICATION; BASAL; SEGMENTS; AORTA; MICE; NO	Arterial media calcification is an active cell process. This encompasses osteochondrogenic transdifferentiation of vascular smooth muscle cells followed by the deposition of calcium-phosphate crystals. Increasing evidence suggests a significant role for endothelial cells (ECs) in the development of arterial media calcification. This manuscript explores a role for endothelial dysfunction in the disease progression of arterial media calcification. Male rats were randomly assigned to four different groups. The first group received standard chow. The second group was given L-NAME (approximate to 50 mg kg(-1) center dot d(-1)), to induce endothelial dysfunction, in addition to standard chow. The third group and fourth group received a warfarin-supplemented diet to induce mild calcification and the latter group was co-administered L-NAME. Prior to sacrifice, non-invasive measurement of aortic distensibility was performed. Animals were sacrificed after 6 weeks. Arterial media calcification was quantified by measuring aortic calcium and visualized on paraffin-embedded slices by the Von Kossa method. Arterial stiffness and aortic reactivity was assessed on isolated carotid segments using specialized organ chamber setups. Warfarin administration induced mineralization. Simultaneous administration of warfarin and L-NAME aggravated the arterial media calcification process. Through organ chamber experiments an increased vessel tonus was found, which could be linked to reduced basal NO availability, in arteries of warfarin-treated animals. Furthermore, increased calcification because of L-NAME administration was related to a further compromised endothelial function (next to deteriorated basal NO release also deteriorated stimulated NO release). Our findings suggest early EC changes to impact the disease progression of arterial media calcification.	[Van den Bergh, Geoffrey; Van den Branden, Astrid; Opdebeeck, Britt; Neven, Ellen; D'Haese, Patrick C.; Verhulst, Anja] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Univ Pl 1,Campus Drie Eiken, Antwerp, Belgium; [Fransen, Paul; De Meyer, Guido] Univ Antwerp, Dept Pharmaceut Sci, Lab Physiopharmacol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Verhulst, A (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Univ Pl 1,Campus Drie Eiken, Antwerp, Belgium.	anja.verhulst@uantwerpen.be	Opdebeeck, Britt/GQA-8470-2022; Neven, Ellen/GVR-7948-2022	Van den Branden, Astrid/0000-0001-6325-4997; Fransen, Paul/0000-0002-4577-3416; Van den Bergh, Geoffrey/0000-0002-8870-1965	Fonds Wetenschappelijk Onderzoek (FWO) [1S18818N, G045120N]; Universiteit Antwerpen (GOA-BOF) [33932]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Universiteit Antwerpen (GOA-BOF)	Fonds Wetenschappelijk Onderzoek (FWO), Grant/Award Number: 1S18818N and G045120N; Universiteit Antwerpen (GOA-BOF), Grant/Award Number: 33932	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Alique M, 2020, COMPUT STRUCT BIOTEC, V18, P953, DOI 10.1016/j.csbj.2020.04.006; [Anonymous], 2018, VP, DOI DOI 10.20517/2574-1209.2018.51; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Campos-Staffico AM, 2020, ATHEROSCLEROSIS, V292, P70, DOI 10.1016/j.atherosclerosis.2019.11.007; Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218; Charytan DM, 2015, AM J KIDNEY DIS, V66, P196, DOI 10.1053/j.ajkd.2014.12.016; Csonka C, 2015, BRIT J PHARMACOL, V172, P1620, DOI 10.1111/bph.12832; De Mare A, 2019, TOXINS, V11, DOI 10.3390/toxins11070428; De Moudt S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00157; Dowell FJ, 1999, EUR J PHARMACOL, V379, P175, DOI 10.1016/S0014-2999(99)00511-7; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Farrar EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123257; Fransen P, 2008, PFLUG ARCH EUR J PHY, V455, P811, DOI 10.1007/s00424-007-0337-9; Fuglerud BM., 2021, BIORXIV2020091129399, DOI [10.1101/2020.09.11.293993, DOI 10.1101/2020.09.11.293993]; Godia EC, 2007, J ULTRAS MED, V26, P1157, DOI 10.7863/jum.2007.26.9.1157; Guo J., 2016, CIRCULATION, V133, pAMP66; Guo JC, 2017, HYPERTENSION, V69, P102, DOI 10.1161/HYPERTENSIONAHA.116.08459; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Knapp M, 2019, ACTA PHARMACOL SIN, V40, P1, DOI 10.1038/s41401-018-0042-6; KUNG CF, 1995, HYPERTENSION, V26, P744, DOI 10.1161/01.HYP.26.5.744; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lee JS, 2012, ATHEROSCLEROSIS, V224, P340, DOI 10.1016/j.atherosclerosis.2012.07.023; Leloup A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00858; Leloup AJA, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13934; Leloup AJA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00582; Leloup AJA, 2016, J PHYSIOL-LONDON, V594, P6105, DOI 10.1113/JP272623; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Oe Y, 2021, AM J PATHOL, V191, P283, DOI 10.1016/j.ajpath.2020.10.012; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Pechanova Olga, 2020, Pathophysiology, V27, P46, DOI 10.3390/pathophysiology27010007; Proudfoot D, 2006, NEPHROLOGY, V11, P455, DOI 10.1111/j.1440-1797.2006.00660.x; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Roumeliotis S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082359; Sambe T, 2018, BIOMED PHARMACOTHER, V98, P149, DOI 10.1016/j.biopha.2017.12.023; Sanchez-Duffhues G, 2019, J PATHOL, V247, P333, DOI 10.1002/path.5193; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Schantl AE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14091-4; Schantl AE, 2019, ADV THER-GERMANY, V2, DOI 10.1002/adtp.201800094; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Simionescu A, 2005, BIOCHEM BIOPH RES CO, V334, P524, DOI 10.1016/j.bbrc.2005.06.119; Van den Bergh G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111615; Van den Bergh G, 2019, TRENDS MOL MED, V25, P1133, DOI 10.1016/j.molmed.2019.08.006; van Langen J, 2012, EUR J PHARMACOL, V696, P111, DOI 10.1016/j.ejphar.2012.09.016; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Yuan C, 2021, MICROVASC RES, V134, DOI 10.1016/j.mvr.2020.104105; Zhang XY, 2016, VASC PHARMACOL, V81, P83, DOI 10.1016/j.vph.2016.01.002; Zhang YX, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12980; Zhao JL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22717-9	50	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22315	10.1096/fj.202101919R	http://dx.doi.org/10.1096/fj.202101919R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3HL	35429059	hybrid			2022-12-28	WOS:000782732900001
J	Yoshida, M; Ishihara, T; Isobe, Y; Arita, M				Yoshida, Mio; Ishihara, Tomoaki; Isobe, Yosuke; Arita, Makoto			Genetic deletion of Cyp4f18 disrupts the omega-3 epoxidation pathway and results in psoriasis-like dermatitis	FASEB JOURNAL			English	Article						dendritic cell; fatty acid metabolism; lipid mediator; n-3 polyunsaturated fatty acids; psoriasis	EICOSAPENTAENOIC ACID; LANGERHANS CELLS; INDUCED LIPOKINE; PIVOTAL ROLE; RESOLVIN E1; T-CELLS; INFLAMMATION; SKIN; MICE; N-3	Cyp4f18 catalyzes the conversion of n-3 polyunsaturated fatty acids (PUFAs) into omega-3 epoxides, such as 17,18-epoxyeicosatetraenoic acid (17,18-EpETE) and 19,20-epoxydocosapentaenoic acid (19,20-EpDPE) from eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), respectively. Cyp4f18-deficient mice spontaneously develop psoriasis-like dermatitis. A significant increase in the number of IL-17A-positive gamma delta (gamma delta) T cells in the skin and enlargement of draining lymph nodes was observed. These symptoms were drastically suppressed by antibiotic treatment. Cyp4f18 is highly expressed in dendritic cells (DCs), and Cyp4f18-deficient bone marrow-derived dendritic cells (BMDCs) show markedly increased expression levels of cytokines such as IL-23 and IL-1 beta in response to lipopolysaccharide (LPS) stimulation. Lipidomic analysis of lymph nodes and BMDCs revealed a significant decrease in a series of omega-3 epoxidized metabolites. Among them, 17,18-dihydroxyeicosatetraenoic acid (17,18-diHETE), a vicinal diol derived from EPA omega-3 epoxidation suppressed IL-23 production in LPS-stimulated BMDCs in Cyp4f18-deficient mice. These results demonstrate that Cyp4f18 endogenously produces omega-3-epoxidized metabolites in the draining lymph nodes, and these metabolites contribute to skin homeostasis by suppressing the excessive activation of the IL-23/IL-17 axis initiated by DCs.	[Yoshida, Mio; Isobe, Yosuke; Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Yoshida, Mio; Ishihara, Tomoaki; Isobe, Yosuke; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan; [Isobe, Yosuke; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epignt Lab, Yokohama, Kanagawa, Japan; [Ishihara, Tomoaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Keio University; RIKEN; Yokohama City University; Nagasaki International University	Arita, M (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Minato Ku, Tokyo 1058512, Japan.	arita-mk@pha.keio.ac.jp			Japan Society for the Promotion of Science [15H05897, 15H05898, 20H00495]; Exploratory Research for Advanced Technology [JPMJER2101]; RIKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exploratory Research for Advanced Technology; RIKEN	Japan Society for the Promotion of Science, Grant/Award Number: 15H05897, 15H05898 and 20H00495; Exploratory Research for Advanced Technology, Grant/Award Number: JPMJER2101; RIKEN, Grant/Award Number: Glyco-Lipidologue Initiative and Junior Research Associate Program	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Goto Haruka, 2021, JAAD Int, V2, P51, DOI 10.1016/j.jdin.2020.10.011; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hecker M, 2018, BBA-MOL CELL BIOL L, V1863, P1016, DOI 10.1016/j.bbalip.2018.06.011; Isobe Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26325-4; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Ito Y, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109052; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kubota T, 2014, FASEB J, V28, P586, DOI 10.1096/fj.13-236224; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Li JP, 2018, CARCINOGENESIS, V39, P1380, DOI 10.1093/carcin/bgy117; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Mochimaru T, 2018, ALLERGY, V73, P369, DOI 10.1111/all.13297; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Nagatake T, 2018, J ALLERGY CLIN IMMUN, V142, P470, DOI 10.1016/j.jaci.2017.09.053; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Nakamizo S, 2015, SEMIN IMMUNOPATHOL, V37, P73, DOI 10.1007/s00281-014-0452-6; Naldi Luigi, 2004, Current Drug Targets - Inflammation and Allergy, V3, P121, DOI 10.2174/1568010043343958; Ninomiya T, 2013, ATHEROSCLEROSIS, V231, P261, DOI 10.1016/j.atherosclerosis.2013.09.023; Qin S, 2014, MOL MED REP, V9, P2097, DOI 10.3892/mmr.2014.2136; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Saito-Sasaki N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23623-9; Sawada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30373-1; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Singh TP, 2010, J IMMUNOL, V184, P7257, DOI 10.4049/jimmunol.0903719; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Xiao CY, 2017, J DERMATOL SCI, V85, P170, DOI 10.1016/j.jdermsci.2016.12.003; Xu JT, 2018, J DERMATOL SCI, V89, P127, DOI 10.1016/j.jdermsci.2017.10.016; Yan D, 2017, CURR DERMATOL REP, V6, P94, DOI 10.1007/s13671-017-0178-5; Yokomizo T, 2018, J CLIN INVEST, V128, P2691, DOI 10.1172/JCI97946; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zeng JR, 2017, J DERMATOL, V44, P863, DOI 10.1111/1346-8138.13806; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22648	10.1096/fj.202200982R	http://dx.doi.org/10.1096/fj.202200982R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SH	36374250				2022-12-28	WOS:000883024300001
J	Zhu, HX; Wang, HX; Cheng, Y; Liu, DY; Zhang, AZ; Wen, ZZ; Gao, JA				Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Wen, Zongzhuang; Gao, Jiangang			Hadh deficiency induced oligoasthenoteratozoospermia through the TNF-alpha/Bcl-2 pathway in male mice	FASEB JOURNAL			English	Article						apoptosis; etanercept; Hadh; multinucleated giant germ cells; testicular inflammation	NECROSIS-FACTOR-ALPHA; MULTINUCLEATED SPERMATOCYTES; MALE-INFERTILITY; FATTY-ACIDS; INFLAMMATION; EXPRESSION; APOPTOSIS; TESTIS; SPERMATOGENESIS; STEROIDOGENESIS	The process of spermatogenesis is a complex and delicate process that is still not fully understood. In this study, we examined the role of fatty acid oxidase 3-hydroxy acyl CoA dehydrogenase (HADH) in maintaining normal spermatogenesis in mice. In male mice, ablation of the Hadh gene using CRISPR/Cas9 technology arrested spermatocyte meiosis, increased multinucleated giant germ cells and vacuoles in seminiferous tubules, and accompanied with acrosomal dysplasia. Hadh(-/-) male mice showed the typical features of oligoasthenoteratozoospermia (OAT), including decreased sperm concentration and motility and increased sperm abnormalities. Next, we explored the molecular events in the testes of the mutant mice. We found fatty acids accumulated in the testis of Hadh(-/-) mice. And also, inflammatory factors TNF-alpha, IL-1 beta, and IL-6 were significantly increased, apoptosis-related protein Bcl-2 was decreased, and Bax and cleaved-Caspase3 were increased in Hadh(-/-) male mice testis. After using etanercept, a specific inhibitor of TNF-alpha, testis injury caused by Hadh knockout was significantly alleviated, the sperm quality and motility were improved, and germ cell apoptosis was reduced. So our study demonstrated that Hadh deletion caused an increase in fatty acids. The accumulated fatty acids further induced testicular inflammation and germ cell apoptosis through the TNF-alpha/Bcl-2 signaling pathway, finally resulting in OAT in the Hadh(-/-) mice. Inhibiting TNF-alpha may be used as a new treatment approach for testicular inflammation and OAT.	[Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Gao, Jiangang] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Gao, Jiangang] Shandong Univ, Key Lab Minist Educ Expt Teratol, Jinan 250100, Peoples R China; [Wen, Zongzhuang; Gao, Jiangang] Shandong First Med Univ, Med Sci & Technol Innovat Ctr, Jinan 250117, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Gao, JA (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.; Gao, JA (corresponding author), Shandong Univ, Key Lab Minist Educ Expt Teratol, Jinan 250100, Peoples R China.; Wen, ZZ; Gao, JA (corresponding author), Shandong First Med Univ, Med Sci & Technol Innovat Ctr, Jinan 250117, Peoples R China.	wenzongzhuang@sdfmu.edu.cn; jggao@sdu.edu.cn			MOST | National Key Research and Development Program of China [2018YFC1003602]	MOST | National Key Research and Development Program of China	MOST | National Key Research and Development Program of China (NKPs), Grant/Award Number: 2018YFC1003602	Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Babakhanzadeh E, 2020, INT J GEN MED, V13, P29, DOI 10.2147/IJGM.S241099; Beurois J, 2020, BEST PRACT RES CL EN, V34, DOI 10.1016/j.beem.2020.101473; Cao ZH, 2013, CELL BIOCHEM BIOPHYS, V67, P1239, DOI 10.1007/s12013-013-9642-4; Cao Z, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114748; Cavallini G, 2006, ASIAN J ANDROL, V8, P143, DOI 10.1111/j.1745-7262.2006.00123.x; DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389; Du ZX, 2021, SCI PROGRESS-UK, V104, DOI 10.1177/00368504211011344; Dutta S, 2022, REPROD SCI, V29, P2707, DOI 10.1007/s43032-021-00721-0; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Foomani FH, 2021, IEEE J TRANSL ENG HE, V9, P1, DOI 10.1109/JTEHM.2021.3104966; Fritsche KL, 2015, ADV NUTR, V6, p293S, DOI 10.3945/an.114.006940; Fu YF, 2002, ACTA BIOCH BIOPH SIN, V34, P389; Gao Q, 2020, J BIOL CHEM, V295, P6289, DOI 10.1074/jbc.RA119.012375; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hedger MP, 2011, J ANDROL, V32, P625, DOI 10.2164/jandrol.111.012989; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Heinrich A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.077; Heslegrave AJ, 2013, J CLIN ENDOCR METAB, V98, P496, DOI 10.1210/jc.2012-3134; HOLSTEIN AF, 1986, ANDROLOGIA, V18, P5; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Huang T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2235-4; Hwang DH, 2016, EUR J PHARMACOL, V785, P24, DOI 10.1016/j.ejphar.2016.04.024; Jha KN, 2017, J CELL SCI, V130, P1835, DOI 10.1242/jcs.202721; Jiang HM, 2021, GENOMICS, V113, P3556, DOI 10.1016/j.ygeno.2021.08.008; Kapoor RR, 2010, REV ENDOCR METAB DIS, V11, P185, DOI 10.1007/s11154-010-9148-y; Li ZB, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.725933; Liu Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03755-z; Lu XS, 2018, J CELL BIOCHEM, V119, P4760, DOI 10.1002/jcb.26668; MACGREGOR GR, 1990, P NATL ACAD SCI USA, V87, P5016, DOI 10.1073/pnas.87.13.5016; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Maltesen HR, 2010, RHEUMATOLOGY, V49, P2037, DOI 10.1093/rheumatology/keq213; MIETHING A, 1993, ANDROLOGIA, V25, P317; Pelechas E, 2019, EXPERT OPIN BIOL TH, V19, P173, DOI 10.1080/14712598.2019.1566456; Rogero MM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040432; Sadasivam M, 2015, INFLAMM RES, V64, P549, DOI 10.1007/s00011-015-0835-8; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; Schuppe HC, 2005, CHEM IMMUNOL ALLERGY, V88, P1, DOI 10.1159/000087816; Shen CC, 2017, ONCOTARGET, V8, P76279, DOI 10.18632/oncotarget.19348; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tuttelmann F, 2018, MED GENET-BERLIN, V30, P12, DOI 10.1007/s11825-018-0181-7; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varuzhanyan G, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.199686; Vertika S, 2020, MITOCHONDRION, V54, P26, DOI 10.1016/j.mito.2020.06.003; Wen ZZ, 2020, EXP CELL RES, V395, DOI 10.1016/j.yexcr.2020.112178; Wettersten HI, 2017, NAT REV NEPHROL, V13, P410, DOI 10.1038/nrneph.2017.59; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; XIONG YT, 1993, ENDOCRINOLOGY, V133, P2568, DOI 10.1210/en.133.6.2568; Yeung CH, 2002, BIOL REPROD, V67, P269, DOI 10.1095/biolreprod67.1.269; Zerbini CAF, 2017, OSTEOPOROSIS INT, V28, P429, DOI 10.1007/s00198-016-3769-2; ZHANG Y, 2021, FRONTIERS MOL BIOSCI, V0008; Zhao JL, 2017, GEN COMP ENDOCR, V252, P48, DOI 10.1016/j.ygcen.2017.07.013	53	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22661	10.1096/fj.202201144R	http://dx.doi.org/10.1096/fj.202201144R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L3ID	36398584				2022-12-28	WOS:000888079000001
J	Mai, XY; Shang, JY; Chen, QY; Gu, SJ; Hong, Y; Zhou, JG; Zhang, MZ				Mai, Xiaoyi; Shang, Jinyan; Chen, Qiuyuan; Gu, Shijie; Hong, Yu; Zhou, Jiaguo; Zhang, Minzhou			Endophilin A2 protects against renal fibrosis by targeting TGF-beta/Smad signaling	FASEB JOURNAL			English	Article						endophilin A2; renal fibrosis; TGF-beta; Smad signaling; tubular epithelial cell	BETA RECEPTOR; SH3 DOMAIN; TUBULOINTERSTITIAL FIBROSIS; MECHANISMS; INSIGHTS; MEMBRANE; PHOSPHORYLATION; ENDOCYTOSIS; ACTIVATION; BLOCKADE	Renal fibrosis underlies all forms of end-stage kidney disease. Endophilin A2 (EndoA2) plays a role in nephrotic syndrome; however, its effect on renal fibrosis remains unknown. Here, we demonstrate that EndoA2 protects against kidney interstitial fibrosis via the transforming growth factor-beta (TGF-beta)/Smad signaling pathway. Mouse kidneys with fibrosis or kidney biopsy specimens from patients with fibrotic nephropathy had lower levels of EndoA2 protein expression than that in kidneys without fibrosis. In vivo overexpression of EndoA2 with the endophilin A2 transgene (EndoA2(Tg)) notably prevented renal fibrosis, decreased the protein expression of profibrotic molecules, suppressed tubular injury, and reduced apoptotic tubular cells in the obstructed kidney cortex of mice with unilateral ureteral obstruction (UUO). In vivo and in vitro overexpression of EndoA2 markedly inhibited UUO- or TGF-beta 1-induced phosphorylation of Smad2/3 and tubular epithelial cells dedifferentiation. Furthermore, EndoA2 was co-immunoprecipitated with the type II TGF-beta receptor (T beta RII), thus inhibiting the binding of the type I TGF-beta receptor (T beta RI) to T beta RII. These findings indicate that EndoA2 mitigates renal fibrosis, at least partially, via modulating the TGF-beta/Smad signaling. Targeting EndoA2 may be a new potential therapeutic strategy for treatment of renal fibrosis.	[Mai, Xiaoyi; Zhang, Minzhou] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Intens Care Res Team Tradit Chinese Med, Ill Dade Rd, Guangzhou 510120, Peoples R China; [Mai, Xiaoyi; Zhang, Minzhou] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, AMI Key Lab Chinese Med Guangzhou, Guangzhou 510120, Peoples R China; [Shang, Jinyan; Hong, Yu; Zhou, Jiaguo] Sun Yat Sen Univ, Cardiac & Cerebral Vasc Res Ctr, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Peoples R China; [Chen, Qiuyuan; Gu, Shijie] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Organ Transplantat, Guangzhou, Peoples R China; [Zhang, Minzhou] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Crit Care Med, Guangzhou, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Mai, XY; Zhang, MZ (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Intens Care Res Team Tradit Chinese Med, Ill Dade Rd, Guangzhou 510120, Peoples R China.; Mai, XY; Zhang, MZ (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, AMI Key Lab Chinese Med Guangzhou, Guangzhou 510120, Peoples R China.	xiaoyi200701@126.com; zzyxzyytd@gzucm.edu.cn			National Natural Science Foundation of China [81703593, 81803519]; Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine [ZY2022KY11]; Natural Science Foundation of Guangdong Province [2019A1515011428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The authors thank Yanjun Chen for generously providing endophilin A2 adenovirus and the vector. This work was supported by the National Natural Science Foundation of China (grant numbers 81703593 and 81803519), the Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine (No. ZY2022KY11), and the Natural Science Foundation of Guangdong Province (grant number 2019A1515011428).	Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Bai M, 2019, AM J PHYSIOL-RENAL, V317, pF1430, DOI 10.1152/ajprenal.00230.2019; Beker BM, 2018, INT UROL NEPHROL, V50, P705, DOI 10.1007/s11255-017-1781-x; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desrochers G, 2017, J BIOL CHEM, V292, P6325, DOI 10.1074/jbc.M116.754440; Djudjaj S, 2019, MOL ASPECTS MED, V65, P16, DOI 10.1016/j.mam.2018.06.002; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eitner F, 2003, CURR OPIN NEPHROL HY, V12, P227, DOI 10.1097/00041552-200305000-00002; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Gifford CC, 2021, CLIN SCI, V135, P275, DOI 10.1042/CS20201213; Gohda T, 2020, J DIABETES INVEST, V11, P435, DOI 10.1111/jdi.13139; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu CZ, 2016, CIRC J, V80, P2397, DOI 10.1253/circj.CJ-16-0793; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu Y, 2016, J MOL CELL CARDIOL, V92, P122, DOI 10.1016/j.yjmcc.2016.02.004; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Luo L, 2016, J BIOL CHEM, V291, P9411, DOI 10.1074/jbc.M115.703108; Mai XY, 2016, J AM SOC NEPHROL, V27, P3063, DOI 10.1681/ASN.2015080889; Mai XY., 2020, FRONT PHARMACOL, V11, P1; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mondal S, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016118; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Tschumperlin DJ, 2013, CURR OPIN RHEUMATOL, V25, P92, DOI 10.1097/BOR.0b013e32835b13cd; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Woo YM, 2004, CURR OPIN NEPHROL HY, V13, P607, DOI 10.1097/00041552-200411000-00005; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Yang H, 2012, HYPERTENSION, V60, P1287, DOI 10.1161/HYPERTENSIONAHA.112.198648; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	49	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22603	10.1096/fj.202101769R	http://dx.doi.org/10.1096/fj.202101769R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5K4QE	36259445				2022-12-28	WOS:000869711200001
J	Seth, A; Rivera, A; Chahdi, A; Choi, IS; Medina-Martinez, O; Lewis, S; O'Neill, M; Ridgeway, A; Moore, J; Jorgez, C; Lamb, DJ				Seth, Abhishek; Rivera, Armando; Chahdi, Ahmed; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; O'Neill, Marisol; Ridgeway, Alex; Moore, Joshua; Jorgez, Carolina; Lamb, Dolores J.			Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function	FASEB JOURNAL			English	Article						copy number variant; cryptorchidism; KCTD13; penile anomalies	AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; COPY NUMBER; 16P11.2; PROTEIN; MICE; DEGRADATION; CHROMOSOME; DISORDERS; MUTATIONS	Despite the high prevalence of hypospadias and cryptorchidism, the genetic basis for these conditions is only beginning to be understood. Using array-comparative-genomic-hybridization (aCGH), potassium-channel-tetramerization-domain-containing-13 (KCTD13) encoded at 16p11.2 was identified as a candidate gene involved in hypospadias, cryptorchidism and other genitourinary (GU) tract anomalies. Copy number variants (CNVs) at 16p11.2 are among the most common syndromic genomic variants identified to date. Many patients with CNVs at this locus exhibit GU and/or neurodevelopmental phenotypes. KCTD13 encodes a substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (B-cell receptor (BCR) [BTB (the BTB domain is a conserved motif involved in protein-protein interactions) Cullin3 complex RING protein Rbx1] E3-ubiqutin-protein-ligase complex), which has essential roles in the regulation of cellular cytoskeleton, migration, proliferation, and neurodevelopment; yet its role in GU development is unknown. The prevalence of KCTD13 CNVs in patients with GU anomalies (2.58%) is significantly elevated when compared with patients without GU anomalies or in the general population (0.10%). KCTD13 is robustly expressed in the developing GU tract. Loss of KCTD13 in cell lines results in significantly decreased levels of nuclear androgen receptor (AR), suggesting that loss of KCTD13 affects AR sub-cellular localization. Kctd13 haploinsufficiency and homozygous deletion in mice cause a significant increase in the incidence of cryptorchidism and micropenis. KCTD13-deficient mice exhibit testicular and penile abnormalities together with significantly reduced levels of nuclear AR and SOX9. In conclusion, gene-dosage changes of murine Kctd13 diminish nuclear AR sub-cellular localization, as well as decrease SOX9 expression levels which likely contribute in part to the abnormal GU tract development in Kctd13 mouse models and in patients with CNVs in KCTD13.	[Seth, Abhishek; Rivera, Armando; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; Jorgez, Carolina; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Seth, Abhishek; Rivera, Armando; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; O'Neill, Marisol; Ridgeway, Alex; Moore, Joshua; Jorgez, Carolina; Lamb, Dolores J.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Seth, Abhishek; Chahdi, Ahmed] Nemours Childrens Hosp, Dept Surg, 6535 Nemours Pkwy, Orlando, FL 32827 USA; [O'Neill, Marisol; Ridgeway, Alex; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, James Buchanan Brady Fdn, Ctr Reprod Genom, Dept Urol, New York, NY 10065 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, Englander Inst Personalized Med, 525 East 68th St,Box 94, New York, NY 10065 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, James Buchanan Urol, Ctr Reprod Genom, 525 East 68th St,Box 94, New York, NY 10065 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cornell University; Cornell University; Cornell University	Seth, A (corresponding author), Nemours Childrens Hosp, Dept Surg, 6535 Nemours Pkwy, Orlando, FL 32827 USA.; Lamb, DJ (corresponding author), Weill Cornell Med Coll, Englander Inst Personalized Med, 525 East 68th St,Box 94, New York, NY 10065 USA.; Lamb, DJ (corresponding author), Weill Cornell Med Coll, James Buchanan Urol, Ctr Reprod Genom, 525 East 68th St,Box 94, New York, NY 10065 USA.	abhishek.seth@nemours.org; dlamb@med.cornell.edu		Choi, In-Seon/0000-0001-5237-0255; Lewis, Shaye Kamal/0000-0001-8937-0857; Rivera, Armando/0000-0001-7076-8566; Ridgeway, Alex/0000-0001-6055-6375; Moore, Joshua A/0000-0001-7879-0135	National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program from the National Institute of Digestive Diseases and Kidney [K12DK0083014]; National Institutes of Health, National Institute of Digestive Diseases and Kidney [R01DK078121]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD100985]; Society for Pediatric Urology annual research award (2017); Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; Robert S. Dow Professorship; Integrated Microscopy Core at Baylor College of Medicine; NIH [DK56338, CA125123]; CPRIT [RP150578]; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics;  [T32DK007763]	National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program from the National Institute of Digestive Diseases and Kidney; National Institutes of Health, National Institute of Digestive Diseases and Kidney; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Society for Pediatric Urology annual research award (2017); Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; Robert S. Dow Professorship; Integrated Microscopy Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; 	This study was supported in part by The National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program K12DK0083014 from the National Institute of Digestive Diseases and Kidney to D.J.L (AS, SL and CJJ were K12 scholars), R01DK078121 from the National Institutes of Health, National Institute of Digestive Diseases and Kidney to DJL, and 1R01HD100985 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to AS and CJJ and the Society for Pediatric Urology annual research award (2017) to AS. MO was a pre-doctoral trainee supported on T32DK007763 (to DJL). DJL is also supported in part by the Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust and the Robert S. Dow Professorship. We thank Drs. Francesco DeMayo and Jason Heaney at the Baylor College of Medicine's GEM core for their assistance in generating the Kctd13 deleted mice and Dr. Victor Ruthig, Ms. Adlai Nelson, and Carolyn Schum for helpful editing of the manuscript. The Optical Imaging and Vital Microscopy core used in this project was supported by the Integrated Microscopy Core at Baylor College of Medicine with funding from the NIH (DK56338, and CA125123), CPRIT (RP150578), the Dan L. Duncan Comprehensive Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. The authors thank Dr. Ahmed Chahdi for his contributions towards this study.	Arbogast T, 2019, HUM MOL GENET, V28, P1474, DOI 10.1093/hmg/ddy436; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bouty A, 2015, SEX DEV, V9, P239, DOI 10.1159/000441988; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Davies Jamie A, 2012, Methods Mol Biol, V886, P185, DOI 10.1007/978-1-61779-851-1_17; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Escamilla CO, 2017, NATURE, V551, P227, DOI 10.1038/nature24470; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Feng S, 2009, ANN NY ACAD SCI, V1160, P197, DOI 10.1111/j.1749-6632.2009.03841.x; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fu XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018232; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Haller M, 2018, P NATL ACAD SCI USA, V115, pE1849, DOI 10.1073/pnas.1716092115; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Hernando C, 2002, J Med Genet, V39, pE24, DOI 10.1136/jmg.39.5.e24; Hornig NC, 2016, J CLIN ENDOCR METAB, V101, P4468, DOI 10.1210/jc.2016-1990; Hughes IA, 2007, ENDOCRIN DEV, V11, P47, DOI 10.1159/000111057; Ishikawa N, 2006, CANCER SCI, V97, P737, DOI 10.1111/j.1349-7006.2006.00258.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kino T, 2012, J CLIN ENDOCR METAB, V97, pE1557, DOI 10.1210/jc.2011-3493; Kolon TF, 2014, J UROLOGY, V192, P337, DOI 10.1016/j.juro.2014.05.005; Konyukh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017289; Kumar A, 2014, DEV DYNAM, V243, P937, DOI [10.1002/DVDY.24125, 10.1002/dvdy.24125]; Kusenda M, 2015, J CHILD NEUROL, V30, P1947, DOI 10.1177/0883073815602066; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Loke J, 2014, HUM MOL GENET, V23, P1073, DOI 10.1093/hmg/ddt502; Morandell J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23123-x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nik-Zainal S, 2011, J MED GENET, V48, P197, DOI 10.1136/jmg.2010.082412; O'Neill M, 2017, J SEX MED, V14, P1533, DOI 10.1016/j.jsxm.2017.10.065; Ostrer H, 2014, J CLIN ENDOCR METAB, V99, P1503, DOI 10.1210/jc.2013-3690; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Phillips TR, 2015, SEX DEV, V9, P162, DOI 10.1159/000431010; Pluciennik A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134565; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sampson MG, 2010, AM J MED GENET A, V152A, P2618, DOI 10.1002/ajmg.a.33628; Sasaki G, 2019, ENDOCR J, V66, P837, DOI 10.1507/endocrj.EJ19-0111; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shinawi M, 2010, AM J MED GENET A, V152A, P1832, DOI 10.1002/ajmg.a.33475; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Sreenivasan R, 2017, J STEROID BIOCHEM, V170, P28, DOI 10.1016/j.jsbmb.2016.10.009; Srivastava D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.1; Stockley P, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-66; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; Tannour-Louet M, 2014, NAT MED, V20, P715, DOI 10.1038/nm.3580; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Tomiyama H, 2003, J PEDIATR SURG, V38, P1793, DOI 10.1016/j.jpedsurg.2003.08.047; Tucker T, 2013, MOL GENET GENOM MED, V1, P87, DOI 10.1002/mgg3.12; Vlaskamp DRM, 2019, EUR J MED GENET, V62, P265, DOI 10.1016/j.ejmg.2018.08.002; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wen SM, 2020, ASIAN J UROL, V7, P203, DOI 10.1016/j.ajur.2019.11.001; Wirth J, 1996, HUM GENET, V97, P186, DOI 10.1007/BF02265263; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112; Zhou L, 2015, J NEUROL SCI, V358, P362, DOI 10.1016/j.jns.2015.09.363	69	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22567	10.1096/fj.202200558R	http://dx.doi.org/10.1096/fj.202200558R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9ID	36196997				2022-12-28	WOS:000863879600001
J	Yang, CY; Liu, Y; Wang, ZY; Lin, MM; Liu, C				Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao			Controlled mechanical loading improves bone regeneration by regulating type H vessels in a S1Pr1-dependent manner	FASEB JOURNAL			English	Article						angiogenesis; bone regeneration; mechanobiology; osteoprogenitors; S1Pr1	PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; STEM-CELLS; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; S1P; DIFFERENTIATION; OSTEOGENESIS	Despite the best treatment, approximately 10% of fractures still face undesirable repair and result in delayed unions or non-unions. Dynamic mechanical stimulation promotes bone formation, when applied at the correct time frame, with optimal loading magnitude, frequency, and repetition. Controlled mechanical loading significantly increases osteogenic cells during the matrix deposition phase of bone repair. In the bone defect, the blood vessel network guides the initial bone formation activities. A unique blood vessel subtype (Type H) exists in bone, which expresses high levels of CD31 and endomucin, and functions to couple angiogenesis and osteogenesis. However, how this form of controlled mechanical loading regulates the Type H vessels and promotes bone formation is still not clear. Sphingosine 1-phosphate (S1P) participates in the bone anabolic process and is a key regulator of the blood vessel. Its receptor, sphingosine 1-phosphate receptor 1 (S1Pr1), is a mechanosensitive protein that regulates vascular integrity. Therefore, we hypothesis that controlled anabolic mechanical loading promotes bone repair by acting on Type H vessels. To study the effect of S1Pr1 on loading induced-bone repair, we utilized a stabilized tibial defect model, which allows for the application of anabolic mechanical loading. Mechanical loading upregulated S1Pr1 within the entire defect, with up to 80% expressed in blood vessels, as observed by deep tissue imaging. Additionally, S1Pr1 antagonism by W146 inhibited the anabolic effects of mechanical loading. We showed that mechanical loading or activating S1Pr1 could induce YAP nuclear translocation, a key regulator in the cell's mechanical response, in endothelial cells (ECs) in vitro. Inhibition of S1Pr1 in endothelial cells by siRNA reduced loading-induced YAP nuclear translocation and expressions of angiogenic genes. In vivo, YAP nuclear translocation in Type H vessels was up-regulated after mechanical loading but was inhibited by antagonizing S1Pr1. S1Pr1 agonist, FTY720, increased bone volume and Type H vessel volume, similar to that of mechanical stimulation. In conclusion, controlled anabolic mechanical loading enhanced bone formation mainly through Type H vessels in a S1Pr1-dependent manner.	[Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao] Southern Univ Sci & Technol, Coll Engn, Dept Biomed Engn, 1088 Xueyuan Ave,Coll Engn Bldg,South Room 732, Shenzhen 518055, Peoples R China; [Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao] Southern Univ Sci & Technol, Guangdong Prov Key Lab Adv Biomat, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology	Liu, C (corresponding author), Southern Univ Sci & Technol, Coll Engn, Dept Biomed Engn, 1088 Xueyuan Ave,Coll Engn Bldg,South Room 732, Shenzhen 518055, Peoples R China.	liuc33@sustech.edu.cn	Wang, Ziyan/HII-8458-2022; Liu, Chao/E-2667-2019	Liu, Yang/0000-0002-2226-0941; Liu, Chao/0000-0001-6637-1689	Shenzhen Science and Technology Innovation Commission [JCYJ20190809114209434, KQTD20200820113012029]; Guangdong Provincial Key Laboratory of Advanced Biomaterials [2022B1212010003]	Shenzhen Science and Technology Innovation Commission; Guangdong Provincial Key Laboratory of Advanced Biomaterials	The work was supported by Shenzhen Science and Technology Innovation Commission (Grant No. JCYJ20190809114209434, KQTD20200820113012029), Guangdong Provincial Key Laboratory of Advanced Biomaterials (2022B1212010003) for financial support. We acknowledge the assistance of Ying Wang for the micro-CT imaging and confocal imaging from the SUSTech Core Research Core Research Facilities. The authors also would like to thank Mr. Hui Guo from SUSTech Laboratory Animal Center for her generous help during the animal tests.	Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI [10.1089/ten.tea.2009.0539, 10.1089/ten.TEA.2009.0539]; Augat P, 2005, OSTEOPOROSIS INT, V16, pS36, DOI 10.1007/s00198-004-1728-9; Bao XM, 2020, GLIA, V68, P1757, DOI 10.1002/glia.23803; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Cartier A, 2020, P NATL ACAD SCI USA, V117, P3157, DOI 10.1073/pnas.1906246117; Castillo AB, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0537-9; Chen Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107828; Geng X, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137652; Golan K, 2013, PHARMACEUTICALS, V6, P1145, DOI 10.3390/ph6091145; Grewe JM, 2022, BONE RES, V10, DOI 10.1038/s41413-022-00205-0; Higashi K, 2016, BONE, V93, P1, DOI 10.1016/j.bone.2016.09.003; Huang C, 2016, MOL MED REP, V14, P927, DOI 10.3892/mmr.2016.5342; Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lin CW, 2017, ELIFE, V6, DOI 10.7554/eLife.21130; Liu C, 2019, J BONE MINER RES, V34, P896, DOI 10.1002/jbmr.3668; Liu C, 2018, BONE, V108, P145, DOI 10.1016/j.bone.2017.12.027; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Main RP, 2020, J ORTHOP RES, V38, P233, DOI 10.1002/jor.24466; Matsuzaki E, 2022, J DENT SCI, V17, P787, DOI 10.1016/j.jds.2021.10.004; McDermott AM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7756; Meshcheryakova A, 2017, EXPERT OPIN THER TAR, V21, P725, DOI 10.1080/14728222.2017.1332180; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Nakajima H, 2017, DEV CELL, V40, P523, DOI 10.1016/j.devcel.2017.02.019; Newby J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00739-6; Prasad J, 2010, J BIOMECH, V43, P2765, DOI 10.1016/j.jbiomech.2010.06.030; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Ruehle MA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb6351; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Salhotra A, 2020, NAT REV MOL CELL BIO, V21, P696, DOI 10.1038/s41580-020-00279-w; Shen B, 2021, NATURE, V591, P438, DOI 10.1038/s41586-021-03298-5; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Tantikanlayaporn D, 2018, JBMR PLUS, V2, P217, DOI 10.1002/jbm4.10037; Thompson MS, 2007, MED ENG PHYS, V29, P820, DOI 10.1016/j.medengphy.2006.08.012; Wang XH, 2017, DEV CELL, V42, P462, DOI 10.1016/j.devcel.2017.08.002; Wang XT, 2021, FASEB J, V35, DOI 10.1096/fj.202001080RR; Wang ZY, 2021, FASEB J, V35, DOI 10.1096/fj.202101045RR; Weske S, 2018, NAT MED, V24, P667, DOI 10.1038/s41591-018-0005-y; Wildemann B, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00289-8; Xiao L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01409; Xiao L, 2018, J BONE MINER RES, V33, P1090, DOI 10.1002/jbmr.3396; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan Y, 2021, CELL RES, V31, P1263, DOI 10.1038/s41422-021-00566-x	47	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22530	10.1096/fj.202200339RRR	http://dx.doi.org/10.1096/fj.202200339RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I1IL	36063128				2022-12-28	WOS:000850330000001
J	Aryee, KE; Burzenski, LM; Yao, LC; Keck, JG; Greiner, DL; Shultz, LD; Brehm, MA				Aryee, Ken-Edwin; Burzenski, Lisa M.; Yao, Li-Chin; Keck, James G.; Greiner, Dale L.; Shultz, Leonard D.; Brehm, Michael A.			Enhanced development of functional human NK cells in NOD-scid-IL2rg(null) mice expressing human IL15	FASEB JOURNAL			English	Article						Hu-IL15; humanized mice; NK cells; NSG; transgenic	NATURAL-KILLER-CELLS; T-CELLS; PROGNOSTIC-SIGNIFICANCE; MELANOMA-CELLS; MOUSE MODELS; SERUM-LEVELS; CANCER; IL-15; INTERLEUKIN-15; RESISTANCE	Human innate immunity plays a critical role in tumor surveillance and in immunoregulation within the tumor microenvironment. Natural killer (NK) cells are innate lymphoid cells that have opposing roles in the tumor microenvironment, including NK cell subsets that mediate tumor cell cytotoxicity and subsets with regulatory function that contribute to the tumor immune suppressive environment. The balance between effector and regulatory NK cell subsets has been studied extensively in murine models of cancer, but there is a paucity of models to study human NK cell function in tumorigenesis. Humanized mice are a powerful alternative to syngeneic mouse tumor models for the study of human immuno-oncology and have proven effective tools to test immunotherapies targeting T cells. However, human NK cell development and survival in humanized NOD-scid-IL2rg(null) (NSG) mice are severely limited. To enhance NK cell development, we have developed NSG mice that constitutively expresses human Interleukin 15 (IL15), NSG-Tg(Hu-IL15). Following hematopoietic stem cell engraftment of NSG-Tg(Hu-IL15) mice, significantly higher levels of functional human CD56+ NK cells are detectable in blood and spleen, as compared to NSG mice. Hematopoietic stem cell (HSC)-engrafted NSG-Tg(Hu-IL15) mice also supported the development of human CD3+ T cells, CD20+ B cells, and CD33+ myeloid cells. Moreover, the growth kinetics of a patient-derived xenograft (PDX) melanoma were significantly delayed in HSC-engrafted NSG-Tg(Hu-IL15) mice as compared to HSC-engrafted NSG mice demonstrating that human NK cells have a key role in limiting the tumor growth. Together, these data demonstrate that HSC-engrafted NSG-Tg(Hu-IL15) mice support enhanced development of functional human NK cells, which limit the growth of PDX tumors.	[Aryee, Ken-Edwin; Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Chan Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA; [Burzenski, Lisa M.; Shultz, Leonard D.] Jackson Lab, Bar Harbor, MA USA; [Yao, Li-Chin; Keck, James G.] Jackson Lab, Sacramento, CA USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Brehm, MA (corresponding author), Univ Massachusetts, Chan Med Sch, Diabet Ctr Excellence, Program Mol Med, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu			HHS | National Institutes of Health (NIH) [CA034196, AI132963, DK104218]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: CA034196, AI132963 and DK104218	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02878; Besser MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057922; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brehm MA, 2003, J IMMUNOL, V170, P4077, DOI 10.4049/jimmunol.170.8.4077; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chauvin JM, 2020, CLIN CANCER RES, V26, P5520, DOI 10.1158/1078-0432.CCR-20-0575; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041; Cichocki F, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5618; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; de Andrade LF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133103; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Douam F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07478-2; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Fang F, 2017, SEMIN IMMUNOL, V31, P37, DOI 10.1016/j.smim.2017.07.009; Felices M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96219; Fiore PF, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001428; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Greppi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040890; Guil-Luna S, 2021, ANNU REV CANC BIOL, V5, P119, DOI 10.1146/annurev-cancerbio-050520-100526; Hasgur S, 2016, METHODS MOL BIOL, V1438, P67, DOI 10.1007/978-1-4939-3661-8_4; Hatfield SD, 2018, VIROLOGY, V519, P131, DOI 10.1016/j.virol.2018.04.012; Hauser A, 2013, CYTOM PART A, V83A, P316, DOI 10.1002/cyto.a.22245; Herndler-Brandstetter D, 2017, P NATL ACAD SCI USA, V114, pE9626, DOI 10.1073/pnas.1705301114; Huntington ND, 2014, IMMUNOL CELL BIOL, V92, P210, DOI 10.1038/icb.2014.1; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; KAGESHITA T, 1993, CANCER RES, V53, P3349; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Katano I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.532684; Katano I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17442-7; Katano I, 2015, J IMMUNOL, V194, P3513, DOI 10.4049/jimmunol.1401323; Koury J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/9585614; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Lamana A, 2010, EUR CYTOKINE NETW, V21, P186, DOI 10.1684/ecn.2010.0203; Landtwing V, 2016, J CLIN INVEST, V126, P3772, DOI 10.1172/JCI86923; Li Y, 2016, EUR J IMMUNOL, V46, P1291, DOI 10.1002/eji.201546132; Li Y, 2015, SCI CHINA LIFE SCI, V58, P1233, DOI 10.1007/s11427-015-4970-9; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Maeng H, 2018, CURR OPIN IMMUNOL, V51, P111, DOI 10.1016/j.coi.2018.03.001; Marshall HT, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00315; Martinov T, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.643852; Matsuda M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800195; Maykel J, 2014, DIGEST DIS SCI, V59, P1169, DOI 10.1007/s10620-014-3168-5; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; O'Donnell JS, 2017, CANCER TREAT REV, V52, P71, DOI 10.1016/j.ctrv.2016.11.007; OLDHAM RK, 1983, CANCER METAST REV, V2, P323, DOI 10.1007/BF00048565; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Patel SA, 2018, IMMUNITY, V48, P417, DOI 10.1016/j.immuni.2018.03.007; Patidar M, 2016, CYTOKINE GROWTH F R, V31, P49, DOI 10.1016/j.cytogfr.2016.06.001; Pearson Todd, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1521s81; Pek EA, 2011, IMMUNOBIOLOGY, V216, P218, DOI 10.1016/j.imbio.2010.04.008; Phung SK, 2021, MOL DIAGN THER, V25, P577, DOI 10.1007/s40291-021-00550-6; Rajashekar JK, 2021, CELL HOST MICROBE, V29, P904, DOI 10.1016/j.chom.2021.04.014; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rautela J, 2017, CURR OPIN IMMUNOL, V44, P1, DOI 10.1016/j.coi.2016.10.004; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sottile R, 2016, EUR J IMMUNOL, V46, P409, DOI 10.1002/eji.201445289; Stolk D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01990; Suzuki J, 2001, J RHEUMATOL, V28, P2389; Vallera DA, 2016, CLIN CANCER RES, V22, P3440, DOI 10.1158/1078-0432.CCR-15-2710; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Waldmann Thomas A, 2013, J Investig Dermatol Symp Proc, V16, pS28, DOI 10.1038/jidsymp.2013.8; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877; Wege AK, 2018, BIODRUGS, V32, P245, DOI 10.1007/s40259-018-0275-4; Woan KV, 2021, CELL STEM CELL, V28, P2062, DOI 10.1016/j.stem.2021.08.013; Yao LC, 2019, METHODS MOL BIOL, V1954, P241, DOI 10.1007/978-1-4939-9145-7_15; Yee C, 2018, CURR OPIN IMMUNOL, V51, P197, DOI 10.1016/j.coi.2018.04.007; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	85	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22476	10.1096/fj.202200045R	http://dx.doi.org/10.1096/fj.202200045R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4EP	35959876	hybrid			2022-12-28	WOS:000839551400001
J	Chen, Y; Liu, YB; Zhang, YY; Yu, JM; Tang, L				Chen, Yu; Liu, Yanbin; Zhang, Yangyang; Yu, Jiangming; Tang, Liang			Galectin-1 deletion in mice causes bone loss via impaired osteogenic differentiation potential of BMSCs	FASEB JOURNAL			English	Article						bone homeostasis; bone marrow stromal cells; galectin-1; osteogenic differentiation; osteoporosis; beta-catenin	STROMAL CELLS; GENE-EXPRESSION; STEM-CELLS; PRE-B; OSTEOBLAST; PROLIFERATION; ANGIOGENESIS; LIGAND; LRP5	Bone formation is dependent on the osteoblasts which are differentiated from bone marrow stromal cells (BMSCs). In addition to potent proliferation, self-renewal, and pluripotent differentiation, BMSCs have been extensively studied due to their low immunogenicity and immunomodulatory effects. Recently, galectin-1 (Gal-1) has been proposed as a potent mediator of immunomodulatory properties of BMSCs. Previous study demonstrated that Gal-1 showed age-related decline in mice serum and serum Gal-1 was positively associated with bone mass in mice. The current study makes attempts to elucidate the functional role of Gal-1 in skeletal system by investigating the regulation of Gal-1 expression during BMSCs osteogenic differentiation and the molecular mechanisms underlying the effects of Gal-1 on BMSCs osteogenic differentiation. In Gal-1 null (-/-) mice, bone loss was observed due to bone formation attenuation. In in vitro experiments, Gal-1 supported the osteogenic differentiation of BMSCs by binding to CD146 to activate Lrp5 expression and Wnt/beta-catenin signaling pathway. Meanwhile, there was positive feedback regulation via Wnt/beta-catenin signaling to maintain Gal-1 high-level expression during osteogenic differentiation of BMSCs. More importantly, Gal-1 down-regulation in BMSCs and attenuation of osteogenic differentiation potential of BMSCs were observed in aged mice compared with young mice. Gal-1 over-expression could enhance osteogenic differentiation potential of aged BMSCs. Our study will benefit not only for deeper insights into the functional role of Gal-1 but also for finding new targets to modulate BMSCs osteogenic differentiation.	[Chen, Yu] Fudan Univ, Huashan Hosp, Dept Orthoped, Shanghai, Peoples R China; [Liu, Yanbin] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Orthoped, Shanghai, Peoples R China; [Zhang, Yangyang; Yu, Jiangming; Tang, Liang] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Orthoped Surg, Sch Med, 1111 XianXia Rd, Shanghai 200336, Peoples R China	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, JM; Tang, L (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Orthoped Surg, Sch Med, 1111 XianXia Rd, Shanghai 200336, Peoples R China.	yjm_st@163.com; hts03@126.com	zhang, yangyang/GZG-7467-2022		Natural Science Foundation of Shanghai [20ZR1469800]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Natural Science Foundation of Shanghai (20ZR1469800).	An G, 2016, BLOOD, V128, P1590, DOI 10.1182/blood-2016-03-707547; Andersen H, 2003, J BONE MINER RES, V18, P195, DOI 10.1359/jbmr.2003.18.2.195; Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003; Bibens-Laulan N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187194; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ellies DL, 2006, CELL, V125, P840, DOI 10.1016/j.cell.2006.05.022; Freitag N, 2013, P NATL ACAD SCI USA, V110, P11451, DOI 10.1073/pnas.1303707110; Frith J, 2008, TRANSFUS MED HEMOTH, V35, P216, DOI [10.1159/000127448, 000127448]; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Han YJ, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0019-6; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Iacobini C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112481; Jones E, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0144-8; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Kadri T, 2005, STEM CELLS DEV, V14, P204, DOI 10.1089/scd.2005.14.204; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Muller J, 2019, CANCERS, V11, DOI 10.3390/cancers11020261; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Simon D, 2017, BONE, V105, P35, DOI 10.1016/j.bone.2017.08.013; Sioud M, 2011, INT J ONCOL, V38, P385, DOI 10.3892/ijo.2010.869; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Troen BR, 2003, EXP GERONTOL, V38, P605, DOI 10.1016/S0531-5565(03)00069-X; Xu WT, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04272-y; Yun SP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.3; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; Zhang M, 2009, J CELL BIOCHEM, V108, P896, DOI 10.1002/jcb.22319; Zhang YY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4862861	54	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22516	10.1096/fj.202200397R	http://dx.doi.org/10.1096/fj.202200397R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Z2IN	36006656				2022-12-28	WOS:000844243300001
J	Manville, RW; Redford, KE; van der Horst, J; Hogenkamp, DJ; Jepps, TA; Abbott, GW				Manville, Rian W.; Redford, Kaitlyn E.; van der Horst, Jennifer; Hogenkamp, Derk J.; Jepps, Thomas A.; Abbott, Geoffrey W.			KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine	FASEB JOURNAL			English	Article						bark; hypotensive; KCNQ; Kv7; tannin; vasorelaxant	POTASSIUM CHANNELS; KV7.4; EXPRESSION; CELLS; ACID; ELLAGITANNINS; VASOPRESSIN; BEHAVIOR; EXTRACT; ASPIRIN	Tree and shrub barks have been used as folk medicine by numerous cultures across the globe for millennia, for a variety of indications, including as vasorelaxants and antispasmodics. Here, using electrophysiology and myography, we discovered that the KCNQ5 voltage-gated potassium channel mediates vascular smooth muscle relaxant effects of barks used in Native American folk medicine. Bark extracts (1%) from Birch, Cramp Bark, Slippery Elm, White Oak, Red Willow, White Willow, and Wild Cherry each strongly activated KCNQ5 expressed in Xenopus oocytes. Testing of a subset including both the most and the least efficacious extracts revealed that Red Willow, White Willow, and White Oak KCNQ-dependently relaxed rat mesenteric arteries; in contrast, Black Haw bark neither activated KCNQ5 nor induced vasorelaxation. Two compounds common to the active barks (gallic acid and tannic acid) had similarly potent and efficacious effects on both KCNQ5 activation and vascular relaxation, and this together with KCNQ5 modulation by other tannins provides a molecular basis for smooth muscle relaxation effects of Native American folk medicine bark extracts.	[Manville, Rian W.; Redford, Kaitlyn E.; Hogenkamp, Derk J.; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D,ZOT 4560, Irvine, CA 92697 USA; [van der Horst, Jennifer; Jepps, Thomas A.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Vasc Biol Grp, 12-5-30,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of California System; University of California Irvine; University of Copenhagen	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D,ZOT 4560, Irvine, CA 92697 USA.; Jepps, TA (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, Vasc Biol Grp, 12-5-30,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	tjepps@sund.ku.dk; ahhottg@hs.uci.edu		Abbott, Geoffrey/0000-0003-4552-496X; Manville, Rian/0000-0002-0057-3541	European Union's Horizon 2020 Research and Innovation Program [801199]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM130377]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [T32NS045540]; Lundbeckfonden (Lundbeck Foundation) [R323-2018-3674]; Samueli Scholarship	European Union's Horizon 2020 Research and Innovation Program; HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); Lundbeckfonden (Lundbeck Foundation); Samueli Scholarship	European Union & apos;s Horizon 2020 Research and Innovation Program, Grant/Award Number: 801199; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM130377; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: T32NS045540; Lundbeckfonden (Lundbeck Foundation), Grant/Award Number: R323--2018--3674; Samueli Scholarship	Abbott GW, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.777057; Abbott GW, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00583; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Baldwin SN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.598779; Brueggemann LI, 2007, AM J PHYSIOL-HEART C, V292, pH1352, DOI 10.1152/ajpheart.00065.2006; Brueggemann LI, 2014, J BIOL CHEM, V289, P2099, DOI 10.1074/jbc.M113.527820; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2014, MOL PHARMACOL, V86, P330, DOI 10.1124/mol.114.093799; Chadha PS, 2014, ARTERIOSCL THROM VAS, V34, P887, DOI 10.1161/ATVBAHA.114.303405; CHANDLER RF, 1979, J ETHNOPHARMACOL, V1, P49, DOI 10.1016/0378-8741(79)90016-3; Densmore F., 1928, SI BAE ANN REP, V44, P273; Desborough MJR, 2017, BRIT J HAEMATOL, V177, P674, DOI 10.1111/bjh.14520; Dwivedi S, 2007, J ETHNOPHARMACOL, V114, P114, DOI 10.1016/j.jep.2007.08.003; Gilmore MR., 1933, SOME CHIPPEWA USES P; Grieve M., 1971, MODERN HERBAL MED CU; Hamel P.B., 1975, CHEROKEE PLANTS THEI; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hartzfeld PW, 2002, J AGR FOOD CHEM, V50, P1785, DOI 10.1021/jf0111155; Herrick JW., 1977, IROQUOIS MEDICAL BOT; Inskeep RR., 1969, S AFR ARCHAEOL BULL, V24, P21; JARBOE CH, 1967, J MED CHEM, V10, P488, DOI 10.1021/jm00315a045; Jensen HS, 2005, MOL BRAIN RES, V139, P52, DOI 10.1016/j.molbrainres.2005.05.007; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; Knuth S, 2013, PLANTA MED, V79, P1489, DOI 10.1055/s-0033-1350898; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Levesque H, 2000, REV MED INTERNE, V21, p8S, DOI 10.1016/S0248-8663(00)88720-2; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; MAKKAR HPS, 1993, J CHEM ECOL, V19, P613, DOI 10.1007/BF00984996; Manville RW, 2019, P NATL ACAD SCI USA, V116, P21236, DOI 10.1073/pnas.1907511116; Manville RW, 2019, FASEB J, V33, P11349, DOI 10.1096/fj.201900485R; Manville RW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06339-2; Matschke V, 2016, CELL PHYSIOL BIOCHEM, V40, P1549, DOI 10.1159/000453205; McCallum LA, 2009, PFLUG ARCH EUR J PHY, V457, P1111, DOI 10.1007/s00424-008-0567-5; Miller A L, 1998, Altern Med Rev, V3, P422; Mistry HD, 2011, HYPERTENSION, V58, P497, DOI 10.1161/HYPERTENSIONAHA.111.173740; Moerman D.E., 2009, NATIVE AM MED PLANTS; Newsome AG, 2016, J AGR FOOD CHEM, V64, P1326, DOI 10.1021/acs.jafc.5b04966; NICHOLSON JA, 1972, P SOC EXP BIOL MED, V140, P457; Oh KS, 2008, BIOL PHARM BULL, V31, P2090, DOI 10.1248/bpb.31.2090; Panchal SK, 2013, EUR J NUTR, V52, P397, DOI 10.1007/s00394-011-0277-1; Redford Kaitlyn E, 2021, Cell Physiol Biochem, V55, P46, DOI 10.33594/000000337; Redford KE, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1089-8; Smith H.H., 1932, B PUBLIC MUSEUM CITY, V4, P327; Syed AA, 2016, J ETHNOPHARMACOL, V193, P555, DOI 10.1016/j.jep.2016.10.008; Tantaquidgeon G., 1972, PENN HIST COMM ANTH, V3, P28; Taylor LA., 1940, PLANTS USED CURATIVE; van der Horst J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00727; Vlachojannis J, 2011, PHYTOTHER RES, V25, P1102, DOI 10.1002/ptr.3386; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Zhang XM, 2011, AM J PHYSIOL-CELL PH, V301, pC1017, DOI 10.1152/ajpcell.00185.2011; Zhang X, 2015, EUR J PHARMACOL, V764, P633, DOI 10.1016/j.ejphar.2015.06.048; Zhang YY, 2016, J PHARM PHARMACOL, V68, P494, DOI 10.1111/jphp.12527; Zhao CY, 2019, TETRAHEDRON, V75, P1997, DOI 10.1016/j.tet.2019.02.024	57	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22457	10.1096/fj.202200724R	http://dx.doi.org/10.1096/fj.202200724R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X7AQ	35997997				2022-12-28	WOS:000843190200001
J	Park, SY; Kang, MJ; Jin, NR; Lee, SY; Lee, YY; Jo, S; Eom, JY; Han, H; Chung, SI; Jang, K; Kim, TH; Park, J; Han, JS				Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Lee, So Young; Lee, Yun Young; Jo, Sungsin; Eom, Jeong Yun; Han, Heejae; Chung, Sook In; Jang, Kiseok; Kim, Tae-Hwan; Park, Jungwon; Han, Joong-Soo			House dust mite-induced Akt-ERK1/2-C/EBP beta pathway triggers CCL20-mediated inflammation and epithelial-mesenchymal transition for airway remodeling	FASEB JOURNAL			English	Article						airway remodeling; asthma; CCL20 (C-C chemokine ligand 20); house dust mites; NLRP3 (Nod-like receptor family pyrin domain containing 3	INNATE IMMUNE ACTIVATION; GROWTH-FACTOR-BETA; NLRP3 INFLAMMASOME; PULMONARY INFLAMMATION; NALP3 INFLAMMASOME; ASTHMA; CELLS; CCL20; FIBROSIS; RECRUITMENT	House dust mite (HDM) allergens cause inflammatory responses and chronic allergic diseases such as bronchial asthma and atopic dermatitis. Here, we investigate the mechanism by which HDM induces C-C chemokine ligand 20 (CCL20) expression to promote chronic inflammation and airway remodeling in an HDM-induced bronchial asthma mouse model. We showed that HDM increased CCL20 levels via the Akt-ERK1/2-C/EBP beta pathway. To investigate the role of CCL20 in chronic airway inflammation and remodeling, we made a mouse model of CCL20-induced bronchial asthma. Treatment of anti-CCL20Ab in this mouse model showed the reduced airway hyper-responsiveness and inflammatory cell infiltration into peribronchial region by neutralizing CCL20. In addition, CCL20 induced the Nod-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation through NLRP3 deubiquitination and transcriptional upregulation in BEAS-2B cells. As expected, anti-CCL20Ab markedly suppressed NLRP3 activation induced by CCL20. Moreover, HDM-induced CCL20 leads to epithelial-mesenchymal transition in the lung epithelium which appears to be an important regulator of airway remodeling in allergic asthma. We also found that anti-CCL20Ab attenuates airway inflammation and remodeling in an HDM-induced mouse model of bronchial asthma. Taken together, our results suggest that HDM-induced CCL20 is required for chronic inflammation that contributes airway remodeling in a mouse model of asthma.	[Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Han, Joong-Soo] Hanyang Univ, Coll Med, Biomed Res Inst, 222 Wangsimni Ro, Seoul 04763, South Korea; [Park, Shin-Young; Kang, Min-Jeong; Jin, Nuri; Han, Joong-Soo] Hanyang Univ, Coll Med, Dept Biochem, 222 Wangsimni Ro, Seoul 04763, South Korea; [Lee, So Young] EONE DIAGN Genome Ctr Co Ltd, Incheon, South Korea; [Lee, Yun Young] Gencurix Inc, Seoul, South Korea; [Jo, Sungsin; Kim, Tae-Hwan] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea; [Eom, Jeong Yun; Jang, Kiseok] Hanyang Univ Hosp, Dept Pathol, Seoul, South Korea; [Han, Heejae; Chung, Sook In; Park, Jungwon] Yonsei Univ, Inst Allergy, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University Hospital; Yonsei University; Yonsei University Health System	Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Biomed Res Inst, 222 Wangsimni Ro, Seoul 04763, South Korea.; Park, SY; Han, JS (corresponding author), Hanyang Univ, Coll Med, Dept Biochem, 222 Wangsimni Ro, Seoul 04763, South Korea.	ttokttoki@hanyang.ac.kr; jshan@hanyang.ac.kr	park, shiny/ABY-8695-2022; Jo, Sungsin/AAL-3659-2021	park, shiny/0000-0002-6073-4634; Jo, Sungsin/0000-0003-3034-5029	National Research Foundation of Korea (NRF) [2021R1A2C1008317, 2018R1A1A1A05022185]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2C1008317 and 2018R1A1A1A05022185	Al-Alawi M, 2014, RESP MED, V108, P1409, DOI 10.1016/j.rmed.2014.08.008; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Artlett CM, 2015, ANTIOXID REDOX SIGN, V22, P1162, DOI 10.1089/ars.2014.6148; Artlett Carol M, 2012, Open Rheumatol J, V6, P80, DOI 10.2174/1874312901206010080; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Faiz A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00310-2018; Fehrenbach H, 2017, CELL TISSUE RES, V367, P551, DOI 10.1007/s00441-016-2566-8; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garcia G, 2005, CURR ALLERGY ASTHM R, V5, P155, DOI 10.1007/s11882-005-0090-0; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Groslambert M, 2018, J INFLAMM RES, V11, P359, DOI 10.2147/JIR.S141220; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Hill Charlotte, 2019, J Lung Health Dis, V3, P31; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hong GH, 2016, J IMMUNOL, V196, P2021, DOI 10.4049/jimmunol.1500747; Hosokawa Y, 2016, CELL PHYSIOL BIOCHEM, V38, P153, DOI 10.1159/000438617; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Huang FL, 2018, IMMUNOBIOLOGY, V223, P300, DOI 10.1016/j.imbio.2017.10.035; Huang QQ, 2020, AGING-US, V12, P5812, DOI 10.18632/aging.102978; Jacquet Alain, 2013, ISRN Allergy, V2013, P735031, DOI 10.1155/2013/735031; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Lee AYS, 2014, IMMUNOL CELL BIOL, V92, P354, DOI 10.1038/icb.2013.97; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Liu D, 2019, CLIN SCI, V133, P565, DOI 10.1042/CS20180600; Liu Y, 2016, ONCOTARGET, V7, P25328, DOI 10.18632/oncotarget.8291; Lu AL, 2017, J IMMUNOL, V198, P1119, DOI 10.4049/jimmunol.1600659; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Marsigliante S, 2016, MOL CARCINOGEN, V55, P1175, DOI 10.1002/mc.22360; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Persson IM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0725-z; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Porsbjerg C, 2016, CLIN EXP ALLERGY, V46, P564, DOI 10.1111/cea.12702; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shimizu H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46116-9; Song C, 2016, J CELL MOL MED, V20, P2064, DOI 10.1111/jcmm.12898; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Wang Huaying, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P758, DOI 10.3785/j.issn.1008-9292.2020.12.11; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Xiao Fenglin WS., 2021, MOL CELL TOXICOL, V17, P315; Zahid A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02538	52	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22452	10.1096/fj.202200150RR	http://dx.doi.org/10.1096/fj.202200150RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L4XD	35916017				2022-12-28	WOS:000834764400001
J	Li, T; Yan, B; Xiao, XJ; Zhou, L; Zhang, J; Yuan, Q; Shan, LT; Wu, HL; Efferth, T				Li, Ting; Yan, Bo; Xiao, Xiujuan; Zhou, Li; Zhang, Jin; Yuan, Qiang; Shan, Letian; Wu, Huiling; Efferth, Thomas			Onset of p53/NF-kappa B signaling crosstalk in human melanoma cells in response to anti-cancer theabrownin	FASEB JOURNAL			English	Article						crosstalk; DNA damage; melanoma; senescence; theabrownin; zebrafish	NF-KAPPA-B; DRINKING GREEN TEA; DNA-DAMAGE; SKIN-CANCER; BLACK TEA; P53; PROTECTION; POLY(ADP-RIBOSYL)ATION; PHOTOCARCINOGENESIS; CARCINOGENESIS	As a major tea component, theabrownin represents a promising anti-cancer candidate. However, its effect on the melanoma is unknown. To evaluate the in vitro and in vivo anti-melanoma efficacy of TB, we conducted cell viability, immunostaining, comet, and TUNEL assays on human A375 melanoma cells, and employed a zebrafish xenograft model of A375 cells. Real-time PCR (qPCR) and western blot were conducted to explore the molecular mechanisms of TB. In vitro, TB significantly inhibited the proliferation of A375 cells, and A375 cells showed the highest inhibitory rate among the other melanoma cell line (A875) and human dermal fibroblasts. TB triggered DNA damage and induced apoptosis of A375 cells and significantly inhibited the growth of A375 xenograft tumors in zebrafishes. Several key molecular events were activated by TB, including DNA damage-associated p53 and NF-kappa B pathways, through up-regulation of GADD45 alpha, gamma-H2A.X, phospho-ATM(p-ATM), phospho-ATR (p-ATR), phospho-p53 (p-p53), phospho-IKK alpha/beta (p-IKK alpha/beta), phospho-p65 (p-p65), etc. However, the TB-activated molecular events were counteracted by either knockdown of p53 or p65, and only dual knockdown of both p53 and p65 completed counteracted the anti-melanoma efficacy of TB. In conclusion, TB triggered DNA damage and thereby inhibited proliferation and induced cellular senescence and apoptosis of melanoma cells through mechanisms mediated by p53/NF-kappa B signaling crosstalk. This is the first report on the efficacy and mechanisms of TB on melanoma cells, making TB a promising candidate for anti-melanoma agent development.	[Li, Ting; Wu, Huiling] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China; [Li, Ting; Wu, Huiling] Zhejiang Univ, Dept Plast & Aesthet Ctr, Affiliated Hosp 1, Hangzhou, Peoples R China; [Yan, Bo; Xiao, Xiujuan; Yuan, Qiang] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China; [Yan, Bo] Shangyu Biotechnol Co Ltd, Hangzhou Reg Cell Preparat Ctr, Cell Resource Bank, Hangzhou, Peoples R China; [Yan, Bo] Shangyu Biotechnol Co Ltd, Hangzhou Reg Cell Preparat Ctr, Integrated Cell Preparat Ctr Xiaoshan Dist, Hangzhou, Peoples R China; [Zhou, Li; Shan, Letian] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Peoples R China; [Zhang, Jin] Theabio Co Ltd, Hangzhou, Peoples R China; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Mainz, Germany	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Johannes Gutenberg University of Mainz	Wu, HL (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China.; Shan, LT (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Peoples R China.	letian.shan@zcmu.edu.cn; zywhl@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81774331, 81873049]; Zhejiang Provincial Natural Science Foundation of China (ZJNSF) [LY18H270004, LQ20H150008]; Zhejiang Provincial Basic Public Welfare Research Program [LGF22H150017]; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China [ZYX2018006]; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China [2016ZZ011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China (ZJNSF)(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Basic Public Welfare Research Program; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81774331 and 81873049; Zhejiang Provincial Natural Science Foundation of China (ZJNSF), Grant/Award Number: LY18H270004 and LQ20H150008; Zhejiang Provincial Basic Public Welfare Research Program, Grant/Award Number: LGF22H150017; Zhejiang Provincial Key Construction University Superiority Characteristic Discipline (Traditional Chinese Pharmacology) Opening Foundation of China, Grant/Award Number: ZYX2018006; Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine of China, Grant/Award Number: 2016ZZ011	Abraham I, 2016, ALLERGY, V71, P593, DOI 10.1111/all.12815; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Baliga MS, 2006, PHOTOCH PHOTOBIO SCI, V5, P243, DOI 10.1039/b505311k; Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR; Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; Bauer J, 2003, PIGM CELL RES, V16, P297, DOI 10.1034/j.1600-0749.2003.00047.x; Candido S, 2014, ONCOL REP, V31, P1079, DOI 10.3892/or.2014.2977; Carra G, 2020, CELL MOL LIFE SCI, V77, P4449, DOI 10.1007/s00018-020-03524-9; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dimitriou F, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0732-8; Duan R, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1057943; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Guo L, 2020, ARCH BIOCHEM BIOPHYS, V692, DOI 10.1016/j.abb.2020.108519; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Han C, 1999, Wei Sheng Yan Jiu, V28, P343; Hawkes JE, 2016, SEMIN ONCOL, V43, P591, DOI 10.1053/j.seminoncol.2016.08.003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Huang MT, 1997, CANCER RES, V57, P2623; Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242; Jin WD, 2020, ONCOL REP, V44, P2621, DOI 10.3892/or.2020.7801; Jin WD, 2018, J CELL MOL MED, V22, P4423, DOI 10.1111/jcmm.13742; Katiyar Santosh K., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P234, DOI 10.2174/1568008033340171; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kwon M, 2016, CELL CYCLE, V15, P3105, DOI 10.1080/15384101.2016.1235104; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Mao XB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215249; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Muruzabal D, 2021, ARCH TOXICOL, V95, P2825, DOI 10.1007/s00204-021-03102-3; Nakachi K, 1998, JPN J CANCER RES, V89, P254, DOI 10.1111/j.1349-7006.1998.tb00556.x; Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Record IR, 1998, MUTAT RES-FUND MOL M, V422, P191, DOI 10.1016/S0027-5107(98)00192-4; Record IR, 1998, NUTR CANCER, V32, P71, DOI 10.1080/01635589809514721; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Shan ZG, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6256618; Shirakami Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23092284; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Tian LW, 2014, J AGR FOOD CHEM, V62, P12229, DOI 10.1021/jf5036959; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WANG ZY, 1992, CANCER RES, V52, P6657; WANG ZY, 1994, CANCER RES, V54, P3428; WANG ZY, 1991, CARCINOGENESIS, V12, P1527, DOI 10.1093/carcin/12.8.1527; Wu CE, 2018, BRIT J CANCER, V118, P495, DOI 10.1038/bjc.2017.433; Wu EK, 2020, EUR J NUTR, V59, P1937, DOI 10.1007/s00394-019-02044-y; Wu FF, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00465; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yang KM, 2018, CANCER EPIDEM BIOMAR, V27, P1115, DOI [10.1158/1055-9965.EPI-18-0243, 10.1158/1055-9965.epi-18-0243]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yue XT, 2017, J MOL BIOL, V429, P1595, DOI 10.1016/j.jmb.2017.03.030; Zhou L, 2017, FRONT PHARMACOL, V8, P1, DOI 10.3389/fphar.2017.00075; Zhu K, 2021, CRIT REV FOOD SCI, V61, P1556, DOI 10.1080/10408398.2020.1762161	63	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22426	10.1096/fj.202200261R	http://dx.doi.org/10.1096/fj.202200261R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2P8PV	35779042				2022-12-28	WOS:000819996500001
J	Liu, X; Fan, WL; Zhang, XJ; Zhan, SY; Zhong, T; Guo, JZ; Wang, Y; Cao, JX; Li, L; Zhang, HP; Wang, LJ				Liu, Xin; Fan, Wenli; Zhang, Xujia; Zhan, Siyuan; Zhong, Tao; Guo, Jiazhong; Wang, Yan; Cao, Jiaxue; Li, Li; Zhang, Hongping; Wang, Linjie			Maternal L-carnitine supplementation promotes brown adipose tissue thermogenesis of newborn goats after cold exposure	FASEB JOURNAL			English	Article						brown adipose tissue; cold exposure; L-carnitine; lipidomics; thermogenesis	OXIDATIVE-METABOLISM; FATTY-ACIDS; GLUCOSE; OBESE; EXPRESSION; INDUCTION; CHROMIUM; ELOVL3; MASS	Brown adipose tissue (BAT) is an important component of energy expenditure and necessary to maintain body temperature for newborn mammals. In the previous study, we found that L-carnitine was enriched in BAT and promoted BAT adipogenesis and thermogenesis in goat brown adipocytes. However, whether dietary L-carnitine regulates BAT heat production and energy expenditure in lambs remains unclear. In this study, maternal L-carnitine supplementation elevated the rectal temperature, as well as the expression of UCP1 and mitochondrial DNA content to promote BAT thermogenesis in newborn goats. Moreover, maternal L-carnitine supplementation increased the levels of triglycerides (TG), non-esterified fatty acids (NEFA), and lactate in plasma, as well as the content of lipid droplet and glycogen in BAT of newborn goats. Lipidomic analysis showed that maternal L-carnitine supplementation remodeled the lipid composition of BAT in newborn goats. L-carnitine significantly increased the levels of TG and diglyceride (DG) and decreased the levels of glycerophospholipids and sphingolipids in BAT. Further studies showed that L-carnitine promoted TG and glycogen deposition in brown adipocytes through AMPK alpha. Our results indicate that maternal L-carnitine supplementation promotes BAT development and thermogenesis in newborn goats and provides new evidence for newborn goats to maintain body temperature in response to cold exposure.	[Liu, Xin; Zhan, Siyuan; Zhong, Tao; Li, Li; Wang, Linjie] Sichuan Agr Univ, Coll Anim & Technol, Key Lab Livestock & Poultry Multiom, Minist Agr & Rural Affairs, Chengdu 611130, Sichuan, Peoples R China; [Liu, Xin; Fan, Wenli; Zhang, Xujia; Zhan, Siyuan; Zhong, Tao; Guo, Jiazhong; Wang, Yan; Cao, Jiaxue; Li, Li; Zhang, Hongping; Wang, Linjie] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University	Wang, LJ (corresponding author), Sichuan Agr Univ, Coll Anim & Technol, Key Lab Livestock & Poultry Multiom, Minist Agr & Rural Affairs, Chengdu 611130, Sichuan, Peoples R China.	wanglinjie@sicau.edu.cn		Wang, Yan/0000-0003-1412-5499	National Key Research and Development Program of China [2021YFD1100202]	National Key Research and Development Program of China	This study was supported by the grant from the National Key Research and Development Program of China (2021YFD1100202).	ARDUINI A, 1992, J BIOL CHEM, V267, P12673; Arenas J, 1998, EARLY HUM DEV, V53, pS43, DOI 10.1016/S0378-3782(98)00064-4; Bai Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.75; Basse AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1405-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chapa AM, 2001, SMALL RUMINANT RES, V40, P13, DOI 10.1016/S0921-4488(00)00218-2; Chen Y, 2019, NATURE, V565, P180, DOI 10.1038/s41586-018-0801-z; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; delosReyes B, 1996, BBA-MOL BASIS DIS, V1315, P37, DOI 10.1016/0925-4439(95)00099-2; Dragan G I, 1987, Physiologie, V24, P23; Emmett MJ, 2017, NATURE, V546, P544, DOI 10.1038/nature22819; Fainberg HP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27376-3; Fuller-Jackson JP, 2018, FASEB J, V32, P3859, DOI 10.1096/fj.201701504R; Fuller-Jackson JP, 2018, J ENDOCRINOL, V237, pR99, DOI 10.1530/JOE-18-0090; Gao X, 2020, FOOD FUNCT, V11, P7707, DOI 10.1039/d0fo01743d; Ghandour RA, 2018, J LIPID RES, V59, P452, DOI 10.1194/jlr.M081091; Hamza RT, 2016, ARCH MED RES, V47, P541, DOI 10.1016/j.arcmed.2016.11.010; Huang Z, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110575; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Kaikaew K, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.652444; Keinan O, 2021, NATURE, V599, P296, DOI 10.1038/s41586-021-04019-8; Kim JH, 2015, BIOCHEM BIOPH RES CO, V464, P568, DOI 10.1016/j.bbrc.2015.07.009; Kim YJ, 2008, GENES NUTR, V2, P353, DOI 10.1007/s12263-007-0070-1; Kobayashi T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1461, DOI 10.1152/ajpendo.00623.2011; Kon K, 2017, HEPATOL RES, V47, pE44, DOI 10.1111/hepr.12720; Lee MS, 2006, J MED FOOD, V9, P468, DOI 10.1089/jmf.2006.9.468; Li Y, 2022, CELL, V185, P949, DOI 10.1016/j.cell.2022.02.004; Lim Chae Young, 2010, Korean J Gastroenterol, V55, P384, DOI 201006256; Liu LX, 2017, CIRC RES, V121, P1370, DOI 10.1161/CIRCRESAHA.117.311456; Bargut TCL, 2019, MOL CELL ENDOCRINOL, V482, P18, DOI 10.1016/j.mce.2018.12.003; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; MACCARI F, 1987, LIPIDS, V22, P1005, DOI 10.1007/BF02536440; Marcher AB, 2015, CELL REP, V13, P2000, DOI 10.1016/j.celrep.2015.10.069; Mayeuf-Louchart A, 2019, CELL REP, V29, P1410, DOI 10.1016/j.celrep.2019.09.073; McCoard S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-684; McKnight SM, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa118; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Puttabyatappa M, 2020, MOL CELL ENDOCRINOL, V503, DOI 10.1016/j.mce.2019.110691; Rahman MS, 2021, PHYTOTHER RES, V35, P920, DOI 10.1002/ptr.6845; Richards EM, 2019, AM J PHYSIOL-ENDOC M, V317, pE573, DOI 10.1152/ajpendo.00007.2019; Ringseis R, 2018, ARCH ANIM NUTR, V72, P1, DOI 10.1080/1745039X.2017.1421340; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; RONCARI DAK, 1976, CAN J BIOCHEM CELL B, V54, P923, DOI 10.1139/o76-133; Seron-Ferre M, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2016.00232; SILIPRANDI N, 1990, ADV EXP MED BIOL, V272, P175; Smith SB, 2020, ASIAN AUSTRAL J ANIM, V33, P506, DOI 10.5713/ajas.18.0179; Sneddon AA, 2009, NUTRIENTS, V1, P178, DOI 10.3390/nu1020178; Symonds ME, 2018, J ENDOCRINOL, V238, pR53, DOI 10.1530/JOE-18-0084; Symonds ME, 2015, ANNU REV NUTR, V35, P295, DOI 10.1146/annurev-nutr-071813-105330; Symonds ME, 2012, P NUTR SOC, V71, P363, DOI 10.1017/S0029665112000584; Vecchio Michele, 2021, J Funct Morphol Kinesiol, V6, DOI 10.3390/jfmk6040093; Walker DK, 2005, J ANIM PHYSIOL AN N, V89, P413, DOI 10.1111/j.1439-0396.2005.00563.x; Wang LJ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091626; Wang LJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080904; Wang Y, 2021, FASEB J, V35, DOI 10.1096/fj.202100493RR; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Woodworth JC, 2007, J ANIM SCI, V85, P2524, DOI 10.2527/jas.2006-284; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Xu ZY, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0693-x; Yang JY, 2006, J MED FOOD, V9, P459, DOI 10.1089/jmf.2006.9.459; Zhang FL, 2018, FOOD FUNCT, V9, P2043, DOI [10.1039/c7fo01817g, 10.1039/C7FO01817G]; Zhang T, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040193; Zhou BR, 2013, BIOL TRACE ELEM RES, V155, P221, DOI 10.1007/s12011-013-9790-9	64	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22461	10.1096/fj.202200637R	http://dx.doi.org/10.1096/fj.202200637R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X8VZ	35838582				2022-12-28	WOS:000825478000001
J	Lu, J; Zhang, W; Yu, KK; Zhang, LL; Lou, YQ; Gu, P; Nie, W; Qian, J; Xu, J; Wang, HM; Zhong, H; Han, BH				Lu, Jun; Zhang, Wei; Yu, Keke; Zhang, Lele; Lou, Yuqing; Gu, Ping; Nie, Wei; Qian, Jie; Xu, Jun; Wang, Huimin; Zhong, Hua; Han, Baohui			Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer	FASEB JOURNAL			English	Article						anlotinib; biomarker; liquid biopsy; non-small cell lung cancer; proteomics	EXTRACELLULAR VESICLES; NSCLC; 3RD	Anlotinib has been demonstrated to be effective in advanced non-small cell lung cancer (NSCLC) patients. The response stratification of anlotinib remains unclear. In this study, plasma samples from 28 anlotinib-treated NSCLC patients (discovery cohort: 14 responders and 14 non-responders) were subjected to proteomic analysis, and plasma samples from 35 anlotinib-treated NSCLC patients (validation cohort) were subjected to validation analysis. Liquid chromatography-tandem mass spectrometry analysis was performed on samples with different time points, namely baseline (BL), best response (BR), and progression disease (PD). Bioinformatics analysis was performed to screen for the underlying differential proteins. Enzyme-linked immunosorbent assay was performed to detect plasma ARHGDIB, FN1, CDH1, and KNG1 levels respectively. The Kaplan-Meier survival analysis was used for biomarker-based responsive stratification. Our results indicated that differential proteins between responders and non-responders showed that proteomic technology potentially contributes to biomarker screening in plasma samples at BL. Furthermore, our results suggested that the detection of plasma ARHGDIB, FN1, CDH1, and KNG1 levels have potential predictive value for anlotinib response both in the discovery cohort and validation cohort. Collectively, this study offers novel insights into the value of plasma biomarker screening via proteomic examination and suggests that plasma ARHGDIB, FN1, CDH1, and KNG1 levels could be used as biomarkers for anlotinib stratification in NSCLC patients.	[Lu, Jun; Zhang, Wei; Zhang, Lele; Lou, Yuqing; Gu, Ping; Nie, Wei; Wang, Huimin; Zhong, Hua; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Sch Med, Shanghai 200030, Peoples R China; [Lu, Jun; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Inst Thorac Oncol, Sch Med, Shanghai, Peoples R China; [Lu, Jun; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Translat Med Res Platform Thorac Oncol, Sch Med, Shanghai, Peoples R China; [Lu, Jun; Yu, Keke] Shanghai Jiao Tong Univ, Dept Biobank, Sch Med, Shanghai Chest Hosp, Shanghai, Peoples R China; [Qian, Jie] Shanghai Jiao Tong Univ, Dept Emergency Med, Sch Med, Shanghai Chest Hosp, Shanghai, Peoples R China; [Xu, Jun] Anhui Med Univ, Dept Emergency Med, Hosp 1, Hefei, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Anhui Medical University	Zhong, H; Han, BH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Sch Med, Shanghai 200030, Peoples R China.	eddiedong8@hotmail.com; 18930858216@163.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		foundation of Shanghai Chest Hospital [2019YNJCM11, YJXT20190102]; Shanghai Leading Talents Program (2013); program of system biomedicine innovation center from Shanghai Jiao Tong University [15ZH4009, YG2021QN121]; key program of translational medicine from Shanghai Jiao Tong University School of Medicine [15ZH1008]; foundation of Chinese Society of Clinical Oncology [Y-2019AZZD-0355, Y-QL2019-0125]	foundation of Shanghai Chest Hospital; Shanghai Leading Talents Program (2013); program of system biomedicine innovation center from Shanghai Jiao Tong University; key program of translational medicine from Shanghai Jiao Tong University School of Medicine; foundation of Chinese Society of Clinical Oncology	The authors thank the patients and investigators for their participation in the clinical trial. This work was supported by the foundation of Shanghai Chest Hospital (Project No. 2019YNJCM11 & YJXT20190102); the Shanghai Leading Talents Program (2013), the program of system biomedicine innovation center from Shanghai Jiao Tong University (Project No. 15ZH4009 & YG2021QN121); the key program of translational medicine from Shanghai Jiao Tong University School of Medicine (Project No. 15ZH1008); the foundation of Chinese Society of Clinical Oncology (Project No. Y-2019AZZD-0355 & Y-QL2019-0125).	Barnabas GD, 2019, MOL CELL PROTEOMICS, V18, P865, DOI 10.1074/mcp.RA119.001362; Boccellino M, 2019, J CELL PHYSIOL, V234, P23798, DOI 10.1002/jcp.28948; CHENG Y, 2019, ANN ONCOL, V30, P711; Chi YHBL, 2018, CLIN CANCER RES, V24, P5233, DOI 10.1158/1078-0432.CCR-17-3766; Cho KR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10187; Chu TQ, 2021, CANCER BIOL MED, V18, P816, DOI 10.20892/j.issn.2095-3941.2020.0212; Eckert MA, 2019, NATURE, V569, P723, DOI 10.1038/s41586-019-1173-8; Fujita K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42961; Han BH, 2018, JAMA ONCOL, V4, P1569, DOI 10.1001/jamaoncol.2018.3039; Han BH, 2018, BRIT J CANCER, V118, P654, DOI 10.1038/bjc.2017.478; Henderson MC, 2019, CLIN CANCER RES, V25, P142, DOI 10.1158/1078-0432.CCR-18-0843; Hristova VA, 2019, EXPERT REV PROTEOMIC, V16, P93, DOI 10.1080/14789450.2019.1559062; Huang Z, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600240; Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8; Lee J, 2015, PROTEOMICS, V15, P3331, DOI 10.1002/pmic.201500037; Li JQ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01961; Lin BY, 2018, GENE, V654, P77, DOI 10.1016/j.gene.2018.02.026; Liu ZJ, 2018, CANCER MED-US, V7, P3011, DOI 10.1002/cam4.1584; Loriot Y, 2021, ANN ONCOL, V32, P1381, DOI 10.1016/j.annonc.2021.08.1748; Lou YQ, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03439-8; Lu J, 2022, CHINESE J CANCER RES, V34, DOI 10.21147/j.issn.1000-9604.2022.01.03; Lu J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.732125; Lu J, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.723670; Lu J, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00886; Lu J, 2019, ADV SCI, V6, DOI 10.1002/advs.201900721; Lu J, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01562-2018; Lu J, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818801809; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Peng LY, 2018, MOL OMICS, V14, P405, DOI 10.1039/c8mo00126j; Pilotto S, 2014, CURR PHARM DESIGN, V20, P3958, DOI 10.2174/13816128113196660757; Sun YK, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0332-8; Wang J, 2018, CANCER BIOL MED, V15, P443, DOI 10.20892/j.issn.2095-3941.2018.0158; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Xie CY, 2018, CANCER SCI, V109, P1207, DOI 10.1111/cas.13536; Xu W, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4108474; Zhang YW, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01049; Zhou AP, 2019, ONCOLOGIST, V24, pE702, DOI 10.1634/theoncologist.2018-0839	37	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22465	10.1096/fj.202101658R	http://dx.doi.org/10.1096/fj.202101658R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3C6WH	35867072	Green Submitted			2022-12-28	WOS:000828761500001
J	Zegallai, HM; Abu-El-Rub, E; Olayinka-Adefemi, F; Cole, LK; Sparagna, GC; Marshall, AJ; Hatch, GM				Zegallai, Hana M.; Abu-El-Rub, Ejlal; Olayinka-Adefemi, Folayemi; Cole, Laura K.; Sparagna, Genevieve C.; Marshall, Aaron J.; Hatch, Grant M.			Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes	FASEB JOURNAL			English	Article						activated B lymphocytes; Barth syndrome; cardiolipin; immune function; lipopolysaccharide; mesenchymal stem cells; mitochondria; tafazzin	BARTH SYNDROME; CARDIOLIPIN; PLASMABLASTS; QUANTITATION; RESPONSES; INHIBIT	Barth Syndrome (BTHS) is a rare X-linked genetic disorder caused by mutation in the TAFAZZIN gene. Tafazzin (Taz) deficiency in BTHS patients results in an increased risk of infections. Mesenchymal stem cells (MSCs) are well known for their immune-inhibitory function. We examined how Taz-deficiency in murine MSCs impact their ability to modulate the function of lipopolysaccharide (LPS)-activated wild type (WT) B lymphocytes. MSCs from tafazzin knockdown (TazKD) mice exhibited a reduction in mitochondrial cardiolipin compared to wild type (WT) MSCs. However, mitochondrial bioenergetics and membrane potential were unaltered. In contrast, TazKD MSCs exhibited increased reactive oxygen species generation and increased glycolysis. The increased glycolysis was associated with an elevated proliferation, phosphatidylinositol-3-kinase expression and expression of the immunosuppressive markers indoleamine-2,3-dioxygenase, cytotoxic T-lymphocyte-associated protein 4, interleukin-10, and cluster of differentiation 59 compared to controls. Inhibition of glycolysis with 2-deoxyglucose attenuated the TazKD-mediated increased expression of cytotoxic T-lymphocyte-associated protein 4 and interleukin-10. When co-cultured with LPS-activated WT B cells, TazKD MSCs inhibited B cell proliferation and growth rate and reduced B cell secretion of immunoglobulin M compared to controls. In addition, co-culture of LPS-activated WT B cells with TazKD MSCs promoted B cell differentiation toward interleukin-10 secreting plasma cells and B regulatory cells compared to controls. The results indicate that Taz deficiency in MSCs promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes.	[Zegallai, Hana M.; Cole, Laura K.; Hatch, Grant M.] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Rady Fac Hlth Sci, Dept Pharmacol Therapeut,Diabetes Res Envisioned, 501C JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada; [Abu-El-Rub, Ejlal] Yarmouk Univ, Dept Basic Med Sci, Physiol & Pathophysiol, Fac Med, Irbid, Jordan; [Abu-El-Rub, Ejlal] Univ Manitoba, Physiol & Pathophysiol, Regenerat Med, Fac Med, Winnipeg, MB, Canada; [Olayinka-Adefemi, Folayemi; Marshall, Aaron J.] Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Winnipeg, MB, Canada; [Sparagna, Genevieve C.] Univ Colorado Anschutz Med Ctr, Div Cardiol, Dept Med, Aurora, CO USA	University of Manitoba; Children's Hospital Research Institute of Manitoba; Yarmouk University; University of Manitoba; University of Manitoba	Hatch, GM (corresponding author), Univ Manitoba, Childrens Hosp Res Inst Manitoba, Rady Fac Hlth Sci, Dept Pharmacol Therapeut,Diabetes Res Envisioned, 501C JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	ghatch@chrim.ca			Canada Research Chairs (Chaires de recherche du Canada); Gouvernement du Canada | IRSC | Institute of Infection and Immunity (III); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Canada (HSF); Children's Hospital Foundation of Manitoba | Children's Hospital Research Institute of Manitoba (CHRIM); University of Manitoba (UM)	Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Gouvernement du Canada | IRSC | Institute of Infection and Immunity (III); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Canada (HSF)(Heart & Stroke Foundation of Canada); Children's Hospital Foundation of Manitoba | Children's Hospital Research Institute of Manitoba (CHRIM); University of Manitoba (UM)	Canada Research Chairs (Chaires de recherche du Canada); Gouvernement du Canada | IRSC | Institute of Infection and Immunity (III); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Canada (HSF); The Children's Hospital Foundation of Manitoba | Children's Hospital Research Institute of Manitoba (CHRIM); University of Manitoba (UM)	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Ahn S, 2009, EXPERT REV CLIN IMMU, V5, P557, DOI 10.1586/ECI.09.43; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnham AJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.609277; Chen J, 2013, TISSUE ENG PART B-RE, V19, P516, DOI [10.1089/ten.teb.2012.0672, 10.1089/ten.TEB.2012.0672]; Cho KA, 2017, CELL MOL IMMUNOL, V14, P895, DOI 10.1038/cmi.2016.59; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Corrado M, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.003; Dai YC, 2017, MOL MED REP, V16, P3, DOI 10.3892/mmr.2017.6605; Dibattista M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187619; Dudek J, 2017, CARDIOVASC RES, V113, P399, DOI 10.1093/cvr/cvx014; Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005; Espinosa G, 2020, VET IMMUNOL IMMUNOP, V221, DOI 10.1016/j.vetimm.2019.109975; Fossati V, 2010, J IMMUNOL, V184, P1251, DOI 10.4049/jimmunol.0901922; Franck T, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10123486; Gaber T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082312; Geisberger R, 2006, IMMUNOLOGY, V118, P429, DOI 10.1111/j.1365-2567.2006.02386.x; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ichii Michiko, 2014, World J Stem Cells, V6, P421, DOI 10.4252/wjsc.v6.i4.421; Ikon N, 2017, LIPIDS, V52, P99, DOI 10.1007/s11745-016-4229-7; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jiang W, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12712; Kaundal U, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1403-0; Klingemann H, 2008, TRANSFUS MED HEMOTH, V35, P272, DOI 10.1159/000142333; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lin X, 2020, ADV EXP MED BIOL, V1254, P145, DOI 10.1007/978-981-15-3532-1_11; Liu JL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01843; Liu SY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01076; Liu YJ, 2019, STEM CELL TRANSL MED, V8, P93, DOI 10.1002/sctm.18-0070; Lou WJ, 2018, BBA-MOL CELL BIOL L, V1863, P857, DOI 10.1016/j.bbalip.2018.04.015; Ma OKF, 2016, WORLD J STEM CELLS, V8, P268, DOI 10.4252/wjsc.v8.i9.268; Maguire Aindriu R R, 2021, Immunohorizons, V5, P182, DOI 10.4049/immunohorizons.2000040; Maity PC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005887; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Moise Ana, 2010, J Med Life, V3, P60; Mumaw JL, 2015, RES VET SCI, V103, P60, DOI 10.1016/j.rvsc.2015.09.010; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Oyewole-Said D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608024; Paradies G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070728; Pioli PD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02768; Rosado MM, 2015, STEM CELLS DEV, V24, P93, DOI 10.1089/scd.2014.0155; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003842; Seneviratne AK, 2019, CELL STEM CELL, V24, P621, DOI 10.1016/j.stem.2019.02.020; Shammaa R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00072; Magana-Guerrero FS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10962-2; Sohn J, 2022, BLOOD ADV, V6, P2557, DOI 10.1182/bloodadvances.2021005720; Soland MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060461; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Tarique M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01636; VALLE A, 1989, EUR J IMMUNOL, V19, P1463, DOI 10.1002/eji.1830190818; Vazquez MI, 2015, CYTOKINE, V74, P318, DOI 10.1016/j.cyto.2015.02.007; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang F, 2016, CELL PHYSIOL BIOCHEM, V39, P1369, DOI 10.1159/000447841; Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0; Zegallai HM., 2021, BIORXIV; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	62	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22443	10.1096/fj.202200145R	http://dx.doi.org/10.1096/fj.202200145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0GM	35816277				2022-12-28	WOS:000822843200001
J	Zhu, DX; Wang, ZH; Zhang, GZ; Ma, CW; Qiu, XM; Wang, YD; Liu, MQ; Guo, XD; Chen, HW; Deng, Q; Kang, XW				Zhu, Daxue; Wang, Zhaoheng; Zhang, Guangzhi; Ma, Congwen; Qiu, Xiaoming; Wang, Yidian; Liu, Mingqiang; Guo, Xudong; Chen, Haiwei; Deng, Qiang; Kang, Xuewen			Periostin promotes nucleus pulposus cells apoptosis by activating the Wnt/beta-catenin signaling pathway	FASEB JOURNAL			English	Article						apoptosis; degeneration; intervertebral disc; mechanism; nucleus pulposus; periostin	INTERVERTEBRAL DISC DEGENERATION; NEUROLOGICAL FUNCTION; INFLAMMATION; EXPRESSION; DEATH; ENHANCEMENT; MECHANISMS; AUTOPHAGY; BIOLOGY; MODEL	Intervertebral disc (IVD) degeneration (IVDD) is closely linked to degenerative spinal disease, resulting in disability, poor quality of life, and financial burden. Apoptosis of nucleus pulposus (NP) cells (NPCs) is a key pathological basis of IVDD. Periostin (POSTN), an extracellular matrix protein, is expressed in many tissues, whereas its abnormal expression is associated with IVDD. The conventional Wnt/beta-catenin pathway is also involved in IVDD and contributes to NPCs apoptosis. However, research on the mechanisms of POSTN in IVDD is lacking. This study investigated the relationship between POSTN and beta-catenin expression in degenerated IVDs. We detected the expression of POSTN, beta-catenin, and cleaved-caspase-3 (C-caspase3) in degenerated and non-degenerated IVD tissues of different grades (n = 8) using RT-qPCR, immunohistochemical staining, and western blotting analysis. Next, we explored the effects of recombinant periostin (rPOSTN) and isoquercitrin (Iso), an inhibitor of the Wnt/beta-catenin pathway, on NPCs apoptosis. Finally, we inhibited the expression of POSTN in degenerated NPCs in vivo and investigated the anti-apoptotic effect. The expression of beta-catenin, POSTN, and C-caspase3 in severe degenerative IVDs was significantly higher than that in mild degenerative IVDs. These findings were confirmed in rat and cell-based degenerative models. When treated with rPOSTN, the Wnt/beta-catenin pathway activity and cell apoptosis were time- and dose-dependent. However, rPOSTN-induced NPCs apoptosis decreased after iso-induced inhibition of the Wnt/beta-catenin pathway. POSTN inhibition reduced apoptosis but was restored by rPOSTN re-addition. Lastly, POSTN inhibition ameliorated puncture-induced IVDD in vivo. Overall, our study demonstrated that POSTN promotes NPCs apoptosis and aggravates degeneration by activating the Wnt/beta-catenin pathway.	[Zhu, Daxue; Wang, Zhaoheng; Zhang, Guangzhi; Ma, Congwen; Qiu, Xiaoming; Wang, Yidian; Liu, Mingqiang; Guo, Xudong; Chen, Haiwei; Kang, Xuewen] Lanzhou Univ Second Hosp, 82 Cuiyingmen, Lanzhou 730030, Peoples R China; [Zhu, Daxue; Wang, Zhaoheng; Zhang, Guangzhi; Ma, Congwen; Qiu, Xiaoming; Wang, Yidian; Liu, Mingqiang; Guo, Xudong; Chen, Haiwei; Kang, Xuewen] Orthopaed Key Lab Gansu Prov, Lanzhou, Peoples R China; [Deng, Qiang] Gansu Hosp Tradit Chinese Med, Lanzhou, Peoples R China		Kang, XW (corresponding author), Lanzhou Univ Second Hosp, 82 Cuiyingmen, Lanzhou 730030, Peoples R China.	ery_kangxw@lzu.edu.cn	Wang, Zhaoheng/AGY-7365-2022		Special Fund Project for the Doctoral Training Program of the Lanzhou University Second Hospital [YJS-BD-09]; Lanzhou Talents Innovation and Entrepreneurship Project [2021-RC-126]; Transfer payments from the central government to local projects in 2021 [20210200111]; joint project of TCM and western medicine to tackle major diseases; Robot-assisted precise treatment solution for scoliosis [KXW-2021-J]	Special Fund Project for the Doctoral Training Program of the Lanzhou University Second Hospital; Lanzhou Talents Innovation and Entrepreneurship Project; Transfer payments from the central government to local projects in 2021; joint project of TCM and western medicine to tackle major diseases; Robot-assisted precise treatment solution for scoliosis	Special Fund Project for the Doctoral Training Program of the Lanzhou University Second Hospital, Grant/Award Number: YJS-BD-09; Lanzhou Talents Innovation and Entrepreneurship Project, Grant/Award Number: 2021-RC-126; Transfer payments from the central government to local projects in 2021, Grant/Award Number: 20210200111; A joint project of TCM and western medicine to tackle major diseases; Robot-assisted precise treatment solution for scoliosis, Grant/Award Number: KXW-2021-J	Amin K, 2016, SCAND J IMMUNOL, V84, P75, DOI 10.1111/sji.12448; Arima K, 2015, ALLERGOL INT, V64, P41, DOI 10.1016/j.alit.2014.06.001; Asada Y, 2019, ALLERGOL INT, V68, P233, DOI 10.1016/j.alit.2018.09.007; Attur M, 2021, ARTHRITIS RES THER, V23, DOI 10.1186/s13075-021-02477-z; Attur M, 2015, FASEB J, V29, P4107, DOI 10.1096/fj.15-272427; Bian XH, 2019, J CELL PHYSIOL, V234, P22857, DOI 10.1002/jcp.28849; Bonnet N, 2017, J BONE MINER RES, V32, P1432, DOI 10.1002/jbmr.3136; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Brophy RH, 2019, OSTEOARTHR CARTILAGE, V27, P1778, DOI 10.1016/j.joca.2019.08.002; Burgess JK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.01286-2020; Cai L, 2019, FASEB J, V33, P8386, DOI 10.1096/fj.201802281R; Chen J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0085-5; Cheng S, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/2785207; Chijimatsu R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0682-3; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Ding F, 2013, APOPTOSIS, V18, P777, DOI 10.1007/s10495-013-0839-1; Fan BT, 2020, INFLAMMATION, V43, P455, DOI 10.1007/s10753-019-01129-4; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gruber HE, 2011, BIOTECH HISTOCHEM, V86, P199, DOI 10.3109/10520291003722774; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Hall JA, 2019, APPL HEALTH ECON HEA, V17, P467, DOI 10.1007/s40258-019-00471-w; Han TZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231501; He RJ, 2021, AUTOPHAGY, V17, P3338, DOI 10.1080/15548627.2021.1872227; Hiyama A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4379; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Ho J, 2020, CURR OPIN ALLERGY CL, V20, P23, DOI 10.1097/ACI.0000000000000602; Iwata M, 2015, J CELL PHYSIOL, V230, P180, DOI 10.1002/jcp.24697; Izuhara K, 2019, ALLERGY, V74, P2116, DOI 10.1111/all.13814; Izuhara K, 2017, CELL MOL LIFE SCI, V74, P4293, DOI 10.1007/s00018-017-2648-0; Kadow T, 2015, CLIN ORTHOP RELAT R, V473, P1903, DOI 10.1007/s11999-014-3774-8; Lai A, 2021, JOR SPINE, V4, DOI 10.1002/jsp2.1150; Lehmann M, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2020.109588; Li ZL, 2019, J CELL BIOCHEM, V120, P12519, DOI 10.1002/jcb.28518; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Moue T, 2017, IN VIVO, V31, P79, DOI 10.21873/invivo.11028; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ohnishi T, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030394; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Qin H, 2019, CELL REPROGRAM, V21, P122, DOI 10.1089/cell.2018.0051; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; Rosselli-Murai LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083580; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Sun K, 2021, AUTOPHAGY, V17, P2082, DOI 10.1080/15548627.2020.1822097; Tsai TT, 2013, SPINE J, V13, P289, DOI 10.1016/j.spinee.2013.01.040; Vergroesen PPA, 2015, OSTEOARTHR CARTILAGE, V23, P1057, DOI 10.1016/j.joca.2015.03.028; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wang JJ, 2020, EUR REV MED PHARMACO, V24, P499, DOI 10.26355/eurrev_202001_20023; Wang JX, 2016, CELL PROLIFERAT, V49, P362, DOI 10.1111/cpr.12254; Wang MN, 2012, ARTHRITIS RHEUM-US, V64, P2611, DOI 10.1002/art.34469; Wu ZL, 2021, PATHOL RES PRACT, V220, DOI 10.1016/j.prp.2021.153366; Xie HX, 2016, INT J MOL MED, V37, P859, DOI 10.3892/ijmm.2016.2470; Xu HG, 2016, OSTEOARTHR CARTILAGE, V24, P158, DOI 10.1016/j.joca.2015.07.019; Yao L, 2020, MOL CELL PROBE, V53, DOI 10.1016/j.mcp.2020.101596; Yue HR, 2021, GYNECOL ONCOL, V160, P530, DOI 10.1016/j.ygyno.2020.11.026; Zhang F, 2016, INT J MOL MED, V37, P1439, DOI 10.3892/ijmm.2016.2573; Zhang J, 2021, BIOMATER SCI-UK, V9, P745, DOI 10.1039/c9bm01446b; Zhang J, 2021, NEURAL REGEN RES, V16, P1068, DOI 10.4103/1673-5374.300458; Zhang SW, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820977489; Zhang XB, 2021, INT J MED SCI, V18, P2799, DOI 10.7150/ijms.59171; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Zhao YT, 2020, EUR REV MED PHARMACO, V24, P9807, DOI 10.26355/eurrev_202010_23190; Zhong H, 2021, MECH AGEING DEV, V194, DOI 10.1016/j.mad.2020.111417; Zhu DX, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.694800; Zhu DX, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6645193	68	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22369	10.1096/fj.202200123R	http://dx.doi.org/10.1096/fj.202200123R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2I4LC	35747912				2022-12-28	WOS:000814950600001
J	Xiang, XY; Ohshiro, K; Zaidi, S; Yang, XC; Bhowmick, K; Vegesna, AK; Bernstein, D; Crawford, JM; Mishra, B; Latham, PS; Gough, NR; Rao, SY; Mishra, L				Xiang, Xiyan; Ohshiro, Kazufumi; Zaidi, Sobia; Yang, Xiaochun; Bhowmick, Krishanu; Vegesna, Anil K.; Bernstein, David; Crawford, James M.; Mishra, Bibhuti; Latham, Patricia S.; Gough, Nancy R.; Rao, Shuyun; Mishra, Lopa			Impaired reciprocal regulation between SIRT6 and TGF-beta signaling in fatty liver	FASEB JOURNAL			English	Article						fatty liver; NASH; SIRT6; TGF-beta signaling	INSULIN-RESISTANCE; PROTECTS; DISEASE; SMAD3; BETA-2-SPECTRIN; STEATOHEPATITIS; SUPPRESSION; DEFICIENCY; ACTIVATION; FIBROSIS	Dysregulated transforming growth factor-beta (TGF-beta) signaling contributes to fibrotic liver disease and hepatocellular cancer (HCC), both of which are associated with fatty liver disease. SIRT6 limits fibrosis by inhibiting TGF-beta signaling through deacetylating SMAD2 and SMAD3 and limits lipogenesis by inhibiting SREBP1 and SREBP2 activity. Here, we showed that, compared to wild-type mice, high-fat diet-induced fatty liver is worse in TGF-beta signaling-deficient mice (SPTBN1(+/-)) and the mutant mice had reduced SIRT6 abundance in the liver. Therefore, we hypothesized that altered reciprocal regulation between TGF-beta signaling and SIRT6 contributes to these liver pathologies. We found that deficiency in SMAD3 or SPTBN1 reduced SIRT6 mRNA and protein abundance and impaired TGF-beta induction of SIRT6 transcripts, and that SMAD3 bound to the SIRT6 promoter, suggesting that an SMAD3-SPTBN1 pathway mediated the induction of SIRT6 in response to TGF-beta. Overexpression of SIRT6 in HCC cells reduced the expression of TGF-beta-induced genes, consistent with the suppressive role of SIRT6 on TGF-beta signaling. Manipulation of SIRT6 abundance in HCC cells altered sterol regulatory element-binding protein (SREBP) activity and overexpression of SIRT6 reduced the amount of acetylated SPTBN1 and the abundance of both SMAD3 and SPTBN1. Furthermore, induction of SREBP target genes in response to SIRT6 overexpression was impaired in SPTBN1 heterozygous cells. Thus, we identified a regulatory loop between SIRT6 and SPTBN1 that represents a potential mechanism for susceptibility to fatty liver in the presence of dysfunctional TGF-beta signaling.	[Xiang, Xiyan; Ohshiro, Kazufumi; Zaidi, Sobia; Yang, Xiaochun; Bhowmick, Krishanu; Vegesna, Anil K.; Mishra, Bibhuti; Gough, Nancy R.; Rao, Shuyun; Mishra, Lopa] Northwell Hlth, Feinstein Inst Med Res, Inst Bioelect Med, Manhasset, NY 11030 USA; [Xiang, Xiyan; Zaidi, Sobia; Yang, Xiaochun; Bhowmick, Krishanu; Mishra, Lopa] Cold Spring Harbor Lab, Manhasset, NY USA; [Bernstein, David] Northwell Hlth & Donald, Div Hepatol, Hempstead, NY USA; [Bernstein, David] Hofstra Northwell, Barbara Zucker Sch, Hempstead, NY USA; [Crawford, James M.] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Dept Pathol & Lab Med, Hempstead, NY USA; [Mishra, Bibhuti] Northwell Hlth, Dept Neurol, Manhasset, NY 11030 USA; [Latham, Patricia S.] George Washington Univ, Dept Pathol, Washington, DC USA; [Mishra, Lopa] Northwell Hlth, Div Gastroenterol, Dept Med, Manhasset, NY 11030 USA; [Mishra, Lopa] George Washington Univ, Dept Surg, Washington, DC USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health; George Washington University; Northwell Health; George Washington University	Mishra, L (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Inst Bioelect Med, Div Gastroenterol, Manhasset, NY 11030 USA.; Mishra, L (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Inst Bioelect Med, Div Hepatol, Manhasset, NY 11030 USA.; Mishra, L (corresponding author), Northwell Hlth, Cold Spring Harbor Lab, Manhasset, NY 11030 USA.; Rao, SY (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Inst Bioelect Med, Div Gastroenterol & Hepatol,Dept Med, Manhasset, NY 11030 USA.	srao14@northwell.edu; lmishra1@northwell.edu	Xiang, Xiyan/GLR-1454-2022; Bhowmick, Krishanu/CEH-1458-2022; Yang, Xiaochun/CAG-2002-2022	Yang, Xiaochun/0000-0002-7026-8809; Bhowmick, Krishanu/0000-0001-6213-8230	NIH [R01AA023146, R01 CA236591, U01 CA230690]; George Washington University school of medicine and health science Elaine H. Snyder Cancer Research Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington University school of medicine and health science Elaine H. Snyder Cancer Research Award	This research work was supported by NIH grants R01AA023146 (L. Mishra), NIH R01 CA236591 (L. Mishra), NIH U01 CA230690 (L. Mishra), and by George Washington University school of medicine and health science Elaine H. Snyder Cancer Research Award (L. Mishra).	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Baek HJ, 2016, INT J BIOL SCI, V12, P172, DOI 10.7150/ijbs.13420; Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230; Cai J, 2020, KIDNEY INT, V97, P106, DOI 10.1016/j.kint.2019.08.028; Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chen J, 2018, GASTROENTEROLOGY, V154, P195, DOI 10.1053/j.gastro.2017.09.007; Chen J, 2017, HEPATOLOGY, V65, P678, DOI 10.1002/hep.28927; Chen J, 2016, J CLIN INVEST, V126, P527, DOI 10.1172/JCI80937; Cheng JR, 2017, BBA-MOL BASIS DIS, V1863, P2783, DOI 10.1016/j.bbadis.2017.08.004; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Gough NR, 2021, GASTROENTEROLOGY, V161, P434, DOI 10.1053/j.gastro.2021.04.064; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Juanola O, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105227; Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78056-0; Kumar R, 2020, J CLIN TRANSL HEPATO, V8, P76, DOI 10.14218/JCTH.2019.00051; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Maity S, 2020, J BIOL CHEM, V295, P415, DOI 10.1074/jbc.RA118.007212; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; Massalha H, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209682; Mitra A, 2017, HEPATOLOGY, V65, P1222, DOI 10.1002/hep.28951; Naiman S, 2019, CELL REP, V29, P4127, DOI 10.1016/j.celrep.2019.11.067; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Rao SY, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abk2267; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Sun H, 2017, ONCOGENE, V36, P2957, DOI 10.1038/onc.2016.447; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Wandrer F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2411-6; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Xu FY, 2016, J HISTOCHEM CYTOCHEM, V64, P157, DOI 10.1369/0022155415627681; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang JH, 2021, HEPATOLOGY, V73, P1140, DOI 10.1002/hep.31418; Zhong XL, 2020, CELL MOL GASTROENTER, V10, P341, DOI 10.1016/j.jcmgh.2020.04.005; Zhou R, 2018, CELL PHYSIOL BIOCHEM, V51, P2397, DOI 10.1159/000495898; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	45	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6								10.1096/fj.202101518R	http://dx.doi.org/10.1096/fj.202101518R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0Y3UX	35506565	hybrid			2022-12-28	WOS:000790318200001
J	Lechuga, S; Cartagena-Rivera, AX; Khan, A; Crawford, BI; Narayanan, V; Conway, DE; Lehtimaki, J; Lappalainen, P; Rieder, F; Longworth, MS; Ivanov, AI				Lechuga, Susana; Cartagena-Rivera, Alexander X.; Khan, Afshin; Crawford, Bert, I; Narayanan, Vani; Conway, Daniel E.; Lehtimaki, Jaakko; Lappalainen, Pekka; Rieder, Florian; Longworth, Michelle S.; Ivanov, Andrei I.			A myosin chaperone, UNC-45A, is a novel regulator of intestinal epithelial barrier integrity and repair	FASEB JOURNAL			English	Article						adherens junctions; cell migration; epithelial barriers; myosins; tight junctions	E-CADHERIN; CAENORHABDITIS-ELEGANS; CELL-JUNCTIONS; ISOFORMS; ACTOMYOSIN; TENSION; MUTATIONS; COMPLEX; MODULES; ROLES	The actomyosin cytoskeleton serves as a key regulator of the integrity and remodeling of epithelial barriers by controlling assembly and functions of intercellular junctions and cell-matrix adhesions. Although biochemical mechanisms that regulate the activity of non-muscle myosin II (NM-II) in epithelial cells have been extensively investigated, little is known about assembly of the contractile myosin structures at the epithelial adhesion sites. UNC-45A is a cytoskeletal chaperone that is essential for proper folding of NM-II heavy chains and myofilament assembly. We found abundant expression of UNC-45A in human intestinal epithelial cell (IEC) lines and in the epithelial layer of the normal human colon. Interestingly, protein level of UNC-45A was decreased in colonic epithelium of patients with ulcerative colitis. CRISPR/Cas9-mediated knock-out of UNC-45A in HT-29cf8 and SK-CO15 IEC disrupted epithelial barrier integrity, impaired assembly of epithelial adherence and tight junctions and attenuated cell migration. Consistently, decreased UNC-45 expression increased permeability of the Drosophila gut in vivo. The mechanisms underlying barrier disruptive and anti-migratory effects of UNC-45A depletion involved disorganization of the actomyosin bundles at epithelial junctions and the migrating cell edge. Loss of UNC-45A also decreased contractile forces at apical junctions and matrix adhesions. Expression of deletion mutants revealed roles for the myosin binding domain of UNC-45A in controlling IEC junctions and motility. Our findings uncover a novel mechanism that regulates integrity and restitution of the intestinal epithelial barrier, which may be impaired during mucosal inflammation.	[Lechuga, Susana; Khan, Afshin; Crawford, Bert, I; Rieder, Florian; Longworth, Michelle S.; Ivanov, Andrei I.] Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NC22, Cleveland, OH 44195 USA; [Cartagena-Rivera, Alexander X.] Natl Inst Biomed Imaging & Bioengn, Sect Mechanobiol, NIH, Bethesda, MD USA; [Narayanan, Vani; Conway, Daniel E.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Lehtimaki, Jaakko; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Lehtimaki, Jaakko; Lappalainen, Pekka] Univ Helsinki, Helsinki Inst Life Sci, Helsinki, Finland; [Rieder, Florian] Cleveland Clin Fdn, Digest Dis & Surg Inst, Dept Gastroenterol Hepatol & Nutr, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Virginia Commonwealth University; University of Helsinki; University of Helsinki; Cleveland Clinic Foundation	Ivanov, AI (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NC22, Cleveland, OH 44195 USA.	ivanova2@ccf.org	longworth, michelle/S-8456-2019; Cartagena-Rivera, Alexander X./I-6101-2016	Narayanan, Vani/0000-0002-5358-8472; Cartagena-Rivera, Alexander X./0000-0001-6227-2499	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK108278, RO1 DK126702]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R35 GM119617]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R21 AI153780]; HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) [ZIAEB000094]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: RO1 DK108278 and RO1 DK126702; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35 GM119617; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R21 AI153780; HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB), Grant/Award Number: ZIAEB000094	Acharya BR, 2017, CELL REP, V18, P2854, DOI 10.1016/j.celrep.2017.02.078; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Arsenovic PT, 2016, BIOPHYS J, V110, P34, DOI 10.1016/j.bpj.2015.11.014; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Cartagena-Rivera AX, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat9934; Cartagena-Rivera AX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01145-8; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Eisa NH, 2019, J BIOL CHEM, V294, P5246, DOI 10.1074/jbc.RA118.006597; Esteve C, 2018, AM J HUM GENET, V102, P364, DOI 10.1016/j.ajhg.2018.01.009; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Garrido-Casado M, 2021, ANNU REV CELL DEV BI, V37, P285, DOI 10.1146/annurev-cellbio-042721-105528; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; Gupta Shafali, 2021, Fac Rev, V10, P56, DOI 10.12703/r/10-56; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Habicht J, 2021, J CELL SCI, V134, DOI 10.1242/jcs.248815; Habicht J, 2019, CANCER BIOL THER, V20, P1304, DOI 10.1080/15384047.2019.1632637; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellerschmied D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12667-8; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Iizuka Y, 2017, MOL BIOL CELL, V28, P1337, DOI 10.1091/mbc.E16-06-0381; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Krivosheeva IA, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01584-2; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lechuga S, 2019, BBA-MOL CELL RES, V1866, P395, DOI 10.1016/j.bbamcr.2018.10.001; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Lechuga S, 2014, MOL BIOL CELL, V25, P3133, DOI 10.1091/mbc.E14-03-0815; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lehtimaki JI, 2017, J CELL BIOL, V216, P4053, DOI 10.1083/jcb.201703107; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mitchell DM, 2004, IN VITRO CELL DEV-AN, V40, P297; Mooneyham A, 2019, MOL CANCER RES, V17, P370, DOI 10.1158/1541-7786.MCR-18-0670; Narayanan V, 2020, CURR BIOL, V30, P624, DOI 10.1016/j.cub.2019.12.025; Naydenov NG, 2021, CANCERS, V13, DOI 10.3390/cancers13040741; Naydenov NG, 2016, SCI REP-UK, V6, DOI 10.1038/srep24161; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Ngo P, 2006, METH MOL B, V341, P103; Ni Weiming, 2015, Subcell Biochem, V78, P133, DOI 10.1007/978-3-319-11731-7_7; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; ROEDIGER WEW, 1979, GUT, V20, P484, DOI 10.1136/gut.20.6.484; Schoultz I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020193; Sluysmans S, 2017, BIOL CELL, V109, P139, DOI 10.1111/boc.201600075; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Varadarajan S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.229286; VENOLIA L, 1990, GENETICS, V126, P345; Wang DD, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-019-1241-x; Zaidel-Bar R, 2015, J CELL SCI, V128, P2209, DOI 10.1242/jcs.170068; Zulueta-Coarasa T, 2017, MECH DEVELOP, V144, P43, DOI 10.1016/j.mod.2016.11.004	65	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22290	10.1096/fj.202200154R	http://dx.doi.org/10.1096/fj.202200154R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0G7GE	35344227	Green Submitted, Green Published			2022-12-28	WOS:000778208100001
J	Muscat, S; Nichols, AEC; Gira, E; Loiselle, AE				Muscat, Samantha; Nichols, Anne E. C.; Gira, Emma; Loiselle, Alayna E.			CCR2 is expressed by tendon resident macrophage and T cells, while CCR2 deficiency impairs tendon healing via blunted involvement of tendon-resident and circulating monocytes/macrophages	FASEB JOURNAL			English	Article						CCR2; fibrosis; macrophage; myofibroblast; tendon healing	DUAL ROLE; FIBROSIS; MATRIX	During tendon healing, macrophages are thought to be a key mediator of scar tissue formation, which prevents successful functional restoration of the tendon. However, macrophages are critical for successful tendon healing as they aid in wound debridement, extracellular matrix deposition, and promote fibroblast proliferation. Recent work has sought to better define the multi-faceted functions of macrophages using depletion studies, while other studies have identified a tendon resident macrophage population. To begin to delineate the functions of tendon-resident versus circulation-derived macrophages, we examined the tendon healing phenotype in Chemokine Receptor 2 (CCR2) reporter (CCR2(GFP/+)), and knockout mice. CCR2 is a chemokine receptor primarily found on the surface of circulating bone marrow-derived monocytes, with CCR2 being an important mediator of macrophage recruitment to wound environments. Surprisingly, CCR2(GFP/+) cells were present in the tendon during adult homeostasis, and single-cell RNA sequencing identified these cells as tendon-resident macrophages and T cells. During both homeostasis and healing, CCR2 knockout resulted in a substantial decrease in CCR2(GFP+) cells and pan-macrophages. Additionally, loss of CCR2 resulted in reduced numbers of myofibroblasts and impeded functional recovery during late healing. This study highlights the heterogeneity of tendon-resident and recruited immune cells and their contributions following injury, and establishes an important role for CCR2 in modulating both the adult tendon cell environment and tendon healing process.	[Muscat, Samantha; Nichols, Anne E. C.; Gira, Emma; Loiselle, Alayna E.] Univ Rochester, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Med Ctr, 601 Elmwood Ave,Box 665-G, Rochester, NY 14642 USA.	alayna_loiselle@urmc.rochester.edu		Loiselle, Alayna/0000-0002-7548-6653	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR077527, R01AR073169, T32 AR076950, K99 AR080757, P30AR069655]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01 AR077527, R01AR073169, T32 AR076950, K99 AR080757 and P30AR069655	Ackerman JE, 2021, CURR RHEUMATOL REP, V23, DOI 10.1007/s11926-021-00981-4; Ackerman JE, 2019, ELIFE, V8, DOI 10.7554/eLife.45342; Ackerman JE, 2016, JOVE-J VIS EXP, DOI 10.3791/54433; Arvind V., 2021, BIORXIV, DOI [10.1101/2021.05.12.443424, DOI 10.1101/2021.05.12.443424]; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Bakos E, 2017, J IMMUNOL, V198, P4659, DOI 10.4049/jimmunol.1601458; Best KT, 2021, ELIFE, V10, DOI 10.7554/eLife.62203; Blanc RS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17620-8; Boniakowski AE, 2018, EUR J IMMUNOL, V48, P1445, DOI 10.1002/eji.201747400; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Chamberlain CS, 2019, STEM CELLS, V37, P652, DOI 10.1002/stem.2988; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Crosio G, 2022, EUR CELLS MATER, V43, P39, DOI [10.22203/eCM.v043a05ISSN1473-2262, 10.22203/eCM.v043a05]; de la Durantaye M, 2014, J ORTHOP RES, V32, P279, DOI 10.1002/jor.22504; Dick SA, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abf7777; Dyment NA, 2016, JOVE-J VIS EXP, DOI 10.3791/54468; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Freedman BR, 2022, ACTA BIOMATER, V143, P63, DOI 10.1016/j.actbio.2022.03.006; Galatz LM, 2015, J ORTHOP RES, V33, P823, DOI 10.1002/jor.22853; Garcia-Melchor E, 2021, ANN RHEUM DIS, V80, P1075, DOI 10.1136/annrheumdis-2020-219335; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Howell KL, 2021, FASEB J, V35, DOI 10.1096/fj.202100049R; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Komiya H, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00607-3; Korcari A, 2022, CONNECT TISSUE RES, DOI 10.1080/03008207.2022.2102004; Kuroda N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45012-6; Lehner C, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.041384; Leong NL, 2020, J ORTHOP RES, V38, P7, DOI 10.1002/jor.24475; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Nichols AEC, 2019, TRANSL RES, V209, P156, DOI 10.1016/j.trsl.2019.02.002; Pakshir P, 2020, J CELL SCI, V133, DOI 10.1242/jcs.227900; Pakshir P, 2018, MATRIX BIOL, V68-69, P81, DOI 10.1016/j.matbio.2018.01.019; Pedragosa J, 2020, J CEREBR BLOOD F MET, V40, pS98, DOI 10.1177/0271678X20909055; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schuster R, 2021, IMMUNOL REV, V302, P126, DOI 10.1111/imr.12971; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; Sugiyama Y, 2019, BIOMED REP, V10, P238, DOI 10.3892/br.2019.1200; Sunwoo JY, 2020, J ORTHOP RES, V38, P1666, DOI 10.1002/jor.24667; Vierhout M, 2021, WOUND REPAIR REGEN, V29, P548, DOI 10.1111/wrr.12946; Watad A, 2020, ANN RHEUM DIS, V79, P1044, DOI 10.1136/annrheumdis-2020-217309; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Xia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077493; Yan ZX, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00406; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075	51	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22607	10.1096/fj.202201162R	http://dx.doi.org/10.1096/fj.202201162R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5I8XZ	36250393				2022-12-28	WOS:000868634100001
J	Zhang, XF; Zuo, LG; Geng, ZJ; Song, X; Li, J; Ge, ST; Jiang, YF; Yang, Z; Liu, GY; Zhao, YJ; Zhao, H; Yu, L; Hu, JG				Zhang, Xiaofeng; Zuo, Lugen; Geng, Zhijun; Song, Xue; Li, Jing; Ge, Sitang; Jiang, Yifan; Yang, Zi; Liu, Guangyong; Zhao, Yajing; Zhao, Hao; Yu, Liang; Hu, Jianguo			Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway	FASEB JOURNAL			English	Article						colitis; Crohn's disease; intestinal barrier damage; macrophage-mediated inflammation; vindoline	POLARIZATION; MACROPHAGES; CELLS	Intestinal inflammation and intestinal barrier damage are important pathological changes in Crohn's disease (CD). Vindoline is a natural monomer with anti-inflammatory effects. We employed CD model mice to explore the effect of Vindoline on CD-like colitis and the possible mechanism. Il-10-deficient (Il-10(-/-)) mice and wild-type (WT) mice (both aged 15 weeks, male) were used to explore the effect of Vindoline on colitis and intestinal barrier damage, as well as macrophage-mediated inflammation. Bone-marrow-derived macrophages (BMDMs) and colonic organoids from mice were used to explore the inhibitory effect of Vindoline on macrophage-mediated inflammation and the protective effect on inflammation-induced intestinal barrier damage as well as the possible mechanism. We found that Vindoline significantly ameliorated colitis in CD mice, as evidenced by increased weight change and colon length and decreased the colon macroscopic injury score, histological inflammatory score, and the expression of pro-inflammatory mediators. Vindoline also protected against intestinal barrier damage in CD mice. Furthermore, Vindoline inhibited macrophage-mediated inflammation and protected against inflammation-induced intestinal barrier damage in the coculture system. In addition, Vindoline ameliorated colitis in CD mice by protecting against inflammation-induced intestinal barrier damage, which may be caused by inhibition of MAPK signaling pathway. This protective effect suggests that Vindoline has potential value for clinical application in the treatment of CD.	[Zhang, Xiaofeng; Zuo, Lugen; Geng, Zhijun; Song, Xue; Li, Jing; Ge, Sitang; Yang, Zi; Zhao, Hao; Yu, Liang] Bengbu Med Coll, Dept Cent Lab, Affiliated Hosp 1, Bengbu, Peoples R China; [Zhang, Xiaofeng; Geng, Zhijun; Song, Xue; Jiang, Yifan; Liu, Guangyong; Zhao, Yajing; Hu, Jianguo] Bengbu Med Coll, Anhui Key Lab Tissue Transplantat, Bengbu, Peoples R China; [Zuo, Lugen; Ge, Sitang] Bengbu Med Coll, Dept Gastrointestinal Surg, Affiliated Hosp 1, Bengbu, Peoples R China; [Li, Jing; Hu, Jianguo] Bengbu Med Coll, Dept Clin Lab, Affiliated Hosp 1, 287 Changhuai Rd, Bengbu 233004, Anhui, Peoples R China	Bengbu Medical College; Bengbu Medical College; Bengbu Medical College; Bengbu Medical College	Hu, JG (corresponding author), Bengbu Med Coll, Dept Clin Lab, Affiliated Hosp 1, 287 Changhuai Rd, Bengbu 233004, Anhui, Peoples R China.	jghu9200@bbmc.edu.cn			Major science and technology project incubation program of Bengbu Medical College [2020byfy003]; National Natural Science Foundation of China (NSFC) [82070561]; First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars [2019byyfyjq01]; First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars [2019byyfyyq02, 2019byyfyyq08]	Major science and technology project incubation program of Bengbu Medical College; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars; First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars	Major science and technology project incubation program of Bengbu Medical College, Grant/Award Number: 2020byfy003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82070561; The First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars, Grant/Award Number: 2019byyfyjq01; The First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars, Grant/Award Number: 2019byyfyyq02 and 2019byyfyyq08	APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Ferre MPB, 2018, MED CLIN-BARCELONA, V151, P26, DOI 10.1016/j.medcli.2017.10.036; Cao ST, 2020, FREE RADICAL BIO MED, V147, P8, DOI 10.1016/j.freeradbiomed.2019.12.004; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Di Tommaso N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312836; Feuerstein JD, 2017, MAYO CLIN PROC, V92, P1088, DOI 10.1016/j.mayocp.2017.04.010; Funes SC, 2018, IMMUNOLOGY, V154, P186, DOI 10.1111/imm.12910; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Goboza M, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108638; Han X, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9230; Jia YF, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101534; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kim Y, 2018, MATRIX BIOL, V66, P93, DOI 10.1016/j.matbio.2017.09.003; Lauro A, 2017, EXPERT REV GASTROENT, V11, P1105, DOI 10.1080/17474124.2017.1367665; Li J, 2019, J CELL MOL MED, V23, P5632, DOI 10.1111/jcmm.14471; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Liu LL, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-00355-y; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Motta JP, 2021, J CROHNS COLITIS, V15, P787, DOI 10.1093/ecco-jcc/jjaa229; Oguntibeju OO, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7030059; Patterson L, 2020, FASEB J, V34, P15922, DOI 10.1096/fj.202001669R; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Schoultz I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020193; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sertel S, 2011, BIOCHEM PHARMACOL, V81, P723, DOI 10.1016/j.bcp.2010.12.026; SHARIF H, 1992, INT SURG, V77, P15; Song X, 2022, J CELL MOL MED, V26, P216, DOI 10.1111/jcmm.17077; Spalinger MR, 2020, GASTROENTEROLOGY, V159, P1763, DOI 10.1053/j.gastro.2020.07.004; Talamonti E, 2017, CELL MOL LIFE SCI, V74, P2815, DOI 10.1007/s00018-017-2498-9; Tang Y, 2020, DIGEST DIS, V38, P211, DOI 10.1159/000501122; Turpin W, 2020, GASTROENTEROLOGY, V159, DOI 10.1053/j.gastro.2020.08.005; Vrakas S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170034; Wang HG, 2013, BRIT J NUTR, V109, P1990, DOI 10.1017/S0007114512004308; Wang ZX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.563784; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yang BL, 2018, WORLD J GASTROENTERO, V24, P3414, DOI 10.3748/wjg.v24.i30.3414; Yin Z, 2018, J CELL BIOCHEM, V119, P9419, DOI 10.1002/jcb.27259; Zhan YF, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01587; Zhou X, 2019, CELL REP, V27, P1176, DOI 10.1016/j.celrep.2019.03.028; Zhu B, 2018, J ETHNOPHARMACOL, V226, P143, DOI 10.1016/j.jep.2018.08.023; Zhu YS, 2016, INT IMMUNOPHARMACOL, V30, P74, DOI 10.1016/j.intimp.2015.11.031; Zuo LG, 2019, J CELL MOL MED, V23, P5588, DOI 10.1111/jcmm.14457; Zuo LG, 2019, J CROHNS COLITIS, V13, P931, DOI 10.1093/ecco-jcc/jjz001; Zuo LG, 2014, J CROHNS COLITIS, V8, P1710, DOI 10.1016/j.crohns.2014.08.008	45	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22589	10.1096/fj.202200234RR	http://dx.doi.org/10.1096/fj.202200234RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9QR	36197455				2022-12-28	WOS:000863903200001
J	Zhuang, ZY; Jin, CY; Li, XB; Han, YN; Yang, QL; Huang, YP; Zheng, YF; Li, WR				Zhuang, Ziyao; Jin, Chanyuan; Li, Xiaobei; Han, Yineng; Yang, Qiaolin; Huang, Yiping; Zheng, Yunfei; Li, Weiran			Knockdown of circHIPK3 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells through activating the autophagy flux	FASEB JOURNAL			English	Article						autophagy; BMSCs; circHIPK3; human antigen R (HUR); osteogenesis	CIRCULAR RNAS	Many circular RNAs (circRNAs) involved in the osteogenesis of human bone marrow mesenchymal stem cells (hBMSCs) have recently been discovered. The role of circHIPK3 in osteogenesis has yet to be determined. Cell transfection was conducted using small-interfering RNAs (siRNAs). Expression of osteogenic markers were detected by quantitative reverse transcription-polymerase chain reaction, western blotting analysis, and immunofluorescence staining. Ectopic bone formation models in nude mice were used to examined the bone formation ability in vivo. The autophagy flux was examined via western blotting analysis, immunofluorescence staining and transmission electron microscopy analysis. RNA immunoprecipitation (RIP) analysis was carried out to analyze the binding between human antigen R (HUR) and circHIPK3 or autophagy-related 16-like 1 (ATG16L1). Actinomycin D was used to determine the mRNA stability. Our results demonstrated that silencing circHIPK3 promoted the osteogenesis of hBMSCs while silencing the linear mHIPK3 did not affect osteogenic differentiation, both in vivo and in vitro. Moreover, we found that knockdown of circHIPK3 activated autophagy flux. Activation of autophagy enhanced the osteogenesis of hBMSCs and inhibition of autophagy reduced the osteogenesis through using autophagy regulators chloroquine and rapamycin. We also discovered that circHIPK3 and ATG16L1 both bound to HUR. Knockdown of circHIPK3 released the binding sites of HUR to ATG16L1, which stabilized the mRNA expression of ATG16L1, resulting in the upregulation of ATG16L1 and autophagy activation. CircHIPK3 functions as an osteogenesis and autophagy regulator and has the potential for clinical application in the future.	[Zhuang, Ziyao; Li, Xiaobei; Han, Yineng; Yang, Qiaolin; Huang, Yiping; Zheng, Yunfei; Li, Weiran] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China; [Zhuang, Ziyao; Jin, Chanyuan; Li, Xiaobei; Han, Yineng; Yang, Qiaolin; Huang, Yiping; Zheng, Yunfei; Li, Weiran] Natl Ctr Stomatol, Natl Clin Res Ctr Oral Dis, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Jin, Chanyuan] Peking Univ, Clin Div 2, Sch & Hosp Stomatol, Beijing, Peoples R China	Peking University; Peking University	Li, WR (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China.	weiranli@bjmu.edu.cn		Han, Yineng/0000-0002-8651-3282	National Natural Science Foundation of China (NSFC) [82071142, 82071119]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071142 and 82071119	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Chen B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020177; Chen HT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1030-2; Chen WR, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111883; Chen X, 2020, CYTOKINE, V136, DOI 10.1016/j.cyto.2020.155292; Chen YJ, 2019, CELL DEATH DIFFER, V26, P1346, DOI 10.1038/s41418-018-0220-6; Cheng XW, 2019, AUTOPHAGY, V15, P1120, DOI [10.1080/15548627.2019.1596500, 10.1080/15548627.2019.1634945]; De S, 2019, CELL SIGNAL, V61, P78, DOI 10.1016/j.cellsig.2019.05.008; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Dudekulay DB, 2016, RNA BIOL, V13, P34, DOI 10.1080/15476286.2015.1128065; Gagliardi M, 2016, METHODS MOL BIOL, V1480, P73, DOI 10.1007/978-1-4939-6380-5_7; Gao JW, 2020, J CELL MOL MED, V24, P13648, DOI 10.1111/jcmm.15813; Gao MJ, 2021, J CELL PHYSIOL, V236, P6793, DOI 10.1002/jcp.30363; Gomez-Barrena E, 2020, INJURY, V51, pS55, DOI 10.1016/j.injury.2020.02.030; Gomez-Barrena E, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/6025918; Grammatikakis I, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1372; Hu B, 2018, ACTA BIOMATER, V76, P275, DOI 10.1016/j.actbio.2018.06.017; Hu YP, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1097-9; Jin CY, 2022, BIOCELL, V46, P1717, DOI 10.32604/biocell.2022.018706; Jin CY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02813-2; Jin CY, 2016, STEM CELLS, V34, P2707, DOI 10.1002/stem.2439; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Li KC, 2016, BIOMATERIALS, V74, P155, DOI 10.1016/j.biomaterials.2015.09.046; Li N, 2021, EXP CELL RES, V407, DOI 10.1016/j.yexcr.2021.112780; Li SL, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-021-00940-2; Li XX, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00492-19; Li XB, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0976-0; Li YW, 2017, EMBO REP, V18, P1646, DOI 10.15252/embr.201643581; Li Z, 2019, STEM CELLS, V37, P1542, DOI 10.1002/stem.3091; Liang YK, 2021, MOL THER-NUCL ACIDS, V23, P355, DOI 10.1016/j.omtn.2020.11.012; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Menshikov M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9091178; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Nabors LB, 2001, CANCER RES, V61, P2154; Palanisamy K, 2019, J CELL PHYSIOL, V234, P7448, DOI 10.1002/jcp.27502; Pieles O, 2021, ARCH ORAL BIOL, V122, DOI 10.1016/j.archoralbio.2020.104951; Qiu ZM, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00448-6; Rojewski MT, 2019, CYTOTHERAPY, V21, P468, DOI 10.1016/j.jcyt.2019.03.001; Sankar DS, 2021, AUTOPHAGY, V17, P2689, DOI 10.1080/15548627.2020.1847461; Vidoni C, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0414-7; Wang IK, 2020, J CELL BIOCHEM, V121, P4522, DOI 10.1002/jcb.29669; We MY, 2020, EUR REV MED PHARMACO, V24, P12849, DOI 10.26355/eurrev_202012_24187; Xiao L, 2021, GASTROENTEROLOGY, V161, P1303, DOI 10.1053/j.gastro.2021.05.060; Xie YM, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2019.117252; Yang YH, 2020, FASEB J, V34, P8876, DOI 10.1096/fj.201903216RR; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yao R, 2020, INT J BIOL MACROMOL, V155, P1432, DOI 10.1016/j.ijbiomac.2019.11.119; Zeng KX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0454-8; Zhang ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06862-2; Zhang P, 2020, AGING-US, V12, P2084, DOI 10.18632/aging.102723; Zhang YL, 2020, AM J TRANSL RES, V12, P6694; Zhang YL, 2019, EBIOMEDICINE, V48, P277, DOI 10.1016/j.ebiom.2019.09.051; Zhang YZ, 2020, MOL IMMUNOL, V117, P12, DOI 10.1016/j.molimm.2019.10.025; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zheng YF, 2017, J PERIODONTOL, V88, P906, DOI 10.1902/jop.2017.170078; Zhi F, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02214-y	57	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22590	10.1096/fj.202200832R	http://dx.doi.org/10.1096/fj.202200832R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5D7IP	36208289				2022-12-28	WOS:000865110700001
J	Moran, AL; Fehilly, JD; Jones, DF; Collery, R; Kennedy, BN				Moran, Ailis L.; Fehilly, John D.; Jones, Daniel Floss; Collery, Ross; Kennedy, Breandan N.			Regulation of the rhythmic diversity of daily photoreceptor outer segment phagocytosis in vivo	FASEB JOURNAL			English	Review						circadian; cone; in vivo; outer segment phagocytosis; photoreceptor; regulators; retina; retinal disease; rod; RPE	RETINAL-PIGMENT EPITHELIUM; FOCAL ADHESION KINASE; MER TYROSINE KINASE; ALPHA-V-BETA-5 INTEGRIN; CONSTANT LIGHT; RAT RETINA; ROD; GENE; CELLS; RECEPTOR	Outer segment phagocytosis (OSP) is a highly-regulated, biological process wherein photoreceptor outer segment (OS) tips are cyclically phagocytosed by the adjacent retinal pigment epithelium (RPE) cells. Often an overlooked retinal process, rhythmic OSP ensures the maintenance of healthy photoreceptors and vision. Daily, the photoreceptors renew OS at their base and the most distal, and likely oldest, OS tips, are phagocytosed by the RPE, preventing the accumulation of photo-oxidative compounds by breaking down phagocytosed OS tips and recycling useful components to the photoreceptors. Light changes often coincide with an escalation of OSP and within hours the phagosomes formed in each RPE cell are resolved. In the last two decades, individual molecular regulators were elucidated. Some of the molecular machinery used by RPE cells for OSP is highly similar to mechanisms used by other phagocytic cells for the clearance of apoptotic cells. Consequently, in the RPE, many molecular regulators of retinal phagocytosis have been elucidated. However, there is still a knowledge gap regarding the key regulators of physiological OSP in vivo between endogenous photoreceptors and the RPE. Understanding the regulation of OSP is of significant clinical interest as age-related macular degeneration (AMD) and inherited retinal diseases (IRD) are linked with altered OSP. Here, we review the in vivo timing of OSP peaks in selected species and focus on the reported in vivo environmental and molecular regulators of OSP.	[Moran, Ailis L.; Fehilly, John D.; Jones, Daniel Floss; Kennedy, Breandan N.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Moran, Ailis L.; Fehilly, John D.; Jones, Daniel Floss; Kennedy, Breandan N.] Univ Coll Dublin, UCD Conway Inst, Dublin, Ireland; [Collery, Ross] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI USA; [Collery, Ross] Wisconsin Eye Inst, Dept Ophthalmol & Visual Sci, Med Coll, Milwaukee, WI USA	University College Dublin; University College Dublin; Medical College of Wisconsin	Kennedy, BN (corresponding author), Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland.	brendan.kennedy@ucd.ie		Kennedy, Breandan/0000-0001-7991-4689; Moran, Ailis/0000-0002-8706-9777	Irish Research Council [EPS2019/526]; Science Foundation Ireland [20/FFP--P/8538]; Fighting Blindness [FB21KEN]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fighting Blindness	Irish Research Council EPS2019/526. Science Foundation Ireland 20/FFP--P/8538. Fighting Blindness grant award FB21KEN.	ANDERSON DH, 1995, J COMP NEUROL, V360, P1, DOI 10.1002/cne.903600102; ANDERSON DH, 1980, EXP EYE RES, V30, P559, DOI 10.1016/0014-4835(80)90040-8; BASINGER S, 1976, SCIENCE, V194, P1074, DOI 10.1126/science.1086510; BASINGER S F, 1980, Neurochemistry International, V1, P81, DOI 10.1016/0197-0186(80)90052-2; BASINGER SF, 1982, VISION RES, V22, P1533, DOI 10.1016/0042-6989(82)90220-6; BASSI CJ, 1990, INVEST OPHTH VIS SCI, V31, P2314; BERNSTEIN SA, 1984, J CELL BIOL, V99, P379, DOI 10.1083/jcb.99.2.379; BESHARSE JC, 1979, INVEST OPHTH VIS SCI, V18, P1019; BIRKLE DL, 1989, CURR EYE RES, V8, P557, DOI 10.3109/02713688908995754; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Bobu C, 2009, INVEST OPHTH VIS SCI, V50, P3495, DOI 10.1167/iovs.08-3145; Bonilha VL, 2006, ADV EXP MED BIOL, V572, P519; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; Burgess B, 2006, MOL VIS, V12, P1437; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Campbell LJ, 2017, INVEST OPHTH VIS SCI, V58, P5604, DOI 10.1167/iovs.17-21958; Carter SP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00136; Cockram TOJ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.629979; CURRIE JR, 1978, VISION RES, V18, P995, DOI 10.1016/0042-6989(78)90027-5; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; DeVera C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23105302; DeVera C, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107988; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Felder-Schmittbuhl M.-P., 2017, CHRONOPHYSIOLOGY THE, V7, P33, DOI DOI 10.2147/CPT.S115251; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2006, ADV EXP MED BIOL, V572, P499; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; FISHER SK, 1983, INVEST OPHTH VIS SCI, V24, P844; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Ghazi NG, 2016, HUM GENET, V135, P327, DOI 10.1007/s00439-016-1637-y; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; GORDON WC, 1990, VISUAL NEUROSCI, V4, P95, DOI 10.1017/S0952523800002790; Goyal V, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.10; Grace MS, 1999, VISUAL NEUROSCI, V16, P909, DOI 10.1017/S0952523899165106; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P291; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P277; HOLLYFIELD JG, 1978, NATURE, V274, P794, DOI 10.1038/274794a0; ILLC D, 1995, NATURE, V377, P539; IMMEL JH, 1985, CELL TISSUE RES, V239, P667; Inana G, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1434-6; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kocaoglu OP, 2016, BIOMED OPT EXPRESS, V7, P4554, DOI 10.1364/BOE.7.004554; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kopitz J, 2004, BIOCHIMIE, V86, P825, DOI 10.1016/j.biochi.2004.09.029; Korshunov KS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00091; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Krigel A, 2010, MOL VIS, V16, P2873; Kwon W, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.604205; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Laurent V, 2017, EXP EYE RES, V165, P90, DOI 10.1016/j.exer.2017.09.007; LaVail MM, 2016, ADV EXP MED BIOL, V854, P487, DOI 10.1007/978-3-319-17121-0_65; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1978, INVEST OPHTH VIS SCI, V17, P1189; Law AL, 2015, J BIOL CHEM, V290, P4941, DOI 10.1074/jbc.M114.628297; Law AL, 2009, MOL BIOL CELL, V20, P3896, DOI 10.1091/mbc.E08-12-1204; Lewis TR, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0177-9; LONG KO, 1986, EXP EYE RES, V43, P193, DOI 10.1016/S0014-4835(86)80087-2; Lorach H., 2018, SCI REP-UK, V8, P1; Mao YY, 2016, ADV EXP MED BIOL, V854, P717, DOI 10.1007/978-3-319-17121-0_95; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; Mazzoni F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38363-z; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Milicevic N, 2021, FASEB J, V35, DOI 10.1096/fj.202100293RR; Moran AL, 2022, FASEB J, V36, DOI 10.1096/fj.202101897R; Mustafi D, 2013, FASEB J, V27, P4585, DOI 10.1096/fj.13-237537; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nandrot EF, 2008, OPHTHALMIC RES, V40, P120, DOI 10.1159/000119861; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Notomi S, 2019, P NATL ACAD SCI USA, V116, P23724, DOI 10.1073/pnas.1906643116; Numrich J, 2014, BIOL CHEM, V395, P327, DOI 10.1515/hsz-2013-0258; ODAY WT, 1978, J CELL BIOL, V76, P593, DOI 10.1083/jcb.76.3.593; Picard E, 2010, AGING-US, V2, P981, DOI 10.18632/aging.100218; Rajala RVS, 2010, J LIPID RES, V51, P4, DOI 10.1194/jlr.R000232; Ramsden CM., 2017, SCI REP-UK, V7, P1; REME C, 1986, BRAIN RES, V369, P356, DOI 10.1016/0006-8993(86)90550-0; RetNet the Retinal Information Network, US; Reyes-Reveles J, 2017, J BIOL CHEM, V292, P8038, DOI 10.1074/jbc.M116.770784; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Schreiter S, 2020, STEM CELL REP, V15, P1347, DOI 10.1016/j.stemcr.2020.10.013; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Sethna S, 2016, J BIOL CHEM, V291, P6494, DOI 10.1074/jbc.M115.687004; Sharma VK, 2005, CURR SCI INDIA, V89, P1136; Strauss O, 1998, ACTA ANAT, V162, P101; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; TABOR GA, 1980, EXP EYE RES, V30, P545, DOI 10.1016/0014-4835(80)90039-1; TAMAI M, 1978, INVEST OPHTH VIS SCI, V17, P558; TEIRSTEIN PS, 1980, INVEST OPHTH VIS SCI, V19, P1268; TERMAN JS, 1993, BRAIN RES, V605, P256; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Toulis V, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108360; Vargas JA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073661; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; WILLIAMS DS, 1987, INVEST OPHTH VIS SCI, V28, P184; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Ying GX, 2018, J BIOL CHEM, V293, P17546, DOI 10.1074/jbc.RA118.005484; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; YOUNG RW, 1971, J ULTRA MOL STRUCT R, V34, P190, DOI 10.1016/S0022-5320(71)90014-1; Yu C, 2019, J CELL SCI, V132, DOI 10.1242/jcs.239426; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zigler JS, 2016, BBA-GEN SUBJECTS, V1860, P287, DOI 10.1016/j.bbagen.2015.05.017; Zihni C., 2021, BIORXIV, DOI [10.1101/2021.03.25.436833, DOI 10.1101/2021.03.25.436833]	118	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22556	10.1096/fj.202200990RR	http://dx.doi.org/10.1096/fj.202200990RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4V9KT	36165194	hybrid			2022-12-28	WOS:000859789400001
J	Gart, E; van Duyvenvoorde, W; Caspers, MPM; van Trigt, N; Snabel, J; Menke, A; Keijer, J; Salic, K; Morrison, MC; Kleemann, R				Gart, Eveline; van Duyvenvoorde, Wim; Caspers, Martien P. M.; van Trigt, Nikki; Snabel, Jessica; Menke, Aswin; Keijer, Jaap; Salic, Kanita; Morrison, Martine C.; Kleemann, Robert			Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr-/-.Leiden mice with manifest obesity-associated NASH	FASEB JOURNAL			English	Article						branched-chain amino acids; diacylglycerols; insulin resistance; lipid metabolism; non-alcoholic steatohepatitis; oxidative stress	CHAIN AMINO-ACIDS; NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; HEPATIC STEATOSIS; MICROVESICULAR STEATOSIS; MITOCHONDRIAL-FUNCTION; GLUCOSE-METABOLISM; MECHANISMS; DIET; PATHWAY	Non-alcoholic steatohepatitis (NASH) is associated with a disturbed metabolism in liver, insulin resistance, and excessive accumulation of ectopic fat. Branched-chain amino acids (BCAAs) may beneficially modulate hepatic lipids, however, it remains unclear whether individual BCAAs can attenuate already established NASH and associated oxidative-inflammatory stress. After a 26 weeks run-in on fast food diet (FFD), obese Ldlr-/-.Leiden mice were treated for another 12 weeks with either valine or isoleucine (3% of FFD) and then compared to FFD controls. Valine and isoleucine did not affect obesity, dyslipidemia, gut permeability, or fecal fatty acid excretion, but significantly reduced hyperinsulinemia. Valine and isoleucine reduced ALT, CK18-M30, and liver steatosis with a particularly pronounced suppression of the microvesicular component (-61% by valine and -71% by isoleucine). Both BCAAs decreased intrahepatic diacylglycerols and 4-hydroxynonenal immunoreactivity, a marker for oxidative stress-induced lipid peroxidation. Functional genomics analysis demonstrated that valine and isoleucine affected BCAA metabolism genes, deactivated master regulators of anabolic pathways related to steatosis (e.g., SREBPF1), and activated master regulators of mitochondrial biogenesis (e.g., PPARGC1A) and lipid catabolism (e.g., ACOX1, AMPK). This correction of critical metabolic pathways on gene expression level was accompanied by a significant decrease in histological liver inflammation, and suppression of FFD-stimulated cytokine and chemokine proteins KC/CXCL1, MCP-1/CCL2, and MIP-2/CXCL2 and their pathways. In conclusion, dietary intervention with either valine or isoleucine corrected liver diacylglycerols, gene expression of multiple metabolic processes, and reduced NASH histology with profound hepatoprotective effects on oxidative stress and inflammatory proteins.	[Gart, Eveline; van Duyvenvoorde, Wim; van Trigt, Nikki; Snabel, Jessica; Menke, Aswin; Salic, Kanita; Morrison, Martine C.; Kleemann, Robert] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, NL-2333 CK Leiden, Netherlands; [Gart, Eveline; Keijer, Jaap; Morrison, Martine C.] Wageningen Univ, Human & Anim Physiol, Wageningen, Netherlands; [Caspers, Martien P. M.] Netherlands Org Appl Sci Res TNO, Dept Microbiol & Syst Biol, Zeist, Netherlands; [Kleemann, Robert] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands	Netherlands Organization Applied Science Research; Wageningen University & Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gart, E (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, NL-2333 CK Leiden, Netherlands.	eveline.gart@tno.nl	Morrison, Martine/C-3168-2014	Morrison, Martine/0000-0003-4996-943X	PPP Allowance by Health-Holland, Top Sector Life Sciences Health; TNO [PMC 9, PMC 13]	PPP Allowance by Health-Holland, Top Sector Life Sciences Health; TNO	This study was performed within the public-private partnership (PPP) ProLiver, a collaboration project that is co-funded by a PPP Allowance made available by Health-Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. The work described here was also supported by the TNO Research Programs Food and Nutrition, and Biomedical Health (PMC 9 and PMC 13) and assays developed in the ERP Body brain interactions.	Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Bijland S, 2011, TOXICOL SCI, V123, P290, DOI 10.1093/toxsci/kfr142; Bishop CA, 2020, FASEB J, V34, P9727, DOI 10.1096/fj.202000195R; Bruckbauer A, 2016, INT J HEPATOL, V2016, DOI 10.1155/2016/9185987; Chalasani N, 2018, ALIMENT PHARM THER, V47, P1639, DOI 10.1111/apt.14674; Chen KH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071921; Cianflone K, 1996, J BIOL CHEM, V271, P29136, DOI 10.1074/jbc.271.46.29136; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Gao J, 2014, J CELL BIOL, V207, P213, DOI 10.1083/jcb.201403129; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gart E, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9121954; Gart E, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082836; Gray N, 2021, TALANTA, V223, DOI 10.1016/j.talanta.2020.121872; Honda T, 2017, METABOLISM, V69, P177, DOI 10.1016/j.metabol.2016.12.013; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hwang S, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.751802; Garcia-Berumen CI, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1024-5; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jiang LQ, 2016, AM J PHYSIOL-ENDOC M, V310, pE51, DOI 10.1152/ajpendo.00209.2015; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Lee J., 2021, ENDOCRINOLOGY, V162, pBQAB062, DOI [10.1210/ENDOCR/BQAB062, DOI 10.1210/ENDOCR/BQAB062]; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Liu R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060565; Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyu K, 2020, CELL METAB, V32, P654, DOI 10.1016/j.cmet.2020.08.001; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McGarrah RW, 2020, AM J PHYSIOL-ENDOC M, V318, pE216, DOI 10.1152/ajpendo.00334.2019; Meyer A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00536; Morrison MC, 2018, HEPATOL COMMUN, V2, P1513, DOI 10.1002/hep4.1270; Morrison MC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00132; Muller AM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.601160; Mulder P., 2015, INFLAMM CELL SIGNAL, V2, DOI [10.14800/ics.804, DOI 10.14800/ICS.804]; Nagata C, 2013, AM J EPIDEMIOL, V178, P1226, DOI 10.1093/aje/kwt112; Nakanishi C, 2010, TOHOKU J EXP MED, V221, P151, DOI 10.1620/tjem.221.151; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P1240, DOI 10.1111/j.1440-1746.2006.04313.x; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Niederreiter L., 2018, LIVER RES, V2, P14, DOI [10.1016/j.livres.2018.03.003, DOI 10.1016/J.LIVRES.2018.03.003]; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; NRC (National Research Council), 1995, NUTR REQ LAB AN, VFourth Revised, DOI [10.17226/4758, DOI 10.17226/4758]; Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004; PRINCEN HMG, 1995, ARTERIOSCL THROM VAS, V15, P325, DOI 10.1161/01.ATV.15.3.325; Richardson Nicole E, 2021, Nat Aging, V1, P73, DOI 10.1038/s43587-020-00006-2; Ruocco C, 2021, CURR OPIN CLIN NUTR, V24, P88, DOI 10.1097/MCO.0000000000000704; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Salic K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184359; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scorletti E, 2022, J HEPATOL, V76, P934, DOI 10.1016/j.jhep.2021.11.009; Smith GI, 2020, J CLIN INVEST, V130, P1453, DOI 10.1172/JCI134165; Sunny NE, 2015, AM J PHYSIOL-ENDOC M, V309, pE311, DOI 10.1152/ajpendo.00161.2015; Tahri-Joutey M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168969; Takegoshi K, 2017, ONCOTARGET, V8, P18191, DOI 10.18632/oncotarget.15304; Tedesco L, 2018, AM J PHYSIOL-GASTR L, V314, pG566, DOI 10.1152/ajpgi.00231.2017; Tobias DK, 2018, CLIN CHEM, V64, P1203, DOI 10.1373/clinchem.2017.285841; Tremblay F, 2001, J BIOL CHEM, V276, P38052; van den Hoek AM, 2021, METABOLISM, V124, DOI 10.1016/j.metabol.2021.154873; van den Hoek AM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092014; van Koppen A, 2018, CELL MOL GASTROENTER, V5, P83, DOI 10.1016/j.jcmgh.2017.10.001; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; White PJ, 2019, SCIENCE, V363, P582, DOI 10.1126/science.aav0558; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Woo SL, 2019, AM J CLIN NUTR, V109, P1569, DOI 10.1093/ajcn/nqz024; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yu DY, 2021, CELL METAB, V33, P905, DOI 10.1016/j.cmet.2021.03.025; Zhao P, 2020, SCIENCE, V367, P652, DOI 10.1126/science.aay0542; Zhou YY, 2018, HEPATOL COMMUN, V2, P376, DOI 10.1002/hep4.1155	78	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22435	10.1096/fj.202200111R	http://dx.doi.org/10.1096/fj.202200111R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2V4HL	35830259				2022-12-28	WOS:000823809300001
J	Koutsogiannaki, S; Bu, WM; Maisat, W; Manzor, M; Zhang, ZK; Ohto, U; Eckenhoff, RG; Yuki, K				Koutsogiannaki, Sophia; Bu, Weiming; Maisat, Wiriya; Manzor, Mariel; Zhang, Zhikuan; Ohto, Umeharu; Eckenhoff, Roderic G.; Yuki, Koichi			Propofol directly binds to and inhibits TLR7	FASEB JOURNAL			English	Article						photolabeling; propofol; TLR7 antagonist	ANESTHETICS ISOFLURANE; SEDATION; DEXMEDETOMIDINE; INFUSION	Sedatives/anesthetics are important medical tools to facilitate medical care and increase patients' comfort. Increasingly, there is recognition that sedatives/anesthetics can modulate immune functions. Toll-like receptors (TLRs) are major pattern recognition receptors involved in the recognition of microbial components. TLR7 recognizes single-strand RNA virus such as influenza and SARS-CoV2 viruses and initiates interferon (IFN) responses. IFN production triggered by TLR7 stimulation is a critical anti-viral response. For example, patients with TLR7 variants including loss-of- function variants were associated with severe COVID-19. Taken together, it is important to determine if sedatives/anesthetics mitigate TLR7 function. We have previously showed that TLR7-mediated activation was not affected by volatile anesthetics. However, we found that propofol attenuated TLR7 activation among intravenous sedatives in the reporter assay. TLR7 agonist R837 stimulation increased TNF-alpha, IL-1 beta, IL-6, IL-10, and IFN-beta mRNA levels in bone marrow-derived dendritic cells, while these levels were attenuated by propofol. Our murine lung slice experiments showed that propofol attenuated IFN production. R837 increased IFN-beta expression in the lungs, and propofol attenuated IFN-beta expression in an in vivo model of R837 intranasal instillation. We also found that propofol directly bound to and hindered its association of TLR7 with MyD88. Our analysis using fropofol, propofol derivative showed that the hydroxyl group in propofol was important for propofol-TLR7 interaction.	[Koutsogiannaki, Sophia; Maisat, Wiriya; Manzor, Mariel; Yuki, Koichi] Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA; [Koutsogiannaki, Sophia; Maisat, Wiriya; Yuki, Koichi] Harvard Med Sch, Dept Anaesthesia & Immunol, Boston, MA 02115 USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Zhang, Zhikuan; Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Tokyo	Yuki, K (corresponding author), Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu			CHMC Anesthesia Foundation; NIH [R21AI158886]	CHMC Anesthesia Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CHMC Anesthesia Foundation, NIH R21AI158886 (K.Y.).	ALBANESE J, 1990, ANESTHESIOLOGY, V73, P214, DOI 10.1097/00000542-199008000-00004; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Elborn JS, 2016, EUR RESPIR J, V47, P420, DOI 10.1183/13993003.00592-2015; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Favetta P, 2002, BRIT J ANAESTH, V88, P653, DOI 10.1093/bja/88.5.653; GEPTS E, 1987, ANESTH ANALG, V66, P1256; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Jeon YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139845; Kang S, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e33; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Knights KM, 2013, BRIT J CLIN PHARMACO, V76, P587, DOI 10.1111/bcp.12086; Koutsogiannaki S, 2020, FASEB J, V34, P14645, DOI 10.1096/fj.202000791RR; Koutsogiannaki S, 2019, J SURG RES, V233, P323, DOI 10.1016/j.jss.2018.07.075; Koutsogiannaki S, 2017, TOXICOL SCI, V156, P402, DOI 10.1093/toxsci/kfw261; Mitsui Y, 2020, ANESTH ANALG, V131, P631, DOI 10.1213/ANE.0000000000004741; Mourits VP, 2020, IMMUNOLOGY, V159, P289, DOI 10.1111/imm.13145; Nseir S, 2010, CRIT CARE, V14, DOI 10.1186/cc8907; Okuno T, 2019, FASEB J, V33, P14528, DOI 10.1096/fj.201901570R; Olafson K, 2012, ANN PHARMACOTHER, V46, P9, DOI 10.1345/aph.1Q446; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sahinovic MM, 2018, CLIN PHARMACOKINET, V57, P1539, DOI 10.1007/s40262-018-0672-3; SHORT TG, 1994, BRIT J ANAESTH, V72, P302, DOI 10.1093/bja/72.3.302; Solanich X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.719115; Stegemann-Koniszewski S, 2013, J INNATE IMMUN, V5, P84, DOI 10.1159/000345112; Tojo S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19025-z; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Wu XH, 2019, METHODS MOL BIOL, V1940, P297, DOI 10.1007/978-1-4939-9086-3_21; Yarbrough J, 2012, J CHROMATOGR SCI, V50, P162, DOI 10.1093/chromsci/bmr042; Yuki K, 2021, INT IMMUNOPHARMACOL, V98, DOI 10.1016/j.intimp.2021.107909; Yuki K, 2021, BIOCHEM BIOPH RES CO, V557, P254, DOI 10.1016/j.bbrc.2021.04.045; Yuki K, 2020, BIOCHEM BIOPH RES CO, V525, P909, DOI 10.1016/j.bbrc.2020.03.037; Zhang ZK, 2018, CELL REP, V25, P3371, DOI 10.1016/j.celrep.2018.11.081	34	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22481	10.1096/fj.202200312R	http://dx.doi.org/10.1096/fj.202200312R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3F9KX	35899460				2022-12-28	WOS:000830980000001
J	Li, R; Wu, XL; Zhao, P; Xue, K; Li, JM				Li, Ran; Wu, Xiaolu; Zhao, Ping; Xue, Kai; Li, Junmin			A pan-cancer analysis identifies HDAC11 as an immunological and prognostic biomarker	FASEB JOURNAL			English	Article						drug sensitivity; HDAC11; immune infiltration; microsatellite instability; pan-cancer; prognosis; tumor mutation burden	HISTONE; EXPRESSION	Histone deacetylase 11 (HDAC11) is aberrantly expressed in many types of cancer, and such abnormalities are associated with tumor immunity and heterogeneous clinical outcomes. Here, we explore the prognostic value and immunological function of HDAC11 across 33 cancer types. We observe HDAC11 is aberrantly expressed in 25 cancer types and positively or negatively associated with prognosis in different cancers. HDAC11 played a protective prognostic role in KIRP, KIRC, LGG, PCPG, READ, and UVM, which was contrary to the conventional opinion that HDAC11 was an oncogenic gene. Moreover, HDAC11 is negatively associated with tumor immune components, most immune checkpoint genes, and key cytokine expression. HDAC11 is correlated with tumor mutational burden in 11 cancer types and with microsatellite instability in 9 cancer types, suggesting HDAC11 may affect a patient's response to immune checkpoint inhibitor (ICI) therapy. In addition, HDAC11 is negatively correlated with the drug sensitivity of oxaliplatin, carmustine, ifosfamide, imexon, lomustine, and BN-2629, indicating the potential synergy between HDAC11 inhibitors and these anti-tumor drugs. In vitro assays indicate that HDAC11 inhibitor SIS17 combined with oxaliplatin shows a synergistic cytotoxic role in K562 cells while SIS17 has an antagonistic effect on the cytotoxic role of oxaliplatin in 769P cells. HDAC11 is also associated with hallmark pathways, including epithelial mesenchymal transition, IL-6/JAK/STAT3, and allograft rejection pathways. Overall, we provide clues regarding the key role of HDAC11 in multiple cancers.	[Li, Ran; Xue, Kai; Li, Junmin] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China; [Wu, Xiaolu] Nanjing Med Univ, Womens Hosp, Dept Child Hlth Care, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Peoples R China; [Zhao, Ping] Univ North Alabama, Dept Biol, Florence, AL USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Nanjing Medical University	Xue, K; Li, JM (corresponding author), Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China.	xuekaishanghai@126.com; lijunminhematology@163.com		Li, Junmin/0000-0003-1338-8764; Li, Ran/0000-0003-1526-0182	National Key Research and Development Program of China [2019YFA0905900]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (2019YFA0905900)	Bi L, 2021, CANCER RES, V81, P2015, DOI 10.1158/0008-5472.CAN-20-3044; Boltz TA, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5973-x; Bora-Singhal N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61295-6; Chung DC, 1997, J CLIN INVEST, V100, P404, DOI 10.1172/JCI119547; Dang Fabin, 2022, Semin Cancer Biol, V85, P209, DOI 10.1016/j.semcancer.2021.03.001; Deubzer HE, 2013, INT J CANCER, V132, P2200, DOI 10.1002/ijc.27876; Fei Q, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01325-5; Gainor JF, 2020, ANN ONCOL, V31, P404, DOI 10.1016/j.annonc.2019.11.015; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Handkiewicz-Junak D, 2016, EUR J NUCL MED MOL I, V43, P1267, DOI 10.1007/s00259-015-3303-3; Huang JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09211-3; Janjigian YY, 2018, CANCER DISCOV, V8, P49, DOI 10.1158/2159-8290.CD-17-0787; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kalafati L, 2020, CELL, V183, P771, DOI 10.1016/j.cell.2020.09.058; Leslie PL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12222-5; Liu HD, 2008, J NEUROSCI RES, V86, P537, DOI 10.1002/jnr.21521; Liu SS, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110607; Ready N, 2019, J CLIN ONCOL, V37, P992, DOI 10.1200/JCO.18.01042; Sahakian E, 2015, MOL IMMUNOL, V63, P579, DOI 10.1016/j.molimm.2014.08.002; Shinohara H, 2017, J IMMUNOL, V199, P1505, DOI 10.4049/jimmunol.1700167; Tobin JWD, 2019, J CLIN ONCOL, V37, P3300, DOI 10.1200/JCO.18.02365; Vancurova I, 2018, TRENDS PHARMACOL SCI, V39, P295, DOI 10.1016/j.tips.2017.11.008; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang WL, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00724; Woods DM, 2017, BLOOD, V130, P146, DOI 10.1182/blood-2016-08-731505; Yao MJ, 2020, CELL, V180, P502, DOI 10.1016/j.cell.2019.12.024; Yue LZ, 2020, BLOOD, V135, P191, DOI 10.1182/blood.2019895326	27	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22326	10.1096/fj.202101742RR	http://dx.doi.org/10.1096/fj.202101742RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1U5CF	35657209				2022-12-28	WOS:000805429900001
J	Yu, GR; Lim, DW; Karunarathne, WAHM; Kim, GY; Kim, H; Kim, JE; Park, WH				Yu, Ga-Ram; Lim, Dong-Woo; Karunarathne, Wisurumuni Arachchilage Hasitha Maduranga; Kim, Gi-Young; Kim, Hyuck; Kim, Jai-Eun; Park, Won-Hwan			A non-polar fraction of Saponaria officinalis L. acted as a TLR4/MD2 complex antagonist and inhibited TLR4/MyD88 signaling in vitro and in vivo	FASEB JOURNAL			English	Article						immunomodulation; M1 polarization; molecular docking simulation; Saponaria officinalis L; saponarin; TLR4; MD2 complex; TLR4; MyD88 complex; zebrafish	NF-KAPPA-B; RAW 264.7 MACROPHAGES; STRUCTURAL BASIS; ENDOTOXIN; SAPONINS; INFLAMMATION; TAK-242; POLARIZATION; SUPPRESSION; ACTIVATION	Targeting Toll-like receptor 4/myeloid differentiation factor 2 (TLR4/MD2) signaling is regarded as a potential strategy for treating inflammatory diseases. Saponaria officinalis L. is rich in saponin, which include quillaic acid, gypsogenin, saponarin, and hederagenin. We evaluated the pharmacological activity of a Saponaria officinalis extract in THP-1 derived macrophages and RAW264.7 macrophages. TLR4/MyD88 complex formation and downstream signals were investigated by co-immunoprecipitation (Co-IP). In silico docking simulation was conducted to predict binding scores and perform 3D modeling of saponarin-TLR4/MD2 complex. A hexane fraction of Saponaria officinalis (SH) and fr.1 (a sub-fraction 1 of SH) inhibited mitogen-activated protein kinase (MAPK) signaling, nuclear factor kappa b (NF-kappa B) activity, cytokine production, and the expressions of marker genes specific for M1 polarization. The inhibitory effects of fr.1 and saponarin on TLR4/MyD88 complex formation were observed by western blotting TLR4 co-immunoprecipitated proteins. Saponarin and fr.1 markedly attenuated LPS-induced inflammatory cytokines, thus reducing mortality and morphological abnormality in zebrafish larvae. Finally, docking simulation revealed that saponarin can directly interact with TLR4/MD2 complex to inhibit downstream signalings. Our findings suggest that saponarin reduces downstream inflammatory response by disrupting TLR4/MD2 complex and blocking MyD88-dependent inflammatory signaling.	[Yu, Ga-Ram; Lim, Dong-Woo; Kim, Hyuck; Park, Won-Hwan] Dongguk Univ, Dept Diagnost, Coll Korean Med, Dongguk Ro 32, Goyang 10326, South Korea; [Lim, Dong-Woo; Kim, Jai-Eun] Dongguk Univ, Dept Pathol, Coll Korean Med, Dongguk Ro 32, Goyang 10326, South Korea; [Lim, Dong-Woo; Kim, Hyuck] Dongguk Univ, Inst Korean Med, Goyang, South Korea; [Karunarathne, Wisurumuni Arachchilage Hasitha Maduranga; Kim, Gi-Young] Jeju Natl Univ, Dept Marine Life Sci, Jeju, South Korea	Dongguk University; Dongguk University; Dongguk University; Jeju National University	Park, WH (corresponding author), Dongguk Univ, Dept Diagnost, Coll Korean Med, Dongguk Ro 32, Goyang 10326, South Korea.; Kim, JE (corresponding author), Dongguk Univ, Dept Pathol, Coll Korean Med, Dongguk Ro 32, Goyang 10326, South Korea.	herbqueen@dongguk.ac.kr; diapwh@dongguk.ac.kr	Lim, Dongwoo/GLU-0640-2022	Lim, Dongwoo/0000-0002-3179-9439; park, won hwan/0000-0002-2464-8317; Karunarathne, Wisurumuni Arachchilage Hasitha Maduranga/0000-0001-6398-8552; Kim, Jaieun/0000-0002-1368-6684; Kim, Hyuck/0000-0002-7017-1521; Yu, Ga-Ram/0000-0003-1559-4326	National Research Foundation of Korea (NRF) [2018R1D1A1B07048467, 2019RIF1A1051652]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2018R1D1A1B07048467 and 2019RIF1A1051652	Anwar MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07657; Billod JM, 2016, MOLECULES, V21, DOI 10.3390/molecules21080994; Bousoik E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00287; Buchacher T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143593; Choi YH, 2014, DRUG DES DEV THER, V8, P1941, DOI 10.2147/DDDT.S71957; Cuesta CM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312830; Cui JJ, 2018, MOL IMMUNOL, V101, P221, DOI 10.1016/j.molimm.2018.05.028; Fu QA, 2010, J NAT PROD, V73, P1234, DOI 10.1021/np100057y; Gaitonde V., 2020, DRUG DISCOVERY DEV N, P27; Gonzalez PJ, 2020, FOOD HYDROCOLLOID, V101, DOI 10.1016/j.foodhyd.2019.105541; Huang MH, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030362; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Karunarathne WAHM, 2020, PHYTOMEDICINE, V76, DOI 10.1016/j.phymed.2020.153237; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; KENAROVA B, 1990, JPN J PHARMACOL, V54, P447, DOI 10.1254/jjp.54.447; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Lacaille-Dubois MA, 2005, STUD NAT PROD CHEM, V32, P209; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li YH, 2019, J BIOL CHEM, V294, P2744, DOI 10.1074/jbc.RA118.003137; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moses T, 2014, CRIT REV BIOCHEM MOL, V49, P439, DOI 10.3109/10409238.2014.953628; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Obmann A, 2011, CARBOHYD RES, V346, P1868, DOI 10.1016/j.carres.2011.04.031; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Palmer C, 2018, INNATE IMMUN-LONDON, V24, P411, DOI 10.1177/1753425918798904; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Sarikahya NB, 2018, PHYTOMEDICINE, V38, P135, DOI 10.1016/j.phymed.2017.11.009; Schrodinger L., 2020, PYMOL; Serbian I, 2020, PHYTOCHEM LETT, V39, P35, DOI 10.1016/j.phytol.2020.06.005; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shi H, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13757; Shih JH, 2020, MAR DRUGS, V18, DOI 10.3390/md18100496; SOLTYSIK S, 1993, ANN NY ACAD SCI, V690, P392; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Vyncke L, 2016, STRUCTURE, V24, P437, DOI 10.1016/j.str.2015.12.018; Wang GM, 2016, FUTURE MED CHEM, V8, DOI 10.4155/fmc-2016-0143; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Xu HL, 2022, J GINSENG RES, V46, P156, DOI 10.1016/j.jgr.2021.05.011; Yang LL, 2014, MOLECULES, V19, P2390, DOI 10.3390/molecules19022390; Yao Y, 2014, J FOOD SCI, V79, pH1018, DOI 10.1111/1750-3841.12425; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Yu Q, 2016, INT IMMUNOPHARMACOL, V38, P104, DOI 10.1016/j.intimp.2016.05.010; Zaffaroni L, 2018, FUTURE MED CHEM, V10, P461, DOI 10.4155/fmc-2017-0172; Zali H, 2019, IRAN J PHARM RES, V18, P1639, DOI 10.22037/ijpr.2019.2394; Zhou MQ, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.624059; Zhu RL, 2019, IMMUNOPHARM IMMUNOT, V41, P172, DOI 10.1080/08923973.2019.1568451	62	1	1	9	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22387	10.1096/fj.202200018RR	http://dx.doi.org/10.1096/fj.202200018RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2B3WB	35696068	hybrid			2022-12-28	WOS:000810120600001
J	Zong, GN; Shears, SB; Wang, HN				Zong, Guangning; Shears, Stephen B.; Wang, Huanchen			Structural and catalytic analyses of the InsP(6) kinase activities of higher plant ITPKs	FASEB JOURNAL			English	Article						catalysis; crystal structure; enzyme-coupled assay; inositol pyrophosphate; ITPK; kinase; phosphate homeostasis; phytate; substrate binding	INOSITOL 1,3,4-TRISPHOSPHATE; PHOSPHORYLATION; FAMILY; 1,3,4,6-TETRAKISPHOSPHATE; SPECIFICITY; PROTEINS; EFFLUX	Inositol phosphate signaling in plants is of substantial agricultural interest, with a considerable focus on the inositol tris/tetrakisphosphate kinase (ITPK) family of inositol phosphate kinases. Historically, the 4-6 isoforms of ITPKs that higher plants each express have been studied for their multiplexing a metabolic pathway to synthesize inositol hexakisphosphate (ie InsP(6) or phytate), through the phosphorylation and dephosphorylation of multiple inositol phosphates, including Ins(1,3,4,5,6)P-5 (inositol-1,3,4,5,6-pentakisphosphate). A more recent discovery is ITPK-catalyzed phosphorylation of InsP(6) to inositol pyrophosphates, which regulate plant immunity and phosphate homeostasis. However, a molecular-based explanation for these alternate catalytic activities has been missing, because no plant ITPK structure has previously been solved. Herein, we provide biochemical and structural analyses of ITPKs from Zea mays and Glycine max. For this work we introduce a simple, enzyme-coupled microplate-based assay of InsP(6) kinase activity that should promote more general access to this important field. Furthermore, a ZmITPK1/InsP(6) crystal complex is described at a resolution of 2.6 angstrom, which identifies a number of catalytically important residues; their functionality is confirmed by mutagenesis. We further demonstrate that ZmITPK1 adds a beta-phosphate to the 3-position of Ins(1,2,3,4,5)P-5, yielding a candidate signal for regulating phosphate homeostasis. An impactful discovery is our description of a 29-residue catalytic specificity element; by interchanging this element between GmITPK1 and GmITPK2, we demonstrate how its isoform-specific sequence specifically determines whether the host protein phosphorylates InsP(6), without substantially affecting Ins(1,3,4,5,6)P-5 metabolism. Our structural rationalization of key catalytic differences between alternate ITPK isoforms will complement future research into their functional diversity.	[Zong, Guangning; Shears, Stephen B.; Wang, Huanchen] NIEHS, Inositol Signaling Sect, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wang, HN (corresponding author), NIEHS, Inositol Signaling Sect, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	huanchen.wang@nih.gov			Intramural Research Program of the NIH, National Institute of Environmental Health Sciences	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. We are grateful to the NIEHS Collaborative crystallography group, and the Advanced Photon Source (APS) SE Regional Collaborative Access Team (SER-CAT) 22-ID and 22-BM beam lines, for assistance with crystallographic data collection.	Adepoju O., 2019, INOSITOL TRISPHOSPHA, DOI 10.1101/724914; BALLA T, 1987, J BIOL CHEM, V262, P9952; Chamberlain PP, 2007, J BIOL CHEM, V282, P28117, DOI 10.1074/jbc.M703121200; Desfougeres Y, 2019, P NATL ACAD SCI USA, V116, P24551, DOI 10.1073/pnas.1911431116; Dong JS, 2019, MOL PLANT, V12, P1463, DOI 10.1016/j.molp.2019.08.002; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Freed C, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010115; Ganapathi SB, 2013, HYPERTENSION, V61, P174, DOI 10.1161/HYPERTENSIONAHA.112.194209; Ganguli Shubhra, 2020, Advances in Biological Regulation, V75, P100662, DOI 10.1016/j.jbior.2019.100662; Gulabani H, 2022, PLANT CELL REP, V41, P347, DOI 10.1007/s00299-021-02812-3; Ho MWY, 2002, CURR BIOL, V12, P477, DOI 10.1016/S0960-9822(02)00713-3; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; HUGHES PJ, 1989, J BIOL CHEM, V264, P19871; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jiang M, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8050114; Josefsen L, 2007, GENE, V397, P114, DOI 10.1016/j.gene.2007.04.018; Kirk CJ., 1990, PEPTIDE HORMONE ACTI, P151; Kuo HF, 2018, PLANT J, V95, P613, DOI 10.1111/tpj.13974; Laha Debabrata, 2021, Advances in Biological Regulation, V79, P100782, DOI 10.1016/j.jbior.2020.100782; Laha D, 2019, ACS CHEM BIOL, V14, P2127, DOI 10.1021/acschembio.9b00423; Laha D, 2015, PLANT CELL, V27, P1082, DOI 10.1105/tpc.114.135160; Li XY, 2020, P NATL ACAD SCI USA, V117, P3568, DOI 10.1073/pnas.1908830117; Marathe A, 2018, PLANT PHYSIOL BIOCH, V123, P331, DOI 10.1016/j.plaphy.2017.12.026; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Raboy Victor, 2006, V39, P71; Riemer E, 2021, MOL PLANT, V14, P1864, DOI 10.1016/j.molp.2021.07.011; Riley AM, 2006, FEBS LETT, V580, P324, DOI 10.1016/j.febslet.2005.12.016; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; SHEARS SB, 1989, J BIOL CHEM, V264, P19879; Shears Stephen B., 2019, Advances in Biological Regulation, V71, P118, DOI 10.1016/j.jbior.2018.10.006; Shukla A, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01198-8; Stiles AR, 2008, FEBS LETT, V582, P1853, DOI 10.1016/j.febslet.2008.04.054; Sweetman D, 2007, FEBS LETT, V581, P4165, DOI 10.1016/j.febslet.2007.07.046; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Whitfield H, 2020, BIOCHEM J, V477, P2621, DOI 10.1042/BCJ20200423; Yang XN, 2000, BIOCHEM J, V351, P551, DOI 10.1042/0264-6021:3510551; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zong GN, 2021, FASEB J, V35, DOI 10.1096/fj.202001489R; Zonia L, 2002, PLANT CELL, V14, P2233, DOI 10.1105/tpc.003830	45	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22380	10.1096/fj.202200393R	http://dx.doi.org/10.1096/fj.202200393R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1P9BE	35635723				2022-12-28	WOS:000802296100001
J	Dikeocha, IJ; Al-Kabsi, AM; Miftahussurur, M; Alshawsh, MA				Dikeocha, Ifeoma Julieth; Al-Kabsi, Abdelkodose Mohammed; Miftahussurur, Muhammad; Alshawsh, Mohammed Abdullah			Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism	FASEB JOURNAL			English	Review						drug metabolism; gut microbiota; microbiome; pharmacomicrobiomics; xenobiotics	PROTON PUMP INHIBITORS; INTESTINAL MICROBIOTA; PERSONALIZED MEDICINE; GERM-FREE; INACTIVATION; DIETARY; DIGOXIN; SYSTEMS; IMPACT; HOST	Gut microbiota is the most diverse and complex biological ecosystem, which is estimated to consist of greater than 5 million distinct genes and 100 trillion cells which are in constant communication with the host environment. The interaction between the gut microbiota and drugs and other xenobiotic compounds is bidirectional, quite complicated, and not fully understood yet. The impact of xenobiotics from pollution, manufacturing processes or from the environment is harmful to human health at varying degrees and this needs to be recognized and addressed. The gut microbiota is capable of biotransforming/metabolizing of various drugs and xenobiotic compounds as well as altering the activity and toxicity of these substances, thereby influencing how a host responds to drugs and xenobiotics and this emerging field is known as pharmacomicrobiomics. In this review, we discussed different mechanisms of drug-gut microbiota interaction and highlighted the influence of drug-gut microbiome interactions on the clinical response in humans.	[Dikeocha, Ifeoma Julieth; Al-Kabsi, Abdelkodose Mohammed] Univ Cyberjaya, Fac Med, Cyberjaya, Malaysia; [Miftahussurur, Muhammad] Univ Airlangga, Inst Trop Dis, Helicobacter Pylori & Microbiota Study Grp, Surabaya 60286, Indonesia; [Miftahussurur, Muhammad] Univ Airlangga, Dr Soetomo Teaching Hosp, Div Gastroentero Hepatol, Dept Internal Med,Fac Med, Surabaya, Indonesia; [Alshawsh, Mohammed Abdullah] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Airlangga University; Airlangga University; Universiti Malaya	Miftahussurur, M (corresponding author), Univ Airlangga, Inst Trop Dis, Helicobacter Pylori & Microbiota Study Grp, Surabaya 60286, Indonesia.; Alshawsh, MA (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	muhammad-m@lk.unair.ac.id; alshaweshmam@um.edu.my	Alshawsh, Mohammed Abdullah/B-2887-2010	Alshawsh, Mohammed Abdullah/0000-0001-8342-5183; Dikeocha, Ifeoma Julieth/0000-0003-1700-828X	UM \ Institut Pengurusan dan Pemantauan Penyelidikan, Universiti Malaya (Institute of Research Management and Monitoring, University of Malaya) [ST070-2021]; Universitas Airlangga (UNAIR)	UM \ Institut Pengurusan dan Pemantauan Penyelidikan, Universiti Malaya (Institute of Research Management and Monitoring, University of Malaya); Universitas Airlangga (UNAIR)	UM vertical bar Institut Pengurusan dan Pemantauan Penyelidikan, Universiti Malaya (Institute of Research Management and Monitoring, University of Malaya), Grant/Award Number: ST070-2021; Universitas Airlangga (UNAIR)	Abdelsalam NA, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00390; Abou Abdallah R, 2017, ANTON LEEUW INT J G, V110, P1327, DOI 10.1007/s10482-017-0871-1; Aguilera M, 2013, NEUROGASTROENT MOTIL, V25, pE515, DOI 10.1111/nmo.12154; Alfarouk KO, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0221-1; ASHIDA N, 1993, BIOCHEM PHARMACOL, V46, P2201, DOI 10.1016/0006-2952(93)90610-9; Aziz RK, 2018, OMICS, V22, P295, DOI 10.1089/omi.2018.0041; Aziz Ramy K., 2012, Current Pharmacogenomics & Personalized Medicine, V10, P258; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P1307, DOI 10.4161/cbt.4.12.2315; Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chi L, 2019, ARCH TOXICOL, V93, P25, DOI 10.1007/s00204-018-2332-7; Chia CTW, 2014, SINGAP MED J, V55, P363, DOI 10.11622/smedj.2014087; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Colebrook L, 1936, LANCET, V2, P1323; Collins SL, 2020, ACTA PHARMACOL SIN B, V10, P19, DOI 10.1016/j.apsb.2019.12.001; Crouwel F, 2021, J CROHNS COLITIS, V15, P307, DOI 10.1093/ecco-jcc/jjaa143; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Diakite A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66738-8; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dikeocha IJ, 2022, NUTR REV, V80, P22, DOI 10.1093/nutrit/nuab006; Dong MY, 2019, CHEM RES TOXICOL, V32, P2320, DOI 10.1021/acs.chemrestox.9b00316; ElRakaiby M, 2014, OMICS, V18, P402, DOI 10.1089/omi.2014.0018; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Finlay BB, 2020, NAT REV IMMUNOL, V20, P522, DOI 10.1038/s41577-020-0374-6; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Gievic A., 2019, TOXICITY AZO DYES PH, p581; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GOLDMAN P, 1974, AM J CLIN NUTR, V27, P1348; Gratz SW, 2013, APPL ENVIRON MICROB, V79, P1821, DOI 10.1128/AEM.02987-12; Grundmann O., 2010, J DRUG METAB TOXICOL, V1, P104, DOI DOI 10.4172/2157-7609.1000104; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Halden RU, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1788; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jin MJ, 2014, J AGR FOOD CHEM, V62, P9632, DOI 10.1021/jf502557f; Jin MJ, 2010, J TOXICOL ENV HEAL A, V73, P1441, DOI 10.1080/15287394.2010.511549; Khan AA, 2021, EXPERT OPIN BIOL TH, V21, P413, DOI 10.1080/14712598.2021.1828858; KHAN AKA, 1983, CLIN SCI, V64, P349, DOI 10.1042/cs0640349; Kim DH, 2015, DRUG METAB DISPOS, V43, P1581, DOI 10.1124/dmd.115.063867; Koppel N, 2018, ELIFE, V7, DOI [10.7554/eLife.33953, 10.7554/elife.33953]; Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770; Lam KN, 2019, CELL HOST MICROBE, V26, P22, DOI 10.1016/j.chom.2019.06.011; Lee HJ, 2012, XENOBIOTICA, V42, P791, DOI 10.3109/00498254.2012.660508; Li HK, 2016, EXPERT OPIN DRUG MET, V12, P31, DOI 10.1517/17425255.2016.1121234; Li WY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.644454; Lin XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039764; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; MAGNUSSON JO, 1982, BRIT J CLIN PHARMACO, V14, P284, DOI 10.1111/j.1365-2125.1982.tb01976.x; Mallick H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1359-z; Markey SP, 2007, PRINCIPLES OF CLINICAL PHARMACOLOGY, 2ND EDITION, P143, DOI 10.1016/B978-012369417-1/50051-1; MATHAN VI, 1989, GUT, V30, P971, DOI 10.1136/gut.30.7.971; Meinl W, 2009, DRUG METAB DISPOS, V37, P1179, DOI 10.1124/dmd.108.025916; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Michalopoulos GK, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P566; Misal SA, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0206-8; Mohiuddin AK., 2019, ARCH BIOMED ENG BIOT, V2, P538; Nakayama H, 1997, PHARMACOGENETICS, V7, P35, DOI 10.1097/00008571-199702000-00005; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nogacka AM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082051; Okuda H, 1997, DRUG METAB DISPOS, V25, P270; OVERVIK E, 1990, FOOD CHEM TOXICOL, V28, P253, DOI 10.1016/0278-6915(90)90037-N; Pellock SJ, 2019, J MOL BIOL, V431, P970, DOI 10.1016/j.jmb.2019.01.013; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peterson MA, 2016, WEED TECHNOL, V30, P303, DOI 10.1614/WT-D-15-00131.1; Petrie B, 2015, WATER RES, V72, P3, DOI 10.1016/j.watres.2014.08.053; Poole AC., 2016, MSPHERE, V1; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rizkallah Mariam Reyad, 2010, Current Pharmacogenomics & Personalized Medicine, V8, P182; Rybak MJ, 2020, AM J HEALTH-SYST PH, V77, P835, DOI 10.1093/ajhp/zxaa036; Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314; Scher JU, 2020, NAT REV RHEUMATOL, V16, P282, DOI 10.1038/s41584-020-0395-3; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Secombe KR, 2019, INT J CANCER, V144, P2365, DOI 10.1002/ijc.31836; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sinha R, 2002, MUTAT RES-FUND MOL M, V506, P197, DOI 10.1016/S0027-5107(02)00166-5; Spady DK., 1995, RECENT ADV MEDICAL T; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; STRONG HA, 1987, XENOBIOTICA, V17, P685, DOI 10.3109/00498258709043976; Suez J, 2015, GUT MICROBES, V6, P149, DOI 10.1080/19490976.2015.1017700; Sun YM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230197; Swanson HI, 2015, DRUG METAB DISPOS, V43, P1499, DOI 10.1124/dmd.115.065714; Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492; Tan HJ, 2013, J DIGEST DIS, V14, P1, DOI 10.1111/1751-2980.12000; Tozaki H, 1997, J PHARM PHARMACOL, V49, P164, DOI 10.1111/j.2042-7158.1997.tb06773.x; Tu PC., 2019, SCI REP-UK, V9, P1; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Winkler GC, 2014, REGUL TOXICOL PHARM, V70, P46, DOI 10.1016/j.yrtph.2014.06.012; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Xu JX, 2014, NUTRITION, V30, P584, DOI 10.1016/j.nut.2013.10.018; Yang HX, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4116; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin NY, 2015, ENVIRON SCI TECHNOL, V49, P10675, DOI 10.1021/acs.est.5b03046; Yoo DH, 2014, DRUG METAB DISPOS, V42, P1508, DOI 10.1124/dmd.114.058354; Zahran SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41894-8; Zemanova N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65595-9; Zhang JB, 2017, TOXICOL SCI, V159, P266, DOI 10.1093/toxsci/kfx132; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	105	1	1	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22350	10.1096/fj.202101986R	http://dx.doi.org/10.1096/fj.202101986R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1H5YE	35579628				2022-12-28	WOS:000796618400001
J	He, WF; Qin, R; Gao, YH; Zhou, J; Wei, JJ; Liu, J; Hou, XF; Ma, HP; Xian, CJ; Li, XY; Chen, KM				He, Wen-Fang; Qin, Rong; Gao, Yu-Hai; Zhou, Jian; Wei, Juan-Juan; Liu, Jing; Hou, Xue-Feng; Ma, Hui-Ping; Xian, Cory J.; Li, Xue-Yan; Chen, Ke-Ming			The interdependent relationship between the nitric oxide signaling pathway and primary cilia in pulse electromagnetic field-stimulated osteoblastic differentiation	FASEB JOURNAL			English	Article						endothelial nitric oxide synthase; nitric oxide; osteogenic differentiation; primary cilia; pulsed electromagnetic fields	PROLIFERATION; MATURATION; CAMP	Pulsed electromagnetic fields (PEMFs) have long been recognized being safe and effective in treating bone fracture nonunion and osteoporosis. However, the mechanism of osteogenic action of PEMFs is still unclear. While primary cilia are reported to be a sensory organelle for PEMFs, and nitric oxide (NO) plays an indispensable role in osteogenic effect of PEMFs, the relationship between NO and primary cilia is unknown. In this study, effects of treatment with 50 Hz 0.6 mT PEMFs on osteogenic differentiation and mineralization, NO secretion, and ciliary location of specific proteins were examined in rat calvarial osteoblasts (ROBs) with normal or abrogated primary cilia. It was found that PEMFs stimulated the osteogenic differentiation by activating the NOS/NO/sGC/cGMP/PKG signaling pathway, which need the existence of primary cilia. All components of the signaling pathway including iNOS, eNOS, sGC, PKG-1, and PKG-2 were localized to primary cilia, and eNOS was phosphorylated inside the primary cilia. Besides, primary cilia were elongated significantly by PEMF treatment and changed dynamically with the activation NO/cGMP pathway. When the pathway was blocked by L-NAME, PEMFs could no longer elongate the primary cilia and stimulate the osteoblastic differentiation. Thus, this study for the first time observed activation of the NO/cGMP signaling pathway in ciliary compartment of osteoblasts, and PEMFs could not stimulate the osteoblastic differentiation if the NO signaling pathway was blocked or the ciliogenesis was inhibited. Our findings indicate the interdependent relationship between NO and primary cilia in the PEMF-promoted osteogenesis.	[He, Wen-Fang; Qin, Rong; Gao, Yu-Hai; Zhou, Jian; Wei, Juan-Juan; Liu, Jing; Hou, Xue-Feng; Ma, Hui-Ping; Chen, Ke-Ming] 940th Hosp Joint Logist Support Force, Peoples Liberat Army China, Fundamental Med Sci Res Labs, Lanzhou 730050, Peoples R China; [He, Wen-Fang; Li, Xue-Yan] Lanzhou Univ Technol, Sch Life Sci & Engn, Dept Bioengn, Lanzhou, Peoples R China; [He, Wen-Fang; Chen, Ke-Ming] Key Lab Stem Cells & Gene Drugs Gansu Prov, Lanzhou, Peoples R China; [Xian, Cory J.] Univ South Australia, UniSA Clin & Hlth Sci, Adelaide, SA, Australia	Lanzhou University of Technology; University of South Australia	Chen, KM (corresponding author), 940th Hosp Joint Logist Support Force, Peoples Liberat Army China, Fundamental Med Sci Res Labs, Lanzhou 730050, Peoples R China.; Li, XY (corresponding author), Lanzhou Univ Technol, Sch Life Sci & Engn, Lanzhou 730050, Peoples R China.	lixneyan@lut.cn; chenkm@lut.cn		zhou, jian/0000-0001-7211-1680; Liu, Jing/0000-0002-7005-611X; gao, yu hai/0000-0001-7845-3796	National Natural Science Foundation of China [81270963, 81770879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by project grants from the National Natural Science Foundation of China (Grant No. 81270963, 81770879).	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Bassett C A, 1978, Acta Orthop Belg, V44, P706; Bradley SA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5681036; Buerk Donald G., 2011, Critical Reviews in Biomedical Engineering, V39, P397, DOI 10.1615/CritRevBiomedEng.v39.i5.40; Cheng GZ, 2011, NITRIC OXIDE-BIOL CH, V25, P316, DOI 10.1016/j.niox.2011.05.009; Diniz P, 2002, NITRIC OXIDE-BIOL CH, V7, P18, DOI 10.1016/S1089-8603(02)00004-6; Falk N, 2015, CELLS-BASEL, V4, P500, DOI 10.3390/cells4030500; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Garland D E, 1999, J Spinal Cord Med, V22, P239; Gutierrez S, 2010, CELL PROLIFERAT, V43, P505, DOI 10.1111/j.1365-2184.2010.00700.x; Hannemann PEW, 2014, BONE JOINT J, V96B, P1070, DOI 10.1302/0301-620X.96B8.33767; Hofmann F, 2020, BIOL CHEM, V401, P447, DOI 10.1515/hsz-2019-0386; Jansen JHW, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-188; Johnson JLF, 2010, TRENDS CELL BIOL, V20, P435, DOI 10.1016/j.tcb.2010.05.005; Kalyanaraman H, 2018, NITRIC OXIDE-BIOL CH, V76, P62, DOI 10.1016/j.niox.2018.03.007; Kim SM, 2021, ANN NY ACAD SCI, V1487, P21, DOI 10.1111/nyas.14486; Li YH, 2020, AM J PHYSIOL-CELL PH, V318, pC73, DOI 10.1152/ajpcell.00273.2019; Maziarz A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0312-5; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Meskens M W, 1990, Acta Orthop Belg, V56, P483; Ota KT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011236; Pala R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120233; Petecchia L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13856; Saternos HC, 2018, NITRIC OXIDE-BIOL CH, V80, P108, DOI 10.1016/j.niox.2018.08.003; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schnoke M, 2007, J ORTHOP RES, V25, P933, DOI 10.1002/jor.20373; Shao X, 2021, AM J PHYSIOL-ENDOC M, V320, pE951, DOI 10.1152/ajpendo.00655.2020; Shao ZK, 2010, BRAIN RES, V1361, P67, DOI 10.1016/j.brainres.2010.09.011; Shi WG, 2017, J BIOL CHEM, V292, P20883, DOI 10.1074/jbc.M117.809517; Spasic M, 2017, EUR CELLS MATER, V33, P158, DOI 10.22203/eCM.v033a12; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Syed MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147588; TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Verghese E, 2011, CELL BIOL INT, V35, P909, DOI 10.1042/CBI20090154; Wang P, 2019, J CELL PHYSIOL, V234, P10588, DOI 10.1002/jcp.27734; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; We SR, 2013, RHEUMATOLOGY, V52, P815, DOI 10.1093/rheumatology/kes063; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhou J, 2019, J BONE MINER RES, V34, P1336, DOI 10.1002/jbmr.3704	43	0	0	7	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22376	10.1096/fj.202101577RR	http://dx.doi.org/10.1096/fj.202101577RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AQ	35616355	Green Accepted			2022-12-28	WOS:000800257900001
J	Noomuna, P; Hausman, JM; Sansoya, R; Kalfa, T; Risinger, M; Low, PS				Noomuna, Panae; Hausman, John M.; Sansoya, Ruhani; Kalfa, Theodosia; Risinger, Mary; Low, Philip S.			Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening	FASEB JOURNAL			English	Article						Band 3 tyrosine phosphorylation; calpain proteolysis; cleavage of PTP1B; phosphatase activity; PTP1B; sickle cells	RED-BLOOD-CELLS; THROMBIN GENERATION; HUMAN-ERYTHROCYTES; FREE HEMOGLOBIN; ENDOTHELIAL-CELLS; CALPAIN; BAND-3; MICROPARTICLES; DEOXYGENATION; PTP1B	Although both protein tyrosine phosphatases and kinases are constitutively active in healthy human red blood cells (RBCs), the preponderance of phosphatase activities maintains the membrane proteins in a predominantly unphosphorylated state. We report here that unlike healthy RBCs, proteins in sickle cells are heavily tyrosine phosphorylated, raising the question regarding the mechanism underpinning this tyrosine phosphorylation. Upon investigating possible causes, we observe that protein tyrosine phosphatase 1B (PTP1B), the major erythrocyte tyrosine phosphatase, is largely digested to a lower molecular weight fragment in sickle cells. We further find that the resulting truncated form of PTP1B is significantly less active than its intact counterpart, probably accounting for the intense tyrosine phosphorylation of Band 3 in sickle erythrocytes. Because this tyrosine phosphorylation of Band 3 promotes erythrocyte membrane weakening that causes release of both membrane vesicles and cell free hemoglobin that in turn initiates vaso-occlusive events, we conclude that cleavage of PTP1B could contribute to the symptoms of sickle cell disease. We further posit that methods to inhibit proteolysis of PTP1B could mitigate symptoms of the disease.	[Noomuna, Panae; Hausman, John M.; Sansoya, Ruhani; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Noomuna, Panae; Hausman, John M.; Low, Philip S.] Purdue Univ, Inst Drug Discovery, 720 Clin Dr, W Lafayette, IN 47907 USA; [Kalfa, Theodosia; Risinger, Mary] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Kalfa, Theodosia] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Low, PS (corresponding author), Purdue Univ, Inst Drug Discovery, 720 Clin Dr, W Lafayette, IN 47907 USA.	plow@purdue.edu		Hausman, John/0000-0002-5600-0304; Noomuna, Panae/0000-0001-7696-4488; Kalfa, Theodosia/0000-0002-0426-9686	NIH [GM24417-40]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by funds from the NIH (GM24417-40) (P.S.L.).	ADVANI R, 1992, BLOOD, V79, P1058; Alaarg A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00365; Atmis A, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.4681.4681; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bogdanova A, 2013, INT J MOL SCI, V14, P9848, DOI 10.3390/ijms14059848; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; Bragadin M, 2007, ANN NY ACAD SCI, V1095, P193, DOI 10.1196/annals.1397.023; Browning JA, 2007, BLOOD, V109, P2622, DOI 10.1182/blood-2006-03-001404; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; Ciana A, 2004, BIOELECTROCHEMISTRY, V62, P169, DOI 10.1016/j.bioelechem.2003.07.004; DANFORTH WH, 1962, P NATL ACAD SCI USA, V48, P1191, DOI 10.1073/pnas.48.7.1191; De Franceschi L, 2013, FASEB J, V27, P750, DOI 10.1096/fj.12-217836; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; DUMASWALA UJ, 1984, TRANSFUSION, V24, P490, DOI 10.1046/j.1537-2995.1984.24685066807.x; Ellory JC, 2007, BLOOD CELL MOL DIS, V39, P1, DOI 10.1016/j.bcmd.2007.02.011; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Fibach E, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.604738; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Kato GJ, 2017, J CLIN INVEST, V127, P750, DOI 10.1172/JCI89741; KAUL DK, 1993, BLOOD, V81, P2429; KAWASAKI H, 1993, ARCH BIOCHEM BIOPHYS, V305, P467, DOI 10.1006/abbi.1993.1448; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kucukal E, 2018, AM J HEMATOL, V93, P1050, DOI 10.1002/ajh.25159; Lon HK, 2019, CLIN PHARM DRUG DEV, V8, P290, DOI 10.1002/cpdd.598; Lorenz Ulrike, 2011, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1107s93; Ma YL, 2012, J PHYSIOL-LONDON, V590, P2095, DOI 10.1113/jphysiol.2012.229609; Merciris P, 2001, BLOOD, V98, P3121, DOI 10.1182/blood.V98.10.3121; Minetti G, 2004, BIOCHEM J, V377, P489, DOI 10.1042/BJ20031401; Noomuna P, 2020, BRIT J HAEMATOL, V190, P599, DOI 10.1111/bjh.16671; Parise Leslie V, 2003, Curr Hematol Rep, V2, P102; Picha KM, 2007, J BIOL CHEM, V282, P2911, DOI 10.1074/jbc.M610096200; Puchulu-Campanella E, 2016, P NATL ACAD SCI USA, V113, P13732, DOI 10.1073/pnas.1611904113; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SCHARFF O, 1981, ACTA BIOL MED GER, V40, P457; Siciliano A, 2010, BLOOD CELL MOL DIS, V44, P233, DOI 10.1016/j.bcmd.2010.02.007; Terra HTMB, 1998, AM J HEMATOL, V58, P224, DOI 10.1002/(SICI)1096-8652(199807)58:3<224::AID-AJH11>3.0.CO;2-9; Tiffert T., 2003, RED CELL MEMBRANE TR, P373, DOI DOI 10.1007/978-3-662-05181-8_15; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Wautier JL, 2013, CLIN HEMORHEOL MICRO, V53, P11, DOI 10.3233/CH-2012-1572; Whelihan MF, 2016, J THROMB HAEMOST, V14, P1941, DOI 10.1111/jth.13416; Zhang YX, 2017, J BIOL CHEM, V292, P407, DOI 10.1074/jbc.M116.766832	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22360	10.1096/fj.202100809RR	http://dx.doi.org/10.1096/fj.202100809RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5UG	35593742				2022-12-28	WOS:000797983400001
J	Shang, YL; Huang, J; Li, WD; Zhang, YA; Zhou, X; Shao, QQ; Tan, TC; Yin, S; Zhang, LR; Wang, SX				Shang, Yongliang; Huang, Ju; Li, Weidong; Zhang, Yanan; Zhou, Xu; Shao, Qiqi; Tan, Taicong; Yin, Shen; Zhang, Liangran; Wang, Shunxin			MEIOK21 regulates oocyte quantity and quality via modulating meiotic recombination	FASEB JOURNAL			English	Article						fertility; MEIOK21; meiosis; oocyte; recombination; synapsis	DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; SEXUAL-DIMORPHISM; FEMALE MEIOSIS; CROSSING-OVER; GERM-CELL; ANEUPLOIDY; INSIGHTS; REPAIR; SPO11	The reproductive life span of females is largely determined by the number and quality of oocytes. Previously, we identified MEIOK21 as a meiotic recombination regulator required for male fertility. Here, we characterize the important roles of MEIOK21 in regulating female meiosis and oocyte number and quality. MEIOK21 localizes at recombination sites as a component of recombination bridges in oogenesis like in spermatogenesis. Meiok21(-/-) female mice show subfertility. Consistently, the size of the primordial follicle pool in Meiok21(-/- )females is only similar to 40% of wild-type females because a great number of oocytes with defects in meiotic recombination and/or synapsis are eliminated. Furthermore, the numbers of primordial and growing follicles show a more marked decrease in an age-dependent manner compared with wild-type females. Further analysis shows Meiok21(-/- )oocytes also have reduced rates of germinal vesicle breakdown and the first polar body extrusion when cultured in vitro, indicating poor oocyte quality. Additionally, Meiok21(-/-) oocytes have more chromosomes bearing a single distally localized crossover (chiasmata), suggesting a possible defect in crossover maturation. Taken together, our findings indicate critical roles for MEIOK21 in ensuring the number and quality of oocytes in the follicles.	[Shang, Yongliang; Huang, Ju; Li, Weidong; Zhang, Yanan; Zhou, Xu; Shao, Qiqi; Tan, Taicong; Zhang, Liangran; Wang, Shunxin] Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, Jinan, Peoples R China; [Shang, Yongliang; Li, Weidong; Zhou, Xu; Shao, Qiqi; Zhang, Liangran] Shandong Univ, Adv Med Res Inst, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Huang, Ju; Zhang, Yanan; Wang, Shunxin] Shandong Prov Clin Res Ctr Reprod Hlth, Jinan, Peoples R China; [Yin, Shen] Qingdao Agr Univ, Coll Life Sci, Inst Reprod Sci, Qingdao, Peoples R China; [Zhang, Liangran] Shandong Normal Univ, Coll Life Sci, Shandong Prov Key Lab Anim Resistance Biol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Qingdao Agricultural University; Shandong Normal University	Wang, SX (corresponding author), Shandong Univ, Cheeloo Coll Med, Ctr Reprod Med, Jinan, Peoples R China.	shunxinwang@sdu.edu.cn			National Key Research and Development Program of China [2021YFC2700103, 2018YFC1003700]; National Natural Science Foundation of China [32070837, 31801203]; Taishan Scholars Youth Project of Shandong Province	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Youth Project of Shandong Province	This work was supported by the National Key Research and Development Program of China (2021YFC2700103 and 2018YFC1003700), National Natural Science Foundation of China (32070837, 31801203); Taishan Scholars Youth Project of Shandong Province.	Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Bolcun-Filas E, 2018, BIOL REPROD, V99, P112, DOI 10.1093/biolre/ioy021; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Brandsma I, 2019, CELL REP, V27, P3790, DOI 10.1016/j.celrep.2019.05.096; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Cahoon CK, 2019, CHROMOSOMA, V128, P199, DOI 10.1007/s00412-019-00692-x; Capalbo A, 2017, HUM REPROD UPDATE, V23, P706, DOI 10.1093/humupd/dmx026; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Dubois E, 2019, P NATL ACAD SCI USA, V116, P12400, DOI 10.1073/pnas.1901237116; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; El Yakoubi W, 2017, ADV EXP MED BIOL, V1002, P1, DOI 10.1007/978-3-319-57127-0_1; Felipe-Medina N, 2020, ELIFE, V9, DOI 10.7554/eLife.56996; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Gray S, 2016, ANNU REV GENET, V50, P175, DOI 10.1146/annurev-genet-120215-035111; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Huang CZ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.652407; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Hunter N, 2017, COLD SH Q B, V82, P235, DOI 10.1101/sqb.2017.82.035394; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jones KT, 2011, RESULTS PROBL CELL D, V53, P343, DOI 10.1007/978-3-642-19065-0_15; Kang R, 2018, MOL CELL, V69, P725, DOI 10.1016/j.molcel.2018.02.021; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Li M, 2020, J GENET GENOMICS, V47, P451, DOI 10.1016/j.jgg.2020.08.001; Li WD, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12809; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; Matsuzaki K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09190-1; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Pacheco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04851-z; Pan B, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-018-0445-8; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Qiao HY, 2018, MOL CELL, V72, P211, DOI 10.1016/j.molcel.2018.08.031; Qiao H, 2014, NAT GENET, V46, P194, DOI 10.1038/ng.2858; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Qu W, 2021, ASIAN J ANDROL, V23, P572, DOI 10.4103/aja202191; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Ribeiro J, 2016, CHROMOSOMA, V125, P265, DOI 10.1007/s00412-015-0552-7; Rinaldi VD, 2017, MOL CELL, V67, P1026, DOI 10.1016/j.molcel.2017.07.027; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Shang YL, 2020, NUCLEIC ACIDS RES, V48, P6624, DOI 10.1093/nar/gkaa406; Shi BL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007952; Takemoto K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107686; Tharp ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14055-8; Titus S, 2015, SEMIN REPROD MED, V33, P384, DOI 10.1055/s-0035-1567824; Wang C, 2017, CELL MOL LIFE SCI, V74, P2547, DOI 10.1007/s00018-017-2480-6; Wang JJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0492-2; Wang SX, 2021, ASIAN J ANDROL, V23, P562, DOI 10.4103/aja.aja_86_20; Wang SX, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800221; Wang SX, 2019, CELL, V177, P326, DOI 10.1016/j.cell.2019.02.021; Wang S, 2017, CELL, V168, P977, DOI 10.1016/j.cell.2017.02.002; Widger A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04850-0; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yan H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1208-3; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhang B, 2020, CELL DEATH DIFFER, V27, P2176, DOI 10.1038/s41418-020-0493-4; Zhang JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15954-x; Zhang JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08676-2; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zhang MJ, 2012, CELL MOL LIFE SCI, V69, P1279, DOI 10.1007/s00018-011-0867-3; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626; Zickler D, 2016, SEMIN CELL DEV BIOL, V54, P135, DOI 10.1016/j.semcdb.2016.02.024	79	0	0	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22357	10.1096/fj.202101950R	http://dx.doi.org/10.1096/fj.202101950R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9ZS	35593531				2022-12-28	WOS:000798270300001
J	Zhang, L; Li, W; Gong, MJ; Zhang, ZY; Xue, XD; Mao, JR; Zhang, HB; Li, SQ; Liu, XW; Wu, F; Shi, JM; Fu, GR				Zhang, Lin; Li, Wei; Gong, Minjie; Zhang, Zeyu; Xue, Xiaodong; Mao, Jiarong; Zhang, Haibao; Li, Siqi; Liu, Xiawan; Wu, Feng; Shi, Jingming; Fu, Guorong			C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease	FASEB JOURNAL			English	Article						autophagy; C3a; C3aR axis; C-reactive protein; diabetic kidney disease; podocyte	COMPLEMENT ACTIVATION; APOPTOSIS; RECEPTOR; SYSTEM; CELL; C3A; INFLAMMATION; GLUCOSE; PATHOGENESIS; NEPHROPATHY	Numerous studies have reported the pathogenic roles of C-reactive protein (CRP) and complement activation in diabetic kidney disease (DKD) individually. However, considering the potent regulatory effect of CRP on complement activation, it remains unclear whether CRP participates in DKD pathogenesis by regulating complement activation. Moreover, this work focuses on complement activation in rats, which aims at settling the dispute that whether rat CRP can activate the complement system. To address this question, the complement effectors C3a, C5a, and C5b-9 were examined in human patients with diabetic nephropathy (DN) and wt, Crp(-/-), and huCRPtg rats with STZ-diabetic DKD. The Crp(-/-) rats showed more C3a accumulation in blood and glomeruli than wt and huCRPtg rats. The balance between autophagy and apoptosis was evaluated in DKD rats, and Crp(-/-) rats showed increased podocyte autophagy compared with wt and huCRPtg rats. Meanwhile, stable CRP-overexpression and CRP-knockout cell lines were established and used to demonstrate that CRP suppresses C3a-induced podocyte autophagy under high-glucose conditions. We further verified that the inhibition of C3a-induced podocyte autophagy by CRP was dependent on C3aR expression and that this effect could be reversed with a C3aR antagonist and agonist. Therefore, our findings provide evidence that CRP suppresses podocyte autophagy to accelerate the development of DKD by inhibiting C3a/C3aR axis signaling, which may help in the development of a new therapeutic strategy for the management of podocyte autophagy and DKD. In addition, rat CRP has been shown to be identical to human CRP in the activation of autologous complement and interspecific complement.	[Zhang, Lin; Li, Wei; Gong, Minjie; Zhang, Haibao; Li, Siqi; Liu, Xiawan; Wu, Feng] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian, Peoples R China; [Zhang, Lin; Li, Wei; Gong, Minjie; Zhang, Haibao; Li, Siqi; Liu, Xiawan; Wu, Feng] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ, Xian, Peoples R China; [Zhang, Zeyu; Shi, Jingming] Xizang Minzu Univ, Sch Basic Med, Xianyang 712082, Peoples R China; [Xue, Xiaodong] Natl Univ Singapore, Sch Comp Sci, Singapore, Singapore; [Mao, Jiarong] Shaanxi Prov Hosp Chinese Med, Dept Pathol, Xian, Peoples R China; [Fu, Guorong] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian 710061, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xizang Minzu University; National University of Singapore; Xi'an Medical University; Xi'an Jiaotong University	Shi, JM (corresponding author), Xizang Minzu Univ, Sch Basic Med, Xianyang 712082, Peoples R China.; Fu, GR (corresponding author), Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian 710061, Peoples R China.	shijingming5272@126.com; pipifu@126.com	Shi, Jing-Ming/ACS-3321-2022	Shi, Jing-Ming/0000-0002-8185-3130	National Natural Science Foundation of China [82070876, 82170697, 32160215]; China Postdoctoral Science Foundation [2020M673421]; Project of Shaanxi Key Research and Development Plan [2020SF-]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Project of Shaanxi Key Research and Development Plan	This work was supported by the following grants: National Natural Science Foundation of China (grant numbers 82070876, 82170697, 32160215), the China Postdoctoral Science Foundation (grant number 2020M673421), Project of Shaanxi Key Research and Development Plan (grant number 2020SF-	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Alghamdi TA, 2017, J AM SOC NEPHROL, V28, P2642, DOI 10.1681/ASN.2016111208; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Angeletti A, 2020, J EXP MED, V217, DOI 10.1084/jem.20191699; BIANCONE L, 1994, KIDNEY INT, V45, P451, DOI 10.1038/ki.1994.59; Burwick RM, 2013, HYPERTENSION, V62, P1040, DOI 10.1161/HYPERTENSIONAHA.113.01420; Chen WS, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0230-z; Chowdhury S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00027; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Cui J, 2020, ADV EXP MED BIOL, V1207, P487, DOI 10.1007/978-981-15-4272-5_36; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; Ding Y, 2015, J ENDOCRINOL, V224, pR15, DOI 10.1530/JOE-14-0437; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; ELSNER J, 1994, BLOOD, V83, P3324; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Flyvbjerg A, 2017, NAT REV NEPHROL, V13, P311, DOI 10.1038/nrneph.2017.31; Fu HY, 2019, MOL METAB, V30, P250, DOI 10.1016/j.molmet.2019.10.005; Fujita Y, 2011, CLIN CHEM, V57, P1398, DOI 10.1373/clinchem.2011.168625; Gao S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01875; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Hamzawy M, 2017, ENDOCRINE, V58, P66, DOI 10.1007/s12020-017-1402-6; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jarva H, 1999, J IMMUNOL, V163, P3957; Jin J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1177-1; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Laumonnier Yves, 2020, Curr Protoc Immunol, V130, pe100, DOI 10.1002/cpim.100; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lenoir O, 2015, AUTOPHAGY, V11, P1130, DOI 10.1080/15548627.2015.1049799; Li L, 2015, METABOLISM, V64, P597, DOI 10.1016/j.metabol.2015.01.014; Li QY, 2017, J AM SOC NEPHROL, V28, P3044, DOI 10.1681/ASN.2016070735; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Liu WJ, 2018, EUR REV MED PHARMACO, V22, P3182, DOI 10.26355/eurrev_201805_15079; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Lu R, 2019, FASEB J, V33, P11845, DOI 10.1096/fj.201900727R; Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018; Ma YJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03046; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Mejias-Pena Y, 2017, AGING-US, V9, P408, DOI 10.18632/aging.101167; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roy N, 2016, BBA-GEN SUBJECTS, V1860, P1118, DOI 10.1016/j.bbagen.2016.02.012; Shen ZY., 2021, FRONT IMMUNOL, V12; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Tagawa A, 2016, DIABETES, V65, P755, DOI 10.2337/db15-0473; Takahashi A, 2017, DIABETES, V66, P1359, DOI 10.2337/db16-0397; Tan SM, 2020, DIABETES, V69, P83, DOI 10.2337/db19-0043; Tang S, 1999, J IMMUNOL, V162, P4336; Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4; Tharaux PL, 2016, DIABETES, V65, P539, DOI 10.2337/dbi15-0026; Turkmen K, 2017, INT UROL NEPHROL, V49, P837, DOI 10.1007/s11255-016-1488-4; Wang XW, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008024; Wolbink GJ, 1996, J IMMUNOL, V157, P473; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110; Xin W, 2016, METABOLISM, V65, P1307, DOI 10.1016/j.metabol.2016.05.015; Yang DY, 2018, CELL MOL LIFE SCI, V75, P669, DOI 10.1007/s00018-017-2639-1; Yasuda-Yamahara M, 2015, AUTOPHAGY, V11, P2385, DOI 10.1080/15548627.2015.1115173; Yuan SZ, 2021, RENAL FAILURE, V43, P968, DOI 10.1080/0886022X.2021.1936040; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhang L, 2019, FASEB J, V33, P6551, DOI 10.1096/fj.201801865RR; Zheng HJ, 2020, J CELL MOL MED, V24, P8276, DOI 10.1111/jcmm.15301	65	2	3	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22332	10.1096/fj.202200198R	http://dx.doi.org/10.1096/fj.202200198R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0X8AC	35503088				2022-12-28	WOS:000789921400001
J	Hsiao, PF; Huang, YT; Lu, PH; Chiu, LY; Weng, TH; Hung, CF; Wu, NL				Hsiao, Pa-Fan; Huang, Yi-Ting; Lu, Po-Hsuan; Chiu, Ling-Ya; Weng, Tzu-Han; Hung, Chi-Feng; Wu, Nan-Lin			Thioredoxin-interacting protein regulates keratinocyte differentiation: Implication of its role in psoriasis	FASEB JOURNAL			English	Article						differentiation; EGFR; keratinocyte; psoriasis; TXNIP	HUMAN EPIDERMAL-KERATINOCYTES; INVOLUCRIN EXPRESSION; FACTOR-ALPHA; SKIN; TXNIP; ACTIVATION; GENE; P63; PATHOGENESIS; CONTRIBUTES	Thioredoxin-interacting protein (TXNIP), also known as Vitamin-D upregulated protein-1 (VDUP-1), interacts with thioredoxin to regulate redox responses and participates in diverse disorders including metabolic, cardiovascular, inflammatory and malignant diseases. Psoriasis is characterized by chronic skin inflammation and an aberrant pattern of keratinocyte differentiation. Clinically, psoriasis is associated with various cardiometabolic comorbidities but studies on TXNIP's biological role in skin disorders are limited. In this study, we investigated TXNIP expression in psoriasis and its regulation in normal human epidermal keratinocytes (NHEKs), and then explored how TXNIP regulated skin keratinocyte differentiation to determine its role in psoriasis pathogenesis. Our immunohistochemical study demonstrated extensive TXNIP expression in the upper and lower epidermis of psoriasis compared to predominant TXNIP expression in the basal layer of normal skin. 1, 25-dihydroxyvitamin D-3 suppressed but TGF-alpha and EGF enhanced TXNIP expression in NHEKs. An inducer of keratinocyte differentiation, phorbol 12-myristate 13-acetate (PMA), also diminished TXNIP expression, which was reversed by PKC-delta knockdown. TXNIP knockdown reduced PMA-induced involucrin and transglutaminse-1 expression, and increased p63 expression in NHEKs but did not significantly affect cell proliferation. H2O2-induced ROS production and EGFR phosphorylation decreased in NHEKs with TXNIP knockdown. Furthermore, PMA-induced PKC-delta phosphorylation, TGF-alpha, and EGF-triggered EGFR phosphorylation were attenuated by TXNIP knockdown. Our results unraveled the regulation and function of TXNIP expression in skin keratinocytes and the cross-regulation between TXNIP and EGFR signaling. These findings imply a role of TXNIP in psoriasis and provide insight into the possible impact of TXNIP regulators on the skin or psoriasis.	[Hsiao, Pa-Fan; Lu, Po-Hsuan; Wu, Nan-Lin] MacKay Mem Hosp, Dept Dermatol, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan; [Hsiao, Pa-Fan; Lu, Po-Hsuan; Wu, Nan-Lin] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Hsiao, Pa-Fan; Wu, Nan-Lin] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Huang, Yi-Ting; Chiu, Ling-Ya] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chiu, Ling-Ya] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Weng, Tzu-Han] MacKay Mem Hosp, Dept Med Educ, Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan; [Wu, Nan-Lin] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Mackay Medical College	Wu, NL (corresponding author), MacKay Mem Hosp, Dept Dermatol, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan.	alvinwu.alvinwu@gmail.com	huang, yiting/HDM-3648-2022		Ministry of Science and Technology, Taiwan (MOST) [MOST 106-2314-B-195-003-, MOST 105-2314-B-195-006-MY3]; MacKay Medical College [1081A03]; MacKay Memorial Hospital [MMH107-19]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); MacKay Medical College; MacKay Memorial Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 106-2314-B-195-003- and MOST 105-2314-B-195-006-MY3; MacKay Medical College, Grant/Award Number: 1081A03; MacKay Memorial Hospital, Grant/Award Number: MMH107-19	Abu el Maaty MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030796; Abu el Maaty MA, 2017, BBA-MOL CELL RES, V1864, P1618, DOI 10.1016/j.bbamcr.2017.06.019; Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; BERNARD BA, 1988, J INVEST DERMATOL, V90, P801, DOI 10.1111/1523-1747.ep12462014; BOURKE JF, 1993, BRIT J DERMATOL, V129, P74, DOI 10.1111/j.1365-2133.1993.tb03315.x; Cadenas C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2599; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Champliaud MF, 2003, J INVEST DERMATOL, V121, P781, DOI 10.1046/j.1523-1747.2003.12539.x; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chong CR, 2014, CARDIOVASC DRUG THER, V28, P347, DOI 10.1007/s10557-014-6538-5; Denning MF, 2010, J INVEST DERMATOL, V130, P1968, DOI 10.1038/jid.2010.194; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Domingues A, 2020, ANGIOGENESIS, V23, P249, DOI 10.1007/s10456-019-09704-x; Duvic M, 1998, J AM ACAD DERMATOL, V39, pS129, DOI 10.1016/S0190-9622(98)70309-3; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; Elmets CA, 2019, J AM ACAD DERMATOL, V80, P1073, DOI 10.1016/j.jaad.2018.11.058; Gegotek A, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201800119; Griffiths CEM, 2021, LANCET, V397, P1301, DOI 10.1016/S0140-6736(20)32549-6; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Higashiyama Mari, 1994, Journal of Dermatological Science, V7, P45, DOI 10.1016/0923-1811(94)90021-3; Hu JH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4582130; Iqbal MA, 2021, FEBS J, V288, P471, DOI 10.1111/febs.15353; ISHIDAYAMAMOTO A, 1995, J INVEST DERMATOL, V104, P391, DOI 10.1111/1523-1747.ep12665870; Jo SH, 2013, DIABETOLOGIA, V56, P2723, DOI 10.1007/s00125-013-3050-6; Kadam DP, 2010, INDIAN J CLIN BIOCHE, V25, P388, DOI 10.1007/s12291-010-0043-9; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meszaros M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96220-y; Moreci RS, 2020, CURR BIOL, V30, pR144, DOI 10.1016/j.cub.2020.01.004; Mustacich D, 2004, CARCINOGENESIS, V25, P1983, DOI 10.1093/carcin/bgh195; NANNEY LB, 1986, J INVEST DERMATOL, V86, P260, DOI 10.1111/1523-1747.ep12285389; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Plenkowska J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176206; Pomari E, 2015, FASEB J, V29, P508, DOI 10.1096/fj.14-251363; Qayyum N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052754; Rizova E, 2001, BRIT J DERMATOL, V144, P3, DOI 10.1046/j.1365-2133.2001.00041.x; Samidurai M, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.661505; Tian H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00269; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Tsubaki H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249357; WAKITA H, 1992, J INVEST DERMATOL, V99, P101, DOI 10.1111/1523-1747.ep12611882; Wang JY, 2020, J DERMATOL SCI, V98, P119, DOI 10.1016/j.jdermsci.2020.03.007; Wang SJ, 2019, AM J TRANSL RES, V11, P520; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wu NL, 2016, J INVEST DERMATOL, V136, P192, DOI 10.1038/JID.2015.381; Wu NL, 2013, BBA-MOL BASIS DIS, V1832, P1538, DOI 10.1016/j.bbadis.2013.05.020; Wu NL, 2011, J INVEST DERMATOL, V131, P874, DOI 10.1038/jid.2010.402; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	58	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22313	10.1096/fj.202101772R	http://dx.doi.org/10.1096/fj.202101772R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KQ	35471587				2022-12-28	WOS:000787348900001
J	Zeid, AM; Lamontagne, JO; Zhang, H; Marneros, AG				Zeid, Alia M.; Lamontagne, Joseph O.; Zhang, Hui; Marneros, Alexander G.			Epidermal growth factor deficiency predisposes to progressive renal disease	FASEB JOURNAL			English	Article						epidermal growth factor; glomerulonephritis; kidney; renal failure; renal fibrosis	EGF RECEPTOR; KIDNEY; EXPRESSION; SEX	Epidermal growth factor (EGF) is produced in the kidney by thick ascending limbs of the loop of Henle and by distal convoluted tubules (DCTs). Reduced urinary EGF levels have been associated with chronic kidney disease but it is not known whether physiological levels of EGF protect the kidney from progressive renal disease. Here, we show that EGF-deficient mice on a mixed genetic background had increased urinary microalbumin, and a subset of these mice developed severe progressive renal disease with azotemia that was not seen in WT or TGF alpha-deficient littermates with this mixed genetic background. These azotemic EGF-deficient mice developed crescentic glomerulonephritis linked to HB-EGF/EGFR hyperactivation in glomeruli, as well as attenuation of the proximal tubule brush border, distal convoluted tubule (DCT) dilatation, and kidney fibrosis associated with renal beta-catenin/mTOR hyperactivation. The observation of these severe renal pathologies only in a subset of EGF-deficient mice suggests that independent segregation of strain-specific modifier alleles contributes to the severity of the renal abnormalities that only manifest when EGF is lacking. These findings link the lack of EGF to renal pathologies in the adult mammalian kidney, in support of a role of physiological levels of EGF for maintaining the function of glomeruli, proximal tubules, and DCTs. These observations suggest that diminished EGF levels predispose kidneys to progressive renal disease.	[Zeid, Alia M.; Lamontagne, Joseph O.; Zhang, Hui; Marneros, Alexander G.] Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Dept Dermatol, CNY 149,Rm 3-215B,13th St, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Marneros, AG (corresponding author), Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Dept Dermatol, CNY 149,Rm 3-215B,13th St, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Zhang, Hui/0000-0002-4936-4791	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK118134, R01DK121178]; HHS | NIH | National Institute on Aging (NIA) [R21AG063377]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/ Award Number: R01DK118134 and R01DK121178; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: R21AG063377	Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; CALLEGARI C, 1988, EUR J APPL PHYSIOL, V58, P26, DOI 10.1007/BF00636599; Chou JS, 1997, ANN CLIN LAB SCI, V27, P116; GATTONE VH, 1995, DEV BIOL, V169, P504, DOI 10.1006/dbio.1995.1164; Gesualdo L, 1996, KIDNEY INT, V49, P656, DOI 10.1038/ki.1996.94; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; Jung JY, 2005, AM J PHYSIOL-RENAL, V288, pF227, DOI 10.1152/ajprenal.00058.2004; Lanktree MB, 2019, KIDNEY INT REP, V4, P995, DOI 10.1016/j.ekir.2019.04.018; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marneros AG, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108616; Marneros AG, 2020, DEV CELL, V54, P348, DOI 10.1016/j.devcel.2020.05.026; Meybosch S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211212; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Norvik JV, 2021, NEPHROL DIAL TRANSPL, V36, P1882, DOI 10.1093/ndt/gfaa208; Pavlov TS, 2013, J AM SOC NEPHROL, V24, P1053, DOI 10.1681/ASN.2012080839; PERHEENTUPA J, 1985, PEDIATR RES, V19, P428, DOI 10.1203/00006450-198505000-00004; RAABERG L, 1988, HISTOCHEMISTRY, V89, P351, DOI 10.1007/BF00500636; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Staruschenko A, 2013, AM J PHYSIOL-RENAL, V305, pF12, DOI 10.1152/ajprenal.00112.2013; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	24	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22286	10.1096/fj.202101837R	http://dx.doi.org/10.1096/fj.202101837R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0P5AC	35442545	Green Accepted			2022-12-28	WOS:000784231400001
J	Zheng, Y; Zhao, TJ; Wang, JR; Jiang, RZ; Huang, JB; Li, WM; Wang, JH				Zheng, Yang; Zhao, Tiejian; Wang, Jiaru; Jiang, Ruizhu; Huang, Jinbiao; Li, Weimin; Wang, Jiahui			Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells	FASEB JOURNAL			English	Article						autophagy; curcumol; ferroptosis; hepatic fibrosis; NCOA4; therapeutic target	FERRITINOPHAGY; FIBROGENESIS; ACTIVATION; PROMOTES; DEATH	To explore the effect of curcumol on autophagy and ferroptosis of hepatic stellate cells, and to clarify the molecular mechanism of its anti-hepatic fibrosis. In the present study, we report that curcumol promotes the death of activated HSCs and reduces the deposition of extracellular matrix. Interestingly, curcumol treatment can trigger ferroptosis to eliminate activated HSCs characterized by iron overload, lipid ROS accumulation, glutathione depletion, and lipid peroxidation. Curcumol promotes HSC autophagy, which may be the key mechanism for its induction of ferroptosis. It is worth noting that the upregulation of nuclear receptor coactivator 4 (NCOA4) may play a key molecular mechanism. NCOA4 mediates the release of iron ions and induces the occurrence of ferroptosis. Overall, curcumol promotes autophagy in hepatic stellate cells, mediates the degradation of NCOA4 and FTH1 complexes, releases iron ions, leads to iron overload, and induces ferroptosis, which may be an important mechanism for its anti-hepatic fibrosis effect.	[Zheng, Yang; Jiang, Ruizhu; Huang, Jinbiao; Wang, Jiahui] Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China; [Zhao, Tiejian; Wang, Jiaru; Li, Weimin] Guangxi Univ Chinese Med, Coll Basic Med, Nanning 530222, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Wang, JH (corresponding author), Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China.; Li, WM (corresponding author), Guangxi Univ Chinese Med, Coll Basic Med, Nanning 530222, Guangxi, Peoples R China.	676057107@qq.com; 344689018@qq.com		zheng, yang/0000-0001-7646-511X	The National Natural Science Foundation of China; Guangxi Natural Science Foundation [82204755, 82160954, 81960751, 81960761, 81660705]; Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project [2020GXNSFBA297094]; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund [GXZYZZ2020- 07, GXZYZZ2019- 1]; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project [2020QN006];  [2022MS008];  [2022QJ001]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project; ; 	The National Natural Science Foundation of China, Grant/Award Number: 82204755, 82160954, 81960751, 81960761 and 81660705; Guangxi Natural Science Foundation, Grant/Award Number: 2020GXNSFBA297094; Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project, Grant/Award Number: 2022KY1667 and 2020KY59009; Guangxi Zhuangyao Pharmaceutical Key Laboratory, Grant/Award Number: GXZYZZ2020- 07 and GXZYZZ2019- 1; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund, Grant/Award Number: 2020QN006; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project, Grant/Award Number: 2022MS008 and 2022QJ001	Azad AI, 2020, HEPATOLOGY, V72, P1013, DOI 10.1002/hep.31211; Bian ML, 2017, BIOFACTORS, V43, P836, DOI 10.1002/biof.1390; Bridle KR, 2003, AM J PATHOL, V162, P1661, DOI 10.1016/S0002-9440(10)64300-3; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; del Rey MQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00238; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gryzik M, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118913; Gryzik M, 2017, BBA-GEN SUBJECTS, V1861, P2710, DOI 10.1016/j.bbagen.2017.07.015; Hazari Y, 2020, J HEPATOL, V72, P183, DOI 10.1016/j.jhep.2019.08.026; Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038; Karvar S, 2020, HEPATOLOGY, V72, P1073, DOI 10.1002/hep.31078; Kong DS, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101600; Kong ZY, 2019, BIOMED PHARMACOTHER, V109, P2043, DOI 10.1016/j.biopha.2018.11.030; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Li GY, 2020, PHYTOTHER RES, V34, P1421, DOI 10.1002/ptr.6616; Liu J, 2020, CELL CHEM BIOL, V27, P420, DOI 10.1016/j.chembiol.2020.02.005; Liu JF, 2019, BRIT J PHARMACOL, V176, P4666, DOI 10.1111/bph.14831; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mou YH, 2021, BMC CANCER, V21, DOI 10.1186/s12885-020-07726-z; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Qi XY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.13107; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Shan L, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105765; Shi BH, 2019, J CELL PHYSIOL, V234, P12562, DOI 10.1002/jcp.28125; Song J, 2018, J PHARM PHARMACOL, V70, P393, DOI 10.1111/jphp.12877; Stoyanovsky DA, 2019, FREE RADICAL BIO MED, V133, P153, DOI 10.1016/j.freeradbiomed.2018.09.008; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Tang MZ, 2018, J CELL PHYSIOL, V233, P9179, DOI 10.1002/jcp.26954; Tian Y, 2020, NEUROTHERAPEUTICS, V17, P1796, DOI 10.1007/s13311-020-00929-z; Xiu ZR, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.930958; Xu HD, 2019, ADV EXP MED BIOL, V1206, P109, DOI 10.1007/978-981-15-0602-4_5; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yi JZ, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00768-7; Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512; Zhang ZL, 2021, BIOFACTORS, V47, P801, DOI 10.1002/biof.1764; Zhang ZL, 2020, AUTOPHAGY, V16, P1482, DOI 10.1080/15548627.2019.1687985; Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146; Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021; Zheng Y, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/8590638; 郑洋, 2021, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V32, P58	44	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22665	10.1096/fj.202200933RR	http://dx.doi.org/10.1096/fj.202200933RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L3FG	36398583				2022-12-28	WOS:000888071500001
J	Sethakorn, N; Heninger, E; Breneman, MT; Recchia, E; Ding, AB; Jarrard, DF; Hematti, P; Beebe, DJ; Kosoff, D				Sethakorn, Nan; Heninger, Erika; Breneman, Matthew T.; Recchia, Emma; Ding, Adeline B.; Jarrard, David F.; Hematti, Peiman; Beebe, David J.; Kosoff, David			Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform	FASEB JOURNAL			English	Article						high throughput; microfluidics; multi-culture; multiplex; organoid; primary cells; tumor microenvironment	CANCER; POLARIZATION	The tumor microenvironment (TME) is a complex network of non-malignant cells and stroma that perform a wide array of vital roles in tumor growth, immune evasion, metastasis, and therapeutic resistance. These highly diverse roles have been shown to be critically important to the progression of cancers and have already shown potential as therapeutic targets. Therefore, there has been a tremendous push to elucidate the pathways that underlie these roles and to develop new TME-directed therapies for cancer treatment. Unfortunately, TME-focused research has been limited by a lack of translational in vitro culture platforms that can model this highly complex niche and can support the integrated analysis of cell biology and function. In the current study, we investigate whether an independently developed reconfigurable microfluidic platform, known as Stacks, can address the critical need for translational multi-cellular tumor models and integrated analytics in TME research. We present data on multi-cellular culture of primary human cells in Stacks as well as the orthogonal analysis of cellular polarization, differentiation, migration, and cytotoxicity in this reconfigurable system. These expanded capabilities of Stacks are highly relevant to the cancer research community with the potential to enhance clinical translation of pre-clinical TME studies and to yield novel biological insight into TME crosstalk, metastasis, and responses to novel drug combinations or immune therapies.	[Sethakorn, Nan; Ding, Adeline B.; Hematti, Peiman; Kosoff, David] Univ Wisconsin, Dept Med, Madison, WI USA; [Sethakorn, Nan; Heninger, Erika; Breneman, Matthew T.; Recchia, Emma; Hematti, Peiman; Beebe, David J.; Kosoff, David] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Jarrard, David F.] Univ Wisconsin, Dept Urol, Madison, WI USA; [Beebe, David J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Kosoff, David] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Kosoff, D (corresponding author), Univ Wisconsin, Dept Med, Carbone Canc Ctr, 1111 Highland Ave,WIMR 7105, Madison, WI 53705 USA.	dkosoff1@medicine.wisc.edu		Heninger, Erika/0000-0003-0166-9972; Kosoff, David/0000-0001-8559-6357	US Department of Defense [W81XWH-18-1-0273]; US Department of Veteran Affairs Advanced Fellowship in Womens Health; University of Wisconsin Department of Hematology [T32 HL07899]; National Institutes of Health [P30 CA014520]	US Department of Defense(United States Department of Defense); US Department of Veteran Affairs Advanced Fellowship in Womens Health(US Department of Veterans Affairs); University of Wisconsin Department of Hematology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US Department of Defense, Grant/Award Number: W81XWH-18-1-0273; US Department of Veteran Affairs Advanced Fellowship in Womens Health and the University of Wisconsin Department of Hematology, Grant/Award Number: T32 HL07899; National Institutes of Health, Grant/Award Number: P30 CA014520	Bejarano L, 2021, CANCER DISCOV, V11, P933, DOI 10.1158/2159-8290.CD-20-1808; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chinnadurai R, 2019, STEM CELLS, V37, P1119, DOI 10.1002/stem.3035; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diedrich JD, 2016, ONCOTARGET, V7, P64854, DOI 10.18632/oncotarget.11712; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donnenberg AD, 2007, CLIN LAB MED, V27, P627, DOI 10.1016/j.cll.2007.05.013; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Emont MP, 2015, ENDOCRINOLOGY, V156, P4761, DOI 10.1210/en.2015-1567; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Giraldo NA, 2019, BRIT J CANCER, V120, P45, DOI 10.1038/s41416-018-0327-z; Hallin J, 2020, CANCER DISCOV, V10, P54, DOI 10.1158/2159-8290.CD-19-1167; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardaway AL, 2015, CLIN EXP METASTAS, V32, P353, DOI 10.1007/s10585-015-9714-5; Heninger E, 2021, MED ONCOL, V38, DOI 10.1007/s12032-021-01582-y; House IG, 2020, CLIN CANCER RES, V26, P487, DOI 10.1158/1078-0432.CCR-19-1868; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kosoff D, 2018, LAB CHIP, V18, P3011, DOI 10.1039/c8lc00431e; Linxweiler J, 2019, J CANCER RES CLIN, V145, P551, DOI 10.1007/s00432-018-2803-5; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Shen JX, 2021, ADV SCI, V8, DOI 10.1002/advs.202100106; Skoulidis F, 2021, NEW ENGL J MED, V384, P2371, DOI 10.1056/NEJMoa2103695; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Wessely A, 2019, FASEB J, V33, P11884, DOI 10.1096/fj.201900925R; Wolff A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11081313; Wu MM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026447; Yu JQ, 2019, NAT BIOMED ENG, V3, P830, DOI 10.1038/s41551-019-0421-4; Yu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11415-2	42	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22540	10.1096/fj.202200684RR	http://dx.doi.org/10.1096/fj.202200684RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4J8EX	36083096	hybrid, Green Published			2022-12-28	WOS:000851497300001
J	Alam, I; Gerard-O'Riley, RL; Acton, D; Hardman, SL; Murphy, M; Alvarez, MB; Blosser, RJ; Sinn, A; Srour, EF; Kacena, MA; Econs, MJ				Alam, Imranul; Gerard-O'Riley, Rita L.; Acton, Dena; Hardman, Sara L.; Murphy, Madeline; Alvarez, Marta B.; Blosser, Rachel J.; Sinn, Anthony; Srour, Edward F.; Kacena, Melissa A.; Econs, Michael J.			Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice	FASEB JOURNAL			English	Article						bone marrow transplantation; bone phenotypes; chloride channel 7; osteoclasts; osteopetrosis	STEM-CELL TRANSPLANTATION; ALBERS-SCHONBERG-DISEASE; HEMATOPOIETIC STEM; INTERFERON-GAMMA; MUTATIONS	Autosomal dominant osteopetrosis type II (ADO2) is a heritable bone disease of impaired osteoclastic bone resorption caused by missense mutations in the chloride channel 7 (CLCN7) gene. Clinical features of ADO2 include fractures, osteomyelitis of jaw, vision loss, and in severe cases, bone marrow failure. Currently, there is no effective therapy for ADO2, and patients usually receive symptomatic treatments. Theoretically, bone marrow transplantation (BMT), which is commonly used in recessive osteopetrosis, could be used to treat ADO2, although the frequency of complications related to BMT is quite high. We created an ADO2 knock-in (p.G213R mutation) mouse model on the 129 genetic background, and their phenotypes mimic the human disease of ADO2. To test whether BMT could restore osteoclast function and rescue the bone phenotypes in ADO2 mice, we transplanted bone marrow cells from 6-8 weeks old male WT donor mice into recipient female ADO2 mice. Also, to determine whether age at the time of transplant may play a role in transplant success, we performed BMT in young (12-week-old) and old (9-month-old) ADO2 mice. Our data indicate that ADO2 mice transplanted with WT marrow achieved more than 90% engraftment up to 6 months post-transplantation at both young and old ages. The in-vivo DXA data revealed that young ADO2 mice transplanted with WT marrow had significantly lower whole body and spine areal bone mineral density (aBMD) at month 6 post-transplantation compared to the ADO2 control mice. The old ADO2 mice also displayed significantly lower whole body, femur, and spine aBMD at months 4 and 5 post-transplantation compared to the age-matched control mice. The in-vivo micro-CT data showed that ADO2 experimental mice transplanted with WT marrow had significantly lower BV/TV at months 2 and 4 post-transplantation compared to the ADO2 control mice at a young age. In contrast, ADO2 control and experimental mice displayed similar BV/TV values for all post-transplantation time points at old age. In addition, serum CTX was significantly higher at month 2 post-transplantation in both young and old ADO2 experimental mice compared to the ADO2 control mice. Serum P1NP levels in young ADO2 experimental mice were significantly higher at baseline and month 2 post-transplantation compared to the ADO2 control mice. These data suggest that BMT may provide, at least, some beneficial effect at both young and adult ages.	[Alam, Imranul; Gerard-O'Riley, Rita L.; Acton, Dena; Hardman, Sara L.; Murphy, Madeline; Srour, Edward F.; Econs, Michael J.] Indiana Univ Sch Med, Dept Med, 1120 West Michigan St,CL459, Indianapolis, IN 46202 USA; [Alvarez, Marta B.; Blosser, Rachel J.; Kacena, Melissa A.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Sinn, Anthony; Srour, Edward F.; Kacena, Melissa A.] Indiana Univ Sch Med, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA; [Econs, Michael J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Alam, I (corresponding author), Indiana Univ Sch Med, Dept Med, 1120 West Michigan St,CL459, Indianapolis, IN 46202 USA.	ialam@iu.edu		Kacena, Melissa/0000-0001-7293-0088	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR069583]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR069583	Abinun M, 2010, ARCH DIS CHILD, V95, P984, DOI 10.1136/adc.2010.194928; Alam I, 2015, J BONE MINER RES, V30, P2005, DOI 10.1002/jbmr.2545; Benichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6; Capulli M, 2015, MOL THER-NUCL ACIDS, V4, P1, DOI 10.1038/mtna.2015.21; Chu K, 2006, J BONE MINER RES, V21, P1089, DOI 10.1359/JBMR.060409; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Duran-Struuck R, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-10; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Eapen M, 1998, BONE MARROW TRANSPL, V22, P941, DOI 10.1038/sj.bmt.1701474; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Imel EA, 2019, J BONE MINER RES, V34, P1436, DOI 10.1002/jbmr.3715; JOHNSTON CC, 1968, MEDICINE, V47, P149, DOI 10.1097/00005792-196803000-00004; KEY L, 1984, NEW ENGL J MED, V310, P409, DOI 10.1056/NEJM198402163100701; KEY LL, 1992, J PEDIATR-US, V121, P119, DOI 10.1016/S0022-3476(05)82557-0; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Martinez C, 2010, BONE MARROW TRANSPL, V45, P939, DOI 10.1038/bmt.2009.277; Maurizi A, 2018, BONE, V110, P343, DOI 10.1016/j.bone.2018.02.031; Maximova N, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115144; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Palagano E, 2017, BONE, V97, P126, DOI 10.1016/j.bone.2017.01.012; Penna S, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.048940; Schulz AS., 2015, CONSENSUS GUIDELINES; Shadur B, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27010; Stepensky P, 2019, BLOOD ADV, V3, P862, DOI 10.1182/bloodadvances.2018025890; Steward CG, 2010, PEDIATR CLIN N AM, V57, P171, DOI 10.1016/j.pcl.2009.11.006; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; Weber DR., 2014, IBMS BONEKEY, V11, P520; Zhu GH, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01955-6	34	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22471	10.1096/fj.202200678R	http://dx.doi.org/10.1096/fj.202200678R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4BV	35959867				2022-12-28	WOS:000839544000001
J	Sano, M; Akagi, D; Naito, M; Hoshina, K; Miyata, K; Kataoka, K; Ishihara, S				Sano, Masaya; Akagi, Daisuke; Naito, Mitsuru; Hoshina, Katsuyuki; Miyata, Kanjiro; Kataoka, Kazunori; Ishihara, Soichiro			Systemic single administration of anti-inflammatory microRNA 146a-5p loaded in polymeric nanomedicines with active targetability attenuates neointimal hyperplasia by controlling inflammation in injured arteries in a rat model	FASEB JOURNAL			English	Article						anti-inflammatory effect; microRNA; miR146a-5p; nanomedicine; neointimal hyperplasia; polyion complex micelle	CYCLIC RGD PEPTIDE; POLYPLEX MICELLES; BALLOON INJURY; CAROTID-ARTERY; GENE DELIVERY; EXPRESSION; DISEASE; SIRNA; LESIONS; CANCER	Neointimal hyperplasia (NIH) after revascularization is a key unsolved clinical problem. Various studies have shown that attenuation of the acute inflammatory response on the vascular wall can prevent NIH. MicroRNA146a-5p (miR146a-5p) has been reported to show anti-inflammatory effects by inhibiting the NF-kappa B pathway, a well-known key player of inflammation of the vascular wall. Here, a nanomedicine, which can reach the vascular injury site, based on polymeric micelles was applied to deliver miR146a-5p in a rat carotid artery balloon injury model. In vitro studies using inflammation-induced vascular smooth muscle cell (VSMC) was performed. Results showed anti-inflammatory response as an inhibitor of the NF-kappa B pathway and VSMC migration, suppression of reactive oxygen species production, and proinflammatory cytokine gene expression in VSMCs. A single systemic administration of miR146a-5p attenuated NIH and vessel remodeling in a carotid artery balloon injury model in both male and female rats in vivo. MiR146a-5p reduced proinflammatory cytokine gene expression in injured arteries and monocyte/macrophage infiltration into the vascular wall. Therefore, miR146a-5p delivery to the injury site demonstrated therapeutic potential against NIH after revascularization.	[Sano, Masaya; Akagi, Daisuke; Hoshina, Katsuyuki; Ishihara, Soichiro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Naito, Mitsuru] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo, Japan; [Miyata, Kanjiro] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo, Japan; [Kataoka, Kazunori] Kawasaki Inst Ind Promot, Innovat Ctr NanoMed, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Akagi, D (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	dakagi-tky@umin.ac.jp	Kataoka, Kazunori/K-7108-2012; Ishihara, Soichiro/AFK-1375-2022	Kataoka, Kazunori/0000-0002-8591-413X; Miyata, Kanjiro/0000-0001-7044-190X; Sano, Masaya/0000-0002-0704-7042; Akagi, Daisuke/0000-0002-5995-6379; NAITO, Mitsuru/0000-0002-4237-871X	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS) [17K10748]	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The 46th Japan Heart Foundation Grant; Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17K10748	Akagi D, 2007, GENE THER, V14, P1029, DOI 10.1038/sj.gt.3302945; Ashino T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26291; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cao BJ, 2019, IUBMB LIFE, V71, P125, DOI 10.1002/iub.1946; Chen SJ, 1996, CIRCULATION, V93, P577, DOI 10.1161/01.CIR.93.3.577; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Christie RJ, 2012, ACS NANO, V6, P5174, DOI 10.1021/nn300942b; Das S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009343; Golzar J, 2020, J ENDOVASC THER, V27, P296, DOI 10.1177/1526602820901723; Ho KJ, 2008, AM J PHYSIOL-HEART C, V295, pH1132, DOI 10.1152/ajpheart.00079.2008; Huang C, 2016, INT IMMUNOPHARMACOL, V32, P46, DOI 10.1016/j.intimp.2016.01.009; Kagaya H, 2012, GENE THER, V19, P61, DOI 10.1038/gt.2011.74; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lacona JR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1533; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mann M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00972-z; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e; Miller AP, 2003, HYPERTENSION, V42, P657, DOI 10.1161/01.HYP.0000085560.02979.0C; Miyahara T, 2006, J VASC SURG, V43, P592, DOI 10.1016/j.jvs.2005.11.010; Monteiro R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/615917; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nishida H, 2016, J CONTROL RELEASE, V231, P29, DOI 10.1016/j.jconrel.2016.03.016; Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133; Paterson MR, 2017, PHYSIOL GENOMICS, V49, P243, DOI 10.1152/physiolgenomics.00133.2016; Rosenfield K, 2015, NEW ENGL J MED, V373, P145, DOI 10.1056/NEJMoa1406235; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Suhara M, 2018, J CONTROL RELEASE, V286, P394, DOI 10.1016/j.jconrel.2018.07.049; Szilagyi Bernadett, 2019, EJIFCC, V30, P128; Taniguchi R, 2016, MOL PHARMACEUT, V13, P2108, DOI 10.1021/acs.molpharmaceut.6b00219; Tasaki Y, 2021, CANCER RES, V81, P1654, DOI 10.1158/0008-5472.CAN-20-3021; Tulis David A., 2007, V139, P3; Wu B, 2018, J VASC SURG, V68, p188S, DOI 10.1016/j.jvs.2018.05.206; Yoshimura S, 2001, GENE THER, V8, P1635, DOI 10.1038/sj.gt.3301566; Zhang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48759-0; Zhang YQ, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02855-7	40	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22486	10.1096/fj.202101481R	http://dx.doi.org/10.1096/fj.202101481R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5JM	35929425				2022-12-28	WOS:000836183500001
J	Hou, JX; Bi, HR; Ge, QT; Teng, HJ; Wan, GQ; Yu, B; Jiang, Q; Gu, XS				Hou, Jinxing; Bi, Huiru; Ge, Qiting; Teng, Huajian; Wan, Guoqiang; Yu, Bin; Jiang, Qing; Gu, Xiaosong			Heterogeneity analysis of astrocytes following spinal cord injury at single-cell resolution	FASEB JOURNAL			English	Article						astrocytes; heterogeneity; single-cell RNA sequencing; spinal cord injury	REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; DUAL ROLE; REGENERATION; PROTEIN; NEUROPROTECTION; ASTROGLIOSIS; REPAIR; CORTEX; SCAR	Astrocytes play many important functions in response to spinal cord injury (SCI) in an activated manner, including clearance of necrotic tissue, formation of protective barrier, maintenance of microenvironment balance, interaction with immune cells, and formation of the glial scar. More and more studies have shown that the astrocytes are heterogeneous, such as inflammatory astrocyte 1 (A1) and neuroprotective astrocyte 2 (A2) types. However, the subtypes of astrocyte resulting from SCI have not been clearly defined. In this study, using single-cell RNA sequencing, we constructed the transcriptomic profile of astrocytes from uninjured spinal cord tissue and injured tissue nearby the lesion epicenter at 0.5, 1, 3, 7, 14, 60, and 90 days after mouse hemisection spinal cord surgery. Our analysis uncovered six transcriptionally distinct astrocyte states, including Atp1b2(+), S100a4(+), Gpr84(+), C3(+)/G0s2(+), GFAP(+)/Tm4sf1(+), and Gss(+)/Cryab(+) astrocytes. We used these new signatures combined with canonical astrocyte markers to determine the distribution of morphologically and physiologically distinct astrocyte population at injured sites by immunofluorescence staining. Then we identified the dynamic evolution process of each astrocyte subtype following SCI. Finally, we also revealed the evolution of highly expressed genes in these astrocyte subtypes at different phases of SCI. Together, we provided six astrocyte subtypes at single-cell resolution following SCI. These data not only contribute to understand the heterogeneity of astrocytes during SCI but also help to find new astrocyte subtypes as a target for SCI repair.	[Hou, Jinxing; Bi, Huiru; Ge, Qiting; Teng, Huajian; Jiang, Qing] Nanjing Univ, Div Sports Med & Adult Reconstruct Surg, State Key Lab Pharmaceut Biotechnol,Med Sch, Dept Orthoped Surg,Nanjing Drum Tower Hosp,Affili, 321 Zhongshan Rd, Nanjing 210008, Peoples R China; [Hou, Jinxing; Bi, Huiru; Ge, Qiting; Teng, Huajian; Jiang, Qing] Branch Natl Clin Res Ctr Orthoped Sports Med & Re, Nanjing, Peoples R China; [Wan, Guoqiang] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Yu, Bin; Gu, Xiaosong] Nantong Univ, CoInnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Peoples R China; [Yu, Bin; Gu, Xiaosong] Nantong Univ, CoInnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Minist Educ, Nantong 226001, Peoples R China	Nanjing University; Nanjing University; Nantong University; Nantong University	Jiang, Q (corresponding author), Nanjing Univ, Div Sports Med & Adult Reconstruct Surg, State Key Lab Pharmaceut Biotechnol,Med Sch, Dept Orthoped Surg,Nanjing Drum Tower Hosp,Affili, 321 Zhongshan Rd, Nanjing 210008, Peoples R China.; Gu, XS (corresponding author), Nantong Univ, CoInnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Peoples R China.; Gu, XS (corresponding author), Nantong Univ, CoInnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Minist Educ, Nantong 226001, Peoples R China.	qingj@nju.edu.cn; nervegu@ntu.edu.cn		Hou, Jinxing/0000-0002-4137-2789	Key Program of NSFC [81730067]; Major Project of NSFC [81991514]; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation; Fundamental Research Funds for the Central Universities [14380493, 14380494]	Key Program of NSFC(National Natural Science Foundation of China (NSFC)); Major Project of NSFC; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Ms. Meng Tan and Mr. Xiaotao Cheng for their comments on the data analysis and manuscript. This work was supported by the Key Program of NSFC (81730067), Major Project of NSFC (81991514), Jiangsu Provincial Key Medical Center Foundation, Jiangsu Provincial Medical Outstanding Talent Foundation, Jiangsu Provincial Medical Youth Talent Foundation, Jiangsu Provincial Key Medical Talent Foundation, and the Fundamental Research Funds for the Central Universities (14380493, 14380494).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anjum A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207533; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bi HR, 2021, CNS NEUROSCI THER, V27, P174, DOI 10.1111/cns.13454; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boghdadi AG, 2020, J NEUROTRAUM, V37, P681, DOI 10.1089/neu.2019.6938; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Bradley RA, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170910; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Cheng XX, 2018, EXP NEUROL, V299, P97, DOI 10.1016/j.expneurol.2017.10.014; Courtine G, 2019, NAT MED, V25, P898, DOI 10.1038/s41591-019-0475-6; Cristovao JS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00463; Dmytriyeva O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2202; Figueroa JD, 2016, J NEUROTRAUM, V33, P1436, DOI 10.1089/neu.2015.4186; Gottipati MK, 2020, ACTA BIOMATER, V117, P273, DOI 10.1016/j.actbio.2020.09.057; Grubman A, 2019, NAT NEUROSCI, V22, P2087, DOI 10.1038/s41593-019-0539-4; Guo WB, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa127; Guttenplan KA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17514-9; Habib N, 2020, NAT NEUROSCI, V23, P701, DOI 10.1038/s41593-020-0624-8; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Hilton BJ, 2019, NAT PROTOC, V14, P1235, DOI 10.1038/s41596-019-0140-z; Hou JX, 2021, J NEUROSCI, V41, P4976, DOI 10.1523/JNEUROSCI.2455-19.2021; Kagawa Y, 2020, MOL NEUROBIOL, V57, P4891, DOI 10.1007/s12035-020-02057-3; Koda Masao, 2021, Brain, V144, P789, DOI 10.1093/brain/awaa466; Kuipers HF, 2017, P NATL ACAD SCI USA, V114, pE1745, DOI 10.1073/pnas.1621314114; Lamantia C, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011014; Laug D, 2019, J CLIN INVEST, V129, P4408, DOI 10.1172/JCI127492; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee-Liu D, 2013, GENESIS, V51, P529, DOI 10.1002/dvg.22406; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Messing A, 2020, ASN NEURO, V12, DOI 10.1177/1759091420949680; Milich Lindsay M, 2021, J Exp Med, V218, DOI 10.1084/jem.20210040; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Mulherkar S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010245; Nagao M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11102; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Noristani HN, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0133-0; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okada S, 2018, NEUROSCI RES, V126, P39, DOI 10.1016/j.neures.2017.10.004; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Qian DF, 2019, CELL CYCLE, V18, P3010, DOI 10.1080/15384101.2019.1667189; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Sandoval M, 2013, BRAIN RES, V1520, P1, DOI 10.1016/j.brainres.2013.04.049; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schlomann U, 2000, J NEUROSCI, V20, P7964; Siddiqui AM, 2015, PROG BRAIN RES, V218, P15, DOI 10.1016/bs.pbr.2014.12.007; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang H, 2021, J NEUROSCI, V41, P8163, DOI 10.1523/JNEUROSCI.2432-20.2021; Wang H, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105212; Wilhelmsson U, 2017, CEREB CORTEX, V27, P3360, DOI 10.1093/cercor/bhx069; Yu B, 2019, FRONT MED-PRC, V13, P131, DOI 10.1007/s11684-018-0642-z; Yu CR, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.736120; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao XF, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0114-19.2019; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	67	5	5	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22442	10.1096/fj.202200463R	http://dx.doi.org/10.1096/fj.202200463R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0IT	35816276				2022-12-28	WOS:000822849400001
J	Qi, F; Zhang, X; Wang, LK; Ren, CX; Zhao, XY; Luo, JY; Lu, D				Qi, Fang; Zhang, Xin; Wang, Likun; Ren, Caixia; Zhao, Xuyang; Luo, Jianyuan; Lu, Dan			E3 ubiquitin ligase NEURL3 promotes innate antiviral response through catalyzing K63-linked ubiquitination of IRF7	FASEB JOURNAL			English	Article						antiviral immune response; E3 ubiquitin ligase; IRF7; NEURL3; viral infection	INTERFERON; ACTIVATION; LUNG	Interferon regulatory factor 7 (IRF7), as the interferon-stimulated gene, maximally drives type I interferon (IFN) production. However, the mechanisms by which the biological function of IRF7 is regulated remain elusive. In this study, we found that IRF7 selectively interacted with the neuralized E3 ubiquitin-protein ligase 3 (NEURL3). In concomitant with IRF7 induction, NEURL3 is upregulated by NF-kappa B signaling in the late phase of viral infection. Moreover, NEURL3 augmented the host antiviral immune response through ubiquitinating IRF7. A mechanistic study revealed that NEURL3 triggered K63-linked poly-ubiquitination on IRF7 lysine 375, which in turn epigenetically enhanced the transcription of interferon-stimulated genes (ISGs) through disruption of the association of IRF7 with Histone Deacetylase 1 (HDAC1), consequently augmenting host antiviral immune response. Accordingly, Neurl3(-/-) mice produced less type I IFNs and exhibited increased susceptibility to viral infection. Taken together, our findings identify NEURL3 as an E3 ubiquitin ligase of IRF7 and shed new light on the positive regulation of IRF7 in host antiviral immune signaling.	[Qi, Fang; Zhang, Xin; Wang, Likun; Zhao, Xuyang; Lu, Dan] Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Ren, Caixia] Peking Univ, Dept Human Anat Histol & Embryol, Hlth Sci Ctr, Beijing, Peoples R China; [Luo, Jianyuan] Peking Univ, Dept Med Genet, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Peking University; Peking University	Lu, D (corresponding author), Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China.	taotao@bjmu.edu.cn		Lu, Dan/0000-0002-3000-5094; Qi, Fang/0000-0001-9856-926X	Clinical Medicine Plus X-Young Scholars Project, Peking University [PKU2021LCXQ026]; National Natural Science Foundation of China [82022032, 81991505, 82171826]; Fundamental Research Funds for the Central Universities [BMU2018YJ003]	Clinical Medicine Plus X-Young Scholars Project, Peking University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Clinical Medicine Plus X-Young Scholars Project, Peking University, Grant/Award Number: PKU2021LCXQ026; The National Natural Science Foundation of China, Grant/Award Number: 82022032, 81991505 and 82171826; Fundamental Research Funds for the Central Universities, Grant/Award Number: BMU2018YJ003	Carty M, 2021, BIOCHEM PHARMACOL, V183, DOI 10.1016/j.bcp.2020.114316; Chen HH, 2013, PROTEIN CELL, V4, P27, DOI 10.1007/s13238-012-2063-0; Glanz A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040575; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu Y, 2005, BIOCHEM BIOPH RES CO, V333, P253, DOI 10.1016/j.bbrc.2005.05.102; Jefferies CA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00325; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Ling T, 2019, MOL IMMUNOL, V109, P116, DOI 10.1016/j.molimm.2019.02.019; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Londhe VA, 2015, DEV DYNAM, V244, P827, DOI 10.1002/dvdy.24286; Lu D, 2020, NAT IMMUNOL, V21, P287, DOI 10.1038/s41590-019-0577-9; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Outlioua A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00853; Smith JB, 2002, AM J PHYSIOL-LUNG C, V283, pL636, DOI 10.1152/ajplung.00496.2001; Smith Jeffrey B, 2004, Proc Am Thorac Soc, V1, P275, DOI 10.1513/pats.200402-017MS; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tracz M, 2021, CELL MOL BIOL LETT, V26, DOI 10.1186/s11658-020-00245-6; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhao YN, 2018, J VIROL, V92, DOI 10.1128/JVI.01123-18	25	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22409	10.1096/fj.202200316R	http://dx.doi.org/10.1096/fj.202200316R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5SN	35792897				2022-12-28	WOS:000821172000001
J	Dumolt, J; Powell, TL; Jansson, T; Rosario, FJ				Dumolt, Jerad; Powell, Theresa L.; Jansson, Thomas; Rosario, Fredrick J.			Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring	FASEB JOURNAL			English	Article						fetal programming; glucose intolerance; insulin resistance; metabolic diseases	FULL-LENGTH ADIPONECTIN; HUMAN SKELETAL-MUSCLE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; POTENTIAL ROLE; RECEPTOR; PHOSPHORYLATION; TRANSPORT; PROTEIN; AKT	Infants born to obese mothers have a greater risk for childhood obesity and insulin resistance. However, the underlying biological mechanism remains elusive, which constitutes a significant roadblock for developing specific prevention strategies. Maternal adiponectin levels are lower in obese pregnant women, which is linked with increased placental nutrient transport and fetal overgrowth. We have previously reported that adiponectin supplementation to obese dams during the last four days of pregnancy prevented the development of obesity, glucose intolerance, muscle insulin resistance, and fatty liver in three months old offspring. In the present study, we tested the hypothesis that 6-9-month-old offspring of obese dams show glucose intolerance associated with muscle insulin resistance and mitochondrial dysfunction and that normalization of maternal adiponectin in obese pregnant mice prevents the development of this phenotype in the offspring. Male and female offspring of obese mice exhibited in vivo glucose intolerance and insulin resistance at 6 and 9 months of age. In gastrocnemius muscles ex vivo, male and female offspring of obese dams showed reduced phosphorylation of insulin receptor substrate 1(Tyr-608), Akt(Thr-308), and decreased Glut4 plasma membrane translocation upon insulin stimulation. These metabolic abnormalities in offspring born to obese mice were largely prevented by normalization of maternal adiponectin levels in late pregnancy. We provide evidence that low circulating maternal adiponectin is a critical mechanistic link between maternal obesity and the development of metabolic disease in offspring. Strategies aimed at improving maternal adiponectin levels may prevent long-term metabolic dysfunction in offspring of obese mothers.	[Dumolt, Jerad; Powell, Theresa L.; Jansson, Thomas; Rosario, Fredrick J.] Univ Colorado, Dept OB GYN, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Powell, Theresa L.] Univ Colorado, Dept Pediat, Sect Neonatol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosario, FJ (corresponding author), Univ Colorado, Dept Obstet & Gynecol, 12700 East 19th Ave,Anschutz Med Campus, Aurora, CO 80045 USA.	fredrick.joseph@cuanschutz.edu		Dumolt, Jerad/0000-0002-7974-3418	National Institute of Child Health and Human Development [HD065007-07A1]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institute of Child Health and Human Development, Grant/Award Number: HD065007-07A1	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Caminos JE, 2005, J CLIN ENDOCR METAB, V90, P4276, DOI 10.1210/jc.2004-0930; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Dube JJ, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz272; Duval F, 2018, J MOL ENDOCRINOL, V61, P139, DOI 10.1530/JME-18-0013; Esposito DL, 2003, J CLIN ENDOCR METAB, V88, P1468, DOI 10.1210/jc.2002-020933; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hinkle SN, 2019, INT J OBESITY, V43, P1422, DOI 10.1038/s41366-018-0255-2; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kovacs P, 2003, DIABETES, V52, P3005, DOI 10.2337/diabetes.52.12.3005; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Lekva T, 2017, J CLIN ENDOCR METAB, V102, P2552, DOI 10.1210/jc.2017-00289; LEMARCHANDBRUSTEL Y, 1985, NATURE, V315, P676, DOI 10.1038/315676a0; Lobstein T, 2004, Obes Rev, V5 Suppl 1, P4; McCurdy CE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86612; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; McMurray F, 2019, FASEB J, V33, P13515, DOI 10.1096/fj.201901150R; Mente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066808; Middelbeek RJW, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.13; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Norena I, 2018, BIOMEDICA, V38, P427, DOI 10.7705/biomedica.v38i4.4035; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okesene-Gafa KAM, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.003; Ozanne S. E., 1996, American Journal of Physiology, V271, pE1128; Paulsen ME, 2019, FASEB J, V33, P2899, DOI 10.1096/fj.201801015R; Perichart-Perera O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180874; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Qiao LP, 2017, DIABETES, V66, P1126, DOI 10.2337/db16-1096; Qiao LP, 2016, DIABETOLOGIA, V59, P2417, DOI 10.1007/s00125-016-4061-x; Rosario FJ, 2015, OBESITY, V23, P1663, DOI 10.1002/oby.21165; Rosario FJ, 2012, J PHYSIOL-LONDON, V590, P1495, DOI 10.1113/jphysiol.2011.226399; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Vo T, 2013, J ENDOCRINOL, V218, P85, DOI 10.1530/JOE-13-0055; Wang GX, 2020, DIABETES, V69, P2294, DOI 10.2337/db20-0439; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Zhang RF, 2019, FASEB J, V33, P13310, DOI 10.1096/fj.201901117RR; Zheng A., 2021, NUTR DIABETES, V71, P219	71	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22383	10.1096/fj.202200326R	http://dx.doi.org/10.1096/fj.202200326R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1W9BN	35670755				2022-12-28	WOS:000807062200001
J	Li, J; Li, RS; Tuleta, I; Hernandez, SC; Humeres, C; Hanna, A; Chen, BJ; Frangogiannis, NG				Li, Jun; Li, Ruoshui; Tuleta, Izabela; Hernandez, Silvia C.; Humeres, Claudio; Hanna, Anis; Chen, Bijun; Frangogiannis, Nikolaos G.			The role of endogenous Smad7 in regulating macrophage phenotype following myocardial infarction	FASEB JOURNAL			English	Article						fibrosis; inflammation; macrophage; myocardial infarction; TGF-beta	GROWTH-FACTOR-BETA; COLONY-STIMULATING FACTOR; RESIDENT CARDIAC MACROPHAGES; TGF-BETA; STEADY-STATE; CHEMOATTRACTANT PROTEIN-1; NEGATIVE REGULATION; MOUSE MACROPHAGES; TYROSINE KINASE; EXPRESSION	Smad7 restrains TGF-beta responses, and has been suggested to exert both pro- and anti-inflammatory actions that may involve effects on macrophages. Myocardial infarction triggers a macrophage-driven inflammatory response that not only plays a central role in cardiac repair, but also contributes to adverse remodeling and fibrosis. We hypothesized that macrophage Smad7 expression may regulate inflammation and fibrosis in the infarcted heart through suppression of TGF-beta responses, or via TGF-independent actions. In a mouse model of myocardial infarction, infiltration with Smad7+ macrophages peaked 7 days after coronary occlusion. Myeloid cell-specific Smad7 loss in mice had no effects on homeostatic functions and did not affect baseline macrophage gene expression. RNA-seq predicted that Smad7 may promote TREM1-mediated inflammation in infarct macrophages. However, these alterations in the transcriptional profile of macrophages were associated with a modest and transient reduction in infarct myofibroblast infiltration, and did not affect dysfunction, chamber dilation, scar remodeling, collagen deposition, and macrophage recruitment. In vitro, RNA-seq and PCR arrays showed that TGF-beta has profound effects on macrophage profile, attenuating pro-inflammatory cytokine/chemokine expression, modulating synthesis of matrix remodeling genes, inducing genes associated with sphingosine-1 phosphate activation and integrin signaling, and inhibiting cholesterol biosynthesis genes. However, Smad7 loss did not significantly affect TGF-beta-mediated macrophage responses, modulating synthesis of only a small fraction of TGF-beta-induced genes, including Itga5, Olfml3, and Fabp7. Our findings suggest a limited role for macrophage Smad7 in regulation of post-infarction inflammation and repair, and demonstrate that the anti-inflammatory effects of TGF-beta in macrophages are not restrained by endogenous Smad7 induction.	[Li, Jun; Li, Ruoshui; Tuleta, Izabela; Hernandez, Silvia C.; Humeres, Claudio; Hanna, Anis; Chen, Bijun; Frangogiannis, Nikolaos G.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, Bronx, NY 10467 USA; [Li, Jun] Fourth Mil Med Univ, Sch Basic Med, Dept Physiol & Pathophysiol, Xian, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Air Force Military Medical University	Frangogiannis, NG (corresponding author), Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, 1300 Morris Pk Ave,Forchheimer G46B, Bronx, NY 10461 USA.	nikolaos.frangogiannis@einsteinmed.edu	Hanna, Anis/AAO-7244-2020	Hanna, Anis/0000-0002-5212-3403; Frangogiannis, Nikolaos/0000-0002-8186-5131; Hernandez, Silvia C./0000-0002-6525-5296	NIH [R01 HL76246, R01 HL85440, R01 HL149407]; Department of Defense [PR181464]; American Heart Association; Chinese Scholarship Council; Deutsche Forschungsgemeinschaft [TU 632/1-1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); Chinese Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	NIH, Grant/Award Number: R01 HL76246, R01 HL85440 and R01 HL149407; Department of Defense, Grant/Award Number: PR181464; American Heart Association; Chinese Scholarship Council; Deutsche Forschungsgemeinschaft, Grant/Award Number: TU 632/1-1	ALLEN JB, 1990, J EXP MED, V171, P231, DOI 10.1084/jem.171.1.231; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Boufenzer A, 2015, CIRC RES, V116, P1772, DOI 10.1161/CIRCRESAHA.116.305628; BOUTARD V, 1995, J IMMUNOL, V155, P2077; BRONZERT DA, 1990, MOL ENDOCRINOL, V4, P981, DOI 10.1210/mend-4-7-981; CELADA A, 1992, J IMMUNOL, V148, P1102; Chen BJ, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-08278-x; Chen BJ, 2019, CIRC RES, V125, P55, DOI 10.1161/CIRCRESAHA.119.315069; Comalada M, 2003, J IMMUNOL, V170, P4450, DOI 10.4049/jimmunol.170.9.4450; van Capelle CD, 2020, CRIT REV BIOCHEM MOL, V55, P691, DOI 10.1080/10409238.2020.1828260; DeBerge M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139576; Dennis EA, 2018, MUCOSAL IMMUNOL, V11, P1694, DOI 10.1038/s41385-018-0041-4; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Feinberg MW, 2000, J BIOL CHEM, V275, P25766, DOI 10.1074/jbc.M002664200; Fraccarollo D, 2019, HYPERTENSION, V73, P102, DOI 10.1161/HYPERTENSIONAHA.118.12162; Frangogiannis NG, 2000, J IMMUNOL, V165, P2798, DOI 10.4049/jimmunol.165.5.2798; Frangogiannis NG, 2022, NAT REV CARDIOL, V19, P435, DOI 10.1038/s41569-021-00646-w; Frangogiannis NG, 2017, J THORAC DIS, V9, pS52, DOI 10.21037/jtd.2016.11.19; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Frodermann V, 2018, PHYSIOL REV, V98, P2523, DOI 10.1152/physrev.00068.2017; Frunza O, 2016, AM J PATHOL, V186, P1114, DOI 10.1016/j.ajpath.2015.12.017; Gal-Oz ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12348-6; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hanna A, 2020, AM J PHYSIOL-HEART C, V319, pH948, DOI 10.1152/ajpheart.00318.2020; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hong YH, 1997, J IMMUNOL, V159, P2418; Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857; Huang CK, 2020, CIRC RES, V127, P953, DOI 10.1161/CIRCRESAHA.119.315807; Huang SB, 2019, J MOL CELL CARDIOL, V132, P84, DOI 10.1016/j.yjmcc.2019.05.006; Humeres C, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI146926; Imhof BA, 2020, FASEB J, V34, P15559, DOI 10.1096/fj.202000751RR; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kitamura M, 1997, J IMMUNOL, V159, P1404; Kleiter I, 2010, BRAIN, V133, P1067, DOI 10.1093/brain/awq039; Lavine KJ, 2018, J AM COLL CARDIOL, V72, P2213, DOI 10.1016/j.jacc.2018.08.2149; Lemarie J, 2015, ESC HEART FAIL, V2, P90, DOI 10.1002/ehf2.12029; Ma YG, 2018, TRANSL RES, V191, P15, DOI 10.1016/j.trsl.2017.10.001; McDonald PP, 1999, J IMMUNOL, V163, P6164; Mia MM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000941; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Mojsilovic SS, 2015, CELL BIOL INT, V39, P619, DOI 10.1002/cbin.10435; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Mouton AJ, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0686-x; MURRY CE, 1994, AM J PATHOL, V145, P1450; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nie J, 2007, PERITON DIALYSIS INT, V27, P580; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Petz A, 2019, CIRC RES, V124, P1433, DOI 10.1161/CIRCRESAHA.118.313285; Reboll MR, 2017, CIRCULATION, V136, P1809, DOI 10.1161/CIRCULATIONAHA.117.029980; Rienks M, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0630-5; ROSE DM, 1995, J IMMUNOL, V155, P5819; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shinde AV, 2017, BBA-MOL BASIS DIS, V1863, P298, DOI 10.1016/j.bbadis.2016.11.006; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Shirakawa K, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017071; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; TAKAISHI T, 1994, AM J PHYSIOL, V267, pC25, DOI 10.1152/ajpcell.1994.267.1.C25; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WAHL SM, 1993, P NATL ACAD SCI USA, V90, P4577, DOI 10.1073/pnas.90.10.4577; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; WISEMAN DM, 1988, BIOCHEM BIOPH RES CO, V157, P793, DOI 10.1016/S0006-291X(88)80319-X; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Wu XK, 2021, CARDIOVASC RES, V117, P1257, DOI 10.1093/cvr/cvaa287; Xiao YQ, 2006, J IMMUNOL, V176, P1209, DOI 10.4049/jimmunol.176.2.1209; XIE B, 1994, J IMMUNOL, V152, P3637; Zhang S, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00042	84	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22400	10.1096/fj.202101956RR	http://dx.doi.org/10.1096/fj.202101956RR			26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2B3TH	35695814				2022-12-28	WOS:000810113400001
J	Schroder-Heurich, B; Buder, T; Meyer, N; Vu, TH; Richter, K; Ramachandran, D; Brodowski, L; von Kaisenberg, CS; von Versen-Hoynck, F				Schroeder-Heurich, Bianca; Bueder, Tim; Meyer, Nadia; Thu Huong Vu; Richter, Katja; Ramachandran, Dhanya; Brodowski, Lars; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke			Downregulation of miR-1270 mediates endothelial progenitor cell function in preeclampsia: Role for ATM in the Src/VE-cadherin axis	FASEB JOURNAL			English	Article						ATM; cardiovascular risk; ECFC; endothelial progenitor cells; miR-1270; preeclampsia; VE-cadherin	VE-CADHERIN; ADHERENS JUNCTIONS; BARRIER FUNCTION; GROWTH-FACTOR; VITAMIN-D; DYSFUNCTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; ACTIVATION; KINASE	Preeclampsia, a pregnancy-related hypertensive disorder, is associated with endothelial dysfunction and increased cardiovascular risk of the offspring in adulthood. In preeclampsia, endothelial colony-forming cells (ECFC) are reduced in number and function. Recently, we have shown that miR-1270, which is involved in cancer in vitro proliferation, migration, and tumor progression, is downregulated in fetal ECFC from preeclamptic pregnancies. We now hypothesize that miR-1270 dysregulation contributes to vascular endothelial dysfunction occurring after preeclampsia via ATM (ataxia telangiectasia mutated) overexpression, the key kinase of DNA damage repair. Here, we show that miR-1270 silencing in normal ECFC and downregulation in preeclamptic ECFC are accompanied by an increase in the expression levels of ATM. Furthermore, ATM activation correlates with upregulated tyrosine kinase Src leading to phosphorylation and internalization of VE-cadherin (vascular endothelial-cadherin) which subsequently compromises endothelial barrier permeability and morphodynamic cell parameters. Treatment with specific ATM inhibitors reveals a novel role of ATM upstream of tyrosine kinase Src activation. Subsequently, Src phosphorylation and internalization of VE-cadherin compromise endothelial barrier permeability. Our findings suggest that downregulation of miR-1270 contributes to impaired ECFC function via the associated ATM overexpression, which further identifies ATM as a novel and critical factor for ECFC defects in preeclampsia. Our study provides new insights into the understanding of ECFC impairment associated with cardiovascular risk in preeclamptic offspring and identifies potential novel therapeutic targets.	[Schroeder-Heurich, Bianca; Bueder, Tim; Meyer, Nadia; Thu Huong Vu; Richter, Katja; Ramachandran, Dhanya; von Versen-Hoeynck, Frauke] Hannover Med Sch, Gynecol Res Unit, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Thu Huong Vu; Brodowski, Lars; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany	Hannover Medical School; Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Gynecol Res Unit, Carl Neuberg Str 1, D-30625 Hannover, Germany.	vonversen-hoeynck.fratike@mh-hannover.de	von Versen-Höynck, Frauke/H-3719-2019	von Versen-Höynck, Frauke/0000-0002-1924-5695; Ramachandran, Dhanya/0000-0001-8139-7799; Schroder-Heurich, Bianca/0000-0002-5996-2373	German Research Foundation [DFG VE 490/15-1]	German Research Foundation(German Research Foundation (DFG))	German Research Foundation, Grant/Award Number: DFG VE 490/15-1; HilF project grant	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bautista-Nino PK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050748; Bieri M, 2009, MOL IMMUNOL, V46, P866, DOI 10.1016/j.molimm.2008.09.011; Bounds KR, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00060; Brodowski L, 2019, AM J PHYSIOL-CELL PH, V317, pC348, DOI 10.1152/ajpcell.00109.2019; Brodowski L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105320; Brodowski L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178340; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Cao JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02373-8; Chang FM, 2017, J PHYSIOL-LONDON, V595, P5143, DOI 10.1113/JP274189; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hakim J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953150; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; King Thomas F J, 2014, J Stem Cells, V9, P93, DOI jsc.2014.9.2.93; Klomp JE, 2019, CELL CHEM BIOL, V26, P1081, DOI 10.1016/j.chembiol.2019.04.007; Lamarca B, 2012, Minerva Ginecol, V64, P309; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; Ma YX, 2018, BBA-MOL CELL RES, V1865, P1293, DOI 10.1016/j.bbamcr.2018.06.011; Munoz-Hernandez R, 2014, HYPERTENSION, V64, P165, DOI 10.1161/HYPERTENSIONAHA.113.03058; Olcina MM, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29903; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Sacks KN, 2018, PREGNANCY HYPERTENS, V13, P181, DOI 10.1016/j.preghy.2018.06.013; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Schroder-Heurich B, 2019, FASEB J, V33, P9142, DOI 10.1096/fj.201802750RR; Schroder-Heurich B, 2014, FASEB J, V28, P1331, DOI 10.1096/fj.13-236984; Shen CX, 2013, P NATL ACAD SCI USA, V110, P11869, DOI 10.1073/pnas.1220898110; Skalis Georgios, 2019, Microrna, V8, P28, DOI 10.2174/2211536607666180813123303; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Van Craenenbroeck AH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.12.34; von Versen-Hoynck F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098990; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang YP, 2007, FRONT BIOSCI-LANDMRK, V12, P2412, DOI 10.2741/2243; Yi TB, 2019, BIOMED PHARMACOTHER, V109, P2357, DOI 10.1016/j.biopha.2018.08.150; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhao H, 2008, CELL CYCLE, V7, P1490, DOI 10.4161/cc.7.10.5963; Zhong L, 2018, IUBMB LIFE, V70, P625, DOI 10.1002/iub.1753; Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30	48	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22379	10.1096/fj.202200040RR	http://dx.doi.org/10.1096/fj.202200040RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1S6VY	35648632				2022-12-28	WOS:000804188100001
J	Widjaja-Adhi, MAK; Kolesnikov, AV; Vasudevan, S; Park, PSH; Kefalov, VJ; Golczak, M				Widjaja-Adhi, Made Airanthi K.; Kolesnikov, Alexander, V; Vasudevan, Sreelakshmi; Park, Paul S. -H; Kefalov, Vladimir J.; Golczak, Marcin			Acyl-CoA:wax alcohol acyltransferase 2 modulates the cone visual cycle in mouse retina	FASEB JOURNAL			English	Article						AWAT2; cone visual cycle; dark adaptation; MFAT; visual chromophore	MULTIFUNCTIONAL O-ACYLTRANSFERASE; PIGMENT REGENERATION; SUBSTRATE-SPECIFICITY; VITAMIN-A; WILD-TYPE; IDENTIFICATION; RPE65; ROD; PHOTORECEPTORS; ISOMERASE	The daylight and color vision of diurnal vertebrates depends on cone photoreceptors. The capability of cones to operate and respond to changes in light brightness even under high illumination is attributed to their fast rate of recovery to the ground photosensitive state. This process requires the rapid replenishing of photoisomerized visual chromophore (11-cis-retinal) to regenerate cone visual pigments. Recently, several gene candidates have been proposed to contribute to the cone-specific retinoid metabolism, including acyl-CoA wax alcohol acyltransferase 2 (AWAT2, aka MFAT). Here, we evaluated the role of AWAT2 in the regeneration of visual chromophore by the phenotypic characterization of Awat2(-/-) mice. The global absence of AWAT2 enzymatic activity did not affect gross retinal morphology or the rate of visual chromophore regeneration by the canonical RPE65-dependent visual cycle. Analysis of Awat2 expression indicated the presence of the enzyme throughout the murine retina, including the retinal pigment epithelium (RPE) and Muller cells. Electrophysiological recordings revealed reduced maximal rod and cone dark-adapted responses in AWAT2-deficient mice compared to control mice. While rod dark adaptation was not affected by the lack of AWAT2, M-cone dark adaptation both in isolated retina and in vivo was significantly suppressed. Altogether, these results indicate that while AWAT2 is not required for the normal operation of the canonical visual cycle, it is a functional component of the cone-specific visual chromophore regenerative pathway.	[Widjaja-Adhi, Made Airanthi K.; Golczak, Marcin] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kolesnikov, Alexander, V; Kefalov, Vladimir J.] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA 92697 USA; [Vasudevan, Sreelakshmi; Park, Paul S. -H] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Kefalov, Vladimir J.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Golczak, Marcin] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; University of California System; University of California Irvine; Case Western Reserve University; University of California System; University of California Irvine; Case Western Reserve University	Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Kefalov, VJ (corresponding author), Univ Calif Irvine, Dept Ophthalmol, 2121 Gillespiel837 Hlth Sci Rd, Irvine, CA 92697 USA.	vkefalov@uci.edu; mxg149@case.edu	Vasudevan, Sreelakshmi/Q-1381-2019	Vasudevan, Sreelakshmi/0000-0001-9534-4559; Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	NIH [EY023948, EY025696, EY030912, EY011373]; Research to Prevent Blindness	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	We thank Catherine Doller, Anthony Gardella, and Maryanne Pendergast from the Visual Science Core Facility at CWRU for their expert help with histology, microscopy, and imaging. Also, we would like to acknowledge Wiktor Golczak for his contribution to the editing of this manuscript. This work was supported by NIH grants EY023948 (M.G.), EY025696 and EY030912 (V.J.K.), and NIH P30 core grant EY011373 to the Visual Sciences Research Center Core Facilities at CWRU, and an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology at the University of California Irvine.	Arne JM, 2017, J LIPID RES, V58, P719, DOI 10.1194/jlr.M073692; Babino D, 2015, FASEB J, V29, P216, DOI 10.1096/fj.14-261693; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Campomanes P, 2019, COMMUN CHEM, V2, DOI 10.1038/s42004-019-0175-7; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Giusto NM, 2010, J LIPID RES, V51, P685, DOI 10.1194/jlr.R001891; Golczak M, 2015, NAT CHEM BIOL, V11, P26, DOI 10.1038/nchembio.1687; Golczak M, 2010, METHODS MOL BIOL, V652, P229, DOI 10.1007/978-1-60327-325-1_13; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hofmann L, 2015, PROG RETIN EYE RES, V49, P46, DOI 10.1016/j.preteyeres.2015.07.004; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P45, DOI 10.1016/j.cbd.2009.09.004; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; de Carvalho JRL, 2020, J BIOL CHEM, V295, P6767, DOI 10.1074/jbc.RA120.012695; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Miklaszewska M, 2013, ACTA BIOCHIM POL, V60, P209; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Sander CL, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202101063; Sawai M, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102478; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Vincent SD, 2003, GENESIS, V37, P54, DOI 10.1002/gene.10226; Ward R, 2020, J BIOL CHEM, V295, P6482, DOI 10.1074/jbc.RA119.011374; Widjaja-Adhi MAK, 2020, FASEB J, V34, P13792, DOI 10.1096/fj.202001191R; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Zhang JY, 2019, J BIOL CHEM, V294, P19137, DOI 10.1074/jbc.RA119.011169	59	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22390	10.1096/fj.202101855RRR	http://dx.doi.org/10.1096/fj.202101855RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1V6TZ	35665537				2022-12-28	WOS:000806221000001
J	Xu, B; Li, QF; Wu, YF; Wang, H; Xu, JM; Liu, H; Xuan, AG				Xu, Biao; Li, Qingfeng; Wu, Yuanfei; Wang, Huan; Xu, Jiamin; Liu, Hui; Xuan, Aiguo			Mettl3-mediated m(6)A modification of Lrp2 facilitates neurogenesis through Ythdc2 and elicits antidepressant-like effects	FASEB JOURNAL			English	Article						depression; Lrp2; Mettl3; 14; N-6-methyladenosine; neurogenesis; Ythdc2	ADULT HIPPOCAMPAL NEUROGENESIS; METHYLATION; MEGALIN; PROTEIN; MEMORY; SEX; FTO	N-6-methyladenosine (m(6)A) is the most abundant mRNA modification affecting diverse biological processes. However, the functions and precise mechanisms of m(6)A signaling in adult hippocampal neurogenesis and neurogenesis-related depression remain largely enigmatic. We found that depletion of Mettl3 or Mettl14 in neural stem cells (NSCs) dramatically reduced m(6)A abundance, proliferation, and neuronal genesis, coupled with enhanced glial differentiation. Conversely, overexpressing Mettl3 promoted proliferation and neuronal differentiation. Mechanistically, the m(6)A modification of Lrp2 mRNA by Mettl3 enhanced its stability and translation efficiency relying on the reader protein Ythdc2, which in turn promoted neurogenesis. Importantly, mice lacking Mettl3 manifested reduced hippocampal neurogenesis, which could contribute to spatial memory decline, and depression-like behaviors. We found that these defective behaviors were notably reversed by Lrp2 overexpression. Moreover, Mettl3 overexpression in the hippocampus of depressive mice rescues behavioral defects. Our findings uncover the biological role of m(6)A modification in Lrp2-mediated neurogenesis via m(6)A-binding protein Ythdc2, and propose a rationale that targeting Mettl3-Ythdc2-Lrp2 axis regulation of neurogenesis might serve as a promising antidepressant strategy.	[Xu, Biao; Li, Qingfeng; Wu, Yuanfei; Wang, Huan; Xu, Jiamin; Liu, Hui; Xuan, Aiguo] Guangzhou Med Univ, Inst Neurosci, Guangzhou, Peoples R China; [Xu, Biao; Li, Qingfeng; Wu, Yuanfei; Wang, Huan; Xu, Jiamin; Liu, Hui; Xuan, Aiguo] Guangzhou Med Univ, Affiliated Hosp 2, Sch Basic Med Sci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Peoples R China; [Xuan, Aiguo] Guangdong Prov Key Lab Psychiat Disorders, Guangzhou, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Xuan, AG (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou 510260, Peoples R China.	xag2005@163.com			National Natural Science Foundation of China [81371217]; Research Grant of Guangdong Province Key Laboratory of Psychiatric Disorders [N201901]; Innovation and Strong College Program of Guangdong [2018KTSCX183]; Natural Science Foundation of Guangdong [2022A1515012121]; Key discipline of Guangzhou Education Bureau [201851839]; Disciplinary Construction Foundation of Guangzhou Medical University [JCXKJS2021C01, JCXKJS2021D08]; Guangzhou Medical University Discipline Construction Funds [JCXKJS2022A09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grant of Guangdong Province Key Laboratory of Psychiatric Disorders; Innovation and Strong College Program of Guangdong; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Key discipline of Guangzhou Education Bureau; Disciplinary Construction Foundation of Guangzhou Medical University; Guangzhou Medical University Discipline Construction Funds	National Natural Science Foundation of China, Grant/Award Number: 81371217; Research Grant of Guangdong Province Key Laboratory of Psychiatric Disorders, Grant/Award Number: N201901; Innovation and Strong College Program of Guangdong, Grant/Award Number: 2018KTSCX183; Natural Science Foundation of Guangdong, Grant/Award Number: 2022A1515012121; Key discipline of Guangzhou Education Bureau, Grant/Award Number: 201851839; Disciplinary Construction Foundation of Guangzhou Medical University, Grant/Award Number: JCXKJS2021C01 and JCXKJS2021D08; Guangzhou Medical University Discipline Construction Funds, Grant/Award Number: JCXKJS2022A09	Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Bailey AS, 2017, ELIFE, V6, DOI 10.7554/eLife.26116; Bartolome F, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0800-2; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bedi RK, 2020, CHEMMEDCHEM, V15, P744, DOI 10.1002/cmdc.202000011; Caglayan AO, 2016, J HUM GENET, V61, P395, DOI 10.1038/jhg.2015.160; Cao YH, 2020, HUM MOL GENET, V29, P727, DOI 10.1093/hmg/ddz274; Chen JC, 2019, GENOM PROTEOM BIOINF, V17, P154, DOI 10.1016/j.gpb.2018.12.007; Cheng YM, 2019, CELL REP, V28, P1703, DOI 10.1016/j.celrep.2019.07.032; Egeland M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.68; Epp JR, 2013, NEUROPSYCHOPHARMACOL, V38, P2297, DOI 10.1038/npp.2013.132; Fanale D, 2014, EXPERT OPIN THER TAR, V18, P841, DOI 10.1517/14728222.2014.920324; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Garbo S, 2021, DRUG DISCOV TODAY, V26, P2559, DOI 10.1016/j.drudis.2021.06.004; Gomes JR, 2016, CELL DEATH DIFFER, V23, P1749, DOI 10.1038/cdd.2016.64; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Kretschmer J, 2018, RNA, V24, P1339, DOI 10.1261/rna.064238.117; Landowski LM, 2016, J BIOL CHEM, V291, P1092, DOI 10.1074/jbc.M115.668996; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li LP, 2017, HUM MOL GENET, V26, P2398, DOI 10.1093/hmg/ddx128; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Ma ZZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01709-8; Mateus-Pinheiro A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.141; Moroz-Omori EV, 2021, CHEMMEDCHEM, V16, P3035, DOI 10.1002/cmdc.202100291; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Wang Y, 2018, NAT NEUROSCI, V21, P195, DOI 10.1038/s41593-017-0057-1; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Wojtas MN, 2017, MOL CELL, V68, P374, DOI 10.1016/j.molcel.2017.09.021; Xiang JX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005175; Yang N, 2020, CARCINOGENESIS, V41, P761, DOI 10.1093/carcin/bgaa012; Yankova E, 2021, NATURE, V593, P597, DOI 10.1038/s41586-021-03536-w; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Zhao XY, 2019, AM J CANCER RES, V9, P2156; Zywitza V, 2018, CELL REP, V25, P2457, DOI 10.1016/j.celrep.2018.11.003	42	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22392	10.1096/fj.202200133RR	http://dx.doi.org/10.1096/fj.202200133RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E9HD	35716070				2022-12-28	WOS:000812530700001
J	Wellmerling, J; Rayner, RE; Chang, SW; Kairis, EL; Kim, SH; Sharma, A; Boyaka, PN; Cormet-Boyaka, E				Wellmerling, Jack; Rayner, Rachael E.; Chang, Sheng-Wei; Kairis, Elizabeth L.; Kim, Sun Hee; Sharma, Amit; Boyaka, Prosper N.; Cormet-Boyaka, Estelle			Targeting the EGFR-ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del	FASEB JOURNAL			English	Article						CFTR; EGFR; human bronchial epithelial cells; MAPK pathways	TRANSMEMBRANE CONDUCTANCE REGULATOR; EPIDERMAL-GROWTH-FACTOR; RECEPTOR ACTIVATION; EPITHELIAL-CELLS; MUCIN PRODUCTION; QUALITY-CONTROL; MEMBRANE; DELTA-F508-CFTR; INFLAMMATION; PATHOGENESIS	Mutations in the CFTR gene lead to cystic fibrosis, a genetic disease associated with chronic infection and inflammation and ultimately respiratory failure. The most common CF-causing mutation is F508del and CFTR modulators (correctors and potentiators) are being developed to rescue its trafficking and activity defects. However, there are currently no modulators that stabilize the rescued membrane F508del-CFTR which is endocytosed and quickly degraded resulting in a shorter half-life than wild-type (WT). We previously reported that the extracellular signal-regulated kinase (ERK) MAPK pathway is involved in CFTR degradation upon cigarette smoke exposure. Interestingly, we found that ERK phosphorylation was increased in CF human bronchial epithelial (HBE) cells (CF-HBE41o- and primary CF-HBE) compared to non-CF controls, and this was likely due to signaling by the epidermal growth factor receptor (EGFR). EGFR can be activated by several ligands, and we provide evidence that amphiregulin (AREG) is important for activating this signaling axis in CF. The natural osmolyte ectoine stabilizes membrane macromolecules. We show that ectoine decreases ERK phosphorylation, increases the half-life of rescued CFTR, and increases CFTR-mediated chloride transport in combination with the CFTR corrector VX-661. Additionally, ectoine reduces production of AREG and interleukin-8 by CF primary bronchial epithelial cells. In conclusion, EGFR-ERK signaling negatively regulates CFTR and is hyperactive in CF, and targeting this axis with ectoine may prove beneficial for CF patients.	[Wellmerling, Jack; Rayner, Rachael E.; Chang, Sheng-Wei; Kairis, Elizabeth L.; Kim, Sun Hee; Sharma, Amit; Boyaka, Prosper N.; Cormet-Boyaka, Estelle] Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd,Goss Lab 303, Columbus, OH 43220 USA; [Sharma, Amit] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43220 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cormet-Boyaka, E (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd,Goss Lab 303, Columbus, OH 43220 USA.	Boyaka.2@osu.edu	Kim, Sun/GSN-4867-2022	Cormet-Boyaka, Estelle/0000-0001-9839-384X	Cystic Fibrosis Foundation (CF Foundation) [CORMET16G0]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [AI125136]	Cystic Fibrosis Foundation (CF Foundation); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)	Cystic Fibrosis Foundation (CF Foundation), Grant/Award Number: CORMET16G0; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI125136	Amin R, 2014, EXPERT OPIN EMERG DR, V19, P143, DOI 10.1517/14728214.2014.882316; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Bell HL, 2010, AM J MED SCI, V339, P105, DOI 10.1097/MAJ.0b013e3181cb4487; Tran BH, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7945091; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; COHEN S, 1965, DEV BIOL, V12, P394; COHEN S, 1962, J BIOL CHEM, V237, P1555; Cormet-Boyaka E, 2012, TOXICOL SCI, V125, P418, DOI 10.1093/toxsci/kfr310; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Farinha Carlos M, 2018, Small GTPases, V9, P136, DOI 10.1080/21541248.2017.1317700; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Gan XQ, 2013, J BIOL CHEM, V288, P33978, DOI 10.1074/jbc.M113.477406; Gobillot TA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050503; Haji R, 2007, J PATHOL, V211, P340, DOI 10.1002/path.2118; Harada C, 2011, AM J RESP CRIT CARE, V183, P743, DOI 10.1164/rccm.201002-0188OC; Hassan F, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-69; Heijerman HGM, 2019, LANCET, V394, P1940, DOI 10.1016/S0140-6736(19)32597-8; Hull J, 1997, THORAX, V52, P557, DOI 10.1136/thx.52.6.557; Izuhara K, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1054801; Kamei S, 2019, BIOCHEM BIOPH RES CO, V509, P521, DOI 10.1016/j.bbrc.2018.12.152; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Kondapaka SB, 1997, INT J CANCER, V70, P722, DOI 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.3.CO;2-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Massip-Copiz M, 2018, J CELL BIOCHEM, V119, P2911, DOI 10.1002/jcb.26483; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Okiyoneda T, 2018, DEV CELL, V44, P694, DOI 10.1016/j.devcel.2018.02.001; Peuschel H, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-48; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Rayner RE, 2020, J CYST FIBROS, V19, P752, DOI 10.1016/j.jcf.2020.05.007; Rayner RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36735-z; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Roychoudhury A, 2013, BIOL CHEM, V394, P1465, DOI 10.1515/hsz-2013-0173; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Singh Bhuminder, 2016, F1000Res, V5, DOI 10.12688/f1000research.9025.1; Stolarczyk M, 2018, AM J PHYSIOL-LUNG C, V314, P1555, DOI 10.1152/ajplung.00458.2017; Stolarczyk M, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1067134; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Sydlik U, 2013, EUR RESPIR J, V41, P433, DOI 10.1183/09031936.00132211; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Trzcinska-Daneluti AM, 2015, MOL CELL PROTEOMICS, V14, P1569, DOI 10.1074/mcp.M114.046375; Trzcinska-Daneluti AM, 2012, MOL CELL PROTEOMICS, V11, P745, DOI 10.1074/mcp.M111.016626; Unfried K, 2016, INT J CHRONIC OBSTR, V11, P2573, DOI 10.2147/COPD.S115061; Dao VA, 2019, EUR ARCH OTO-RHINO-L, V276, P775, DOI 10.1007/s00405-019-05324-9; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Xu XH, 2015, BBA-GEN SUBJECTS, V1850, P1224, DOI 10.1016/j.bbagen.2015.02.004; Yamaoka T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164021; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Ziady AG, 2014, INT J BIOCHEM CELL B, V52, P113, DOI 10.1016/j.biocel.2014.03.006; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	66	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22270	10.1096/fj.202100458RRR	http://dx.doi.org/10.1096/fj.202100458RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0L0ZX	35412656				2022-12-28	WOS:000781213700001
J	Zhang, JJ; Jiang, CY; Liu, XH; Jiang, CX; Cao, QQ; Yu, B; Ni, YH; Mao, SS				Zhang, Junjie; Jiang, Chunyi; Liu, Xiaohong; Jiang, Chen-Xiao; Cao, Qianqian; Yu, Bin; Ni, Yaohui; Mao, Susu			The metabolomic profiling identifies N, N-dimethylglycine as a facilitator of dorsal root ganglia neuron axon regeneration after injury	FASEB JOURNAL			English	Article						axon regeneration; dorsal root ganglia; metabolomic profiling; N; N-dimethylglycine; sciatic nerve injury	PENTOSE-PHOSPHATE PATHWAY; HISTIDINE-DIPEPTIDES; SCIATIC-NERVE; BILE-ACIDS; HEALTH; LESION; ROLES	Identifying novel molecules involved in axon regeneration of neurons in the peripheral nervous system (PNS) will be of benefit in obtaining a therapeutic strategy for repairing axon damage both in the PNS and the central nervous system (CNS). Metabolism and axon regeneration are tightly connected. However, the overall metabolic processes and the landscape of the metabolites in axon regeneration of PNS neurons are uncovered. Here, we used an ultra high performance liquid tandem chromatography quadrupole time of flight mass spectrometry (UHPLC-QTOFMS)-based untargeted metabolomics to analyze dorsal root ganglia (DRG) metabolic characteristics at different time points post sciatic nerve injury and acquired hundreds of differentially changed metabolites. In addition, the results reveal that several metabolic pathways were significantly altered, such as 'Histidine metabolism', 'Glycine serine and threonine metabolism', 'Arginine and proline metabolism', 'taurine and hypotaurine metabolism' and so on. Given metabolite could alter a cell's or an organism's phenotype, further investigation demonstrated that N, N-dimethylglycine (DMG) has a promoting effect on the regenerative ability post injury. Overall, our data may serve as a resource useful for further understanding how metabolites contribute to axon regeneration in DRG during sciatic nerve regeneration and suggest DMG may be a candidate drug to repair nerve injury.	[Zhang, Junjie; Jiang, Chunyi; Liu, Xiaohong; Cao, Qianqian; Yu, Bin; Mao, Susu] Nantong Univ, Coinnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Key Lab Neuroregenerat,Jiangsu & Minist Educ, Nantong 226001, Peoples R China; [Jiang, Chunyi] Nantong Univ, Dept Pathol, Affiliated Hosp, Nantong, Peoples R China; [Jiang, Chen-Xiao] Nantong Univ, Med Sch, Nantong, Peoples R China; [Ni, Yaohui] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Mao, SS (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Key Lab Neuroregenerat,Jiangsu & Minist Educ, Nantong 226001, Peoples R China.; Ni, YH (corresponding author), Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Peoples R China.	niyaohui200688@126.com; maosusu@ntu.edu.cn	Jiang, Chenxiao/GQA-6713-2022		National Major Project of Research and Development [2017YFA0104701, 2021YFA1201402]; Collegiate Natural Science Fund of Jiangsu Province [21KJA180002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX21_3073, KYCX21_3095]	National Major Project of Research and Development; Collegiate Natural Science Fund of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Postgraduate Research & Practice Innovation Program of Jiangsu Province	National Major Project of Research and Development, Grant/Award Number: 2017YFA0104701 and 2021YFA1201402; Collegiate Natural Science Fund of Jiangsu Province, Grant/Award Number: 21KJA180002; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Postgraduate Research & Practice Innovation Program of Jiangsu Province, Grant/Award Number: KYCX21_3073 and KYCX21_3095	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Aon MA, 2020, CELL METAB, V32, P100, DOI 10.1016/j.cmet.2020.04.018; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Brosnan ME, 2020, J NUTR, V150, p2570S, DOI 10.1093/jn/nxaa079; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chen K, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180157; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Delibas B, 2021, J CHEM NEUROANAT, V117, DOI 10.1016/j.jchemneu.2021.102002; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Farshid AA, 2015, DRUG CHEM TOXICOL, V38, P436, DOI 10.3109/01480545.2014.981753; Friesen RW, 2007, J NUTR, V137, P2641; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gemelli T, 2018, MOL NEUROBIOL, V55, P5101, DOI 10.1007/s12035-017-0711-3; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Guijas C, 2018, NAT BIOTECHNOL, V36, P316, DOI 10.1038/nbt.4101; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Han Q, 2020, CELL METAB, V31, P623, DOI 10.1016/j.cmet.2020.02.002; Hariganesh K, 2000, J PHARM PHARMACOL, V52, P1519, DOI 10.1211/0022357001777568; HARTMAN PE, 1990, PHOTOCHEM PHOTOBIOL, V51, P59, DOI 10.1111/j.1751-1097.1990.tb01684.x; Hausott B, 2019, ANAT REC, V302, P1261, DOI 10.1002/ar.24126; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Hoffman Jay R, 2018, Adv Food Nutr Res, V84, P183, DOI 10.1016/bs.afnr.2017.12.003; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Holecek M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030848; Hsieh CP, 2020, TOXICOLOGY, V446, DOI 10.1016/j.tox.2020.152613; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kern JK, 2001, J CHILD NEUROL, V16, P169, DOI 10.1177/088307380101600303; Lawson Brian R, 2007, BMC Complement Altern Med, V7, P20, DOI 10.1186/1472-6882-7-20; Leonardi R., 2007, ECOSAL PLUS, V2, DOI [10.1128/ecosalplus.3.6.3.4, DOI 10.1128/ECOSALPLUS.3.6.3.42, DOI 10.1128/ECOSALPLUS.3.6.3.4]; Mao SS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2027-x; Mao SS, 2018, EXP NEUROL, V308, P80, DOI 10.1016/j.expneurol.2018.07.003; McDearmid JR, 2006, P NATL ACAD SCI USA, V103, P9679, DOI 10.1073/pnas.0504871103; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Moro J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051414; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Muniandy K, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3142073; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nguyen A, 2008, CELL SIGNAL, V20, P2180, DOI 10.1016/j.cellsig.2008.06.014; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sahoo PK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05647-x; Saijilafu, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3690; Schuhmacher R, 2013, ANAL BIOANAL CHEM, V405, P5003, DOI 10.1007/s00216-013-6939-5; Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004; Shen X, 2021, ARTHRITIS RHEUMATOL, V73, P1738, DOI 10.1002/art.41733; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Skytt DM, 2012, NEUROCHEM INT, V61, P490, DOI 10.1016/j.neuint.2012.04.014; Song BC, 2014, NUTR RES PRACT, V8, P3, DOI 10.4162/nrp.2014.8.1.3; Takahashi T, 2009, J REPROD DEVELOP, V55, P339, DOI 10.1262/jrd.20124; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; Vance JE, 2005, J BIOL CHEM, V280, P10877, DOI 10.1074/jbc.R400038200; Vaughan RA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-14; Wang D, 2020, J BIOL CHEM, V295, P8374, DOI 10.1074/jbc.RA119.011917; Wang PL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16355-w; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Weng YL, 2017, NEURON, V94, P337, DOI 10.1016/j.neuron.2017.03.034; Wolbert J, 2020, P NATL ACAD SCI USA, V117, P9466, DOI 10.1073/pnas.1912139117; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiang H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01488; Yang C, 2020, NEURON, V105, P276, DOI 10.1016/j.neuron.2019.10.009; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Ydens E, 2020, NAT NEUROSCI, V23, P676, DOI 10.1038/s41593-020-0618-6; Yu B, 2015, PROG NEUROBIOL, V134, P122, DOI 10.1016/j.pneurobio.2015.09.006; Zhang PX, 2017, BBA-BIOMEMBRANES, V1859, P1583, DOI 10.1016/j.bbamem.2017.04.007; Zhao LL, 2021, NEUROSCI BULL, V37, P569, DOI 10.1007/s12264-021-00647-2; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101	75	0	0	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22305	10.1096/fj.202101698R	http://dx.doi.org/10.1096/fj.202101698R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0I4HD	35394692				2022-12-28	WOS:000779381300001
J	Capitini, C; Pesce, L; Fani, G; Mazzamuto, G; Genovese, M; Franceschini, A; Paoli, P; Pieraccini, G; Zasloff, M; Chiti, F; Pavone, FS; Calamai, M				Capitini, Claudia; Pesce, Luca; Fani, Giulia; Mazzamuto, Giacomo; Genovese, Massimo; Franceschini, Alessandra; Paoli, Paolo; Pieraccini, Giuseppe; Zasloff, Michael; Chiti, Fabrizio; Pavone, Francesco S.; Calamai, Martino			Studying the trafficking of labeled trodusquemine and its application as nerve marker for light-sheet and expansion microscopy	FASEB JOURNAL			English	Article						intracellular trafficking; lipid membrane; nerve fiber staining; neurodegeneration; optical imaging; squalamine	ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; SQUALAMINE; PROTEINS; CHOLESTEROL; GENERATION; ORGANELLES; OLIGOMERS; DYNAMICS; PHASE	Trodusquemine is an aminosterol with a variety of biological and pharmacological functions, such as acting as an antimicrobial, stimulating body weight loss and interfering with the toxicity of proteins involved in the development of Alzheimer's and Parkinson's diseases. The mechanisms of interaction of aminosterols with cells are, however, still largely uncharacterized. Here, by using fluorescently labeled trodusquemine (TRO-A594 and TRO-ATTO565), we show that trodusquemine binds initially to the plasma membrane of living cells, that the binding affinity is dependent on cholesterol, and that trodusquemine is then internalized and mainly targeted to lysosomes after internalization. We also found that TRO-A594 is able to strongly and selectively bind to myelinated fibers in fixed mouse brain slices, and that it is a marker compatible with tissue clearing and light-sheet fluorescence microscopy or expansion microscopy. In conclusion, this work contributes to further characterize the biology of aminosterols and provides a new tool for nerve labeling suitable for the most advanced microscopy techniques.	[Capitini, Claudia; Pesce, Luca; Mazzamuto, Giacomo; Franceschini, Alessandra; Pavone, Francesco S.; Calamai, Martino] Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy; [Capitini, Claudia; Pesce, Luca; Mazzamuto, Giacomo; Franceschini, Alessandra; Pavone, Francesco S.] Univ Florence, Dept Phys, Sesto Fiorentino, Italy; [Fani, Giulia; Genovese, Massimo; Paoli, Paolo; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Sect Biochem, Florence, Italy; [Mazzamuto, Giacomo; Pavone, Francesco S.; Calamai, Martino] Natl Res Council CNR INO, Natl Inst Opt, Sesto Fiorentino, Italy; [Pieraccini, Giuseppe] Univ Florence, CISM Mass Spectrometry Ctr, Sesto Fiorentino, Italy; [Zasloff, Michael] Enterin Inc, Philadelphia, PA USA; [Zasloff, Michael] Georgetown Univ, MedStar Georgetown Transplant Inst, Sch Med, Washington, DC USA	University of Florence; University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; Georgetown University	Calamai, M (corresponding author), Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy.	calamai@lens.unifi.it			European Union; General Hospital Corporation Center of the National Institutes of Health [654148];  [MH117023]	European Union(European Commission); General Hospital Corporation Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	European Union & apos;s Horizon 2020 research and innovation programme, Grant/Award Number: 654148 Laserlab- Europe; General Hospital Corporation Center of the National Institutes of Health, Grant/Award Number: MH117023	A. H.Marblestone, 2019, bioRxiv, DOI 10.1101/829903; Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Asano Shoh M, 2018, Curr Protoc Cell Biol, V80, pe56, DOI 10.1002/cpcb.56; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bianchini P, 2021, METHOD CELL BIOL, V161, P275, DOI 10.1016/bs.mcb.2020.07.001; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourebaba L, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02102-x; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chozinski TJ, 2016, NAT METHODS, V13, P485, DOI [10.1038/NMETH.3833, 10.1038/nmeth.3833]; Costantini I, 2021, BIOMED OPT EXPRESS, V12, P3684, DOI 10.1364/BOE.415555; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Desai MK, 2011, GLIA, V59, P627, DOI 10.1002/glia.21131; Errico S, 2021, ACS CHEM NEUROSCI, V12, P3189, DOI 10.1021/acschemneuro.1c00327; Errico S, 2020, NANOSCALE, V12, P22596, DOI 10.1039/d0nr05285j; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fani G, 2021, ACS CHEM NEUROSCI, V12, P766, DOI 10.1021/acschemneuro.0c00811; FARMER JA, 1992, CLIN THER, V14, P708; Gallagher BR, 2021, NEUROBIOL DIS, V154, DOI 10.1016/j.nbd.2021.105362; Gao MF, 2021, METHOD CELL BIOL, V161, P15, DOI 10.1016/bs.mcb.2020.06.001; Higgins RD, 2000, INVEST OPHTH VIS SCI, V41, P1507; Jensen KHR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32674; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lai HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03359-w; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Limbocker R, 2022, NAT PROD REP, V39, P742, DOI 10.1039/d1np00042j; Limbocker R, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.680026; Limbocker R, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01140-8; Limbocker R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07699-5; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; MANDERS EMM, 1992, J CELL SCI, V103, P857; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Ottana R, 2019, BIOORG CHEM, V92, DOI 10.1016/j.bioorg.2019.103211; Pearson K, 1902, BIOMETRIKA, V2, P357; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Perni M, 2018, ACS CHEM BIOL, V13, P2308, DOI 10.1021/acschembio.8b00466; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Pesce L, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03390-0; Pesce L, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900018; Rao MN, 2000, J NAT PROD, V63, P631, DOI 10.1021/np990514f; Ricke KM, 2020, J NEUROSCI, V40, P1581, DOI 10.1523/JNEUROSCI.2120-19.2019; Sakagami K, 2018, MOL PHARMACEUT, V15, P1332, DOI 10.1021/acs.molpharmaceut.7b01130; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sills AK, 1998, CANCER RES, V58, P2784; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; Wassie AT, 2019, NAT METHODS, V16, P33, DOI 10.1038/s41592-018-0219-4; WEHRLI SL, 1993, STEROIDS, V58, P370, DOI 10.1016/0039-128X(93)90040-T; Wen G, 2020, ACS NANO, V14, P7860, DOI 10.1021/acsnano.9b09259; Williams JI, 2001, CLIN CANCER RES, V7, P724; Zasloff M, 2001, INT J OBESITY, V25, P689, DOI 10.1038/sj.ijo.0801599; Zasloff M, 2011, P NATL ACAD SCI USA, V108, P15978, DOI 10.1073/pnas.1108558108; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao H, 2018, CANCER RES, V78, P2115, DOI 10.1158/0008-5472.CAN-17-3202	65	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22655	10.1096/fj.202201276R	http://dx.doi.org/10.1096/fj.202201276R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O1NC	36421008				2022-12-28	WOS:000890011200001
J	Kim, JY; Lee, EJ; Seo, J; Lee, Y; Ahn, Y; Park, S; Bae, YJ; Lee, J; Lim, BJ; Kim, D; Cho, JW; Oh, SH				Kim, Ji Young; Lee, Eun Jung; Seo, Jimyung; Lee, Yangsin; Ahn, Yuri; Park, Sujin; Bae, Yu Jeong; Lee, Jinu; Lim, Beom Jin; Kim, Doyoung; Cho, Jin Won; Oh, Sang Ho			Nephrin expression in human epidermal keratinocytes and its implication in poor wound closure	FASEB JOURNAL			English	Article						cell migration; keratinocytes; nephrin; wound healing; zonula occludens-1	SLIT DIAPHRAGM; ACTIN CYTOSKELETON; CELL-PROLIFERATION; SKIN; PROTEINS; PODOCIN; KIDNEY; YAP; CD2AP; GENE	Nephrin is a type-1 transmembrane protein and a component of the slit diaphragm renal-filtration barrier. It has several functions in actin remodeling and cell-cell adhesion. Nephrin is principally located in the kidney glomerulus, but several studies have reported that nephrin is found in the pancreas, brain, and placenta. However, nephrin expression and its role in human skin have not yet been reported. First, using single-cell RNA sequencing, immunohistochemistry, and immuno-electron microscopy, nephrin expression was confirmed in human-skin epidermal keratinocytes. Nephrin expression colocalized with the expression of zonula occludens-1 in keratinocytes and was closely related to keratinocyte cell density, proliferation, and migration. High glucose treatment decreased nephrin expression and compromised keratinocyte cell migration without yes-associated protein nuclear entry. This reduced cell migration under high glucose conditions was improved in nephrin-overexpressing keratinocytes. Nephrin was highly expressed on the margins of re-epithelized epidermis based on in vivo mice and ex vivo human skin wound models. The results demonstrate that nephrin is expressed in human-skin keratinocytes and functions in cell adhesion, proliferation, and migration. In conclusion, this study suggests that nephrin may have a variety of physiological roles in human skin.	[Kim, Ji Young; Lee, Eun Jung; Seo, Jimyung; Ahn, Yuri; Park, Sujin; Bae, Yu Jeong; Kim, Doyoung; Oh, Sang Ho] Yonsei Univ, Coll Med, Severance Hosp, Dept Dermatol, Seoul, South Korea; [Kim, Ji Young; Lee, Eun Jung; Seo, Jimyung; Ahn, Yuri; Park, Sujin; Bae, Yu Jeong; Kim, Doyoung; Oh, Sang Ho] Yonsei Univ, Coll Med, Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea; [Lee, Eun Jung] Yonsei Univ, Coll Med, Brain Korea Project 21, Grad Sch Med Sci, Seoul, South Korea; [Seo, Jimyung] Korea Adv Inst Sci & Engn, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Lee, Yangsin; Cho, Jin Won] Yonsei Univ, Glycosylat Network Res Ctr, Seoul, South Korea; [Lee, Jinu] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Lim, Beom Jin] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Cho, Jin Won] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Oh, SH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Dermatol, Seoul, South Korea.; Oh, SH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea.	oddung93@yuhs.ac		Lim, Beom Jin/0000-0003-2856-0133; Oh, Sang Ho/0000-0002-4477-1400; Kim, Do Young/0000-0002-0194-9854	Korean Dermatological Association (KDA); National Research Foundation of Korea (NRF) [2019R1A2C4069490, 2016R1A5A1010764]; Ministry of Health and Welfare, Republic of Korea [HP20C0019]	Korean Dermatological Association (KDA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Korean Dermatological Association (KDA); National Research Foundation of Korea (NRF), Grant/Award Number: 2019R1A2C4069490 and 2016R1A5A1010764; Ministry of Health and Welfare, Republic of Korea, Grant/Award Number: HP20C0019	Astrom E, 2006, CELL MOL LIFE SCI, V63, P498, DOI 10.1007/s00018-005-5498-0; Beall MH, 2005, J SOC GYNECOL INVEST, V12, P298, DOI 10.1016/j.jsgi.2005.02.009; Brandner JM, 2006, SKIN PHARMACOL PHYS, V19, P71, DOI 10.1159/000091973; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Chahi AK, 2016, J BIOL CHEM, V291, P12799, DOI 10.1074/jbc.M116.724245; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan Q, 2006, KIDNEY INT, V69, P1207, DOI 10.1038/sj.ki.5000245; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Giampietro C, 2015, J CELL BIOL, V211, P1177, DOI 10.1083/jcb.201501089; Gruber R, 2015, AM J PATHOL, V185, P2777, DOI 10.1016/j.ajpath.2015.06.021; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Itoh M, 2018, GENES CELLS, V23, P546, DOI 10.1111/gtc.12598; Jim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036041; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Juhila J, 2010, AM J PATHOL, V176, P51, DOI 10.2353/ajpath.2010.080843; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim D, 2020, NAT MED, V26, P236, DOI 10.1038/s41591-019-0733-7; Kim SY, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9091264; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Li LF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00024; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu L, 2001, ACTA MED OKAYAMA, V55, P161; Lu XY, 2019, AM J PHYSIOL-RENAL, V317, pF1605, DOI 10.1152/ajprenal.00215.2019; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; Martin CE, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00302; McKelvey Kelly, 2014, World J Biol Chem, V5, P169, DOI 10.4331/wjbc.v5.i2.169; McMurray RJ, 2015, J TISSUE ENG REGEN M, V9, P528, DOI 10.1002/term.1957; Mo JS, 2017, BMB REP, V50, P71, DOI 10.5483/BMBRep.2017.50.2.199; Moll I, 1998, J INVEST DERMATOL, V111, P251, DOI 10.1046/j.1523-1747.1998.00265.x; Nair PR, 2019, J CELL BIOL, V218, P1092, DOI 10.1083/jcb.201902035; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Palmen T, 2001, DIABETOLOGIA, V44, P1274, DOI 10.1007/s001250100641; Pellegrini C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112485; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakabe M, 2017, P NATL ACAD SCI USA, V114, P10918, DOI 10.1073/pnas.1704030114; Schlondorff J, 2008, KIDNEY INT, V73, P524, DOI 10.1038/sj.ki.5002741; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Wagner N, 2011, HUM MOL GENET, V20, P2182, DOI 10.1093/hmg/ddr106; WEINSTEIN GD, 1984, J INVEST DERMATOL, V82, P623, DOI 10.1111/1523-1747.ep12261462; Yun BH, 2015, MOL MED REP, V12, P5116, DOI 10.3892/mmr.2015.4044; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	57	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22424	10.1096/fj.202100455RR	http://dx.doi.org/10.1096/fj.202100455RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2I4HG	35747929				2022-12-28	WOS:000814940600001
J	Migulina, N; Tjin, G; Faiz, A; Borghuis, T; Zhao, FH; Kaper, HJ; Metzlar, M; van Dijk, E; Sharma, PK; Timens, W; Gosens, R; Brandsma, CA; Burgess, JK				Migulina, Nataliya; Tjin, Gavin; Faiz, Alen; Borghuis, Theo; Zhao, Fenghua; Kaper, Hans J.; Metzlar, Marit; van Dijk, Eline; Sharma, Prashant K.; Timens, Wim; Gosens, Reinoud; Brandsma, Corry-Anke; Burgess, Janette K.			Differential roles for lysyl oxidase (like), family members in chronic obstructive pulmonary disease; from gene and protein expression to function	FASEB JOURNAL			English	Article						collagen; COPD; ECM; lysyl oxidase; smoking	COLLAGEN; LUNG; STIFFNESS; INHIBITION; EMPHYSEMA; LOX	Chronic obstructive pulmonary disease (COPD) is characterized by long-term airflow obstruction with cigarette smoke as a key risk factor. Extracellular matrix (ECM) alterations in COPD may lead to small airway wall fibrosis. Altered collagen cross-linking, potentially mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1-4), orchestrates disturbed ECM homeostasis. In this study, we investigated the effects of smoking status and presence and severity of COPD on LOs gene and protein expression in the airways and the impact of LOs inhibition on airway contraction in an ex vivo mouse model. We used gene expression data from bronchial brushings, airway smooth muscle (ASM) cells in vitro and immunohistochemistry in lung tissue to assess smoke- and COPD-associated differences in LOs gene and protein expression in the small airways. We found higher LOX expression in current- compared to ex-smokers and higher LOXL1 expression in COPD compared to non-COPD patients. LOX and LOXL2 expression were upregulated in COPD ASM cells treated with cigarette smoke extract. LOXL1 and LOXL2 protein levels were higher in small airways from current- compared to non-smokers. In COPD patients, higher LOXL1 and lower LOX protein levels were observed, but no differences for LOXL2, LOXL3, and LOXL4 protein were detected in small airways. Inhibiting LOs activity increased airway contraction in murine lung slices. COPD-associated changes in LOs, in particular LOX and LOXL1, may be related to smoking and contribute to impaired airway function, providing potential novel targets for preventing or treating small airways changes in COPD.	[Migulina, Nataliya; Faiz, Alen; Borghuis, Theo; Timens, Wim; Brandsma, Corry-Anke; Burgess, Janette K.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Dept Pathol & Med Biol, Groningen, Netherlands; [Tjin, Gavin] Woolcock Inst Med Res, Resp Cellular & Mol Biol, Sydney, NSW, Australia; [Tjin, Gavin] Univ Sydney, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia; [Tjin, Gavin] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia; [Faiz, Alen] Univ Technol Sydney, Fac Sci Resp Bioinformat & Mol Biol, Ultimo, NSW, Australia; [Zhao, Fenghua; Kaper, Hans J.; Sharma, Prashant K.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst Biomed Engn & Mat Sci FB41, Groningen, Netherlands; [Zhao, Fenghua; Kaper, Hans J.; Sharma, Prashant K.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn FB40, Groningen, Netherlands; [Metzlar, Marit; van Dijk, Eline; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Burgess, Janette K.] Univ Groningen, Univ Med Ctr Groningen, KOLFF Inst, Dept Pathol & Med Biol, Groningen, Netherlands; [Tjin, Gavin] St Vincents Inst Med Res, Fitzroy, Vic, Australia	University of Groningen; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; University of Technology Sydney; University of Groningen; University of Groningen; University of Groningen; University of Groningen; St. Vincent's Institute of Medical Research	Migulina, N (corresponding author), Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1,IPC EA11,Rm T2-212, NL-9713 GZ Groningen, Netherlands.	n.migulina@umcg.nl	Burgess, Janette/M-7117-2019; Faiz, Alen/HII-9884-2022; Timens, Wim/K-5570-2013	Faiz, Alen/0000-0003-1740-3538; Timens, Wim/0000-0002-4146-6363; Sharma, Prashant/0000-0002-8342-8939; Burgess, Janette/0000-0001-9868-9966	Stichting Astma Bestrijding [2015/035]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [015.013.010]; University of Groningen; European Union; UMCG; Noordelijke Cara Stichting	Stichting Astma Bestrijding; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Groningen; European Union(European Commission); UMCG; Noordelijke Cara Stichting	Stichting Astma Bestrijding, Grant/Award Number: 2015/035; Noordelijke Cara Stichting and Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 015.013.010; University of Groningen; European Union; UMCG	Abraham T, 2010, J STRUCT BIOL, V171, P189, DOI 10.1016/j.jsb.2010.04.006; Adler A, 1998, J APPL PHYSIOL, V85, P231, DOI 10.1152/jappl.1998.85.1.231; Annoni R, 2012, EUR RESPIR J, V40, P1362, DOI 10.1183/09031936.00192611; [Anonymous], 2016, GIL TERM PHAS 2 STUD; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; Besiktepe N, 2017, J TRACE ELEM MED BIO, V44, P247, DOI 10.1016/j.jtemb.2017.08.011; Bourke JE, 2014, AM J RESP CELL MOL, V50, P748, DOI 10.1165/rcmb.2013-0247OC; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065544; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Dutch federation of Biomedical Scientific Societies, COD COND; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eurlings IMJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-90; Ferreira S, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020312; Fischer RS, 2012, NAT PROTOC, V7, P2056, DOI 10.1038/nprot.2012.127; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Gao S, 2005, TOXICOL SCI, V87, P197, DOI 10.1093/toxsci/kfi212; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Groningen UMC, 2018, RES COD; Higham A, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1017-y; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; LAURENT GJ, 1986, THORAX, V41, P418, DOI 10.1136/thx.41.6.418; Li WD, 2011, INT J ENV RES PUB HE, V8, P161, DOI 10.3390/ijerph8010161; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smithen DA, 2020, J MED CHEM, V63, P2308, DOI 10.1021/acs.jmedchem.9b01112; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Tjin G, 2017, DIS MODEL MECH, V10, P1301, DOI 10.1242/dmm.030114; Tjin G, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036005; Toni LS, 2018, METHODSX, V5, P599, DOI 10.1016/j.mex.2018.05.011; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; World Health Organization, 2021, TOP 10 CAUS DEATH; Zhang W, 2018, ONCOTARGET, V9, P5480, DOI 10.18632/oncotarget.23869	38	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22374	10.1096/fj.202101553R	http://dx.doi.org/10.1096/fj.202101553R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1X9VS	35670745	Green Published			2022-12-28	WOS:000807796800001
J	Yamada, Y; Onda, T; Hagiuda, A; Kan, RJ; Matsunuma, M; Hamada, K; Kikkawa, Y; Nomizu, M				Yamada, Yuji; Onda, Toru; Hagiuda, Ayami; Kan, Ryuji; Matsunuma, Masumi; Hamada, Keisuke; Kikkawa, Yamato; Nomizu, Motoyoshi			RGDX(1)X(2) motif regulates integrin alpha v beta 5 binding for pluripotent stem cell adhesion	FASEB JOURNAL			English	Article						cell adhesion; induced pluripotent stem cell; integrin; RGD motif	RGD-CONTAINING PEPTIDES; SELF-RENEWAL; FIBRONECTIN; EXPRESSION; DESIGN; ALPHA-8-BETA-1; VITRONECTIN; CILENGITIDE; FIBRINOGEN; DERIVATION	The arginine-glycine-aspartic acid (RGD) motif is a cell adhesion sequence that binds to integrins. Some RGD-containing peptides promote adhesion of both embryonic stem cells and induced pluripotent stem cells (iPSCs); however, not all such RGD-containing peptides are active. In this study, we elucidated the role of RGD-neighboring sequences on iPSC adhesion using diverse synthetic peptides and recombinant proteins. Our results indicate that iPSC adhesion requires RGDX(1)X(2) sequences, such as RGDVF and RGDNY, and that the X1X2 residues are essential for the adhesion via integrin alpha v beta 5 but not alpha v beta 3. iPSCs express integrin alpha v beta 5 but not alpha v beta 3; therefore, iPSC adhesion requires the RGDX(1)X(2)-containing sequences. The importance of the X1X2 residues was confirmed with both HeLa and A549 cells, which express integrin alpha v beta 5 but not alpha v beta 3. Analysis of RGD-neighboring sequences provides important insights into ligand-binding specificity of integrins. Identification of integrin alpha v beta 5-binding motifs is potentially useful in drug development, drug delivery, cell culture, and tissue engineering.	[Yamada, Yuji; Onda, Toru; Hagiuda, Ayami; Kan, Ryuji; Matsunuma, Masumi; Hamada, Keisuke; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Yamada, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yuyamada@toyaku.ac.jp		Yamada, Yuji/0000-0003-2338-6906; Hamada, Keisuke/0000-0002-7774-0790	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP20K20204, JP20K07622, JP21K06563]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K20204; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K07622; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP21K06563	Aksorn N, 2019, ANTICANCER RES, V39, P541, DOI 10.21873/anticanres.13146; Alipour M, 2020, J BIOMED MATER RES A, V108, P839, DOI 10.1002/jbm.a.36862; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andronati SA, 2004, CURR MED CHEM, V11, P1183, DOI 10.2174/0929867043365314; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bachmann M, 2019, PHYSIOL REV, V99, P1655, DOI 10.1152/physrev.00036.2018; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001; Cheng Y, 2019, EUR J PHARM SCI, V128, P8, DOI 10.1016/j.ejps.2018.11.023; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dhavalikar P, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.202000795; Fabricius EM, 2011, EXP THER MED, V2, P9, DOI 10.3892/etm.2010.171; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hatley RJD, 2018, ANGEW CHEM INT EDIT, V57, P3298, DOI 10.1002/anie.201707948; Hayashi H, 2021, EXP CELL RES, V400, DOI 10.1016/j.yexcr.2020.112440; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Huang XZ, 1998, J CELL SCI, V111, P2189; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Li F, 2013, PATHOL RES PRACT, V209, P105, DOI 10.1016/j.prp.2012.11.001; Ludwig BS, 2021, CANCERS, V13, DOI 10.3390/cancers13071711; Magnussen SN, 2021, CANCERS, V13, DOI 10.3390/cancers13050959; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Mittelbronn M, 2013, HISTOL HISTOPATHOL, V28, P749, DOI 10.14670/HH-28.749; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Nader D, 2020, DRUG DISCOV TODAY, V25, P2317, DOI 10.1016/j.drudis.2020.09.038; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Noh K, 2017, CELL REP, V21, P2785, DOI 10.1016/j.celrep.2017.11.020; Park J, 2012, CANCER GENE THER, V19, P741, DOI 10.1038/cgt.2012.64; Pennington BO, 2015, STEM CELL TRANSL MED, V4, P165, DOI 10.5966/sctm.2014-0179; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Rubtsov MA, 2016, CURR PHARM DESIGN, V22, P925, DOI 10.2174/1381612822666151209153636; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2; Schittenhelm J, 2013, INT J CLIN EXP PATHO, V6, P2719; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Slack RJ, 2022, NAT REV DRUG DISCOV, V21, P60, DOI 10.1038/s41573-021-00284-4; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Sung TY, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00561-0; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yamada S, 1995, CELL ADHES COMMUN, V3, P311, DOI 10.3109/15419069509081016; Yamada Y, 2019, ACS APPL MATER INTER, V11, P34688, DOI 10.1021/acsami.9b12152; Yamada Y, 2020, BIOMACROMOLECULES, V21, P3765, DOI 10.1021/acs.biomac.0c00871; Zhou P, 2018, COLLOID SURFACE B, V171, P451, DOI 10.1016/j.colsurfb.2018.07.050	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22389	10.1096/fj.202200317R	http://dx.doi.org/10.1096/fj.202200317R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1U6IW	35657599				2022-12-28	WOS:000805515000001
J	Tian, Y; Sun, P; Liu, WX; Shan, LY; Hu, YT; Fan, HT; Shen, W; Liu, YB; Zhou, Y; Zhang, T				Tian, Yu; Sun, Peng; Liu, Wen-Xiang; Shan, Li-Ying; Hu, Yan-Ting; Fan, Hai-Tao; Shen, Wei; Liu, Yong-bin; Zhou, Yang; Zhang, Teng			Single-cell RNA sequencing of the Mongolia sheep testis reveals a conserved and divergent transcriptome landscape of mammalian spermatogenesis	FASEB JOURNAL			English	Article						developmental trajectories; mongolia Sheep; spermatogenesis; single-cell transcriptome	SPERMATOGONIAL STEM-CELLS; SEMINIFEROUS EPITHELIUM; CYCLE; EXPRESSION; DELETION; PATHWAY; COMPLEX; TEX101; ATLAS; MICE	Spermatogenesis is a highly coordinated and complex process, and is pivotal for transmitting genetic information between mammalian generations. In this study, we investigated the conservation, differences, and biological functions of homologous genes during spermatogenesis in Mongolia sheep, humans, cynomolgus monkey, and mice using single-cell RNA sequencing technology. We compared X chromosome meiotic inactivation events in Mongolia sheep, humans, cynomolgus monkey, and mice to uncover the concerted activity of X chromosome genes. Subsequently, we focused on the dynamics of gene expression, key biological functions, and signaling pathways at various stages of spermatogenesis in Mongolia sheep and humans. Additionally, the ligand-receptor networks of Mongolia sheep and humans in testicular somatic and germ cells at different developmental stages were mapped to reveal conserved germ cell-soma communication using single-cell resolution. These datasets provided novel information and insights to unravel the molecular regulatory mechanisms of Mongolia sheep spermatogenesis and highlight conservation in gene expression during spermatogenesis between Mongolia sheep and humans, providing a foundation for the establishment of a large mammalian disease model of male infertility.	[Tian, Yu; Sun, Peng; Liu, Wen-Xiang; Shan, Li-Ying; Hu, Yan-Ting; Fan, Hai-Tao; Liu, Yong-bin; Zhou, Yang; Zhang, Teng] Inner Mongolia Univ, Coll Life Sci, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot 010010, Peoples R China; [Sun, Peng] Inner Mongolia Med Univ, Coll Basic Med, Lab Microbiol & Immunol, Hohhot, Peoples R China; [Shen, Wei] Qingdao Agr Univ, Coll Life Sci, Inst Reprod Sci, Qingdao, Peoples R China; [Liu, Yong-bin] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia Medical University; Qingdao Agricultural University	Zhou, Y; Zhang, T (corresponding author), Inner Mongolia Univ, Coll Life Sci, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot 010010, Peoples R China.	zhouyang106@126.com; zhangteng428@163.com			National Natural Science Foundation of China [32000582, 31900595]; Science and Technology Major Project of Inner Mongolia Autonomous Region of China; State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock [2019ZD031, 2021ZD0048]; Major science and technology projects of Inner Mongolia [2020ZD0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project of Inner Mongolia Autonomous Region of China; State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock; Major science and technology projects of Inner Mongolia	This study was supported by the National Natural Science Foundation of China (32000582 to TZ; 31900595 to YZ), the Science and Technology Major Project of Inner Mongolia Autonomous Region of China to the State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock (2019ZD031 to TZ and 2021ZD0048 to YZ), the Major science and technology projects of Inner Mongolia (2020ZD0003 to YL)	Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655; Banin E, 2015, MOL THER, V23, P1423, DOI 10.1038/mt.2015.114; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Deng XX, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.557341; Ernst C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09182-1; Fainberg J., 2019, F1000RES, V8, P1; Fayomi AP, 2018, STEM CELL RES, V29, P207, DOI 10.1016/j.scr.2018.04.009; Franca LR, 1998, BIOL REPROD, V59, P1371, DOI 10.1095/biolreprod59.6.1371; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Guan YJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3385-8; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hochereau-de Reviers M T, 1987, J Reprod Fertil Suppl, V34, P101; Huang SS, 2017, ASIAN J ANDROL, V19, P619, DOI 10.4103/1008-682X.194420; Jia WY, 2017, LIFE SCI, V186, P1, DOI 10.1016/j.lfs.2017.07.025; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Lau XZ, 2020, DEV CELL, V54, P548, DOI 10.1016/j.devcel.2020.07.018; Li SY, 2017, MOL CELL, V68, P605, DOI 10.1016/j.molcel.2017.10.009; Liu ZS, 2019, NAT IMMUNOL, V20, P18, DOI 10.1038/s41590-018-0262-4; March MR, 2002, CONTRACEPTION, V65, P279, DOI 10.1016/S0010-7824(02)00296-2; Marshall GR, 1996, BIOL REPROD, V54, P1192, DOI 10.1095/biolreprod54.6.1192; Martianov I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32069; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Morton JD, 2013, INVEST OPHTH VIS SCI, V54, P389, DOI 10.1167/iovs.12-11088; Nayernia K, 2002, MOL CELL BIOL, V22, P3046, DOI 10.1128/MCB.22.9.3046-3052.2002; Nixon B, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00319; Olofsson SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121300; PANIAGUA R, 1987, ANAT EMBRYOL, V176, P225, DOI 10.1007/BF00310055; Pinnapureddy AR, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0327-5; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rolland AD, 2013, HUM REPROD, V28, P199, DOI 10.1093/humrep/des360; Sethi G, 2015, MOL CARCINOGEN, V54, P1772, DOI 10.1002/mc.22249; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; Staub C, 2018, ANIMAL, V12, pS27, DOI [10.1017/S1751731118000435, 10.1017/s1751731118000435]; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Wang X, 2020, ADV CLIN CHEM, V98, P51, DOI 10.1016/bs.acc.2020.02.003; Wang YT, 2012, J BIOL CHEM, V287, P34626, DOI 10.1074/jbc.M112.390401; Wood AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6467; WROBEL KH, 1995, ANN ANAT, V177, P19, DOI 10.1016/S0940-9602(11)80126-3; Wu Y, 2022, CURR ISSUES MOL BIOL, V44, P483, DOI 10.3390/cimb44020033; YANG H, 2021, FASEB J OFFICIAL PUB, V0035; Yu XW, 2021, ZOOL RES, V42, P401, DOI 10.24272/j.issn.2095-8137.2020.373; Zhang T, 2022, GUT, V71, P78, DOI 10.1136/gutjnl-2020-323347; Zhang T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006293; Zheng X, 2018, BIOCHEM BIOPH RES CO, V503, P572, DOI 10.1016/j.bbrc.2018.06.011; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003; Zhu FX, 2016, AM J HUM GENET, V99, P942, DOI 10.1016/j.ajhg.2016.08.004	60	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22348	10.1096/fj.202200152R	http://dx.doi.org/10.1096/fj.202200152R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1I2NA	35583907				2022-12-28	WOS:000797069600001
J	Wang, SH; Liu, MF; Li, XJ; Zhang, J; Wang, FP; Zhang, CJ; Roden, A; Ryu, JH; Warrington, KJ; Sun, J; Matteson, EL; Tschumperlin, DJ; Vassallo, R				Wang, Shaohua; Liu, Mengfei; Li, Xiujuan; Zhang, Jie; Wang, Faping; Zhang, Chujie; Roden, Anja; Ryu, Jay H.; Warrington, Kenneth J.; Sun, Jie; Matteson, Eric L.; Tschumperlin, Daniel J.; Vassallo, Robert			Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; interstitial lung disease; Janus kinase 2; rheumatoid arthritis; STAT3 transcription factor; STAT5 transcription factor	INHIBITOR AZD1480; HISTONE H3Y41; JAK/STAT; MUTATION; PATHWAY; MECHANISMS; MODELS	Idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis-associated interstitial lung disease (RA-ILD) are two fibrotic interstitial lung diseases that share the usual interstitial pneumonia (UIP) injury pattern. Here, we report that RNA sequencing of lung biopsies from patients with RA-ILD and IPF revealed shared and distinct disease-causing pathways. Analysis of transcriptomic data identified a JAK2 related JAK/STAT signaling pathway gene signature that distinguishes RA-UIP from idiopathic UIP. This was further confirmed by immunohistostaining, which identified JAK2 phosphorylation with two distinct forms of activation: a cytoplasmic form of JAK2 activation in most IPF cases (13/20) and a nuclear form of p-JAK2 in RA-UIP (5/5) and a minority of IPF (6/20) cases. Further immunohistostaining identified STAT5A&B as the downstream transcriptional activator for JAK2-mediated canonical signal transduction and phosphorylation of Tyr41 on histone H3 (H3Y41ph) as the downstream epigenetic regulation site for JAK2-mediated noncanonical signal transduction. Gene Set Enrichment Analysis (GSEA) of the RNA-Seq data further supported this shared pathogenic mechanism for the two diseases with the enrichment of STAT5A&B target gene sets as well as the JAK2 regulated H3Y41ph target gene set. This regulatory role of JAK2 in the pathogenesis of pulmonary fibrosis was further demonstrated by the attenuation of bleomycin-induced murine pulmonary fibrosis using a JAK2-selective pharmacological inhibitor CEP33779. In vitro studies with normal and IPF derived lung fibroblasts revealed a central role for JAK2 as an essential intermediary molecule in TGF-beta-mediated myofibroblast trans-differentiation, proliferation, and extracellular matrix protein production. These observations support a crucial role for JAK2 as an intermediary molecule in fibrotic lung disease development.	[Wang, Shaohua; Zhang, Chujie; Ryu, Jay H.; Sun, Jie; Vassallo, Robert] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Coll Med & Sci, Rochester, MN 55902 USA; [Liu, Mengfei] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Coll Med & Sci, Rochester, MN USA; [Li, Xiujuan] Chongqing Med Univ, Dept Med, Div Endocrinol, Affiliated Hosp 1, Chongqing, Peoples R China; [Zhang, Jie] Chongqing Gen Hosp, Dept Med, Div Pulm Med, Chongqing, Peoples R China; [Wang, Faping] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Peoples R China; [Roden, Anja] Mayo Clin, Dept Lab Med & Pathol, Coll Med & Sci, Rochester, MN USA; [Warrington, Kenneth J.; Matteson, Eric L.] Mayo Clin, Dept Hlth Sci Res, Div Rheumatol, Coll Med & Sci, Rochester, MN USA; [Tschumperlin, Daniel J.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med & Sci, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Chongqing Medical University; Sichuan University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Vassallo, R (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Coll Med & Sci, Rochester, MN 55902 USA.	vassallo.robert@mayo.edu	Liu, Meng/GRF-0962-2022; Warrington, Kenneth/CAG-1626-2022; li, xiu/GXV-1745-2022		Rheumatology Research Foundation (RRF); Mayo Clinic (The Mayo Clinic); Pfizer	Rheumatology Research Foundation (RRF); Mayo Clinic (The Mayo Clinic); Pfizer(Pfizer)	Rheumatology Research Foundation (RRF); Mayo Clinic (The Mayo Clinic); Pfizer	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Ballester B, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA4902; Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9; Barahmand-Pour F, 1998, J BIOL CHEM, V273, P12567, DOI 10.1074/jbc.273.20.12567; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bousoik E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00287; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Dawson MA, 2012, CELL REP, V2, P470, DOI 10.1016/j.celrep.2012.08.016; Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448; Feldman AL, 2013, GENE CHROMOSOME CANC, V52, P1097, DOI 10.1002/gcc.22104; Fisher Mark, 2017, J Manag Care Spec Pharm, V23, pS17, DOI 10.18553/jmcp.2017.23.3-b.s17; Fragoulis GE, 2019, RHEUMATOLOGY, V58, P43, DOI 10.1093/rheumatology/key276; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jayatilaka Hasini, 2018, Oncotarget, V9, P32556, DOI 10.18632/oncotarget.25863; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee KJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228640; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu F, 2015, MOL MED REP, V12, P5455, DOI 10.3892/mmr.2015.4050; Liu YD, 2014, J IMMUNOL, V192, P59, DOI 10.4049/jimmunol.1301513; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; McInnes IB, 2017, LANCET, V389, P2328, DOI 10.1016/S0140-6736(17)31472-1; Milara J, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0728-9; Montero P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126211; Noble PW, 2008, EUR RESPIR REV, V17, P123, DOI 10.1183/09059180.00010904; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Paulin F, 2015, REV INVEST CLIN, V67, P280; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rajasekaran S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00254; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Shkumatov A., 2015, AM J PHYSIOL-LUNG C, V308; Stump KL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3329; Talotta R, 2021, IMMUNOTHERAPY-UK, V13, P241, DOI 10.2217/imt-2020-0270; Verstovsek S, 2015, LEUKEMIA RES, V39, P157, DOI 10.1016/j.leukres.2014.11.018; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Zhang J, 2019, AM J PHYSIOL-LUNG C, V316, pL487, DOI 10.1152/ajplung.00301.2018; Zouein FA, 2011, GROWTH FACTORS, V29, P245, DOI 10.3109/08977194.2011.614949	48	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22336	10.1096/fj.202101436R	http://dx.doi.org/10.1096/fj.202101436R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1A0VC	35522243				2022-12-28	WOS:000791483600001
J	Kutil, Z; Meleshin, M; Baranova, P; Havlinova, B; Schutkowski, M; Barinka, C				Kutil, Zsofia; Meleshin, Marat; Baranova, Petra; Havlinova, Barbora; Schutkowski, Mike; Barinka, Cyril			Characterization of the class IIa histone deacetylases substrate specificity	FASEB JOURNAL			English	Article						class IIa histone deacetylases; deacetylation; peptide library; sequence specificity; substrates	CONTROLS CHONDROCYTE HYPERTROPHY; CATALYTIC-ACTIVITY; ACETYLATION; H3; PHOSPHORYLATION; PROTEINS; SIR3	Class IIa histone deacetylases (HDACs) play critical roles in vertebrate development and physiology, yet direct evidence of their intrinsic deacetylase activity and on substrate specificity regarding the peptide sequence is still missing. In this study, we designed and synthesized a combinatorial peptide library allowing us to profile class IIa HDACs sequence specificity at positions +3 through -3 from the central lysine modified by the well-accepted trifluoroacetyl function. Our data revealed a strong preference for bulky aromatic acids directly flanking the central trifluoroacetyllysine, while all class IIa HDACs disfavor positively charged residues and proline at the +1/-1 positions. The chemical nature of amino acid residues N-terminally to the central trifluoroacetyllysine has a more profound effect on substrate recognition as compared to residues located C-terminally. These findings were validated by designing selected favored and disfavored peptide sequences, with the favored ones are accepted with catalytic efficacy of 75 000 and 525 000 M-1 s(-1) for HDAC7 and HDAC5, respectively. Results reported here could help in developing class IIa HDACs inhibitors and also in the search for new natural class IIa HDACs substrates.	[Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, Inst Biotechnol, BIOCEV, Vestec, Czech Republic; [Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Martin Luther University Halle Wittenberg	Schutkowski, M (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany.; Barinka, C (corresponding author), Inst Biotechnol, Lab Struct Biol, Prumyslova 595, Vestec 25250, Czech Republic.	mike.schutkowski@biochemtech.uni-halle.de; cyril.barinka@ibt.cas.cz		Kutil, Zsofia/0000-0001-9936-9518	CAS [86652036]; Grantova Agentura Ceske Republiky (GACR) [21-31806]	CAS(Chinese Academy of Sciences); Grantova Agentura Ceske Republiky (GACR)(Grant Agency of the Czech Republic)	CAS, Grant/Award Number: RVO and 86652036; Grantova Agentura Ceske Republiky (GACR), Grant/Award Number: 21-31806	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kutil Z, 2019, FASEB J, V33, P4035, DOI 10.1096/fj.201801680R; Kutil Z, 2018, ACS CHEM BIOL, V13, P685, DOI 10.1021/acschembio.7b00942; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liokatis S, 2012, NAT STRUCT MOL BIOL, V19, P819, DOI 10.1038/nsmb.2310; Liu NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16869; Luo LQ, 2019, CELL REP, V29, P749, DOI 10.1016/j.celrep.2019.09.023; Masch A., 2015, EPIGENETIC TECHNOLOG, P169; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Moreno-Yruela C, 2018, CELL CHEM BIOL, V25, P849, DOI 10.1016/j.chembiol.2018.04.007; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Toro TB, 2021, BIOCHEMISTRY-US, V60, P2524, DOI 10.1021/acs.biochem.1c00384; Toro TB, 2020, FASEB J, V34, P13140, DOI 10.1096/fj.202001301RR; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Zessin M, 2019, BIOCHEMISTRY-US, V58, P4777, DOI 10.1021/acs.biochem.9b00786; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8	36	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22287	10.1096/fj.202101663R	http://dx.doi.org/10.1096/fj.202101663R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0G8CR	35349187				2022-12-28	WOS:000778267400001
J	Cao, YQ; Zhu, SX; Yu, B; Yao, C				Cao, Yuqi; Zhu, Shunxing; Yu, Bin; Yao, Chun			Single-cell RNA sequencing for traumatic spinal cord injury	FASEB JOURNAL			English	Review						intercellular communication; microenvironment; single-cell RNA sequencing; spatial transcriptomics; traumatic spinal cord injury	GENOME-WIDE EXPRESSION; GENE-EXPRESSION; INFLAMMATORY RESPONSE; SEQ; RAT; TRANSPLANTATION; ARCHITECTURE; MACROPHAGES; MICROGLIA; DEFINES	Traumatic spinal cord injury (tSCI) is a severe injury of the central nervous system (CNS) with complicated pathological microenvironment that results in hemorrhage, inflammation, and scar formation. The microenvironment of the injured spinal cord comprises heterogeneous neurons, glial cells, inflammatory cells, and stroma-related cells. Increasing evidence has indicated that the altered cellular and molecular microenvironment following tSCI is a key factor impeding functional recovery. Single-cell RNA sequencing (scRNA-seq) has provided deep insights into the dynamic cellular and molecular changes in the microenvironment by comprehensively characterizing the diversity of spinal cord cell types. Specifically, scRNA-seq enables the exploration of the molecular mechanisms underlying tSCI by elucidating intercellular communication in spinal cord samples between normal and injury conditions at a single-cell resolution. Here, we first described the pathological and physiological processes after tSCI and gave a brief introduction of the scRNA-seq technology. We then focused on the recent scRNA-seq researches in tSCI, which characterized diverse cell-type populations and specific cell-cell interactions in tSCI. In addition, we also highlighted some potential directions for the research of scRNA-seq in tSCI in the future.	[Cao, Yuqi; Yu, Bin; Yao, Chun] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Cao, Yuqi; Yu, Bin; Yao, Chun] Nantong Univ, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Minist Educ, Nantong, Peoples R China; [Zhu, Shunxing] Nantong Univ, Lab Anim Ctr, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Yao, C (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.; Yao, C (corresponding author), Nantong Univ, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Minist Educ, Nantong, Peoples R China.; Zhu, SX (corresponding author), Nantong Univ, Lab Anim Ctr, Nantong, Peoples R China.	zsx@ntu.edu.cn; yaochun@ntu.edu.cn			National Key R&D Program of China [2020YFA0113600]; Collegiate Natural Science Fund of Jiangsu Province [22KJA180002]	National Key R&D Program of China; Collegiate Natural Science Fund of Jiangsu Province	The National Key R&D Program of China, Grant/Award Number: 2020YFA0113600; Collegiate Natural Science Fund of Jiangsu Province, Grant/Award Number: 22KJA180002	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Alcantar-Garibay Oscar V, 2022, Neural Regen Res, V17, P2649, DOI 10.4103/1673-5374.339475; An XL, 2018, METHODS MOL BIOL, V1698, P153, DOI 10.1007/978-1-4939-7428-3_9; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Badhiwala JH, 2019, J NEUROSURG-SPINE, V30, P1, DOI 10.3171/2018.9.SPINE18682; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Blum JA, 2022, TRENDS GENET, V38, P904, DOI 10.1016/j.tig.2022.03.016; Blum JA, 2021, NAT NEUROSCI, V24, P572, DOI 10.1038/s41593-020-00795-0; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Brennan FH, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31797-0; Brennan FH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98254; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chamankhah M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-583; Chen G, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00317; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Darman J, 2004, J NEUROSCI, V24, P7566, DOI 10.1523/JNEUROSCI.2002-04.2004; David G, 2019, NAT REV NEUROL, V15, P718, DOI 10.1038/s41582-019-0270-5; Delile J, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.173807; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; Ding J, 2020, NAT BIOTECHNOL, V38, P737, DOI 10.1038/s41587-020-0465-8; Dong YF, 2021, NAT NEUROSCI, V24, P489, DOI 10.1038/s41593-021-00801-z; Dorrier CE, 2021, NAT NEUROSCI, V24, P234, DOI 10.1038/s41593-020-00770-9; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fan BY, 2018, CELL TRANSPLANT, V27, P853, DOI 10.1177/0963689718755778; Filipp ME, 2019, NEURAL REGEN RES, V14, P7, DOI 10.4103/1673-5374.243694; Golestani A, 2022, NEUROEPIDEMIOLOGY, V56, P219, DOI 10.1159/000524867; Gong LL, 2022, NEUROSCI BULL, DOI 10.1007/s12264-022-00897-8; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Guerout N, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081886; Hakim R, 2021, J NEUROSCI, V41, P8441, DOI 10.1523/JNEUROSCI.0860-21.2021; Haring M, 2018, NAT NEUROSCI, V21, P869, DOI 10.1038/s41593-018-0141-1; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hildreth AD, 2021, NAT IMMUNOL, V22, P639, DOI 10.1038/s41590-021-00922-4; Hou JX, 2022, FASEB J, V36, DOI 10.1096/fj.202200463R; Jin LJ, 2014, MOL BIOL REP, V41, P3169, DOI 10.1007/s11033-014-3176-8; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Koffler J, 2019, NAT MED, V25, P263, DOI 10.1038/s41591-018-0296-z; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Laredo F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00546; Le Gac S, 2017, MOL HUM REPROD, V23, P213, DOI 10.1093/molehr/gaw061; Li C, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00885-4; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Li Y, 2020, NATURE, V587, P613, DOI 10.1038/s41586-020-2795-6; Liao J, 2021, TRENDS BIOTECHNOL, V39, P43, DOI 10.1016/j.tibtech.2020.05.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Louis DN, 2021, NEURO-ONCOLOGY, V23, P1231, DOI 10.1093/neuonc/noab106; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maniatis S, 2019, SCIENCE, V364, P89, DOI 10.1126/science.aav9776; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mereu E, 2020, NAT BIOTECHNOL, V38, P747, DOI 10.1038/s41587-020-0469-4; Milich Lindsay M, 2021, J Exp Med, V218, DOI 10.1084/jem.20210040; Moffitt JR, 2016, METHOD ENZYMOL, V572, P1, DOI 10.1016/bs.mie.2016.03.020; Moor AE, 2017, CURR OPIN BIOTECH, V46, P126, DOI 10.1016/j.copbio.2017.02.004; Ni J, 2020, ACTA BIOCH BIOPH SIN, V52, P457, DOI 10.1093/abbs/gmaa007; Noristani HN, 2017, FRONT AGING NEUROSCI, V9, DOI [10.3389/fnagi.2017.00227, 10.3389/fnagi.2017.00230]; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rao A, 2021, NATURE, V596, P211, DOI 10.1038/s41586-021-03634-9; Rao DA, 2020, NAT REV NEPHROL, V16, P238, DOI 10.1038/s41581-019-0232-6; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Sathyamurthy A, 2018, CELL REP, V22, P2216, DOI 10.1016/j.celrep.2018.02.003; SCHNEIDER RC, 1958, J NEUROL NEUROSUR PS, V21, P216, DOI 10.1136/jnnp.21.3.216; Selewa A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58327-6; Shi LL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3532-x; Shu MY, 2022, SCI CHINA LIFE SCI, V65, P295, DOI 10.1007/s11427-020-1930-0; Song BG, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116218; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Sun JJ, 2022, CELL MOL NEUROBIOL, V42, P2629, DOI 10.1007/s10571-021-01159-3; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Valdebenito-Maturana B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222413623; Vallejos CA, 2017, NAT METHODS, V14, P565, DOI [10.1038/NMETH.4292, 10.1038/nmeth.4292]; Venkatesh K, 2019, CELL TISSUE RES, V377, P125, DOI 10.1007/s00441-019-03039-1; Vickovic S, 2019, NAT METHODS, V16, P987, DOI 10.1038/s41592-019-0548-y; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Wang HF, 2017, NEURAL REGEN RES, V12, P1724, DOI 10.4103/1673-5374.217354; Wang JY, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04864-z; Wang JJ, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.720271; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Watanabe T, 1999, J NEUROTRAUM, V16, P255, DOI 10.1089/neu.1999.16.255; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wu HJ, 2019, J AM SOC NEPHROL, V30, P23, DOI 10.1681/ASN.2018090912; Yao C, 2022, FASEB J, V36, DOI 10.1096/fj.202200337R; Zhang Q, 2021, EMBO REP, V22, DOI 10.15252/embr.202152728	102	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22656	10.1096/fj.202200943R	http://dx.doi.org/10.1096/fj.202200943R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SF	36374259				2022-12-28	WOS:000883024100001
J	Saha, S; Bose, R; Chakraborty, S; Ain, R				Saha, Sarbani; Bose, Rumela; Chakraborty, Shreeta; Ain, Rupasri			Tipping the balance toward stemness in trophoblast: Metabolic programming by Cox6B2	FASEB JOURNAL			English	Article						CDX2; differentiation; miRNA; mitochondria; self-renewal; stem cell	CYTOCHROME-C-OXIDASE; SUBUNIT-VIB; CELL-PROLIFERATION; GROWTH; DIFFERENTIATION; TROPHECTODERM; FATE	Metabolic effector(s) driving cell fate is an emerging concept in stem cell biology. Here we showed that Cytochrome C Oxidase Subunit 6B2 (Cox6B2) is essential to maintain the stemness of trophoblast stem (TS) cells. RNA interference of Cox6b2 resulted in decreased mitochondrial Complex IV activity, ATP production, and oxygen consumption rate in TS cells. Furthermore, depletion of Cox6b2 in TS cells led to decreased self-renewal capacity indicated by compromised BrdU incorporation, Ki67 staining, and decreased expression of TS cell genetic markers. As expected, the consequence of Cox6b2 knockdown was the induction of differentiation. TS cell stemness factor CDX2 transactivates Cox6b2 promoter in TS cells. In differentiated cells, Cox6b2 is post-transcriptionally regulated by two microRNAs, miR-322-5p and miR-503-5p, leading to its downregulation as demonstrated by the gain-in or loss of function of these miRNAs. Cox6b2 transcripts gradually rise in placental trophoblast gestation progresses in both mice and rats with predominant expression in labyrinthine trophoblast. Cox6b2 expression is compromised in the growth-restricted placenta of rats with reciprocal up-regulation of miR-322-5p and miR-503-5p. These data highlight the importance of Cox6B2 in the regulation of TS cell state and uncompromised placental growth.	[Saha, Sarbani; Bose, Rumela; Chakraborty, Shreeta; Ain, Rupasri] CSIR Indian Inst Chem Biol, Div Cell Biol & Physiol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Chakraborty, Shreeta] NICHHD, Bethesda, MD 20892 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ain, R (corresponding author), CSIR Indian Inst Chem Biol, Div Cell Biol & Physiol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	rupasri@iicb.res.in	Ain, Rupasri/HHS-4162-2022		Council of Scientific and Industrial Research, India (CSIR) [BSC0206]	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research, India (CSIR), Grant/Award Number: BSC0206	Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; Amin S, 2016, CELL REP, V17, P3165, DOI 10.1016/j.celrep.2016.11.069; Baines KJ, 2017, PROG MOL BIOL TRANSL, V145, P39, DOI 10.1016/bs.pmbts.2016.12.003; Basak T, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02844-w; Basak T, 2021, STEM CELLS, V39, P210, DOI 10.1002/stem.3305; Bhattacharya D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00480; Chakraborty S, 2020, STEM CELLS DEV, V29, P682, DOI 10.1089/scd.2019.0296; Chakraborty S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26590-3; Chakraborty S, 2017, J BIOL CHEM, V292, P6600, DOI 10.1074/jbc.M116.742627; Cheng CC, 2020, ELIFE, V9, DOI 10.7554/eLife.58108; COPP AJ, 1979, J EMBRYOL EXP MORPH, V51, P109; Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Latos PA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8776; Lees JG, 2015, REPRODUCTION, V150, P367, DOI 10.1530/REP-14-0633; Long JT, 2015, TUMOR BIOL, V36, P8697, DOI 10.1007/s13277-015-3623-8; Mahato B, 2014, STEM CELLS, V32, P2880, DOI 10.1002/stem.1817; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Maxfield KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9840; Nie K, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0231-2; Peng Y, 2014, ONCOL LETT, V7, P1233, DOI 10.3892/ol.2014.1868; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saha S, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000674; Saha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16566-0; Saha S, 2015, MOL CELL ENDOCRINOL, V414, P186, DOI 10.1016/j.mce.2015.07.030; Sampson V, 2001, EUR J BIOCHEM, V268, P6534, DOI 10.1046/j.0014-2956.2001.02608.x; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TAANMAN JW, 1991, GENE, V102, P237, DOI 10.1016/0378-1119(91)90083-N; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Todd LR, 2010, MOL BIOL CELL, V21, P1225, DOI 10.1091/mbc.E09-11-0937; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; WEISHAUPT A, 1992, BIOCHEMISTRY-US, V31, P11477, DOI 10.1021/bi00161a028; Xiao FQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-195; Yang H, 2015, ONCOTARGET, V6, P27736, DOI 10.18632/oncotarget.4811	36	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22600	10.1096/fj.202200703RR	http://dx.doi.org/10.1096/fj.202200703RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0WI	36250984				2022-12-28	WOS:000868767500001
J	Shi, K; Li, YQ; Yang, L; Zhang, ZC; Guo, D; Zhang, JZ; Lu, YC				Shi, Ke; Li, Yueqi; Yang, Liang; Zhang, Zichao; Guo, Dan; Zhang, Jinzhong; Lu, Yucheng			Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing	FASEB JOURNAL			English	Article						cell communication; ESCC; heterogeneity; single-cell RNA sequencing; transcriptomic signatures; tumor microenvironment	EPCAM	Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignancies with complex tumor microenvironment (TME) which has been proven to be associated with therapeutic failure or resistance. A deeper understanding of the complex TME and cellular heterogeneity is urgently needed in ESCC. Here, we generated single-cell RNA sequencing (scRNA-seq) of 25 796 immune and 8197 non-immune cells from three primary tumor and paired normal samples in ESCC patients. The results revealed intratumoral and intertumoral epithelium heterogeneity and tremendously differences in tumor and normal epithelium. The infiltration of myofibroblasts, one subtype of fibroblasts, might play important roles in the progression of ESCC. We also found that some differentially expressed genes and markers in epithelium and fibroblast subtypes showed prognostic values for ESCC. Diverse cell subtypes of T cells and myeloid cells were identified, including tumor-enriched HAVCR2(+) CD4(+) T cells with significantly exhausted signature. The epithelium and myeloid cells had more frequent cell-cell communication compared with epithelium and T cells. Taken together, this study provided in-depth insights into the cellular heterogeneity of TME in ESCC and highlighted potential therapeutic targets including for immunotherapy.	[Shi, Ke; Yang, Liang; Guo, Dan; Zhang, Jinzhong] Henan Med Coll, Dept Biochem & Med Genet, Zhengzhou 451191, Henan, Peoples R China; [Li, Yueqi] Zhengzhou Univ, Sch Med, Dept Clin Med, Zhengzhou, Peoples R China; [Zhang, Zichao] Linyi Hlth Sch Shandong Prov, Linyi, Shandong, Peoples R China; [Zhang, Zichao] Linyi Peoples Hosp, Dept Thorac Surg, Linyi, Shandong, Peoples R China; [Lu, Yucheng] Linyi Peoples Hosp, Biobank, Linyi 276002, Shandong, Peoples R China; [Lu, Yucheng] Linyi Peoples Hosp, Cent Lab, Linyi, Shandong, Peoples R China	Henan Medical College; Zhengzhou University	Zhang, JZ (corresponding author), Henan Med Coll, Dept Biochem & Med Genet, Zhengzhou 451191, Henan, Peoples R China.; Lu, YC (corresponding author), Linyi Peoples Hosp, Biobank, Linyi 276002, Shandong, Peoples R China.	jinzhongzhang1@163.com; luyu-20@163.com			Key Research Projects of Henan Higher Education Institutions [23A320068]; Young Backbone Teachers of Higher Vocational Schools of Henan Province [2019GZGG087]; Scientific and Technological Project of Henan Province [192102310110, 212102310684]; Medical and Health Science and Technology Development Project of Shandong Province [2019WS125]	Key Research Projects of Henan Higher Education Institutions; Young Backbone Teachers of Higher Vocational Schools of Henan Province; Scientific and Technological Project of Henan Province; Medical and Health Science and Technology Development Project of Shandong Province	Key Research Projects of Henan Higher Education Institutions, Grant/Award Number: 23A320068; Young Backbone Teachers of Higher Vocational Schools of Henan Province, Grant/Award Number: 2019GZGG087; Scientific and Technological Project of Henan Province, Grant/Award Number: 192102310110 and 212102310684; Medical and Health Science and Technology Development Project of Shandong Province, Grant/Award Number: 2019WS125	Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Bozzi F, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0475-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Chen YP, 2020, CELL RES, V30, P1024, DOI 10.1038/s41422-020-0374-x; Chen ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18916-5; Chen ZC, 2021, EBIOMEDICINE, V69, DOI 10.1016/j.ebiom.2021.103459; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Dong DZ, 2021, CANCER RES, V81, P910, DOI 10.1158/0008-5472.CAN-20-0912; Du XL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2114-z; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanley CJ, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx121; Hornburg M, 2021, CANCER CELL, V39, P928, DOI 10.1016/j.ccell.2021.04.004; Jiang YY, 2020, GASTROENTEROLOGY, V159, P1311, DOI 10.1053/j.gastro.2020.06.050; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; Kieffer Y, 2020, CANCER DISCOV, V10, P1330, DOI 10.1158/2159-8290.CD-19-1384; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin W, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00776-9; Liu RM, 2018, CANCER LETT, V412, P289, DOI 10.1016/j.canlet.2017.10.018; Lu ZL, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.459; Matsuda T, 2014, ANN SURG ONCOL, V21, P356, DOI 10.1245/s10434-014-3579-8; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pelon F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14134-w; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Penticuff JC, 2019, NAT REV UROL, V16, P318, DOI 10.1038/s41585-019-0171-9; Qiao Y, 2018, ONCOGENE, V37, P873, DOI 10.1038/onc.2017.387; Ren Y, 2005, ANN SURG, V242, P55, DOI 10.1097/01.sla.0000168555.97710.bb; Sathe A, 2020, CLIN CANCER RES, V26, P2640, DOI 10.1158/1078-0432.CCR-19-3231; Thrift AP, 2021, NAT REV GASTRO HEPAT, V18, P432, DOI 10.1038/s41575-021-00419-3; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Wang W, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.253; Wang Y, 2020, THERANOSTICS, V10, P11535, DOI 10.7150/thno.45261; Wu Z, 2021, NAT GENET, V53, P881, DOI 10.1038/s41588-021-00859-2; Yang H, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01165-x; Yang YM, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00323-3; Yao JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17492-y; Zhang HF, 2019, CLIN CANCER RES, V25, P1989, DOI 10.1158/1078-0432.CCR-18-0773; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang XN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25539-x; Zheng YX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20019-0	45	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22620	10.1096/fj.202200898R	http://dx.doi.org/10.1096/fj.202200898R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5K6DS	36260317				2022-12-28	WOS:000869815800001
J	Wu, X; Zhou, XL; Lai, SQ; Liu, JC; Qi, JW				Wu, Xia; Zhou, Xueliang; Lai, Songqing; Liu, Jichun; Qi, Jianwei			Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo	FASEB JOURNAL			English	Article						curcumin; diabetic cardiomyopathy; hyperglycemia; Nrf2; HO-1 signaling; reactive oxygen species	ANTIOXIDANT; APOPTOSIS; MODEL	The hallmark feature of Diabetes mellitus (DM) is hyperglycemia which can lead to excess production of reactive oxygen species (ROS) in the myocardium, contributing to diabetic cardiomyopathy (DCM). Nuclear factor erythroid2-related factor2 (Nrf2), a transcriptional activator, enhances its ability to resist oxidative stress by activating multiple downstream anti-oxidants, anti-inflammatory proteins, and detoxifying enzymes. However, the mechanism of Nrf2 signaling in HG-induced DCM is unclear. In this study, we used HG pretreated H9c2 cells as the experimental basis in vitro, and established a high fat-diet, streptozotocin (STZ) induced Type 2 diabetic rat model in vivo. Meanwhile, we used shRNA-Nrf2 and curcumin (CUR) (as an activator) to affect H9c2 cells, to verify the role of the Nrf2 signaling pathway in DCM. The results showed that the excessive production of ROS caused by HG, which could inhibit the activation of Nrf2-related signaling, resulting in a decrease in cell energy metabolism and an increase in cell apoptosis. Surprisingly, we found that the activation of the Nrf2 signaling pathway significantly increased cardiomyocyte viability, reduced ROS formation, increased antioxidant enzyme activity, and inhibited cardiomyocyte apoptosis. In conclusion, these findings conclusively infer that CUR activation of the Nrf2/HO-1 signaling pathway exerts myocardial protection by reducing ROS formation.	[Wu, Xia] Nanjing Med Univ, Nanjing First Hosp, Dept Pharmacol, Nanjing, Peoples R China; [Zhou, Xueliang; Lai, Songqing; Liu, Jichun] Nanchang Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, 17 Yong Wai Zheng St, Nanchang 330006, Jiangxi, Peoples R China; [Qi, Jianwei] Nanjing Med Univ, Nanjing First Hosp, Dept Otolaryngol, 68 Chang Le Rd, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University; Nanchang University; Nanjing Medical University	Liu, JC (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, 17 Yong Wai Zheng St, Nanchang 330006, Jiangxi, Peoples R China.; Qi, JW (corresponding author), Nanjing Med Univ, Nanjing First Hosp, Dept Otolaryngol, 68 Chang Le Rd, Nanjing 210006, Jiangsu, Peoples R China.	2826664060@qq.com; qjw70818@163.com			National Natural Science Foundation of China (NSFC) [81860054, 81570262]; Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund) [700207006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81860054 and 81570262; Natural Science Foundation of Jiangxi Province (Jiangxi Province natural Science Fund), Grant/Award Number: 700207006	Abdelsamia EM, 2019, BIOMED PHARMACOTHER, V109, P2136, DOI 10.1016/j.biopha.2018.11.064; Adapala RK, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0775-5; Al-Rasheed NM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1092015; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Althunibat OY, 2019, LIFE SCI, V221, P83, DOI 10.1016/j.lfs.2019.02.017; Arow M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-019-0980-4; Bayliss AL, 2020, ANGIOGENESIS, V23, P371, DOI 10.1007/s10456-020-09715-z; Bhakkiyalakshmi E, 2015, PHARMACOL RES, V91, P104, DOI 10.1016/j.phrs.2014.10.004; Chene G, 2014, EUR J OBSTET GYN R B, V183, P89, DOI 10.1016/j.ejogrb.2014.10.003; Corbi G, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00364; Dhalla NS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072413; Dludla PV, 2017, MOLECULES, V22, DOI 10.3390/molecules22010129; Ge TW, 2019, AM J PHYSIOL-HEART C, V317, pH264, DOI 10.1152/ajpheart.00123.2019; Ge ZD, 2019, INT HEART J, V60, P512, DOI 10.1536/ihj.18-476; Hou G, 2018, CELL PHYSIOL BIOCHEM, V47, P257, DOI 10.1159/000489804; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Jiang GJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3155; Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00012; Knapp M, 2019, ACTA PHARMACOL SIN, V40, P1, DOI 10.1038/s41401-018-0042-6; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Lahiri SK, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0807-1; Li H, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.108754; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23693; Li L, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2018.11.034; Li R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3206542; Lindner M, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0810-6; Liu SX, 2012, INT J CARDIOL, V160, P95, DOI 10.1016/j.ijcard.2011.03.033; Lv MH, 2021, CELL BIOL TOXICOL, V37, P209, DOI 10.1007/s10565-020-09541-5; Murtaza G, 2019, PROG CARDIOVASC DIS, V62, P315, DOI 10.1016/j.pcad.2019.03.003; Nakamura M, 2020, J PHYSIOL-LONDON, V598, P2977, DOI 10.1113/JP276747; Nakmareong S, 2011, N-S ARCH PHARMACOL, V383, P519, DOI 10.1007/s00210-011-0624-z; Paolillo S, 2019, HEART FAIL CLIN, V15, P341, DOI 10.1016/j.hfc.2019.02.003; Parsamanesh N, 2018, PHARMACOL RES, V136, P181, DOI 10.1016/j.phrs.2018.09.012; Qiao KL, 2021, ANGIOGENESIS, V24, P83, DOI 10.1007/s10456-020-09744-8; Qin CX, 2017, PHARMACOL RES, V116, P45, DOI 10.1016/j.phrs.2016.12.016; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Topcu-Tarladacalisir Y, 2013, J MED FOOD, V16, P296, DOI 10.1089/jmf.2012.2550; Tsai CY, 2017, J CELL BIOCHEM, V118, P1659, DOI 10.1002/jcb.25785; Wang PJ, 2020, AM J HYPERTENS, V33, P610, DOI 10.1093/ajh/hpaa024; Wischmann P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0799-x; Wu X, 2020, BIOCHEM BIOPH RES CO, V530, P15, DOI 10.1016/j.bbrc.2020.05.053; Yao Q, 2018, J MOL CELL CARDIOL, V124, P26, DOI 10.1016/j.yjmcc.2018.10.004; Zeng XY, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0498-2; Zhang Y, 2020, ANGIOGENESIS, V23, P17, DOI 10.1007/s10456-019-09684-y; Zhou XX, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01549-2	45	1	1	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22505	10.1096/fj.202200543RRR	http://dx.doi.org/10.1096/fj.202200543RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0ID	35971779				2022-12-28	WOS:000840652800001
J	Shen, RR; Zuo, DC; Chen, KH; Yin, YH; Tang, K; Hou, SW; Han, B; Xu, YW; Liu, Z; Chen, HJ				Shen, Rongrong; Zuo, Dongchuan; Chen, Kuihao; Yin, Yiheng; Tang, Kai; Hou, Shangwei; Han, Bo; Xu, Yawei; Liu, Zheng; Chen, Haijun			K2P1 leak cation channels contribute to ventricular ectopic beats and sudden death under hypokalemia	FASEB JOURNAL			English	Article						cardiac arrhythmia; hypokalemia; ventricular ectopic beat	DOMAIN POTASSIUM CHANNEL; EXPRESSION; TASK-1; AUTOMATICITY; MUTATION; PLASMA; TWIK-1; TREK-1; ADULT; GENES	Hypokalemia causes ectopic heartbeats, but the mechanisms underlying such cardiac arrhythmias are not understood. In reduced serum K+ concentrations that occur under hypokalemia, K2P1 two-pore domain K+ channels change ion selectivity and switch to conduct inward leak cation currents, which cause aberrant depolarization of resting potential and induce spontaneous action potential of human cardiomyocytes. K2P1 is expressed in the human heart but not in mouse hearts. We test the hypothesis that K2P1 leak cation channels contribute to ectopic heartbeats under hypokalemia, by analysis of transgenic mice, which conditionally express induced K2P1 specifically in hearts, mimicking K2P1 channels in the human heart. Conditional expression of induced K2P1 specifically in the heart of hypokalemic mice results in multiple types of ventricular ectopic beats including single and multiple ventricular premature beats as well as ventricular tachycardia and causes sudden death. In isolated mouse hearts that express induced K2P1, sustained ventricular fibrillation occurs rapidly after perfusion with low K+ concentration solutions that mimic hypokalemic conditions. These observed phenotypes occur rarely in control mice or in the hearts that lack K2P1 expression. K2P1-expressing mouse cardiomyocytes of transgenic mice much more frequently fire abnormal single and/or rhythmic spontaneous action potential in hypokalemic conditions, compared to wild type mouse cardiomyocytes without K2P1 expression. These findings confirm that K2P1 leak cation channels induce ventricular ectopic beats and sudden death of transgenic mice with hypokalemia and imply that K2P1 leak cation channels may play a critical role in human ectopic heartbeats under hypokalemia.	[Shen, Rongrong; Yin, Yiheng; Tang, Kai; Xu, Yawei; Liu, Zheng] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Cardiol, Shanghai, Peoples R China; [Shen, Rongrong; Yin, Yiheng; Tang, Kai; Xu, Yawei; Liu, Zheng] Tongji Univ, Heart Lung & Blood Ctr, Pan Vasc Res Inst, Sch Med, Shanghai, Peoples R China; [Zuo, Dongchuan] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent & Treatment Cardio, Minist Educ,Key Lab Med Electrophysiol, Luzhou, Peoples R China; [Zuo, Dongchuan; Chen, Kuihao; Chen, Haijun] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Chen, Kuihao] Ningbo Univ, Sch Med, Dept Pharmacol, Ningbo, Peoples R China; [Hou, Shangwei; Han, Bo] Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Key Lab Translat Res & Innovat Therapeut Gastroin, Shanghai, Peoples R China; [Liu, Zheng] Southern Univ Sci & Technol, Cryoelectron Microscopy Ctr, Shenzhen, Guangdong, Peoples R China	Tongji University; Tongji University; Southwest Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Ningbo University; Shanghai Jiao Tong University; Southern University of Science & Technology	Chen, HJ (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.; Liu, Z (corresponding author), Southern Univ Sci & Technol, Cryoelectron Microscopy Ctr, Shenzhen, Guangdong, Peoples R China.	liuz3@sustech.edu.cn; hchen01@albany.edu		Liu, Zheng/0000-0001-6952-3406	American Heart Association (AHA) [11GRNT7270014]; HHS \ National Institutes of Health (NIH) [R01GM102943]; National Natural Science Foundation of China (NSFC) [81870246, 82070329, 81800303]	American Heart Association (AHA)(American Heart Association); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	American Heart Association (AHA), Grant/Award Number: 11GRNT7270014; HHS | National Institutes of Health (NIH), Grant/Award Number: R01GM102943; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870246, 82070329 and 81800303	ABBRECHT PH, 1972, AM J PHYSIOL, V223, P555, DOI 10.1152/ajplegacy.1972.223.3.555; Abraham DM, 2018, J CLIN INVEST, V128, P4843, DOI 10.1172/JCI95945; Atkinson AJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000246; Christensen AH, 2016, J MOL CELL CARDIOL, V97, P24, DOI 10.1016/j.yjmcc.2016.04.006; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; Davies L, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000340; Decher N, 2017, PROG BIOPHYS MOL BIO, V130, P223, DOI 10.1016/j.pbiomolbio.2017.05.005; Decher N, 2017, EMBO MOL MED, V9, P403, DOI 10.15252/emmm.201606690; Decher N, 2015, PFLUG ARCH EUR J PHY, V467, P1055, DOI 10.1007/s00424-014-1637-5; DENYER JC, 1990, J PHYSIOL-LONDON, V428, P405, DOI 10.1113/jphysiol.1990.sp018219; FITZOVICH DE, 1991, J AM COLL CARDIOL, V18, P1105, DOI 10.1016/0735-1097(91)90774-4; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; GADSBY DC, 1977, J GEN PHYSIOL, V70, P725, DOI 10.1085/jgp.70.6.725; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Haqqani HM, 2019, HEART LUNG CIRC, V28, P39, DOI 10.1016/j.hlc.2018.08.025; HOLLAND OB, 1988, AM J HYPERTENS, V1, P380, DOI 10.1093/ajh/1.4.380; Huang ZR, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003396; Prado NJ, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12605; KATZUNG BG, 1977, CIRC RES, V40, P105, DOI 10.1161/01.RES.40.1.105; KOHT A, 1983, INTENS CARE MED, V9, P275, DOI 10.1007/BF01691254; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Li EM, 2020, PROTEIN CELL, V11, P661, DOI 10.1007/s13238-020-00713-x; Li XH, 2020, BIOSCI BIOTECH BIOCH, V84, P2199, DOI 10.1080/09168451.2020.1793292; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Liang B, 2014, J MOL CELL CARDIOL, V67, P69, DOI 10.1016/j.yjmcc.2013.12.014; Limberg SH, 2011, CELL PHYSIOL BIOCHEM, V28, P613, DOI 10.1159/000335757; Liu W, 2004, CLIN EXP PHARMACOL P, V31, P174, DOI 10.1111/j.1440-1681.2004.03964.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Martin I., 2014, HEART LUNG CIRC, V23, pE14; MCCULLOUGH JR, 1990, CIRC RES, V66, P191, DOI 10.1161/01.RES.66.1.191; Megahed AA, 2016, J DAIRY SCI, V99, P7330, DOI 10.3168/jds.2015-10821; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Oshita K, 2019, J PHYSIOL SCI, V69, P653, DOI 10.1007/s12576-019-00684-7; Peng WH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007030; Pezhouman A, 2015, CIRCULATION, V132, P1528, DOI 10.1161/CIRCULATIONAHA.115.016217; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Schaefer TJ, 2005, EMERG MED CLIN N AM, V23, P723, DOI 10.1016/j.emc.2005.03.016; Singh Manpreet, 2015, J La State Med Soc, V167, P97; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; SPIEGLER PA, 1995, CAN J PHYSIOL PHARM, V73, P1165, DOI 10.1139/y95-166; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Trefz FM, 2018, J VET INTERN MED, V32, P1447, DOI 10.1111/jvim.15220; VASSALLE M, 1965, AM J PHYSIOL, V208, P770, DOI 10.1152/ajplegacy.1965.208.4.770; WALDO AL, 1970, CIRCULATION, V42, P653, DOI 10.1161/01.CIR.42.4.653; Wang W, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00246; Wogan John M., 1993, Journal of Emergency Medicine, V11, P47, DOI 10.1016/0736-4679(93)90009-V; Xiong J, 2018, J MOL CELL CARDIOL, V117, P26, DOI 10.1016/j.yjmcc.2018.02.014; Zuo DC, 2017, J PHYSIOL-LONDON, V595, P5129, DOI 10.1113/JP274268	52	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22455	10.1096/fj.202200707R	http://dx.doi.org/10.1096/fj.202200707R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3F9LU	35899468				2022-12-28	WOS:000830982300001
J	Sarver, DC; Xu, C; Carreno, D; Arking, A; Terrillion, CE; Aja, S; Wong, GW				Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Terrillion, Chantelle E.; Aja, Susan; Wong, G. William			CTRP11 contributes modestly to systemic metabolism and energy balance	FASEB JOURNAL			English	Article						C1QL4; C1QTNF11; metabolism; obesity reversal; secreted hormone	ADIPOSE-TISSUE INFLAMMATION; FOOD-INTAKE; INSULIN SENSITIVITY; HEPATIC STEATOSIS; SECRETED PROTEIN; SKELETAL-MUSCLE; SEX-DIFFERENCES; RECEPTOR BAI3; FAMILY; OBESITY	C1q/TNF-related proteins (CTRP1-15) constitute a conserved group of secreted proteins of the C1q family with diverse functions. In vitro studies have shown that CTRP11/C1QL4 can inhibit adipogenesis, antagonize myoblast fusion, and promote testosterone synthesis and secretion. Whether CTRP11 is required for these processes in vivo remains unknown. Here, we show that knockout (KO) mice lacking CTRP11 have normal skeletal muscle mass and function, and testosterone level, suggesting that CTRP11 is dispensable for skeletal muscle development and testosterone production. We focused our analysis on whether this nutrient-responsive secreted protein plays a role in controlling sugar and fat metabolism. At baseline when mice are fed a standard chow, CTRP11 deficiency affects metabolic parameters in a sexually dimorphic manner. Only Ctrp11-KO female mice have significantly higher fasting serum ketones and reduced physical activity. In the refeeding phase following food withdrawal, Ctrp11-KO female mice have reduced food intake and increased metabolic rate and energy expenditure, highlighting CTRP11's role in fasting-refeeding response. When challenged with a high-fat diet to induce obesity and metabolic dysfunction, CTRP11 deficiency modestly exacerbates obesity-induced glucose intolerance, with more pronounced effects seen in Ctrp11-KO male mice. Switching to a low-fat diet after obesity induction results in greater fat loss in wild type relative to KO male mice, suggesting impaired response to obesity reversal and reduced metabolic flexibility in the absence of CTRP11. Collectively, our data provide genetic evidence for novel sex-dependent metabolic regulation by CTRP11, but note the overall modest contribution of CTRP11 to systemic energy homeostasis.	[Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Sarver, Dylan C.; Xu, Cheng; Carreno, Dana; Arking, Alexander; Aja, Susan; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA; [Terrillion, Chantelle E.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA.	gwwong@jhmi.edu			HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), [DK084171]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK084171	Appari M, 2017, CIRC RES, V120, P66, DOI 10.1161/CIRCRESAHA.116.309398; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Cho Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg6069; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Hamoud N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06897-5; Han S, 2018, CIRC RES, V123, pE5, DOI 10.1161/CIRCRESAHA.118.312871; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Lahav R, 2021, AM J PHYSIOL-ENDOC M, V321, pE702, DOI 10.1152/ajpendo.00299.2021; Lei X, 2019, J BIOL CHEM, V294, P15638, DOI 10.1074/jbc.RA119.009230; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Li YX, 2019, FASEB J, V33, P9627, DOI 10.1096/fj.201900293RRR; Little HC, 2019, FASEB J, V33, P8666, DOI 10.1096/fj.201900520R; Liu F, 2017, MOL CELL BIOCHEM, V424, P57, DOI 10.1007/s11010-016-2842-7; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Masschelin PM, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01638; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Miller LR, 2017, FASEB J, V31, P29, DOI 10.1096/fj.201600781R; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Murayama MA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.607346; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Noda T, 2019, ANDROLOGY-US, V7, P644, DOI 10.1111/andr.12621; Park S, 2020, BIOL REPROD, V103, P195, DOI 10.1093/biolre/ioaa084; Park YK, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00554-16; Park YK, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00260-16; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Ressl S, 2015, STRUCTURE, V23, P688, DOI 10.1016/j.str.2015.01.019; Rodriguez S, 2019, FASEB J, V33, P14748, DOI 10.1096/fj.201901279R; Rodriguez S, 2021, AM J PHYSIOL-REG I, V320, pR19, DOI 10.1152/ajpregu.00139.2020; Rodriguez S, 2020, FASEB J, V34, P2657, DOI 10.1096/fj.201900558RR; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Sarver DC, 2021, FASEB J, V35, DOI 10.1096/fj.202100733RR; Sarver DC, 2020, AM J PHYSIOL-ENDOC M, V319, pE1084, DOI 10.1152/ajpendo.00448.2020; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tan AN, 2019, FASEB J, V33, P4893, DOI 10.1096/fj.201801620RR; Tan SY, 2020, AM J PHYSIOL-ENDOC M, V319, pE146, DOI 10.1152/ajpendo.00533.2019; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xia JY, 2018, DIABETOLOGIA, V61, P932, DOI 10.1007/s00125-017-4516-8; Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557; Youngstrom DW, 2020, J ORTHOP RES, V38, P996, DOI 10.1002/jor.24553; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Zuo AJ, 2020, J CELL MOL MED, V24, P2635, DOI 10.1111/jcmm.14982; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	77	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22347	10.1096/fj.202200189RR	http://dx.doi.org/10.1096/fj.202200189RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1H5ZA	35579659	hybrid, Green Published			2022-12-28	WOS:000796620600001
J	Zhao, H; Chen, Z; Li, H; Zhao, YH; Wang, Q; Li, WW				Zhao, Hui; Chen, Zhe; Li, Hao; Zhao, Yue-Hong; Wang, Qun; Li, Wei-Wei			Suppressed COP9 signalosome 5 promotes hemocyte proliferation through Cyclin E in the early G1 phase to defend against bacterial infection in crab	FASEB JOURNAL			English	Article						antibacterial immunity; CSN5; Cyclin E; Eriocheir sinensis; hemocytes proliferation	CELL-CYCLE; DEGRADATION; JAB1/CSN5; IDENTIFICATION; PROGRESSION; SEPARATION; RECEPTOR	Hemocytes are invertebrate immune cells that are similar to blood cells in vertebrates and play a crucial role in innate immunity. Previous work has found that mature circulating hemocytes lack the ability to proliferate. However, recent single-cell RNA sequencing and functional studies in invertebrate have challenged this view. Here, we report that bacteria induced hemocytes proliferation in the Chinese mitten crab, Eriocheir sinensis. Flow cytometry was used to collect non-proliferating and proliferating hemocytes populations, while the expression of EsCyclin E was highly expressed in proliferating hemocytes, but the expression of EsCsn5 was significantly suppressed in proliferating hemocytes. Subsequent studies have found EsCsn5 distributed in two fractions include holo-complex and monomeric form, whereas knockdown of EsCsn5 has little impact on the amount of the holo-complex. EsCsn5 was widely expressed in different crab tissues, while its expression was significantly reduced upon bacterial infection. Crab hemocytes showed significantly enhanced proliferation when EsCsn5 was genetically knocked down, suggesting a critical role for CSN5 in the negative regulation of crab hemocyte proliferation. Moreover, EsCSN5 but not the EsCSN8 was demonstrated to negatively regulate the early G1 phase of the cell cycle by controlling the degradation of EsCyclin E through ubiquitination steps, rather than affecting its transcription. Furthermore, in the EsCyclin E-suppressed crab there was a significantly reduced survival rate and an up-regulated hemolymph bacterial concentration. Taken together, this study provides evidence demonstrating that invertebrate hemocytes down-regulate the expression of EsCsn5 upon bacterial challenge, thus promoting proliferation in an EsCyclin E-dependent manner in order to protect the crab from infection.	[Zhao, Hui; Chen, Zhe; Li, Hao; Zhao, Yue-Hong; Wang, Qun; Li, Wei-Wei] East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def, 500 Dongchuan Rd, Shanghai 200241, Peoples R China	East China Normal University	Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	Shanghai Rising--Star Program [20QA1403000]; National Natural Science Foundation of China [31972820, 31970490]	Shanghai Rising--Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Shanghai Rising--Star Program (Grant 20QA1403000 to WWL) and National Natural Science Foundation of China (Grants 31972820 to WWL and 31970490 to QW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dantas-Lima JJ, 2013, AQUACULTURE, V408, P128, DOI 10.1016/j.aquaculture.2013.04.031; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Eibel H, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0434-8; Junkunlo K, 2019, J BIOL CHEM, V294, P708, DOI 10.1074/jbc.RA118.005489; Koiwai K, 2021, ELIFE, V10, DOI 10.7554/eLife.66954; Kondo MTS., 2012, AQUACULTURE SCI, V60, P151; Kruisbeek Ada M, 2004, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0312s60; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li H, 2021, J IMMUNOL, V207, P2265, DOI 10.4049/jimmunol.2100575; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Patel S, 2017, GENE, V626, P209, DOI 10.1016/j.gene.2017.05.043; Raddi G, 2020, SCIENCE, V369, P1128, DOI 10.1126/science.abc0322; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Soderhall I, 2016, DEV COMP IMMUNOL, V58, P129, DOI 10.1016/j.dci.2015.12.009; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tattikota SG, 2020, ELIFE, V9, DOI 10.7554/eLife.54818; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yang L, 2019, J BIOL CHEM, V294, P14704, DOI 10.1074/jbc.RA119.009559; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; Zhao YH, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100943; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	38	0	0	11	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22321	10.1096/fj.202101710RRRR	http://dx.doi.org/10.1096/fj.202101710RRRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3DF	35429011				2022-12-28	WOS:000782721900001
J	Wisniewski, E; Czaran, D; Kovacs, F; Bahurek, E; Nemeth, A; Sasvari, P; Szanda, G; Pettko-Szandtner, A; Klement, E; Ligeti, E; Csepanyi-Komi, R				Wisniewski, Eva; Czaran, Domonkos; Kovacs, Fanni; Bahurek, Eniko; Nemeth, Afrodite; Sasvari, Peter; Szanda, Gergo; Pettko-Szandtner, Aladar; Klement, Eva; Ligeti, Erzsebet; Csepanyi-Komi, Roland			A novel BRET-Based GAP assay reveals phosphorylation-dependent regulation of the RAC-specific GTPase activating protein ARHGAP25	FASEB JOURNAL			English	Article						ARHGAP25; bioluminescence resonance energy transfer (BRET); GTPase activating protein (GAP); phosphorylation; RAC (RAC GTPase)	NADPH OXIDASE; CELL-ADHESION; RHO GTPASES; PATHWAY; GROWTH; GEFS	ARHGAP25, a RAC-specific GTPase activating protein (GAP), is an essential regulator of phagocyte effector functions such as phagocytosis, superoxide production, and transendothelial migration. Furthermore, its complex role in tumor behavior has recently been recognized. We previously demonstrated that phosphorylation of serine 363 in ARHGAP25 regulates hematopoietic stem cells and progenitor cells in mouse bone marrow. However, the significance of other potential phosphorylation sites of ARHGAP25 remained unknown. Now, we developed a novel, real-time bioluminescence resonance energy transfer (BRET) assay to monitor the GAP activity of ARHGAP25 in vitro. Using this approach, we revealed that phosphorylation of S363 and S488, but not that of S379-380, controls ARHGAP25's RACGAP activity. On the other hand, we found in granulocyte-differentiated human PLB-985 cells that superoxide production and actin depolymerization are regulated by residues S363 and S379-380. The present data demonstrate the value of our BRET-GAP assay and show that different phosphorylation patterns regulate ARHGAP25's GAP activity and its effect on superoxide production and phagocytosis.	[Wisniewski, Eva; Czaran, Domonkos; Kovacs, Fanni; Bahurek, Eniko; Nemeth, Afrodite; Sasvari, Peter; Szanda, Gergo; Ligeti, Erzsebet; Csepanyi-Komi, Roland] Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary; [Pettko-Szandtner, Aladar; Klement, Eva] Biol Res Ctr, Lab Prote Res, Szeged, Hungary; [Klement, Eva] Hungarian Ctr Excellence Mol Med, Single Cell Omics ACF, Szeged, Hungary	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Csepanyi-Komi, R (corresponding author), Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary.	csepanyi-komi.roland@med.semmelweis-univ.hu	; Wisniewski, Eva/O-9233-2015	Sasvari, Peter/0000-0002-6026-9226; Wisniewski, Eva/0000-0001-8698-6867	Development and Innovation Office of Hungary [GINOP-2.3.2-15-2016-00032]; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program [739593]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation [UNKP-20-5-SE-2]; NKFI \ National Research, Development and Innovation Office [FK_18 128376, FK_124038, 119236]; VEKOP [2.3.2-16-2016-00002]	Development and Innovation Office of Hungary; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation; NKFI \ National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); VEKOP	Development and Innovation Office of Hungary, Grant/Award Number: GINOP-2.3.2-15-2016-00032; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program, Grant/Award Number: 739593; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation, Grant/Award Number: UNKP-20-5-SE-2; NKFI vertical bar National Research, Development and Innovation Office, Grant/Award Number: FK_18 128376, FK_124038 and 119236; VEKOP, Grant/Award Number: 2.3.2-16-2016-00002	BECKER EL, 1979, AM J PATHOL, V95, P81; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; COHEN HJ, 1981, BLOOD, V58, P975; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Csepanyi-Komi R, 2016, J IMMUNOL, V197, P2807, DOI 10.4049/jimmunol.1502342; Csepanyi-Komi R, 2012, BLOOD, V119, P573, DOI 10.1182/blood-2010-12-324053; Csepanyi-Komi R, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12993; Csepanyi-Komi Roland, 2013, Small GTPases, V4, P90, DOI 10.4161/sgtp.23708; Ding FP, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02308-w; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang WK, 2021, INT J BIOL SCI, V17, P1808, DOI 10.7150/ijbs.55919; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Katoh M, 2004, INT J MOL MED, V14, P333; Kaya AI, 2020, P NATL ACAD SCI USA, V117, P14139, DOI 10.1073/pnas.1918736117; Klement E, 2019, METHODS MOL BIOL, V2026, P41, DOI 10.1007/978-1-4939-9612-4_4; Kobayashi K, 2015, EMBO J, V34, P1992, DOI 10.15252/embj.201490899; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Lorincz AM, 2014, FREE RADICAL BIO MED, V68, P65, DOI 10.1016/j.freeradbiomed.2013.12.001; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Nomura M, 2003, MOL CARCINOGEN, V38, P25, DOI 10.1002/mc.10140; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Tao L, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172476; Tao L, 2019, BIOTECHNOL APPL BIOC, V66, P787, DOI 10.1002/bab.1784; Thuault S, 2016, MOL BIOL CELL, V27, P2653, DOI 10.1091/mbc.E16-01-0041; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Wang LD, 2016, BLOOD, V128, P1465, DOI 10.1182/blood-2016-05-711424; Xu K, 2019, ONCOTARGETS THER, V12, P6699, DOI 10.2147/OTT.S207540	37	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22584	10.1096/fj.202200689R	http://dx.doi.org/10.1096/fj.202200689R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A9UZ	36190314	Green Accepted, hybrid			2022-12-28	WOS:000863225300001
J	Zan, CF; Yang, BS; Brandhofer, M; El Bounkari, O; Bernhagen, J				Zan, Chunfang; Yang, Bishan; Brandhofer, Markus; El Bounkari, Omar; Bernhagen, Jurgen			D-dopachrome tautomerase in cardiovascular and inflammatory diseases-A new kid on the block or just another MIF?	FASEB JOURNAL			English	Review						atypical chemokine; chemokine; cytokine; D-dopachrome tautomerase (D-DT); inflammation; macrophage migration inhibitory factor (MIF); receptor; signaling	MIGRATION-INHIBITORY FACTOR; CRYSTAL-STRUCTURE; CHEMOKINE RECEPTORS; FACTOR DEFICIENCY; INDUCED APOPTOSIS; MOUSE MODEL; FACTOR GENE; MACROPHAGE; EXPRESSION; CYTOKINE	Macrophage migration inhibitory factor (MIF) as well as its more recently described structural homolog D-dopachrome tautomerase (D-DT), now also termed MIF-2, are atypical cytokines and chemokines with key roles in host immunity. They also have an important pathogenic role in acute and chronic inflammatory conditions, cardiovascular diseases, lung diseases, adipose tissue inflammation, and cancer. Although our mechanistic understanding of MIF-2 is relatively limited compared to the extensive body of evidence available for MIF, emerging data suggests that MIF-2 is not only a functional phenocopy of MIF, but may have differential or even oppositional activities, depending on the disease and context. In this review, we summarize and discuss the similarities and differences between MIF and MIF-2, with a focus on their structures, receptors, signaling pathways, and their roles in diseases. While mainly covering the roles of the MIF homologs in cardiovascular, inflammatory, autoimmune, and metabolic diseases, we also discuss their involvement in cancer, sepsis, and chronic obstructive lung disease (COPD). A particular emphasis is laid upon potential mechanistic explanations for synergistic or cooperative activities of the MIF homologs in cancer, myocardial diseases, and COPD as opposed to emerging disparate or antagonistic activities in adipose tissue inflammation, metabolic diseases, and atherosclerosis. Lastly, we discuss potential future opportunities of jointly targeting MIF and MIF-2 in certain diseases, whereas precision targeting of only one homolog might be preferable in other conditions. Together, this article provides an update of the mechanisms and future therapeutic avenues of human MIF proteins with a focus on their emerging, surprisingly disparate activities, suggesting that MIF-2 displays a variety of activities that are distinct from those of MIF.	[Zan, Chunfang; Yang, Bishan; Brandhofer, Markus; El Bounkari, Omar; Bernhagen, Jurgen] Ludwig Maximilian Univ LMU, Inst Stroke & Dementia Res ISD, LMU Klinikum, Vasc Biol, Munich, Germany; [Bernhagen, Jurgen] Deutsch Zentrum Herz Kreislauferkrankungen DZHK, Munich Heart Alliance, Munich, Germany; [Bernhagen, Jurgen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich	Bernhagen, J (corresponding author), Ludwig Maximilian Univ LMU, LMU Klinikum, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany.	juergen.bernhagen@med.uni-muenchen.de		Brandhofer, Markus/0000-0002-1629-8353	Deutsche Forschungsgemeinschaft (DFG) [SFB1123/A3, EXC 2145, 390857198]; Friedrich-Baur-Foundation at LMU Munich [FBS 54/22]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Baur-Foundation at LMU Munich	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1123/A3 and EXC 2145 SyNergy--ID 390857198; Friedrich-Baur-Foundation at LMU Munich, Grant/Award Number: FBS 54/22	Aday AW, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00016; Aksakal A, 2021, J MED VIROL, V93, P6519, DOI 10.1002/jmv.27189; Alampour-Rajabi S, 2015, FASEB J, V29, P4497, DOI 10.1096/fj.15-273904; AROCA P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P266, DOI 10.1016/0304-4165(90)90088-E; Assis DN, 2014, HEPATOLOGY, V59, P580, DOI 10.1002/hep.26664; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Attwood MM, 2020, NAT REV DRUG DISCOV, V19, P695, DOI 10.1038/s41573-020-0078-4; Ayoub S, 2008, NAT CLIN PRACT RHEUM, V4, P98, DOI 10.1038/ncprheum0701; Baron-Stefaniak J, 2019, HPB, V21, P465, DOI 10.1016/j.hpb.2018.08.008; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Benedek G, 2017, P NATL ACAD SCI USA, V114, pE8421, DOI 10.1073/pnas.1712288114; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bernhagen J, 2021, EBIOMEDICINE, V69, DOI 10.1016/j.ebiom.2021.103479; Bilsborrow JB, 2019, EXPERT OPIN THER TAR, V23, P733, DOI 10.1080/14728222.2019.1656718; Bjork P, 1996, EUR J HAEMATOL, V57, P254; Bleilevens C, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020332; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brandhofer M, 2022, STRUCTURE, V30, P787, DOI 10.1016/j.str.2022.05.005; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Calandra T, 2017, CRIT REV IMMUNOL, V37, P359, DOI 10.1615/CritRevImmunol.v37.i2-6.90; Caltabiano R, 2021, MOLECULES, V26, DOI 10.3390/molecules26010184; Cavalli E, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100284; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chatterjee M, 2014, CIRC RES, V115, P939, DOI 10.1161/CIRCRESAHA.115.305171; Cheng Y, 2019, BBA-REV CANCER, V1871, P289, DOI 10.1016/j.bbcan.2019.01.005; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Cuthbert RJ, 2009, EUR J CANCER, V45, P1654, DOI 10.1016/j.ejca.2009.02.005; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Dankers W, 2020, IMMUNOL CELL BIOL, V98, P782, DOI 10.1111/imcb.12376; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dayawansa NH, 2014, CLIN SCI, V127, P149, DOI 10.1042/CS20130828; De la Cruz-Mosso U, 2018, CELL IMMUNOL, V324, P42, DOI 10.1016/j.cellimm.2017.12.010; Dickerhof N, 2015, FREE RADICAL BIO MED, V89, P498, DOI 10.1016/j.freeradbiomed.2015.09.009; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; El Bounkari O., 2021, BIORXIV, DOI [10.1101/2021.12.28.474328, DOI 10.1101/2021.12.28.474328]; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Esumi N, 1998, MAMM GENOME, V9, P753, DOI 10.1007/s003359900858; Fan CP, 2013, P NATL ACAD SCI USA, V110, P10994, DOI 10.1073/pnas.1221817110; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Florez-Sampedro L, 2020, AM J PHYSIOL-LUNG C, V318, pL1183, DOI 10.1152/ajplung.00521.2019; Gencer S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020226; Georgakis MK, 2022, EUR HEART J, V43, P1799, DOI 10.1093/eurheartj/ehac094; Gil-Yarom N, 2017, P NATL ACAD SCI USA, V114, P562, DOI 10.1073/pnas.1612195114; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Grieb G, 2014, MINI-REV MED CHEM, V14, P1125; Grieb G, 2010, BURNS, V36, P335, DOI 10.1016/j.burns.2009.04.019; Guo DW, 2016, INT J CANCER, V139, P2056, DOI 10.1002/ijc.30278; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776; Hertelendy J, 2018, CURR MED CHEM, V25, P601, DOI 10.2174/0929867324666170714114200; Hoffmann A, 2020, IMMUNOL CELL BIOL, V98, P704, DOI 10.1111/imcb.12388; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Hou JJ, 2021, NAT REV CLIN ONCOL, V18, P261, DOI 10.1038/s41571-020-00459-9; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Iwata T, 2017, CYTOKINE, V96, P195, DOI 10.1016/j.cyto.2017.04.017; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Ji H., 2021, J NEUROINFLAMMATION, V18, P1; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Kapurniotu A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00003; Kim BS, 2020, FASEB J, V34, P4219, DOI 10.1096/fj.201901511R; Kim BS, 2016, BURNS, V42, P1265, DOI 10.1016/j.burns.2016.02.005; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Kok T, 2018, DRUG DISCOV TODAY, V23, P1910, DOI 10.1016/j.drudis.2018.06.017; KONNO R, 1992, INT J BIOCHEM, V24, P519, DOI 10.1016/0020-711X(92)90322-R; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Krammer C, 2021, CHEMBIOCHEM, V22, P1012, DOI 10.1002/cbic.202000574; Lacy M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23554-5; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Lang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04581-2; Lang TL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00577; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Lawler Patrick R, 2021, Eur Heart J, V42, P113, DOI 10.1093/eurheartj/ehaa099; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Leng L, 2009, CYTOKINE, V48, P177, DOI 10.1016/j.cyto.2009.07.002; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Li F, 2018, CNS NEUROSCI THER, V24, P947, DOI 10.1111/cns.12845; Li TL, 2022, SHOCK, V57, P666, DOI 10.1097/SHK.0000000000001918; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2019, J AM COLL CARDIOL, V74, P1594, DOI 10.1016/j.jacc.2019.07.061; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Liehn EA, 2013, ARTERIOSCL THROM VAS, V33, P2180, DOI 10.1161/ATVBAHA.113.301633; Lin SG, 2000, CIRC RES, V87, P1202, DOI 10.1161/01.RES.87.12.1202; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Luedike P, 2018, CYTOKINE, V110, P104, DOI 10.1016/j.cyto.2018.04.033; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Ma YN, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128900; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Michelet C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100740; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MITCHELL R, 1995, J IMMUNOL, V154, P3863; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Noels H, 2019, ARTERIOSCL THROM VAS, V39, P583, DOI 10.1161/ATVBAHA.118.312037; O'Reilly C, 2016, MED RES REV, V36, P440, DOI 10.1002/med.21385; ODH G, 1993, BIOCHEM BIOPH RES CO, V197, P619, DOI 10.1006/bbrc.1993.2524; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Pantouris G, 2018, BIOCHEMISTRY-US, V57, P3599, DOI 10.1021/acs.biochem.8b00344; Pantouris G, 2018, ANGEW CHEM INT EDIT, V57, P7116, DOI 10.1002/anie.201803191; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Pohl J, 2017, J CRIT CARE, V40, P52, DOI 10.1016/j.jcrc.2017.03.012; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Rahman SH, 2007, ANN SURG, V245, P282, DOI 10.1097/01.sla.0000245471.33987.4b; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Rassaf T, 2014, CARDIOVASC RES, V102, P321, DOI 10.1093/cvr/cvu071; Reutershan J, 2006, DRUG NEWS PERSPECT, V19, P615, DOI 10.1358/dnp.2006.19.10.1068009; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, CIRC RES, V124, P437, DOI 10.1161/CIRCRESAHA.118.313129; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Rodrigues DAS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008230; Roger T, 2007, EUR J IMMUNOL, V37, P3509, DOI 10.1002/eji.200737357; Rolin J, 2014, TOXINS, V6, P2840, DOI 10.3390/toxins6092840; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Sanchez-Zuno GA, 2022, J CLIN MED, V11, DOI 10.3390/jcm11010120; Santagata S, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.591386; Sauler M, 2014, AM J PHYSIOL-LUNG C, V306, pL487, DOI 10.1152/ajplung.00284.2013; Savva A, 2016, P NATL ACAD SCI USA, V113, P3597, DOI 10.1073/pnas.1520727113; Schinagl A, 2018, BIOCHEMISTRY-US, V57, P1523, DOI 10.1021/acs.biochem.7b01156; Schindler L, 2021, J LEUKOCYTE BIOL, V110, P893, DOI 10.1002/JLB.3A0420-242RRR; Schindler L, 2018, REDOX BIOL, V15, P135, DOI 10.1016/j.redox.2017.11.028; Schmitz C, 2018, FASEB J, V32, P4428, DOI 10.1096/fj.201800058R; Schurigt U, 2008, ARTHRITIS RHEUM-US, V58, P3030, DOI 10.1002/art.23904; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shin MS, 2019, ARTHRITIS RHEUMATOL, V71, P109, DOI 10.1002/art.40672; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Skeens E, 2022, STRUCTURE, V30, P840, DOI 10.1016/j.str.2022.03.007; Soehnlein O, 2021, NAT REV DRUG DISCOV, V20, P589, DOI 10.1038/s41573-021-00198-1; Song SS, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04038-8; Song SS, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103412; Soppert J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009384; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Stoppe C, 2015, ANTIOXID REDOX SIGN, V23, P865, DOI 10.1089/ars.2014.6243; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Thiele M, 2015, J IMMUNOL, V195, P2343, DOI 10.4049/jimmunol.1500572; Thomson AW, 2003, CYTOKINE HDB; Tilstam PV, 2017, EXPERT OPIN THER TAR, V21, P671, DOI 10.1080/14728222.2017.1336227; Tilstam PV, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI127171; Tilstam PV, 2019, J BIOL CHEM, V294, P18522, DOI 10.1074/jbc.RA119.009860; Toldi J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87613-0; Vandenbark AA, 2021, CELL IMMUNOL, V370, DOI 10.1016/j.cellimm.2021.104439; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vincent FB, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1042; Wang QY, 2017, INT J GYNECOL CANCER, V27, P634, DOI 10.1097/IGC.0000000000000951; Wang S., 2021, COND MED, V4, P39; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Wirtz TH, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2020.100221; Wu GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30067; Xiao ZP, 2022, J MED CHEM, V65, P2059, DOI 10.1021/acs.jmedchem.1c01598; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101; Yang ML, 2022, LIPIDS HEALTH DIS, V21, DOI 10.1186/s12944-022-01693-z; Yao J, 2021, ARTHRITIS RHEUMATOL, V73, P1931, DOI 10.1002/art.41753; Yao J, 2016, J CLIN INVEST, V126, P732, DOI 10.1172/JCI81937; YOKOYAMA K, 1994, J BIOL CHEM, V269, P27080; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113; Zan C., 2021, COND MED, V4, P216; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C	199	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22601	10.1096/fj.202201213R	http://dx.doi.org/10.1096/fj.202201213R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5M0AN	36269019				2022-12-28	WOS:000870769700001
J	Kaur, D; Verma, P; Singh, M; Sharma, A; Lata, K; Mukhopadhaya, A; Chattopadhyay, K				Kaur, Deepinder; Verma, Pratima; Singh, Mahendra; Sharma, Arpita; Lata, Kusum; Mukhopadhaya, Arunika; Chattopadhyay, Kausik			Pore formation-independent cell death induced by a beta-barrel pore-forming toxin	FASEB JOURNAL			English	Article						apoptosis; mitochondrial damage; mitochondrial membrane permeability transition; mitochondrial ROS; pore-forming toxin; programmed cell death; Vibrio cholerae cytolysin	VIBRIO-CHOLERAE CYTOLYSIN; BIOTYPE EL-TOR; HEMOLYSIN PRODUCTION; CRYSTAL-STRUCTURE; MECHANISMS; APOPTOSIS; TRANSLOCATION; MITOCHONDRIA; ACTIVATION; COMPLEX	Vibrio cholerae cytolysin (VCC) is a beta-barrel pore-forming toxin (beta-PFT). It exhibits potent hemolytic activity against erythrocytes that appears to be a direct outcome of its pore-forming functionality. However, VCC-mediated cell-killing mechanism is more complicated in the case of nucleated mammalian cells. It induces apoptosis in the target nucleated cells, mechanistic details of which are still unclear. Furthermore, it has never been explored whether the ability of VCC to trigger programmed cell death is stringently dependent on its pore-forming activity. Here, we show that VCC can evoke hallmark features of the caspase-dependent apoptotic cell death even in the absence of the pore-forming ability. Our study demonstrates that VCC mutants with abortive pore-forming hemolytic activity can trigger apoptotic cell death responses and cytotoxicity, similar to those elicited by the wild-type toxin. VCC as well as its pore formation-deficient mutants display prominent propensity to translocate to the target cell mitochondria and cause mitochondrial membrane damage. Therefore, our results for the first time reveal that VCC, despite being an archetypical beta-PFT, can kill target nucleated cells independent of its pore-forming functionality. These findings are intriguing for a beta-PFT, whose destination is generally expected to remain limited on the target cell membranes, and whose mode of action is commonly attributed to the membrane-damaging pore-forming ability. Taken together, our study provides critical new insights regarding distinct implications of the two important virulence functionalities of VCC for the V. cholerae pathogenesis process: hemolytic activity for iron acquisition and cytotoxicity for tissue damage by the bacteria.	[Kaur, Deepinder; Verma, Pratima; Singh, Mahendra; Sharma, Arpita; Lata, Kusum; Mukhopadhaya, Arunika; Chattopadhyay, Kausik] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India; [Kaur, Deepinder] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Memorial Sloan Kettering Cancer Center	Mukhopadhaya, A; Chattopadhyay, K (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India.	arunika@iisermohali.ac.in; kausik@iisermohali.ac.in			Council of Scientific and Industrial Research, India (CSIR); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB) [CRG/2018/001973]; Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB); Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)(University Grants Commission, India)	Council of Scientific and Industrial Research, India (CSIR); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB), Grant/Award Number: CRG/2018/001973; Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)	Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; Arcidiacono D, 2008, CELL MICROBIOL, V10, P899, DOI 10.1111/j.1462-5822.2007.01092.x; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bortner CD, 2001, METHOD CELL BIOL, V66, P49; Bouillot S, 2018, TOXINS, V10, DOI 10.3390/toxins10100387; Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07; Brito C, 2019, CELL MOL LIFE SCI, V76, P1319, DOI 10.1007/s00018-018-2992-8; Castro-Cordova P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21355-5; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; De Biasi Sara, 2015, Curr Protoc Cytom, V72, DOI 10.1002/0471142956.cy0732s72; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gupta S, 2015, J BIOL CHEM, V290, P31051, DOI 10.1074/jbc.M115.670182; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang MX, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00349-0; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kathuria R, 2018, BIOCHEM J, V475, P3039, DOI 10.1042/BCJ20180387; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Marino G, 2013, CELL RES, V23, P1247, DOI 10.1038/cr.2013.115; Menzl K, 1996, EUR J BIOCHEM, V240, P646, DOI 10.1111/j.1432-1033.1996.0646h.x; Mondal AK, 2021, MOL MICROBIOL, V115, P508, DOI 10.1111/mmi.14631; Mondal AK, 2018, ADV EXP MED BIOL, V1112, P281, DOI 10.1007/978-981-13-3065-0_19; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Paul K, 2014, BIOCHEM BIOPH RES CO, V443, P189, DOI 10.1016/j.bbrc.2013.11.078; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rai AK, 2014, J BIOL CHEM, V289, P16978, DOI 10.1074/jbc.M114.567099; Rai S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17666-8; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; RICHARDSON K, 1986, INFECT IMMUN, V54, P415, DOI 10.1128/IAI.54.2.415-420.1986; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Verma P, 2021, BIOCHEM SOC T, V49, P455, DOI 10.1042/BST20200836; Vogel U, 1998, J CELL SCI, V111, P825; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; ZAMZAMI N, 2003, METH MOL B, V282, P103; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhivotovsky B, 2003, ESSAYS BIOCHEM, V39, P25, DOI 10.1042/bse0390025; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; Zitzer A, 1997, INFECT IMMUN, V65, P1293, DOI 10.1128/IAI.65.4.1293-1298.1997	51	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22557	10.1096/fj.202200788R	http://dx.doi.org/10.1096/fj.202200788R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1RX	36125006				2022-12-28	WOS:000857904800001
J	Shen, ZM; Chen, M; Gao, Y; Dong, FF; Cen, CH; Wu, HW; Wang, N; Cui, XH; Han, CS; Gao, F				Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei			The function of Foxo1 in spermatogonia development is independent of PI3K/PTEN signaling	FASEB JOURNAL			English	Article						fertility; Foxo1; Pten; spermatogenesis; spermatogonia	PRIMORDIAL GERM-CELLS; STEM-CELLS; MOUSE; GENERATION; GONOCYTES; PROGRAM; SPERMATOGENESIS; PLURIPOTENCY	Spermatogenesis is a highly coordinated process that initiates shortly after birth and continues throughout the lifespan of male animals. Foxo1 is a transcription factor and is involved in many biological processes. It has been reported that the inactivation of Foxo1 in gonocytes during the embryonic stage causes the defects of spermatogenesis. In the present study, we found that the inactivation of Foxo1 in spermatogonia after birth also caused germ cell loss and male infertility. We found that the initiation of meiosis was not affected; however, the germ cell development was arrested after meiosis and lack of mature spermatozoa in the cauda epididymis. We also found that the proliferation of Foxo1-deficient spermatogonia stem cells was significantly reduced under in vitro conditions. Further study revealed that inactivation of Pten in postnatal spermatogonia using Stra8-Cre did not affect germ cell development and the subcellular location of FOXO1 in Pten-deficient spermatogonia. This study demonstrated that Foxo1 was involved in the development of spermatogonia after birth and the function of Foxo1 was probably not regulated by PI3K/PTEN signaling.	[Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stern Cell & Reprod Biol, Beijing, Peoples R China; [Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Han, Chunsheng; Gao, Fei] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Chen, Min; Han, Chunsheng; Gao, Fei] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stern Cell & Reprod Biol, Beijing, Peoples R China.	gaof@ioz.ac.cn			National Key Research and Development Program of China [2018YFA0107700]; National Natural Science Foundation of China (NSFC) [32170855, 31970785]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0107700; National Natural Science Foundation of China (NSFC), Grant/Award Number: 32170855 and 31970785	Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287; Culty M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110544; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; Dong FF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.673258; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Liu PL, 2017, CELL DEATH DIFFER, V24, P1672, DOI 10.1038/cdd.2017.90; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nagano R, 2000, ANAT REC, V258, P210; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pui HP, 2017, MECH DEVELOP, V144, P125, DOI 10.1016/j.mod.2017.03.002; Qin Y, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174128; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Sinha D, 2018, FASEB J, V32, P4984, DOI 10.1096/fj.201701096RR; Wang S, 2015, STEM CELLS DEV, V24, P471, DOI 10.1089/scd.2014.0376; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	30	0	0	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22522	10.1096/fj.202200640RR	http://dx.doi.org/10.1096/fj.202200640RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H1FA	36052752				2022-12-28	WOS:000849626700001
J	Takami, Y; Wang, C; Nakagami, H; Yamamoto, K; Nozato, Y; Imaizumi, Y; Nagasawa, M; Takeshita, H; Nakajima, T; Takeda, S; Takeya, Y; Kaneda, Y; Rakugi, H				Takami, Yoichi; Wang, Cheng; Nakagami, Hironori; Yamamoto, Koichi; Nozato, Yoichi; Imaizumi, Yuki; Nagasawa, Motonori; Takeshita, Hikari; Nakajima, Tsuneo; Takeda, Shuko; Takeya, Yasushi; Kaneda, Yasufumi; Rakugi, Hiromi			Novel pathophysiological roles of alpha-synuclein in age-related vascular endothelial dysfunction	FASEB JOURNAL			English	Article						aging; endothelial function; eNOS; alpha-synuclein	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ALZHEIMERS-DISEASE; SENESCENCE; EXPRESSION; SIRT1; PRECURSOR; PROTEIN	Although alpha-synuclein (SNCA) is a well-known pathological molecule involved in synucleinopathy in neurons, its physiological roles remain largely unknown. We reported that serum SNCA levels have a close inverse correlation with blood pressure and age, which indicates the involvement of SNCA in age-related endothelial dysfunction. Therefore, this study aimed to elucidate the molecular functions of SNCA in the endothelium. We confirmed that SNCA was expressed in and secreted from endothelial cells (ECs). Exogenous treatment with recombinant SNCA (rSNCA) activated the Akt-eNOS axis and increased nitric oxide production in ECs. Treatment with rSNCA also suppressed TNF-alpha- and palmitic acid-induced NF-kappa B activation, leading to the suppression of VCAM-1 upregulation and restoration of eNOS downregulation in ECs. As for endogenous SNCA expression, replicative senescence resulted in the attenuation of SNCA expression in cultured ECs, similar to the effects of physiological aging on mice aortas. The siRNA-mediated silencing of SNCA consistently resulted in senescent phenotypes, such as eNOS downregulation, increased beta-gal activity, decreased Sirt1 expression, and increased p53 expression, in ECs. Ex vivo assessment of endothelial functions using aortic rings revealed impaired endothelium-dependent acetylcholine-induced relaxation in SNCA knockout (KO) mice. Furthermore, SNCA KO mice, especially those on a high-fat diet, displayed elevated blood pressure compared with wild-type mice; this could be eNOS dysfunction-dependent because of the lower difference caused by L-NAME administration. These results indicate that exogenous and endogenous SNCA in ECs might physiologically maintain vascular integrity, and age-related endothelial dysfunction might be partially ascribed to loss-of-function of SNCA in ECs.	[Takami, Yoichi; Wang, Cheng; Yamamoto, Koichi; Nozato, Yoichi; Imaizumi, Yuki; Nagasawa, Motonori; Takeshita, Hikari; Nakajima, Tsuneo; Takeya, Yasushi; Rakugi, Hiromi] Osaka Univ, Dept Geriatr & Gen Med, Grad Sch Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Nakagami, Hironori] Osaka Univ, Dept Hlth Dev & Med, Grad Sch Med, Osaka, Japan; [Takeda, Shuko] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Osaka, Japan; [Takeda, Shuko] Osaka Psychiat Med Ctr, Osaka Psychiat Res Ctr, Osaka, Japan; [Kaneda, Yasufumi] Osaka Univ, Dept Genome Biol, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Takami, Y (corresponding author), Osaka Univ, Dept Geriatr & Gen Med, Grad Sch Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takami@geriat.med.osaka-u.ac.jp			Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI [24790756]; Osaka Heart Club	Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka Heart Club	Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI, Grant/Award Number: 24790756; Osaka Heart Club	Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bassil F, 2020, NEURON, V105, P260, DOI 10.1016/j.neuron.2019.10.010; Bobela W, 2015, BIOMOLECULES, V5, P2675, DOI 10.3390/biom5042675; Bozic M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15732-9; Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cortes-Canteli M, 2020, J AM COLL CARDIOL, V75, P942, DOI 10.1016/j.jacc.2019.10.062; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Cui XP, 2012, BIOL PHARM BULL, V35, P2192, DOI 10.1248/bpb.b12-00598; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Donato AJ, 2009, AGING-US, V1, P678, DOI 10.18632/aging.100080; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fecchio C, 2018, MOLECULES, V23, DOI 10.3390/molecules23071531; Ghosh A, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0357-5; Gurnev PA, 2014, BIOPHYS J, V106, P556, DOI 10.1016/j.bpj.2013.12.028; Haque F, 2010, J PHYS CHEM B, V114, P4070, DOI 10.1021/jp1006704; Katusic ZS, 2016, CIRC J, V80, P1499, DOI 10.1253/circj.CJ-16-0423; Kayed R, 2020, J PARKINSON DIS, V10, P791, DOI 10.3233/JPD-201965; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kubota T, 2013, REV ENDOCR METAB DIS, V14, P207, DOI 10.1007/s11154-013-9242-z; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Loov C, 2016, CELL MOL NEUROBIOL, V36, P437, DOI 10.1007/s10571-015-0317-0; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Man AWC, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01173; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Pak T, 2005, MED SCI MONITOR, V11, pBR357; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Puschmann Andreas, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS24, DOI 10.1016/S1353-8020(11)70010-4; Rodriguez-Araujo G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12081; Rodriguez-Araujo G, 2013, CELL MOL LIFE SCI, V70, P1123, DOI 10.1007/s00018-012-1198-8; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Sharma SK, 2017, CELL MOL LIFE SCI, V74, P617, DOI 10.1007/s00018-016-2340-9; Simonsen AH, 2016, BIOMARK MED, V10, P19, DOI 10.2217/BMM.14.105; Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tamo W, 2002, NEUROSCI LETT, V326, P5, DOI 10.1016/S0304-3940(02)00297-5; Toda N, 2012, PHARMACOL THERAPEUT, V133, P159, DOI 10.1016/j.pharmthera.2011.10.004; Xia N, 2013, NITRIC OXIDE-BIOL CH, V32, P29, DOI 10.1016/j.niox.2013.04.001; Xiao WB, 2014, IMMUNOBIOLOGY, V219, P836, DOI 10.1016/j.imbio.2014.07.014	51	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22555	10.1096/fj.202101621R	http://dx.doi.org/10.1096/fj.202101621R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1RR	36125010				2022-12-28	WOS:000857904200001
J	Lee, D; Nakai, A; Miwa, Y; Tomita, Y; Kunimi, H; Chen, JH; Ikeda, SI; Tsubota, K; Negishi, K; Kurihara, T				Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Tsubota, Kazuo; Negishi, Kazuno; Kurihara, Toshihide			Retinal degeneration induced in a mouse model of ischemia-reperfusion injury and its management by pemafibrate treatment	FASEB JOURNAL			English	Article						fibroblast growth factor 21 (FGF21); inflammation; neuroprotection; pemafibrate; peroxisome proliferator-activated receptor alpha (PPAR alpha); retinal ischemia and degeneration	GANGLION-CELL DEATH; VASCULAR-PERMEABILITY; CAPILLARY DEGENERATION; C-JUN; EXPRESSION; APOPTOSIS; MINOCYCLINE; ACTIVATION; INDUCTION; GLAUCOMA	Retinal ischemia-reperfusion (I/R) injury is a common cause of visual impairment. To date, no effective treatment is available for retinal I/R injury. In addition, the precise pathological mechanisms still need to be established. Recently, pemafibrate, a peroxisome proliferator-activated receptor alpha (PPAR alpha) modulator, was shown to be a promising drug for retinal ischemia. However, the role of pemafibrate in preventing retinal I/R injury has not been documented. Here, we investigated how retinal degeneration occurs in a mouse model of retinal I/R injury by elevation of intraocular pressure and examined whether pemafibrate could be beneficial against retinal degeneration. Adult mice were orally administered pemafibrate (0.5 mg/kg/day) for 4 days, followed by retinal I/R injury. The mice were continuously administered pemafibrate once every day until the end of the experiments. Retinal functional changes were measured using electroretinography. Retina, liver, and serum samples were used for western blotting, quantitative PCR, immunohistochemistry, or enzyme linked immunosorbent assay. Retinal degeneration induced by retinal inflammation was prevented by pemafibrate administration. Pemafibrate administration increased the hepatic PPARa target gene expression and serum levels of fibroblast growth factor 21, a neuroprotective molecule in the eye. The expression of hypoxia-response and pro-and an ti-apoptotic/inflam matory genes increased in the retina following retinal I/R injury; however, these changes were modulated by pemafibrate administration. In conclusion, pemafibrate is a promising preventive drug for ischemic retinopathies.	[Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Negishi, Kazuno; Kurihara, Toshihide] Keio Univ, Lab Photobiol, Sch Med, Tokyo 1608582, Japan; [Lee, Deokho; Nakai, Ayaka; Miwa, Yukihiro; Tomita, Yohei; Kunimi, Hiromitsu; Chen, Junhan; Ikeda, Shin-Ichi; Kurihara, Toshihide] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Nakai, Ayaka] Nihon Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Miwa, Yukihiro] Aichi Anim Eye Clin, Aichi, Aichi 4, Japan; [Tomita, Yohei] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University; Nihon University; Harvard University; Boston Children's Hospital; Harvard Medical School	Kurihara, T (corresponding author), Keio Univ, Lab Photobiol, Sch Med, Tokyo 1608582, Japan.	kurihara@z8.keio.jp		Kurihara, Toshihide/0000-0002-5457-2720; Lee, Deokho/0000-0002-5992-9039	JST SPRING [JPMJSP2123]; KAKENHI [15K10881, 18K09424, 20K18393]	JST SPRING; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JST SPRING, Grant/Award Number: JPMJSP2123; KAKENHI, Grant/Award Number: 15K10881, 18K09424 and 20K18393	Abcouwer SF, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02237-5; Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Abcouwer SF, 2010, INVEST OPHTH VIS SCI, V51, P5920, DOI 10.1167/iovs.10-5264; Ahmed A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14450-5; Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; Andreeva K, 2014, OPHTHALMOL EYE DIS, V6, P43, DOI 10.4137/OED.S17671; Araki E, 2018, DIABETES CARE, V41, P538, DOI 10.2337/dc17-1589; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Ascaso FJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/432685; Bando Hidenori, 2021, JMA J, V4, P135, DOI 10.31662/jmaj.2020-0104; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Belhocine S, 2022, GLIA, V70, P572, DOI 10.1002/glia.24124; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Cao X, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3487607; Chang Yo-Chen, 2013, Rev Diabet Stud, V10, P121, DOI 10.1900/RDS.2013.10.121; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Cheng ZQ, 2021, PPAR RES, V2021, DOI 10.1155/2021/6632137; Chidlow G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114838; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chopra Rupali, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS6, DOI 10.4103/2230-8210.94244; Dohmen K, 2021, KOR J GASTROENTEROL, V78, P227, DOI 10.4166/kjg.2021.092; Dordoe C, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.671131; Ergorul C, 2010, J MOL NEUROSCI, V42, P183, DOI 10.1007/s12031-010-9343-z; Ezra-Elia R, 2017, CURR EYE RES, V42, P452, DOI 10.1080/02713683.2016.1193615; Fu ZJ, 2018, DIABETES, V67, P974, DOI 10.2337/db17-0830; Fu ZJ, 2017, CELL REP, V18, P1606, DOI 10.1016/j.celrep.2017.01.014; Fujita N, 2021, MOL BIOL REP, V48, P195, DOI 10.1007/s11033-020-06032-y; Goebel U, 2021, NEURAL REGEN RES, V16, P192, DOI 10.4103/1673-5374.290098; Grotegut P, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02012-y; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Horikawa T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05431; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RJ, 2018, MOL VIS, V24, P367; Ida S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0845-x; Itoh N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00107; Ji KB, 2021, EXP EYE RES, V209, DOI 10.1016/j.exer.2021.108683; Jiang Y, 2020, SEMIN OPHTHALMOL, V35, P280, DOI 10.1080/08820538.2020.1818796; Jiang YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030824; Kawanishi H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235362; Kim BJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0093-4; Kim SJ, 2016, CURR EYE RES, V41, P844, DOI 10.3109/02713683.2015.1050736; Komiya I, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01434-8; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Kunimi H, 2021, FASEB J, V35, DOI 10.1096/fj.202100572R; Kunimi H, 2019, PEERJ, V7, DOI 10.7717/peerj.7849; Kunimi H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133171; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; Lee DK, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/7727648; Lee DK, 2021, LIFE-BASEL, V11, DOI 10.3390/life11111168; Lee D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179408; Lee D, 2021, PEERJ, V9, DOI 10.7717/peerj.11665; Lee D, 2022, KEIJO J MED, V71, P1, DOI [10.2302/kjm.2021-0004-IR, 10.2302/kjm.2021-0004-IR)]; Lee D, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14030223; Lee D, 2020, JOVE-J VIS EXP, DOI 10.3791/61865; Lee D, 2020, EXP EYE RES, V201, DOI 10.1016/j.exer.2020.108275; Levkovitch-Verbin H, 2006, ARCH OPHTHALMOL-CHIC, V124, P520, DOI 10.1001/archopht.124.4.520; Li J, 2016, CELL PHYSIOL BIOCHEM, V39, P1196, DOI 10.1159/000447826; Li Y, 2003, INVEST OPHTH VIS SCI, V44, P1299, DOI 10.1167/iovs.02-0235; Lima-Fontes Mario, 2020, Porto Biomed J, V5, pe104, DOI 10.1097/j.pbj.0000000000000104; Lin W, 2021, DIABET METAB SYND OB, V14, P3281, DOI 10.2147/DMSO.S317096; Liu L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204346; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Minhas G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00444; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Nakajima A, 2021, ALIMENT PHARM THER, V54, P1263, DOI 10.1111/apt.16596; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Oshitari T, 2014, BRAIN RES BULL, V101, P18, DOI 10.1016/j.brainresbull.2013.12.002; Park JW, 2007, NEUROSCI LETT, V413, P260, DOI 10.1016/j.neulet.2006.11.052; Park JW, 2020, CURR EYE RES, V45, P955, DOI 10.1080/02713683.2019.1705493; Park Sang-Woo, 2012, Chonnam Med J, V48, P116, DOI 10.4068/cmj.2012.48.2.116; Pertl L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08295-1; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ramirez AI, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00214; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rashid K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01975; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Ritzel RM, 2016, MOL VIS, V22, P575; Sasaki Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225682; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimazawa M, 2005, BRAIN RES, V1053, P185, DOI 10.1016/j.brainres.2005.06.053; Shinojima A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10235496; Shiono A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67579-1; Smith RO, 2020, ELIFE, V9, DOI 10.7554/eLife.54056; Storgaard L, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.733080; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Sung MS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205159; Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Tomita Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10204666; Tomita Y, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100433; Tomita Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176243; Tomita Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235878; Tsukamoto Y, 2019, J VET MED SCI, V81, P937, DOI 10.1292/jvms.18-0712; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Wang DX, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01921-2; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yamashita S, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-0823-5; Yao F., 2021, ORIGINAL RES, V8, DOI [10.3389/fmed.2021.788663, DOI 10.3389/FMED.2021.788663]; Ye LX, 2019, EXP NEUROL, V317, P34, DOI 10.1016/j.expneurol.2019.02.013; Yoshida M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01132-2; Zadeh JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194685; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zoppini G, 2012, METABOLISM, V61, P22, DOI 10.1016/j.metabol.2011.05.004	117	2	2	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22497	10.1096/fj.202200455RRR	http://dx.doi.org/10.1096/fj.202200455RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7JT	35969144				2022-12-28	WOS:000840446400001
J	Liu, TT; Zhu, XL; Huang, CL; Chen, J; Shu, S; Chen, GQ; Xu, Y; Hu, YM				Liu, Tingting; Zhu, Xiaolei; Huang, Chaoli; Chen, Jiang; Shu, Shu; Chen, Guiquan; Xu, Yun; Hu, Yimin			ERK inhibition reduces neuronal death and ameliorates inflammatory responses in forebrain-specific Ppp2c alpha knockout mice	FASEB JOURNAL			English	Article						ERK1; 2; neuroinflammation; neuronal apoptosis; PD98059; PP2A	SIGNAL-REGULATED KINASE; TAU HYPERPHOSPHORYLATION; ADULT NEUROGENESIS; MOUSE MODEL; APOPTOSIS; ACTIVATION; PROTEIN; PP2A; PATHWAYS; PHOSPHORYLATION	It has been shown that PP2A is critical for apoptosis in neural progenitor cells. However, it remains unknown whether PP2A is required for neuronal survival. To address this question, we generated forebrain-specific Ppp2c alpha knockout (KO) mice. We show that Ppp2c alpha KO mice display robust neuronal apoptosis and inflammatory responses in the postnatal cortex. Previous evidence has revealed that PD98059 is a potent ERK inhibitor and may protect the brain against cell death after cardiac arrest. To study whether PD98059 may have any effects on Ppp2c alpha KO mice, the latter was treated with this inhibitor. We demonstrated that the total number of cleaved caspase3 positive (+) cells in the cortex was significantly reduced in Ppp2c alpha KO mice treated with PD98059 compared with those without PD98059 treatment. We observed that the total number of IBA1+ cells in the cortex was significantly decreased in Ppp2c alpha KO mice treated with PD98059. Mechanistic analysis reveals that deletion of PP2Aca causes DNA damage, which may be attenuated by PD98059. Together, this study suggests that inhibition of ERK may be an effective strategy to reduce cell death in brain diseases with abnormal neuronal apoptosis.	[Liu, Tingting; Zhu, Xiaolei; Chen, Jiang; Shu, Shu; Xu, Yun] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China; [Liu, Tingting; Zhu, Xiaolei; Chen, Jiang; Shu, Shu; Xu, Yun] Nanjing Univ, Inst Brain Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Huang, Chaoli; Chen, Guiquan] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Hu, Yimin] Nanjing Med Univ, Dept Anesthesiol, Affiliated Changzhou 2 Peoples Hosp, Changzhuu 213003, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Inst Brain Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.; Hu, YM (corresponding author), Nanjing Med Univ, Dept Anesthesiol, Affiliated Changzhou 2 Peoples Hosp, Changzhuu 213003, Peoples R China.	xuyun20042001@aliyun.com; guyueym@njmu.edu.cn		Zhu, Xiaolei/0000-0003-4696-9696	Changzhou Municipal Key Research Program [CJ20210112]; China Postdoctoral Science Foundation [2021M691547]; Jiangsu Postdoctoral Research Funding Program [2021K155B]; National Natural Science Foundation of China (NSFC) [82101388]; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) [BK20201255]	Changzhou Municipal Key Research Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Research Funding Program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)(Natural Science Foundation of Jiangsu Province)	Changzhou Municipal Key Research Program, Grant/Award Number: CJ20210112; China Postdoctoral Science Foundation, Grant/Award Number: 2021M691547; Jiangsu Postdoctoral Research Funding Program, Grant/Award Number: 2021K155B; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82101388; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), Grant/Award Number: BK20201255	Bi HR, 2021, CNS NEUROSCI THER, V27, P174, DOI 10.1111/cns.13454; Bodai L, 2012, BIOESSAYS, V34, P142, DOI 10.1002/bies.201100116; Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; Broad KD, 2009, DEV NEUROBIOL, V69, P314, DOI 10.1002/dneu.20702; Chen LX, 2021, HEPATOLOGY, V73, P2411, DOI 10.1002/hep.31545; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen WF, 2017, PHYTOMEDICINE, V25, P93, DOI 10.1016/j.phymed.2016.12.017; Cheng SS, 2019, J NEUROSCI, V39, P2195, DOI 10.1523/JNEUROSCI.2523-18.2019; Cheng SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10535; Cheng SS, 2014, INT J BIOCHEM CELL B, V57, P186, DOI 10.1016/j.biocel.2014.10.029; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Ehling M, 2020, CIRC RES, V127, P707, DOI 10.1161/CIRCRESAHA.119.316071; Fujita Y, 2014, APOPTOSIS, V19, P339, DOI 10.1007/s10495-013-0917-4; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gokce O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005292; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gu PY, 2012, GENESIS, V50, P429, DOI 10.1002/dvg.20815; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hou JX, 2016, CNS NEUROSCI THER, V22, P244, DOI 10.1111/cns.12509; Hou JX, 2022, FASEB J, V36, DOI 10.1096/fj.202200463R; Hou JX, 2021, J NEUROSCI, V41, P4976, DOI 10.1523/JNEUROSCI.2455-19.2021; Huang CL, 2020, CEREB CORTEX, V30, P4183, DOI 10.1093/cercor/bhaa042; Javadpour P, 2019, CELL MOL LIFE SCI, V76, P2277, DOI 10.1007/s00018-019-03063-y; Kanterewicz BI, 2000, J NEUROSCI, V20, P3057, DOI 10.1523/JNEUROSCI.20-09-03057.2000; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Lee HR, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104466; Lee YJ, 2014, CHEMOSPHERE, V94, P121, DOI 10.1016/j.chemosphere.2013.09.059; Liu B, 2018, INT J BIOCHEM CELL B, V95, P53, DOI 10.1016/j.biocel.2017.12.015; Liu D., 2022, ADV NEUROL, V1; Liu TT, 2017, CNS NEUROSCI THER, V23, P885, DOI 10.1111/cns.12763; Maino B, 2017, EXPERT OPIN DRUG DIS, V12, P249, DOI 10.1080/17460441.2017.1280023; Martin L, 2011, NEUROCHEM INT, V59, P235, DOI 10.1016/j.neuint.2011.05.010; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Salguero I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12929-5; Schafe GE, 2000, J NEUROSCI, V20, P8177; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shen YN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02013-x; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Teng XY, 2022, FASEB J, V36, DOI 10.1096/fj.202101652R; Thiels E, 2002, J NEUROSCI, V22, P2054, DOI 10.1523/JNEUROSCI.22-06-02054.2002; Wang H, 2021, J NEUROSCI, V41, P8163, DOI 10.1523/JNEUROSCI.2432-20.2021; Wang H, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105212; Wang H, 2017, CNS NEUROSCI THER, V23, P99, DOI 10.1111/cns.12647; Wang QH, 2021, EXP NEUROL, V343, DOI 10.1016/j.expneurol.2021.113788; Wong FK, 2019, ANNU REV CELL DEV BI, V35, P523, DOI 10.1146/annurev-cellbio-100818-125204; Xia Y., 2022, DEVELOPMENT, V149; Xu CY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00330; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zeng QY, 2015, CELL MOL LIFE SCI, V72, P4867, DOI 10.1007/s00018-015-1976-1; Zheng JH, 2020, DRUG DES DEV THER, V14, P1107, DOI 10.2147/DDDT.S231980; Zhu LQ, 2010, J NEUROSCI, V30, P3839, DOI 10.1523/JNEUROSCI.5174-09.2010	58	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22515	10.1096/fj.202200293R	http://dx.doi.org/10.1096/fj.202200293R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3X5DG	35997299				2022-12-28	WOS:000843060700001
J	Yokomizo, S; Roessing, M; Morita, A; Kopp, T; Ogawa, E; Katagiri, W; Feil, S; Huang, PL; Atochin, DN; Kashiwagi, S				Yokomizo, Shinya; Roessing, Malte; Morita, Atsuyo; Kopp, Timo; Ogawa, Emiyu; Katagiri, Wataru; Feil, Susanne; Huang, Paul L.; Atochin, Dmitriy N.; Kashiwagi, Satoshi			Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase	FASEB JOURNAL			English	Article						endothelial nitric oxide synthase; near-infrared II; nitric oxide; photobiomodulation	CYTOCHROME-C-OXIDASE; ELECTRON-PARAMAGNETIC-RES; BIPHASIC DOSE-RESPONSE; LASER IRRADIATION; NITROSYL HEMOGLOBIN; CELL-PROLIFERATION; MAMMALIAN-CELLS; MULTIPLE ROLES; IN-VITRO; LIGHT	There is solid evidence of the beneficial effect of photobiomodulation (PBM) with low-power near-infrared (NIR) light in the NIR-I window in increasing bioavailable nitric oxide (NO). However, it is not established whether this effect can be extended to NIR-II light, limiting broader applications of this therapeutic modality. Since we have demonstrated PBM with NIR laser in the NIR-II window, we determined the causal relationship between NIR-II irradiation and its specific biological effects on NO bioavailability. We analyzed the impact of NIR-II irradiation on NO release in cultured human endothelial cells using a NO-sensitive fluorescence probe and single-cell live imaging. Two distinct wavelengths of NIR-II laser (1064 and 1270 nm) and NIR-I (808 nm) at an irradiance of 10 mW/cm(2) induced NO release from endothelial cells. These lasers also enhanced Akt phosphorylation at Ser 473, endothelial nitric oxide synthase (eNOS) phosphorylation at Ser 1177, and endothelial cell migration. Moreover, the NO release and phosphorylation of eNOS were abolished by inhibiting mitochondrial respiration, suggesting that Akt activation caused by NIR-II laser exposure involves mitochondrial retrograde signaling. Other inhibitors that inhibit known Akt activation pathways, including a specific inhibitor of PI3K, Src family PKC, did not affect this response. These two wavelengths of NIR-II laser induced no appreciable NO generation in cultured neuronal cells expressing neuronal NOS (nNOS). In short, NIR-II laser enhances bioavailable NO in endothelial cells. Since a hallmark of endothelial dysfunction is suppressed eNOS with concomitant NO deficiency, NIR-II laser technology could be broadly used to restore endothelial NO and treat or prevent cardiovascular diseases.	[Yokomizo, Shinya; Kashiwagi, Satoshi] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA; [Yokomizo, Shinya] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo, Japan; [Roessing, Malte; Kopp, Timo; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem IFIB, Tubingen, Germany; [Roessing, Malte; Morita, Atsuyo; Kopp, Timo; Huang, Paul L.; Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, 149 13th St, Charlestown, MA 02129 USA; [Ogawa, Emiyu] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Katagiri, Wataru] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa, Japan	Harvard University; Massachusetts General Hospital; Tokyo Metropolitan University; Eberhard Karls University of Tubingen; Harvard University; Massachusetts General Hospital; Kitasato University; Keio University	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA.; Atochin, DN (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, 149 13th St, Charlestown, MA 02129 USA.	atochin@cvrc.mgh.harvard.edu; skashiwagi@mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019		CMI Inc.; National Institute of Allergy and Infectious Diseases (NIAID) [R21AI144103]; German Research Foundation [335549539-GRK2381]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS096237]; Massachusetts General Hospital (MGH); Reinhard Frank-Stiftung	CMI Inc.; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation(German Research Foundation (DFG)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts General Hospital (MGH); Reinhard Frank-Stiftung	CMI Inc., Grant/Award Number: Study Abroad Scholarship; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R21AI144103; German Research Foundation, Grant/Award Number: 335549539-GRK2381; National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS096237; Massachusetts General Hospital (MGH), Grant/Award Number: Executive Committee On Research (ECOR) Interim Support Funding; Reinhard Frank-Stiftung	Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; BOELENS R, 1983, BIOCHIM BIOPHYS ACTA, V724, P176, DOI 10.1016/0005-2728(83)90136-6; BOELENS R, 1982, BIOCHIM BIOPHYS ACTA, V679, P84, DOI 10.1016/0005-2728(82)90258-4; Bohovych I, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00109; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao J, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00487; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chen CH, 2008, LASER SURG MED, V40, P46, DOI 10.1002/lsm.20589; Chen GY, 2012, ACS NANO, V6, P8280, DOI 10.1021/nn302972r; Chinnathambi S, 2019, SCI TECHNOL ADV MAT, V20, P337, DOI 10.1080/14686996.2019.1590731; da Cunha FM, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/482582; Dang XN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39502-w; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dolgova D, 2019, BIOMED OPT EXPRESS, V10, P4261, DOI 10.1364/BOE.10.004261; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gelfand JA, 2019, FASEB J, V33, P3074, DOI 10.1096/fj.201801095R; GHIGO D, 1995, J EXP MED, V181, P9, DOI 10.1084/jem.181.1.9; Grant MKO, 2002, LIFE SCI, V71, P813, DOI 10.1016/S0024-3205(02)01732-0; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Karu T, 2010, PHOTOMED LASER SURG, V28, P159, DOI 10.1089/pho.2010.2789; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Kashiwagi S, 2020, FASEB J, V34, P3485, DOI 10.1096/fj.201902164R; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Katagiri W, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.3.036003; Kawabata A, 1996, BRIT J PHARMACOL, V117, P236, DOI 10.1111/j.1476-5381.1996.tb15181.x; Keszler A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00305; Khan I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10581; Khokhlova A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54905-5; Kimizuka Y, 2018, J IMMUNOL, V201, P3587, DOI 10.4049/jimmunol.1701687; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lohr NL, 2013, J MOL CELL CARDIOL, V62, P36, DOI 10.1016/j.yjmcc.2013.05.007; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Poyton RO, 2011, DISCOV MED, V11, P154; Quirk BJ, 2020, PHOTOBIOMOD PHOTOMED, V38, P527, DOI 10.1089/photob.2020.4905; Reichenbach Gustavo, 2005, Curr Drug Targets Cardiovasc Haematol Disord, V5, P65; Sarti P, 2000, BIOCHEM BIOPH RES CO, V274, P183, DOI 10.1006/bbrc.2000.3117; Sarti P., 2012, INT J CELL BIOL, V2012; Sobrevia L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9782346; Srivastava K, 2012, CELL MOL NEUROBIOL, V32, P319, DOI 10.1007/s10571-011-9777-z; Stael Simon, 2022, Methods Mol Biol, V2447, P127, DOI 10.1007/978-1-0716-2079-3_11; STAMLER JS, 1989, CIRC RES, V65, P796, DOI 10.1161/01.RES.65.3.796; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Stirling DR, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04344-9; Suarez-Arnedo A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232565; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Umbrello M, 2013, ANTIOXID REDOX SIGN, V19, P1690, DOI 10.1089/ars.2012.4979; Uruno A, 2004, HYPERTENS RES, V27, P887, DOI 10.1291/hypres.27.887; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	74	1	1	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22490	10.1096/fj.202101890R	http://dx.doi.org/10.1096/fj.202101890R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N6HZ	35929438				2022-12-28	WOS:000836248900001
J	Halle, JL; Counts, BR; Zhang, Q; Carson, JA				Halle, Jessica L.; Counts, Brittany R.; Zhang, Quan; Carson, James A.			Short duration treadmill exercise improves physical function and skeletal muscle mitochondria protein expression after recovery from FOLFOX chemotherapy in male mice	FASEB JOURNAL			English	Article						aerobic exercise; fatigue; glycolytic muscle; oxidative muscle; OXPHOS; physical activity	CANCER SURVIVORS; COLON-CANCER; TOXICITY; FATIGUE; CACHEXIA; 5-FLUOROURACIL; TIME; MASS	FOLFOX (5-FU, leucovorin, oxaliplatin) is a chemotherapy treatment for colorectal cancer which induces toxic side effects involving fatigue, weakness, and skeletal muscle dysfunction. There is a limited understanding of the recovery from these toxicities after treatment cessation. Exercise training can improve chemotherapy-related toxicities. However, how exercise accelerates recovery and the dose required for these benefits are not well examined. The purpose of this study was to examine the effect of exercise duration on physical function, muscle mass, and mitochondria protein expression during the recovery from FOLFOX chemotherapy. 12-week-old male mice were administered four cycles of either PBS or FOLFOX over 8-weeks. Outcomes were assessed after the fourth cycle and after either 4 (short-term; STR) or 10 weeks (long-term; LTR) recovery. Subsets of mice performed 14 sessions (6 d/wk, 18 m/min, 5% grade) of 60 min/d (long) or 15 min/d (short duration) treadmill exercise during STR. Red and white gastrocnemius mRNA and protein expression were examined. FOLFOX treatment decreased run time (RT) (-53%) and grip strength (GS) (-9%) compared to PBS. FOLFOX also reduced muscle OXPHOS complexes, COXIV, and VDAC protein expression. At LTR, FOLFOX RT (-36%) and GS (-16%) remained reduced. Long- and short-duration treadmill exercise improved RT (+58% and +56%) without restoring GS in FOLFOX mice. Both exercise durations increased muscle VDAC and COXIV expression in FOLFOX mice. These data provide evidence that FOLFOX chemotherapy induces persistent deficits in physical function that can be partially reversed by short-duration aerobic exercise.	[Halle, Jessica L.; Counts, Brittany R.; Zhang, Quan; Carson, James A.] Univ Tennessee Hlth Sci Ctr, Div Rehabil Sci, Coll Hlth Profess, Integrat Muscle Biol Lab, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	Carson, JA (corresponding author), Univ Tennessee Hlth Sci Ctr, Coll Hlth Profess, 630 Madison Ave,Suite 633, Memphis, TN 38163 USA.	jcarso16@uthsc.edu	Zhang, Quan/ABF-9541-2020	Zhang, Quan/0000-0001-6028-6977; Counts, Brittany/0000-0002-4525-9820; Carson, James/0000-0003-3733-8796; Halle, Jessica/0000-0002-3174-5713	National Institutes of Health Grant (National Cancer Institute) [R21 CA-231131]	National Institutes of Health Grant (National Cancer Institute)	This work was supported by the National Institutes of Health Grant (National Cancer Institute) R21 CA-231131 to James A. Carson. The study results are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.	Aapro M, 2017, CLIN COLORECTAL CANC, V16, P275, DOI 10.1016/j.clcc.2016.04.010; de Lima EA, 2020, CANCERS, V12, DOI 10.3390/cancers12113466; Anderson Elizabeth, 2019, Sports Med Health Sci, V1, P3, DOI 10.1016/j.smhs.2019.08.006; [Anonymous], 2008, MEDICINE; Avila JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00974; Ballaro R, 2021, CANCERS, V13, DOI 10.3390/cancers13040850; Ballaro R, 2019, FASEB J, V33, P5482, DOI 10.1096/fj.201801862R; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Barreto R, 2016, ONCOTARGET, V7, P43442, DOI 10.18632/oncotarget.9779; Berger Ann M, 2010, Oncol Nurs Forum, V37, pE359, DOI 10.1188/10.ONF.E359-E369; Bland KA, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08701-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredahl EC, 2016, MED SCI SPORT EXER, V48, P1468, DOI 10.1249/MSS.0000000000000926; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Brown JC, 2018, PSYCHO-ONCOLOGY, V27, P1221, DOI 10.1002/pon.4655; Burnet K, 2019, PHYSIOL BEHAV, V199, P33, DOI 10.1016/j.physbeh.2018.11.007; Burnham TR, 2002, MED SCI SPORT EXER, V34, P1863, DOI 10.1097/00005768-200212000-00001; Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116; Campelj DG, 2021, CANCERS, V13, DOI 10.3390/cancers13143615; Cannioto RA, 2021, JNCI-J NATL CANCER I, V113, P54, DOI 10.1093/jnci/djaa046; Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005; Chung E, 2020, CANCERS, V12, DOI 10.3390/cancers12010060; Counts BR, 2022, MED SCI SPORT EXER, V54, P77, DOI 10.1249/MSS.0000000000002772; Courneya KS, 2003, MED SCI SPORT EXER, V35, P1846, DOI 10.1249/01.MSS.0000093622.41587.B6; Denlinger CS, 2009, J NATL COMPR CANC NE, V7, P883, DOI 10.6004/jnccn.2009.0058; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Feliciano EMC, 2017, CANCER-AM CANCER SOC, V123, P4868, DOI 10.1002/cncr.30950; Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001; George-Gay Beverly, 2003, J Perianesth Nurs, V18, P96, DOI 10.1053/jpan.2003.50013; Geppert J, 2022, CANCERS, V14, DOI 10.3390/cancers14010090; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Groennebaek T, 2020, AM J PHYSIOL-ENDOC M, V318, pE886, DOI 10.1152/ajpendo.00101.2020; Halle Jessica L, 2020, Sports Med Health Sci, V2, P186, DOI 10.1016/j.smhs.2020.11.004; Halle JL., 2021, FRONT CELL DEV BIOL, V9; Jung HW, 2015, SUPPORT CARE CANCER, V23, P687, DOI 10.1007/s00520-014-2418-6; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Kojouharov BM, 2014, ONCOTARGET, V5, P802, DOI 10.18632/oncotarget.1773; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lucini D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030968; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Medysky ME, 2021, J AGING PHYS ACTIV, V29, P1042, DOI 10.1123/japa.2020-0269; Mijwel S, 2018, FASEB J, V32, P5495, DOI 10.1096/fj.201700968R; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Moller AB, 2019, J CANCER RES CLIN, V145, P1449, DOI 10.1007/s00432-019-02911-5; Ormel HL, 2018, PSYCHO-ONCOLOGY, V27, P713, DOI 10.1002/pon.4612; Park SS, 2019, INT NEUROUROL J, V23, pS32, DOI 10.5213/inj.1938046.023; Park SB, 2022, EXPERT REV NEUROTHER, V22, P65, DOI 10.1080/14737175.2022.2018300; Peddle CJ, 2008, DIS COLON RECTUM, V51, P1242, DOI 10.1007/s10350-008-9324-2; Pin F, 2019, J CACHEXIA SARCOPENI, V10, P140, DOI 10.1002/jcsm.12360; Pin F, 2018, CURR OPIN SUPPORT PA, V12, P420, DOI 10.1097/SPC.0000000000000382; Puppa MJ, 2012, J CACHEXIA SARCOPENI, V3, P117, DOI 10.1007/s13539-011-0047-1; Rock CL, 2022, CA-CANCER J CLIN, V72, P230, DOI 10.3322/caac.21719; Rybalka E, 2018, MITOCHONDRION, V42, P33, DOI 10.1016/j.mito.2017.10.010; Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00049; Schmitz KH, 2019, CA-CANCER J CLIN, V69, P468, DOI 10.3322/caac.21579; Schuell B, 2005, BRIT J CANCER, V93, P744, DOI 10.1038/sj.bjc.6602783; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Siegel RL, 2020, CA-CANCER J CLIN, V70, P145, DOI 10.3322/caac.21601; Smoak Peter, 2021, Int J Exerc Sci, V14, P162; Smuder AJ, 2019, AM J PHYSIOL-REG I, V317, pR662, DOI 10.1152/ajpregu.00161.2019; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Sorensen JC, 2016, CANCER CHEMOTH PHARM, V78, P673, DOI 10.1007/s00280-016-3045-3; Taniguchi H, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12618; Thong MSY, 2013, EUR J CANCER, V49, P1957, DOI 10.1016/j.ejca.2013.01.012; Toth MJ, 2020, J APPL PHYSIOL, V128, P1654, DOI 10.1152/japplphysiol.00203.2020; Tremblay MS, 2005, EUR J APPL PHYSIOL, V94, P505, DOI 10.1007/s00421-005-1380-x; Tschakert G, 2022, PHYSIOL REP, V10, DOI 10.14814/phy2.15168; Vanderveen BN, 2020, MED SCI SPORT EXER, V52, P2320, DOI 10.1249/MSS.0000000000002393; VanderVeen BN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.593468; Whalen LB, 2022, GYNECOL ONCOL REP, V39, DOI 10.1016/j.gore.2022.100927; White JP, 2013, BIOL OPEN, V2, P1346, DOI 10.1242/bio.20136544; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010	74	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22437	10.1096/fj.202200460R	http://dx.doi.org/10.1096/fj.202200460R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0GO	35816153				2022-12-28	WOS:000822843400001
J	Lee, CJ; Qiu, TA; Hong, ZL; Zhang, ZK; Min, YH; Zhang, LZX; Dai, L; Zhao, HM; Si, T; Sweedler, JV				Lee, Cindy J.; Qiu, Tian A.; Hong, Zhilai; Zhang, Zhenkun; Min, Yuhao; Zhang, Linzixuan; Dai, Lei; Zhao, Huimin; Si, Tong; Sweedler, Jonathan V.			Profiling of d-alanine production by the microbial isolates of rat gut microbiota	FASEB JOURNAL			English	Article						amino acid; gastrointestinal microbiome; host microbial interactions; mass spectrometry; rats	D-ASPARTIC ACID; D-AMINO ACIDS; LIQUID-CHROMATOGRAPHIC DETERMINATION; BACILLUS-ANTHRACIS; SERINE RACEMASE; PERFORMANCE; BRAIN; IDENTIFICATION; GERMINATION; MODULATION	d-alanine (d-Ala) and several other d-amino acids (d-AAs) act as hormones and neuromodulators in nervous and endocrine systems. Unlike the endogenously synthesized d-serine in animals, d-Ala may be from exogenous sources, e.g., diet and intestinal microorganisms. However, it is unclear if the capability to produce d-Ala and other d-AAs varies among different microbial strains in the gut. We isolated individual microorganisms of rat gut microbiota and profiled their d-AA production in vitro, focusing on d-Ala. Serial dilutions of intestinal contents from adult male rats were plated on agar to obtain clonal cultures. Using MALDI-TOF MS for rapid strain typing, we identified 38 unique isolates, grouped into 11 species based on 16S rRNA gene sequences. We then used two-tier screening to profile bacterial d-AA production, combining a d-amino acid oxidase-based enzymatic assay for rapid assessment of non-acidic d-AA amount and chiral LC-MS/MS to quantify individual d-AAs, revealing 19 out of the 38 isolated strains as d-AA producers. LC-MS/MS analysis of the eight top d-AA producers showed high levels of d-Ala in all strains tested, with substantial inter- and intra-species variations. Though results from the enzymatic assay and LC-MS/MS analysis aligned well, LC-MS/MS further revealed the existence of d-glutamate and d-aspartate, which are poor substrates for this enzymatic assay. We observed large inter- and intra-species variation of d-AA production profiles from rat gut microbiome species, demonstrating the importance of chemical profiling of gut microbiota in addition to sequencing, furthering the idea that microbial metabolites modulate host physiology.	[Lee, Cindy J.; Qiu, Tian A.; Min, Yuhao; Zhang, Linzixuan; Zhao, Huimin; Sweedler, Jonathan V.] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA; [Lee, Cindy J.; Qiu, Tian A.; Min, Yuhao; Zhang, Linzixuan; Zhao, Huimin; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Hong, Zhilai; Zhang, Zhenkun; Dai, Lei; Si, Tong] Chinese Acad Sci, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, CAS Key Lab Quantitat Engn Biol, Shenzhen 518055, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Sweedler, JV (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA.; Sweedler, JV (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.; Si, T (corresponding author), Chinese Acad Sci, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, CAS Key Lab Quantitat Engn Biol, Shenzhen 518055, Peoples R China.	tong.si@siat.ac.cn; jsweedler@illinois.edu	; Sweedler, Jonathan/A-9405-2009	Zhao, Huimin/0000-0002-9069-6739; Lee, Cindy/0000-0002-4707-3755; Sweedler, Jonathan/0000-0003-3107-9922; Zhang, Linzixuan/0000-0001-7163-4906	American Diabetes Association (ADA) [1-18-VSN-19]	American Diabetes Association (ADA)(American Diabetes Association)	American Diabetes Association (ADA), Grant/Award Number: 1-18-VSN-19	Aliashkevich A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00683; Bastings JJAJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092205; Bellais S, 2006, J BIOL CHEM, V281, P11586, DOI 10.1074/jbc.M600114200; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Chang CH, 2021, J PSYCHOPHARMACOL, V35, P265, DOI 10.1177/0269881120972331; Chesnokova ON, 2009, J BACTERIOL, V191, P1303, DOI 10.1128/JB.01098-08; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; D'Aniello A, 2000, FASEB J, V14, P699, DOI 10.1096/fasebj.14.5.699; Dione N, 2016, CLIN MICROBIOL INFEC, V22, P53, DOI 10.1016/j.cmi.2015.10.032; Dodd D, 2007, J BACTERIOL, V189, P5265, DOI 10.1128/JB.00352-07; Etoh S, 2009, ANAL BIOANAL CHEM, V393, P217, DOI 10.1007/s00216-008-2401-5; FOX A, 1993, J CLIN MICROBIOL, V31, P887, DOI 10.1128/JCM.31.4.887-894.1993; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; Hamasu K, 2010, AMINO ACIDS, V38, P57, DOI 10.1007/s00726-008-0204-9; Hernandez SB, 2016, ENVIRON MICROBIOL, V18, P1673, DOI 10.1111/1462-2920.13072; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Ishii C, 2020, CHROMATOGRAPHY, V41, P1, DOI 10.15583/jpchrom.2020.004; Kajitani K, 2021, ENZYME MICROB TECH, V149, DOI 10.1016/j.enzmictec.2021.109835; Karakawa S, 2013, ANAL BIOANAL CHEM, V405, P8083, DOI 10.1007/s00216-013-7071-2; Kawase T, 2017, BRIT J NUTR, V117, P775, DOI [10.1017/S0007114517000678, 10.1017/s0007114517000678]; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; KRAMER R, 1994, FEMS MICROBIOL REV, V13, P75, DOI 10.1111/j.1574-6976.1994.tb00036.x; Krause K., 2015, OPEN FORUM INFECT DI, V2, P881; Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Laubach T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-110; Lee CJ, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140482; Lee RJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7703; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Li DY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45840; Lin CH, 2019, PHARMACOL BIOCHEM BE, V185, DOI 10.1016/j.pbb.2019.172760; Lin CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13951-7; Liu YL, 2020, TRENDS ENDOCRIN MET, V31, P818, DOI 10.1016/j.tem.2020.02.012; Lockridge AD, 2016, ISLETS, V8, P195, DOI 10.1080/19382014.2016.1260797; Marcone GL, 2020, APPL MICROBIOL BIOT, V104, P555, DOI 10.1007/s00253-019-10264-9; Matsumoto M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36244-z; Morikawa A, 2007, BIOCHEM BIOPH RES CO, V355, P872, DOI 10.1016/j.bbrc.2007.02.056; Mortuza R., 2017, THESIS PHENOTYPIC MO; Mothet JP, 2015, J NEUROCHEM, V135, P210, DOI 10.1111/jnc.13204; Nakade Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97957; Ota N, 2014, BIOCHEM BIOPH RES CO, V447, P328, DOI 10.1016/j.bbrc.2014.03.153; Patnode ML, 2021, CELL HOST MICROBE, V29, P664, DOI 10.1016/j.chom.2021.01.007; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Pollegioni L, 2011, TRENDS BIOTECHNOL, V29, P276, DOI 10.1016/j.tibtech.2011.01.010; PRESTON RA, 1984, J GEN MICROBIOL, V130, P3123; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rastelli M, 2019, ENDOCR REV, V40, P1271, DOI 10.1210/er.2018-00280; Reynolds PE, 2005, ANTIMICROB AGENTS CH, V49, P21, DOI 10.1128/AAC.49.1.21-25.2005; Roshanzamir F, 2017, INT J REPROD BIOMED, V15, P1; Rosini E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134574; Rosini E, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00102; Sasabe J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.125, 10.1038/nmicrobiol.2016.125]; Savignac HM, 2013, NEUROCHEM INT, V63, P756, DOI 10.1016/j.neuint.2013.10.006; Seckler JM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197325; Sela U, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006726; Sieradzki K, 1996, FEMS MICROBIOL LETT, V142, P161; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Suzuki M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6480; Trachtenberg S, 1998, J STRUCT BIOL, V124, P244, DOI 10.1006/jsbi.1998.4063; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Wang LP, 2011, J BIOL CHEM, V286, P13765, DOI 10.1074/jbc.M110.178228; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wong D, 2020, J ALZHEIMERS DIS, V73, P1385, DOI 10.3233/JAD-190773; Yang C, 2020, CELL HOST MICROBE, V27, P467, DOI 10.1016/j.chom.2020.01.016; Zeng D, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026989	68	0	0	11	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22446	10.1096/fj.202101595R	http://dx.doi.org/10.1096/fj.202101595R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0GL	35816159				2022-12-28	WOS:000822843100001
J	Meganathan, V; Hamilton, CE; Natarajan, K; Keshava, S; Boggaram, V				Meganathan, Velmurugan; Hamilton, Cory E.; Natarajan, Kartiga; Keshava, Shiva; Boggaram, Vijay			NADPH and xanthine oxidases control induction of inflammatory mediator expression by organic dust in the lung	FASEB JOURNAL			English	Article						cytokines; gene regulation; occupational lung diseases; oxidative stress	NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; LIVESTOCK BUILDINGS; OXIDATIVE STRESS; GENE-EXPRESSION; NOX FAMILY; SWINE DUST; BARN DUST; IL-8; ACID	Exposure to organic dust in animal and agricultural farms and the ensuing lung inflammation are linked to the development of respiratory diseases. We found previously that elevated production of reactive oxygen species (ROS) by aqueous poultry organic dust extract (hereafter referred to as dust extract) mediates induction of proinflammatory mediators in airway epithelial cells. In the present study, we investigated whether ROS generated by NADPH oxidases (NOX) and xanthine oxidase (XO) controls induction of inflammatory mediators by dust extract and the underlying mechanisms in bronchial epithelial cells. Using chemical inhibitors and siRNA targeted knockdown, we found that NOX1, NOX2, NOX4, and XO-derived ROS regulates induction of proinflammatory mediator levels. Like airway epithelial cells in vitro, NOX inhibitor VAS2870 reduced keratinocyte chemoattractant (KC), IL-6, and TNF-alpha production and 4-hydroxynonenal (4-HNE) staining induced by dust extract in mouse lungs. VAS2870 inhibition of proinflammatory mediators was associated with reduced NF kappa B and Stat3 activation indicating that NOX generated ROS activates NF kappa B and Stat3 to induce proinflammatory gene expression. Dust extract increased the membrane association of p47(phox) in airway epithelial cells indicating NOX2 activation but had no effect on NOX2 protein levels. In summary, our studies have shown that NOX and XO generated ROS control organic dust induction of proinflammatory mediators in airway epithelial cells via NF kappa B and Stat3 activation.	[Meganathan, Velmurugan; Hamilton, Cory E.; Natarajan, Kartiga; Keshava, Shiva; Boggaram, Vijay] Univ Texas Tyler, Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75708 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Boggaram, V (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Highway 271, Tyler, TX 75708 USA.	vijay.boggaram@uthct.edu		Boggaram, Vijayakumar/0000-0002-6144-5703	National Institute of Occupational Safety and Health [U54OH007541]	National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Centers for Disease Control and the National Institute of Occupational Safety and Health, Grant/Award Number: U54OH007541 Dedicated to the memory of Usha R. Pendurthi, Ph.D., a great friend and colleague who has made outstanding contributions in the field of thrombosis and hemostasis.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Augsburger F, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101272; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Blanc PD, 2019, AM J RESP CRIT CARE, V199, P1312, DOI 10.1164/rccm.201904-0717ST; Boggaram V, 2016, PHYSIOL GENOMICS, V48, P281, DOI 10.1152/physiolgenomics.00096.2015; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Brandes RP, 2014, ANTIOXID REDOX SIGN, V20, P887, DOI 10.1089/ars.2013.5414; CLARK S, 1983, AM IND HYG ASSOC J, V44, P537, DOI 10.1080/15298668391405265; Cleave J, 2010, J TOXICOL ENV HEAL A, V73, P1090, DOI 10.1080/15287394.2010.482916; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Gottipati KR, 2015, AM J PHYSIOL-LUNG C, V308, pL11, DOI 10.1152/ajplung.00215.2014; Hassoun PM, 1998, AM J RESP CRIT CARE, V158, P299, DOI 10.1164/ajrccm.158.1.9709116; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-110; Huang CT, 2014, BBA-MOL CELL RES, V1843, P483, DOI 10.1016/j.bbamcr.2013.11.015; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; Larsson BM, 1997, THORAX, V52, P638, DOI 10.1136/thx.52.7.638; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liu QJ, 2017, BIOMED RES-INDIA, V28, P5020; Loffredo L, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8630275; Meganathan V, ROLE NADPH OXIDASES; Meganathan V, 2020, AM J PHYSIOL-LUNG C, V319, pL893, DOI 10.1152/ajplung.00107.2020; Mitchell CT., 2015, THESIS U TEXAS HLTH; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Namai-Takahashi A, 2019, AM J HYPERTENS, V32, P26, DOI 10.1093/ajh/hpy143; Natarajan K, 2019, AM J PHYSIOL-LUNG C, V317, pL127, DOI 10.1152/ajplung.00448.2018; Natarajan K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0455-z; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Palmberg L, 1998, THORAX, V53, P260, DOI 10.1136/thx.53.4.260; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Poole JA, 2011, AM J RESP CELL MOL, V45, P711, DOI 10.1165/rcmb.2010-0427OC; Poole JA, 2010, J TOXICOL ENV HEAL A, V73, P684, DOI 10.1080/15287390903578539; Poole JA, 2009, AM J PHYSIOL-LUNG C, V296, pL1085, DOI 10.1152/ajplung.90622.2008; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Radon K, 2001, OCCUP ENVIRON MED, V58, P405, DOI 10.1136/oem.58.6.405; Romberger DJ, 2002, J APPL PHYSIOL, V93, P289, DOI 10.1152/japplphysiol.00815.2001; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Smith JK, 2012, FREE RADICAL BIO MED, V52, P1101, DOI 10.1016/j.freeradbiomed.2011.12.025; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Takai H, 1998, J AGR ENG RES, V70, P59, DOI 10.1006/jaer.1997.0280; Dao VTV, 2020, FREE RADICAL BIO MED, V148, P60, DOI 10.1016/j.freeradbiomed.2019.12.038; Wang Z, 1997, EUR RESPIR J, V10, P381, DOI 10.1183/09031936.97.10020381; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Wyatt TA, 2007, AM J PHYSIOL-LUNG C, V293, pL1163, DOI 10.1152/ajplung.00103.2007	54	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22381	10.1096/fj.202100732R	http://dx.doi.org/10.1096/fj.202100732R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1V6YX	35661421				2022-12-28	WOS:000806233800001
J	Rosenberg, T; Marco, A; Kisliouk, T; Haron, A; Shinder, D; Druyan, S; Meiri, N				Rosenberg, Tali; Marco, Asaf; Kisliouk, Tatiana; Haron, Amit; Shinder, Dmitry; Druyan, Shelly; Meiri, Noam			Embryonic heat conditioning in chicks induces transgenerational heat/immunological resilience via methylation on regulatory elements	FASEB JOURNAL			English	Article						cross-tolerance; embryonic heat conditioning; epigenetics; heredity; hypothalamus; stress	DNA METHYLATION; STRESS; ORGANIZATION; METHYLOME; MOUSE; CTCF; INHERITANCE; MACROPHAGE; ENHANCERS; PROMOTES	The question of whether behavioral traits are heritable is under debate. An obstacle in demonstrating transgenerational inheritance in mammals originates from the maternal environment's effect on offspring phenotype. Here, we used in ovo embryonic heat conditioning (EHC) of first-generation chicks, demonstrating heredity of both heat and immunological resilience, confirmed by a reduced fibril response in their untreated offspring to either heat or LPS challenge. Concordantly, transcriptome analysis confirmed that EHC induces changes in gene expression in the anterior preoptic hypothalamus (APH) that contribute to these phenotypes in the offspring. To study the association between epigenetic mechanisms and trait heritability, DNA-methylation patterns in the APH of offspring of control versus EHC fathers were evaluated. Genome-wide analysis revealed thousands of differentially methylated sites (DMSs), which were highly enriched in enhancers and CCCTC-binding factor (CTCF) sites. Overlap analysis revealed 110 differentially expressed genes that were associated with altered methylation, predominantly on enhancers. Gene-ontology analysis shows pathways associated with immune response, chaperone-mediated protein folding, and stress response. For the proof of concept, we focused on HSP25 and SOCS3, modulators of heat and immune responses, respectively. Chromosome conformational capture (3C) assay identified interactions between their promoters and methylated enhancers, with the strongest frequency on CTCF binding sites. Furthermore, gene expression corresponded with the differential methylation patterns, and presented increased CTCF binding in both hyper- and hypomethylated DMSs. Collectively, we demonstrate that EHC induces transgenerational thermal and immunological resilience traits. We propose that one of the mechanisms underlying inheritance depends on three-dimensional (3D) chromatin reorganization.	[Rosenberg, Tali; Kisliouk, Tatiana; Haron, Amit; Shinder, Dmitry; Druyan, Shelly; Meiri, Noam] Agr Res Org, Inst Anim Sci, Volcani Ctr, Rishon Leziyyon, Israel; [Marco, Asaf] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Meiri, N (corresponding author), Agr Res Org, Inst Anim Sci, Volcani Ctr, Rishon Leziyyon, Israel.	noam.meiri@mail.huji.ac.il		Meiri, Noam/0000-0002-4198-5665	Division of Integrative Organismal Systems (IOS) [2041923]; United States-Israel Binational Science Foundation (BSF) [2020663]	Division of Integrative Organismal Systems (IOS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	Division of Integrative Organismal Systems (IOS), Grant/Award Number: 2041923; United States-Israel Binational Science Foundation (BSF), Grant/Award Number: 2020663	Aarabi M, 2015, HUM MOL GENET, V24, P6301, DOI 10.1093/hmg/ddv338; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baheti S, 2017, EPIGENOMICS-UK, V9, P1423, DOI 10.2217/epi-2017-0050; Frost DB, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020129; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bartelt A, 2018, NAT MED, V24, P292, DOI 10.1038/nm.4481; Bomans K, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0522-z; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boskovic A, 2018, ANNU REV GENET, V52, P21, DOI 10.1146/annurev-genet-120417-031404; Braccioli L, 2019, ESSAYS BIOCHEM, V63, P157, DOI 10.1042/EBC20180069; Cobb-Vantress, 2018, BROIL MAN GUID; Cobo I, 2018, NATURE, V554, P533, DOI 10.1038/nature25751; Cramer T, 2019, MOL PSYCHIATR, V24, P1013, DOI 10.1038/s41380-018-0280-5; Damaschke NA, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00869-7; Dekker J, 2017, NATURE, V549, P219, DOI 10.1038/nature23884; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duman R, 2018, J PHARM RES INT, V21, DOI 10.9734/JPRI/2018/39888; Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Foissac S, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0726-5; Freschi A, 2021, HUM MOL GENET, V30, P1509, DOI 10.1093/hmg/ddab132; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Godden KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106977; Golzenleuchter M, 2015, EPIGENETICS-US, V10, P200, DOI 10.1080/15592294.2015.1006493; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231; Haller S, 2015, NUCL MED BIOL, V42, P226, DOI 10.1016/j.nucmedbio.2014.10.010; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huber E, 2020, ANIM REPROD SCI, V216, DOI 10.1016/j.anireprosci.2020.106348; Janaszak-Jasiecka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22775; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Kern C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22100-8; Kim YM, 2018, INT J DEV BIOL, V62, P145, DOI 10.1387/ijdb.170283jh; Kisliouk T, 2013, NEUROSCIENCE, V238, P114, DOI 10.1016/j.neuroscience.2013.02.020; Kisliouk T, 2017, J NEUROCHEM, V141, P358, DOI 10.1111/jnc.14014; Kovar H, 2014, EXPERT OPIN THER TAR, V18, P1315, DOI 10.1517/14728222.2014.947963; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Levine M, 2020, ELIFE, V9, DOI 10.7554/eLife.59201; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu JZ, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.595603; Liu JZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00267; Soto EJL, 2020, ELIFE, V9, DOI 10.7554/eLife.54879; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; Meriin AB, 2018, P NATL ACAD SCI USA, V115, pE7043, DOI 10.1073/pnas.1803130115; Nanavaty V, 2020, MOL CELL, V78, P752, DOI 10.1016/j.molcel.2020.03.024; Niklasson CU, 2021, DEV DYNAM, V250, P191, DOI 10.1002/dvdy.253; Nohara K, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00375-3; Norouzitallab P, 2014, FASEB J, V28, P3552, DOI 10.1096/fj.14-252049; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Piestun Y, 2008, POULTRY SCI, V87, P1516, DOI 10.3382/ps.2008-00030; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rajarajan P, 2016, NAT REV NEUROSCI, V17, P681, DOI 10.1038/nrn.2016.124; Rea M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41474; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg T, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00767; Rosenberg T, 2021, EPIGENETICS-US, V16, P228, DOI 10.1080/15592294.2020.1795596; Roy S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02745; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schoenfelder S, 2019, NAT REV GENET, V20, P437, DOI 10.1038/s41576-019-0128-0; Sharifi-Zarchi A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4353-7; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Tanaka S, 2019, INT J MOL MED, V43, P2164, DOI 10.3892/ijmm.2019.4143; Tanaka S, 2016, BRAIN BEHAV IMMUN, V57, P58, DOI 10.1016/j.bbi.2016.06.009; Tarjan DR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12166-w; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Umeda M, 2019, CURR OPIN PLANT BIOL, V51, P1, DOI 10.1016/j.pbi.2019.03.001; van Arensbergen J, 2014, TRENDS CELL BIOL, V24, P695, DOI 10.1016/j.tcb.2014.07.004; Voisin AS, 2022, EPIGENETICS-US, V17, P473, DOI 10.1080/15592294.2021.1921337; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wei L, 2020, INT J BIOCHEM CELL B, V120, DOI 10.1016/j.biocel.2020.105685; Wiehle L, 2019, GENOME RES, V29, P750, DOI 10.1101/gr.239707.118; Xu CH, 2018, SCIENCE, V359, P1166, DOI 10.1126/science.aan5480; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	83	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22406	10.1096/fj.202101948R	http://dx.doi.org/10.1096/fj.202101948R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6PE	35713935	hybrid			2022-12-28	WOS:000812348200001
J	Chen, EY; Chang, HQ; Gao, R; Qiu, YH; Chen, H; Cheng, X; Gan, L; Ye-Lehmann, S; Zhu, T; Liu, J; Chen, G; Chen, C				Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Chen, Hai; Cheng, Xu; Gan, Lu; Ye-Lehmann, Shixin; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan			Poly(I:C) attenuates myocardial ischemia/reperfusion injury by restoring autophagic function	FASEB JOURNAL			English	Article						autophagy; cardio-protection; ischemia; reperfusion injury; Poly(I; C)	ISCHAEMIA/REPERFUSION INJURY; PI3K/AKT/MTOR PATHWAY; REPERFUSION INJURY; HEART; ISCHEMIA; PROTEIN; CARDIOPROTECTION; CONTRIBUTES; PROTECTION; CLEARANCE	Polyinosinic-polycytidylic acid (poly(I:C)) is the agonist of Toll-like receptor 3 (TLR3), which participates in innate immune responses under the condition of myocardial ischemia/reperfusion injury (MIRI). It has been shown that poly(I:C) exhibited cardioprotective activities through the PI3K/Akt pathway, which is the main signal transduction pathway during autophagy. However, the precise mechanism by whether poly(I:C) regulates autophagy remains poorly understood. Thus, this study was designed to investigate the therapeutic effect of poly(I:C) against MIRI and the underlying pathway connection with autophagy. We demonstrated that 1.25 and 5 mg/kg poly(I:C) preconditioning significantly reduced myocardial infarct size and cardiac dysfunction. Moreover, poly(I:C) significantly promoted cell survival by restoring autophagy flux and then regulating it to an adequate level Increased autophagy protein Beclin1 and LC3II together with p62 degradation after additional chloroquine. In addition, mRFP-GFP-LC3 adenoviruses exhibited autophagy activity in neonatal rat cardiac myocytes (NRCMs). Mechanistically, poly(I:C) activated the PI3K/AKT/mTOR pathway to induce autophagy, which was abolished by LY294002 (PI3K antagonist), rapamycin (autophagy activator and mTOR inhibitor), or 3-methyladenine (autophagy inhibitor), suggesting either inhibition of the PI3K/Akt/mTOR pathway or autophagy activity interrupt the beneficial effect of poly(I:C) preconditioning. In conclusion, poly(I:C) promotes cardiomyocyte survival from ischemia/reperfusion injury by regulating autophagy via the PI3K/Akt/mTOR pathway.	[Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Cheng, Xu; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan] Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu, Peoples R China; [Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Cheng, Xu; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan] Chinese Acad Med Sci, Lab Anesthesia & Crit Care Med, Natl Clin Res Ctr Geriatr, Translat Neurosci Ctr,Res Units West China, Chengdu, Peoples R China; [Chen, Hai] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Targeted Tracer Res & Dev Lab, Chengdu, Peoples R China; [Gan, Lu] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China; [Ye-Lehmann, Shixin] Univ Paris Scalay, Bicetre Hosp, Dis & Hormones Nervous Syst, INSERM Tenured Researcher CR INSERM Res Unit U119, Le Kremlin Bicetre, France	Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Sichuan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Chen, G; Chen, C (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu, Peoples R China.	grace_chenguo@hotmail.com; xychenchan@gmail.com		Chen, Chan/0000-0001-5823-8247	National Natural Science Foundation of China [82171185, 81870858, 81671062]; National Key R&D Program of China [2018YFC2001800]; Science and Technology Plan Project of Sichuan Province [2020YJ0051]; Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau [2015-HM01-00446-SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science and Technology Plan Project of Sichuan Province; Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau	This work was supported by the National Natural Science Foundation of China (Grant No. 82171185 and No. 81870858 to Dr. Chan Chen; No. 81671062 to Dr. Tao Zhu); the National Key R&D Program of China (Grant No. 2018YFC2001800 to Dr. Tao Zhu); Science and Technology Plan Project of Sichuan Province (No. 2020YJ0051 to Chen Chan). Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau (No. 2015--HM01-00446--SF to Dr. Yanhua Qiu)	Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Chen EY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00257-w; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dong JW, 2010, AM J PHYSIOL-HEART C, V298, pH1079, DOI 10.1152/ajpheart.00306.2009; Fan SN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/161020; Gao T, 2018, J CELL MOL MED, V22, P395, DOI 10.1111/jcmm.13328; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Gottlieb RA, 2011, AUTOPHAGY, V7, P434, DOI 10.4161/auto.7.4.14442; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hernandez-Resendiz S, 2018, CURR MED CHEM, V25, P1275, DOI 10.2174/0929867324666170329100619; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li HY, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100111; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma XC, 2012, AUTOPHAGY, V8, P1394, DOI 10.4161/auto.21036; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roy B, 2014, CHEM-BIOL INTERACT, V210, P96, DOI 10.1016/j.cbi.2014.01.003; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shanmugam K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9173436; Sun H, 2013, ANTI-CANCER AGENT ME, V13, P1048, DOI 10.2174/18715206113139990130; Tao ZW, 2018, ASAIO J, V64, pE105, DOI 10.1097/MAT.0000000000000765; van der Bijl P, 2020, JACC-HEART FAIL, V8, P131, DOI 10.1016/j.jchf.2019.08.014; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Xu Xianghua, 2009, J Vis Exp, DOI 10.3791/1308; Zacharowski K, 2000, ARTERIOSCL THROM VAS, V20, P1521, DOI 10.1161/01.ATV.20.6.1521; Zheng YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.7; Zhou H, 2018, CELL SIGNAL, V45, P12, DOI 10.1016/j.cellsig.2018.01.020; Zuurbier CJ, 2019, CARDIOVASC RES, V115, P1131, DOI 10.1093/cvr/cvy304	40	1	1	7	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22317	10.1096/fj.202101220RR	http://dx.doi.org/10.1096/fj.202101220RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O5YU	35438806				2022-12-28	WOS:000783602200001
J	Garrison, HH; Ley, TJ				Garrison, Howard H.; Ley, Timothy J.			Physician-scientists in the United States at 2020: Trends and concerns	FASEB JOURNAL			English	Article						physician-scientist; research; training; workforce	TRAINING-PROGRAM; CLINICIAN-SCIENTISTS; INVESTIGATORS; CHALLENGES; WORKFORCE; RECOMMENDATIONS; OPPORTUNITIES; PERSPECTIVE; MEDICINE; PIPELINE	Physician-scientists comprise a unique and valuable part of the biomedical workforce, but for decades there has been concern about the number of physicians actively engaged in research. Reports have outlined the challenges facing physician-scientists, and programs have been initiated to encourage and facilitate research careers for medically trained scientists. Many of these initiatives have demonstrated successful outcomes, but there has not been a recent summary of the impact of the past decade of effort. This report compiles available data from surveys of medical education and physician research participation to assess changes in the physician-scientist workforce from 2011-2020. Several trends are positive: rising enrollments in MD-PhD programs, greater levels of interest in research careers among matriculating medical students, more research experience during medical school and rising numbers of physicians in academic medicine, and an increase in first R01 grants to physician-scientists. However, there are now decreased levels of interest in research careers among graduating medical students, a steady decline in MDs applying for NIH loan repayment program support, an increased age at first R01 grant success for physicians, and fewer physicians reporting research as their primary work activity: all of these indicators create concern for the stability of the career path. Despite a recommendation by the Physician-Scientist Workforce in 2014 to create "real-time" reporting on NIH grants and grantees to help the public assess trends, this initiative has not been completed. Better information is still needed to fully understand the status of the physician-scientist workforce, and to assess efforts to stabilize this vulnerable career path.	[Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Genet, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Garrison, HH (corresponding author), 5604 Harwick Rd, Bethesda, MD 20816 USA.	hhgarrison9650@gmail.com		Garrison, Howard/0000-0001-9455-3527	Doris Duke Charitable Foundation; Barnes Jewish Hospital Foundation; Lewis T. and Rosalind B. Apple Chair in Oncology	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Barnes Jewish Hospital Foundation; Lewis T. and Rosalind B. Apple Chair in Oncology	This work was supported by the Doris Duke Charitable Foundation. The views expressed in this paper, however, are those of the authors and may not represent those of the Doris Duke Charitable Foundation. TJL was supported by the Barnes Jewish Hospital Foundation and the Lewis T. and Rosalind B. Apple Chair in Oncology.	Akabas MH., AM ASS MED COLL REPO; American Board of Dermatology, INV TRAIN TRACK INV; American Board of Internal Medicine, RES PATHW POL REQ RE; American Board of Pediatrics, INT RES PATHW INT RE; American Board of Radiology, HOLM RES PATHW; American Medical Association, 1980, PHYS CHAR DISTR US; Andriole DA, 2008, JAMA-J AM MED ASSOC, V300, P1165, DOI 10.1001/jama.300.10.1165; Andriole DA, 2020, ANN SURG, V271, P590, DOI 10.1097/SLA.0000000000003015; Andriole DA, 2016, MED EDUC ONLINE, V21, DOI 10.3402/meo.v21.30941; Association of American Medical Colleges, 2021, 2021 FACTS ENR GRAD; Association of American Medical Colleges, 2018, PHYS SPECIALTY DATA; Association of American Medical Colleges, 2020, PHYS SPECIALTY DATA; Association of American Medical Colleges, 2012, MED SCH GRAD QUEST A; Association of American Medical Colleges, 2016, PHYS SPECIALTY DATA; Association of American Medical Colleges, POL PRIOR IMPR OUR N; Association of American Medical Colleges, 2012, MATR STUD QUEST ALL; Association of American Medical Colleges, 2021 FACTS APPL MATR; Blish CA, 2018, J INFECT DIS, V218, pS40, DOI 10.1093/infdis/jiy093; Brass LF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133009; Buja LM, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1535-9; Calhoun A, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00328-4; Daye D, 2015, J CLIN INVEST, V125, P883, DOI 10.1172/JCI80933; Dickler HB, 2007, JAMA-J AM MED ASSOC, V297, P2496, DOI 10.1001/jama.297.22.2496; Ellaithy A, 2019, NEUROLOGY, V92, P1159, DOI 10.1212/WNL.0000000000007657; Escobar-Alvarez SN, 2013, ACAD MED, V88, P1740, DOI 10.1097/ACM.0b013e3182a7a38e; Garrison HH, 2014, FASEB J, V28, P1049, DOI 10.1096/fj.13-241687; GILL GN, 1984, AM SCHOLAR, V53, P353; Goldstein AM, 2019, ANN SURG, V269, P66, DOI 10.1097/SLA.0000000000002840; Goldstein JL, 2012, SCIENCE, V338, P1033, DOI 10.1126/science.1231699; Hall AK, 2017, ACAD MED, V92, P1382, DOI 10.1097/ACM.0000000000001859; Ikizler TA, 2015, AM J KIDNEY DIS, V65, P381, DOI 10.1053/j.ajkd.2014.11.008; Jain MK, 2019, NEW ENGL J MED, V381, P399, DOI 10.1056/NEJMp1904482; Jeffe DB, 2018, J INVEST MED, V66, P340, DOI 10.1136/jim-2017-000515; Keenan HT, 2020, PEDIATR CRIT CARE ME, V21, P672, DOI 10.1097/PCC.0000000000002348; King A, 2013, J SURG RES, V184, P66, DOI 10.1016/j.jss.2013.03.050; Lauer M., 2021, LONG TERM TRENDS AGE; Ley TJ, 2008, SCIENCE, V322, P1472, DOI 10.1126/science.1165878; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; McElvaine AT, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149948; Milewicz DM, 2015, J CLIN INVEST, V125, P3742, DOI 10.1172/JCI84170; MOODY FG, 1987, AM J SURG, V153, P337, DOI 10.1016/0002-9610(87)90572-1; Muslin AJ, 2009, ACAD MED, V84, P468, DOI 10.1097/ACM.0b013e31819a8158; National Institutes of Health, 2014, PHYS SCI WORKF REP; National Institutes of Health, 2021, TABL 201 NIH IND POS; National Institutes of Health, 2021, LOAN REP PROGR DASHB; National Institutes of Health Office of the Budget, 2021, HIST C APPR FISC YEA; Nikaj S, 2019, ACAD MED, V94, P708, DOI 10.1097/ACM.0000000000002543; Ognibene FP, 2016, ACAD MED, V91, P1684, DOI 10.1097/ACM.0000000000001245; Okeigwe I, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.007; Remick DG., 2016, ACAD PATHOL, V3, DOI [10.1177/237428516632240, DOI 10.1177/237428516632240]; Roberts SF, 2012, ACAD MED, V87, P266, DOI 10.1097/ACM.0b013e3182446fa3; Rockey S, 2013, ROCK TALK BLOG 0201; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; Salata RA, 2018, ACAD MED, V93, P565, DOI 10.1097/ACM.0000000000001950; Shen KL, 2020, WORLD J PEDIATR, V16, P232, DOI 10.1007/s12519-020-00362-4; Steinman RA, 2020, ACAD MED, V95, P1373, DOI 10.1097/ACM.0000000000003197; Strong MJ, 2018, ACAD MED, V93, P172, DOI 10.1097/ACM.0000000000001857; THIER SO, 1980, CLIN RES, V28, P85; Traill CL, 2016, INTERN MED J, V46, P550, DOI 10.1111/imj.13043; Usadi RS, 2014, FERTIL STERIL, V102, P1542, DOI 10.1016/j.fertnstert.2014.09.002; Van Epps JS, 2011, ACAD EMERG MED, V18, P759, DOI 10.1111/j.1553-2712.2011.01118.x; Wong Mitchell D, 2016, J Grad Med Educ, V8, P85, DOI 10.4300/JGME-D-15-00135.1; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303; Youngclaus J., 2020, PHYS ED DEBT COST AT; Zell A, 2018, J CLIN TRANSL SCI, V2, P305, DOI 10.1017/cts.2018.328; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221	67	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22253	10.1096/fj.202200327	http://dx.doi.org/10.1096/fj.202200327			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0A6EH	35349197	Green Published, hybrid			2022-12-28	WOS:000774044900001
J	Naser, W; Maymand, S; Rivera, LR; Connor, T; Liongue, C; Smith, CM; Aston-Mourney, K; McCulloch, DR; McGee, SL; Ward, AC				Naser, Wasan; Maymand, Saeed; Rivera, Leni R.; Connor, Timothy; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.			Cytokine-inducible SH2 domain containing protein contributes to regulation of adiposity, food intake, and glucose metabolism	FASEB JOURNAL			English	Article						adiposity; appetite; CISH; cytokine; glucose metabolism; leptin; SOCS	ENERGY-EXPENDITURE; INSULIN-RESISTANCE; MICE LACKING; LEPTIN RECEPTOR; GENE-EXPRESSION; NEUROPEPTIDE-Y; SOCS PROTEINS; T-CELLS; SUPPRESSOR; DELETION	The cytokine-inducible SH2 domain containing protein (CISH) is the founding member of the suppressor of cytokine signaling (SOCS) family of negative feedback regulators and has been shown to be a physiological regulator of signaling in immune cells. This study sought to investigate novel functions for CISH outside of the immune system. Mice deficient in CISH were generated and analyzed using a range of metabolic and other parameters, including in response to a high fat diet and leptin administration. CISH knockout mice possessed decreased body fat and showed resistance to diet-induced obesity. This was associated with reduced food intake, but unaltered energy expenditure and microbiota composition. CISH ablation resulted in reduced basal expression of the orexigenic Agrp gene in the arcuate nucleus (ARC) region of the brain. Cish was basally expressed in the ARC, with evidence of co-expression with the leptin receptor (Lepr) gene in Agrp-positive neurons. CISH-deficient mice also showed enhanced leptin responsiveness, although Cish expression was not itself modulated by leptin. CISH-deficient mice additionally exhibited improved insulin sensitivity on a high-fat diet, but not glucose tolerance despite reduced body weight. These data identify CISH as an important regulator of homeostasis through impacts on appetite control, mediated at least in part by negative regulation of the anorexigenic effects of leptin, and impacts on glucose metabolism.	[Naser, Wasan; Maymand, Saeed; Rivera, Leni R.; Connor, Timothy; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.] Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia; [Naser, Wasan] Univ Baghdad, Coll Sci, Baghdad, Iraq; [Rivera, Leni R.; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.] Deakin Univ, IMPACT, Geelong, Vic, Australia	Deakin University; University of Baghdad; Deakin University	Ward, AC (corresponding author), Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia.	award@deakin.edu.au			IMPACT at Deakin University; Higher Committee for Education Development (HCED) of Iraq	IMPACT at Deakin University; Higher Committee for Education Development (HCED) of Iraq	The authors recognize the support of funding from IMPACT at Deakin University, while W.N. was supported by the Higher Committee for Education Development (HCED) of Iraq	Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; Banks AS, 2005, J CLIN INVEST, V115, P2462, DOI 10.1172/JCI23853; Barrios-Correa AA, 2018, J MOL NEUROSCI, V66, P390, DOI 10.1007/s12031-018-1185-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bond ST, 2017, FASEB J, V31, P2592, DOI 10.1096/fj.201601215R; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Gaur V, 2017, DIABETES OBES METAB, V19, P936, DOI 10.1111/dom.12896; Gaur V, 2016, CELL REP, V16, P2802, DOI 10.1016/j.celrep.2016.08.005; Gholizadeh P, 2019, MICROB PATHOGENESIS, V127, P48, DOI 10.1016/j.micpath.2018.11.031; He Z, 2012, MOL CELL BIOL, V32, P1867, DOI 10.1128/MCB.06712-11; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Jamieson E, 2005, J BIOL CHEM, V280, P31516, DOI 10.1074/jbc.M502163200; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Kasagi Y, 2004, ENDOCR J, V51, P145, DOI 10.1507/endocrj.51.145; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Keating N, 2019, CYTOKINE, V118, P64, DOI 10.1016/j.cyto.2018.03.033; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Krebs DL, 2004, P NATL ACAD SCI USA, V101, P15446, DOI 10.1073/pnas.0406870101; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lebrun P, 2010, DIABETOLOGIA, V53, P1935, DOI 10.1007/s00125-010-1786-9; Lee SJ, 2013, J NEUROSCI, V33, P15306, DOI 10.1523/JNEUROSCI.0837-13.2013; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Louis C, 2020, J EXP MED, V217, DOI 10.1084/jem.20191421; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; McCabe IC, 2019, J CELL BIOCHEM, V120, P4398, DOI 10.1002/jcb.27726; Mercer AJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE904, DOI 10.1152/ajpendo.00540.2013; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nohara K, 2011, ENDOCRINOLOGY, V152, P1661, DOI 10.1210/en.2010-1288; Palmer DC, 2015, J EXP MED, V212, P2095, DOI 10.1084/jem.20150304; Piaggi P, 2018, J ENDOCRINOL INVEST, V41, P83, DOI 10.1007/s40618-017-0732-9; Puff R, 2010, ISLETS, V2, P252, DOI 10.4161/isl.2.4.12556; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Rugarn O, 1999, PEPTIDES, V20, P81, DOI 10.1016/S0196-9781(98)00139-9; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sachithanandan N, 2011, DIABETES, V60, P2023, DOI 10.2337/db11-0259; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Seyfarth Julia, 2018, Mol Cell Pediatr, V5, P2, DOI 10.1186/s40348-018-0080-7; Sobah ML, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.727987; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Strebovsky J, 2012, FRONT BIOSCI-LANDMRK, V17, P1627, DOI 10.2741/4008; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; URBAN JH, 1993, ENDOCRINOLOGY, V132, P139, DOI 10.1210/en.132.1.139; Val CH, 2020, J NUTR BIOCHEM, V76, DOI 10.1016/j.jnutbio.2019.108304; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Vink T, 2001, MOL PSYCHIATR, V6, P325, DOI 10.1038/sj.mp.4000854; Vlacich G, 2010, ISLETS, V2, P308, DOI 10.4161/isl.2.5.13058; Wang TT, 2022, AGEING RES REV, V77, DOI 10.1016/j.arr.2022.101611; Wang XL, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-017-0435-2; Wang Z, 2019, AM J PHYSIOL-REG I, V316, pR338, DOI 10.1152/ajpregu.00163.2018; Wauman J, 2018, BBA-MOL CELL RES, V1865, P1312, DOI 10.1016/j.bbamcr.2018.06.009; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	77	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22320	10.1096/fj.202101882R	http://dx.doi.org/10.1096/fj.202101882R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0T8JK	35470501				2022-12-28	WOS:000787209100001
J	Ampong, I; Zimmerman, KD; Perumalla, DS; Wallis, KE; Li, G; Huber, HF; Li, C; Nathanielsz, PW; Cox, LA; Olivier, M				Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Li, Ge; Huber, Hillary F.; Li, Cun; Nathanielsz, Peter W.; Cox, Laura A.; Olivier, Michael			Maternal obesity alters offspring liver and skeletal muscle metabolism in early post-puberty despite maintaining a normal post-weaning dietary lifestyle	FASEB JOURNAL			English	Article						developmental programming; maternal obesity; metabolic disorders; metabolism; metabolomics	FATTY LIVER; METABOLOMICS; BABOONS	Maternal obesity (MO) during pregnancy is linked to increased and premature risk of age-related metabolic diseases in the offspring. However, the underlying molecular mechanisms still remain not fully understood. Using a well-established nonhuman primate model of MO, we analyzed tissue biopsies and plasma samples obtained from post-pubertal offspring (3-6.5 y) of MO mothers (n = 19) and from control animals born to mothers fed a standard diet (CON, n = 13). All offspring ate a healthy chow diet after weaning. Using untargeted gas chromatography-mass spectrometry metabolomics analysis, we quantified a total of 351 liver, 316 skeletal muscle, and 423 plasma metabolites. We identified 58 metabolites significantly altered in the liver and 46 in the skeletal muscle of MO offspring, with 8 metabolites shared between both tissues. Several metabolites were changed in opposite directions in males and females in both liver and skeletal muscle. Several tissue-specific and 4 shared metabolic pathways were identified from these dysregulated metabolites. Interestingly, none of the tissue-specific metabolic changes were reflected in plasma. Overall, our study describes characteristic metabolic perturbations in the liver and skeletal muscle in MO offspring, indicating that metabolic programming in utero persists postnatally, and revealing potential novel mechanisms that may contribute to age-related metabolic diseases later in life.	[Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Li, Ge; Cox, Laura A.; Olivier, Michael] Wake Forest Univ Sch Med, Ctr Precis Med, Winston Salem, NC 27157 USA; [Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Cox, Laura A.; Olivier, Michael] Wake Forest Univ Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Huber, Hillary F.; Nathanielsz, Peter W.; Cox, Laura A.] Southwest Natl Primate Res Ctr, Texas Biomed Res Inst, San Antonio, TX USA; [Li, Cun; Nathanielsz, Peter W.] Univ Wyoming, Ctr Pregnancy & Newborn Res, Laramie, WY USA	Wake Forest University; Wake Forest University; Texas Biomedical Research Institute; University of Wyoming	Ampong, I; Olivier, M (corresponding author), Wake Forest Univ Sch Med, Ctr Precis Med, Winston Salem, NC 27157 USA.	iampong@wakehealth.edu; molivier@wakehealth.edu		Olivier, Michael/0000-0003-1632-1063	National Institute of Health (NIH);  [U19 AG057758]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	ACKNOWLEDGMENTS This work was funded by the National Institute of Health (NIH) grant U19 AG057758 to PWN, LAC, and MO. The authors would like to also acknowledge the Texas Biomedical Research Institute staff for the veterinary services and animal maintenance support.	Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014; Ampong I, 2022, METABOLITES, V12, DOI 10.3390/metabo12050429; Ashrafian H, 2021, MED PRIN PRACT, V30, P301, DOI 10.1159/000513545; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202183; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Cox LA, 2017, ILAR J, V58, P235, DOI 10.1093/ilar/ilx025; Cox LA, 2013, ILAR J, V54, P106, DOI 10.1093/ilar/ilt038; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Glastras SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180050; Higgins PB, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-71; Jin R, 2016, J PEDIATR-US, V172, P14, DOI 10.1016/j.jpeds.2016.01.026; Kurt Z, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0205-7; Leon-Aguilar LF, 2019, INT J OBESITY, V43, P1231, DOI 10.1038/s41366-018-0291-y; Li C, 2019, J MED PRIMATOL, V48, P90, DOI 10.1111/jmp.12396; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Lynch C, 2017, J DEV ORIG HLTH DIS, V8, P263, DOI 10.1017/S2040174416000805; Mahaney MC, 2018, J MED PRIMATOL, V47, P3, DOI 10.1111/jmp.12283; McCoski S, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11082216; Misra BB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214487; Nathanielsz PW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12564; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Romijn JA, 2009, J PHYSIOL-LONDON, V587, P1637, DOI 10.1113/jphysiol.2009.171868; Safi-Stibler S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061572; Schoonejans JM, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14694; Snow SJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73361-0; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Wang QR, 2019, FASEB J, V33, P2587, DOI 10.1096/fj.201800988R; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088; Zhu NL, 2021, METABOLITES, V11, DOI 10.3390/metabo11060374	32	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22644	10.1096/fj.202201473R	http://dx.doi.org/10.1096/fj.202201473R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1PL	36415994				2022-12-28	WOS:000887962200001
J	Mitra, R; Nersesyan, A; Pentland, K; Melin, MM; Levy, RM; Ebong, EE				Mitra, Ronodeep; Nersesyan, Alina; Pentland, Kaleigh; Melin, M. Mark; Levy, Robert M.; Ebong, Eno E.			Diosmin and its glycocalyx restorative and anti-inflammatory effects on injured blood vessels	FASEB JOURNAL			English	Article						diosmin; endothelial dysfunction; endothelial glycocalyx; endothelium functionality; glycocalyx regeneration; vascular homeostasis	ENDOTHELIAL GLYCOCALYX; NITRIC-OXIDE; BARRIER PROPERTIES; CAROTID-ARTERY; IN-VIVO; INFLAMMATION; MODEL; MOUSE; FLOW; ATHEROSCLEROSIS	The endothelium, a crucial homeostatic organ, regulates vascular permeability and tone. Under physiological conditions, endothelial stimulation induces vasodilator endothelial nitric oxide (eNO) release and prevents adhesion molecule accessibility and leukocyte adhesion and migration into vessel walls. Endothelium dysfunction is a principal event in cardiovascular disorders, including atherosclerosis. Minimal attention is given to an important endothelial cell structure, the endothelial glycocalyx (GCX), a negatively charged heterogeneous polysaccharide that serves as a protective covering for endothelial cells and enables endothelial cells to transduce mechanical stimuli into various biological and chemical activities. Endothelial GCX shedding thus plays a role in endothelial dysfunction, for example by increasing vascular permeability and decreasing vessel tone. Consequently, there is increasing interest in developing therapies that focus on GCX repair to limit downstream endothelium dysfunction and prevent further downstream cardiovascular events. Here, we present diosmin (3 ',5,7-trihydroxy-4 '-methoxyflavone-7-rhamnoglucoside), a flavone glycoside of diosmetin, which downregulates adhesive molecule expression, decreases inflammation and capillary permeability, and upregulates eNO expression. Due to these pleiotropic effects of diosmin on the vasculature, a possible unidentified mechanism of action is through GCX restoration. We hypothesize that diosmin positively affects GCX integrity along with GCX-related endothelial functions. Our hypothesis was tested in a partial ligation left carotid artery (LCA) mouse model, where the right carotid artery was the control for each mouse. Diosmin (50 mg/kg) was administered daily for 7 days, 72 h after ligation. Within the ligated mice LCAs, diosmin treatment elevated the activated eNO synthase level, inhibited inflammatory cell uptake, decreased vessel wall thickness, increased vessel diameter, and increased GCX coverage of the vessel wall. ELISA showed a decrease in hyaluronan concentration in plasma samples of diosmin-treated mice, signifying reduced GCX shedding. In summary, diosmin supported endothelial GCX integrity, to which we attribute diosmin's preservation of endothelial function as indicated by attenuated expression of inflammatory factors and restored vascular tone.	[Mitra, Ronodeep; Pentland, Kaleigh; Ebong, Eno E.] Northeastern Univ, Dept Chem Engn, 805 Columbus Ave, Boston, MA 02120 USA; [Nersesyan, Alina; Ebong, Eno E.] Northeastern Univ, Dept Bioengn, Boston, MA 02120 USA; [Melin, M. Mark] M Hlth Fairview Wound Healing Inst, Edina, MN USA; [Levy, Robert M.] Primus Pharmaceut Inc, Clin Dev, Scottsdale, AZ USA; [Ebong, Eno E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	Northeastern University; Northeastern University; Yeshiva University	Ebong, EE (corresponding author), Northeastern Univ, Dept Chem Engn, 805 Columbus Ave, Boston, MA 02120 USA.	e.ebong@northeastern.edu		Melin, Matthew/0000-0002-1368-0426	National Institutes of Health (NIH) [K01 HL125499]; Primus Pharmaceuticals	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Primus Pharmaceuticals	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: K01 HL125499; Primus Pharmaceuticals	Abdel-Daim MM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3281670; Al Shoyaib A, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-019-2745-x; Campanero MA, 2010, J PHARMACEUT BIOMED, V51, P875, DOI 10.1016/j.jpba.2009.09.012; Annecke T, 2011, BRIT J ANAESTH, V107, P679, DOI 10.1093/bja/aer269; Banerjee S, 2021, IND ENG CHEM RES, V60, P17328, DOI 10.1021/acs.iecr.1c03074; Bergan JJ, 2001, ANGIOLOGY, V52, pS43, DOI 10.1177/0003319701052001S06; Berkoz M, 2019, GEN PHYSIOL BIOPHYS, V38, P315, DOI 10.4149/gpb_2019010; Boisnic S, 2018, J COSMET DERMATOL-US, V17, P848, DOI 10.1111/jocd.12778; Cancel LM, 2016, ATHEROSCLEROSIS, V252, P136, DOI 10.1016/j.atherosclerosis.2016.07.930; Cao RN, 2019, CHINESE MED J-PEKING, V132, P963, DOI 10.1097/CM9.0000000000000177; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Cheng LS, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12070672; Cheng MJ, 2016, INT J NANOMED, V11, P3305, DOI 10.2147/IJN.S106299; Chung S, 2020, FOOD SCI NUTR, V8, P5976, DOI 10.1002/fsn3.1883; Crespo ME, 1999, PLANTA MED, V65, P651, DOI 10.1055/s-2006-960838; Daniels BA., 2013, THERAPEUTIC SULFATED; Dogne S, 2020, AM J PATHOL, V190, P768, DOI 10.1016/j.ajpath.2019.11.016; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Freag MS, 2013, INT J PHARMACEUT, V454, P462, DOI 10.1016/j.ijpharm.2013.06.039; Friesenecker B, 1995, INT J MICROCIRC, V15, P17, DOI 10.1159/000179090; Fuster JJ, 2012, PROG MOL BIOL TRANSL, V105, P1, DOI 10.1016/B978-0-12-394596-9.00001-9; Guevara RB, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00031-20; Harding IC, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1721-2; Hassan AA, 2018, PAK J PHARM SCI, V31, P1191; HENDERSON AH, 1991, BRIT HEART J, V65, P116; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hermann Matthias, 2006, J Clin Hypertens (Greenwich), V8, P17, DOI 10.1111/j.1524-6175.2006.06032.x; Hippensteel JA, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2534-2; Itskovich VV, 2003, MAGNET RESON MED, V49, P381, DOI 10.1002/mrm.10360; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Katsenis Konstantinos, 2005, Current Vascular Pharmacology, V3, P1, DOI 10.2174/1570161052773870; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Kumase F, 2010, ACTA MED OKAYAMA, V64, P277; Kuzlan M, 1997, PERITON DIALYSIS INT, V17, P295; Li TJ, 2017, ONCOTARGET, V8, P91350, DOI 10.18632/oncotarget.20518; Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x; Long RM., 2016, U.S. Patent, Patent No. [US20160296603A1, 20160296603]; Machin DR., 2019, FASEB J, V33; Mastantuono T, 2015, MICROCIRCULATION, V22, P378, DOI 10.1111/micc.12207; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mensah SA, 2020, FASEB J, V34, P6166, DOI 10.1096/fj.201901920R; Mensah SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186116; Mitra Ronodeep, 2018, Transl Med Commun, V3, DOI 10.1186/s41231-018-0029-9; Mitra R, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0691-9; MONSIGNY M, 1979, EUR J BIOCHEM, V98, P39, DOI 10.1111/j.1432-1033.1979.tb13157.x; Nam Douglas, 2010, J Vis Exp, DOI 10.3791/1861; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nemes KB, 2000, J PHARM PHARMACOL, V52, P47, DOI 10.1211/0022357001773670; Offeddu GS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01774-2; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Park SA, 2020, BIOMOL THER, V28, P542, DOI 10.4062/biomolther.2020.135; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ramelet AA, 2001, ANGIOLOGY, V52, pS49, DOI 10.1177/0003319701052001S07; Russo R, 2018, MOLECULES, V23, DOI 10.3390/molecules23092174; Ryva B, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00100; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz BG, 2010, INT J IMPOT RES, V22, P77, DOI 10.1038/ijir.2009.59; Sciences CH., 2019, ARTEROSIL ARTERY SUP; Senthamizhselvan O, 2014, EUR J PHARMACOL, V736, P131, DOI 10.1016/j.ejphar.2014.04.026; Serra H, 2008, BIOORGAN MED CHEM, V16, P4009, DOI 10.1016/j.bmc.2008.01.028; Shabani S, 2018, BIOMED PHARMACOTHER, V108, P1376, DOI 10.1016/j.biopha.2018.09.127; Shalkami AS, 2018, HUM EXP TOXICOL, V37, P78, DOI 10.1177/0960327117694075; Silambarasan T, 2012, EUR J PHARMACOL, V679, P81, DOI 10.1016/j.ejphar.2011.12.040; Smith C, 1999, J VASC RES, V36, P24, DOI 10.1159/000054071; Sullivan CJ, 2002, ARTERIOSCL THROM VAS, V22, P1100, DOI 10.1161/01.ATV.0000023230.17493.E3; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Tong NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061794; Uchimido R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2292-6; Ushiyama A, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0182-z; Vafa A, 2020, HUM EXP TOXICOL, V39, P1133, DOI 10.1177/0960327119889655; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500; Wang GQ, 2020, ARTERIOSCL THROM VAS, V40, P350, DOI 10.1161/ATVBAHA.119.313399; Yang J, 2012, J CHROMATOGR B, V898, P95, DOI 10.1016/j.jchromb.2012.04.024; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zhang R, 2015, BIOTECHNOL LETT, V37, P1257, DOI 10.1007/s10529-015-1792-6; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	88	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22630	10.1096/fj.202200053RR	http://dx.doi.org/10.1096/fj.202200053RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5U5CO	36315163				2022-12-28	WOS:000876565000001
J	Zhao, SJ; Wu, KY; Min, XY; Wang, CX; Cao, B; Ma, N; Yang, XL; Zhu, ZR; Fu, RG; Zhou, WD; Yang, JR; Li, K				Zhao, Shu-Juan; Wu, Kun-Yi; Min, Xiao-Yun; Wang, Chun-Xuan; Cao, Bo; Ma, Ning; Yang, Xue-Ling; Zhu, Zhuo-Ran; Fu, Rong-Guo; Zhou, Wuding; Yang, Ju-Rong; Li, Ke			Protective role for C3aR in experimental chronic pyelonephritis	FASEB JOURNAL			English	Article						C3aR; chronic inflammation; chronic pyelonephritis; persistent infection; phagocytosis; renal fibrosis	ESCHERICHIA-COLI; ANAPHYLATOXIN RECEPTOR; INHIBITING NEUTROPHIL; CHRONIC INFLAMMATION; COMPLEMENT; MODEL; DISRUPTION; FIBROSIS; DISEASE; MICE	Emerging evidence suggest that C3aR plays important roles in homeostasis, host defense and disease. Although it is known that C3aR is protective in several models of acute bacterial infections, the role for C3aR in chronic infection is largely unknown. Here we show that C3aR is protective in experimental chronic pyelonephritis. Global C3aR deficient (C3ar(-/-)) mice had higher renal bacterial load, more pronounced renal histological lesions, increased renal apoptotic cell accumulation, tissue inflammation and extracellular matrix deposition following renal infection with uropathogenic E. coli (UPEC) strain IH11128, compared to WT control mice. Myeloid C3aR deficient (Lyz2-C3ar(-/-)) mice exhibited a similar disease phenotype to global C3ar(-/-) mice. Pharmacological treatment with a C3aR agonist reduced disease severity in experimental chronic pyelonephritis. Furthermore, macrophages of C3ar(-/-) mice exhibited impaired ability to phagocytose UPEC. Our data clearly demonstrate a protective role for C3aR against experimental chronic pyelonephritis, macrophage C3aR plays a major role in the protection, and C3aR is necessary for phagocytosis of UPEC by macrophages. Our observation that C3aR agonist curtailed the pathology suggests a therapeutic potential for activation of C3aR in chronic infection.	[Zhao, Shu-Juan; Wu, Kun-Yi; Min, Xiao-Yun; Cao, Bo; Ma, Ning; Zhu, Zhuo-Ran; Li, Ke] Xi An Jiao Tong Univ, Core Res Lab, Affiliated Hosp 2, Xian, Peoples R China; [Wang, Chun-Xuan; Yang, Xue-Ling; Yang, Ju-Rong] Chongqing Med Univ, Affiliated Hosp 3, Dept Nephrol, Chongqing 401120, Peoples R China; [Fu, Rong-Guo] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nephrol, Xian, Peoples R China; [Zhou, Wuding] Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England	Xi'an Jiaotong University; Chongqing Medical University; Xi'an Jiaotong University; University of London; King's College London	Yang, JR (corresponding author), Chongqing Med Univ, Affiliated Hosp 3, Dept Nephrol, Chongqing 401120, Peoples R China.; Li, K (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Core Res Lab, Xian 710004, Peoples R China.	yjr923@163.com; ke.li@mail.xjtu.edu.cn		Fu, Rongguo/0000-0002-5308-9980	National Natural Science Foundation of China [81970596, 81900620]; Chongqing Talent Program Project [cstc2021ycjh-bgzxm0090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Talent Program Project	National Natural Science Foundation of China, Grant/Award Number: 81970596 and 81900620; The Chongqing Talent Program Project, Grant/Award Number: cstc2021ycjh-bgzxm0090	Choudhry N, 2016, KIDNEY INT, V90, P540, DOI 10.1016/j.kint.2016.04.023; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Goluszko P, 1997, J CLIN INVEST, V99, P1662, DOI 10.1172/JCI119329; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Heptinstall RH, 1983, PYELONEPHRITIS PATHO; Herrero-Cervera A, 2022, CELL MOL IMMUNOL, V19, P177, DOI 10.1038/s41423-021-00832-3; Hollmann TJ, 2008, MOL IMMUNOL, V45, P1907, DOI 10.1016/j.molimm.2007.10.037; HUGLI T E, 1981, Critical Reviews in Immunology, V1, P321; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Janeway C., 2004, IMMUNOBIOLOGY; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Laumonnier Y, 2017, MOL IMMUNOL, V89, P44, DOI 10.1016/j.molimm.2017.05.019; Li K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97626; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Mueller-Ortiz SL, 2006, AM J PHYSIOL-LUNG C, V291, pL157, DOI 10.1152/ajplung.00358.2005; Muenstermann M, 2019, VIRULENCE, V10, P677, DOI 10.1080/21505594.2019.1640035; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; NOWICKI B, 1987, INFECT IMMUN, V55, P3168, DOI 10.1128/IAI.55.12.3168-3173.1987; NOWICKI B, 1986, MICROB PATHOGENESIS, V1, P169, DOI 10.1016/0882-4010(86)90019-7; Qiao P, 2022, FASEB J, V36, DOI 10.1096/fj.202101458R; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Stenvinkel P, 2021, KIDNEY INT REP, V6, P1775, DOI 10.1016/j.ekir.2021.04.023; Uribe-Querol E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01066; VAISANENRHEN V, 1984, INFECT IMMUN, V46, P401; Wei LL, 2020, ARTERIOSCL THROM VAS, V40, P2070, DOI 10.1161/ATVBAHA.120.314150; Wu KY, 2019, KIDNEY INT, V96, P612, DOI 10.1016/j.kint.2019.03.005; Wu KY., 2019, KIDNEY INT, V21, P30321; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110; Zheng QY, 2020, FASEB J, V34, P10590, DOI 10.1096/fj.202000384R	39	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22599	10.1096/fj.202201007R	http://dx.doi.org/10.1096/fj.202201007R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0YD	36250902				2022-12-28	WOS:000868772200001
J	Liu, CH; Zhang, W; Xu, GZ; Zhang, DL; Zhang, C; Qiao, S; Wang, ZM; Wang, HM				Liu, Chunhua; Zhang, Wei; Xu, Guozheng; Zhang, Daolai; Zhang, Cheng; Qiao, Sen; Wang, Zhimei; Wang, Hongmei			Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas' disease progression	FASEB JOURNAL			English	Article						gliomas; inflammation; lipid metabolism; menopause; neurotransmitters; ovariectomy	GLIOBLASTOMA; CELLS; PROLIFERATION; ACTIVATION; MANAGEMENT; PROGNOSIS; AUTOPHAGY; THERAPY; JNK	The risk of high-grade gliomas is lower in young females, however, its incidence enhances after menopause, suggesting potential protective roles of female sex hormones. Hormone oscillations after menopause have received attention as a possible risk factor. Little is known about risk factors for adult gliomas. We examined the association of the aging brain after menopause, determining the risk of gliomas with proteomics and the MALDI-MSI experiment. Menopause caused low neurotransmitter levels such as GABA and ACH, high inflammatory factor levels like il-1 beta, and increased lipid metabolism-related levels like triglycerides in the brain. Upregulated and downregulated proteins after menopause were correlated with differentially expressed glioma genes, such as ACTA2, CAMK2D, FNBPIL, ARL1, HEBP1, CAST, CLIC1, LPCAT4, MAST3, and DOCK9. Furthermore, differential gene expression analysis of monocytes showed that the downregulated gene LPCAT4 could be used as a marker to prevent menopausal gliomas in women. Our findings regarding the association of menopause with the risk of gliomas are consistent with several extensive cohort studies. In view of the available evidence, postmenopausal status is likely to represent a significant risk factor for gliomas.	[Liu, Chunhua; Xu, Guozheng] Shandong First Med Univ, Dept Physiol & Neurobiol, Jinan, Peoples R China; [Zhang, Wei; Wang, Hongmei] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Zhang, Daolai; Zhang, Cheng; Wang, Hongmei] Binzhou Med Univ, Sch Pharm, Yantai, Peoples R China; [Qiao, Sen] Saarland Univ, Ctr Mol Signaling PZMS, Sch Med, Pharmacol & Toxicol, Homburg, Germany; [Wang, Zhimei] Southeast Univ, Jiangsu Prov Hi Tech Key Lab Biomed Res, Nanjing 211189, Peoples R China; [Wang, Zhimei] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Southeast University - China; Binzhou Medical University; Universitatsklinikum des Saarlandes; Southeast University - China; Southeast University - China	Wang, HM (corresponding author), Southeast Univ, Sch Med, Nanjing 210009, Peoples R China.; Wang, ZM (corresponding author), Southeast Univ, Jiangsu Prov Hi Tech Key Lab Biomed Res, Nanjing 211189, Peoples R China.; Wang, ZM (corresponding author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China.	wangzm@seu.edu.cn; 101012573@seu.edu.cn	wang, hongmei/HGT-7374-2022	wang, hongmei/0000-0002-6975-9467	National Natural Science Foundation of China (NSFC) [81602327]; Shandong First Medical University (SFMU) [2019QL009]; zhishan scholars program [2242021R41070]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong First Medical University (SFMU); zhishan scholars program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81602327; Shandong First Medical University (SFMU), Grant/Award Number: 2019QL009; zhishan scholars program, Grant/Award Number: 2242021R41070	Ahmadzai P, 2018, NEUROLOGY, V90, pE1588, DOI 10.1212/WNL.0000000000005459; Belkhiri A, 2016, ONCOTARGET, V7, P17631, DOI 10.18632/oncotarget.7268; Blinkouskaya Y, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111575; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Castro MG, 2011, CURR GENE THER, V11, P155; Chen XR, 2020, THERANOSTICS, V10, P998, DOI 10.7150/thno.40076; de Pablos RM, 2019, PHARMACOL RES, V143, P58, DOI 10.1016/j.phrs.2019.03.005; Deli T, 2020, PATHOL ONCOL RES, V26, P63, DOI 10.1007/s12253-018-00569-x; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Ding J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26310-y; Dono Antonio, 2020, CNS Oncol, V9, pCNS57, DOI 10.2217/cns-2020-0007; Edwards H, 2019, MENOPAUSE, V26, P45, DOI 10.1097/GME.0000000000001171; Elmaci I, 2019, CLIN NEUROL NEUROSUR, V177, P77, DOI 10.1016/j.clineuro.2018.12.022; Falkenstetter S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00155; Fang C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050756; Ferioli M, 2019, J CELL PHYSIOL, V234, P14852, DOI 10.1002/jcp.28304; Gava G, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100668; Gelosa P, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3454212; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Guo YJ, 2019, CELL RES, V29, P151, DOI 10.1038/s41422-018-0123-6; Hajj GNM, 2020, MOL ONCOL, V14, P159, DOI 10.1002/1878-0261.12595; Hamadi A, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-42; Hara Y, 2015, PHYSIOL REV, V95, P785, DOI 10.1152/physrev.00036.2014; He LM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.652512; Huang D, 2020, ONCOTARGETS THER, V13, P10525, DOI 10.2147/OTT.S234773; Jabeen S, 2020, J COMPUT ASSIST TOMO, V44, P692, DOI 10.1097/RCT.0000000000001080; Jia G, 2018, BIOMATERIALS, V178, P302, DOI 10.1016/j.biomaterials.2018.06.029; Katsushima K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13616; Khayum MA, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2020.104610; Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024; Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113; Li MJ, 2012, CHEM-EUR J, V18, P8724, DOI 10.1002/chem.201103025; Liao JF, 2021, MOL NEUROBIOL, DOI 10.1007/s12035-021-02427-5; Liu W, 2020, ONCOTARGETS THER, V13, P2275, DOI 10.2147/OTT.S243953; Liu ZY, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170168; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Maki PM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.562275; Masui K, 2019, NEUROPATHOLOGY, V39, P3, DOI 10.1111/neup.12535; Mosconi L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90084-y; Patil V, 2020, PEERJ, V8, DOI 10.7717/peerj.9755; Pei Z, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113814; Phillips NA, 2021, MENOPAUSE, V28, P109, DOI 10.1097/GME.0000000000001714; Qu F, 2020, AUTOPHAGY, V16, P1413, DOI 10.1080/15548627.2019.1687210; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Roldan-Valadez E, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150502; Romoli M, 2019, ANN CLIN TRANSL NEUR, V6, P2261, DOI 10.1002/acn3.50919; Santoro N, 2021, J CLIN ENDOCR METAB, V106, P1, DOI 10.1210/clinem/dgaa764; Than S, 2021, J CLIN ENDOCR METAB, V106, P410, DOI 10.1210/clinem/dgaa847; Wang Hao, 2018, Zhejiang Da Xue Xue Bao Yi Xue Ban, V47, P19; Watts NB, 2021, ENDOCR PRACT, V27, P379, DOI 10.1016/j.eprac.2021.02.001; Xian D, 2019, J CELL MOL MED, V23, P3808, DOI 10.1111/jcmm.14071; Xu SC, 2020, CANCER LETT, V476, P1, DOI 10.1016/j.canlet.2020.02.002; Zhang GQ, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003731; Zhang LD, 2019, MOL CANCER THER, V18, P173, DOI 10.1158/1535-7163.MCT-17-0782; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhu C, 2020, ONCOTARGETS THER, V13, P1129, DOI 10.2147/OTT.S237162; Zhu DS, 2019, LANCET PUBLIC HEALTH, V4, pE553, DOI 10.1016/S2468-2667(19)30155-0	57	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22570	10.1096/fj.202200427RR	http://dx.doi.org/10.1096/fj.202200427RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4X4ZW	36165217				2022-12-28	WOS:000860853200003
J	Shi, ZH; Zhao, Z; Liu, LZ; Bian, XL; Zhang, Y				Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun			Pore-forming protein beta gamma-CAT promptly responses to fasting with capacity to deliver macromolecular nutrients	FASEB JOURNAL			English	Article						albumin; fasting; fatty acid; nutrient; pore-forming protein	ALBUMIN; MACROPINOCYTOSIS; HOST	During animal fasting, the nutrient supply and metabolism switch from carbohydrates to a new reliance on the catabolism of energy-dense lipid stores. Assembled under tight regulation, beta gamma-CAT (a complex of non-lens beta gamma-crystallin and trefoil factor) is a pore-forming protein and trefoil factor complex identified in toad Bombina maxima. Here, we determined that this protein complex is a constitutive component in toad blood, that actively responds to the animal fasting. The protein complex was able to promote cellular albumin and albumin-bound fatty acid (FA) uptake in a variety of epithelial and endothelial cells, and the effects were attenuated by a macropinocytosis inhibitor. Endothelial cell-derived exosomes containing largely enriched albumin and FAs, called nutrisomes, were released in the presence of beta gamma-CAT. These specific nutrient vesicles were readily taken up by starved myoblast cells to support their survival. The results uncovered that pore-forming protein beta gamma-CAT is a fasting responsive element able to drive cell vesicular import and export of macromolecular nutrients.	[Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Engn Lab Peptides, Kunming, Yunnan, Peoples R China; [Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, 17 Longxin Rd, Kunming 650201, Yunnan, Peoples R China; [Shi, Zhi-Hong; Liu, Ling-Zhen] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhao, Zhong] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci, Beijing, Peoples R China; [Bian, Xian-Ling] Univ Sci & Technol China, Div Life Sci & Med, Sch Life Sci, Hefei, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, 17 Longxin Rd, Kunming 650201, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn		Shi, Zhi-Hong/0000-0002-7665-6685	National Natural Science Foundation of China (NSFC) [31572268, U1602225, 31872226]; Yunling Scholar Program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunling Scholar Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31572268, U1602225 and 31872226; Yunling Scholar Program to Yun Zhang	Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dang LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01368; Deng CJ, 2020, FASEB J, V34, P13609, DOI 10.1096/fj.202001176R; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Finicle BT, 2018, NAT REV CANCER, V18, P619, DOI 10.1038/s41568-018-0048-x; Fung KYY, 2018, TRAFFIC, V19, P5, DOI 10.1111/tra.12533; Gao ZH, 2019, FASEB J, V33, P782, DOI 10.1096/fj.201800087R; Giovannoli C, 2012, TALANTA, V94, P65, DOI 10.1016/j.talanta.2012.02.052; Grasselli E, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00418; Guo XL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0304-y; Hillyard SD, 2011, ACTA PHYSIOL, V202, P533, DOI 10.1111/j.1748-1716.2010.02200.x; Jorgensen CB, 1997, BIOL REV, V72, P153, DOI 10.1017/S0006323196004963; Kimura I, 2020, PHYSIOL REV, V100, P171, DOI 10.1152/physrev.00041.2018; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Ko CW, 2020, NAT REV GASTRO HEPAT, V17, P169, DOI 10.1038/s41575-019-0250-7; Ktistakis Nicholas T, 2015, Cold Spring Harb Protoc, V2015, P751, DOI 10.1101/pdb.prot086264; Li SA, 2017, J INFECT DIS, V215, P1753, DOI 10.1093/infdis/jix183; Liu L, 2021, J IMMUNOL, V207, P888, DOI 10.4049/jimmunol.2001056; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Mobley CB, 2017, J DAIRY SCI, V100, P48, DOI 10.3168/jds.2016-11341; Palm W, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0285; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Secor SM, 2016, COMPR PHYSIOL, V6, P773, DOI 10.1002/cphy.c150013; Shao HL, 2018, CHEM REV, V118, P1917, DOI 10.1021/acs.chemrev.7b00534; SPECTOR AA, 1986, METHOD ENZYMOL, V128, P320; Sun XL, 2020, CELL METAB, V31, P189, DOI 10.1016/j.cmet.2019.10.014; Swanson JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0146; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Varga JFA, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03128; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Viscarra JA, 2013, METABOLISM, V62, P889, DOI 10.1016/j.metabol.2012.12.014; Wang QQ, 2020, J BIOL CHEM, V295, P10293, DOI 10.1074/jbc.RA120.013556; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Wu W, 2020, THERANOSTICS, V10, P2859, DOI 10.7150/thno.41279; Xiang Y, 2014, P NATL ACAD SCI USA, V111, P6702, DOI 10.1073/pnas.1321317111; Yang TQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081287; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang Y, 2021, ZOOL RES, V42, P141, DOI 10.24272/j.issn.2095-8137.2020.358; Zhang Yun, 2015, Zoological Research, V36, P183, DOI 10.13918/j.issn.2095-8137.2015.4.183; Zhang YX, 2005, PROTEIN SCI, V14, P2469, DOI 10.1110/ps.051551105; Zhao Z, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03686-1	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22533	10.1096/fj.202200528R	http://dx.doi.org/10.1096/fj.202200528R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H7GW	36065711	hybrid, Green Submitted			2022-12-28	WOS:000850045800001
J	Zhang, SJ; Li, R; Ma, YR; Yan, Y; Ma, M; Zhang, KQ; Zhou, Y; Li, L; Pan, LL; Ying, H; Xue, Y				Zhang, Shengjie; Li, Ran; Ma, Yiruo; Yan, Ying; Ma, Mei; Zhang, Keqin; Zhou, Yun; Li, Ling; Pan, Lingling; Ying, Hao; Xue, Ying			Thyroid-stimulating hormone regulates cardiac function through modulating HCN2 via targeting microRNA-1a	FASEB JOURNAL			English	Article						cardiac dysfunction; hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2); hypothyroid heart disease; microRNA-1a; thyroid-stimulating hormone (TSH)	MESSENGER-RNA; SUBCLINICAL HYPOTHYROIDISM; HEART-DISEASE; I-F; EXPRESSION; CHANNELS; ALPHA; RATS	Previous studies have found microRNA-1 (miR-1) and hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) may be involved in the pathogenesis of thyroid hormone (TH) induced cardiac hypertrophy. However, little is known about the role of miR-1 and HCN2 in thyroid stimulation hormone (TSH)-induced cardiac dysfunction. In order to investigate the molecular mechanisms of TSH induced cardiac dysfunction and the role of miR-1/HCN2 in that process, we evaluated the expression of miR-1a/HCN2 in the ventricular myocardium of hypothyroid mice and in TSH-stimulated H9c2 cardiomyocytes. Our data revealed that hypothyroidism mice had smaller hearts, ventricular muscle atrophy, and cardiac contractile dysfunction compared with euthyroid controls. The upregulation of miR-1a and downregulation of HCN2 were found in ventricular myocardium of hypothyroid mice and TSH-stimulated H9c2 cardiomyocytes, indicating that miR-1a and HCN2 may be involved in TSH-induced cardiac dysfunction. We also found that the regulation of miR-1a and HCN2 expression and HCN2 channel activity by TSH requires TSHR, while the regulation of HCN2 expression and HCN2 channel function by TSH requires miR-1a. Thus, our data revealed the potential mechanism of TSH-induced cardiac dysfunction and might shed new light on the pathological role of miR-1a/HCN2 in hypothyroid heart disease.	[Zhang, Shengjie; Li, Ran; Zhang, Keqin; Zhou, Yun; Li, Ling; Pan, Lingling; Xue, Ying] Tongji Univ, Tongji Hosp, Dept Endocrinol & Metab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Zhang, Shengjie; Ma, Yiruo; Yan, Ying; Ma, Mei; Ying, Hao] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Univ Chinese Acad Sci, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS	Xue, Y (corresponding author), Tongji Univ, Tongji Hosp, Dept Endocrinol & Metab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.	xy2007@alumni.sjtu.edu.cn			Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC) [81974105, 81670805, 81700743]; Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program [2019PJD050]	Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program(Shanghai Pujiang Program)	Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974105, 81670805 and 81700743; Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program, Grant/Award Number: 2019PJD050	Chen S, 2014, EUR J HEART FAIL, V16, P217, DOI 10.1002/ejhf.42; Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015; Diniz GP, 2017, J CELL PHYSIOL, V232, P3360, DOI 10.1002/jcp.25781; Diniz GP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0504-7; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Duan L, 2014, MOL BIOSYST, V10, P2775, DOI 10.1039/c4mb00338a; Fernandez-Ruocco J, 2019, THYROID, V29, P934, DOI 10.1089/thy.2018.0709; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; Gassanov N, 2009, PFLUG ARCH EUR J PHY, V458, P1061, DOI 10.1007/s00424-009-0691-x; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; GREEN NK, 1989, J ENDOCRINOL, V122, P193, DOI 10.1677/joe.0.1220193; He W, 2016, EXP THER MED, V12, P433, DOI 10.3892/etm.2016.3290; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Huang WQ, 2011, CARDIOVASC PATHOL, V20, P110, DOI 10.1016/j.carpath.2010.01.007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Jabbar A, 2017, NAT REV CARDIOL, V14, P39, DOI 10.1038/nrcardio.2016.174; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Klee GG, 1997, ENDOCRIN METAB CLIN, V26, P763, DOI 10.1016/S0889-8529(05)70281-4; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Martinez-Quintana E, 2013, PEDIATR CARDIOL, V34, P912, DOI 10.1007/s00246-012-0571-6; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Pachucki J, 1999, CIRC RES, V85, P498, DOI 10.1161/01.RES.85.6.498; Riesen SC, 2013, SCHWEIZ ARCH TIERH, V155, P143, DOI 10.1024/0036-7281/a000431; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Song T, 2011, MOL MED REP, V4, P569, DOI 10.3892/mmr.2011.455; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Wang F, 2017, ENDOCRINE, V57, P125, DOI 10.1007/s12020-017-1331-4; Xia S, 2010, BIOCHEM BIOPH RES CO, V395, P330, DOI 10.1016/j.bbrc.2010.04.003; Yao X, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-38; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22561	10.1096/fj.202200574R	http://dx.doi.org/10.1096/fj.202200574R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1SK	36125044				2022-12-28	WOS:000857906100001
J	Miyata, N; Ito, T; Nakashima, M; Fujii, S; Kuge, O				Miyata, Non; Ito, Takanori; Nakashima, Miyu; Fujii, Satoru; Kuge, Osamu			Mitochondrial phosphatidylethanolamine synthesis affects mitochondrial energy metabolism and quiescence entry through attenuation of Snf1/AMPK signaling in yeast	FASEB JOURNAL			English	Article						carbon metabolism; mitochondrial energy metabolism; phosphatidylethanolamine; quiescence entry; Snf1; AMPK; Ups2-Mdm35 complex	SNF1 PROTEIN-KINASE; MEMBRANE-LIPID SYNTHESIS; CELL-CYCLE PROGRESSION; ACETYL-COA CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PHOSPHATIDYLSERINE DECARBOXYLASE; TUMOR-SUPPRESSOR; ACTIVATION; AMP	The Ups2-Mdm35 complex mediates intramitochondrial phosphatidylserine (PS) transport to facilitate mitochondrial phosphatidylethanolamine (PE) synthesis. In the present study, we found that ups2 increment yeast showed increased mitochondrial ATP production and enhanced quiescence (G0) entry in the post-diauxic shift phase. Transcriptomic and biochemical analyses revealed that the depletion of Ups2 leads to overactivation of the yeast AMPK homolog Snf1. Inactivation of Snf1 by depletion of an Snf1-activating kinase, Sak1 canceled the changes in mitochondrial ATP production and quiescence entry observed in ups2 increment cells. Furthermore, among the factors regulated by Snf1, upregulation of pyruvate carboxylase, Pyc1 and downregulation of acetyl-CoA carboxylase, Acc1, respectively, were sufficient to increase mitochondrial ATP production and quiescence entry. These results suggested that a normal PE synthesis mediated by Ups2-Mdm35 complex attenuates Snf1/AMPK activity, and that Snf1-mediated regulation of carbon metabolisms has great impacts on mitochondrial energy metabolism and quiescence entry. We also found that depletion of Ups2 together with the cell-cycle regulators Whi5 and Whi7, functional orthologs of the Rb1 tumor suppressor, caused a synthetic growth defect in yeast. Similarly, knockdown of PRELID3b, the human homolog of Ups2, decreased the viability of Rb1-deficient breast cancer cells, suggesting that PRELID3b is a potential target for cancer therapy.	[Miyata, Non; Ito, Takanori; Nakashima, Miyu; Fujii, Satoru; Kuge, Osamu] Kyushu Univ, Dept Chem, Fac Sci, Fukuoka, Japan	Kyushu University	Miyata, N (corresponding author), Kyushu Univ, Dept Chem, Fac Sci, Nishi Ku, Motooka 744, Fukuoka 8190395, Japan.	miyata@chem.kyushu-univ.jp		, Non/0000-0001-5766-8771	MEXT | Japan Society for the Promotion of Science (JSPS) [JP20K06643, JP19H03226, JP20J12899]; Takeda Medical Research Foundation; Naito Foundation; Yamada Science Foundation; Ono Medical Research Foundation; Nagase Science Technology Foundation	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation; Naito Foundation(Naito Memorial Foundation); Yamada Science Foundation; Ono Medical Research Foundation; Nagase Science Technology Foundation	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K06643, JP19H03226 and JP20J12899; Takeda Medical Research Foundation; Naito Foundation; Yamada Science Foundation; Ono Medical Research Foundation; Nagase Science Technology Foundation	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borrull A, 2015, EUR J LIPID SCI TECH, V117, P274, DOI 10.1002/ejlt.201400064; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Cao L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006458; CARLSON M, 1984, GENETICS, V107, P19; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Cooper K, 2006, ONCOGENE, V25, P5228, DOI 10.1038/sj.onc.1209630; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Dai ZJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05409-9; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Flis VV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013235; Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036; Gomar-Alba M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00374-1; Haase SB, 1997, METHOD ENZYMOL, V283, P322; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li P, 2021, CURR GENET, V67, P207, DOI 10.1007/s00294-020-01126-3; Liu CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189007; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; May AI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18805-x; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Menendez J, 1998, FEMS MICROBIOL LETT, V164, P345, DOI 10.1111/j.1574-6968.1998.tb13108.x; Milanesi R, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060862; Miles S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006088; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shevade A, 2018, MSPHERE, V3, DOI 10.1128/msphere.00482-17; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Strogolova V, 2012, EUKARYOT CELL, V11, P1568, DOI 10.1128/EC.00127-12; Sun BH, 2010, CELL CYCLE, V9, P1122, DOI 10.4161/cc.9.6.10990; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Verwaal R, 2004, YEAST, V21, P747, DOI 10.1002/yea.1106; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; WOODS A, 1994, J BIOL CHEM, V269, P19509; Woods A, 2017, CELL REP, V18, P3043, DOI 10.1016/j.celrep.2017.03.011; WOOLLARD A, 1995, BIOESSAYS, V17, P481, DOI 10.1002/bies.950170604; Xiberras J, 2020, FEMS YEAST RES, V20, DOI 10.1093/femsyr/foz086; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Yang X, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.665261; Yi C, 2017, DEV CELL, V41, P59, DOI 10.1016/j.devcel.2017.03.007	69	0	0	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22355	10.1096/fj.202101600RR	http://dx.doi.org/10.1096/fj.202101600RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1SH	35639425				2022-12-28	WOS:000803156900001
J	Wei, WW; Wang, X; Zhou, YZ; Shang, XJ; Yu, HS				Wei, Wenwen; Wang, Xin; Zhou, Yuanzhong; Shang, Xuejun; Yu, Hongsong			The genetic risk factors for pregnancy-induced hypertension: Evidence from genetic polymorphisms	FASEB JOURNAL			English	Review						genetics; preeclampsia; pregnancy-induced hypertension; single nucleotide polymorphisms; susceptibility	SINGLE NUCLEOTIDE POLYMORPHISMS; ANGIOTENSIN-ALDOSTERONE SYSTEM; MATERNAL SUSCEPTIBILITY LOCUS; PREECLAMPSIA SUSCEPTIBILITY; G894T POLYMORPHISM; ACE I/D; ASSOCIATION; MTHFR; SERUM; COMPONENTS	Pregnancy-induced hypertension (PIH) is a multifactorial and severe pregnancy complication including preeclampsia/eclampsia, gestational hypertension, chronic (pre-existing) hypertension, and preeclampsia/eclampsia variants superimposed on chronic hypertension. PIH-induced maternal mortality accounts for approximately 9% of all maternal deaths over the world. A large number of case-control studies have established the importance of various genetic factors in the occurrence and development of PIH. In this narrative review, we summarized the genetic risk factors involved in the renin-angiotensin system, endothelin system, inflammatory factors, oxidative stress, and other functional networks, with the aim of sorting out the genetic factors that may play a potential role in PIH and providing new ideas to elucidate the pathogenesis of PIH.	[Wei, Wenwen; Wang, Xin; Yu, Hongsong] Zunyi Med Univ, Special Key Lab Ocular Dis Guizhou Prov, Sch Basic Med Sci, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China; [Zhou, Yuanzhong] Zunyi Med Univ, Sch Publ Hlth, Zunyi, Guizhou, Peoples R China; [Shang, Xuejun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Androl, Nanjing, Peoples R China	Zunyi Medical University; Zunyi Medical University; Nanjing University	Yu, HS (corresponding author), Zunyi Med Univ, Special Key Lab Ocular Dis Guizhou Prov, Sch Basic Med Sci, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.	yuhongsong@163.com	Yu, Hongsong/J-9106-2014	Yu, Hongsong/0000-0002-1209-2104; Wang, Xin/0000-0002-0245-8045	National Key R & D Program of China [2018YFC1004300]; National Natural Science Foundation Project of China [82160154, 81670844]; Key Project of Guizhou Provincial Science and Technology Department [QKH-JC-2019-1464]; Excellent Talent Support Program of Guizhou Provincial Education Department [QJH-KY-2017-077]; Science and Technology Foundation of Guizhou Province [QKH-PTRC-2017-5733-003, QKH-PTRC-2018-5772-042]; Program for Excellent Young Talents of Zunyi Medical University [18-ZY-001, F-874]; Science and Technology Program Project of Zunyi [ZSKH-HZ-2020-35]	National Key R & D Program of China; National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Key Project of Guizhou Provincial Science and Technology Department; Excellent Talent Support Program of Guizhou Provincial Education Department; Science and Technology Foundation of Guizhou Province; Program for Excellent Young Talents of Zunyi Medical University; Science and Technology Program Project of Zunyi	This work was supported by the National Key R & D Program of China (grant number: 2018YFC1004300), the National Natural Science Foundation Project of China (grant number: 82160154, 81670844), the Key Project of Guizhou Provincial Science and Technology Department (grant number: QKH-JC-2019-1464), the Excellent Talent Support Program of Guizhou Provincial Education Department (grant number: QJH-KY-2017-077), the Science and Technology Foundation of Guizhou Province (grant number: QKH-PTRC-2017-5733-003, QKH-PTRC-2018-5772-042), the Program for Excellent Young Talents of Zunyi Medical University (18-ZY-001, F-874), and the Science and Technology Program Project of Zunyi (ZSKH-HZ-2020-35).	Abbasi H, 2021, FETAL PEDIATR PATHOL, V40, P455, DOI 10.1080/15513815.2019.1710880; Abd Rahman R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072504; Aggarwal PK, 2009, J HYPERTENS, V27, P2044, DOI 10.1097/HJH.0b013e32832f7f3f; Akther L, 2019, J OBSTET GYNAECOL RE, V45, P113, DOI 10.1111/jog.13791; Alaee E, 2019, ANN HUM GENET, V83, P418, DOI 10.1111/ahg.12323; Anton Lauren, 2008, Ther Adv Cardiovasc Dis, V2, P349, DOI 10.1177/1753944708094529; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Aung M, 2017, EUR J OBSTET GYN R B, V215, P180, DOI 10.1016/j.ejogrb.2017.05.011; Aydemir B, 2019, GYNECOL ENDOCRINOL, V35, P417, DOI 10.1080/09513590.2018.1532990; Azimi-Nezhad M, 2020, FETAL PEDIATR PATHOL, V39, P373, DOI 10.1080/15513815.2019.1655819; Barisic A, 2018, GENE, V647, P48, DOI 10.1016/j.gene.2018.01.010; Chen AP, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/4683798; Chen JY, 2019, GENET TEST MOL BIOMA, V23, P180, DOI 10.1089/gtmb.2018.0279; Cubro H, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0833-7; Dargahi H, 2019, IRAN J PUBLIC HEALTH, V48, P531, DOI 10.18502/ijph.v48i3.898; Do AA, 2018, J HUM HYPERTENS, V32, P825, DOI 10.1038/s41371-018-0096-4; Lopes ACD, 2019, MOL CELL PROBE, V45, P43, DOI 10.1016/j.mcp.2019.04.004; Du L, 2017, J HUM HYPERTENS, V31, P49, DOI 10.1038/jhh.2016.17; Duan WC, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20190209; Fan DM, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16018588; Farajian-Mashhadi Farzaneh, 2020, Clin Exp Hypertens, V42, P171, DOI 10.1080/10641963.2019.1601203; Feng YN, 2020, PLACENTA, V90, P1, DOI 10.1016/j.placenta.2019.11.004; Ferreira LC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86240-z; Gannoun MBA, 2017, CYTOKINE, V97, P175, DOI 10.1016/j.cyto.2017.06.010; Glotov AS, 2019, J MATERN-FETAL NEO M, V32, P2790, DOI 10.1080/14767058.2018.1449204; Gonzalez-Garrido JA, 2017, PREGNANCY HYPERTENS, V10, P22, DOI 10.1016/j.preghy.2017.04.001; Granger JP, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0828-4; Guan LB, 2016, EUR J OBSTET GYN R B, V204, P31, DOI 10.1016/j.ejogrb.2016.07.491; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hill LD, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-64; Hou JY, 2020, GYNECOL ENDOCRINOL, V36, P322, DOI 10.1080/09513590.2019.1658188; Jakovljevic TS, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13105; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Keshavarzi F, 2019, CLIN EXP HYPERTENS, V41, P274, DOI 10.1080/10641963.2018.1469644; Khani M, 2015, PREGNANCY HYPERTENS, V5, P267, DOI 10.1016/j.preghy.2015.01.002; Kintiraki E, 2015, HORM-INT J ENDOCRINO, V14, P211, DOI 10.14310/horm.2002.1582; Kong DH, 2018, EXP THER MED, V16, P1982, DOI 10.3892/etm.2018.6393; Laasanen J, 2003, EUR J HUM GENET, V11, P232, DOI 10.1038/sj.ejhg.5200951; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Li CY, 2018, HYPERTENS PREGNANCY, V37, P87, DOI 10.1080/10641955.2018.1460666; Li J, 2020, EUR REV MED PHARMACO, V24, P1602, DOI 10.26355/eurrev_202002_20334; Li X, 2018, PREGNANCY HYPERTENS, V12, P155, DOI 10.1016/j.preghy.2017.11.010; Li X, 2016, SCI REP-UK, V6, DOI 10.1038/srep38030; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097230; Li YX, 2015, HYPERTENS PREGNANCY, V34, P241, DOI 10.3109/10641955.2015.1009543; Li Y, 2016, REPROD SCI, V23, P1402, DOI 10.1177/1933719116641760; Lokki A Inkeri, 2011, BMC Res Notes, V4, P545, DOI 10.1186/1756-0500-4-545; Ma Q, 2016, HYPERTENS RES, V39, P899, DOI 10.1038/hr.2016.95; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; Magee LA, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002783; Mazloomi S, 2020, CLIN EXP HYPERTENS, V42, P590, DOI 10.1080/10641963.2020.1739700; Mendelova A, 2018, GEN PHYSIOL BIOPHYS, V37, P185, DOI [10.4149/gph_2017028, 10.4149/gpb_2017028]; Mo H, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.642; Mohammadpour-Gharehbagh A, 2019, INT J BIOL MACROMOL, V134, P1205, DOI 10.1016/j.ijbiomac.2019.05.040; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Mowad HH, 2019, PREGNANCY HYPERTENS, V18, P173, DOI 10.1016/j.preghy.2019.09.016; Ou MH, 2020, FASEB J, V34, P6070, DOI 10.1096/fj.201902280R; Palei ACT, 2010, CLIN CHIM ACTA, V411, P874, DOI 10.1016/j.cca.2010.03.002; Qu HM, 2020, AM J PHYSIOL-HEART C, V319, pH661, DOI 10.1152/ajpheart.00202.2020; Raguema N, 2018, PREGNANCY HYPERTENS, V11, P105, DOI 10.1016/j.preghy.2018.01.011; Rahimi Z, 2014, GENE, V538, P176, DOI 10.1016/j.gene.2013.12.013; Rezavand N, 2019, J CELL BIOCHEM, V120, P6441, DOI 10.1002/jcb.27934; Sakar MN, 2015, J MATERN-FETAL NEO M, V28, P1907, DOI 10.3109/14767058.2014.971748; Sakowicz A, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/1371425; Saleh Langeza, 2016, Ther Adv Cardiovasc Dis, V10, P282, DOI 10.1177/1753944715624853; Seamon K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00396; Shaheen G, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.799; Sheng CZ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020319; Soltani S, 2019, INT J GYNECOL OBSTET, V145, P337, DOI 10.1002/ijgo.12816; Soltani-Zangbar Mohammad Sadegh, 2018, J Reprod Infertil, V19, P95; Sun C, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038355; Thakoordeen S, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0891-x; Veisian M, 2020, FETAL PEDIATR PATHOL, V39, P491, DOI 10.1080/15513815.2019.1675110; Veisian M, 2020, FETAL PEDIATR PATHOL, V39, P518, DOI 10.1080/15513815.2019.1683919; Vural P, 2015, INT IMMUNOPHARMACOL, V28, P521, DOI 10.1016/j.intimp.2015.07.019; Wang C, 2020, J ASSIST REPROD GEN, V37, P3121, DOI 10.1007/s10815-020-01971-8; Wang LL, 2018, CYTOKINE, V111, P278, DOI 10.1016/j.cyto.2018.09.002; Wang RJ, 2021, MICROVASC RES, V135, DOI 10.1016/j.mvr.2020.104130; Wang XY, 2020, IMMUNOL INVEST, V49, P120, DOI 10.1080/08820139.2019.1659812; Webster K, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5119; Wu XM, 2015, J ASSIST REPROD GEN, V32, P797, DOI 10.1007/s10815-014-0408-8; Yang J, 2013, J MOL ENDOCRINOL, V50, pR53, DOI 10.1530/JME-12-0216; Yu N, 2019, EUR REV MED PHARMACO, V23, P6800, DOI 10.26355/eurrev_201908_18718; Yuan JP, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6909672; Zhang H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05411-z; Zhang YY, 2019, EXP THER MED, V18, P637, DOI 10.3892/etm.2019.7591; Zhao AX, 2020, EXP THER MED, V20, P3798, DOI 10.3892/etm.2020.9084; Zhao LL, 2013, ANN HUM GENET, V77, P277, DOI 10.1111/ahg.12021; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61; Zhou L, 2016, INFLAMM RES, V65, P717, DOI 10.1007/s00011-016-0953-y; Zitouni H, 2018, J RENIN-ANGIO-ALDO S, V19, DOI 10.1177/1470320317753924	93	0	0	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22413	10.1096/fj.202101853RR	http://dx.doi.org/10.1096/fj.202101853RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2B3OV	35696055				2022-12-28	WOS:000810101800001
J	Yang, JH; Sun, XL; Huang, N; Li, P; He, JQ; Jiang, L; Zhang, XM; Han, S; Xin, H				Yang, Jiahong; Sun, Xiaolin; Huang, Ning; Li, Peng; He, Jiaqi; Jiang, Lan; Zhang, Xuemei; Han, Shu; Xin, Hong			Entacapone alleviates acute kidney injury by inhibiting ferroptosis	FASEB JOURNAL			English	Article						entacapone; ferroptosis; ischemia; reperfusion; NRF2	TRANSCRIPTION FACTOR NRF2; RHABDOMYOLYSIS; INACTIVATION; ACTIVATION; PROTECTS; SYSTEM; GPX4	Acute kidney injury (AKI) is a common clinical problem and an efficacious treatment is lacking. Ferroptosis, a newly discovered type of programmed cell death, has been reported to alleviate renal tubular injury in ischemia/reperfusion-induced acute kidney injury (I/R-AKI). Entacapone is a specific inhibitor of catechol-O-methyltransferase, which is used as an adjuvant drug against Parkinson's disease. We demonstrated that entacapone prevents renal I/R injury by inhibiting ferroptosis. Compared with a sham group, entacapone treatment mitigated I/R-induced pathological alterations, improved renal function, and inhibited ferroptosis. In HK-2 cells, entacapone treatment significantly reduced the lipid peroxidation and iron accumulation induced by the ferroptosis inducers erastin and RSL3, and significantly regulated expression of ferroptosis-related proteins. Entacapone upregulates p62 expression and affects the p62-KEAP1-NRF2 pathway, thereby upregulating nuclear translocation of NRF2. This action results in increased expression of the downstream SLC7A11, and significant suppression of oxidative stress and ferroptosis. Our results identify entacapone as a ferroptosis inhibitor that enhances antioxidant capacity. Entacapone may serve as a novel strategy to improve treatment of, and recovery from, I/R-AKI.	[Yang, Jiahong; Sun, Xiaolin; Huang, Ning; Li, Peng; He, Jiaqi; Jiang, Lan; Zhang, Xuemei; Xin, Hong] Fudan Univ, Sch Pharm, Dept Pharmacol, Zhangheng Rd 826, Shanghai 201203, Peoples R China; [Han, Shu] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Fengyang Rd 415, Shanghai 200003, Peoples R China	Fudan University; Naval Medical University	Xin, H (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Zhangheng Rd 826, Shanghai 201203, Peoples R China.; Han, S (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Fengyang Rd 415, Shanghai 200003, Peoples R China.	hanshu73@163.com; xinhong@fudan.edu.cn			Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [20ZR140710]	Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 20ZR140710	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS45; Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Fang XX, 2020, CIRC RES, V127, P486, DOI 10.1161/CIRCRESAHA.120.316509; Goetz Christopher G., 1998, Neurology, V50, pS26; Gonsalez SR, 2019, PHARMACOL THERAPEUT, V200, P1, DOI 10.1016/j.pharmthera.2019.04.001; Gordin A, 2004, J NEURAL TRANSM, V111, P1343, DOI 10.1007/s00702-004-0190-3; Grunig D, 2017, TOXICOL IN VITRO, V42, P337, DOI 10.1016/j.tiv.2017.05.013; Guerrero-Hue M, 2019, FASEB J, V33, P8961, DOI 10.1096/fj.201900077R; Haasio K, 2010, INT REV NEUROBIOL, V95, P163, DOI [10.1016/B978-0-12-381326-8-00007-7, 10.1016/B978-0-12-381326-8.00007-7]; Hou K, 2021, EBIOMEDICINE, V69, DOI 10.1016/j.ebiom.2021.103456; Hu ZX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2256-z; Hu ZX, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8010614; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lang XT, 2019, CANCER DISCOV, V9, P1673, DOI 10.1158/2159-8290.CD-19-0338; Levey AS, 2017, ANN INTERN MED, V167, pITC65, DOI 10.7326/AITC201711070; Li DY, 2021, BRIT J PHARMACOL, V178, P1182, DOI 10.1111/bph.15364; Li X, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.680544; Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Liu JY, 2020, MOL THER, V28, P2358, DOI 10.1016/j.ymthe.2020.08.021; Lyoo CH, 2011, J NEUROL, V258, P1893, DOI 10.1007/s00415-011-6041-x; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Muhoberac BB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01195; Najib J, 2001, CLIN THER, V23, P802, DOI 10.1016/S0149-2918(01)80071-0; Pitakpatapee Yuvadee, 2021, Tremor Other Hyperkinet Mov (N Y), V11, P39, DOI 10.5334/tohm.641; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Qiu YM, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104919; Ren XY, 2021, REDOX BIOL, V46, DOI 10.1016/j.redox.2021.102122; Schrag A, 2005, LANCET NEUROL, V4, P366, DOI 10.1016/S1474-4422(05)70098-3; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Song XX, 2018, CURR BIOL, V28, P2388, DOI 10.1016/j.cub.2018.05.094; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Sun YR, 2020, MOL NEUROBIOL, V57, P4628, DOI 10.1007/s12035-020-02049-3; Takubo H, 2003, PARKINSONISM RELAT D, V9, pS31, DOI 10.1016/S1353-8020(02)00122-0; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Ursini F, 2020, FREE RADICAL BIO MED, V152, P175, DOI 10.1016/j.freeradbiomed.2020.02.027; Wang LY, 2020, CELL DEATH DIFFER, V27, P662, DOI 10.1038/s41418-019-0380-z; Wang Y, 2021, J ADV RES, V28, P231, DOI 10.1016/j.jare.2020.07.007; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7; Zhang MY, 2021, J ETHNOPHARMACOL, V274, DOI 10.1016/j.jep.2021.114064; Zhao Z, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02871-6	55	3	3	17	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22399	10.1096/fj.202200241RR	http://dx.doi.org/10.1096/fj.202200241RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2A6BP	35691001				2022-12-28	WOS:000809585500001
J	Zhou, HY; Yang, DF; Cheng, HS; McCoy, MG; Perez-Cremades, D; Haemmig, S; Wong, D; Chen, L; Feinberg, MW				Zhou, Haoyang; Yang, Dafeng; Cheng, Henry S.; McCoy, Michael G.; Perez-Cremades, Daniel; Haemmig, Stefan; Wong, Danny; Chen, Lei; Feinberg, Mark W.			miR-181b regulates vascular endothelial aging by modulating an MAP3K3 signaling pathway	FASEB JOURNAL			English	Article						apoptosis; atherosclerosis; endothelium; microRNA; senescence	NF-KAPPA-B; CELLULAR SENESCENCE; OXIDATIVE STRESS; APOPTOSIS; ACTIVATION; CANCER; CELLS; MECHANISMS; EXPRESSION; BIOMARKER	Endothelial cell (EC) aging plays a vital role in the pathogenesis of cardiovascular disease (CVD). MicroRNAs have emerged as crucial regulators of target gene expression by inhibiting mRNA translation and/or promoting mRNA degradation. We identify an aging-related and oxidative stress-responsive microRNA, miR-181b, that inhibits endothelial cell apoptosis and senescence. In gain- or loss-of-function studies, miR-181b regulated the expression of key apoptosis markers (Bcl2, Bax, cleaved-Caspase3) and senescence markers (p16, p21, gamma H2AX) and the ratio of apoptotic cells (TUNEL-positive) and senescent cells (SA-beta gal-positive) in H2O2-induced ECs. Mechanistically, miR-181b targets MAP3K3 and modulates a MAP3K3/MKK/MAPK signaling pathway. MAP3K3 knockdown recapitulated the phenotype of miR-181b overexpression and miR-181b was dependent on MAP3K3 for regulating EC apoptosis and senescence. In vivo, miR-181b expression showed a negative correlation with increasing age in the mouse aorta. Endothelial-specific deficiency of miR-181a2b2 increased the target MAP3K3, markers of vascular senescence (p16, p21), and DNA double-strand breaks (gamma H2AX) in the aorta of aged mice. Collectively, this study unveils an important role of miR-181b in regulating vascular endothelial aging via an MAP3K3-MAPK signaling pathway, providing new potential therapeutic targets for antiaging therapy in CVD.	[Zhou, Haoyang; Yang, Dafeng; Cheng, Henry S.; McCoy, Michael G.; Perez-Cremades, Daniel; Haemmig, Stefan; Wong, Danny; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA; [Zhou, Haoyang; Yang, Dafeng; Chen, Lei] Cent South Univ, Dept Cardiol, Xiangya Hosp 2, Changsha, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central South University	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Yang, Dafeng/HIK-2106-2022	Yang, Dafeng/0000-0002-8320-8215; Feinberg, Mark/0000-0001-9523-3859; Perez-Cremades, Daniel/0000-0002-0969-8762	National Institutes of Health [HL115141, HL134849, HL148207, HL148355, HL153356]; American Heart Association [18SFRN33900144, 20SFRN35200163]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health (HL115141, HL134849, HL148207, HL148355, HL153356 to M.W.F.), and the American Heart Association (18SFRN33900144 and 20SFRN35200163 to M.W.F.)	Anton B, 2005, ANN NY ACAD SCI, V1057, P525, DOI 10.1196/annals.1356.040; Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Chamoli M, 2014, AGING CELL, V13, P641, DOI 10.1111/acel.12218; Chen H, 2010, SCI CHINA LIFE SCI, V53, P101, DOI 10.1007/s11427-010-0002-y; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Dangwal S, 2014, ANNU REV PHARMACOL, V54, P185, DOI 10.1146/annurev-pharmtox-011613-135957; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563; Ellinger-Ziegelbauer H, 1999, MOL CELL BIOL, V19, P3857; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gude NA, 2018, NAT REV CARDIOL, V15, P523, DOI 10.1038/s41569-018-0061-5; Guo SY, 2012, ONCOL REP, V27, P441, DOI 10.3892/or.2011.1509; Guo YM, 2017, AGING CELL, V16, P837, DOI 10.1111/acel.12615; Haemmig S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw1868; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001; Kuo LJ, 2008, IN VIVO, V22, P305; Lam JKW, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.23; Li DF, 2014, INT J CLIN EXP PATHO, V7, P7672; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Ling L, 2021, INFLAMMATION, V44, P1263, DOI 10.1007/s10753-020-01411-w; Liu B, 2019, EXP THER MED, V17, P1537, DOI 10.3892/etm.2019.7159; Liu J, 2014, BIOMED REP, V2, P7, DOI 10.3892/br.2013.199; Liu YQ, 2016, PROTEIN CELL, V7, P722, DOI 10.1007/s13238-016-0313-2; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Lv Y, 2020, MOL CELL BIOCHEM, V464, P193, DOI 10.1007/s11010-019-03660-2; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Munzel T, 2017, J AM COLL CARDIOL, V70, P212, DOI 10.1016/j.jacc.2017.05.035; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Pang XL, 2019, J CELL BIOCHEM, V120, P12822, DOI 10.1002/jcb.28553; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002; Ungvari Z, 2018, NAT REV CARDIOL, V15, P555, DOI 10.1038/s41569-018-0030-z; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang L, 2019, J CELL PHYSIOL, V234, P15206, DOI 10.1002/jcp.28162; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yang DF, 2022, ATHEROSCLEROSIS, V350, P9, DOI 10.1016/j.atherosclerosis.2022.04.010; Yang L, 2014, FEBS LETT, V588, P124, DOI 10.1016/j.febslet.2013.11.019; Yang XF, 2020, INT J MOL MED, V46, P1755, DOI 10.3892/ijmm.2020.4720; Zhi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109124; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179; Zhu FX, 2019, J CELL PHYSIOL, V234, P18963, DOI 10.1002/jcp.28536; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	70	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22353	10.1096/fj.202200046R	http://dx.doi.org/10.1096/fj.202200046R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5GG	35593587				2022-12-28	WOS:000797946600001
J	DeOre, BJ; Partyka, PP; Fan, F; Galie, PA				DeOre, Brandon J.; Partyka, Paul P.; Fan, Fan; Galie, Peter A.			CD44 mediates shear stress mechanotransduction in an in vitro blood-brain barrier model through small GTPases RhoA and Rac1	FASEB JOURNAL			English	Article						biophysics; blood-brain barrier; hyaluronic acid	ENDOTHELIAL-CELLS; HYALURONAN; JUNCTIONS; OLIGOSACCHARIDES; ACTIVATION; COMPLEX; MATRIX	Fluid shear stress is an important mediator of vascular permeability, yet the molecular mechanisms underlying the effect of shear on the blood-brain barrier (BBB) have yet to be clarified in cerebral vasculature despite its importance for brain homeostasis. The goal of this study is to probe components of shear mechanotransduction within the BBB to gain a better understanding of pathologies associated with changes in cerebral perfusion including ischemic stroke. Interrogating the effects of shear stress in vivo is complicated by the complexity of factors in the brain parenchyma and the difficulty associated with modulating blood flow regimes. The in vitro model used in this study is compatible with real-time measurement of barrier function using a transendothelial electrical resistance as well as immunocytochemistry and dextran permeability assays. These experiments reveal that there is a threshold level of shear stress required for barrier formation and that the composition of the extracellular matrix, specifically the presence of high molecular weight hyaluronan, dictates the flow response. Gene editing to modulate the expression of CD44, a mechanosensitive receptor for hyaluronan, demonstrates that the receptor is required for the endothelial response to shear stress. Manipulation of small GTPase activity reveals CD44 activates Rac1 while inhibiting RhoA activation. Additionally, adducin-gamma localizes to tight junctions in response to shear stress and RhoA inhibition and is required to maintain the barrier. This study identifies specific components of the mechanosensing complex associated with the BBB response to fluid shear stress and, therefore, illuminates potential targets for barrier manipulation in vivo.	[DeOre, Brandon J.; Partyka, Paul P.; Galie, Peter A.] Rowan Univ, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA; [Fan, Fan] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	Rowan University; University of Mississippi; University of Mississippi Medical Center	Galie, PA (corresponding author), Rowan Univ, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA.	galie@rowan.edu		Galie, Peter/0000-0001-5161-4924; DeOre, Brandon/0000-0001-8586-3646	American Heart Association Scientist Development Grant [17SDG33460432]; National Institute of Health [RO1AG057842]; National Science Foundation Graduate Research Fellowship [2019287762]	American Heart Association Scientist Development Grant(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	We express gratitude to Kiet Tran for his invaluable assistance in helping to fabricate 3D vessels used in our experiments. We would also like to thank Dr. Robert Nagele of Rowan's School of Osteopathic Medicine for providing the hCMEC/D3 cell line used for these experiments. This work was supported by an American Heart Association Scientist Development Grant awarded to P.A.G. (17SDG33460432), National Institute of Health grant awarded to F.F. (RO1AG057842), and National Science Foundation Graduate Research Fellowship (2019287762) awarded to B.J.D.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adamson R. H., 1994, Microcirculation (New York), V1, P251, DOI 10.3109/10739689409146752; Al-Ahmad AJ, 2019, J CEREBR BLOOD F MET, V39, P1759, DOI 10.1177/0271678X18767748; Baines AJ, 2014, BBA-BIOMEMBRANES, V1838, P605, DOI 10.1016/j.bbamem.2013.05.030; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Bouhrira N, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab5898; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bowers HC, 2019, EXP CELL RES, V376, P49, DOI 10.1016/j.yexcr.2019.01.012; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Cyphert Jaime M, 2015, Int J Cell Biol, V2015, P563818, DOI 10.1155/2015/563818; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Fan F, 2017, AM J PHYSIOL-RENAL, V312, pF971, DOI 10.1152/ajprenal.00529.2016; Galie PA, 2015, LAB CHIP, V15, P1205, DOI 10.1039/c4lc01236d; Gao WJ, 2021, AM J PHYSIOL-RENAL, V320, pF97, DOI 10.1152/ajprenal.00423.2020; Givens C, 2016, ANTIOXID REDOX SIGN, V25, P373, DOI 10.1089/ars.2015.6493; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; HUDETZ AG, 1994, ADV EXP MED BIOL, V345, P633; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kugelmann D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31408-3; Kugelmann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126213; Lai AY, 2018, J NEUROCHEM, V144, P659, DOI 10.1111/jnc.14130; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Partyka PP, 2017, BIOMATERIALS, V115, P30, DOI 10.1016/j.biomaterials.2016.11.012; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Polacheck WJ, 2017, NATURE, V552, P258, DOI 10.1038/nature24998; Ponce AG., 2019, FASEB J, V33, DOI [10.1096/fasebj.2019.33.1_supplement.686.3, DOI 10.1096/FASEBJ.2019.33.1_SUPPLEMENT.686.3]; Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Razinia Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16486-z; Reed MJ, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1651157; Shekhar Shashank, 2017, J Pharm Sci Exp Pharmacol, V2017, P21; Sherman LS, 2002, GLIA, V38, P93, DOI 10.1002/glia.10053; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Sladojevic N, 2017, EXPERT REV NEUROTHER, V17, P1167, DOI 10.1080/14737175.2017.1395700; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wimmer I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00711; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2	56	9	9	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22278	10.1096/fj.202100822RR	http://dx.doi.org/10.1096/fj.202100822RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZF	35436025	Green Submitted			2022-12-28	WOS:000783258200001
J	Jiang, XX; Zhang, K; Gao, CY; Ma, WZ; Liu, MQ; Guo, XY; Bao, GW; Han, B; Hu, H; Zhao, ZH				Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang			Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics	FASEB JOURNAL			English	Article						autophagy; cardiac hypertrophy; FMS-like receptor tyrosine kinase 3; isoprenaline; mitochondrial dynamics	LYSOSOMAL BIOGENESIS; IN-VITRO; FLT3; SIRT1; DEACETYLATION; PROMOTES; HEART; DEGRADATION; EXPRESSION; PROGENITOR	FMS-like receptor tyrosine kinase 3 (Flt3) expression was reported to increase in the heart in response to pathological stress, but the role of Flt3 activation and its underlying mechanisms remain poorly elucidated. This study was designed to investigate the role of Flt3 activation in sympathetic hyperactivity-induced cardiac hypertrophy and its mechanisms through autophagy and mitochondrial dynamics. In vivo, cardiac hypertrophy was established by subcutaneous injection of isoprenaline (6 mg/kg center dot day) in C57BL/6 mice for 7 consecutive days. The Flt3-ligand intervention was launched 2 h prior to isoprenaline each day. In vitro, experiments of cardiomyocyte hypertrophy, autophagy, and mitochondrial dynamics were performed in neonatal rat cardiomyocytes (NRCMs). Our results revealed that the expression level of Flt3 protein was significantly increased in the hypertrophic myocardium provoked by isoprenaline administration. Flt3-ligand intervention alleviated isoprenaline-induced cardiac oxidative stress, hypertrophy, fibrosis, and contractile dysfunction. Isoprenaline stimulation impaired autophagic flux in hypertrophic mouse hearts, supported by the accumulation of LC3II and P62 proteins, while Flt3-ligand restored the impairment of autophagic flux. Flt3 activation normalized the imbalance of mitochondrial fission and fusion in the hearts of mice evoked by isoprenaline as evidenced by the neutralization of elevated mitochondrial fission markers and reduced mitochondrial fusion markers. In NRCMs, Flt3-ligand treatment attenuated isoprenaline-stimulated hypertrophy, which was abolished by a Flt3-specific blocker AC220. Activating Flt3 reversed isoprenaline-induced autophagosome accumulation and impairment of autophagic flux probably by enhancing SIRT1 expression and consequently TFEB nuclear translocation. Flt3 activation improved the imbalance of mitochondrial dynamics induced by isoprenaline in NRCMs through the SIRT1/P53 pathway. Activation of Flt3 mitigated ISO-stimulated hypertrophy probably involves the restoration of autophagic flux and balance of mitochondrial dynamics. Therefore, activation of Flt3 attenuates isoprenaline-induced cardiac hypertrophy in vivo and in vitro, the potential mechanism probably attributes to SIRT1/TFEB-mediated autophagy promotion and SIRT1/P53-mediated mitochondrial dynamics balance. These findings suggest that activation of Flt3 may be a novel target for protection against cardiac remodeling and heart failure during sympathetic hyperactivity.	[Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian 710061, Peoples R China	Xi'an Jiaotong University	Zhao, ZH (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian 710061, Peoples R China.	zzh@mail.xjtu.edu.cn		zhenghang, Zhao/0000-0003-0421-2046	National Natural Science Foundation of China (NSFC) [81470510, 82270296]; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation) [2020JM- 029]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81470510 and 82270296; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation), Grant/Award Number: 2020JM- 029	Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Bao JT, 2016, PROTEIN CELL, V7, P417, DOI 10.1007/s13238-016-0269-2; Bertero E, 2018, NAT REV CARDIOL, V15, P457, DOI 10.1038/s41569-018-0044-6; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; DELAPEYRIERE O, 1995, DIFFERENTIATION, V58, P351, DOI 10.1007/s002580050094; Della Verde G, 2021, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101112; Ding W, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587438; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dong FF, 2022, FEBS J, V289, P262, DOI 10.1111/febs.16138; Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003; Forte M, 2021, BRIT J PHARMACOL, V178, P2060, DOI 10.1111/bph.15068; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gyongyosi A, 2019, CURR PHARM DESIGN, V25, P2192, DOI 10.2174/1381612825666190619145025; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li LF, 2016, ACTA BIOCH BIOPH SIN, V48, P491, DOI 10.1093/abbs/gmw025; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li ZH, 2015, INT J BIOL SCI, V11, P672, DOI 10.7150/ijbs.11883; Lin Jianguo, 2022, Front Cardiovasc Med, V9, P917135, DOI 10.3389/fcvm.2022.917135; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020682; Lu G, 2022, MEDCOMM, V3, DOI 10.1002/mco2.150; LYMAN SD, 1994, BLOOD, V83, P2795, DOI 10.1182/blood.V83.10.2795.2795; Ma SX, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.551318; Ma WZ, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13519; Meeran MFN, 2020, FOOD FUNCT, V11, P965, DOI [10.1039/c9fo00530g, 10.1039/C9FO00530G]; Pfister O, 2014, J AM COLL CARDIOL, V63, P1011, DOI 10.1016/j.jacc.2013.08.1647; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Qi J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00176; Ramirez-Sagredo A, 2021, FASEB J, V35, DOI 10.1096/fj.202002598R; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Shah AK, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060931; Takahashi Shinichiro, 2020, Leuk Res Rep, V13, P100187, DOI 10.1016/j.lrr.2019.100187; Tran DT, 2022, AM J TRANSPLANT, V22, P386, DOI 10.1111/ajt.16882; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Wang WC, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04059-y; Wei X, 2015, CIRCULATION, V131, P1506, DOI 10.1161/CIRCULATIONAHA.114.013789; Yu HY, 2011, J CARDIOVASC PHARM T, V16, P205, DOI 10.1177/1074248410385683; Zech ATL, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.01.013; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071; Zhang P, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1121323; Zhang YX, 2017, MOL MED REP, V16, P8253, DOI 10.3892/mmr.2017.7601; Zhang ZL, 2017, BIOMED PHARMACOTHER, V89, P1055, DOI 10.1016/j.biopha.2017.02.103; Zhao JC, 2022, BLOOD REV, V52, DOI 10.1016/j.blre.2021.100905; Zheng YH, 2021, AGING-US, V13, P7096, DOI 10.18632/aging.202566	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12								10.1096/fj.202200419RR	http://dx.doi.org/10.1096/fj.202200419RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6R5SA	36440960				2022-12-28	WOS:000892361600019
J	Young, LV; Wakelin, G; Cameron, AWR; Springer, SA; Ross, JP; Wolters, G; Murphy, JP; Arsenault, MG; Ng, S; Collao, N; De Lisio, M; Ljubicic, V; Johnston, APW				Young, Laura, V; Wakelin, Griffen; Cameron, Alasdair W. R.; Springer, Stevan A.; Ross, Joel P.; Wolters, Grant; Murphy, J. Patrick; Arsenault, Michel G.; Ng, Sean; Collao, Nicolas; De Lisio, Michael; Ljubicic, Vladimir; Johnston, Adam P. W.			Muscle injury induces a transient senescence-like state that is required for myofiber growth during muscle regeneration	FASEB JOURNAL			English	Article						muscle; regeneration; senescence; single-cell RNA sequencing	CELLULAR SENESCENCE; SKELETAL-MUSCLE; STEM-CELLS; DIFFERENTIATION; MECHANISMS	Cellular senescence is the irreversible arrest of normally dividing cells and is driven by the cell cycle inhibitors Cdkn2a, Cdkn1a, and Trp53. Senescent cells are implicated in chronic diseases and tissue repair through their increased secretion of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). Here, we use spatial transcriptomics and single-cell RNA sequencing (scRNAseq) to demonstrate that cells displaying senescent characteristics are "transiently" present within regenerating skeletal muscle and within the muscles of D2-mdx mice, a model of Muscular Dystrophy. Following injury, multiple cell types including macrophages and fibrog-adipogenic progenitors (FAPs) upregulate senescent features such as senescence pathway genes, SASP factors, and senescence-associated beta-gal (SA-beta-gal) activity. Importantly, when these cells were removed with ABT-263, a senolytic compound, satellite cells are reduced, and muscle fibers were impaired in growth and myonuclear accretion. These results highlight that an "acute" senescent phenotype facilitates regeneration similar to skin and neonatal myocardium.	[Young, Laura, V; Wakelin, Griffen; Cameron, Alasdair W. R.; Springer, Stevan A.; Ross, Joel P.; Wolters, Grant; Murphy, J. Patrick; Arsenault, Michel G.; Johnston, Adam P. W.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE, Canada; [Ng, Sean; Ljubicic, Vladimir] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Collao, Nicolas; De Lisio, Michael] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Johnston, Adam P. W.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada; [Johnston, Adam P. W.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	University of Prince Edward Island; McMaster University; University of Ottawa; University of Prince Edward Island; Dalhousie University	Johnston, APW (corresponding author), Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada.	adamjohnston@dal.ca		Wakelin, Griffen/0000-0001-9339-5387	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05747]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: RGPIN-2016-05747	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Behmoaras J, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202010162; Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020; De Micheli AJ, 2020, CELL REP, V30, P3583, DOI 10.1016/j.celrep.2020.02.067; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530; Flamini V, 2018, STEM CELL REP, V10, P970, DOI 10.1016/j.stemcr.2018.01.007; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069; Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kats I., 2021, BIORXIV; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Mademtzoglou D, 2018, ELIFE, V7, DOI 10.7554/eLife.33337; Magimaidas A, 2016, ONCOTARGET, V7, P26935, DOI 10.18632/oncotarget.8854; McKellar DW., 2020, BIORXIV; Moses L, 2022, NAT METHODS, V19, P534, DOI 10.1038/s41592-022-01409-2; Motohashi N, 2014, JOVE-J VIS EXP, DOI 10.3791/50846; Noel T, 2022, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.809346; Noren Hooten N, 2017, JOVE-J VIS EXP, DOI 10.3791/55533; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saito Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14734-x; Shimizu I, 2019, J CARDIOL, V74, P313, DOI 10.1016/j.jjcc.2019.05.002; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu Q, 2016, ONCOTARGET, V7, P60290, DOI 10.18632/oncotarget.11200; Young LV, 2021, AM J PHYSIOL-CELL PH, V321, pC94, DOI 10.1152/ajpcell.00397.2020; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9	39	1	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22587	10.1096/fj.202200289RR	http://dx.doi.org/10.1096/fj.202200289RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0AB	36190443				2022-12-28	WOS:000863238500001
J	Mohapatra, P; Mohanty, S; Ansari, SA; Shriwas, O; Ghosh, A; Rath, R; Das Majumdar, SK; Swain, RK; Raghav, SK; Dash, R				Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Shriwas, Omprakash; Ghosh, Arup; Rath, Rachna; Das Majumdar, Saroj Kumar; Swain, Rajeeb K.; Raghav, Sunil K.; Dash, Rupesh			CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis	FASEB JOURNAL			English	Article						CMTM6; CX-5461; OSCC; ribosome biogenesis	RNA-POLYMERASE-I; C-MYC; TRANSCRIPTION; ACTIVATION; CARCINOMAS; EXPRESSION; TARGET; GENES; PD-L1	CMTM6, a type 3 transmembrane protein, is known to stabilize the expression of programmed cell death ligand 1 (PD-L1) and hence facilitates the immune evasion of tumor cells. Recently, we demonstrated that CMTM6 is a major driver of cisplatin resistance in oral squamous cell carcinomas (OSCC). However, the detailed mechanism of how CMTM6 rewires cisplatin resistance in OSCC is yet to be explored. RNA sequencing analysis of cisplatin-resistant OSCC lines stably expressing Nt shRNA and CMTM6 shRNA revealed that CMTM6 might be a potential regulator of the ribosome biogenesis network. Knocking down CMTM6 significantly inhibited transcription of 47S precursor rRNA and hindered the nucleolar structure, indicating reduced ribosome biogenesis. When CMTM6 was ectopically over-expressed in CMTM6KD cells, almost all ribosomal machinery components were rescued. Mechanistically, CMTM6 induced the expression of C-Myc, which promotes RNA polymerase I mediated rDNA transcription. In addition to this, CMTM6 was also found to regulate the AKT-mTORC1-dependent ribosome biogenesis and protein synthesis in cisplatin-resistant lines. The nude mice and zebrafish xenograft experiments indicate that blocking ribosome synthesis either by genetic inhibitor (CMTM6KD) or pharmacological inhibitor (CX-5461) significantly restores cisplatin-mediated cell death in chemoresistant OSCC. Overall, our study suggests that CMTM6 is a major regulator of the ribosome biogenesis network and targeting the ribosome biogenesis network is a viable target to overcome chemoresistance in OSCC. The novel combination of CX-5461 and cisplatin deserves further clinical investigation in advanced OSCC.	[Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Shriwas, Omprakash; Ghosh, Arup; Swain, Rajeeb K.; Raghav, Sunil K.; Dash, Rupesh] Inst Life Sci, Canc Biol Unit, Bhubaneswar, India; [Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Raghav, Sunil K.] Reg Ctr Biotechnol, Faridabad, India; [Rath, Rachna] Sriram Chandra Bhanj Dent Coll & Hosp, Cuttack, India; [Das Majumdar, Saroj Kumar] All India Inst Med Sci, Dept Radiotherapy, Bhubaneswar, India; [Raghav, Sunil K.] Manipal Acad Higher Educ, Manipal, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Srirama Chandra Bhanja Medical College & Hospital; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Manipal Academy of Higher Education (MAHE)	Dash, R (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India.	rupeshdash@ils.res.in			ICMR [5/13/9/2019-NCD-III]; DBT [BT/INF/22/SP28293/2018]	ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This work is supported by ICMR (5/13/9/2019-NCD-III), Institute of Life Sciences, Bhubaneswar intramural support, and DBT BT/INF/22/SP28293/2018 (for imaging facility).	Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chaturvedi A, 2020, HEAD NECK PATHOL, V14, P616, DOI 10.1007/s12105-019-01082-6; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Cornelison R, 2017, CLIN CANCER RES, V23, P6529, DOI 10.1158/1078-0432.CCR-17-0282; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DERENZINI M, 1991, VIRCHOWS ARCH B, V61, P1; Devlin JR, 2016, CANCER DISCOV, V6, P59, DOI 10.1158/2159-8290.CD-14-0673; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; John LSS, 2000, CANCER GENE THER, V7, P749, DOI 10.1038/sj.cgt.7700166; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Maji S, 2019, CARCINOGENESIS, V40, P173, DOI 10.1093/carcin/bgy135; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Maji S, 2015, ONCOTARGET, V6, P16623, DOI 10.18632/oncotarget.3932; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohapatra P, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143643; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Penzo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010055; Saeboe-Larssen S, 1998, GENETICS, V148, P1215; Sanderson RJ, 2002, BMJ-BRIT MED J, V325, P822, DOI 10.1136/bmj.325.7368.822; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shriwas O, 2021, BRIT J CANCER, V124, P2004, DOI 10.1038/s41416-021-01336-7; Shriwas O, 2020, APOPTOSIS, V25, P233, DOI 10.1007/s10495-020-01591-8; Teng FY, 2021, CELL MOL LIFE SCI, V78, P6557, DOI 10.1007/s00018-021-03921-8; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	36	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22566	10.1096/fj.202200808RR	http://dx.doi.org/10.1096/fj.202200808RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W0NA	36165231				2022-12-28	WOS:000859863200001
J	Xu, J; Chen, P; Yu, CQ; Shi, QQ; Wei, SS; Li, YX; Qi, HZ; Cao, QL; Guo, CL; Wu, XG; Di, GH				Xu, Jing; Chen, Peng; Yu, Chaoqun; Shi, Qiangqiang; Wei, Susu; Li, Yaxin; Qi, Hongzhao; Cao, Qilong; Guo, Chuanlong; Wu, Xianggen; Di, Guohu			Hypoxic bone marrow mesenchymal stromal cells-derived exosomal miR-182-5p promotes liver regeneration via FOXO1-mediated macrophage polarization	FASEB JOURNAL			English	Article						exosomes; hypoxia; liver regeneration; mesenchymal stromal cells; miR-182-5p	EXTRACELLULAR VESICLES; NONPARENCHYMAL CELLS; CARTILAGE REPAIR; PROLIFERATION; INTERLEUKIN-6	Mesenchymal stromal cells (MSCs) are attractive candidates for treating hepatic disorders given their potential to enhance liver regeneration and function. The paracrine paradigm may be involved in the mechanism of MSC-based therapy, and exosomes (Exo) play an important role in this paracrine activity. Hypoxia significantly improves the effectiveness of MSC transplantation. However, whether hypoxia preconditioned MSCs (Hp-MSCs) can enhance liver regeneration, and whether this enhancement is mediated by Exo, are unknown. In this study, mouse bone marrow-derived MSCs (BM-MSCs) and secreted Exo were injected through the tail vein. We report that Hp-MSCs promote liver regeneration after partial hepatectomy in mice through their secreted exosomes. Interestingly, MSC-Exo were concentrated in liver 6 h after administration and mainly taken up by macrophages, but not hepatocytes. Compared with normoxic MSC-Exo (N-Exo), hypoxic MSC-Exo (Hp-Exo) enhanced M2 macrophage polarization both in vivo and in vitro. Microarray analysis revealed significant enrichment of microRNA (miR)-182-5p in Hp-Exo compared with that in N-Exo. In addition, miR-182-5p knockdown partially abolished the beneficial effect of Hp-Exo. Finally, Hp-MSC-derived exosomal miR-182-5p inhibited theprotein expression of forkhead box transcription factor 1 (FOXO1) in macrophages, which inhibited toll-like receptor 4 (TLR4) expression and subsequently induced an anti-inflammatory response. These results highlight the therapeutic potential of Hp-Exo in liver regeneration and suggest that miR-182-5p from Hp-Exo facilitates macrophage polarization during liver regeneration by modulating the FOXO1/TLR4 signaling pathway.	[Xu, Jing; Chen, Peng; Yu, Chaoqun; Shi, Qiangqiang; Wei, Susu; Li, Yaxin; Di, Guohu] Qingdao Univ, Coll Med, Sch Basic Med, 308 Ningxia Rd, Qingdao 266071, Peoples R China; [Qi, Hongzhao] Qingdao Univ, Inst Translat Med, Qingdao, Peoples R China; [Cao, Qilong] Qingdao Haier Biotech Co Ltd, Qingdao, Peoples R China; [Guo, Chuanlong; Wu, Xianggen] Qingdao Univ Sci & Technol, Coll Chem Engn, Qingdao, Peoples R China; [Di, Guohu] Qingdao Univ, Sch Basic Med, Inst Stem Cell & Regenerat Med, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University of Science & Technology; Qingdao University	Di, GH (corresponding author), Qingdao Univ, Coll Med, Sch Basic Med, 308 Ningxia Rd, Qingdao 266071, Peoples R China.	diguohu@qdu.edu.cn		Di, Guohu/0000-0001-9940-730X	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research) [2018YFA0109800]; China Postdoctoral Science Foundation [2019M652328]	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research), Grant/Award Number: 2018YFA0109800; China Postdoctoral Science Foundation, Grant/Award Number: 2019M652328	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Behnke K, 2018, HEPATOLOGY, V68, P2348, DOI 10.1002/hep.30088; Chen L, 2020, THERANOSTICS, V10, P9425, DOI 10.7150/thno.43315; Chen X, 2018, CANCER LETT, V435, P80, DOI 10.1016/j.canlet.2018.08.001; Cheng H, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01737-0; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Dai YX, 2020, J MOL CELL CARDIOL, V142, P65, DOI 10.1016/j.yjmcc.2020.02.007; Di GH, 2017, INVEST OPHTH VIS SCI, V58, P4344, DOI 10.1167/iovs.17-21506; Ding HR, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00412; Du LM, 2019, CELL METAB, V29, P1363, DOI 10.1016/j.cmet.2019.01.006; Ezquer F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0469-y; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fang SB, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1723260; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feng R, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1783869; Ferreira JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02837; Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97; Goikoetxea-Usandizaga N, 2022, HEPATOLOGY, V75, P550, DOI 10.1002/hep.32149; Haider KH, 2012, PROG MOL BIOL TRANSL, V111, P323, DOI 10.1016/B978-0-12-398459-3.00015-0; Heidari N, 2021, J CELL PHYSIOL, V236, P5906, DOI 10.1002/jcp.30275; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492; Hu YQ, 2019, CELL BIOCHEM FUNCT, V37, P504, DOI 10.1002/cbf.3423; Hu ZM, 2020, HEPATOLOGY, V71, P1421, DOI 10.1002/hep.30919; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; Izumi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07747-0; Kaido T, 2004, HEPATO-GASTROENTEROL, V51, P1667; Kan C, 2021, WORLD J CLIN CASES, V9, P10616, DOI [10.12998/wjcc.v9.i34.10616, 10.1299841/wjcc/v.i31.10616]; Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261; Kang XW, 2021, EXP CELL RES, V405, DOI 10.1016/j.yexcr.2021.112635; Kim H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010028; Lee KS, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12152; Leung WKC, 2015, CANCER LETT, V362, P97, DOI 10.1016/j.canlet.2015.03.023; Lewis PS, 2020, J HEPATOL, V73, P349, DOI 10.1016/j.jhep.2020.02.031; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Liu W, 2020, ACTA BIOMATER, V103, P196, DOI 10.1016/j.actbio.2019.12.020; Liu YN, 2021, AM J PATHOL, V191, P1974, DOI 10.1016/j.ajpath.2021.07.010; Lu QJ, 2021, MOLECULES, V26, DOI 10.3390/molecules26082231; Luo ZC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1410-y; Malik R, 2002, SEMIN CELL DEV BIOL, V13, P425, DOI 10.1016/S1084952102001301; Maroto R, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1359478; Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Penas-Martinez J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041926; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Rai RM, 1997, HEPATOLOGY, V25, P889, DOI 10.1002/hep.510250417; Rong YL, 2021, ACTA BIOMATER, V122, P325, DOI 10.1016/j.actbio.2020.12.034; Shin HS, 2018, STEM CELLS, V36, P1020, DOI 10.1002/stem.2818; Song XJ, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118821; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; Tanei T, 2016, CANCER RES, V76, P429, DOI 10.1158/0008-5472.CAN-15-1576; Tang SZ, 2021, EXP EYE RES, V205, DOI 10.1016/j.exer.2021.108485; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Uetsuka K, 2005, EXP MOL PATHOL, V79, P51, DOI 10.1016/j.yexmp.2005.02.002; Xie K, 2019, IUBMB LIFE, V71, P2020, DOI 10.1002/iub.2147; Yu CQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71337-8; Zhang DX, 2015, DIGEST DIS SCI, V60, P2718, DOI 10.1007/s10620-015-3676-y; Zhang SP, 2018, BIOMATERIALS, V156, P16, DOI 10.1016/j.biomaterials.2017.11.028; Zhao JX, 2019, CARDIOVASC RES, V115, P1205, DOI 10.1093/cvr/cvz040; Zheng J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903746; Zhu CH, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02625-x; Zhu LP, 2018, THERANOSTICS, V8, P6163, DOI 10.7150/thno.28021	67	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22553	10.1096/fj.202101868RRR	http://dx.doi.org/10.1096/fj.202101868RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N7UN	36111980				2022-12-28	WOS:000854221800001
J	Goetzl, EJ; Srihari, VH; Mustapic, M; Kapogiannis, D; Heninger, GR				Goetzl, Edward J.; Srihari, Vinod H.; Mustapic, Maja; Kapogiannis, Dimitrios; Heninger, George R.			Abnormal levels of mitochondrial Ca2+ channel proteins in plasma neuron-derived extracellular vesicles of early schizophrenia	FASEB JOURNAL			English	Article						biomarkers; calcium homeostasis; mental illness; psychosis	EXOSOMES	Structural alterations or quantitative abnormalities of some mitochondrial ion channels and exchangers are associated with altered neuronal functions and increased susceptibility to mental illness. Here we have assessed levels of functionally prominent mitochondrial calcium ion channel proteins in plasma neuron-derived extracellular vesicles (NDEVs) of living patients with first episodes of psychosis (FP) and matched controls (Cs). NDEVs were enriched with an established method of precipitation and immunoabsorption by anti-human CD171 neural adhesion protein (L1CAM) antibody and extracted proteins quantified with ELISAs. CD81 exosome marker-normalized NDEV levels of leucine zipper EF-hand containing transmembrane 1 protein (LETM1), transient receptor potential cation channel subfamily M, member 4 (TRPM4), and solute carrier family 8 member B1 (SLC24A6) or mitochondrial Na+/Ca2+ exchanger (NCLX) were significantly lower for FP patients (n = 10) than Cs (n = 10), whereas NDEV levels of voltage-dependent L-type calcium channel subunit alpha-1C (CACNA-1C) were significantly higher for FP patients than Cs. Abnormal structures or mitochondrial levels of LETM1, NCLX, and CACNA-1C have been linked through analyses of individual proteins, genome-wide association studies, and whole exome protein-coding sequence studies to neurodevelopmental disorders, mental retardation, schizophrenia, and major depressive diseases. A greater understanding of the altered calcium homeostasis in schizophrenia, that is attributable to underlying mitochondrial calcium channel abnormalities, will lead to improved diagnosis and treatment.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA USA; [Goetzl, Edward J.] Res Dept, Campus Jewish Living, San Francisco, CA USA; [Srihari, Vinod H.; Heninger, George R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Intramural Res Program, Biomed Res Ctr, Baltimore, MD USA	University of California System; University of California San Francisco; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), UCSF, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu			National Institutes of Health [01MH103831]; Gustavus and Louise Pfeiffer Research Foundation; Intramural Program of the National Institute on Aging, NIH	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gustavus and Louise Pfeiffer Research Foundation; Intramural Program of the National Institute on Aging, NIH	These studies were supported in part by grant 01MH103831 from the National Institutes of Health (Srihari), Gustavus and Louise Pfeiffer Research Foundation (SRIhari), and the Intramural Program of the National Institute on Aging, NIH. The authors are grateful to Judith H. Goetzl for the preparation of the illustrations.	Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Goetzl EJ, 2021, MOL PSYCHIATR, V26, P7355, DOI 10.1038/s41380-021-01268-x; Goetzl EJ, 2021, FASEB J, V35, DOI 10.1096/fj.202002519R; Goetzl EJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01046-3; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Heyes S, 2015, PROG NEUROBIOL, V134, P36, DOI 10.1016/j.pneurobio.2015.09.002; Hoppe UC, 2010, FEBS LETT, V584, P1975, DOI 10.1016/j.febslet.2010.04.017; Iyegbe CO, 2022, NATURE, V604, DOI 10.1038/d41586-022-00773-5; Kawamoto EM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00061; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Michels S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0061-6; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Natarajan GK, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.637852; Noterman MF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019046118; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Stavsky A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02114-0; Yan J, 2020, SCIENCE, V370, P191, DOI 10.1126/science.aay3302	19	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22466	10.1096/fj.202200792RR	http://dx.doi.org/10.1096/fj.202200792RR			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3C6WK	35867070				2022-12-28	WOS:000828761800001
J	Chen, Q; Cui, K; Zhao, ZQ; Xu, X; Liu, YT; Shen, YN; Chen, F; Mai, KS; Ai, QH				Chen, Qiang; Cui, Kun; Zhao, Zengqi; Xu, Xiang; Liu, Yongtao; Shen, Yanan; Chen, Fan; Mai, Kangsen; Ai, Qinghui			LPS stimulation stabilizes HIF-1 alpha by enhancing HIF-1 alpha acetylation via the PARP1-SIRT1 and ACLY-Tip60 pathways in macrophages	FASEB JOURNAL			English	Article						acetylation; HIF-1 alpha; LPS; NAD(+); ROS	HYPOXIA; IMMUNOMETABOLISM; HOMEOSTASIS; ACTIVATION; MECHANISMS; HEALTH; SIRT1	Hypoxia and inflammatory mediators stabilize hypoxia-inducible factor (HIF)-1 alpha through posttranslational modifications, such as phosphorylation and succinylation. Here, we identified sirtuin 1 (SIRT1) and 60 kDa Tat-interactive protein (Tip60)-mediated acetylation as another critical posttranslational modification that regulates HIF-1 alpha protein stability under lipopolysaccharide (LPS) stimulation. Mechanistically, DNA damage induced by excessive reactive oxygen species (ROS) activated poly (ADP-ribose) polymerase 1 (PARP1) to consume oxidized nicotinamide adenine dinucleotide (NAD(+)). Correspondingly, SIRT1 activity was decreased with the decline in NAD(+) levels, resulting in increased HIF-1 alpha acetylation. LPS also activated the ATP-citrate lyase (ACLY)-Tip60 pathway to further enhance HIF-1 alpha acetylation. Acetylation contributed to HIF-1 alpha stability and exacerbated LPS-induced inflammation. Thus, inhibiting HIF-1 alpha stability by decreasing its acetylation could partly alleviate LPS-induced inflammation. In conclusion, we revealed the mechanism by which LPS stabilized HIF-1 alpha by increasing its acetylation via the PARP1-SIRT1 and ACLY-Tip60 pathways in fish macrophages. This study may provide novel insights for manipulation of HIF-1 alpha acetylation as a therapeutic strategy against inflammation from the perspective of acetylation in vertebrates.	[Chen, Qiang; Cui, Kun; Zhao, Zengqi; Xu, Xiang; Liu, Yongtao; Shen, Yanan; Chen, Fan; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Chen, Qiang; Cui, Kun; Zhao, Zengqi; Xu, Xiang; Liu, Yongtao; Shen, Yanan; Chen, Fan; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Mai, Kangsen; Ai, Qinghui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Ai, QH (corresponding author), Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Ai, QH (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	qhai@ouc.edu.cn			Agriculture Research System of China (China's Agricultural Research System) [CARS-47-11]; National Natural Science Foundation of China-Shandong Joint Fund (NSFC-Shandong Joint Fund) [U2106232]; NSFC \ Key Programme [31830103]; Scientific and Technological Innovation of Blue Granary [2018YFD0900402]; Ten-thousand Talents Program [2018-29]	Agriculture Research System of China (China's Agricultural Research System); National Natural Science Foundation of China-Shandong Joint Fund (NSFC-Shandong Joint Fund); NSFC \ Key Programme; Scientific and Technological Innovation of Blue Granary; Ten-thousand Talents Program	Agriculture Research System of China (China's Agricultural Research System), Grant/Award Number: CARS-47-11; National Natural Science Foundation of China-Shandong Joint Fund (NSFC-Shandong Joint Fund), Grant/Award Number: U2106232; NSFC vertical bar Key Programme, Grant/Award Number: 31830103; Scientific and Technological Innovation of Blue Granary, Grant/Award Number: 2018YFD0900402; Ten-thousand Talents Program, Grant/Award Number: 2018-29	Albanese A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010268; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chen Q, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103244; Chen QC, 2021, FASEB J, V35, DOI 10.1096/fj.202100739RR; Chen XL, 2014, TRENDS BIOTECHNOL, V32, P337, DOI 10.1016/j.tibtech.2014.04.003; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Cui K, 2020, DEV COMP IMMUNOL, V102, DOI 10.1016/j.dci.2019.103477; Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Khoyratty TE, 2021, NAT IMMUNOL, V22, P1093, DOI 10.1038/s41590-021-00968-4; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menzies KJ, 2016, NAT REV ENDOCRINOL, V12, P43, DOI 10.1038/nrendo.2015.181; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Peacock SJ, 2008, T ROY SOC TROP MED H, V102, P5, DOI 10.1016/j.trstmh.2007.06.004; Perez-Perri JI, 2016, CELL REP, V16, P37, DOI 10.1016/j.celrep.2016.05.082; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Plouffe DA, 2005, XENOTRANSPLANTATION, V12, P266, DOI 10.1111/j.1399-3089.2005.00227.x; Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7; Sivanand S, 2017, MOL CELL, V67, P252, DOI 10.1016/j.molcel.2017.06.008; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; Sun HJ, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101813; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Wang SF, 2018, REDOX BIOL, V17, P89, DOI 10.1016/j.redox.2018.04.006; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yu YY, 2019, ISCIENCE, V19, P821, DOI 10.1016/j.isci.2019.08.034; Zhu BB, 2021, IMMUNITY, V54, P1200, DOI 10.1016/j.immuni.2021.04.001	47	1	1	18	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22418	10.1096/fj.202200256R	http://dx.doi.org/10.1096/fj.202200256R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6GO	35713568				2022-12-28	WOS:000812325200001
J	Yan, WX; Chen, GH; Li, JC				Yan, Wenxia; Chen, Guanhao; Li, Jianchao			Structure of the Harmonin PDZ2 and coiled-coil domains in a complex with CDHR2 tail and its implications	FASEB JOURNAL			English	Article						coiled-coil; Harmonin; PDZ domain; Usher syndrome	USHER-SYNDROME TYPE-1; SCAFFOLD PROTEIN; MYOSIN VIIA; HAIR-CELLS; CADHERIN-23; FORM; ORGANIZATION; MICROVILLI; USH1C; MUTATIONS	Harmonin is a protein containing multiple PDZ domains and is required for the development and maintenance of hair cell stereocilia and brush border microvilli. Mutations in the USH1C gene can cause Usher syndrome type 1C, a severe inheritable disease characterized by the loss of hearing and vision. Here, by solving the high-resolution crystal structure of Harmonin PDZ2 and coiled-coil domains in a complex with the tail of cadherin-related family member 2, we demonstrated that mutations located in the Harmonin PDZ2 domain and found in patients could affect its stability, and thus, the target binding capability. The structure also implies that the coiled-coil domain could form antiparallel dimers under high concentrations, possibly when Harmonin underwent liquid-liquid phase separation in the upper tip-link density in hair cell stereocilia or microvilli of enterocytes of the intestinal epithelium. The crystal structure, together with the biochemical analysis, provided mechanistic implications for Harmonin mutations causing Usher syndrome, non-syndromic deafness, or enteropathy.	[Yan, Wenxia] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou, Peoples R China; [Chen, Guanhao; Li, Jianchao] South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China; [Li, Jianchao] South China Univ Technol, Sch Med, Guangzhou Peoples Hosp 1, Dept Otorhinolaryngol, Guangzhou, Peoples R China	South China University of Technology; South China University of Technology; South China University of Technology	Li, JC (corresponding author), South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China.	lijch@scut.edu.cn	LI, Jianchao/J-2053-2017	LI, Jianchao/0000-0002-8921-1626	National Natural Science Foundation of China (NSFC) [31971140, 21907033]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31971140 and 21907033	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Bahloul A, 2017, FEBS LETT, V591, P2299, DOI 10.1002/1873-3468.12729; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crawley SW, 2016, DEV CELL, V36, P190, DOI 10.1016/j.devcel.2015.12.022; Crawley SW, 2014, J CELL BIOL, V207, P441, DOI 10.1083/jcb.201407015; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Delhommel F, 2018, FEBS J, V285, P3738, DOI 10.1111/febs.14614; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geleoc GGS, 2020, HEARING RES, V394, DOI 10.1016/j.heares.2020.107932; Gray MJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001463; Gregory FD, 2013, J PHYSIOL-LONDON, V591, P3253, DOI 10.1113/jphysiol.2013.254367; Gregory FD, 2011, NAT NEUROSCI, V14, P1109, DOI 10.1038/nn.2895; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; He YY, 2019, CELL REP, V29, P974, DOI 10.1016/j.celrep.2019.09.027; Houdusse A, 2021, CURR BIOL, V31, pR586, DOI 10.1016/j.cub.2021.04.005; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Khubchandani SR, 2011, ULTRASTRUCT PATHOL, V35, P87, DOI 10.3109/01913123.2010.537438; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li JC, 2017, P NATL ACAD SCI USA, V114, pE3776, DOI 10.1073/pnas.1702251114; Li JC, 2016, DEV CELL, V36, P179, DOI 10.1016/j.devcel.2015.12.020; Li TC, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031492; Lin L, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.642666; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cb.08.110192.001105; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michalski N, 2019, ANNU REV NEUROSCI, V42, P67, DOI 10.1146/annurev-neuro-070918-050428; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Nagel-Wolfrum K., 2021, BIORXIV, P457962, DOI [10.1101/2021.08.27.457962, DOI 10.1101/2021.08.27.457962]; Nambiar R, 2010, CELL MOL LIFE SCI, V67, P1239, DOI 10.1007/s00018-009-0254-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Reiners J, 2005, MOL VIS, V11, P347; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sauvanet C, 2015, ANNU REV CELL DEV BI, V31, P593, DOI 10.1146/annurev-cellbio-100814-125234; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wilson W, 2001, CAN J GASTROENTEROL, V15, P61, DOI 10.1155/2001/743925; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Yu F, 2019, J APPL CRYSTALLOGR, V52, P472, DOI 10.1107/S1600576719001183; Yu IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15864; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	57	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22425	10.1096/fj.202200403RR	http://dx.doi.org/10.1096/fj.202200403RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2I4MK	35747925				2022-12-28	WOS:000814954000001
J	Jin, LN; Yu, BF; Liu, GJ; Nie, WY; Wang, JN; Chen, JH; Xiao, L; Xia, HG; Han, F; Yang, Y				Jin, Lini; Yu, Binfeng; Liu, Guangjun; Nie, Wanyun; Wang, Junni; Chen, Jianghua; Xiao, Liang; Xia, Hongguang; Han, Fei; Yang, Yi			Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis	FASEB JOURNAL			English	Article						chronic kidney disease; mitochondrial fitness; mitophagy; renal fibrosis	KIDNEY INJURY; MECHANISMS; INFLAMMATION; PROTECTS; MACROPHAGES; ACTIVATION; CONTRIBUTE; DISEASE	Renal fibrosis is the final common outcome of chronic kidney disease (CKD), which remains a huge challenge due to a lack of targeted treatment. Growing evidence suggests that during the process of CKD, the integrity and function of mitochondria in renal tubular epithelial cells (TECs) are generally impaired and strongly connected with the progression of renal fibrosis. Mitophagy, a selective form of autophagy, could remove aberrant mitochondria to maintain mitochondrial homeostasis. Deficiency of mitophagy has been reported to aggravate renal fibrosis. However, whether induction of mitophagy could alleviate renal fibrosis has not been stated. In this study, we explored the effect of mitophagy activation by UMI-77, a compound recently verified to induce mitophagy, on murine CKD model of unilateral ureteral obstruction (UUO) in vivo and TECs in vitro. In UUO mice, we found the changes of mitochondrial damage, ROS production, transforming growth factor (TGF)-beta 1/Smad pathway activation, as well as epithelial-mesenchymal transition phenotype and renal fibrosis, and these changes were ameliorated by mitophagy enhancement using UMI-77. Moreover, TEC apoptosis, nuclear factor (NF)-kappa B signaling activation, and interstitial inflammation after UUO were significantly mitigated by augmented mitophagy. Then, we found UMI-77 could effectively and safely induce mitophagy in TECs in vitro, and reduced TGF-beta 1/Smad signaling and downstream profibrotic responses in TGF-beta 1-treated TECs. These changes were restored by a mitophagy inhibitor. In conclusion, we demonstrated that mitophagy activation protected against renal fibrosis through improving mitochondrial fitness, downregulating TGF-beta 1/Smad signaling and alleviating TEC injuries and inflammatory infiltration in kidneys.	[Jin, Lini; Yu, Binfeng; Liu, Guangjun; Nie, Wanyun; Wang, Junni; Chen, Jianghua; Xiao, Liang; Han, Fei; Yang, Yi] Zhejiang Univ, Affiliated Hosp 1, Key Lab Kidney Dis Prevent & Control Technol, Kidney Dis Ctr,Inst Nephrol,Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Hongguang] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Liangzhu Lab,Med Ctr,Dept Biochem, Hangzhou, Peoples R China; [Xia, Hongguang] Zhejiang Univ, Affiliated Hosp 1, Res Ctr Clin Pharm, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Han, F; Yang, Y (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Kidney Dis Prevent & Control Technol, Kidney Dis Ctr,Inst Nephrol,Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	hanf8876@zju.edu.cn; yangyikx@zju.edu.cn	Xiao, Liang/HCI-1002-2022	Xiao, Liang/0000-0003-0312-7149	National Natural Science Foundation of China [81770674]; Primary Research and Development Plan of Zhejiang Province [2020C03034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Primary Research and Development Plan of Zhejiang Province	This study was supported by the funding from National Natural Science Foundation of China (82170681) to Yi Yang, and Primary Research and Development Plan of Zhejiang Province (2020C03034) and National Natural Science Foundation of China (81770674) to Fei Han.	Abulwerdi F, 2014, MOL CANCER THER, V13, P565, DOI 10.1158/1535-7163.MCT-12-0767; Aranda-Rivera AK, 2021, FREE RADICAL BIO MED, V172, P65, DOI 10.1016/j.freeradbiomed.2021.05.034; Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cao Q, 2015, PHYSIOLOGY, V30, P183, DOI 10.1152/physiol.00046.2014; Cen XF, 2021, AUTOPHAGY, V17, P818, DOI 10.1080/15548627.2020.1860542; Cen XF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19547-6; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Eirin A, 2014, CARDIOVASC RES, V103, P461, DOI 10.1093/cvr/cvu157; Aparicio-Trejo OE, 2020, FREE RADICAL BIO MED, V154, P18, DOI 10.1016/j.freeradbiomed.2020.04.016; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Jiang ZZ, 2013, TOXICOL APPL PHARM, V266, P198, DOI 10.1016/j.taap.2012.07.008; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P842; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li S, 2020, FREE RADICAL BIO MED, V152, P632, DOI 10.1016/j.freeradbiomed.2019.12.005; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Ma HJ, 2022, KIDNEY INT, V101, P315, DOI 10.1016/j.kint.2021.10.028; MacVicar TDB, 2014, J CELL SCI, V127, P2313, DOI 10.1242/jcs.144337; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Quan Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020402; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Sang XY, 2020, FASEB J, V34, P14539, DOI 10.1096/fj.202000781RRR; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Tang CY, 2021, NAT REV NEPHROL, V17, P299, DOI 10.1038/s41581-020-00369-0; Tang CY, 2020, NAT REV NEPHROL, V16, P489, DOI 10.1038/s41581-020-0309-2; Tang CY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1899-0; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Wang JN, 2021, HYPERTENSION, V77, P1613, DOI 10.1161/HYPERTENSIONAHA.120.16900; Wang Y, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101767; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang J, 2022, CELL DEATH DIFFER, V29, P556, DOI 10.1038/s41418-021-00874-0; Zhang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.206; Zhang SX, 2017, NEPHROL DIAL TRANSPL, V32, P1628, DOI 10.1093/ndt/gfw469	42	3	3	7	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22342	10.1096/fj.202200199RR	http://dx.doi.org/10.1096/fj.202200199RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1A5QE	35524750				2022-12-28	WOS:000791810200001
J	Tian, L; Liu, Y; Xu, XF; Jiao, PR; Hu, GF; Cui, YQ; Chen, JX; Ma, YC; Jin, X; Wang, KJ; Sun, Q				Tian, Lei; Liu, Yu; Xu, Xiaofang; Jiao, Pengrui; Hu, Gaofei; Cui, Yaqian; Chen, Jixiang; Ma, Yucheng; Jin, Xi; Wang, Kunjie; Sun, Qun			Lactiplantibacillus plantarum J-15 reduced calcium oxalate kidney stones by regulating intestinal microbiota, metabolism, and inflammation in rats	FASEB JOURNAL			English	Article						gut microbiota; inflammation; intestinal barrier; kidney stones; Lactiplantibacillus plantarum; metabolites	TIGHT JUNCTION DISRUPTION; TUBULAR EPITHELIAL-CELLS; GUT MICROBIOTA; PREVENTION; PROBIOTICS; DEPOSITION; BACTERIA; ACIDS	The prevention role of Lactiplantibacillus plantarum against the formation of kidney stones has been increasingly recognized; its mechanism, however, has mainly been focused on inhibiting the inflammation in the colon in the gastrointestinal (GI) system, and the intestinal metabolites from microflora have not been revealed fully with regarding to the stone formation. In this study, we investigated the effect of L. plantarum J-15 on kidney stone formation in renal calcium oxalate (CaOx) rats induced by ethylene glycol and monitored the changes of intestinal microflora and their metabolites detected by 16S rRNA sequencing and widely targeted analysis, followed by the evaluation of the intestinal barrier function and inflammation levels in the colon, blood and kidney. The results showed that L. plantarum J-15 effectively reduced renal crystallization and urinary oxalic acid. Ten microbial genera, including anti-inflammatory and SCFAs-related Faecalibaculum, were enriched in the J-15 treatment group. There are 136 metabolites from 11 categories significantly different in the J-15 supplementation group compared with CaOx model rats, most of which were enriched in the amino acid metabolic and secondary bile acid pathways. The expression of intestinal tight junction protein Occludin and the concentration of pro-inflammatory cytokines and prostaglandin were decreased in the intestine, which further reduced the translocated lipopolysaccharide and inflammation levels in the blood upon J-15 treatment. Thus, the inflammation and injury in the kidney might be alleviated by downregulating TLR4/NF-kappa B/COX-2 signaling pathway. It suggested that L. plantarum J-15 might reduce kidney stone formation by restoring intestinal microflora and metabolic disorder, protecting intestinal barrier function, and alleviating inflammation. This finding provides new insights into the therapies for renal stones.	[Tian, Lei; Xu, Xiaofang; Jiao, Pengrui; Hu, Gaofei; Cui, Yaqian; Sun, Qun] Sichuan Univ, Coll Life Sci, Key Lab Bioresource & Ecoenvironm, Minist Educ, 24 South Sect 1,Yihuan Rd, Chengdu 610065, Sichuan, Peoples R China; [Liu, Yu; Chen, Jixiang; Ma, Yucheng; Jin, Xi; Wang, Kunjie] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol,Lab Reconstruct Urol, 37 Guoxue Alley, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Sun, Q (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresource & Ecoenvironm, Minist Educ, 24 South Sect 1,Yihuan Rd, Chengdu 610065, Sichuan, Peoples R China.; Wang, KJ (corresponding author), Sichuan Univ, West China Hosp, Inst Urol, Dept Urol,Lab Reconstruct Urol, 37 Guoxue Alley, Chengdu 610041, Peoples R China.	wangkj@scu.edu.cn; qunsun@scu.edu.cn			Sichuan Science and Technology Program [2021ZHFP0045, 2021YFN0092]; International Research and Development Program of Sichuan [2019YFH0113, 2021YFH0060, 2021YFH0072]; Sichuan-Guangdong Cross-Regional Innovation Cooperation Programme [22QYCX0027]	Sichuan Science and Technology Program; International Research and Development Program of Sichuan; Sichuan-Guangdong Cross-Regional Innovation Cooperation Programme	This work was supported by Sichuan Science and Technology Program (2021ZHFP0045, 2021YFN0092), International Research and Development Program of Sichuan (2019YFH0113, 2021YFH0060, 2021YFH0072), Sichuan-Guangdong Cross-Regional Innovation Cooperation Programme (22QYCX0027).	Budden KF, 2019, LANCET RESP MED, V7, P907, DOI 10.1016/S2213-2600(18)30510-1; Campieri C, 2001, KIDNEY INT, V60, P1097, DOI 10.1046/j.1523-1755.2001.0600031097.x; Chen YY, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1756-4; Chen ZQ, 2003, CHINESE MED J-PEKING, V116, P1749; Cheng N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745517; Cristofori F, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.578386; Esgalhado M, 2017, FUTURE MICROBIOL, V12, P1413, DOI 10.2217/fmb-2017-0059; Fung TC, 2019, NAT MICROBIOL, V4, P2064, DOI 10.1038/s41564-019-0540-4; Giardina S, 2014, J FOOD SCI, V79, pM384, DOI 10.1111/1750-3841.12344; Glassner KL, 2020, J ALLERGY CLIN IMMUN, V145, P16, DOI 10.1016/j.jaci.2019.11.003; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Grissa MH, 2011, AM J EMERG MED, V29, P203, DOI 10.1016/j.ajem.2009.09.019; Kemis UH, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008073; Khan SR, 2021, NAT REV NEPHROL, V17, P417, DOI 10.1038/s41581-020-00392-1; Khan SR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.8; Kim MG, 2021, KIDNEY RES CLIN PRAC, V40, P335, DOI 10.23876/j.krcp.21.053; Knauf F, 2019, NAT REV NEPHROL, V15, P263, DOI 10.1038/s41581-019-0118-7; Kullin B.R., 2016, ROLE BACTERIA UROLOG, P63, DOI [10.1007/978-3-319-17732-8_7, DOI 10.1007/978-3-319-17732-8_7]; Lai JL, 2017, INFLAMMATION, V40, P1, DOI 10.1007/s10753-016-0447-7; Li FX, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00206; Liebman M, 2011, ADV NUTR, V2, P254, DOI 10.3945/an.111.000414; Lieske JC, 2005, KIDNEY INT, V68, P1244, DOI 10.1111/j.1523-1755.2005.00520.x; Lieske JC, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.11.86; Ling ZX, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.634069; Liu Y, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.743097; Liu Y, 2020, FASEB J, V34, P11200, DOI 10.1096/fj.202000786R; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lu XL, 2012, UROL RES, V40, P717, DOI 10.1007/s00240-012-0507-x; Ma Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.591408; Morteau Olivier, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P473; Nirumand MC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030765; Orhan N, 2015, J ETHNOPHARMACOL, V163, P60, DOI 10.1016/j.jep.2015.01.009; Paul E, 2018, MICROBIOL RES, V215, P65, DOI 10.1016/j.micres.2018.06.009; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Plaza-Diaz J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060555; Qi SY, 2020, UROLITHIASIS, V48, P9, DOI 10.1007/s00240-019-01143-z; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Robertson WG, 2016, UROLITHIASIS, V44, P9, DOI 10.1007/s00240-015-0849-2; Romero Victoriano, 2010, Rev Urol, V12, pe86; Sadaf H, 2017, MICROB PATHOGENESIS, V109, P287, DOI 10.1016/j.micpath.2017.06.009; Sakhaee K, 2009, KIDNEY INT, V75, P585, DOI 10.1038/ki.2008.626; Sasikumar P, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0086-y; Shirani M., 2020, Clinical Phytoscience, V6, DOI 10.1186/s40816-020-00209-5; Shirfule AL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/763720; Skolarikos A, 2018, CURR OPIN UROL, V28, P403, DOI 10.1097/MOU.0000000000000523; Stern JM, 2016, UROLITHIASIS, V44, P399, DOI 10.1007/s00240-016-0882-9; Sun Y, 2020, IUBMB LIFE, V72, P1065, DOI 10.1002/iub.2250; Taguchi K, 2019, INT J UROL, V26, P688, DOI 10.1111/iju.13957; Tang RQ, 2018, UROLITHIASIS, V46, P503, DOI 10.1007/s00240-018-1037-y; Tong T, 2021, POL J MICROBIOL, V70, P235, DOI 10.33073/pjm-2021-022; Tozawa K, 2008, INT J UROL, V15, P924, DOI 10.1111/j.1442-2042.2008.02131.x; Vega A, 2006, J LEUKOCYTE BIOL, V80, P152, DOI 10.1189/jlb.0705411; Vijay A, 2022, EUR J CLIN NUTR, V76, P489, DOI 10.1038/s41430-021-00991-6; Wei ZT, 2021, FASEB J, V35, DOI 10.1096/fj.202100887RR; Wu ZY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.716816; Yang DT, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.705763; Yu L, 2017, RENAL FAILURE, V39, P440, DOI 10.1080/0886022X.2017.1305968; Zhang F, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3921315; Zhang YC, 2022, AMINO ACIDS, V54, P353, DOI 10.1007/s00726-021-03011-w; Zhao EY, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11819; Zhao TT, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110325; Zhu H, 2021, CELL METAB, V33, P1926, DOI 10.1016/j.cmet.2021.06.014	62	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22340	10.1096/fj.202101972RR	http://dx.doi.org/10.1096/fj.202101972RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1A5MT	35524736				2022-12-28	WOS:000791801300001
J	Forzisi, E; Yu, W; Rajwade, P; Sesti, F				Forzisi, Elena; Yu, Wei; Rajwade, Parth; Sesti, Federico			Antagonistic roles of Ras-MAPK and Akt signaling in integrin-K+ channel complex-mediated cellular apoptosis	FASEB JOURNAL			English	Article						apoptosis; integrin; neuroscience; oxidative stress; potassium channel	BAD PHOSPHORYLATION; PROTEIN-KINASE; DEATH; ACTIVATION; PROLIFERATION; ASSOCIATION; MODULATION; MECHANISMS; OXIDATION; PATHWAYS	Complexes formed with alpha 5-integrins and the voltage-gated potassium (K+) channel KCNB1 (Kv2.1), known as IKCs, transduce the electrical activity at the plasma membrane into biochemical events that impinge on cytoskeletal remodeling, cell differentiation, and migration. However, when cells are subject to stress of oxidative nature IKCs turn toxic and cause inflammation and death. Here, biochemical, pharmacological, and cell viability evidence demonstrates that in response to oxidative insults, IKCs activate an apoptotic Mitogen-activated protein kinase/extracellular signal-regulated kinase (Ras-MAPK) signaling pathway. Simultaneously, wild-type (WT) KCNB1 channels sequester protein kinase B (Akt) causing dephosphorylation of BCL2-associated agonist of cell death (BAD), a major sentinel of apoptosis progression. In contrast, IKCs formed with C73A KCNB1 variant that does not induce apoptosis (IKCC73A), do not sequester Akt and thus are able to engage cell survival mechanisms. Taken together, these data suggest that apoptotic and survival forces co-exist in IKCs. Integrins send death signals through Ras-MAPK and KCNB1 channels simultaneously sabotage survival mechanisms. Thus, the combined action of integrins and KCNB1 channels advances life or death.	[Forzisi, Elena; Yu, Wei; Rajwade, Parth; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu			NIA [R01AG060919]; NSF [2030348]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF(National Science Foundation (NSF))	This work was supported by an NIA grant (R01AG060919) and a NSF (2030348) to FS	Al-Owais MMA, 2012, J BIOL CHEM, V287, P24754, DOI 10.1074/jbc.M112.357012; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Cagnol Sebastien, 2011, J Signal Transduct, V2011, P834948, DOI 10.1155/2011/834948; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Cotella D, 2013, FASEB J, V27, P1381, DOI 10.1096/fj.12-222778; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Girault A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0263-x; He K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129498; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lodish H, 2000, MOL CELL BIOL, V4th; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Vachon Pierre H, 2011, J Signal Transduct, V2011, P738137, DOI 10.1155/2011/738137; Wei JF, 2008, J CELL PHYSIOL, V217, P544, DOI 10.1002/jcp.21530; Wei Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0886-1; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yu W., 2019, FASEB J, V33, P14680, DOI DOI 10.1096/FJ.201901792R; Yu W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.160; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	45	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22292	10.1096/fj.202200180R	http://dx.doi.org/10.1096/fj.202200180R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0D8GT	35357039	Green Accepted			2022-12-28	WOS:000776227800001
J	Qiu, S; Liang, ZR; Wu, QA; Wang, M; Yang, ML; Chen, C; Zheng, HT; Zhu, ZM; Li, L; Yang, GY				Qiu, Sheng; Liang, Zerong; Wu, Qinan; Wang, Miao; Yang, Mengliu; Chen, Chen; Zheng, Hongting; Zhu, Zhiming; Li, Ling; Yang, Gangyi			Hepatic lipid accumulation induced by a high-fat diet is regulated by Nrf2 through multiple pathways	FASEB JOURNAL			English	Article						autophagy; lipid accumulation; NAFLD; Nrf2; SREBP-1c	OXIDATIVE STRESS; INDUCED OBESITY; AUTOPHAGY; LIVER; EXPRESSION; GENE; MICE; STEATOHEPATITIS; ADIPOCYTES; PROTEINS	Nuclear factor erythroid 2-related factor 2 (Nrf2) is reportedly involved in hepatic lipid metabolism, but the results are contradictory, and the underlying mechanism remains unclear. Here, we focused on elucidating the effects of Nrf2 on hepatic adipogenesis and on determining the possible underlying mechanism. We established a non-alcoholic fatty liver disease (NAFLD) model in a high-fat diet (HFD)-fed Nrf2 knockout (Nrf2 KO) mice; further, a cell model of lipid accumulation was established using mouse primary hepatocytes (MPHs) treated with free fatty acids (FAs). Using these models, we investigated the relationship between Nrf2 and autophagy and its role in the development of NAFLD. We observed that Nrf2 expression levels were upregulated in patients with NAFLD and diet-induced obese mice. Nrf2 deficiency led to hepatic lipid accumulation in vivo and in vitro, in addition to, promoting lipogenesis mainly by increasing SREBP-1c activity. Moreover, Nrf2 deficiency attenuated autophagic flux and inhibited the fusion of autophagosomes and lysosomes in vivo and in vitro. Decreased autophagy caused reduced lipolysis in the liver. Importantly, chromatin immunoprecipitation-qPCR (ChIP-qPCR) and dual-luciferase assay results proved that Nrf2 bound to the LAMP1 promoter and regulated its transcriptional activity. Accordingly, we report that Nrf2-LAMP1 interaction plays an indispensable role in Nrf2-regulated hepatosteatosis. Our data collectively confirm that Nrf2 deficiency promotes hepatosteatosis by enhancing SREBP-1c activity and attenuating autophagy. Our findings provide a novel multi-pathway effect of Nrf2 on lipid metabolism in the liver. We believe that multi-target intervention of Nrf2 is a novel strategy for the treatment of NAFLD.	[Qiu, Sheng; Liang, Zerong; Wang, Miao; Yang, Mengliu; Yang, Gangyi] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Liang, Zerong; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, Chongqing, Peoples R China; [Wu, Qinan] Chongqing Med Univ, Peoples Hosp Dazu, Endocrinol Dept, Dazu Hosp, Chongqing, Peoples R China; [Yang, Mengliu; Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Zheng, Hongting] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Daping Hosp, Chongqing Inst Hypertens, Dept Hypertens & Endocrinol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Queensland; Army Medical University; Army Medical University	Yang, GY (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China.; Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, Chongqing, Peoples R China.	liling@cqmu.edu.cn; gangyiyang@hospital.cqmu.edu.cn	Chen, Chen/B-4284-2010	Chen, Chen/0000-0003-2104-534X	National Natural Science Foundation of China [82170816, 81670755]; Chongqing Science and Technology Bureau [cstc2019jxjl130006, 2020zy013540]; Health Commission; China Postdoctoral Science Foundation [2020M683263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Bureau; Health Commission; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China, Grant/Award Number: 82170816 and 81670755; Chongqing Science and Technology Bureau, Grant/Award Number: cstc2019jxjl130006 and 2020zy013540; Health Commission; China Postdoctoral Science Foundation, Grant/Award Number: 2020M683263	Anty R, 2019, PRESSE MED, V48, P1468, DOI 10.1016/j.lpm.2019.09.051; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Babuta M, 2019, HEPATOLOGY, V70, P2123, DOI 10.1002/hep.30766; Chartoumpekis DV, 2018, AM J PHYSIOL-ENDOC M, V315, pE180, DOI 10.1152/ajpendo.00311.2017; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Colca J, 2020, EXPERT OPIN INV DRUG, V29, P191, DOI 10.1080/13543784.2020.1715940; Cui AF, 2019, J CLIN INVEST, V129, P2266, DOI 10.1172/JCI66062; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Fu JH, 2018, CELL PHYSIOL BIOCHEM, V48, P2409, DOI 10.1159/000492656; Ghosh S, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109521; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang DD, 2020, AGING-US, V12, P5977, DOI 10.18632/aging.102990; Huda N, 2019, METHODS MOL BIOL, V1880, P481, DOI 10.1007/978-1-4939-8873-0_30; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Khambu Bilon, 2018, Liver Res, V2, P112, DOI 10.1016/j.livres.2018.09.004; Kim YR, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0340-1; Kim YN, 2021, EXP MOL MED, V53, P468, DOI 10.1038/s12276-021-00573-3; Kim YS, 2021, HEPATOLOGY, V73, P1307, DOI 10.1002/hep.31423; Kitaoka Y, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13064; Li L, 2020, REDOX BIOL, V30, DOI 10.1016/j.redox.2019.101412; Liu XL, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.123; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-1, 10.1128/MCB.00677-14]; Mialet-Perez J, 2017, ESSAYS BIOCHEM, V61, P721, DOI 10.1042/EBC20170022; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Ren HH, 2019, AGING-US, V11, P9461, DOI 10.18632/aging.102396; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XD, 2020, ANTIOXID REDOX SIGN, V32, P173, DOI 10.1089/ars.2019.7769; Tanaka S, 2016, HEPATOLOGY, V64, P1994, DOI 10.1002/hep.28820; Tang JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.555; Tang MP, 2018, NEUROBIOL AGING, V63, P128, DOI 10.1016/j.neurobiolaging.2017.12.001; Wang J, 2017, CELL CYCLE, V16, P1053, DOI 10.1080/15384101.2017.1312224; Wang XJ, 2018, FASEB J, V32, P37, DOI 10.1096/fj.201601393R; Wang Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.265; Xu L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235920; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang M, 2019, FASEB J, V33, P10077, DOI 10.1096/fj.201802544RR; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Zhang C, 2019, DIABETES, V68, P1902, DOI 10.2337/db18-1055; Zhang X, 2017, THERANOSTICS, V7, P2822, DOI 10.7150/thno.19068; Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014; Zhou MJ, 2020, FASEB J, V34, P7058, DOI 10.1096/fj.201901836RR; Zhou T, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101120	49	0	0	7	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22280	10.1096/fj.202101456R	http://dx.doi.org/10.1096/fj.202101456R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0I4IB	35394671	Green Submitted			2022-12-28	WOS:000779383700001
J	Zeng, RH; Liu, B; Guo, TT; Guo, JW; Yu, G; Xu, YN; Lin, R; Tan, XZ; Xie, KQ; Zhou, YB				Zeng, Ruhui; Liu, Bin; Guo, Tingting; Guo, Jinwei; Yu, Gang; Xu, Yineng; Lin, Rui; Tan, Xiangzhai; Xie, Kaiqi; Zhou, Yingbi			Prostaglandin F-2 alpha evokes vasoconstrictor and vasodepressor activities that are both independent of the F prostanoid receptor	FASEB JOURNAL			English	Article						blood pressure; prostanoid; prostanoid receptor; vasoconstriction	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTACYCLIN SYNTHESIS; LATANOPROST ACID; TP-RECEPTORS; RELAXATION; EXPRESSION; AORTA; THROMBOXANE; MECHANISM; F2-ALPHA	The F prostanoid receptor (FP), which accounts for the therapeutic effect of PGF(2 alpha) in uterine atony that leads to postpartum hemorrhage and maternal morbidity, could possibly mediate vasoconstrictor effect in small or resistance arteries to elevate blood pressure that limits the clinical use of the agent in patients with cardiovascular disorders. This study aimed to test the above hypothesis with genetically altered mice. Ex vivo and in vivo experiments were performed on control wild-type (WT) mice and mice with deficiencies in FP (FP-/-) or thromboxane (Tx)-prostanoid receptor (the original receptor of TxA(2); TP-/-), and/or those with an additional deficiency in E prostanoid receptor-3 (one of the vasoconstrictor receptors of PGE(2); EP3(-/-)). Here, we show that PGF(2 alpha) indeed evoked vasoconstrictor responses in the above-mentioned tissues of WT mice, which were however unaltered by FP-/-. Interestingly, such contractile responses were reversed into dilations by TP-/-/EP3(-/-). A similar pattern of results was observed with the pressor effect of PGF(2 alpha) under in vivo conditions. However, TP-/- alone (which could largely remove the contractile responses) did not result in relaxation to PGF(2 alpha). Also, either the ex vivo vasodilator effect or the in vivo depressor response of PGF(2 alpha) obtained after the removal of TP and EP3-mediated actions was unaltered by FP-/-. Therefore, both the ex vivo vasoconstrictor action in small or resistance arteries and the systemic pressor effect of PGF(2 alpha) can reflect vasoconstrictor activities derived from the non-FP receptors TP and EP3 outweighing a concurrently activated dilator effect, which is again independent of FP.	[Zeng, Ruhui] Shantou Univ, Affiliated Hosp 1, Dept Gynaecol & Obstet, Med Coll, Shantou, Peoples R China; [Zeng, Ruhui; Liu, Bin; Guo, Tingting; Guo, Jinwei; Yu, Gang; Xu, Yineng; Lin, Rui; Tan, Xiangzhai; Xie, Kaiqi; Zhou, Yingbi] Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Liu, Bin; Guo, Jinwei; Xie, Kaiqi] Shantou Univ, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Med Coll, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Liu, B; Zhou, YB (corresponding author), Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	bliu@stu.edu.cn; yz_sumc@163.com			National Natural Science Foundation of China [81970433, 82070506]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515011650]; Medical Scientific Research Foundation of Guangdong Province [A2021324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province	National Natural Science Foundation of China, Grant/Award Number: 81970433; 82070506; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515011650; The Medical Scientific Research Foundation of Guangdong Province, Grant/Award Number: A2021324	Abe S, 2013, J OCUL PHARMACOL TH, V29, P55, DOI 10.1089/jop.2011.0197; Astin M, 1997, EUR J PHARMACOL, V340, P195, DOI 10.1016/S0014-2999(97)01414-3; Astin M, 1998, J OCUL PHARMACOL TH, V14, P119, DOI 10.1089/jop.1998.14.119; Boersma JI, 1999, BRIT J PHARMACOL, V128, P1505, DOI 10.1038/sj.bjp.0702965; Chandraharan E, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3875; CHEN J, 1995, BRIT J PHARMACOL, V116, P3035, DOI 10.1111/j.1476-5381.1995.tb15960.x; Chen Y, 2021, PHARMACOLOGY, V106, P477, DOI 10.1159/000516631; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.010; Daray FM, 2003, BRIT J PHARMACOL, V139, P1409, DOI 10.1038/sj.bjp.0705375; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; DORN GW, 1992, J BIOL CHEM, V267, P24897; Errasti AE, 2009, EUR J PHARMACOL, V610, P68, DOI 10.1016/j.ejphar.2009.03.022; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; Georgescu A, 2003, FUND CLIN PHARMACOL, V17, P683, DOI 10.1046/j.1472-8206.2003.00196.x; GILES H, 1991, BRIT J PHARMACOL, V104, P541, DOI 10.1111/j.1476-5381.1991.tb12465.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; HAUGEN G, 1991, GYNECOL OBSTET INVES, V31, P208, DOI 10.1159/000293160; HAUGEN G, 1992, SCAND J CLIN LAB INV, V52, P141, DOI 10.3109/00365519209088778; HAYASHI S, 1985, J PHARMACOL EXP THER, V233, P628; Hu CJ, 2018, EUR J PHARMACOL, V836, P11, DOI 10.1016/j.ejphar.2018.08.012; Islam MZ, 2017, MICROVASC RES, V114, P52, DOI 10.1016/j.mvr.2017.06.001; Jones RL, 2011, BRIT J PHARMACOL, V162, P521, DOI 10.1111/j.1476-5381.2010.01039.x; JONES RL, 1982, BRIT J PHARMACOL, V76, P423, DOI 10.1111/j.1476-5381.1982.tb09236.x; Kashiwagi H, 2019, THROMB HAEMOSTASIS, V119, P1311, DOI 10.1055/s-0039-1688906; KAWAI Y, 1991, AM J PHYSIOL, V260, pH1538, DOI 10.1152/ajpheart.1991.260.5.H1538; LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P817, DOI 10.1111/j.1476-5381.1992.tb09063.x; Li ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42167; Liu B, 2020, FASEB J, V34, P16105, DOI 10.1096/fj.202000845RR; Liu B, 2020, FASEB J, V34, P2568, DOI 10.1096/fj.201901611R; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, EUR J PHARMACOL, V813, P140, DOI 10.1016/j.ejphar.2017.08.015; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Saito O, 2003, AM J PHYSIOL-RENAL, V284, pF1164, DOI 10.1152/ajprenal.00441.2002; SENIOR J, 1992, BRIT J PHARMACOL, V107, P215, DOI 10.1111/j.1476-5381.1992.tb14489.x; Snetkov VA, 2006, J PHYSIOL-LONDON, V571, P147, DOI 10.1113/jphysiol.2005.101394; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; TODA N, 1988, J CARDIOVASC PHARM, V11, P354, DOI 10.1097/00005344-198803000-00014; Wang YY, 2018, DIABETES, V67, P1748, DOI 10.2337/db17-1521; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Xiao B, 2015, ARTERIOSCL THROM VAS, V35, P1687, DOI 10.1161/ATVBAHA.115.305445; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhang YZ, 2021, EUR J PHARMACOL, V893, DOI 10.1016/j.ejphar.2020.173828; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005	48	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22293	10.1096/fj.202101908R	http://dx.doi.org/10.1096/fj.202101908R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0A6EG	35349198				2022-12-28	WOS:000774044800001
J	Li, YQ; Lin, HC; Shu, SS; Sun, YX; Lai, WY; Chen, WF; Hu, ZY; Peng, H				Li, Yuanqing; Lin, Hongchun; Shu, Shuangshuang; Sun, Yuxiang; Lai, Weiyan; Chen, Wenfang; Hu, Zhaoyong; Peng, Hui			Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy	FASEB JOURNAL			English	Article						chronic kidney disease; diabetic nephropathy; podocytes; scRNA-seq; transcriptomics	MECHANISMS; EXPRESSION; GENES; IDENTIFICATION; ORGANIZATION; NEPHRIN; DISEASE; BARRIER; ACTIN	Cell heterogeneity has impeded the accurate interpretation of the bulk transcriptome data from patients with diabetic nephropathy (DN). We performed an analysis by integrating bulk and single-cell transcriptome datasets to uncover novel mechanisms leading to DN, especially in the podocytes. Microdissected glomeruli and tubules transcriptome datasets were selected from Gene Expression Omnibus (GEO). Then the consistency between datasets was evaluated. The analysis of the bulk dataset and single-nucleus RNA dataset was integrated to reveal the cell type-specific responses to DN. The candidate genes were validated in kidney tissues from DN patients and diabetic mice. We compared 4 glomerular and 4 tubular datasets and found considerable discrepancies among datasets regarding the deferentially expressed genes (DEGs), involved signaling pathways, and the hallmark enrichment profiles. Deconvolution of the bulk data revealed that the variations in cell-type proportion contributed greatly to this discrepancy. The integrative analysis uncovered that the dysregulation of spermatogenesis-related genes, including TEKT2 and PIAS2, was involved in the development of DN. Importantly, the mRNA level of TEKT2 was negatively correlated with the mRNA levels of NPHS1 (r = -.66, p < .0001) and NPHS2 (r = -.85, p < .0001) in human diabetic glomeruli. Immunostaining confirmed that the expression of TEKT2 and PIAS2 were up-regulated in podocytes of DN patients and diabetic mice. Knocking down TEKT2 resisted high glucose-induced cytoskeletal remodeling and down-regulation of NPHS1 protein in the cultured podocyte. In conclusion, the integrative strategy can help us efficiently use the publicly available transcriptomics resources. Using this approach and combining it with classical research methods, we identified TEKT2 and PIAS2, two spermatogenesis-related genes involved in the pathogenesis of DN. Furthermore, TEKT2 is involved in this pathogenesis by regulating the podocyte cytoskeleton.	[Li, Yuanqing; Lin, Hongchun; Shu, Shuangshuang; Sun, Yuxiang; Lai, Weiyan; Peng, Hui] Sun Yat Sen Univ, Affiliated Hosp 3, Nephrol Div, 600 Tianhe Ave, Guangzhou 510630, Guangdong, Peoples R China; [Chen, Wenfang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China; [Hu, Zhaoyong] Baylor Coll Med, Nephrol Div, Dept Med, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine	Peng, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Nephrol Div, 600 Tianhe Ave, Guangzhou 510630, Guangdong, Peoples R China.	pengh@mail.sysu.edu.cn			National Natural Science Foundation of China (NSFC) [81873613, 82170762]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2022A1515012637]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81873613 and 82170762; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2022A1515012637	Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Azushima K, 2018, NAT REV NEPHROL, V14, P48, DOI 10.1038/nrneph.2017.142; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chung SR, 2001, ENDOCRINOLOGY, V142, P4272, DOI 10.1210/en.142.10.4272; Denisenko E, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02048-6; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Fan Y, 2019, DIABETES, V68, P2301, DOI 10.2337/db19-0204; Fu J, 2019, J AM SOC NEPHROL, V30, P533, DOI 10.1681/ASN.2018090896; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geng XD, 2019, J DIABETES INVEST, V10, P972, DOI 10.1111/jdi.12986; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Grayson PC, 2018, ANN RHEUM DIS, V77, P1227, DOI 10.1136/annrheumdis-2017-212935; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Jew B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15816-6; Soler MJ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.09.104; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Karaiskos N, 2018, J AM SOC NEPHROL, V29, P2060, DOI 10.1681/ASN.2018030238; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01900-x; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin JS, 2015, J PATHOL, V236, P30, DOI 10.1002/path.4508; Liu L, 2001, ACTA MED OKAYAMA, V55, P161; Magalhaes J, 2021, MOL PSYCHIATR, V26, P6083, DOI 10.1038/s41380-021-01207-w; Malinen M, 2017, NUCLEIC ACIDS RES, V45, P619, DOI 10.1093/nar/gkw855; Maresch CC, 2018, HUM REPROD UPDATE, V24, P86, DOI 10.1093/humupd/dmx033; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muto Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22368-w; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pan Y, 2018, DIABETES, V67, P717, DOI 10.2337/db17-0755; Park J, 2019, KIDNEY INT, V96, P862, DOI 10.1016/j.kint.2019.03.035; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pichler R, 2017, AM J PHYSIOL-RENAL, V312, pF716, DOI 10.1152/ajprenal.00314.2016; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rabellino A, 2017, CANCER RES, V77, P1542, DOI 10.1158/0008-5472.CAN-16-2958; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Relle M, 2011, MODERN PATHOL, V24, P1101, DOI 10.1038/modpathol.2011.58; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schell C, 2017, J AM SOC NEPHROL, V28, P3166, DOI 10.1681/ASN.2017020143; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Setter PW, 2006, EXP CELL RES, V312, P2880, DOI 10.1016/j.yexcr.2006.05.014; Singh DK, 2008, NAT CLIN PRACT NEPHR, V4, P216, DOI 10.1038/ncpneph0757; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393; Wang RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16624-7; Wang XR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08023-x; Wilson PC, 2019, P NATL ACAD SCI USA, V116, P19619, DOI 10.1073/pnas.1908706116; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wu R, 2020, J BIOL CHEM, V295, P6741, DOI 10.1074/jbc.RA119.012338; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang YM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5171; Zhou LW, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0172-4	62	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22592	10.1096/fj.202200740RR	http://dx.doi.org/10.1096/fj.202200740RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J1EC	36251411				2022-12-28	WOS:000868787900001
J	Srivastava, T; Garola, RE; Zhou, JP; Boinpelly, VC; Priya, L; Ali, MF; Rezaiekhaligh, MH; Heruth, DP; Novak, J; Alon, US; Joshi, T; Jiang, YX; McCarthy, ET; Savin, VJ; Johnson, ML; Sharma, R; Sharma, M				Srivastava, Tarak; Garola, Robert E.; Zhou, Jianping; Boinpelly, Varun C.; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Heruth, Daniel P.; Novak, Jan; Alon, Uri S.; Joshi, Trupti; Jiang, Yuexu; McCarthy, Ellen T.; Savin, Virginia J.; Johnson, Mark L.; Sharma, Ram; Sharma, Mukut			Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors	FASEB JOURNAL			English	Article						fluid-flow shear stress; glomerular filtration barrier; glomerular hemodynamics; hyperfiltration; podocytes	PROSTAGLANDIN-E RECEPTORS; FLOW SHEAR-STRESS; STAGE RENAL-DISEASE; CYCLOOXYGENASE-2 EXPRESSION; BIOMECHANICAL FORCES; BETA-CATENIN; URINARY PROSTAGLANDIN-E2; CONGENITAL-ANOMALIES; NEPHROTIC SYNDROME; POTENTIAL ROLE	Increased fluid-flow shear stress (FFSS) contributes to hyperfiltration-induced podocyte and glomerular injury resulting in progression of chronic kidney disease (CKD). We reported that increased FFSS in vitro and in vivo upregulates PGE2 receptor EP2 (but not EP4 expression), COX2-PGE(2)-EP2 axis, and EP2-linked Akt-GSK3 beta-beta-catenin signaling pathway in podocytes. To understand and use the disparities between PGE2 receptors, specific agonists, and antagonists of EP2 and EP4 were used to assess phosphorylation of Akt, GSK3 beta and beta-catenin in podocytes using Western blotting, glomerular filtration barrier function using in vitro albumin permeability (P-alb) assay, and mitigation of hyperfiltration-induced injury in unilaterally nephrectomized (UNX) mice at 1 and 6 months. Results show an increase in P-alb by PGE(2), EP2 agonist (EP2(AGO)) and EP4 antagonist (EP4(ANT)), but not by EP2 antagonist (EP2(ANT)) or EP4 agonist (EP4(AGO)). Pretreatment with EP2(ANT) blocked the effect of PGE(2) or EP2(AGO) on P-alb. Modulation of EP2 and EP4 also induced opposite effects on phosphorylation of Akt and beta-Catenin. Individual agonists or antagonists of EP2 or EP4 did not induce significant improvement in albuminuria in UNX mice. However, treatment with a combination EP2(ANT) + EP4(AGO) for 1 or 6 months caused a robust decrease in albuminuria. EP2(ANT) + EP4(AGO) combination did not impact adaptive hypertrophy or increased serum creatinine. Observed differences between expression of EP2 and EP4 on the glomerular barrier highlight these receptors as potential targets for intervention. Safe and effective mitigating effect of EP2(ANT) + EP4(AGO) presents a novel opportunity to delay the progression of hyperfiltration-associated CKD as seen in transplant donors.	[Srivastava, Tarak; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Alon, Uri S.] Childrens Mercy Hosp, Sect Nephrol, Kansas City, MO 64128 USA; [Srivastava, Tarak; Garola, Robert E.; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Heruth, Daniel P.; Alon, Uri S.] Univ Missouri, Kansas City, MO 64110 USA; [Srivastava, Tarak; Zhou, Jianping; Boinpelly, Varun C.; Sharma, Mukut] Midwest Vet Biomed Res Fdn MVBRF, Kansas City, MO USA; [Srivastava, Tarak; Johnson, Mark L.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Garola, Robert E.] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64128 USA; [Zhou, Jianping; Boinpelly, Varun C.; Savin, Virginia J.; Sharma, Ram; Sharma, Mukut] Kansas City VA Med Ctr, Renal Res Lab, Kansas City, MO USA; [Heruth, Daniel P.] Childrens Mercy Hosp, Childrens Mercy Res Inst, Kansas City, MO 64128 USA; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Joshi, Trupti] Univ Missouri, Dept Hlth Management & Informat, Columbia, MO USA; [Joshi, Trupti; Jiang, Yuexu] Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO USA; [Joshi, Trupti; Jiang, Yuexu] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Joshi, Trupti] Univ Missouri, MU Inst Data Sci & Informat, Columbia, MO USA; [McCarthy, Ellen T.; Savin, Virginia J.; Sharma, Mukut] Univ Kansas, Med Ctr, Dept Internal Med, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; Children's Mercy Hospital; University of Alabama System; University of Alabama Birmingham; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Srivastava, T (corresponding author), Childrens Mercy Hosp, Sect Nephrol, Pediat, 2401 Gillham Rd, Kansas City, MO 64128 USA.	tsrivastava@cmh.edu		Srivastava, Tarak/0000-0002-8654-0627	HHS \ NIH \ NIDDK \ Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) [R01DK107490]; U.S. Department of Veterans Affairs (VA) [VA BX001037]	HHS \ NIH \ NIDDK \ Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS vertical bar NIH vertical bar NIDDK vertical bar Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM), Grant/Award Number: R01DK107490; U.S. Department of Veterans Affairs (VA), Grant/Award Number: VA BX001037	ARGUESO LR, 1992, PEDIATR NEPHROL, V6, P412, DOI 10.1007/BF00873996; Aringer I, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040832; BLUM M, 1981, CLIN NEPHROL, V15, P87; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Carrisoza-Gaytan R, 2014, AM J PHYSIOL-RENAL, V307, pF195, DOI 10.1152/ajprenal.00634.2013; Chen X., 2016, J CLIN EXP NEPHROL, V1, P18, DOI DOI 10.21967/JBB.V1I1.37; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng HF, 2007, J AM SOC NEPHROL, V18, P551, DOI 10.1681/ASN.2006090990; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Chun KS, 2010, J BIOL CHEM, V285, P39672, DOI 10.1074/jbc.M110.117689; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Dahly-Vernon AJ, 2005, HYPERTENSION, V45, P643, DOI 10.1161/01.HYP.0000153791.89776.43; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DESANTO NG, 1994, NEPHRON, V66, P45, DOI 10.1159/000187764; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fukushima K, 2022, FEBS OPEN BIO, V12, P775, DOI 10.1002/2211-5463.13378; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ganesh T, 2014, J MED CHEM, V57, P4454, DOI 10.1021/jm401431x; GOMEZMARTINO JR, 1994, NEPHROL DIAL TRANSPL, V9, P251; Grams ME, 2016, NEW ENGL J MED, V374, P411, DOI 10.1056/NEJMoa1510491; Griffin Karen A., 1992, American Journal of Physiology, V263, pF1057; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Horiba N, 2002, NEPHRON, V91, P134, DOI 10.1159/000057615; Ibrahim HN, 2016, J AM SOC NEPHROL, V27, P2885, DOI 10.1681/ASN.2015091018; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Imig JD, 2002, AM J PHYSIOL-RENAL, V283, pF415, DOI 10.1152/ajprenal.00351.2001; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Katsuyama M, 1998, BIOCHEM BIOPH RES CO, V251, P727, DOI 10.1006/bbrc.1998.9540; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Komers R, 2007, CLIN EXP PHARMACOL P, V34, P36, DOI 10.1111/j.1440-1681.2007.04534.x; Kriz W, 2017, KIDNEY INT, V91, P1283, DOI 10.1016/j.kint.2017.02.032; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Martineau LC, 2004, AM J PHYSIOL-RENAL, V286, pF693, DOI 10.1152/ajprenal.00331.2003; Massie AB, 2017, J AM SOC NEPHROL, V28, P2749, DOI 10.1681/ASN.2016101084; Matas AJ, 2018, AM J TRANSPLANT, V18, P1140, DOI 10.1111/ajt.14671; MATHIESEN ER, 1988, DIABETIC MED, V5, P145, DOI 10.1111/j.1464-5491.1988.tb00961.x; McCarthy ET, 2002, KIDNEY INT, V61, P534, DOI 10.1046/j.1523-1755.2002.00172.x; Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NATH KA, 1987, AM J PHYSIOL, V252, pF829, DOI 10.1152/ajprenal.1987.252.5.F829; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Nusing RM, 2005, J AM SOC NEPHROL, V16, P2354, DOI 10.1681/ASN.2004070556; O'Keeffe LM, 2018, ANN INTERN MED, V168, P276, DOI [10.7326/M17-1235, 10.7326/L18-0341]; Pai R, 2003, FASEB J, V17, P1640, DOI 10.1096/fj.02-1011com; Powell WS, 2021, CLIN SCI, V135, P1945, DOI 10.1042/CS20190657; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Rangel-Filho A, 2005, J AM SOC NEPHROL, V16, P852, DOI 10.1681/ASN.2005010029; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rosenberg M E, 1988, Contrib Nephrol, V68, P157; ROSENBERG M E, 1987, American Journal of Physiology, V253, pF1083; Sanchez PL, 1999, HYPERTENSION, V34, P848, DOI 10.1161/01.HYP.34.4.848; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sharma M, 2006, EXP BIOL MED, V231, P99; Sharma M, 2004, EXP BIOL MED, V229, P85, DOI 10.1177/153537020422900111; Sharma M, 2017, PROSTAG OTH LIPID M, V132, P59, DOI 10.1016/j.prostaglandins.2017.01.003; Sharma R, 2006, FRONT BIOSCI-LANDMRK, V11, P968, DOI 10.2741/1853; Sluter MN, 2021, J MED CHEM, V64, P11816, DOI 10.1021/acs.jmedchem.1c00816; Srivastava T, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051253; Srivastava T, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106403; Srivastava T, 2018, TRANSPLANTATION, V102, P1624, DOI 10.1097/TP.0000000000002304; Srivastava T, 2018, AM J PHYSIOL-RENAL, V314, pF22, DOI 10.1152/ajprenal.00325.2017; Srivastava T, 2017, NEPHROL DIAL TRANSPL, V32, P759, DOI 10.1093/ndt/gfw430; Srivastava T, 2014, AM J PHYSIOL-RENAL, V307, pF1323, DOI 10.1152/ajprenal.00335.2014; Srivastava T, 2014, NEPHROL DIAL TRANSPL, V29, P65, DOI 10.1093/ndt/gft387; Srivastava T, 2013, PROSTAG OTH LIPID M, V104, P49, DOI 10.1016/j.prostaglandins.2012.11.001; Srivastava T, 2010, J CELL COMMUN SIGNAL, V4, P79, DOI 10.1007/s12079-010-0088-9; STAHL RAK, 1986, NEPHRON, V42, P252, DOI 10.1159/000183676; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; SUZUKI S, 1980, PROSTAG LEUKOTR ESS, V4, P377, DOI 10.1016/0161-4630(80)90011-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VELOSA JA, 1985, MAYO CLIN PROC, V60, P586, DOI 10.1016/S0025-6196(12)60980-X; Vleeshouwers W, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613286; VRIESENDORP R, 1986, AM J MED, V81, P84, DOI 10.1016/0002-9343(86)90910-1; VRIESENDORP R, 1986, CLIN NEPHROL, V25, P105; Vukicevic S, 2006, KIDNEY INT, V70, P1099, DOI 10.1038/sj.ki.5001715; Wang JL, 1998, AM J PHYSIOL-RENAL, V275, pF613, DOI 10.1152/ajprenal.1998.275.4.F613; Westland R, 2013, NEPHROL DIAL TRANSPL, V28, P1844, DOI 10.1093/ndt/gft012; Westland R, 2013, PEDIATRICS, V131, pE478, DOI 10.1542/peds.2012-2088; Yao B, 2006, AM J PHYSIOL-RENAL, V291, pF368, DOI 10.1152/ajprenal.00500.2005; Young Sarah, 2007, Curr Protoc Hum Genet, VChapter 17, DOI 10.1002/0471142905.hg1703s54	95	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22559	10.1096/fj.202200875R	http://dx.doi.org/10.1096/fj.202200875R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4P3PA	36125047				2022-12-28	WOS:000855307500001
J	Lawson, LY; Migotsky, N; Chermside-Scabbo, CJ; Shuster, JT; Joeng, KS; Civitelli, R; Lee, B; Silva, MJ				Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Joeng, Kyu Sang; Civitelli, Roberto; Lee, Brendan; Silva, Matthew J.			Loading-induced bone formation is mediated by Wnt1 induction in osteoblast-lineage cells	FASEB JOURNAL			English	Article						bone; mechanobiology; osteoblasts; osteocytes; osteogenesis; Wnt signaling pathway	OSTEOGENIC RESPONSE; MOUSE; MODEL; LRP5; MICE; AGE	Mechanical loading on the skeleton stimulates bone formation. Although the exact mechanism underlying this process remains unknown, a growing body of evidence indicates that the Wnt signaling pathway is necessary for the skeletal response to loading. Recently, we showed that Wnts produced by osteoblast lineage cells mediate the osteo-anabolic response to tibial loading in adult mice. Here, we report that Wnt1 specifically plays a crucial role in mediating the mechano-adaptive response to loading. Independent of loading, short-term loss of Wnt1 in the Osx-lineage resulted in a decreased cortical bone area in the tibias of 5-month-old mice. In females, strain-matched loading enhanced periosteal bone formation in Wnt1F/F controls, but not in Wnt1F/F; OsxCreERT2 knockouts. In males, strain-matched loading increased periosteal bone formation in both control and knockout mice; however, the periosteal relative bone formation rate was 65% lower in Wnt1 knockouts versus controls. Together, these findings show that Wnt1 supports adult bone homeostasis and mediates the bone anabolic response to mechanical loading.	[Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Silva, Matthew J.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Lawson, Lisa Y.; Migotsky, Nicole; Chermside-Scabbo, Christopher J.; Shuster, John T.; Civitelli, Roberto; Silva, Matthew J.] Washington Univ, Musculoskeletal Res Ctr, Sch Med, St Louis, MO 63130 USA; [Migotsky, Nicole; Silva, Matthew J.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Chermside-Scabbo, Christopher J.] Washington Univ, Med Scient Training Program, Sch Med, St Louis, MO 63130 USA; [Joeng, Kyu Sang] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA USA; [Civitelli, Roberto] Washington Univ, Div Bone & Mineral Dis, Dept Med, St Louis, MO 63130 USA; [Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Waco, TX USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); Baylor College of Medicine	Lawson, LY (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	lylawson@wustl.edu		Lee, Brendan/0000-0001-8573-4211; Lawson, Lisa/0000-0002-4436-5357	Washington University Musculoskeletal Research Center [P30 AR074992]; NIH [T32 AR060719, R01 AR047867]	Washington University Musculoskeletal Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Washington University Musculoskeletal Research Center, Grant/Award Number: P30 AR074992; NIH, Grant/Award Number: T32 AR060719 and R01 AR047867	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Chermside-Scabbo CJ, 2020, J BONE MINER RES, V35, P1751, DOI 10.1002/jbmr.4031; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Harris TL, 2021, BONE, V150, DOI 10.1016/j.bone.2021.116019; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Joeng KS, 2017, J CLIN INVEST, V127, P2678, DOI 10.1172/JCI92617; Joeng KS, 2014, HUM MOL GENET, V23, P4035, DOI 10.1093/hmg/ddu117; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Lawson LY, 2022, J BONE MINER RES, V37, P108, DOI 10.1002/jbmr.4445; Luther J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau7137; Maes C, 2007, ANN NY ACAD SCI, V1116, P149, DOI 10.1196/annals.1402.060; Main RP, 2020, J ORTHOP RES, V38, P233, DOI 10.1002/jor.24466; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Song DY, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0081-8; Sun D, 2018, J ORTHOP RES, V36, P682, DOI 10.1002/jor.23727; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Wang F, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115754; Zhong ZDA, 2015, BONE, V81, P614, DOI 10.1016/j.bone.2015.07.034	27	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22502	10.1096/fj.202200591R	http://dx.doi.org/10.1096/fj.202200591R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7JS	35969160	Green Submitted			2022-12-28	WOS:000840446300001
J	Nehme, A; Ghahramanpouri, M; Ahmed, I; Golsorkhi, M; Thomas, N; Munoz, K; Abdipour, A; Tang, XL; Wilson, SM; Wasnik, S; Baylink, DJ				Nehme, Antoine; Ghahramanpouri, Mahdis; Ahmed, Iqbal; Golsorkhi, Mohadese; Thomas, Natasha; Munoz, Kevin; Abdipour, Amir; Tang, Xiaolei; Wilson, Sean M.; Wasnik, Samiksha; Baylink, David J.			Combination therapy of insulin-like growth factor I and BTP-2 markedly improves lipopolysaccharide-induced liver injury in mice	FASEB JOURNAL			English	Article							NF-KAPPA-B; CALCIUM; CYTOKINES; ENDOCYTOSIS; HORMONE; CELLS; MODEL; TRANSCRIPTION; PERMEABILITY; ACTIVATION	Acute liver injury is a common disease without effective therapy in humans. We sought to evaluate a combination therapy of insulin-like growth factor 1 (IGF-I) and BTP-2 in a mouse liver injury model induced by lipopolysaccharide (LPS). We chose this model because LPS is known to increase the expression of the transcription factors related to systemic inflammation (i.e., NF kappa B, CREB, AP1, IRF 3, and NFAT), which depends on calcium signaling. Notably, these transcription factors all have pleiotropic effects and account for the other observed changes in tissue damage parameters. Additionally, LPS is also known to increase the genes associated with a tissue injury (e.g., NGAL, SOD, caspase 3, and type 1 collagen) and systemic expression of pro-inflammatory cytokines. Finally, LPS compromises vascular integrity. Accordingly, IGF-I was selected because its serum levels were shown to decrease during systemic inflammation. BTP-2 was chosen because it was known to decrease cytosolic calcium, which is increased by LPS. This current study showed that IGF-I, BTP-2, or a combination therapy significantly altered and normalized all of the aforementioned LPS-induced gene changes. Additionally, our therapies reduced the vascular leakage caused by LPS, as evidenced by the Evans blue dye technique. Furthermore, histopathologic studies showed that IGF-I decreased the proportion of hepatocytes with ballooning degeneration. Finally, IGF-I also increased the expression of the hepatic growth factor (HGF) and the receptor for the epidermal growth factor (EGFR), markers of liver regeneration. Collectively, our data suggest that a combination of IGF-I and BTP-2 is a promising therapy for acute liver injury.	[Nehme, Antoine; Ghahramanpouri, Mahdis; Golsorkhi, Mohadese; Munoz, Kevin; Tang, Xiaolei; Wasnik, Samiksha; Baylink, David J.] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA; [Ahmed, Iqbal] Loma Linda Univ, Pathol & Lab Med, Loma Linda, CA 92350 USA; [Thomas, Natasha] La Sierra Univ, Riverside, CA USA; [Abdipour, Amir] Loma Linda Univ, Med Ctr, Div Nephrol, Loma Linda, CA USA; [Tang, Xiaolei] Long Isl Univ, Coll Vet Med, Dept Vet Biomed Sci, Brookville, NY USA; [Wilson, Sean M.] Loma Linda Univ, Lawrence D Longo MD Ctr Perinatal Biol, Dept Basic Sci, Sch Med, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Baylink, DJ (corresponding author), Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA.	dbaylink@llu.edu	wilson, sean/D-1206-2017	wilson, sean/0000-0003-4404-1173; Nehme, Antoine/0000-0002-6729-2445	NSF [MRI-DBI 0923559]; Loma Linda University School of Medicine	NSF(National Science Foundation (NSF)); Loma Linda University School of Medicine	Imaging was performed in the LLUSM Advanced Imaging and Microscopy Core with the support of NSF Grant No. MRI-DBI 0923559 and the Loma Linda University School of Medicine.	Adamek B, 2017, CLIN EXP HEPATOL, V3, P9, DOI 10.5114/ceh.2017.65499; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Asgharzadeh F, 2017, AVICENNA J PHYTOMEDI, V7, P502; Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Bajaj JS, 2012, GUT, V61, P1219, DOI 10.1136/gutjnl-2012-302339; Bianda T, 1997, J INTERN MED, V241, P143, DOI 10.1046/j.1365-2796.1997.94101000.x; Bonnard B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82279-0; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Ciesielska A, 2021, CELL MOL LIFE SCI, V78, P1233, DOI 10.1007/s00018-020-03656-y; Ciocca M, 2007, PEDIATR INFECT DIS J, V26, P711, DOI 10.1097/INF.0b013e3180f60bed; Denson LA, 2003, AM J PHYSIOL-GASTR L, V284, pG646, DOI 10.1152/ajpgi.00178.2002; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; DONAGHY A, 1995, HEPATOLOGY, V21, P680, DOI 10.1002/hep.1840210313; Doonan F, 2008, METHODS, V44, P200, DOI 10.1016/j.ymeth.2007.11.006; Fang CWH, 2002, J TRAUMA, V53, P957, DOI 10.1097/00005373-200211000-00024; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Giovannini L, 2001, TRANSPLANT P, V33, P2366, DOI 10.1016/S0041-1345(01)02023-1; Gonzalez-Reimers E, 2013, BIOL TRACE ELEM RES, V154, P281, DOI 10.1007/s12011-013-9734-4; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hoffmann K, 2020, BMC SURG, V20, DOI 10.1186/s12893-019-0664-8; Hu XM, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.634690; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kim SJ, 2017, BMB REP, V50, P55, DOI 10.5483/BMBRep.2017.50.2.011; Kwon HK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15623; Li CH, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4529-7; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liu Q, 2009, BLOOD PURIFICAT, V28, P331, DOI 10.1159/000232940; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4; Munoz K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105244; Mustafa SB, 1999, AM J PHYSIOL-GASTR L, V277, pG351, DOI 10.1152/ajpgi.1999.277.2.G351; Nguyen GC, 2008, HEPATOLOGY, V48, P1336, DOI 10.1002/hep.22536; O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010; Ohga K, 2008, PULM PHARMACOL THER, V21, P360, DOI 10.1016/j.pupt.2007.09.003; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Park MJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01611; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Platanitis E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02542; Poirier C, 2011, RESP PHYSIOL NEUROBI, V179, P334, DOI 10.1016/j.resp.2011.08.012; Qiu XC, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107039; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Rahman S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13343-x; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Richard G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031341; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Saul S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1639; Schappe MS, 2018, IMMUNITY, V48, P59, DOI 10.1016/j.immuni.2017.11.026; Siddiqui M, 2015, J VASC RES, V52, P396, DOI 10.1159/000445772; Srikanth S, 2013, MOL CELLS, V35, P182, DOI 10.1007/s10059-013-0073-2; Takada S, 2020, J VET MED SCI, V82, P23, DOI 10.1292/jvms.19-0499; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tilg H, 2001, CAN J GASTROENTEROL, V15, P661, DOI 10.1155/2001/746736; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Urena-Peralta JR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237066; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vasanthkumar T, 2019, CYTOTECHNOLOGY, V71, P963, DOI 10.1007/s10616-019-00338-x; Vukcevic M, 2010, J BIOL CHEM, V285, P16003, DOI 10.1074/jbc.M109.066704; Wang HY, 2013, MOL CELL BIOCHEM, V379, P153, DOI 10.1007/s11010-013-1637-3; Wasnik S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114095; Wei YL, 2021, SCIENCE, V371, P906, DOI 10.1126/science.abb1625; Wu LZ, 2020, BIOCHEM BIOPH RES CO, V527, P200, DOI 10.1016/j.bbrc.2020.04.048; Yan J, 2014, INT REV IMMUNOL, V33, P498, DOI 10.3109/08830185.2014.889129; Yang Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0039-0; Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011; Yin J, 2019, AM J PHYSIOL-LUNG C, V316, pL35, DOI 10.1152/ajplung.00012.2018; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zeng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20931; Zhang KJ, 2014, MOL BIOL REP, V41, P4253, DOI 10.1007/s11033-014-3296-1; Zhang W, 2017, INFLAMMATION, V40, P778, DOI 10.1007/s10753-017-0522-8; Zhou D, 2018, MOL MED REP, V17, P5368, DOI 10.3892/mmr.2018.8495; Zhou HS, 2018, MICROVASC RES, V115, P58, DOI 10.1016/j.mvr.2017.08.008	74	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22444	10.1096/fj.202200227RR	http://dx.doi.org/10.1096/fj.202200227RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X9IP	35839071	hybrid			2022-12-28	WOS:000825510800001
J	Fabris, L; Milani, C; Fiorotto, R; Mariotti, V; Kaffe, E; Seller, B; Sonzogni, A; Strazzabosco, M; Cadamuro, M				Fabris, Luca; Milani, Chiara; Fiorotto, Romina; Mariotti, Valeria; Kaffe, Eleanna; Seller, Barbara; Sonzogni, Aurelio; Strazzabosco, Mario; Cadamuro, Massimiliano			Dysregulation of the Scribble/YAP/beta-catenin axis sustains the fibroinflammatory response in a PKHD1(-/-) mouse model of congenital hepatic fibrosis	FASEB JOURNAL			English	Article						chronic cholangiopathy; congenital hepatic fibrosis; fibrocystin; Scribble; YAP	POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; YAP ACTIVATION; YAP/TAZ; LIVER; BILIARY; PROLIFERATION; CYSTOGENESIS; VERTEPORFIN; EXPRESSION	Congenital hepatic fibrosis (CHF), a genetic cholangiopathy characterized by fibropolycystic changes in the biliary tree, is caused by mutations in the PKHD1 gene, leading to defective fibrocystin (FPC), changes in planar cell polarity (PCP) and increased beta-catenin-dependent chemokine secretion. In this study, we aimed at understanding the role of Scribble (a protein involved in PCP), Yes-associated protein (YAP), and beta-catenin in the regulation of the fibroinflammatory phenotype of FPC-defective cholangiocytes. Immunohistochemistry showed that compared with wild type (WT) mice, in FPC-defective (Pkhd1(del4/del4)) mice nuclear expression of YAP/TAZ in cystic cholangiocytes, significantly increased and correlated with connective tissue growth factor (CTGF) expression and pericystic fibrosis, while Scribble expression on biliary cyst cells was markedly decreased. Cholangiocytes isolated from WT mice showed intense Scribble immunoreactivity at the membrane, but minimal nuclear expression of YAP, which conversely increased, together with CTGF, after small interfering RNA (siRNA) silencing of Scribble. In FPC-defective cholangiocytes, inhibition of YAP nuclear import reduced beta-catenin nuclear expression, and CTGF, integrin beta 6, CXCL1, and CXCL10 mRNA levels, whereas inhibition of beta-catenin signaling did not affect nuclear translocation of YAP. Notably, siRNA silencing of Scribble and YAP in WT cholangiocytes mimics the fibroinflammatory changes of FPC-defective cholangiocytes. Conditional deletion of beta-catenin in Pkhd1(del4/del4) mice reduced cyst growth, inflammation and fibrosis, without affecting YAP nuclear expression. In conclusion, the defective anchor of Scribble to the membrane facilitates the nuclear translocation of YAP and beta-catenin with gain of a fibroinflammatory phenotype. The Scribble/YAP/beta-catenin axis is a critical factor in the sequence of events linking the genetic defect to fibrocystic trait of cholangiocytes in CHF.	[Fabris, Luca; Mariotti, Valeria; Cadamuro, Massimiliano] Univ Padua, Dept Mol Med DMM, Padua, Italy; [Fabris, Luca; Cadamuro, Massimiliano] Univ Milano Bicocca, Int Ctr Digest Hlth ICDH, Milan, Italy; [Fabris, Luca; Fiorotto, Romina; Mariotti, Valeria; Kaffe, Eleanna; Strazzabosco, Mario] Yale Univ, Liver Ctr, Dept Internal Med, New Haven, CT 06517 USA; [Milani, Chiara; Seller, Barbara] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Sonzogni, Aurelio] ASST Papa Giovanni XXIII Hosp, Dept Pathol, Bergamo, Italy; [Mariotti, Valeria] Ist Sci San Raffaele, Div Neurosci, INSpe, Neuroimmunol Unit, Milan, Italy; [Kaffe, Eleanna] Yale Univ, Dept Immunobiol, New Haven, CT 06517 USA	University of Padua; University of Milano-Bicocca; Yale University; University of Milano-Bicocca; ASST Papa Giovanni XXIII; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University	Cadamuro, M (corresponding author), Univ Padua, Dept Mol Med DMM, Padua, Italy.; Strazzabosco, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Cedar St 333 Room LMP1080, New Haven, CT 06517 USA.; Cadamuro, M (corresponding author), Univ Padua, Dept Mol Med, Gabelli St 63, I-35121 Padua, Italy.	mario.strazzabosco@yale.edu; massimiliano.cadamuro@unipd.it	Cadamuro, Massimiliano/AAC-6169-2022	Cadamuro, Massimiliano/0000-0002-0899-7613; FABRIS, LUCA/0000-0001-8538-6317	Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; Project Cariplo 2014, Cariplo Foundation, Italy [2014-1099]; NIH [R01 DK096096, R01 DK101528]; Yale Liver Center award [NIH P30 DK034989]	Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; Project Cariplo 2014, Cariplo Foundation, Italy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center award	LF was supported by Progetti di Ricerca di Dipartimento (PRID) 2017, University of Padua, Italy; CM and MC were supported by Project Cariplo 2014 (cod: 2014-1099), Cariplo Foundation, Italy; RF and MS were supported by NIH (R01 DK096096 and R01 DK101528). This project was supported in part by the Yale Liver Center award NIH P30 DK034989 Morphology and Cellular Molecular cores. The authors sincerely thank Prof. Paolo Simioni [General Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padova, Italy] for the insightful suggestions and the critical revision of the manuscript.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Banales JM, 2009, HEPATOLOGY, V49, P160, DOI 10.1002/hep.22636; Cadamuro M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00115; Cadamuro M, 2016, CANCER RES, V76, P4775, DOI 10.1158/0008-5472.CAN-16-0188; Chen WS, 2015, BIOCHEM BIOPH RES CO, V466, P221, DOI 10.1016/j.bbrc.2015.09.012; Cohen J, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1609877; Cohen J, 2019, J CELL BIOL, V218, P1390, DOI 10.1083/jcb.201807216; Daulat AM, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800487; Daulat AM, 2017, TRENDS CANCER, V3, P113, DOI 10.1016/j.trecan.2017.01.001; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Di Benedetto A, 2016, ONCOTARGET, V7, P43188, DOI 10.18632/oncotarget.9668; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fabris L, 2019, NAT REV GASTRO HEPAT, V16, P497, DOI 10.1038/s41575-019-0156-4; Feng JT, 2016, ONCOTARGETS THER, V9, P5371, DOI 10.2147/OTT.S109979; Furu L, 2003, J AM SOC NEPHROL, V14, P2004, DOI 10.1097/01.ASN.0000078805.87038.05; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Ito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118336; Jiang Lu, 2017, Gene Expression, V17, P313, DOI 10.3727/105221617X15034976037343; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Locatelli L, 2016, HEPATOLOGY, V63, P965, DOI 10.1002/hep.28382; Lodillinsky C, 2016, ONCOGENE, V35, P344, DOI 10.1038/onc.2015.87; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Masyuk T, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100345; Masyuk TV, 2017, HEPATOLOGY, V66, P1197, DOI 10.1002/hep.29284; Masyuk TV, 2017, CURR DRUG TARGETS, V18, P950, DOI 10.2174/1389450116666150427161743; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Nagasawa-Masuda A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174633; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pinto C, 2018, BBA-MOL BASIS DIS, V1864, P1270, DOI 10.1016/j.bbadis.2017.07.024; Quinn HM, 2021, CANCER RES, V81, P2116, DOI 10.1158/0008-5472.CAN-20-2801; RUFFOLO RR, 1987, AM J MED SCI, V294, P244, DOI 10.1097/00000441-198710000-00005; Shome D, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4910280; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Veigel MC, 2009, PEDIATR RADIOL, V39, P317, DOI 10.1007/s00247-008-1070-z; Walter TJ, 2014, AM J PATHOL, V184, P1479, DOI 10.1016/j.ajpath.2014.01.030; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; Wang Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0606-1; Woollard JR, 2007, KIDNEY INT, V72, P328, DOI 10.1038/sj.ki.5002294; Xu DC, 2018, FASEB J, V32, P4394, DOI 10.1096/fj.201701376RR; Yonem O, 2007, WORLD J GASTROENTERO, V13, P1930, DOI 10.3748/wjg.v13.i13.1930; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang XY, 2017, INT J CLIN EXP PATHO, V10, P11968; Zheng HX, 2014, WORLD J GASTROENTERO, V20, P17092, DOI 10.3748/wjg.v20.i45.17092	52	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22364	10.1096/fj.202101924R	http://dx.doi.org/10.1096/fj.202101924R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J5UL	35593740				2022-12-28	WOS:000797983900001
J	Gentile, A; Magnacca, N; Matteis, R; Moreno, M; Cioffi, F; Giacco, A; Lanni, A; Lange, P; Senese, R; Goglia, F; Silvestri, E; Lombardi, A				Gentile, Alessandra; Magnacca, Nunzia; Matteis, Rita; Moreno, Maria; Cioffi, Federica; Giacco, Antonia; Lanni, Antonia; Lange, Pieter; Senese, Rosalba; Goglia, Fernando; Silvestri, Elena; Lombardi, Assunta			Ablation of uncoupling protein 3 affects interrelated factors leading to lipolysis and insulin resistance in visceral white adipose tissue	FASEB JOURNAL			English	Article						endoplasmic reticulum; insulin resistance; lipolysis; mitochondria; uncoupling protein; white adipose tissue	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; ER STRESS; ADIPONECTIN; OBESITY; EXPRESSION; SECRETION; ACTIVATION; HORMONE; GENE	The physiological role played by uncoupling protein 3 (UCP3) in white adipose tissue (WAT) has not been elucidated so far. In the present study, we evaluated the impact of the absence of the whole body UCP3 on WAT physiology in terms of ability to store triglycerides, oxidative capacity, response to insulin, inflammation, and adipokine production. Wild type (WT) and UCP3 Knockout (KO) mice housed at thermoneutrality (30 degrees C) have been used as the animal model. Visceral gonadic WAT (gWAT) from KO mice showed an impaired capacity to store triglycerides (TG) as indicated by its lowered weight, reduced adipocyte diameter, and higher glycerol release (index of lipolysis). The absence of UCP3 reduces the maximal oxidative capacity of gWAT, increases mitochondrial free radicals, and activates ER stress. These processes are associated with increased levels of monocyte chemoattractant protein-1 and TNF-alpha. The response of gWAT to in vivo insulin administration, revealed by (ser473)-AKT phosphorylation, was blunted in KO mice, with a putative role played by eif2a, JNK, and inflammation. Variations in adipokine levels in the absence of UCP3 were observed, including reduced adiponectin levels both in gWAT and serum. As a whole, these data indicate an important role of UCP3 in regulating the metabolic functionality of gWAT, with its absence leading to metabolic derangement. The obtained results help to clarify some aspects of the association between metabolic disorders and low UCP3 levels.	[Gentile, Alessandra; Magnacca, Nunzia; Lombardi, Assunta] Univ Naples Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy; [Matteis, Rita] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Moreno, Maria; Cioffi, Federica; Giacco, Antonia; Goglia, Fernando; Silvestri, Elena] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Lanni, Antonia; Lange, Pieter; Senese, Rosalba] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Gentile, Alessandra] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	University of Naples Federico II; University of Urbino; University of Sannio; Universita della Campania Vanvitelli; University of Milan	Lombardi, A (corresponding author), Univ Naples Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy.; Silvestri, E (corresponding author), Univ Sannio, Dept Sci & Technol, Benevento, Italy.	silvestri@unisannio.it; assunta.lombardi@unina.it		Silvestri, Elena/0000-0002-0592-9033	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Agarwal S, 2017, BBA-MOL BASIS DIS, V1863, P174, DOI 10.1016/j.bbadis.2016.10.002; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Roman DAD, 2010, METABOLISM, V59, P608, DOI 10.1016/j.metabol.2009.09.004; de Vries MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047134; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Foley KP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100440; FREDHOLM BB, 1981, INT J OBESITY, V5, P643; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Lombardi A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080916; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mensink M, 2007, DIABETES OBES METAB, V9, P594, DOI 10.1111/j.1463-1326.2006.00628.x; Mondal AK, 2012, METAB SYNDR RELAT D, V10, P297, DOI 10.1089/met.2012.0002; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Ramezani-Moghadam M, 2015, J BIOL CHEM, V290, P5533, DOI 10.1074/jbc.M114.598011; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Siddals KW, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740289; Silvestri E, 2020, FASEB J, V34, P15146, DOI 10.1096/fj.202000995R; Sobel BE, 1999, CIRCULATION, V99, P2496, DOI 10.1161/01.CIR.99.19.2496; Sohn JH, 2018, J BIOL CHEM, V293, P13974, DOI 10.1074/jbc.RA118.003541; Torre-Villalvazo I, 2018, J CELL BIOCHEM, V119, P5970, DOI 10.1002/jcb.26794; Villalobos-Labra R, 2019, MOL ASPECTS MED, V66, P49, DOI 10.1016/j.mam.2018.11.001; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Xu L, 2010, HORM METAB RES, V42, P643, DOI 10.1055/s-0030-1255034; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi Toshimasa, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P243, DOI 10.2174/1568008033340090	51	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22325	10.1096/fj.202101816RR	http://dx.doi.org/10.1096/fj.202101816RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0Q2SG	35452152	hybrid			2022-12-28	WOS:000784773400001
J	Pyrshev, K; Khayyat, NH; Stavniichuk, A; Tomilin, VN; Zaika, O; Ramkumar, N; Pochynyuk, O				Pyrshev, Kyrylo; Khayyat, Naghmeh Hassanzadeh; Stavniichuk, Anna; Tomilin, Viktor N.; Zaika, Oleg; Ramkumar, Nirupama; Pochynyuk, Oleh			ClC-K2 Cl- channel allows identification of A- and B-type of intercalated cells in split-opened collecting ducts	FASEB JOURNAL			English	Article						acid-base disorders; AE1; intracellular pH; pendrin; V-ATPase	CHLORIDE CHANNEL; BASOLATERAL MEMBRANE; METABOLIC-ACIDOSIS; CONNECTING TUBULE; RAT; TRANSPORT; EXPRESSION; PENDRIN; LOCALIZATION; ADAPTATION	The collecting duct is a highly adaptive terminal part of the nephron, which is essential for maintaining systemic homeostasis. Principal and intercalated cells perform different physiological tasks and exhibit distinctive morphology. However, acid-secreting A- and base secreting B-type of intercalated cells cannot be easily separated in functional studies. We used BCECF-sensitive intracellular pH (pH(i)) measurements in split-opened collecting ducts followed by immunofluorescent microscopy in WT and intercalated cell-specific ClC-K2(-/-) mice to demonstrate that ClC-K2 inhibition enables to distinguish signals from A- and B-intercalated cells. We show that ClC-K2 Cl- channel is expressed on the basolateral side of intercalated cells, where it governs Cl--dependent H+/HCO3- transport. ClC-K2 blocker, NPPB, caused acidification or alkalization in different subpopulations of intercalated cells in WT but not ClC-K2(-/-) mice. Immunofluorescent assessment of the same collecting ducts revealed that NPPB increased pH(i) in AE1-positive A-type and decreased pH(i) in pendrin-positive B-type of intercalated cells. Induction of metabolic acidosis led to a significantly augmented abundance and H+ secretion in A-type and decreased proton transport in B-type of intercalated cells, whereas metabolic alkalosis caused the opposite changes in intercalated cell function, but did not substantially change their relative abundance. Overall, we show that inhibition of ClC-K2 can be employed to discriminate between A- and B-type of intercalated cells in split-opened collecting duct preparations. We further demonstrate that this method can be used to independently monitor changes in the functional status and abundance of A- and B-type in response to systemic acid/base stimuli.	[Pyrshev, Kyrylo; Khayyat, Naghmeh Hassanzadeh; Stavniichuk, Anna; Tomilin, Viktor N.; Zaika, Oleg; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA; [Ramkumar, Nirupama] Univ Utah Hlth, Div Nephrol & Hypertens, Salt Lake City, UT USA	University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Pyrshev, Kyrylo/P-3003-2018	Pyrshev, Kyrylo/0000-0001-5722-0707	NIH-NIDDK [DK095029, DK117865]; AHA [EIA35260097];  [AHA-19CDA34660148]	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); 	This research was supported by NIH--NIDDK DK095029, DK117865, AHA EIA35260097 (to O. Pochynyuk), and AHA--19CDA34660148 (to V. N. Tomilin)	ADACHI S, 1994, J BIOL CHEM, V269, P17677; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; ATKINS JL, 1985, AM J PHYSIOL, V249, pF485, DOI 10.1152/ajprenal.1985.249.4.F485; Berg P, 2020, J AM SOC NEPHROL, V31, P1711, DOI 10.1681/ASN.2020010053; Bernardinelli E, 2016, CELL PHYSIOL BIOCHEM, V38, P1984, DOI 10.1159/000445559; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Hennings JC, 2017, J AM SOC NEPHROL, V28, P209, DOI 10.1681/ASN.2016010085; Jeck N, 2004, KIDNEY INT, V65, P190, DOI 10.1111/j.1523-1755.2004.00363.x; Khayyat NH, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100347; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Lourdel S, 2003, J GEN PHYSIOL, V121, P287, DOI 10.1085/jgp.200208737; Madsen KM., 1986, AM J PHYSIOL, V250, pF1; Mamenko M, 2016, J AM SOC NEPHROL, V27, P2035, DOI 10.1681/ASN.2014121200; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Miller RL, 2009, KIDNEY INT, V75, P435, DOI 10.1038/ki.2008.569; Mironova Elena, 2013, Methods Mol Biol, V998, P341, DOI 10.1007/978-1-62703-351-0_27; Nissant A, 2006, AM J PHYSIOL-RENAL, V290, pF1421, DOI 10.1152/ajprenal.00274.2005; PALMER LG, 1986, P NATL ACAD SCI USA, V83, P2767, DOI 10.1073/pnas.83.8.2767; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pham TD, 2020, J AM SOC NEPHROL, V31, P483, DOI 10.1681/ASN.2019050551; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Rice WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057051; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Sage CL, 2001, HEARING RES, V160, P1, DOI 10.1016/S0378-5955(01)00308-2; Sands JM, 2006, ANN INTERN MED, V144, P186, DOI 10.7326/0003-4819-144-3-200602070-00007; Schild L, 1996, NEPHROLOGIE, V17, P395; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; Sile S, 2009, J HYPERTENS, V27, P298, DOI 10.1097/HJH.0b013e3283140c9e; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tomilin V, 2019, AM J PHYSIOL-RENAL, V316, pF948, DOI 10.1152/ajprenal.00043.2019; Tomilin VN, 2018, PFLUG ARCH EUR J PHY, V470, P339, DOI 10.1007/s00424-017-2084-x; Tsuruoka S, 1996, J CLIN INVEST, V97, P1076, DOI 10.1172/JCI118500; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; VERLANDER J W, 1987, American Journal of Physiology, V253, pF1142; Verlander JW, 1996, KIDNEY INT, V50, pS137; Wall SM, 2020, PHYSIOL REV, V100, P1119, DOI 10.1152/physrev.00011.2019; Zaidman NA, 2020, P NATL ACAD SCI USA, V117, P26470, DOI 10.1073/pnas.2007620117; Zaika O, 2020, AM J PHYSIOL-RENAL, V318, pF870, DOI 10.1152/ajprenal.00572.2019; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pP923, DOI 10.1152/ajprenal.00577.2015; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pF311, DOI 10.1152/ajprenal.00436.2015; Zaika O, 2015, AM J PHYSIOL-RENAL, V308, pF39, DOI 10.1152/ajprenal.00545.2014	53	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22275	10.1096/fj.202200160R	http://dx.doi.org/10.1096/fj.202200160R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0K2CZ	35349181				2022-12-28	WOS:000780602600001
J	Smith, CA; Humphreys, PA; Bates, N; Naven, MA; Cain, SA; Dvir-Ginzberg, M; Kimber, SJ				Smith, Christopher A.; Humphreys, Paul A.; Bates, Nicola; Naven, Mark A.; Cain, Stuart A.; Dvir-Ginzberg, Mona; Kimber, Susan J.			SIRT1 activity orchestrates ECM expression during hESC-chondrogenic differentiation	FASEB JOURNAL			English	Article						chondrogenesis; embryonic stem cells; human pluripotent stem cells; matrix; SIRT1	EMBRYONIC STEM-CELLS; ARTICULAR-CARTILAGE; CHONDROITIN SULFATE; GENE-EXPRESSION; SOX9; CHONDROCYTES; DEACETYLATION; P53; MOUSE; TRANSCRIPTION	Epigenetic modification is a key driver of differentiation, and the deacetylase Sirtuin1 (SIRT1) is an established regulator of cell function, ageing, and articular cartilage homeostasis. Here we investigate the role of SIRT1 during development of chondrocytes by using human embryonic stem cells (hESCs). HESC-chondroprogenitors were treated with SIRT1 activator; SRT1720, or inhibitor; EX527, during differentiation. Activation of SIRT1 early in 3D-pellet culture led to significant increases in the expression of ECM genes for type-II collagen (COL2A1) and aggrecan (ACAN), and chondrogenic transcription factors SOX5 and ARID5B, with SOX5 ChIP analysis demonstrating enrichment on the chondrocyte specific -10 (A1) enhancer of ACAN. Unexpectedly, when SIRT1 was activated, while ACAN was enhanced, glycosaminoglycans (GAGs) were reduced, paralleled by down regulation of gene expression for N-acetylgalactosaminyltransferase type 1 (GALNT1) responsible for GAG chain initiation/elongation. A positive correlation between ARID5B and COL2A1 was observed, and co-IP assays indicated association of ARID5B with SIRT1, further suggesting that COL2A1 expression is promoted by an ARID5B-SIRT1 interaction. In conclusion, SIRT1 activation positively impacts on the expression of the main ECM proteins, while altering ECM composition and suppressing GAG content during human cartilage development. These results suggest that SIRT1 activity has a differential effect on GAGs and proteins in developing hESC-chondrocytes and could only be beneficial to cartilage development and matrix protein synthesis if balanced by addition of positive GAG mediators.	[Smith, Christopher A.; Humphreys, Paul A.; Bates, Nicola; Naven, Mark A.; Cain, Stuart A.; Kimber, Susan J.] Univ Manchester, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Oxford Rd, Manchester M13 9PT, Lancs, England; [Dvir-Ginzberg, Mona] Hebrew Univ Jerusalem, Fac Dent Med, Lab Cartilage Biol, Jerusalem, Israel	University of Manchester; Hebrew University of Jerusalem	Smith, CA; Kimber, SJ (corresponding author), Univ Manchester, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Oxford Rd, Manchester M13 9PT, Lancs, England.	christopher.smith-2@manchester.ac.uk; sue.kimber@manchester.ac.uk	; Smith, Christopher Andrew/A-7229-2015	Kimber, Susan/0000-0002-0568-6342; Smith, Christopher Andrew/0000-0001-6478-2310; Naven, Mark/0000-0002-9703-4009; Dvir-Ginzberg, Mona/0000-0003-3089-6875; Cain, Stuart/0000-0001-8417-1058; Humphreys, Paul/0000-0002-1833-4864; Bates, Nicola/0000-0001-5875-548X	Rosetrees Trust [A1984]; RCUK | Medical Research Council (MRC) [MR/K026666]; RCUK | Engineering and Physical Sciences Research Council	Rosetrees Trust(Rosetrees Trust); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK | Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Rosetrees Trust, Grant/Award Number: A1984; RCUK | Medical Research Council (MRC), Grant/Award Number: MR/K026666; RCUK | Engineering and Physical Sciences Research Council	Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Buchert J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174295; Buhrmann C, 2014, J BIOL CHEM, V289, P22048, DOI 10.1074/jbc.M114.568790; Cheng AX, 2018, TISSUE ENG PT A, V24, P968, DOI [10.1089/ten.tea.2017.0285, 10.1089/ten.TEA.2017.0285]; Cheng AX, 2014, STEM CELL TRANSL MED, V3, P1287, DOI 10.5966/sctm.2014-0101; Craft AM, 2015, NAT BIOTECHNOL, V33, P638, DOI [10.1038/nbt.3210, 10.10.38/nbt.3210]; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Diederichs S, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00270; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Elayyan J, 2017, FASEB J, V31, P3116, DOI 10.1096/fj.201601253R; FOSANG AJ, 1991, MATRIX, V11, P17, DOI 10.1016/S0934-8832(11)80223-4; Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Gibson JD, 2017, STEM CELL TRANSL MED, V6, P40, DOI 10.5966/sctm.2016-0020; Goldring MB, 2004, METH MOLEC MED, V100, P37; Griffiths R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61734-4; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3850; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Jang J, 2017, STEM CELL REP, V9, P629, DOI 10.1016/j.stemcr.2017.06.001; Kokkola T, 2014, FEBS LETT, V588, P1523, DOI 10.1016/j.febslet.2014.03.020; Kumar A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214973; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre V, 2017, CONNECT TISSUE RES, V58, P2, DOI 10.1080/03008207.2016.1183667; Liu B, 2016, J HUAZHONG U SCI-MED, V36, P350, DOI 10.1007/s11596-016-1590-y; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Lou GH, 2015, CELL PHYSIOL BIOCHEM, V35, P2192, DOI 10.1159/000374024; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mu WL, 2015, STEM CELLS, V33, P2135, DOI 10.1002/stem.2012; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Oppenheimer H, 2014, J BONE MINER RES, V29, P348, DOI 10.1002/jbmr.2052; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vynios DH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/452315; Wang T, 2019, STEM CELL RES, V39, DOI 10.1016/j.scr.2019.101497; Williams EO, 2016, CELL REP, V17, P809, DOI 10.1016/j.celrep.2016.09.046; Yamada D, 2021, NAT BIOMED ENG, V5, P926, DOI 10.1038/s41551-021-00778-x; Yamashita A, 2015, STEM CELL REP, V4, P404, DOI 10.1016/j.stemcr.2015.01.016; Ye JP, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0561-y; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V404, P610, DOI 10.1016/j.bbrc.2010.12.014; Zhang ZN, 2014, STEM CELLS, V32, P157, DOI 10.1002/stem.1532	58	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22314	10.1096/fj.202200169R	http://dx.doi.org/10.1096/fj.202200169R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0L9HO	35416346	Green Published, Green Submitted			2022-12-28	WOS:000781777000001
J	Koizumi, M; Eto, H; Saeki, M; Seki, M; Fukushima, T; Mukai, S; Ide, H; Sera, Y; Iwasaki, M; Suzuki, Y; Tohei, A; Kishi, Y; Honda, H				Koizumi, Miho; Eto, Hikaru; Saeki, Mai; Seki, Masahide; Fukushima, Tsuyoshi; Mukai, Shoichiro; Ide, Hisamitsu; Sera, Yasuyuki; Iwasaki, Masayuki; Suzuki, Yutaka; Tohei, Atsushi; Kishi, Yusuke; Honda, Hiroaki			UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death	FASEB JOURNAL			English	Article						histone demethylase; hydrocephalus; Kabuki syndrome; neuronal stem; progenitor cells; UTX; ventriculomegaly	H3K27ME3 DEMETHYLASE UTX; READ ALIGNMENT; STEM-CELLS; GENE; KDM6A; EXPRESSION; MUTATIONS; CHROMATIN; MECHANISMS; DIFFERENTIATION	Recent studies have demonstrated that epigenetic modifications are deeply involved in neurogenesis; however, the precise mechanisms remain largely unknown. To determine the role of UTX (also known as KDM6A), a demethylase of histone H3K27, in neural development, we generated Utx-deficient mice in neural stem/progenitor cells (NSPCs). Since Utx is an X chromosome-specific gene, the genotypes are sex-dependent; female mice lose both Utx alleles (Utx(Delta/Delta)), and male mice lose one Utx allele yet retain one Uty allele, the counterpart of Utx on the Y chromosome (Utx(Delta/Uty)). We found that Utx(Delta/Delta) mice exhibited fetal ventriculomegaly and died soon after birth. Immunofluorescence staining and EdU labeling revealed a significant increase in NSPCs and a significant decrease in intermediate-progenitor and differentiated neural cells. Molecular analyses revealed the downregulation of pathways related to DNA replication and increased H3K27me3 levels around the transcription start sites in Utx(Delta/Delta) NSPCs. These results indicate that UTX globally regulates the expression of genes required for proper neural development in NSPCs, and UTX deficiency leads to impaired cell cycle exit, reduced differentiation, and neonatal death. Interestingly, although Utx(Delta/Uty) mice survived the postnatal period, most died of hydrocephalus, a clinical feature of Kabuki syndrome, a congenital anomaly involving UTX mutations. Our findings provide novel insights into the role of histone modifiers in neural development and suggest that Utx(Delta/Uty) mice are a potential disease model for Kabuki syndrome.	[Koizumi, Miho; Sera, Yasuyuki; Iwasaki, Masayuki; Honda, Hiroaki] Tokyo Womens Med Univ, Inst Lab Anim, Field Human Dis Models, Adv Life Sci & Med, 8-1 Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan; [Eto, Hikaru; Saeki, Mai; Kishi, Yusuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Saeki, Mai; Kishi, Yusuke] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Neurobiol, Tokyo, Japan; [Seki, Masahide; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Fukushima, Tsuyoshi] Univ Miyazaki, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki, Japan; [Mukai, Shoichiro] Univ Miyazaki, Fac Med, Dept Urol, Miyazaki, Japan; [Ide, Hisamitsu] Dokkyo Med Univ, Saitama Med Ctr, Dept Urol, Saitama, Japan; [Tohei, Atsushi] Nippon Vet & Life Sci Univ, Lab Expt Anim Sci, Tokyo, Japan; [Kishi, Yusuke] Univ Tokyo, Inst Quantitat Biosci, 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan	Tokyo Women's Medical University; University of Tokyo; University of Tokyo; University of Tokyo; University of Miyazaki; University of Miyazaki; Dokkyo Medical University; Nippon Veterinary & Life Science University; University of Tokyo	Honda, H (corresponding author), Tokyo Womens Med Univ, Inst Lab Anim, Field Human Dis Models, Adv Life Sci & Med, 8-1 Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan.; Kishi, Y (corresponding author), Univ Tokyo, Inst Quantitat Biosci, 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan.	ykisi@iqb.u-tokyo.ac.jp; honda.hiroaki@twmu.ac.jp			AMED-PRIME [JP22gm6110021]; KAKENHI [JP20H03179, 19K22546, 21H00242, 22H04687, 16H06279]; Secom Science and Technology Foundation (SSTF)	AMED-PRIME; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Secom Science and Technology Foundation (SSTF)	AMED-PRIME, Grant/Award Number: JP22gm6110021; KAKENHI, Grant/Award Number: JP20H03179, 19K22546, 21H00242, 22H04687 and 16H06279; Secom Science and Technology Foundation (SSTF)	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Amemiya T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36636-1; Andricovich J, 2018, CANCER CELL, V33, P512, DOI 10.1016/j.ccell.2018.02.003; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Boniel S, 2021, GENES-BASEL, V12, DOI 10.3390/genes12040468; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Denton D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3916; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eto H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19556-5; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gozdecka M, 2018, NAT GENET, V50, P883, DOI 10.1038/s41588-018-0114-z; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo ZM, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0724-4; Head B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71760-x; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karimy JK, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16278; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kishi Yusuke, 2021, STAR Protoc, V2, P100540, DOI 10.1016/j.xpro.2021.100540; Kobatake K, 2020, CLIN CANCER RES, V26, P2065, DOI 10.1158/1078-0432.CCR-19-2230; Kompanikova P, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04314-1; Langmead B, 2019, BIOINFORMATICS, V35, P421, DOI 10.1093/bioinformatics/bty648; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lei XP, 2018, STEM CELL REP, V10, P1193, DOI 10.1016/j.stemcr.2018.02.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liddelow SA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00032; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Miyake N, 2013, HUM MUTAT, V34, P108, DOI 10.1002/humu.22229; Morimoto-Suzki N, 2014, DEVELOPMENT, V141, P4343, DOI 10.1242/dev.112276; Nakagawa T, 2020, GLIA, V68, P1554, DOI 10.1002/glia.23818; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Petruk S, 2017, CELL REP, V19, P295, DOI 10.1016/j.celrep.2017.03.035; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sera Y, 2021, BLOOD, V137, P908, DOI 10.1182/blood.2019001044; Shan YL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14028-x; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tang GB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00267; Tang QY, 2020, STEM CELL REP, V15, P439, DOI 10.1016/j.stemcr.2020.06.015; Telley L, 2019, SCIENCE, V364, P547, DOI 10.1126/science.aav2522; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuboi M, 2019, CURR OPIN NEUROBIOL, V59, P164, DOI 10.1016/j.conb.2019.07.003; Tsuboi M, 2018, DEV CELL, V47, P758, DOI 10.1016/j.devcel.2018.11.018; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Umutoni D, 2020, GENES CELLS, V25, P402, DOI 10.1111/gtc.12767; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Yamada S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101058; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Yoo KH, 2016, MOL CELL BIOL, V36, P2108, DOI 10.1128/MCB.00089-16; Yoshii SR, 2016, DEV CELL, V39, P116, DOI 10.1016/j.devcel.2016.09.001	83	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22662	10.1096/fj.202201002RR	http://dx.doi.org/10.1096/fj.202201002RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1DN	36412518				2022-12-28	WOS:000887930300001
J	Li, Y; Lin, SB; Xu, X; Jin, WL; Su, YL; Yuan, FQ; Zhang, YT; Li, ZY; Zhou, YH; Zhu, LH; Zhang, L				Li, Yun; Lin, Shibo; Xu, Xu; Jin, Weilai; Su, Yinglin; Yuan, Fuqiang; Zhang, Yiting; Li, Zhengying; Zhou, Yahui; Zhu, Lihong; Zhang, Le			Skeletal muscle HSF1 prevents insulin resistance by improving glucose utilization	FASEB JOURNAL			English	Article						HSF1; insulin sensitivity; myofiber switch; obesity	HEAT-SHOCK FACTOR-1; ACTIVATION; STRESS; HYPERGLYCEMIA; PROTEOSTASIS; ASSOCIATION	The regulation of muscle glucose utilization has significant potential for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Heat shock factor 1 (HSF1) is involved in cellular metabolism and regulation of muscle metabolism. However, it is unclear how HSF1 regulates muscle glucose metabolism. In the present study, the development of obesity in mice was associated with HSF1 downregulation. Serum samples and muscle biopsies were obtained from obese and healthy humans. Fasting glucose and insulin levels and the homeostasis model assessment of insulin resistance value showed that obesity was associated with insulin resistance. The skeletal muscle level of HSF1 was decreased in obese and ob/ob mice. HSF1 was selectively over-expressed in the skeletal muscles of high fat diet (HFD)-fed mice. Muscle HSF1 over-expression successfully triggered glycolytic-to-oxidative myofiber switch and increased fatty acid metabolism and insulin sensitivity in the skeletal muscles of HFD-fed mice. Moreover, HSF1 improved energy expenditure and blocked muscle accumulation of triglycerides in HFD-fed mice. Consequently, muscle HSF1 mitigated the impaired muscle insulin signaling and insulin resistance in HFD-fed mice. In conclusion, T2DM and obesity in HFD-fed mice may be treated with selective HSF1-directed programming of exercise-like effects in skeletal muscle. These findings may aid the development of a new therapeutic approach for obesity and T2DM.	[Li, Yun; Jin, Weilai; Yuan, Fuqiang; Zhang, Yiting] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat Lab, Wuxi, Peoples R China; [Lin, Shibo] Nanjing Med Univ, Affiliated Hosp 1, Dept Bariatr & Metab Surg, Nanjing, Peoples R China; [Xu, Xu; Zhu, Lihong] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi, Peoples R China; [Su, Yinglin; Li, Zhengying; Zhou, Yahui; Zhang, Le] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi, Peoples R China; [Zhu, Lihong] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi 214023, Jiangsu, Peoples R China; [Zhang, Le] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi 214023, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, LH (corresponding author), Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi 214023, Jiangsu, Peoples R China.; Zhang, L (corresponding author), Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi 214023, Jiangsu, Peoples R China.	lihongzhuwuxi@163.com; zhle@njmu.edu.cn			Medical key discipline program of Wuxi Health commission [ZDXK2021007]; Project of Wuxi health commission [Z202109, M202003]; Top medical expert team of Wuxi Taihu Talent Program [DJTD202106]; Top talent support program for young and middle - aged people of Wuxi Health Committee [BJ2020089]; Wuxi Science and Technology Association [N20202003, N20192039]; National Natural Science Foundation of China [81700744]	Medical key discipline program of Wuxi Health commission; Project of Wuxi health commission; Top medical expert team of Wuxi Taihu Talent Program; Top talent support program for young and middle - aged people of Wuxi Health Committee; Wuxi Science and Technology Association; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Medical key discipline program of Wuxi Health commission, Grant/Award Number: ZDXK2021007; Project of Wuxi health commission, Grant/Award Number: Z202109 and M202003; Top medical expert team of Wuxi Taihu Talent Program, Grant/Award Number: DJTD202106; Top talent support program for young and middle - aged people of Wuxi Health Committee, Grant/Award Number: BJ2020089; Wuxi Science and Technology Association (?????????), Grant/Award Number: N20202003 and N20192039; National Natural Science Foundation of China, Grant/Award Number: 81700744	Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS100, DOI 10.2337/dc21-S008; Batista TM, 2021, DIABETOLOGIA, V64, P994, DOI 10.1007/s00125-021-05415-5; Buse JB, 2020, DIABETES CARE, V43, P487, DOI 10.2337/dci19-0066; Casanova-Vallve N, 2022, MOL METAB, V61, DOI 10.1016/j.molmet.2022.101504; Chang YW, 2021, CELL STRESS CHAPERON, V26, P835, DOI 10.1007/s12192-021-01224-2; Chen ZZ, 2017, DIABETES, V66, P1185, DOI 10.2337/db16-0993; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dewi FRP, 2021, AUTOPHAGY, V17, P1001, DOI 10.1080/15548627.2020.1741318; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; Frampton J, 2020, NAT METAB, V2, P840, DOI 10.1038/s42255-020-0188-7; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Sanchez L, 2021, J CLIN MED, V10, DOI 10.3390/jcm10245748; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Hoff FW, 2021, BLOOD, V137, P1050, DOI 10.1182/blood.2020005208; Isermann T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24064-1; Karkkainen O, 2019, CARDIOVASC RES, V115, P107, DOI 10.1093/cvr/cvy155; Kruta M, 2021, CELL STEM CELL, V28, P1950, DOI 10.1016/j.stem.2021.07.009; Lewis GF, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142239; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu KS, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9624; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Maharjan BR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222413639; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Richter EA, 2001, J PHYSIOL-LONDON, V535, P313, DOI 10.1111/j.1469-7793.2001.t01-2-00313.x; Srivastava P, 2021, FEBS LETT, V595, P1933, DOI 10.1002/1873-3468.14139; Stefan N, 2018, LANCET DIABETES ENDO, V6, P249, DOI 10.1016/S2213-8587(17)30292-9; Sun ZR, 2022, BRIT J PHARMACOL, V179, P1237, DOI 10.1111/bph.15678; ter Horst KW, 2016, METABOLISM, V65, P757, DOI 10.1016/j.metabol.2016.02.010; Tye BW, 2021, MOL BIOL CELL, V32, P1800, DOI 10.1091/mbc.E21-01-0014; Uchiyama T, 2011, METABOLISM, V60, P789, DOI 10.1016/j.metabol.2010.07.029; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Watanabe K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094982; Xirouchaki CE, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abl4988; Xu DQ, 2021, J CACHEXIA SARCOPENI, V12, P192, DOI 10.1002/jcsm.12650; Xu DQ, 2020, J CACHEXIA SARCOPENI, V11, P1306, DOI 10.1002/jcsm.12581; Xu DQ, 2019, J CELL PHYSIOL, V234, P7510, DOI 10.1002/jcp.27512; Xu DQ, 2018, LIFE SCI, V209, P313, DOI 10.1016/j.lfs.2018.08.028; Xu L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.22; Zhang HC, 2022, NAT CELL BIOL, V24, P340, DOI 10.1038/s41556-022-00846-7	41	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22667	10.1096/fj.202201160RR	http://dx.doi.org/10.1096/fj.202201160RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O0JE	36421020				2022-12-28	WOS:000889932300001
J	Lin, ZY; Chen, A; Cui, HW; Shang, RH; Su, T; Li, XY; Wang, KK; Yang, J; Gao, KL; Lv, J; Shen, J; Wang, SZ; Qi, YH; Guo, MH; Zhu, YJ				Lin, Ziyan; Chen, Ai; Cui, Hongwang; Shang, Ruihua; Su, Tian; Li, Xiaoyan; Wang, Kekun; Yang, Jing; Gao, Keli; Lv, Jie; Shen, Jie; Wang, Shanzhi; Qi, Yonghui; Guo, Minghao; Zhu, Yongjun			Renal tubular epithelial cell necroptosis promotes tubulointerstitial fibrosis in patients with chronic kidney disease	FASEB JOURNAL			English	Article						chronic kidney disease; Interstitial fibroblasts; Necroptosis; Transforming growth factor beta 1; Tubulointerstitial fibrosis	INFLAMMATION; MECHANISMS; INJURY; ORIGIN; BETA	Renal fibrosis, a common pathological manifestation of virtually all types of chronic kidney disease (CKD), ultimately predisposes patients to end-stage renal disease. However, there is no effective therapy for renal fibrosis. Our earlier studies proved that RIP3-mediated necroptosis might be an important mode of renal tubular cell death in rats with chronic renal injury. Under transmission electron microscopy (TEM), we found morphological changes in the necrosis of human renal tissue, and the percentage of necrotic cells increased significantly in patients with stages 2 and 3a CKD. Immunofluorescence analyses showed that the percentages of TUNEL+/RIP3(+) double-positive and TUNEL+/MLKL+ double-positive tubular epithelial cells in renal tubules of patients with stages 2 and 3a CKD were significantly increased compared to those in control patients without renal disease. Immunohistochemistry analyses of renal biopsy specimens from patients with CKD revealed RIP3, MLKL, and p-MLKL upregulation in patients with stages 2 and 3a CKD, suggesting that necroptosis of renal tubular epithelial cells in CKD patients occurs, and the peak of necroptosis was in stages 2 and 3a CKD. We showed that profibrotic factor proteins (TGF-beta 1, Smad2 and Smad3) and fibroblast activation markers (alpha-SMA and Vimentin) were specifically upregulated in stage 2 and 3a CKD patients. In addition, Pearson correlation analysis showed that the percentage of necroptotic renal tubular epithelial cells was positively correlated with TGF-beta 1 and collagen-I. We also showed that RIP1/3 or MLKL inhibitors decreased the expression of RIP3, MLKL, TGF-beta 1, and Smad3 in HK-2 cells treated with TNF-alpha. FGF-2, alpha-SMA, Vimentin and FN were overexpressed in the hRIFs cultured with the supernatant of necroptotic HK-2 cells, whereas necroptosis blockers (Nec-1s, GSK'872 and NSA) and TGF-beta 1/Smad3 pathway antagonists (LY364947 and SIS3) reduced FGF-2, alpha-SMA, Vimentin and FN levels. Collectively, necroptosis of renal tubular epithelial cells in CKD patients occurs, and the peak of necroptosis was in stages 2 and 3a CKD. Renal tubular epithelial cell necroptosis mediates renal tubulointerstitial fibrosis in patients with chronic kidney disease, which is related to the TGF-beta 1/Smad3 signaling pathway.	[Lin, Ziyan; Chen, Ai; Li, Xiaoyan; Yang, Jing; Gao, Keli; Lv, Jie; Shen, Jie; Wang, Shanzhi; Zhu, Yongjun] Hainan Med Univ, Dept Nephrol, Affiliated Hosp 1, Haikou, Peoples R China; [Cui, Hongwang; Su, Tian] Hainan Med Univ, Dept Orthoped, Affiliated Hosp 1, Haikou, Peoples R China; [Shang, Ruihua; Guo, Minghao] Xinxiang Med Univ, Dept Nephrol, Affiliated Hosp 1, Urumqi, Peoples R China; [Wang, Kekun] Qionghai Peoples Hosp, Dept Nephrol, Qionghai, Peoples R China; [Qi, Yonghui] Hainan Med Univ, Blood Purificat Ctr, Hannan Affiliated Hosp, Haikou, Peoples R China	Hainan Medical University; Hainan Medical University; Xinxiang Medical University; Hainan Medical University	Zhu, YJ (corresponding author), Hainan Med Univ, Dept Nephrol, Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China.; Guo, MH (corresponding author), Xinxiang Med Univ, Dept Nephrol, Affiliated Hosp 1, 88 Jiankang Rd, Xinxiang 453100, Henan, Peoples R China.	guomh@163.com; zyj418207195@yeah.net			Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province) [2019215]; National Natural Science Foundation of China (NSFC) [82060143]; Natural Science Foundation of Hainan Province [821RC693]	Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province	Key Research and Development Project of Hainan Province (Key R&D Project of Hainan Province), Grant/Award Number: 2019215; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82060143; Natural Science Foundation of Hainan Province, Grant/Award Number: 821RC693	Cho Min Hyun, 2010, Korean J Pediatr, V53, P735, DOI 10.3345/kjp.2010.53.7.735; Collins A, 2006, KIDNEY INT, V69, P781, DOI 10.1038/sj.ki.5000250; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Elson EL, 2019, PROG BIOPHYS MOL BIO, V144, P30, DOI 10.1016/j.pbiomolbio.2018.08.004; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Liu SH, 2021, CELL MOL LIFE SCI, V78, P7199, DOI 10.1007/s00018-021-03947-y; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YP, 2019, INT J MOL MED, V44, P771, DOI 10.3892/ijmm.2019.4244; Ma TT, 2019, ADV EXP MED BIOL, V1165, P347, DOI 10.1007/978-981-13-8871-2_16; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Meng YX, 2021, CELL DEATH DIFFER, V28, P861, DOI 10.1038/s41418-020-00722-7; Murakami K, 1997, PEDIATR NEPHROL, V11, P334, DOI 10.1007/s004670050289; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nikolic-Paterson DJ, 2014, KIDNEY INT SUPPL, V4, P34, DOI 10.1038/kisup.2014.7; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Tan RJ, 2016, KIDNEY DIS-BASEL, V2, P136, DOI 10.1159/000446336; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Zhan CN, 2021, THERANOSTICS, V11, P4759, DOI 10.7150/thno.54072; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhu YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228385; Zhu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156729; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	27	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22625	10.1096/fj.202200706RR	http://dx.doi.org/10.1096/fj.202200706RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6WI	36331546				2022-12-28	WOS:000878739400001
J	Liu, G				Liu, Gang			Revision of cytogenetic dosimetry in the IAEA manual 2011 based on data about radio-sensitivity and dose-rate findings contributing	FASEB JOURNAL			English	Article						biological dosimetry; dicentric chromosome; dose rate	BIOLOGICAL DOSIMETRY; IONIZING-RADIATION; BIODOSIMETRY; EXPOSURES; ASSAY	In order to achieve the goal of rapid response, effective controland protection of life inlarge-scale radiation events, the IAEA Manual 2011 has been revised based on the data of radio-sensitivity, dose-rate findings. Analyze individual differences in radiation sensitivity using Co-60 radiation (0.27 Gy/min). Chromosomal aberrations with different irradiation dose rates were used to establish the biological dose curve and analyze the excess of the "dicentric + ring" caused by the dose rate at each dose point; DAPI-images and Metafer 4 were used to capture metaphase images and make further analysis. The data were collected in 2020, Dicentric + ring/100 Cells was 17.5-43.8, the average value was28.32 +/- 6.98. The mean value of Dicentric + ring/100 Cells was 31.37 in males while 25.27 in females, there are significant differences (p < .01). The irradiation dose is dominant, At each dose point, the value of"(dicentric chromosome + centric rings)/cell" is proportional to "dose rate", that is, Y = kx + b, within the dose range of 1-5 Gy, "(dicentric chromosome + centric rings)/Cell" holds a quadratic linear relationship with dose rate, that is, y = ax(2) + bx + c; The DAPI-images might give you more hints than those of conventional Giemsa-stain. The authors recommend that the IAEA Manual 2011 could be revised based on data of radio-sensitivity and dose-rate, which may contribute to the establishment of a unified dose-response calibration curve and stimulation of potential for automation in cytogenetic biodosimetry. (1) Individual differences of radiosensitivity are very large. (2) At each dose point, "(dicentric chromosome + centric rings)/cell" is proportional to "dose rate", that is, Y = kx + b. (3) "(dicentric chromosome + centric rings)/Cell" is a quadratic linear relationship with dose rate, that is, y = ax(2) + bx + c. (4) We created a "Unity Standard Curve of Biological Dose Estimation". Creating a Unity Standard Curve of Biological Dose, under these circumstances, we can form a joint and rapid response to a nuclear and radiological accident.	[Liu, Gang] Chinese Acad Med Sci, Gansu Prov Ctr Dis Control & Prevent, Joint Lab Inst Radiol, Lanzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College	Liu, G (corresponding author), Chinese Acad Med Sci, Gansu Prov Ctr Dis Control & Prevent, Joint Lab Inst Radiol, Lanzhou, Peoples R China.	lgscfll@163.com			Health Commission of Gansu Province [GSWSKY2018-48]; Lanzhou Science and Technology Bureau (Science and Technology Bureau of Lanzhou) [2018-1-127]; Science and Technology Department of Gansu Province [21JR7RA653]	Health Commission of Gansu Province; Lanzhou Science and Technology Bureau (Science and Technology Bureau of Lanzhou); Science and Technology Department of Gansu Province	Health Commission of Gansu Province, Grant/Award Number: GSWSKY2018-48; Lanzhou Science and Technology Bureau (Science and Technology Bureau of Lanzhou), Grant/Award Number: 2018-1-127; Science and Technology Department of Gansu Province, Grant/Award Number: 21JR7RA653	Agrawala PK, 2010, J PHARM BIOALLIED SC, V2, P197, DOI 10.4103/0975-7406.68501; Balakrishnan S, 2010, MUTAT RES-GEN TOX EN, V699, P11, DOI 10.1016/j.mrgentox.2010.03.008; Fenech M, 2006, MUTAT RES-FUND MOL M, V600, P58, DOI 10.1016/j.mrfmmm.2006.05.028; Gnanasekaran TS, 2021, RADIAT ONCOL J, V39, P159, DOI 10.3857/roj.2021.00339; Guo Y, 2015, HEALTH PHYS, V109, P323, DOI 10.1097/HP.0000000000000331; Hahn MB, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.052419; IAEA, 2011, CYT DOS APPL PREP RE; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Li S, 2019, RADIAT RES, V192, P399, DOI 10.1667/RR15355.1; Ludovici GM, 2021, EUR PHYS J PLUS, V136, DOI 10.1140/epjp/s13360-021-01447-3; Ministry of Health PRC Standardization Administration of China, 2012, 282362011 GBT; Pujol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114137; Pujol M, 2012, RADIAT PROT DOSIM, V149, P392, DOI 10.1093/rpd/ncr326; Pujol-Canadell M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228350; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Simmons JackA., 2000, RAD PROTECTION DOSIM; Sproull M, 2016, RADIAT RES, V186, P423, DOI 10.1667/RR14452.1; Swartz HM, 2014, RADIAT ENVIRON BIOPH, V53, P221, DOI 10.1007/s00411-014-0522-0; Tian XL, 2021, MUTAT RES-GEN TOX EN, V867, DOI 10.1016/j.mrgentox.2021.503370; Vinnikov V, 2022, SEMIN NUCL MED, V52, P114, DOI 10.1053/j.semnuclmed.2021.11.008; Wang Q, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69460-7; Wang Q, 2019, RADIAT RES, V191, P342, DOI 10.1667/RR15243.1; Wilkins RC, 2015, INT J RADIAT BIOL, V91, P443, DOI 10.3109/09553002.2015.1012305	23	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22621	10.1096/fj.202200769RR	http://dx.doi.org/10.1096/fj.202200769RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5K6DP	36260291				2022-12-28	WOS:000869815500001
J	Hu, BF; Gong, Q; Chen, SQ; Yue, L; Ma, WX; Wang, F; Feng, XW; Wang, JN; Li, C; Liu, MM; Wang, XF; Meng, XM; Li, J; Wen, JG				Hu, Bing-feng; Gong, Qian; Chen, Shi-qing; Yue, Lin; Ma, Wen-xian; Wang, Fang; Feng, Xiao-wen; Wang, Jia-nan; Li, Chao; Liu, Ming-ming; Wang, Xue-fu; Meng, Xiao-ming; Li, Jun; Wen, Jia-gen			Protective effect of inhibiting necroptosis on gentamicin-induced nephrotoxicity	FASEB JOURNAL			English	Article						acute kidney injury; gentamicin; necroptosis; necrostatin-1; nephrotoxicity; RIPK1	NONAPOPTOTIC CELL-DEATH; INFLAMMATION; PHARMACOKINETICS; CYTOTOXICITY; ACCUMULATION; CONTRIBUTES; KINASES; RATS	Necroptosis is defined as a novel programmed cell necrosis that is mediated by receptor interacting serine-threonine protein kinase 1 (RIPK1) and other related signals. Necrosis, apoptosis and inflammation are commonly considered as the leading mechanism in acute kidney injury (AKI) induced by gentamicin (GEN), which is a useful antibiotic for treating the infection of Gram-negative bacterial. However, the necroptosis in the pathogenesis of GEN-induced AKI is unknown. In this study, to investigate the process and function of necroptosis in GEN-induced AKI, NRK-52E and HK-2 cells and SD rats were used as the models. The necroptosis-related proteins, including RIPK1, RIPK3, mixed lineage kinase domain-like (MLKL) and phosphorylated MLKL (p-MLKL), were all increasing time-dependently when GEN was continuously given. By using the RIPK1 inhibitor necrostatin-1 (NEC-1) and RIPK3 inhibitor (CPD42), the GEN-induced toxicity of tubular cells was alleviated. Moreover, it was validated that GEN-induced cell apoptosis and inflammation were attenuated after treating with NEC-1 or CPD42, both in vivo and in vitro. When MLKL was knocked down by siRNA, NEC-1 and CPD42 can not further protect the damage of tubular cells by GEN. Although the using of pan-caspase inhibitor Z-VAD significantly decreased GEN-induced apoptosis, it enhanced necroptosis and slightly promoted the decreased cell viability in GEN-treated cells, with the protective effects weaker than NEC-1 or CPD42. Finally, in vitro minimum inhibitory concentration (MIC) tests and bacteriostatic ring studies showed that NEC-1 did not interfere with the antibiotic effects of GEN. Thus, suppressing necroptosis can serve as a promising strategy for the prevention of GEN-induced nephrotoxicity.	[Hu, Bing-feng; Chen, Shi-qing; Yue, Lin; Ma, Wen-xian; Wang, Fang; Feng, Xiao-wen; Wang, Jia-nan; Li, Chao; Liu, Ming-ming; Wang, Xue-fu; Meng, Xiao-ming; Li, Jun; Wen, Jia-gen] Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China; [Gong, Qian] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Peoples R China; [Wang, Fang] Anhui Med Univ, Luan Hosp, Luan Peoples Hosp Anhui Prov, Dept Pharm, Luan, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wen, JG (corresponding author), Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China.	jiagen168@163.com			National Natural Science Foundation of China [81800606]; Doctoral Research Funding Program of Anhui Medical University [XJ201626]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Research Funding Program of Anhui Medical University	This work was supported by the National Natural Science Foundation of China (No. 81800606) and Doctoral Research Funding Program of Anhui Medical University (No. XJ201626).	Ahn JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048952; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Chen CH, 2015, MOL MED, V21, P886, DOI 10.2119/molmed.2015.00196; Chen SF, 2017, APOPTOSIS, V22, P626, DOI 10.1007/s10495-017-1358-2; Chen YC, 2011, EUR J PHARMACOL, V658, P213, DOI 10.1016/j.ejphar.2011.02.025; CHIU PJS, 1979, KIDNEY INT, V15, P618, DOI 10.1038/ki.1979.81; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Edwards Joshua R., 2007, BMC Physiology, V7, P1, DOI 10.1186/1472-6793-7-1; Gai ZB, 2016, ANTIMICROB AGENTS CH, V60, P5573, DOI 10.1128/AAC.00907-16; Gong XZ, 2012, RENAL FAILURE, V34, P487, DOI 10.3109/0886022X.2012.655684; Goodlet KJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02165-18; GYSELYNCK AM, 1971, J INFECT DIS, V124, pS70, DOI 10.1093/infdis/124.Supplement_1.S70; Hassanein EHM, 2021, ENVIRON SCI POLLUT R, V28, P11558, DOI 10.1007/s11356-020-11416-5; Hayward RS, 2018, BRIT J CLIN PHARMACO, V84, P223, DOI 10.1111/bcp.13439; He SD, 2018, NAT IMMUNOL, V19, P912, DOI 10.1038/s41590-018-0188-x; Karimi Z, 2020, CLIN EXP PHARMACOL P, V47, P1584, DOI 10.1111/1440-1681.13334; Li J, 2009, EUR J PHARMACOL, V620, P97, DOI 10.1016/j.ejphar.2009.08.021; LUFT FC, 1981, RES COMMUN CHEM PATH, V34, P89; MATHEW TH, 1992, MED J AUSTRALIA, V156, P724, DOI 10.5694/j.1326-5377.1992.tb121517.x; McWilliam SJ, 2017, PEDIATR NEPHROL, V32, P2015, DOI 10.1007/s00467-016-3533-z; Nagai J, 2002, J PHARM PHARMACOL, V54, P1491, DOI 10.1211/00223570272; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Ouyang ZZ, 2012, PHARMAZIE, V67, P725, DOI 10.1691/ph.2012.1837; PRINS JM, 1993, LANCET, V341, P335, DOI 10.1016/0140-6736(93)90137-6; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Seo J, 2021, EXP MOL MED, V53, P1007, DOI 10.1038/s12276-021-00634-7; SIMON VK, 1973, ANTIMICROB AGENTS CH, V3, P445, DOI 10.1128/AAC.3.4.445; Speir M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050646; Sureshbabu A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98411; SUZUKI S, 1995, COMP BIOCHEM PHYS C, V112, P15, DOI 10.1016/0742-8413(95)00075-5; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tristao VR, 2012, RENAL FAILURE, V34, P373, DOI 10.3109/0886022X.2011.647343; Varzi HN, 2007, J VET PHARMACOL THER, V30, P477, DOI 10.1111/j.1365-2885.2007.00901.x; VERPOOTEN GA, 1989, CLIN PHARMACOL THER, V45, P22, DOI 10.1038/clpt.1989.4; Wang F, 2022, ACTA PHARMACOL SIN, V43, P330, DOI 10.1038/s41401-021-00649-w; Wang J, 2021, INT IMMUNOPHARMACOL, V98; Wang JN, 2019, CLIN SCI, V133, P1609, DOI 10.1042/CS20190599; Yao L, 2020, ACTA PHARMACOL SIN, V41, P866, DOI 10.1038/s41401-019-0342-5; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zappitelli M, 2011, NEPHROL DIAL TRANSPL, V26, P144, DOI 10.1093/ndt/gfq375; Zelic M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109112; Zeng G., 2021, IMMUNOL INVEST, V51, P1; Zhang C, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02545-9; Zhang H, 2019, J MED CHEM, V62, P6665, DOI 10.1021/acs.jmedchem.9b00611; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050; Zhu KZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0524-y	47	2	2	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22487	10.1096/fj.202200163R	http://dx.doi.org/10.1096/fj.202200163R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Q4LJ	35947125				2022-12-28	WOS:000838204400001
J	Wang, S; Liu, XN; Meng, ZQ; Feng, Q; Lin, YL; Niu, HL; Yu, C; Zong, YH; Guo, LL; Yang, WW; Ma, YH; Zhang, WJ; Li, CY; Yang, YR; Wang, WJ; Gao, XR; Hu, YX; Liu, C; Nie, L				Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Niu, Honglin; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Liu, Chao; Nie, Lei			DCBLD2 regulates vascular hyperplasia by modulating the platelet derived growth factor receptor-beta endocytosis through Caveolin-1 in vascular smooth muscle cells	FASEB JOURNAL			English	Article						Caveolin-1; DCBLD2; PDGFR-beta; vascular hyperplasia; vascular smooth muscle cell	PDGFR-BETA; TYROSINE PHOSPHORYLATION; UP-REGULATION; PROLIFERATION; MIGRATION; INTERNALIZATION; ASSOCIATION; HOMEOSTASIS; SURVIVAL; FAMILY	DCBLD2 is a neuropilin-like transmembrane protein that is up-regulated during arterial remodeling in humans, rats, and mice. Activation of PDGFR-beta via PDGF triggers receptor phosphorylation and endocytosis. Subsequent activation of downstream signals leads to the stimulation of phenotypic conversion of VSMCs and arterial wall proliferation, which are common pathological changes in vascular remodeling diseases such as atherosclerosis, hypertension, and restenosis after angioplasty. In this study, we hypothesized that DCBLD2 regulates neointimal hyperplasia through the regulation of PDGFR-beta endocytosis of vascular smooth muscle cells (VSMCs) through Caveolin-1 (Cav-1). Compared with wild-type (WT) mice or control littermate mice, the germline or VSMC conditional deletion of the Dcbld2 gene resulted in a significant increase in the thickness of the tunica media in the carotid artery ligation. To elucidate the underlying molecular mechanisms, VSMCs were isolated from the aorta of WT or Dcbld2(-/-) mice and were stimulated with PDGF. Western blotting assays demonstrated that Dcbld2 deletion increased the PDGF signaling pathway. Biotin labeling test and membrane-cytosol separation test showed that after DCBLD2 was knocked down or knocked out, the level of PDGFR-beta on the cell membrane was significantly reduced, while the amount of PDGFR-beta in the cytoplasm increased. Co-immunoprecipitation experiments showed that after DCBLD2 gene knock-out, the binding of PDGFR-beta and Cav-1 in the cytoplasm significantly increased. Double immunofluorescence staining showed that PDGFR-beta accumulated Cav-1/lysosomes earlier than for control cells, which indicated that DCBLD2 gene knock-down or deletion accelerated the endocytosis of PDGF-induced PDGFR-beta in VSMCs. In order to confirm that DCBLD2 affects the relationship between Cav-1 and PDGFR-beta, proteins extracted from VSMCs cultured in vitro were derived from WT and Dcbld2(-/-) mice, whereas co-immunoprecipitation suggested that the combination of DCBLD2 and Cav-1 reduced the bond between Cav-1 and PDGFR-beta, and DCBLD2 knock-out was able to enhance the interaction between Cav-1 and PDGFR-beta. Therefore, the current results suggest that DCBLD2 may inhibit the caveolae-dependent endocytosis of PDGFR-beta by anchoring the receptor on the cell membrane. Based on its ability to regulate the activity of PDGFR-beta, DCBLD2 may be a novel therapeutic target for the treatment of cardiovascular diseases.	[Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin] Hebei Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Nie, Lei] Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Wang, Shuai; Liu, Xiaoning; Meng, Zeqi; Feng, Qi; Lin, Yanling; Yu, Chao; Zong, Yanhong; Guo, Lingling; Yang, Weiwei; Ma, Yuehua; Zhang, Wenjun; Li, Chenyang; Yang, Yunran; Wang, Wenjuan; Gao, Xurui; Hu, Yaxin; Nie, Lei] Hebei Med Univ, Cardiovasc Med Sci Ctr, Shijiazhuang, Hebei, Peoples R China; [Niu, Honglin] Hebei Med Univ, Sch Nursing, Shijiazhuang 050017, Hebei, Peoples R China; [Liu, Chao] Hebei Med Univ, Dept Lab Anim Sci, Shijiazhuang, Hebei, Peoples R China; [Liu, Chao] Hebei Med Univ, Key Lab Anim Sci Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Nie, L (corresponding author), Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Niu, HL (corresponding author), Hebei Med Univ, Sch Nursing, Shijiazhuang 050017, Hebei, Peoples R China.	niuhonglin126@126.com; leinie@hebmu.edu.cn		Niu, Honglin/0000-0003-0710-5959	Innovation Capability Support Program Project in Hebei Province [20567610D]; Research Project of Hebei Province Colleges and Universities [BJ2019026]; Precision medicine joint fund of Hebei Province of China [2021206393, 2020206432]; Natural Science Foundation of Hebei Province [2016206226]; National Natural Science Foundation of China [81600576, 31771268, 31571176]	Innovation Capability Support Program Project in Hebei Province; Research Project of Hebei Province Colleges and Universities; Precision medicine joint fund of Hebei Province of China; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Innovation Capability Support Program Project in Hebei Province, Grant/Award Number: 20567610D; Research Project of Hebei Province Colleges and Universities, Grant/Award Number: BJ2019026; Precision medicine joint fund of Hebei Province of China, Grant/Award Number: 2021206393 and 2020206432; Natural Science Foundation of Hebei Province, Grant/Award Number: 2016206226; National Natural Science Foundation of China, Grant/Award Number: 81600576, 31771268 and 31571176	Alhamoudi KM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92026-0; Aten TM, 2013, FEBS LETT, V587, P2313, DOI 10.1016/j.febslet.2013.05.064; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Caglayan E, 2011, J AM COLL CARDIOL, V57, P2527, DOI 10.1016/j.jacc.2011.02.037; Chanakira A, 2012, AM J PHYSIOL-HEART C, V302, pH1173, DOI 10.1152/ajpheart.00411.2011; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Cheng C, 2012, ARTERIOSCL THROM VAS, V32, P1289, DOI 10.1161/ATVBAHA.112.245530; Cheng S, 2021, NEUROREPORT, V32, P507, DOI 10.1097/WNR.0000000000001611; Critchley WR, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030022; Dong LH, 2015, CIRC RES, V117, P684, DOI 10.1161/CIRCRESAHA.115.306233; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI 10.1172/JCI73093; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Guo XJ, 2009, J BIOL CHEM, V284, P29376, DOI 10.1074/jbc.M109.049684; Gutierrez-Pajares Jorge L, 2015, Front Cardiovasc Med, V2, P27, DOI 10.3389/fcvm.2015.00027; He J, 2020, CELL ONCOL, V43, P409, DOI 10.1007/s13402-020-00495-8; Jastrzebski K, 2017, J CELL SCI, V130, P577, DOI 10.1242/jcs.191213; Kazlauskas A, 2017, GENE, V614, P1, DOI 10.1016/j.gene.2017.03.003; Kikuta K, 2017, BBA-PROTEINS PROTEOM, V1865, P1160, DOI 10.1016/j.bbapap.2017.06.023; Kim Y, 2014, EUR J PHARMACOL, V733, P81, DOI 10.1016/j.ejphar.2014.03.037; Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Lu QB, 2018, REDOX BIOL, V14, P656, DOI 10.1016/j.redox.2017.11.012; Lv P, 2016, AM J PHYSIOL-CELL PH, V311, pC758, DOI 10.1152/ajpcell.00033.2016; Mulder AB, 1996, BLOOD, V88, P1306, DOI 10.1182/blood.V88.4.1306.bloodjournal8841306; Nakayama A, 2013, GENE DEV, V27, P2576, DOI 10.1101/gad.224089.113; Nehru V, 2013, TRAFFIC, V14, P1242, DOI 10.1111/tra.12121; Nie L, 2013, J CLIN INVEST, V123, P5082, DOI 10.1172/JCI67752; Omote S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27672-y; Park ES, 2011, J PHARMACOL SCI, V116, P204, DOI 10.1254/jphs.10276FP; Park ES, 2013, EXP CELL RES, V319, P982, DOI 10.1016/j.yexcr.2012.12.024; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schmoker AM, 2019, BIOCHEM J, V476, P931, DOI 10.1042/BCJ20190022; Schmoker AM, 2017, BIOCHEM J, V474, P3963, DOI 10.1042/BCJ20170615; Sorokin V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599415; Thyberg J, 2000, LAB INVEST, V80, P915, DOI 10.1038/labinvest.3780095; Westerdijk K, 2020, BRIT J CLIN PHARMACO, V86, P258, DOI 10.1111/bcp.14185; Xie P, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.669285; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhu BY, 2017, CELL TISSUE RES, V368, P591, DOI 10.1007/s00441-017-2587-y	40	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22488	10.1096/fj.202200156RR	http://dx.doi.org/10.1096/fj.202200156RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3N5LI	35929441				2022-12-28	WOS:000836188600001
J	Shi, FF; Xu, YX; Zhang, SH; Fu, ZH; Yu, Q; Zhang, SZ; Sun, MZ; Zhao, X; Feng, XZ				Shi, Feifei; Xu, Yixin; Zhang, Shuhui; Fu, Zhenhua; Yu, Qian; Zhang, Shaozhi; Sun, Mingzhu; Zhao, Xin; Feng, Xizeng			Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice	FASEB JOURNAL			English	Article						behavioral defects; decabromodiphenyl ethane; DNA damage; embryotoxicity; F-actin	BROMINATED FLAME RETARDANTS; POLYBROMINATED DIPHENYL ETHERS; DIETARY EXPOSURE; DNA-DAMAGE; GENOMIC STABILITY; HUMAN-MILK; ZSCAN4; STRESS; LEGACY; PBDES	Decabromodiphenyl ethane (DBDPE) is a novel retardant. DBDPE is used in various flammable consumer products such as electronics, building materials, textiles, and children's toys. The presence of DBDPE in humans makes it extremely urgent to assess the health effects of DBDPE exposure. Here, we used female mice as an animal model to investigate the effects of DBDPE on embryonic development and offspring health. The results showed that 50 mu g/kg bw/day of DBDPE exposure did not affect spindle rotation in oocytes after fertilization, but led to a decrease of pronuclei (PN) in zygotes. Further investigation found that DBDPE interferes with the self-assembly of F-actin in PN, resulting in PN reduction, DNA damage, and reduced expression of zygotic genome activating genes, and finally leading to abnormal embryonic development. More importantly, we found that maternal DBDPE exposure did not affect the growth and development of the first generation of offspring (F1) mice, but resulted in behavioral defects in F1 mice. Female F1 mice from DBDPE-exposed mothers exhibited increased motor activity and deficits in social behavior. Both female and male F1 mice from DBDPE-exposed mothers exhibited cognitive memory impairment. These results suggest that DBDPE has developmental toxicity on embryos and has a cross-generational interference effect. It is suggested that people should pay attention to the reproductive toxicity of DBDPE. In addition, it also provides a reference for studying the origin of neurological diseases and indicates that adult diseases caused by environmental pollutants may have begun in the embryonic stage.	[Shi, Feifei; Xu, Yixin; Zhang, Shuhui; Yu, Qian; Zhang, Shaozhi; Feng, Xizeng] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin 300071, Peoples R China; [Fu, Zhenhua; Sun, Mingzhu; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Feng, XZ (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin 300071, Peoples R China.; Zhao, X (corresponding author), Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China.	zhaoxin@nankai.edu.cn; xzfeng@nankai.edu.cn			Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation [62027812]; National Key R&D Program of China [2019YFB1309704]	Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation; National Key R&D Program of China	This project was initiated in the College of Life Science at Nankai University. This work was supported by the Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation (Grant no: 62027812) and the National Key R&D Program of China (Grant no: 2019YFB1309704).	[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Baarlink C, 2017, NAT CELL BIOL, V19, P1389, DOI 10.1038/ncb3641; Bartolini L, 1996, PHARMACOL BIOCHEM BE, V53, P277, DOI 10.1016/0091-3057(95)02021-7; Belcher SM, 2014, TOXICOL LETT, V228, P93, DOI 10.1016/j.toxlet.2014.04.017; Belin BJ, 2015, ELIFE, V4, DOI [10.7554/eLife.07735, 10.7554/eLife.11935]; Besis A, 2017, ENVIRON POLLUT, V230, P871, DOI 10.1016/j.envpol.2017.07.032; Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357; Brivio P, 2020, CELL MOL NEUROBIOL, V40, P1037, DOI 10.1007/s10571-020-00793-7; Caridi CP, 2018, NATURE, V559, P54, DOI 10.1038/s41586-018-0242-8; Chen T, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105179; Cheng ZL, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107877; Dicks N, 2020, MOL REPROD DEV, V87, P161, DOI 10.1002/mrd.23305; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Fernie KJ, 2009, ENVIRON SCI TECHNOL, V43, P2124, DOI 10.1021/es8027346; Gao L, 2016, ANAL BIOANAL CHEM, V408, P7835, DOI 10.1007/s00216-016-9887-z; Gillera SEA, 2020, NEUROTOXICOL TERATOL, V79, DOI 10.1016/j.ntt.2019.106840; Gozal D, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01456-2017; Han XB, 2013, ENVIRON POLLUT, V182, P120, DOI 10.1016/j.envpol.2013.06.045; Harrad S, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135834; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; He MJ, 2012, SCI TOTAL ENVIRON, V419, P109, DOI 10.1016/j.scitotenv.2011.12.035; HERTZPICCIOTTO I, 1988, NEW ENGL J MED, V319, P1483; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Hu GC, 2010, J ENVIRON SCI, V22, P1833, DOI 10.1016/S1001-0742(09)60328-4; Ingle ME, 2021, ENVIRON RES, V192, DOI 10.1016/j.envres.2020.110226; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Jing L, 2019, CHEMOSPHERE, V223, P675, DOI 10.1016/j.chemosphere.2019.02.115; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Lee SC, 2015, CHINESE MED J-PEKING, V128, P1543, DOI 10.4103/0366-6999.157693; Li XY, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106307; Li XY, 2017, BIOMATER SCI-UK, V5, P849, DOI 10.1039/c7bm00068e; Liang S, 2016, ENVIRON SCI POLLUT R, V23, P14889, DOI 10.1007/s11356-016-6491-x; Main KM, 2007, ENVIRON HEALTH PERSP, V115, P1519, DOI 10.1289/ehp.9924; MARO B, 1984, J EMBRYOL EXP MORPH, V81, P211; Marteinson SC, 2012, CHEMOSPHERE, V89, P1077, DOI 10.1016/j.chemosphere.2012.05.073; McGrath TJ, 2017, ENVIRON POLLUT, V230, P741, DOI 10.1016/j.envpol.2017.07.009; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Molosh AI, 2014, NAT NEUROSCI, V17, P1583, DOI 10.1038/nn.3822; Okuno T, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107824; Pellegrini L, 2014, PEDIATR ANESTH, V24, P749, DOI 10.1111/pan.12372; Plessner M, 2019, CURR OPIN CELL BIOL, V56, P1, DOI 10.1016/j.ceb.2018.08.005; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Schrank BR, 2018, NATURE, V559, P61, DOI 10.1038/s41586-018-0237-5; Shen KH, 2019, ENVIRON POLLUT, V250, P79, DOI 10.1016/j.envpol.2019.03.090; Shi FF, 2021, FASEB J, V35, DOI 10.1096/fj.202002585R; Shi FF, 2021, ECOTOX ENVIRON SAFE, V207, DOI 10.1016/j.ecoenv.2020.111290; Shi ZX, 2018, CHEMOSPHERE, V198, P522, DOI 10.1016/j.chemosphere.2018.01.161; Shi ZX, 2016, ENVIRON INT, V96, P82, DOI 10.1016/j.envint.2016.09.005; Srinivasan R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz9115; Stubbings WA, 2014, ENVIRON INT, V71, P164, DOI 10.1016/j.envint.2014.06.007; Sueyoshi T, 2014, TOXICOL SCI, V137, P292, DOI 10.1093/toxsci/kft243; Sun RB, 2018, BIOMED ENVIRON SCI, V31, P12, DOI 10.3967/bes2018.002; Sun YM, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135783; Tao F, 2016, ENVIRON SCI TECHNOL, V50, P13052, DOI 10.1021/acs.est.6b02816; Tay JH, 2018, ENVIRON INT, V115, P285, DOI 10.1016/j.envint.2018.03.038; Tseng LH, 2013, ENVIRON TOXICOL, V28, P380, DOI 10.1002/tox.20729; Ulferts S, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a040121; Wang FX, 2010, ENVIRON SCI TECHNOL, V44, P5655, DOI 10.1021/es101158e; Wang HY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz5004; Wang XC, 2019, ENVIRON SCI TECHNOL, V53, P8437, DOI 10.1021/acs.est.9b02831; Wapner RJ, 2010, CLIN OBSTET GYNECOL, V53, P628, DOI 10.1097/GRF.0b013e3181ee2793; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yu LH, 2021, ENVIRON SCI POLLUT R, V28, P12566, DOI 10.1007/s11356-020-11132-0; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zheng XB, 2014, ENVIRON TOXICOL CHEM, V33, P1712, DOI 10.1002/etc.2588; Zhu ZY, 2003, BIOL REPROD, V68, P943, DOI 10.1095/biolreprod.102.009910; Zuiderveen EAR, 2020, CHEMOSPHERE, V255, DOI 10.1016/j.chemosphere.2020.126816	69	1	1	16	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22445	10.1096/fj.202200586R	http://dx.doi.org/10.1096/fj.202200586R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0HC	35816173				2022-12-28	WOS:000822844900001
J	Zhang, XQ; Zhou, WQ; Niu, YY; Zhu, SY; Zhang, YY; Li, XG; Yu, C				Zhang, Xiaoqin; Zhou, Wenqian; Niu, Yangyang; Zhu, Saiya; Zhang, Yingying; Li, Xiaogang; Yu, Chen			Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by beta-arrestin/ERK/STAT3 pathway	FASEB JOURNAL			English	Article						ERK; STAT3; LOX; renal fibrosis; STAT3-pY705; beta-arrestin pathway	BETA-ARRESTIN; SIGNALING PATHWAYS; ACTIVATION; ERK; PACKAGE; ROLES	Lysyl oxidase (LOX) is a copper-dependent monoamine oxidase whose primary function is the covalent cross-linking of collagen in the extracellular matrix (ECM). Evidence has shown that LOX is associated with cancer and some fibrotic conditions. We recently found that serum LOX is a potential diagnostic biomarker for renal fibrosis, but the mechanism by which LOX is regulated and contributes to renal fibrosis remains unknown. The current study demonstrates the following: (1) LOX expression was increased in fibrotic kidneys including ischemia-reperfusion injury-(IRI-), unilateral ureteral obstruction-(UUO-), and folic acid- (FA-) induced fibrotic kidneys as well as in the paraffin-embedded sections of human kidneys from the patients with renal fibrosis. (2) The increasing deposition and cross-linking of collagen induced by LOX was observed in IRI-, UUO- and FA-kidneys. (3) LOX was regulated by the beta-arrestin-ERK-STAT3 pathway in renal fibrosis. STAT3 was the downstream of AT1R-beta-arrestin-ERK, ERK entered the nucleus and activated STAT3-pY705 but not STAT3-pS727. (4) STAT3 nuclear subtranslocation and binding to the LOX promoter may be responsible for the upregulation of LOX expression. (5) Pharmacologic inhibition of LOX with BAPN in vivo inhibited the upregulation of LOX, decreased collagen over cross-linking and ameliorated renal fibrosis after ischemic injury. Collectively, these observations suggest that LOX plays an essential role in the development of renal fibrosis by catalyzing collagen over cross-linking. Thus, strategies targeting LOX could be a new avenue in developing therapeutics against renal fibrosis.	[Zhang, Xiaoqin; Zhou, Wenqian; Niu, Yangyang; Zhu, Saiya; Zhang, Yingying; Yu, Chen] Tongji Univ, Shanghai Tongji Hosp, Dept Nephrol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Li, Xiaogang] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Li, Xiaogang] Mayo Clin, Dpartment Biochem & Mol Biol, Rochester, MN USA	Tongji University; Mayo Clinic; Mayo Clinic	Yu, C (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Dept Nephrol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.	yuchen@tongji.edu.cn			Foundation for the National Institutes of Health (FNIH) [R01 DK 129241, R01 DK126662]; National Natural Science Foundation of China (NSFC) [82170696, 81873609]	Foundation for the National Institutes of Health (FNIH); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01 DK 129241 and R01 DK126662; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82170696 and 81873609	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bologna Z, 2017, BIOMOL THER, V25, P12, DOI 10.4062/biomolther.2016.165; Canelon SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166392; Chen LJ, 2019, J DRUG TARGET, V27, P790, DOI 10.1080/1061186X.2018.1550649; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberson LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124013; Eishingdrelo H, 2015, J BIOMOL SCREEN, V20, P341, DOI 10.1177/1087057114557233; Gu YJ, 2015, ACTA PHARMACOL SIN, V36, P1277, DOI 10.1038/aps.2015.74; He Weichun, 2015, Curr Pathobiol Rep, V3, P183; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Klepfish M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00480; Kumari S, 2017, INDIAN J CLIN BIOCHE, V32, P134, DOI 10.1007/s12291-016-0576-7; Li J, 2013, P NATL ACAD SCI USA, V110, P7395, DOI 10.1073/pnas.1221608110; Li LX, 2017, J CLIN INVEST, V127, P2751, DOI 10.1172/JCI90921; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell Louis M., 2006, V332, P3; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Nguyen XX, 2021, AM J PHYSIOL-LUNG C, V320, pL29, DOI 10.1152/ajplung.00173.2020; Niu YY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2404-5; Papachroni KK, 2010, J CELL MOL MED, V14, P2460, DOI 10.1111/j.1582-4934.2009.00841.x; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saatci O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16199-4; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan L, 2018, J MED CHEM, V61, P9841, DOI 10.1021/acs.jmedchem.8b00435; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Wang TH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010062; Wang YD, 2017, AM J PHYSIOL-RENAL, V313, pF1, DOI 10.1152/ajprenal.00588.2016; Wuest M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0609-9; Xia J, 2016, J INTEGR MED-JIM, V14, P165, DOI 10.1016/S2095-4964(16)60256-X; Xu HY, 2018, J MOL MED, V96, P97, DOI 10.1007/s00109-017-1606-5; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang CY, 2017, IMMUNOL CELL BIOL, V95, P943, DOI 10.1038/icb.2017.73; Zhang XQ, 2020, AM J NEPHROL, V51, P907, DOI 10.1159/000509381; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	50	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22427	10.1096/fj.202200573R	http://dx.doi.org/10.1096/fj.202200573R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5OB	35792886	Green Published			2022-12-28	WOS:000821160400001
J	Gerassimov, N; Crain, C; Bilyeu, C; Jacob, A; Fan, CM				Gerassimov, Nathalie; Crain, Colt; Bilyeu, Colin; Jacob, Andrew; Fan, Chen-Ming			Examining the lineage autonomous role of beta 3-integrin in muscle regeneration	FASEB JOURNAL			English	Article						differentiation; mouse; muscle stem cells; regeneration; beta 1-integrin; beta 3-integrin	GENOTYPE-PHENOTYPE CORRELATION; SATELLITE CELLS; SKELETAL-MUSCLE; GLANZMANN THROMBASTHENIA; MUSCULAR-DYSTROPHY; STEM-CELLS; INTEGRIN; DISTINCT; DEFECTS; PROGENITORS	Skeletal muscles can regenerate over the lifetime from resident muscle stem cells (MuSCs). Interactions between MuSCs and extracellular matrix (ECM) proteins are essential for muscle regeneration. The best-known receptors for ECM proteins are integrins, a family composed of twenty-some heterodimeric combinations of an alpha- and a beta-subunit. beta 1-integrin (encoded by Itgb1) is required for quiescence, proliferation, migration, and fusion of Pax7(+) MuSCs in the mouse model. beta 3-integrin (encoded by Itgb3) has been reported to be critical for the myogenic differentiation of C2C12 myoblasts, and Itgb3 germline mutant mice were shown to regenerate few if any myofibers after injury. To investigate the autonomous role of Itgb3 in the myogenic lineage in vivo, we conditionally inactivated a floxed Itgb3 allele (Itgb3(F)) by constitutive Pax7-Cre and tamoxifen-inducible Pax7-CreERT2 drivers. Unexpectedly, we found no defects in muscle regeneration in both conditional knockout models. In vitro studies using Itgb3 mutant myoblasts or RNAi knockdown of Itgb3 in myoblasts also did not reveal a role for myogenic differentiation. As beta 1- and beta 3-integrins share ECM ligands and downstream signaling effectors, we further examined Itgb3's role in a Itgb1 haploid background. Still, we found no evidence for an autonomous role of Itgb3 in muscle regeneration in vivo. Thus, while Itgb3 is critical for the differentiation of C2C12 cells, the regenerative defects reported for the Itgb3 germline mutant are not due to its role in the MuSC. We conclude that if beta 3-integrin does have a role in Pax7(+) MuSCs, it is compensated by beta 1- and/or another beta-integrin(s).	[Gerassimov, Nathalie; Crain, Colt; Bilyeu, Colin; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Crain, Colt; Fan, Chen-Ming] Johns Hopkins Univ, Dept Cell Mol & Dev Biol, Baltimore, MD USA; [Jacob, Andrew] Seraxis Inc, Germantown, MD USA	Carnegie Institution for Science; Johns Hopkins University	Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	fan@carnegiescience.edu			National Institutes of Health (NIH) [AR071976, AR072644]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: AR071976 and AR072644	Baghdadi MB, 2018, NATURE, V557, P714, DOI 10.1038/s41586-018-0144-9; Blaschuk KL, 1997, DEV BIOL, V184, P266, DOI 10.1006/dbio.1997.8527; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Boppart MD, 2019, AM J PHYSIOL-CELL PH, V317, pC629, DOI 10.1152/ajpcell.00009.2019; Bui T, 2019, CELL REP, V29, P589, DOI 10.1016/j.celrep.2019.09.004; Chamberlain J, 2006, DUCHENNE MUSCULAR DY; Csapo R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00253; Duan DS, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00248-3; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Ishii K, 2018, STEM CELL REP, V10, P568, DOI 10.1016/j.stemcr.2017.12.013; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Liu HJ, 2011, FASEB J, V25, P1914, DOI 10.1096/fj.10-170449; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; Mukund K, 2020, WIRES SYST BIOL MED, V12, DOI 10.1002/wsbm.1462; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Relaix F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20760-6; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Webster MT, 2016, CELL STEM CELL, V18, P243, DOI 10.1016/j.stem.2015.11.005; Wosczyna MN, 2018, DEV CELL, V46, P135, DOI 10.1016/j.devcel.2018.06.018; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	43	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22385	10.1096/fj.202200464	http://dx.doi.org/10.1096/fj.202200464			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2H8AQ	35734962	Green Published			2022-12-28	WOS:000814512000001
J	Hu, YX; Jin, LL; Pan, Y; Zou, J; Wang, Z				Hu, Yuexin; Jin, Liangli; Pan, Yang; Zou, Jue; Wang, Zhi			Apela gene therapy alleviates pulmonary hypertension in rats	FASEB JOURNAL			English	Article						adeno-associated virus; Apela; gene therapy; pulmonary artery hypertension	TO-MESENCHYMAL TRANSITION; ARTERIAL-HYPERTENSION; ENDOTHELIUM; MODEL; AAV	Pulmonary artery hypertension (PAH) is a common disease that threatens human health. At present, no treatment can cure PAH, and the prognosis is poor. Therefore, it is important to determine new targets for PAH treatment. Recently, a novel endogenous ligand Apela (ELABELA/Toddler/ELA32) of apelin peptide jejunum (APJ) receptor was identified as a possible PAH target. This study explored the potential effect of Apela gene therapy on rats with PAH. An AAV-ELA32 recombinant expression vector was constructed by molecular cloning. Purified adeno-associated virus (AAV) was injected into monocrotaline (MCT)-induced PAH rats via tail vein 1 and 2 weeks after modeling. Apela gene therapy significantly reduced the increased right ventricular systolic pressure and N-terminal pro-brain natriuretic peptide (NT-proBNP) in PAH rats. The results of histopathology and immunofluorescence showed that Apela gene therapy not only reduced the rate of pulmonary arteriole muscularization and media thickening in PAH rats but also inhibited the endothelial-to-mesenchymal transition of the pulmonary arteriole. Western blotting showed that Apela gene therapy up-regulated the expression of KLF2/eNOs and BMPRII/SMAD4 in pulmonary arterioles of PAH rats. Overall, the results show that Apela gene therapy can inhibit pulmonary arteriolar vascular remodeling and reduce pulmonary artery pressure in PAH rats. These effects may be related to KLF2/eNOs and BMPRII/SMAD4 signaling pathways. The apelinergic system may be a potential new target for the prevention and treatment of PAH.	[Hu, Yuexin; Jin, Liangli; Pan, Yang; Zou, Jue; Wang, Zhi] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiovasc Med, Nanjing, Peoples R China; [Hu, Yuexin; Jin, Liangli; Pan, Yang; Zou, Jue; Wang, Zhi] Nanjing Med Univ, Affiliated Nanjing Brain & Hosp, Dept Pathol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, Z (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiol, 264 Guangzhou Rd, Nanjing 210029, Peoples R China.	wangzhil977nj@126.com	Wang, Zhi/AAW-9056-2021		National Natural Science Foundation of China (NSFC) [81570365]; National Science Foundation of Jiangsu Provinve [BK20211019]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Provinve	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570365; National Science Foundation of Jiangsu Provinve, Grant/Award Number: BK20211019	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Bisserier M, 2020, REV CARDIOVASC MED, V21, P163, DOI 10.31083/j.rcm.2020.02.597; Bueno-Beti C, 2018, METHODS MOL BIOL, V1816, P233, DOI 10.1007/978-1-4939-8597-5_18; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019; Gorelova A, 2021, ANTIOXID REDOX SIGN, V34, P891, DOI 10.1089/ars.2020.8169; Hopper RK, 2016, CIRCULATION, V133, P1783, DOI 10.1161/CIRCULATIONAHA.115.020617; Jin LL, 2021, J CELL MOL MED, V25, P8537, DOI 10.1111/jcmm.16814; Kim J, 2014, MOL CELLS, V37, P196, DOI 10.14348/molcells.2014.2308; Kishimoto Y, 2015, J THORAC CARDIOV SUR, V150, P645, DOI 10.1016/j.jtcvs.2015.05.052; Kuba K, 2019, PEPTIDES, V111, P62, DOI 10.1016/j.peptides.2018.04.011; Leopold JA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050761; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2021, HEART FAIL REV, V26, P1249, DOI 10.1007/s10741-020-09957-5; Marsault E, 2019, ANN NY ACAD SCI, V1455, P12, DOI 10.1111/nyas.14123; Naso MF, 2017, BIODRUGS, V31, P317, DOI 10.1007/s40259-017-0234-5; Ozkan M, 2001, LUNG, V179, P233, DOI 10.1007/s004080000064; Pan Y, 2020, J CELL MOL MED, V24, P10382, DOI 10.1111/jcmm.15651; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Rai N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031179; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Ramos MF, 2008, TOXICOL PATHOL, V36, P311, DOI 10.1177/0192623307311402; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Schreiber CA, 2016, CURR GENE THER, V16, P349, DOI 10.2174/1566523217666161121111906; Shin K, 2018, COMPR PHYSIOL, V8, P407, DOI 10.1002/cphy.c170028; Sitbon O, 2012, EUR RESPIR REV, V21, P321, DOI 10.1183/09059180.00004812; Somani A, 2019, TRANSL RES, V210, P1, DOI 10.1016/j.trsl.2019.04.005; Soon E, 2014, AM J RESP CRIT CARE, V189, P1435, DOI 10.1164/rccm.201311-2019IM; Sunjaya Anthony P, 2019, Glob Cardiol Sci Pract, V2019, pe201915, DOI 10.21542/gcsp.2019.15; van Lieshout LP, 2019, METHODS MOL BIOL, V1950, P361, DOI 10.1007/978-1-4939-9139-6_21; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Xi Y, 2019, INT J CARDIOL, V292, P180, DOI 10.1016/j.ijcard.2019.04.089; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yun E, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8120639	36	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22431	10.1096/fj.202200266R	http://dx.doi.org/10.1096/fj.202200266R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2I4JF	35747913				2022-12-28	WOS:000814945700001
J	Wiesehofer, C; Wiesehofer, M; Dankert, JT; Chung, JJ; von Ostau, NE; Singer, BB; Wennemuth, G				Wiesehoefer, Caroline; Wiesehoefer, Marc; Dankert, Jaroslaw Thomas; Chung, Jean-Ju; von Ostau, Nicola Edith; Singer, Bernhard Bonaventura; Wennemuth, Gunther			CatSper and its CaM-like Ca2+ sensor EFCAB9 are necessary for the path chirality of sperm	FASEB JOURNAL			English	Article						4D sperm movement; capacitation; CatSper; EFCAB9; path chirality	MOUSE SPERM; TYROSINE PHOSPHORYLATION; HOLOGRAPHIC MICROSCOPY; CHANNEL; SPERMATOZOA; CALCIUM; MOTILITY; ACTIVATION; ENTRY; HYPERACTIVATION	Successful fertilization depends on sperm motility adaptation. Ejaculated and activated sperm beat symmetrically in high frequency, move linearly, and swim with clockwise chirality. After capacitation, sperm beat asymmetrically with lower amplitude and a high lateral head excursion. This motility change called hyperactivation requires CatSper activation and an increase in intracellular Ca2+. However, whether CatSper-mediated Ca2+ influx participates in controlling the swim path chirality is unknown. In this study, we show that the clockwise path chirality is preserved in mouse sperm regardless of capacitation state but is lost in the sperm either lacking the entire CatSper channel or its Ca2+ sensor EFCAB9. Pharmacological inhibition of CatSper with either mibefradil or NNC 55-0396 leads to the same loss in swim path chirality. Exposure of sperm to the recombinant N-terminal part of the zona pellucida protein 2 randomizes chirality in capacitated cells, but not in non-capacitated ones. We conclude that Ca2+ sensitive regulation of CatSper activity orchestrates clockwise swim path chirality of sperm and any substantial change, such as the physiological stimulus of zona pellucida glycoproteins, results in a loss of chirality.	[Wiesehoefer, Caroline; Wiesehoefer, Marc; Dankert, Jaroslaw Thomas; von Ostau, Nicola Edith; Singer, Bernhard Bonaventura; Wennemuth, Gunther] Univ Duisburg Essen, Dept Anat, D-45147 Essen, Germany; [Chung, Jean-Ju] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [von Ostau, Nicola Edith] Univ Hosp Essen, Dept Urol, Essen, Germany	University of Duisburg Essen; Yale University; University of Duisburg Essen	Wennemuth, G (corresponding author), Univ Duisburg Essen, Dept Anat, D-45147 Essen, Germany.	gunther.wennemuth@uk-essen.de	Dankert, Jaroslaw Thomas/GWV-8070-2022; Dankert, Jaroslaw Thomas/A-2400-2017	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Chung, Jean-Ju/0000-0001-8018-1355	Deutsche Forschungsgemeinschaft (DFG) [WE 2344/9-3]; HHS \ NIH \ National Institute of Child Health and Human Development (NICHD) [R01HD096745]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS \ NIH \ National Institute of Child Health and Human Development (NICHD)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE 2344/9-3; HHS vertical bar NIH vertical bar National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD096745	Alvarez L, 2012, J CELL BIOL, V196, P653, DOI 10.1083/jcb.201106096; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Avella MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9946; Babcock DF, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0067-3; Baibakov B, 2012, J CELL BIOL, V197, P897, DOI 10.1083/jcb.201203062; Balbach M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572735; BALTZ JM, 1988, BIOPHYS J, V54, P643, DOI 10.1016/S0006-3495(88)83000-5; Ben-Yehuda K, 2022, ADV INTELL SYST-GER, V4, DOI 10.1002/aisy.202100200; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; Caballero-Campo P, 2006, BIOL REPROD, V74, P760, DOI 10.1095/biolreprod.105.047522; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai C, 2019, GENET MED, V21, P431, DOI 10.1038/s41436-018-0064-y; Daloglu MU, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/lsa.2017.121; Dardikman-Yoffe G, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay7619; De Toni L, 2018, PROTEIN PEPTIDE LETT, V25, P446, DOI 10.2174/0929866525666180418122203; Ded L, 2020, ELIFE, V9, DOI 10.7554/eLife.62043; Di Caprio G, 2015, J BIOPHOTONICS, V8, P779, DOI 10.1002/jbio.201400093; Di Caprio G, 2014, BIOMED OPT EXPRESS, V5, P690, DOI 10.1364/BOE.5.000690; Di Caprio G, 2010, IEEE J SEL TOP QUANT, V16, P833, DOI 10.1109/JSTQE.2009.2036741; Dubey V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39523-5; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Gong A, 2021, EUR PHYS J E, V44, DOI 10.1140/epje/s10189-021-00076-z; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Ishikawa Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135418; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jikeli JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8985; Karako L., 2021, FRONT PHYS-LAUSANNE, V9, P1; KATZ DF, 1981, BIOL REPROD, V25, P785, DOI 10.1095/biolreprod25.4.785; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KNOX C, 1966, SCIENCE, V153, P989, DOI 10.1126/science.153.3739.989; Lin SY, 2021, NATURE, V595, P746, DOI 10.1038/s41586-021-03742-6; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Muschol M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199678; Nandagiri A, 2021, ELIFE, V10, DOI 10.7554/eLife.62524; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rennhack A, 2018, BRIT J PHARMACOL, V175, P3144, DOI 10.1111/bph.14355; Sanchez-Cardenas C, 2018, BIOL REPROD, V99, P1010, DOI 10.1093/biolre/ioy132; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Seifert R, 2015, EMBO J, V34, P379, DOI 10.15252/embj.201489376; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Su TW, 2016, ANIM REPROD SCI, V169, P45, DOI 10.1016/j.anireprosci.2015.12.012; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Tateno H, 2013, P NATL ACAD SCI USA, V110, P18543, DOI 10.1073/pnas.1317113110; Ramirez-Gomez HV, 2019, METHOD CELL BIOL, V151, P473, DOI 10.1016/bs.mcb.2018.12.002; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wang HF, 2021, NAT REV UROL, V18, P46, DOI 10.1038/s41585-020-00390-9; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; Yanagimachi R., 1994, P189; Zhao Y., 2021, 448910 BIORXIV	88	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22288	10.1096/fj.202101656RR	http://dx.doi.org/10.1096/fj.202101656RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O5SD	35438819	hybrid			2022-12-28	WOS:000783584900001
J	Chen, R; Ma, TB; Du, SY; Luo, JY; Zhang, H; Xu, X; Cao, ZJ; Yuan, ZQ; Sun, H; Liu, MG; Xiong, B; Shi, QH; Liu, JY				Chen, Rui; Ma, Tingbin; Du, Shiyue; Luo, Junyu; Zhang, Huan; Xu, Xuan; Cao, Zhijian; Yuan, Zhangqi; Sun, Hao; Liu, Mugen; Xiong, Bo; Shi, Qinghua; Liu, Jing Yu			Impaired fertility in 4930590J08Rik mutant male mice is associated with defective sperm energy metabolism	FASEB JOURNAL			English	Article						energy metabolism; fertility; progressive motility; sperm-egg interaction; testis-specifically expressed gene	ACROSIN ACTIVITY; MOUSE; PROTEIN; FERTILIZATION; GENES; INFERTILITY; MECHANISMS; ENVELOPE; MOTILITY; CYCLE	Testis-specifically expressed genes are important for male reproduction according to their unique expression patterns. However, the functions of most of these genes in reproduction are unclear. Here, we showed that mouse 4930590J08Rik was a testis-specifically expressed gene. 4930590J08Rik knockout mice exhibited a delay in the first wave of spermatogenesis and a reduction of cauda epididymal sperm. Furthermore, knockout spermatozoa exhibited defective acrosome reactions and decreased progressive motility, which led to impaired in vivo fertilization. Transcriptome analysis of testes revealed that most of the differentially expressed genes in knockout testes were associated with metabolic processes. 4930590J08Rik knockout sperm exhibited oxidative phosphorylation deficiency and were highly dependent on increased anaerobic glycolysis to compensate for ATP demands. Taken together, the 4930590J08Rik-disrupted mouse partially mimics the phenotypes of human asthenospermia and oligozoospermia, which provides a new model for further understanding the pathogenesis of idiopathic male infertility.	[Chen, Rui; Du, Shiyue; Luo, Junyu; Cao, Zhijian; Yuan, Zhangqi; Sun, Hao; Liu, Mugen] Huazhong Univ Sci & Technol HUST, Coll Life Sci & Technol, Wuhan, Peoples R China; [Ma, Tingbin; Xu, Xuan; Liu, Jing Yu] Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci, Shanghai, Peoples R China; [Zhang, Huan; Shi, Qinghua] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Biomed Sci & Hlth Lab Anhui Prov,Sch Basic Med Sc, Affiliated Hosp USTC 1,Div Reprod & Genet,Div Lif, Hefei, Peoples R China; [Xiong, Bo] Tongji Med Coll, Dept Forens Med, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology	Liu, JY (corresponding author), Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci, Shanghai 200031, Peoples R China.; Shi, QH (corresponding author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Biomed Sci & Hlth Lab Anhui Prov,Sch Basic Med Sc, Affiliated Hosp USTC 1,Div Reprod & Genet,Div Lif, Hefei 230027, Peoples R China.	qshi@ustc.edu.cn; liujy@ion.ac.cn			National Natural Science Foundation of China [31871262]; Shanghai Municipal Science and Technology [2018SHZDZX05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology	National Natural Science Foundation of China, Grant/Award Number: 31871262; Shanghai Municipal Science and Technology, Grant/Award Number: 2018SHZDZX05	AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Balbach M, 2020, BIOL REPROD, V103, P791, DOI 10.1093/biolre/ioaa114; Barry DM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916643724; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bracke A, 2018, REPROD BIOMED ONLINE, V36, P327, DOI 10.1016/j.rbmo.2017.12.005; Chen LG, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4769; Chen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0183-x; Chen Y, 2018, CELL RES, V28, P879, DOI 10.1038/s41422-018-0074-y; Cheng ST, 2016, EXP BIOL MED, V241, P205, DOI 10.1177/1535370215597199; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; Devlin DJ, 2020, BIOL REPROD, V103, P205, DOI 10.1093/biolre/ioaa082; Engeli KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211679; Fujihara Y, 2020, P NATL ACAD SCI USA, V117, P9393, DOI 10.1073/pnas.1917060117; Gao J, 2008, UROL INT, V81, P256, DOI 10.1159/000151400; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Hidalgo DM, 2020, MOL REPROD DEV, V87, P1037, DOI 10.1002/mrd.23421; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Kashiwabara SI, 2016, J REPROD DEVELOP, V62, P305, DOI 10.1262/jrd.2016-023; KENNEDY WP, 1989, J ANDROL, V10, P221; Kleene KC, 2013, REPRODUCTION, V146, pR1, DOI 10.1530/REP-12-0362; Krausz C, 2018, NAT REV UROL, V15, P369, DOI 10.1038/s41585-018-0003-3; Kuang WH, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109025; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lu YG, 2019, BIOL REPROD, V101, P501, DOI 10.1093/biolre/ioz103; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miwa N, 2015, MOLECULES, V20, P9468, DOI 10.3390/molecules20059468; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Noda T, 2020, P NATL ACAD SCI USA, V117, P11493, DOI 10.1073/pnas.1922650117; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Odet F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108530; Oud MS, 2017, HUM MUTAT, V38, P1592, DOI 10.1002/humu.23312; Oyama Y, 2022, ASIAN J ANDROL, V24, P266, DOI 10.4103/aja.aja_63_21; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Robertson MJ, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00826-z; Rydell-Tormanen K, 2019, METHODS MOL BIOL, V1940, P3, DOI 10.1007/978-1-4939-9086-3_1; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shahrokhi SZ, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13463; Shang X, 2018, CELL MOL LIFE SCI, V75, P4371, DOI 10.1007/s00018-018-2878-9; Shen CL, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107086; Shu FP, 2015, J ASSIST REPROD GEN, V32, P1643, DOI 10.1007/s10815-015-0548-5; Sreedhar A, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800353; Sreedhar A, 2017, ONCOTARGET, V8, P95504, DOI 10.18632/oncotarget.20762; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Taft Robert, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094508; Takasaki N, 2014, P NATL ACAD SCI USA, V111, P1120, DOI 10.1073/pnas.1310777111; Wang GF, 2015, CRYOBIOLOGY, V71, P464, DOI 10.1016/j.cryobiol.2015.08.016; Wang XN, 2018, CELL PHYSIOL BIOCHEM, V50, P952, DOI 10.1159/000494479; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Xiong WF, 2019, MOL REPROD DEV, V86, P935, DOI 10.1002/mrd.23180; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhao K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8327506; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	62	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22634	10.1096/fj.202200805RR	http://dx.doi.org/10.1096/fj.202200805RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5X6WQ	36331537				2022-12-28	WOS:000878740300001
J	Gaulton, N; Wakelin, G; Young, LV; Wotherspoon, S; Kamal, M; Parise, G; Nederveen, JP; Holwerda, A; Verdijk, LB; van Loon, LJC; Snijders, T; Johnston, AP				Gaulton, Nick; Wakelin, Griffen; Young, Laura V.; Wotherspoon, Scott; Kamal, Michael; Parise, Gianni; Nederveen, Joshua P.; Holwerda, Andy; Verdijk, Lex B.; van Loon, Luc J. C.; Snijders, Tim; Johnston, Adam P.			Twist2-expressing cells reside in human skeletal muscle and are responsive to aging and resistance exercise training	FASEB JOURNAL			English	Article						aging; progenitor cells; sarcopenia; skeletal muscle; Twist2	SATELLITE CELLS; STEM-CELLS	Skeletal muscle is maintained and repaired by sub-laminar, Pax7-expressing satellite cells. However, recent mouse investigations have described a second myogenic progenitor population that resides within the myofiber interstitium and expresses the transcription factor Twist2. Twist2-expressing cells exclusively repair and maintain type IIx/b muscle fibers. Currently, it is unknown if Twist2-expressing cells are present in human skeletal muscle and if they function as myogenic progenitors. Here, we perform a combination of single-cell RNA sequencing analysis and immunofluorescence staining to demonstrate the identity and localization of Twist2-expressing cells in human skeletal muscle. Twist2-expressing cells were identified to be anatomically and transcriptionally comparable to fibro-adipogenic progenitors (FAPs) and lack expression of typical satellite cell markers such as Pax7. Comparative analysis revealed that human and mouse Twist2-expressing cells were highly transcriptionally analogous and resided within the same anatomical structures in vivo. Examination of young and aged skeletal muscle biopsy samples revealed that Twist2-positive cells are more prevalent in aged muscle and increase following 12-weeks of resistance exercise training (RET) in humans. However, the quantity of Twist2-positive cells was not correlated with indices of muscle mass or muscle fiber cross-sectional area (CSA) in young or older muscle, and their abundance was surprisingly, negatively correlated with CSA and myonuclear domain size following RET. Taken together, we have identified cells expressing Twist2 in human skeletal muscle which are responsive to aging and exercise. Further examination of their myogenic potential is warranted.	[Gaulton, Nick; Wakelin, Griffen; Young, Laura V.; Johnston, Adam P.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE, Canada; [Wakelin, Griffen; Johnston, Adam P.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada; [Wotherspoon, Scott] Queen Elizabeth Hosp, Charlottetown, PE, Canada; [Kamal, Michael; Parise, Gianni] McMaster Univ, Fac Sci, Dept Kinesiol, Hamilton, ON, Canada; [Nederveen, Joshua P.] McMaster Univ, Dept Pediat, Childrens Hosp, Hamilton, ON, Canada; [Holwerda, Andy; Verdijk, Lex B.; van Loon, Luc J. C.; Snijders, Tim] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands	University of Prince Edward Island; Dalhousie University; McGill University; McMaster University; McMaster University; Maastricht University	Johnston, AP (corresponding author), Life Sci Res Inst, Brain Repair Ctr, Dept Med Neurosci, 1348 Summer St, Halifax, NS B3H 4R2, Canada.	adamjohnston@dal.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05747]; USRA; Naomi Cermac Grant	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); USRA; Naomi Cermac Grant	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-2016-05747 and USRA; Naomi Cermac Grant	Alasdair C., 2022, AM J PHYSIOL-CELL PH, DOI [10.1152/ajpcell.00364.2022, DOI 10.1152/AJPCELL.00364.2022]; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen W, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200048; Dalle S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01045; De Micheli AJ, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00236-3; Fragala MS, 2019, J STRENGTH COND RES, V33, P2019, DOI 10.1519/JSC.0000000000003230; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Hepple RT, 2016, J PHYSIOL-LONDON, V594, P1965, DOI 10.1113/JP270561; Holwerda AM, 2018, J NUTR, V148, P1723, DOI 10.1093/jn/nxy169; Joanisse S, 2017, GERONTOLOGY, V63, P91, DOI 10.1159/000450922; Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Li S, 2019, DEV CELL, V51, P89, DOI 10.1016/j.devcel.2019.08.002; Li S, 2019, GENE DEV, V33, P626, DOI 10.1101/gad.324467.119; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; McKendry J, 2021, COMPR PHYSIOL, V11, P2249, DOI 10.1002/cphy.c200029; Mcleod JC, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00645; Moore DR, 2018, J CACHEXIA SARCOPENI, V9, P747, DOI 10.1002/jcsm.12306; Morton RW, 2018, CURR OPIN CRIT CARE, V24, P124, DOI 10.1097/MCC.0000000000000488; Murach KA, 2019, J APPL PHYSIOL, V127, P1632, DOI 10.1152/japplphysiol.00624.2019; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Snijders T, 2019, J PHYSIOL-LONDON, V597, P105, DOI 10.1113/JP276260; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Sousa-Victor P, 2014, CELL CYCLE, V13, P3183, DOI 10.4161/15384101.2014.965072; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050	32	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22642	10.1096/fj.202201349RR	http://dx.doi.org/10.1096/fj.202201349RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6D9SJ	36374263				2022-12-28	WOS:000883024500001
J	Matsumura, S; Miyakita, M; Miyamori, H; Kyo, S; Ishikawa, F; Sasaki, T; Jinno, T; Tanaka, J; Fujita, K; Yokokawa, T; Goto, T; Momma, K; Takenaka, S; Inoue, K				Matsumura, Shigenobu; Miyakita, Motoki; Miyamori, Haruka; Kyo, Satomi; Ishikawa, Fuka; Sasaki, Tsutomu; Jinno, Tomoki; Tanaka, Jin; Fujita, Kotomi; Yokokawa, Takumi; Goto, Tsuyoshi; Momma, Keiko; Takenaka, Shigeo; Inoue, Kazuo			CRTC1 deficiency, specifically in melanocortin-4 receptor-expressing cells, induces hyperphagia, obesity, and insulin resistance	FASEB JOURNAL			English	Article						high-fat diet; melanocortins; obesity; transcription factors	COACTIVATOR CRTC1; CREB; ACTIVATION; PROMOTERS; MUTATIONS; TRANSPORT; GLUCOSE; FAMILY; ACID; GENE	Melanocortin-4 receptor (MC4R) is a critical regulator of appetite and energy expenditure in rodents and humans. MC4R deficiency causes hyperphagia, reduced energy expenditure, and impaired glucose metabolism. Ligand binding to MC4R activates adenylyl cyclase, resulting in increased levels of intracellular cyclic adenosine monophosphate (cAMP), a secondary messenger that regulates several cellular processes. Cyclic adenosine monophosphate responsive element-binding protein-1-regulated transcription coactivator-1 (CRTC1) is a cytoplasmic coactivator that translocates to the nucleus in response to cAMP and is reportedly involved in obesity. However, the precise mechanism through which CRTC1 regulates energy metabolism remains unknown. Additionally, there are no reports linking CRTC1 and MC4R, although both CRTC1 and MC4R are known to be involved in obesity. Here, we demonstrate that mice lacking CRTC1, specifically in MC4R cells, are sensitive to high-fat diet (HFD)-induced obesity and exhibit hyperphagia and increased body weight gain. Moreover, the loss of CRTC1 in MC4R cells impairs glucose metabolism. MC4R-expressing cell-specific CRTC1 knockout mice did not show changes in body weight gain, food intake, or glucose metabolism when fed a normal-chow diet. Thus, CRTC1 expression in MC4R cells is required for metabolic adaptation to HFD with respect to appetite regulation. Our results revealed an important protective role of CRTC1 in MC4R cells against dietary adaptation.	[Matsumura, Shigenobu; Miyakita, Motoki; Miyamori, Haruka; Ishikawa, Fuka; Jinno, Tomoki; Tanaka, Jin; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto, Japan; [Matsumura, Shigenobu; Fujita, Kotomi; Takenaka, Shigeo] Osaka Metropolitan Univ, Dept Nutr, 3-7-30 Habikino, Osaka 5838555, Japan; [Kyo, Satomi; Momma, Keiko] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan; [Sasaki, Tsutomu] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan	Kyoto University; Osaka Metropolitan University; Kyoto Womens University; Osaka University	Matsumura, S (corresponding author), Osaka Metropolitan Univ, Dept Nutr, 3-7-30 Habikino, Osaka 5838555, Japan.	smatsumura@omu.ac.jp		Matsumura, Shigenobu/0000-0002-7149-1375	JSPS [19H02909, 18K19174]; Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	JSPS, Grant/Award Number: 19H02909 and 18K19174; Sugiyama Sangyo-Kagaku General Incorporated Foundation; Takeda Life Science Foundation	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baldini G, 2019, J ENDOCRINOL, V241, pR1, DOI 10.1530/JOE-18-0596; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Belgacem YH, 2017, ADV EXP MED BIOL, V1015, P19, DOI 10.1007/978-3-319-62817-2_2; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Gannon NP, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700756; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Grill HJ, 1998, J NEUROSCI, V18, P10128; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Li C, 2021, MOL PSYCHIATR, V26, P3701, DOI 10.1038/s41380-020-00922-0; Li L, 2017, MOL BIOSYST, V13, P2392, DOI 10.1039/c7mb00167c; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mann G, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.702826; Matsumura S, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab076; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Di Bonaventura EM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113502; Mitchell CS, 2021, J NEUROENDOCRINOL, V33, DOI 10.1111/jne.12952; Moghei M, 2016, AM J PHYSIOL-CELL PH, V311, pC518, DOI 10.1152/ajpcell.00062.2016; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Muller TD, 2021, NAT METAB, V3, P1134, DOI 10.1038/s42255-021-00451-2; Nibuya M, 1996, J NEUROSCI, V16, P2365; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Pan Y, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109398; Panaro BL, 2013, P NATL ACAD SCI USA, V110, P7050, DOI 10.1073/pnas.1304707110; Parra-Damas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18215-y; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Podyma B, 2018, J BIOL CHEM, V293, P10993, DOI 10.1074/jbc.RA118.003450; Ravnskjaer K, 2016, HANDB EXP PHARMACOL, V233, P29, DOI 10.1007/164_2015_32; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sharma S., 2019, MOL BASEL SWITZERLAN, V24; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tan K, 2009, ENDOCRINOLOGY, V150, P114, DOI 10.1210/en.2008-0721; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van der Klaauw AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13055; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Xia GB, 2021, MOL PSYCHIATR, V26, P2837, DOI 10.1038/s41380-021-01053-w; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Zhang WB, 2020, NEUROREPORT, V31, P1007, DOI 10.1097/WNR.0000000000001508	47	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22645	10.1096/fj.202200617R	http://dx.doi.org/10.1096/fj.202200617R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Z7VW	36349991				2022-12-28	WOS:000880177400001
J	Kim, H; Osaki, T; Kamm, RD; Asada, HH				Kim, Hyeonyu; Osaki, Tatsuya; Kamm, Roger D.; Asada, H. Harry			Tri-culture of spatially organizing human skeletal muscle cells, endothelial cells, and fibroblasts enhances contractile force and vascular perfusion of skeletal muscle tissues	FASEB JOURNAL			English	Article						angiogenesis; extracellular matrix; skeletal muscle tissue; tri-culture; vascularization	STIFFNESS; MODEL	Constructing engineered human skeletal muscle tissues that resemble the function and microstructure of human skeletal muscles is key to utilizing them in a variety of applications such as drug development, disease modeling, regenerative medicine, and engineering biological machines. However, current in vitro skeletal muscle tissues are far inferior to native muscles in terms of contractile function and lack essential cues for muscle functions, particularly heterotypic cell-cell interactions between myoblasts, endothelial cells, and fibroblasts. Here, we develop an engineered muscle tissue with a coaxial three-layered tubular structure composed of an inner endothelial cell layer, an endomysium-like layer with fibroblasts in the middle, and an outer skeletal muscle cell layer, similar to the architecture of native skeletal muscles. Engineered skeletal muscle tissues with three spatially organized cell types produced thicker myotubes and lowered Young's modulus through extracellular matrix remodeling, resulting in 43% stronger contractile force. Furthermore, we demonstrated that fibroblasts localized in the endomysium layer induced angiogenic sprouting of endothelial cells into the muscle layer more effectively than fibroblasts homogeneously distributed in the muscle layer. This layered tri-culture system enables a structured spatial configuration of the three main cell types of skeletal muscle and promotes desired paracrine signaling, resulting in improved angiogenesis and increased contractile force. This research offers new insights to efficiently obtain new human skeletal muscle models, transplantable tissues, and actuators for biological machines.	[Kim, Hyeonyu; Osaki, Tatsuya; Kamm, Roger D.; Asada, H. Harry] MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kamm, Roger D.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kim, Hyeonyu] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Kim, Hyeonyu] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Osaki, Tatsuya] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health	Kim, H (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Kim, H (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	hyeonyu@stanford.edu		Kim, Hyeonyu/0000-0002-1303-9954; Osaki, Tatsuya/0000-0001-7174-0629	National Science Foundation (NSF) [CBET--0939511, CMMI--1762961]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	National Science Foundation (NSF), Grant/Award Number: CBET--0939511 and CMMI--1762961	Aydin O, 2019, P NATL ACAD SCI USA, V116, P19841, DOI 10.1073/pnas.1907051116; Bersini S, 2018, CELL REP, V25, P3858, DOI 10.1016/j.celrep.2018.11.092; Bogdanowicz DR, 2013, BIOTECHNOL J, V8, P395, DOI 10.1002/biot.201300054; Carlsen RW, 2014, SMALL, V10, P3831, DOI 10.1002/smll.201400384; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chapman MA, 2016, DIFFERENTIATION, V92, P108, DOI 10.1016/j.diff.2016.05.007; Duong H, 2009, TISSUE ENG PT A, V15, P1865, DOI 10.1089/ten.tea.2008.0319; Elashry MI, 2012, J ANAT, V220, P603, DOI 10.1111/j.1469-7580.2012.01503.x; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Feng ZG, 2014, BIOMATERIALS, V35, P8078, DOI 10.1016/j.biomaterials.2014.05.072; Gholobova D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30123-3; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Han YL, 2018, P NATL ACAD SCI USA, V115, P4075, DOI 10.1073/pnas.1722619115; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P319, DOI 10.1016/B978-0-12-370469-6.00012-X; Hicks MR, 2012, J APPL PHYSIOL, V113, P465, DOI 10.1152/japplphysiol.01545.2011; Kamm RD, 2018, APL BIOENG, V2, DOI 10.1063/1.5038337; Kim H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39522-6; Laschi C, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aah3690; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Lindner D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875742; Maffioletti SM, 2018, CELL REP, V23, P899, DOI 10.1016/j.celrep.2018.03.091; Morrow DA, 2010, J MECH BEHAV BIOMED, V3, P124, DOI 10.1016/j.jmbbm.2009.03.004; Neal D, 2015, TISSUE ENG PT A, V21, P1848, DOI [10.1089/ten.tea.2014.0317, 10.1089/ten.TEA.2014.0317]; Neal D, 2014, LAB CHIP, V14, P1907, DOI 10.1039/c4lc00023d; Osaki T, 2018, BIOMATERIALS, V156, P65, DOI 10.1016/j.biomaterials.2017.11.041; Perry L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0161-0; Raman R, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700030; Raman R, 2016, P NATL ACAD SCI USA, V113, P3497, DOI 10.1073/pnas.1516139113; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Ricotti L, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aaq0495; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Sun WJ, 2019, ADV SCI, V6, DOI 10.1002/advs.201801039; Takahashi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32163-1; Torisawa YS, 2009, INTEGR BIOL-UK, V1, P649, DOI 10.1039/b915965g; Williams BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4081; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	36	1	1	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22453	10.1096/fj.202200500R	http://dx.doi.org/10.1096/fj.202200500R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X9IO	35838893	Green Published			2022-12-28	WOS:000825510700001
J	Batan, D; Peters, DK; Schroeder, ME; Aguado, BA; Young, MW; Weiss, RM; Anseth, KS				Batan, Dilara; Peters, Douglas K.; Schroeder, Megan E.; Aguado, Brian A.; Young, Mark W.; Weiss, Robert M.; Anseth, Kristi S.			Hydrogel cultures reveal Transient Receptor Potential Vanilloid 4 regulation of myofibroblast activation and proliferation in valvular interstitial cells	FASEB JOURNAL			English	Article						aortic valve disease; calcium signaling; fibrosis; hydrogels; transient receptor potential channels	AORTIC-VALVE STENOSIS; ION-CHANNEL; TRPV4; MECHANOTRANSDUCTION; DIFFERENTIATION; ELASTICITY; MECHANISMS; PHENOTYPES; RISK	As aortic valve stenosis develops, valve tissue becomes stiffer. In response to this change in environmental mechanical stiffness, valvular interstitial cells (VICs) activate into myofibroblasts. We aimed to investigate the role of mechanosensitive calcium channel Transient Receptor Potential Vanilloid type 4 (TRPV4) in stiffness induced myofibroblast activation. We verified TRPV4 functionality in VICs using live calcium imaging during application of small molecule modulators of TRPV4 activity. We designed hydrogel biomaterials that mimic mechanical features of healthy or diseased valve tissue microenvironments, respectively, to investigate the role of TRPV4 in myofibroblast activation and proliferation. Our results show that TRPV4 regulates VIC proliferation in a microenvironment stiffness-independent manner. While there was a trend toward inhibiting myofibroblast activation on soft microenvironments during TRPV4 inhibition, we observed near complete deactivation of myofibroblasts on stiff microenvironments. We further identified Yes-activated protein (YAP) as a downstream target for TRPV4 activity on stiff microenvironments. Mechanosensitive TRPV4 channels regulate VIC myofibroblast activation, whereas proliferation regulation is independent of the microenvironmental stiffness. Collectively, the data suggests differential regulation of stiffness-induced proliferation and myofibroblast activation. Our data further suggest a regulatory role for TRPV4 regarding YAP nuclear localization. TRPV4 is an important regulator for VIC myofibroblast activation, which is linked to the initiation of valve fibrosis. Although more validation studies are necessary, we suggest TRPV4 as a promising pharmaceutical target to slow aortic valve stenosis progression.	[Batan, Dilara; Peters, Douglas K.; Schroeder, Megan E.; Aguado, Brian A.; Young, Mark W.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA; [Batan, Dilara] Univ Colorado, Dept Biochem, Boulder, CO 80303 USA; [Peters, Douglas K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80303 USA; [Schroeder, Megan E.; Aguado, Brian A.; Young, Mark W.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Jennie Smoly Caruthers Biotechnol Bldg, Boulder, CO 80303 USA; [Weiss, Robert M.] Univ Iowa, Div Cardiovasc Med, Iowa City, IA USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Iowa	Anseth, KS (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Jennie Smoly Caruthers Biotechnol Bldg, Boulder, CO 80303 USA.	kristi.anseth@colorado.edu			National Science Foundation (NSF) [DGE 1650115]; American Heart Association [20PRE35200068, 18IPA34170040]; NIH [R01 AI151636, F32 HL137256, K99 HL148542, T32 HL007822, R01 HL142935, RO1 HL132353]; Burroughs Wellcome Fund	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	National Science Foundation (NSF), Grant/Award Number: DGE 1650115; American Heart Association, Grant/ Award Number: 20PRE35200068 and 18IPA34170040; NIH, Grant/Award Number: R01 AI151636, F32 HL137256, K99 HL148542, T32 HL007822, R01 HL142935, R01 HL142935 and RO1 HL132353; Burroughs Wellcome Fund	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Aguado BA, 2022, CIRCULATION, V145, P513, DOI 10.1161/CIRCULATIONAHA.121.054108; Aguado BA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3233; Al-Shammari H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240532; Baratchi S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00006; Brown TE, 2018, J AM CHEM SOC, V140, P11585, DOI 10.1021/jacs.8b07551; Castella LF, 2010, EXP CELL RES, V316, P2390, DOI 10.1016/j.yexcr.2010.04.033; Cheung M, 2017, ACS MED CHEM LETT, V8, P549, DOI 10.1021/acsmedchemlett.7b00094; Cobbaut M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010151; Duscher D, 2014, J BIOMECH, V47, P1997, DOI 10.1016/j.jbiomech.2014.03.031; Gilchrist CL, 2019, P NATL ACAD SCI USA, V116, P1992, DOI 10.1073/pnas.1811095116; Goody PR, 2020, ARTERIOSCL THROM VAS, V40, P885, DOI 10.1161/ATVBAHA.119.313067; Goyal N, 2019, AM J CARDIOVASC DRUG, V19, P335, DOI 10.1007/s40256-018-00320-6; Grim JC, 2020, ARTERIOSCL THROM VAS, V40, pE296, DOI 10.1161/ATVBAHA.120.315261; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Hu Fen, 2019, Biophysics Reports, V5, P254, DOI 10.1007/s41048-019-00100-y; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; Ji CF, 2021, FEBS J, V288, P5867, DOI 10.1111/febs.15665; Jia J, 2016, ACTA BIOMATER, V45, P110, DOI 10.1016/j.actbio.2016.09.006; Jia XL, 2020, CARDIOVASC TOXICOL, V20, P492, DOI 10.1007/s12012-020-09572-8; Jones JL, 2019, CARDIOVASC RES, V115, P46, DOI 10.1093/cvr/cvy156; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Killaars AR, 2020, P NATL ACAD SCI USA, V117, P21258, DOI 10.1073/pnas.2006765117; Kuehlmann B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051423; Lee HP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08465-x; Lee WH, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.39; Li XC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03181-7; Liang FX, 2020, LANCET, V396, P600, DOI 10.1016/S0140-6736(20)30624-3; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Ma H, 2020, MACROMOL BIOSCI, V20, DOI 10.1002/mabi.202000268; Ma H, 2017, BIOMATERIALS, V131, P131, DOI 10.1016/j.biomaterials.2017.03.040; Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; Mohan ML., 2019, SCI SIGNAL, V12, P1; Nakazawa J, 2012, J AM CHEM SOC, V134, P2750, DOI 10.1021/ja210400u; Okada Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167200; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Randhawa PK, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0512-7; Sava P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96352; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Sharma S, 2019, CELL MOL BIOENG, V12, P139, DOI 10.1007/s12195-018-00565-w; Sharma S, 2019, J CELL MOL MED, V23, P761, DOI 10.1111/jcmm.13972; Sharma S, 2017, AM J PHYSIOL-CELL PH, V312, pC562, DOI 10.1152/ajpcell.00187.2016; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101179; Tang SC, 2018, ADV SCI, V5, DOI 10.1002/advs.201800638; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thoppil RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14257; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Pinto MCX, 2015, CELL SIGNAL, V27, P2139, DOI 10.1016/j.cellsig.2015.08.006; Xu SW, 2016, ONCOTARGET, V7, P37622, DOI 10.18632/oncotarget.9376; Yue ZC, 2013, CURR TOP MED CHEM, V13, P270; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zhan L, 2018, GENE, V642, P1, DOI 10.1016/j.gene.2017.10.067; Zhao YL, 2018, MOL CANCER RES, V16, P1046, DOI 10.1158/1541-7786.MCR-17-0593	60	2	2	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22306	10.1096/fj.202101863R	http://dx.doi.org/10.1096/fj.202101863R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0L0HF	35385164				2022-12-28	WOS:000781165100001
J	Qian, FH; Arner, BE; Kelly, KM; Annageldiyev, C; Sharma, A; Claxton, DF; Paulson, RF; Prabhu, KS				Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Annageldiyev, Charyguly; Sharma, Arati; Claxton, David F.; Paulson, Robert F.; Prabhu, K. Sandeep			Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia	FASEB JOURNAL			English	Article						AML; H-PGDS; IL-4; PPAR gamma; prostaglandin	CHRONIC LYMPHOCYTIC-LEUKEMIA; ENDOTHELIAL GROWTH-FACTOR; CANCER-CELLS; HODGKIN-LYMPHOMA; BREAST-CANCER; PPAR-GAMMA; APOPTOSIS; LIGAND; EXPRESSION; ACTIVATION	Interleukin-4 (IL-4) is a signature cytokine pivotal in Type 2 helper T cell (Th2) immune response, particularly in allergy and hypersensitivity. Interestingly, IL-4 increases endogenous levels of prostaglandin D-2 (PGD(2)) and its metabolites, Delta(12)-prostaglandin J(2) (Delta(12)-PGJ(2)) and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), collectively called cyclopentenone PGs (CyPGs). However, the therapeutic role of IL-4 in hematologic malignancies remains unclear. Here, we employed a murine model of acute myeloid leukemia (AML), where human MLL-AF9 fusion oncoprotein was expressed in hematopoietic progenitor cells, to test the effect of IL-4 treatment in vivo. Daily intraperitoneal treatment with IL-4 at 60 mu g/kg/d significantly alleviated the severity of AML, as seen by decreased leukemia-initiating cells (LICs). The effect of IL-4 was mediated, in part, by the enhanced expression of hematopoietic- PGD(2) synthase (H-PGDS) to effect endogenous production of CyPGs, through autocrine and paracrine signaling mechanisms. Similar results were seen with patient-derived AML cells cultured ex vivo with IL-4. Use of GW9662, a peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist, suggested endogenous CyPGs-PPAR gamma axis mediated p53-dependent apoptosis of LICs by IL-4. Taken together, our results reveal a beneficial role of IL-4 treatment in AML suggesting a potential therapeutic regimen worthy of clinical trials in patients with AML.	[Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Kelly, Kathleen M.] Penn State Univ, Dept Vet & Biomed Sci, Mammalian Pathol Sect, Anim Diagnost Lab, University Pk, PA 16802 USA; [Annageldiyev, Charyguly; Sharma, Arati; Claxton, David F.] Penn State Univ, Penn State Canc Inst, Div Hematol & Oncol, Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Paulson, RF; Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	rfp5@psu.edu; ksprabhu@psu.edu			USDA \ National Institute of Food and Agriculture (NIFA) [4771]	USDA \ National Institute of Food and Agriculture (NIFA)	HHS vertical bar| National Institutes of Health (NIH), Grant/Award Number: DK077152; USDA vertical bar National Institute of Food and Agriculture (NIFA), Grant/Award Number: 4771	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; AKASHI K, 1991, J CLIN INVEST, V88, P223, DOI 10.1172/JCI115281; AKASHI K, 1993, LEUKEMIA LYMPHOMA, V9, P205, DOI 10.3109/10428199309147371; Bankaitis KV, 2015, CLIN EXP METASTAS, V32, P847, DOI 10.1007/s10585-015-9747-9; Barrett AJ, 2020, BRIT J HAEMATOL, V188, P147, DOI 10.1111/bjh.16310; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; DEFRANCE T, 1992, BLOOD, V79, P990; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; Finch ER, 2015, CANCER PREV RES, V8, P989, DOI 10.1158/1940-6207.CAPR-15-0050; Food and Drug Administration, 2005, CTR DRUG EVAL RES CD, V7; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; GIVON T, 1992, BLOOD, V79, P2392; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; Hegde S, 2011, BLOOD, V118, P6909, DOI 10.1182/blood-2010-11-317750; HERRMANN F, 1991, BLOOD, V78, P2070; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; JANSEN JH, 1993, LEUKEMIA, V7, P643; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Joukov V, 1996, EMBO J, V15, P290; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kawakami M, 2005, BLOOD, V105, P3707, DOI 10.1182/blood-2004-08-3216; Kim EH, 2008, CARCINOGENESIS, V29, P688, DOI 10.1093/carcin/bgm299; Kim S, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01839-4; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kudva AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080622; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin J, 2001, BRIT J HAEMATOL, V112, P155, DOI 10.1046/j.1365-2141.2001.02525.x; LUO HY, 1991, J IMMUNOTHER, V10, P418, DOI 10.1097/00002371-199112000-00005; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; Martinez PEP., 2014, BLOOD, V124, P2146; McKenna HJ, 1996, EXP HEMATOL, V24, P378; Mitchell K, 2018, J EXP MED, V215, P1709, DOI 10.1084/jem.20180147; Narayan N, 2017, LEUKEMIA, V31, P808, DOI 10.1038/leu.2016.279; Narayan N, 2018, EXP HEMATOL, V62, P1, DOI 10.1016/j.exphem.2018.03.007; Norris D., 2008, WHO CLASSIFICATION T, V2; Pena-Martinez P, 2018, LEUKEMIA, V32, P588, DOI 10.1038/leu.2017.261; PURI RK, 1994, INT J CANCER, V58, P574, DOI 10.1002/ijc.2910580421; Qian FH, 2019, CRIT REV BIOCHEM MOL, V54, P484, DOI 10.1080/10409238.2020.1717430; Scavelli C, 2004, LEUKEMIA, V18, P1054, DOI 10.1038/sj.leu.2403355; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shay AE, 2017, J BIOL CHEM, V292, P14544, DOI 10.1074/jbc.M117.785014; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Tao M, 2001, LEUKEMIA LYMPHOMA, V41, P161, DOI 10.3109/10428190109057966; URADE Y, 1987, J BIOL CHEM, V262, P3820; Venmar KT, 2014, CANCER RES, V74, P4329, DOI 10.1158/0008-5472.CAN-14-0093; Volkert S, 2014, GENE CHROMOSOME CANC, V53, P402, DOI 10.1002/gcc.22151; Wang R, 2020, CANCER LETT, V469, P151, DOI 10.1016/j.canlet.2019.10.032; Wiernik PH, 2010, J IMMUNOTHER, V33, P1006, DOI 10.1097/CJI.0b013e3181f5dfc5; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	56	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22328	10.1096/fj.202200251R	http://dx.doi.org/10.1096/fj.202200251R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KS	35471732				2022-12-28	WOS:000787349100001
J	Li, CH; Peng, X; Peng, ZY; Yan, B				Li, Chenghui; Peng, Xiang; Peng, Zhiyong; Yan, Bin			circBGN accelerates gastric cancer cell proliferation and invasion via activating IL6/STAT3 signaling pathway	FASEB JOURNAL			English	Article						circBGN; circular RNA; gastric cancer; IL6; STAT3; miR-149-5p	METASTASIS; MIR-149; GROWTH; STAT3	Circular RNAs participate in the pathogenesis of various tumors, including gastric cancer (GC). In this study, we investigated the role of circBGN in regulating proliferation and invasion of GC cells and elucidated the mechanism. The expression of circBGN was assessed by quantitative reverse-transcription PCR and in situ hybridization. In addition, loss- and gain-of-function investigations in vitro and in vivo were performed to determine the biological functions of circBGN. Luciferase reporter assays and rescue experiments were applied to investigate the interaction between circBGN and miR-149-5p as well as the relationship between miR-149-5p and IL6. Our results showed that circBGN expression was significantly elevated in GC tissues and cells. Knockdown of circBGN dramatically suppressed GC cell proliferation and invasion in vitro. Xenograft experiments revealed that knockdown of circBGN delayed tumor growth in vivo. Furthermore, circBGN can directly bind to miR-149-5p, thereby preventing miR-149-5p from binding to its target mRNA [IL6 mRNA], thus activating IL6/STAT3 signaling pathway. Rescue assays indicated that circBGN regulates GC cell proliferation and invasion by upregulating miR-149-5p/IL6 axis output. Taken together, our investigation indicates that circBGN supports GC progression by activating IL6/STAT3 signaling pathway, thus pointing to a new possible therapeutic target in GC.	[Li, Chenghui; Peng, Xiang; Peng, Zhiyong; Yan, Bin] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Gen Surg, 1158 Gongyuan Dong Rd, Shanghai 201700, Peoples R China	Fudan University	Yan, B (corresponding author), Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Gen Surg, 1158 Gongyuan Dong Rd, Shanghai 201700, Peoples R China.	yanbin7506@163.com			Shanghai Municipal Health Commission [201840069]	Shanghai Municipal Health Commission	Shanghai Municipal Health Commission, Grant/Award Number: 201840069	Chen SM, 2021, RES VET SCI, V136, P25, DOI 10.1016/j.rvsc.2021.01.024; Fang YT, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705850; Fu XL, 2017, CANCER IMMUNOL IMMUN, V66, P1597, DOI 10.1007/s00262-017-2052-5; Ghafouri-Fard S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010415; Ham IH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0972-8; Jin DC, 2021, MOL THER-NUCL ACIDS, V26, P360, DOI 10.1016/j.omtn.2021.05.021; Kaneva MK, 2021, FASEB J, V35, DOI 10.1096/fj.202001801R; Kim KW, 2021, GASTRIC CANCER, V24, P844, DOI 10.1007/s10120-021-01163-y; Li P, 2015, CELL RES, V25, P588, DOI 10.1038/cr.2015.51; Li R, 2020, CELL MOL LIFE SCI, V77, P1661, DOI 10.1007/s00018-019-03345-5; Ma CY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01268-5; Rau B, 2020, GASTRIC CANCER, V23, P11, DOI 10.1007/s10120-019-00978-0; Rong DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0958-6; Sanchez-Gonzalez I, 2020, CANCER RES, V80, P1330, DOI 10.1158/0008-5472.CAN-19-1934; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tu S, 2021, FASEB J, V35, DOI 10.1096/fj.202002402R; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wang LY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12981; Wang ST, 2022, ENVIRON TOXICOL, V37, P1597, DOI 10.1002/tox.23509; Wang XY, 2020, BIOCHEM BIOPH RES CO, V532, P329, DOI 10.1016/j.bbrc.2020.05.135; Wang XL, 2022, J EXP CLIN CANC RES, V41, DOI 10.1186/s13046-022-02432-z; Yang R, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01567-z; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Zang XY, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01606-9; Zhang X, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0935-5; Zhao GB, 2016, ONCOL REP, V35, P1787, DOI 10.3892/or.2016.4544	26	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22604	10.1096/fj.202200957RR	http://dx.doi.org/10.1096/fj.202200957RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0WK	36250950				2022-12-28	WOS:000868767700001
J	Liu, ZX; Chen, MM; Sun, YN; Li, X; Cao, L; Ma, XC				Liu, Zixuan; Chen, Mingming; Sun, Yini; Li, Xu; Cao, Liu; Ma, Xiaochun			Transforming growth factor-beta receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-beta/Smad/Rho signaling pathway activation	FASEB JOURNAL			English	Article						acute lung injury; heparin-binding protein (HBP); infection; transforming growth factor-beta receptor type 2 (TGF-beta-R2); vascular permeability	ORGAN DYSFUNCTION; SEPSIS; FIBROBLASTS; HBP/CAP37; CELLS; CAP37; LINK	Heparin-binding protein (HBP), as a granule protein secreted by polymorphonuclear neutrophils, participates in the pathophysiological process of sepsis. It has been reported that HBP is a biomarker of sepsis related to the severity of septic shock and organ dysfunction. HBP binds to vascular endothelial cells as a primary target site. However, it is still unclear whether HBP-binding protein receptors exist on the surface of endothelial cells. The effect of HBP on vascular permeability in sepsis and its mechanism needs to be explored. We conducted in vivo and in vitro studies and demonstrated that HBP binds to transforming growth factor-beta receptor type 2 (TGF-beta-R2) as a ligand. Glutathione S-transferase pulldown analysis revealed that HBP mainly interacts with the extracellular domain of TGF-beta-R2. HBP induces acute lung injury and vascular leakage via activation of the TGF-beta/SMAD2/3 signaling pathway. A permeability assay suggested that TGF-beta-R2 is necessary for HBP-induced increased permeability. We also defined the role of HBP and its potential membrane receptor TGF-beta-R2 in the blood-gas barrier in the pathogenesis of HBP-related acute lung injury.	[Liu, Zixuan; Chen, Mingming; Sun, Yini; Li, Xu; Ma, Xiaochun] China Med Univ, Dept Crit Care Med, Hosp 1, 155 Nanjing North St, Shenyang 11000, Liaoning, Peoples R China; [Liu, Zixuan] Chinese Acad Med Sci, Inst Hematol, Dept Crit Care Med, Tianjin, Peoples R China; [Liu, Zixuan] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Cao, Liu] China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Inst Translat Med, Key Lab Cell Biol,Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Cao, Liu] China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; China Medical University; China Medical University	Ma, XC (corresponding author), China Med Univ, Dept Crit Care Med, Hosp 1, 155 Nanjing North St, Shenyang 11000, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Inst Translat Med, Key Lab Cell Biol,Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	lcao@cmu.edu.cn; maxc_cmu@sina.com			Clinical Research Center of Critical Care Medicine, Shenyang [20-204-4-41]; National 14th Five-Year Key Research and Development Plan [2021YFC2500805]; National Natural Science Foundation of China [82102266]; Clinical Research Center of Critical Care Medicine, Liaoning province [1586657730871]	Clinical Research Center of Critical Care Medicine, Shenyang; National 14th Five-Year Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Research Center of Critical Care Medicine, Liaoning province	Clinical Research Center of Critical Care Medicine, Shenyang, Grant/ Award Number: 20-204-4-41; The National 14th Five-Year Key Research and Development Plan, Grant/Award Number: 2021YFC2500805; The National Natural Science Foundation of China, Grant/Award Number: 82102266; Clinical Research Center of Critical Care Medicine, Liaoning province, Grant/Award Number: 1586657730871	Al-Ani B, 2013, SAUDI MED J, V34, P477; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Fisher J, 2017, J INTERN MED, V281, P562, DOI 10.1111/joim.12604; Friedrich M, 2019, MUCOSAL IMMUNOL, V12, P656, DOI 10.1038/s41385-019-0135-7; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gonzalez ML, 2004, MICROVASC RES, V67, P168, DOI 10.1016/j.mvr.2003.12.007; Griffith GL, 2013, INVEST OPHTH VIS SCI, V54, P6712, DOI 10.1167/iovs.13-12054; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Karnad DR, 2014, INTENS CARE MED, V40, P830, DOI 10.1007/s00134-014-3278-8; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2015, CRIT CARE MED, V43, P2378, DOI 10.1097/CCM.0000000000001265; Liu Y, 2018, LIFE SCI, V203, P92, DOI 10.1016/j.lfs.2018.04.029; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McAuley DF, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-47; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; Olofsson AM, 1999, J CLIN INVEST, V104, P885, DOI 10.1172/JCI6671; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; OSTERGAARD E, 1992, J LEUKOCYTE BIOL, V51, P316, DOI 10.1002/jlb.51.4.316; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Pereira HA, 1996, J LEUKOCYTE BIOL, V60, P415, DOI 10.1002/jlb.60.3.415; Persson BP, 2014, ACTA ANAESTH SCAND, V58, P549, DOI 10.1111/aas.12301; SHAFER WM, 1984, INFECT IMMUN, V45, P29, DOI 10.1128/IAI.45.1.29-35.1984; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Suzuki K, 2020, BRIT J PHARMACOL, V177, P4021, DOI 10.1111/bph.15153; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; Varon C, 2006, EXP CELL RES, V312, P3604, DOI 10.1016/j.yexcr.2006.08.006; Wu QG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9819; Wu YL, 2021, CRIT CARE MED, V49, pE80, DOI 10.1097/CCM.0000000000004738; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Zhou M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01612	35	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22580	10.1096/fj.202200228RRRRR	http://dx.doi.org/10.1096/fj.202200228RRRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A7PL	36189652	hybrid			2022-12-28	WOS:000863075200001
J	Chowdhury, K; Huang, MH; Kim, HG; Dong, XC				Chowdhury, Kushan; Huang, Menghao; Kim, Hyeong-Geug; Dong, X. Charlie			Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function	FASEB JOURNAL			English	Article						deacetylation; fibrosis; hippo; Sirtuin 6; TEAD	LIVER FIBROSIS; STELLATE CELLS; HIPPO PATHWAY; MECHANISMS; HEPATOCYTES	Hepatic fibrosis occurs in response to prolonged tissue injury in the liver, which results in abnormal accumulation of extracellular matrix. Hepatic stellate cells (HSCs) have been suggested to play a major role in liver fibrosis. However, the molecular mechanisms remain incompletely understood. Sirtuin 6 (SIRT6), an NAD(+)-dependent deacetylase, has been previously implicated in the regulation of the transforming growth factor beta (TGF beta)-SMAD3 pathway that plays a significant role in liver fibrosis. In this work, we aimed to identify other important players during hepatic fibrogenesis, which are modulated by SIRT6. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ or WWTR1), key players in the Hippo pathway, have been implicated in the promotion of hepatic fibrosis. Our data show that HSC-specific Sirt6 knockout mice are more susceptible to high-fat-cholesterol-cholate diet-induced hepatic fibrosis than their wildtype counterparts. Our signaling analyses suggest that in addition to the TGF beta-SMAD3 pathway, YAP and TAZ are also highly activated in the SIRT6-deficient HSCs. As it is not clear how SIRT6 might regulate YAP and TAZ, we have decided to elucidate the mechanism underlying the regulation of YAP and TAZ by SIRT6 in HSCs. Overexpression or knockdown of SIRT6 corroborates the role of SIRT6 in the negative regulation of YAP and TAZ. Further biochemical analyses reveal that SIRT6 deacetylates YAP and TAZ and reprograms the composition of the TEA domain transcription factor complex to suppress their downstream target genes, particularly those involved in hepatic fibrosis. In conclusion, our data suggest that SIRT6 plays a critical role in the regulation of the Hippo pathway to protect against hepatic fibrosis.	[Chowdhury, Kushan; Huang, Menghao; Kim, Hyeong-Geug; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-1021D, Indianapolis, IN 46202 USA; [Dong, X. Charlie] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Dong, X. Charlie] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-1021D, Indianapolis, IN 46202 USA.	xcdong@iu.edu		Dong, X Charlie/0000-0001-5452-6882	 [R01DK121925];  [R01DK120689];  [R01AA028506];  [R21AG072288]	; ; ; 	The authors want to thank Dr. Heather Francis, Dr. Hongxia Ren, and Dr. Ronald C. Wek at Indiana University School of Medicine for their comments and suggestions. This work was supported in part by the following funding sources: R01DK121925 (X.C.D.), R01DK120689 (X.C.D.), R01AA028506 (X.C.D), and R21AG072288 (X.C.D). The sponsors had no role in the study design and data collection, analysis, or interpretation.	Aparicio-Vergara M, 2017, METHODS MOL BIOL, V1639, P161, DOI 10.1007/978-1-4939-7163-3_16; Cai J, 2020, KIDNEY INT, V97, P106, DOI 10.1016/j.kint.2019.08.028; Chang WJ, 2014, ACTA BIOCH BIOPH SIN, V46, P291, DOI 10.1093/abbs/gmt143; Dai YJ, 2021, J ENDOCRINOL, V249, P149, DOI 10.1530/JOE-20-0561; Dong XC, 2021, ANTIOXID REDOX SIGN, V35, P689, DOI 10.1089/ars.2021.0076; Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Hata S, 2012, J BIOL CHEM, V287, P22089, DOI 10.1074/jbc.M111.334714; Huang MH, 2020, HEPATOLOGY, V71, P76, DOI 10.1002/hep.30820; Jin J, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11091477; Khajehahmadi Z, 2019, IUBMB LIFE, V71, P1382, DOI 10.1002/iub.2068; Kim CL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050468; Liu LM, 2021, INT J STEM CELLS, V14, P310, DOI 10.15283/ijsc20184; Liu Y, 2019, J HEPATOL, V71, P719, DOI 10.1016/j.jhep.2019.05.029; Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Mao B, 2014, ONCOGENE, V33, P1468, DOI 10.1038/onc.2013.88; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mooring M, 2020, HEPATOLOGY, V71, P1813, DOI 10.1002/hep.30928; Reggiani F, 2021, TRENDS BIOCHEM SCI, V46, P154, DOI 10.1016/j.tibs.2020.08.012; Salloum S, 2021, CELL MOL GASTROENTER, V12, P1297, DOI 10.1016/j.jcmgh.2021.06.003; Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Wang XB, 2020, CELL METAB, V31, P969, DOI 10.1016/j.cmet.2020.03.010; Wang XB, 2019, HEPATOL COMMUN, V3, P1221, DOI 10.1002/hep4.1405; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang YG, 2019, HEPATOLOGY, V70, P1409, DOI 10.1002/hep.30668; Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004; Zhang JH, 2021, HEPATOLOGY, V73, P1140, DOI 10.1002/hep.31418; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30029; Zhong XL, 2020, CELL MOL GASTROENTER, V10, P341, DOI 10.1016/j.jcmgh.2020.04.005	34	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22529	10.1096/fj.202200522R	http://dx.doi.org/10.1096/fj.202200522R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4D1JO	36036554	Green Published			2022-12-28	WOS:000846902600001
J	Halmetoja, E; Nagy, I; Szabo, Z; Alakoski, T; Yrjola, R; Vainio, L; Viitavaara, E; Lin, RZ; Rahtu-Korpela, L; Vainio, S; Kerkela, R; Magga, J				Halmetoja, Eveliina; Nagy, Irina; Szabo, Zoltan; Alakoski, Tarja; Yrjola, Raisa; Vainio, Laura; Viitavaara, Eliina; Lin, Ruizhu; Rahtu-Korpela, Lea; Vainio, Seppo; Kerkela, Risto; Magga, Johanna			Wnt11 in regulation of physiological and pathological cardiac growth	FASEB JOURNAL			English	Article						cardiac hypertrophy; left ventricle remodeling; pressure overload; Wnt11 protein	PRESSURE-OVERLOAD; CARDIOMYOCYTE PROLIFERATION; CELLS; CONTRIBUTES; ACTIVATION; PATHWAY; ROLES; WNT5A	Wnt11 regulates early cardiac development and left ventricular compaction in the heart, but it is not known how Wnt11 regulates postnatal cardiac maturation and response to cardiac stress in the adult heart. We studied cell proliferation/maturation in postnatal and adolescent Wnt11 deficient (Wnt11-/-) heart and subjected adult mice with partial (Wnt11+/-) and complete Wnt11 (Wnt11-/-) deficiency to cardiac pressure overload. In addition, we subjected primary cardiomyocytes to recombinant Wnt proteins to study their effect on cardiomyocyte growth. Wnt11 deficiency did not affect cardiomyocyte proliferation or maturation in the postnatal or adolescent heart. However, Wnt11 deficiency led to enlarged heart phenotype that was not accompanied by significant hypertrophy of individual cardiomyocytes. Analysis of stressed adult hearts from wild-type mice showed a progressive decrease in Wnt11 expression in response to pressure overload. When studied in experimental cardiac pressure overload, Wnt11 deficiency did not exacerbate cardiac hypertrophy or remodeling and cardiac function remained identical between the genotypes. When subjecting cardiomyocytes to hypertrophic stimulus, the presence of recombinant Wnt11 together with Wnt5a reduced protein synthesis. In conclusion, Wnt11 deficiency does not affect postnatal cardiomyocyte proliferation but leads to cardiac growth. Interestingly, Wnt11 deficiency alone does not substantially modulate hypertrophic response to pressure overload in vivo. Wnt11 may require cooperation with other noncanonical Wnt proteins to regulate hypertrophic response under stress.	[Halmetoja, Eveliina; Szabo, Zoltan; Alakoski, Tarja; Yrjola, Raisa; Vainio, Laura; Viitavaara, Eliina; Lin, Ruizhu; Rahtu-Korpela, Lea; Kerkela, Risto; Magga, Johanna] Univ Oulu, Res Unit Biomed, Aapistie 5B, Oulu 90220, Finland; [Nagy, Irina] Univ Oulu, Med Res Ctr, Canc & Translat Med Res Unit, Dept Clin Chem, Oulu, Finland; [Nagy, Irina] Oulu Univ Hosp, Northern Finland Lab Ctr NordLab, Oulu, Finland; [Vainio, Seppo] Univ Oulu, Ctr Cell Matrix Res, Lab Dev Biol, Oulu, Finland; [Vainio, Seppo] Univ Oulu, Kvantum Inst, Infotech Oulu, Oulu, Finland; [Kerkela, Risto] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kerkela, Risto] Univ Oulu, Oulu, Finland; [Kerkela, Risto; Magga, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Magga, J (corresponding author), Univ Oulu, Res Unit Biomed, Aapistie 5B, Oulu 90220, Finland.	johanna.magga@oulu.fi			Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA) [268505, 297094]; Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA), Grant/Award Number: 268505 and 297094; Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Albanese I, 2017, ARTERIOSCL THROM VAS, V37, P543, DOI 10.1161/ATVBAHA.116.308394; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Burgy O, 2018, MATRIX BIOL, V68-69, P67, DOI 10.1016/j.matbio.2018.03.017; Bywater MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15552-x; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Doetschman T, 2012, CIRC RES, V110, P1498, DOI 10.1161/CIRCRESAHA.112.265066; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Eisenberg LM, 2007, THESCIENTIFICWORLDJO, V7, P161, DOI 10.1100/tsw.2007.71; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Foulquier S, 2018, PHARMACOL REV, V70, P68, DOI 10.1124/pr.117.013896; Gude NA, 2018, PHARMACOL RES, V127, P110, DOI 10.1016/j.phrs.2017.06.007; Hirai M, 2016, CIRC RES, V118, P916, DOI 10.1161/CIRCRESAHA.115.308101; Jiang JH, 2018, BBA-MOL BASIS DIS, V1864, P3459, DOI 10.1016/j.bbadis.2018.07.035; Kerkela R, 2013, MOL CELL BIOL, V33, P3321, DOI 10.1128/MCB.00432-13; Kerkela R, 2011, CTS-CLIN TRANSL SCI, V4, P236, DOI 10.1111/j.1752-8062.2011.00294.x; Lin H, 2016, AM J PHYSIOL-CELL PH, V311, pC710, DOI 10.1152/ajpcell.00137.2016; Magga J, 2019, MOL THER, V27, P600, DOI 10.1016/j.ymthe.2019.01.013; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mazzotta S, 2016, STEM CELL REP, V7, P764, DOI 10.1016/j.stemcr.2016.08.008; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moon J, 2017, P NATL ACAD SCI USA, V114, P1649, DOI 10.1073/pnas.1621346114; Mori H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21520; Morishita Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21705; Nagy II, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0131-z; Nagy II, 2010, CARDIOVASC RES, V85, P100, DOI 10.1093/cvr/cvp254; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sinha T, 2015, DEV BIOL, V398, P177, DOI 10.1016/j.ydbio.2014.11.005; Stubenvoll A, 2015, HUM MOL GENET, V24, P802, DOI 10.1093/hmg/ddu498; Szabo Z, 2020, FASEB J, V34, P9911, DOI 10.1096/fj.201903074RR; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tolonen AM, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.56; Touma M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94904; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vainio LE, 2019, JACC-BASIC TRANSL SC, V4, P83, DOI 10.1016/j.jacbts.2018.10.007; van de Schans VAM, 2007, HYPERTENSION, V49, P473, DOI 10.1161/01.HYP.0000255946.55091.24; van Vliet PP, 2017, DEV BIOL, V429, P249, DOI 10.1016/j.ydbio.2017.06.021; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; Xiang FL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00840-w; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zou Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04152-2; Zuo S, 2012, STEM CELLS DEV, V21, P598, DOI 10.1089/scd.2011.0071	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22544	10.1096/fj.202101856RRRR	http://dx.doi.org/10.1096/fj.202101856RRRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1HR	36098469	hybrid			2022-12-28	WOS:000853079300001
J	Li, XH; Kordsmeier, J; Nookaew, I; Kim, HN; Xiong, JH				Li, Xuehua; Kordsmeier, Jacob; Nookaew, Intawat; Kim, Ha-Neui; Xiong, Jinhu			Piezo1 stimulates mitochondrial function via cAMP signaling	FASEB JOURNAL			English	Article							GENE-EXPRESSION; CALCIUM; DIFFERENTIATION; EXERCISE; TISSUE	Mechanical signals stimulate mitochondrial function but the molecular mechanisms are not clear. Here, we show that the mechanically sensitive ion channel Piezo1 plays a critical role in mitochondrial adaptation to mechanical stimulation. The activation of Piezo1 induced mitochondrial calcium uptake and oxidative phosphorylation (OXPHOS). In contrast, loss of Piezo1 reduced the mitochondrial oxygen consumption rate (OCR) and adenosine triphosphate (ATP) production in calvarial cells and these changes were associated with increased expression of the phosphodiesterases Pde4a and lower cyclic AMP (cAMP) levels. In addition, Piezo1 increased cAMP production and the activation of a cAMP-responsive transcriptional reporter. Consistent with this, cAMP was sufficient to increase mitochondrial OCR and the inhibition of phosphodiesterases augmented the increase in OCR induced by Piezo1. Moreover, the inhibition of cAMP production or activity of protein kinase A, a kinase activated by cAMP, prevented the increase in OCR induced by Piezo1. These results demonstrate that cAMP signaling contributes to the increase in mitochondrial OXPHOS induced by activation of Piezo1.	[Li, Xuehua; Kordsmeier, Jacob; Xiong, Jinhu] Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [Li, Xuehua; Kordsmeier, Jacob; Nookaew, Intawat; Kim, Ha-Neui; Xiong, Jinhu] Univ Arkansas Med Sci, Ctr Musculoskeletal Dis Res, Little Rock, AR 72205 USA; [Nookaew, Intawat] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Kim, Ha-Neui] Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Xiong, JH (corresponding author), Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA.	jxiong@uams.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR076979]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20GM125503]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR076979; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM125503	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Atcha H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23482-5; Bartolak-Suki E, 2015, NAT MATER, V14, P1049, DOI [10.1038/NMAT4358, 10.1038/nmat4358]; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Boppart MD, 1998, BONE, V23, P409, DOI 10.1016/S8756-3282(98)00119-7; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chakraborty M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108609; Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, pE87, DOI 10.1152/ajpendo.00457.2019; Chen X, 2018, NEURON, V100, P799, DOI 10.1016/j.neuron.2018.09.046; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Lima JE, 2016, ELIFE, V5, DOI 10.7554/eLife.15593; De Rasmo D, 2016, BBA-BIOENERGETICS, V1857, P350, DOI 10.1016/j.bbabio.2016.01.006; De Rasmo D, 2015, BBA-MOL CELL RES, V1853, P183, DOI 10.1016/j.bbamcr.2014.10.016; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; Dobson PF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68566-2; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Gao J, 2018, CELL DEATH DIFFER, V25, P229, DOI 10.1038/cdd.2017.144; Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014; Helle SCJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30292; Hendrickx G, 2021, J BONE MINER RES, V36, P369, DOI 10.1002/jbmr.4198; Hwang JH, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28247-2; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jiang F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21178-4; Kim B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111409; Kim HN, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138815; Lee WC, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108108; Lewis KJ, 2020, JBMR PLUS, V4, DOI 10.1002/jbm4.10366; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li XH, 2021, CURR OSTEOPOROS REP, V19, P101, DOI 10.1007/s11914-020-00650-y; Li XH, 2019, ELIFE, V8, DOI 10.7554/eLife.49631; Liu CSC, 2018, J IMMUNOL, V200, P1255, DOI 10.4049/jimmunol.1701118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tharp KM, 2021, CELL METAB, V33, P1322, DOI 10.1016/j.cmet.2021.04.017; Trevellin E, 2014, DIABETES, V63, P2800, DOI 10.2337/db13-1234; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8; Zannit HM, 2019, JBMR PLUS, V3, DOI 10.1002/jbm4.10227; Zhou TF, 2020, ELIFE, V9, DOI 10.7554/eLife.52779	58	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22519	10.1096/fj.202200300R	http://dx.doi.org/10.1096/fj.202200300R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4F5SO	36052712				2022-12-28	WOS:000848572100001
J	Ding, CJ; Hong, Y; Che, Y; He, TY; Wang, Y; Zhang, SL; Wu, JW; Xu, WF; Hou, JY; Hao, HP; Cao, LJ				Ding, Chujie; Hong, Yu; Che, Yuan; He, Tianyu; Wang, Yun; Zhang, Shule; Wu, Jiawei; Xu, Wanfeng; Hou, Jingyi; Hao, Haiping; Cao, Lijuan			Bile acid restrained T cell activation explains cholestasis aggravated hepatitis B virus infection	FASEB JOURNAL			English	Article						bile acid; hepatitis B virus; SOCE; T cell activation	CALCIUM; INFLAMMATION; METABOLITES; MANAGEMENT; MECHANISM; GENES	Cholestasis is a common complication of hepatitis B virus (HBV) infection, characterized by increased intrahepatic and plasma bile acid levels. Cholestasis was found negatively associated with hepatitis outcome, however, the exact mechanism by which cholestasis impacts anti-viral immunity and impedes HBV clearance remains elusive. Here, we found that cholestatic mice are featured with dysfunctional T cells response, as indicated by decreased sub-population of CD25(+)/CD69(+) CD4(+) and CD8(+) cells, while CTLA-4(+) CD4(+) and CD8(+) subsets were increased. Mechanistically, bile acids disrupt intracellular calcium homeostasis via inhibiting mitochondria calcium uptake and elevating cytoplasmic Ca2+ concentration, leading to STIM1 and ORAI1 decoupling and impaired store-operated Ca2+ entry which is essential for NFAT signaling and T cells activation. Moreover, in a transgenic mouse model of HBV infection, we confirmed that cholestasis compromised both CD4(+) and CD8(+) T cells activation resulting in poor viral clearance. Collectively, our results suggest that bile acids play pivotal roles in anti-HBV infection via controlling T cells activation and metabolism and that targeting the regulation of bile acids may be a therapeutic strategy for host-virus defense.	[Ding, Chujie; Hong, Yu; Che, Yuan; He, Tianyu; Wang, Yun; Zhang, Shule; Wu, Jiawei; Xu, Wanfeng; Hou, Jingyi; Hao, Haiping; Cao, Lijuan] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China	China Pharmaceutical University	Hao, HP; Cao, LJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China.	haipinghao@cpu.edu.cn; caolijuan0702@cpu.edu.cn		HONG, YU/0000-0001-5220-2382; Hao, Haiping/0000-0003-2522-7546	China Postdoctoral Science Foundation [2021M693514]; Chinese Academy of Medical Sciences (CAMS) [2021-I2M-5-011]; National Key Research and Development Program of China [2021YFA1301300]; National Natural Science Foundation of China (NSFC) [81720108032, 81930109, 81973559, 82173886]; Overseas Expertise Introduction Project For Discipline Innovation [G20582017001]; Sanming Project of Medicine in Shenzhen [SZSM201801060]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Medical Sciences (CAMS); National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project For Discipline Innovation; Sanming Project of Medicine in Shenzhen	China Postdoctoral Science Foundation, Grant/Award Number: 2021M693514; Chinese Academy of Medical Sciences (CAMS), Grant/Award Number: 2021-I2M-5-011; National Key Research and Development Program of China, Grant/Award Number: 2021YFA1301300; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108032, 81930109, 81973559 and 82173886; Overseas Expertise Introduction Project For Discipline Innovation, Grant/Award Number: G20582017001; Sanming Project of Medicine in Shenzhen, Grant/Award Number: SZSM201801060	Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Biagioli M, 2019, CELL MOL GASTROENTER, V8, P447, DOI 10.1016/j.jcmgh.2019.06.003; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Chen YY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02048; FERRARI C, 1990, J IMMUNOL, V145, P3442; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Guo XH, 2018, INT J ANTIMICROB AG, V52, P201, DOI 10.1016/j.ijantimicag.2018.04.002; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hao HP, 2017, CELL METAB, V25, P856, DOI 10.1016/j.cmet.2017.03.007; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hosseinkhani F, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1882927; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jena PK, 2019, J DERMATOL SCI, V95, P13, DOI 10.1016/j.jdermsci.2019.05.007; Jiang RA, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021416; Lang E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30627-y; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; NICCHITTA CV, 1984, J BIOL CHEM, V259, P2978; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Postnikova OA, 2012, B EXP BIOL MED+, V153, P899, DOI 10.1007/s10517-012-1854-x; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Sang C, 2021, J PROTEOME RES, V20, P2340, DOI 10.1021/acs.jproteome.0c00852; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Sigalov Alexander B, 2022, Biochimie, V195, P86, DOI 10.1016/j.biochi.2021.11.005; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Vaeth Martin, 2018, F1000Res, V7, P260, DOI 10.12688/f1000research.13426.1; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Wang JX, 2022, J CARDIOVASC TRANSL, V15, P350, DOI 10.1007/s12265-021-10164-2; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wong GLH, 2020, LANCET GASTROENTEROL, V5, P776, DOI 10.1016/S2468-1253(20)30190-4; Wu MQ, 2017, J PROTEOME RES, V16, P2250, DOI 10.1021/acs.jproteome.7b00111; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Xu WF, 2021, CELL METAB, V33, P424, DOI 10.1016/j.cmet.2020.11.018; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang YY, 2018, EUR J GASTROEN HEPAT, V30, P682, DOI [10.1097/MEG.0000000000001100, 10.1097/meg.0000000000001100]; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003	46	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22468	10.1096/fj.202200332R	http://dx.doi.org/10.1096/fj.202200332R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L0WD	35913801	Green Submitted			2022-12-28	WOS:000834490100001
J	Zhang, XM; Yin, XX; Dai, JD; Sun, GX; Zhang, HR; Liang, JY; Zhao, JG; Zhu, S; Chen, JR; Zhu, XD; Ni, YC; Wang, ZP; Liu, ZH; Chen, N; Shen, PF; Zeng, H				Zhang, Xingming; Yin, Xiaoxue; Dai, Jindong; Sun, Guangxi; Zhang, Haoran; Liang, Jiayu; Zhao, Jinge; Zhu, Sha; Chen, Junru; Zhu, Xudong; Ni, Yuchao; Wang, Zhipeng; Liu, Zhenhua; Chen, Ni; Shen, Pengfei; Zeng, Hao			The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism	FASEB JOURNAL			English	Article						27-HC; apoptosis; CDKN1B; c-IAP2; RCC; TNFR1	NF-KAPPA-B; SURVIVAL OUTCOMES; EXPRESSION; 27-HYDROXYCHOLESTEROL; RECEPTOR; P27(KIP1); FAMILY; ROLES	As a key approach to mediate cholesterol metabolism, the role of the CYP27A1/27-HC axis in renal cell carcinoma (RCC) remains unclear. Analysis of CYP27A1 expression from public databases and metastatic cases in our center suggested that CYP27A1 was obviously downregulated in RCC tissues, and survival analysis further showed its correlation with favorable clinicopathological features and prognosis. In vitro, up and downregulation of CYP27A1 expression in RCC cell lines could definitely illustrate its anticipation involving apoptosis, proliferation, invasion, migration, and clonality. This could be achieved through upregulation of 27-HC concentration, which mediates the activation of signaling pathways of apoptosis and cell cycle arrest. Further, recovery of CYP27A1 expression could definitely inhibit the proliferation of RCC tumors in vivo. This is the first study to explore the role of the CYP27A1/27-HC axis in RCC. Attempts to maintain the normal function of the axis may be a potential strategy in the treatment of RCC, and the predictive value of CYP27A1 detection on the efficacy of targeted therapy in metastatic RCC is also worthy of attention.	[Zhang, Xingming; Dai, Jindong; Sun, Guangxi; Zhang, Haoran; Liang, Jiayu; Zhao, Jinge; Zhu, Sha; Chen, Junru; Zhu, Xudong; Ni, Yuchao; Wang, Zhipeng; Liu, Zhenhua; Shen, Pengfei; Zeng, Hao] Sichuan Univ, Inst Urol, West China Hosp, Dept Urol, 37 Guoxue Alley, Chengdu, Sichuan, Peoples R China; [Yin, Xiaoxue; Chen, Ni] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Shen, PF; Zeng, H (corresponding author), Sichuan Univ, Inst Urol, West China Hosp, Dept Urol, 37 Guoxue Alley, Chengdu, Sichuan, Peoples R China.	cdhx510@163.com; kucaizeng@163.com	Zhu, Sha/E-1703-2019; Dai, Jin/GVT-2414-2022; yin, xiaoxue/GSD-3308-2022	Dai, Jin/0000-0003-3063-746X; 	China Postdoctoral Science Foundation [2020M673239, 2021M692286]; National Natural Science Foundation of China (NSFC) [81902577, 82103097]; Post-Doctor Research Project, West China Hospital, Sichuan University [20HXBH026]; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan) [2021YFS0119]; Research Foundation for the Postdoctoral Program of Sichuan University [2021SCU12014]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Post-Doctor Research Project, West China Hospital, Sichuan University; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan); Research Foundation for the Postdoctoral Program of Sichuan University	China Postdoctoral Science Foundation, Grant/Award Number: 2020M673239 and 2021M692286; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902577 and 82103097; Post-Doctor Research Project, West China Hospital, Sichuan University, Grant/Award Number: 20HXBH026; SPDST | Sichuan Province Science and Technology Support Program (Science and Technology Project of Sichuan), Grant/Award Number: 2021YFS0119; the Research Foundation for the Postdoctoral Program of Sichuan University, Grant/ Award Number: 2021SCU12014	Al-Lamki RS, 2010, AM J PATHOL, V177, P943, DOI 10.2353/ajpath.2010.091218; Alfaqih MA, 2017, CANCER RES, V77, P1662, DOI 10.1158/0008-5472.CAN-16-2738; Baek AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00910-z; Barata PC, 2017, CA-CANCER J CLIN, V67, P507, DOI 10.3322/caac.21411; Berquist SW, 2017, MINERVA UROL NEFROL, V69, P501, DOI 10.23736/S0393-2249.17.02788-6; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Haddad AQ, 2015, UROLOGY, V86, P1146, DOI 10.1016/j.urology.2015.09.015; He SS, 2019, ENDOCR-RELAT CANCER, V26, P659, DOI 10.1530/ERC-18-0572; Jensen MB, 2010, J STEROID BIOCHEM, V121, P376, DOI 10.1016/j.jsbmb.2010.03.069; Ji YC, 2016, AM J TRANSL RES, V8, P4434; Kimbung S, 2017, ENDOCR-RELAT CANCER, V24, P339, DOI 10.1530/ERC-16-0533; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lee H, 2017, CLIN GENITOURIN CANC, V15, pE935, DOI 10.1016/j.clgc.2017.05.008; Li B, 2020, INT BRAZ J UROL, V46, P158, DOI [10.1590/s1677-5538.ibju.2019.0560, 10.1590/S1677-5538.IBJU.2019.0560]; Liang ZJ, 2019, CELL CYCLE, V18, P34, DOI 10.1080/15384101.2018.1558868; Liu Z, 2018, BIOCHEM BIOPH RES CO, V502, P69, DOI 10.1016/j.bbrc.2018.05.122; Liu Z, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-51; Lu DL, 2019, JNCI-J NATL CANCER I, V111, P365, DOI 10.1093/jnci/djy115; Matusiak D, 2007, J HISTOCHEM CYTOCHEM, V55, P1257, DOI 10.1369/jhc.7A7286.2007; Migita T, 2008, INT J ONCOL, V33, P41; Naito S, 2017, BRIT J CANCER, V116, P1203, DOI 10.1038/bjc.2017.77; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Santoni M, 2022, CRIT REV ONCOL HEMAT, V176, DOI 10.1016/j.critrevonc.2022.103731; Shi SZ, 2019, AM J CANCER RES, V9, P2194; Silke J, 2014, METHOD ENZYMOL, V545, P35, DOI 10.1016/B978-0-12-801430-1.00002-0; Sun GX, 2019, NEOPLASIA, V21, P921, DOI 10.1016/j.neo.2019.07.004; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2015, METHODS MOL BIOL, V1280, P269, DOI 10.1007/978-1-4939-2422-6_15; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006; Xin J, 2018, ONCOL LETT, V16, P1439, DOI 10.3892/ol.2018.8846	31	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22499	10.1096/fj.202101146RR	http://dx.doi.org/10.1096/fj.202101146RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7LS	35969149				2022-12-28	WOS:000840451500001
J	Shukla, S; Cho, WK; Elbasiony, E; Singh, RB; Mittal, SK; Chauhan, SK				Shukla, Sachin; Cho, Won Kyung; Elbasiony, Elsayed; Singh, Rohan B.; Mittal, Sharad K.; Chauhan, Sunil K.			Non-immune and immune functions of interleukin-36 gamma suppress epithelial repair at the ocular surface	FASEB JOURNAL			English	Article						epithelium; innate inflammation; interleukin 36; interleukin 36 gamma blockade; tissue injury; tissue regeneration	CELLS; ACTIVATION; PSORIASIS	Regulation of innate inflammation is critical for maintaining tissue homeostasis and barrier function, especially in those interfacing the external environments such as the skin and cornea. Expression of pro-inflammatory cytokines by injured tissues has been shown to exacerbate the inflammatory cascade, causing tissue damage. Interleukin 36, a subfamily of the IL-1 superfamily, consists of three pro-inflammatory agonists-IL36 alpha, IL36 beta, and IL36 gamma and an IL36 receptor antagonist (IL36Ra). The current investigation, for the first time, reports that IL36 gamma is the primary agonist expressed by the corneal epithelium, which is significantly upregulated following corneal injury. The function of IL36 gamma on non-immune cells, in addition to innate inflammatory cells, in regulating tissue homeostasis has not been well investigated. Using a loss-of-function approach via neutralizing antibody treatment, our data demonstrate that blocking endogenously expressed IL36 gamma in epithelial cells promotes rapid re-epithelialization in in vitro wound closure assay. Finally, by utilizing a naturally occurring antagonist IL36Ra in a well-established murine model of ocular injury, our study demonstrates that inhibition of IL36 gamma accelerates epithelial regeneration and suppresses tissue inflammation. Given rapid wound healing is critical for re-establishing normal tissue structure and function, our investigation on the function of IL36 gamma provides evidence for the development of novel IL36 gamma-targeting strategies to promote tissue repair.	[Shukla, Sachin; Cho, Won Kyung; Elbasiony, Elsayed; Singh, Rohan B.; Mittal, Sharad K.; Chauhan, Sunil K.] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA; [Shukla, Sachin] LV Prasad Eye Inst, Hyderabad, India; [Singh, Rohan B.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; L. V. Prasad Eye Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mittal, SK (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA.; Chauhan, SK (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	sharad_mittal@meei.harvard.edu; sunil_chauhan@meei.harvard.edu	SHUKLA, SACHIN/N-1274-2017; Chauhan, Sunil/HDN-5614-2022	SHUKLA, SACHIN/0000-0003-2113-6073; Singh, Rohan/0000-0002-2426-3900	Department of Defense [W81XWH-20-1-0822]; National Institutes of Health [R01EY024602, P30EY003790]	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Department of Defense (W81XWH-20-1-0822) and the National Institutes of Health (R01EY024602 and P30EY003790).	Amouzegar A, 2017, STEM CELLS, V35, P1532, DOI 10.1002/stem.2611; Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Boutet MA, 2016, CLIN EXP IMMUNOL, V184, P159, DOI 10.1111/cei.12761; Buhl AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01162; Cho WK, 2021, AM J PATHOL, V191, P1108, DOI 10.1016/j.ajpath.2021.02.016; Cho W, 2020, OCUL SURF, V18, P857, DOI 10.1016/j.jtos.2020.09.002; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Ding LP, 2018, ONCOTARGET, V9, P2895, DOI 10.18632/oncotarget.22814; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Foulsham W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44973-y; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Gao N, 2018, J IMMUNOL, V201, P688, DOI 10.4049/jimmunol.1800046; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Kovtun A, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8173983; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Mai SZ, 2018, INT IMMUNOPHARMACOL, V58, P103, DOI 10.1016/j.intimp.2018.03.011; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Me R, 2021, J IMMUNOL, V207, P2868, DOI 10.4049/jimmunol.2001246; Mittal SK, 2019, STEM CELL TRANSL MED, V8, P1030, DOI 10.1002/sctm.19-0004; Mittal SK, 2018, INVEST OPHTH VIS SCI, V59, P1191, DOI 10.1167/iovs.17-23067; Mittal SK, 2016, STEM CELL REP, V7, P583, DOI 10.1016/j.stemcr.2016.09.001; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Omoto M, 2017, MOL THER, V25, P1881, DOI 10.1016/j.ymthe.2017.04.020; Queen D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00317; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Sahu SK, 2018, INVEST OPHTH VIS SCI, V59, P1732, DOI 10.1167/iovs.17-23398; Satoh TK, 2020, J CLIN INVEST, V130, P1417, DOI 10.1172/JCI128678; Sommerfeld SD, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax4783; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873	34	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22414	10.1096/fj.202200174RR	http://dx.doi.org/10.1096/fj.202200174RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2Q4EU	35781326				2022-12-28	WOS:000820378600001
J	Sugden, CJ; Iorio, V; Troughton, LD; Liu, K; Morais, MRPT; Lennon, R; Bou-Gharios, G; Hamill, KJ				Sugden, Conor J.; Iorio, Valentina; Troughton, Lee D.; Liu, Ke; Morais, Mychel R. P. T.; Lennon, Rachel; Bou-Gharios, George; Hamill, Kevin J.			Laminin N-terminus alpha 31 expression during development is lethal and causes widespread tissue-specific defects in a transgenic mouse model	FASEB JOURNAL			English	Article						basement membrane; development; laminin; netrin	HEMATOPOIETIC STEM-CELLS; BASEMENT-MEMBRANE; MUSCULAR-DYSTROPHY; EXTRACELLULAR-MATRIX; NEPHROTIC SYNDROME; FETAL LIVER; CHAIN; MUTATION; MICE; DOMAINS	Laminins (LMs) are essential components of all basement membranes where they regulate an extensive array of tissue functions. Alternative splicing from the laminin alpha 3 gene produces a non-laminin but netrin-like protein, Laminin N terminus alpha 31 (LaNt alpha 31). LaNt alpha 31 is widely expressed in intact tissue and is upregulated in epithelial cancers and during wound healing. In vitro functional studies have shown that LaNt alpha 31 can influence numerous aspects of epithelial cell behavior via modifying matrix organization, suggesting a new model of laminin auto-regulation. However, the function of this protein has not been established in vivo. Here, a mouse transgenic line was generated using the ubiquitin C promoter to drive inducible expression of LaNt alpha 31. When expression was induced at embryonic day 15.5, LaNt alpha 31 transgenic animals were not viable at birth, exhibiting localized regions of erythema. Histologically, the most striking defect was widespread evidence of extravascular bleeding across multiple tissues. Additionally, LaNt alpha 31 transgene expressing animals exhibited kidney epithelial detachment, tubular dilation, disruption of the epidermal basal cell layer and of the hair follicle outer root sheath, and similar to 50% reduction of cell numbers in the liver, associated with depletion of hematopoietic erythrocytic foci. These findings provide the first in vivo evidence that LaNt alpha 31 can influence tissue morphogenesis.	[Sugden, Conor J.; Iorio, Valentina; Liu, Ke; Bou-Gharios, George; Hamill, Kevin J.] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England; [Troughton, Lee D.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Stritch Sch Med, Maywood, IL USA; [Morais, Mychel R. P. T.; Lennon, Rachel] Univ Manchester, Come Ctr Cell Matrix Res, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England	University of Liverpool; Loyola University Chicago; University of Manchester	Hamill, KJ (corresponding author), Univ Liverpool, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England.	khamill@liverpool.ac.uk		Hamill, Kevin/0000-0002-7852-1944; Sugden, Conor James/0000-0002-9543-1676	Biotechnology and Biological Sciences Research Council [BB/L020513/1]; University of Liverpool Crossley Barnes Bequest fund	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Liverpool Crossley Barnes Bequest fund	This work was supported by the Biotechnology and Biological Sciences Research Council [grant number BB/L020513/1] and the University of Liverpool Crossley Barnes Bequest fund.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Barrera V, 2018, INVEST OPHTH VIS SCI, V59, P4082, DOI 10.1167/iovs.18-24037; Barzegar M, 2013, BRIT J DERMATOL, V169, P1353, DOI 10.1111/bjd.12522; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; Cheng KW, 2021, BIOCHEM J, V478, P2309, DOI 10.1042/BCJ20210015; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; COLOMA MJ, 1992, J IMMUNOL METHODS, V152, P89, DOI 10.1016/0022-1759(92)90092-8; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; DeBiase PJ, 2006, J HISTOCHEM CYTOCHEM, V54, P665, DOI 10.1369/jhc.5A6889.2006; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Di Russo J, 2017, EMBO J, V36, P1464, DOI 10.15252/embj.201797000; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Funk SD, 2018, MATRIX BIOL, V71-72, P250, DOI 10.1016/j.matbio.2018.04.008; Funk SD, 2018, J AM SOC NEPHROL, V29, P949, DOI 10.1681/ASN.2017090997; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Guler-Gane G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155340; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hamill KJ, 2010, DERMATOL CLIN, V28, P79, DOI 10.1016/j.det.2009.10.009; Hamill KJ, 2009, J BIOL CHEM, V284, P35588, DOI 10.1074/jbc.M109.052811; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hohenester E, 2019, ESSAYS BIOCHEM, V63, P285, DOI 10.1042/EBC20180075; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Horejs CM, 2014, P NATL ACAD SCI USA, V111, P5908, DOI 10.1073/pnas.1403139111; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Iorio V., 2019, BIORXIV617597, P617597, DOI [10.1101/617597, DOI 10.1101/617597]; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jarad G, 2006, J CLIN INVEST, V116, P2272, DOI 10.1172/JCI28414; Jones LK, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189183; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kiritsi D, 2013, CELL ADHES MIGR, V7, P135, DOI 10.4161/cam.22418; Kiyozumi D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900515; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANGHOFER M, 1993, J CELL SCI, V105, P753; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Libby RT, 1999, J NEUROSCI, V19, P9399; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; McKee KK, 2018, MATRIX BIOL, V67, P32, DOI 10.1016/j.matbio.2018.01.012; McLean WHI, 2003, HUM MOL GENET, V12, P2395, DOI 10.1093/hmg/ddg234; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Morales-Nebreda LI, 2015, AM J RESP CELL MOL, V52, P503, DOI 10.1165/rcmb.2014-0057OC; Morrissey MA, 2015, J CELL SCI, V128, P1661, DOI 10.1242/jcs.168021; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Ochiai H, 2011, J BIOSCI BIOENG, V112, P432, DOI 10.1016/j.jbiosc.2011.07.001; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; Payne S, 2018, ARTERIOSCL THROM VAS, V38, P2550, DOI 10.1161/ATVBAHA.118.309669; Penton CM, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0116-4; Petajaniemi N, 2002, J HISTOCHEM CYTOCHEM, V50, P1113, DOI 10.1177/002215540205000813; Pierce RA, 1998, AM J RESP CELL MOL, V19, P237, DOI 10.1165/ajrcmb.19.2.3087; Polisetti N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04916-x; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Poulos MG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000778; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; Purvis A, 2012, J BIOL CHEM, V287, P44270, DOI 10.1074/jbc.M112.418426; Qian H, 2007, BLOOD, V110, P2399, DOI 10.1182/blood-2006-10-051276; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Reuten R, 2021, NAT MATER, V20, P892, DOI 10.1038/s41563-020-00894-0; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Sekiguchi R, 2018, CURR TOP DEV BIOL, V130, P143, DOI 10.1016/bs.ctdb.2018.02.005; Shaw L, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.707087; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; SUNADA Y, 1995, NEUROLOGY, V45, P2084, DOI 10.1212/WNL.45.11.2084; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Troughton LD, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0264430; Troughton LD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239889; Vainionpaa N, 2007, CELL TISSUE RES, V328, P317, DOI 10.1007/s00441-006-0366-2; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Walma DAC, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.175596; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yamada KM, 2019, INT J EXP PATHOL, V100, P144, DOI 10.1111/iep.12329; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; YURCHENCO PD, 1994, CONTRIB NEPHROL, V107, P47; Yurchenco PD, 2018, MATRIX BIOL, V71-72, P174, DOI 10.1016/j.matbio.2017.11.009; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; YUSPA SH, 1974, EXP CELL RES, V86, P95, DOI 10.1016/0014-4827(74)90653-3; Zenker M, 2005, AM J MED GENET A, V138A, P73, DOI 10.1002/ajmg.a.30894; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	103	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22318	10.1096/fj.202002588RRR	http://dx.doi.org/10.1096/fj.202002588RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1S6TT	35648586	Green Published, Green Submitted			2022-12-28	WOS:000804182300001
J	Jiang, W; He, F; Ding, GM; Wu, JS				Jiang, Wu; He, Fan; Ding, Guoming; Wu, Junsong			Topoisomerase 1 inhibition modulates pyroptosis to improve recovery after spinal cord injury	FASEB JOURNAL			English	Article						camptothecin; neuroinflammation; pyroptosis; spinal cord injury; topoisomerase 1	NF-KAPPA-B; PROMOTES FUNCTIONAL RECOVERY; NLRP3 INFLAMMASOME; CELL-DEATH; TNF-ALPHA; NEURONAL DEATH; IN-VITRO; IL-1-BETA; ACTIVATION; EXPRESSION	Excessive neuroinflammation and neuronal loss contribute to mechanisms of spinal cord injury (SCI). Accumulating evidence has suggested that topoisomerase 1 (Top1) inhibition can suppress exacerbated immune responses and protect against lethal inflammation. Pyroptosis is a recently identified pro-inflammatory programmed mode of cell death. However, the effects and underlying mechanisms of Top1 inhibition in SCI remains unclear. Locomotor functional recovery in mice was evaluated through Basso Mouse Scale (BMS). Neuronal loss was evaluated by immunochemistry staining of NeuN. Pyroptosis was determined by immunofluorescence staining, western blot, flow cytometry, cell viability, and cytotoxicity assays. In the present study, we estimated the effects of chemical inhibition of Top1 in an SCI model. Administration of Top1 inhibitor camptothecin (CPT) to mice significantly improved locomotor functional recovery after SCI. Moreover, CPT reduced Top1 level, inhibited nucleotide-binding oligomerization domain-like receptor 3 (NLRP3) inflammasome activation and pyroptosis, attenuated proinflammatory cytokines levels, diminished the number of neutrophil and neuronal loss in mice. Furthermore, CPT in oxygen-glucose deprivation neurons down-regulated Top1 level, attenuated NLRP3 inflammasome activation, and suppressed pyroptosis and inflammatory response. Together, our findings indicate that inhibition of Top1 with CPT can inhibit pyroptosis, control neuroinflammation, and improve functional recovery after SCI.	[Jiang, Wu; Wu, Junsong] Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Wu; He, Fan; Ding, Guoming] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Orthoped, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Wu, JS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	drwujunsong@sina.com			Zhejiang Provincial Medical and Healthy Technology Project [2020KY699]; Zhejiang Provincial Pubilc Welfare Research Project [LGF20H060014]	Zhejiang Provincial Medical and Healthy Technology Project; Zhejiang Provincial Pubilc Welfare Research Project	Zhejiang Provincial Medical and Healthy Technology Project, Grant/Award Number: 2020KY699; Zhejiang Provincial Pubilc Welfare Research Project, Grant/Award Number: LGF20H060014	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-6; Burke SJ, 2014, MOL IMMUNOL, V62, P54, DOI 10.1016/j.molimm.2014.05.019; Chen J, 2019, NEUROSCIENCE, V408, P430, DOI 10.1016/j.neuroscience.2019.03.055; Chen S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00014; Cheng Zhijian, 2021, J NEURORESTORATOLOGY, V9, P106, DOI [DOI 10.26599/JNR.2021.9040009, 10.26599/JNR.2021.9040009]; Fan YX, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00426; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Fu HT, 2018, J NEUROTRAUM, V35, P2507, DOI 10.1089/neu.2017.5606; Guo XD, 2021, J NEURORESTORATOLOGY, V9, P31, DOI 10.26599/JNR.2021.9040003; He DW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.619761; Hsieh H, 2016, TOXICOL IN VITRO, V35, P24, DOI 10.1016/j.tiv.2016.05.003; Hu JL, 2017, NEUROBIOL DIS, V98, P25, DOI 10.1016/j.nbd.2016.11.006; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jin JJ, 2019, J SURG RES, V235, P83, DOI 10.1016/j.jss.2018.08.057; Kadioglu O, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00711; Kijima K, 2019, EBIOMEDICINE, V41, P659, DOI 10.1016/j.ebiom.2019.03.003; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lago N, 2018, BRAIN BEHAV IMMUN, V73, P416, DOI 10.1016/j.bbi.2018.06.002; Ledesma E, 2004, CYTOKINE, V26, P66, DOI 10.1016/j.cyto.2003.12.009; Lee JY, 2015, J NEUROTRAUM, V32, P633, DOI 10.1089/neu.2014.3527; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Leonard SC, 2017, ANTI-CANCER DRUG, V28, P1086, DOI 10.1097/CAD.0000000000000545; Li T, 2018, INT J NEUROSCI, V128, P778, DOI 10.1080/00207454.2018.1424154; Lin WP, 2016, SPINAL CORD, V54, P778, DOI 10.1038/sc.2016.20; Lin XL, 2019, EUR REV MED PHARMACO, V23, P1891, DOI 10.26355/eurrev_201903_17226; Liu LM, 2018, INT J ONCOL, V53, P1897, DOI 10.3892/ijo.2018.4531; Liu SC, 2016, TAIWAN J OBSTET GYNE, V55, P213, DOI 10.1016/j.tjog.2016.02.011; Liu T, 2019, J ALLERGY CLIN IMMUN, V144, P777, DOI 10.1016/j.jaci.2019.05.006; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.460; Lu FF, 2020, J CELL PHYSIOL, V235, P3207, DOI 10.1002/jcp.29268; Lu YH, 2016, BIOMATERIALS, V90, P27, DOI 10.1016/j.biomaterials.2016.03.003; Mazzone GL, 2017, NEUROSCIENCE, V343, P398, DOI 10.1016/j.neuroscience.2016.12.008; McKenzie BA, 2020, TRENDS NEUROSCI, V43, P55, DOI 10.1016/j.tins.2019.11.005; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Namjoo Z, 2018, J CELL BIOCHEM, V119, P10195, DOI 10.1002/jcb.27361; Oleszycka E, 2016, FEBS J, V283, P9, DOI 10.1111/febs.13546; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993; Riedlinger T, 2019, CANCERS, V11, DOI 10.3390/cancers11060883; Shi DL, 2019, NEUROSCI LETT, V694, P161, DOI 10.1016/j.neulet.2018.12.006; Silvestris N, 2014, INT J MOL SCI, V15, P15767, DOI 10.3390/ijms150915767; Slaets H, 2014, MOL NEUROBIOL, V50, P1142, DOI 10.1007/s12035-014-8795-5; Sun WJ, 2019, J PHYSIOL BIOCHEM, V75, P531, DOI 10.1007/s13105-019-00702-7; Tsai KD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060318; Wang S, 2019, INT IMMUNOPHARMACOL, V67, P458, DOI 10.1016/j.intimp.2018.12.019; Wang X, 2021, ARTHRITIS RHEUMATOL, V73, P1478, DOI 10.1002/art.41685; Wang YZ, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5556659; Wu JL, 2019, AGING DIS, V10, P1094, DOI 10.14336/AD.2019.0116; Xiao LX, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118130; Yang ZX, 2020, BIOCHEM BIOPH RES CO, V522, P61, DOI 10.1016/j.bbrc.2019.11.031; Yates AG, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02050-6; Yoshizaki S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1536-y; Yuin Ho JS., 2020, BIORXIV; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang DP, 2019, J NEUROSCI RES, V97, P645, DOI 10.1002/jnr.24385; Zhang SX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0543-8; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhang YX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1468-6; Zheng G, 2019, EBIOMEDICINE, V40, P643, DOI 10.1016/j.ebiom.2018.12.059; Zhou W, 2017, J NEUROPHYSIOL, V117, P2282, DOI 10.1152/jn.00936.2016; Zhu S, 2019, NEUROCHEM INT, V124, P141, DOI 10.1016/j.neuint.2019.01.003	68	1	1	9	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22294	10.1096/fj.202100713RR	http://dx.doi.org/10.1096/fj.202100713RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1H6IJ	35579890				2022-12-28	WOS:000796644900001
J	Kamphuis, JBJ; Reber, LL; Eutamene, H; Theodorou, V				Kamphuis, J. B. J.; Reber, L. L.; Eutamene, H.; Theodorou, V			Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts	FASEB JOURNAL			English	Article						advanced glycation end products; fermentable carbohydrates; FODMAPs; goblet cells; intestinal barrier; mast cells; mucosal irritation; mucus barrier dysregulation	CHAIN FATTY-ACIDS; END-PRODUCTS; INTESTINAL BARRIER; METHYLGLYOXAL; FIBER; PYRIDOXAMINE; ACTIVATION; EXPRESSION; PROTEINS; RELEASE	Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder for which dietary interventions can be a useful treatment. In recent years, the low-FODMAP approach is gaining traction in this regard. The fermentation of these non-absorbed carbohydrates by the gut microbiota can generate toxic glycating metabolites, such as methylglyoxal. These metabolites can have harmful effects by their role in the generation of advanced glycation end products (AGEs), which activates Receptor for AGEs (AGER). Mast cells can be stimulated by AGEs and play a role in IBS. We have treated mice with lactose or fructo-oligosaccharides (FOS), with or without co-administration of pyridoxamine and investigated the colonic mucus barrier. We have found that an increased intake of lactose and fructo-oligosaccharides induces a dysregulation of the colonic mucus barrier, increasing mucus discharge in empty colon, while increasing variability and decreasing average thickness mucus layer covering the fecal pellet. Changes were correlated with increased mast cell counts, pointing to a role for the crosstalk between these and goblet cells. Additionally, AGE levels in colonic epithelium were increased by treatment with the selected fermentable carbohydrates. Observed effects were prevented by co-treatment with anti-glycation agent pyridoxamine, implicating glycation processes in the negative impact of fermentable carbohydrate ingestion. This study shows that excessive intake of fermentable carbohydrates can cause colonic mucus barrier dysregulation in mice, by a process that involves glycating agents and increased mucosal mast cell counts.	[Kamphuis, J. B. J.; Eutamene, H.; Theodorou, V] Univ Toulouse III, Inst Natl Rech Agr Alimentat & Environm INRAE Tox, UMR1331, INRAE,INP, Toulouse, France; [Kamphuis, J. B. J.; Reber, L. L.] Univ Toulouse III, CNRS, Toulouse Inst Infect & Inflammatory Dis Infin, INSERM,UMR1291,UMR5051, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Kamphuis, JBJ (corresponding author), Univ Toulouse III, CHU Purpan, CNRS, INSERM,UMR1291,UMR5051, BP 3028, F-31024 Toulouse, France.; Eutamene, H (corresponding author), Univ Toulouse III, UMR 1331, INRAE, INP, 180 Chemin Tournefeuille, F-31027 Toulouse, France.	jasper.kamphuis@inserm.fr; helene.eutamene@inrae.fr	Kamphuis, Jasper/R-8471-2016	Kamphuis, Jasper/0000-0002-8494-613X	People Programme of the EU's 7th Framework Programme under REA [607652]; Institut National de la Sante et de la Recherche Medicale (INSERM) ATIP-Avenir program; French Medical Research Foundation (FRM) [SPF202005011962]; INSERM; French Medical Research Foundation [FRM EQU202103012566]; ATIP-Avenir program; French National Research Agency [ANR18-CE18-0023, ANR-20-CE15-0026]	People Programme of the EU's 7th Framework Programme under REA; Institut National de la Sante et de la Recherche Medicale (INSERM) ATIP-Avenir program; French Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Medical Research Foundation(Fondation pour la Recherche Medicale); ATIP-Avenir program; French National Research Agency(French National Research Agency (ANR))	The research leading to these results has received funding from the People Programme of the EU's 7th Framework Programme under REA grant agreement no. 607652 (ITN NeuroGut). JBJK was supported by fellowships from the Institut National de la Sante et de la Recherche Medicale (INSERM) ATIP-Avenir program, and from the French Medical Research Foundation (FRM) (SPF202005011962). LLR acknowledges support from the INSERM, the French Medical Research Foundation (FRM EQU202103012566), ATIP-Avenir program and the French National Research Agency (ANR18-CE18-0023 and ANR-20-CE15-0026)	Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2011, J NEUROGASTROENTEROL, V17, P349, DOI 10.5056/jnm.2011.17.4.349; Bashashati M, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13192; Bennet SMP, 2016, AM J GASTROENTEROL, V111, P1165, DOI 10.1038/ajg.2016.223; Bergstrom K, 2020, SCIENCE, V370, P467, DOI 10.1126/science.aay7367; Brownlee IA, 2003, P NUTR SOC, V62, P245, DOI 10.1079/PNS2003206; Campbell AK, 2010, TOXICOLOGY, V278, P268, DOI 10.1016/j.tox.2010.09.001; Cardoso S, 2014, J BIOENERG BIOMEMBR, V46, P347, DOI 10.1007/s10863-014-9551-2; Castagliuolo I, 1996, AM J PHYSIOL-GASTR L, V271, pG884, DOI 10.1152/ajpgi.1996.271.5.G884; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Enck P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.14; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Genda T, 2017, J NUTR, V147, P1900, DOI 10.3945/jn.117.253955; Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x; Guarner F, 2006, J NUTR, V136, P2269, DOI 10.1093/jn/136.8.2269; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302; Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994; Kamphuis JBJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08938-3; Kamphuis JBJ, 2020, GASTROENTEROLOGY, V158, P652, DOI 10.1053/j.gastro.2019.10.037; Kingsley SF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85046-3; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; McIntosh K, 2017, GUT, V66, P1241, DOI 10.1136/gutjnl-2015-311339; Paturi G, 2012, J FUNCT FOODS, V4, P520, DOI 10.1016/j.jff.2012.02.013; Rabbani N, 2016, GLYCOCONJUGATE J, V33, P513, DOI 10.1007/s10719-016-9705-z; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V125, P525, DOI 10.1016/S1095-6433(00)00183-5; Sick E, 2010, BRIT J PHARMACOL, V161, P442, DOI 10.1111/j.1476-5381.2010.00905.x; Ten Bruggencate SJM, 2006, J NUTR, V136, P70, DOI 10.1093/jn/136.1.70; Ten Bruggencate SJM, 2005, J NUTR, V135, P837, DOI 10.1093/jn/135.4.837; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tsukahara T, 2002, J NUTR SCI VITAMINOL, V48, P311; Vanuytsel T, 2014, GUT, V63, P1293, DOI 10.1136/gutjnl-2013-305690; Voziyan PA, 2005, CELL MOL LIFE SCI, V62, P1671, DOI 10.1007/s00018-005-5082-7; Wautier MP, 2017, DIABETES METAB SYND, V11, P305, DOI 10.1016/j.dsx.2016.09.009; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Wouters MM, 2016, GUT, V65, P155, DOI 10.1136/gutjnl-2015-309151; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61	42	2	2	6	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22297	10.1096/fj.202100494RRR	http://dx.doi.org/10.1096/fj.202100494RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0K8YB	35394686	Green Published			2022-12-28	WOS:000781073500001
J	Qiao, P; Zhi, DL; Yu, C; Zhang, C; Wu, KY; Fang, H; Shao, S; Yin, W; Dang, EL; Li, K; Wang, G				Qiao, Pei; Zhi, Dalong; Yu, Chen; Zhang, Chen; Wu, Kunyi; Fang, Hui; Shao, Shuai; Yin, Wen; Dang, Erle; Li, Ke; Wang, Gang			Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis	FASEB JOURNAL			English	Article						C3a anaphylatoxin receptor; complement; downregulation; keratin; proliferation; psoriasis	COMPLEMENT; SKIN; C5A; HYPERPROLIFERATION; PATHOGENESIS; NEUTROPHIL; EXPRESSION; SYSTEM; K16	Emerging evidence suggests that signaling through the C3a anaphylatoxin receptor (C3aR) protects against various inflammation-related diseases. However, the role of C3aR in psoriasis remains unknown. The purpose of this study was to investigate the possible protective role of C3aR in psoriasis and to explore the underlying molecular mechanisms. We initially found that the psoriatic epidermis exhibited significantly decreased C3aR expression. C3aR showed protective roles in mouse models of imiquimod (IMQ)- and interleukin-23-induced psoriasis. Furthermore, increased epidermal thickness and keratin 6 (K6), K16, and K17 expression occurred in the ears and backs of C3aR(-/-) mice. Pharmacological treatment with a C3aR agonist ameliorated IMQ-induced psoriasiform lesions in mice and decreased the expression of K6, K16, and K17. Additionally, the signal transducer and activator of transcription 3 (STAT3) pathway participated in the protective function of C3aR. More importantly, the expression levels of K6, K16, and K17 in keratinocytes were all restored in HaCaT cells transfected with a C3aR-overexpression plasmid after treating them with colivelin (a STAT3 activator). Our findings demonstrate that C3aR protects against the development of psoriasis and suggest that C3aR confers protection by negatively regulating K6, K16, and K17 expression in a STAT3-dependent manner, thus inhibiting keratinocyte proliferation and helping reverse the pathogenesis of psoriasis.	[Qiao, Pei; Zhi, Dalong; Yu, Chen; Zhang, Chen; Fang, Hui; Shao, Shuai; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changle Western Rd, Xian 710032, Peoples R China; [Qiao, Pei; Yin, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Xian, Peoples R China; [Wu, Kunyi; Li, Ke] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710004, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changle Western Rd, Xian 710032, Peoples R China.; Li, K (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710004, Peoples R China.	ke.li@mail.xjtu.edu.cn; xjwgang@fmmu.edu.cn	Wang, Gang/H-6710-2019	Yu, Chen/0000-0001-7387-1198	National Natural Science Foundation of China [82173411, 82030096, 81972929, 81903206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (nos. 82173411, 82030096, 81972929, and 81903206).	Ahmad S, 2019, NEUROMOL MED, V21, P467, DOI 10.1007/s12017-019-08545-7; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Giacomassi C, 2017, J INVEST DERMATOL, V137, P760, DOI 10.1016/j.jid.2016.11.011; Giang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00639; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Jiang S, 2015, GENOM PROTEOM BIOINF, V13, P224, DOI 10.1016/j.gpb.2015.04.002; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; KORGE B, 1990, J INVEST DERMATOL, V95, P450, DOI 10.1111/1523-1747.ep12555613; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Ma Q, 2014, BONE MARROW TRANSPL, V49, P972, DOI 10.1038/bmt.2014.75; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Mommers JM, 2000, DERMATOLOGY, V201, P15, DOI 10.1159/000018422; Muenstermann M, 2019, VIRULENCE, V10, P677, DOI 10.1080/21505594.2019.1640035; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; OHKOHCHI K, 1986, Journal of Dermatology (Tokyo), V13, P266; Panelius J, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00003; Pozo-Rodrigalvarez A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.604812; Qiao P, 2019, J INVEST DERMATOL, V139, P1470, DOI 10.1016/j.jid.2018.12.019; Qiao P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00235-3; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosenberg EW, 1999, CLIN EXP DERMATOL, V24, P339; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; TAKEMATSU H, 1986, BRIT J DERMATOL, V114, P1, DOI 10.1111/j.1365-2133.1986.tb02773.x; Timar KK, 2006, MOL IMMUNOL, V43, P317, DOI 10.1016/j.molimm.2005.02.009; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194; Wei LL, 2020, ARTERIOSCL THROM VAS, V40, P2070, DOI 10.1161/ATVBAHA.120.314150; Wende E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062257; Wu KY, 2019, KIDNEY INT, V96, P612, DOI 10.1016/j.kint.2019.03.005; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110; Zhang XW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080807; Zheng QY, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106692; Zheng QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33489	38	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22322	10.1096/fj.202101458R	http://dx.doi.org/10.1096/fj.202101458R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3GL	35429062				2022-12-28	WOS:000782730300001
J	She, M; Li, T; Shi, WQ; Li, B; Zhou, XD				She, Man; Li, Tao; Shi, Wenqing; Li, Bing; Zhou, Xiaodong			AREG is involved in scleral remodeling in form-deprivation myopia via the ERK1/2-MMP-2 pathway	FASEB JOURNAL			English	Article						AREG; ERK1; 2; MMP-2; myopia; scleral remodeling	GROWTH-FACTOR RECEPTOR; OCULAR GROWTH; AMPHIREGULIN; KINASE	Previous studies have found that amphiregulin (AREG) may participate in eye elongation during the development of myopia, but the mechanism remains unclear. Here, we tested tear concentrations of AREG in adults and detected the role of AREG in scleral remodeling in form-deprivation myopia (FDM) in guinea pigs. We found the tear concentrations of AREG in myopes were significantly higher than those in emmetropes using enzyme-linked immunosorbent assay (ELISA). Tear concentrations of AREG were negatively correlated with spherical equivalent refraction and positively correlated with axial length (AL) and AL/corneal radii. We then used RNAi, DNA transfection and PD98059 treatments to determine the effects of AREG on extracellular signal-regulated kinase 1/2 (ERK1/2) and matrix metalloprotease-2 (MMP-2) in primary scleral fibroblasts (SFs). The hypothesis was further verified via loss- and gain-of-function experiments by intravitreal application of anti-AREG antibody (anti-AR) or AREG in form-deprivation eyes in guinea pigs. Immunofluorescence assay was used for cell type identification. Western-blot and q-PCR were used for the detection of relative expressions. Transmission electron microscopy was performed for posterior scleral observation. In vitro, we found AREG overexpression increased phospho-ERK1/2 and MMP-2 expression, while depletion of AREG inhibited their expressions. PD98059 (an effective ERK1/2 inhibitor) inhibited AREG-induced MMP-2 upregulation. In vivo, we found anti-AR treatments suppressed FDM by inhibiting scleral remodeling, while AREG treatments promoted FDM. Our results suggest that AREG in tear fluids can serve as a potential biomarker in myopes. AREG is involved in scleral remodeling through the ERK1/2-MMP-2 pathway. AREG is a potential target for myopia control.	[She, Man; Li, Tao; Shi, Wenqing; Zhou, Xiaodong] Fudan Univ, Dept Ophthalmol, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China; [Li, Bing] Fudan Univ, Cent Lab, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China	Fudan University; Fudan University	Zhou, XD (corresponding author), Fudan Univ, Dept Ophthalmol, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China.; Li, B (corresponding author), Fudan Univ, Cent Lab, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China.	libingbm@163.com			Project of Shanghai Shenkang Hospital Development Center [SHDC2020CR1043B--004]; Project of Shanghai Jinshan District's Family Planning Commission [JSZK2019H01]	Project of Shanghai Shenkang Hospital Development Center; Project of Shanghai Jinshan District's Family Planning Commission	This work was supported by Project of Shanghai Shenkang Hospital Development Center (grant No. SHDC2020CR1043B--004) and Project of Shanghai Jinshan District's Family Planning Commission (grant No. JSZK2019H01)	Aluru SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051979; Atta G, 2021, HISTOCHEM CELL BIOL, V156, P123, DOI 10.1007/s00418-021-01985-y; Baird PN, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00231-4; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Boote C, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.100773; Dong L, 2019, ACTA OPHTHALMOL, V97, pE460, DOI 10.1111/aos.14080; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Hagan S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0065-3; Harper AR, 2015, EXP EYE RES, V133, P100, DOI 10.1016/j.exer.2014.07.015; Huang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11541-1; Iomdina Elena, 2015, Pomeranian J Life Sci, V61, P146; Jiang WJ, 2017, EBIOMEDICINE, V17, P134, DOI 10.1016/j.ebiom.2017.02.021; Jonas JB, 2021, GRAEF ARCH CLIN EXP, V259, P3229, DOI 10.1007/s00417-021-05200-5; Kastelan S, 2020, BIOCHEM MEDICA, V30, DOI 10.11613/BM.2020.030502; Li M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/5126560; Lin YY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00276; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; Metlapally R, 2015, PROG MOL BIOL TRANSL, V134, P241, DOI 10.1016/bs.pmbts.2015.05.005; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Peterson JL, 2014, INVEST OPHTH VIS SCI, V55, P2870, DOI 10.1167/iovs.13-12943; Platen C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4310419; Qiu C, 2018, INVEST OPHTH VIS SCI, V59, P2401, DOI 10.1167/iovs.18-23855; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; Resnikoff S, 2019, INVEST OPHTH VIS SCI, V60, pMI, DOI 10.1167/iovs.18-25983; Sahay P, 2017, INVEST OPHTH VIS SCI, V58, pBIO106, DOI 10.1167/iovs.17-21723; Sharma NS, 2019, INDIAN J OPHTHALMOL, V67, P38, DOI 10.4103/ijo.IJO_568_18; She M, 2022, CURR EYE RES, V47, P477, DOI 10.1080/02713683.2021.1998543; She M, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9802; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071441; Tung SL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.25; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Wang SF, 2021, CANCER LETT, V523, P82, DOI 10.1016/j.canlet.2021.09.043; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Wong CW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52156-y; Wu H, 2018, P NATL ACAD SCI USA, V115, pE7091, DOI 10.1073/pnas.1721443115; Yao BY, 2017, EXP CELL RES, V359, P10, DOI 10.1016/j.yexcr.2017.06.024; Yotsumoto F, 2010, CANCER SCI, V101, P2351, DOI 10.1111/j.1349-7006.2010.01671.x; You JJ, 2013, MOL VIS, V19, P509; Zhao F, 2018, AM J PATHOL, V188, P1754, DOI 10.1016/j.ajpath.2018.04.011	42	0	0	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22289	10.1096/fj.202200132R	http://dx.doi.org/10.1096/fj.202200132R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZW	35436023				2022-12-28	WOS:000783259900001
J	Song, AR; Wen, AQ; Wen, YE; Dzieciatkowska, M; Kellems, RE; Juneja, HS; D'Alessandro, A; Xia, Y				Song, Anren; Wen, Alexander Q.; Wen, Y. Edward; Dzieciatkowska, Monika; Kellems, Rodney E.; Juneja, Harinder S.; D'Alessandro, Angelo; Xia, Yang			p97 dysfunction underlies a loss of quality control of damaged membrane proteins and promotes oxidative stress and sickling in sickle cell disease	FASEB JOURNAL			English	Article						p97; reactive oxygen species; sickle cell disease; ubiquitin-proteasome system	ERYTHROCYTE-MEMBRANE; CHEMICAL DIFFERENCE; UBIQUITIN; PROTEOMICS; ATPASE; LYSOSOME; SYSTEM	Sickling is the central pathogenic process of sickle cell disease (SCD), one of the most prevalent inherited hemolytic disorders. Having no easy access to antioxidants in the cytosol, elevated levels of reactive oxygen species (ROS) residing at the plasma membrane in sickle red blood cells (sRBCs) easily oxidize membrane proteins and thus contribute to sickling. Although the ubiquitin-proteasome system (UPS) is essential to rapidly clear ROS-damaged membrane proteins and maintain cellular homeostasis, the function and regulatory mechanism of the UPS for their clearance in sRBCs remains unidentified. Elevated levels of polyubiquitinated membrane-associated proteins in human sRBCs are reported here. High throughput and untargeted proteomic analyses of membrane proteins immunoprecipitated by ubiquitin antibodies detected elevated levels of ubiquitination of a series of proteins including cytoskeletal proteins, transporters, ROS-related proteins, and UPS machinery components in sRBCs. Polyubiquitination of membrane-associated catalase was increased in sRBCs, associated with decreased catalase activity and elevated ROS. Surprisingly, shuttling of p97 (ATP-dependent valosin-containing chaperone protein), a key component of the UPS to shuttle polyubiquitinated proteins from the membrane to cytosol for proteasomal degradation, was significantly impaired, resulting in significant accumulation of p97 along with polyubiquitinated proteins in the membrane of human sRBCs. Functionally, inhibition of p97 directly promoted accumulation of polyubiquitinated membrane-associated proteins, excessive ROS levels, and sickling in response to hypoxia. Overall, we revealed that p97 dysfunction underlies impaired UPS and contributes to oxidative stress in sRBCs.	[Song, Anren; Wen, Alexander Q.; Wen, Y. Edward; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Wen, Alexander Q.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Wen, Y. Edward] Univ Texas Southwestern Med Sch, Dallas, TX USA; [Dzieciatkowska, Monika; D'Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Grad Program Biochem & Cell Biol, MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Juneja, Harinder S.] Univ Texas Houston, Dept Internal Med, Div Hematol, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Wen, Y. Edward/0000-0002-7376-0014; Dzieciatkowska, Monika/0000-0002-9947-2520	American Heart Assocation [19CDA34670038]; Univeristy of Texas-McGovern Medical School; National Institutes of Health [HL113574, HL146442, HL149714, HL148151, HL150032]	American Heart Assocation; Univeristy of Texas-McGovern Medical School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	American Heart Assocation, Grant/ Award Number: 19CDA34670038; Univeristy of Texas-McGovern Medical School; National Institutes of Health, Grant/Award Number: HL113574, HL146442, HL149714, HL148151 and HL150032	Adebiyi MG, 2019, BLOOD ADV, V3, P1347, DOI 10.1182/bloodadvances.2018030619; Ahmed TA, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13081148; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chapman E, 2015, MOLECULES, V20, P3027, DOI 10.3390/molecules20023027; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; D'Alessandro A, 2020, CURR OPIN HEMATOL, V27, P155, DOI 10.1097/MOH.0000000000000574; D'Alessandro A, 2017, BLOOD TRANSFUS-ITALY, V15, P182, DOI 10.2450/2017.0293-16; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Darrow MC, 2016, J CELL SCI, V129, P3511, DOI 10.1242/jcs.189225; Ghatpande SS, 2004, CELL MOL BIOL, V50, P67; Ghatpande SS, 2010, J PROTEOMICS, V73, P619, DOI 10.1016/j.jprot.2009.11.003; Goodman SR, 2016, EXP BIOL MED, V241, P772, DOI 10.1177/1535370216640150; Goodman SR, 2013, EXP BIOL MED, V238, P509, DOI 10.1177/1535370213488474; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Herrick James B., 2001, Yale Journal of Biology and Medicine, V74, P179; Silva DGH, 2013, FREE RADICAL BIO MED, V65, P1101, DOI 10.1016/j.freeradbiomed.2013.08.181; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kakhniashvili DG, 2005, EXP BIOL MED, V230, P787, DOI 10.1177/153537020523001102; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Maher P., 2014, BIOPROTOC, V4, P1028; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mockesch B, 2017, BRIT J HAEMATOL, V178, P468, DOI 10.1111/bjh.14693; Neelam S, 2011, EXP BIOL MED, V236, P580, DOI 10.1258/ebm.2011.010394; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rocha S, 2008, BLOOD CELL MOL DIS, V41, P5, DOI 10.1016/j.bcmd.2008.02.008; Rocha S, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183172; Rocha S, 2009, BLOOD CELL MOL DIS, V43, P68, DOI 10.1016/j.bcmd.2009.03.002; Rogers SC, 2013, BLOOD, V121, P1651, DOI 10.1182/blood-2012-02-414037; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sommer T, 2014, BBA-MOL CELL RES, V1843, P1, DOI 10.1016/j.bbamcr.2013.09.009; Song AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14108; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Strader MB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71096-6; Sun KQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13667-8; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Sundd P, 2019, ANNU REV PATHOL-MECH, V14, P263, DOI 10.1146/annurev-pathmechdis-012418-012838; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vona R, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020296; Warang P, 2018, BRIT J HAEMATOL, V182, P559, DOI 10.1111/bjh.15437; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29637; Xu GYG, 2017, MOL PHARMACEUT, V14, P3499, DOI 10.1021/acs.molpharmaceut.7b00553; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	57	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22246	10.1096/fj.202101500RR	http://dx.doi.org/10.1096/fj.202101500RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0J9BZ	35405035	hybrid			2022-12-28	WOS:000780394800001
J	Yan, YX; Dong, J; Li, YL; Lu, YK; Yang, K; Wang, T; Zhang, X; Xiao, HB				Yan, Yu-Xiang; Dong, Jing; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun; Wang, Tao; Zhang, Xiao; Xiao, Huan-Bo			CircRNA hsa_circ_0071336 is associated with type 2 diabetes through targeting the miR-93-5p/GLUT4 axis	FASEB JOURNAL			English	Article						biomarker; GLUT4; hsa_circ_0071336; type 2 diabetes	INSULIN-RESISTANCE; POTENTIAL BIOMARKERS; THERAPEUTIC TARGETS; CIRCULAR RNAS; GLUT4; MUSCLE; BLOOD; MESSENGERS; MICRORNAS; REVEALS	Glucose transporter 4 (GLUT4) is a dominant regulator of whole-body glucose homeostasis. Accumulating evidence has shown that circular RNAs (circRNAs) play significant roles in the pathogenesis of disease. The aim of the present study was to identify the circRNA that can be used as a novel biomarker for type 2 diabetes (T2D) through regulating GLUT4. Based on previous microarray analysis comparing T2D cases and healthy controls, hsa_circ_0071336, which was predicted to be a regulator of GLUT4 by acting as a competitive endogenous RNAs (ceRNA) to sponge miR-93-5p, was selected for further validation. The clinical significance of circulating hsa_circ_0071336 was investigated in a large independent cohort. The results showed that circulating hsa_circ_0071336 was significantly downregulated in blood in T2D and had a high diagnostic accuracy for discriminating T2D and impaired fasting glucose (IFG) from healthy controls. Low expression of circ_0071336 was an independent predictor of T2D, IFG and insulin resistance. A luciferase reporter assay and western-blot analysis indicated that miR-93-5p was a direct target of hsa_circ_0071336, and miR-93-5p may negatively regulate the expression of GLUT4. The expression levels of hsa_circ_007136 were negatively related to miR-93-5p expression and positively correlated with the mRNA expression of GLUT4 in adipose tissues. In conclusion, hsa_circRNA_0071336 can be considered as a potential novel and stable biomarker for T2D and its early detection. hsa_circ_0071336 regulates the GLUT4 expression by sponging miR-93-5p and maybe involved in the pathogenesis of T2D. These findings may unveil new targets for the prevention, diagnosis and treatment of T2D.	[Yan, Yu-Xiang; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 10 Xitoutiao, Beijing 100069, Peoples R China; [Yan, Yu-Xiang; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Dong, Jing] Capital Med Univ, Xuanwu Hosp, Hlth Management Ctr, Beijing, Peoples R China; [Wang, Tao; Zhang, Xiao] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Tao; Zhang, Xiao] China Int Neurosci Inst China INI, Beijing, Peoples R China; [Xiao, Huan-Bo] Capital Med Univ, Dept Prevent Med, Yanjing Med Coll, 4 Dadong Rd, Beijing 101300, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Yan, YX (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 10 Xitoutiao, Beijing 100069, Peoples R China.; Xiao, HB (corresponding author), Capital Med Univ, Dept Prevent Med, Yanjing Med Coll, 4 Dadong Rd, Beijing 101300, Peoples R China.	yanyxepi@ccmu.edu.cn; smallmoon1973@163.com	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81773511, 81573214]; Beijing Municipal Natural Science Foundation [7162020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (81773511, 81573214) and the Beijing Municipal Natural Science Foundation (7162020).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amiral J, 2021, TRANSFUS APHER SCI, V60, DOI 10.1016/j.transci.2021.103209; Bayoumi AS, 2018, ACTA PHARMACOL SIN, V39, P1100, DOI 10.1038/aps.2017.196; Buysschaert M, 2016, CURR DIABETES REV, V12, P8, DOI 10.2174/1573399811666150122150233; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen XF, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23439; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Gratchev A, 2012, IMMUNOBIOLOGY, V217, P476, DOI 10.1016/j.imbio.2012.01.008; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Guo HF, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11051207; Hayashi Y, 2010, BIOL PHARM BULL, V33, P1033, DOI 10.1248/bpb.33.1033; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kipmen-Korgun D, 2009, SCAND J CLIN LAB INV, V69, P350, DOI 10.1080/00365510802632163; Lu YK, 2021, J CLIN ENDOCR METAB, V106, pE2688, DOI 10.1210/clinem/dgab101; Mirra P, 2015, EPIGENOMICS-UK, V7, P653, DOI [10.2217/EPI.15.18, 10.2217/epi.15.18]; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Stoll L, 2018, MOL METAB, V9, P69, DOI 10.1016/j.molmet.2018.01.010; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yan YX, 2016, J EPIDEMIOL, V26, P355, DOI 10.2188/jea.JE20150183; Yan YX., IDENTIFICATION CIRCU; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaiou M, 2019, ADV EXP MED BIOL, V1134, P177, DOI 10.1007/978-3-030-12668-1_10; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang WZ, 2021, ADIPOCYTE, V10, P189, DOI 10.1080/21623945.2021.1908655; Zhao ZZ, 2017, ACTA DIABETOL, V54, P237, DOI 10.1007/s00592-016-0943-0; Zhao ZD, 2021, GENOMICS, V113, P3967, DOI 10.1016/j.ygeno.2021.09.020; Zhou M, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.11968; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zou HL, 2017, GRAEF ARCH CLIN EXP, V255, P1159, DOI 10.1007/s00417-017-3638-5	37	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22324	10.1096/fj.202200149RR	http://dx.doi.org/10.1096/fj.202200149RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O6CY	35439323				2022-12-28	WOS:000783613100001
J	Andres, F; Hannan, NJ; Walker, SP; MacDonald, TM; Wong, GRP; Murphy, C; Cannon, P; Kandel, M; Masci, J; Nguyen, TV; Abboud, A; Idzes, D; Kyritsis, V; Pritchard, N; Tong, SP; Kaituu-Lino, TJ				Andres, Faith; Hannan, Natalie J.; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Abboud, Alison; Idzes, Danica; Kyritsis, Valerie; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.			Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction	FASEB JOURNAL			English	Article						EPCR; placenta; preeclampsia; protein C; SGA	HYPERTENSION; COAGULATION; EXPRESSION; EFFICACY; SAFETY; WOMEN; EPCR	Placental dysfunction is the leading cause of both preeclampsia and fetal growth restriction. This study aimed to characterize endothelial protein C receptor (EPCR) in preterm preeclampsia, term preeclampsia, and fetal growth restriction (defined by delivery of a small for gestational age [SGA] infant [<10% birthweight centile]) and examine its regulation in primary syncytiotrophoblast. Placental EPCR mRNA and protein were significantly increased in patients with preterm preeclampsia (<34 weeks gestation) compared to gestation-matched controls (p < .0001). In the plasma, EPCR was also significantly elevated (p = .01) in established preterm preeclampsia while its substrate, protein C (PC) was significantly reduced (p = .0083). Placentas from preterm small for gestational age (SGA) cases, had elevated EPCR mRNA expression (p < .0001) relative to controls. At 36 weeks, no significant changes in plasma EPCR were detected in samples from patients destined to develop preeclampsia or deliver an SGA infant at term. In terms of syncytiotrophoblast, hypoxia significantly increased EPCR mRNA expression (p = .008), but Tumor Necrosis Factor Alpha (TNF-alpha) decreased EPCR mRNA. Interleukin-6 (IL-6) had no significant effect on EPCR mRNA expression. When isolated syncytiotrophoblast was treated with metformin under hypoxia (1% O-2) or normoxia (8% O-2), EPCR mRNA expression was significantly reduced (p = .008) relative to control. In conclusion, EPCR is markedly elevated in the placenta and the circulation of patients with established preterm preeclampsia and placental increases may be associated with hypoxia. Additionally, fetal growth-restricted pregnancies (as defined by the delivery of an SGA infant) also demonstrated elevated placental EPCR.	[Andres, Faith; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; [Andres, Faith; Hannan, Natalie J.; Walker, Susan P.; MacDonald, Teresa M.; Wong, Georgia P.; Murphy, Ciara; Cannon, Ping; Kandel, Manju; Masci, Joshua; Nguyen, Tuong-Vi; Abboud, Alison; Idzes, Danica; Kyritsis, Valerie; Pritchard, Natasha; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha J.] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia; [Hannan, Natalie J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Therapeut Discovery & Vasc Funct Grp, Heidelberg, Vic, Australia	University of Melbourne; University of Melbourne	Kaituu-Lino, TJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, 163 Studley Rd, Heidelberg, Vic 3084, Australia.	t.klino@unimelb.edu.au			National Health and Medical Research Council;  [1183854];  [1160711];  [2000732];  [1159261];  [1146128];  [1136418]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; ; 	National Health and Medical Research Council, Grant/Award Number: 1183854, 1160711, 2000732, 1159261, 1146128 and 1136418	[Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Aouache R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051496; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Cluver C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025809; Cluver CA, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2103; de Alwis N, 2020, PLACENTA, V102, P10, DOI 10.1016/j.placenta.2020.08.022; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; Lamarca B, 2010, Minerva Ginecol, V62, P105; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McCarthy FP, 2018, PREGNANCY HYPERTENS, V14, P72, DOI 10.1016/j.preghy.2018.03.010; Moser G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225639; Murphy CN, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147467; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Phillips JK, 2010, J MATERN-FETAL NEO M, V23, P622, DOI 10.3109/14767050903258746; Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rousseau A, 2009, EUR J OBSTET GYN R B, V146, P46, DOI 10.1016/j.ejogrb.2009.06.001; Saposnik B, 2012, THROMB RES, V129, P152, DOI 10.1016/j.thromres.2011.07.023; Shamshirsaz AA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/374047; Simcox LE, 2015, INT J MOL SCI, V16, P28418, DOI 10.3390/ijms161226104; Sood R, 2006, BLOOD, V107, P3173, DOI 10.1182/blood-2005-10-4111; Stevens W, 2017, AM J OBSTET GYNECOL, V217, P237, DOI 10.1016/j.ajog.2017.04.032; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Tong S, 2022, AM J OBSTET GYNECOL, V226, pS1157, DOI 10.1016/j.ajog.2020.09.014; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; von Dadelszen P, 2018, PREGNANCY HYPERTENS, V13, P121, DOI 10.1016/j.preghy.2018.05.009; Wang H, 2020, J CELL MOL MED, V24, P3370, DOI 10.1111/jcmm.15011; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915	37	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22651	10.1096/fj.202201150R	http://dx.doi.org/10.1096/fj.202201150R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1MY	36394528				2022-12-28	WOS:000887955700001
J	Bae, WJ; Kim, S; Ahn, JM; Han, JH; Lee, D				Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Han, Jae Ho; Lee, Dakeun			Estrogen-responsive cancer-associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production	FASEB JOURNAL			English	Article						cancer-associated fibroblast; CD147; estrogen; gastric cancer; matrix metalloproteinase	RECEPTOR-ALPHA; EMMPRIN; EXPRESSION; PROGNOSIS; INDUCER; TUMOR; BETA; SEX	Estrogen signaling has been extensively studied, especially in cancers that express estrogen receptor alpha (ER alpha). However, little is known regarding the effect of estrogen on cancer-associated fibroblasts (CAFs). Here, we explored the role of estrogen signaling of CAFs in gastric cancer (GC) progression. We investigated the phenotypic changes in CAFs upon 17 beta-estradiol (E2) treatment using ER alpha-negative/positive CAFs, and the conditioned media (CM) collected from these were compared with regard to cancer cell proliferation, migration, and invasion. A paracrine factor was found using a cytokine array and was confirmed using qRT-PCR, western blotting, and enzyme-linked immunosorbent assays. ER alpha-CD147-matrix metalloproteinase (MMP) axis was confirmed by knockdown experiments using specific siRNAs. We found that a subset of CAFs expressed ER alpha. ER alpha-positive CAFs were responsive to E2, inducing ER alpha expression in a dose-dependent manner. Although E2 did not induce the proliferation of ER alpha-positive CAFs, the CM from E2-bound ER alpha-positive CAFs significantly promoted cancer cell migration and invasion. Cytokine array revealed that CD147 was induced in ER alpha-positive CAFs upon E2 treatment; this was mediated via ER alpha. Increased CD147 upregulated MMP2 and MMP9 in CAFs, and also influenced cancer cells in a paracrine manner to increase MMPs and CD147 in cancer cells. High CD147 expression in tumor tissue was associated with a worse prognosis in GC patients. Our data suggest that estrogen signaling activation in CAFs and the byproduct CD147 are among the critical mediators between the interplay of CAFs and cancer cells to facilitate cancer progression.	[Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Han, Jae Ho; Lee, Dakeun] Ajou Univ, Dept Pathol, Sch Med, Suwon, South Korea; [Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Lee, Dakeun] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, South Korea	Ajou University; Ajou University	Han, JH; Lee, D (corresponding author), Ajou Univ, Dept Pathol, Sch Med, 164 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea.	hanpathol@ajou.ac.kr; dakeun@gmail.com			National Research Foundation of Korea (NRF) [2021R1A2C2005853, 2018R1A6A3A01013116, 2021R1A4A1031856]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2C2005853, 2018R1A6A3A01013116 and 2021R1A4A1031856	Baba M, 2008, BIOCHEM BIOPH RES CO, V374, P111, DOI 10.1016/j.bbrc.2008.06.122; BISWAS C, 1995, CANCER RES, V55, P434; Burnett LA, 2012, J CLIN ENDOCR METAB, V97, P4613, DOI 10.1210/jc.2012-2098; Caudron A, 2016, EXP DERMATOL, V25, P618, DOI 10.1111/exd.13022; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Cirri P, 2011, AM J CANCER RES, V1, P482; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; Hua H, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0116-7; Humar B, 2009, CANCER RES, V69, P2050, DOI 10.1158/0008-5472.CAN-08-2457; Kameda C, 2010, BRIT J CANCER, V102, P738, DOI 10.1038/sj.bjc.6605517; Kim HW, 2016, ANN SURG ONCOL, V23, P4344, DOI 10.1245/s10434-016-5448-0; Kunz PL, 2012, J CLIN ONCOL, V30, P3507, DOI 10.1200/JCO.2011.35.8028; Landras A, 2019, CANCERS, V11, DOI 10.3390/cancers11111803; Langdon SP, 2020, CANCERS, V12, DOI 10.3390/cancers12102744; Lee D, 2017, GASTRIC CANCER, V20, P591, DOI 10.1007/s10120-016-0669-2; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; MATSUI M, 1992, SURG TODAY, V22, P421, DOI 10.1007/BF00308791; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; MIYAUCHI T, 1991, J BIOCHEM-TOKYO, V110, P770, DOI 10.1093/oxfordjournals.jbchem.a123657; Oesterreich S, 2003, CANCER RES, V63, P5203; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; RIBEIRO MM, 1981, CANCER, V47, P780, DOI 10.1002/1097-0142(19810215)47:4<780::AID-CNCR2820470424>3.0.CO;2-G; Sienel W, 2008, MODERN PATHOL, V21, P1130, DOI 10.1038/modpathol.2008.102; Srinivasan S, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1187; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Ulrich H, 2020, STEM CELL REV REP, V16, P434, DOI 10.1007/s12015-020-09976-7; Walter M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078056; Xiong LJ, 2014, INT J MOL SCI, V15, P17411, DOI 10.3390/ijms151017411; Xu CY, 2010, ANN SURG ONCOL, V17, P2503, DOI 10.1245/s10434-010-1031-2; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Yi JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07592; Zhao XH, 2003, WORLD J GASTROENTERO, V9, P665, DOI 10.3748/wjg.v9.i4.665	35	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22597	10.1096/fj.202200164RR	http://dx.doi.org/10.1096/fj.202200164RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9QN	36197688				2022-12-28	WOS:000863902600001
J	Hatakeyama, D; Sunada, H; Totani, Y; Watanabe, T; Felletar, I; Fitchett, A; Eravci, M; Anagnostopoulou, A; Miki, R; Okada, A; Abe, N; Kuzuhara, T; Kemenes, I; Ito, E; Kemenes, G				Hatakeyama, Dai; Sunada, Hiroshi; Totani, Yuki; Watanabe, Takayuki; Felletar, Ildiko; Fitchett, Adam; Eravci, Murat; Anagnostopoulou, Aikaterini; Miki, Ryosuke; Okada, Ayano; Abe, Naoya; Kuzuhara, Takashi; Kemenes, Ildiko; Ito, Etsuro; Kemenes, Gyorgy			Molecular and functional characterization of an evolutionarily conserved CREB-binding protein in the Lymnaea CNS	FASEB JOURNAL			English	Article						cerebral giant cell; CREB-binding protein; histone acetyltransferase; long-term memory; Lymnaea; synaptic plasticity	HISTONE ACETYLTRANSFERASE ACTIVITY; CENTRAL-NERVOUS-SYSTEM; LONG-TERM-MEMORY; CONDITIONED TASTE-AVERSION; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; STRUCTURAL BASIS; COACTIVATOR CBP; MESSENGER-RNA	In eukaryotes, CREB-binding protein (CBP), a coactivator of CREB, functions both as a platform for recruiting other components of the transcriptional machinery and as a histone acetyltransferase (HAT) that alters chromatin structure. We previously showed that the transcriptional activity of cAMP-responsive element binding protein (CREB) plays a crucial role in neuronal plasticity in the pond snail Lymnaea stagnalis. However, there is no information on the molecular structure and HAT activity of CBP in the Lymnaea central nervous system (CNS), hindering an investigation of its postulated role in long-term memory (LTM). Here, we characterize the Lymnaea CBP (LymCBP) gene and identify a conserved domain of LymCBP as a functional HAT. Like CBPs of other species, LymCBP possesses functional domains, such as the KIX domain, which is essential for interaction with CREB and was shown to regulate LTM. In-situ hybridization showed that the staining patterns of LymCBP mRNA in CNS are very similar to those of Lymnaea CREB1. A particularly strong LymCBP mRNA signal was observed in the cerebral giant cell (CGC), an identified extrinsic modulatory interneuron of the feeding circuit, the key to both appetitive and aversive LTM for taste. Biochemical experiments using the recombinant protein of the LymCBP HAT domain showed that its enzymatic activity was blocked by classical HAT inhibitors. Preincubation of the CNS with such inhibitors blocked cAMP-induced synaptic facilitation between the CGC and an identified follower motoneuron of the feeding system. Taken together, our findings suggest a role for the HAT activity of LymCBP in synaptic plasticity in the feeding circuitry.	[Hatakeyama, Dai; Felletar, Ildiko; Fitchett, Adam; Eravci, Murat; Anagnostopoulou, Aikaterini; Kemenes, Ildiko; Kemenes, Gyorgy] Univ Sussex, Sch Life Sci, Sussex Neurosci, Brighton BN1 9QG, E Sussex, England; [Hatakeyama, Dai; Miki, Ryosuke; Okada, Ayano; Abe, Naoya; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Sunada, Hiroshi; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Totani, Yuki; Ito, Etsuro] Waseda Univ, Dept Biol, Tokyo, Japan; [Watanabe, Takayuki] Sokendai Hayama, Lab Neuroethol, Hayama, Kanagawa, Japan	University of Sussex; Tokushima Bunri University; Tokushima Bunri University; Waseda University; Graduate University for Advanced Studies - Japan	Kemenes, G (corresponding author), Univ Sussex, Sch Life Sci, Sussex Neurosci, Brighton BN1 9QG, E Sussex, England.; Hatakeyama, D (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan.	daihatake926@ph.bunri-u.ac.jp; g.kemenes@sussex.ac.uk	ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Anagnostopoulou, Aikaterini/0000-0002-1357-6573	UKRI I Medical Research Council (MRC) [MRC/G0400551]; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H009906/1, BB/P00766X/1]; Waseda University [2018K141, 2020C135]	UKRI I Medical Research Council (MRC); UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Waseda University	UKRI I Medical Research Council (MRC), Grant/Award Number: MRC/G0400551; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/H009906/1 and BB/P00766X/1; Waseda University, Grant/Award Number: 2018K141 and 2020C135	Ahmed T, 2011, SYNAPSE, V65, P572, DOI 10.1002/syn.20876; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Belviranli M, 2013, BIOGERONTOLOGY, V14, P187, DOI 10.1007/s10522-013-9422-y; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chatterjee S, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00886-1; Chatterjee S, 2013, J NEUROSCI, V33, P10698, DOI 10.1523/JNEUROSCI.5772-12.2013; Cheng YF, 2013, NEUROCHEM RES, V38, P98, DOI 10.1007/s11064-012-0894-y; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Coste C, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091266; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Gachon F, 2002, VIROLOGY, V299, P271, DOI 10.1006/viro.2002.1501; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hatakeyama D, 2006, J MOL BIOL, V356, P569, DOI 10.1016/j.jmb.2005.12.009; Hatakeyama D, 2004, CELL TISSUE RES, V318, P631, DOI 10.1007/s00441-004-0965-8; Hatakeyama D, 2004, ACTA BIOL HUNG, V55, P157, DOI 10.1556/ABiol.55.2004.1-4.19; Hatakeyama D., 2013, METHODS NEUROETHOLOG, P151; Hatakeyama D, 2022, FEBS J, V289, P231, DOI 10.1111/febs.16123; Hatakeyama D, 2021, BIOCHEM BIOPH RES CO, V557, P273, DOI 10.1016/j.bbrc.2021.03.173; Hatakeyama D, 2018, BIOCHEM BIOPH RES CO, V504, P635, DOI 10.1016/j.bbrc.2018.09.007; Hatakeyama D, 2018, J BIOL CHEM, V293, P7126, DOI 10.1074/jbc.RA117.001683; Hatakeyama D, 2014, J BIOL CHEM, V289, P24980, DOI 10.1074/jbc.M114.559708; Hatakeyama Dai, 2013, Communicative & Integrative Biology, V6, pe23955, DOI 10.4161/cib.23955; Hatakeyama D, 2010, J NEUROSCI RES, V88, P1374, DOI 10.1002/jnr.22296; Hirano Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13471; Ito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043151; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kemenes I, 2006, CURR BIOL, V16, P1269, DOI 10.1016/j.cub.2006.05.049; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lakhina V, 2015, NEURON, V85, P330, DOI 10.1016/j.neuron.2014.12.029; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Laviv T, 2020, NEURON, V105, P799, DOI 10.1016/j.neuron.2019.11.028; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Liu DX, 2014, BEHAV BRAIN RES, V271, P116, DOI 10.1016/j.bbr.2014.05.068; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Maddox SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054463; Maddox SA, 2013, LEARN MEMORY, V20, P109, DOI 10.1101/lm.029157.112; Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f; Marra V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2591; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Matos MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10266-1; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Merschbaecher K, 2016, LEARN MEMORY, V23, P83, DOI 10.1101/lm.039438.115; Monsey MS, 2017, NEUROPSYCHOPHARMACOL, V42, P587, DOI 10.1038/npp.2016.117; Monsey MS, 2015, NEUROPSYCHOPHARMACOL, V40, P1278, DOI 10.1038/npp.2014.315; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Murakami J, 2013, J NEUROSCI, V33, P371, DOI 10.1523/JNEUROSCI.0679-12.2013; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Nakai J, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120422; Nakai J, 2020, INVERTEBR NEUROSCI, V20, DOI 10.1007/s10158-020-00241-7; Nakamura H, 1999, ZOOL SCI, V16, P387, DOI 10.2108/zsj.16.387; Namgyal D, 2020, TOXICOLOGY, V442, DOI 10.1016/j.tox.2020.152542; Nikitin ES, 2008, CURR BIOL, V18, P1221, DOI 10.1016/j.cub.2008.07.030; Nikitin ES, 2013, CURR BIOL, V23, P614, DOI 10.1016/j.cub.2013.02.048; Ortega E, 2018, NATURE, V562, P538, DOI 10.1038/s41586-018-0621-1; Plotnikov AN, 2014, STRUCTURE, V22, P353, DOI 10.1016/j.str.2013.10.021; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Raisner R, 2018, CELL REP, V24, P1722, DOI 10.1016/j.celrep.2018.07.041; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ribeiro MJ, 2003, EUR J NEUROSCI, V18, P1223, DOI 10.1046/j.1460-9568.2003.02856.x; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Scheibenstock A, 2002, J NEUROPHYSIOL, V88, P1584, DOI 10.1152/jn.2002.88.4.1584; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shen LL, 2015, NEURAL REGEN RES, V10, P925, DOI 10.4103/1673-5374.158358; Sunada H, 2017, ZOOL SCI, V34, P72, DOI 10.2108/zs160152; Tang HM, 2009, LIFE SCI, V85, P1, DOI 10.1016/j.lfs.2009.03.013; Totani Y, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0088-20.2020; Vavoulis DV, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00019; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu L, 2017, FEBS J, V284, P3422, DOI 10.1111/febs.14198; Yamanaka M, 2000, NEUROSCI LETT, V278, P113, DOI 10.1016/S0304-3940(99)00916-7; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131525; Zhang Y, 2018, NAT STRUCT MOL BIOL, V25, P841, DOI 10.1038/s41594-018-0114-9; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012; Zhou L, 2015, J NEUROSCI, V35, P1617, DOI 10.1523/JNEUROSCI.3330-14.2015	84	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22593	10.1096/fj.202101225RR	http://dx.doi.org/10.1096/fj.202101225RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J1EJ	36251357	hybrid, Green Accepted			2022-12-28	WOS:000868788600001
J	Yamamura, Y; Iwata, Y; Furuichi, K; Kato, T; Yamamoto, N; Horikoshi, K; Ogura, H; Sato, K; Oshima, M; Nakagawa, S; Miyagawa, T; Kitajima, S; Toyama, T; Hara, A; Sakai, N; Shimizu, M; Horike, S; Daikoku, T; Nishinakamura, R; Wada, T				Yamamura, Yuta; Iwata, Yasunori; Furuichi, Kengo; Kato, Takahiro; Yamamoto, Naoki; Horikoshi, Keisuke; Ogura, Hisayuki; Sato, Koichi; Oshima, Megumi; Nakagawa, Shiori; Miyagawa, Taro; Kitajima, Shinji; Toyama, Tadashi; Hara, Akinori; Sakai, Norihiko; Shimizu, Miho; Horike, Shinichi; Daikoku, Takiko; Nishinakamura, Ryuichi; Wada, Takashi			Kif26b contributes to the progression of interstitial fibrosis via migration and myofibroblast differentiation in renal fibroblast	FASEB JOURNAL			English	Article						Kif26b; Myh9; nonmuscle myosin heavy chain II; renal fibroblast; renal fibrosis	KINESIN; MYH9; GENE; MUTATIONS; PROTEIN	Kinesin family member 26b (Kif26b) is essential for kidney development, and its deletion in mice leads to kidney agenesis. However, the roles of this gene in adult settings remain elusive. Thus, this study aims to investigate the role of Kif26b in the progression of renal fibrosis. A renal fibrosis model with adenine administration using Kif26b heterozygous mice and wild-type mice was established. Renal fibrosis and the underlying mechanism were investigated. The underlying pathways and functions of Kif26b were evaluated in an in vitro model using primary renal fibroblasts. Kif26b heterozygous mice were protected from renal fibrosis with adenine administration. Renal expressions of connective tissue growth factor (CTGF) and myofibroblast accumulation were reduced in Kif26b heterozygous mice. The expression of nonmuscle myosin heavy chain II (NMHCII), which binds to the C-terminus of Kif26b protein, was also suppressed in Kif26b heterozygous mice. The in vitro study revealed reduced expressions of CTGF, alpha-smooth muscle actin, and myosin heavy chain 9 (Myh9) via transfection with siRNAs targeting Kif26b in renal fibroblasts (RFB). RFBs, which were transfected by the expression vector of Kif26b, demonstrated higher expressions of these genes than non-transfected cells. Finally, Kif26b suppression and NMHCII blockage led to reduced abilities of migration and collagen gel contraction in renal fibroblasts. Taken together, Kif26b contributes to the progression of interstitial fibrosis via migration and myofibroblast differentiation through Myh9 in the renal fibrosis model. Blockage of this pathway at appropriate timing might be a therapeutic approach for renal fibrosis.	[Yamamura, Yuta; Iwata, Yasunori; Kato, Takahiro; Yamamoto, Naoki; Horikoshi, Keisuke; Ogura, Hisayuki; Sato, Koichi; Oshima, Megumi; Nakagawa, Shiori; Miyagawa, Taro; Kitajima, Shinji; Toyama, Tadashi; Hara, Akinori; Sakai, Norihiko; Shimizu, Miho; Wada, Takashi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Nephrol & Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan; [Iwata, Yasunori] Kanazawa Univ Hosp, Div Infect Control, Kanazawa, Ishikawa, Japan; [Furuichi, Kengo] Kanazawa Med Univ, Dept Nephrol, Sch Med, Uchinada, Ishikawa, Japan; [Kitajima, Shinji; Sakai, Norihiko] Kanazawa Univ Hosp, Div Blood Purificat, Kahoku, Ishikawa, Japan; [Horike, Shinichi; Daikoku, Takiko] Kanazawa Univ, Res Ctr Expt Modeling Human Dis, Kanazawa, Ishikawa, Japan; [Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan	Kanazawa University; Kanazawa University; Kanazawa Medical University; Kanazawa University; Kumamoto University	Iwata, Y (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Nephrol & Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	iwatay@staff.kanazawa-u.ac.jp			MEXT \ Japan Science and Technology Agency (JST) [JP19K08699]; MEXT \ Japan Society for the Promotion of Science (JSPS) [JP20K22897]	MEXT \ Japan Science and Technology Agency (JST); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT vertical bar Japan Science and Technology Agency (JST), Grant/Award Number: JP19K08699; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K22897	Cirio MC, 2014, PEDIATR NEPHROL, V29, P553, DOI 10.1007/s00467-013-2597-2; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Karuna EP, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040196; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kramann R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99561; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lillie SH, 1998, J CELL BIOL, V140, P873, DOI 10.1083/jcb.140.4.873; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Okumura T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142843; Rahman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192531; Recuenco MC, 2015, J AM SOC NEPHROL, V26, P1081, DOI 10.1681/ASN.2014030281; Ruiz-Ortega M, 2020, NAT REV NEPHROL, V16, P269, DOI 10.1038/s41581-019-0248-y; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Schimmenti LA, 2011, EUR J HUM GENET, V19, P1207, DOI 10.1038/ejhg.2011.102; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Seri M, 2000, NAT GENET, V26, P103; Si J, 2010, LAB INVEST, V90, P448, DOI 10.1038/labinvest.2009.142; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Southern BD, 2016, J BIOL CHEM, V291, P6083, DOI 10.1074/jbc.M115.712380; Sun XH, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.573524; Terabayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039714; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Yokota M, 2021, FASEB J, V35, DOI 10.1096/fj.201902836R; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	32	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22606	10.1096/fj.202200355R	http://dx.doi.org/10.1096/fj.202200355R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0XH	36250931				2022-12-28	WOS:000868770000001
J	Holloway, C; Zhong, G; Kim, YK; Ye, H; Sampath, H; Hammerling, U; Isoherranen, N; Quadro, L				Holloway, Chelsee; Zhong, Guo; Kim, Youn-Kyung; Ye, Hong; Sampath, Harini; Hammerling, Ulrich; Isoherranen, Nina; Quadro, Loredana			Retinoic acid regulates pyruvate dehydrogenase kinase 4 (Pdk4) to modulate fuel utilization in the adult heart: Insights from wild-type and beta-carotene 9 ',10 ' oxygenase knockout mice	FASEB JOURNAL			English	Article						heart; metabolic flexibility; retinoic acid; beta-carotene 9 ',10 '-dioxygenase	CARDIOVASCULAR-DISEASE MORTALITY; MITOCHONDRIAL FUSION; GENE-EXPRESSION; OXIDATIVE STRESS; METABOLISM; ACYLTRANSFERASE; STARVATION; LECITHIN; FAILURE; MUSCLE	Regulation of the pyruvate dehydrogenase (PDH) complex by the pyruvate dehydrogenase kinase PDK4 enables the heart to respond to fluctuations in energy demands and substrate availability. Retinoic acid, the transcriptionally active form of vitamin A, is known to be involved in the regulation of cardiac function and growth during embryogenesis as well as under pathological conditions. Whether retinoic acid also maintains cardiac health under physiological conditions is unknown. However, vitamin A status and intake of its carotenoid precursor beta-carotene have been linked to the prevention of heart diseases. Here, we provide in vitro and in vivo evidence that retinoic acid regulates cardiac Pdk4 expression and thus PDH activity. Furthermore, we show that mice lacking beta-carotene 9',10'-oxygenase (BCO2), the only enzyme of the adult heart that cleaves beta-carotene to generate retinoids (vitamin A and its derivatives), displayed cardiac retinoic acid insufficiency and impaired metabolic flexibility linked to a compromised PDK4/PDH pathway. These findings provide novel insights into the functions of retinoic acid in regulating energy metabolism in adult tissues, especially the heart.	[Holloway, Chelsee] Rutgers State Univ, Grad Program Endocrinol & Anim Biosci, New Brunswick, NJ 08901 USA; [Holloway, Chelsee; Kim, Youn-Kyung; Ye, Hong; Hammerling, Ulrich; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA; [Holloway, Chelsee; Kim, Youn-Kyung; Ye, Hong; Sampath, Harini; Hammerling, Ulrich; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Holloway, Chelsee; Kim, Youn-Kyung; Ye, Hong; Sampath, Harini; Hammerling, Ulrich; Quadro, Loredana] Rutgers State Univ, Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Zhong, Guo; Isoherranen, Nina] Univ Washington, Dept Pharmaceut Hlth Sci, Seattle, WA 98195 USA; [Ye, Hong; Sampath, Harini] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	lquadro@sebs.rutgers.edu			HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD057493]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK126963]; HHS | NIH | National Institute of General Medical Sciences NIGMS) [GM111772]; NIH F31 Ruth Kirschstein Predoctoral individual research award [1F31HL143930]; Rutgers Center for Lipid Research small grant program; USDA, Hatch Project [1018402]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute of General Medical Sciences NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH F31 Ruth Kirschstein Predoctoral individual research award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Center for Lipid Research small grant program; USDA, Hatch Project	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/ Award Number: R01 HD057493; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK126963; HHS | NIH | National Institute of General Medical Sciences NIGMS), Grant/Award Number: GM111772; NIH F31 Ruth Kirschstein Predoctoral individual research award, Grant/Award Number: 1F31HL143930; Rutgers Center for Lipid Research small grant program; USDA, Hatch Project, Grant/Award Number: 1018402	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Becker JS, 2005, CIRCULATION, V111, P2112, DOI 10.1161/01.cir.0000162506.61443.15; Belyaeva OV, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010005; Blaner William S, 2016, Subcell Biochem, V81, P95; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129303; Brazionis L, 2012, NUTR METAB CARDIOVAS, V22, P914, DOI 10.1016/j.numecd.2011.08.009; Burchat N, 2022, BBA-MOL CELL BIOL L, V1867, DOI 10.1016/j.bbalip.2022.159195; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chandel NS, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a040535; Chen F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120398; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cheng HM, 2019, CRIT REV FOOD SCI, V59, P141, DOI 10.1080/10408398.2017.1362630; Chidipi B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051202; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Di WC, 2018, CURR ISSUES MOL BIOL, V28, P29, DOI 10.21775/cimb.028.029; Distel E, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600920; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gey KF, 2010, ATHEROSCLEROSIS, V208, P270, DOI 10.1016/j.atherosclerosis.2009.07.018; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guo X, 2017, J NUTR BIOCHEM, V46, P74, DOI 10.1016/j.jnutbio.2017.02.019; Han Y, 2019, ONCOGENE, V38, P7089, DOI 10.1038/s41388-019-0949-5; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harrison EH, 2018, ANNU REV NUTR, V38, P153, DOI 10.1146/annurev-nutr-082117-051841; HOLNESS MJ, 1989, BIOCHEM J, V258, P529, DOI 10.1042/bj2580529; Honarbakhsh M, 2021, J LIPID RES, V62, DOI 10.1016/j.jlr.2021.100046; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hsiao YT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86209-y; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang JQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26639-4; Ip BC, 2015, J NUTR, V145, P268, DOI 10.3945/jn.114.200238; Iskakova M, 2015, CAN J PHYSIOL PHARM, V93, P1065, DOI 10.1139/cjpp-2014-0522; Isoherranen N, 2019, PHARMACOL THERAPEUT, V204, DOI 10.1016/j.pharmthera.2019.107400; Jensen SK, 2018, J CARDIOPULM REHABIL, V38, P388, DOI 10.1097/HCR.0000000000000331; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kang HW, 2007, MOL CELL ENDOCRINOL, V271, P18, DOI 10.1016/j.mce.2007.03.002; Karppi J, 2012, NUTR METAB CARDIOVAS, V22, P921, DOI 10.1016/j.numecd.2012.01.008; Karppi J, 2013, INT J CARDIOL, V168, P1841, DOI 10.1016/j.ijcard.2012.12.072; Karppi J, 2013, ATHEROSCLEROSIS, V226, P172, DOI 10.1016/j.atherosclerosis.2012.10.077; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; Kkeveetil CV, 2016, TZU CHI MED J, V28, P143, DOI 10.1016/j.tcmj.2016.08.001; Klyuyeva A, 2019, J BIOL CHEM, V294, P838, DOI 10.1074/jbc.RA118.006433; Komakula SSB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33151-1; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; Liu LX, 2017, CIRC RES, V121, P1370, DOI 10.1161/CIRCRESAHA.117.311456; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Liu XL, 2012, MOL CELL BIOL, V32, P4493, DOI 10.1128/MCB.01092-12; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Lopaschuk GD, 2021, CIRC RES, V128, P1487, DOI 10.1161/CIRCRESAHA.121.318241; Manolescu DC, 2014, APPL PHYSIOL NUTR ME, V39, P1127, DOI 10.1139/apnm-2014-0005; McClintick JN, 2006, J NUTR BIOCHEM, V17, P345, DOI 10.1016/j.jnutbio.2005.08.006; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Mori J, 2013, AM J PHYSIOL-HEART C, V304, pH1103, DOI 10.1152/ajpheart.00636.2012; Napoli JL, 2022, NUTRIENTS, V14, DOI 10.3390/nu14081553; Napoli JL, 2020, METHOD ENZYMOL, V637, P27, DOI 10.1016/bs.mie.2020.02.003; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Paiva SAR, 2005, J NUTR, V135, P2326, DOI 10.1093/jn/135.10.2326; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Peters SJ, 2001, AM J PHYSIOL-REG I, V280, pR661, DOI 10.1152/ajpregu.2001.280.3.R661; Quadro L, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158591; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Saeed A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55988-w; SAFRANSKI TJ, 1993, BIOL REPROD, V48, P669, DOI 10.1095/biolreprod48.3.669; Schulze PC, 2016, CIRC RES, V118, P1736, DOI 10.1161/CIRCRESAHA.116.306842; Sharma P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020637; Sirbu IO, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158636; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Spiegler E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27071-3; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Wassef L, 2015, J NUTR, V145, P1408, DOI 10.3945/jn.114.207043; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wong AP, 2016, AM J CARDIOVASC DIS, V6, P81; Wu L, 2021, FREE RADICAL BIO MED, V164, P271, DOI 10.1016/j.freeradbiomed.2021.01.003; Wu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15222-x; Wu L, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600576; Wu L, 2016, EXP BIOL MED, V241, P1879, DOI 10.1177/1535370216657900; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Yang N, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.137593; Yu YR, 2019, AM J CLIN NUTR, V109, P449, DOI 10.1093/ajcn/nqy320; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007; Zhitkovich A, 2019, CHEM RES TOXICOL, V32, P1318, DOI 10.1021/acs.chemrestox.9b00152; Zhong G, 2019, J BIOL CHEM, V294, P11166, DOI 10.1074/jbc.RA119.009023; Zolfaghari R, 2009, ARCH BIOCHEM BIOPHYS, V489, P1, DOI 10.1016/j.abb.2009.08.001	100	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22513	10.1096/fj.202101910RR	http://dx.doi.org/10.1096/fj.202101910RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Y9KK	36004605	Green Published			2022-12-28	WOS:000844041100001
J	Lopez-Yus, M; Lorente-Cebrian, S; Del Moral-Bergos, R; Horndler, C; Garcia-Sobreviela, MP; Casamayor, C; Sanz-Paris, A; Bernal-Monterde, V; Arbones-Mainar, JM				Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Horndler, Carlos; Pilar Garcia-Sobreviela, Maria; Casamayor, Carmen; Sanz-Paris, Alejandro; Bernal-Monterde, Vanesa; Arbones-Mainar, Jose M.			Identification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression	FASEB JOURNAL			English	Article						adipose tissue; fatty liver; mesenchymal stem cell; obesity	CYTOKINE SIGNALING-3; STEM-CELLS; OBESITY; SUPPRESSOR; ADIPOGENESIS; LIPOGENESIS; METABOLISM; LIPIDS; DUSP1	Obesity is a major risk factor for the development of Nonalcoholic fatty liver disease (NAFLD). We hypothesize that a dysfunctional subcutaneous white adipose tissue (scWAT) may lead to an accumulation of ectopic fat in the liver. Our aim was to investigate the molecular mechanisms involved in the causative role of scWAT in NALFD progression. We performed a RNA-sequencing analysis in a discovery cohort (n = 45) to identify genes in scWAT correlated with fatty liver index, a qualitative marker of liver steatosis. We then validated those targets in a second cohort (n = 47) of obese patients who had liver biopsies available. Finally, we obtained scWAT mesenchymal stem cells (MSCs) from 13 obese patients at different stages of NAFLD and established in vitro models of human MSC (hMSC)-derived adipocytes. We observed impaired adipogenesis in hMSC-derived adipocytes as liver steatosis increased, suggesting that an impaired adipogenic capacity is a critical event in the development of NAFLD. Four genes showed a differential expression pattern in both scWAT and hMSC-derived adipocytes, where their expression paralleled steatosis degree: SOCS3, DUSP1, SIK1, and GADD45B. We propose these genes as key players in NAFLD progression. They could eventually constitute potential new targets for future therapies against liver steatosis.	[Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Pilar Garcia-Sobreviela, Maria; Arbones-Mainar, Jose M.] Univ Hosp Miguel Servet, Inst Aragones Ciencias Salud IACS, Translat Res Unit, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain; [Lopez-Yus, Marta; Lorente-Cebrian, Silvia; Del Moral-Bergos, Raquel; Horndler, Carlos; Pilar Garcia-Sobreviela, Maria; Casamayor, Carmen; Sanz-Paris, Alejandro; Bernal-Monterde, Vanesa; Arbones-Mainar, Jose M.] Inst Invest Sanitaria IIS Aragon, Zaragoza, Spain; [Lorente-Cebrian, Silvia] Univ Zaragoza, Dept Farmacol Fisiol & Med Legal & Forense, Zaragoza, Spain; [Lorente-Cebrian, Silvia] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain; [Horndler, Carlos] Miguel Servet Univ Hosp, Pathol Dept, Zaragoza, Spain; [Casamayor, Carmen] Miguel Servet Univ Hosp, Gen & Digest Surg Dept, Endocrine Bariatr & Breast Surg Unit, Zaragoza, Spain; [Sanz-Paris, Alejandro] Miguel Servet Univ Hosp, Nutr Dept, Zaragoza, Spain; [Bernal-Monterde, Vanesa] Miguel Servet Univ Hosp, Gastroenterol Dept, Zaragoza, Spain; [Arbones-Mainar, Jose M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain	Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arbones-Mainar, JM (corresponding author), Hosp Univ Miguel Servet, Adipocyte & Fat Biol Lab AdipoFat, Inst Invest Sanitaria IIS, Unidad Invest Traslac,Inst Aragones Ciencias Salu, Isabel Catolica 1-3, Zaragoza 50009, Spain.	jmarbones.iacs@aragon.es	Lorente-Cebrián, Silvia/N-2578-2019; del moral, raquel/ABF-5069-2021; GARCIA-SOBREVIELA, MARIA PILAR/AHD-2939-2022	Lorente-Cebrián, Silvia/0000-0002-1033-6152; del moral, raquel/0000-0002-0914-5578; Lopez Yus, Marta/0000-0002-5822-9823; GARCIA-SOBREVIELA, MARIA PILAR/0000-0001-5485-8983; Bernal-Monterde, Vanesa/0000-0002-4016-2165; Arbones-Mainar, Jose M/0000-0002-8982-3737; Sanz Paris, Alejandro/0000-0002-7758-3588	Instituto de Salud Carlos III [PI17/02268]; FEDER founds: "Una manera de hacer Europa"; regional government of Aragon [B03_20R]; FEDER Aragon	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER founds: "Una manera de hacer Europa"; regional government of Aragon(Gobierno de Aragon); FEDER Aragon	This study was sponsored by a grant (PI17/02268) from the Instituto de Salud Carlos III and by FEDER founds: "Una manera de hacer Europa" and by the regional government of Aragon (B03_20R), co-financed with the FEDER Aragon 2014-2020: "Construyendo Europa desde Aragon".	Azzu V, 2020, GASTROENTEROLOGY, V158, P1899, DOI 10.1053/j.gastro.2019.12.054; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963; Ferguson BS, 2016, J CELL PHYSIOL, V231, P1562, DOI 10.1002/jcp.25248; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Guiu B, 2012, EUR RADIOL, V22, P855, DOI 10.1007/s00330-011-2326-9; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Khadir A, 2015, AM J PHYSIOL-ENDOC M, V308, pE71, DOI 10.1152/ajpendo.00577.2013; Kim H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010050; Kitazawa A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257352; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lawan A, 2015, MOL CELL BIOL, V35, P26, DOI 10.1128/MCB.00503-14; Louwen F, 2018, OBES REV, V19, P888, DOI 10.1111/obr.12679; Mastrangelo A, 2016, BIOCHEM J, V473, P2187, DOI 10.1042/BCJ20160241; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mossel DM., 2020, FRONT IMMUNOL, V11, P1; Nixon M, 2016, MOL METAB, V5, P34, DOI 10.1016/j.molmet.2015.10.004; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Oliva-Olivera W, 2017, J CLIN ENDOCR METAB, V102, P478, DOI 10.1210/jc.2016-2256; Onate B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-625; Perez LM, 2016, OBESITY, V24, P661, DOI 10.1002/oby.21405; Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123397; Perez-Diaz S, 2017, AM J PHYSIOL-CELL PH, V312, pC83, DOI 10.1152/ajpcell.00246.2016; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Serena C, 2016, STEM CELLS, V34, P2559, DOI 10.1002/stem.2429; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Silva KR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0029-x; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Torres-Perez E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0203-6; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109	43	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22429	10.1096/fj.202200118RR	http://dx.doi.org/10.1096/fj.202200118RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5UR	35792898	Green Submitted			2022-12-28	WOS:000821177600001
J	Szuszkiewicz, J; Myszczynski, K; Reliszko, ZP; Heifetz, Y; Kaczmarek, MM				Szuszkiewicz, Joanna; Myszczynski, Kamil; Reliszko, Zaneta P.; Heifetz, Yael; Kaczmarek, Monika M.			Early steps of embryo implantation are regulated by exchange of extracellular vesicles between the embryo and the endometrium	FASEB JOURNAL			English	Article						embryo; extracellular vesicles; implantation; invasion; migration; miRNA; pregnancy; proliferation; transcriptome; trophoblast	PREGNANCY; BLASTOCYST; MICRORNAS; PORCINE; PIG; REPRODUCTION; INFLAMMATION; BIOGENESIS; CYTOSCAPE; MECHANISM	In early pregnancy, as the embryo arrives in the uterus, intensive communication between the embryo and uterus begins. Hundreds of molecules are known to be involved, but despite numerous findings, full understanding of the complexity of the embryo-maternal dialog remains elusive. Recently, extracellular vesicles, nanoparticles able to transfer functionally active cargo between cells, have emerged as important players in cell-cell communication, and as such, they have gained great attention over the past decade also in reproductive biology. Here, we use a domestic animal model (Sus scrofa) with an epitheliochorial, superficial type of placentation because of its advantage in studding uterine luminal fluid extracellular vesicles. We show that during early pregnancy, the uterine lumen is abundant with extracellular vesicles that carry a plethora of miRNAs able to target genes involved in embryonic and organismal development. These extracellular vesicles, upon the delivery to primary trophoblast cells, affect genes governing development as well as cell-to-cell signaling and interactions, consequently having an impact on trophoblast cell proliferation, migration, and invasion. We conclude that the exchange of a unique population of extracellular vesicles and their molecular cargo at the maternal-embryo interface is the key to the success of embryo implantation and pregnancy.	[Szuszkiewicz, Joanna; Reliszko, Zaneta P.; Kaczmarek, Monika M.] Polish Acad Sci, Inst Anim Reprod & Food Res, Dept Hormonal Action Mech, Tuwima 10, PL-10748 Olsztyn, Poland; [Myszczynski, Kamil; Heifetz, Yael] Polish Acad Sci, Mol Biol Lab, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Heifetz, Yael] Hebrew Univ Jerusalem, Dept Entomol, Rehovot, Israel	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Hebrew University of Jerusalem	Kaczmarek, MM (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Dept Hormonal Action Mech, Tuwima 10, PL-10748 Olsztyn, Poland.	m.kaczmarek@pan.olsztyn.pl	; SZUSZKIEWICZ, Joanna/H-7226-2017; KACZMAREK, Monika M./N-4892-2015	Myszczynski, Kamil/0000-0002-3118-0900; SZUSZKIEWICZ, Joanna/0000-0002-0884-4895; KACZMAREK, Monika M./0000-0002-8213-4381	Institute of Animal Reproduction and Food Research, Polish Academy of Sciences [1/FBW/2022]; Ministerstwo Edukacji i Nauki (MNiSW) [0041/DIA/2014/43]; Narodowe Centrum Nauki (NCN) [2014/15/B/NZ9/04932, 2016/21/N/NZ9/03443]	Institute of Animal Reproduction and Food Research, Polish Academy of Sciences; Ministerstwo Edukacji i Nauki (MNiSW); Narodowe Centrum Nauki (NCN)(National Science Centre, Poland)	Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Grant/Award Number: 1/FBW/2022; Ministerstwo Edukacji i Nauki (MNiSW), Grant/Award Number: 0041/DIA/2014/43; Narodowe Centrum Nauki (NCN), Grant/Award Number: 2014/15/B/NZ9/04932 and 2016/21/N/NZ9/03443	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrews S., 2015, BABRAHAM BIOINF; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauersachs S, 2012, ANIM REPROD SCI, V134, P84, DOI 10.1016/j.anireprosci.2012.08.015; Bazer F. W., 1982, Control of pig reproduction, P227; Bazer FW, 2015, ANIM NUTR, V1, P85, DOI 10.1016/j.aninu.2015.07.005; Bazer Fuller W, 2011, Front Biosci (Schol Ed), V3, P745, DOI 10.2741/s184; Bidarimath M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40476; Blitek A, 2012, THERIOGENOLOGY, V78, P951, DOI 10.1016/j.theriogenology.2012.05.016; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burns GW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134973; Chavan AR, 2017, CURR OPIN GENET DEV, V47, P24, DOI 10.1016/j.gde.2017.08.004; Chen PD, 2018, NAT IMMUNOL, V19, P1040, DOI 10.1038/s41590-018-0215-y; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Core Development Team R., 2021, R LANG ENV STAT COMP; Curry E., 2010, IDENTIFICATION CHARA; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dziuk P. J., 1987, Manipulating pig production. Proceedings of the inaugural conference of the Australasian Pig Science Association (APSA), held in Albury, NSW on November 23 to 25, 1987., P28; Erhard F, 2014, GENOME RES, V24, P906, DOI 10.1101/gr.166702.113; Escudero CA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00098; Flint A. P. F., 1982, Control of pig reproduction, P253; GEISERT RD, 1982, BIOL REPROD, V27, P941, DOI 10.1095/biolreprod27.4.941; Giacomini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05549-w; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; HAKIM RB, 1995, AM J OBSTET GYNECOL, V172, P1510, DOI 10.1016/0002-9378(95)90489-1; Hu Q, 2022, THERIOGENOLOGY, V178, P8, DOI 10.1016/j.theriogenology.2021.10.021; Hua RW, 2021, GENE, V766, DOI 10.1016/j.gene.2020.145117; Jalali BM, 2015, J PROTEOMICS, V125, P76, DOI 10.1016/j.jprot.2015.05.003; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kaczmarek MM, 2021, ANIMAL, V15, DOI 10.1016/j.animal.2021.100182; Kaczmarek MM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062229; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Krawczynski K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2172-2; Krawczynski K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123588; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee ES, 2004, ANIM REPROD SCI, V84, P257, DOI 10.1016/j.anireprosci.2004.02.003; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Mellisho EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178306; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Nakao K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54804-9; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; O'Neil EV, 2020, BIOL REPROD, V102, P1020, DOI 10.1093/biolre/ioaa019; Ofir-Birin Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01011; Pijuan J, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00107; Raposo G, 2019, NAT REV MOL CELL BIO, V20, P509, DOI 10.1038/s41580-019-0158-7; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reliszko ZP, 2017, REPRODUCTION, V154, P217, DOI [10.1530/REP-17-0224, 10.1530/rep-17-0224]; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; SAMUEL CA, 1972, J ANAT, V113, P139; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon C, 2018, ENDOCR REV, V39, P292, DOI 10.1210/er.2017-00229; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spencer T. E., 2013, Animal Frontiers, V3, P48, DOI 10.2527/af.2013-0033; Szuszkiewicz J, 2022, BIOL REPROD, V107, P590, DOI 10.1093/biolre/ioac071; Tan Q, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030645; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tong M, 2016, HUM REPROD, V31, P687, DOI 10.1093/humrep/dew004; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Soom A, 2011, REPROD FERT DEVELOP, V23, pIII, DOI 10.1071/RDv23n8_FO; Wang JX, 2015, IEEE ACM T COMPUT BI, V12, P815, DOI 10.1109/TCBB.2014.2361348; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wright EC., 2012, MICRORNA EXPRESSION; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zang XP, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.584995; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	76	2	2	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22450	10.1096/fj.202200677R	http://dx.doi.org/10.1096/fj.202200677R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2Z2VO	35848638	Green Submitted			2022-12-28	WOS:000826441600001
J	Li, KF; Schon, M; Naviaux, JC; Monk, JM; Alchus-Laiferova, N; Wang, L; Straka, I; Matejicka, P; Valkovic, P; Ukropec, J; Tarnopolsky, MA; Naviaux, RK; Ukropcova, B				Li, Kefeng; Schon, Martin; Naviaux, Jane C.; Monk, Jonathan M.; Alchus-Laiferova, Nikoleta; Wang, Lin; Straka, Igor; Matejicka, Peter; Valkovic, Peter; Ukropec, Jozef; Tarnopolsky, Mark A.; Naviaux, Robert K.; Ukropcova, Barbara			Cerebrospinal fluid and plasma metabolomics of acute endurance exercise	FASEB JOURNAL			English	Article						acute exercise response; cell danger response; cerebrospinal fluid metabolomics; exerkines; hormesis; integrated cell stress response; metabolic memory; mitochondria; purinergic signaling	FALSE DISCOVERY RATE; PHYSICAL-ACTIVITY; STRESS; MITOCHONDRIA; METABOLISM; DOPAMINE; DISORDER; DISEASE; HEALTH; CELLS	Metabolomics has emerged as a powerful new tool in precision medicine. No studies have yet been published on the metabolomic changes in cerebrospinal fluid (CSF) produced by acute endurance exercise. CSF and plasma were collected from 19 young active adults (13 males and 6 females) before and 60 min after a 90-min monitored outdoor run. The median age, BMI, and VO2 max of subjects was 25 years (IQR 22-31), 23.2 kg/m(2) (IQR 21.7-24.5), and 47 ml/kg/min (IQR 38-51), respectively. Targeted, broad-spectrum metabolomics was performed by liquid chromatography, tandem mass spectrometry (LC-MS/MS). In the CSF, purines and pyrimidines accounted for 32% of the metabolic impact after acute endurance exercise. Branch chain amino acids, amino acid neurotransmitters, fatty acid oxidation, phospholipids, and Krebs cycle metabolites traceable to mitochondrial function accounted for another 52% of the changes. A narrow but important channel of metabolic communication was identified between the brain and body by correlation network analysis. By comparing these results to previous work in experimental animal models, we found that over 80% of the changes in the CSF correlated with a cascade of mitochondrial and metabolic changes produced by ATP signaling. ATP is released as a co-neurotransmitter and neuromodulator at every synapse studied to date. By regulating brain mitochondrial function, ATP release was identified as an early step in the kinetic cascade of layered benefits produced by endurance exercise.	[Li, Kefeng; Naviaux, Jane C.; Wang, Lin; Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Li, Kefeng; Wang, Lin; Naviaux, Robert K.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Schon, Martin; Alchus-Laiferova, Nikoleta; Ukropec, Jozef; Ukropcova, Barbara] Slovak Acad Sci, Inst Expt Endocrinol, Biomed Res Ctr, Bratislava, Slovakia; [Naviaux, Jane C.] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA; [Monk, Jonathan M.] Univ Calif San Diego, Sch Med, Dept Bioengn, San Diego, CA 92103 USA; [Alchus-Laiferova, Nikoleta; Ukropcova, Barbara] Comenius Univ, Inst Pathophysiol, Fac Med, Bratislava, Slovakia; [Straka, Igor; Matejicka, Peter; Valkovic, Peter] Comenius Univ, Dept Neurol 2, Fac Med, Bratislava, Slovakia; [Straka, Igor; Matejicka, Peter; Valkovic, Peter] Univ Hosp Bratislava, Bratislava, Slovakia; [Valkovic, Peter] Slovak Acad Sci, Inst Normal & Pathol Physiol, Ctr Med Expt, Bratislava, Slovakia; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Slovak Academy of Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego; Comenius University Bratislava; Comenius University Bratislava; Slovak Medical University Bratislava; Slovak Academy of Sciences; McMaster University; University of California System; University of California San Diego; University of California System; University of California San Diego	Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.; Ukropcova, B (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Biomed Res Ctr, Bratislava, Slovakia.	rnaviaux@health.ucsd.edu; barbara.ukropcova@savba.sk	Li, Kefeng/U-9431-2018	Li, Kefeng/0000-0002-7233-4347	Malone Family Foundation; SAS-MOST Joint Research Cooperation grant [2018/10]; Scientific Grant agency of Slovak Academy of Sciences VEGA [2/0107/18]; Slovak Research and Development Agency [APVV-20-0466]; UCSD Christini Fund; Jane Botsford Johnson Foundation; UCSD Mitochondrial Research Fund; Daniel and Kelly White Family; Westreich Foundation	Malone Family Foundation; SAS-MOST Joint Research Cooperation grant; Scientific Grant agency of Slovak Academy of Sciences VEGA(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); UCSD Christini Fund; Jane Botsford Johnson Foundation; UCSD Mitochondrial Research Fund; Daniel and Kelly White Family; Westreich Foundation	Malone Family Foundation; SAS-MOST Joint Research Cooperation grant, Grant/Award Number: 2018/10; Scientific Grant agency of Slovak Academy of Sciences VEGA, Grant/Award Number: 2/0107/18; Slovak Research and Development Agency, Grant/Award Number: APVV-20-0466; UCSD Christini Fund; Jane Botsford Johnson Foundation; UCSD Mitochondrial Research Fund; Daniel and Kelly White Family; Westreich Foundation	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; Arrieta H, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0770-y; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; Bucolo C, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.07.003; Burma NE, 2017, NAT MED, V23, P355, DOI 10.1038/nm.4281; Burnstock G, 2017, CNS NEUROL DISORD-DR, V16, P257, DOI 10.2174/1871527315666160922104848; Burnstock G, 2016, NEUROPHARMACOLOGY, V104, P4, DOI 10.1016/j.neuropharm.2015.05.031; Calabrese EJ, 2022, IUBMB LIFE, V74, P8, DOI 10.1002/iub.2529; Calabrese EJ, 2021, PHARMACOL RES, V167, DOI 10.1016/j.phrs.2021.105526; Calabrese EJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102871; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cardoso AM, 2021, PURINERG SIGNAL, V17, P649, DOI 10.1007/s11302-021-09816-4; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Cheffer A, 2018, MOL PSYCHIATR, V23, P94, DOI 10.1038/mp.2017.188; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341; El Hayek L, 2019, J NEUROSCI, V39, P2369, DOI 10.1523/JNEUROSCI.1661-18.2019; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Filzmoser P, 2009, J CHEMOMETR, V23, P160, DOI 10.1002/cem.1225; Frisch K. V., 1941, ZEITSCHR VERGLEICH PHYSIOL, V29, P46; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Giardullo L, 2021, INT J IMMUNOPATH PH, V35, DOI 10.1177/20587384211015034; Giuliani AL, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.619458; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Graves SM, 2020, NAT NEUROSCI, V23, P15, DOI 10.1038/s41593-019-0556-3; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hendriks KDW, 2019, CURR OPIN PHARMACOL, V45, P87, DOI 10.1016/j.coph.2019.07.001; Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Karnib N, 2019, NEUROPSYCHOPHARMACOL, V44, P1152, DOI 10.1038/s41386-019-0313-z; Lammers MD, 2020, J HYPERTENS, V38, P2490, DOI 10.1097/HJH.0000000000002578; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Li H, 2021, J INFECT DIS, V224, P914, DOI 10.1093/infdis/jiab027; Li KF, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1264-1; Liu AM, 2019, ANN CLIN LAB SCI, V49, P353; Liu WY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00240; MacAulay N, 2022, FLUIDS BARRIERS CNS, V19, DOI 10.1186/s12987-022-00323-1; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032; Mink R, 2007, BRAIN RES, V1147, P256, DOI 10.1016/j.brainres.2007.02.004; Mirzoev TM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105081; Mocking RJT, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01182-w; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557; Morville T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108554; Naviaux RK, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020027; Naviaux RK, 2019, MITOCHONDRION, V46, P278, DOI 10.1016/j.mito.2018.08.001; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Picard M, 2018, FRONT NEUROENDOCRIN, V49, P72, DOI 10.1016/j.yfrne.2018.01.001; Picard M, 2018, PSYCHOSOM MED, V80, P126, DOI 10.1097/PSY.0000000000000544; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Saito K, 2020, METABOLITES, V10, DOI 10.3390/metabo10050185; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Schon M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38201-2; Seo JH., 2021, INT J MOL SCI, V22, P1; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Taruno A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030808; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Vornov JJ, 2016, ADV PHARMACOL, V76, P215, DOI 10.1016/bs.apha.2016.01.007; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wichmann TO, 2022, FRONT HUM NEUROSCI, V15, DOI 10.3389/fnhum.2021.737217; Yau SY, 2014, P NATL ACAD SCI USA, V111, P15810, DOI 10.1073/pnas.1415219111; Zhang J, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102494; Zolkipli-Cunningham Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248771	74	0	0	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22408	10.1096/fj.202200509R	http://dx.doi.org/10.1096/fj.202200509R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6GH	35713567	hybrid			2022-12-28	WOS:000812324500001
J	Moszynska, A; Jaskiewicz, M; Serocki, M; Cabaj, A; Crossman, DK; Bartoszewska, S; Gebert, M; Dabrowski, M; Collawn, JF; Bartoszewski, R				Moszynska, Adrianna; Jaskiewicz, Maciej; Serocki, Marcin; Cabaj, Aleksandra; Crossman, David K.; Bartoszewska, Sylwia; Gebert, Magdalena; Dabrowski, Michal; Collawn, James F.; Bartoszewski, Rafal			The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells	FASEB JOURNAL			English	Article						EPAS1; HIF1A; HIF-1 alpha; HIF-2 alpha	INDUCIBLE FACTOR-I; BINDING-SITES; EXPRESSION; COLLECTION; FEEDBACK; HOCOMOCO; IDENTIFICATION; PHOSPHATASE; ASSOCIATION; HIF-1-ALPHA	The cellular adaptive response to hypoxia relies on the expression of hypoxia-inducible factors (HIFs), HIF-1 and HIF-2. HIFs regulate global gene expression changes during hypoxia that are necessary for restoring oxygen homeostasis and promoting cell survival. In the early stages of hypoxia, HIF-1 is elevated, whereas at the later stages, HIF-2 becomes the predominant form. What governs the transition between the two HIFs (the HIF switch) and the role of miRNAs in this regulation are not completely clear. Genome-wide expression studies on the miRNA content of RNA-induced silencing complexes (RISC) in HUVECs exposed to hypoxia compared to the global miRNA-Seq analysis revealed very specific differences between these two populations. We analyzed the miRNA and mRNA composition of RISC at 2 h (mainly HIF-1 driven), 8 h (HIF-1 and HIF-2 elevated), and 16 h (mainly HIF-2 driven) in a gene ontology context. This allowed for determining the direct impact of the miRNAs in modulating the cellular signaling pathways involved in the hypoxic adaptive response. Our results indicate that the miRNA-mRNA RISC components control the adaptive responses, and this does not always rely on the miRNA transcriptional elevations during hypoxia. Furthermore, we demonstrate that the hypoxic levels of the vast majority of HIF-1-dependent miRNAs (including miR-210-3p) are also HIF-2 dependent and that HIF-2 governs the expression of 11 specific miRNAs. In summary, the switch from HIF-1 to HIF-2 during hypoxia provides an important level of miRNA-driven control in the adaptive pathways in endothelial cells.	[Moszynska, Adrianna; Jaskiewicz, Maciej; Serocki, Marcin; Gebert, Magdalena; Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland; [Cabaj, Aleksandra; Dabrowski, Michal] Polish Acad Sci, Lab Bioinformat, Nencki Inst Expt Biol, Warsaw, Poland; [Crossman, David K.] Univ Alabama Birmingham, Dept Genet, UAB Genom Core Facil, Birmingham, AL USA; [Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland; [Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham	Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland.	rafalbar@gumed.edu.pl	Bartoszewska, Sylwia/L-3922-2019; Jaśkiewicz, Maciej/Q-6646-2018; Bartoszewski, Rafal A/D-6311-2011	Bartoszewska, Sylwia/0000-0001-8063-1272; Jaśkiewicz, Maciej/0000-0003-4797-2635; Bartoszewski, Rafal A/0000-0002-2864-6757; Cabaj, Aleksandra/0000-0002-3341-9137; Moszynska, Adrianna/0000-0002-7262-4117				Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Akhtar S, 2015, HYPERTENSION, V66, P1220, DOI 10.1161/HYPERTENSIONAHA.115.05886; Ayoubian H, 2019, J VIROL, V93, DOI 10.1128/JVI.01297-18; Bach DH, 2018, MOL THER-NUCL ACIDS, V12, P817, DOI 10.1016/j.omtn.2018.07.016; Bartoszewska S, 2021, CELL MOL BIOL LETT, V26, DOI 10.1186/s11658-021-00255-y; Bartoszewska S, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00212-1; Bartoszewska S, 2019, FASEB J, V33, P11541, DOI 10.1096/fj.201900600RR; Bartoszewska S, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0054-0; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Bartoszewski R, 2020, FEBS J, V287, P2923, DOI 10.1111/febs.15195; Bartoszewski R, 2019, FASEB J, V33, P7929, DOI 10.1096/fj.201802650RR; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Blick C, 2015, BRIT J CANCER, V113, P634, DOI 10.1038/bjc.2015.203; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camps C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-28; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Degrauwe N, 2016, CELL REP, V15, P1634, DOI 10.1016/j.celrep.2016.04.086; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Flores O, 2014, NUCLEIC ACIDS RES, V42, P4629, DOI 10.1093/nar/gkt1393; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Ge XX, 2016, ONCOTARGET, V7, P24466, DOI 10.18632/oncotarget.8228; Gebert M, 2021, CELL MOL LIFE SCI, V78, P7061, DOI 10.1007/s00018-021-03952-1; Greco S, 2014, ANTIOXID REDOX SIGN, V21, P1202, DOI 10.1089/ars.2013.5403; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Huang HY, 2020, NUCLEIC ACIDS RES, V48, pD148, DOI 10.1093/nar/gkz896; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Janas MM, 2012, RNA, V18, P2041, DOI 10.1261/rna.035675.112; Janaszak-Jasiecka A, 2018, ANGIOGENESIS, V21, P711, DOI 10.1007/s10456-018-9620-y; Janaszak-Jasiecka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22775; Juzenas S, 2017, NUCLEIC ACIDS RES, V45, P9290, DOI 10.1093/nar/gkx706; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kochan-Jamrozy K, 2019, CELL SIGNAL, V54, P150, DOI 10.1016/j.cellsig.2018.11.020; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Krystkowiaky I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat069; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lai X, 2016, NUCLEIC ACIDS RES, V44, P6019, DOI 10.1093/nar/gkw550; Landau D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196684; Lee MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29311; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu Y, 2014, FEBS LETT, V588, P3137, DOI 10.1016/j.febslet.2014.05.067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madanecki P, 2013, CELL MOL BIOL LETT, V18, P47, DOI 10.2478/s11658-012-0037-0; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nagpal N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09650; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Seok JK, 2014, NUCLEIC ACIDS RES, V42, P8062, DOI 10.1093/nar/gku515; Serocki M, 2018, ANGIOGENESIS, V21, P183, DOI 10.1007/s10456-018-9600-2; Seton-Rogers S, 2011, NAT REV CANCER, V11, P391, DOI 10.1038/nrc3074; Shen ZX, 2020, ADV PHOTONICS, V2, DOI 10.1117/1.AP.2.3.036002; Skulski M, 2019, J CELL MOL MED, V23, P487, DOI 10.1111/jcmm.13951; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Spinello I, 2015, HAEMATOLOGICA, V100, P1160, DOI 10.3324/haematol.2014.120295; Su J, 2015, HIGH ALT MED BIOL, V16, P318, DOI 10.1089/ham.2015.0015; Tausendschon M, 2015, BBA-GENE REGUL MECH, V1849, P10, DOI 10.1016/j.bbagrm.2014.10.006; Thomas JD, 2008, RNA, V14, P771, DOI 10.1261/rna.857308; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang XW, 2016, EXP BIOL MED, V241, P177, DOI 10.1177/1535370215600548; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wu Jiayan, 2014, Genomics Proteomics & Bioinformatics, V12, P57, DOI 10.1016/j.gpb.2014.04.002; Xie YB, 2016, MOL MED REP, V14, P2503, DOI 10.3892/mmr.2016.5578; Yang Y, 2016, J MOL MED, V94, P711, DOI 10.1007/s00109-016-1387-2; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhao J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.565	79	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22412	10.1096/fj.202101987R	http://dx.doi.org/10.1096/fj.202101987R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6LV	35713587				2022-12-28	WOS:000812339300001
J	Miller-Rhodes, P; Li, H; Velagapudi, R; Chiang, W; Terrando, N; Gelbard, HA				Miller-Rhodes, Patrick; Li, Herman; Velagapudi, Ravikanth; Chiang, Wesley; Terrando, Niccolo; Gelbard, Harris A.			URMC-099 prophylaxis prevents hippocampal vascular vulnerability and synaptic damage in an orthopedic model of delirium superimposed on dementia	FASEB JOURNAL			English	Article						blood-brain barrier; CVN-AD; delirium superimposed on dementia; leucine-rich repeat kinase type 2; microgliosis; mixed lineage kinase type 3; neuroinflammation; URMC-099; vascular cell adhesion molecule type 1	3 INHIBITOR URMC-099; BLOOD-BRAIN-BARRIER; MOUSE MODEL; ALZHEIMERS-DISEASE; ENDOTHELIAL-CELLS; MURINE MODEL; MICROGLIA; PROTEIN; NEUROINFLAMMATION; EXPRESSION	Systemic perturbations can drive a neuroimmune cascade after surgical trauma, including affecting the blood-brain barrier (BBB), activating microglia, and contributing to cognitive deficits such as delirium. Delirium superimposed on dementia (DSD) is a particularly debilitating complication that renders the brain further vulnerable to neuroinflammation and neurodegeneration, albeit these molecular mechanisms remain poorly understood. Here, we have used an orthopedic model of tibial fracture/fixation in APPSwDI/mNos2(-/-) AD (CVN-AD) mice to investigate relevant pathogenetic mechanisms underlying DSD. We conducted the present study in 6-month-old CVN-AD mice, an age at which we speculated amyloid-beta pathology had not saturated BBB and neuroimmune functioning. We found that URMC-099, our brain-penetrant anti-inflammatory neuroprotective drug, prevented inflammatory endothelial activation, breakdown of the BBB, synapse loss, and microglial activation in our DSD model. Taken together, our data link post-surgical endothelial activation, microglial MafB immunoreactivity, and synapse loss as key substrates for DSD, all of which can be prevented by URMC-099.	[Miller-Rhodes, Patrick; Li, Herman; Gelbard, Harris A.] Univ Rochester, Ctr Neurotherapeut Discovery, Dept Neurol, Med Ctr, Rochester, NY USA; [Miller-Rhodes, Patrick] Univ Rochester, Neurosci Grad Program, Med Ctr, Rochester, NY USA; [Velagapudi, Ravikanth; Terrando, Niccolo] Duke Univ, Ctr Translat Pain Med, Dept Anesthesiol, Med Ctr, Durham, NC USA; [Chiang, Wesley] Univ Rochester, Dept Biochem & Biophys, Med Ctr, Rochester, NY USA; [Terrando, Niccolo] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Terrando, Niccolo] Duke Univ, Dept Immunol, Med Ctr, Durham, NC USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Gelbard, Harris A.] Univ Rochester, Dept Neurosci, Med Ctr, Rochester, NY USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Gelbard, Harris A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Duke University; University of Rochester; Duke University; Duke University; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Terrando, N (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.	niccolo.terrando@duke.edu		ravikanth, velagapudi/0000-0001-9363-3154; Terrando, Niccolo/0000-0003-1803-5853; Li, Herman/0000-0003-2471-8562; Chiang, Wesley/0000-0003-0847-2056	NIA [R01AG057525]; NIH [T32 GM135134]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIA R01AG057525 (NT); NIH T32 GM135134 (WC).	Bellizzi MJ, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0245-18.2018; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bos PH, 2019, CELL CHEM BIOL, V26, P1703, DOI 10.1016/j.chembiol.2019.10.005; Cavallari M, 2016, BRAIN, V139, P1282, DOI 10.1093/brain/aww010; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Colton CA, 2014, J NEUROPATH EXP NEUR, V73, P752, DOI 10.1097/NEN.0000000000000094; Counts SE, 2014, NEUROPHARMACOLOGY, V79, P172, DOI 10.1016/j.neuropharm.2013.10.018; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; Dong WG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0646-z; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Femenia T, 2018, J NEUROSCI, V38, P452, DOI 10.1523/JNEUROSCI.1797-17.2017; Feng XM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91229; Fong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goodfellow VS, 2013, J MED CHEM, V56, P8032, DOI 10.1021/jm401094t; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hendrickx DAE, 2017, J NEUROIMMUNOL, V309, P12, DOI 10.1016/j.jneuroim.2017.04.007; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hoos MD, 2013, J PROTEOME RES, V12, P4462, DOI 10.1021/pr4005103; Joost E, 2019, BRAIN STRUCT FUNCT, V224, P1301, DOI 10.1007/s00429-019-01834-8; Kan MJ, 2015, J NEUROSCI, V35, P5969, DOI 10.1523/JNEUROSCI.4668-14.2015; Kiyota T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1172-y; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; LASSMANN H, 1991, J NEUROSCI RES, V28, P236, DOI 10.1002/jnr.490280211; Lee HB, 2017, AM J GERIAT PSYCHIAT, V25, P308, DOI 10.1016/j.jagp.2016.10.008; Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2018.12.012, 10.1016/j.immuni.2019.02.012]; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Tran MTN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01711-0; Marker DF, 2013, J NEUROSCI, V33, P9998, DOI 10.1523/JNEUROSCI.0598-13.2013; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Miller-Rhodes P., 2021, MATTERS ZH, V2021, P1; Miller-Rhodes P, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1582-5; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Pai ELL, 2019, CELL REP, V26, P1157, DOI 10.1016/j.celrep.2019.01.031; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Polesskaya O, 2014, MOL IMMUNOL, V58, P214, DOI 10.1016/j.molimm.2013.11.016; Puccini JM, 2015, J NEUROSCI, V35, P5271, DOI 10.1523/JNEUROSCI.0650-14.2015; Savage JC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01340; Schulman-Green D, 2022, J AM GERIATR SOC, V70, P1495, DOI 10.1111/jgs.17624; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Spangenberg E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11674-z; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Tang JS, 2020, ACTA PHARMACOL SIN B, V10, P987, DOI 10.1016/j.apsb.2020.02.015; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Thomsen MS, 2017, J NEUROCHEM, V140, P741, DOI 10.1111/jnc.13747; Tomita K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94488; Tozaki-Saitoh H, 2019, GLIA, V67, P729, DOI 10.1002/glia.23570; Tucsek Z, 2017, GEROSCIENCE, V39, P385, DOI 10.1007/s11357-017-9981-y; Wang P, 2020, ALZHEIMERS DEMENT, V16, P734, DOI 10.1002/alz.12064; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilson JE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00223-4; Yang X, 2018, MOL PSYCHIATR, V23, P199, DOI 10.1038/mp.2016.151; Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4; Yu WM, 2013, ELIFE, V2, DOI 10.7554/eLife.01341; Zhu L, 2019, BRAIN BEHAV IMMUN, V81, P292, DOI 10.1016/j.bbi.2019.06.026	66	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22343	10.1096/fj.202200184RR	http://dx.doi.org/10.1096/fj.202200184RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1B7UT	35535564	Green Published, Green Submitted			2022-12-28	WOS:000792639100001
J	Bian, Y; Li, JP; Shen, HF; Li, YY; Hou, Y; Huang, L; Song, GY; Qiao, C				Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong			WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia	FASEB JOURNAL			English	Article						early-onset preeclampsia; N6-methyladenosine; preeclampsia; trophoblast; WTAP	RNA M(6)A METHYLATION; BINDING-PROTEIN HMGN3; MESSENGER-RNA; CANCER; CELLS; DIFFERENTIATION; STABILITY	Early-onset preeclampsia (ePE) originates from abnormal implantation and placentation that involves trophoblast invasion, but its pathophysiology is not entirely understood. N6-methyladenosine (m6A) regulators mediate the progression of various cancers. The invasiveness of trophoblast cells is similar to that of tumor cells. However, little is known regarding the potential role of m6A modification in ePE and the underlying mechanism. This study aimed to explore the m6A level in placental tissue samples collected from ePE patients and to investigate whether m6A modification was an essential part of PE pathogenesis. The m6A level in placental tissue samples of 80 PE participants was examined. MeRIP-microarray, RNA-Seq, luciferase reporter assay, and RNA immunoprecipitation chip (RIP) assay were performed. The m6A level in the ePE group was significantly reduced compared with the control group. Wilms' tumor 1-associating protein (WTAP) regulated trophoblast cell migration and invasion. Mechanistically, the high mobility group nucleosomal binding domain 3 (HMGN3) gene was a target gene of WTAP in trophoblast (p < .05). WTAP enhanced the stability of HMGN3 mRNA through binding with its 3'-UTR m6A site(+485A, +522A). HMGN3 was recognized by m6A recognition protein insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1), which was inhibited when knocking down WTAP. Both m6A and WTAP levels were downregulated in ePE. The m6A modification mediated by WTAP/IGF2BP1/HMGN3 axis might contribute to abnormal trophoblast invasion. Our work provided a foundation for further exploration of RNA epigenetic regulatory patterns in ePE, and indicated a new treatment strategy for ePE.	[Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] Key Lab Maternal Fetal Med Liaoning Prov, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] Key Lab Obstet & Gynecol Higher Educ Liaoning Prov, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] China Med Univ Birth Cohort, Res Ctr, Shenyang, Peoples R China	China Medical University	Qiao, C (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China.	qiaochong2002@hotmail.com		qiao, chong/0000-0002-4979-3545				[Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Barkess G, 2012, BIOCHEM J, V442, P495, DOI 10.1042/BJ20111502; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Carvajal L, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.637594; Chen LZ, 2018, ONCOL LETT, V16, P6966, DOI 10.3892/ol.2018.9554; Chen SJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02847-6; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Edens BM, 2019, CELL REP, V28, P845, DOI 10.1016/j.celrep.2019.06.072; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fondjo LA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2623-x; Fu Y, 2020, J BIOL REG HOMEOS AG, V34, P1505, DOI 10.23812/20-325-L; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Han X, 2020, CANCER CONTROL, V27, DOI 10.1177/1073274820960460; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hong K, 2018, ONCOL LETT, V16, P5519, DOI 10.3892/ol.2018.9395; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Imam H, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.584283; Imanishi M, 2017, CHEM COMMUN, V53, P12930, DOI 10.1039/c7cc07699a; Jo HJ, 2013, J GASTROENTEROL, V48, P1271, DOI 10.1007/s00535-013-0748-7; Kobayashi M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00116-18; Kurahashi T, 2010, J CELL BIOCHEM, V109, P49, DOI 10.1002/jcb.22377; Li BQ, 2019, CANCER LETT, V451, P48, DOI 10.1016/j.canlet.2019.02.043; Li DD, 2015, MOL CELL ENDOCRINOL, V413, P13, DOI 10.1016/j.mce.2015.05.038; Li T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1038-7; Li YY, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117441; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Liu JD, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108120; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu SY, 2020, J CELL MOL MED, V24, P2070, DOI 10.1111/jcmm.14847; Liu ZX, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00089; Ma Z, 2020, CELL BIOL INT, V44, P2524, DOI 10.1002/cbin.11459; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Price AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19787-6; Redman Cwg, 2014, Pregnancy Hypertens, V4, P246, DOI 10.1016/j.preghy.2014.04.020; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Shulman Z, 2020, NAT IMMUNOL, V21, P501, DOI 10.1038/s41590-020-0650-4; SOULA C, 1990, International Journal of Developmental Biology, V34, P351; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Tang C, 2018, P NATL ACAD SCI USA, V115, pE325, DOI 10.1073/pnas.1717794115; Tang JY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0706-6; Tang YJ, 2021, NUCLEIC ACIDS RES, V49, pD134, DOI 10.1093/nar/gkaa692; Wang J, 2020, PEERJ, V8, DOI 10.7717/peerj.9880; Wang J, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00710-y; Wang W, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/9371953; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng L, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01240-5; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yu HL, 2019, ONCOTARGETS THER, V12, P6191, DOI 10.2147/OTT.S205730; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang F, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008120; Zhang L, 2021, THERANOSTICS, V11, P1100, DOI 10.7150/thno.49345; Zhang WH, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110570; Zhang Z, 2018, INT J MOL MED, V42, P1508, DOI 10.3892/ijmm.2018.3701; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw104	60	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22617	10.1096/fj.202200700RR	http://dx.doi.org/10.1096/fj.202200700RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6K1EQ	36412513				2022-12-28	WOS:000887255100001
J	Chen, K; Xue, R; Geng, YP; Zhang, SS				Chen, Ke; Xue, Ran; Geng, Yaping; Zhang, Shenshen			Galangin inhibited ferroptosis through activation of the PI3K/AKT pathway in vitro and in vivo	FASEB JOURNAL			English	Article						ferroptosis; galangin; glutathione peroxidase 4; signaling pathway	CELL-DEATH; REPERFUSION INJURY; APOPTOSIS; ISCHEMIA; STRESS	Ferroptosis is an iron-dependent form of nonapoptotic cell death characterized by the accumulation of lipid peroxides in cells. In recent years, extensive attention has been dedicated to exploring safe and effective natural ferroptosis regulators which can provide novel treatment strategies for ferroptosis-related diseases. This study identified galangin, a natural flavonoid, as an effective inhibitor of ferroptosis, which could increase cell viability in RSL3-inhibited HT1080 cells, decrease levels of lipid ROS and MDA, improve PTGS2 mRNA expression, and enhance the expression of glutathione peroxidase 4 (GPX4). Ferroptosis is widely present in ischemia-reperfusion (IR) injury. This study found that galangin significantly ameliorated the pathological damage of liver tissue in mice with IR, reduced levels of serum ALT, AST, and MDA, and increased the expression of GPX4. The results of RNA-seq exhibited ferroptosis was significant and the PI3K/AKT pathway deserved to explore the inhibition effects of galangin on ferroptosis. Indeed, galangin treatment significantly rescued RSL3-inhibited phosphorylation levels of PI3K, AKT, and CREB proteins, and the ferroptosis inhibitory effects of galangin were counteracted by PI3K inhibitor LY294002. These findings indicated that galangin may exert its anti-ferroptosis effects via activating the PI3K/AKT/CREB signaling pathway and it will hopefully serve as a promising effective measure to attenuate IR injury by inhibiting ferroptosis.	[Chen, Ke; Geng, Yaping; Zhang, Shenshen] Zhengzhou Univ, Coll Publ & Hlth, Nutr & Hlth Food Res Inst, Dept Nutr & Food Hyg, Zhengzhou, Peoples R China; [Xue, Ran] Jinan Ctr Dis Control & Prevent, Inst TB Control, Jinan, Peoples R China	Zhengzhou University	Zhang, SS (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Dept Precis Nutr Innovat Ctr, Zhengzhou, Peoples R China.	zsslb2005@163.com		Zhang, Shenshen/0000-0002-7849-371X	National Natural Science Foundation of China [81903314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81903314) .	Abubakar IB, 2018, J ETHNOPHARMACOL, V224, P45, DOI 10.1016/j.jep.2018.05.027; Bi M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00618-0; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Choi MJ, 2017, BIOCHEM PHARMACOL, V144, P120, DOI 10.1016/j.bcp.2017.07.021; Dare AJ, 2015, REDOX BIOL, V5, P163, DOI 10.1016/j.redox.2015.04.008; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fang XX, 2019, P NATL ACAD SCI USA, V116, P2672, DOI 10.1073/pnas.1821022116; Fu C, 2022, J ETHNOPHARMACOL, V289, DOI 10.1016/j.jep.2022.115021; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Guan X, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118660; Han C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00239; He Y, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00828-5; Huang HZ, 2020, MOLECULES, V25, DOI 10.3390/molecules25071579; Jiang Y, 2015, J NEUROCHEM, V134, P173, DOI 10.1111/jnc.13097; Kitagawa H, 2017, J NEUROSCI, V37, P1, DOI [10.1523/JNEUROSCI.0943-16.2017, 10.1523/JNEUROSCI.0943-16.2016]; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Le HN, 2018, INT J MOL MED, V41, P888, DOI 10.3892/ijmm.2017.3296; Li BD, 2022, EUR J PHARMACOL, V917, DOI 10.1016/j.ejphar.2022.174759; Li C, 2021, PHARMACOL RES, V174, DOI 10.1016/j.phrs.2021.105933; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Y, 2018, CELL PHYSIOL BIOCHEM, V51, P1354, DOI 10.1159/000495553; Liao J, 2021, TOXICOL RES-UK, V10, P551, DOI 10.1093/toxres/tfab009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Qiu YM, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104919; Rampogu S, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111808; Revathidevi S, 2019, SEMIN CANCER BIOL, V59, P80, DOI 10.1016/j.semcancer.2019.06.002; Shen ZY, 2018, ADV MATER, V30, DOI 10.1002/adma.201704007; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su LJ, 2019, J BIOL CHEM, V294, P19395, DOI 10.1074/jbc.RA119.010949; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Wang HB, 2019, J CELL PHYSIOL, V234, P15654, DOI 10.1002/jcp.28216; Weiland A, 2019, MOL NEUROBIOL, V56, P4880, DOI 10.1007/s12035-018-1403-3; Wu J, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00660-4; Wu X, 2018, NEUROCHEM RES, V43, P886, DOI 10.1007/s11064-018-2494-y; Wu Y, 2022, CELL DEATH DIFFER, V29, P1705, DOI 10.1038/s41418-022-00957-6; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yan HF, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00428-9; Yan HF, 2020, ZOOL RES, V41, P220, DOI 10.24272/j.issn.2095-8137.2020.042; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yi JM, 2020, P NATL ACAD SCI USA, V117, P31189, DOI 10.1073/pnas.2017152117; Yi ZJ, 2020, HEPATOLOGY, V72, P1394, DOI 10.1002/hep.31147; Zhong XW, 2020, CANCER MED-US, V9, P5546, DOI 10.1002/cam4.3195	47	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22569	10.1096/fj.202200935R	http://dx.doi.org/10.1096/fj.202200935R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6MA	36183339				2022-12-28	WOS:000862998100001
J	Jiang, TT; He, XY; Zhao, ZN; Zhang, X; Wang, T; Jia, LT				Jiang, Tongtong; He, Xinyi; Zhao, Zhining; Zhang, Xiao; Wang, Ting; Jia, Lintao			RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression	FASEB JOURNAL			English	Article						breast cancer; IGF2BP; metastasis; N6-methyladenosine (m6A); RNA modification; SLIT2	BINDING PROTEIN	Triple-negative breast cancer (TNBC) is a group of fatal malignancies characterized by high metastatic capacity, the underlying mechanisms of which remain largely elusive. We have found here that insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) is highly expressed in TNBC and correlates clinically with distant metastasis-free survival of TNBC patients. IGF2BP3 promotes the migration and invasion capabilities of TNBC cells dependent upon cellular RNA N6-methyladenosine (m6A) modification. Mechanistically, IGF2BP3 binds to and destabilizes m6A-methylated mRNA of the extracellular matrix glycoprotein, SLIT2, impairs its downstream signaling via the cognate receptor ROBO1, and consequently triggers the activation of canonical PI3K/AKT and MEK/ERK pathways. The IGF2BP3/SLIT2 axis is critically involved in the regulation of TNBC metastasis in vivo. These findings shed light into the regulatory network of distant metastasis of breast cancer and provide rationale for targeting the m6A machinery in the treatment of TNBC.	[Jiang, Tongtong; He, Xinyi; Zhang, Xiao; Wang, Ting; Jia, Lintao] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Peoples R China; [Zhao, Zhining] Fourth Mil Med Univ, Dept Clin Lab, Xijing Hosp 986, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jia, LT (corresponding author), Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Peoples R China.	jialth@fmmu.edu.cn			National Natural Science Foundation of China (NSFC) [81872303, 82172910]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81872303 and 82172910	Badve SS, 2019, JNCI-J NATL CANCER I, V111, P1118, DOI 10.1093/jnci/djz052; Bianchini G, 2022, NAT REV CLIN ONCOL, V19, P91, DOI 10.1038/s41571-021-00565-2; Burgess HM, 2021, GENE DEV, V35, P1005, DOI 10.1101/gad.348320.121; Chai CS, 2022, CANCER LETT, V527, P41, DOI 10.1016/j.canlet.2021.12.003; Dahlem C, 2022, ACS CHEM BIOL, V17, P361, DOI 10.1021/acschembio.1c00833; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Derakhshan F, 2022, ANNU REV PATHOL-MECH, V17, P181, DOI 10.1146/annurev-pathol-042420-093238; Einstein JM, 2021, MOL CELL, V81, P3048, DOI 10.1016/j.molcel.2021.06.014; Gu F, 2015, FRONT MED-PRC, V9, P431, DOI 10.1007/s11684-015-0416-9; Han B, 2021, CANCER LETT, V518, P256, DOI 10.1016/j.canlet.2021.07.047; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Kuiken HJ, 2022, ONCOGENE, V41, P112, DOI 10.1038/s41388-021-02075-y; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Li XX, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01558-0; Li XY, 2021, MOL THER, V29, P1940, DOI 10.1016/j.ymthe.2021.04.032; Li ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16306-5; Lin YX, 2022, ANN TRANSL MED, V10, DOI 10.21037/atm-21-6857; Liu MM, 2021, MEDCOMM, V2, P587, DOI 10.1002/mco2.100; Maity A, 2016, FEBS J, V283, P1607, DOI 10.1111/febs.13614; Mancarella C, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020273; Mancarella C, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00363; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mizutani R, 2016, ONCOGENE, V35, P3495, DOI 10.1038/onc.2015.410; Pogoda K, 2020, J ONCOL, V2020, DOI 10.1155/2020/8545643; Samanta S, 2016, ONCOGENE, V35, P1111, DOI 10.1038/onc.2015.164; Sanjana NE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8288; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Shi Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01126; Tong MF, 2019, J CANCER, V10, P2694, DOI 10.7150/jca.31877; Wang SS, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.580036; Yang Z, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01714-8; Zhao YC, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00872-8; Zheng FC, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-021-00295-8; Zhou LL, 2021, RSC CHEM BIOL, V2, P1352, DOI 10.1039/d1cb00075f; Zhou ZJ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01216-3	35	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22618	10.1096/fj.202200751RR	http://dx.doi.org/10.1096/fj.202200751RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0XR	36250924				2022-12-28	WOS:000868771000001
J	Du, H; Huang, ZX; Zhou, X; Kuang, XL; Long, CD; Tang, H; Zeng, JS; Huang, H; Liu, HJ; Zhu, BB; Fu, LC; Hu, K; Lin, SB; Wang, H; Zhang, QJ; Yan, JH; Shen, HX				Du, Han; Huang, Zixin; Zhou, Xin; Kuang, Xielan; Long, Chongde; Tang, Han; Zeng, Jingshu; Huang, Hao; Liu, Huijun; Zhu, Binbin; Fu, Licheng; Hu, Ke; Lin, ShuiBin; Wang, Hua; Zhang, Qingjiong; Yan, Jianhua; Shen, Huangxuan			Oxidative stress-induced lncRNA CYLD-AS1 promotes RPE inflammation via Nrf2/miR-134-5p/NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						AMD; inflammation; lncRNA; miRNA; oxidative stress; RPE	DAMAGE; DEGENERATION	Oxidative stress-induced damage to and dysfunction of retinal pigment epithelium (RPE) cells are important pathogenetic factors of age-related macular degeneration (AMD); however, the underlying molecular mechanism is not fully understood. Long noncoding RNAs (lncRNAs) have important roles in various biological processes. In this study, using an oxidative damage model in RPE cells, we identified a novel oxidation-related lncRNA named CYLD-AS1. We further revealed that the expression of CYLD-AS1 was increased in RPEs during oxidative stress. Depletion of CYLD-AS1 promoted cell proliferation and mitochondrial function and protected RPE cells against hydrogen peroxide (H2O2)-induced damage. Mechanistically, CYLD-AS1 also regulated the expression of NRF2, which is related to oxidative stress, and NF-kappa B signaling pathway members, which are related to inflammation. Remarkably, these two signaling pathways were mediated by the CYLD-AS1 interactor miR-134-5p. Moreover, exosomes secreted by CYLD-AS1 knockdown RPE cells had a lower proinflammatory effect than those secreted by control cells. In summary, our study revealed that CYLD-AS1 affects the oxidative stress-related and inflammatory functions of RPE cells by sponging miR-134-5p to mediate NRF2/NF-kappa B signaling pathway activity, suggesting that targeting CYLD-AS1 could be a promising strategy for the treatment of AMD and related diseases.	[Du, Han; Huang, Zixin; Zhou, Xin; Kuang, Xielan; Long, Chongde; Tang, Han; Zeng, Jingshu; Huang, Hao; Liu, Huijun; Zhu, Binbin; Fu, Licheng; Hu, Ke; Zhang, Qingjiong; Yan, Jianhua; Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlie Rd, Guangzhou 510060, Peoples R China; [Zhou, Xin] Univ Florida, Dept Mol Genet & Microbiol, Coll Med, Gainesville, FL USA; [Kuang, Xielan; Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Biobank Eye, Guangzhou, Peoples R China; [Huang, Hao] Guangzhou Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Liu, Huijun] Wuhan Univ Sci & Technol, Tianyou Hosp, Dept Ophthalmol, Wuhan, Peoples R China; [Lin, ShuiBin] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Precis Med Inst, Guangzhou, Peoples R China; [Wang, Hua] Southern Med Univ, Zhujiang Hosp, Dept Intens Care, Guangzhou, Peoples R China	Sun Yat Sen University; State University System of Florida; University of Florida; Sun Yat Sen University; Guangzhou Medical University; Wuhan University of Science & Technology; Sun Yat Sen University; Southern Medical University - China	Yan, JH; Shen, HX (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlie Rd, Guangzhou 510060, Peoples R China.	yanjh2011@126.com; shenhx@mail.sysu.edu.cn			National Natural Science Foundation of China [81670874, 81670885]; Natural Science Foundation of Guangdong Province of China [2020A1515010144, 2021A1515010513, 2022A1515012442]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Open Research Funds of the State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Open Research Funds of the State Key Laboratory of Ophthalmology	The work was supported by the National Natural Science Foundation of China (81670874 and 81670885), Natural Science Foundation of Guangdong Province of China (Nos. 2020A1515010144, 2021A1515010513, and 2022A1515012442), and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (No. N/A) and the Open Research Funds of the State Key Laboratory of Ophthalmology (No. N/A).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Biswas S, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.3.20; Bridges MC, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202009045; Brown EE, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101201; Chen X, 2020, MOL THER, V28, P929, DOI 10.1016/j.ymthe.2020.01.010; Cho MJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0327-y; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Du YY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2684672; Eamegdool SS, 2020, FREE RADICAL BIO MED, V146, P357, DOI 10.1016/j.freeradbiomed.2019.11.018; Fan YT, 2018, ARCH BIOCHEM BIOPHYS, V650, P1, DOI 10.1016/j.abb.2018.05.008; Felszeghy S, 2019, REDOX BIOL, V20, P1, DOI 10.1016/j.redox.2018.09.011; Flores-Bellver M, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12165; Gallenga CE, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060848; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Guo J, 2022, EUR J MED CHEM, V242, DOI 10.1016/j.ejmech.2022.114630; He J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3681707; He Y, 2020, AM J PHYSIOL-ENDOC M, V320, pE598, DOI 10.1152/ajpendo.00089.2020; Huang H, 2021, CELL SIGNAL, V88, DOI 10.1016/j.cellsig.2021.110153; Jadeja RN, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101336; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kaarniranta K, 2020, PROG RETIN EYE RES, V79, DOI 10.1016/j.preteyeres.2020.100858; Ke YF, 2020, J CELL BIOCHEM, V121, P4849, DOI 10.1002/jcb.29713; Liu LY, 2017, MOL MED REP, V16, P730, DOI 10.3892/mmr.2017.6625; Liva F, 2019, CURR DRUG TARGETS, V20, P903, DOI 10.2174/1389450120666190122114857; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Plafker SM, 2012, INT REV CEL MOL BIO, V298, P135, DOI 10.1016/B978-0-12-394309-5.00004-3; Postnikova OA, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030205; Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002; Rinn JL, 2020, ANNU REV BIOCHEM, V89, P283, DOI 10.1146/annurev-biochem-062917-012708; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Tomida D, 2011, INVEST OPHTH VIS SCI, V52, P3193, DOI 10.1167/iovs.10-6737; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Uemura A, 2021, PROG RETIN EYE RES, V84, DOI 10.1016/j.preteyeres.2021.100954; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Wan PX, 2020, CELL DEATH DIFFER, V27, P176, DOI 10.1038/s41418-019-0351-4; Wang CY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4586839; Zhang H, 2020, J CELL MOL MED, V24, P12368, DOI 10.1111/jcmm.15736; Zhang Y, 2020, THERANOSTICS, V10, P10823, DOI 10.7150/thno.47830; Zhao D, 2020, CLIN SCI, V134, P2419, DOI 10.1042/CS20200694; Zhao JW, 2022, CELL DEATH DISCOV, V8, DOI 10.1038/s41420-022-01146-7	44	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22577	10.1096/fj.202200887R	http://dx.doi.org/10.1096/fj.202200887R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1SF	36165267				2022-12-28	WOS:000859945000001
J	Hsieh, YC; Wu, PS; Lin, YT; Huang, YH; Hou, MC; Lee, KC; Lin, HC				Hsieh, Yun-Cheng; Wu, Pei-Shan; Lin, Yi-Tsung; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh			(Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis	FASEB JOURNAL			English	Article						chronic liver injury; gene silencing; handle region peptide; lipid metabolism; nonalcoholic fatty liver disease	FATTY LIVER; NONPROTEOLYTIC ACTIVATION; HEPATIC STEATOSIS; LIPID-METABOLISM; HANDLE REGION; DECOY PEPTIDE; PRORENIN; MODEL; PHOSPHATIDYLCHOLINE; GLOMERULOSCLEROSIS	The (Pro)renin receptor (PRR) is reportedly involved in hepatic lipid metabolism and hepatocyte PRR knockdown protects mice against hepatosteatosis. However, the impact of PRR inhibition on liver inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) remains unclear. Herein, C57BL/6 mice were fed a normal chow diet or fast food diet (FFD) for 24 weeks. Lentivirus-mediated PRR short hairpin RNA (shRNA) or handle region peptide (HRP), a PRR blocker, was administered for PRR inhibition. Mouse primary hepatocytes were cultured with palmitic acid, prorenin, siRNA-targeted PRR, and HRP. In FFD-fed mice, PRR inhibition via lentivirus-mediated PRR knockdown or HRP significantly attenuated liver steatosis, inflammation, and fibrosis. Mechanistically, PRR knockdown or HRP decreased hepatic acetyl-CoA carboxylase (ACC) abundance and upregulated peroxisome proliferator-activated receptor-alpha (PPAR alpha). HRP treatment also decreased hepatic PRR expression. In addition, intrahepatic oxidative stress, apoptosis and inflammatory cell recruitment were ameliorated by PRR knockdown or HRP treatment, along with suppression of proinflammatory cytokine expression. PRR inhibition downregulated the hepatic expression of profibrotic factors, as well as TGF-beta 1/SMAD3 pathway. In primary mouse hepatocytes, PRR knockdown with siRNA or HRP downregulated cellular ACC and increased PPAR alpha expression. In conclusion, our findings revealed that PRR inhibition attenuated hepatic steatosis, inflammation, and fibrosis in mice with NASH. Accordingly, targeting PRR signaling may serve as a potential treatment for NASH.	[Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan; [Hsieh, Yun-Cheng; Wu, Pei-Shan; Lin, Yi-Tsung; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Med, Taipei, Taiwan; [Wu, Pei-Shan] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lee, KC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan.	kclee2@vghtpe.gov.tw			Ministry of Science and Technology, Taiwan [108-2628-B-075-016, 109-2628-B-075-016, 110-2628-B-075-016, 110-2314-B-075-006-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Ms. Hsiu-Ying, Chen, and Fu-Jung, Shou for their excellent technical assistance. This study was supported by the grants from the Ministry of Science and Technology, Taiwan 108-2628-B-075-016, 109-2628-B-075-016, 110-2628-B-075-016, and 110-2314-B-075-006-MY3.	Aihara Y, 2013, HEPATOL RES, V43, P1241, DOI 10.1111/hepr.12081; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Calvente CJ, 2015, HEPATOLOGY, V62, P1285, DOI 10.1002/hep.27936; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hsieh YC, 2021, CELL MOL GASTROENTER, V12, P813, DOI 10.1016/j.jcmgh.2021.05.017; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Ichihara A, 2008, J MOL MED, V86, P629, DOI 10.1007/s00109-008-0327-1; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Im YR, 2021, HEPATOLOGY, V74, P1884, DOI 10.1002/hep.31897; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Krebs C, 2008, KIDNEY INT, V74, P823, DOI 10.1038/ki.2008.315; Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020; Lee KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077817; Lemoinne S, 2019, CURR OPIN PHARMACOL, V49, P60, DOI 10.1016/j.coph.2019.09.006; Li Yating, 2018, Oncotarget, V9, P24155, DOI 10.18632/oncotarget.23816; Lu XF, 2016, CIRC RES, V118, P222, DOI 10.1161/CIRCRESAHA.115.306799; Nabeshima Y, 2009, J HEPATOL, V50, P1226, DOI 10.1016/j.jhep.2009.01.018; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Raal FJ, 2020, NEW ENGL J MED, V382, P1520, DOI 10.1056/NEJMoa1913805; Ren LW, 2018, CIRC RES, V122, P730, DOI [10.1161/CIRCRESAHA.117.312422, 10.1161/circresaha.117.312422]; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Satofuka S, 2007, INVEST OPHTH VIS SCI, V48, P422, DOI 10.1167/iovs.06-0534; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Tan P, 2014, OBESITY, V22, P2201, DOI 10.1002/oby.20844; te Riet L, 2014, AM J PHYSIOL-RENAL, V306, pF1179, DOI 10.1152/ajprenal.00010.2014; Toblli JE, 2008, OBESITY, V16, P770, DOI 10.1038/oby.2007.114; VANCE JE, 1985, CAN J BIOCHEM CELL B, V63, P870, DOI 10.1139/o85-108; Wallace MC, 2015, LAB ANIM-UK, V49, P21, DOI 10.1177/0023677215573040; Wilkinson-Berka JL, 2010, HYPERTENSION, V55, P1454, DOI 10.1161/HYPERTENSIONAHA.109.148221; Wu CH, 2016, HYPERTENSION, V68, P213, DOI 10.1161/HYPERTENSIONAHA.115.06954; YAO ZM, 1988, J BIOL CHEM, V263, P2998	45	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22526	10.1096/fj.202200594R	http://dx.doi.org/10.1096/fj.202200594R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H4LJ	36063123				2022-12-28	WOS:000849851600001
J	Matveyenka, M; Zhaliazka, K; Rizevsky, S; Kurouski, D				Matveyenka, Mikhail; Zhaliazka, Kiryl; Rizevsky, Stanislav; Kurouski, Dmitry			Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates	FASEB JOURNAL			English	Article						AFM-IR; amyloid aggregates; lipids; lysozyme; ROS; toxicity	ALPHA-SYNUCLEIN OLIGOMERS; AMYLOID FIBRILS; RAMAN-SPECTROSCOPY; FIBRILLATION; ORGANIZATION; MECHANISM; KINETICS; STATE	Abrupt aggregation of misfolded proteins is a hallmark of the large group of amyloid pathologies that include diabetes type 2, Alzheimer and Parkinson's diseases. Protein aggregation yields oligomers and fibrils, beta-sheet-rich structures that exert cell toxicity. Microscopic examination of amyloid deposits reveals the presence of lipids membranes, which suggests that lipids can be involved in the process of pathogenic protein assembly. In this study, we show that lipids can uniquely alter the aggregation rates of lysozyme, a protein that is associated with systemic amyloidosis. Specifically, cardiolipin (CL), ceramide (CER), and sphingomyelin (SM) accelerate, phosphatidylcholine (PC) strongly inhibits, whereas phosphatidylserine (PS) has no effect on the rate of protein aggregation. Furthermore, lipids uniquely alter the secondary structure of lysozyme aggregates. Furthermore, we found that lysozyme aggregates grown in the presence of CL, CER, SM, PS, and CL:PC mixtures exert significantly lower production of reactive oxygen species and mitochondrial dysfunction compared to lysozyme:PC aggregates and lysozyme fibrils grown in the lipid-free environment. These findings suggest that a change in the lipid composition of cell membranes, which is taken place upon neurodegeneration, may trigger the formation of toxic protein species that otherwise would not be formed.	[Matveyenka, Mikhail; Zhaliazka, Kiryl; Rizevsky, Stanislav; Kurouski, Dmitry] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Rizevsky, Stanislav] Binh Duong Univ, Dept Biotechnol, Thu Dau Mot, Vietnam; [Kurouski, Dmitry] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kurouski, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dkurouski@tamu.edu			National Institute of Health [R35GM142869]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the National Institute of Health for the provided financial support (R35GM142869).	Alecu I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00328; Alza NP, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00175; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Cataldi R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01490-3; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dazzi A, 2017, CHEM REV, V117, P5146, DOI 10.1021/acs.chemrev.6b00448; De Simone A, 2019, ACS OMEGA, V4, P12308, DOI 10.1021/acsomega.9b01531; Dou TY, 2021, J PHYS CHEM LETT, V12, P4407, DOI 10.1021/acs.jpclett.1c00820; Dou TY, 2020, ANAL CHEM, V92, P11297, DOI 10.1021/acs.analchem.0c01971; Fitzner D, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108132; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Galvagnion C, 2016, P NATL ACAD SCI USA, V113, P7065, DOI 10.1073/pnas.1601899113; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Hong DP, 2011, PROTEIN PEPTIDE LETT, V18, P230, DOI 10.2174/092986611794578332; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kurouski D, 2020, CHEM SOC REV, V49, P3315, DOI 10.1039/c8cs00916c; Kurouski D, 2015, ANALYST, V140, P4967, DOI 10.1039/c5an00342c; Kurouski D, 2014, J AM CHEM SOC, V136, P2302, DOI 10.1021/ja407583r; Kurouski D, 2012, BIOCHEM BIOPH RES CO, V422, P97, DOI 10.1016/j.bbrc.2012.04.113; Kurouski D, 2010, CHEM COMMUN, V46, P7154, DOI 10.1039/c0cc02423f; La Rosa C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948323; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Matveyenka M, 2022, J PHYS CHEM LETT, V13, P4563, DOI 10.1021/acs.jpclett.2c00559; Matveyenka M, 2022, FEBS LETT, V596, P1424, DOI 10.1002/1873-3468.14369; MICHAELSON DM, 1983, BIOCHEM J, V211, P155, DOI 10.1042/bj2110155; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; O'Leary EI, 2019, BBA-PROTEINS PROTEOM, V1867, P483, DOI 10.1016/j.bbapap.2018.09.012; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Ramer G, 2018, ACS NANO, V12, P6612, DOI 10.1021/acsnano.8b01425; Rizevsky S, 2022, J PHYS CHEM C, V126, P4157, DOI 10.1021/acs.jpcc.1c09643; Rizevsky S, 2022, J PHYS CHEM LETT, V13, P2467, DOI 10.1021/acs.jpclett.1c04012; Ruggeri FS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8831; Ruggeri FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16728-1; Ruggeri FS, 2020, ACS NANO, V14, P5213, DOI 10.1021/acsnano.9b09676; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Scollo F, 2018, J PHYS CHEM LETT, V9, P5125, DOI 10.1021/acs.jpclett.8b02241; Shashilov V, 2007, J AM CHEM SOC, V129, P6972, DOI 10.1021/ja070038c; Shashilov VA, 2008, J AM CHEM SOC, V130, P309, DOI 10.1021/ja076225s; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Xu M, 2007, J AM CHEM SOC, V129, P11002, DOI 10.1021/ja073798w; Xu M, 2007, PROTEIN SCI, V16, P815, DOI 10.1110/ps.062639307	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22543	10.1096/fj.202200841R	http://dx.doi.org/10.1096/fj.202200841R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4L6CX	36094052				2022-12-28	WOS:000852719000001
J	Gentile, GM; Gamarra, JR; Engels, NM; Blue, RE; Hoerr, I; Wiedner, HJ; Hinkle, ER; Cote, JL; Leverence, E; Mills, CA; Herring, LE; Tan, XM; Giudice, J				Gentile, Gabrielle M.; Gamarra, Jennifer R.; Engels, Nichlas M.; Blue, R. Eric; Hoerr, Isabel; Wiedner, Hannah J.; Hinkle, Emma R.; Cote, Jessica L.; Leverence, Elise; Mills, Christine A.; Herring, Laura E.; Tan, Xianming; Giudice, Jimena			The synaptosome-associated protein 23 (SNAP23) is necessary for proper myogenesis	FASEB JOURNAL			English	Article						IGF1; myogenesis; proliferation; secretion; SNAP23	CELL-CYCLE REGULATORS; SKELETAL-MUSCLE; BINDING-PROTEIN; IGF-I; DIFFERENTIATION; EXPRESSION; MYOD; SECRETION; TRAFFICKING; INHIBITION	Vesicle-mediated transport is necessary for maintaining cellular homeostasis and proper signaling. The synaptosome-associated protein 23 (SNAP23) is a member of the SNARE protein family and mediates the vesicle docking and membrane fusion steps of secretion during exocytosis. Skeletal muscle has been established as a secretory organ; however, the role of SNAP23 in the context of skeletal muscle development is still unknown. Here, we show that depletion of SNAP23 in C2C12 mouse myoblasts reduces their ability to differentiate into myotubes as a result of premature cell cycle exit and early activation of the myogenic transcriptional program. This effect is rescued when cells are seeded at a high density or when cultured in conditioned medium from wild type cells. Proteomic analysis of collected medium indicates that SNAP23 depletion leads to a misregulation of exocytosis, including decreased secretion of the insulin-like growth factor 1 (IGF1), a critical protein for muscle growth, development, and function. We further demonstrate that treatment of SNAP23-depleted cells with exogenous IGF1 rescues their myogenic capacity. We propose that SNAP23 mediates the secretion of specific proteins, such as IGF1, that are important for achieving proper differentiation of skeletal muscle cells during myogenesis. This work highlights the underappreciated role of skeletal muscle as a secretory organ and contributes to the understanding of factors necessary for myogenesis.	[Gentile, Gabrielle M.; Gamarra, Jennifer R.; Engels, Nichlas M.; Blue, R. Eric; Hoerr, Isabel; Wiedner, Hannah J.; Hinkle, Emma R.; Cote, Jessica L.; Leverence, Elise; Giudice, Jimena] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 6340B Med Biomol Res Bldg,111 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Gentile, Gabrielle M.; Hinkle, Emma R.; Giudice, Jimena] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Mills, Christine A.; Herring, Laura E.] Univ North Carolina Chapel Hill, Dept Pharmacol, UNC Prote Core Facil, Chapel Hill, NC USA; [Tan, Xianming] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC USA; [Tan, Xianming] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Giudice, Jimena] Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Giudice, J (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 6340B Med Biomol Res Bldg,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jimena_giudice@med.unc.edu	; Giudice, Jimena/N-5156-2016	Gentile, Gabrielle/0000-0002-2669-1861; Blue, Eric/0000-0002-9774-6778; Engels, Nichlas/0000-0003-0613-0925; Giudice, Jimena/0000-0002-3330-7784	American Heart Association (AHA) [19CDA34660248]; National Institutes of Health (NIH) [R01GM130866]; March of Dimes Foundation (MDF) [5-FY18-36]; National Science Foundation (NSF) [DGE-1650116]; Nutrition Obesity Research Center, University of North Carolina (NORC) [P30-DK056350]; Cancer Center Core Support Grant [P30 CA016086]; National Institutes of Health (NIH)-NIGMS training award [R25GM089569, T32GM119999, 5T32GM007092]; National Institutes of Health (NIAH)-NIAMS F31 predoctoral fellowship [AR077381-01A1]	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation (MDF)(March of Dimes); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Nutrition Obesity Research Center, University of North Carolina (NORC); Cancer Center Core Support Grant; National Institutes of Health (NIH)-NIGMS training award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIAH)-NIAMS F31 predoctoral fellowship	American Heart Association (AHA), Grant/Award Number: 19CDA34660248; National Institutes of Health (NIH), Grant/Award Number: R01GM130866; March of Dimes Foundation (MDF), Grant/Award Number: 5--FY18--36; National Science Foundation (NSF), Grant/Award Number: DGE--1650116; Nutrition Obesity Research Center, University of North Carolina (NORC), Grant/Award Number: P30--DK056350; Cancer Center Core Support Grant to the Lineberger Comprehensive Cancer Center, Grant/Award Number: P30 CA016086; National Institutes of Health (NIH)-NIGMS training award, Grant/Award Number: R25GM089569, T32GM119999 and 5T32GM007092; National Institutes of Health (NIAH)--NIAMS F31 predoctoral fellowship, Grant/Award Number: AR077381--01A1	Ahmad SS, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081773; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bohm J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003430; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chan XCY, 2007, J PROTEOME RES, V6, P698, DOI 10.1021/pr060448k; Chowdhury SR, 2010, J BIOSCI BIOENG, V109, P310, DOI 10.1016/j.jbiosc.2009.09.042; Csapo R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00253; D'Alessandro M, 2015, DEV CELL, V35, P186, DOI 10.1016/j.devcel.2015.09.018; Dowling JJ, 2008, TRAFFIC, V9, P1035, DOI 10.1111/j.1600-0854.2008.00716.x; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Feng DR, 2018, J CLIN INVEST, V128, P3941, DOI 10.1172/JCI99217; Florin Antoine, 2020, Osteoarthr Cartil Open, V2, P100019, DOI 10.1016/j.ocarto.2019.100019; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Fu Y, 2016, BBA-MOL CELL RES, V1863, P1839, DOI 10.1016/j.bbamcr.2015.11.004; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Fuste NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11581; Gerard C, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0075; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Giudice J, 2017, CURR OPIN PHARMACOL, V34, P49, DOI 10.1016/j.coph.2017.05.005; Giudice J, 2016, CELL REP, V17, P1923, DOI 10.1016/j.celrep.2016.10.072; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Grassi D, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.23; Grube L, 2018, J PROTEOME RES, V17, P879, DOI 10.1021/acs.jproteome.7b00684; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hernandez-Hernandez M, 2017, SEMIN CELL DEV BIOL, V72, P10, DOI 10.1016/j.semcdb.2017.11.010; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kaspar P, 2005, EXP CELL RES, V309, P419, DOI 10.1016/j.yexcr.2005.06.016; Kaul S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118311; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kunii M, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.201910080; Kunii M, 2016, J CELL BIOL, V215, P121, DOI 10.1083/jcb.201604030; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Lindon C, 2001, DEV BIOL, V240, P574, DOI 10.1006/dbio.2001.0435; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Liu XL, 2020, FOOD FUNCT, V11, P328, DOI [10.1039/c9fo01346f, 10.1039/C9FO01346F]; Murphy David P, 2019, Wellcome Open Res, V4, P6, DOI 10.12688/wellcomeopenres.15055.1; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Stallaert W, 2022, CELL SYST, V13, P230, DOI 10.1016/j.cels.2021.10.007; Strauss JA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12662; Suh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018444; Sun XL, 2017, CELL SIGNAL, V30, P118, DOI 10.1016/j.cellsig.2016.11.019; Tanaka K, 2011, MUSCLE NERVE, V44, P968, DOI 10.1002/mus.22224; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Williams CM, 2018, BLOOD ADV, V2, P3627, DOI 10.1182/bloodadvances.2018023291; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhang WY, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00579-4; Zhu JJ, 2017, P NATL ACAD SCI USA, V114, P8271, DOI 10.1073/pnas.1700561114	72	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22441	10.1096/fj.202101627RR	http://dx.doi.org/10.1096/fj.202101627RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2U0GW	35816155				2022-12-28	WOS:000822844200001
J	Slominski, AT; Kim, TK; Slominski, RM; Song, YW; Janjetovic, Z; Podgorska, E; Reddy, SB; Song, YH; Raman, C; Tang, EKY; Fabisiak, A; Brzeminski, P; Sicinski, RR; Atigadda, V; Jetten, AM; Holick, MF; Tuckey, RC				Slominski, Andrzej T.; Kim, Tae-Kang; Slominski, Radomir M.; Song, Yuwei; Janjetovic, Zorica; Podgorska, Ewa; Reddy, Sivani B.; Song, Yuhua; Raman, Chander; Tang, Edith K. Y.; Fabisiak, Adrian; Brzeminski, Pawel; Sicinski, Rafal R.; Atigadda, Venkatram; Jetten, Anton M.; Holick, Michael F.; Tuckey, Robert C.			Metabolic activation of tachysterol(3) to biologically active hydroxyderivatives that act on VDR, AhR, LXRs, and PPAR gamma receptors	FASEB JOURNAL			English	Article						keratinocytes; receptors; skin; tachysterol; tachysterol hydroxymetabolites; ultraviolet B; vitamin D3	VITAMIN-D; CYTOCHROME P450SCC; INHIBITS PROLIFERATION; 20-HYDROXYVITAMIN D3; CRYSTAL-STRUCTURE; NUCLEAR RECEPTOR; ROR-ALPHA; PATHWAY; SKIN; 7-DEHYDROCHOLESTEROL	CYP11A1 and CYP27A1 hydroxylate tachysterol(3), a photoproduct of previtamin D-3, producing 20S-hydroxytachysterol(3) [20S(OH)T-3] and 25(OH)T-3, respectively. Both metabolites were detected in the human epidermis and serum. Tachysterol(3) was also detected in human serum at a concentration of 7.3 +/- 2.5 ng/ml. 20S(OH)T-3 and 25(OH)T-3 inhibited the proliferation of epidermal keratinocytes and dermal fibroblasts and stimulated the expression of differentiation and anti-oxidative genes in keratinocytes in a similar manner to 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3]. They acted on the vitamin D receptor (VDR) as demonstrated by image flow cytometry and the translocation of VDR coupled GFP from the cytoplasm to the nucleus of melanoma cells, as well as by the stimulation of CYP24A1 expression. Functional studies using a human aryl hydrocarbon receptor (AhR) reporter assay system revealed marked activation of AhR by 20S(OH)T-3, a smaller effect by 25(OH)T-3, and a minimal effect for their precursor, tachysterol(3). Tachysterol(3) hydroxyderivatives showed high-affinity binding to the ligan-binding domain (LBD) of the liver X receptor (LXR) alpha and beta, and the peroxisome proliferator-activated receptor gamma (PPAR gamma) in LanthaScreen TR-FRET coactivator assays. Molecular docking using crystal structures of the LBDs of VDR, AhR, LXRs, and PPAR gamma revealed high docking scores for 20S(OH)T-3 and 25(OH)T-3, comparable to their natural ligands. The scores for the non-genomic-binding site of the VDR were very low indicating a lack of interaction with tachysterol(3) ligands. Our identification of endogenous production of 20S(OH)T-3 and 25(OH)T-3 that are biologically active and interact with VDR, AhR, LXRs, and PPAR gamma, provides a new understanding of the biological function of tachysterol(3).	[Slominski, Andrzej T.; Kim, Tae-Kang; Slominski, Radomir M.; Song, Yuwei; Janjetovic, Zorica; Podgorska, Ewa; Reddy, Sivani B.; Raman, Chander; Atigadda, Venkatram] Univ Alabama Birmingham, Dept Dermatol, VH 476C,1720 2nd Ave South, Birmingham, AL 35294 USA; [Slominski, Radomir M.; Song, Yuwei] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Slominski, Radomir M.; Song, Yuwei] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA; [Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Tang, Edith K. Y.; Tuckey, Robert C.] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [Fabisiak, Adrian; Brzeminski, Pawel; Sicinski, Rafal R.] Univ Warsaw, Dept Chem, Warsaw, Poland; [Jetten, Anton M.] NIEHS, Cell Biol Sect, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Holick, Michael F.] Boston Univ, Dept Med, Boston, MA 02215 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Western Australia; University of Warsaw; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Boston University	Slominski, AT (corresponding author), Univ Alabama Birmingham, Dept Dermatol, VH 476C,1720 2nd Ave South, Birmingham, AL 35294 USA.; Tuckey, RC (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia.; Holick, MF (corresponding author), Boston Univ, Dept Med, Boston, MA 02215 USA.	mfholick@bu.edu; robert.tuckey@uwa.edu.au		Tuckey, Robert/0000-0002-5022-4729; Slominski, Andrzej/0000-0001-8963-3995; Podgorska, Ewa/0000-0002-1550-0871	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1R01AR073004-01A1, R01AR071189-01A, R21 AI149267-01A1]; U.S. Department of Veterans Affairs (VA) [1I01BX004293-01A1]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: 1R01AR073004-01A1, R01AR071189-01A and R21 AI149267-01A1; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1I01BX004293-01A1	Acimovic J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28462; [Anonymous], 2015, MAESTR VERS 10 2; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bikle D, 2020, NAT REV ENDOCRINOL, V16, P234, DOI 10.1038/s41574-019-0312-5; Bikle DD, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvz038; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Brzeminski P, 2022, BIOORG CHEM, V121, DOI 10.1016/j.bioorg.2022.105660; Bunaciu RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135668; Carlberg C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00250; Chaiprasongsuk A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249374; Chaiprasongsuk A, 2020, FREE RADICAL BIO MED, V155, P87, DOI 10.1016/j.freeradbiomed.2020.05.016; Chaiprasongsuk A, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101206; Chen JJ, 2014, ANTICANCER RES, V34, P2153; Chen TC, 2000, J NUTR BIOCHEM, V11, P267, DOI 10.1016/S0955-2863(00)00077-2; Christakos S, 2019, METABOLISM, V98, P112, DOI 10.1016/j.metabol.2019.06.010; Endo-Umeda K, 2014, J STEROID BIOCHEM, V140, P7, DOI 10.1016/j.jsbmb.2013.11.010; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1987, ARCH DERMATOL, V123, P1677, DOI 10.1001/archderm.123.12.1677; HOLICK MF, 1978, FED PROC, V37, P2567; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janjetovic Z, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqaa198; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Jenkinson C, 2021, CLIN CHEM LAB MED, V59, P1642, DOI 10.1515/cclm-2021-0441; Jenkinson C, 2019, CELL BIOCHEM FUNCT, V37, P408, DOI 10.1002/cbf.3421; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kim TK, 2020, MOLECULES, V25, DOI 10.3390/molecules25112583; Kim TK, 2012, MOL CELL ENDOCRINOL, V361, P143, DOI 10.1016/j.mce.2012.04.001; Li W, 2010, STEROIDS, V75, P926, DOI 10.1016/j.steroids.2010.05.021; Lin ZT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19183-7; Lin ZT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10917-7; Liu WG, 2011, J MED CHEM, V54, P8541, DOI 10.1021/jm201061j; MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884; Matsui Y, 2015, BIOORG MED CHEM LETT, V25, P3914, DOI 10.1016/j.bmcl.2015.07.047; Mier-Aguilar CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168155; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oda Y, 2018, J INVEST DERMATOL, V138, P2423, DOI 10.1016/j.jid.2018.04.033; Pikuleva I, 2003, ARCH BIOCHEM BIOPHYS, V420, P35, DOI 10.1016/j.abb.2003.09.028; Podgorska E, 2021, CANCERS, V13, DOI 10.3390/cancers13133111; Postlethwaite AE, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.678487; Reichrath J, 2017, MOL CELL ENDOCRINOL, V453, P96, DOI 10.1016/j.mce.2017.05.001; Reichrath J, 2016, REV ENDOCR METAB DIS, V17, P405, DOI 10.1007/s11154-016-9353-4; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rowse AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052658; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Skobowiat C, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12501; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; Slominski A, 2013, J CLIN ENDOCR METAB, V98, pE298, DOI 10.1210/jc.2012-3074; Slominski AT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87061-w; Slominski AT, 2020, CELL BIOCHEM BIOPHYS, V78, P165, DOI 10.1007/s12013-020-00913-6; Slominski AT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103072; Slominski AT, 2018, J STEROID BIOCHEM, V177, P159, DOI 10.1016/j.jsbmb.2017.06.013; Slominski AT, 2017, J STEROID BIOCHEM, V173, P42, DOI 10.1016/j.jsbmb.2016.09.024; Slominski AT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10202-7; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Slominski RM, 2021, MOL CELL ENDOCRINOL, V530, DOI 10.1016/j.mce.2021.111238; Slominski RM, 2020, GENES IMMUN, V21, P150, DOI 10.1038/s41435-020-0096-6; Stachel SJ, 2016, J MED CHEM, V59, P3489, DOI 10.1021/acs.jmedchem.6b00176; Tieu EW, 2012, J STEROID BIOCHEM, V129, P163, DOI 10.1016/j.jsbmb.2011.11.012; Tongkao-On W, 2015, J STEROID BIOCHEM, V148, P72, DOI 10.1016/j.jsbmb.2014.11.015; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Tuckey RC, 2021, J STEROID BIOCHEM, V212, DOI 10.1016/j.jsbmb.2021.105929; Tuckey RC, 2019, J STEROID BIOCHEM, V186, P4, DOI 10.1016/j.jsbmb.2018.09.003; Tuckey RC, 2018, J STEROID BIOCHEM, V181, P1, DOI 10.1016/j.jsbmb.2018.02.008; Tuckey RC, 2014, INT J BIOCHEM CELL B, V55, P24, DOI 10.1016/j.biocel.2014.08.004; Tuckey RC, 2011, DRUG METAB DISPOS, V39, P1577, DOI 10.1124/dmd.111.040071; Wang J, 2012, ANTICANCER RES, V32, P739; Woods ST, 1998, ARCH BIOCHEM BIOPHYS, V353, P109, DOI 10.1006/abbi.1998.0621; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62	85	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22451	10.1096/fj.202200578R	http://dx.doi.org/10.1096/fj.202200578R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2X9JV	35838947				2022-12-28	WOS:000825514000001
J	Nadeem, T; Bommareddy, A; Bolarinwa, L; Cuervo, H				Nadeem, Taliha; Bommareddy, Apoorva; Bolarinwa, Lolade; Cuervo, Henar			Pericyte dynamics in the mouse germinal matrix angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; germinal matrix; intraventricular hemorrhage; mice; pericytes	CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; PDGF-B; CEREBRAL-HEMORRHAGE; INTRAVENTRICULAR HEMORRHAGE; WHITE-MATTER; INTEGRITY; CELLS; MICE; RECRUITMENT	Germinal matrix-intraventricular hemorrhage (GM-IVH) is the most devastating neurological complication in premature infants. GM-IVH usually begins in the GM, a highly vascularized region of the developing brain where glial and neuronal precursors reside underneath the lateral ventricular ependyma. Previous studies using human fetal tissue have suggested increased angiogenesis and paucity of pericytes as key factors contributing to GM-IVH pathogenesis. Yet, despite its relevance, the mechanisms underlying the GM vasculature's susceptibility to hemorrhage remain poorly understood. To gain better understanding on the vascular dynamics of the GM, we performed a comprehensive analysis of the mouse GM vascular endothelium and pericytes during development. We hypothesize that vascular development of the mouse GM will provide a good model for studies of human GM vascularization and provide insights into the role of pericytes in GM-IVH pathogenesis. Our findings show that the mouse GM presents significantly greater vascular area and vascular branching compared to the developing cortex (CTX). Analysis of pericyte coverage showed abundance in PDGFR beta-positive and NG2-positive pericyte coverage in the GM similar to the developing CTX. However, we found a paucity in Desmin-positive pericyte coverage of the GM vasculature. Our results underscore the highly angiogenic nature of the GM and reveal that pericytes in the developing mouse GM exhibit distinct phenotypical and likely functional characteristics compared to other brain regions which might contribute to the high susceptibility of the GM vasculature to hemorrhage.	[Nadeem, Taliha; Bommareddy, Apoorva; Bolarinwa, Lolade; Cuervo, Henar] Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott Ave E-202, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cuervo, H (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott Ave E-202, Chicago, IL 60612 USA.	hcuervo@uic.edu		Cuervo, Henar/0000-0001-8293-9377; Nadeem, Taliha/0000-0003-3394-2427	University of Illinois Chicago; UIC Provost's Award for Graduate Research	University of Illinois Chicago; UIC Provost's Award for Graduate Research	University of Illinois Chicago; UIC Provost's Award for Graduate Research	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Atienza-Navarro I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218343; Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Ballabh P, 2007, NAT MED, V13, P477, DOI 10.1038/nm1558; Ballabh P, 2021, NAT REV NEUROL, V17, P199, DOI 10.1038/s41582-020-00447-8; Ballabh P, 2014, CLIN PERINATOL, V41, P47, DOI 10.1016/j.clp.2013.09.007; Bilguvar K, 2009, J PEDIATR-US, V155, P743, DOI 10.1016/j.jpeds.2009.04.014; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Brazel CY, 2003, PROG NEUROBIOL, V69, P49, DOI 10.1016/S0301-0082(03)00002-9; Chen VS, 2017, TOXICOL PATHOL, V45, P705, DOI 10.1177/0192623317728134; Cherian SS, 2003, J NEUROPATH EXP NEUR, V62, P292, DOI 10.1093/jnen/62.3.292; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Cuervo H, 2017, ANGIOGENESIS, V20, P655, DOI 10.1007/s10456-017-9570-9; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dave JM, 2018, DEV CELL, V47, P388, DOI 10.1016/j.devcel.2018.10.019; Dawes WJ, 2016, DEV NEUROSCI-BASEL, V38, P430, DOI 10.1159/000455839; Del Bigio MR, 2011, BRAIN, V134, P1344, DOI 10.1093/brain/awr052; Eilken HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01738-3; El-Khoury N, 2006, PEDIATR RES, V59, P673, DOI 10.1203/01.pdr.0000214975.85311.9c; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Garcia MT, 2017, FEBS LETT, V591, P3942, DOI 10.1002/1873-3468.12829; Garton TP, 2016, BRAIN RES, V1635, P86, DOI 10.1016/j.brainres.2015.12.060; Georgiadis P, 2008, STROKE, V39, P3378, DOI 10.1161/STROKEAHA.107.510883; Geranmayeh MH, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0340-8; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Goulding DS, 2020, J NEUROSURG-PEDIATR, V26, P613, DOI 10.3171/2020.5.PEDS20124; Guide for the Care and Use of Laboratory Animals, 2011, NAT AC COLL REP FUND; Gundersen GA, 2014, BRAIN STRUCT FUNCT, V219, P2181, DOI 10.1007/s00429-013-0629-0; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Inder TE, 2018, VOLPES NEUROLOGY NEW, V6th, P637; JIANG B, 1994, J CELL SCI, V107, P2499; Jung B, 2018, J CEREBR BLOOD F MET, V38, P456, DOI 10.1177/0271678X17697720; Kinoshita Y, 2001, AM J NEURORADIOL, V22, P382; Klebe D, 2014, STROKE, V45, P2475, DOI 10.1161/STROKEAHA.114.005079; Klebermass-Schrehof K, 2012, CHILD NERV SYST, V28, P2085, DOI 10.1007/s00381-012-1897-3; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Lekic T, 2017, CURR DRUG TARGETS, V18, P1316, DOI 10.2174/1389450117666160615100538; Lekic T, 2012, EXP NEUROL, V236, P69, DOI 10.1016/j.expneurol.2012.04.003; Letinic K, 1997, J COMP NEUROL, V384, P373; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Licht T, 2015, J CLIN INVEST, V125, P1319, DOI 10.1172/JCI79401; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Ma S, 2017, DEV CELL, V41, P366, DOI 10.1016/j.devcel.2017.04.014; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Brown NM, 2018, GENE DEV, V32, P466, DOI 10.1101/gad.309823.117; Patra K, 2006, J PEDIATR-US, V149, P169, DOI 10.1016/j.jpeds.2006.04.002; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Segado-Arenas A, 2018, MOL NEUROBIOL, V55, P4896, DOI 10.1007/s12035-017-0693-1; SMART IHM, 1976, J ANAT, V121, P71; Song HW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69096-7; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Torok O, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016587118; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Vavasseur Claudine, 2007, J Pediatr, V151, pe6, DOI 10.1016/j.jpeds.2007.03.051; Vinukonda G, 2016, J NEUROSCI, V36, P872, DOI 10.1523/JNEUROSCI.3297-15.2016; Vinukonda G, 2010, BRAIN, V133, P2264, DOI 10.1093/brain/awq107; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Yamanishi E, 2012, DEV GROWTH DIFFER, V54, P785, DOI 10.1111/dgd.12007; Yang D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005794	72	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22339	10.1096/fj.202200120R	http://dx.doi.org/10.1096/fj.202200120R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0Y3VC	35506590	hybrid			2022-12-28	WOS:000790318700001
J	Jung, SW; Kim, SM; Kim, A; Park, SH; Moon, JY; Lee, SH				Jung, Su Woong; Kim, Su-Mi; Kim, Arum; Park, Seon Hwa; Moon, Ju-Young; Lee, Sang-Ho			Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-beta signaling	FASEB JOURNAL			English	Article						fibroblast-myofibroblast transition; midbody; renal fibroblasts; TGF-beta; Smad signaling	PRIMARY CILIA; CYTOKINESIS; CELLS; CILIOGENESIS; COLCHICINE; POLARITY; SEPTINS	The transition of fibroblasts into myofibroblasts is a crucial step in kidney fibrosis. However, the biological processes involved in this transdifferentiation are incompletely understood. In this study, we discovered that the midbody plays a role in the fibroblast-myofibroblast transition by mediating TGF-beta/Smad signaling. Combining bulk RNA-seq, histology, and the western blot of unilateral ureteral obstruction kidneys, we demonstrated that the pathway related to microtubules is implicated in kidney fibrosis, and the blocking of microtubule dynamics by colchicine improved kidney fibrosis. Subsequently, to explore microtubule-based organelles in detail, we cultured NRK-49F (rat kidney fibroblast cell line) and HKC-8 (human proximal tubule cell line) under transforming growth factor-beta 1 (TGF-beta 1) stimulation, which caused deciliation in both cell lines during epithelial-mesenchymal and fibroblast-myofibroblast transition. We identified another microtubule-based organelle, the midbody, whose formation is promoted by TGF-beta 1 in fibroblasts as a result of proliferation in contrast to tubular cells. Notably, TGF-beta receptors were present in the midbody of both cell lines. In TGF-beta 1-treated fibroblasts, colchicine or Hedgehog pathway inhibitor 4 impaired the midbody formation, and attenuated the upregulation of canonical TGF-beta/Smad signaling and alpha-SMA expression. These findings offer novel insight into the midbody as an active organelle involved in fibroblast-myofibroblast transition by mediating TGF-beta/Smad signaling, which could be a potential therapeutic target.	[Jung, Su Woong; Kim, Su-Mi; Kim, Arum; Park, Seon Hwa; Moon, Ju-Young; Lee, Sang-Ho] Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, 892 Dongnam Ro, Seoul 05278, South Korea	Kyung Hee University; Kyung Hee University Hospital	Lee, SH (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, 892 Dongnam Ro, Seoul 05278, South Korea.	lshkidney@khu.ac.kr		Jung, Su Woong/0000-0002-9053-924X	National Research Foundation of Korea Grant - Korean government, Ministry of Science and ICT [2020R1A2B5B03001928]	National Research Foundation of Korea Grant - Korean government, Ministry of Science and ICT	This work was supported by the National Research Foundation of Korea Grant funded by the Korean government, Ministry of Science and ICT (2020R1A2B5B03001928).	Bernabe-Rubio M, 2016, J CELL BIOL, V214, P259, DOI 10.1083/jcb.201601020; Capalbo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12507-9; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Crowell EF, 2014, J CELL SCI, V127, P3840, DOI 10.1242/jcs.154732; D'Avino PP, 2016, SEMIN CELL DEV BIOL, V53, P57, DOI 10.1016/j.semcdb.2016.01.018; Dionne LK, 2015, CURR OPIN CELL BIOL, V35, P51, DOI 10.1016/j.ceb.2015.04.010; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fumoto K, 2012, J CELL SCI, V125, P4822, DOI 10.1242/jcs.108142; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Han SJ, 2018, BIOCHEM BIOPH RES CO, V496, P450, DOI 10.1016/j.bbrc.2018.01.079; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27775; Horgan CP, 2011, CELL BIOL INT, V35, P171, DOI 10.1042/CBI20100284; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Huang ZN, 2015, NUCLEIC ACIDS RES, V43, pD328, DOI 10.1093/nar/gku1125; Itano S, 2017, MOL MED REP, V15, P4169, DOI 10.3892/mmr.2017.6539; Johnson CA, 2017, FEBS LETT, V591, P4009, DOI 10.1002/1873-3468.12676; Jung SW, 2021, J GERONTOL A-BIOL, V76, P385, DOI 10.1093/gerona/glaa318; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim S, 2018, KOREAN J INTERN MED, V33, P568, DOI 10.3904/kjim.2016.131; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Peterman E, 2019, J CELL BIOL, V218, P3903, DOI 10.1083/jcb.201906148; Peterman E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10871-0; Rozycki M, 2014, MOL BIOL CELL, V25, P643, DOI 10.1091/mbc.E13-07-0429; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Silverman-Gavrila R, 2008, THESCIENTIFICWORLDJO, V8, P611, DOI 10.1100/tsw.2008.87; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Sobh M, 1998, NEPHRON, V79, P452, DOI 10.1159/000045092; Takahashi K, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208769; TUCKER RW, 1979, CELL, V18, P1065, DOI 10.1016/0092-8674(79)90219-8; Vestergaard ML, 2016, METHODS MOL BIOL, V1307, P123, DOI 10.1007/7651_2014_127; Villalobos E, 2019, CIRCULATION, V139, P2342, DOI 10.1161/CIRCULATIONAHA.117.028752; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1	40	0	0	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22272	10.1096/fj.202101613R	http://dx.doi.org/10.1096/fj.202101613R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZG	35436011				2022-12-28	WOS:000783258300001
J	Nishad, R; Mukhi, D; Kethavath, S; Raviraj, S; Paturi, ASV; Motrapu, M; Kurukuti, S; Pasupulati, AK				Nishad, Rajkishor; Mukhi, Dhanunjay; Kethavath, Srinivas; Raviraj, Sumathi; Paturi, Atreya S. V.; Motrapu, Manga; Kurukuti, Sreenivasulu; Pasupulati, Anil Kumar			Podocyte derived TNF-alpha mediates monocyte differentiation and contributes to glomerular injury	FASEB JOURNAL			English	Article						diabetic kidney disease; growth hormone; macrophages; podocytes; TNF-alpha	NECROSIS-FACTOR-ALPHA; GROWTH-HORMONE; DIABETIC-NEPHROPATHY; CHEMOATTRACTANT PROTEIN-1; MACROPHAGES; PATHOGENESIS; METABOLISM; EXPRESSION; PROLIFERATION; EXCRETION	Diabetes shortens the life expectancy by more than a decade, and the excess mortality in diabetes is correlated with the incidence of kidney disease. Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. Macrophage accumulation predicts the severity of kidney injury in human biopsies and experimental models of DKD. However, the mechanism underlying macrophage recruitment in diabetes glomeruli is unclear. Elevated plasma growth hormone (GH) levels in type I diabetes and acromegalic individuals impaired glomerular biology. In this study, we examined whether GH-stimulated podocytes contribute to macrophage accumulation. RNA-seq analysis revealed elevated TNF-alpha signaling in GH-treated human podocytes. Conditioned media from GH-treated podocytes (GH-CM) induced differentiation of monocytes to macrophages. On the other hand, neutralization of GH-CM with the TNF-alpha antibody diminished GH-CM's action on monocytes. The treatment of mice with GH resulted in increased macrophage recruitment, podocyte injury, and proteinuria. Furthermore, we noticed the activation of TNF-alpha signaling, macrophage accumulation, and fibrosis in DKD patients' kidney biopsies. Our findings suggest that podocytes could secrete TNF-alpha and contribute to macrophage migration, resulting in DKD-related renal inflammation. Inhibition of either GH action or TNF-alpha expression in podocytes could be a novel therapeutic approach for DKD treatment.	[Nishad, Rajkishor; Mukhi, Dhanunjay; Raviraj, Sumathi; Paturi, Atreya S. V.; Motrapu, Manga; Pasupulati, Anil Kumar] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, India; [Kethavath, Srinivas; Kurukuti, Sreenivasulu] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, India; [Nishad, Rajkishor; Pasupulati, Anil Kumar] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India	University of Hyderabad; University of Hyderabad; University of Hyderabad	Nishad, R; Pasupulati, AK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India.	biochemistry1520@gmail.com; pasupulati.anilkumar@gmail.com		Atreya Sai, Venkata/0000-0003-0170-9284	MOHFW | Department of Health Research, India (DHR) [12020/02/2019 HR]; University of Hyderabad [IoE/RC1--20-21]	MOHFW | Department of Health Research, India (DHR); University of Hyderabad(University of Hyderabad)	MOHFW | Department of Health Research, India (DHR), Grant/Award Number: 12020/02/2019 HR; University of Hyderabad, Grant/Award Number: IoE/RC1--20-21	Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Bellush LL, 2000, ENDOCRINOLOGY, V141, P163, DOI 10.1210/en.141.1.163; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Chen Y, 2020, KIDNEY DIS-BASEL, V6, P215, DOI 10.1159/000506634; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chung CH, 2015, NEPHRON EXTRA, V5, P1, DOI 10.1159/000369576; DiPetrillo K, 2003, AM J PHYSIOL-RENAL, V284, pF113, DOI 10.1152/ajprenal.00026.2002; Doi SQ, 2000, J AM SOC NEPHROL, V11, P1419, DOI 10.1681/ASN.V1181419; DOI T, 1988, AM J PATHOL, V131, P398; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Guo YF, 2017, ONCOTARGET, V8, P53276, DOI 10.18632/oncotarget.18394; Haffner D, 2021, PEDIATR NEPHROL, V36, P2511, DOI 10.1007/s00467-021-05097-6; Hill GS, 2001, KIDNEY INT, V60, P1893, DOI 10.1046/j.1523-1755.2001.00017.x; Kim SH, 2017, ANN PEDIATR ENDOCRIN, V22, P145, DOI 10.6065/apem.2017.22.3.145; Klessens CQF, 2017, NEPHROL DIAL TRANSPL, V32, P1322, DOI 10.1093/ndt/gfw260; Koike N, 2007, LIFE SCI, V80, P1721, DOI 10.1016/j.lfs.2007.02.001; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Kumar PA, 2011, CURR DIABETES REV, V7, P50, DOI 10.2174/157339911794273900; Kumar PA, 2010, J BIOL CHEM, V285, P31148, DOI 10.1074/jbc.M110.132332; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Mensah-Brown EPK, 2005, CYTOKINE, V31, P180, DOI 10.1016/j.cyto.2005.04.006; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriwaki Y, 2007, ACTA DIABETOL, V44, P215, DOI 10.1007/s00592-007-0007-6; Mukhi D, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00102; Murakami A, 2010, NEPHROL DIAL TRANSPL, V25, P3884, DOI 10.1093/ndt/gfq323; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Niewczas MA, 2019, NAT MED, V25, P805, DOI 10.1038/s41591-019-0415-5; Nishad R, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03643-6; Nishad R, 2019, J BIOL CHEM, V294, P16109, DOI 10.1074/jbc.RA119.008966; Pasupulati AK, 2019, CURR OPIN NEPHROL HY, V28, P10, DOI 10.1097/MNH.0000000000000468; Pilmore HL, 2000, TRANSPLANTATION, V69, P2658, DOI 10.1097/00007890-200006270-00028; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; Rovin BH, 1996, AM J KIDNEY DIS, V27, P640, DOI 10.1016/S0272-6386(96)90097-9; Segev Y, 1999, J AM SOC NEPHROL, V10, P2374; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Vemula MH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01347; Vijayakumar Archana, 2011, Front Endocrinol (Lausanne), V2, P32, DOI 10.3389/fendo.2011.00032; Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313; Whitney JL, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-12; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; YOUNG BA, 1995, KIDNEY INT, V48, P439, DOI 10.1038/ki.1995.312; Zhang XL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103067	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22622	10.1096/fj.202200923R	http://dx.doi.org/10.1096/fj.202200923R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6P1IR	36421039				2022-12-28	WOS:000890688400001
J	Chen, J; Lu, HX; Wang, XY; Yang, J; Luo, J; Wang, LM; Yi, XL; He, YN; Chen, KH				Chen, Jia; Lu, Hongxiang; Wang, Xiaoyue; Yang, Jie; Luo, Jia; Wang, Limin; Yi, Xiangling; He, Yani; Chen, Kehong			VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression	FASEB JOURNAL			English	Article						AKI-CKD transition; cellular senescence; renal tubular cells; retinoblastoma 1; vanin-1	OXIDATIVE STRESS; VANIN-1; PANTETHEINASE; REPLICATION; PATHWAY; CYCLE	The mechanisms underlying acute kidney injury (AKI) and chronic kidney disease (CKD) progression include interstitial inflammation, cellular senescence, and oxidative stress (OS). Although vanin-1 (VNN1) plays an important role in OS, its contribution to the AKI-CKD transition remains unknown. Here, we explored the roles and mechanisms of VNN1 in the progression of the AKI-CKD transition. We observed that VNN1 expression was upregulated after ischemia/reperfusion (I/R) injury and high VNN1 expression levels were associated with poor renal repair after I/R injury. In VNN1 knockout (KO) mice, recovery of serum creatinine and blood urea nitrogen levels after I/R injury was accelerated and renal fibrosis was inhibited after severe I/R injury. Furthermore, in VNN1 KO mice, senescence of renal tubular cells was inhibited after severe I/R injury, as assessed by P16 expression and SA-beta-Gal assays. However, our results also revealed that VNN1 KO renal tubular cells did not resist senescence when OS was blocked. To elucidate the mechanism underlying VNN1-mediated regulation of senescence during the AKI-CKD transition, retinoblastoma 1 (RB1) was identified as a potential target. Our results suggest that the reduced senescence in VNN1 KO renal tubular cells was caused by suppressed RB1 expression and phosphorylation. Collectively, our results unveil a novel molecular mechanism by which VNN1 promotes AKI-CKD transition via inducing senescence of renal tubular cells by activating RB1 expression and phosphorylation after severe renal injury. The present study proposes a new strategy for designing therapies wherein VNN1 can be targeted to obstruct the AKI-CKD transition.	[Chen, Jia; Wang, Xiaoyue; Yang, Jie; Luo, Jia; Wang, Limin; Yi, Xiangling; He, Yani; Chen, Kehong] Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China; [Lu, Hongxiang] Gen Hosp Xinjiang Mil Reg, Dept Traumat Orthopaed, Urumqi, Xinjiang, Peoples R China; [Lu, Hongxiang; He, Yani; Chen, Kehong] Army Med Univ, Daping Hosp, Inst Surg Res, Wound Trauma Med Ctr,State Key Lab Trauma Burns &, Chongqing, Peoples R China	Army Medical University; Army Medical University	He, YN; Chen, KH (corresponding author), Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China.	heynmail@163.com; chenkehong@foxmail.com			Chongqing technology innovation project [2022YSZX-JCX0007CSTB]; National Natural Science Foundation of China (NSFC) [82102276]	Chongqing technology innovation project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Chongqing technology innovation project, Grant/Award Number: 2022YSZX-JCX0007CSTB; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82102276	Andrade L, 2018, CELL TRANSPLANT, V27, P739, DOI 10.1177/0963689717743512; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005; Chen KH, 2020, FASEB J, V34, P8858, DOI 10.1096/fj.202000053R; Chen KH, 2019, FASEB J, V33, P4571, DOI 10.1096/fj.201801749RRR; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4; Ferreira DW, 2015, CURR MED CHEM, V22, P2407, DOI 10.2174/092986732220150722124307; Fiorentino M, 2018, CONTRIB NEPHROL, V193, P45, DOI 10.1159/000484962; Fu JD, 2021, ACTA CIR BRAS, V36, DOI [10.1590/ACB360802, 10.1590/acb360802]; Hosohata K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111448; Hosohata K, 2012, J PHARMACOL EXP THER, V341, P656, DOI 10.1124/jpet.112.192807; Hu JX, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02717-5; Hu YW, 2016, J LIPID RES, V57, P1398, DOI 10.1194/jlr.M065565; Jansen PAM, 2009, J INVEST DERMATOL, V129, P2167, DOI 10.1038/jid.2009.67; Kavian N, 2016, J IMMUNOL, V197, P3326, DOI 10.4049/jimmunol.1502511; Kellum JA, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00284-z; Kim JY, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113939; Kim SR, 2020, AM J PHYSIOL-RENAL, V318, pF1167, DOI 10.1152/ajprenal.00535.2019; Knoppert SN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00770; Knudsen ES, 2019, TRENDS CANCER, V5, P308, DOI 10.1016/j.trecan.2019.03.005; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Li CZ, 2021, FASEB J, V35, DOI 10.1096/fj.202001855RR; Li J, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.820071; Li YX, 2020, HYPERTENSION, V76, P1069, DOI 10.1161/HYPERTENSIONAHA.120.14594; Martin F, 2004, J CLIN INVEST, V113, P591, DOI 10.1172/JCI200419557; Naquet P, 2014, BIOCHEM SOC T, V42, P1094, DOI 10.1042/BST20140092; Pabla N, 2015, P NATL ACAD SCI USA, V112, P5231, DOI 10.1073/pnas.1424313112; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; Tanemoto F, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15020123; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Unterschemmann K, 2021, AM J PHYSIOL-RENAL, V320, pF61, DOI 10.1152/ajprenal.00373.2020; Valentijn FA, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10122020; Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Washino S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040899; Yamashita N, 2017, BIOCHEM BIOPH RES CO, V489, P466, DOI 10.1016/j.bbrc.2017.05.172; Yang JR, 2017, J AM SOC NEPHROL, V28, P532, DOI 10.1681/ASN.2016010009; Yang XA, 2017, TOXICOLOGY, V382, P75, DOI 10.1016/j.tox.2017.03.009; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931	41	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22472	10.1096/fj.202200496RR	http://dx.doi.org/10.1096/fj.202200496RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4MN	35959877				2022-12-28	WOS:000839572200001
J	Jiang, SL; Lin, JY; Zhang, Q; Liao, YJ; Lu, F; Cai, JR				Jiang, Shenglu; Lin, Jiayan; Zhang, Qian; Liao, Yunjun; Lu, Feng; Cai, Junrong			The fates of different types of adipose tissue after transplantation in mice	FASEB JOURNAL			English	Article						beige adipose tissue; brown adipose tissue; fat grafting; white adipose tissue	GRAFT-SURVIVAL; ER STRESS; BROWN; WHITE; ADIPOCYTES; BEIGE; CONVERSION; INSIGHTS; OBESITY; DEATH	Fat grafting is one of the most commonly applied procedure for soft-tissue repair. However, it remains unclear whether the type of adipose tissue would have any effects on fat graft survival. The present study aimed to determine fates of fat grafting of three different types of fat tissue. In this study, mice were randomly divided into three groups, white adipose tissue (WAT) group, beige adipose tissue (beige AT) group and brown adipose tissue (BAT) group. Before transplantation, donor mice were injected with rosiglitazone or phosphate-buffered saline (PBS). The WAT and BAT were obtained from PBS-treated mice while beige AT was obtained from the rosiglitazone-treated mice. Three types of fat tissue (150 mg each) were transplanted in three groups, respectively, and harvested at 2, 4 or 12 weeks. The BAT and beige AT contained smaller adipocytes and expressed higher level of uncoupling protein-1 gene. The retention rate of the transplanted fat was significantly higher for beige than for white fat, but was significantly lower for brown than for white fat. Transplanted brown fat was characterized by upregulated inflammation and high endoplasmic reticulum stress. By contrast, fat grafts in beige AT group showed the best adipogenic capacity, moderate inflammation level and superior angiongenesis. In vitro, under hypoxic condition, fewer apoptotic cells were found in beige adipocyte group than that in brown and white adipocyte group. Conditioned medium from brown adipocytes induced M1 polarization of RAW 264.7 macrophages while that from beige adipocytes effectively promoted M2 polarization. Therefore, we suggest that beige AT provides a new potential choice for fat grafting because of low inflammation and superior survival but BAT might not be ideal for fat grafting due to its poor survival.	[Jiang, Shenglu; Lin, Jiayan; Zhang, Qian; Liao, Yunjun; Lu, Feng; Cai, Junrong] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China; [Jiang, Shenglu] Taizhou Univ Hosp, Dept Basic Med Sci, Taizhou Cent Hosp, Taizhou, Peoples R China	Southern Medical University - China; Taizhou University	Lu, F; Cai, JR (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	drjunrongcai@outlook.com; doctorlufeng@hotmail.com			Nanfang Hospital [2018Z010, 2016B001, 2016Z010]; National Natural Science Foundation of China (NSFC) [81772101, 81901976, 81971852]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2017A030313900]	Nanfang Hospital; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	Nanfang Hospital, Grant/Award Number: 2018Z010, 2016B001 and 2016Z010; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772101, 81901976 and 81971852; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2017A030313900; Nanfang Hospital, Grant/Award Number: 2018Z010, 2016B001 and 2016Z010; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772101, 81901976 and 81971852; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2017A030313900	BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Cai JR, 2022, FASEB J, V36, DOI 10.1096/fj.202101144R; Cai JR, 2018, PLAST RECONSTR SURG, V141, P930, DOI 10.1097/PRS.0000000000004220; Canizares O, 2017, PLAST RECONSTR SURG, V140, P933, DOI 10.1097/PRS.0000000000003812; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; Fenzl A, 2014, HORM MOL BIOL CLIN I, V19, P25, DOI 10.1515/hmbci-2014-0022; Fernandez-Verdejo R, 2019, MOL ASPECTS MED, V68, P82, DOI 10.1016/j.mam.2019.07.003; Grigoras A, 2018, ANN ANAT, V219, P102, DOI 10.1016/j.aanat.2018.06.004; Grimpo K, 2014, J LIPID RES, V55, P398, DOI 10.1194/jlr.M042895; Heinonen S, 2020, OBES REV, V21, DOI 10.1111/obr.12958; Hwang I, 2019, DIABETES METAB J, V43, P752, DOI 10.4093/dmj.2019.0174; Jiang L, 2020, MOL MED REP, V22, P1072, DOI 10.3892/mmr.2020.11163; Jung DW, 2015, ANN PLAS SURG, V75, P463, DOI 10.1097/SAP.0000000000000580; Kaisanlahti A, 2019, J PHYSIOL BIOCHEM, V75, P1, DOI 10.1007/s13105-018-0658-5; Khan S, 2014, MOL MED REP, V10, P2234, DOI 10.3892/mmr.2014.2532; Khouri RK, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000183; Kim J, 2019, PLAST RECONSTR SURG, V144, p619E, DOI 10.1097/PRS.0000000000006036; Larosche I, 2007, J PHARMACOL EXP THER, V321, P526, DOI 10.1124/jpet.106.114546; Laschke MW, 2011, TISSUE ENG PT A, V17, P841, DOI [10.1089/ten.tea.2010.0329, 10.1089/ten.TEA.2010.0329]; Li F, 2015, AESTHET SURG J, V35, P319, DOI 10.1093/asj/sju046; Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048; Lu KY, 2020, CYTOTHERAPY, V22, P521, DOI 10.1016/j.jcyt.2020.06.004; Lu XD, 2019, ADIPOCYTE, V8, P77, DOI 10.1080/21623945.2019.1574194; Luong QE, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020023; Medina CB, 2016, CELL DEATH DIFFER, V23, P979, DOI 10.1038/cdd.2016.13; Merrifield BA, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001869; Miyazawa N, 1996, J APPL PHYSIOL, V80, P86, DOI 10.1152/jappl.1996.80.1.86; Mojallal A, 2011, AESTHET PLAST SURG, V35, P1061, DOI 10.1007/s00266-011-9734-8; Montanari T, 2017, OBES REV, V18, P495, DOI 10.1111/obr.12520; O'Neill CM, 2013, ENDOCRINOLOGY, V154, P3077, DOI 10.1210/en.2012-2138; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pu LLQ, 2015, CLIN PLAST SURG, V42, pIX, DOI 10.1016/j.cps.2015.02.001; Qing H, 2020, CELL, V182, P372, DOI 10.1016/j.cell.2020.05.054; Qiu LH, 2018, PLAST RECONSTR SURG, V142, P392, DOI 10.1097/PRS.0000000000004603; Rasmussen BS, 2017, AESTHET SURG J, V37, pS46, DOI 10.1093/asj/sjx008; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; Saha S, 2017, IMMUNOL REV, V280, P102, DOI 10.1111/imr.12603; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Scheja L, 2016, J HEPATOL, V64, P1176, DOI 10.1016/j.jhep.2016.01.025; Schoettl T, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.162958; Simonacci F, 2017, ANN MED SURG, V20, P49, DOI 10.1016/j.amsu.2017.06.059; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Suszynski TM, 2019, PLAST RECONSTR SURG, V143, P1648, DOI 10.1097/PRS.0000000000005626; Tang QQ, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.607113; Villarroya F, 2017, TRENDS ENDOCRIN MET, V28, P855, DOI 10.1016/j.tem.2017.10.005; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; White JD, 2019, MOL ASPECTS MED, V68, P74, DOI 10.1016/j.mam.2019.06.004; Zhang YQ, 2017, ACS NANO, V11, P9223, DOI 10.1021/acsnano.7b04348	52	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22510	10.1096/fj.202200408R	http://dx.doi.org/10.1096/fj.202200408R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Y9MV	36004579				2022-12-28	WOS:000844047500001
J	Sorin, S; Kubota, S; Hamidi, S; Yokomizo-Nakano, T; Vaeteewoottacharn, K; Wongkham, S; Waraasawapati, S; Pairojkul, C; Bai, J; Morii, M; Sheng, GJ; Sawanyawisuth, K; Sashida, G				Sorin, Supannika; Kubota, Sho; Hamidi, Sofiane; Yokomizo-Nakano, Takako; Vaeteewoottacharn, Kulthida; Wongkham, Sopit; Waraasawapati, Sakda; Pairojkul, Chawalit; Bai, Jie; Morii, Mariko; Sheng, Guojun; Sawanyawisuth, Kanlayanee; Sashida, Goro			HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner	FASEB JOURNAL			English	Article						epithelial mesenchymal transition; histone deacetylase; HMGN; liver fluke; transcription factor	E-CADHERIN EXPRESSION; MESENCHYMAL TRANSITIONS; CHROMOSOMAL-PROTEINS; CELL-LINE; SNAIL; ESTABLISHMENT; DIAGNOSIS; SLUG	High mobility group nucleosome-binding protein 3 (HMGN3), a member of the HMGN family, modulates the structure of chromatin and regulates transcription through transcription factors. HMGN3 has been implicated in the development of various cancers; however, the underlying mechanisms remain unclear. We herein demonstrated that the high expression of HMGN3 correlated with the metastasis of liver fluke infection-induced cholangiocarcinoma (CCA) in patients in northeastern Thailand. The knockdown of HMGN3 in CCA cells significantly impaired the oncogenic properties of colony formation, migration, and invasion. HMGN3 inhibited the expression of and blocked the intracellular polarities of epithelial regulator genes, such as the CDH1/E-cadherin and TJAP1 genes in CCA cells. A chromatin immunoprecipitation sequencing analysis revealed that HMGN3 required the transcription factor SNAI2 to bind to and repress the expression of epithelial regulator genes, at least in part, due to histone deacetylases (HDACs), the pharmacological inhibition of which reactivated these epithelial regulators in CCA, leading to impairing the cell migration capacity. Therefore, the overexpression of HMGN3 represses the transcription of and blocks the polarities of epithelial regulators in CCA cells in a manner that is dependent on the SNAI2 gene and HDACs.	[Sorin, Supannika; Vaeteewoottacharn, Kulthida; Wongkham, Sopit; Sawanyawisuth, Kanlayanee] Khon Kaen Univ, Dept Biochem, Ctr Translat Med, Fac Med, 123 Mittraphap Rd, Khon Kaen 40002, Thailand; [Sorin, Supannika; Vaeteewoottacharn, Kulthida; Sawanyawisuth, Kanlayanee] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand; [Kubota, Sho; Yokomizo-Nakano, Takako; Bai, Jie; Morii, Mariko; Sashida, Goro] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Lab Transcript Regulat Leukemogenesis, Kumamoto 8600811, Japan; [Hamidi, Sofiane; Sheng, Guojun] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Lab Dev Morphogenesis, Kumamoto, Japan; [Waraasawapati, Sakda; Pairojkul, Chawalit] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Kumamoto University; Kumamoto University; Khon Kaen University	Sawanyawisuth, K (corresponding author), Khon Kaen Univ, Dept Biochem, Ctr Translat Med, Fac Med, 123 Mittraphap Rd, Khon Kaen 40002, Thailand.; Sashida, G (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Lab Transcript Regulat Leukemogenesis, Kumamoto 8600811, Japan.	kanlayanee@kkumail.com; sashidag@kumamoto-u.ac.jp	Vaeteewoottacharn, Kulthida/GSE-1017-2022; Sashida, Goro/N-5259-2014; hamidi, sofiane/GQA-3848-2022	Vaeteewoottacharn, Kulthida/0000-0001-6557-9680; Sashida, Goro/0000-0003-2318-5987; Hamidi, Sofiane/0000-0002-1189-843X; Yokomizo-Nakano, Takako/0000-0003-3879-7046; Kubota, Sho/0000-0001-6119-1259; Sorin, Supannika/0000-0002-5075-0139	NSRF under the Basic Research Fund of Khon Kaen University under through Cholangiocarcinoma Research Institute (CARI), an Invitation research grant from the Faculty of Medicine, Khon Kaen University [IN62237]; MEXT of Japan [18H02842, 21H02952]; CARI [07/2560]; JASSO of Japan	NSRF under the Basic Research Fund of Khon Kaen University under through Cholangiocarcinoma Research Institute (CARI), an Invitation research grant from the Faculty of Medicine, Khon Kaen University; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CARI; JASSO of Japan	This study was supported by NSRF under the Basic Research Fund of Khon Kaen University under through Cholangiocarcinoma Research Institute (CARI), an Invitation research grant (IN62237) from the Faculty of Medicine, Khon Kaen University (to KS), and Grants-in-Aid for Scientific Research (18H02842 and 21H02952) from the MEXT of Japan (to GS). Supannika Sorin was supported by scholarships from CARI (07/2560) and JASSO of Japan	Anderson CD, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-1-43; Banales JM, 2020, NAT REV GASTRO HEPAT, V17, P557, DOI 10.1038/s41575-020-0310-z; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Bustin M, 2010, BBA-GENE REGUL MECH, V1799, P1, DOI 10.1016/j.bbagrm.2010.01.006; Chung YE, 2009, RADIOGRAPHICS, V29, P683, DOI 10.1148/rg.293085729; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Fitzgibbons PL, 2014, ARCH PATHOL LAB MED, V138, P595, DOI 10.5858/arpa.2013-0566-CP; Fukase K, 2008, CANCER SCI, V99, P1785, DOI 10.1111/j.1349-7006.2008.00898.x; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Jusakul A, 2017, CANCER DISCOV, V7, P1116, DOI 10.1158/2159-8290.CD-17-0368; Kugler JE, 2013, J BIOL CHEM, V288, P16690, DOI 10.1074/jbc.M113.463315; Marin JJG, 2018, BBA-MOL BASIS DIS, V1864, P1444, DOI 10.1016/j.bbadis.2017.06.005; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Reeves R, 2015, DNA REPAIR, V36, P122, DOI 10.1016/j.dnarep.2015.09.015; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Sheng GJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.198036; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Sripa B, 2020, HUM CELL, V33, P695, DOI 10.1007/s13577-020-00334-w; Techasen A, 2014, TUMOR BIOL, V35, P8645, DOI 10.1007/s13277-014-2087-6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda T, 2009, MOL CELL BIOL, V29, P5264, DOI 10.1128/MCB.00526-09; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vaquero J, 2017, J HEPATOL, V66, P424, DOI 10.1016/j.jhep.2016.09.010; West KL, 2004, MOL CELL BIOL, V24, P3747, DOI 10.1128/MCB.24.9.3747-3756.2004; West KL, 2001, J BIOL CHEM, V276, P25959, DOI 10.1074/jbc.M101692200; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Zhang KJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-88; Zhu AX, 2015, BEST PRACT RES CL GA, V29, P355, DOI 10.1016/j.bpg.2015.02.010	34	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22345	10.1096/fj.202200386R	http://dx.doi.org/10.1096/fj.202200386R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1P9BN	35635715				2022-12-28	WOS:000802297000001
J	Xiao, Y; Li, XZ; Qiu, SF; Wang, YJ; Zhang, DS				Xiao, Ying; Li, Xiaozhou; Qiu, Shuangfa; Wang, Yongjun; Zhang, Dongshan			LncRNA 122049 suppresses apoptosis of renal tubular epithelial cells in ischemic AKI by targeting the miR-330-5p/ELK1 axis	FASEB JOURNAL			English	Article						apoptosis; ELK1; I; R; LncRNA 122049; miR-330-5p; AKI	ACUTE KIDNEY INJURY; PROGRESSION; BIOMARKER; PROMOTES; CANCER; DRIVES	Several studies have reported that long non-coding RNAs (LncRNAs) were associated with the progression of acute kidney injury (AKI). However, the role and regulation mechanism of lncRNA122049 in ischemic AKI remains unknown. In the present study, we found that lncRNA 122049 protected against the ischemia/reperfusion (I/R) induced apoptosis in BUMPT cells. Mechanistically, the lncRNA 122049 directly sponged miR-330-5p, then increased the expression of ELK1(ETS transcription factor ELK1) to decrease renal cell apoptosis. In addition, miR-330-5p inhibitor completely reversed the pro-apoptotic effect of LncRNA 122049 siRNA on I/R-induced BUMPT cells apoptosis. Finally, overexpression of lncRNA 122049 attenuated ischemic mice AKI via targeting of the miR-330-5p/ELK1 axis. Collectively, the data demonstrated that LncRNA 122049 prevented the I/R-induced renal cell apoptosis via regulation of the miR-330-5p/ELK1 axis, which brings new insights into the pathogenesis and potential targeted treatment of ischemic AKI.	[Xiao, Ying; Wang, Yongjun] Cent South Univ, Xiangya Hosp 2, Dept Blood Transfus, Changsha 410011, Hunan, Peoples R China; [Xiao, Ying; Li, Xiaozhou; Qiu, Shuangfa; Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410011, Hunan, Peoples R China; [Xiao, Ying; Li, Xiaozhou; Qiu, Shuangfa; Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Emergency Med & Difficult Dis Inst, Changsha, Peoples R China; [Zhang, Dongshan] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University	Wang, YJ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Blood Transfus, Changsha 410011, Hunan, Peoples R China.; Zhang, DS (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410011, Hunan, Peoples R China.	wangyongjun@csu.edu.cn; dongshanzhang@csu.edu.cn			National Natural Science Foundation of China (NSFC) [81870475, 81570646, 82171088]; Changsha Science and Technology Bureau Project [kq1907144, kq2001039]; Key Project of Hunan Provincial Science and Technology Innovation [2020SK1014]; Hunan Provincial Science and Technology Department (HSTD) [2020WK2009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Changsha Science and Technology Bureau Project; Key Project of Hunan Provincial Science and Technology Innovation; Hunan Provincial Science and Technology Department (HSTD)	Hunan Provincial Science and Technology Department (HSTD), Grant/Award Number: 2020WK2009; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870475,81570646,82171088, 81570646 and 82171088; Changsha Science and Technology Bureau Project, Grant/Award Number: kq2001039 and kq1907144; Key Project of Hunan Provincial Science and Technology Innovation, Grant/Award Number: 2020SK1014	Aboutaleb N, 2019, BIOMED PHARMACOTHER, V110, P9, DOI 10.1016/j.biopha.2018.11.045; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Brandenburger T, 2018, KIDNEY INT, V94, P870, DOI 10.1016/j.kint.2018.06.033; Ge YN, 2019, MOL THER-NUCL ACIDS, V17, P741, DOI 10.1016/j.omtn.2019.07.007; Geng XM, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0253-8; Gong D, 2020, MOL THER-NUCL ACIDS, V19, P482, DOI 10.1016/j.omtn.2019.10.007; Gonsalez SR, 2019, PHARMACOL THERAPEUT, V200, P1, DOI 10.1016/j.pharmthera.2019.04.001; Guo CY, 2019, NAT REV NEPHROL, V15, P220, DOI 10.1038/s41581-018-0103-6; Haddad G, 2021, J AM SOC NEPHROL, V32, P323, DOI 10.1681/ASN.2020060775; Jiang XX, 2019, J CELL BIOCHEM, V120, P16273, DOI 10.1002/jcb.28909; Lee KH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143529; Li D, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.590633; Li Xiaoying, 2020, Aging (Albany NY), V13, P340, DOI 10.18632/aging.104152; Li XZ, 2022, EBIOMEDICINE, V76, DOI 10.1016/j.ebiom.2022.103859; Liu XL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00622; Liu ZW, 2020, THERANOSTICS, V10, P11963, DOI 10.7150/thno.50093; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Ma J, 2021, MOL THER-NUCL ACIDS, V24, P905, DOI 10.1016/j.omtn.2021.04.011; Ortiz A, 2003, BIOCHEM PHARMACOL, V66, P1589, DOI 10.1016/S0006-2952(03)00515-X; Priante G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143598; Ren GL, 2019, J CELL PHYSIOL, V234, P2266, DOI 10.1002/jcp.27203; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Tang Q, 2019, AGING-US, V11, P9982, DOI 10.18632/aging.102356; Tomar D, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2019.04.005; Vijayan A, 2021, NAT REV NEPHROL, V17, P87, DOI 10.1038/s41581-020-00390-3; Wang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.509; Wang L, 2020, AGING-US, V12, P21674, DOI 10.18632/aging.103971; Wang YX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1153-1; Wu YL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186738; Xia X, 2020, CELL MOL NEUROBIOL, V40, P1383, DOI 10.1007/s10571-020-00824-3; Xu LY, 2019, THERANOSTICS, V9, P2712, DOI 10.7150/thno.31424; Xu X, 2019, FASEB J, V33, P4513, DOI 10.1096/fj.201801515R; Xue QL, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8884438; Yang J, 2020, J CELL MOL MED, V24, P554, DOI 10.1111/jcmm.14762; Zhang DS, 2017, J AM SOC NEPHROL, V28, P1131, DOI 10.1681/ASN.2016030337; Zhang P, 2020, MOL THER-NUCL ACIDS, V19, P1027, DOI 10.1016/j.omtn.2019.12.037; Zhu J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1458-8	37	2	2	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22395	10.1096/fj.202200064RR	http://dx.doi.org/10.1096/fj.202200064RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2B3QF	35695811	hybrid			2022-12-28	WOS:000810105400001
J	Mori, K; Kuroha, S; Hou, J; Jeong, H; Ogawa, M; Ikeda, S; Kang, J; Negishi, K; Torii, H; Arita, M; Kurihara, T; Tsubota, K				Mori, Kiwako; Kuroha, Sayoko; Hou, Jing; Jeong, Heonuk; Ogawa, Mamoru; Ikeda, Shin-ichi; Kang, Jing X.; Negishi, Kazuno; Torii, Hidemasa; Arita, Makoto; Kurihara, Toshihide; Tsubota, Kazuo			Lipidomic analysis revealed n-3 polyunsaturated fatty acids suppressed choroidal thinning and myopia progression in mice	FASEB JOURNAL			English	Article						choroidal thickness; eicosapentaenoic acid; lipidomic analysis; myopia; n-3 polyunsaturated fatty acid	EICOSAPENTAENOIC ACID; 17,18-EPOXYEICOSATETRAENOIC ACID; OUTDOOR ACTIVITY; TRANSGENIC MICE; MURINE MODEL; AXIAL LENGTH; BLOOD-FLOW; OMEGA-3-FATTY-ACIDS; THICKNESS; CROCETIN	Myopia is increasing worldwide and its preventable measure should urgently be pursued. N-3 polyunsaturated fatty acids (PUFAs) have been reported to have various effects such as vasodilative and anti-inflammatory, which myopia may be involved in. This study is to investigate the inhibitory effect of PUFAs on myopia progression. A lens-induced myopia (LIM) model was prepared using C57B L6/J 3-week-old mice, which were equipped with a -30 diopter lens to the right eye. Chows containing two different ratios of n-3/n-6 PUFA were administered to the mice, and myopic shifts were confirmed in choroidal thickness, refraction, and axial length in the n-3 PUFA-enriched chow group after 5 weeks. To exclude the possibility that the other ingredients in the chow may have taken the suppressive effect, fat-1 transgenic mice, which can produce n-3 PUFAs endogenously, demonstrated significant suppression of myopia. To identify what elements in n-3 PUFAs took effects on myopia suppression, enucleated eyes were used for targeted lipidomic analysis, and eicosapentaenoic acid (EPA) were characteristically distributed. Administration of EPA to the LIM model confirmed the inhibitory effect on choroidal thinning and myopia progression. Subsequently, to identify the elements and the metabolites of fatty acids effective on myopia suppression, targeted lipidomic analysis was performed and it demonstrated that metabolites of EPA were involved in myopia suppression, whereas prostaglandin E2 and 14,15-dihydrotestosterone were associated with progression of myopia. In conclusion, EPA and its metabolites are related to myopia suppression and inhibition of choroidal thinning.	[Mori, Kiwako; Hou, Jing; Jeong, Heonuk; Ogawa, Mamoru; Ikeda, Shin-ichi; Negishi, Kazuno; Torii, Hidemasa; Kurihara, Toshihide; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Mori, Kiwako; Kuroha, Sayoko; Hou, Jing; Jeong, Heonuk; Ikeda, Shin-ichi; Torii, Hidemasa; Kurihara, Toshihide] Keio Univ, Lab Photobiol, Sch Med, Tokyo, Japan; [Kuroha, Sayoko; Ogawa, Mamoru; Arita, Makoto] Keio Univ, Div Physiol Chem & Metab, Fac Pharm, Tokyo, Japan; [Kuroha, Sayoko; Arita, Makoto] RIKEN, Lab Metabol, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Kang, Jing X.] Harvard Med Sch, Massachusetts Gen Hosp, Lab Lipid Med & Technol, Boston, MA USA; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University; Keio University; RIKEN; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yokohama City University	Kurihara, T (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.; Arita, M (corresponding author), Keio Univ, Div Physiol Chem & Metab, Fac Pharm, Minato Ku, Tokyo 1050011, Japan.	kurihara@z8.keio.jp; arita-mk@pha.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20K22743, 21K16882, 21H03096]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank X. Jiang, A. Shinojima, E. Yotsukura, Y. Zang, M. Ibuki, C. Shoda, Y. Miwa, H. Kunimi, and Y. Katada in the Laboratory of Photobiology, Keio University School of Medicine, A. Hori and M. Honda in the Laboratory for Metabolomics, RIKEN IMS, and H. Kawano from Mochida Pharmaceutical Co., Ltd. for their technical and administrative support. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI, Grants 20K22743, 21K16882 K.M.), and 21H03096 (K.T.) from the Ministry of Education, Culture, Sports, Science and Technology. This work was also supported by a grant for myopia research from Tsubota Laboratory, Inc., Tokyo, Japan.	Al-Namaeh M, 2020, THER ADV OPHTHALMOL, V12, DOI 10.1177/2515841420952188; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Bullimore MA, 2020, OPHTHAL PHYSL OPT, V40, P254, DOI 10.1111/opo.12686; Bullimore MA, 2019, OPTOMETRY VISION SCI, V96, P463, DOI 10.1097/OPX.0000000000001367; Burla B, 2018, J LIPID RES, V59, P2001, DOI 10.1194/jlr.S087163; Carracedo M, 2019, SEMIN IMMUNOPATHOL, V41, P757, DOI 10.1007/s00281-019-00767-y; Cholewski M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111662; Chua SYL, 2016, OPHTHAL PHYSL OPT, V36, P388, DOI 10.1111/opo.12305; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002; Fernandez-Albarral JA, 2020, NEURAL REGEN RES, V15, P1408, DOI 10.4103/1673-5374.274325; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Flores-Moreno I, 2013, AM J OPHTHALMOL, V155, P314, DOI 10.1016/j.ajo.2012.07.015; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Huang PC, 2020, BRIT J OPHTHALMOL, V104, P956, DOI 10.1136/bjophthalmol-2019-314101; Ikeda K., 2015, MASS SPECTROMETRIC A; Innis SM, 2007, EARLY HUM DEV, V83, P761, DOI 10.1016/j.earlhumdev.2007.09.004; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jiang XY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018840118; Jiang XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20272-w; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Khan F, 2003, CARDIOVASC RES, V59, P955, DOI 10.1016/S0008-6363(03)00395-X; Krueger K, 2022, CRIT REV FOOD SCI, V62, P7518, DOI 10.1080/10408398.2021.1915242; Kubota T, 2014, FASEB J, V28, P586, DOI 10.1096/fj.13-236224; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Leslie E, 2021, AM J PHYSIOL-LUNG C, V320, pL770, DOI 10.1152/ajplung.00469.2020; Li ZY, 2017, CONTACT LENS ANTERIO, V40, P417, DOI 10.1016/j.clae.2017.09.010; Madore C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19861-z; Maruko I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34102-6; Mendivil CO, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.617652; MILLER CC, 1990, J NUTR, V120, P36, DOI 10.1093/jn/120.1.36; Miyata J, 2015, ALLERGOL INT, V64, P27, DOI 10.1016/j.alit.2014.08.003; Mori K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010180; Mori K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081179; Mori K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36576-w; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Mudgil P, 2020, OCUL SURF, V18, P74, DOI 10.1016/j.jtos.2019.10.001; Naoe S, 2019, METABOLITES, V9, DOI 10.3390/metabo9100241; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Ogawa M, 2020, FASEB J, V34, P12492, DOI 10.1096/fj.202000483R; Pan MZ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104689118; Qiu M, 2013, INVEST OPHTH VIS SCI, V54, P830, DOI 10.1167/iovs.12-11158; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Sala-Vila A, 2016, JAMA OPHTHALMOL, V134, P1142, DOI 10.1001/jamaophthalmol.2016.2906; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sharma D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070761; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; Suzumura A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100920; Tsugawa H, 2020, NAT BIOTECHNOL, V38, P1159, DOI 10.1038/s41587-020-0531-2; Vidal E, 2020, J LIPID RES, V61, P1733, DOI 10.1194/jlr.RA120001057; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Welty FK, 2021, FASEB J, V35, DOI 10.1096/fj.202002471R; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Wysoczanski T, 2016, CURR MED CHEM, V23, P816, DOI 10.2174/0929867323666160122114439; Xuan B, 1999, J OCUL PHARMACOL TH, V15, P143, DOI 10.1089/jop.1999.15.143; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; Yanai R, 2014, P NATL ACAD SCI USA, V111, P9603, DOI 10.1073/pnas.1401191111; Ye LY, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.14.15; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhang S, 2019, INVEST OPHTH VIS SCI, V60, P3074, DOI 10.1167/iovs.18-26397; Zheng SG, 2006, J CARDIOVASC PHARM, V47, P70, DOI 10.1097/01.fjc.0000194686.11712.02; Zhong YY, 2021, EUR J NUTR, V60, P3013, DOI 10.1007/s00394-020-02445-4; Zhu YF, 2021, CARDIOVASC RES, V117, P2450, DOI 10.1093/cvr/cvaa296	69	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22312	10.1096/fj.202101947R	http://dx.doi.org/10.1096/fj.202101947R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1B4NJ	35532744				2022-12-28	WOS:000792413600001
J	Dang, D; Meng, ZL; Zhang, C; Li, ZY; Wei, JQ; Wu, H				Dang, Dan; Meng, Zhaoli; Zhang, Chuan; Li, Zhenyu; Wei, Jiaqi; Wu, Hui			Heme induces intestinal epithelial cell ferroptosis via mitochondrial dysfunction in transfusion-associated necrotizing enterocolitis	FASEB JOURNAL			English	Article						ferroptosis; heme; intestinal epithelial cell; mitochondrial dysfunction; necrotizing enterocolitis	ANEMIA; INFANTS; DAMAGE	Transfusion-associated necrotising enterocolitis (TANEC) is a life-threatening disease with a poor prognosis in preterm infants. This study explored whether and how heme induces ferroptosis in TANEC gut injury. A TANEC mouse model and a cell culture system for heme and Caco-2 cells were established. Ferroptosis was assessed by measuring iron and malondialdehyde (MDA) levels and mitochondrial morphology in intestinal tissues and Caco-2 cells. Mitochondrial dysfunction was evaluated by measuring mitochondrial reactive oxygen species (ROS) production and membrane potential using JC-1. The intestinal injury grade was higher in the anemia-transfusion group than in the control group (p < .0001). Higher intestinal iron concentration (p < .0001), elevated levels of lipid peroxidation MDA (p = .0021), and ferroptotic mitochondrial morphological changes were found in mice of the anemia-transfusion group; specific ferroptosis inhibitor could alleviate anemia-transfusion gut injury, suggesting that ferroptosis play a role in the TANEC gut injury. Next, we explored whether heme released by hemolysis of erythrocytes induces ferroptosis in intestinal epithelial cells in vitro. The viability of Caco-2 cells significantly decreased after heme treatment (p < .0001). Iron accumulation, MDA elevated levels, and mitochondrial dysfunction also existed in the co-culture system, which ferroptosis inhibitors could reduce. In summary, ferroptosis was discovered in TANEC, and heme could induce ferroptosis in intestinal epithelial cells via mitochondrial dysfunction. Heme-inducing ferroptosis may be a possible mechanism and therapeutic target for TANEC.	[Dang, Dan; Li, Zhenyu; Wei, Jiaqi; Wu, Hui] First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China; [Meng, Zhaoli] First Hosp Jilin Univ, Dept Translat Med Res Inst, Changchun, Peoples R China; [Zhang, Chuan] First Hosp Jilin Univ, Dept Pediat Surg, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Wu, H (corresponding author), First Hosp Jilin Univ, Dept Neonatol, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China.	wuhui@jlu.edu.cn						Arthur CM, 2019, TRANSFUSION, V59, P1233, DOI 10.1111/trf.15254; Bailey SM, 2015, BLOOD TRANSFUS-ITALY, V13, P429, DOI 10.2450/2015.0212-14; Barcellos-de-Souza P, 2013, AM J PHYSIOL-CELL PH, V304, pC170, DOI 10.1152/ajpcell.00078.2012; Canesin G, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071801; Christensen RD, 2010, TRANSFUSION, V50, P1106, DOI 10.1111/j.1537-2995.2009.02542.x; Cunningham KE, 2017, J SURG RES, V213, P158, DOI 10.1016/j.jss.2017.02.029; Dani C, 2017, TRANSFUSION, V57, P1304, DOI 10.1111/trf.14080; Deng GH, 2020, FREE RADICAL BIO MED, V148, P151, DOI 10.1016/j.freeradbiomed.2019.12.026; Gan BY, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202105043; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Li YY, 2020, SMALL, V16, DOI 10.1002/smll.202001356; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Luo LJ, 2022, BMC PEDIATR, V22, DOI 10.1186/s12887-022-03276-4; Ma HD, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9067610; Maheshwari A, 2018, SEMIN PEDIATR SURG, V27, P47, DOI 10.1053/j.sempedsurg.2017.11.009; Mayr L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15646-6; Meng ZJ, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119935; Menon AV, 2022, BLOOD, V139, P936, DOI 10.1182/blood.2020008455; MohanKumar K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11199-5; NaveenKumar SK, 2019, BBA-MOL BASIS DIS, V1865, P2303, DOI 10.1016/j.bbadis.2019.05.009; NaveenKumar SK, 2018, ACS CHEM BIOL, V13, P1996, DOI 10.1021/acschembio.8b00458; Nie HB, 2016, FREE RADICAL RES, V50, P1200, DOI 10.1080/10715762.2016.1225955; Oates PS, 2006, WORLD J GASTROENTERO, V12, P4281, DOI 10.3748/wjg.v12.i27.4281; Osiak W, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7140496; Patankar JV, 2020, NAT REV GASTRO HEPAT, V17, P543, DOI 10.1038/s41575-020-0326-4; Piel RB, 2019, MOL GENET METAB, V128, P198, DOI 10.1016/j.ymgme.2019.01.006; Pietropaoli AP, 2019, TRANSFUSION, V59, P2007, DOI 10.1111/trf.15218; Ryter SW, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115509; Ryter SW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030515; Say B, 2015, TRANSFUSION MED, V25, P170, DOI 10.1111/tme.12207; Sayari AJ, 2016, J PEDIATR SURG, V51, P927, DOI 10.1016/j.jpedsurg.2016.02.052; Singh R, 2012, SEMIN PERINATOL, V36, P277, DOI 10.1053/j.semperi.2012.04.008; Stone CA, 2018, NEONATOLOGY, V113, P366, DOI 10.1159/000487388; Subramanian Saravanan, 2020, Shengli Xuebao, V72, P308, DOI 10.13294/j.aps.2020.0039; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Tang ZM, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101971; Xu MY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2299-1; Xu S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03559-1; Xu YF, 2021, AM J TRANSL RES, V13, P10315; Yang WC, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.865689; Zhu LJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6551069	41	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22649	10.1096/fj.202200853RRR	http://dx.doi.org/10.1096/fj.202200853RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6F9WX	36383399				2022-12-28	WOS:000884412400001
J	Zhang, RN; Sun, ZJ; Zhang, L				Zhang, Ruo-Nan; Sun, Zhi-Jun; Zhang, Lu			Pyroptosis in inflammatory bone diseases: Molecular insights and targeting strategies	FASEB JOURNAL			English	Review						caspase; gasdermin; inflammasome; inflammatory bone diseases; pyroptosis; targeting strategies	HUMAN GINGIVAL FIBROBLASTS; NLRP3 INFLAMMASOME; CELL-DEATH; GASDERMIN-D; NONCANONICAL ACTIVATION; RHEUMATOID-ARTHRITIS; APICAL PERIODONTITIS; DEPENDENT PYROPTOSIS; SECONDARY NECROSIS; IMMUNE-RESPONSES	Inflammatory bone diseases include osteoarthritis (OA) and rheumatoid arthritis (RA), which can cause severe bone damage in a chronic inflammation state, putting tremendous pressure on the patients' families and government agencies regarding medical costs. In addition, the complexity of osteoimmunology makes research on these diseases difficult. Hence, it is urgent to determine the potential mechanisms and find effective drugs to target inflammatory bone diseases to reduce the negative effects of these diseases. Recently, pyroptosis, a gasdermin-induced necrotic cell death featuring secretion of pro-inflammatory cytokines and lysis, has become widely known. Based on the effect of pyroptosis on immunity, this process has gradually emerged as a vital component in the etiopathogenesis of inflammatory bone diseases. Herein, we review the characteristics and mechanisms of pyroptosis and then focus on its clinical significance in inflammatory bone diseases. In addition, we summarize the current research progress of drugs targeting pyroptosis to enhance the therapeutic efficacy of inflammatory bone diseases and provide new insights for future directions.	[Zhang, Ruo-Nan; Sun, Zhi-Jun; Zhang, Lu] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hub, Wuhan, Peoples R China; [Zhang, Ruo-Nan; Zhang, Lu] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China; [Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Endodont, Wuhan, Peoples R China; [Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Sun, ZJ; Zhang, L (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hub, Wuhan, Peoples R China.	sunzj@whu.edu.cn; luzhang2012@whu.edu.cn	Sun, Zhi-Jun/AAD-8791-2022	Sun, Zhi-Jun/0000-0003-0932-8013	National Natural Science Foundation of China;  [81974148];  [82170941]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; 	ACKNOWLEDGMENT This work was supported by the National Natural Science Foundation of China (grant number: 81974148, 82170941).	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Al-Salam S, 2011, PEDIATRICS, V128, pE464, DOI 10.1542/peds.2010-2998; Alam MI, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116096; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Bai H, 2022, J CELL MOL MED, V26, P4230, DOI 10.1111/jcmm.17438; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Raneros AB, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9111614; Baron L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.576; Ben Lagha A, 2019, TOXINS, V11, DOI 10.3390/toxins11110662; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bertheloot D, 2022, EMBO MOL MED, V14, DOI 10.15252/emmm.202115415; Bhawal UK, 2012, J CELL BIOCHEM, V113, P3246, DOI 10.1002/jcb.24205; Bourdonnay E, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167253; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Burdette BE, 2021, ACTA PHARM SIN B, V11, P2768, DOI 10.1016/j.apsb.2021.02.006; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chen Q, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.663037; Chen SJ, 2021, CELL CYCLE, V20, P1107, DOI 10.1080/15384101.2021.1916272; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cheng R, 2018, BBA-MOL BASIS DIS, V1864, P226, DOI 10.1016/j.bbadis.2017.10.025; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116; Deng WY, 2022, NATURE, V602, P496, DOI 10.1038/s41586-021-04384-4; Di AK, 2018, IMMUNITY, V49, P56, DOI 10.1016/j.immuni.2018.04.032; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Doherty M, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/kep086; Dong XW, 2020, CELL MOL IMMUNOL, V17, P261, DOI 10.1038/s41423-019-0201-9; Duncan JA, 2018, IMMUNOL REV, V281, P115, DOI 10.1111/imr.12607; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; England BR, 2021, ANN RHEUM DIS, V80, P286, DOI 10.1136/annrheumdis-2020-218282; Fan WM, 2021, J INFLAMM RES, V14, P3523, DOI [10.2147/JIR.S320912, 10.2147/JIR.S320912DovePress]; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ge GR, 2022, SCI CHINA LIFE SCI, V65, P588, DOI 10.1007/s11427-020-1939-1; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Gu LL, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-05047-6; Han XD, 2022, CELLS TISSUES ORGANS, V211, P57, DOI 10.1159/000519569; He DW, 2022, J PERIODONTAL IMPLAN, V52, P28, DOI 10.5051/jpis.2101380069; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Herman S, 2008, TRENDS MOL MED, V14, P245, DOI 10.1016/j.molmed.2008.04.001; Hiranmayi KV, 2017, J PHARM BIOALLIED SC, V9, P155, DOI 10.4103/jpbs.JPBS_288_16; Hong ZY, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/4566851; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Hsu SK, 2021, THERANOSTICS, V11, P8813, DOI 10.7150/thno.62521; Hu JM, 2020, J ETHNOPHARMACOL, V247, DOI 10.1016/j.jep.2019.112261; Hu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2476-2; Hu YK, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6324912; Huang CC, 2020, DRUG DES DEV THER, V14, P4901, DOI 10.2147/DDDT.S269223; Jager E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17749-6; Jiang JM, 2022, AUTOIMMUNITY, V55, P21, DOI 10.1080/08916934.2021.1983802; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jin TC, 2013, PROTEINS, V81, P1266, DOI 10.1002/prot.24287; Jing YB, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/5074305; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Jun HK, 2018, CELL DEATH DIFFER, V25, P380, DOI 10.1038/cdd.2017.167; Kavanagh N, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00084-17; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; LaRock DL, 2022, NATURE, V605, P527, DOI 10.1038/s41586-022-04717-x; Lawlor KE., 2018, APOPTOSIS MANY WAYS, P317; Levy M, 2017, TRENDS IMMUNOL, V38, P248, DOI 10.1016/j.it.2017.01.001; Li G, 2022, J ORTHOP SURG RES, V17, DOI 10.1186/s13018-021-02886-5; Li HW, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2609-7; Li Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.691013; Li YY, 2019, CELL METAB, V30, P477, DOI 10.1016/j.cmet.2019.06.016; Li YY, 2021, INFLAMMATION, V44, P846, DOI 10.1007/s10753-020-01379-7; Li ZH, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8868361; Lin XB, 2021, PHYTOMEDICINE, V84, DOI 10.1016/j.phymed.2021.153521; Liu G, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.617270; Liu J, 2019, J CLIN PERIODONTOL, V46, P894, DOI 10.1111/jcpe.13162; Liu QB, 2019, GENE, V712, DOI 10.1016/j.gene.2019.143959; Liu S, 2014, INT ENDOD J, V47, P949, DOI 10.1111/iej.12240; Liu SS, 2020, J MOL HISTOL, V51, P221, DOI 10.1007/s10735-020-09874-9; Liu W, 2018, J DENT RES, V97, P1391, DOI 10.1177/0022034518775036; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YX, 2019, INFLAMM RES, V68, P597, DOI 10.1007/s00011-019-01244-w; Lu WL, 2019, INT ENDOD J, V52, P999, DOI 10.1111/iej.13091; Lv XF, 2021, INT IMMUNOPHARMACOL, V101, DOI 10.1016/j.intimp.2021.108338; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Marchesan JT, 2020, PERIODONTOL 2000, V82, P93, DOI 10.1111/prd.12269; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mouasni S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1412-9; Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348, DOI 10.1177/154411130401500604; O'Neil LJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2688; Oka S, 2021, ALL LIFE, V14, P300, DOI 10.1080/26895293.2021.1915886; Oka S, 2021, J PERIODONTAL RES, V56, P492, DOI 10.1111/jre.12849; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pan JX, 2022, BIOENGINEERED, V13, P1908, DOI 10.1080/21655979.2021.2020396; Park SY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.52; Pereira D, 2015, ACTA MEDICA PORT, V28, P99; Qian JT, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-020-02121-7; Qing LM, 2017, EXP THER MED, V13, P63, DOI 10.3892/etm.2016.3940; Ran S, 2019, INT ENDOD J, V52, P44, DOI 10.1111/iej.12965; Ran SJ, 2017, ARCH ORAL BIOL, V78, P39, DOI 10.1016/j.archoralbio.2017.02.006; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Sanders J, 2013, ORTHOPEDICS, V36, P368, DOI 10.3928/01477447-20130426-07; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Silva MT, 2010, J LEUKOCYTE BIOL, V88, P885, DOI 10.1189/jlb.0410205; Sordi MB, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23095078; Takeuchi Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98145-y; Tang H, 2022, HUM CELL, V35, P803, DOI 10.1007/s13577-022-00678-5; Tian J, 2021, CLIN EXP IMMUNOL, V204, P396, DOI 10.1111/cei.13587; Tsuchiya K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010426; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang GH, 2020, DRUG DEVELOP RES, V81, P859, DOI 10.1002/ddr.21699; Wang HY, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106985; Wang LL, 2022, J ORAL MICROBIOL, V14, DOI 10.1080/20002297.2021.2015130; Wang Q, 2022, J BIOCHEM MOL TOXIC, V36, DOI 10.1002/jbt.22951; Wang SY, 2021, INFLAMMOPHARMACOLOGY, V29, P695, DOI 10.1007/s10787-021-00814-x; Wang XZ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910349; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wu T., 2021, FRONT CELL DEV BIOL, V9; Wu XS, 2019, LAB INVEST, V99, P499, DOI 10.1038/s41374-018-0135-3; Xia YR, 2021, INFLAMMATION, V44, P2531, DOI 10.1007/s10753-021-01522-y; Xu HG, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/9972805; Yan JB, 2022, EXP THER MED, V23, DOI 10.3892/etm.2022.11146; Yan ZJ, 2020, J CELL MOL MED, V24, P13046, DOI 10.1111/jcmm.15905; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Yang K, 2021, INT IMMUNOPHARMACOL, V94, DOI 10.1016/j.intimp.2021.107456; Yang PP, 2021, J MOL HISTOL, V52, P661, DOI 10.1007/s10735-021-09988-8; Yang XM, 2010, RADIOLOGY, V254, P651, DOI 10.1148/radiol.09091264; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yin W, 2019, SMALL METHODS, V3, DOI 10.1002/smtd.201900378; Yu H, 2021, J ETHNOPHARMACOL, V266, DOI 10.1016/j.jep.2020.113447; Zhai ZQ, 2022, ARTHRITIS RHEUMATOL, V74, P427, DOI 10.1002/art.41963; Zhang L, 2021, BIOENGINEERED, V12, P9949, DOI 10.1080/21655979.2021.1985342; Zhang L, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2165918; Zhang L, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6326517; Zhang SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5657; Zhang XL, 2021, IN VITRO CELL DEV-AN, V57, P404, DOI 10.1007/s11626-021-00583-5; Zhang Y, 2021, BIOCHEM BIOPH RES CO, V553, P119, DOI 10.1016/j.bbrc.2021.03.055; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9; Zhao LR, 2018, MOL MED REP, V17, P5463, DOI 10.3892/mmr.2018.8520; Zhao YH, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00356-1; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548; Zhu XB, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.03.40; Zu SQ, 2020, CELL BIOL INT, V44, P2140, DOI 10.1002/cbin.11422; Zu Y, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1307-6	165	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22670	10.1096/fj.202201229R	http://dx.doi.org/10.1096/fj.202201229R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1NN	36412502				2022-12-28	WOS:000887957200001
J	Bogaards, FA; Gehrmann, T; Beekman, M; Ben van den Akker, E; van de Rest, O; Hangelbroek, RWJ; Noordam, R; Mooijaart, SP; de Groot, LCPGM; Reinders, MJT; Slagboom, PE				Bogaards, Fatih A.; Gehrmann, Thies; Beekman, Marian; Ben van den Akker, Erik; van de Rest, Ondine; Hangelbroek, Roland W. J.; Noordam, Raymond; Mooijaart, Simon P.; de Groot, Lisette C. P. G. M.; Reinders, Marcel J. T.; Slagboom, P. Eline			PLIS: A metabolomic response monitor to a lifestyle intervention study in older adults	FASEB JOURNAL			English	Article						bioinformatics; healthy ageing; lifestyle intervention; machine learning; metabolomics; response monitor	IMMUNE-SYSTEM; PROTEIN; OBESE; INFLAMMATION; OUTCOMES	The response to lifestyle intervention studies is often heterogeneous, especially in older adults. Subtle responses that may represent a health gain for individuals are not always detected by classical health variables, stressing the need for novel biomarkers that detect intermediate changes in metabolic, inflammatory, and immunity-related health. Here, our aim was to develop and validate a molecular multivariate biomarker maximally sensitive to the individual effect of a lifestyle intervention; the Personalized Lifestyle Intervention Status (PLIS). We used H-1-NMR fasting blood metabolite measurements from before and after the 13-week combined physical and nutritional Growing Old TOgether (GOTO) lifestyle intervention study in combination with a fivefold cross-validation and a bootstrapping method to train a separate PLIS score for men and women. The PLIS scores consisted of 14 and four metabolites for females and males, respectively. Performance of the PLIS score in tracking health gain was illustrated by association of the sex-specific PLIS scores with several classical metabolic health markers, such as BMI, trunk fat%, fasting HDL cholesterol, and fasting insulin, the primary outcome of the GOTO study. We also showed that the baseline PLIS score indicated which participants respond positively to the intervention. Finally, we explored PLIS in an independent physical activity lifestyle intervention study, showing similar, albeit remarkably weaker, associations of PLIS with classical metabolic health markers. To conclude, we found that the sex-specific PLIS score was able to track the individual short-term metabolic health gain of the GOTO lifestyle intervention study. The methodology used to train the PLIS score potentially provides a useful instrument to track personal responses and predict the participant's health benefit in lifestyle interventions similar to the GOTO study.	[Bogaards, Fatih A.; Gehrmann, Thies; Beekman, Marian; Ben van den Akker, Erik; Slagboom, P. Eline] Leiden Univ, Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Bogaards, Fatih A.; Gehrmann, Thies; Ben van den Akker, Erik; Reinders, Marcel J. T.] Leiden Computat Biol Ctr, Leiden, Netherlands; [Bogaards, Fatih A.; van de Rest, Ondine; Hangelbroek, Roland W. J.; de Groot, Lisette C. P. G. M.] Wageningen Univ & Res, Human Nutr & Hlth, Wageningen, Netherlands; [Ben van den Akker, Erik; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Noordam, Raymond; Mooijaart, Simon P.] Leiden Univ, Sect Gerontol & Geriatr, Internal Med, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Slagboom, PE (corresponding author), Leiden Univ, Mol Epidemiol, Med Ctr, Leiden, Netherlands.	p.slagboom@lumc.nl	; Beekman, Marian/L-3004-2019	Bogaards, Fatih/0000-0003-2553-5346; van den Akker, Erik/0000-0002-7693-0728; Beekman, Marian/0000-0003-0585-6206; Reinders, Marcel/0000-0002-1148-1562; de Groot, Lisette/0000-0003-2778-2789; Hangelbroek, Roland/0000-0002-0442-5378; Noordam, Raymond/0000-0001-7801-809X; Mooijaart, Simon/0000-0003-3106-3568	BBMRI-NL [NWO 184.021.007, NWO 184.033.111]; Horizon 2020 ERC advanced grant; Netherlands Consortium for Healthy Ageing [050-060-810]; ZonMw project VOILA	BBMRI-NL; Horizon 2020 ERC advanced grant; Netherlands Consortium for Healthy Ageing; ZonMw project VOILA	BBMRI-NL, Grant/Award Number: NWO 184.021.007 and NWO 184.033.111; Horizon 2020 ERC advanced grant, Grant/Award Number: GEROPROTECT; Netherlands Consortium for Healthy Ageing, Grant/ Award Number: NWO grant 050-060-810; ZonMw project VOILA	Aderemi AV, 2021, METABOLITES, V11, DOI 10.3390/metabo11070418; Akram M, 2020, ROLE PHENYLALANINE I; Aktas MF, 2019, EUR J CLIN NUTR, V73, P805, DOI 10.1038/s41430-018-0371-z; Anisimova AS, 2020, P NATL ACAD SCI USA, V117, P15581, DOI 10.1073/pnas.2001788117; Aucott L, 2011, OBES REV, V12, pe412, DOI 10.1111/j.1467-789X.2010.00819.x; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Balagopal P, 2003, INT J OBESITY, V27, P1250, DOI 10.1038/sj.ijo.0802388; Barrett PHR, 2003, CURR OPIN LIPIDOL, V14, P61, DOI 10.1097/01.mol.0000052851.26236.75; Bartke A, 2021, WORLD J MENS HEALTH, V39, P222, DOI 10.5534/wjmh.200112; Beetham KS., 2018, BMC NEPHROL, V19, P1; Burgess E, 2017, CLIN OBES, V7, P123, DOI 10.1111/cob.12183; Campbell KL, 2017, OBESITY, V25, pS40, DOI 10.1002/oby.22010; Cirulli ET, 2019, CELL METAB, V29, P488, DOI 10.1016/j.cmet.2018.09.022; Colleluori G, 2019, CELL METAB, V30, P261, DOI 10.1016/j.cmet.2019.06.008; Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8; Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564; Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11311-9; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Dorling JL, 2020, EUR J CLIN NUTR, V74, P1210, DOI 10.1038/s41430-020-0593-8; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Fisher R.A., 1992, BREAKTHROUGHS STAT, P66, DOI DOI 10.1007/978-1-4612-4380-9_6; Fitzgerald KN, 2021, AGING-US, V13, P9419, DOI 10.18632/aging.202913; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hishikawa D, 2017, FEBS LETT, V591, P2730, DOI 10.1002/1873-3468.12825; Holecek M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030848; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; LeVatte M, 2021, LIFESTYLE GENOM, DOI 10.1159/000518489; Li BB, 2017, MOLECULES, V22, DOI 10.3390/molecules22071173; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Marseglia A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00349; Mensink M, 2005, OBES RES, V13, P1354, DOI 10.1038/oby.2005.164; Mierziak J, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030402; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Paley CA, 2018, BMC SPORTS SCI MED R, V10, DOI 10.1186/s13102-018-0097-1; Parthasarathy A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00029; Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Puchades-Carrasco L, 2017, CURR TOP MED CHEM, V17, P2740, DOI 10.2174/1568026617666170707120034; Ravera S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46749-w; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Rojas-Morales P, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101395; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675; Sander M, 2015, AGE AGEING, V44, P185, DOI 10.1093/ageing/afu189; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327; Suburu Janel, 2013, Food Biosci, V4, P1; Thomas DD, 2019, J ENDOCR SOC, V3, P1727, DOI 10.1210/js.2019-00065; van de Rest O, 2016, AGING-US, V8, P111, DOI 10.18632/aging.100877; van de Rest O, 2013, AMINO ACIDS, V45, P1035, DOI 10.1007/s00726-013-1583-0; van den Akker EB, 2020, CIRC-GENOM PRECIS ME, V13, P541, DOI 10.1161/CIRCGEN.119.002610; Villareal DT, 2006, AM J CLIN NUTR, V84, P1317, DOI 10.1093/ajcn/84.6.1317; Vroege DP, 2014, J MED INTERNET RES, V16, P19, DOI 10.2196/jmir.3643; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weyand CM, 2016, ANN AM THORAC SOC, V13, pS422, DOI 10.1513/AnnalsATS.201602-095AW; Weyh C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030622; Wing RR, 2021, OBESITY, V29, P1246, DOI 10.1002/oby.23158; Yang Y, 2011, J GERONTOL A-BIOL, V66, P493, DOI 10.1093/gerona/glr003	63	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22578	10.1096/fj.202201037R	http://dx.doi.org/10.1096/fj.202201037R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A5RT	36183353	hybrid			2022-12-28	WOS:000862945400001
J	Ma, LJ; Wang, L; Gao, MD; Zhang, XJ; Zhao, XD; Xie, DB; Zhang, J; Wang, Z; Hou, LF; Zeng, FL				Ma, Lujie; Wang, Le; Gao, Mengdi; Zhang, Xinjie; Zhao, Xiangdong; Xie, Debao; Zhang, Jing; Wang, Zhen; Hou, Lifeng; Zeng, Fanli			Rtr1 is required for Rpb1-Rpb2 assembly of RNAPII and prevents their cytoplasmic clump formation	FASEB JOURNAL			English	Article						assembly factor; Gpn3; Npa3; RNA polymerase II; Rtr1	POLYMERASE-II; PHOSPHATASE RTR1; NUCLEAR IMPORT; SERINE 5; PHOSPHORYLATION; BIOGENESIS; SUBUNITS; GTPASES; RPB4; SER5	RNA polymerase II (RNAPII) is an essential machinery for catalyzing mRNA synthesis and controlling cell fate in eukaryotes. Although the structure and function of RNAPII have been relatively defined, the molecular mechanism of its assembly process is not clear. The identification and functional analysis of assembly factors will provide new understanding to transcription regulation. In this study, we identify that RTR1, a known transcription regulator, is a new multicopy genetic suppressor of mutants of assembly factors Gpn3, Gpn2, and Rba50. We demonstrate that Rtr1 is directly required to assemble the two largest subunits of RNAPII by coordinating with Gpn3 and Npa3. Deletion of RTR1 leads to cytoplasmic clumping of RNAPII subunit and multiple copies of RTR1 can inhibit the formation of cytoplasmic clump of RNAPII subunit in gpn3-9 mutant, indicating a new layer function of Rtr1 in checking proper assembly of RNAPII. In addition, we find that disrupted activity of Rtr1 phosphatase does not trigger the formation of cytoplasmic clump of RNAPII subunit in a catalytically inactive mutant of RTR1. Based on these results, we conclude that Rtr1 cooperates with Gpn3 and Npa3 to assemble RNAPII core.	[Ma, Lujie; Wang, Zhen; Zeng, Fanli] State Key Lab North China Crop Improvement & Regu, Baoding, Peoples R China; [Ma, Lujie; Wang, Le; Gao, Mengdi; Zhang, Xinjie; Zhao, Xiangdong; Xie, Debao; Zhang, Jing; Hou, Lifeng; Zeng, Fanli] Hebei Agr Univ, Coll Life Sci, Baoding, Peoples R China; [Wang, Zhen] Hebei Agr Univ, Coll Sci & Technol, Cangzhou, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Zeng, FL (corresponding author), State Key Lab North China Crop Improvement & Regu, Baoding, Peoples R China.	fanli.zeng@pku.edu.cn			National Natural Science Foundation of China [32070574]; Outstanding Youth Project from Natural Science Foundation of Hebei Province [C2020204109]; Hebei Provincial Department of Bureau of Science and Technology [360-0803-JSN-3YGS]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Project from Natural Science Foundation of Hebei Province; Hebei Provincial Department of Bureau of Science and Technology	We are grateful to Dr. Lilin Du and all lab members for helpful discussions and suggestions in this work. This work was supported by grants from the National Natural Science Foundation of China (no. 32070574), Outstanding Youth Project from Natural Science Foundation of Hebei Province (no. C2020204109) and Hebei Provincial Department of Bureau of Science and Technology (360-0803-JSN-3YGS).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Calera MR, 2011, BBA-MOL CELL RES, V1813, P1708, DOI 10.1016/j.bbamcr.2011.07.005; Carre C, 2011, MOL CELL BIOL, V31, P3953, DOI 10.1128/MCB.05442-11; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2019, NATURE, V573, P45, DOI 10.1038/s41586-019-1517-4; Egloff S, 2012, MOL CELL, V45, P111, DOI 10.1016/j.molcel.2011.11.006; Fianu I, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02088-z; Forget D, 2013, NUCLEIC ACIDS RES, V41, P6881, DOI 10.1093/nar/gkt455; Garrido-Godino AI, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042002; Garrido-Godino AI, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.669300; Gibney PA, 2008, EUKARYOT CELL, V7, P938, DOI 10.1128/EC.00042-08; Gomez-Navarro N, 2015, BBA-GENE REGUL MECH, V1849, P1354, DOI 10.1016/j.bbagrm.2015.10.003; Guerrero-Serrano G, 2017, BBA-MOL CELL RES, V1864, P451, DOI 10.1016/j.bbamcr.2016.12.010; Hsu PL, 2014, J MOL BIOL, V426, P2970, DOI 10.1016/j.jmb.2014.06.010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter GO, 2016, MOL CELL BIOL, V36, P2236, DOI 10.1128/MCB.00870-15; Irani S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4805; Ishihama A, 1981, Adv Biophys, V14, P1; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Li YX, 2018, PLANT CELL, V30, P466, DOI 10.1105/tpc.17.00380; Liu XQ, 2020, FASEB J, V34, P15547, DOI 10.1096/fj.202001523R; Ma LJ, 2022, INT J BIOL MACROMOL, V206, P837, DOI 10.1016/j.ijbiomac.2022.03.081; Minaker SW, 2021, CELL CYCLE, V20, P1361, DOI 10.1080/15384101.2021.1943879; Minaker SW, 2013, GENETICS, V193, P853, DOI 10.1534/genetics.112.148726; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Niesser J, 2016, MOL CELL BIOL, V36, P820, DOI 10.1128/MCB.01009-15; Osman S, 2020, ANNU REV CELL DEV BI, V36, P1, DOI 10.1146/annurev-cellbio-042020-021954; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Turowski TW, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.680090; Victorino JF, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008317; Wang XX, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110732; Wild T, 2012, TRENDS BIOCHEM SCI, V37, P99, DOI 10.1016/j.tibs.2011.12.001; Xiang KH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1947; Xie DB, 2022, INT J BIOL MACROMOL, V204, P565, DOI 10.1016/j.ijbiomac.2022.02.052; Zeng FL, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00091-18	38	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22585	10.1096/fj.202200698RR	http://dx.doi.org/10.1096/fj.202200698RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0AU	36190433				2022-12-28	WOS:000863240400001
J	Petrillo, F; Chernyakov, D; Esteva-Font, C; Poulsen, SB; Edemir, B; Fenton, RA				Petrillo, Federica; Chernyakov, Dmitry; Esteva-Font, Cristina; Poulsen, Soren B.; Edemir, Bayram; Fenton, Robert A.			Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus	FASEB JOURNAL			English	Article						AQP2; aquaporin-2; ELF5; ETS transcription factor; NDI; urinary concentration	PROTEIN-KINASE-A; VASOPRESSIN RECEPTOR; TRANSCRIPTION FACTOR; AQUAPORIN-2 EXPRESSION; EPIGENETIC REGULATION; ESSENTIAL REGULATOR; UREA TRANSPORTERS; BINDING PROTEIN; AQP2 EXPRESSION; KIDNEY	Water homeostasis is tightly regulated by the kidneys via the process of urine concentration. During reduced water intake, the antidiuretic hormone arginine vasopressin (AVP) binds to the vasopressin receptor type II (V2R) in the kidney to enhance countercurrent multiplication and medullary osmolality, and increase water reabsorption via aquaporin-2 (AQP2) water channels. The importance of this AVP, V2R, and AQP2 axis is highlighted by low urine osmolality and polyuria in people with various water balance disorders, including nephrogenic diabetes insipidus (NDI). ELF5 and nuclear factor of activated T cells 5 (NFAT5) are two transcription factors proposed to regulate Aqp2 expression, but their role is poorly defined. Here we generated two novel mouse lines with principal cell (PC)-specific deletion of ELF5 or NFAT5 and phenotyped them in respect to renal water handling. ELF5-deficient mice (ELF5(PC-KO)) had a very mild phenotype, with no clear differences in AQP2 abundance, and mild differences in renal water handling and maximal urinary concentrating capacity. In contrast, NFAT5 (NFAT5(PC-KO)) mice had significantly higher water intake and their 24 h urine volume was almost 10-fold greater than controls. After challenging with dDAVP or 8 h water restriction, NFAT5(PC-KO) mice were unable to concentrate their urine, demonstrating that they suffer from NDI. The abundance of AQP2, other AQPs, and the urea transporter UT-A1 were greatly decreased in NFAT5(PC-KO) mice. In conclusion, NFAT5 is a major regulator of not only Aqp2 gene transcription, but also other genes important for water homeostasis and its absence leads to the development of NDI.	[Petrillo, Federica; Esteva-Font, Cristina; Poulsen, Soren B.; Fenton, Robert A.] Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3,Bldg 1233, DK-8000 Aarhus C, Denmark; [Chernyakov, Dmitry; Edemir, Bayram] Martin Luther Univ Halle Wittenberg, Dept Med Hematol & Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany; [Edemir, Bayram] Witten Herdecke Univ, Inst Physiol Pathophysiol & Toxicol, Witten, Germany	Aarhus University; Martin Luther University Halle Wittenberg	Fenton, RA (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3,Bldg 1233, DK-8000 Aarhus C, Denmark.; Edemir, B (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Med Hematol & Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	bayram.edemir@uk-halle.de; robert.a.fenton@biomed.au.dk		Petrillo, Federica/0000-0003-3297-4953	Independent Research Fund Denmark [1026-00063B]; Novo Nordisk Foundation [NNF21OC0067647, NNF17OC0028812, NNF20OC0063837, NNF19OC0058439]; Carlsberg Foundation; German Research Foundation [ED181-9/1]	Independent Research Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); German Research Foundation(German Research Foundation (DFG))	Support for this study was provided to Robert Fenton by the Independent Research Fund Denmark (Project No. 1026-00063B), the Novo Nordisk Foundation (NNF21OC0067647, NNF17OC0028812, NNF20OC0063837, NNF19OC0058439), and the Carlsberg Foundation. Support for Bayram Edemir was provided by the German Research Foundation (Project No. ED181-9/1).	Abraham S, 2021, AM J PHYSIOL-RENAL, V320, pF404, DOI 10.1152/ajprenal.00371.2020; Blasum BS, 2016, FASEB J, V30, P3588, DOI 10.1096/fj.201600319R; Bockenhauer D, 2013, AM J PHYSIOL-RENAL, V304, pF1037, DOI 10.1152/ajprenal.00639.2012; Castro-Mondragon JA, 2022, NUCLEIC ACIDS RES, V50, pD165, DOI 10.1093/nar/gkab1113; Centrone M, 2017, CELL PHYSIOL BIOCHEM, V44, P515, DOI 10.1159/000485088; Chen LH, 2021, J AM SOC NEPHROL, V32, P897, DOI 10.1681/ASN.2020101406; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Fenton RA, 2002, AM J PHYSIOL-RENAL, V283, pF817, DOI 10.1152/ajprenal.00263.2001; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Grassmeyer J, 2017, DEV BIOL, V424, P77, DOI 10.1016/j.ydbio.2017.02.007; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hinze C, 2021, J AM SOC NEPHROL, V32, P291, DOI 10.1681/ASN.2020070930; Hozawa Shigenari, 1996, American Journal of Physiology, V270, pC1695; Ju HJ, 2019, KIDNEY RES CLIN PRAC, V38, P145, DOI 10.23876/j.krcp.19.002; Jung HJ, 2018, J AM SOC NEPHROL, V29, P1490, DOI 10.1681/ASN.2017050545; Kandabarau S, 2020, CANCERS, V12, DOI 10.3390/cancers12010006; Kikuchi H, 2021, AM J PHYSIOL-RENAL, V321, pF389, DOI 10.1152/ajprenal.00204.2021; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Kortenoeven MLA, 2014, BBA-GEN SUBJECTS, V1840, P1533, DOI 10.1016/j.bbagen.2013.12.002; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Kortenoeven MLA, 2011, J BIOL CHEM, V286, P13002, DOI 10.1074/jbc.M110.207878; Kuper C, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00507; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lin ST, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01308; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; MA TH, 1994, AM J PHYSIOL, V266, pC189, DOI 10.1152/ajpcell.1994.266.1.C189; Maric K, 1998, AM J PHYSIOL-RENAL, V275, pF796, DOI 10.1152/ajprenal.1998.275.5.F796; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Morancho B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-13; Mukherjee M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110692; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Olesen ETB, 2021, NAT REV NEPHROL, V17, P765, DOI 10.1038/s41581-021-00447-x; Petrillo F, 2021, J AM SOC NEPHROL, V32, P1339, DOI 10.1681/ASN.2020010031; Piggin CL, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0666-0; Poulsen SB, 2018, CLIN SCI, V132, P1779, DOI 10.1042/CS20180060; Poulsen SB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91042; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Rose R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91369-y; Sandoval PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34863; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Stewart GS, 2004, AM J PHYSIOL-RENAL, V286, pF979, DOI 10.1152/ajprenal.00334.2003; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yde J, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00046; Yu L, 2014, MOL CELL BIOL, V34, P1929, DOI 10.1128/MCB.01659-13; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhang XY, 2014, P NATL ACAD SCI USA, V111, P2277, DOI 10.1073/pnas.1323977111	65	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22583	10.1096/fj.202200856R	http://dx.doi.org/10.1096/fj.202200856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9HX	36197017				2022-12-28	WOS:000863879000001
J	Wu, SQ; Lin, S; Zhang, XL; Alizada, M; Wang, LM; Zheng, YQ; Ke, QF; Xu, J				Wu, Shiqiang; Lin, Shu; Zhang, Xiaolu; Alizada, Mujahid; Wang, Liangmin; Zheng, Yiqiang; Ke, Qingfeng; Xu, Jie			Recent advances in cell-based and cell-free therapeutic approaches for sarcopenia	FASEB JOURNAL			English	Review						aging; cell-based and cell-free therapeutics; exosomes; sarcopenia	SKELETAL-MUSCLE AUTOPHAGY; STEM-CELLS; AEROBIC EXERCISE; TNF-ALPHA; VITAMIN-D; DIFFERENTIATION; PROLIFERATION; RESISTANCE; STRENGTH; EXOSOMES	Sarcopenia is a progressive loss of muscle mass and function that is connected with increased hospital expenditures, falls, fractures, and mortality. Although muscle loss has been related to aging, injury, hormonal imbalances, and diseases such as malignancies, chronic obstructive pulmonary disease, heart failure, and kidney failure, the underlying pathogenic mechanisms of sarcopenia are unclear. Exercise-based interventions and multimodal strategies are currently being considered as potential therapeutic approaches to prevent or treat these diseases. Although drug therapy research is ongoing, no drug has yet been proven to have a substantial safety and clinical value to be the first drug therapy to be licensed for sarcopenia. To better understand the molecular alterations underlying sarcopenia and effective treatments, we review leading research and available findings from the systemic change to the muscle-specific microenvironment. Furthermore, we explore possible mechanisms of sarcopenia and provide new knowledge for the development of novel cell-free and cell-based therapeutics. This review will assist researchers in developing better therapies to improve muscle health in the elderly.	[Wu, Shiqiang; Zhang, Xiaolu; Wang, Liangmin; Zheng, Yiqiang; Ke, Qingfeng] Fujian Med Univ, Dept Orthoped, Affiliated Hosp 2, Quanzhou, Peoples R China; [Lin, Shu] Fujian Med Univ, Ctr Neurol & Metab Res, Affiliated Hosp 2, Quanzhou, Fujian, Peoples R China; [Lin, Shu] Garvan Inst Med Res, Grp Neuroendocrinol, Sydney, NSW, Australia; [Alizada, Mujahid] Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 2, Quanzhou, Peoples R China; [Xu, Jie] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350003, Fujian, Peoples R China; [Xu, Jie] Fujian Prov Hosp, Dept Orthoped, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Garvan Institute of Medical Research; Fujian Medical University; Fujian Medical University; Fujian Provincial Hospital	Lin, S (corresponding author), Fujian Med Univ, Ctr Neurol & Metab Res, Affiliated Hosp 2, Quanzhou, Fujian, Peoples R China.; Xu, J (corresponding author), Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350003, Fujian, Peoples R China.	shulin1956@126.com; jiexud@fjmu.edu.cn			Fujian Provincial Department of Science and Technology [2021J1274]; Science and Technology Bureau of Quanzhou [2020CT003]	Fujian Provincial Department of Science and Technology; Science and Technology Bureau of Quanzhou	Fujian Provincial Department of Science and Technology (), Grant/Award Number: 2021J1274; Science and Technology Bureau of Quanzhou (), Grant/Award Number: 2020CT003	Agrawal A, 2017, CELL STRESS CHAPERON, V22, P429, DOI 10.1007/s12192-017-0795-8; Ahn B, 2018, REDOX BIOL, V17, P47, DOI 10.1016/j.redox.2018.04.004; An HJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165678; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aoi W, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.697204; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Avci H, 2017, EXP TOXICOL PATHOL, V69, P317, DOI 10.1016/j.etp.2017.02.002; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bai LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119396; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bao JK, 2020, ADV EXP MED BIOL, V1207, P681, DOI 10.1007/978-981-15-4272-5_50; Bauer J, 2019, J CACHEXIA SARCOPENI, V10, P956, DOI 10.1002/jcsm.12483; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Beaudart C, 2014, J CLIN ENDOCR METAB, V99, P4336, DOI 10.1210/jc.2014-1742; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bozzetti F, 2020, CURR TREAT OPTION ON, V21, DOI 10.1007/s11864-019-0691-9; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chapman IM, 2004, BEST PRACT RES CL EN, V18, P437, DOI 10.1016/j.beem.2004.02.004; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Choi JS, 2016, J CONTROL RELEASE, V222, P107, DOI 10.1016/j.jconrel.2015.12.018; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Crouch ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181086; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Daly LE, 2018, J CACHEXIA SARCOPENI, V9, P315, DOI 10.1002/jcsm.12267; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Davis MP, 2019, ANN PALLIAT MED, V8, P86, DOI 10.21037/apm.2018.08.02; De Biase D., 2021, INT J MOL SCI, V22, P3; Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; dos Santos SL, 2015, REDOX BIOL, V5, P267, DOI 10.1016/j.redox.2015.05.006; El Assar M, 2020, FREE RADICAL BIO MED, V149, P72, DOI 10.1016/j.freeradbiomed.2019.08.011; Englund DA, 2017, EXP GERONTOL, V91, P51, DOI 10.1016/j.exger.2017.02.072; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Fatouros IG, 2009, DIABETES CARE, V32, P2161, DOI 10.2337/dc08-1994; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Filareto Antonio, 2012, J Stem Cell Res Ther, V10; Flatt T, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0562-z; Forterre A, 2014, CELL CYCLE, V13, P78, DOI 10.4161/cc.26808; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Geraci A, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.682012; Grunewald M, 2021, SCIENCE, V373, P533, DOI 10.1126/science.abc8479; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Guescini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125094; Han XJ, 2019, AUTOPHAGY, V15, P1860, DOI 10.1080/15548627.2019.1596481; He MY, 2019, AGING CELL, V18, DOI 10.1111/acel.13003; Hepple RT, 2016, FREE RADICAL BIO MED, V98, P177, DOI 10.1016/j.freeradbiomed.2016.03.017; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huang DD, 2019, EXP GERONTOL, V119, P61, DOI 10.1016/j.exger.2019.01.022; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Jia L, 2014, INT J MOL SCI, V15, P296, DOI 10.3390/ijms15010296; Jiao JQ, 2017, CURR OPIN PHARMACOL, V34, P1, DOI 10.1016/j.coph.2017.03.009; Kahroba H, 2019, CELL MOL LIFE SCI, V76, P1747, DOI 10.1007/s00018-019-03035-2; Katayama M, 2019, DIABETES, V68, P515, DOI 10.2337/db18-0470; Kemmler W, 2020, J BONE MINER RES, V35, P1634, DOI 10.1002/jbmr.4027; Kitaoka Y, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13998; Kohut ML, 2006, BRAIN BEHAV IMMUN, V20, P201, DOI 10.1016/j.bbi.2005.12.002; Lambert KC, 2004, J LEUKOCYTE BIOL, V75, P1166, DOI 10.1189/jlb.1103589; Landi F, 2017, AGING CLIN EXP RES, V29, P89, DOI 10.1007/s40520-016-0715-2; Landi F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020069; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Li GH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.479; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li ZY, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.681267; Little RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06581-6; Livshits G, 2019, AGEING RES REV, V56, DOI 10.1016/j.arr.2019.100980; Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma DW, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00366; Magli A, 2017, CELL REP, V19, P2867, DOI 10.1016/j.celrep.2017.06.005; Mao G, 2017, OSTEOARTHR CARTILAGE, V25, P521, DOI 10.1016/j.joca.2016.11.006; Martin N, 2018, CELL CALCIUM, V70, P16, DOI 10.1016/j.ceca.2017.04.001; Martinez-Gutierrez A, 2021, AGING-US, V13, P12308, DOI 10.18632/aging.203010; Marzetti E, 2018, EXP GERONTOL, V113, P48, DOI 10.1016/j.exger.2018.09.017; Meftahi GH, 2020, INFLAMM RES, V69, P825, DOI 10.1007/s00011-020-01372-8; Muller R, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55110730; Murphy C, 2018, MOL ASPECTS MED, V60, P123, DOI 10.1016/j.mam.2017.09.006; Mytidou C, 2021, FASEB J, V35, DOI 10.1096/fj.201902468RR; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Ngeuleu A, 2017, RHEUMATOL INT, V37, P1015, DOI 10.1007/s00296-017-3665-x; Park SS, 2019, BMB REP, V52, P64, DOI 10.5483/BMBRep.2019.52.1.292; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Perez-Lopez FR, 2016, CLIMACTERIC, V19, P37, DOI 10.3109/13697137.2015.1115261; Picca A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040973; Prestes J, 2009, J SPORT SCI, V27, P1607, DOI 10.1080/02640410903352923; Qazi TH, 2019, J CACHEXIA SARCOPENI, V10, P501, DOI 10.1002/jcsm.12416; Rodrigues F, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19020874; Rudolf R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00099; Sabatino A, 2021, J NEPHROL, V34, P1347, DOI 10.1007/s40620-020-00840-y; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandini M, 2018, JAMA SURG, V153, P809, DOI 10.1001/jamasurg.2018.0979; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Sculthorpe N, 2012, MED SCI SPORT EXER, V44, P610, DOI 10.1249/MSS.0b013e318237c5c0; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shin MJ, 2018, WORLD J MENS HEALTH, V36, P192, DOI 10.5534/wjmh.180001; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Smith L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051708; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Son NK, 2016, J GERIATR PHYS THER, V39, P51, DOI 10.1519/JPT.0000000000000042; Soriano-Arroquia A, 2016, BIOGERONTOLOGY, V17, P641, DOI 10.1007/s10522-016-9638-8; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stenvinkel P, 2016, NEPHROL DIAL TRANSPL, V31, P1070, DOI 10.1093/ndt/gfv122; Takafuji Y, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115298; Talar K, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081630; Tamaki T, 2020, EXPERT OPIN BIOL TH, V20, P1361, DOI 10.1080/14712598.2020.1793953; Tan BL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01162; Tey SR, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00284; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Torii M, 2019, MOD RHEUMATOL, V29, P589, DOI 10.1080/14397595.2018.1510565; Tsao J., 2016, J STEM CELL RES THER, V6, P370; Ueno A, 2020, SUPPORT CARE CANCER, V28, P4249, DOI 10.1007/s00520-019-05279-x; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Wang HD, 2019, PLAST RECONSTR SURG, V143, p329E, DOI 10.1097/PRS.0000000000005273; Wang PY, 2021, NUTRITION, V84, DOI 10.1016/j.nut.2020.111104; Wei W, 2016, J CELL SCI, V129, P39, DOI 10.1242/jcs.174235; Welch C, 2020, AGING DIS, V11, P1345, DOI 10.14336/AD.2020.1014; White JP, 2018, STEM CELL REP, V11, P425, DOI 10.1016/j.stemcr.2018.06.014; Wierdsma NJ, 2021, CLIN NUTR ESPEN, V43, P369, DOI 10.1016/j.clnesp.2021.03.021; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Xu Q, 2018, BIOCHEM BIOPH RES CO, V498, P32, DOI 10.1016/j.bbrc.2018.02.144; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yang YF, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04400-5; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yin JY, 2020, J CELL MOL MED, V24, P4900, DOI 10.1111/jcmm.15197; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4; El Baradie KBY, 2021, CONNECT TISSUE RES, V62, P99, DOI 10.1080/03008207.2020.1781102; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zampieri S, 2015, J GERONTOL A-BIOL, V70, P163, DOI 10.1093/gerona/glu006; Zhang AQ, 2018, J CACHEXIA SARCOPENI, V9, P755, DOI 10.1002/jcsm.12296; Zhang KL, 2019, CHEM SCI, V10, P1555, DOI 10.1039/c8sc03224f	137	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22614	10.1096/fj.202200675R	http://dx.doi.org/10.1096/fj.202200675R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5I8EG	36250337				2022-12-28	WOS:000868582800001
J	Xiao, F; Deng, JL; Jiao, FX; Hu, XM; Jiang, HZ; Yuan, FX; Chen, SH; Niu, YG; Jiang, XX; Guo, FF				Xiao, Fei; Deng, Jiali; Jiao, Fuxin; Hu, Xiaoming; Jiang, Haizhou; Yuan, Feixiang; Chen, Shanghai; Niu, Yuguo; Jiang, Xiaoxue; Guo, Feifan			Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB)	FASEB JOURNAL			English	Article						CISH; CREB; gluconeogenesis; liver; SOCS	INSULIN-RESISTANCE; GLUCOSE; SUPPRESSOR; DELETION; METABOLISM; SOCS-3; SIGNALING-3; INHIBITION; STEATOSIS; GLUCAGON	Impairment of gluconeogenesis is a key factor responsible for hyperglycemia in patients with type 2 diabetes. As an important member of the suppressors of cytokine signaling (SOCS) protein family, many physiological functions of cytokine-inducible SH2-containing protein (CISH) have been described; however, the role of hepatic CISH in gluconeogenesis is poorly understood. In the present study, we observed that hepatic CISH expression was reduced in fasted wild-type (WT) mice. Overexpression of CISH decreased glucose production in mouse primary hepatocytes, while silencing of CISH had the opposite effects. In addition, adenovirus-mediated hepatic CISH overexpression resulted in improved glucose tolerance and decreased gluconeogenesis in WT and leptin receptor-deficient diabetic (db/db) mice. In contrast, adenovirus-mediated hepatic CISH knockdown impaired glucose tolerance and increased gluconeogenesis in WT mice. We also generated liver-specific CISH knockout (LV-CISH KO) mice and discovered that these mice had a similar phenotype in glucose tolerance and gluconeogenesis as mice injected with adenoviruses that knockdown CISH expression. Mechanistically, we found that CISH overexpression decreased and CISH knockdown increased the mRNA and protein levels of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase 1 (PEPCK), two key enzymes involved in gluconeogenesis, in vitro, and in vivo. Moreover, we discovered that the phosphorylation of cAMP-responsive element binding protein 1 (CREB), a transcription factor of G6pase and Pepck, was required for regulating gluconeogenesis by CISH. Taken together, this study identifies hepatic CISH as an important regulator of gluconeogenesis. Our results also provide important insights into the metabolic functions of the SOCS protein family and the potential targets for the treatment of diabetes.	[Xiao, Fei; Hu, Xiaoming; Yuan, Feixiang; Chen, Shanghai; Guo, Feifan] Fudan Univ, MOE Frontiers Ctr Brain Sci, Inst Translat Brain Res, Jinshan Hosp,State Key Lab Med Neurobiol, 131 Dong Rd, Shanghai 200032, Peoples R China; [Deng, Jiali; Jiao, Fuxin; Jiang, Haizhou; Niu, Yuguo; Jiang, Xiaoxue] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS	Guo, FF (corresponding author), Fudan Univ, MOE Frontiers Ctr Brain Sci, Inst Translat Brain Res, Jinshan Hosp,State Key Lab Med Neurobiol, 131 Dong Rd, Shanghai 200032, Peoples R China.	ffguo@fudan.edu.cn			National Natural Science Foundation of China [91957207, 31830044, 81970742, 81870592, 81770852, 82170868, 81970731, 82000764]; National Key R&D Program of China [2018YFA0800600]; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2008-10]; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan" [21ZR1475900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan"	National Natural Science Foundation of China, Grant/Award Number: 91957207, 31830044, 81970742, 81870592, 81770852, 82170868, 81970731 and 82000764; National Key R&D Program of China, Grant/Award Number: 2018YFA0800600; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund, Grant/Award Number: NNCAS-2008-10; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan", Grant/Award Number: 21ZR1475900	Akhtar S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90952-7; Banks AS, 2005, J CLIN INVEST, V115, P2462, DOI 10.1172/JCI23853; Carow B, 2017, TUBERCULOSIS, V107, P175, DOI 10.1016/j.tube.2017.09.007; CHAN TM, 1975, AM J PHYSIOL, V229, P1702, DOI 10.1152/ajplegacy.1975.229.6.1702; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Dai ZR, 2015, AM J PHYSIOL-ENDOC M, V308, pE849, DOI 10.1152/ajpendo.00540.2014; De Felice FG, 2022, NAT REV NEUROSCI, V23, P215, DOI 10.1038/s41583-022-00558-9; Deng JL, 2020, AUTOPHAGY, V16, P451, DOI 10.1080/15548627.2019.1628537; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feng XT, 2014, MOL BIOL REP, V41, P2265, DOI 10.1007/s11033-014-3079-8; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Santos MRG, 2020, BONE, V140, DOI 10.1016/j.bone.2020.115538; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jiang MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00070; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jin ES, 2013, METABOLISM, V62, P152, DOI 10.1016/j.metabol.2012.07.012; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Keating N, 2019, CYTOKINE, V118, P64, DOI 10.1016/j.cyto.2018.03.033; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lebrun P, 2009, DIABETOLOGIA, V52, P2201, DOI 10.1007/s00125-009-1474-9; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; MONTGOMERY R, 1957, ARCH BIOCHEM BIOPHYS, V67, P378, DOI 10.1016/0003-9861(57)90292-8; Naser W, 2022, FASEB J, V36, DOI 10.1096/fj.202101882R; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Rahnert JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159181; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Sobah ML, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.727987; Strebovsky J, 2012, FRONT BIOSCI-LANDMRK, V17, P1627, DOI 10.2741/4008; Sun XJ, 2015, J BIOL CHEM, V290, P2189, DOI 10.1074/jbc.M114.612358; Ueda H, 2000, DIABETOLOGIA, V43, P932, DOI 10.1007/s001250051472; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Xiao F, 2019, MOL METAB, V20, P138, DOI 10.1016/j.molmet.2018.12.003; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Xie Y, 2018, BIOCHEM BIOPH RES CO, V503, P1409, DOI 10.1016/j.bbrc.2018.07.056; Ye J, 2012, PEDIATR RES, V72, P550, DOI 10.1038/pr.2012.123; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang X, 2021, METABOLISM, V122, DOI 10.1016/j.metabol.2021.154823; Zhu H, 2020, CELL STEM CELL, V27, P224, DOI 10.1016/j.stem.2020.05.008	53	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22541	10.1096/fj.202200870R	http://dx.doi.org/10.1096/fj.202200870R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4J8GC	36083102				2022-12-28	WOS:000851500400001
J	Zhang, W; Ye, FH; Xiong, J; He, F; Yang, L; Yin, F; Peng, J; Wang, XL				Zhang, Wen; Ye, Fanghua; Xiong, Juan; He, Fang; Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole			Silencing of miR-132-3p protects against neuronal injury following status epilepticus by inhibiting IL-1 beta-induced reactive astrocyte (A1) polarization	FASEB JOURNAL			English	Article						astrocyte; epilepsy; microRNAs; neuronal damage	TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL MOSSY FIBERS; IMMATURE RAT MODEL; DOWN-REGULATION; EXPRESSION; MICRORNA-132; INTERLEUKIN-1-BETA; INFLAMMATION; ACTIVATION; MIR-146A	Mesial temporal lobe epilepsy (MTLE) is one of the most common refractory epilepsies and is usually accompanied by a range of brain pathological changes, such as neuronal injury and astrocytosis. Naive astrocytes are readily converted to cytotoxic reactive astrocytes (A1) in response to inflammatory stimulation, suppressing the polarization of A1 protects against neuronal death in early central nervous system injury. Our previous study found that pro-inflammatory cytokines and miR-132-3p (hereinafter referred to as "miR-132") expression were upregulated, but how miR-132 affected reactive astrocyte polarization and neuronal damage during epilepsy is not fully understood. Here, we aimed to explore the effect and mechanism of miR-132 on A1 polarization. Our results confirmed that A1 markers were significantly elevated in the hippocampus of MTLE rats and IL-1 beta-treated primary astrocytes. In vivo, knockdown of miR-132 by lateral ventricular injection reduced A1 astrocytes, neuronal loss, mossy fiber sprouting, and remitted the severity of status epilepticus and the recurrence of spontaneous recurrent seizures. In vitro, the neuronal cell viability and axon length were reduced by additional treatment with A1 astrocyte conditioned media (ACM), and downregulation of astrocyte miR-132 rescued the inhibition of cell activity by A1 ACM, while the length of axons was further inhibited. The regulation of miR-132 on A1 astrocytes may be related to its target gene expression. Our results show that interfering with astrocyte polarization may be a breakthrough in the treatment of refractory epilepsy, which may extend to the research of other astrocyte polarization-mediated brain injuries.	[Zhang, Wen; Ye, Fanghua; Xiong, Juan; He, Fang; Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole] Cent South Univ, Xiangya Hosp, Dept Pediat, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole] Hunan Intellectual & Dev Disabil Res Ctr, Pediat, Changsha, Peoples R China	Central South University	Peng, J; Wang, XL (corresponding author), Cent South Univ, Xiangya Hosp, Dept Pediat, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	pengjing627@126.com; 1195663129@qq.com		Zhang, Wen/0000-0003-4391-8199	Central South University (CSU) [2019zzts347]; National Natural Science Foundation of China (NSFC) [81371434, 81771408, 81801297]	Central South University (CSU); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Central South University (CSU), Grant/Award Number: 2019zzts347; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81371434, 81771408 and 81801297	Althammer F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01892-4; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aten Sydney, 2016, RNA Dis, V3; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Chai G, 2015, INT J BIOCHEM CELL B, V64, P11, DOI 10.1016/j.biocel.2015.03.013; Damaye CA, 2011, INT J NEUROSCI, V121, P575, DOI 10.3109/00207454.2011.598979; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Diaz-Castro B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8546; Dokalis N, 2019, SEMIN IMMUNOPATHOL, V41, P699, DOI 10.1007/s00281-019-00764-1; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Gottipati MK, 2020, ACTA BIOMATER, V117, P273, DOI 10.1016/j.actbio.2020.09.057; Gross C, 2016, CELL REP, V17, P37, DOI 10.1016/j.celrep.2016.08.074; Guo MF, 2020, J NEUROIMMUNOL, V346, DOI 10.1016/j.jneuroim.2020.577284; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Haan N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0327-3; Hayakawa K, 2014, STEM CELL RES, V12, P531, DOI 10.1016/j.scr.2013.12.008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hinkle JT, 2019, MOVEMENT DISORD, V34, P959, DOI 10.1002/mds.27718; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Huang YY, 2014, INT J CLIN EXP MED, V7, P1639; Ikegaya Y, 1999, J NEUROSCI, V19, P802; Iori V, 2017, NEUROBIOL DIS, V99, P12, DOI 10.1016/j.nbd.2016.12.007; Itoh N, 2018, P NATL ACAD SCI USA, V115, pE302, DOI 10.1073/pnas.1716032115; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; King A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080503; Kong HM, 2015, J MOL NEUROSCI, V57, P28, DOI 10.1007/s12031-015-0574-x; Korotkov A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11510-8; Korotkov A, 2020, GLIA, V68, P60, DOI 10.1002/glia.23700; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lado FA, 2001, EPILEPSIA, V42, P458, DOI 10.1046/j.1528-1157.2001.30900.x; Li SY, 2018, BIOCHEM PHARMACOL, V151, P245, DOI 10.1016/j.bcp.2017.12.023; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu DSH, 2009, NEUROBIOL DIS, V35, P337, DOI 10.1016/j.nbd.2009.05.009; Liu M, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01946-7; del Rey NLG, 2022, NEUROPATH APPL NEURO, V48, DOI 10.1111/nan.12812; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Numakawa T, 2011, NEUROSCI LETT, V505, P242, DOI 10.1016/j.neulet.2011.10.025; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pohlen MS, 2017, EPILEPSY RES, V137, P56, DOI 10.1016/j.eplepsyres.2017.09.012; Rahimian P, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0716-2; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; REPRESA A, 1993, HIPPOCAMPUS, V3, P257, DOI 10.1002/hipo.450030303; Rothhammer V, 2015, SEMIN IMMUNOPATHOL, V37, P625, DOI 10.1007/s00281-015-0515-3; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salta E, 2014, DEV CELL, V30, P423, DOI 10.1016/j.devcel.2014.07.006; Sano F, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.135391; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Sloviter RS, 2006, J COMP NEUROL, V494, P944, DOI 10.1002/cne.20850; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song YJ, 2019, J CELL BIOCHEM, V120, P9147, DOI 10.1002/jcb.28190; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; Vangoor VR, 2019, J NEUROSCI, V39, P5064, DOI 10.1523/JNEUROSCI.3014-18.2019; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang XL, 2018, EPILEPSY RES, V139, P14, DOI 10.1016/j.eplepsyres.2017.10.006; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xia L, 2017, ONCOTARGET, V8, P40668, DOI 10.18632/oncotarget.16541; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; Xu B, 2017, CELL RES, V27, P882, DOI 10.1038/cr.2017.62; Yao CC, 2019, BRIT J PHARMACOL, V176, P337, DOI 10.1111/bph.14530; Yoshimura A, 2016, NEUROCHEM INT, V97, P26, DOI 10.1016/j.neuint.2016.04.013; Yuan JX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5108489; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang LF, 2021, J NEUROCHEM, V158, P880, DOI 10.1111/jnc.15457; Zhang YN, 2021, INT J BIOL SCI, V17, P2795, DOI 10.7150/ijbs.60509; Zhu XJ, 2012, NEUROBIOL DIS, V45, P253, DOI 10.1016/j.nbd.2011.08.009; Zou HJ, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.628917; Zou LH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00429	88	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22554	10.1096/fj.202200110RR	http://dx.doi.org/10.1096/fj.202200110RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N7UO	36111973				2022-12-28	WOS:000854221900001
J	Zou, J; Tan, W; Liu, KC; Chen, BL; Duan, TQ; Xu, HZ				Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo			Wnt inhibitory factor 1 ameliorated diabetic retinopathy through the AMPK/mTOR pathway-mediated mitochondrial function	FASEB JOURNAL			English	Article						AMPK; mTOR pathway; angiogenesis; diabetic retinopathy; mitochondrial dysfunction; wnt inhibitory factor 1	HIGH-GLUCOSE; APOPTOSIS; ANGIOGENESIS; INFLAMMATION; AUTOPHAGY; CELLS	Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus and will lead to visual impairment. We aim to explore the effects and mechanisms of wnt inhibitory factor 1 (WIF1) in the progression of DR. To establish DR in vitro and in vivo, human retinal pigment epithelium (RPE) cell line ARPE-19 was treated with high-glucose (HG) and diabetic mice models were induced by streptozotocin (STZ), respectively. Different dose of recombinant WIF1 protein was used to treat DR. qRT-PCR and western blotting results demonstrated that WIF1 was downregulated, while VEGFA was upregulated in HG-induced ARPE-19 cells. WIF1 overexpression promoted cell migration. The ARPE-19 cells culture medium treated with WIF1 inhibited retinal endothelial cell tube formation and downregulated VEGFA expression. Moreover, WIF1 decreased the levels of ROS and MDA, while increasing the activity of SOD and GPX. WIF1 increased the Delta psi m in the mitochondria and downregulated the expression of mitochondrial autophagy-related proteins including Parkin, Pink1, LC3-II/LC3-I ratio, cleaved caspase 3, and cyt-c, which ameliorated mitochondrial dysfunction. The in vivo studies further demonstrated the consistent effects of WIF1 in STZ-induced mice. Taken together, WIF1 ameliorated mitochondrial dysfunction in DR by downregulating the AMPK/mTOR pathway.	[Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo] Cent South Univ, Xiangya Hosp, Eye Ctr, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China	Central South University; Central South University	Xu, HZ (corresponding author), Cent South Univ, Xiangya Hosp, Eye Ctr, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	xhz1030@csu.edu.cn			Hunan Natural Science Foundation [2019JJ40528]	Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by a grant from the Hunan Natural Science Foundation (No. 2019JJ40528) to Huizhuo Xu.	AnandBabu K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216899; Bernkopf DB, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1458015; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chang ML, 2014, ADV EXP MED BIOL, V801, P609, DOI 10.1007/978-1-4614-3209-8_77; Chen H, 2018, BIOMED PHARMACOTHER, V108, P1201, DOI 10.1016/j.biopha.2018.09.140; Cohen SR, 2016, DEV OPHTHALMOL, V55, P137, DOI 10.1159/000438970; Deissler HL, 2020, EXP EYE RES, V194, DOI 10.1016/j.exer.2020.108004; Drenser KA, 2016, EYE BRAIN, V8, P141, DOI 10.2147/EB.S94452; Due WW, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1610751; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Fu T, 2014, MOL CELL BIOL, V34, P4130, DOI 10.1128/MCB.00596-14; Hombrebueno JR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129760; Hou J, 2021, BIOL TRACE ELEM RES, V199, P1062, DOI 10.1007/s12011-020-02212-w; Houzelle A, 2020, J CELL PHYSIOL, V235, P9851, DOI 10.1002/jcp.29797; Jenkins Alicia J, 2015, Rev Diabet Stud, V12, P159, DOI 10.1900/RDS.2015.12.159; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Kanamori H, 2015, AUTOPHAGY, V11, P1146, DOI 10.1080/15548627.2015.1051295; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Laferriere CA, 2020, J AM ASSOC LAB ANIM, V59, P254, DOI 10.30802/AALAS-JAALAS-19-000081; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Lambuk L, 2019, INT J OPHTHALMOL-CHI, V12, P746, DOI 10.18240/ijo.2019.05.08; Liang PF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1194-5; Liu QP, 2019, CELL TISSUE RES, V376, P165, DOI 10.1007/s00441-018-2974-z; Ma MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091086; Mehta H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011599.pub2; Miao JH, 2019, AGING CELL, V18, DOI 10.1111/acel.13004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poggi L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00167; Qi F, 2020, EUR REV MED PHARMACO, V24, P6486, DOI 10.26355/eurrev_202006_21631; Qian C, 2019, RNA BIOL, V16, P1461, DOI 10.1080/15476286.2019.1637696; Qin D, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/9490642; Romero-Aroca P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2156273; Shao Y, 2019, STEM CELLS, V37, P1331, DOI 10.1002/stem.3049; Shi Y, 2019, BIOSCI BIOTECH BIOCH, V83, P869, DOI 10.1080/09168451.2019.1569499; Sun H, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29277-6; Sun J, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101811; Sun Y, 2018, EUR REV MED PHARMACO, V22, P2941, DOI 10.26355/eurrev_201805_15048; Tan W, 2022, BIOFACTORS, V48, P683, DOI 10.1002/biof.1824; Wan WC, 2021, J INFLAMM RES, V14, P2411, DOI 10.2147/JIR.S303540; Wang W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061816; Wang Y, 2020, CELL CYCLE, V19, P1314, DOI 10.1080/15384101.2020.1749484; Wu MY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3420187; Xi XT, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109924; Xia T, 2017, VISION RES, V139, P72, DOI 10.1016/j.visres.2017.02.006; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680; Yang Y., 2020, J CLIN ENDOCR METAB, V105, P3404; Zha X, 2020, AGING-US, V12, P8137, DOI 10.18632/aging.103130; Zhang F, 2020, AM J PHYSIOL-CELL PH, V319, pC720, DOI 10.1152/ajpcell.00014.2020; Zhang YP, 2019, BIOMED PHARMACOTHER, V111, P1315, DOI 10.1016/j.biopha.2019.01.034; Zhao WY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01526; Zhou LL, 2019, KIDNEY INT, V95, P830, DOI 10.1016/j.kint.2018.10.032; Zhou P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030213; Zhu ZY, 2020, ARCH MED SCI, V16, P898, DOI 10.5114/aoms.2020.95667	54	1	1	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22531	10.1096/fj.202200366RR	http://dx.doi.org/10.1096/fj.202200366RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H5GL	36063130				2022-12-28	WOS:000849906800001
J	Cao, LL; Zhou, SM; Qiu, XS; Qiu, S				Cao, Lili; Zhou, Siming; Qiu, Xueshan; Qiu, Shui			Trehalose improves palmitic acid-induced apoptosis of osteoblasts by regulating SIRT3-medicated autophagy via the AMPK/mTOR/ULK1 pathway	FASEB JOURNAL			English	Article						autophagy; lipotoxicity; palmitic acid; SIRT3; Trehalose	MESENCHYMAL STEM-CELLS; POSTMENOPAUSAL WOMEN; DIFFERENTIATION; MECHANISM; THERAPY	Accumulation of lipid substances decreased the activity of osteoblasts. Trehalose is a typical stress metabolite to form a protective membrane on cell surface which has been demonstrated to regulate lipid metabolism. This activity of Trehalose indicates the potential effect of osteoporosis treatment. Our study aimed to determine the therapeutic effect of Trehalose in high fat-induced osteoporosis. We used palmitic acid (PA) to mimic the state of high fat and observed the apoptosis ratio of osteoblasts increased. After adding Trehalose, the apoptosis ratio decreased obviously. Autophagy is a regulatory means involved in the process of apoptosis. We detected the autophagy protein and found that the expression of Beclin-1, Atg5, and LC3 II increased, and p62 decreased after Trehalose treatment. When adding an autophagy inhibitor (3-MA), the expression of Beclin-1, Atg5, and LC3 II decreased, and p62 increased. These results indicated autophagy was an important factor involved in the preventive effect of Trehalose in PA-induced apoptosis. SIRT3 is a mitochondrial gene that can inhibit apoptosis, which has been reported to promote autophagy. We used SIRT3-siRNA to silence the expression of SIRT3 and found the effect of Trehalose was counteracted. The apoptosis ratio increased and the expression of Beclin-1, Atg5, and LC3 II decreased, p62 increased. Additionally, we also fed the mice with a high-fat diet (HFD) and intragastrical Trehalose. The results showed that Trehalose could inhibit the bone mass loss with HFD. Our study revealed the effect and mechanism of Trehalose in the treatment of osteoporosis.	[Cao, Lili] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China; [Zhou, Siming; Qiu, Shui] China Med Univ, Hosp 1, Dept Orthoped, 155 Nanjing North St, Shenyang, Peoples R China; [Qiu, Xueshan] China Med Univ, Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Qiu, Xueshan] Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Qiu, S (corresponding author), China Med Univ, Hosp 1, Dept Orthoped, 155 Nanjing North St, Shenyang, Peoples R China.	qiushuii@hotmail.com			China Medical University (CMU)	China Medical University (CMU)(China Medical University)	China Medical University (CMU)	Arai C, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00443-1; Benini C, 2020, MINERVA OBSTET GYNEC, V73, P704, DOI 10.23736/S2724-606X.20.04682-1; Casado-Diaz A, 2017, EXP GERONTOL, V90, P71, DOI 10.1016/j.exger.2017.01.024; Cefalu WT, 2001, J WOMEN HEALTH GEN-B, V10, P241, DOI 10.1089/152460901300139998; Dalla Valle A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00726; Elbers LPB, 2021, DRUGS, V81, P1645, DOI 10.1007/s40265-021-01587-x; Fathollahi A, 2018, LUPUS, V27, P1053, DOI 10.1177/0961203318768889; GUDMANDHOYER E, 1994, AM J CLIN NUTR, V59, p735S, DOI 10.1093/ajcn/59.3.735S; Hase K, 2021, METABOLITES, V11, DOI 10.3390/metabo11060348; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Huang SY, 2022, BIOPRESERV BIOBANK, V20, P384, DOI 10.1089/bio.2021.0071; Ji ZJ, 2022, J GENET GENOMICS, V49, P287, DOI 10.1016/j.jgg.2021.11.005; Kang DW, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166084; Lee HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0749-9; Lei SS, 2021, INT J BIOL MACROMOL, V193, P1996, DOI 10.1016/j.ijbiomac.2021.11.030; Leonhardt Y, 2021, QUANT IMAG MED SURG, V11, P3715, DOI 10.21037/qims-20-1373; Li ZZ, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114904; Li ZY, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.680328; Lu WJ, 2021, FOOD FUNCT, V12, P2995, DOI [10.1039/D0FO02906H, 10.1039/d0fo02906h]; Ma BC, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/5563660; Mehta Devan, 2021, J Orthop Sci, DOI 10.1016/j.jos.2021.11.005; Migliorini F, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02678-x; Moseley KF, 2018, ENDOCR RES, V43, P155, DOI 10.1080/07435800.2018.1441868; Pan B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.774709; Pilato CA, 2018, JOVE-J VIS EXP, DOI 10.3791/57263; Pomeisl K, 2020, MOLECULES, V25, DOI 10.3390/molecules25030497; Saad RK, 2022, OSTEOPOROSIS INT, V33, P511, DOI 10.1007/s00198-021-06206-9; Wang Z, 2021, INT J BIOL SCI, V17, P4192, DOI 10.7150/ijbs.61950; Wu NX, 2020, MOL CELL BIOCHEM, V470, P175, DOI 10.1007/s11010-020-03760-4; Xu XQ, 2020, FASEB J, V34, P8402, DOI 10.1096/fj.201902528RRR; Yang KD, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10751; Yang SH, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.649698; Yu LB, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02636-8; Zhao JW, 2011, AM J MED SCI, V341, P460, DOI 10.1097/MAJ.0b013e31820865d5; Zhao WY, 2021, LIFE SCI, V286, DOI 10.1016/j.lfs.2021.120005; Zhao X, 2019, EXP CLIN ENDOCR DIAB, V127, P50, DOI 10.1055/a-0762-0341; Zhou XJ, 2021, INT J BIOL SCI, V17, P3456, DOI 10.7150/ijbs.60401	37	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22491	10.1096/fj.202200608RR	http://dx.doi.org/10.1096/fj.202200608RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2QH	35947089				2022-12-28	WOS:000838762600001
J	Jiang, WS; Ruan, WF; Wang, ZQ				Jiang, Wangsheng; Ruan, Wenfeng; Wang, Zhengqiang			Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease	FASEB JOURNAL			English	Article						apoptosis; cardiovascular disease; heme oxygenase-1; inflammation effect; rats; vascular smooth muscle cells	SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INFLAMMATION; ACTIVATION; CANDIDUM	Vascular calcification is very common in patients with chronic kidney disease (CKD), but so far, there is no effective treatment. Dendrobium officinale polysaccharide (DOP), a natural component of Chinese herbal medicine, has been shown to exert anti-inflammatory and anti-apoptotic activity. Inflammation and apoptosis play an essential role in the progression of vascular calcification. However, the exact role and molecular mechanisms of DOP in vascular calcification remain unclear. In this study, we investigated the effects of DOP on vascular calcification using vascular smooth muscle cells (VSMCs), arterial rings, and CKD rats. Alizarin red staining and gene expression analysis revealed that DOP inhibited calcification and osteogenic differentiation of rat VSMCs in a dose-dependent manner. Similarly, ex vivo studies revealed that DOP inhibited the calcification of rat arterial rings. Furthermore, the administration of DOP alleviated vascular calcification in CKD rats. Moreover, DOP treatment suppressed VSMC inflammation and apoptosis. Finally, DOP treatment upregulated mRNA and protein levels of heme oxygenase-1 (HMOX-1); both pharmacological inhibition of HMOX-1 by the HMOX-1 inhibitor zinc protoporphyrin-9ZnPP9 and knockdown of HMOX-1 by siRNA markedly abrogated the suppression of inflammation and osteogenic differentiation of VSMCs by DOP. Collectively, these results suggest that DOP alleviates vascular calcification in CKD by suppressing apoptosis and inflammation via HMOX-1 activation. These results may provide a promising treatment for vascular calcification in CKD.	[Jiang, Wangsheng] Taikang Ningbo Hosp Co Ltd, Ningbo 315000, Peoples R China; [Ruan, Wenfeng; Wang, Zhengqiang] Taikang Tongji Wuhan Hosp, Dept Orthoped, Wuhan, Peoples R China		Jiang, WS (corresponding author), Taikang Ningbo Hosp Co Ltd, Ningbo 315000, Peoples R China.; Wang, ZQ (corresponding author), Taikang Tongji Wuhan Hosp, Dept Orthoped Surg, Wuhan 430050, Peoples R China.	jiangwangsheng2441@163.com; 7726915@qq.com						Antonic DD, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111589; Atta MG, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI156257; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Chang JZ, 2019, J CELL BIOCHEM, V120, P13924, DOI 10.1002/jcb.28666; Chen L, 2020, CELL MOL BIOL, V66, P66, DOI 10.14715/cmb/2020.66.7.11; Cui L, 2020, FREE RADICAL BIO MED, V161, P23, DOI 10.1016/j.freeradbiomed.2020.09.028; Ge JC, 2018, CARBOHYD POLYM, V189, P289, DOI 10.1016/j.carbpol.2018.02.054; Gong XY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01542; Guo ZB, 2019, BIOMED PHARMACOTHER, V110, P371, DOI 10.1016/j.biopha.2018.11.149; Hruska KA, 2009, CIRC RES, V104, P710, DOI 10.1161/CIRCRESAHA.109.195487; Hu WX, 2021, FASEB J, V35, DOI 10.1096/fj.202001588RR; Jin DH, 2022, FASEB J, V36, DOI 10.1096/fj.202100625RR; Li MX, 2020, INT J BIOL MACROMOL, V149, P717, DOI 10.1016/j.ijbiomac.2020.01.305; Li WX, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI150051; Li XL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00073; Liang YM, 2021, BIOMED PHARMACOTHER, V143, DOI 10.1016/j.biopha.2021.112101; Liu B, 2020, INT J BIOL MACROMOL, V143, P651, DOI 10.1016/j.ijbiomac.2019.12.041; Liu YG, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112308; Marelli G, 2017, CANCER RES, V77, P4472, DOI 10.1158/0008-5472.CAN-16-2501; Nakano T, 2019, CIRCULATION, V139, P78, DOI 10.1161/CIRCULATIONAHA.118.034588; Peng H, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12624; Saito E, 2008, J ATHEROSCLER THROMB, V15, P130, DOI 10.5551/jat.E556; Sanchis P, 2019, KIDNEY INT, V95, P958, DOI 10.1016/j.kint.2018.12.014; Shi J, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04679-y; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tziakas DN, 2019, CIRCULATION, V139, P2032, DOI 10.1161/CIRCULATIONAHA.118.037166; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09174-1; Wang MY, 2018, LIFE SCI, V200, P31, DOI 10.1016/j.lfs.2018.03.025; Wang SS, 2020, J CELL MOL MED, V24, P13564, DOI 10.1111/jcmm.16005; Wen YF, 2021, CHEM-BIOL INTERACT, V347, DOI 10.1016/j.cbi.2021.109615; Wu YY, 2018, BIOMED PHARMACOTHER, V101, P953, DOI 10.1016/j.biopha.2018.03.030; Yang K, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155058; Yang XL, 2021, FREE RADICAL BIO MED, V172, P530, DOI 10.1016/j.freeradbiomed.2021.06.020; Zeng Q, 2017, J ETHNOPHARMACOL, V208, P214, DOI 10.1016/j.jep.2017.07.006; Zhang K, 2021, CARBOHYD POLYM, V264, DOI 10.1016/j.carbpol.2021.118018; Zhang XL, 2020, ARTERIOSCL THROM VAS, V40, P751, DOI 10.1161/ATVBAHA.119.313414	36	0	0	14	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22504	10.1096/fj.202200353RRR	http://dx.doi.org/10.1096/fj.202200353RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3W3GW	35980507				2022-12-28	WOS:000842238500001
J	Chen, JN; Li, XH; Zeng, P; Zhang, XJ; Bi, KF; Lin, CH; Jiang, JJ; Diao, HY				Chen, Jianing; Li, Xuehui; Zeng, Ping; Zhang, Xujun; Bi, Kefan; Lin, Chenhong; Jiang, Jingjing; Diao, Hongyan			Lamina propria interleukin 17 A aggravates natural killer T-cell activation in autoimmune hepatitis	FASEB JOURNAL			English	Article						autoimmune hepatitis; interleukin 17 A; lamina propria; natural killer T cells	MAIT CELLS; LIVER-INJURY; RECOGNITION; SALMONELLA; MECHANISM; CYTOKINE; IL-17	Autoimmune hepatitis is an interface hepatitis characterized by the progressive destruction of the liver parenchyma, the cause of which is still obscure. Interleukin (IL)-17A is a major driver of autoimmunity, which can be produced by innate immune cells against several intracellular pathogens. Here, we investigated the involvement of IL-17A in a mice model of immune-mediated hepatitis with the intestine exposed to Salmonella typhimurium. Our results showed more severe Concanavalin (Con) A-induced liver injury and gut microbiome dysbiosis when the mice were treated with a gavage of S. typhimurium. Then, the natural killer (NK) T cells were overactivated by the accumulated IL-17A in the liver in the Con A and S. typhimurium administration group. IL-17A could activate NKT cells by inducing CD178 expression via IL-4/STAT6 signaling. Furthermore, via the portal tract, the laminae propria mucosal-associated invariant T (MAIT)-cell-derived IL-17A could be the original driver of NKT cell overactivation in intragastric administration of S. typhimurium and Con A injection. In IL-17A-deficient mice, Con A-induced liver injury and NKT cell activation were alleviated. However, when AAV-sh-mIL-17a was used to specifically knock down IL-17A in liver, it seemed that hepatic IL-17a knock down did not significantly influence the liver injury. Our results suggested that, under Con A-induction, laminae propria MAIT-derived IL-17A activated hepatic NKT, and this axis could be a therapeutic target in autoimmune liver disease.	[Chen, Jianing; Li, Xuehui; Zeng, Ping; Zhang, Xujun; Bi, Kefan; Lin, Chenhong; Jiang, Jingjing; Diao, Hongyan] Zhejiang Univ, Natl Clin Res Ctr Infect Dis, Coll Med,Collaborat Innovat Ctr Diag & Treatment, Affiliated Hosp 1,State Key Lab Diag & Treatment, Hangzhou 310003, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Diao, HY (corresponding author), Zhejiang Univ, Natl Clin Res Ctr Infect Dis, Coll Med,Collaborat Innovat Ctr Diag & Treatment, Affiliated Hosp 1,State Key Lab Diag & Treatment, Hangzhou 310003, Peoples R China.	diaohy@zju.edu.cn			National Key Research and Development Program of China [2021YFA1301100, 2018YFC2000500]; Key Research & Development Plan of Zhejiang Province [2019C04005]; Research Project of Jinan Microecological Biomedicine Shandong Laboratory [JNL-2022012B]; National Natural Science Foundation of China [81700499]	National Key Research and Development Program of China; Key Research & Development Plan of Zhejiang Province; Research Project of Jinan Microecological Biomedicine Shandong Laboratory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China (2021YFA1301100, 2018YFC2000500), Key Research & Development Plan of Zhejiang Province (2019C04005), Research Project of Jinan Microecological Biomedicine Shandong Laboratory (JNL-2022012B), the National Natural Science Foundation of China (No. 81700499).	Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Awad W, 2018, IMMUNOL CELL BIOL, V96, P588, DOI 10.1111/imcb.12017; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen JN, 2014, SCI REP-UK, V4, DOI 10.1038/srep07259; Chen XY, 2019, LAB INVEST, V99, P37, DOI 10.1038/s41374-018-0134-4; Chen YL, 2014, IMMUNOLOGY, V141, P388, DOI 10.1111/imm.12201; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Cheng J, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2441634; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Davies A, 2004, J IMMUNOL, V172, P6828, DOI 10.4049/jimmunol.172.11.6828; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Haga K, 2016, J GASTROEN HEPATOL, V31, P965, DOI 10.1111/jgh.13242; Hardie C, 2016, EBIOMEDICINE, V14, P65, DOI 10.1016/j.ebiom.2016.11.021; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kunzmann LK, 2020, HEPATOLOGY, V72, P1310, DOI 10.1002/hep.31140; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lantz O, 2018, IMMUNOL CELL BIOL, V96, P564, DOI 10.1111/imcb.1034; Liberal R, 2021, LANCET GASTROENTEROL, V6, P315, DOI 10.1016/S2468-1253(20)30328-9; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Renand A, 2020, J HEPATOL, V73, P1379, DOI 10.1016/j.jhep.2020.05.053; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tedesco D, 2018, GASTROENTEROLOGY, V154, P2178, DOI 10.1053/j.gastro.2018.02.019; Trebicka J, 2021, J HEPATOL, V75, pS67, DOI 10.1016/j.jhep.2020.11.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vierling JM, 2020, HEPATOLOGY, V72, P753, DOI 10.1002/hep.31407; Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523; Yadav J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00514; Yin YS, 2013, ISME J, V7, P615, DOI 10.1038/ismej.2012.128; You ZR, 2021, HEPATOLOGY, DOI 10.1002/hep.31739; Zhang YY, 2019, BIOMED PHARMACOTHER, V110, P692, DOI 10.1016/j.biopha.2018.12.025; Zhao N, 2011, J IMMUNOL, V187, P5007, DOI 10.4049/jimmunol.1101315	40	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22346	10.1096/fj.202101734RRR	http://dx.doi.org/10.1096/fj.202101734RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1I2MF	35583908				2022-12-28	WOS:000797067500001
J	Zhao, JY; Xie, W; Yang, ZC; Zhao, M; Ke, T; Xu, CQ; Li, H; Chen, QY; Wang, QK				Zhao, Jinyan; Xie, Wen; Yang, Zhongcheng; Zhao, Miao; Ke, Tie; Xu, Chengqi; Li, Hui; Chen, Qiuyun; Wang, Qing K.			Identification and characterization of a special type of subnuclear structure: AGGF1-coated paraspeckles	FASEB JOURNAL			English	Article						AGGF1; alternative splicing; NONO; paraspeckle; PSF; SFPQ	KLIPPEL-TRENAUNAY-SYNDROME; NONCODING RNA NEAT1; ANGIOGENIC FACTOR; AGGF1 ACTS; TRANSCRIPTION; EXPRESSION; PROTEIN; SFPQ; SUBPOPULATION; SPECIFICATION	AGGF1 is an angiogenic factor with G-Patch and FHA domains 1 described by our group. Gain-of-function mutations in AGGF1 cause Klippel-Trenaunay syndrome, whereas somatic loss-of-function mutations cause cancer. Paraspeckles are small membraneless subnuclear structures with a diameter of 0.5-1 mu m, and composed of lncRNA NEAT1 as the scaffold and three core RNA-binding proteins NONO, PSPC1, and PSF. Here, we show that AGGF1 is a key regulatory and structural component of paraspeckles that induces paraspeckle formation, forms an outside rim of paraspeckles, wraps around the NONO/PSF/PSPC1/NEAT1 core, and regulates the size and number of paraspeckles. AGGF1-paraspeckles are larger (>1 mu m) than conventional paraspeckles. RNA-FISH in combination with immunostaining shows that AGGF1, NONO, and NEAT1_2 co-localize in 20.58% of NEAT1_2-positive paraspeckles. Mechanistically, AGGF1 interacts with NONO, PSF, and HNRNPK, and upregulates NEAT1_2, a longer, 23 kb NEAT1 transcript with a key role in regulation of paraspeckle size and number. RNA-immunoprecipitation shows that AGGF1 interacts with NEAT1, which may be another possible mechanism underlying the formation of AGGF1-paraspeckles. NEAT1_2 knockdown reduces the number and size of AGGF1-paraspeckles. Functionally, AGGF1 regulates alternative RNA splicing as it decreases the exon skipping/inclusion ratio in a CD44 model. AGGF1 is also localized in some nuclear foci without NEAT1 or NONO, suggesting that AGGF1 is an important liquid-liquid phase separation (LLPS) driver for other types of AGGF1-positive nuclear condensates (referred to as AGGF1-bodies). Our results identify a special type of AGGF1-coated paraspeckles and provide important insights into the formation, structure, and function of paraspeckles.	[Zhao, Jinyan; Xie, Wen; Yang, Zhongcheng; Zhao, Miao; Ke, Tie; Xu, Chengqi; Li, Hui; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan, Peoples R China; [Chen, Qiuyun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys, Minist Educ,Coll Life Sci & Technol, Wuhan, Peoples R China.; Chen, QY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	chenq_2003@yahoo.com; qingwang118@qq.com		Wang, Qing Kenneth/0000-0002-2235-6572; Zhao, Jinyan/0000-0002-8125-0516; Xu, Chengqi/0000-0002-4269-6830	National Natural Science Foundation of China [31430047, 81630002, 81872116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31430047, 81630002 and 81872116	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; An HY, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0658-x; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barra J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz9072; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen LY, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2582416; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Duvignaud JB, 2016, BIOCHEMISTRY-US, V55, P2553, DOI 10.1021/acs.biochem.5b01240; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.e05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Hirose T, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1545; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Huang CJ, 2016, AGING-US, V8, P3356, DOI 10.18632/aging.101125; Huang J, 2018, J BIOL CHEM, V293, P6593, DOI 10.1074/jbc.RA117.001451; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kessler Sonja M, 2019, Cell Physiol Biochem, V52, P787, DOI 10.33594/000000055; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Li SF, 2018, GENES DIS, V5, P27, DOI 10.1016/j.gendis.2017.11.003; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Li Z, 2020, CIRC RES, V126, P471, DOI 10.1161/CIRCRESAHA.119.315769; Liu LL, 2011, MOL ENDOCRINOL, V25, P1197, DOI 10.1210/me.2010-0517; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Lu YR, 2019, EUR REV MED PHARMACO, V23, P10785, DOI 10.26355/eurrev_201912_19781; Ma YL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0799-3; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; McCluggage F, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000245; Misteli T, 2000, J CELL SCI, V113, P1841; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Peng WZ, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1020-x; Pisani G, 2019, NON-CODING RNA RES, V4, P128, DOI 10.1016/j.ncrna.2019.11.002; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sawyer IA, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1514; Si WX, 2021, CANCER LETT, V497, P28, DOI 10.1016/j.canlet.2020.10.014; Simchovitz A, 2019, FASEB J, V33, P11223, DOI 10.1096/fj.201900830R; Simko EAJ, 2020, NUCLEIC ACIDS RES, V48, P7421, DOI 10.1093/nar/gkaa475; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tu JF, 2017, ONCOTARGET, V8, P111623, DOI 10.18632/oncotarget.22880; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; VISA N, 1993, EUR J CELL BIOL, V60, P308; Wang Y, 2020, ESSAYS BIOCHEM, V64, P875, DOI 10.1042/EBC20200010; West JA, 2016, J CELL BIOL, V214, P817, DOI 10.1083/jcb.201601071; Wu Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0908-z; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Yamazaki T, 2018, MOL CELL, V70, P1038, DOI 10.1016/j.molcel.2018.05.019; Yao HH, 2017, MED SCI MONITOR, V23, P1286, DOI 10.12659/MSM.903248; Yao YF, 2019, DIABETES, V68, P1635, DOI 10.2337/db18-1178; Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w; Yu Y., 2022, J BIOL CHEM, V298; Zan J, 2021, CELL MOL GASTROENTER, V12, P465, DOI 10.1016/j.jcmgh.2021.02.010; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhang X, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6474-7	70	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22366	10.1096/fj.202101690RR	http://dx.doi.org/10.1096/fj.202101690RR			26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35608889				2022-12-28	WOS:000800641200002
J	Jamieson, JJ; Lin, YY; Malloy, NA; Soto, D; Searson, PC; Gerecht, S				Jamieson, John J.; Lin, YingYu; Malloy, Nora A.; Soto, Daniel; Searson, Peter C.; Gerecht, Sharon			Hypoxia-induced blood-brain barrier dysfunction is prevented by pericyte-conditioned media via attenuated actomyosin contractility and claudin-5 stabilization	FASEB JOURNAL			English	Article						blood-brain barrier; brain microvascular endothelial cells; contractility; hypoxia; induced pluripotent stem cells; pericytes; tissue engineering; transendothelial electrical resistance	CAPILLARY ENDOTHELIAL-CELLS; PLURIPOTENT STEM-CELLS; FIBRONECTIN FIBRILLOGENESIS; EXTRACELLULAR-MATRIX; PERMEABILITY; INHIBITION; INCREASES; HIF-1	The blood-brain barrier (BBB) regulates molecular and cellular entry from the cerebrovasculature into the surrounding brain parenchyma. Many diseases of the brain are associated with dysfunction of the BBB, where hypoxia is a common stressor. However, the contribution of hypoxia to BBB dysfunction is challenging to study due to the complexity of the brain microenvironment. In this study, we used a BBB model with brain microvascular endothelial cells and pericytes differentiated from iPSCs to investigate the effect of hypoxia on barrier function. We found that hypoxia-induced barrier dysfunction is dependent upon increased actomyosin contractility and is associated with increased fibronectin fibrillogenesis. We propose a role for actomyosin contractility in mediating hypoxia-induced barrier dysfunction through modulation of junctional claudin-5. Our findings suggest pericytes may protect brain microvascular endothelial cells from hypoxic stresses and that pericyte-derived factors could be candidates for treatment of pathological barrier-forming tissues.	[Jamieson, John J.; Lin, YingYu; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jamieson, John J.; Lin, YingYu; Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA; [Malloy, Nora A.; Soto, Daniel] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21218 USA; [Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Gerecht, Sharon] Duke Univ, Dept Biomed Engn, Duke, NC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University	Searson, PC; Gerecht, S (corresponding author), Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu; sharon.gerecht@duke.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835	DOD \ Defense Threat Reduction Agency (DTRA) [HDTRA1-15-1-0046]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R61 HL154252]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS106008]; Maryland Stem Cell Research Fund (MSCRF) [MSCRFI-2784]; HHS \ NIH \ National Cancer Institute (NCI) [U54CA210173]; American Heart Association (AHA) [19PRE34380896]; Air Force Office of Scientific Research [FA9550-20-1-0356]	DOD \ Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); Maryland Stem Cell Research Fund (MSCRF); HHS \ NIH \ National Cancer Institute (NCI); American Heart Association (AHA)(American Heart Association); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	DOD vertical bar Defense Threat Reduction Agency (DTRA), Grant/Award Number: HDTRA1-15-1-0046; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R61 HL154252; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS106008; Maryland Stem Cell Research Fund (MSCRF), Grant/Award Number: MSCRFI-2784; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: U54CA210173; American Heart Association (AHA), Grant/Award Number: 19PRE34380896; Air Force Office of Scientific Research, Grant/Award Number: FA9550-20-1-0356	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Al Ahmad A, 2009, J CELL PHYSIOL, V218, P612, DOI 10.1002/jcp.21638; Baumann J, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111503; BENSON P F, 1961, Cereb Palsy Bull, V3, P510; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Chi AY, 2010, ANTIOXID REDOX SIGN, V12, P603, DOI 10.1089/ars.2009.2861; Citi Sandra, 2019, Biophys Rev, V11, P783, DOI 10.1007/s12551-019-00582-7; Davidson CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37044-1; DeStefano JG, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0117-2; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Engelhardt S, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-4; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Faal T, 2019, STEM CELL REP, V12, P451, DOI 10.1016/j.stemcr.2019.01.005; Griggs LA, 2017, MATRIX BIOL, V60-61, P157, DOI 10.1016/j.matbio.2017.01.001; Gudzenko T, 2015, MOL BIOL CELL, V26, P3190, DOI [10.1091/mbc.E14-05-1026, 10.1091/mbc.E15-06-0421]; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Hielscher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147600; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Jamieson JJ, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0136-7; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuntz M, 2014, MICROVASC RES, V91, P44, DOI 10.1016/j.mvr.2013.12.002; Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; Lee TH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0529-6; Lippmann ES, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00222-3; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lu JY, 2020, DEV CELL, V52, P631, DOI 10.1016/j.devcel.2020.01.007; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Merali Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171558; Nzou G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66487-8; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Page S, 2019, NEUROMOL MED, V21, P414, DOI 10.1007/s12017-019-08531-z; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Rana MK, 2015, J CELL SCI, V128, P1083, DOI 10.1242/jcs.155036; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saunders JT, 2019, MOL BIOL CELL, V30, P2218, DOI 10.1091/mbc.E19-03-0140; Scott LE, 2015, INTEGR BIOL-UK, V7, P1454, DOI 10.1039/c5ib00217f; Stebbins MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7375; Tornabene E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221103; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Varadaraj A, 2017, MOL BIOL CELL, V28, P1195, DOI 10.1091/mbc.E16-08-0601; Wang P, 2013, CELL PHYSIOL BIOCHEM, V32, P859, DOI 10.1159/000354488; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Yamashita M, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00197-1; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zieseniss A, 2014, HYPOXIA, V2, P11, DOI 10.2147/HP.S53575	50	0	0	7	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22331	10.1096/fj.202200010RR	http://dx.doi.org/10.1096/fj.202200010RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U8EI	35476363				2022-12-28	WOS:000787879900001
J	Shoaib, M; Choudhary, RC; Chillale, RK; Kim, N; Miyara, SJ; Haque, S; Yin, T; Frankfurt, M; Molmenti, EP; Zanos, S; Kim, J; Becker, LB				Shoaib, Muhammad; Choudhary, Rishabh C.; Chillale, Rupesh K.; Kim, Nancy; Miyara, Santiago J.; Haque, Shabirul; Yin, Tai; Frankfurt, Maya; Molmenti, Ernesto P.; Zanos, Stavros; Kim, Junhwan; Becker, Lance B.			Metformin-mediated mitochondrial protection post-cardiac arrest improves EEG activity and confers neuroprotection and survival benefit	FASEB JOURNAL			English	Article						cardiac arrest; electroencephalogram; ischemia; reperfusion injury; metformin; mitochondrial protection; neuroprotection	ACTIVATED PROTEIN-KINASE; HEART-ASSOCIATION GUIDELINES; CARDIOPULMONARY-RESUSCITATION; RAT MODEL; HYPOTHERMIA; SUBUNIT	Cardiac arrest (CA) produces global ischemia/reperfusion injury resulting in substantial multiorgan damage. There are limited efficacious therapies to save lives despite CA being such a lethal disease process. The small population of surviving patients suffer extensive brain damage that results in substantial morbidity. Mitochondrial dysfunction in most organs after CA has been implicated as a major source of injury. Metformin, a first-line treatment for diabetes, has shown promising results in the treatment for other diseases and is known to interact with the mitochondria. For the treatment of CA, prior studies have utilized metformin in a preconditioning manner such that animals are given metformin well before undergoing CA. As the timing of CA is quite difficult to predict, the present study, in a clinically relevant manner, sought to evaluate the therapeutic benefits of metformin administration immediately after resuscitation using a 10 min asphxyial-CA rat model. This is the first study to show that metformin treatment post-CA (a) improves 72 h survival and neurologic function, (b) protects mitochondrial function with a reduction in apoptotic brain injury without activating AMPK, and (c) potentiates earlier normalization of brain electrophysiologic activity. Overall, as an effective and safe drug, metformin has the potential to be an easily translatable intervention for improving survival and preventing brain damage after CA.	[Shoaib, Muhammad; Kim, Nancy; Frankfurt, Maya; Kim, Junhwan; Becker, Lance B.] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA; [Shoaib, Muhammad; Choudhary, Rishabh C.; Kim, Nancy; Miyara, Santiago J.; Yin, Tai; Kim, Junhwan; Becker, Lance B.] Northwell Hlth, Lab Crit Care Physiol, Feinstein Inst Med Res, Manhasset, NY USA; [Shoaib, Muhammad; Choudhary, Rishabh C.; Miyara, Santiago J.; Yin, Tai; Zanos, Stavros; Kim, Junhwan; Becker, Lance B.] Feinstein Inst Med Res, Inst Bioelect Med, Manhasset, NY USA; [Choudhary, Rishabh C.; Kim, Junhwan; Becker, Lance B.] Northwell Hlth, Dept Emergency Med, Manhasset, NY USA; [Chillale, Rupesh K.] Univ Maryland, Neural Syst Lab, College Pk, MD USA; [Miyara, Santiago J.] Elmezzi Grad Sch Mol Med, Manhasset, NY USA; [Haque, Shabirul] Feinstein Inst Med Res, Inst Mol Med, Manhasset, NY USA; [Frankfurt, Maya; Kim, Junhwan; Becker, Lance B.] Hofstra Northwell, Mol Med & Med, Donald & Barbara Zucker Sch Med, Hempstead, NY USA; [Molmenti, Ernesto P.] Northwell Hlth, Dept Surg, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health; University System of Maryland; University of Maryland College Park; Northwell Health; Northwell Health; Northwell Health; Northwell Health	Choudhary, RC (corresponding author), Feinstein Inst Med Res, Dept Emergency Med, 350 Community Dr, Manhasset, NY 11030 USA.; Choudhary, RC (corresponding author), Feinstein Inst Med Res, Lab Crit Care Physiol, 350 Community Dr, Manhasset, NY 11030 USA.	rchoudhary1@northwell.edu	Chillale, Rupesh/GYU-9179-2022		ZOLL Foundation, United Therapeutics; Emergency Department at North Shore University Hospital	ZOLL Foundation, United Therapeutics; Emergency Department at North Shore University Hospital	This work was supported by the ZOLL Foundation, United Therapeutics, and the Emergency Department at North Shore University Hospital	An HY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67030-5; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Benjanuwattra J, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165893; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Chen BH, 2018, NEUROCRIT CARE, V28, P247, DOI 10.1007/s12028-017-0401-z; Chen G, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6410159; Chen Q, 2017, TRANSL RES, V190, P40, DOI 10.1016/j.trsl.2017.09.003; Choi YH, 2006, J PHARM SCI-US, V95, P2543, DOI 10.1002/jps.20744; Choudhary RC, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.636651; Foretz M, 2019, NAT REV ENDOCRINOL, V15, P569, DOI 10.1038/s41574-019-0242-2; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Han F, 2008, CRIT CARE MED, V36, pS447, DOI 10.1097/CCM.0b013e31818a8a51; Han F, 2010, RESUSCITATION, V81, P93, DOI 10.1016/j.resuscitation.2009.09.018; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Hofmeijer J, 2016, CLIN NEUROPHYSIOL, V127, P2047, DOI 10.1016/j.clinph.2016.02.002; Huang KB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003465; Hur KY, 2015, J DIABETES INVEST, V6, P600, DOI 10.1111/jdi.12328; Jia J, 2015, CURR NEUROPHARMACOL, V13, P389, DOI 10.2174/1570159X13666150205143555; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Ke R, 2018, CELL BIOL INT, V42, P384, DOI 10.1002/cbin.10915; Kim J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7463407; Kim M, 2018, FREE RADICAL BIO MED, V124, P517, DOI 10.1016/j.freeradbiomed.2018.06.040; Kuschner CE, 2021, MITOCHONDRION, V60, P112, DOI 10.1016/j.mito.2021.08.009; LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023; Lana D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00322; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Liu J, 2016, AM J EMERG MED, V34, P1080, DOI 10.1016/j.ajem.2016.02.066; Lv ZQ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00191; Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mohsin AA, 2019, J PHARMACOL EXP THER, V369, P282, DOI 10.1124/jpet.118.254300; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Oh SH, 2013, RESUSCITATION, V84, P200, DOI 10.1016/j.resuscitation.2012.09.031; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Tam J, 2018, NEUROCHEM INT, V120, P200, DOI 10.1016/j.neuint.2018.08.013; van den Brule JMD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4143636; Vial G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00294; Wang YW, 2017, DRUG DES DEV THER, V11, P2421, DOI 10.2147/DDDT.S141675; Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Xu X, 2014, HYPERTENSION, V63, P723, DOI 10.1161/HYPERTENSIONAHA.113.02619; Zhang W, 2019, HEART LUNG CIRC, V28, P505, DOI 10.1016/j.hlc.2018.01.008; Zhu J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008389	49	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22307	10.1096/fj.202200121R	http://dx.doi.org/10.1096/fj.202200121R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0I4IA	35394702	Green Submitted			2022-12-28	WOS:000779383600001
J	Garza, S; Chen, LT; Galano, M; Cheung, G; Sottas, C; Li, L; Li, YC; Zirkin, BR; Papadopoulos, V				Garza, Samuel; Chen, Liting; Galano, Melanie; Cheung, Garett; Sottas, Chantal; Li, Lu; Li, Yuchang; Zirkin, Barry R.; Papadopoulos, Vassilios			Mitochondrial dynamics, Leydig cell function, and age-related testosterone deficiency	FASEB JOURNAL			English	Article						aging; bioenergetics; hypogonadism; mitochondrial fusion; optic atrophy 1; steroidogenesis; testosterone; translocator protein	PROTEIN 18 KDA; BENZODIAZEPINE-RECEPTOR; CONTACT SITES; TSPO; CHOLESTEROL; CRISTAE; FUSION; METABOLISM; STEROIDOGENESIS; ACTIVATION	The mitochondrial translocator protein (18 kDa; TSPO) is a high-affinity cholesterol-binding protein that is an integral component of the cholesterol trafficking scaffold responsible for determining the rate of cholesterol import into the mitochondria for steroid biosynthesis. Previous studies have shown that TSPO declines in aging Leydig cells (LCs) and that its decline is associated with depressed circulating testosterone levels in aging rats. However, TSPO's role in the mechanistic decline in LC function is not fully understood. To address the role of TSPO depletion in LC function, we first examined mitochondrial quality in Tspo knockout mouse tumor MA-10 nG1 LCs compared to wild-type MA-10 cells. Tspo deletion caused a disruption in mitochondrial function and membrane dynamics. Increasing mitochondrial fusion via treatment with the mitochondrial fusion promoter M1 or by optic atrophy 1 (OPA1) overexpression resulted in the restoration of mitochondrial function and mitochondrial morphology as well as in steroid formation in TSPO-depleted nG1 LCs. LCs isolated from aged rats form less testosterone than LCs isolated from young rats. Treatment of aging LCs with M1 improved mitochondrial function and increased androgen formation, suggesting that aging LC dysfunction may stem from compromised mitochondrial dynamics caused by the age-dependent LC TSPO decline. These results, taken together, suggest that maintaining or enhancing mitochondrial fusion may provide therapeutic strategies to maintain or restore testosterone levels with aging.	[Garza, Samuel; Chen, Liting; Galano, Melanie; Cheung, Garett; Sottas, Chantal; Li, Lu; Li, Yuchang; Papadopoulos, Vassilios] Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA; [Zirkin, Barry R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Papadopoulos, V (corresponding author), Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	vpapadop@usc.edu		Garza, Samuel/0000-0001-9688-5445	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	USC | School of Pharmacy, University of Southern California (USC School of Pharmacy)	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Barron AM, 2018, BIOCHEM J, V475, P75, DOI 10.1042/BCJ20170645; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Bose HS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101295; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; BROWNING JY, 1981, ENDOCRINOLOGY, V109, P667, DOI 10.1210/endo-109-2-667; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Culty M, 2002, J ANDROL, V23, P439; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; de la Barca JMC, 2016, NEUROBIOL DIS, V90, P20, DOI 10.1016/j.nbd.2015.08.015; Del Dotto V, 2018, BBA-BIOENERGETICS, V1859, P263, DOI 10.1016/j.bbabio.2018.01.005; Dimmer KS, 2017, BBA-MOL CELL BIOL L, V1862, P69, DOI 10.1016/j.bbalip.2016.07.010; Ding MG, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13428; Duarte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045829; Elustondo P, 2017, BBA-MOL CELL BIOL L, V1862, P90, DOI 10.1016/j.bbalip.2016.08.012; Fan JJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010252; Fan JJ, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa001; Fan JJ, 2018, ENDOCRINOLOGY, V159, P1130, DOI 10.1210/en.2017-03065; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Fan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076701; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Georges E., 2021, J BIOCHEM, V170, P239; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Handelsman DJ., 2000, ENDOTEXT; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiser C, 2021, J BIOENERG BIOMEMBR, V53, P463, DOI 10.1007/s10863-021-09905-4; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Hu C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03152-y; Issop L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152919; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Khanum A, 1997, ENDOCRINOLOGY, V138, P1612, DOI 10.1210/en.138.4.1612; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Li L, 2021, NAT REV UROL, V18, P487, DOI 10.1038/s41585-021-00480-2; Li YC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102457; LIAO C, 1993, J STEROID BIOCHEM, V46, P39, DOI 10.1016/0960-0760(93)90207-D; Liu GJ, 2017, CELL CYCLE, V16, P436, DOI 10.1080/15384101.2017.1281477; Midzak AS, 2011, BIOL REPROD, V84, P976, DOI 10.1095/biolreprod.110.087460; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Owen DR, 2017, BIOCHEM J, V474, P3985, DOI 10.1042/BCJ20170648; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; Papadopoulos V, 2021, VITAM HORM, V115, P585, DOI 10.1016/bs.vh.2020.12.023; Papadopoulos V, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12500; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Sokanovic SJ, 2021, J GERONTOL A-BIOL, V76, P177, DOI 10.1093/gerona/glaa132; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Thomson M, 2003, BIOESSAYS, V25, P252, DOI 10.1002/bies.10243; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Veenman L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.294; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; Zirkin BR, 2018, BIOL REPROD, V99, P101, DOI 10.1093/biolre/ioy059; Zirkin BR, 2000, BIOL REPROD, V63, P977, DOI 10.1095/biolreprod63.4.977	67	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22637	10.1096/fj.202201026R	http://dx.doi.org/10.1096/fj.202201026R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Z7VX	36349989				2022-12-28	WOS:000880177500001
J	Han, YN; Yang, QL; Huang, YP; Gao, PF; Jia, LF; Zheng, YF; Li, WR				Han, Yineng; Yang, Qiaolin; Huang, Yiping; Gao, Pengfei; Jia, Lingfei; Zheng, Yunfei; Li, Weiran			Compressive force regulates orthodontic tooth movement via activating the NLRP3 inflammasome	FASEB JOURNAL			English	Article						autophagy; cyclic GMP-AMP synthase; mechanical force; NLRP3 inflammasome	MACROPHAGE POLARIZATION; PERIODONTAL-LIGAMENT; CELL-PROLIFERATION; AUTOPHAGY; MECHANOTRANSDUCTION; OSTEOCLASTOGENESIS; CASPASES; PATHWAYS	Mechanical stress regulates various cellular functions like cell inflammation, immune responses, proliferation, and differentiation to maintain tissue homeostasis. However, the impact of mechanical signals on macrophages and the underlying mechanisms by which mechanical force regulates bone remodeling during orthodontic tooth movement remain unclear. NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome has been reported to promote osteoclastic differentiation to regulate alveolar bone resorption. But the relationship between the compressive force and NLRP3 inflammasome in macrophages remains unknown. In this study, immunohistochemical staining results showed elevated expression of NLRP3 and interleukin-1 beta, as well as an increased number of macrophages expressing NLRP3, on the compression side of the periodontal tissues, after force application for 7 days. Furthermore, the number of tartrate-resistant acid phosphatase-positive osteoclasts, and the mRNA and protein expression levels of osteoclast-related genes in the periodontal tissue decreased in the Nlrp3(-/-) mice compared to the WT mice group after orthodontic movement. In vitro mechanical force activates the NLRP3 inflammasome and inhibits autophagy. Intraperitoneal injection of the autophagy inhibitor 3-methyladenine in Nlrp3(-/-) mice promoted orthodontic tooth movement. This result indicates that the absence of NLRP3 inflammasome activation can be partially compensated for by autophagy inhibitors. Mechanistically, force-induced activation of the NLRP3 inflammasome in macrophages via the cGAS/P2X7R axis. In conclusion, compressive force regulates orthodontic tooth movement via activating the NLRP3 inflammasome.	[Han, Yineng; Yang, Qiaolin; Huang, Yiping; Zheng, Yunfei; Li, Weiran] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China; [Han, Yineng] Zhejiang Univ, Stomatol Hosp, Zhejiang Prov Clin Res Ctr Oral Dis, Sch Stomatol,Sch Med,Key Lab Oral Biomed Res Zhej, Hangzhou, Peoples R China; [Han, Yineng; Yang, Qiaolin; Huang, Yiping; Jia, Lingfei; Zheng, Yunfei; Li, Weiran] Natl Ctr Stomatol, Natl Clin Res Ctr Oral Dis, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Gao, Pengfei] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing, Peoples R China; [Gao, Pengfei] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Jia, Lingfei] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing, Peoples R China; [Jia, Lingfei] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing, Peoples R China	Peking University; Zhejiang University; Peking University; Peking University; Peking University	Zheng, YF; Li, WR (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China.	yunfei_zheng@bjmu.edu.cn; weiranli@bjmu.edu.cn			National Natural Science Foundation of China [82071119, 82071142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (No. 82071119, 82071142).	Albalawi F, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00227; Allaeys I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4365; Cadwell K, 2016, NAT REV IMMUNOL, V16, P661, DOI 10.1038/nri.2016.100; Chen LY, 2019, J PERIODONTOL, V90, P1170, DOI 10.1002/JPER.19-0049; Chen YH, 2015, GENE, V566, P13, DOI 10.1016/j.gene.2015.03.055; Chen YY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12973; Choi JW, 2011, J PERIODONTAL RES, V46, P513, DOI 10.1111/j.1600-0765.2011.01351.x; Danciu TE, 2004, J DENT RES, V83, P596, DOI 10.1177/154405910408300803; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Han YN, 2021, ORAL DIS, V27, P1268, DOI 10.1111/odi.13637; Hayakawa T, 2015, MOL MED REP, V12, P5879, DOI 10.3892/mmr.2015.4141; He D, 2015, J DENT RES, V94, P1286, DOI 10.1177/0022034515589714; He DQ, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01607-9; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Horwood NJ, 2016, CLIN REV ALLERG IMMU, V51, P79, DOI 10.1007/s12016-015-8519-2; Iwawaki Y, 2015, J BIOSCI BIOENG, V120, P456, DOI 10.1016/j.jbiosc.2015.02.006; Jacox LA, 2022, AM J ORTHOD DENTOFAC, V161, P423, DOI 10.1016/j.ajodo.2020.09.034; Jiang N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.666631; Jin SS, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12912; Kameyama S, 2013, INT J MOL MED, V31, P292, DOI 10.3892/ijmm.2012.1220; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Kim SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02563; Lai MY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00116; Li S, 2020, EXP CELL RES, V387, DOI 10.1016/j.yexcr.2019.111745; Li Y, 2021, AM J ORTHOD DENTOFAC, V159, P582, DOI 10.1016/j.ajodo.2020.01.027; Liu H, 2022, FASEB J, V36, DOI 10.1096/fj.202101589R; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Maruyama K, 2019, INFLAMM REGEN, V39, DOI 10.1186/s41232-019-0092-2; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Miller S, 2010, AUTOPHAGY, V6, P805, DOI 10.1126/science.1184429; Miroshnikova YA, 2018, NAT CELL BIOL, V20, P69, DOI 10.1038/s41556-017-0005-z; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatsu S, 2014, J PERIODONTAL RES, V49, P314, DOI 10.1111/jre.12109; Spyropoulou A, 2015, BBA-MOL BASIS DIS, V1852, P1700, DOI 10.1016/j.bbadis.2015.05.010; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Viecilli RF, 2009, AM J ORTHOD DENTOFAC, V135, P694, DOI 10.1016/j.ajodo.2009.02.013; Yan Y, 2015, J DENT RES, V94, P1463, DOI 10.1177/0022034515595003; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Yum S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100225118; Zang Y, 2020, J DENT RES, V99, P1287, DOI 10.1177/0022034520933533; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhao D, 2016, ONCOTARGET, V7, P68292, DOI 10.18632/oncotarget.11944	49	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22627	10.1096/fj.202200447RR	http://dx.doi.org/10.1096/fj.202200447RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5U2DE	36314562				2022-12-28	WOS:000876361900001
J	Li, YY; Wang, H; Chen, HY; Liao, Y; Gou, SX; Yan, QM; Zhuang, ZP; Li, H; Wang, JW; Suo, YY; Lan, T; Liu, Y; Zhao, Y; Zou, QJ; Nie, T; Hui, XY; Lai, LX; Wu, DH; Fan, NN				Li, Yingying; Wang, Hai; Chen, Huangyao; Liao, Yuan; Gou, Shixue; Yan, Quanmei; Zhuang, Zhenpeng; Li, Hao; Wang, Jiaowei; Suo, Yangyang; Lan, Ting; Liu, Yang; Zhao, Yu; Zou, Qingjian; Nie, Tao; Hui, Xiaoyan; Lai, Liangxue; Wu, Donghai; Fan, Nana			Generation of a genetically modified pig model with CREBRFR457Q variant	FASEB JOURNAL			English	Article						CREBRF; obesity; oxidative stress; pig model; type 2 diabetes	LUMAN/CREB3 RECRUITMENT FACTOR; BODY-MASS INDEX; OXIDATIVE STRESS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MISSENSE VARIANT; OBESITY; RISK; GLIOBLASTOMA; ASSOCIATION	Obesity is among the strongest risk factors for type 2 diabetes (T2D). The CREBRF missense allele rs373863828 (p. Arg457Gln, p. R457Q) is associated with increased body mass index but reduced risk of T2D in people of Pacific ancestry. To investigate the functional consequences of the CREBRF variant, we introduced the corresponding human mutation R457Q into the porcine genome. The CREBRFR457Q pigs displayed dramatically increased fat deposition, which was mainly distributed in subcutaneous adipose tissue other than visceral adipose tissue. The CREBRFR457Q variant promoted preadipocyte differentiation. The increased differentiation capacity of precursor adipocytes conferred pigs the unique histological phenotype that adipocytes had a smaller size but a greater number in subcutaneous adipose tissue (SAT) of CREBRFR457Q variant pigs. In addition, in SAT of CREBRFR457Q pigs, the contents of the peroxidative metabolites 4-hydroxy-nonenal and malondialdehyde were significantly decreased, while the activity of antioxidant enzymes, such as glutathione peroxidase, superoxide dismutase, and catalase, was increased, which was in accordance with the declined level of the reactive oxygen species (ROS) in CREBRFR457Q pigs. Together, these data supported a causal role of the CREBRFR457Q variant in the pathogenesis of obesity, partly via adipocyte hyperplasia, and further suggested that reduced oxidative stress in adipose tissue may mediate the relative metabolic protection afforded by this variant despite the related obesity.	[Li, Yingying; Wang, Hai; Chen, Huangyao; Liao, Yuan; Gou, Shixue; Yan, Quanmei; Zhuang, Zhenpeng; Li, Hao; Wang, Jiaowei; Suo, Yangyang; Lan, Ting; Liu, Yang; Zhao, Yu; Nie, Tao; Lai, Liangxue; Wu, Donghai; Fan, Nana] Chinese Acad Sci, GIBH HKU Guangdong Hong Kong Stem Cell & Regenera, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Li, Yingying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Yingying; Wang, Hai; Chen, Huangyao; Gou, Shixue; Zhuang, Zhenpeng; Li, Hao; Wang, Jiaowei; Suo, Yangyang; Lan, Ting; Liu, Yang; Zhao, Yu; Lai, Liangxue; Fan, Nana] Hainan Prov Res Ctr Lab Anim, Sanya Inst Swine Resource, Sanya, Peoples R China; [Li, Yingying; Wang, Hai; Chen, Huangyao; Gou, Shixue; Zhuang, Zhenpeng; Li, Hao; Wang, Jiaowei; Suo, Yangyang; Lan, Ting; Liu, Yang; Zhao, Yu; Lai, Liangxue; Fan, Nana] Chinese Acad Med Sci 2019RU015, Res Unit Generat Large Anim Dis Models, Guangzhou, Peoples R China; [Li, Yingying; Wang, Hai; Chen, Huangyao; Gou, Shixue; Zhuang, Zhenpeng; Li, Hao; Wang, Jiaowei; Suo, Yangyang; Lan, Ting; Liu, Yang; Zhao, Yu; Lai, Liangxue; Wu, Donghai; Fan, Nana] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China; [Liao, Yuan] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Peoples R China; [Zou, Qingjian; Lai, Liangxue] Wuyi Univ, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen, Peoples R China; [Hui, Xiaoyan] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Anhui University; Wuyi University; Chinese University of Hong Kong	Wu, DH; Fan, NN (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Rd,Guangzhou Sci Pk, Guangzhou, Peoples R China.	wu_donghai@gibh.ac.cn; fan_nana@gibh.ac.cn	HUI, Xiaoyan Hannah/M-5175-2019; gou, shixue/HDN-8173-2022	HUI, Xiaoyan Hannah/0000-0002-7525-5812; 	GDSTC | Science and Technology Planning Project of Guangdong Province (S&T Project of Guangdong Province) [2017A050501059, 2020B1212060052, 2021B1212040016, 2020A1515110213]; MOST | National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research) [2017YFA0105103]; Chinese Academy of Sciences [KFJ-BRP-017-57, XDA16030503]; Key Research & Development Program of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory) [2018GZR110105019, 2018GZR110104004]; Science and Technology Program of Guangzhou, China [202007030003]; Chinese Academy of Medical Sciences [2019-I2 M-5-025]; Research Program of Sanya Yazhou Bay Science and Technology City [202002011]	GDSTC | Science and Technology Planning Project of Guangdong Province (S&T Project of Guangdong Province); MOST | National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research & Development Program of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory); Science and Technology Program of Guangzhou, China; Chinese Academy of Medical Sciences; Research Program of Sanya Yazhou Bay Science and Technology City	GDSTC | Science and Technology Planning Project of Guangdong Province (S&T Project of Guangdong Province), Grant/Award Number: 2017A050501059, 2020B1212060052, 2021B1212040016 and 2020A1515110213; MOST | National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research), Grant/Award Number: 2017YFA0105103; Chinese Academy of Sciences, Grant/Award Number: KFJ--BRP-017--57 and XDA16030503; the Key Research & Development Program of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Grant/Award Number: 2018GZR110105019 and 2018GZR110104004; the Science and Technology Program of Guangzhou, China, Grant/Award Number: 202007030003; the 2020 Research Program of Sanya Yazhou Bay Science and Technology City, Grant/Award Number: 202002011; Chinese Academy of Medical Sciences, Grant/Award Number: 2019-I2 M-5-025	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Aouadi M, 2014, AM J PHYSIOL-ENDOC M, V307, pE374, DOI 10.1152/ajpendo.00187.2014; Arslanian KJ, 2021, INT J OBESITY, V45, P45, DOI 10.1038/s41366-020-00659-4; Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Audas TE, 2016, EUR J CELL BIOL, V95, P611, DOI 10.1016/j.ejcb.2016.10.006; Bakhti M, 2019, NAT REV ENDOCRINOL, V15, P155, DOI 10.1038/s41574-018-0132-z; Berry SD, 2018, INT J OBESITY, V42, P603, DOI 10.1038/ijo.2017.230; Boden G, 2001, Endocr Pract, V7, P44; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Burden HJ, 2021, DIABETOLOGIA, V64, P2779, DOI 10.1007/s00125-021-05552-x; Cancello R, 2013, OBESITY, V21, P2562, DOI 10.1002/oby.20417; Carlson JC, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23414; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Dufrane D, 2005, PANCREAS, V30, P138, DOI 10.1097/01.mpa.0000147083.62501.4e; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Frahm KA, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa163; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hanson RL, 2019, DIABETOLOGIA, V62, P1647, DOI 10.1007/s00125-019-4932-z; Hawley NL, 2020, JMIR RES PROTOC, V9, DOI 10.2196/17329; Hoang DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110384; Kang JD, 2017, ONCOTARGET, V8, P115480, DOI 10.18632/oncotarget.23301; Kanshana JS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251895; Kim S, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186213; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Krishnan M, 2020, DIABETOLOGIA, V63, P2169, DOI 10.1007/s00125-020-05202-8; Krishnan M, 2018, DIABETOLOGIA, V61, P1603, DOI 10.1007/s00125-018-4623-1; Lai LX, 2003, CLONING STEM CELLS, V5, P233, DOI 10.1089/153623003772032754; Lee K, 2022, MOL METAB, V59, DOI 10.1016/j.molmet.2022.101464; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu JJ, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101167; Loos RJF, 2016, NAT GENET, V48, P976, DOI 10.1038/ng.3653; Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martyn AC, 2012, MOL CELL BIOL, V32, P5140, DOI 10.1128/MCB.01142-12; Metcalfe LK, 2020, INT J OBESITY, V44, P748, DOI 10.1038/s41366-019-0437-6; Minster RL, 2016, NAT GENET, V48, P1049, DOI 10.1038/ng.3620; Muhammad L J, 2020, SN Comput Sci, V1, P240, DOI 10.1007/s42979-020-00250-8; Naka I, 2017, J HUM GENET, V62, P847, DOI 10.1038/jhg.2017.44; Neeland IJ, 2019, LANCET DIABETES ENDO, V7, P715, DOI 10.1016/S2213-8587(19)30084-1; Newsholme P, 2016, BIOCHEM J, V473, P4527, DOI 10.1042/BCJ20160503C; Ohashi J, 2018, ANN HUM BIOL, V45, P215, DOI 10.1080/03014460.2018.1461928; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Renner S, 2020, CELL TISSUE RES, V380, P341, DOI 10.1007/s00441-019-03158-9; Renner S, 2016, THERIOGENOLOGY, V86, P406, DOI 10.1016/j.theriogenology.2016.04.055; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Sheets TP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22050-0; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stinkens R, 2015, OBES REV, V16, P715, DOI 10.1111/obr.12298; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Toplak H, 2016, WIEN KLIN WOCHENSCHR, V128, pS196, DOI 10.1007/s00508-016-0986-9; Tsikas D, 2017, ANAL BIOCHEM, V524, P13, DOI 10.1016/j.ab.2016.10.021; Unger RH, 2005, BIOCHIMIE, V87, P57, DOI 10.1016/j.biochi.2004.11.014; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wong NKP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071903; Xiong M, 2011, ACTA OTO-LARYNGOL, V131, P914, DOI 10.3109/00016489.2011.577448; Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446; Xue H, 2016, INT J ONCOL, V49, P519, DOI 10.3892/ijo.2016.3576; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Yaghootkar H, 2016, DIABETES, V65, P2448, DOI 10.2337/db15-1671; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250; Zettler S, 2020, ANIM REPROD, V17, DOI [10.1590/1984-3143-AR2020-0064, 10.1590/1984-3143-ar2020-0064]; Zhang L, 2019, ISCIENCE, V19, P162, DOI 10.1016/j.isci.2019.07.025; Zheng QT, 2017, P NATL ACAD SCI USA, V114, pE9474, DOI 10.1073/pnas.1707853114; Zhu CP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05029	71	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22611	10.1096/fj.202201117	http://dx.doi.org/10.1096/fj.202201117			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0PL	36250915				2022-12-28	WOS:000868749400001
J	Zhao, BW; Huang, JQ; Lou, XT; Yao, K; Ye, M; Mou, QX; Wen, Z; Duan, QM; Zhang, H; Zhao, Y				Zhao, Bowen; Huang, Jingqiu; Lou, Xiaotong; Yao, Ke; Ye, Meng; Mou, Qianxue; Wen, Zheng; Duan, Qiming; Zhang, Hong; Zhao, Yin			Endothelial CYP2J2 overexpression restores the BRB via METTL3-mediated ANXA1 upregulation	FASEB JOURNAL			English	Article						ANXA1; BRB; endothelial junctions; vascular development; vascular integrity	GROWTH-FACTOR EXPRESSION; NEURODEGENERATIVE DISEASES; NEUROVASCULAR UNIT; BARRIER FUNCTION; CELL JUNCTIONS; VE-CADHERIN; PROTEIN; PERMEABILITY; INTEGRITY; ACTIN	Blood-retinal barrier (BRB) breakdown is responsible for multiple ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive diseases. Increased vascular permeability contributes to vasogenic edema and tissue damage, with consequent adverse effects on vision. Herein, we found that endothelial CYP2J2 overexpression maintained BRB integrity after ischemia-reperfusion injury and consequently protected against retinal ganglion cell loss. Oxidative stress repressed endothelial ANXA1 expression in vivo and in vitro. CYP2J2 upregulated methyltransferase-like 3 (METTL3) expression and hence promoted ANXA1 translation via ANXA1 m(6)A modification in endothelium under oxidative stress. CYP2J2 maintained the distribution of endothelial tight junctions and adherens junctions in an ANXA1-dependent manner. Endothelial ANXA1 plays an indispensable role in vascular homeostasis and stabilization during development. Endothelial ANXA1 deletion disrupted retinal vascular perfusion as well as BRB integrity. CYP2J2 metabolites restored BRB integrity in the presence of ANXA1. Our findings identified the CYP2J2-METTL3-ANXA1 pathway as a potential therapeutic target for relieving BRB impairments.	[Zhao, Bowen; Lou, Xiaotong; Yao, Ke; Ye, Meng; Mou, Qianxue; Zhang, Hong; Zhao, Yin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430030, Peoples R China; [Huang, Jingqiu] Wuhan Univ, Dept Ophthalmol, Zhongnan Hosp, Wuhan, Peoples R China; [Wen, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China; [Duan, Qiming] Gladstone Inst, San Francisco, CA USA	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology; University of California System; University of California San Francisco; The J David Gladstone Institutes	Zhang, H; Zhao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430030, Peoples R China.	tjyksys@163.com; zhaoyin85@hust.edu.cn	wen, zheng/HII-3705-2022		National Natural Science Foundation of China [82070965]; Tongji Hospital (HUST) Foundation for Excellent Young Scientist [2020YQ18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tongji Hospital (HUST) Foundation for Excellent Young Scientist	The current study was supported by funding from the National Natural Science Foundation of China (grant no. 31800868) and Tongji Hospital (HUST) Foundation for Excellent Young Scientist (grant no. 2020YQ18 to Dr. Yin Zhao), and the National Natural Science Foundation of China (grant no. 82070965 to Dr. Hong Zhang).	Aliwarga T, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8060144; Amadio M, 2012, MOL VIS, V18, P2153; An YY, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01500-4; Antonetti DA, 2021, NAT REV ENDOCRINOL, V17, P195, DOI 10.1038/s41574-020-00451-4; Baker DJ, 2018, J CLIN INVEST, V128, P1208, DOI 10.1172/JCI95145; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006; Cao J, 2021, REDOX BIOL, V45, DOI 10.1016/j.redox.2021.102031; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Claesson-Welsh L, 2021, TRENDS MOL MED, V27, P314, DOI 10.1016/j.molmed.2020.11.006; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Csortos C, 2007, AM J PHYSIOL-LUNG C, V293, pL843, DOI 10.1152/ajplung.00120.2007; Curtis TM, 2018, JOVE-J VIS EXP, DOI 10.3791/57944; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Delorme S, 2021, AM J CANCER RES, V11, P1600; Ding Y, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01891-w; Duplancic R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88101-1; Evangelista EA, 2018, DRUG METAB DISPOS, V46, P380, DOI 10.1124/dmd.117.078840; Geng HX, 2017, NEUROCHEM RES, V42, P2841, DOI 10.1007/s11064-017-2297-6; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Giurdanella G, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11010051; Giurdanella G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207528; Grant ZL, 2020, J CLIN INVEST, V130, P4235, DOI 10.1172/JCI127668; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Huang JQ, 2019, FASEB J, V33, P11194, DOI 10.1096/fj.201900756R; Hui QY, 2020, FREE RADICAL BIO MED, V146, P181, DOI 10.1016/j.freeradbiomed.2019.10.414; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ji LY, 2021, CELL MOL LIFE SCI, V78, P5977, DOI 10.1007/s00018-021-03893-9; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kida T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81482-3; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kulikauskas MR, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04033-z; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Lenard A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002126; Li XG, 2020, J CELL MOL MED, V24, P862, DOI 10.1111/jcmm.14796; Liu H, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.627110; Lou ZL, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8836058; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Minhas G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00444; Mukwaya A, 2021, EXP MOL MED, V53, P189, DOI 10.1038/s12276-021-00566-2; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Musch MW, 2006, AM J PHYSIOL-GASTR L, V290, pG222, DOI 10.1152/ajpgi.00301.2005; Park JC, 2017, AGING CELL, V16, P149, DOI 10.1111/acel.12530; Pellicani R, 2020, MATRIX BIOL, V87, P11, DOI 10.1016/j.matbio.2019.08.002; Ries M, 2021, BRAIN, V144, P1526, DOI 10.1093/brain/awab050; Segarra M, 2018, SCIENCE, V361, DOI 10.1126/science.aao2861; Sharma M, 2009, PROSTAG OTH LIPID M, V89, P43, DOI 10.1016/j.prostaglandins.2009.04.004; Tisi A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010064; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Wettschureck N, 2019, PHYSIOL REV, V99, P1467, DOI 10.1152/physrev.00037.2018; Williams JM, 2007, AM J PHYSIOL-RENAL, V293, pF501, DOI 10.1152/ajprenal.00131.2007; Xiang J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00864-9; Xu Q, 2017, FREE RADICAL BIO MED, V109, P84, DOI 10.1016/j.freeradbiomed.2017.03.004; Xu X, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02174-3; Yamazaki Y, 2016, STROKE, V47, P1068, DOI 10.1161/STROKEAHA.115.010835; Yang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12718; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang CZ, 2020, ONCOGENE, V39, P4507, DOI 10.1038/s41388-020-1303-7; Zhao QS, 2018, J MOL CELL CARDIOL, V123, P118, DOI 10.1016/j.yjmcc.2018.08.027; Zheng B, 2017, MOL THER, V25, P1279, DOI 10.1016/j.ymthe.2017.03.031; Zhuang MR, 2019, NUCLEIC ACIDS RES, V47, P4765, DOI 10.1093/nar/gkz157	68	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22619	10.1096/fj.202201061RR	http://dx.doi.org/10.1096/fj.202201061RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5M0IN	36269280				2022-12-28	WOS:000870790600001
J	Camy, C; Brioche, T; Senni, K; Bertaud, A; Genovesio, C; Lamy, E; Fovet, T; Chopard, A; Pithioux, M; Roffino, S				Camy, Claire; Brioche, Thomas; Senni, Karim; Bertaud, Alexandrine; Genovesio, Cecile; Lamy, Edouard; Fovet, Theo; Chopard, Angele; Pithioux, Martine; Roffino, Sandrine			Effects of hindlimb unloading and subsequent reloading on the structure and mechanical properties of Achilles tendon-to-bone attachment	FASEB JOURNAL			English	Article						Achilles tendon enthesis; collagen II; fibrocartilage; hindlimb suspension; mechanical properties; reloading	SIMULATED MICROGRAVITY; NUCLEUS PULPOSUS; TAIL SUSPENSION; ENTHESIS; STRAIN; COLLAGEN; MUSCLE; DISUSE; FIBROCARTILAGE; PROTEOGLYCANS	While muscle and bone adaptations to deconditioning have been widely described, few studies have focused on the tendon enthesis. Our study examined the effects of mechanical loading on the structure and mechanical properties of the Achilles tendon enthesis. We assessed the fibrocartilage surface area, the organization of collagen, the expression of collagen II, the presence of osteoclasts, and the tensile properties of the mouse enthesis both after 14 days of hindlimb suspension (HU) and after a subsequent 6 days of reloading. Although soleus atrophy was severe after HU, calcified fibrocartilage (CFc) was a little affected. In contrast, we observed a decrease in non-calcified fibrocartilage (UFc) surface area, collagen fiber disorganization, modification of morphological characteristics of the fibrocartilage cells, and altered collagen II distribution. Compared to the control group, restoring normal loads increased both UFc surface area and expression of collagen II, and led to a crimp pattern in collagen. Reloading induced an increase in CFc surface area, probably due to the mineralization front advancing toward the tendon. Functionally, unloading resulted in decreased enthesis stiffness and a shift in site of failure from the osteochondral interface to the bone, whereas 6 days of reloading restored the original elastic properties and site of failure. In the context of spaceflight, our results suggest that care must be taken when performing countermeasure exercises both during missions and during the return to Earth.	[Camy, Claire; Lamy, Edouard; Pithioux, Martine; Roffino, Sandrine] Aix Marseille Univ, Inst Movement Sci, ISM, CNRS, Marseille, France; [Brioche, Thomas; Fovet, Theo; Chopard, Angele] Montpellier Univ, INRAE, DMEM, UMR 866, Montpellier, France; [Senni, Karim] Ecole Biol Ind EBI, Lab EBInnov, Cergy, France; [Bertaud, Alexandrine] Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France; [Bertaud, Alexandrine; Genovesio, Cecile; Lamy, Edouard] Fac Pharm Marseille, Lab Biochim, Marseille, France; [Pithioux, Martine] Aix Marseille Univ, St Marguerite Hosp, AP HM, ISM,Inst Locomot,Dept Orthopaed & Traumatol,CNRS, Marseille, France; [Pithioux, Martine; Roffino, Sandrine] Aix Marseille Univ, AP HM, CNRS, Cent Marseille,ISM,Mecahio Platform,Anat Lab, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Roffino, S (corresponding author), Inst Sci Mouvement, UMR 7287, Parc Sci & Technol Luminy 163,Ave Luminy, F-13288 Marseille 09, France.	sandrine.roffino@univ-amu.fr		CAMY, Claire/0000-0002-3691-8193	Centre National d'Etudes Spatiales (CNES) [4800000797]	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	Centre National d'Etudes Spatiales (CNES), Grant/Award Number: 4800000797	Abraham AC, 2022, J ORTHOP RES, V40, P977, DOI 10.1002/jor.25113; Almeida-Silveira MI, 2000, EUR J APPL PHYSIOL, V81, P252; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; BENJAMIN M, 1992, J ANAT, V180, P327; BENJAMIN M, 1990, J ANAT, V171, P1; BEST TM, 1993, J ORTHOP RES, V11, P897, DOI 10.1002/jor.1100110617; Bloomfield SA, 2016, COMPR PHYSIOL, V6, P645, DOI 10.1002/cphy.c130027; Campbell TM, 2021, J TISSUE ENG REGEN M, V15, P567, DOI 10.1002/term.3195; Chen S, 2017, CELL TISSUE RES, V370, P53, DOI 10.1007/s00441-017-2613-0; Chimenti RL, 2017, J ORTHOP RES, V35, P910, DOI 10.1002/jor.23338; Chimenti RL, 2016, J BIOMECH, V49, P39, DOI 10.1016/j.jbiomech.2015.11.008; Cury DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153568; Deymier AC, 2020, BONE, V131, DOI 10.1016/j.bone.2019.115152; Deymier AC, 2019, ACTA BIOMATER, V83, P302, DOI 10.1016/j.actbio.2018.10.024; Eisner LE, 2022, J BIOMECH ENG-T ASME, V144, DOI 10.1115/1.4053086; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Franchi M, 2013, CONNECT TISSUE RES, V54, P267, DOI 10.3109/03008207.2013.807808; Friese N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155177; Frizziero A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-20; FROWEN P, 1995, J ANAT, V186, P417; Gao YF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00235; Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043; Gerbaix M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00746; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Golman M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi5584; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Hutton WC, 2002, SPINE, V27, P1286, DOI 10.1097/00007632-200206150-00008; Iandolo D, 2021, CURR OSTEOPOROS REP, V19, P626, DOI 10.1007/s11914-021-00713-8; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jensen PT, 2018, J SHOULDER ELB SURG, V27, P739, DOI 10.1016/j.jse.2017.10.030; Juneja SC, 2013, ARTHRITIS, DOI 10.1155/2013/154812; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kannus P, 1996, J BONE MINER RES, V11, P79; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Knowles HJ, 2012, VIRCHOWS ARCH, V461, P205, DOI 10.1007/s00428-012-1274-3; Koike Y, 2005, J ORTHOP RES, V23, P1433, DOI 10.1016/j.orthres.2005.02.015; Krause AR, 2020, NPJ MICROGRAVITY, V6, DOI 10.1038/s41526-020-00126-4; Kubo K, 2000, EUR J APPL PHYSIOL, V83, P463, DOI 10.1007/s004210000309; Kwok AT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90010-2; Lang T, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0013-0; Leyden J, 2019, REGENERATIVE MEDICINE AND PLASTIC SURGERY: SKIN AND SOFT TISSUE, BONE, CARTILAGE, MUSCLE, TENDON AND NERVES, P355, DOI 10.1007/978-3-030-19962-3_25; Lyman J, 2004, AM J SPORT MED, V32, P457, DOI 10.1177/0095399703258621; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Maganaris CN, 2004, SPORTS MED, V34, P1005, DOI 10.2165/00007256-200434140-00005; Matsumoto F, 2003, ARCH PHYS MED REHAB, V84, P662, DOI 10.1016/S0003-9993(03)04834-7; MINNS RJ, 1973, J BIOMECH, V6, P153, DOI 10.1016/0021-9290(73)90084-5; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mutsuzaki H, 2015, KNEE, V22, P469, DOI 10.1016/j.knee.2015.03.004; NAKAGAWA Y, 1989, EUR J APPL PHYSIOL O, V59, P239, DOI 10.1007/BF02386194; Perrier A, 2017, COMPOS PART A-APPL S, V102, P18, DOI 10.1016/j.compositesa.2017.07.018; Potter R, 2014, J BIOMECH, V47, P2314, DOI 10.1016/j.jbiomech.2014.04.036; Reeves ND, 2005, J APPL PHYSIOL, V98, P2278, DOI 10.1152/japplphysiol.01266.2004; Rigozzi S, 2009, J BIOMECH, V42, P1547, DOI 10.1016/j.jbiomech.2009.03.031; Roffino S, 2021, LIFE SCI SPACE RES, V29, P46, DOI 10.1016/j.lssr.2021.03.001; RUFAI A, 1995, J ORTHOP RES, V13, P585, DOI 10.1002/jor.1100130414; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2015, DEVELOPMENT, V142, P196, DOI 10.1242/dev.112714; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Shaw HM, 2007, SCAND J MED SCI SPOR, V17, P303, DOI 10.1111/j.1600-0838.2007.00689.x; Shen H, 2017, FASEB J, V31, P5466, DOI 10.1096/fj.201700320R; Sone T, 1998, BONE, V22, p155S, DOI 10.1016/S8756-3282(98)00004-0; Spiesz EM, 2018, ACTA BIOMATER, V70, P281, DOI 10.1016/j.actbio.2018.01.034; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; VAILAS AC, 1988, J APPL PHYSIOL, V65, P373, DOI 10.1152/jappl.1988.65.1.373; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Yasuoka H, 2007, SPINE, V32, pE734, DOI 10.1097/BRS.0b013e31815b7e51; Zheng PF, 2020, FUSION ENG DES, V161, DOI 10.1016/j.fusengdes.2020.112006	70	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22548	10.1096/fj.202200713R	http://dx.doi.org/10.1096/fj.202200713R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T8QA	36121701	Green Submitted			2022-12-28	WOS:000858373100001
J	Schoonderwoerd, RA; Gutierrez, PD; Blommers, R; van Beurden, AW; Coenen, TCJJ; Klett, NJ; Michel, SH; Meijer, JH				Schoonderwoerd, Robin A.; Gutierrez, Pablo de Torres; Blommers, Ruben; van Beurden, Anouk W.; Coenen, Tineke C. J. J.; Klett, Nathan J.; Michel, Stephan H.; Meijer, Johanna H.			Inhibitory responses to retinohypothalamic tract stimulation in the circadian clock of the diurnal rodent Rhabdomys pumilio	FASEB JOURNAL			English	Article						calcium imaging; diurnality; GABA; glutamate; suprachiasmatic nucleus	4-STRIPED FIELD-MOUSE; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; OPTIC CHIASM; LIGHT; NEURONS; RHYTHM; MELATONIN; MASKING; HAMSTER	In both diurnal and nocturnal mammals, the timing of activity is regulated by the central circadian clock of the suprachiasmatic nucleus (SCN). The SCN is synchronized to the external light cycle via the retinohypothalamic tract (RHT). To investigate potential differences in light processing between nocturnal mice and the diurnal rodent Rhabdomys pumilio, we mimicked retinal input by stimulation of the RHT ex vivo. Using Ca2+ imaging, we observed excitations as well as inhibitions of SCN neurons in response to electrical RHT stimulation. In mice, the vast majority of responses were excitatory (85%), whereas in Rhabdomys, the proportion of excitatory and inhibitory responses was similar (51% excitatory, 49% inhibitory). Glutamate blockers AP5 and CNQX blocked the excitatory responses to RHT stimulation but did not abolish the inhibitory responses in mice or Rhabdomys, indicating that the inhibitions were monosynaptically transmitted via the RHT. Simultaneous application of glutamate blockers with the GABA(A) antagonist gabazine blocked all inhibitory responses in mice, but not in Rhabdomys. Collectively, our results indicate that in Rhabdomys, considerably more inhibitory responses to light are present and that these responses are driven directly by the RHT. We propose that this increased proportion of inhibitory input could reflect a difference in the entrainment mechanism employed by diurnal rodents.	[Schoonderwoerd, Robin A.; Gutierrez, Pablo de Torres; Blommers, Ruben; van Beurden, Anouk W.; Klett, Nathan J.; Michel, Stephan H.; Meijer, Johanna H.] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands; [Coenen, Tineke C. J. J.] Leiden Univ, Cent Anim Facil, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Dept Neurophysiol, Med Ctr, NL-2333 ZC Leiden, Netherlands.	j.h.meijer@lumc.nl		de Torres Gutierrez, Pablo/0000-0002-8387-1885; van Beurden, Anouk/0000-0002-0551-0347	EC | European Research Council (ERC) [834513]; Velux Stiftung (Velux Foundation) [1131]	EC | European Research Council (ERC); Velux Stiftung (Velux Foundation)	EC | European Research Council (ERC), Grant/Award Number: 834513; Velux Stiftung (Velux Foundation), Grant/ Award Number: 1131	Bano-Otalora B, 2021, ELIFE, V10, DOI [10.7554/eLife.68179, 10.7554/eLife.68179.sa1, 10.7554/eLife.68179.sa2]; Bano-Otalora B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100094118; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Choi HJ, 2008, J NEUROSCI, V28, P5450, DOI 10.1523/JNEUROSCI.5750-07.2008; DEVRIES MJ, 1994, BRAIN RES, V642, P206, DOI 10.1016/0006-8993(94)90923-7; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Irwin RP, 2010, EUR J NEUROSCI, V32, P1497, DOI 10.1111/j.1460-9568.2010.07411.x; Irwin RP, 2009, EUR J NEUROSCI, V30, P1462, DOI 10.1111/j.1460-9568.2009.06944.x; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jiao YY, 1999, BRAIN RES, V817, P93, DOI 10.1016/S0006-8993(98)01218-9; Jiao YY, 2003, BRAIN RES, V960, P142, DOI 10.1016/S0006-8993(02)03804-0; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Kiessling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092959; Li XD, 2005, J COMP PHYSIOL A, V191, P23, DOI 10.1007/s00359-004-0569-5; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; MEIJER JH, 1989, BRAIN RES, V501, P315, DOI 10.1016/0006-8993(89)90648-3; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Michel S, 2013, EUR J NEUROSCI, V37, P964, DOI 10.1111/ejn.12109; Moldavan MG, 2013, J PHYSIOL-LONDON, V591, P2475, DOI 10.1113/jphysiol.2012.248047; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Rahman SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54806-7; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; SATO T, 1984, Neuroscience Research, V1, P45, DOI 10.1016/0168-0102(84)90029-4; Schoonderwoerd RA, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2118803119; Schumann DM, 2006, BRAIN RES BULL, V70, P270, DOI 10.1016/j.brainresbull.2006.04.009; Schumann DM, 2005, PHYSIOL BEHAV, V85, P231, DOI 10.1016/j.physbeh.2005.03.024; SCHWARTZ WJ, 1983, BRAIN RES, V274, P184, DOI 10.1016/0006-8993(83)90538-3; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SHIBATA S, 1993, BRAIN RES, V615, P95, DOI 10.1016/0006-8993(93)91118-C; Shuboni DD, 2012, J BIOL RHYTHM, V27, P299, DOI 10.1177/0748730412449723; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Sonoda T, 2020, SCIENCE, V368, P527, DOI 10.1126/science.aay3152; Valenzuela FJ, 2008, ENDOCRINOLOGY, V149, P1454, DOI 10.1210/en.2007-1518; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yan L, 2020, EUR J NEUROSCI, V51, P551, DOI 10.1111/ejn.14172; ZUCKER I, 1983, AM J PHYSIOL, V244, pR472, DOI 10.1152/ajpregu.1983.244.4.R472	41	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22415	10.1096/fj.202200477R	http://dx.doi.org/10.1096/fj.202200477R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3C6WU	35867045	hybrid, Green Published			2022-12-28	WOS:000828762800001
J	Jonsson, WO; Mirek, ET; Wek, RC; Anthony, TG				Jonsson, William O.; Mirek, Emily T.; Wek, Ronald C.; Anthony, Tracy G.			Activation and execution of the hepatic integrated stress response by dietary essential amino acid deprivation is amino acid specific	FASEB JOURNAL			English	Article						dietary restriction; feeding; mammalian; polysomes; postprandial period; protein synthesis	LIVER PROTEIN-SYNTHESIS; TRANSFER-RNA; MTORC1; KINASE; GCN2; PHOSPHORYLATION; METABOLISM; METHIONINE; LEUCINE; GROWTH	Dietary removal of an essential amino acid (EAA) triggers the integrated stress response (ISR) in liver. Herein, we explored the mechanisms that activate the ISR and execute changes in transcription and translation according to the missing EAA. Wild-type mice and mice lacking general control nonderepressible 2 (Gcn2) were fed an amino acid complete diet or a diet devoid of either leucine or sulfur amino acids (methionine and cysteine). Serum and liver leucine concentrations were significantly reduced within the first 6 h of feeding a diet lacking leucine, corresponding with modest, GCN2-dependent increases in Atf4 mRNA translation and induction of selected ISR target genes (Fgf21, Slc7a5, Slc7a11). In contrast, dietary removal of the sulfur amino acids lowered serum methionine, but not intracellular methionine, and yet hepatic mRNA abundance of Atf4, Fgf21, Slc7a5, Slc7a11 substantially increased regardless of GCN2 status. Liver tRNA charging levels did not correlate with intracellular EAA concentrations or GCN2 status and remained similar to mice fed a complete diet. Furthermore, loss of Gcn2 increased the occurrence of ribosome collisions in liver and derepressed mechanistic target of rapamycin complex 1 signal transduction, but these changes did not influence execution of the ISR. We conclude that ISR activation is directed by intracellular EAA concentrations, but ISR execution is not. Furthermore, a diet devoid of sulfur amino acids does not require GCN2 for the ISR to execute changes to the transcriptome.	[Jonsson, William O.; Mirek, Emily T.; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Jersey Inst Food Nutr & Hlth, 59 Dudley Rd Foran Hall,Room 166, New Brunswick, NJ 08901 USA; [Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Rutgers State University New Brunswick; Indiana University System; Indiana University Bloomington	Anthony, TG (corresponding author), Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Jersey Inst Food Nutr & Hlth, 59 Dudley Rd Foran Hall,Room 166, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu	Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884	HHS | National Institutes of Health (NIH) [DK109714]; Rutgers Center for Lipid Research; USDA | National Institute of Food and Agriculture (NIFA) [NC1184]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Center for Lipid Research; USDA | National Institute of Food and Agriculture (NIFA)	HHS | National Institutes of Health (NIH), Grant/Award Number: DK109714; Rutgers Center for Lipid Research; USDA | National Institute of Food and Agriculture (NIFA), Grant/Award Number: NC1184	Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Arpat AB, 2020, GENOME RES, V30, P985, DOI 10.1101/gr.257741.119; Athey J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1793-7; Ball RO, 2006, J NUTR, V136, p1682S, DOI 10.1093/jn/136.6.1682S; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI 10.1177/0271678X20943823; Dunkler D, 2020, TRANSPL INT, V33, P50, DOI 10.1111/tri.13535; Evans ME, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx514; Fox J., 2019, R COMPANION APPL REG, V.; Girstmair H, 2013, CELL REP, V3, P148, DOI 10.1016/j.celrep.2012.12.019; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Gu YC, 2017, MOL CELL, V67, P128, DOI 10.1016/j.molcel.2017.05.030; He HZ, 2014, J BIOL CHEM, V289, P15023, DOI 10.1074/jbc.M114.560789; Jakubek R. S., 2022, LPI CONTRIBUTIONS, V2678; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jonsson WO, 2021, J NUTR, V151, P785, DOI [10.1093/jn/nxaa396.785, 10.1093/jn/nxaa396]; Kassambara A, 2019, GGPUBR GGPLOT2 BASED; Kassambara A., 2021, RSTATIX PIPE FRIENDL; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Lees EK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10381-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Svenningsen S, 2017, NUCLEIC ACIDS RES, V45, P793, DOI 10.1093/nar/gkw1169; Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mazor KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26254-2; Meng DL, 2020, J BIOL CHEM, V295, P2890, DOI 10.1074/jbc.AC119.011578; Meyer KD, 2019, BBA-GENE REGUL MECH, V1862, P301, DOI 10.1016/j.bbagrm.2018.10.006; Misra J., 2021, NUCLEIC ACIDS RES, V18, P1, DOI [10.1093/nar/gkab362/6281481, DOI 10.1093/NAR/GKAB362/6281481]; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nikonorova IA, 2018, J BIOL CHEM, V293, P5005, DOI 10.1074/jbc.RA117.001625; ORENTREICH N, 1993, J NUTR, V123, P269; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pavlova NN., 2020, ELIFE, V9, P1; Pavlova NN., 2021, TRNA CHARGING ASSAY; Pettit AP, 2017, J NUTR, V147, P1031, DOI 10.3945/jn.116.246710; R Core Team, 2020, R LANG ENV STAT COMP; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; RStudio Team, 2020, INT DEV R; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scalise M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00243; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9; Torrence ME, 2021, ELIFE, V10, DOI 10.7554/eLife.63326; Welles JE, 2020, AM J PHYSIOL-ENDOC M, V319, pE26, DOI 10.1152/ajpendo.00555.2019; Wilson GJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE283, DOI 10.1152/ajpendo.00361.2014; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wu CCC, 2020, CELL, V182, P404, DOI 10.1016/j.cell.2020.06.006; Yamaguchi I, 2020, J BIOL CHEM, V295, P6936, DOI 10.1074/jbc.RA119.012213; Yap YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16568-z; Yu DY, 2018, FASEB J, V32, P3471, DOI 10.1096/fj.201701211R; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	62	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22396	10.1096/fj.202200204RR	http://dx.doi.org/10.1096/fj.202200204RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2A6BM	35690926	Green Published			2022-12-28	WOS:000809585200001
J	Lu, ZP; Xiao, S; Chen, WW; Zhu, RK; Yang, H; Steinhoff, M; Li, YQ; Cheng, WK; Yan, XR; Li, LL; Xue, SH; Larkin, C; Zhang, WH; Fan, QQ; Wang, RZ; Wang, JF; Meng, JH				Lu, Zhiping; Xiao, Song; Chen, Weiwei; Zhu, Renkai; Yang, Hua; Steinhoff, Martin; Li, Yanqing; Cheng, Wenke; Yan, Xinrong; Li, Lianlian; Xue, Shanghai; Larkin, Ciara; Zhang, Wenhao; Fan, Qianqian; Wang, Ruizhen; Wang, Jiafu; Meng, Jianghui			IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis	FASEB JOURNAL			English	Article						atopic dermatitis; cytokine; IL-13; IL-13R alpha 1; IL-13R alpha 2; IL-20; toll-like receptor	T-CELLS; SKIN; EXPRESSION; RECEPTORS; KERATINOCYTES; INTERLEUKIN-20; CYTOKINES; DISEASE; ROLES; DIFFERENTIATION	Atopic dermatitis (AD) is a chronic skin disease, which is associated with intense itch, skin barrier dysfunction and eczematous lesions. Aberrant IL-20 expression has been implicated in numerous inflammatory diseases, including psoriasis. However, the role of IL-20 in AD remains unknown. Here, RNA-seq, Q-PCR, and immunocytochemistry were utilized to examine disease-driven changes of IL-20 and its cognate receptor subunits in skin from healthy human subjects, AD patients and murine AD-models. Calcium imaging, knockdown and cytokine array were used to investigate IL-20-evoked responses in keratinocytes and sensory neurons. The murine cheek model and behavioral scoring were employed to evaluate IL-20-elicited sensations in vivo. We found that transcripts and protein of IL-20 were upregulated in skin from human AD and murine AD-like models. Topical MC903 treatment in mice ear enhanced IL-20R1 expression in the trigeminal sensory ganglia, suggesting a lesion-associated and epidermal-driven mechanism for sensitization of sensory IL-20 signaling. IL-20 triggered calcium influx in both keratinocytes and sensory neurons, and promoted their AD-related molecule release and transcription of itch-related genes. In sensory neurons, IL-20 application increased TLR2 transcripts, implicating a link between innate immune response and IL-20. In a murine cheek model of acute itch, intradermal injection IL-20 and IL-13 elicited significant itch-like behavior, though only when co-injected. Our findings provide novel insights into IL-20 function in peripheral (skin-derived) itch and clinically relevant intercellular neuron-epidermal communication, highlighting a role of IL-20 signaling in the pathophysiology of AD, thus forming a new basis for the development of a novel antipruritic strategy via interrupting IL-20 epidermal pathways.	[Lu, Zhiping; Xiao, Song; Chen, Weiwei; Zhu, Renkai; Yang, Hua; Li, Yanqing; Cheng, Wenke; Yan, Xinrong; Li, Lianlian; Xue, Shanghai; Zhang, Wenhao; Fan, Qianqian; Wang, Ruizhen] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [Steinhoff, Martin] Hamad Med Corp, Dept Dermatol & Venereol, Doha, Qatar; [Steinhoff, Martin] Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar; [Steinhoff, Martin] Hamad Med Corp, Acad Hlth Syst, Inst Dermatol, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med Qatar, Dept Dermatol, Doha, Qatar; [Steinhoff, Martin] Qatar Univ, Coll Med, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med, Dept Dermatol, New York, NY USA; [Larkin, Ciara; Wang, Jiafu; Meng, Jianghui] Dublin City Univ, Sch Biotechnol, Fac Sci & Hlth, Dublin 9, Ireland; [Larkin, Ciara; Meng, Jianghui] Dublin City Univ, Natl Inst Cellular Biotechnol, Fac Sci & Hlth, Dublin 9, Ireland	Henan University; Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University; Cornell University; Dublin City University; Dublin City University	Wang, JF (corresponding author), Dublin City Univ, Sch Biotechnol, Fac Sci & Hlth, Dublin 9, Ireland.; Meng, JH (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Fac Sci & Hlth, Dublin 9, Ireland.	Jiafu.wang@dcu.ie; Jianghui.meng@dcu.ie		Meng, Jianghui/0000-0002-3107-4200; Yang, Hua/0000-0002-3370-6726; Wang, Jiafu/0000-0002-3654-4400; xiao, song/0000-0003-2254-9486	Henan University via the Double-First Class Project Program; Science Foundation Ireland [15/SIRG/3508T, 13/CDA/2093]; Type 2 innovation grant from Sanofi Genzyme	Henan University via the Double-First Class Project Program; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Type 2 innovation grant from Sanofi Genzyme	This work is supported by Henan University via the Double-First Class Project Program, and Science Foundation Ireland (15/SIRG/3508T and 13/CDA/2093) and a Type 2 innovation grant from Sanofi Genzyme to JM.	ANAND P, 1991, BRIT J DERMATOL, V124, P547, DOI 10.1111/j.1365-2133.1991.tb04948.x; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2020, ALLERGY, V75, P54, DOI 10.1111/all.13954; Bitton A, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2938; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bodoor K, 2020, CLIN COSMET INV DERM, V13, P419, DOI 10.2147/CCID.S257647; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Brunner PM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09207-z; Cepelak I, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.020501; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Chen JL, 2020, INT J MOL MED, V46, P880, DOI 10.3892/ijmm.2020.4630; Cornelissen C, 2012, J ALLERGY CLIN IMMUN, V129, P426, DOI 10.1016/j.jaci.2011.10.042; Dai XJ, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165719; Datsi A, 2021, ALLERGY, V76, P2982, DOI 10.1111/all.14791; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Drislane C, 2020, ANN ALLERG ASTHMA IM, V124, P36, DOI 10.1016/j.anai.2019.10.008; Ewald DA, 2017, J ALLERGY CLIN IMMUN, V139, P562, DOI 10.1016/j.jaci.2016.08.029; Georgila K, 2019, CANCERS, V11, DOI 10.3390/cancers11081097; Green D, 2016, J CELL BIOL, V213, P155, DOI 10.1083/jcb.201603042; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Ikoma Akihiko, 2006, Nihon Yakurigaku Zasshi, V128, P411; Ishibashi Y, 2006, FEMS IMMUNOL MED MIC, V48, P400, DOI 10.1111/j.1574-695X.2006.00163.x; Jiang HW, 2019, BRAIN BEHAV IMMUN, V80, P464, DOI 10.1016/j.bbi.2019.04.026; Kasperska-Zajac A, 2005, INFLAMMATION, V29, P90, DOI 10.1007/s10753-006-9004-0; Kimura T, 2014, ACTA DERM-VENEREOL, V94, P331, DOI 10.2340/00015555-1709; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Larkin C, 2021, J ALLERGY CLIN IMMUN, V147, P1110, DOI 10.1016/j.jaci.2020.09.028; Lebre MC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4038; Logsdon NJ, 2012, P NATL ACAD SCI USA, V109, P12704, DOI 10.1073/pnas.1117551109; Meng J, 2016, CURR RES TRANSL MED, V64, P203, DOI 10.1016/j.retram.2016.08.006; Meng JH, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.696784; Meng JH, 2019, J INVEST DERMATOL, V139, P2324, DOI 10.1016/j.jid.2019.04.017; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Moraes-Vieira PM, 2020, P NATL ACAD SCI USA, V117, P31309, DOI 10.1073/pnas.2013877117; Niess JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01373; Noske K, 2018, J DERMATOL SCI, V89, P3, DOI 10.1016/j.jdermsci.2017.10.008; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Oh MH, 2013, J IMMUNOL, V191, P5371, DOI 10.4049/jimmunol.1300300; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Piipponen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228790; PINCELLI C, 1990, BRIT J DERMATOL, V122, P745, DOI 10.1111/j.1365-2133.1990.tb06261.x; PINCELLI C, 1991, ARCH DERMATOL RES, V283, P230, DOI 10.1007/BF01106107; Purwar R, 2006, J INVEST DERMATOL, V126, P1043, DOI 10.1038/sj.jid.5700085; Rich BE, 2003, EXPERT OPIN THER TAR, V7, P165, DOI 10.1517/14728222.7.2.165; Rich BE, 2001, CURR BIOL, V11, pR531, DOI 10.1016/S0960-9822(01)00312-8; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2007, EXPERT OPIN THER TAR, V11, P601, DOI 10.1517/14728222.11.5.601; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Schafer PH, 2019, DRUGS R&D, V19, P329, DOI 10.1007/s40268-019-00284-1; Steinhoff M, 2018, LANCET NEUROL, V17, P709, DOI 10.1016/S1474-4422(18)30217-5; Szymanski L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205103; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Walsh CM, 2019, ELIFE, V8, DOI [10.7554/elife.48448, 10.7554/eLife.48448]; Wang F, 2006, J INVEST DERMATOL, V126, P1590, DOI 10.1038/sj.jid.5700310; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wang YM, 2016, EUR J IMMUNOL, V46, P552, DOI 10.1002/eji.201545917; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026; Xiao S, 2021, BRAIN BEHAV IMMUN, V98, P28, DOI 10.1016/j.bbi.2021.08.211; Yosipovitch G, 2013, DERMATOL THER, V26, P83, DOI 10.1111/dth.12033	67	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22334	10.1096/fj.202101800R	http://dx.doi.org/10.1096/fj.202101800R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0W6GP	35486004	Green Published			2022-12-28	WOS:000789122900001
J	Yan, JM; Liu, QH; Tang, Q; Zhang, JH; Jing, XD; Xia, Y; Xu, Y; Li, JH; Li, YP; He, JH				Yan, Jiamin; Liu, Qinhui; Tang, Qin; Zhang, Jinhang; Jing, Xiandan; Xia, Yan; Xu, Ying; Li, Jiahui; Li, Yanping; He, Jinhan			Mesencephalic astrocyte-derived neurotrophic factor alleviates non-alcoholic steatohepatitis induced by Western diet in mice	FASEB JOURNAL			English	Article						inflammation response; lipid accumulation; mesencephalic astrocyte-derived neurotrophic factor; non-alcoholic steatohepatitis; nuclear factor-kappa B; sterol regulatory element binding protein 1	NF-KAPPA-B; LIVER-INJURY; MANF; INFLAMMATION; METABOLISM	Excessive lipid accumulation, inflammation, and fibrosis in the liver are the major characteristics of non-alcoholic steatohepatitis (NASH). Mesencephalic astrocyte-derived neurotrophic factor (MANF) plays an important role in metabolic homeostasis, raising the possibility that it is involved in NASH. Here, we reduced and increased MANF levels in mice in order to explore its influence on hepatic triglyceride homeostasis, inflammation, and fibrosis during NASH progression. The MANF expression was decreased in Western diet-induced NASH mice. In vivo, liver-specific MANF knockout exacerbated hepatic lipid accumulation, inflammation, and fibrosis of mice induced by Western diet, while liver-specific MANF overexpression mitigated these NASH pathogenic features. In vitro, knocking down MANF in primary hepatocyte cultures aggravated hepatic steatosis and inflammation, which MANF overexpression markedly attenuated. Studies in vitro and in vivo suggested that MANF regulated hepatic lipid synthesis by modulating SREBP1 expression. Inhibiting SREBP1 in primary hepatocytes blocked lipid accumulation after MANF knockdown. MANF overexpression reversed LXRs agonist GW3965 induced SREBP1 and LIPIN1 expression. MANF decreased the expression of pro-inflammatory cytokines by inhibiting NF-kappa B phosphorylation. These results suggest that MANF can protect against NASH by regulating SREBP1 expression and NF-kappa B signaling.	[Yan, Jiamin; Zhang, Jinhang; Xia, Yan; Xu, Ying; Li, Jiahui; He, Jinhan] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Dept Pharm, Chengdu, Peoples R China; [Yan, Jiamin; Liu, Qinhui; Tang, Qin; Zhang, Jinhang; Jing, Xiandan; Xia, Yan; Xu, Ying; Li, Jiahui; Li, Yanping; He, Jinhan] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Clin Pharm & Adverse Drug React, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Li, YP; He, JH (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Clin Pharm & Adverse Drug React, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, Dept Pharm, West China Hosp, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	liyanping_512@163.com; jinhanhe@scu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [82025007, 81930020, 81873662, 81870599]; Sichuan Province [2021YJ0458]; West China Hospital of Sichuan University [2020HXBH095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province; West China Hospital of Sichuan University(Sichuan University)	National Natural Science Foundation of China, Grant/Award Number: 82025007, 81930020, 81873662 and 81870599; Research funding from Sichuan Province, Grant/Award Number: 2021YJ0458; Post--Doctor Research Project, West China Hospital of Sichuan University, Grant/Award Number: 2020HXBH095	Alkhouri N, 2012, J HEPATOL, V57, P1312, DOI 10.1016/j.jhep.2012.07.027; Azzu V, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101210; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bindesboll C, 2016, BIOCHEM J, V473, P899, DOI 10.1042/BJ20151077; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658; Danilova T, 2019, DIABETES, V68, P66, DOI 10.2337/db17-1149; Friedman SL, 2022, HEPATOLOGY, V75, P473, DOI 10.1002/hep.32285; Hall Z, 2017, HEPATOLOGY, V65, P1165, DOI 10.1002/hep.28953; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; He M, 2020, WORLD J GASTROENTERO, V26, P1029, DOI 10.3748/wjg.v26.i10.1029; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Huang CY, 2021, FREE RADICAL BIO MED, V169, P110, DOI 10.1016/j.freeradbiomed.2021.04.008; Jantti M, 2020, CELL TISSUE RES, V382, P83, DOI 10.1007/s00441-020-03263-0; Jin KP, 2020, THERANOSTICS, V10, P5290, DOI 10.7150/thno.42658; Kihira Y, 2020, MOL MED REP, V22, P559, DOI 10.3892/mmr.2020.11076; Kim Y, 2017, TRANSL RES, V188, P1, DOI 10.1016/j.trsl.2017.06.010; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Lim JO, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101626; Liu J, 2020, HEPATOLOGY, V71, P1262, DOI 10.1002/hep.30917; Liu W, 2022, DIABETES, V71, P60, DOI 10.2337/db21-0240; Ma XH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03762-0; Neuschwander-Tetri BA, 2020, GASTROENTEROLOGY, V158, P1984, DOI 10.1053/j.gastro.2020.01.051; Orlandi P, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14100995; Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178; Sato K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092180; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Sousa-Victor P, 2019, NAT METAB, V1, P276, DOI 10.1038/s42255-018-0023-6; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takahashi S, 2020, J BIOL CHEM, V295, P4733, DOI 10.1074/jbc.RA119.011913; Tang Q, 2022, TRENDS ENDOCRIN MET, V33, P236, DOI 10.1016/j.tem.2022.01.001; Tokushige K, 2021, J GASTROENTEROL, V56, P951, DOI 10.1007/s00535-021-01796-x; Voutilainen MH, 2015, FEBS LETT, V589, P3739, DOI 10.1016/j.febslet.2015.09.031; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang P, 2021, FREE RADICAL BIO MED, V162, P283, DOI 10.1016/j.freeradbiomed.2020.10.028; Wang XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091476; Wu T, 2021, J EXP MED, V218, DOI 10.1084/jem.20201203; Yagi T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101810; Yang W, 2014, J NEUROL SCI, V344, P129, DOI 10.1016/j.jns.2014.06.042; Yang Y, 2021, LIVER INT, V41, P623, DOI 10.1111/liv.14697; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yu XG, 2020, J PATHOL, V252, P358, DOI 10.1002/path.5530; Yu Y, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6467679; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhang GR, 2021, BIOCHEM BIOPH RES CO, V550, P197, DOI 10.1016/j.bbrc.2021.02.123; Zhao YC, 2022, HEPATOLOGY, V75, P939, DOI 10.1002/hep.32165	47	0	0	8	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22349	10.1096/fj.202101975R	http://dx.doi.org/10.1096/fj.202101975R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1F4UF	35567505				2022-12-28	WOS:000795164400001
J	Sabarwal, A; van Rooyen, JC; Caburet, J; Avgenikos, M; Dheeraj, A; Ali, M; Mishra, D; de Meester, JSB; Stander, S; van Otterlo, WAL; Kaschula, CH; Singh, RP				Sabarwal, Akash; van Rooyen, Jaco C.; Caburet, Jeremy; Avgenikos, Moscos; Dheeraj, Arpit; Ali, Mansoor; Mishra, Deepali; de Meester, Josephine S. B.; Stander, Saskia; van Otterlo, Willem A. L.; Kaschula, Catherine H.; Singh, Rana P.			A novel 4 '-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice	FASEB JOURNAL			English	Article						brominated derivative; fisetin; flavonol; hepatotoxicity; lung cancer; synthetic analogues	DIETARY FLAVONOID FISETIN; BIOLOGICAL EVALUATION; ANTICANCER ACTIVITY; ACTIVATION; PROLIFERATION; REQUIREMENTS; PURIFICATION; VIABILITY; REDUCTASE; PI3K/AKT	The therapeutic toxicity and resistance to currently available treatment options are major clinical challenges for the management of lung cancer. As a novel strategy, we synthesized analogues of a known flavonol, fisetin, which has shown anti-tumorigenic potential against cancer in cell culture with no adverse effects in animal models. We studied the synthetic analogues of fisetin for their anti-cancer potential against lung cancer cells, toxicity in mice and efficacy in a xenograft model. Brominated fisetin analogues were screened for their effects on the viability of A549 and H1299 lung cancer cells, and three analogues (3a, 3b, 3c), showed improved activity compared to fisetin. These analogues were more effective in restricting lung cancer cell proliferation, inducing G(2)M phase cell cycle arrest and apoptosis. The fisetin analogues also downregulated EGFR/ERK1/2/STAT3 pathways. Fisetin analogue-induced apoptosis was accompanied by a higher Bax to Bcl-2 expression ratio. Based on the in vitro studies, the most effective fisetin analogue 3b was evaluated for in vivo toxicity, wherein it did not show any hepatotoxicity or adverse health effects in mice. Furthermore, analogue 3b showed greater antitumor efficacy (p < .001) as compared to its parent compound fisetin in a human lung cancer cell xenograft study in athymic mice. Together, our data suggest that the novel fisetin analogue 3b is more effective in restricting lung cancer cell growth, both in vitro as well as in vivo, without any apparent toxicity, supporting its further development as a novel anti-lung cancer agent.	[Sabarwal, Akash; Dheeraj, Arpit; Ali, Mansoor; Mishra, Deepali; Singh, Rana P.] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi, India; [van Rooyen, Jaco C.; Caburet, Jeremy; Avgenikos, Moscos; de Meester, Josephine S. B.; Stander, Saskia; van Otterlo, Willem A. L.; Kaschula, Catherine H.] Stellenbosch Univ, Dept Chem & Polymer Sci, Matieland, South Africa; [Caburet, Jeremy] Univ Clermont Auvergne, Sigma Clermont, Aubiere, France; [de Meester, Josephine S. B.] Catholic Univ Louvain, Fac Sci, Louvain la Neuve, Belgium; [Singh, Rana P.] Jawaharlal Nehru Univ, Special Ctr Syst Med, New Delhi, India; [Sabarwal, Akash] Boston Childrens Hosp, Div Nephrol, Boston, MA USA; [Sabarwal, Akash] Harvard Med Sch, Boston, MA USA; [Dheeraj, Arpit] Oregon Hlth & Sci Univ, Arpit Dheeraj, Portland, OR USA; [Kaschula, Catherine H.] Stellenbosch Univ, Dept Chem & Polymer Sci, ZA-7800 Matieland, South Africa; [Singh, Rana P.] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi 11067, India	Jawaharlal Nehru University, New Delhi; Stellenbosch University; Universite Clermont Auvergne (UCA); Universite Catholique Louvain; Jawaharlal Nehru University, New Delhi; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Stellenbosch University; Jawaharlal Nehru University, New Delhi	Kaschula, CH (corresponding author), Stellenbosch Univ, Dept Chem & Polymer Sci, ZA-7800 Matieland, South Africa.; Singh, RP (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi 11067, India.	kaschula@sun.ac.za; rana_singh@mail.jnu.ac.in		Sabarwal, Akash/0000-0003-1760-4903; van Otterlo, Willem/0000-0002-3300-6463				Adhami VM, 2012, BIOCHEM PHARMACOL, V84, P1277, DOI 10.1016/j.bcp.2012.07.012; Ahn-Jarvis JH, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070202; Azad Adiba, 2018, J Clin Gastroenterol Hepatol, V2, DOI 10.21767/2575-7733.1000047; Bahirwani R, 2014, SEMIN LIVER DIS, V34, P162, DOI 10.1055/s-0034-1375957; Beutler JA, 1998, J MED CHEM, V41, P2333, DOI 10.1021/jm970842h; Bian CN, 2018, ONCOL LETT, V15, P9655, DOI 10.3892/ol.2018.8587; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Britton RG, 2012, EUR J MED CHEM, V54, P952, DOI 10.1016/j.ejmech.2012.06.031; Burmistrova O, 2014, EUR J MED CHEM, V84, P30, DOI 10.1016/j.ejmech.2014.07.010; Chang H, 2008, ARCH PHARM RES, V31, P1137, DOI 10.1007/s12272-001-1280-8; Chen CC, 2010, ONCOL REP, V23, P639, DOI 10.3892/or_00000679; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; Daskiewicz JB, 2005, J MED CHEM, V48, P2790, DOI 10.1021/jm040770b; Dias TA, 2013, EUR J MED CHEM, V65, P500, DOI 10.1016/j.ejmech.2013.04.064; Forbes AM, 2014, INT J ONCOL, V45, P831, DOI 10.3892/ijo.2014.2452; Gutierrez-Venegas G, 2014, J ASIAN NAT PROD RES, V16, P1009, DOI 10.1080/10286020.2014.932351; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kumar K, 2019, MITOCHONDRION, V48, P1, DOI 10.1016/j.mito.2018.06.003; Lall RK, 2016, MOL NUTR FOOD RES, V60, P1396, DOI 10.1002/mnfr.201600025; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Liang Y, 2021, FOOD FUNCT, V12, P10667, DOI [10.1039/d1fo02002a, 10.1039/D1FO02002A]; Lin MT, 2016, TUMOR BIOL, V37, P6987, DOI 10.1007/s13277-015-4526-4; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MIHARA K, 1975, J BIOCHEM-TOKYO, V78, P1057, DOI 10.1093/oxfordjournals.jbchem.a130983; Min KJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22081285; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; Pouget C, 2001, BIOORG MED CHEM LETT, V11, P3095, DOI 10.1016/S0960-894X(01)00617-5; Punia R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182870; Rodriguez J, 2002, MELANOMA RES, V12, P99, DOI 10.1097/00008390-200204000-00001; Rubio S, 2006, EUR J PHARMACOL, V548, P9, DOI 10.1016/j.ejphar.2006.07.020; Sabarwal A, 2022, CARCINOGENESIS, V43, P360, DOI 10.1093/carcin/bgab126; Sabarwal A, 2020, CANCERS, V12, DOI 10.3390/cancers12071782; Sabarwal A, 2017, MOL CARCINOGEN, V56, P499, DOI 10.1002/mc.22512; Shi ZH, 2014, BIOORG MED CHEM LETT, V24, P4424, DOI 10.1016/j.bmcl.2014.08.006; Tabasum S, 2019, CHEM-BIOL INTERACT, V303, P14, DOI 10.1016/j.cbi.2019.02.020; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; Tang YM, 2022, PHYTOMEDICINE, V101, DOI 10.1016/j.phymed.2022.154109; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; VARSHNEY R, 1990, INT J RADIAT BIOL, V58, P733, DOI 10.1080/09553009014552121; Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002; Wang JJ, 2018, EXP THER MED, V15, P2667, DOI 10.3892/etm.2017.5666; Ye CY, 2017, ONCOTARGET, V8, P2224, DOI 10.18632/oncotarget.13653; Zhang L, 2016, AM J TRANSL RES, V8, P4857; Zhao JQ, 2021, FOOD CHEM TOXICOL, V155, DOI 10.1016/j.fct.2021.112411	48	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22654	10.1096/fj.202200669RR	http://dx.doi.org/10.1096/fj.202200669RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6N0IY	36421014				2022-12-28	WOS:000889246400001
J	Rosario, R; Stewart, HL; Choudhury, NR; Michlewski, G; Charlet-Berguerand, N; Anderson, RA				Rosario, Roseanne; Stewart, Hazel L.; Choudhury, Nila Roy; Michlewski, Gracjan; Charlet-Berguerand, Nicholas; Anderson, Richard A.			Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency	FASEB JOURNAL			English	Article						CGG trinucleotide repeats; FMRpolyG; FXPOI; mRNA gain-of-function	CGG-REPEATS; DROSOPHILA MODEL; PREMUTATION; PROTEIN; TRANSLATION; EXPRESSION; NEURODEGENERATION; TREMOR; WOMEN; GENE	Fragile X-associated premature ovarian insufficiency (FXPOI) is among a family of disorders caused by expansion of a CGG trinucleotide repeat sequence located in the 5 ' untranslated region (UTR) of the fragile X messenger ribonucleoprotein 1 (FMR1) gene on the X chromosome. Women with FXPOI have a depleted ovarian follicle population, resulting in amenorrhea, hypoestrogenism, and loss of fertility before the age of 40. FXPOI is caused by expansions of the CGG sequence to lengths between 55 and 200 repeats, known as a FMRI premutation, however the mechanism by which the premutation drives disease pathogenesis remains unclear. Two main hypotheses exist, which describe an mRNA toxic gain-of-function mechanism or a protein-based mechanism, where repeat-associated non-AUG (RAN) translation results in the production of an abnormal protein, called FMRpolyG. Here, we have developed an in vitro granulosa cell model of the FMR1 premutation by ectopically expressing CGG-repeat RNA and FMRpolyG protein. We show that expanded CGG-repeat RNA accumulated in intranuclear RNA structures, and these aggregates were able to cause significant granulosa cell death independent of FMRpolyG expression. Using an innovative RNA pulldown, mass spectrometry-based approach we have identified proteins that are specifically sequestered by CGG RNA aggregates in granulosa cells in vitro, and thus may be deregulated as consequence of this interaction. Furthermore, we have demonstrated reduced expression of three proteins identified via our RNA pulldown (FUS, PA2G4 and TRA2 beta) in ovarian follicles in a FMR1 premutation mouse model. Collectively, these data provide evidence for the contribution of an mRNA gain-of-function mechanism to FXPOI disease biology.	[Rosario, Roseanne; Stewart, Hazel L.; Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Rosario, Roseanne] Univ Edinburgh, Biomed Sci, Edinburgh, Midlothian, Scotland; [Choudhury, Nila Roy; Michlewski, Gracjan] Univ Edinburgh, Infect Med, Edinburgh, Midlothian, Scotland; [Michlewski, Gracjan] Zhejiang Univ, Zhejiang Univ Univ Edinburgh Inst, Hangzhou, Zhejiang, Peoples R China; [Michlewski, Gracjan] Int Inst Mol & Cell Biol Warsaw, Dioscuri Ctr RNA Prot Interact Human Hlth & Dis, Warsaw, Poland; [Charlet-Berguerand, Nicholas] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire IGBMC, INSERM U 1258, CNRS UMR 7104, Illkirch Graffenstaden, France	University of Edinburgh; University of Edinburgh; University of Edinburgh; Zhejiang University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rosario, R (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	roseanne.rosario@ed.ac.uk	Charlet-Berguerand, Nicolas/I-6727-2016	Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Michlewski, Gracjan/0000-0002-7409-9619	Dioscuri [2019/02/H/NZ1/00002]; Polish National Science Centre [2021/01/1/NZ1/00001]; UKRI | Medical Research Council (MRC) [G1100357, MR/N022556/1]; Wellbeing of Women [PRF005]	Dioscuri; Polish National Science Centre; UKRI | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women(Wellbeing of Women (WoW))	Dioscuri, Grant/Award Number: 2019/02/H/NZ1/00002; Polish National Science Centre, Grant/Award Number: 2021/01/1/NZ1/00001; UKRI | Medical Research Council (MRC), Grant/Award Number: G1100357 and MR/N022556/1; Wellbeing of Women, Grant/Award Number: PRF005	Allen EG, 2007, HUM REPROD, V22, P2142, DOI 10.1093/humrep/dem148; Banez-Coronel M, 2019, LAB INVEST, V99, P929, DOI 10.1038/s41374-019-0241-x; Bayasula, 2012, ENDOCRINOLOGY, V153, P2851, DOI 10.1210/en.2011-1810; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Buijsen RAM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0162-2; Choudhury NR, 2019, METHODS, V152, P12, DOI 10.1016/j.ymeth.2018.06.006; Cid-Samper F, 2018, CELL REP, V25, P3422, DOI 10.1016/j.celrep.2018.11.076; Ciesiolka A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00097; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Deng QD, 2014, J NEUROSCI, V34, P7802, DOI 10.1523/JNEUROSCI.0172-14.2014; Dijkstra AA, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab007; Elizur SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105121; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fernandez JJ, 2012, GENET MOL RES, V11, P467, DOI 10.4238/2012.March.1.4; Friedman-Gohas M, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00623-w; Gleicher N, 2010, OBSTET GYNECOL SURV, V65, P523, DOI 10.1097/OGX.0b013e3181f8bdda; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; He F, 2014, HUM MOL GENET, V23, P5036, DOI 10.1093/hmg/ddu216; Hoffman GE, 2012, J HISTOCHEM CYTOCHEM, V60, P439, DOI 10.1369/0022155412441002; Hukema RK, 2015, HUM MOL GENET, V24, P4948, DOI 10.1093/hmg/ddv216; Hwang I, 2020, EXP MOL MED, V52, P1039, DOI 10.1038/s12276-020-0476-z; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Karnezis AN, 2021, GYNECOL ONCOL, V160, P568, DOI 10.1016/j.ygyno.2020.12.004; Kerr JB, 2013, REPRODUCTION, V146, pR205, DOI 10.1530/REP-13-0181; Krans A, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0782-7; Kronquist KE, 2008, GENET MED, V10, P345, DOI 10.1097/GIM.0b013e31818b0c8a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Ma L, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0796-1; McLaughlin BA, 1996, AM J HUM GENET, V59, P561; Nolin SL, 1996, AM J HUM GENET, V59, P1252; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Oostra BA, 2003, HUM MOL GENET, V12, pR249, DOI 10.1093/hmg/ddg298; Pastore LM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00195; Qurashi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002102; Rife M, 2004, AM J MED GENET A, V124A, P129, DOI 10.1002/ajmg.a.20342; Rosario R, 2020, MOL HUM REPROD, V26, P727, DOI 10.1093/molehr/gaaa057; Ruth KS, 2021, NATURE, V596, DOI 10.1038/s41586-021-03779-7; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shelly KE, 2021, HUM MOL GENET, V30, P923, DOI 10.1093/hmg/ddab083; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sukhanova MV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197020; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2007, RNA, V13, P555, DOI 10.1261/rna.280807; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027; Welt CK, 2004, J CLIN ENDOCR METAB, V89, P4569, DOI 10.1210/jc.2004-0347; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Wheeler AC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00300; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	64	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22612	10.1096/fj.202200468RR	http://dx.doi.org/10.1096/fj.202200468RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0OP	36250920	Green Submitted, Green Published			2022-12-28	WOS:000868747100001
J	Wen, Y; Wang, XQ; Meng, W; Guo, WL; Duan, CY; Cao, JJ; Kang, LF; Guo, NF; Lin, Q; Lv, P; Zhang, R; Xing, LX; Zhang, XH; Shen, HT				Wen, Yue; Wang, Xiuqing; Meng, Wei; Guo, Wenli; Duan, Chenyang; Cao, Jingjing; Kang, Lifei; Guo, Ningfei; Lin, Qiang; Lv, Ping; Zhang, Rong; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao			TNF-alpha-dependent lung inflammation upregulates PD-L1 in monocyte-derived macrophages to contribute to lung tumorigenesis	FASEB JOURNAL			English	Article						chronic inflammation; lung tumorigenesis; Monocyte-derived macrophages; PD-L1; TNF-alpha	TUMOR-ASSOCIATED MACROPHAGES; TISSUE-RESIDENT; HOST-CELLS; EXPRESSION; BLOCKADE; CANCER; INFECTION; PROFILES; IDENTITY; DEVELOP	Chronic inflammation, which is dominated by macrophage-involved inflammatory responses, is an instigator of cancer initiation. Macrophages are the most abundant immune cells in healthy lungs, and associated with lung tumor development and promotion. PD-L1 is a negative molecule in macrophages and correlated with an immunosuppressive function in tumor environment. Macrophages expressing PD-L1, rather than tumor cells, exhibits a critical role in tumor growth and progression. However, whether and how PD-L1 in macrophages contributes to inflammation-induced lung tumorigenesis requires further elucidation. Here, we found that higher expression of PD-L1 in CD11b(+)CD206(+) macrophages was positively correlated with tumor progression and PD-1(+)CD8(+) T cells population in human adenocarcinoma patients. In the urethane-induced inflammation-driven lung adenocarcinoma (IDLA) mouse model, the infiltration of circulating CD11b(high)F4/80(+) monocyte-derived macrophages (MoMs) was increased in pro-tumor inflamed lung tissues and lung adenocarcinoma. PD-L1 was mainly upregulated in MoMs associated with enhanced T cells exhaustion in lung tissues. Anti-PD-L1 treatment can reduce T cells exhaustion at pro-tumor inflammatory stage, and then inhibit tumorigenesis in IDLA. The pro-tumor lung inflammation depended on TNF-alpha to upregulate PD-L1 and CSN6 expression in MoMs, and induced cytokines production by alveolar type-II cells (AT-II). Furthermore, inflammatory AT-II cells could secret TNF-alpha to upregulate PD-L1 expression in bone-marrow driven macrophages (BM-M0). Inhibition of CSN6 decreased PD-L1 expression in TNF-alpha-activated macrophage in vitro, suggesting a critical role of CSN6 in PD-L1 upregulation. Thus, pro-tumor inflammation can depend on TNF-alpha to upregulate PD-L1 in recruited MoMs, which may be essential for lung tumorigenesis.	[Wen, Yue; Wang, Xiuqing; Meng, Wei; Guo, Wenli; Duan, Chenyang; Cao, Jingjing; Guo, Ningfei; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao] Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China; [Wen, Yue] Hebei Med Univ, Hosp 4, Dept Ultrasound, Shijiazhuang, Hebei, Peoples R China; [Wang, Xiuqing; Meng, Wei; Duan, Chenyang; Cao, Jingjing; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao] Hebei Med Univ, Ctr Metab Dis & Canc Res CMCR, Shijiazhuang, Hebei, Peoples R China; [Guo, Wenli; Zhang, Xianghong] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Kang, Lifei] Hebei Chest Hosp, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Lin, Qiang] Hebei Med Univ, North China Petr Bur Gen Hosp, Dept Oncol, Renqiu, Peoples R China; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Rong] Hebei Med Univ, Sch Publ Hlth, Dept Toxicol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, XH; Shen, HT (corresponding author), Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China.	zhangxianghong2008@163.com; haitaoshen78@hotmail.com			National Natural Science Foundation of China [31570894, 81670939, 81672706]; Foundation of Hebei Science and Technology Department, China [216G7707Z]; Natural Science Foundation of Hebei Province (key program), China [H2021206351]; Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China [H2018206120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hebei Science and Technology Department, China; Natural Science Foundation of Hebei Province (key program), China; Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China	This work was supported by the National Natural Science Foundation of China (31570894; 81670939; 81672706), Foundation of Hebei Science and Technology Department, China (216G7707Z), Natural Science Foundation of Hebei Province (key program), China (H2021206351), and Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China (H2018206120).	Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Almatroodi SA, 2016, CANCER MICROENVIRON, V9, P1, DOI 10.1007/s12307-015-0174-x; Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Dey A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00683; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Eldredge LC, 2016, AM J RESP CELL MOL, V54, P273, DOI 10.1165/rcmb.2014-0395OC; Gabrusiewicz K, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1412909; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guilbaud E, 2019, CANCERS, V11, DOI 10.3390/cancers11030298; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo NF, 2020, FASEB J, V34, P12197, DOI 10.1096/fj.202000166RR; Han XJ, 2020, MOL CARCINOGEN, V59, P1088, DOI 10.1002/mc.23239; Hartley G, 2017, CANCER IMMUNOL IMMUN, V66, P523, DOI 10.1007/s00262-017-1955-5; Hartley GP, 2018, CANCER IMMUNOL RES, V6, P1260, DOI 10.1158/2326-6066.CIR-17-0537; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jia YL, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01455-y; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Karabela SP, 2011, NEOPLASIA, V13, P1143, DOI 10.1593/neo.111224; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Lahmar Q, 2016, BBA-REV CANCER, V1865, P23, DOI 10.1016/j.bbcan.2015.06.009; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Liu C, 2020, CELL DEATH DIFFER, V27, P1765, DOI 10.1038/s41418-019-0460-0; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Lu CH, 2018, ONCOGENE, V37, P6327, DOI 10.1038/s41388-018-0411-0; Mandai M, 2016, CLIN CANCER RES, V22, P2329, DOI 10.1158/1078-0432.CCR-16-0224; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mazzaschi G, 2018, CLIN CANCER RES, V24, P407, DOI 10.1158/1078-0432.CCR-17-2156; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Noguchi T, 2017, CANCER IMMUNOL RES, V5, P106, DOI 10.1158/2326-6066.CIR-16-0391; Petty AJ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.146707; Pollari M, 2018, HAEMATOLOGICA, V103, P1908, DOI 10.3324/haematol.2018.197194; Quandt D, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-151; Rana T, 2020, AM J RESP CELL MOL, V62, P319, DOI 10.1165/rcmb.2019-0071OC; Sanfilippo AM, 2015, INFECT IMMUN, V83, P2976, DOI 10.1128/IAI.00142-15; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Su LR, 2020, MOL CARCINOGEN, V59, P520, DOI 10.1002/mc.23176; Sumitomo R, 2019, LUNG CANCER, V136, P136, DOI 10.1016/j.lungcan.2019.08.023; Sun F, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000294; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van Overmeire E, 2016, CANCER RES, V76, P35, DOI 10.1158/0008-5472.CAN-15-0869; Wang X, 2017, IMMUNOL LETT, V184, P7, DOI 10.1016/j.imlet.2017.02.006; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Xiao M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0815-2; Zerdes I, 2018, ONCOGENE, V37, P4639, DOI 10.1038/s41388-018-0303-3; Zong ZY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01643; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	55	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22595	10.1096/fj.202200434RR	http://dx.doi.org/10.1096/fj.202200434RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5D1HL	36205325				2022-12-28	WOS:000864700900001
J	Linzer, RW; Guida, DL; Aminov, J; Snider, JM; Khalife, G; Buyukbayraktar, AB; Alhaddad, C; Resnick, AE; Wang, PL; Pan, CH; Allopenna, JJ; Clarke, CJ				Linzer, Ryan W.; Guida, Danielle L.; Aminov, Jonathan; Snider, Justin M.; Khalife, Gabrielle; Buyukbayraktar, A. Burak; Alhaddad, Charbel; Resnick, Andrew E.; Wang, Pule; Pan, Chun-Hao; Allopenna, Janet J.; Clarke, Christopher J.			Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism	FASEB JOURNAL			English	Article						breast cancer; cell survival; metastasis; oncogene; sphingolipid	CANCER-CELL RESISTANCE; SPHINGOLIPID METABOLISM; MOLECULAR-MECHANISMS; ANOIKIS RESISTANCE; INDUCED APOPTOSIS; UP-REGULATION; CERAMIDE; SPHINGOSINE; DEATH; IDENTIFICATION	Oncogenic reprogramming of cellular metabolism is a hallmark of many cancers, but our mechanistic understanding of how such dysregulation is linked to tumor behavior remains poor. In this study, we have identified dihydroceramide desaturase (DES1)-which catalyzes the last step in de novo sphingolipid synthesis-as necessary for the acquisition of anchorage-independent survival (AIS), a key cancer enabling biology, and establish DES1 as a downstream effector of HER2-driven glucose uptake and metabolism. We further show that DES1 is sufficient to drive AIS and in vitro tumorigenicity and that increased DES1 levels-found in a third of HER2+ breast cancers-are associated with worse survival outcomes. Taken together, our findings reveal a novel pro-tumor role for DES1 as a transducer of HER2-driven glucose metabolic signals and provide evidence that targeting DES1 is an effective approach for overcoming AIS. Results further suggest that DES1 may have utility as a biomarker of aggressive and metastasis-prone HER2+ breast cancer.	[Clarke, Christopher J.] SUNY Stony Brook, Dept Med, 100 Nicolls Rd, Stony Brook, NY 11776 USA; [Clarke, Christopher J.] SUNY Stony Brook, Ctr Canc, 100 Nicolls Rd, Stony Brook, NY 11776 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Clarke, CJ (corresponding author), SUNY Stony Brook, Dept Med, 100 Nicolls Rd, Stony Brook, NY 11776 USA.; Clarke, CJ (corresponding author), SUNY Stony Brook, Ctr Canc, 100 Nicolls Rd, Stony Brook, NY 11776 USA.	christopher.clarke@stonybrookmedicine.edu		Pan, Chun-Hao/0000-0002-0776-9408	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH) [R01 CA248014]; Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH), Grant/Award Number: R01 CA248014; Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Alsanafi M, 2021, CELL BIOCHEM BIOPHYS, V79, P461, DOI 10.1007/s12013-021-00990-1; Alsanafi M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00222-18; Apraiz A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-477; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Becker KA, 2020, J NEUROCHEM, V154, P662, DOI 10.1111/jnc.14985; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Boppana NB, 2017, ANTICANCER RES, V37, P455, DOI 10.21873/anticanres.11337; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cingolani F, 2014, J LIPID RES, V55, P1711, DOI 10.1194/jlr.M049759; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Czubowicz K, 2014, MOL NEUROBIOL, V50, P26, DOI 10.1007/s12035-013-8606-4; da Silva G, 2021, CANCER BIOMARK, V32, P49, DOI 10.3233/CBM-203100; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Ecker J, 2021, GASTROENTEROLOGY, V161, P910, DOI 10.1053/j.gastro.2021.05.009; Foley JM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0466-4; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Guenther GG, 2014, ONCOGENE, V33, P1776, DOI 10.1038/onc.2013.139; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Haakenson JK, 2015, J BIOL CHEM, V290, P8632, DOI 10.1074/jbc.M114.609677; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hartfield PJ, 1997, FEBS LETT, V401, P148, DOI 10.1016/S0014-5793(96)01460-3; Hawk MA, 2018, NAT CELL BIOL, V20, P272, DOI 10.1038/s41556-018-0034-2; Hernandez-Tiedra S, 2016, AUTOPHAGY, V12, P2213, DOI 10.1080/15548627.2016.1213927; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; Holliday MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074768; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Ingram LM, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01437-5; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lee WJ, 2004, EXP MOL MED, V36, P420, DOI 10.1038/emm.2004.54; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Mason JA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108821; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Nagahashi M, 2016, J SURG RES, V204, P435, DOI 10.1016/j.jss.2016.05.022; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Reckzeh ES, 2019, CELL CHEM BIOL, V26, P1214, DOI 10.1016/j.chembiol.2019.06.005; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ryland LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084648; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Siebeneicher H, 2016, CHEMMEDCHEM, V11, P2261, DOI 10.1002/cmdc.201600276; Snider AJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101393; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Snider JM, 2018, J LIPID RES, V59, P1046, DOI 10.1194/jlr.D081646; Spassieva SD, 2012, J LIPID RES, V53, P918, DOI 10.1194/jlr.M019075; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Sundaram K, 2016, BIOCHEM J, V473, P743, DOI 10.1042/BJ20150586; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tam AB, 2018, DEV CELL, V46, P327, DOI 10.1016/j.devcel.2018.04.023; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang XZ, 1999, CANCER RES, V59, P5842; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Yu M, 2017, ONCOTARGET, V8, P43356, DOI 10.18632/oncotarget.17445	77	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22558	10.1096/fj.202200748R	http://dx.doi.org/10.1096/fj.202200748R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1HU	36165222				2022-12-28	WOS:000859917400001
J	Wang, MX; Yan, L; Chen, J; Zhao, JM; Zhu, J; Yu, SH				Wang, Meng-Xi; Yan, Li; Chen, Juan; Zhao, Jun-Mei; Zhu, Jiang; Yu, Shan-He			Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia	FASEB JOURNAL			English	Article						AML1-ETO; c-Kit; CD43; erythroid differentiation; Ldb1; leukemia	ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; AML1-ETO; PROTEIN; BETA; EXPRESSION; PROMOTES; KIT; PROGENITOR; COMPLEXES	Oncoprotein AML1-ETO (AE) derived from t(8;21)(q22;q22) translocation is typically present in a portion of French-American-British-M2 subtype of acute myeloid leukemia (AML). Although these patients have relatively favorable prognoses, substantial numbers of them would relapse after conventional therapy. Here, we explored whether reinforcing the endogenous differentiation potential of t(8;21) AML cells would diminish the associated malignancy. In doing so, we noticed an expansion of immature erythroid blasts featured in both AML1-ETO9a (AE9a) and AE plus c-KIT (N822K) (AK) murine leukemic models. Interestingly, in the AE9a murine model, a spontaneous step-wise erythroid differentiation path, as characterized by the differential expression of CD43/c-Kit and the upregulation of several key erythroid transcription factors (TFs), accompanied the decline or loss of leukemia-initiating potential. Notably, overexpression of one of the key erythroid TFs, Ldb1, potently disrupted the repopulation of AE9a leukemic cells in vivo, suggesting a new promising intervention strategy of t(8;21) AML through enforcing their erythroid differentiation.	[Wang, Meng-Xi; Chen, Juan; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol,Sch Med, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai, Peoples R China; [Yan, Li; Zhao, Jun-Mei] Wuhan Univ, Dept Hematol, Renmin Hosp, Wuhan, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Hematol, Ruijin & Lospital, Sch Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Wuhan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, J; Yu, SH (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol,Sch Med, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai, Peoples R China.	zhujiang@shsmu.edu.cn; yushanhe@shsmu.edu.cn		Yu, Shanhe/0000-0002-0268-7374	National Key Research and Development Program of China [2018YFA0107802]; National Major Scientific and Technological Special Project [2018ZX09101001]; National Natural Science Foundation of China (NSFC) [81430002, 81770206, 81800099, 81900148, 81900168, 82000109, 82100188, 82270154]; Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research [2019CXJQ01]; Shanghai Rising-Star Program [20QC1400100]	National Key Research and Development Program of China; National Major Scientific and Technological Special Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research; Shanghai Rising-Star Program	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0107802; National Major Scientific and Technological Special Project, Grant/Award Number: 2018ZX09101001; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81430002, 81770206, 81800099, 81900148, 81900168, 82000109, 82100188 and 82270154; Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research, Grant/Award Number: 2019CXJQ01; Shanghai Rising-Star Program, Grant/Award Number: 20QC1400100	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Harbi S, 2020, BLOOD ADV, V4, P229, DOI 10.1182/bloodadvances.2019000168; Bagger FO, 2019, NUCLEIC ACIDS RES, V47, pD881, DOI 10.1093/nar/gky1076; Baliakas P, 2014, AM J HEMATOL, V89, P249, DOI 10.1002/ajh.23618; BETTAIEB A, 1988, BLOOD, V71, P1226; Byun HM, 2017, OPEN MED-WARSAW, V12, P76, DOI 10.1515/med-2017-0014; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; Choi YJ, 2005, CRIT REV EUKAR GENE, V15, P207, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.30; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; de The H, 2018, NAT REV CANCER, V18, P117, DOI 10.1038/nrc.2017.103; Desai R, 2020, LEUKEMIA, V34, P1706, DOI 10.1038/s41375-019-0657-8; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Elliott S, 2014, ANN HEMATOL, V93, P181, DOI 10.1007/s00277-013-1947-2; Foster BM, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010031; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jimi E, 2005, INT IMMUNOL, V17, P815, DOI 10.1093/intimm/dxh263; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Long J, 2017, LEUKEMIA, V31, P2761, DOI 10.1038/leu.2017.130; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; Man N, 2017, BLOOD, V129, P2782, DOI 10.1182/blood-2016-10-745034; Marneth AE, 2018, HAEMATOLOGICA, V103, pE395, DOI 10.3324/haematol.2017.180844; Marschalek R, 2015, ARCH PHARM, V348, P221, DOI 10.1002/ardp.201400449; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; MOORE T, 1994, J IMMUNOL, V153, P4978; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Pikman Y, 2018, BLOOD, V132, P1241, DOI 10.1182/blood-2018-04-784157; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tan Y, 2021, BLOOD, V137, P1503, DOI 10.1182/blood.2020005698; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Thiel VN, 2017, LEUKEMIA, V31, P2491, DOI 10.1038/leu.2017.105; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Tonks A, 2003, BLOOD, V101, P624, DOI 10.1182/blood-2002-06-1732; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; YAMASAKI H, 1995, LEUKEMIA, V9, P1147; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Zhu SH, 2020, LEUKEMIA, V34, P2484, DOI 10.1038/s41375-020-0768-2	50	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22562	10.1096/fj.202200026RR	http://dx.doi.org/10.1096/fj.202200026RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4P4DJ	36125067				2022-12-28	WOS:000855344900001
J	Fekry, B; Ribas-Latre, A; Van Drunen, R; Santos, RB; Shivshankar, S; Dai, YL; Zhao, Z; Yoo, SH; Chen, Z; Sun, K; Sladek, FM; Younes, M; Eckel-Mahan, K				Fekry, Baharan; Ribas-Latre, Aleix; Van Drunen, Rachel; Santos, Rafael Bravo; Shivshankar, Samay; Dai, Yulin; Zhao, Zhongming; Yoo, Seung-Hee; Chen, Zheng; Sun, Kai; Sladek, Frances M.; Younes, Mamoun; Eckel-Mahan, Kristin			Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis	FASEB JOURNAL			English	Article						BMAL1; circadian; HCC; hcpatoccllular carcinoma; HNF4 alpha; SR9009	NUCLEAR FACTOR 4-ALPHA; GENE-EXPRESSION; CYCLIN B1; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; CELL-PROLIFERATION; ACID SYNTHASE; DOWN-REGULATION; REV-ERBS; HNF4-ALPHA	Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths, and the most common primary liver malignancy to present in the clinic. With the exception of liver transplant, treatment options for advanced HCC are limited, but improved tumor stratification could open the door to new treatment options. Previously, we demonstrated that the circadian regulator Aryl Hydrocarbon-Like Receptor Like 1 (ARNTL, or Bmal1) and the liver-enriched nuclear factor 4 alpha (HNF4 alpha) are robustly co-expressed in healthy liver but incompatible in the context of HCC. Faulty circadian expression of HNF4 alpha- either by isoform switching, or loss of expression- results in an increased risk for IICC, while BMAL1 gain-of-function in HNF4 alpha-positive HCC results in apoptosis and tumor regression. We hypothesize that the transcriptional programs of HNF4 alpha and BMAL1 are antagonistic in liver disease and HCC. Here, we study this antagonism by generating a mouse model with inducible loss of hepatic HNF4 alpha and BMAL1 expression. The results reveal that simultaneous loss of HNF4 alpha and BMAL1 is protective against fatty liver and HCC in carcinogen-induced liver injury and in the "STAM" model of liver disease. Furthermore, our results suggest that targeting Bmall expression in the absence of HNF4 alpha inhibits HCC growth and progression. Specifically, pharmacological suppression of Bmal1 in HNF4 alpha-deficient, BMAL1-positive HCC with REV-ERB agonist SR9009 impairs tumor cell proliferation and migration in a REV-ERB-dependent manner, while having no effect on healthy hepatocytes. Collectively, our results suggest that stratification of HCC based on HNF4 alpha and BMAL1 expression may provide a new perspective on HCC properties and potential targeted therapeutics.	[Fekry, Baharan; Ribas-Latre, Aleix; Van Drunen, Rachel; Santos, Rafael Bravo; Shivshankar, Samay; Sun, Kai; Eckel-Mahan, Kristin] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, McGovern Med Sch, 1825 Pressler Ave, Houston, TX 77030 USA; [Dai, Yulin; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Yoo, Seung-Hee; Chen, Zheng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Sun, Kai; Eckel-Mahan, Kristin] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Sladek, Frances M.] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA; [Younes, Mamoun] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20052 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Riverside; George Washington University	Eckel-Mahan, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, McGovern Med Sch, 1825 Pressler Ave, Houston, TX 77030 USA.	kristin.l.mahan@uth.tmc.edu		Sun, Kai/0000-0002-4778-4549; Van Drunen, Rachel/0000-0001-7438-1801; dai, yulin/0000-0003-1874-7893	American Cancer Society (ACS) [RSG-17-215-01-C]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180734]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK114037]	American Cancer Society (ACS)(American Cancer Society); Cancer Prevention and Research Institute of Texas (CPRIT); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Cancer Society (ACS), Grant/ Award Number: RSG-17-215-01-C; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/ Award Number: RP180734; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/ Award Number: DK114037	Abitbol S, 2018, J HEPATOL, V68, P1203, DOI 10.1016/j.jhep.2017.12.018; Arboatti AS, 2019, CHEM-BIOL INTERACT, V303, P70, DOI 10.1016/j.cbi.2019.02.024; Argemie J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11004-3; Bahitham W, 2016, BBA-MOL CELL BIOL L, V1861, P482, DOI 10.1016/j.bbalip.2016.03.009; Banerjee SK, 2000, AM J PATHOL, V156, P217, DOI 10.1016/S0002-9440(10)64722-0; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bauerschlag DO, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0511-3; Bjornson E, 2015, CELL REP, V13, P2014, DOI 10.1016/j.celrep.2015.10.045; Bolotin E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-560; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang HY, 2016, NUCLEIC ACIDS RES, V44, P2514, DOI 10.1093/nar/gkw126; Chellappa K, 2016, ELIFE, V5, DOI 10.7554/eLife.10903; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Dean S, 2010, GENE EXPRESSION, V14, P337, DOI 10.3727/105221610X12717040569901; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Dubois V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102185; Dunser MW, 2008, CURR OPIN ANESTHESIO, V21, P122, DOI 10.1097/ACO.0b013e3282f4571a; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Farshadi E, 2019, CELL CYCLE, V18, P16, DOI 10.1080/15384101.2018.1558638; Fekry B, 2019, CANCER RES, V79, P5860, DOI 10.1158/0008-5472.CAN-19-1277; Fekry B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06648-6; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Grohmann M, 2018, CELL, V175, P1289, DOI 10.1016/j.cell.2018.09.053; Half E, 2002, CANCER RES, V62, P1676; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Henkel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34633-y; Henkel J, 2012, LAB INVEST, V92, P1597, DOI 10.1038/labinvest.2012.128; Hui ST, 2018, HEPATOLOGY, V68, P2182, DOI 10.1002/hep.30113; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Jiang L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02927; Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Joo M, 2001, LIVER, V21, P89, DOI 10.1034/j.1600-0676.2001.021002089.x; Kaestner KH, 2010, HEPATOLOGY, V51, P376, DOI 10.1002/hep.23487; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kawamoto H, 1997, AM J PATHOL, V150, P15; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Kim MJ, 2017, MOL CANCER RES, V15, P1230, DOI 10.1158/1541-7786.MCR-17-0061; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lede V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172000; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Li D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14185-z; Liao R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-3; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Lu SY, 2005, CARCINOGENESIS, V26, P153, DOI 10.1093/carcin/bgh278; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Lupien LE, 2019, J PHARMACOL EXP THER, V371, P171, DOI 10.1124/jpet.119.258947; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Mehrotra S, 2006, J PATHOL, V208, P356, DOI 10.1002/path.1907; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oshima T, 2007, PATHOL INT, V57, P82, DOI 10.1111/j.1440-1827.2006.02061.x; Pan XY, 2020, J CLIN INVEST, V130, P4282, DOI 10.1172/JCI132765; Pan XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13011; Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Perez S, 2006, BBA-MOL CELL BIOL L, V1761, P160, DOI 10.1016/j.bbalip.2006.02.003; Peyrou M, 2012, PPAR RES, V2012, DOI 10.1155/2012/757803; Qu M, 2018, P NATL ACAD SCI USA, V115, pE12305, DOI 10.1073/pnas.1816411115; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; SANO H, 1995, CANCER RES, V55, P3785; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Shi DM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00423; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Soria JC, 2000, CANCER RES, V60, P4000; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takano K, 2009, PATHOL INT, V59, P462, DOI 10.1111/j.1440-1827.2009.02394.x; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012; Walker S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212860; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Wang XF, 2020, BRIT J PHARMACOL, V177, P1865, DOI 10.1111/bph.14958; Wang Y, 2009, INT J CANCER, V124, P540, DOI 10.1002/ijc.23995; Wang YJ, 2015, BIOCHEM PHARMACOL, V96, P315, DOI 10.1016/j.bcp.2015.06.010; Wang Z, 2020, ONCOGENE, V39, P1572, DOI 10.1038/s41388-019-1080-3; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yang LH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-25; Yoshiji H, 1999, CANCER RES, V59, P4413; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zang SB, 2013, HUM PATHOL, V44, P1681, DOI 10.1016/j.humpath.2013.04.007; Zhang W, 2012, BIOMED RES-TOKYO, V33, P83, DOI 10.2220/biomedres.33.83; Zhangdi HJ, 2019, WORLD J GASTROENTERO, V25, P4835, DOI 10.3748/wjg.v25.i33.4835; Zhao M., 2006, Experimental Oncology, V28, P44	118	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22482	10.1096/fj.202101398R	http://dx.doi.org/10.1096/fj.202101398R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3R2RK	35947136				2022-12-28	WOS:000838765500001
J	Luo, HG; Liu, YA; Li, Y; Zhang, CK; Yu, BB; Shao, C				Luo, Haoge; Liu, Yanan; Li, Yang; Zhang, Chaoke; Yu, Bingbing; Shao, Chen			Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells	FASEB JOURNAL			English	Article						ARv7; DNA damage response; homologous recombination; olaparib; PARP1; prostate cancer; radiotherapy	STRAND BREAK REPAIR; PARP INHIBITORS; DEPRIVATION; RESISTANCE; THERAPY; COMPLEX; AR-V7	In the treatment of patients with locally advanced prostate cancer (PCa), androgen deprivation therapy (ADT) significantly enhances the efficacy of radiotherapy by weakening the DNA damage response (DDR) pathway. Recently, several studies have suggested that androgen receptor splicing variants (ARvs) may mediate a compensatory DDR pathway when canonical androgen receptor (AR) signaling is inhibited, thus contributing to the resistance of some patients to this combinational treatment. However, the specific roles of certain ARvs as well as the detailed mechanism of how ARvs regulate the DDR are not well understood. Here, we demonstrated that AR splicing variant 7 (ARv7), which is the most abundant form of ARvs, significantly promotes the DDR of PCa cells under severe DNA damage independent of its parental AR by using the ionizing radiation (IR) and doxorubicin (Dox)-treated cell models. Mechanistically, ARv7 is sufficient to upregulate both the homologous recombination (HR) and the nonhomologous end joining (NHEJ) pathways by forming a positive regulatory loop with poly ADP-ribose polymerase 1 (PARP1). Moreover, the presence of ARv7 impairs the synergistic effect between AR antagonists and poly ADP-ribose polymerase (PARP) inhibitor, which has been recently shown to be a promising future treatment strategy for metastatic castration resistant prostate cancer (mCRPC). Combined, our data indicate that constitutively active ARv7 not only contributes to radioresistance after ADT, but may also serve as a potential predictive biomarker for assessing the efficacy of novel PARP inhibitor-based therapy in PCa.	[Luo, Haoge; Liu, Yanan; Li, Yang; Zhang, Chaoke; Yu, Bingbing; Shao, Chen] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, 126 Xinmin St, Changchun 130021, Peoples R China	Jilin University	Shao, C (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, 126 Xinmin St, Changchun 130021, Peoples R China.	shaochen@jlu.edu.cn		, Chen/0000-0001-5008-6912	Jilin University (JLU) [2018B30]; National Natural Science Foundation of China (NSFC) [81802579]	Jilin University (JLU); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Jilin University (JLU), Grant/Award Number: 2018B30; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802579	Antonarakis ES, 2020, EUR UROL ONCOL, V3, P594, DOI 10.1016/j.euo.2020.07.005; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asim M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00393-y; Bastos DA, 2018, EXPERT REV MOL DIAGN, V18, P155, DOI 10.1080/14737159.2018.1427068; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Clarke N, 2018, LANCET ONCOL, V19, P975, DOI 10.1016/S1470-2045(18)30365-6; Dal Pra A, 2010, CURR ONCOL, V17, P219; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; Deshmukh D, 2015, AM J CLIN EXP UROL, V3, P1; Ellisen LW, 2011, CANCER CELL, V19, P165, DOI 10.1016/j.ccr.2011.01.047; Feiersinger GE, 2018, MOL ONCOL, V12, P561, DOI 10.1002/1878-0261.12185; Fujita K, 2019, WORLD J MENS HEALTH, V37, P288, DOI 10.5534/wjmh.180040; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Graham L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0759-3; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; Hopkins TA, 2019, MOL CANCER RES, V17, P409, DOI 10.1158/1541-7786.MCR-18-0138; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kounatidou E, 2019, NUCLEIC ACIDS RES, V47, P5634, DOI 10.1093/nar/gkz286; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Li H, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01227-0; Li LK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7479; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Nizialek E, 2020, CANCER MANAG RES, V12, P8105, DOI 10.2147/CMAR.S227033; Pezaro C, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835919897537; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sprenger CCT, 2014, HORM CANCER-US, V5, P207, DOI 10.1007/s12672-014-0177-y; Wadosky KM, 2017, ONCOTARGET, V8, P18550, DOI 10.18632/oncotarget.14537; Yin LL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0810-7; Yin Y, 2017, CANCER RES, V77, P4745, DOI 10.1158/0008-5472.CAN-17-0164; Yu BB, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100276; Zang YC, 2018, CANCER LETT, V415, P198, DOI 10.1016/j.canlet.2017.11.028; Zhang T, 2020, CLIN GENITOURIN CANC, V18, P1, DOI 10.1016/j.clgc.2019.09.015	42	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22495	10.1096/fj.202200190R	http://dx.doi.org/10.1096/fj.202200190R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Q4LK	35947121				2022-12-28	WOS:000838204500001
J	Ramasubramanian, B; Kim, J; Ke, YB; Li, Y; Zhang, CO; Promnares, K; Tanaka, KA; Birukov, KG; Karki, P; Birukova, AA				Ramasubramanian, Baalachandran; Kim, Junghyun; Ke, Yunbo; Li, Yue; Zhang, Chen-Ou; Promnares, Kamoltip; Tanaka, Kenichi A.; Birukov, Konstantin G.; Karki, Pratap; Birukova, Anna A.			Mechanisms of pulmonary endothelial permeability and inflammation caused by extracellular histone subunits H3 and H4	FASEB JOURNAL			English	Article						cytoskeleton; endothelial adhesion molecules; extracellular histones; inflammatory signaling; lung injury; pulmonary endothelial permeability	MULTIPLE ORGAN FAILURE; LUNG VASCULAR LEAK; BARRIER FUNCTION; THROMBIN GENERATION; CELL JUNCTIONS; MEDIATORS; TRAUMA; AFADIN; ENHANCEMENT; INVOLVEMENT	Extracellular DNA-binding proteins such as histones are danger-associated molecular pattern released by the injured tissues in trauma and sepsis settings, which trigger host immune response and vascular dysfunction. Molecular events leading to histone-induced endothelial cell (EC) dysfunction remain poorly understood. This study performed comparative analysis of H1, H2A, H2B, H3, and H4 histone subunits effects on human pulmonary EC permeability and inflammatory response. Analysis of transendothelial electrical resistance and EC monolayer permeability for macromolecues revealed that H3 and H4, but not H1, H2A, or H2B caused dose-dependent EC permeability accompanied by disassembly of adherens junctions. At higher doses, H3 and H4 activated nuclear factor kappa B inflammatory cascade leading to upregulation EC adhesion molecules ICAM1, VCAM1, E-selectin, and release of inflammatory cytokines. Inhibitory receptor analysis showed that toll-like receptor (TLR) 4 but not TLR1/2 or receptor for advanced glycation end inhibition significantly attenuated deleterious effects of H3 and H4 histones. Inhibitor of Rho-kinase was without effect, while inhibition of Src kinase caused partial preservation of cell-cell junctions, H3/H4-induced permeability and inflammation. Deleterious effects of H3/H4 were blocked by heparin. Activation of Epac-Rap1 signaling restored EC barrier properties after histone challenge. Intravenous injection of histones in mice caused elevation of inflammatory markers and increased vascular leak. Post-treatment with pharmacological Epac/Rap1 activator suppressed injurious effects of histones in vitro and in vivo. These results identify H3 and H4 as key histone subunits exhibiting deleterious effects on pulmonary vascular endothelium via TLR4-dependent mechanism. In conclusion, elevation of circulating histones may represent a serious risk of exacerbated acute lung injury (ALI) and multiple organ injury during severe trauma and infection.	[Ramasubramanian, Baalachandran; Li, Yue; Zhang, Chen-Ou; Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Kim, Junghyun; Ke, Yunbo; Promnares, Kamoltip; Tanaka, Kenichi A.; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Birukova, AA (corresponding author), Univ Maryland, UMSOM Lung Biol Program, Dept Med, Sch Med, 20 Penn St,HSF 2,Room S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL152761, HL155051, HL076259, HL146829]; University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL152761, HL155051, HL076259 and HL146829; University of Maryland Baltimore, Institute for Clinical & Translational Research (ICTR), Grant/Award Number: pilot grant	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Alsaffar H, 2018, AM J PHYSIOL-CELL PH, V314, pC589, DOI 10.1152/ajpcell.00235.2017; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010; Karki P, 2020, PULM CIRC, V10, DOI 10.1177/2045894020965357; Karki P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206251; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Lv X, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0651-5; Meegan JE, 2018, BIOCHEM BIOPH RES CO, V503, P1498, DOI 10.1016/j.bbrc.2018.07.069; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Pannekoek WJ, 2014, CELL ADHES MIGR, V8, P100, DOI 10.4161/cam.27352; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shao Y, 2020, ARTERIOSCL THROM VAS, V40, pE138, DOI 10.1161/ATVBAHA.120.314330; Sharma SK, 2016, J THORAC DIS, V8, P1406, DOI 10.21037/jtd.2016.05.22; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Surapisitchat J, 2011, HANDB EXP PHARMACOL, V204, P193, DOI 10.1007/978-3-642-17969-3_8; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yao Lin, 2010, J Cardiovasc Dis Res, V1, P165, DOI 10.4103/0975-3583.74258; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang YL, 2015, ANESTHESIOLOGY, V122, P127, DOI 10.1097/ALN.0000000000000429	52	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22470	10.1096/fj.202200303RR	http://dx.doi.org/10.1096/fj.202200303RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7MJ	35969180				2022-12-28	WOS:000840453200001
J	Zhang, H; Lu, JF; Shang, HP; Chen, J; Lin, ZX; Liu, YM; Wang, XW; Song, LP; Jiang, X; Jiang, HY; Shi, JD; Yan, DS; Wu, SZ				Zhang, He; Lu, Jinfang; Shang, Huiping; Chen, Juan; Lin, Zhengxiu; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Shi, Jiandong; Yan, Dongsheng; Wu, Shengzhou			Alterations of serine racemase expression determine proliferation and differentiation of neuroblastoma cells	FASEB JOURNAL			English	Article						all-trans retinoic acid; cell cycle; differentiation; D-serine; neuroblastoma; proliferation; serine racemase; valproic acid	NEURONAL DIFFERENTIATION; NMDA RECEPTORS; MOUSE MODEL; CYCLE EXIT; PROTEIN; MIGRATION; LOCALIZATION; INHIBITION; ASTROCYTES; P27(KIP1)	Although the role of serine racemase (SR) in neuropsychiatric disorders has been extensively studied, its role in cell proliferation and differentiation remains unclear. Deletion of Srr, the encoding gene for SR, has been shown to reduce dendritic arborization and dendritic spine density in the brains of adult mice, whereas increased SR levels have been associated with differentiation in cell cultures. Previously, we demonstrated that valproic acid induces differentiation in the N2A neuroblastoma cell line, and that this differentiation is associated with increased SR expression. These observations suggest that SR may have a role in cell proliferation and differentiation. We herein found that both valproic acid and all-trans retinoic acid induced N2A differentiation. In contrast, knockdown of SR reduced levels of differentiation, increased N2A proliferation, promoted cell cycle entry, and modulated expression of cell cycle-related proteins. To further evaluate the effects of SR expression on cell proliferation and differentiation, we used an in vivo model of neuroblastoma in nude mice. N2A cells stably expressing scramble shRNA (Srr(wt)-N2A) or specific Srr shRNA (Srr(kd)-N2A) were subcutaneously injected into nude mice. The weights and volumes of Srr(wt)-N2A-derived tumors were lower than Srr(kd)-N2A-derived tumors. Furthermore, Srr(wt)-N2A-derived tumors were significantly mitigated by intraperitoneal injection of valproic acid, whereas Srr(kd)-N2A-derived tumors were unaffected. Taken together, our findings demonstrate for the first time that alterations in SR expression determine the transition between proliferation and differentiation in neural progenitor cells. Thus, in addition to its well-established roles in neuropsychiatric disorders, our study has highlighted a novel role for SR in cell proliferation and differentiation.	[Zhang, He] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Peoples R China; [Zhang, He] Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, Eye Hosp, Wenzhou 325003, Zhejiang, Peoples R China; [Zhang, He; Shang, Huiping; Chen, Juan; Liu, Yimei; Wang, Xianwei; Song, Liping; Jiang, Xue; Jiang, Haiyan; Yan, Dongsheng; Wu, Shengzhou] Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Visual Sci, Wenzhou, Peoples R China; [Lu, Jinfang] Minist Educ, Key Lab Lab Med, Wenzhou Key Lab Sanit Microbiol, Wenzhou, Peoples R China; [Lu, Jinfang] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Lin, Zhengxiu; Shi, Jiandong] Wenzhou Med Univ, Affiliated Hosp & Yuying Childrens Hosp 2, Wenzhou, Peoples R China	Wenzhou University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, SZ (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China.; Wu, SZ (corresponding author), Wenzhou Med Univ, Eye Hosp, Wenzhou 325003, Zhejiang, Peoples R China.	wszlab@wmu.edu.cn		wu, shengzhou/0000-0003-1154-2369	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University [J02-20190204]; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF) [LY19H090011]; Start-up finding of Wenzhou Medical University [QTJ19019]	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF); Start-up finding of Wenzhou Medical University	Integrated project of State Key Laboratory of Ophthalmology, Optometry, and Visual Science, Wenzhou Medical University, Grant/ Award Number: J02-20190204; NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF), Grant/Award Number: LY19H090011; Start-up finding of Wenzhou Medical University, Grant/Award Number: QTJ19019	Balu DT, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104511; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Balu DT, 2012, NEUROSCI LETT, V517, P77, DOI 10.1016/j.neulet.2012.04.020; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonnefont J, 2021, CURR OPIN NEUROBIOL, V66, P195, DOI 10.1016/j.conb.2020.12.006; Bosse KR, 2016, CANCER-AM CANCER SOC, V122, P20, DOI 10.1002/cncr.29706; Cai JJ, 2019, EXP CELL RES, V374, P231, DOI 10.1016/j.yexcr.2018.11.028; Carruthers S, 2003, MECH DEVELOP, V120, P607, DOI 10.1016/S0925-4773(03)00010-8; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fuchs SA, 2012, JIMD REP, V6, P47, DOI 10.1007/8904_2011_116; Gaviglio AL, 2017, FASEB J, V31, P1903, DOI 10.1096/fj.201600828R; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Jiang MR, 2011, CURR TOP DEV BIOL, V94, P77, DOI 10.1016/B978-0-12-380916-2.00004-8; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muhlethaler-Mottet A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-55; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Nelson DL, 2017, J BIOL CHEM, V292, P13986, DOI 10.1074/jbc.M117.777904; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ohshima K, 2020, NAT METAB, V2, P81, DOI 10.1038/s42255-019-0156-2; Ortiz-Sanz C, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04687-y; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Piubelli L, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01202-3; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Sasaki K, 2000, MOL BRAIN RES, V77, P209, DOI 10.1016/S0169-328X(00)00053-X; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schmitt HP, 2005, PSYCHOPHARMACOLOGY, V179, P151, DOI 10.1007/s00213-004-2110-5; Thompson M, 2012, J NEUROCHEM, V120, P598, DOI 10.1111/j.1471-4159.2011.07601.x; Waters AM, 2015, MOL CANCER THER, V14, P1559, DOI 10.1158/1535-7163.MCT-14-1103; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2; Wu SZ, 2007, CURR ALZHEIMER RES, V4, P243; Xia M, 2016, J NEUROCHEM, V138, P518, DOI 10.1111/jnc.13663; Xiao YG, 2013, J BIOL CHEM, V288, P20034, DOI 10.1074/jbc.M113.458612; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Yasuda K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.19; Zhang H, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194597; Zhang H, 2017, MOL CELL NEUROSCI, V85, P119, DOI 10.1016/j.mcn.2017.09.005	54	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22473	10.1096/fj.202200394RRR	http://dx.doi.org/10.1096/fj.202200394RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3V0NJ	35976172	Green Submitted			2022-12-28	WOS:000841359300001
J	Li, S; Liu, GY; Liu, L; Li, FC				Li, Shu; Liu, Gongyan; Liu, Lei; Li, Fuchang			Methionine can subside hair follicle development prejudice of heat-stressed rex rabbits	FASEB JOURNAL			English	Article						hair follicle development; heat shock; methionine; rabbit; signaling pathway	GENE-EXPRESSION; GROWTH-FACTOR; MORPHOGENESIS; REGULATOR; EGF; METABOLISM; PROTEINS; NOGGIN; FGF5	In the present experiment, we study the function of methionine on hair follicle development in heat-stressed Rex Rabbits and its potential molecular mechanism. Rex rabbits were randomly divided into 5 groups (30 replicates per group): control group (20-25 degrees C, fed basic diet), heat stress group (30-34 degrees C, fed basic diet), heat stress + methionine group (30-34 degrees C, fed 0.15% methionine in addition to the basic diet). fed basic diet (control), heat stress + methionine group (30-34 degrees C, fed 0.3% methionine in addition to the basic diet), heat stress + methionine group (30-34 degrees C, fed 0.45% methionine in addition to the basic diet). The results show that heat stress decreases the hair follicle density of Rex rabbits, and the diet methionine addition significantly increases the hair follicle density of heat-stressed Rabbits (p < .05). Heat stress increased serum HSP70 concentration and skin HSP70 gene expression, 0.15%-0.3% methionine but not 0.45% addition alleviated the effect of heat stress. Dietary 0.15% methionine addition significantly increases the gene expression of Wnt10b, beta-catenin, LEF, FZD4, LRP6, Shh, HGF, EGF, and Noggin in heat-stressed Rex rabbits and observably decreases the gene expression of BMP2/4 and TGFb. There was no significant effect of methionine on the expression of IGF1 and FGF5/7 gene expression. In conclusion, methionine maybe promotes hair follicle development via TGF beta-BMP/Shh-Noggin, Wnt10b/beta-catenin, EGF, and HGF signaling pathways in heat-stressed rabbits.	[Li, Shu; Liu, Lei; Li, Fuchang] Shandong Agr Univ, Dept Anim Sci, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Peoples R China; [Liu, Gongyan] Shandong Acad Agr Sci, Inst Anim Husb & Vet Med, Jinan, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University; Shandong Academy of Agricultural Sciences	Liu, L; Li, FC (corresponding author), Shandong Agr Univ, Dept Anim Sci, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Peoples R China.	leiliu@sdau.edu.cn; chlf@sdau.edu.cn		Li, Shu/0000-0001-8735-3092; Li, Fuchang/0000-0002-5670-8038	National Natural Science Foundation of China (NSFC) [31972594]; China Agriculture Research System of MOF and MARA [CARS-43-B-1]; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong) [ZR2021MC043]; Shandong "Double Tops" Program; Special Economic Animal Industry Technology System of Shandong Province [SDAIT-21-16]; Shandong Post-doctoral Innovation Project	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Agriculture Research System of MOF and MARA(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong); Shandong "Double Tops" Program; Special Economic Animal Industry Technology System of Shandong Province; Shandong Post-doctoral Innovation Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972594; China Agriculture Research System of MOF and MARA, Grant/Award Number: CARS-43-B-1; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong), Grant/Award Number: ZR2021MC043; Shandong "Double Tops" Program; Shandong Post--doctoral Innovation Project; Special Economic Animal Industry Technology System of Shandong Province, Grant/Award Number: SDAIT--21--16	Ahmed K, 2012, INT J HYPERTHER, V28, P1, DOI 10.3109/02656736.2011.627408; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Butt H, 2020, EUR J PHARMACOL, V872, DOI 10.1016/j.ejphar.2020.172958; Calvo-Sanchez MI, 2019, J MOL CELL BIOL, V11, P39, DOI 10.1093/jmcb/mjy051; Chovatiya GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11830-9; Fu C, 2018, ANIMAL, V12, P1895, DOI 10.1017/S1751731117003275; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Iino M, 2007, J INVEST DERMATOL, V127, P1318, DOI 10.1038/sj.jid.5700728; Kim WS, 2020, ANIMAL, V14, P1502, DOI 10.1017/S1751731120000075; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2012, SEMIN CELL DEV BIOL, V23, P906, DOI 10.1016/j.semcdb.2012.08.003; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marai IFM, 2001, TROP ANIM HEALTH PRO, V33, P451, DOI 10.1023/A:1012772311177; Martino PA, 2021, EXP DERMATOL, V30, P512, DOI 10.1111/exd.14204; MOORE GPM, 1987, ANN ZOOTECH, V36, P433, DOI 10.1051/animres:19870407; Morimoto RI, 1990, STRESS PROTEINS BIOL; Nicu C, 2021, J INVEST DERMATOL, V141, P1633, DOI 10.1016/j.jid.2020.12.019; Ock SA, 2020, CELL STRESS CHAPERON, V25, P503, DOI 10.1007/s12192-020-01090-4; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Parkhitko AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13034; Patel S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02872; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P186, DOI 10.1111/1523-1747.ep12371760; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P857, DOI 10.1111/1523-1747.ep12382494; Qiao X, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038589; Richardson GD, 2009, DEVELOPMENT, V136, P2153, DOI 10.1242/dev.031427; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sejian V, 2018, ANIMAL, V12, pS431, DOI 10.1017/S1751731118001945; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; SHINOZUKA H, 1993, J NUTR BIOCHEM, V4, P610, DOI 10.1016/0955-2863(93)90031-Q; Sun HT, 2019, J ANIM PHYSIOL AN N, V103, P501, DOI 10.1111/jpn.13044; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thompson SM, 2018, INT J HYPERTHER, V34, P812, DOI 10.1080/02656736.2017.1385859; Walvekar AS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02624; Wang Y, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020255; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Wu P, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.198671; Yue ZK, 2022, J SCI FOOD AGR, V102, P2291, DOI 10.1002/jsfa.11567; Zhang HH, 2013, J ANIM PHYSIOL AN N, V97, P1036, DOI 10.1111/jpn.12007; Zhao B, 2018, ANIM GENET, V49, P428, DOI 10.1111/age.12701; Zhao JG, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.666860; Zhu YL, 2020, J ANIM PHYSIOL AN N, V104, P379, DOI 10.1111/jpn.13238	48	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22464	10.1096/fj.202200520	http://dx.doi.org/10.1096/fj.202200520			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3E6EJ	35881391				2022-12-28	WOS:000830075700001
J	Miao, RR; Zhan, S; Cui, SX; Qu, XJ				Miao, Rong-Rong; Zhan, Sheng; Cui, Shu-Xiang; Qu, Xian-Jun			Intestinal aberrant sphingolipid metabolism shaped-gut microbiome and bile acids metabolome in the development of hepatic steatosis	FASEB JOURNAL			English	Article						BAs metabolome; conjugated bile acids; gut microbiota; intestinal SphK1; S1P; intestinal SphK2	SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; BETA; ACTIVATION; DISEASE; ROLES	Conjugated bile acids (CBAs) play major roles in hepatic gene regulation via nuclear S1P-inhibited histone deacetylase (HDACs). Gut microbiota modifies bile acid pool to generate CBAs and then CBAs returned to liver to regulate hepatic genes, fatty liver, and non-alcoholic fatty liver disease (NAFLD). However, it is not yet known how the gut microbiota was modified under the environment of inflammatory bowel disease (IBD). Here, we revealed that aberrant intestinal sphingosine kinases (SphKs), a major risk factor of IBD, modified gut microbiota by increasing the proportions of Firmicutes and Verrucomicrobia, which were associated with the increase in CBAs. When exposed to a high-fat diet (HFD), sphingosine kinases 2 knockout (SphK2KO) mice developed more severity of intestinal inflammation and hepatic steatosis than their wild-type (WT) littermates. Due to knockdown of nuclear SphK2, Sphk2KO mice exhibited an increase in sphingosine kinases 1 (SphK1) and sphingosine-1-phosphate (S1P) in intestinal epithelial cells. Therefore, the microbiota was modified in the environment of the SphK1/S1P-induced IBD. 16S rDNA amplicon sequencing of cecal contents indicated an increase of Firmicutes and Verrucomicrobia. Ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) measured an increase in CBAs, including taurocholic acid (TCA), taurodeoxycholic acid (TDCA), and glycocholic acid (GCA), in cecal contents and liver tissues of Sphk2KO mice. These CBAs accumulated in the liver promoted hepatic steatosis through downregulating the acetylation of H3K9, H3K14, H3K18 and H3K27 due to the CBAs-S1PR2-nuclear SphK2-S1P signaling pathway was blocked in HFD-SphK2KO mice. In summary, intestinal aberrant sphingolipid metabolism developed hepatic steatosis through the increase in CBAs associated with an increase in Firmicutes and Verrucomicrobia.	[Miao, Rong-Rong; Zhan, Sheng; Qu, Xian-Jun] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China; [Cui, Shu-Xiang] Capital Med Univ, Sch Publ Hlth, Toxicol & Sanit Chem, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Qu, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing, Peoples R China.	qxj@ccmu.edu.cn			Beijing Municipal Natural Science Foundation [7212149]; National Natural Science Foundation of China [82173841/81872884/81973350]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Municipal Natural Science Foundation (7212149) and National Natural Science Foundation of China (82173841/81872884/81973350).	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Crespo I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030288; Di Pardo A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00100; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gaidos JKJ, 2017, DIGEST DIS SCI, V62, P1362, DOI 10.1007/s10620-017-4552-8; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Hylemon Phillip B, 2017, Liver Res, V1, P10, DOI 10.1016/j.livres.2017.03.002; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307; Kapil S, 2016, J GASTROEN HEPATOL, V31, P213, DOI 10.1111/jgh.13058; Karuppuchamy T, 2017, MUCOSAL IMMUNOL, V10, P162, DOI 10.1038/mi.2016.35; Kwong E, 2015, ACTA PHARM SIN B, V5, P151, DOI 10.1016/j.apsb.2014.12.009; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Milosevic I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020395; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nagahashi M, 2016, J LIPID RES, V57, P1636, DOI 10.1194/jlr.R069286; Nagahashi M, 2015, HEPATOLOGY, V61, P1216, DOI 10.1002/hep.27592; Ni Y, 2016, ANAL CHEM, V88, P8802, DOI 10.1021/acs.analchem.6b02222; Nielsen OH, 2017, TRENDS MOL MED, V23, P362, DOI 10.1016/j.molmed.2017.02.002; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Safari Z, 2019, CELL MOL LIFE SCI, V76, P1541, DOI 10.1007/s00018-019-03011-w; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Suh JH, 2018, INFLAMM BOWEL DIS, V24, P1321, DOI 10.1093/ibd/izy007; Verhoog S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071565; Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang JH, 2013, P NATL ACAD SCI USA, V110, P17017, DOI 10.1073/pnas.1315558110; Wang YQ, 2017, HEPATOLOGY, V65, P2005, DOI 10.1002/hep.29076; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219	46	1	1	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22398	10.1096/fj.202200148RR	http://dx.doi.org/10.1096/fj.202200148RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5TB	35792869				2022-12-28	WOS:000821173400001
J	Zhong, WS; Chen, WM; Liu, YY; Zhang, JM; Lu, Y; Wan, X; Qiao, YJ; Huang, HH; Zeng, ZJ; Li, W; Meng, XJ; Zhao, HJ; Zou, MC; Cai, SX; Dong, HM				Zhong, Wenshan; Chen, Weimou; Liu, Yuanyuan; Zhang, Jinming; Lu, Ye; Wan, Xuan; Qiao, Yujie; Huang, Haohua; Zeng, Zhaojin; Li, Wei; Meng, Xiaojing; Zhao, Haijin; Zou, Mengchen; Cai, Shaoxi; Dong, Hangming			Extracellular HSP90 alpha promotes cellular senescence by modulating TGF-beta signaling in pulmonary fibrosis	FASEB JOURNAL			English	Article						cellular senescence; HSP90 heat-shock proteins; mitochondria; pulmonary fibrosis; reactive oxygen species; transforming growth factor beta	LUNG; SUSCEPTIBILITY; MITOCHONDRIA; FIBROBLASTS; ACTIVATION; MECHANISMS; PROTEINS; RECEPTOR; STRESS; CANCER	Recent findings suggest that extracellular heat shock protein 90 alpha (eHSP90 alpha) promotes pulmonary fibrosis, but the underlying mechanisms are not well understood. Aging, especially cellular senescence, is a critical risk factor for idiopathic pulmonary fibrosis (IPF). Here, we aim to investigate the role of eHSP90 alpha on cellular senescence in IPF. Our results found that eHSP90 alpha was upregulated in bleomycin (BLM)-induced mice, which correlated with the expression of senescence markers. This increase in eHSP90 alpha mediated fibroblast senescence and facilitated mitochondrial dysfunction. eHSP90 alpha activated TGF-beta signaling through the phosphorylation of the SMAD complex. The SMAD complex binding to p53 and p21 promoters triggered their transcription. In vivo, the blockade of eHSP90 alpha with 1G6-D7, a specific eHSP90 alpha antibody, in old mice attenuated the BLM-induced lung fibrosis. Our findings elucidate a crucial mechanism underlying eHSP90 alpha-induced cellular senescence, providing a framework for aging-related fibrosis interventions.	[Zhong, Wenshan; Chen, Weimou; Liu, Yuanyuan; Zhang, Jinming; Lu, Ye; Wan, Xuan; Qiao, Yujie; Huang, Haohua; Zeng, Zhaojin; Zhao, Haijin; Cai, Shaoxi; Dong, Hangming] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou, Peoples R China; [Li, Wei] Univ Southern Calif, Keck Med Ctr, USC Norris Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90007 USA; [Meng, Xiaojing] Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Occupat Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Peoples R China; [Zou, Mengchen] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China	Southern Medical University - China; University of Southern California; Southern Medical University - China; Southern Medical University - China	Cai, SX; Dong, HM (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou, Peoples R China.	hxkc@smu.edu.cn; dhm@smu.edu.cn	liu, yuanyuan/GWZ-5838-2022		NSFC | National Natural Science Foundation of China [81870058, 82170032]	NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	NSFC | National Natural Science Foundation of China, Grant/Award Number: 81870058 and 82170032	Barginear MF, 2008, CURR CANCER DRUG TAR, V8, P522, DOI 10.2174/156800908785699379; Bellaye PS, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00386-2017; Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018; Chanda D, 2019, MOL ASPECTS MED, V65, P56, DOI 10.1016/j.mam.2018.08.004; Chen WM, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.744826; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P769, DOI 10.1289/ehp.0901631; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong HM, 2017, AM J PHYSIOL-LUNG C, V313, pL1006, DOI 10.1152/ajplung.00489.2016; Dong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20605; Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Gupta SD, 2020, INT J BIOL MACROMOL, V161, P1086, DOI 10.1016/j.ijbiomac.2020.06.115; He MY, 2019, AGING CELL, V18, DOI 10.1111/acel.13003; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hernandez-Gonzalez F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137012; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Kanugovi AV, 2020, J CELL BIOCHEM, V121, P2770, DOI 10.1002/jcb.29493; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kolb P, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01105-2019; Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020; Kurundkar A, 2016, REDOX BIOL, V9, P67, DOI 10.1016/j.redox.2016.06.005; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26603-2; Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016; Li XY, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00316-9; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mishra A, 2022, ALLERGY, V77, P1165, DOI 10.1111/all.15180; Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Schuliga M, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101405; Schulte H, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01466; Secli L, 2021, CANCER RES, V81, P4794, DOI 10.1158/0008-5472.CAN-20-3150; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shin HJ, 2021, AGING CELL, V20, DOI 10.1111/acel.13410; Sibinska Z, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01941-2015; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Spagnolo P, 2021, PHARMACOL THERAPEUT, V222, DOI 10.1016/j.pharmthera.2020.107798; Stout-Delgado HW, 2016, AM J RESP CELL MOL, V55, P252, DOI 10.1165/rcmb.2015-0222OC; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tian Y, 2019, J CELL SCI, V132, DOI 10.1242/jcs.228213; Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002; Tsen F, 2013, MOL CELL BIOL, V33, P4947, DOI 10.1128/MCB.00559-13; Tsubouchi K, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0077-6; Yanai H, 2015, AGING-US, V7, P664, DOI 10.18632/aging.100807; Yao LH, 2016, BRIT J PHARMACOL, V173, P2600, DOI 10.1111/bph.13539; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zou M, 2017, ONCOGENE, V36, P2160, DOI 10.1038/onc.2016.375	56	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22475	10.1096/fj.202200406RR	http://dx.doi.org/10.1096/fj.202200406RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3F9XC	35899478	hybrid			2022-12-28	WOS:000831011700001
J	Boyd, RJ; Olson, TL; Zook, JD; Stein, D; Aceves, M; Lin, WH; Craciunescu, FM; Hansen, DT; Anastasiadis, PZ; Singharoy, A; Fromme, P				Boyd, Ryan J.; Olson, Tien L.; Zook, James D.; Stein, Derek; Aceves, Manuel; Lin, Wan-Hsin; Craciunescu, Felicia M.; Hansen, Debra T.; Anastasiadis, Panos Z.; Singharoy, Abhishek; Fromme, Petra			Characterization and computational simulation of human Syx, a RhoGEF implicated in glioblastoma	FASEB JOURNAL			English	Article						Dbl homology; DH domain; GEF; glioblastoma; lipid binding protein; membrane-associated protein; molecular dynamics; oncogene; PH domain; PIP; protein dynamics; protein engineering; protein-protein interactions; RhoA; RhoGEF; small GTPase; structure-guided drug design	GUANINE-NUCLEOTIDE EXCHANGE; PLECKSTRIN HOMOLOGY DOMAINS; CIRCULAR-DICHROISM SPECTRA; WEB SERVER; SELECTIVE-ACTIVATION; ADHERENS JUNCTIONS; PDZ-RHOGEF; PH DOMAIN; PROTEIN; RHOA	Structural discovery of guanine nucleotide exchange factor (GEF) protein complexes is likely to become increasingly relevant with the development of new therapeutics targeting small GTPases and development of new classes of small molecules that inhibit protein-protein interactions. Syx (also known as PLEKHG5 in humans) is a RhoA GEF implicated in the pathology of glioblastoma (GBM). Here we investigated protein expression and purification of ten different human Syx constructs and performed biophysical characterizations and computational studies that provide insights into why expression of this protein was previously intractable. We show that human Syx can be expressed and isolated and Syx is folded as observed by circular dichroism (CD) spectroscopy and actively binds to RhoA as determined by co-elution during size exclusion chromatography (SEC). This characterization may provide critical insights into the expression and purification of other recalcitrant members of the large class of oncogenic-Diffuse B-cell lymphoma (Dbl) homology GEF proteins. In addition, we performed detailed homology modeling and molecular dynamics simulations on the surface of a physiologically realistic membrane. These simulations reveal novel insights into GEF activity and allosteric modulation by the plekstrin homology (PH) domain. These newly revealed interactions between the GEF PH domain and the membrane embedded region of RhoA support previously unexplained experimental findings regarding the allosteric effects of the PH domain from numerous activity studies of Dbl homology GEF proteins. This work establishes new hypotheses for structural interactivity and allosteric signal modulation in Dbl homology RhoGEFs.	[Boyd, Ryan J.; Olson, Tien L.; Zook, James D.; Stein, Derek; Aceves, Manuel; Craciunescu, Felicia M.; Hansen, Debra T.; Singharoy, Abhishek; Fromme, Petra] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, 797 E Tyler St, Tempe, AZ 85287 USA; [Lin, Wan-Hsin; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Hansen, Debra T.] Arizona State Univ, Ctr Innovat Med, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Arizona State University; Arizona State University-Tempe	Boyd, RJ (corresponding author), Arizona State Univ, Biodesign Ctr Appl Struct Discovery, 797 E Tyler St, Tempe, AZ 85287 USA.	rjboyd1@asu.edu; Petra.Fromme@asu.edu	Boyd, Ryan/GZH-1468-2022	Boyd, Ryan/0000-0002-6704-8696	HHS | National Institutes of Health (NIH) [R01NS101721-A1]; Mayo Clinic | Center for Clinical and Translational Science, Mayo Clinic (CCaTS); ASU | Biodesign Institute, Arizona State University	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic | Center for Clinical and Translational Science, Mayo Clinic (CCaTS); ASU | Biodesign Institute, Arizona State University	HHS | National Institutes of Health (NIH), Grant/Award Number: R01NS101721-A1; Mayo Clinic | Center for Clinical and Translational Science, Mayo Clinic (CCaTS); ASU | Biodesign Institute, Arizona State University	Aspenstrom P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123949; Austerberry JI, 2019, BIOCHEMISTRY-US, V58, P3413, DOI 10.1021/acs.biochem.9b00367; Azeez KRA, 2014, BIOCHEM J, V464, P231, DOI 10.1042/BJ20140606; Bielnicki JA, 2011, J BIOL CHEM, V286, P35163, DOI 10.1074/jbc.M111.270918; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Chan P, 2013, SCI REP-UK, V3, DOI 10.1038/srep03333; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Dachsel JC, 2013, MOL CELL BIOL, V33, P4909, DOI 10.1128/MCB.00565-13; DeLuca S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132508; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fort P, 2017, GENOME BIOL EVOL, V9, P1471, DOI 10.1093/gbe/evx100; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Garrard SM, 2001, PROTEIN EXPRES PURIF, V21, P412, DOI 10.1006/prep.2001.1392; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; HARLAN JE, 1995, BIOCHEMISTRY-US, V34, P9859, DOI 10.1021/bi00031a006; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hebditch M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36950-8; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jian XY, 2012, J BIOL CHEM, V287, P24273, DOI 10.1074/jbc.M112.368084; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jubb H, 2012, TRENDS PHARMACOL SCI, V33, P241, DOI 10.1016/j.tips.2012.03.006; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kim S, 2017, J COMPUT CHEM, V38, P1879, DOI 10.1002/jcc.24829; Kosobokova EN, 2016, BIOCHEMISTRY-MOSCOW+, V81, P187, DOI 10.1134/S0006297916030019; Kothiwale S, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0095-1; Lattner J, 2019, ELIFE, V8, DOI 10.7554/eLife.50900; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luningschror P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00689-z; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mavridis L, 2017, BIOINFORMATICS, V33, P56, DOI 10.1093/bioinformatics/btw554; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Miles AJ, 2022, PROTEIN SCI, V31, P37, DOI 10.1002/pro.4153; Naughton FB, 2018, J MOL BIOL, V430, P372, DOI 10.1016/j.jmb.2017.12.011; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Ngok SP, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27132; Ngok SP, 2014, J CELL SCI, V127, P3205, DOI 10.1242/jcs.153197; Ngok SP, 2013, J BIOL CHEM, V288, P6640, DOI 10.1074/jbc.M112.432682; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pina AS, 2014, BIOTECHNOL ADV, V32, P366, DOI 10.1016/j.biotechadv.2013.12.001; Qian MY, 2019, INT J CLIN ONCOL, V24, P1350, DOI 10.1007/s10147-019-01503-0; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Robertson KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53830-x; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Roy N.S., 2016, CELL LOGIST, V6, pe1181700, DOI [10.1080/21592799.2016.1181700, DOI 10.1080/21592799.2016.1181700]; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yamamoto E, 2017, BIOPHYS PHYSICOBIOL, V14, P153, DOI 10.2142/biophysico.14.0_153; Yamamoto E, 2016, STRUCTURE, V24, P1421, DOI 10.1016/j.str.2016.06.002; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	81	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22378	10.1096/fj.202101808RR	http://dx.doi.org/10.1096/fj.202101808RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1RZ	35639414	Green Published, Green Submitted			2022-12-28	WOS:000803156100001
J	Chase, R; de la Pena, JB; Smith, PR; Lawson, J; Lou, TF; Stanowick, AD; Black, BJ; Campbell, ZT				Chase, Rebecca; de la Pena, June Bryan; Smith, Patrick R.; Lawson, Jennifer; Lou, Tzu-Fang; Stanowick, Alexander D.; Black, Bryan J.; Campbell, Zachary T.			Global analyses of mRNA expression in human sensory neurons reveal eIF5A as a conserved target for inflammatory pain	FASEB JOURNAL			English	Article						eIF5A; hiPSC sensory neurons; hypusine; nociceptor plasticity; pain	SATELLITE GLIAL-CELLS; NEUROPATHIC PAIN; PROTEIN-SYNTHESIS; IMMUNE CELLS; HYPUSINE; GANGLIA; PLASTICITY; IDENTIFICATION; ACTIVATION; INHIBITION	Nociceptors are a type of sensory neuron that are integral to most forms of pain. Targeted disruption of nociceptor sensitization affords unique opportunities to prevent pain. An emerging model for nociceptors are sensory neurons derived from human stem cells. Here, we subjected five groups to high-throughput sequencing: human induced pluripotent stem cells (hiPSCs) prior to differentiation, mature hiPSC-derived sensory neurons, mature co-cultures containing hiPSC-derived astrocytes and sensory neurons, mouse dorsal root ganglion (DRG) tissues, and mouse DRG cultures. Co-culture of nociceptors and astrocytes promotes expression of transcripts enriched in DRG tissues. Comparisons of the hiPSC models to tissue samples reveal that many key transcripts linked to pain are present. Markers indicative of a range of neuronal subtypes present in the DRG were detected in mature hiPSCs. Intriguingly, translation factors were maintained at consistently high expression levels across species and culture systems. As a proof of concept for the utility of this resource, we validated expression of eukaryotic initiation factor 5A (eIF5A) in DRG tissues and hiPSC samples. eIF5A is subject to a unique posttranslational hypusine modification required for its activity. Inhibition of hypusine biosynthesis prevented hyperalgesic priming by inflammatory mediators in vivo and diminished hiPSC activity in vitro. Collectively, our results illuminate the transcriptomes of hiPSC sensory neuron models. We provide a demonstration for this resource through our investigation of eIF5A. Our findings reveal hypusine as a potential target for inflammation associated pain in males.	[Chase, Rebecca; de la Pena, June Bryan; Smith, Patrick R.; Lou, Tzu-Fang; Stanowick, Alexander D.; Campbell, Zachary T.] Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd,RL10 BSB 12-510, Richardson, TX 75080 USA; [Lawson, Jennifer; Black, Bryan J.] Univ Massachusetts Lowell, Dept Biomed Engn, Lowell, MA 01854 USA; [Campbell, Zachary T.] Univ Texas Dallas, Ctr Adv Pain Studies, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Massachusetts System; University of Massachusetts Lowell; University of Texas System; University of Texas Dallas	Campbell, ZT (corresponding author), Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd,RL10 BSB 12-510, Richardson, TX 75080 USA.; Black, BJ (corresponding author), Univ Massachusetts Lowell, Dept Biomed Engn, Lowell, MA 01854 USA.	bryan_black@uml.edu; zachary.campbell@utdallas.edu			HHS | NIH | National Center for Advancing Translational Sciences (NCATS) [1UG3TR003149]	HHS | NIH | National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/Award Number: 1UG3TR003149; HHS | NIH | National Institute of Neurological Disorders and	Afroz S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030711; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Allende G, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00628; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balukoff NC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19602-2; Barragan-Iglesias P, 2021, PAIN, V162, P1864, DOI 10.1097/j.pain.0000000000002191; Barragan-Iglesias P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02449-5; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Black BJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00304; Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carlton MDJ., 2006, U.S. Pat Appl Publ, Patent No. [2006/0242724 A1, 20060242724]; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clark AJ, 2017, BRAIN, V140, P898, DOI 10.1093/brain/awx012; Coni S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03174-6; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; de la Pena JB, 2021, J NEUROSCI, V41, P7712, DOI 10.1523/JNEUROSCI.0440-21.2021; de la Pena JB, 2021, BRIT J PHARMACOL, V178, P4675, DOI 10.1111/bph.15646; de la Pena June Bryan, 2018, Neurobiol Pain, V4, P2, DOI 10.1016/j.ynpai.2018.01.003; de la Pena JBI, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1546; Dedek A., 2021, BRAIN, V145, P1124; Dubovy P, 2010, NEURON GLIA BIOL, V6, P73, DOI 10.1017/S1740925X10000074; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Fang CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178960; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Freshour SL, 2021, NUCLEIC ACIDS RES, V49, pD1144, DOI 10.1093/nar/gkaa1084; Gene Ontology Consortium, 2021, NUCLEIC ACIDS RES, V49, pD325, DOI 10.1093/nar/gkaa1113; Gosselin RD, 2010, NEUROSCIENTIST, V16, P519, DOI 10.1177/1073858409360822; Green DP, 2021, NEUROSCI LETT, V744, DOI 10.1016/j.neulet.2020.135544; Hanani M, 2002, NEUROSCIENCE, V114, P279, DOI 10.1016/S0306-4522(02)00279-8; Hasel P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15132; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hou WY, 1997, NEUROSCI LETT, V227, P99, DOI 10.1016/S0304-3940(97)00321-2; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jones I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34280-3; Joseph EK, 2003, PAIN, V105, P143, DOI 10.1016/S0304-3959(03)00175-1; Kendall G, 1996, J NEUROSCI RES, V45, P96, DOI 10.1002/(SICI)1097-4547(19960715)45:2<96::AID-JNR2>3.0.CO;2-A; Khoutorsky A, 2018, TRENDS NEUROSCI, V41, P100, DOI 10.1016/j.tins.2017.11.006; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kupari J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21725-z; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Lin X, 2014, CURR MED CHEM, V21, P4405, DOI 10.2174/0929867321666140915143040; Loerch S., 2021, OXFORD HDB NEURONAL, P426; Manjunath H, 2019, CELL REP, V29, P3134, DOI 10.1016/j.celrep.2019.10.129; McDermott LA, 2019, NEURON, V101, P905, DOI 10.1016/j.neuron.2019.01.047; Meents JE, 2019, PAIN, V160, P1327, DOI 10.1097/j.pain.0000000000001511; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Melemedjian OK, 2010, J NEUROSCI, V30, P15113, DOI 10.1523/JNEUROSCI.3947-10.2010; Mitterreiter JG, 2017, EUR J IMMUNOL, V47, P1181, DOI 10.1002/eji.201746989; Moehring F, 2018, ELIFE, V7, DOI [10.7554/elife.31684, 10.7554/eLife.31684]; Nakanishi S, 2016, AMINO ACIDS, V48, P2353, DOI 10.1007/s00726-016-2275-3; Nguyen M.T., 2021, ELECTRONICS, V10, P1; Pace MC, 2018, J CELL PHYSIOL, V233, P2824, DOI 10.1002/jcp.25993; Park MH, 1997, BIOL SIGNAL, V6, P115; Park MH., 2021, AMINO ACIDS, V1, P1; Pei L, 2011, BRIT J ANAESTH, V107, P948, DOI 10.1093/bja/aer299; Pettingill P, 2019, BRAIN, V142, P3852, DOI 10.1093/brain/awz342; Ray P, 2018, PAIN, V159, P1325, DOI 10.1097/j.pain.0000000000001217; RC Team, 2012, R LANG ENV STAT COMP; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rouwette TPH, 2010, J PAIN, V11, P930, DOI 10.1016/j.jpain.2009.12.017; RStudio Team, 2015, RSTUDIO INT DEV R; Sadler KE, 2020, ELIFE, V9, DOI 10.7554/eLife.58625; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Schultz CR, 2018, BIOCHEM J, V475, P531, DOI 10.1042/BCJ20170597; Sharma DK, 2016, J NUCLEIC ACIDS, V2016, DOI 10.1155/2016/8235121; Shen ZX, 2020, ADV PHOTONICS, V2, DOI 10.1117/1.AP.2.3.036002; Shiers S, 2020, PAIN, V161, P2410, DOI 10.1097/j.pain.0000000000001973; Shipton EA, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/329364; Shukla TN, 2020, RNA BIOL, V17, P417, DOI 10.1080/15476286.2020.1717059; Sikandar S, 2018, BRAIN, V141, P1028, DOI 10.1093/brain/awy009; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; STEPHENSON JL, 1995, EXP NEUROL, V131, P11, DOI 10.1016/0014-4886(95)90003-9; Takeda M, 2009, NEUROSCI BIOBEHAV R, V33, P784, DOI 10.1016/j.neubiorev.2008.12.005; Tavares-Ferreira D., 2022, SCI TRANSL MED, V14, P1; Thacker BE, 2016, ACS CHEM BIOL, V11, P971, DOI 10.1021/acschembio.5b00897; Tracey WD, 2017, CURR BIOL, V27, pR129, DOI 10.1016/j.cub.2017.01.037; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turpaev KT, 2018, BIOCHEMISTRY-MOSCOW+, V83, P863, DOI 10.1134/S0006297918080011; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vellani V, 2004, J PHYSIOL-LONDON, V560, P391, DOI 10.1113/jphysiol.2004.067462; Vinterhoj HSH, 2019, J PROTEOMICS, V190, P27, DOI 10.1016/j.jprot.2018.03.013; Wainger BJ, 2015, NAT NEUROSCI, V18, P17, DOI 10.1038/nn.3886; Wan DJ, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0576-7; Wang CM, 2019, FASEB J, V33, P1360, DOI 10.1096/fj.201800615RR; Wangzhou A, 2020, PAIN, V161, P1497, DOI 10.1097/j.pain.0000000000001866; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Weir GA, 2017, BRAIN, V140, P2570, DOI 10.1093/brain/awx201; WOODHAM P, 1989, NEUROSCI LETT, V98, P8, DOI 10.1016/0304-3940(89)90364-9; Xu AG, 2004, BIOCHEM J, V384, P585, DOI 10.1042/BJ20041232; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zimmer B, 2018, P NATL ACAD SCI USA, V115, pE8775, DOI 10.1073/pnas.1809853115	102	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22422	10.1096/fj.202101933RR	http://dx.doi.org/10.1096/fj.202101933RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2I4WL	35747924				2022-12-28	WOS:000814980400001
J	Green, CD; Weigel, C; Brown, RDR; Bedossa, P; Dozmorov, M; Sanyal, AJ; Spiegel, S				Green, Christopher D.; Weigel, Cynthia; Brown, Ryan D. R.; Bedossa, Pierre; Dozmorov, Mikhail; Sanyal, Arun J.; Spiegel, Sarah			A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; liver cancer; liver fibrosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis	FATTY LIVER-DISEASE; GENE-EXPRESSION; PATHOGENESIS; CHOLESTEROL; FRUCTOSE; CANCER; INFLAMMATION; ACTIVATION; HISTORY; PACKAGE	Non-alcoholic steatohepatitis (NASH) results from the accumulation of excessive liver lipids leading to hepatocellular injury, inflammation, and fibrosis that greatly increase the risk for hepatocellular carcinoma (HCC). Despite the well-characterized clinical and histological pathology for NASH-driven HCC in humans, its etiology remains unclear and there is a deficiency in pre-clinical models that recapitulate the progression of the human disease. Therefore, we developed a new mouse model amenable to genetic manipulations and gene targeting that mimics the gradual NASH to HCC progression observed in humans. C57BL/6NJ mice were fed a Western high-fat diet and sugar water (HFD/SW) and monitored for effects on metabolism, liver histology, tumor development, and liver transcriptome for up to 54 weeks. Chronic HFD/SW feeding led to significantly increased weight gain, serum and liver lipid levels, liver injury, and glucose intolerance. Hepatic pathology progressed and mice developed hepatocellular ballooning, inflammation, and worse fibrosis was apparent at 16 weeks, greatly increased through 32 weeks, and remained elevated at 54 weeks. Importantly, hepatocellular cancer spontaneously developed in 75% of mice on HFD/SW, half of which were HCC, whereas none of the mice on the chow diet developed HCC. Chronic HFD/SW induced molecular markers of de novo lipogenesis, endoplasmic reticulum stress, inflammation, and accumulation of p62, all of which also participate in the human pathology. Moreover, transcriptome analysis revealed activation of HCC-related genes and signatures associated with poor prognosis of human HCC. Overall, we have identified a new preclinical model that recapitulates known hallmarks of NASH-driven HCC that can be utilized for future molecular mechanistic studies of this disease.	[Green, Christopher D.; Weigel, Cynthia; Brown, Ryan D. R.; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, 2-017 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA; [Bedossa, Pierre; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23298 USA; [Bedossa, Pierre] Liverpat, Paris, France; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Biostat, Sch Med, Richmond, VA 23298 USA; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Pathol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Green, CD; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, 2-017 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	christopher.d.green@vcuhealth.org; sarah.spiegel@vcuhealth.org		Brown, Ryan/0000-0003-2880-0301; Weigel, Cynthia/0000-0003-3132-4203	National Institutes of Health [R01GM043880]; NIH-NCI Cancer Center Support [P30CA016059]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, Grant/ Award Number: R01GM043880; NIH-NCI Cancer Center Support, Grant/ Award Number: P30CA016059	Ahn KS, 2021, LIVER CANCER, V10, P593, DOI 10.1159/000516957; Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Cariou B, 2021, DIABETES OBES METAB, V23, P1069, DOI 10.1111/dom.14322; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2012, AM J PHYSIOL-GASTR L, V303, pG9, DOI 10.1152/ajpgi.00008.2012; Febbraio MA, 2019, CELL METAB, V29, P18, DOI 10.1016/j.cmet.2018.10.012; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Guy CD, 2012, HUM PATHOL, V43, P790, DOI 10.1016/j.humpath.2011.07.007; Hansen HH, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01356-2; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hou JJ, 2020, J HEPATOL, V72, P167, DOI 10.1016/j.jhep.2019.08.014; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/EGH.11.8, 10.1586/egh.11.8]; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Li YM, 2019, ONCOL LETT, V17, P4222, DOI 10.3892/ol.2019.10127; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Loomba R, 2012, HEPATOLOGY, V56, P943, DOI 10.1002/hep.25772; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mollerhoj MB, 2022, CTS-CLIN TRANSL SCI, V15, P1167, DOI 10.1111/cts.13235; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Pinyol R, 2021, J HEPATOL, V75, P865, DOI 10.1016/j.jhep.2021.04.049; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reibe S, 2019, NAT REV ENDOCRINOL, V15, P73, DOI 10.1038/s41574-018-0145-7; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohrbach TD, 2019, J LIPID RES, V60, P1311, DOI 10.1194/jlr.M093799; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Walenbergh SMA, 2015, EXPERT REV GASTROENT, V9, P1343, DOI 10.1586/17474124.2015.1092382; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	62	1	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22372	10.1096/fj.202200346R	http://dx.doi.org/10.1096/fj.202200346R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1HS	35639028	Green Published			2022-12-28	WOS:000803129400001
J	Xu, R; Cong, XJ; Zheng, Q; Xu, L; Ni, MJJ; March, CA; Matsunami, H; Golebiowski, J; Ma, MH; Yu, YQ				Xu, Rui; Cong, Xiaojing; Zheng, Qian; Xu, Lun; Ni, Mengjue J.; March, Claire A.; Matsunami, Hiroaki; Golebiowski, Jerome; Ma, Minghong; Yu, Yiqun			Interactions among key residues regulate mammalian odorant receptor trafficking	FASEB JOURNAL			English	Article						functional assay; heterologous expression; odor response; odorant receptor; site-directed mutagenesis	OLFACTORY RECEPTOR; FUNCTIONAL EXPRESSION; INTRACELLULAR RETENTION; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; MOUSE; ACTIVATION; FAMILY; OR1A1	Odorant receptors (ORs) expressed in mammalian olfactory sensory neurons are essential for the sense of smell. However, structure-function studies of many ORs are hampered by unsuccessful heterologous expression. To understand and eventually overcome this bottleneck, we performed heterologous expression and functional assays of over 80 OR variants and chimeras. Combined with literature data and machine learning, we found that the transmembrane domain 4 (TM4) and its interactions with neighbor residues are important for OR functional expression. The data highlight critical roles of T-4.62 therein. ORs that fail to reach the cell membrane can be rescued by modifications in TM4. Consequently, such modifications in MOR256-3 (Olfr124) also alter OR responses to odorants. T161(4.62)P causes the retention of MOR256-3 in the endoplasmic reticulum (ER), while T161(4.62)P/T148(4.49)A reverses the retention and makes receptor trafficking to cell membrane. This study offers new clues toward wide-range functional studies of mammalian ORs.	[Xu, Rui; Zheng, Qian] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Cong, Xiaojing; Golebiowski, Jerome] Univ Cote dAzur, Inst Chim Nice UMR7272, CNRS, Nice, France; [Cong, Xiaojing] Univ Montpellier, INSERM, CNRS, Inst Genom Fonct, F-34094 Montpellier 5, France; [Xu, Lun; Yu, Yiqun] Fudan Univ, Ear Nose & Throat Inst, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai 200031, Peoples R China; [Ni, Mengjue J.; March, Claire A.; Matsunami, Hiroaki] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC USA; [Ni, Mengjue J.; March, Claire A.; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Golebiowski, Jerome] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea; [Ma, Minghong] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yu, Yiqun] Fudan Univ, Clin & Res Ctr Olfactory Disorders, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China	Shanghai University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Fudan University; Duke University; Duke University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of Pennsylvania; Pennsylvania Medicine; Fudan University	Yu, YQ (corresponding author), Fudan Univ, Ear Nose & Throat Inst, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai 200031, Peoples R China.; Ma, MH (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA.	minghong@pennmedicine.upenn.edu; yu_yiqun@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [32070996, 31771155]; Science and Technology Commission of Shanghai Municipality (STCSM) [21140900600]; Eye, Ear, Nose and Throat Hospital, Fudan University, Excellent Doctors-Excellent Clinical Researchers Program [SYB202002]; NeuroMod Institute of the University of Cote d'Azur; Foundation for the National Institutes of Health (FNIH) [R01DC006213, R01DC016224]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); Eye, Ear, Nose and Throat Hospital, Fudan University, Excellent Doctors-Excellent Clinical Researchers Program; NeuroMod Institute of the University of Cote d'Azur; Foundation for the National Institutes of Health (FNIH)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32070996 and 31771155; Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 21140900600; Eye, Ear, Nose and Throat Hospital, Fudan University, Excellent Doctors-Excellent Clinical Researchers Program, Grant/Award Number: SYB202002; the NeuroMod Institute of the University of Cote d'Azur; Foundation for the National Institutes of Health (FNIH), Grant/ Award Number: R01DC006213 and R01DC016224	Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; Belloir C, 2017, PROTEIN EXPRES PURIF, V129, P31, DOI 10.1016/j.pep.2016.09.006; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bubnell J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141712; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bush CF, 2007, J BIOL CHEM, V282, P19042, DOI 10.1074/jbc.M610781200; de March CA, 2015, J AM CHEM SOC, V137, P8611, DOI 10.1021/jacs.5b04659; Fukutani Y, 2019, J BIOL CHEM, V294, P14661, DOI 10.1074/jbc.RA118.007110; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hall RA, 2009, ANN NY ACAD SCI, V1170, P147, DOI 10.1111/j.1749-6632.2009.03879.x; Ikegami K, 2020, P NATL ACAD SCI USA, V117, P2957, DOI 10.1073/pnas.1915520117; Jiang Y, 2015, NAT NEUROSCI, V18, P1446, DOI 10.1038/nn.4104; Kida H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06806-w; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Liu MT, 2018, ORG BIOMOL CHEM, V16, P2541, DOI [10.1039/c8ob00205c, 10.1039/C8OB00205C]; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 2005, CHEM SENSES, V30, pI95, DOI 10.1093/chemse/bjh131; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Singh V, 2019, P NATL ACAD SCI USA, V116, P9598, DOI 10.1073/pnas.1813230116; Tazir B, 2016, EUR J NEUROSCI, V43, P608, DOI 10.1111/ejn.13153; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179067; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	46	1	1	11	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22384	10.1096/fj.202200116RR	http://dx.doi.org/10.1096/fj.202200116RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1R1GW	35639289				2022-12-28	WOS:000803127200001
J	Luo, SQ; Su, T; Zhou, X; Hu, WX; Hu, JP				Luo, Saiqun; Su, Tao; Zhou, Xiang; Hu, Wei-Xin; Hu, Jingping			Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target	FASEB JOURNAL			English	Review						1p deletion; 1q gain; amplification; chromosome 1; multiple myeloma	PROGNOSTIC-FACTOR; HISTONE CHAPERONE; TUMOR-SUPPRESSOR; CD46 EXPRESSION; REMOVES H2A.Z; PROTEIN; ABNORMALITIES; SURVIVAL; PROMOTES; BINDING	Multiple myeloma (MM), the terminally differentiated B cells malignancy, is widely considered to be incurable since many patients have either developed drug resistance or experienced an eventual relapse. To develop precise and efficient therapeutic strategies, we must understand the pathogenesis of MM. Thus, unveiling the driver events of MM and its further clonal evolution will help us understand this complicated disease. Chromosome 1 instabilities are the most common genomic alterations that participate in MM pathogenesis, and these aberrations of chromosome 1 mainly include copy number variations and structural changes. The chromosome 1q gains/amplifications and 1p deletions are the most frequent structural changes of chromosomes in MM. In this review, we intend to focus on the genes that are affected by chromosome 1 instability: some tumor suppressors were lost or down regulated in 1p deletions, and others that contributed to tumorigenesis were upregulated in 1q gains/amplifications. We have summarized their biological function as well as their roles in the MM pathogenesis, hoping to uncover potential novel therapeutical targets and promote the development of future therapeutic approaches.	[Luo, Saiqun; Zhou, Xiang; Hu, Wei-Xin; Hu, Jingping] Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Su, Tao] Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha, Peoples R China	Central South University; Central South University	Hu, JP (corresponding author), Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	jingpinghu@csu.edu.cn		Hu, Jingping/0000-0001-5548-1241	National Natural Science Foundation of China [82070229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 82070229).	Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Beckwith DM, 2020, SEMIN IMMUNOL, V47, DOI 10.1016/j.smim.2020.101389; Berenson JR, 2020, CLIN CANCER RES, V26, P2346, DOI 10.1158/1078-0432.CCR-19-1899; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bolomsky A, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-01007-9; Boyd KD, 2011, CLIN CANCER RES, V17, P7776, DOI 10.1158/1078-0432.CCR-11-1791; Bretz J, 2011, BLOOD, V117, P2179, DOI 10.1182/blood-2010-06-288027; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chang H, 2007, LEUKEMIA RES, V31, P779, DOI 10.1016/j.leukres.2006.08.002; Chen MH, 2012, HUM PATHOL, V43, P858, DOI 10.1016/j.humpath.2011.07.013; Chng WJ, 2010, LEUKEMIA, V24, P833, DOI 10.1038/leu.2010.21; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Cohen AD, 2020, BLOOD, V136, DOI 10.1182/blood-2020-136985; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Egan EA, 1998, MOL CELL BIOL, V18, P3659, DOI 10.1128/MCB.18.7.3659; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Franz A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10612; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Geller A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01074; Giri S, 2020, BLOOD ADV, V4, P2245, DOI 10.1182/bloodadvances.2019001425; Gong JN, 2016, BLOOD, V128, P1834, DOI 10.1182/blood-2016-03-704908; Gursoy-Yuzugullu O, 2015, P NATL ACAD SCI USA, V112, P7507, DOI 10.1073/pnas.1504868112; Hanamura I, 2021, CANCERS, V13, DOI 10.3390/cancers13020256; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Hebraud B, 2014, LEUKEMIA, V28, P675, DOI 10.1038/leu.2013.225; Her C, 2007, FRONT BIOSCI-LANDMRK, V12, P905, DOI 10.2741/2112; Hofman IJF, 2017, LEUKEMIA, V31, P1706, DOI 10.1038/leu.2016.370; Hofman IJF, 2017, HAEMATOLOGICA, V102, pE317, DOI 10.3324/haematol.2016.162198; Hu JP, 2018, CANCER LETT, V414, P214, DOI 10.1016/j.canlet.2017.11.020; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Ise T, 2007, LEUKEMIA, V21, P169, DOI 10.1038/sj.leu.2404445; Kalkat M, 2018, MOL CELL, V72, P836, DOI 10.1016/j.molcel.2018.09.031; Kanasugi J, 2020, CANCER SCI, V111, P1663, DOI 10.1111/cas.14386; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kuchta K, 2016, NUCLEIC ACIDS RES, V44, P3534, DOI 10.1093/nar/gkw222; Kulkarni MS, 2002, LEUKEMIA, V16, P127, DOI 10.1038/sj.leu.2402328; Kumar SK, 2018, NAT REV CLIN ONCOL, V15, P409, DOI 10.1038/s41571-018-0018-y; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lazzari E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01890-w; Leone PE, 2008, CLIN CANCER RES, V14, P6033, DOI 10.1158/1078-0432.CCR-08-0347; Li J, 2017, CANCER CELL, V31, P383, DOI 10.1016/j.ccell.2017.02.001; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Lim YS, 2013, FEBS LETT, V587, P1703, DOI 10.1016/j.febslet.2013.04.036; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lok A, 2018, BLOOD ADV, V2, P3492, DOI 10.1182/bloodadvances.2018025106; Luo SQ, 2020, ONCOGENE, V39, P3354, DOI 10.1038/s41388-020-1222-7; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Manfrini N, 2020, CANCER RES, V80, P4693, DOI 10.1158/0008-5472.CAN-20-1357; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Manier S, 2017, NAT REV CLIN ONCOL, V14, P100, DOI 10.1038/nrclinonc.2016.122; Marchesini M, 2017, CANCER CELL, V32, P88, DOI 10.1016/j.ccell.2017.05.011; Marzin Y, 2006, ANTICANCER RES, V26, P953; Matthes T, 2016, CRIT REV ONCOL HEMAT, V105, P1, DOI 10.1016/j.critrevonc.2016.07.006; McAvoy S, 2008, GENE CHROMOSOME CANC, V47, P165, DOI 10.1002/gcc.20519; Meier T, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-00883-5; Melton PE, 2019, J HYPERTENS, V37, P997, DOI 10.1097/HJH.0000000000002023; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Mikesch JH, 2006, BBA-REV CANCER, V1766, P42, DOI 10.1016/j.bbcan.2006.04.001; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Mroczek S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00578-5; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; Neuse CJ, 2020, LEUKEMIA, V34, P2887, DOI 10.1038/s41375-020-0921-y; Ni Choileain S, 2012, IMMUNOBIOLOGY, V217, P169, DOI 10.1016/j.imbio.2011.06.003; Nijhof IS, 2016, BLOOD, V128, P959, DOI 10.1182/blood-2016-03-703439; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Ong HT, 2006, EXP HEMATOL, V34, P713, DOI 10.1016/j.exphem.2006.03.002; Panani AD, 2004, ANTICANCER RES, V24, P4141; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; Perino M, 2018, NAT GENET, V50, P1002, DOI 10.1038/s41588-018-0134-8; Pluta A, 2006, LEUKEMIA, V20, P757, DOI 10.1038/sj.leu.2404166; Polson AG, 2006, INT IMMUNOL, V18, P1363, DOI 10.1093/intimm/dxl069; Rajkumar SV, 2020, AM J HEMATOL, V95, P548, DOI 10.1002/ajh.25791; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Saha MN, 2013, MOL CANCER THER, V12, P2331, DOI 10.1158/1535-7163.MCT-12-1166; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Saul MC, 2017, GENES BRAIN BEHAV, V16, P328, DOI 10.1111/gbb.12347; Sawyer JR, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0226-4; Schultheis B, 1999, LEUKEMIA, V13, P2099, DOI 10.1038/sj.leu.2401609; Seidl S, 2004, CANCER-AM CANCER SOC, V100, P2598, DOI 10.1002/cncr.20295; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Sherbenou DW, 2016, J CLIN INVEST, V126, P4640, DOI 10.1172/JCI85856; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Teoh PJ, 2018, BLOOD, V132, P1304, DOI 10.1182/blood-2018-02-832576; Tian JY, 2003, ACTA BIOCH BIOPH SIN, V35, P143; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; van Andel H, 2019, LEUKEMIA, V33, P1063, DOI 10.1038/s41375-019-0404-1; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wang GH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14046-9; Wei AH, 2020, BLOOD REV, V44, DOI 10.1016/j.blre.2020.100672; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Xie F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15021; Xu XH, 2017, ANN HEMATOL, V96, P847, DOI 10.1007/s00277-017-2949-2; Yang Z, 2019, AUTOPHAGY, V15, P668, DOI 10.1080/15548627.2018.1539590; Zhan FH, 2007, BLOOD, V109, P4995, DOI 10.1182/blood-2006-07-038703; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhang JW, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07556-z; Zhao JJ, 2014, CANCER RES, V74, P5351, DOI 10.1158/0008-5472.CAN-14-0994; Zhao JJ, 2014, CANCER RES, V74, P1801, DOI 10.1158/0008-5472.CAN-13-3311-T; Zhu D, 2015, NAT MED, V21, P572, DOI 10.1038/nm.3867; Zhu YX, 2017, CANCER RES, V77, P4317, DOI 10.1158/0008-5472.CAN-16-3011	112	1	1	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22341	10.1096/fj.202200354	http://dx.doi.org/10.1096/fj.202200354			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1L7GS	35579877				2022-12-28	WOS:000799453100001
J	He, XG; Chen, JG; Zhou, JM; Mao, AR; Xu, WQ; Zhu, HX; Pan, Q; Zhao, YM; Zhang, N; Wang, LR; Wang, M; Liu, ZY; Zhu, WP; Wang, L				He, Xigan; Chen, Jinggui; Zhou, Jiamin; Mao, Anrong; Xu, Weiqi; Zhu, Hongxu; Pan, Qi; Zhao, Yiming; Zhang, Ning; Wang, Longrong; Wang, Miao; Liu, Zeyang; Zhu, Weiping; Wang, Lu			LncRNA-EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src-YAP signaling axis	FASEB JOURNAL			English	Article						EWSAT1; hepatocellular carcinoma; Hippo-YAP; metastasis; Src	LONG NONCODING RNAS; HIPPO PATHWAY; EWSAT1; EXPRESSION; SURVIVAL	Regardless of the improvements in diagnostic and therapeutic methods, the clinical outcomes of hepatocellular carcinoma (HCC) patients remain poor. Although accumulating evidence indicates that lncRNAs (long noncoding RNAs) are essential within the control of tumorigenesis and the metastasis of cancer, the underlying mechanisms remain largely unknown. This work explored the pattern of expression and functional significance of a newly found lncRNA, Ewing sarcoma-associated transcript 1 (EWSAT1), in HCC metastasis. The results indicated that EWSAT1 was upregulated significantly in HCC relative to that in normal tissues and was correlated with an aggressive phenotype and low patient survival. Functional experiments demonstrated that EWSAT1 could promote proliferation and HCC cell metastasis both in vitro and in vivo. Mechanistically, EWSAT1 binds directly to Yes-associated protein (YAP), promotes Sarcoma gene (Src)-induced phosphorylation of YAP, facilitates nuclear translocation of YAP, and consequently, activates the transcription of Hippo-YAP signaling target genes involved in cancer evolution. This study found that EWSAT1 plays a crucial role in HCC metastasis and that it has the potential to be a prognosis biomarker and a target for therapeutics.	[He, Xigan; Zhou, Jiamin; Mao, Anrong; Xu, Weiqi; Zhu, Hongxu; Pan, Qi; Zhao, Yiming; Zhang, Ning; Wang, Longrong; Wang, Miao; Zhu, Weiping; Wang, Lu] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai, Peoples R China; [Chen, Jinggui] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Gastr Surg, Shanghai, Peoples R China; [Liu, Zeyang] Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan, Peoples R China; [Zhu, Weiping; Wang, Lu] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Shandong University; Fudan University	Zhu, WP; Wang, L (corresponding author), Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai 200032, Peoples R China.	wpzhush@hotmail.com; wangluzl@fudan.edu.cn			National Key project of CHina [2017ZX10203204-007-004]; National Natural Science Foundation of China (NSFC) [81874182, 81874056, 81372314, 81272393]; Public Health Bureau Foundation of Shanghai [201840019]; Research Talent Foundation of Fudan University Shanghai Cancer Center [YJRC1604]; Young Eagle Project of Shanghai Anticancer Association [SACA-CY20A05]	National Key project of CHina; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Health Bureau Foundation of Shanghai; Research Talent Foundation of Fudan University Shanghai Cancer Center; Young Eagle Project of Shanghai Anticancer Association	National Key project of CHina, Grant/Award Number: 2017ZX10203204-007-004; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81874182, 81874056, 81372314 and 81272393; Public Health Bureau Foundation of Shanghai, Grant/Award Number: 201840019; Research Talent Foundation of Fudan University Shanghai Cancer Center, Grant/Award Number: YJRC1604; Young Eagle Project of Shanghai Anticancer Association, Grant/Award Number: SACA-CY20A05	Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen XJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010066; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Faranda T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45604-2; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Fu X, 2017, AM J TRANSL RES, V9, P4094; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Howarth MM, 2014, J CLIN INVEST, V124, P5275, DOI 10.1172/JCI72124; Hsu PC, 2020, CANCERS, V12, DOI 10.3390/cancers12061361; Huang RY, 2015, BIOCHEM BIOPH RES CO, V467, P602, DOI 10.1016/j.bbrc.2015.08.119; Huang Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01188-4; Manganelli M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070813; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mohammadi S, 2020, BIOFACTORS, V46, P514, DOI 10.1002/biof.1634; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen DW, 2021, J CELL MOL MED, V25, P716, DOI 10.1111/jcmm.16121; Song P, 2016, AGING-US, V8, P2948, DOI 10.18632/aging.101103; Sun LS, 2016, DNA CELL BIOL, V35, P812, DOI 10.1089/dna.2016.3467; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tu C, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12887; Yang H, 2020, ONCOL LETT, V20, P1846, DOI 10.3892/ol.2020.11716; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang GY, 2017, EUR REV MED PHARMACO, V21, P5337, DOI 10.26355/eurrev_201712_13918; Zhang R, 2018, EUR REV MED PHARMACO, V22, P6801, DOI 10.26355/eurrev_201810_16146; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou QY, 2020, MOL CELL BIOCHEM, V471, P177, DOI 10.1007/s11010-020-03778-8	31	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22663	10.1096/fj.202200825R	http://dx.doi.org/10.1096/fj.202200825R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O0IQ	36421017				2022-12-28	WOS:000889930700001
J	Luo, X; Huang, SH; Liang, MM; Xue, QS; Rehman, SU; Ren, X; Li, YF; Yang, T; Shi, DS; Li, XP				Luo, Xi; Huang, Shihai; Liang, Mingming; Xue, Qingsong; Rehman, Saif Ur; Ren, Xuan; Li, Yanfang; Yang, Ting; Shi, Deshun; Li, Xiangping			The freezability of Mediterranean buffalo sperm is associated with lysine succinylation and lipid metabolism	FASEB JOURNAL			English	Article						fatty acid; freezability; lysine succinylation; Mediterranean buffalo; sperm	FATTY-ACID-COMPOSITION; MEMBRANE-FLUIDITY; SEMINAL PLASMA; CRYOPRESERVATION; SPERMATOZOA; IDENTIFICATION; SERUM; ROS	Semen cryopreservation is used for the propagation of variety among species and domestic breeding. Mitochondria are implicated in sperm freezability, and their proteins are prone to succinylation, but the relationship between sperm freezability and mitochondrial protein succinylation is unclear. In this study, six bulls were classified as having good or poor freezability ejaculates (GFE or PFE, each 3 bulls). The fresh sperm mitochondrial membrane potential (MMP) and pan succinylation level of the two groups were first detected. Then the lysine succinylome and fatty acid content of the two groups were analyzed using label-free LC-MS/MS and GC-MS/MS in multiple reaction monitoring (MRM) modes, respectively. The results indicated that the GFE sperm had significantly higher MMPs than the PFE group (p < 0.05). A total of 1393 succinylation sites corresponding to 426 proteins were assessed and 5 succinylated peptides of the GFE group were markedly upregulated, while 3 were significantly downregulated (FC > 2.0 - < 0.5 and p-value < 0.05) when compared to the PFE group. Forty-six succinylated proteins were identified to have consistent presence/absence expression. The upregulated succinylated proteins in the GFE sperm were enriched in lipid metabolic processes. A total of 31 fatty acids were further subjected to quantitative analysis of which 23 including arachidic (C20:0), linolenic (C18:3n3), and docosahexaenoic acids (C22:6n3) were decreased in GFE sperm when compared with PFE (p < 0.05). These results suggest that lysine succinylation can potentially influence the sperm freezability of Mediterranean buffaloes through mitochondrial lipid metabolism. This novel study provides our understanding of sperm succinylation and the molecular basis for the mechanism of sperm freezability.	[Luo, Xi; Xue, Qingsong; Ren, Xuan; Li, Yanfang; Yang, Ting; Shi, Deshun; Li, Xiangping] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agro B, Nanning, Peoples R China; [Huang, Shihai; Rehman, Saif Ur] Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China; [Liang, Mingming] Liuzhou Matern & Child Healthcare Hosp, Liuzhou, Peoples R China	Guangxi University; Guangxi University	Li, XP (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agro B, Nanning, Peoples R China.	xiangpingli@163.com			State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources [SKLCUSA-a202204]; Guangxi Bagui Scholar program; Guangxi Natural Science funding [2020GXNSFAA238039]; National Natural Science funding [32060754]; Eighth of Nanning Specially Enrolled Expert Projects	State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources; Guangxi Bagui Scholar program; Guangxi Natural Science funding; National Natural Science funding(National Natural Science Foundation of China (NSFC)); Eighth of Nanning Specially Enrolled Expert Projects	grants from the State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Grant/ Award Number: SKLCUSA-a202204; Guangxi Bagui Scholar program; Guangxi Natural Science funding, Grant/Award Number: 2020GXNSFAA238039; National Natural Science funding, Grant/ Award Number: 32060754; the Eighth of Nanning Specially Enrolled Expert Projects	Adeva-Andany MM, 2019, MITOCHONDRION, V46, P73, DOI 10.1016/j.mito.2018.02.009; Aksoy Y, 2006, PROSTAG LEUKOTR ESS, V75, P75, DOI 10.1016/j.plefa.2006.06.002; Alyethodi RR, 2021, CRYOBIOLOGY, V98, P187, DOI 10.1016/j.cryobiol.2020.11.002; BAHGA CS, 1991, INT J BIOMETEOROL, V35, P222, DOI 10.1007/BF01047289; Bailey JL, 2000, J ANDROL, V21, P1; BARTHELEMY C, 1990, ARCH ANDROLOGY, V25, P29, DOI 10.3109/01485019008987591; Boveda P, 2021, ANDROLOGY-US, V9, P1242, DOI 10.1111/andr.12998; Calderon B, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113354; Conquer JA, 1999, LIPIDS, V34, P793, DOI 10.1007/s11745-999-0425-1; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Diaz R, 2019, ANIM REPROD SCI, V204, P50, DOI 10.1016/j.anireprosci.2019.03.004; Evans HC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77089-9; Fu JL, 2017, THERIOGENOLOGY, V102, P87, DOI 10.1016/j.theriogenology.2017.07.020; Giraud MN, 2000, HUM REPROD, V15, P2160, DOI 10.1093/humrep/15.10.2160; Gomes FP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71015-9; Hasan MM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020095; Hentschel A, 2016, PROTEOMICS, V16, P759, DOI 10.1002/pmic.201500353; Hu BX, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/3240198; Kiernan M, 2013, REPROD FERT DEVELOP, V25, P947, DOI 10.1071/RD12204; Koivisto MB, 2009, REPROD DOMEST ANIM, V44, P587, DOI 10.1111/j.1439-0531.2008.01023.x; Tran VT, 2017, ASIAN AUSTRAL J ANIM, V30, P622, DOI 10.5713/ajas.15.1034; Lewis SEM, 2013, REPROD BIOMED ONLINE, V27, P325, DOI 10.1016/j.rbmo.2013.06.014; Li XL, 2014, J PROTEOME RES, V13, P6087, DOI 10.1021/pr500992r; Liu P, 2020, J THERM BIOL, V89, DOI 10.1016/j.jtherbio.2020.102547; Lopez Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4336-8; Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113; Maccarinelli F, 2017, REPROD FERT DEVELOP, V29, P2005, DOI 10.1071/RD16348; Marti JI, 2011, THERIOGENOLOGY, V75, P473, DOI 10.1016/j.theriogenology.2010.09.015; Martinez-Soto JC, 2013, ANDROLOGY-US, V1, P365, DOI 10.1111/j.2047-2927.2012.00040.x; Meyer JG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208973; Papas M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110539; Rehman SU, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030904; Sa-Ardrit M, 2006, INT J ANDROL, V29, P346, DOI 10.1111/j.1365-2605.2005.00578.x; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Said TM, 2010, REPROD BIOMED ONLINE, V21, P456, DOI 10.1016/j.rbmo.2010.05.011; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Sun B, 2021, CANCER SCI, V112, P2753, DOI 10.1111/cas.14925; Waterhouse KE, 2006, REPRODUCTION, V131, P887, DOI 10.1530/rep.1.01049; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wu F, 2009, CHEM-BIOL INTERACT, V181, P236, DOI 10.1016/j.cbi.2009.05.008; Xu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30212; Yang QZ, 2020, TOXICOL LETT, V318, P30, DOI 10.1016/j.toxlet.2019.10.012; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111; Zampini R, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.587596; Zeng JM, 2020, MOL ORAL MICROBIOL, V35, P240, DOI 10.1111/omi.12312; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhou CL, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900158; Zhou ZQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011056; Zhu ZD, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040591	49	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22635	10.1096/fj.202201254R	http://dx.doi.org/10.1096/fj.202201254R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Y0PS	36333987				2022-12-28	WOS:000878994700001
J	Taylor, HA; Finkel, T; Gao, YL; Ballinger, SW; Campo, R; Chen, R; Chen, SH; Davidson, K; Iruela-Arispe, ML; Jaquish, C; LeBrasseur, NK; Odden, MC; Papanicolaou, GJ; Picard, M; Srinivas, P; Tjurmina, O; Wolz, M; Galis, ZS				Taylor, Herman A.; Finkel, Toren; Gao, Yunling; Ballinger, Scott W.; Campo, Rebecca; Chen, Rong; Chen, Shu Hui; Davidson, Karina; Iruela-Arispe, M. Luisa; Jaquish, Cashell; LeBrasseur, Nathan K.; Odden, Michelle C.; Papanicolaou, George J.; Picard, Martin; Srinivas, Pothur; Tjurmina, Olga; Wolz, Michael; Galis, Zorina S.			Scientific opportunities in resilience research for cardiovascular health and wellness. Report from a National Heart, Lung, and Blood Institute workshop	FASEB JOURNAL			English	Article						adaptation; aging; cardiovascular disease; cardiovascular health; genetic plasticity; health disparities; homeostasis; resilience; stress	LIFES SIMPLE 7; DISEASE BURDEN; BASIC SCIENCE; STRESS; MITOCHONDRIA; ADAPTATION; ALLOSTASIS; RISK; HIPPOCAMPUS; DYSFUNCTION	Exposure of biological systems to acute or chronic insults triggers a host of molecular and physiological responses to either tolerate, adapt, or fully restore homeostasis; these responses constitute the hallmarks of resilience. Given the many facets, dimensions, and discipline-specific focus, gaining a shared understanding of "resilience" has been identified as a priority for supporting advances in cardiovascular health. This report is based on the working definition: "Resilience is the ability of living systems to successfully maintain or return to homeostasis in response to physical, molecular, individual, social, societal, or environmental stressors or challenges," developed after considering many factors contributing to cardiovascular resilience through deliberations of multidisciplinary experts convened by the National Heart, Lung, and Blood Institute during a workshop entitled: "Enhancing Resilience for Cardiovascular Health and Wellness." Some of the main emerging themes that support the possibility of enhancing resilience for cardiovascular health include optimal energy management and substrate diversity, a robust immune system that safeguards tissue homeostasis, and social and community support. The report also highlights existing research challenges, along with immediate and long-term opportunities for resilience research. Certain immediate opportunities identified are based on leveraging existing high-dimensional data from longitudinal clinical studies to identify vascular resilience measures, create a 'resilience index,' and adopt a life-course approach. Long-term opportunities include developing quantitative cell/organ/system/community models to identify resilience factors and mechanisms at these various levels, designing experimental and clinical interventions that specifically assess resilience, adopting global sharing of resilience-related data, and cross-domain training of next-generation researchers in this field.	[Taylor, Herman A.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Taylor, Herman A.] Morehouse Emory Cardiovasc Ctr Hlth Equ, Atlanta, GA USA; [Taylor, Herman A.] Harvard Chan Sch Publ Hlth, Atlanta, GA USA; [Taylor, Herman A.] Emory Sch Med, Atlanta, GA USA; [Finkel, Toren] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Gao, Yunling; Campo, Rebecca; Chen, Shu Hui; Jaquish, Cashell; Papanicolaou, George J.; Srinivas, Pothur; Tjurmina, Olga; Wolz, Michael; Galis, Zorina S.] NHLBI, Div Cardiovasc Sci, NIH, 6705 Rockledge Dr,Room 307H, Bethesda, MD 20892 USA; [Ballinger, Scott W.] Univ Alabama Birmingham, Heersink Sch Med, Birmingham, AL USA; [Chen, Rong] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Chen, Rong] Sema4, Stamford, CT USA; [Davidson, Karina] Northwell Hlth, Feinstein Inst Med Res, New York, NY USA; [Iruela-Arispe, M. Luisa] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [LeBrasseur, Nathan K.] Mayo Clin, Rochester, MN USA; [Odden, Michelle C.] Stanford Univ, Stanford, CA 94305 USA; [Picard, Martin] Columbia Univ, Irving Med Ctr, New York, NY USA; [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Morehouse School of Medicine; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Northwell Health; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Stanford University; Columbia University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute	Gao, YL (corresponding author), NHLBI, Div Cardiovasc Sci, NIH, 6705 Rockledge Dr,Room 307H, Bethesda, MD 20892 USA.	gaoy2@nhlbi.nih.gov		Gao, Yunling/0000-0002-6622-3253; Ballinger, Scott/0000-0003-0300-9820	NHLBI, NIH; AHA [0000031288]; NIH [P50 HL117929, P30 AG024827, R01 HL14266, R01 HL142589, U54 AG075931, UG3 TR004040, R01 AG53832, U54 AG44170, P01 AG62413, R01 HL103859, T32 HL007918, R35 HL140014, R21 HL135195, R01 AG046206, R01 AG062568]; Wharton Fund;  [R01 MH122706];  [R01 AG071019];  [R01 HL151564];  [R24 AG064191];  [R01 LM012836];  [R01 MH119336];  [R01 AG066828];  [R21 MH123927]	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wharton Fund; ; ; ; ; ; ; ; 	The workshop Enhancing Resilience for Cardiovascular Health and Wellness was supported by the NHLBI, NIH. Dr. Taylor was supported by AHA grant 0000031288 and NIH grant P50 HL117929. Dr. Finkel was supported by NIH grant P30 AG024827; R01 HL14266; R01 HL142589 and U54 AG075931. Dr. Chen was supported by NIH grant UG3 TR004040. Dr. LeBrasseur was supported by NIH grants R01 AG53832, U54 AG44170, and P01 AG62413. Dr. Ballinger was supported by NIH grants R01 HL103859 and T32 HL007918. Dr. Iruela-Arispe was supported by NIH grants R35 HL140014. Dr. Odden was supported by NIH grants R21 HL135195, R01 AG046206, R01 AG062568, R01 AG071019, R01 HL151564. Dr. Davidson was supported by NIH grants R24 AG064191 and R01 LM012836. Dr. Picard was supported by NIH grants R01 MH119336, R01 MH122706, R01 AG066828, R21 MH123927, and the Wharton Fund. The authors thank their colleague Dr. Charles Nicholas Serhan (Brigham & Women's Health, Harvard University) for assisting with workshop presentations and Drs. Kathleen Fenton and Laurie Donze (NHLBI) for critical reading and suggestions for the manuscript.	Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442; Allen J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00386; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arnold AM, 2005, J AM GERIATR SOC, V53, P211, DOI 10.1111/j.1532-5415.2005.53105.x; Back M, 2019, FASEB J, V33, P1536, DOI 10.1096/fj.201802445R; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Brown LL., 2022, NATL I HLTH OFFICE D; Cannon W.B., 1932, WISDOM BODY; Carracedo M, 2019, CARDIOVASC RES, V115, P1557, DOI 10.1093/cvr/cvy316; CDC-National Center for Immunization and Respiratory Diseases (NCIRD), 2022, RISK COVID 19 INF HO; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Chen YX, 2008, MED HYPOTHESES, V71, P237, DOI 10.1016/j.mehy.2008.03.026; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631; Chow LS, 2022, NAT REV ENDOCRINOL, V18, P273, DOI 10.1038/s41574-022-00641-2; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Daniels TE, 2020, ANNU REV CLIN PSYCHO, V16, P165, DOI 10.1146/annurev-clinpsy-082719-104030; de Wilde MC, 2002, BRAIN RES, V947, P166, DOI 10.1016/S0006-8993(02)02695-1; Diehr P, 2002, J CLIN EPIDEMIOL, V55, P269, DOI 10.1016/S0895-4356(01)00462-0; Dunham-Snary KJ, 2018, EBIOMEDICINE, V36, P316, DOI 10.1016/j.ebiom.2018.08.036; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Fretts AM, 2014, DIABETES CARE, V37, P2240, DOI 10.2337/dc13-2267; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gao YL, 2021, ARTERIOSCL THROM VAS, V41, P179, DOI 10.1161/ATVBAHA.120.314346; Gartland D, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-134; Giltay EJ, 2006, ARCH INTERN MED, V166, P431, DOI 10.1001/.431; Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030; Hagg S, 2021, HUM GENET, V140, P863, DOI 10.1007/s00439-021-02258-3; Hagg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w; Helgeson VS, 2003, HEALTH PSYCHOL, V22, P30, DOI 10.1037/0278-6133.22.1.30; Islam SJ, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015247; Jacob ME, 2018, J GERONTOL A-BIOL, V73, P194, DOI 10.1093/gerona/glx194; KELLEY RE, 1974, CIRC RES, V35, P862, DOI 10.1161/01.RES.35.6.862; Kim JH, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180505; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kulshreshtha A, 2013, STROKE, V44, P1909, DOI 10.1161/STROKEAHA.111.000352; Layne CM., 2007, PTSD SCI PRACTICE A, P497; Lazarus R., 1987, STRESS APPRAISAL COP, V1, P141, DOI https://doi.org/10.1002/per.2410010304; Leslie M, 2015, SCIENCE, V349, P18, DOI 10.1126/science.347.6217.18; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahmoodpoor A, 2022, GENE, V836, DOI 10.1016/j.gene.2022.146681; de Lemos CMM, 2016, ARQ BRAS CARDIOL, V106, P130, DOI 10.5935/abc.20160012; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen Bruce S, 2011, Cerebrum, V2011, P14; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Most J, 2017, AGEING RES REV, V39, P36, DOI 10.1016/j.arr.2016.08.005; National Heart Lung and Blood Institute (NHLBI), 2022, ENH RES CARD HLTH WE; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Odden MC, 2014, J AM GERIATR SOC, V62, P1692, DOI 10.1111/jgs.13018; Ostendorf BN, 2022, NATURE, V611, P346, DOI 10.1038/s41586-022-05344-2; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010; Picard M, 2019, CURR OPIN BEHAV SCI, V28, P142, DOI 10.1016/j.cobeha.2019.04.015; Picard M, 2018, FRONT NEUROENDOCRIN, V49, P72, DOI 10.1016/j.yfrne.2018.01.001; Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; PINCKARD RN, 1971, CIRC RES, V29, P276, DOI 10.1161/01.RES.29.3.276; Prati G, 2021, PSYCHOL MED, V51, P201, DOI 10.1017/S0033291721000015; Rausser S, 2021, ELIFE, V10, DOI [10.7554/eLife.70899, 10.7554/eLife.70899.sa0, 10.7554/eLife.70899.sa1, 10.7554/eLife.70899.sa2]; Sanders JL, 2016, J AM GERIATR SOC, V64, P1679, DOI 10.1111/jgs.14190; Sanders JL, 2016, J AM GERIATR SOC, V64, P1242, DOI 10.1111/jgs.14163; Schetter CD, 2011, SOC PERSONAL PSYCHOL, V5, P634, DOI 10.1111/j.1751-9004.2011.00379.x; Schulkin J, 2019, TRENDS NEUROSCI, V42, P740, DOI 10.1016/j.tins.2019.07.010; SELYE H, 1951, ANNU REV MED, V2, P327, DOI 10.1146/annurev.me.02.020151.001551; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Shapiro MD, 2018, CIRC RES, V122, P1420, DOI 10.1161/CIRCRESAHA.118.311227; Sheeran FL, 2017, ADV EXP MED BIOL, V982, P65, DOI 10.1007/978-3-319-55330-6_4; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; SUZUKI Y, 1975, JPN CIRC J, V39, P683, DOI 10.1253/jcj.39.683; Thielke SM, 2015, J PERS MED, V5, P440, DOI 10.3390/jpm5040440; Topel ML, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011633; Trans-NIH Resilience Working Group, 2022, RESILIENCE RES DESIG; Vazquez-Coto Daniel, 2022, Mitochondrion, V67, P1, DOI 10.1016/j.mito.2022.09.001; WARTENBERG J, 1973, BRIT HEART J, V35, P845; West JB, 2014, PHYSIOLOGY, V29, P222, DOI 10.1152/physiol.00005.2014; Winovich DT, 2017, STROKE, V48, P1818, DOI 10.1161/STROKEAHA.117.016726; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081; Yang Stephanie Y, 2022, PLoS One, V17, pe0270951, DOI 10.1371/journal.pone.0270951	91	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22639	10.1096/fj.202201407R	http://dx.doi.org/10.1096/fj.202201407R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5W1LK	36322029	Green Accepted			2022-12-28	WOS:000877682900001
J	Beanland, BT; McNeill, EP; Sequeira, DJ; Xue, HS; Shroyer, NF; Speer, AL				Beanland, Brooke T.; McNeill, Eoin P.; Sequeira, David J.; Xue, Hasen; Shroyer, Noah F.; Speer, Allison L.			Investigation of murine host sex as a biological variable in epithelial barrier function and muscle contractility in human intestinal organoids	FASEB JOURNAL			English	Article						human intestinal organoid; intestinal epithelial barrier; muscle contractility; sex as a biological variable; sex-related differences	HUMAN HEMATOPOIETIC STEM; IN-VIVO MODEL; CELLS; ENGRAFTMENT; MOUSE	Intestinal failure (IF) occurs when intestinal surface area or function is not sufficient to support digestion and nutrient absorption. Human intestinal organoid (HIO)-derived tissue-engineered intestine is a potential cure for IF. Research to date has demonstrated successful HIO transplantation (tHIO) into mice with significant in vivo maturation. An area lacking in the literature is exploration of murine host sex as a biological variable (SABV) in tHIO function. In this study, we investigate murine host SABV in tHIO epithelial barrier function and muscle contractility. HIOs were generated in vitro and transplanted into nonobese diabetic, severe combined immunodeficiency gamma chain deficient male and female mice. tHIOs were harvested after 8-12 weeks in vivo. Reverse transcriptase polymerase chain reaction and immunohistochemistry were conducted to compare tight junctions and contractility-related markers in tHIOs. An Ussing chamber and contractility apparatus were used to evaluate tHIO epithelial barrier and muscle contractile function, respectively. The expression and morphology of tight junction and contractility-related markers from tHIOs in male and female murine hosts is not significantly different. Epithelial barrier function as measured by transepithelial resistance, short circuit current, and fluorescein isothiocyanate-dextran permeability is no different in tHIOs from male and female hosts, although these results may be limited by HIO epithelial immaturity and a short flux time. Muscle contractility as measured by total contractile activity, amplitude, frequency, and tension is not significantly different in tHIOs from male and female hosts. The data suggest that murine host sex may not be a significant biological variable influencing tHIO function, specifically epithelial barrier maintenance and muscle contractility, though limitations exist in our model.	[Beanland, Brooke T.; McNeill, Eoin P.; Sequeira, David J.; Xue, Hasen; Speer, Allison L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St MSB 5-254, Houston, TX 77030 USA; [Shroyer, Noah F.] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Speer, AL (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St MSB 5-254, Houston, TX 77030 USA.	allison.l.speer@uth.tmc.edu		Beanland, Brooke/0000-0002-4988-7840	American Pediatric Surgical Association Foundation; Texas Medical Center Digestive Diseases Center [P30 DK056338]; Eunice Kennedy Shriver NICHD/NIH [R24HD102061]	American Pediatric Surgical Association Foundation; Texas Medical Center Digestive Diseases Center; Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	American Pediatric Surgical Association Foundation; Texas Medical Center Digestive Diseases Center, Grant/Award Number: P30 DK056338; Eunice Kennedy Shriver NICHD/NIH, Grant/Award Number: R24HD102061	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Boyle MA, 2021, J SURG RES, V259, P500, DOI 10.1016/j.jss.2020.10.002; Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Chai JK, 1999, AM J PHYSIOL-REG I, V276, pR1366, DOI 10.1152/ajpregu.1999.276.5.R1366; Chang DF, 2020, J TISSUE ENG, V11, DOI 10.1177/2041731420905701; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Collins FL, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13263; Cortez AR, 2018, SURGERY, V164, P643, DOI 10.1016/j.surg.2018.04.048; Duggan CP, 2017, NEW ENGL J MED, V377, P666, DOI 10.1056/NEJMra1602650; Fananas-Baquero S, 2021, HAEMATOLOGICA, V106, P1659, DOI 10.3324/haematol.2019.233924; Finkbeiner SR, 2015, BIOL OPEN, V4, P1462, DOI 10.1242/bio.013235; Ghiselli F, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.723387; Guerriero G, 2009, ANN NY ACAD SCI, V1163, P154, DOI 10.1111/j.1749-6632.2009.04460.x; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Keita AV, 2006, LAB INVEST, V86, P504, DOI 10.1038/labinvest.3700397; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lemini C, 2015, EXP ANIM TOKYO, V64, P81, DOI 10.1538/expanim.14-0052; Mahe MM, 2017, METHODS MOL BIOL, V1597, P229, DOI 10.1007/978-1-4939-6949-4_17; McNeill EP, 2022, DIGEST DIS SCI, V67, P5511, DOI 10.1007/s10620-022-07442-7; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9; Rao M, 2017, GASTROENTEROLOGY, V153, P1068, DOI 10.1053/j.gastro.2017.07.002; Schlieve CR, 2017, STEM CELL REP, V9, P883, DOI 10.1016/j.stemcr.2017.07.017; Shansky RM, 2019, SCIENCE, V364, P825, DOI 10.1126/science.aaw7570; Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686; Singh A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237885; Soni KG, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13936; Thomson A, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1002-4; van der Giessen J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030261; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wales PW, 2004, J PEDIATR SURG, V39, P690, DOI 10.1016/j.jpedsurg.2004.01.036; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233	33	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22613	10.1096/fj.202101740RR	http://dx.doi.org/10.1096/fj.202101740RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0OT	36250916				2022-12-28	WOS:000868747500001
J	Mannelli, M; Gamberi, T; Garella, R; Magherini, F; Squecco, R; Fiaschi, T				Mannelli, Michele; Gamberi, Tania; Garella, Rachele; Magherini, Francesca; Squecco, Roberta; Fiaschi, Tania			Pyruvate prevents the onset of the cachectic features and metabolic alterations in myotubes downregulating STAT3 signaling	FASEB JOURNAL			English	Article						cancer cachexia; metabolism; pyruvate	UBIQUITIN-PROTEASOME SYSTEM; SKELETAL-MUSCLE; MITOCHONDRIAL; CACHEXIA; INHIBITION; TRANSPORT; PATHWAY; MODEL; IL-6	Cachexia is a systemic disease associated with several pathologies, including cancer, that leads to excessive weight loss due to enhanced protein degradation. Previously, we showed that cachectic features in myotubes are provoked by a metabolic shift toward lactic fermentation. Our previous results led us to hyphotesise that increasing pyruvate concentration could impede the metabolic modifications responsible for induction of cachexia in myotubes. Here, we demonstrated that the addition of sodium pyruvate in conditioned media from CT26 colon cancer cells (CM CT26) prevents the onset of either phenotypic and metabolic cachectic features. Myotubes treated with CM CT26 containing sodium pyruvate show a phenotype similar to the healthy counterpart and display lactate production, oxygen consumption, and pyruvate dehydrogenase activity as control myotubes. The use of the Mitochondrial Pyruvate Carrier inhibitor UK5099, highlights the importance of mitochondrial pyruvate amount in the prevention of cachexia. Indeed, UK5099-treated myotubes show cachectic features as those observed in myotubes treated with CM CT26. Finally, we found that sodium pyruvate is able to decrease STAT3 phosphorylation level, a signaling pathway involved in the induction of cachexia in myotubes. Collectively, our results show that cachexia in myotubes could be prevented by the utilization of sodium pyruvate which impedes the metabolic modifications responsible for the acquisition of the cachectic features.	[Mannelli, Michele; Gamberi, Tania; Magherini, Francesca; Fiaschi, Tania] Univ Firenze, Dipartimento Sci Biomed Sperimentali & Clin Mario, Viale Morgagni 50, I-50134 Florence, Italy; [Garella, Rachele; Squecco, Roberta] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy	University of Florence; University of Florence	Fiaschi, T (corresponding author), Univ Firenze, Dipartimento Sci Biomed Sperimentali & Clin Mario, Viale Morgagni 50, I-50134 Florence, Italy.	tania.fiaschi@unifi.it			Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: RICATEN	Anwar S, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188568; Argiles JM, 1996, TRENDS PHARMACOL SCI, V17, P223, DOI 10.1016/0165-6147(96)10021-3; Bernacchioni C, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11040713; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Fontes-Oliveira CC, 2013, BBA-GEN SUBJECTS, V1830, P2770, DOI 10.1016/j.bbagen.2012.11.009; Der-Torossian H, 2013, J CACHEXIA SARCOPENI, V4, P145, DOI 10.1007/s13539-012-0101-7; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fermoselle C, 2013, EXP PHYSIOL, V98, P1349, DOI 10.1113/expphysiol.2013.072496; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; Hu WJ, 2019, BBA-MOL CELL BIOL L, V1864, P1091, DOI 10.1016/j.bbalip.2019.04.006; Ma JF, 2017, EMBO MOL MED, V9, P622, DOI 10.15252/emmm.201607052; Mannelli M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9060698; Martella D, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103077; Miller A, 2017, ONCOGENE, V36, P3059, DOI 10.1038/onc.2016.437; Nunes AM, 2017, HUM MOL GENET, V26, P2018, DOI 10.1093/hmg/ddx083; PAPA S, 1971, FEBS LETT, V12, P285, DOI 10.1016/0014-5793(71)80200-4; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Penna F, 2019, J MOL BIOL, V431, P2674, DOI 10.1016/j.jmb.2019.05.032; Pin F, 2019, FASEB J, V33, P7778, DOI 10.1096/fj.201802799R; Pin F, 2019, J CACHEXIA SARCOPENI, V10, P140, DOI 10.1002/jcsm.12360; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Silva KAS, 2015, J BIOL CHEM, V290, P11177, DOI 10.1074/jbc.M115.641514; Sgrignani J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33048-z; Sharma A, 2019, ELIFE, V8, DOI 10.7554/eLife.45873; Shukla SK, 2020, CANCER LETT, V484, P29, DOI 10.1016/j.canlet.2020.04.017; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wada E, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0140-z; Ying L, 2022, AM J PHYSIOL-CELL PH, V322, pC814, DOI 10.1152/ajpcell.00463.2021; Zimmers TA, 2016, SEMIN CELL DEV BIOL, V54, P28, DOI 10.1016/j.semcdb.2016.02.009	36	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22598	10.1096/fj.202200848R	http://dx.doi.org/10.1096/fj.202200848R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5R9PP	36305891				2022-12-28	WOS:000874835600001
J	Wang, LJ; Wang, C; Sarwar, MS; Chou, PC; Wang, YJ; Su, XY; Kong, ANT				Wang, Lujing; Wang, Chao; Sarwar, Md Shahid; Chou, Pochung; Wang, Yujue; Su, Xiaoyang; Kong, Ah-Ng Tony			PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid	FASEB JOURNAL			English	Article						chemoprevention; epigenetic; metabolomics; prostate cancer; PTEN; ursolic acid	GENE; METHYLATION; GLYCOLYSIS; PREVENTION; APOPTOSIS; DELETION; ALIGNER; PACKAGE; PATHWAY; GROWTH	PTEN (phosphatase and tensin homolog deleted on chromosome 10) is one of the most frequently mutated/deleted tumor suppressor genes in many human cancers. Ursolic acid (UA) is a natural triterpenoid possessing antioxidant, anti-inflammatory, and anticancer effects. However, how PTEN impacts metabolic rewiring and how UA modifies PTEN-driven metabolic and epigenetic reprogramming in prostate cancer (PCa) remains unknown. In the current study, we found that UA protects against PTEN knockout (KO)-induced tumorigenesis at different stages of PCa. Epigenomic CpG methyl-seq revealed UA attenuated PTEN KO-induced differentially methylated regions (DMRs) profiles. Transcriptomic RNA-seq showed UA abrogated PTEN KO-induced differentially expressed genes (DEGs) of PCa-related oncogenes' Has3, Cfh, and Msx1 overexpression, indicating UA plays a crucial role in PTEN KO-mediated gene regulation and its potential consequences on cancer interception. Association analysis of DEGs and DMRs identified that the mRNA expression of tumor suppressor gene BDH2, and oncogenes Ephas, Isg15, and Nos2 were correlated with the promoter CpG methylation status in the early-stage comparison groups indicating UA could regulate the oncogenes or tumor suppressor genes by modulating their promoter methylation at an early stage of prostate tumorigenesis. The metabolomic study showed UA attenuated PTEN KO-regulated cancer-associated metabolisms like purine metabolism/metabolites correlating with RNAseq findings, glycolysis/gluconeogenesis metabolism, as well as epigenetic-related metabolites pyruvate and lactate indicating UA plays a critical role in PTEN KO-mediated metabolic and epigenetic reprogramming and its consequences on cancer development. In this context, UA impacts metabolic rewiring causing epigenetic and transcriptomic reprogramming potentially contributing to the overall protection against prostate-specific PTEN KO-mediated PCa.	[Wang, Lujing; Sarwar, Md Shahid; Chou, Pochung; Kong, Ah-Ng Tony] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut Sci, Piscataway, NJ USA; [Wang, Lujing; Wang, Chao; Chou, Pochung; Kong, Ah-Ng Tony] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ USA; [Wang, Yujue; Su, Xiaoyang] Rutgers Canc Inst New Jersey, Metabol Shared Resource, New Brunswick, NJ USA; [Wang, Yujue; Su, Xiaoyang] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kong, ANT (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Phytochem Epigenome Studies, Dept Pharmaceut, Piscataway, NJ 08854 USA.	kongt@pharmacy.rutgers.edu	Wang, Yujue/HHN-4296-2022		HHS | NIH | National Center for Complementary and Integrative Health (NCCIH) [R01 AT009152]; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [P30 ES005022]	HHS | NIH | National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)	HHS | NIH | National Center for Complementary and Integrative Health (NCCIH), Grant/Award Number: R01 AT009152; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: P30 ES005022	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Alvarez-Cubero MJ, 2017, MOL DIAGN THER, V21, P167, DOI 10.1007/s40291-016-0248-6; Amankwah EK, 2012, CARCINOGENESIS, V33, P1259, DOI 10.1093/carcin/bgs150; Becker LM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107701; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Chen PJ, 2014, ONCOL LETT, V8, P41, DOI 10.3892/ol.2014.2093; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Conteduca V, 2021, TRANSL ANDROL UROL, V10, P3104, DOI 10.21037/tau-20-1339; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; Coronel-Hernandez J, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.676562; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; De Vitto H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102603; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gaspar JM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1909-0; Guo Y, 2017, BIOCHEM PHARMACOL, V135, P22, DOI 10.1016/j.bcp.2017.02.021; Hirsh S., 2014, FASEB J, V28, DOI 10.1096/ fasebj.28.1_supplement. 1044.6 1044.6; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Islam RA, 2017, CURR CANCER DRUG TAR, V17, P707, DOI 10.2174/1568009617666170330150458; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Kariri YA, 2021, BREAST CANCER RES TR, V185, P293, DOI 10.1007/s10549-020-05955-1; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim H, 2016, J NUTR BIOCHEM, V33, P54, DOI 10.1016/j.jnutbio.2015.09.014; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li SY, 2022, MOL CARCINOGEN, V61, P111, DOI 10.1002/mc.23365; Liang H, 2019, J CANCER, V10, P3735, DOI 10.7150/jca.32022; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Locato V, 2018, J EXP BOT, V69, P3373, DOI 10.1093/jxb/ery168; Lodi A, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0024-z; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maxwell PJ, 2013, EUR UROL, V64, P177, DOI 10.1016/j.eururo.2012.08.032; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Neagu M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00348; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ramirez CN, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0177-2; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Seo DY, 2018, KOREAN J PHYSIOL PHA, V22, P235, DOI 10.4196/kjpp.2018.22.3.235; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Shanmugam MK, 2013, BIOCHEM PHARMACOL, V85, P1579, DOI 10.1016/j.bcp.2013.03.006; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Staal J, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090122; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thakur C, 2019, SEMIN CANCER BIOL, V57, P52, DOI 10.1016/j.semcancer.2019.06.006; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Villa E, 2019, CANCERS, V11, DOI 10.3390/cancers11050688; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang C, 2020, FASEB J, V34, P1304, DOI 10.1096/fj.201901205RR; Wang L., 2022, MOL NUTR FOOD RES, V66; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang LJ, 2022, AAPS J, V24, DOI 10.1208/s12248-022-00679-0; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; Willkomm L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176609; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wu RY, 2022, FREE RADICAL BIO MED, V179, P328, DOI 10.1016/j.freeradbiomed.2020.12.007; Wu RY, 2020, MOL CARCINOGEN, V59, P227, DOI 10.1002/mc.23146; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	76	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22626	10.1096/fj.202201195R	http://dx.doi.org/10.1096/fj.202201195R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5R6GT	36305462				2022-12-28	WOS:000874607500001
J	Chen, HW; Li, PW; Chen, JM; Wang, YF; Yu, Q; Wu, YH; Chen, Y; Cai, JT				Chen, Hanwen; Li, Peiwei; Chen, Jiamin; Wang, Yufang; Yu, Qiao; Wu, Yihua; Chen, Yan; Cai, Jianting			Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease	FASEB JOURNAL			English	Article						biomarker; Crohn's disease; diagnosis; miRNA; peripheral blood mononuclear cell; prognosis	INFLAMMATORY-BOWEL-DISEASE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; EXPRESSION; RISK; TUMORIGENESIS; CONTRIBUTES; APOPTOSIS; PROFILES; PLAYERS	Crohn's disease is a recurrent, progressive, immune-mediated inflammatory disease and merely manifests non-specific symptoms at early stage. In this study, we isolated peripheral blood mononuclear cells (PBMCs) to determine whether PBMC miRNAs are reliable biomarkers for Crohn's disease diagnosing and monitoring. 5 Crohn's disease patients and 5 healthy controls were recruited to find differentially expressed miRNAs by next generation sequencing. Candidate PBMC miRNAs were further validated by qRT-PCR in another cohort consisting of 86 Crohn's disease patients and 39 healthy controls. We found PBMC miR-582-5p could diagnose Crohn's disease with the area under receiver operating characteristic curve (AUROC) of 0.701(95%CI 0.606-0.796, p < .001). While PBMC miR-96-5p was significantly higher in active Crohn's disease and correlated with both clinical (rho =0.376, p < .001) and endoscopic activity (rho =0.512, p = .015). Furthermore, PBMC miR-96-5p had a better performance in recognizing active Crohn's disease with AUROC of 0.727 (95%CI 0.609-0.844, p = .001) than C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fecal calprotectin. In conclusion, PBMC miR-582-5p may be further utilized as a diagnostic biomarker, while miR-96-5p may be a novel and valuable biomarker in monitoring disease activity.	[Chen, Hanwen; Li, Peiwei; Chen, Jiamin; Yu, Qiao; Chen, Yan; Cai, Jianting] Zhejiang Univ, Sch Med, Ctr Inflammatory Bowel Dis, Dept Gastroenterol,Affiliated Hosp 2, Hangzhou, Peoples R China; [Wang, Yufang] Third Peoples Hosp Hangzhou, Dept Gastroenterol, Hangzhou, Peoples R China; [Wu, Yihua] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Chen, Y; Cai, JT (corresponding author), Zhejiang Univ, Sch Med, Affiliate Hosp 2, Dept Gastroenterol, 88 Jiefang Rd, Hangzhou, Peoples R China.	chenyan72_72@zju.edu.cn; jtcai6757@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81802881]; Zhejiang Provincial Natural Science Foundation of China [LQ22H160042]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802881; Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LQ22H160042	Bai JA, 2015, WORLD J GASTROENTERO, V21, P6180, DOI 10.3748/wjg.v21.i20.6180; Biasci D, 2019, GUT, V68, P1386, DOI 10.1136/gutjnl-2019-318343; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen P, 2019, ALIMENT PHARM THER, V49, P733, DOI 10.1111/apt.15159; Chen XL, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201267; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Ghorpade DS, 2013, J BIOL CHEM, V288, P33037, DOI 10.1074/jbc.M113.492496; Gong XR, 2022, HUM GENE THER, V00, P1, DOI 10.1089/hum.2022.078; He C, 2016, GUT, V65, P1938, DOI 10.1136/gutjnl-2015-309389; Huang L, 2022, BIOENGINEERED, V13, P12, DOI 10.1080/21655979.2021.1976894; Huang S, 2019, MOL THER-NUCL ACIDS, V16, P91, DOI 10.1016/j.omtn.2019.01.004; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Ji YH, 2018, BIOCHEM BIOPH RES CO, V503, P2443, DOI 10.1016/j.bbrc.2018.06.174; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Lasson A, 2015, J CROHNS COLITIS, V9, P26, DOI 10.1016/j.crohns.2014.06.002; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Li PZ, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04525-1; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078381; Long X, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.4; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Martinez-Hernandez R, 2018, J CLIN ENDOCR METAB, V103, P1139, DOI 10.1210/jc.2017-02318; Mendoza JL, 2009, GASTROEN CLIN BIOL, V33, pS158, DOI 10.1016/S0399-8320(09)73151-3; Mohammadi A, 2019, J CROHNS COLITIS, V13, P1459, DOI 10.1093/ecco-jcc/jjz076; Mohammadi A, 2018, J CROHNS COLITIS, V12, P568, DOI 10.1093/ecco-jcc/jjy010; Netz U, 2018, INFLAMM BOWEL DIS, V24, P159, DOI 10.1093/ibd/izx009; Ormseth MJ, 2020, J RHEUMATOL, V47, P188, DOI 10.3899/jrheum.181029; Palone F, 2016, INFLAMM BOWEL DIS, V22, P2886, DOI 10.1097/MIB.0000000000000938; Pan TL, 2021, CYTOTECHNOLOGY, V73, P473, DOI 10.1007/s10616-021-00471-6; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schonauen K, 2018, INFLAMM BOWEL DIS, V24, P1547, DOI 10.1093/ibd/izy046; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Verstockt S, 2019, J CROHNS COLITIS, V13, P916, DOI 10.1093/ecco-jcc/jjz007; Wang W, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109411; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Yu KK, 2018, J MOL MED, V96, P65, DOI 10.1007/s00109-017-1593-6; Zhou J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10176-2	42	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22549	10.1096/fj.202200452R	http://dx.doi.org/10.1096/fj.202200452R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1QE	36165177				2022-12-28	WOS:000859939500001
J	Singh, G; Senapati, S; Satpathi, S; Behera, PK; Das, B; Nayak, B				Singh, Garima; Senapati, Shantibhusan; Satpathi, Sanghamitra; Behera, Prativa Kumari; Das, Biswajit; Nayak, Bismita			Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application	FASEB JOURNAL			English	Article						bioartificial endocrine pancreas scaffold; biomimetic material; caprine pancreas; decellularization; diabetes; tissue engineering	ENDOGENOUS RETROVIRUS; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; ISLET ISOLATION; CORE PROTEIN; HEART-VALVE; LIVER; COLLAGEN; GROWTH; INFECTION	In this study, the caprine pancreas has been presented as an alternative to the porcine organ for pancreatic xenotransplantation with lesser risk factors. The obtained caprine pancreas underwent a systematic cycle of detergent perfusion for decellularization. It was perfused using anionic (0.5% w/v sodium dodecyl sulfate) as well as non-ionic (0.1% v/v triton X-100, t-octyl phenoxy polyethoxy ethanol) detergents and washed intermittently with 1XPBS supplemented with 0.1% v/v antibiotic and nucleases in a gravitation-driven set-up. After 48 h, a white decellularized pancreas was obtained, and its extracellular matrix (ECM) content was examined for scaffold-like properties. The ECM content was assessed for removal of cellular content, and nuclear material was evaluated with temporal H&E staining. Quantified DNA was found to be present in a negligible amount in the resultant decellularized pancreas tissue (DPT), thus prohibiting it from triggering any immunogenicity. Collagen and fibronectin were confirmed to be preserved upon trichrome and immunohistochemical staining, respectively. SEM and AFM images reveal interconnected collagen fibril networks in the DPT, confirming that collagen was unaffected. sGAG was visualized using Prussian blue staining and quantified with DMMB assay, where DPT has effectively retained this ECM component. Uniaxial tensile analysis revealed that DPT possesses better elasticity than NPT (native pancreatic tissue). Physical parameters like tensile strength, stiffness, biodegradation, and swelling index were retained in the DPT with negligible loss. The cytocompatibility analysis of DPT has shown no cytotoxic effect for up to 72 h on normal insulin-producing cells (MIN-6) and cancerous glioblastoma (LN229) cells in vitro. The scaffold was recellularized using isolated mouse islets, which have established in vitro cell proliferation for up to 9 days. The scaffold received at the end of the decellularization cycle was found to be non-toxic to the cells, retained biological and physical properties of the native ECM, suitable for recellularization, and can be used as a safer and better alternative as a transplantable organ from a xenogeneic source.	[Singh, Garima; Nayak, Bismita] Natl Inst Technol, Dept Life Sci, Immunol & Mol Med Lab, Rourkela 769008, Odisha, India; [Senapati, Shantibhusan; Das, Biswajit] Inst Life Sci, Tumor Microenvironm & Anim Models Lab, Bhubaneswar, India; [Satpathi, Sanghamitra] Hi Tech Med Coll & Hosp, Dept Pathol, Rourkela, India; [Behera, Prativa Kumari] Ispat Gen Hosp, Dept Histopathol, Rourkela, India	National Institute of Technology (NIT System); National Institute of Technology Rourkela; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Nayak, B (corresponding author), Natl Inst Technol, Dept Life Sci, Immunol & Mol Med Lab, Rourkela 769008, Odisha, India.	nayakb@nitrkl.ac.in		DAS, BISWAJIT/0000-0002-5657-5626; Senapati, Shantibhusan/0000-0001-7108-8255				Agarwal T, 2018, J TISSUE ENG REGEN M, V12, pE1678, DOI 10.1002/term.2594; ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1; Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003; Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943; Bhuyan J., 2016, J EVID BASED MED HEA, V3, P4001; Bi HJ, 2020, BIOMATERIALS, V233, DOI 10.1016/j.biomaterials.2019.119673; Bittmann I, 2012, VIROLOGY, V433, P329, DOI 10.1016/j.virol.2012.08.030; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Butler AE, 2016, J CLIN ENDOCR METAB, V101, P523, DOI 10.1210/jc.2015-3566; Choong FJ, 2015, AM J TRANSPLANT, V15, P2851, DOI 10.1111/ajt.13366; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Cross SE, 2017, AM J TRANSPLANT, V17, P451, DOI 10.1111/ajt.13975; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Damania A, 2018, ACS APPL MATER INTER, V10, P114, DOI 10.1021/acsami.7b13727; Das Piyali, 2021, Cartilage, V13, p1292S, DOI 10.1177/1947603519855769; Denner J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080215; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Divya P, 2009, J TISSUE ENG REGEN M, V3, P377, DOI 10.1002/term.174; Duisit J, 2018, ACTA BIOMATER, V73, P339, DOI 10.1016/j.actbio.2018.04.009; Duisit J, 2017, ANN SURG, V266, P754, DOI 10.1097/SLA.0000000000002396; Dunne LW, 2014, BIOMATERIALS, V35, P4940, DOI 10.1016/j.biomaterials.2014.03.003; Eltom A, 2019, ADV MATER SCI ENG, V2019, DOI 10.1155/2019/3429527; Figaro S, 2015, IRBM, V36, P101, DOI 10.1016/j.irbm.2015.01.010; Fischer K., 2016, SCI REP-UK, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015; Fruhauf NR, 2004, SURGERY, V136, P47, DOI 10.1016/j.surg.2003.12.017; Fu RH, 2014, CELL TRANSPLANT, V23, P621, DOI 10.3727/096368914X678382; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; Gaetani R, 2018, TISSUE ENG PART C-ME, V24, P697, DOI [10.1089/ten.tec.2018.0180, 10.1089/ten.TEC.2018.0180]; Gerli MFM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191497; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Gola J, 2014, REPROD BIOL, V14, P68, DOI 10.1016/j.repbio.2014.01.006; Gupta S.K., 2017, BIOL ENG MED, V2, P1, DOI DOI 10.15761/BEM.1000112; Hashemi J, 2018, CELLS TISSUES ORGANS, V205, P72, DOI 10.1159/000487230; He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]; Hou YT, 2020, J BIOSCI BIOENG, V129, P741, DOI 10.1016/j.jbiosc.2019.12.012; Hou YT, 2012, BIOCHEM ENG J, V69, P172, DOI 10.1016/j.bej.2012.09.007; Hussein KH, 2016, MAT SCI ENG C-MATER, V67, P766, DOI 10.1016/j.msec.2016.05.068; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Iacovacci V, 2016, BIOCHEM PHARMACOL, V100, P12, DOI 10.1016/j.bcp.2015.08.107; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed, P168; Jiang YS, 2021, INT J MOL MED, V47, P463, DOI 10.3892/ijmm.2020.4818; Joszko K, 2019, ACTA BIOENG BIOMECH, V21, P87, DOI 10.5277/ABB-01382-2019-02; Kadota Y, 2014, ORGANOGENESIS, V10, P268, DOI 10.4161/org.27879; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Katsuki Y, 2016, PANCREATOLOGY, V16, P922, DOI 10.1016/j.pan.2016.06.007; Kawasaki E, 2004, DIABETES RES CLIN PR, V66, pS27, DOI 10.1016/j.diabres.2003.09.015; Kim MJ, 2014, MACROMOL RES, V22, P575, DOI 10.1007/s13233-014-2097-7; Kim N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165156; Kobayashi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246221; Kular JK., 2014, J TISSUE ENG, V5, P1; Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003; Labriola L, 2007, MOL CELL ENDOCRINOL, V263, P120, DOI 10.1016/j.mce.2006.09.011; Lee PF, 2017, ACTA BIOMATER, V49, P181, DOI 10.1016/j.actbio.2016.11.047; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liao J, 2020, J MATER CHEM B, V8, P10023, DOI 10.1039/d0tb01534b; Lopera HM, 2020, ACTA BIOMATER, V107, P115, DOI 10.1016/j.actbio.2020.03.003; Lozoya OA, 2011, BIOMATERIALS, V32, P7389, DOI 10.1016/j.biomaterials.2011.06.042; Ma FF, 2019, J PROTEOME RES, V18, P3156, DOI 10.1021/acs.jproteome.9b00241; Maghsoudlou P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155324; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mendibil U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155447; Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Mirmalek-Sani SH, 2013, BIOMATERIALS, V34, P5488, DOI 10.1016/j.biomaterials.2013.03.054; Mullen LM, 2010, TISSUE ENG PART C-ME, V16, P1439, DOI [10.1089/ten.tec.2009.0806, 10.1089/ten.TEC.2009.0806]; Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946; Nakamura T, 2018, CELL MOL GASTROENTER, V5, P51, DOI 10.1016/j.jcmgh.2017.10.006; Napierala H, 2017, SCI REP-UK, V7, DOI 10.1038/srep41777; Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033; Peloso A, 2016, ANN SURG, V264, P169, DOI 10.1097/SLA.0000000000001364; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; Rickels MR, 2019, ENDOCR REV, V40, P631, DOI 10.1210/er.2018-00154; Sackett SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28857-1; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Shojaie S, 2015, STEM CELL REP, V4, P419, DOI 10.1016/j.stemcr.2015.01.004; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Spang MT, 2018, ACTA BIOMATER, V68, P1, DOI 10.1016/j.actbio.2017.12.019; Specke V, 2001, VIROLOGY, V285, P177, DOI 10.1006/viro.2001.0934; Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149; Tacke SJ, 2003, INTERVIROLOGY, V46, P17, DOI 10.1159/000068120; Tardalkar K, 2017, TISSUE ENG REGEN MED, V14, P755, DOI 10.1007/s13770-017-0070-1; Townsend SE, 2019, ENDOCRINOLOGY, V160, P1885, DOI 10.1210/en.2019-00206; Tremmel DM, 2018, ORGANOGENESIS, V14, P163, DOI 10.1080/15476278.2018.1517509; Chandrika KU, 2021, TISSUE ENG REGEN MED, V18, P99, DOI 10.1007/s13770-020-00296-y; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009031; Valdoz JC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312690; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x; Venkatasubramanian RT, 2010, ANN BIOMED ENG, V38, P694, DOI 10.1007/s10439-010-9921-9; Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038; Wang YJ, 2015, XENOTRANSPLANTATION, V22, P48, DOI 10.1111/xen.12141; White LJ, 2017, ACTA BIOMATER, V50, P207, DOI 10.1016/j.actbio.2016.12.033; White SA, 2009, LANCET, V373, P1808, DOI 10.1016/S0140-6736(09)60609-7; Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939; Zanardo TEC., 2020, FRONT BIOENG BIOTECH, V8, P1; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhou HY, 2018, ANN SURG, V267, P590, DOI 10.1097/SLA.0000000000002129; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	106	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22574	10.1096/fj.202200807R	http://dx.doi.org/10.1096/fj.202200807R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4X4ZW	36165227				2022-12-28	WOS:000860853200001
J	Murakami, K; Ono, K				Murakami, Kazuma; Ono, Kenjiro			Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration	FASEB JOURNAL			English	Review						amyloid; coaggregation; DNA; G-quadruplex; neurodegenerative disease; nucleic acid-binding protein; oligomer; RNA	RNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; ATOMIC-RESOLUTION STRUCTURE; LIQUID PHASE-SEPARATION; CRYO-EM STRUCTURES; G-QUADRUPLEX RNA; PRION PROTEIN; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; MESSENGER-RNA	The aggregation of amyloidogenic proteins is a pathological hallmark of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. In these diseases, oligomeric intermediates or toxic aggregates of amyloids cause neuronal damage and degeneration. Despite the substantial effort made over recent decades to implement therapeutic interventions, these neurodegenerative diseases are not yet understood at the molecular level. In many cases, multiple disease-causing amyloids overlap in a sole pathological feature or a sole disease-causing amyloid represents multiple pathological features. Various amyloid pathologies can coexist in the same brain with or without clinical presentation and may even occur in individuals without disease. From sparse data, speculation has arisen regarding the coaggregation of amyloids with disparate amyloid species and other biomolecules, which are the same characteristics that make diagnostics and drug development challenging. However, advances in research related to biomolecular condensates and structural analysis have been used to overcome some of these challenges. Considering the development of these resources and techniques, herein we review the cross-seeding of amyloidosis, for example, involving the amyloids amyloid beta, tau, alpha-synuclein, and human islet amyloid polypeptide, and their cross-inhibition by transthyretin and BRICHOS. The interplay of nucleic acid-binding proteins, such as prions, TAR DNA-binding protein 43, fused in sarcoma/translated in liposarcoma, and fragile X mental retardation polyglycine, with nucleic acids in the pathology of neurodegeneration are also described, and we thereby highlight the potential clinical applications in central nervous system therapy.	[Murakami, Kazuma] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Ono, Kenjiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol, Kanazawa, Ishikawa, Japan	Kyoto University; Kanazawa University	Murakami, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.; Ono, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol, Kanazawa, Ishikawa, Japan.	murakami.kazuma.4v@kyoto-u.ac.jp; onoken@med.kanazawa-u.ac.jp	Murakami, Kazuma/GQA-7062-2022	Murakami, Kazuma/0000-0003-3152-1784	Japan Society for the Promotion of Science (JSPS) [20KK0126, 19K07965, 22K07514]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 20KK0126, 19K07965 and 22K07514	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armstrong RA, 1997, NEUROSCI LETT, V227, P193, DOI 10.1016/S0304-3940(97)00343-1; Arseni D, 2022, NATURE, V601, P139, DOI 10.1038/s41586-021-04199-3; Asamitsu S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd9440; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bassil F, 2020, NEURON, V105, P260, DOI 10.1016/j.neuron.2019.10.010; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bera A, 2018, BIOCHEM BIOPHYS REP, V14, P114, DOI 10.1016/j.bbrep.2018.04.006; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bharadwaj P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66602-9; Bhardwaj A, 2013, NUCLEIC ACIDS RES, V41, P5062, DOI 10.1093/nar/gkt189; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brown AL, 2022, NATURE, V603, P131, DOI 10.1038/s41586-022-04436-3; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Brown DR, 2003, J NEUROCHEM, V87, P377, DOI 10.1046/j.1471-4159.2003.02046.x; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; CALVIO C, 1995, RNA, V1, P724; Cao Q, 2019, NAT STRUCT MOL BIOL, V26, P619, DOI 10.1038/s41594-019-0248-4; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Cavaliere P, 2013, NUCLEIC ACIDS RES, V41, P327, DOI 10.1093/nar/gks970; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chen GF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02056-4; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Chuang E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.189928; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Conicella AE, 2020, P NATL ACAD SCI USA, V117, P5883, DOI 10.1073/pnas.1912055117; Conlon EG, 2017, GENE DEV, V31, P1509, DOI 10.1101/gad.304055.117; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78; Dolfe L, 2018, J ALZHEIMERS DIS REP, V2, P27, DOI 10.3233/ADR-170051; Donde A, 2019, ACTA NEUROPATHOL, V138, P813, DOI 10.1007/s00401-019-02042-8; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Feiler MS, 2015, J CELL BIOL, V211, P897, DOI 10.1083/jcb.201504057; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fonda BD, 2021, J AM CHEM SOC, V143, P6657, DOI 10.1021/jacs.1c02424; Fourier A, 2022, J NEURAL TRANSM, V129, P173, DOI 10.1007/s00702-021-02454-5; Gabr MT, 2020, ACS CHEM NEUROSCI, V11, P2051, DOI 10.1021/acschemneuro.0c00281; Ghadami SA, 2020, BIOMACROMOLECULES, V21, P1112, DOI 10.1021/acs.biomac.9b01475; Gharibyan AL, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12030446; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Gohel D, 2019, BBA-MOL BASIS DIS, V1865, P1379, DOI 10.1016/j.bbadis.2019.02.010; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Griner SL, 2019, ELIFE, V8, DOI 10.7554/eLife.46924; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Imperatore JA, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00006; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Ishiguro A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101284; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jiang XW, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.50; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kappel K, 2020, NAT METHODS, V17, P698, DOI 10.1038/s41592-020-0878-9; Khalfallah Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25767-0; Kitamura A, 2018, BIOCHEM BIOPHYS REP, V14, P58, DOI 10.1016/j.bbrep.2018.03.009; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Konstantoulea K, 2022, EMBO J, V41, DOI 10.15252/embj.2021108591; Kuo PH, 2014, NUCLEIC ACIDS RES, V42, P4712, DOI 10.1093/nar/gkt1407; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li QY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21912-y; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu ML, 2007, MOL CELL BIOCHEM, V294, P197, DOI 10.1007/s11010-006-9260-1; Loughlin FE, 2019, MOL CELL, V73, P490, DOI 10.1016/j.molcel.2018.11.012; Louka A, 2020, NUCLEIC ACIDS RES, V48, P11880, DOI 10.1093/nar/gkaa822; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Martinez-Valbuena I, 2018, ACTA NEUROPATHOL, V135, P877, DOI 10.1007/s00401-018-1832-0; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Maury CPJ, 2009, ORIGINS LIFE EVOL B, V39, P141, DOI 10.1007/s11084-009-9165-6; Mazzei G, 2021, AGING CELL, V20, DOI 10.1111/acel.13429; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Mucibabic M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77409-z; Murakami K, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101478; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Myrick LK, 2015, HUM MOL GENET, V24, P1733, DOI 10.1093/hmg/ddu586; Nan SJ, 2021, DRUG DES DEV THER, V15, P2013, DOI 10.2147/DDDT.S289473; Nandi PK, 1998, ARCH VIROL, V143, P1251, DOI 10.1007/s007050050373; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Nandi PK, 1997, ARCH VIROL, V142, P2537, DOI 10.1007/s007050050261; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nilsson L, 2018, J MOL BIOL, V430, P2722, DOI 10.1016/j.jmb.2018.06.005; Nolan M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0358-8; Nonaka T, 2020, CURR OPIN NEUROBIOL, V61, P23, DOI 10.1016/j.conb.2019.11.018; Okuda M, 2017, J ALZHEIMERS DIS, V59, P313, DOI 10.3233/JAD-161017; Olsthoorn RCL, 2014, NUCLEIC ACIDS RES, V42, P9327, DOI 10.1093/nar/gku559; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Ono K, 2017, NEUROCHEM RES, V42, P3362, DOI 10.1007/s11064-017-2382-x; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Oskarsson ME, 2018, P NATL ACAD SCI USA, V115, pE2752, DOI 10.1073/pnas.1715951115; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pasieka A, 2021, ACS CHEM NEUROSCI, V12, P2057, DOI 10.1021/acschemneuro.1c00235; Poska H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66718-y; Poska H, 2016, BIOCHEM J, V473, P3683, DOI 10.1042/BCJ20160277; Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Ren XX, 2019, MOL THER-NUCL ACIDS, V17, P726, DOI 10.1016/j.omtn.2019.07.008; Rengifo-Gonzalez JC, 2021, ELIFE, V10, DOI [10.7554/eLife.67605, 10.7554/eLife.67605.sa1, 10.7554/eLife.67605.sa2]; Rouvinski A, 2014, J CELL BIOL, V204, P423, DOI 10.1083/jcb.201308028; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sama RRK, 2014, ASN NEURO, V6, DOI 10.1177/1759091414544472; Scekic-Zahirovic J, 2016, EMBO J, V35, P1077, DOI 10.15252/embj.201592559; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Sengupta I, 2018, CHEM COMMUN, V54, P6230, DOI 10.1039/c8cc03053g; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Shioda N, 2018, NAT MED, V24, P802, DOI 10.1038/s41591-018-0018-6; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2016, J BIOL CHEM, V291, P15482, DOI 10.1074/jbc.R116.733428; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Spires-Jones TL, 2017, ACTA NEUROPATHOL, V134, P187, DOI 10.1007/s00401-017-1709-7; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Subedi S, 2022, MOLECULES, V27, DOI 10.3390/molecules27061776; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Sugita Y, 2018, NATURE, V563, P137, DOI 10.1038/s41586-018-0630-0; Sun YP, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103701; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tang YJ, 2022, PROTEIN SCI, V31, P485, DOI 10.1002/pro.4247; Tetz G, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9061301; Tetz G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59364-x; Toledo JB, 2012, ACTA NEUROPATHOL, V124, P23, DOI 10.1007/s00401-012-0983-7; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasilyev N, 2015, P NATL ACAD SCI USA, V112, pE5391, DOI 10.1073/pnas.1515737112; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verma AK, 2022, MOL NEUROBIOL, V59, P1992, DOI 10.1007/s12035-021-02697-z; Wada T, 2020, CONGENIT ANOM, V60, P147, DOI 10.1111/cga.12365; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang XY, 2015, NUCLEIC ACIDS RES, V43, P7535, DOI 10.1093/nar/gkv679; Jayaweera SW, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030411; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yagi R, 2018, NUCLEIC ACIDS RES, V46, P5894, DOI 10.1093/nar/gky391; Yang Y, 2022, SCIENCE, V375, P167, DOI 10.1126/science.abm7285; Zekry D, 2002, J AM GERIATR SOC, V50, P1431, DOI 10.1046/j.1532-5415.2002.50367.x; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012; Zinszner H, 1997, J CELL SCI, V110, P1741	201	1	1	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22493	10.1096/fj.202200235R	http://dx.doi.org/10.1096/fj.202200235R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3U0IF	35971743	Green Submitted			2022-12-28	WOS:000840653000001
J	Xu, H; Guan, JN; Jin, ZC; Yin, C; Wu, SN; Sun, W; Zhang, HW; Yan, B				Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Sun, Wen; Zhang, Hanwen; Yan, Bin			Mechanical force modulates macrophage proliferation via Piezo1-AKT-Cyclin D1 axis	FASEB JOURNAL			English	Article						cell proliferation; cyclin D1; ion channel; macrophage; mechanobiology; orthodontics	CYCLIN D1; CELL; DIFFERENTIATION; MECHANOBIOLOGY; POLARIZATION; RECRUITMENT; GROWTH; SHAPE	Orthodontic tooth movement (OTM) is induced by biomechanical stimuli and facilitated by periodontal tissue remodeling, where multiple immune cells participate in this progression. It has been demonstrated that macrophage is essential for mechanical force-induced tissue remodeling. In this study, we first found that mechanical force significantly induced macrophage proliferation in human periodontal samples and murine OTM models. Yet, how macrophages perceive mechanical stimuli and thereby modulate their biological behaviors remain elusive. To illustrate the mechanisms of mechanical force-induced macrophage proliferation, we subsequently identified Piezo1, a novel mechanosensory ion channel, to modulate macrophage response subjected to mechanical stimuli. Mechanical force upregulates Piezo1 expression in periodontal tissues and cultured bone-marrow-derived macrophages (BMDMs). Remarkably, suppressing Piezo1 with GsMTx4 retarded OTM through reduced macrophage proliferation. Moreover, knockdown of Piezo1 effectively inhibited mechanical force-induced BMDMs proliferation. RNA sequencing was further performed to dissect the underlying mechanisms of Piezo1-mediated mechanotransduction utilizing mechanical stretch system. We revealed that Piezo1-activated AKT/GSK3 beta signaling was closely associated with macrophage proliferation upon mechanical stimuli. Importantly, Cyclin D1 (Ccnd1) was authenticated as a critical downstream factor of Piezo1 that facilitated proliferation by enhancing Rb phosphorylation. We generated genetically modified mice in which Ccnd1 could be deleted in macrophages in an inducible manner. Conditional ablation of Ccnd1 inhibited periodontal macrophage proliferation and therefore delayed OTM. Overall, our findings highlight that proliferation driven by mechanical force is a key process by which macrophages infiltrate in periodontal tissue during OTM, where Piezo1-AKT-Ccnd1 axis plays a pivotal role.	[Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Yan, Bin] Nanjing Med Univ, Stomatol Hosp, Dept Orthodont, Nanjing 210029, Peoples R China; [Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Sun, Wen; Yan, Bin] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Peoples R China; [Xu, Hao; Guan, Jiani; Jin, Zhichun; Yin, Cheng; Wu, Shengnan; Yan, Bin] Jiangsu Prov Engn Res Ctr Stomatol Translat Med, Nanjing, Peoples R China; [Zhang, Hanwen] Nanjing Med Univ, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China; [Zhang, Hanwen] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat, Key Lab Targeted Intervent Cardiovasc Dis, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yan, B (corresponding author), Nanjing Med Univ, Stomatol Hosp, Dept Orthodont, Nanjing 210029, Peoples R China.; Zhang, HW (corresponding author), Nanjing Med Univ, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China.	hanwenzhang@njmu.edu.cn; byan@njmu.edu.cn			Key Medical Research Projects of Jiangsu Health Commission [ZDA2020003]; National Natural Science Foundation of China (NSFC) [82071143, 81571005]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD-2018-87]	Key Medical Research Projects of Jiangsu Health Commission; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	Key Medical Research Projects of Jiangsu Health Commission, Grant/Award Number: ZDA2020003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071143 and 81571005; Priority Academic Program Development of Jiangsu Higher Education Institutions, Grant/Award Number: PAPD-2018-87	Akei H, 2006, AM J PHYSIOL-LUNG C, V291, pL572, DOI 10.1152/ajplung.00060.2006; Atcha H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.689397; Atcha H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23482-5; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gois EG, 2012, ANGLE ORTHOD, V82, P495, DOI 10.2319/033011-230.1; Hasegawa K, 2021, J PATHOL, V253, P80, DOI 10.1002/path.5553; He D, 2015, J DENT RES, V94, P1286, DOI 10.1177/0022034515589714; He JH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03481-6; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jiang N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.666631; Ladoux B, 2017, NAT REV MOL CELL BIO, V18, P743, DOI 10.1038/nrm.2017.98; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Li XH, 2019, ELIFE, V8, DOI 10.7554/eLife.49631; Lin WM, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00141-5; Miroshnikova YA, 2018, NAT CELL BIOL, V20, P69, DOI 10.1038/s41556-017-0005-z; Orsini EM, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.767319; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sasaki F, 2020, BIOCHEM BIOPH RES CO, V521, P806, DOI 10.1016/j.bbrc.2019.10.174; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sima C, 2019, J LEUKOCYTE BIOL, V105, P473, DOI 10.1002/JLB.1RU0818-310R; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Uda Y, 2017, CURR OSTEOPOROS REP, V15, P318, DOI 10.1007/s11914-017-0373-0; Wang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14146-6; Wang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34907-5; Zhang MM, 2019, CELL REP, V26, P1419, DOI 10.1016/j.celrep.2019.01.056; Zhang XX, 2020, CURR OPIN BIOTECH, V66, P236, DOI 10.1016/j.copbio.2020.09.004; Zhao SJ, 2020, THERANOSTICS, V10, P17, DOI 10.7150/thno.36930; Zhu XB, 2016, GENET TEST MOL BIOMA, V20, P529, DOI 10.1089/gtmb.2016.0020	40	2	2	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22423	10.1096/fj.202200314R	http://dx.doi.org/10.1096/fj.202200314R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2P0OZ	35775626	hybrid			2022-12-28	WOS:000819452300001
J	Li, XN; McPherson, M; Hager, M; Fang, YM; Bartke, A; Miller, RA				Li, Xinna; McPherson, Madaline; Hager, Mary; Fang, Yimin; Bartke, Andrzej; Miller, Richard A.			Transient early life growth hormone exposure permanently alters brain, muscle, liver, macrophage, and adipocyte status in long-lived Ames dwarf mice	FASEB JOURNAL			English	Article						Ames dwarf (DF) mice; fibronectin type III domain-containing protein 5 (FNDC5); glycosylphosphatidylinositol specific phospholipase D1 (GPLD1); growth hormone; uncoupling protein 1 (UCP1)	BROWN ADIPOSE-TISSUE; FATAL NEOPLASTIC DISEASES; ADULT NEUROGENESIS; DELAYED OCCURRENCE; RESISTANT; OBESITY; SPAN; FIBROBLASTS; DIET; MITOCHONDRIAL	The exceptional longevity of Ames dwarf (DF) mice can be abrogated by a brief course of growth hormone (GH) injections started at 2 weeks of age. This transient GH exposure also prevents the increase in cellular stress resistance and decline in hypothalamic inflammation characteristic of DF mice. Here, we show that transient early-life GH treatment leads to permanent alteration of pertinent changes in adipocytes, fat-associated macrophages, liver, muscle, and brain that are seen in DF mice. Ames DF mice, like Snell dwarf and GHRKO mice, show elevation of glycosylphosphatidylinositol specific phospholipase D1 in liver, neurogenesis in brain as indicated by BDNF and DCX proteins, muscle production of fibronectin type III domain-containing protein 5 (a precursor of irisin), uncoupling protein 1 as an index of thermogenic capacity in brown and white fat, and increase in fat-associated anti-inflammatory macrophages. In each case, transient exposure to GH early in life reverts the DF mice to the levels of each protein seen in littermate control animals, in animals evaluated at 15-18 months of age. Thus, many of the traits seen in long-lived mutant mice, pertinent to age-related changes in inflammation, neurogenesis, and metabolic control, are permanently set by early-life GH levels.	[Li, Xinna; Miller, Richard A.] Univ Michigan, Dept Pathol, Sch Med, Room 3001,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [McPherson, Madaline; Hager, Mary] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Fang, Yimin; Bartke, Andrzej] Southern Illinois Univ, Dept Internal Med, Sch Med, Springfield, IL USA; [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Southern Illinois University System; Southern Illinois University; University of Michigan System; University of Michigan	Miller, RA (corresponding author), Univ Michigan, Dept Pathol, Sch Med, Room 3001,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	millerr@umich.edu			NIH [AG024824]; Glenn Foundation for Medical Research; American Diabetes Association [1-19-IBS-126]; NIA [R21-AG062985]; Longevity Consortium [U19-AG023122]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; American Diabetes Association(American Diabetes Association); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Longevity Consortium	NIH, Grant/Award Number: AG024824; Glenn Foundation for Medical Research; American Diabetes Association, Grant/Award Number: 1-19-IBS-126; NIA, Grant/Award Number: R21-AG062985; Longevity Consortium, Grant/Award Number: U19-AG023122	Bartke A, 1998, ENDOCRINE, V8, P103, DOI 10.1385/ENDO:8:2:103; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Darcy J, 2016, ENDOCRINOLOGY, V157, P4744, DOI 10.1210/en.2016-1593; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Duran-Ortiz S, 2021, AGING CELL, V20, DOI 10.1111/acel.13506; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fulop T, 2016, REV INVEST CLIN, V68, P84; Garg SK, 2014, CRIT REV IMMUNOL, V34, P1; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Hill CM, 2016, AGING CELL, V15, P509, DOI 10.1111/acel.12467; Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Junnila RK, 2016, ENDOCRINOLOGY, V157, P4502, DOI 10.1210/en.2016-1649; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Kinney-Forshee BA, 2004, PHYSIOL BEHAV, V80, P589, DOI 10.1016/j.physbeh.2003.10.018; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Lauterbach MAR, 2017, PFLUG ARCH EUR J PHY, V469, P385, DOI 10.1007/s00424-017-1955-5; LeBoeuf RC, 1998, MAMM GENOME, V9, P710, DOI 10.1007/s003359900851; Lewis KN, 2018, GEROSCIENCE, V40, P105, DOI 10.1007/s11357-018-0014-2; Li XN, 2020, AGING-US, V12, P8766, DOI 10.18632/aging.103380; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Ozkurede U, 2019, J MOL ENDOCRINOL, V63, P123, DOI 10.1530/JME-19-0021; Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085; Sadagurski M, 2015, AGING CELL, V14, P1045, DOI 10.1111/acel.12382; Salmon AB, 2009, FASEB J, V23, P2317, DOI 10.1096/fj.08-122523; Sharma P, 2020, J NUTR BIOCHEM, V84, DOI 10.1016/j.jnutbio.2020.108458; Shen ZQ, 2021, AGING CELL, V20, DOI 10.1111/acel.13345; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stout MB, 2014, AGING-US, V6, P575, DOI 10.18632/aging.100681; Sun LY, 2007, J GERONTOL A-BIOL, V62, P117, DOI 10.1093/gerona/62.2.117; Sun LY, 2017, ELIFE, V6, DOI 10.7554/eLife.24059; Sun LY, 2009, FREE RADICAL BIO MED, V47, P1753, DOI 10.1016/j.freeradbiomed.2009.09.021; Sun LY, 2005, ENDOCRINOLOGY, V146, P1138, DOI 10.1210/en.2004-1115; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	55	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22394	10.1096/fj.202200143R	http://dx.doi.org/10.1096/fj.202200143R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2C8NP	35704312	Green Published			2022-12-28	WOS:000811118200001
J	Chen, WW; Li, YQ; Steinhoff, M; Zhang, WH; Buddenkotte, J; Buhl, T; Zhu, RK; Yan, XR; Lu, ZP; Xiao, S; Wang, JF; Meng, JH				Chen, Weiwei; Li, Yanqing; Steinhoff, Martin; Zhang, Wenhao; Buddenkotte, Joerg; Buhl, Timo; Zhu, Renkai; Yan, Xinrong; Lu, Zhiping; Xiao, Song; Wang, Jiafu; Meng, Jianghui			The PLAUR signaling promotes chronic pruritus	FASEB JOURNAL			English	Article						atopic dermatitis; OSM; OSMR; PLAUR; Serpin E1; toll-like receptor	ATOPIC-DERMATITIS; ONCOSTATIN-M; RECEPTOR 2; EXPRESSION; ITCH; KERATINOCYTES; ACTIVATION; INFLAMMATION; MECHANISMS; UROKINASE	Chronic itch is a complex sensation of the skin frequently associated with skin diseases, such as atopic dermatitis (AD) and psoriasis. Although Serpin E1 is implicated in chronic itch, its receptor and signaling pathways involved in itch are not known. In this study, the clinical relevance of a putative Serpin E1 receptor PLAUR to chronic itch, and the neuro-cutaneous Serpin E1-PLAUR signaling are explored. We found that PLAUR is overexpressed in skin specimens of human lesional AD and lesional psoriasis, and sensory neurons innervating MC903-induced AD-like murine skin. Murine PLAUR(+) sensory neurons responded to Serpin E1, resulting in enrichment of numerous itch- and inflammation-related genes and their protein release. PLAUR resides in TLR2(+) neurons and Serpin E1 stimulus led to transcriptional upregulation of TLR2 and its co-signaling proteins. Agonists of TLR2 propagated itch-related gene transcription including BNP, OSM, and PAR2. OSM induced acute itch in mice and promoted G-CSF and IL-8 release from human keratinocytes. Serpin E1 inhibitor reduced MC903-induced itch, epidermal hyperplasia, immunocyte infiltration, and resulted in lower transcription/expression levels of Serpin E1 and OSM. Taken together, the PLAUR-TLR2-OSM signaling promotes skin-nerve communication, cutaneous inflammation, and itch, all feeding into an aggravation of AD and exaggerated itch circuits.	[Chen, Weiwei; Li, Yanqing; Zhang, Wenhao; Zhu, Renkai; Yan, Xinrong; Lu, Zhiping; Xiao, Song] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Dept Dermatol & Venereol, Doha, Qatar; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar; [Steinhoff, Martin; Buddenkotte, Joerg] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med Qatar, Dept Dermatol, Doha, Qatar; [Steinhoff, Martin] Qatar Univ, Coll Med, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med, Dept Dermatol, New York, NY USA; [Buhl, Timo] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Wang, Jiafu] Dublin City Univ, Fac Sci & Hlth, Sch Biotechnol, Dublin 9, Ireland; [Meng, Jianghui] Dublin City Univ, Fac Sci & Hlth, Natl Inst Cellular Biotechnol, Dublin 9, Ireland	Henan University; Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University; Cornell University; University of Gottingen; Dublin City University; Dublin City University	Wang, JF (corresponding author), Dublin City Univ, Fac Sci & Hlth, Sch Biotechnol, Dublin 9, Ireland.; Meng, JH (corresponding author), Dublin City Univ, Fac Sci & Hlth, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	jiafu.wang@dcu.iess; Jianghui.meng@dcu.ie	Buhl, Timo/AFP-7298-2022	xiao, song/0000-0003-2254-9486; Meng, Jianghui/0000-0002-3107-4200; Buddenkotte, Joerg/0000-0002-2394-3269; Wang, Jiafu/0000-0002-3654-4400	Henan University (HENU); Science Foundation Ireland (SFI) [15/SIRG/3508T]; Sanofi (Sanofi US)	Henan University (HENU); Science Foundation Ireland (SFI)(Science Foundation Ireland); Sanofi (Sanofi US)	Henan University (HENU), Grant/Award Number: Double-first class funding; Science Foundation Ireland (SFI), Grant/Award Number: 15/SIRG/3508T; Sanofi (Sanofi US), Grant/Award Number: Type 2 Innovation Grant	Akiyama T., 2014, MECH TREATMENT; Amarbayasgalan T, 2013, INT ARCH ALLERGY IMM, V160, P63, DOI 10.1159/000339666; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Bando T, 2006, NEUROSCIENCE, V142, P1263, DOI 10.1016/j.neuroscience.2006.07.009; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Braz JM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021386118; Cevikbas F, 2020, PHYSIOL REV, V100, P945, DOI 10.1152/physrev.00017.2019; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; Czekay RP, 2009, J CELL PHYSIOL, V220, P655, DOI 10.1002/jcp.21806; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Huang JT, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108233; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kasraie S, 2011, ALLERGY, V66, P845, DOI 10.1111/j.1398-9995.2011.02545.x; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Larkin C, 2021, J ALLERGY CLIN IMMUN, V147, P1110, DOI 10.1016/j.jaci.2020.09.028; Meng J, 2016, CURR RES TRANSL MED, V64, P203, DOI 10.1016/j.retram.2016.08.006; Meng JH, 2020, BRIT J PHARMACOL, V177, P1025, DOI 10.1111/bph.14952; Meng JH, 2019, J INVEST DERMATOL, V139, P2324, DOI 10.1016/j.jid.2019.04.017; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Nakayama T, 2001, INT IMMUNOL, V13, P95, DOI 10.1093/intimm/13.1.95; Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200; Niebuhr M, 2009, ALLERGY, V64, P1580, DOI 10.1111/j.1398-9995.2009.02050.x; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pastore S, 1997, J CLIN INVEST, V99, P3009, DOI 10.1172/JCI119496; Shin HY, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113177; Simone TM, 2014, ADV WOUND CARE, V3, P281, DOI 10.1089/wound.2013.0512; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Sun LX, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/1824624; Tseng PY, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe3037; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Voisin T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022087118; Wang F, 2021, CELL, V184, P422, DOI 10.1016/j.cell.2020.12.033; Wang F, 2020, IMMUNITY, V52, P753, DOI 10.1016/j.immuni.2020.04.008; Wang TT, 2020, NEUROSCIENCE, V429, P245, DOI 10.1016/j.neuroscience.2020.01.010; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9; Xiao S, 2021, BRAIN BEHAV IMMUN, V98, P28, DOI 10.1016/j.bbi.2021.08.211; Yosipovitch G, 2013, DERMATOL THER, V26, P83, DOI 10.1111/dth.12033	48	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22368	10.1096/fj.202200079R	http://dx.doi.org/10.1096/fj.202200079R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1J9LJ	35596683	Green Published			2022-12-28	WOS:000798232900001
J	Li, K; Ji, X; Seeley, R; Lee, WC; Shi, Y; Song, FF; Liao, XY; Song, C; Huang, XB; Rux, D; Cao, J; Luo, XJ; Anderson, SM; Huang, W; Long, FX				Li, Ke; Ji, Xing; Seeley, Rebecca; Lee, Wen-Chih; Shi, Yu; Song, Fangfang; Liao, Xueyang; Song, Chao; Huang, Xiaobin; Rux, Danielle; Cao, Ju; Luo, Xiaoji; Anderson, Steven M.; Huang, Wei; Long, Fanxin			Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis	FASEB JOURNAL			English	Article						articular cartilage; diabetes; Glut1; glycolysis; osteoarthritis	CHONDROCYTES; PROTEOGLYCAN; TRANSPORT; PROTEIN	Osteoarthritis (OA) is the leading joint disease characterized by cartilage destruction and loss of mobility. Accumulating evidence indicates that the incidence and severity of OA increases with diabetes, implicating systemic glucose metabolism in joint health. However, a definitive link between cellular metabolism in articular cartilage and OA pathogenesis is not yet established. Here, we report that in mice surgically induced to develop knee OA through destabilization of medial meniscus (DMM), expression of the main glucose transporter Glut1 is notably reduced in joint cartilage. Inducible deletion of Glut1 specifically in the Prg4-expressing articular cartilage accelerates cartilage loss in DMM-induced OA. Conversely, forced expression of Glut1 protects against cartilage destruction following DMM. Moreover, in mice with type I diabetes, both Glut1 expression and the rate of glycolysis are diminished in the articular cartilage, and the diabetic mice exhibit more severe cartilage destruction than their nondiabetic counterparts following DMM. The results provide proof of concept that boosting glucose metabolism in articular chondrocytes may ameliorate cartilage degeneration in OA.	[Li, Ke; Luo, Xiaoji; Huang, Wei] Chongqing Med Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Li, Ke; Ji, Xing; Seeley, Rebecca; Lee, Wen-Chih; Shi, Yu; Song, Fangfang; Liao, Xueyang; Song, Chao; Huang, Xiaobin; Rux, Danielle; Long, Fanxin] Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19104 USA; [Cao, Ju] Chongqing Med Univ, Dept Lab Med, Affiliated Hosp 1, Chongqing, Peoples R China; [Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA	Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Chongqing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Long, FX (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Suite 902,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	longf1@chop.edu			China Scholarship Council (CSC) [201908500129]; National Natural Science Foundation of China (NSFC) [81902293]	China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	China Scholarship Council (CSC), Grant/Award Number: 201908500129; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902293	Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Boer CG, 2021, CELL, V184, P4784, DOI 10.1016/j.cell.2021.07.038; Cieza A, 2020, LANCET, V396, P2006, DOI 10.1016/S0140-6736(20)32340-0; Decker RS, 2017, DEV BIOL, V426, P56, DOI 10.1016/j.ydbio.2017.04.006; Decker RS, 2015, CURR OSTEOPOROS REP, V13, P407, DOI 10.1007/s11914-015-0290-z; Dubey NK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103021; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gupta RC, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00192; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hollander JM, 2019, CURR OSTEOPOROS REP, V17, P59, DOI 10.1007/s11914-019-00506-0; Juel NG, 2018, SCAND J RHEUMATOL, V47, P325, DOI 10.1080/03009742.2017.1397189; Karner CM, 2016, J BIOL CHEM, V291, P13028, DOI 10.1074/jbc.M115.708578; Lee SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07316-5; Lee WC, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108108; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; Mobasheri A, 2002, CELL BIOL INT, V26, P297, DOI 10.1006/cbir.2001.0850; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; Shikhman AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE980, DOI 10.1152/ajpendo.00243.2003; Shikhman AR, 2001, J IMMUNOL, V167, P7001, DOI 10.4049/jimmunol.167.12.7001; Smeriglio P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax2332; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Veronese N, 2019, SEMIN ARTHRITIS RHEU, V49, P9, DOI 10.1016/j.semarthrit.2019.01.005; WAINE H, 1961, Tufts Folia Med, V7, P13; Wang CC, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00153-1; Wang CC, 2018, J ORTHOP TRANSL, V12, P66, DOI 10.1016/j.jot.2017.12.004; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205	36	1	1	7	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22377	10.1096/fj.202200485R	http://dx.doi.org/10.1096/fj.202200485R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35608871				2022-12-28	WOS:000800641200004
J	Shi, LX; Huang, L; Long, HZ; Song, AQ; Zhou, Z				Shi, Liuxin; Huang, Li; Long, Haizhen; Song, Aoqun; Zhou, Zheng			Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8	FASEB JOURNAL			English	Article							HISTONE H4-LYSINE 20; DNA-REPLICATION; INHIBITION; STABILITY; MUTATION; PARTICLE; H4	Histone H4 lysine 20 monomethylation (H4K20me1) plays a crucial role in multiple processes including DNA damage repair, DNA replication, and cell cycle control. Histone methyltransferase SET8 (previously named PR-Set7/KMT5A) mediates the chromatin deposition of H4K20me1, but how SET8 recognizes and modifies H4 in the context of the nucleosome is not fully understood. Here, we developed a simple chemical modification approach for H4K20 substitution by using the lysine analog S-ethyl-L-cysteine (Ecx). Substitution of H4K20 with H4Ecx20 improves the stability of the SET8-nucleosome complex, allowing us to determine the cryo-EM structure at 3.2 angstrom resolution. Structural analyses show that SET8 directly interacts with the H4 tail and the H2A-H2B acidic patch to ensure nucleosome binding. SET8 residues R339, K341, K351 make contact with nucleosomal DNA at the super helical location 2 (SHL2). Substitution of SET8 DNA-binding residues with alanines decreases the SET8-nucleosome interaction and impairs the methyltransferase activity. Disrupting the binding between SET8 R192 and H2A-H2B acidic patch decreases the cellular level of H4K20me1. Together, these results reveal a near-atomic resolution structure of SET8-bound nucleosome and provide insights into the SET8-mediated H4K20 recognition and modification. The lysine-to-Ecx substitution approach can be applied to the study of other methyltransferases.	[Shi, Liuxin; Huang, Li; Long, Haizhen; Song, Aoqun; Zhou, Zheng] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shi, Liuxin; Song, Aoqun; Zhou, Zheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Z (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zhouzh@ibp.ac.cn		Shi, Linxin/0000-0002-5994-9515; Zhou, Zheng/0000-0002-1423-7231	Institute of Biophysics, Chinese Academy of Science; National Key Research and Development Program of China [2019YFA0508902, 2021YFA1300102]; Natural Science Foundation of China [32100456, 31671344, 31871318]; Strategic Priority Research Program [XDB08010104]	Institute of Biophysics, Chinese Academy of Science; National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program(Chinese Academy of Sciences)	Our SET8-nucleosome complex structure computation work was performed using High-performance computing resources, the Center for Biological Imaging (CBI), Institute of Biophysics, Chinese Academy of Science. We thank Drs. Yaxin Dai for plasmid construction, Yuanyuan Chen and Xiaoli Feng for assistance in MST and ITC analysis, members in Core Facilities for Protein Science at the Institute of Biophysics, Chinese Academy of Science (IBP, CAS) for technical surpport, members of the Z. Zhou laboratories for helpful discussion and critical comments of the manuscript. This work was supported by research grants from the National Key Research and Development Program of China (2019YFA0508902, 2021YFA1300102 to Z.Z.), grants from the Natural Science Foundation of China (32100456 to Y.H; 31671344, 31871318 to Z.Z.), and grants from the Strategic Priority Research Program (XDB08010104 to Z.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arimura Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08314-x; Bilokapic S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11726-4; Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Brustel J, 2011, TRENDS CELL BIOL, V21, P452, DOI 10.1016/j.tcb.2011.04.006; Butler KV, 2016, J MED CHEM, V59, P9881, DOI 10.1021/acs.jmedchem.6b01244; Chen S, 2019, ELIFE, V8, DOI 10.7554/eLife.45403; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dai LC, 2021, MOL CELL, V81, P2765, DOI 10.1016/j.molcel.2021.05.010; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Girish TS, 2016, J MOL BIOL, V428, P1531, DOI 10.1016/j.jmb.2016.02.025; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Ho CH, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000919; Hsu PL, 2019, MOL CELL, V76, P712, DOI 10.1016/j.molcel.2019.10.013; Janna A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00600; Jayaram H, 2016, P NATL ACAD SCI USA, V113, P6182, DOI 10.1073/pnas.1605523113; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Judge RA, 2016, ACS MED CHEM LETT, V7, P1102, DOI 10.1021/acsmedchemlett.6b00303; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li WQ, 2020, NATURE, DOI 10.1038/s41586-020-03069-8; Liu YY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00261-6; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Shoaib M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06066-8; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Valencia-Sanchez MI, 2021, SCIENCE, V371, P363, DOI 10.1126/science.abc6663; Wilkins BJ, 2015, ACS CHEM BIOL, V10, P939, DOI 10.1021/cb501011v; Worden EJ, 2020, ELIFE, V9, DOI 10.7554/eLife.53199; Worden EJ, 2019, CELL, V176, P1490, DOI 10.1016/j.cell.2019.02.002; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang C, 2021, DRUG DISCOV TODAY, V26, P2423, DOI 10.1016/j.drudis.2021.05.004; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Zhou M, 2021, EMBO J, V40, DOI 10.15252/embj.2020105907	45	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22338	10.1096/fj.202101821R	http://dx.doi.org/10.1096/fj.202101821R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1B4NF	35532550				2022-12-28	WOS:000792413200001
J	Simmet, K; Kurome, M; Zakhartchenko, V; Reichenbach, HD; Springer, C; Bahr, A; Blum, H; Philippou-Massier, J; Wolf, E				Simmet, Kilian; Kurome, Mayuko; Zakhartchenko, Valeri; Reichenbach, Horst-Dieter; Springer, Claudia; Bahr, Andrea; Blum, Helmut; Philippou-Massier, Julia; Wolf, Eckhard			OCT4/POU5F1 is indispensable for the lineage differentiation of the inner cell mass in bovine embryos	FASEB JOURNAL			English	Article						bovine; differentiation; embryo; pluripotency	IN-VITRO; OCT4; ENDOMETRIUM; TROPHOBLAST; EXPRESSION; HYPOBLAST; EPIBLAST; REVEALS; DISC	The mammalian blastocyst undergoes two lineage segregations, that is, formation of the trophectoderm and subsequently differentiation of the hypoblast (HB) from the inner cell mass, leaving the epiblast (EPI) as the remaining pluripotent lineage. To clarify the expression patterns of markers specific for these lineages in bovine embryos, we analyzed day 7, 9, and 12 blastocysts completely produced in vivo by staining for OCT4, NANOG, SOX2 (EPI), and GATA6, SOX17 (HB) and identified genes specific for these developmental stages in a global transcriptomics approach. To study the role of OCT4, we generated OCT4-deficient (OCT4 KO) embryos via somatic cell nuclear transfer or in vitro fertilization. OCT4 KO embryos reached the expanded blastocyst stage by day 8 but lost NANOG and SOX17 expression, while SOX2 and GATA6 were unaffected. Blastocysts transferred to recipient cows from day 6 to 9 expanded, but the OCT4 KO phenotype was not rescued by the uterine environment. Exposure of OCT4 KO embryos to exogenous FGF4 or chimeric complementation with OCT4 intact embryos did not restore NANOG or SOX17 in OCT4-deficient cells. Our data show that OCT4 is required cell autonomously for the maintenance of pluripotency of the EPI and differentiation of the HB in bovine embryos.	[Simmet, Kilian; Kurome, Mayuko; Zakhartchenko, Valeri; Springer, Claudia; Bahr, Andrea; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Dept Vet Sci, Gene Ctr, Munich, Germany; [Simmet, Kilian; Kurome, Mayuko; Zakhartchenko, Valeri; Springer, Claudia; Bahr, Andrea; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Ctr Innovat Med Models CiMM, Oberschleissheim, Germany; [Reichenbach, Horst-Dieter; Wolf, Eckhard] Inst Anim Breeding, Bavarian State Res Ctr Agr, Poing, Germany; [Blum, Helmut; Philippou-Massier, Julia] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Bahr, Andrea] Tech Univ Munich, Klinikum Rechts Isar, Internal Med 1, Munich, Germany	University of Munich; University of Munich; University of Munich; Technical University of Munich	Simmet, K (corresponding author), Hackerstr 27, D-85764 Oberschleissheim, Germany.	k.simmet@gen.vetmed.uni-muenchen.de		Simmet, Kilian/0000-0003-2188-3108	Deutsche Forschungsgemeinschaft (DFG) [405453332, TRR127]; Bayerische Forschungsstiftung [AZ-1300-17]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerische Forschungsstiftung	This work was supported by funds from the Deutsche Forschungsgemeinschaft (DFG) under grants 405453332 and TRR127 and from the Bayerische Forschungsstiftung under grant AZ-1300-17.	Artus J, 2014, CELL MOL LIFE SCI, V71, P3327, DOI 10.1007/s00018-014-1630-3; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bernardo AS, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033282; Cagnone G, 2016, REPRODUCTION, V152, pR247, DOI 10.1530/REP-16-0391; Canizo JR, 2019, BMC DEV BIOL, V19, DOI 10.1186/s12861-019-0193-9; Charpigny G, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.672948; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Daigneault BW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25964-x; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Frum T, 2015, TRENDS GENET, V31, P402, DOI 10.1016/j.tig.2015.04.002; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Gerri C, 2020, ANNU REV CELL DEV BI, V36, P411, DOI 10.1146/annurev-cellbio-022020-024900; Goissis MD, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.111526; Hedegaard C, 2013, FEBS OPEN BIO, V3, P411, DOI 10.1016/j.fob.2013.10.002; Hill CS, 2018, CURR OPIN CELL BIOL, V51, P50, DOI 10.1016/j.ceb.2017.10.005; Khan DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034110; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Kohri N, 2019, J BIOL CHEM, V294, P19209, DOI 10.1074/jbc.RA119.010746; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machado GM, 2013, MOL REPROD DEV, V80, P936, DOI 10.1002/mrd.22230; MESSINGER SM, 1991, J CELL SCI, V100, P289; Mole MA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23758-w; Mutterer J, 2013, J MICROSC-OXFORD, V252, P89, DOI 10.1111/jmi.12069; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Papanayotou C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0539; Pfeffer PL, 2017, ZYGOTE, V25, P265, DOI 10.1017/S0967199417000090; Ramos-Ibeas P, 2020, REPRODUCTION, V160, P579, DOI 10.1530/REP-20-0243; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichenbach M, 2010, TRANSGENIC RES, V19, P549, DOI 10.1007/s11248-009-9333-5; Rosen BD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa021; Schiffmacher AT, 2013, MOL REPROD DEV, V80, P826, DOI 10.1002/mrd.22212; Simmet K, 2018, CELL CYCLE, V17, P1688, DOI 10.1080/15384101.2018.1496747; Simmet K, 2018, P NATL ACAD SCI USA, V115, P2770, DOI 10.1073/pnas.1718833115; Simmet K, 2015, THERIOGENOLOGY, V84, P1603, DOI 10.1016/j.theriogenology.2015.08.012; Springer C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092232; Springer C, 2021, J DEV BIOL, V9, DOI 10.3390/jdb9020015; van Leeuwen J, 2020, P NATL ACAD SCI USA, V117, P16409, DOI 10.1073/pnas.2002008117; van Leeuwen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129787; Velasquez AE, 2019, ZYGOTE, V27, P398, DOI 10.1017/S0967199419000509; Vochozkova P, 2019, METHODS MOL BIOL, V1961, P271, DOI 10.1007/978-1-4939-9170-9_17; Wuensch A, 2007, BIOL REPROD, V76, P983, DOI 10.1095/biolreprod.106.058776	46	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22337	10.1096/fj.202101713RRR	http://dx.doi.org/10.1096/fj.202101713RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0W6GW	35486003				2022-12-28	WOS:000789123600001
J	Wang, XS; Jespers, W; de Waal, JJ; Wolff, KAN; van Uden, L; IJzerman, AP; van Westen, GJP; Heitman, LH				Wang, Xuesong; Jespers, Willem; de Waal, Just J.; Wolff, Kim A. N.; van Uden, Liedeke; IJzerman, Adriaan P.; van Westen, Gerard J. P.; Heitman, Laura H.			Cancer-related somatic mutations alter adenosine A(1) receptor pharmacology-A focus on mutations in the loops and C-terminus	FASEB JOURNAL			English	Article						adenosine A(1) receptor; cancer; G protein-coupled receptors; mutations; yeast system	PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR LOOP; STRUCTURAL DIVERSITY; KEY ROLE; ADENOSINE-A1-RECEPTOR; PATHWAY; ANTAGONIST; ACTIVATION; EXPRESSION; CARCINOMA	G protein-coupled receptors (GPCRs) are known to be involved in tumor progression and metastasis. The adenosine A(1) receptor (A(1)AR) has been detected to be over-expressed in various cancer cell lines. However, the role of A(1)AR in tumor development is not yet well characterized. A series of A(1)AR mutations were identified in the Cancer Genome Atlas from cancer patient samples. In this study, we have investigated the pharmacology of mutations located outside of the 7-transmembrane domain by using a "single-GPCR-one-G protein" yeast system. Concentration-growth curves were obtained with the full agonist CPA for 12 mutant receptors and compared to the wild-type hA(1)AR. Most mutations located at the extracellular loops (EL) reduced the levels of constitutive activity of the receptor and agonist potency. For mutants at the intracellular loops (ILs) of the receptor, an increased constitutive activity was found for mutant receptor L211R(5.69), while a decreased constitutive activity and agonist response were found for mutant receptor L113F(34.51). Lastly, mutations identified on the C-terminus did not significantly influence the pharmacological function of the receptor. A selection of mutations was also investigated in a mammalian system. Overall, similar effects on receptor activation compared to the yeast system were found with mutations located at the EL, but some contradictory effects were observed for mutations located at the IL. Taken together, this study will enrich the insight of A(1)AR structure and function, enlightening the consequences of these mutations in cancer. Ultimately, this may provide potential precision medicine in cancer treatment.	[Wang, Xuesong; Jespers, Willem; de Waal, Just J.; Wolff, Kim A. N.; van Uden, Liedeke; IJzerman, Adriaan P.; van Westen, Gerard J. P.; Heitman, Laura H.] Leiden Acad Ctr Drug Res, Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Heitman, Laura H.] Oncode Inst, Leiden, Netherlands		van Westen, GJP; Heitman, LH (corresponding author), Leiden Acad Ctr Drug Res, Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	gerard@lacdr.leidenuniv.nl; l.h.heitman@lacdr.leidenuniv.nl	van Westen, Gerard/HHZ-3762-2022		China Scholarship Council (CSC); NWO | Stichting voor de Technische Wetenschappen (STW) [14410]	China Scholarship Council (CSC)(China Scholarship Council); NWO | Stichting voor de Technische Wetenschappen (STW)	China Scholarship Council (CSC); NWO | Stichting voor de Technische Wetenschappen (STW), Grant/Award Number: Veni #14410	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Borea PA, 2017, BRIT J PHARMACOL, V174, P1945, DOI 10.1111/bph.13763; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cheng RKY, 2017, STRUCTURE, V25, P1275, DOI 10.1016/j.str.2017.06.012; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dastjerdi MN, 2016, RES PHARM SCI, V11, P303, DOI 10.4103/1735-5362.189301; de Ligt RAF, 2005, EUR J PHARMACOL, V510, P1, DOI 10.1016/j.ejphar.2005.01.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Glukhova A, 2017, CELL, V168, P867, DOI 10.1016/j.cell.2017.01.042; Guo D, 2018, BRIT J PHARMACOL, V175, P1719, DOI 10.1111/bph.14184; Heitman LH, 2009, J MED CHEM, V52, P926, DOI 10.1021/jm8014052; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Johnston JB, 2001, ANN NEUROL, V49, P650, DOI 10.1002/ana.1007; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lappano R, 2012, ACTA PHARMACOL SIN, V33, P351, DOI 10.1038/aps.2011.183; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Liu H, 2020, CANCER CELL, V37, P324, DOI 10.1016/j.ccell.2020.02.006; Liu R, 2015, BIOCHEM PHARMACOL, V95, P290, DOI 10.1016/j.bcp.2015.04.005; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Ma HY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.636373; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Merighi S, 2001, BRIT J PHARMACOL, V134, P1215, DOI 10.1038/sj.bjp.0704352; Mirza A, 2005, CANCER BIOL THER, V4, P1355, DOI 10.4161/cbt.4.12.2196; MORO O, 1993, J BIOL CHEM, V268, P22273; Nasrollahi-Shirazi S, 2020, MOL PHARMACOL, V98, P250, DOI 10.1124/molpharm.120.000003; Navarro G, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0247-4; Nguyen ATN, 2016, MOL PHARMACOL, V90, P703, DOI 10.1124/mol.116.105007; Nguyen ATN, 2016, MOL PHARMACOL, V90, P715, DOI 10.1124/mol.116.105015; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Peeters MC, 2012, BIOCHEM PHARMACOL, V84, P76, DOI 10.1016/j.bcp.2012.03.008; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Peeters MC, 2011, FASEB J, V25, P632, DOI 10.1096/fj.10-164319; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Saito M, 2010, CANCER LETT, V290, P211, DOI 10.1016/j.canlet.2009.09.011; Sek K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123837; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stoy H, 2015, GENES DIS, V2, P108, DOI 10.1016/j.gendis.2015.02.005; Synowitz M, 2006, CANCER RES, V66, P8550, DOI 10.1158/0008-5472.CAN-06-0365; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang JN, 2019, J PHYS CHEM B, V123, P6462, DOI 10.1021/acs.jpcb.9b04867; Wang XS, 2020, EUR J PHARMACOL, V880, DOI 10.1016/j.ejphar.2020.173126; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yang X, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114144; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zamani Rarani M., 2020, INT ELECT J MED, V9, P14; Zhou YH, 2017, CELL PHYSIOL BIOCHEM, V43, P733, DOI 10.1159/000481557	60	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22358	10.1096/fj.202200203RR	http://dx.doi.org/10.1096/fj.202200203RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4PY	35604751	Green Published			2022-12-28	WOS:000800641200001
J	Liang, LYY; Takamiya, R; Miki, Y; Heike, K; Taketomi, Y; Sugimoto, N; Yamaguchi, M; Shitara, H; Nishito, Y; Kobayashi, T; Hirabayashi, T; Murakami, M				Liang, Luyiyun; Takamiya, Rina; Miki, Yoshimi; Heike, Kanako; Taketomi, Yoshitaka; Sugimoto, Nao; Yamaguchi, Midori; Shitara, Hiroshi; Nishito, Yasumasa; Kobayashi, Tetsuyuki; Hirabayashi, Tetsuya; Murakami, Makoto			Group IVE cytosolic phospholipase A(2) limits psoriatic inflammation by mobilizing the anti-inflammatory lipid N-acylethanolamine	FASEB JOURNAL			English	Article						keratinocyte; lipidomics; N-acylethanolamine; phospholipase A(2); psoriasis	ONE-STEP GENERATION; BARRIER FUNCTION; CELL PATHWAY; DISEASE; MODEL; PALMITOYLETHANOLAMIDE; GENE; IDENTIFICATION; CPLA(2)DELTA; ACYLCERAMIDE	Psoriasis is an inflammatory disorder characterized by keratinocyte hyper-proliferation and Th17-type immune responses. However, the roles of bioactive lipids and the regulation of their biosynthesis in this chronic skin disease are not fully understood. Herein, we show that group IVE cytosolic phospholipase A(2) (cPLA(2)epsilon/PLA2G4E) plays a counterregulatory role against psoriatic inflammation by producing the anti-inflammatory lipid N-acylethanolamine (NAE). Lipidomics analysis of mouse skin revealed that NAE species and their precursors (N-acyl-phosphatidylethanolamine and glycerophospho-N-acylethanolamine) were robustly increased in parallel with the ongoing process of imiquimod (IMQ)-induced psoriasis, accompanied by a marked upregulation of cPLA(2)epsilon in epidermal keratinocytes. Genetic deletion of cPLA(2)epsilon exacerbated IMQ-induced ear swelling and psoriatic marker expression, with a dramatic reduction of NAE-related lipids in IMQ-treated, and even normal, skin. Stimulation of cultured human keratinocytes with psoriatic cytokines concomitantly increased PLA2G4E expression and NAE production, and supplementation with NAEs significantly attenuated the cytokine-induced upregulation of the psoriatic marker S100A9. Increased expression of cPLA(2)epsilon was also evident in the epidermis of psoriatic patients. These findings reveal for the first time the in vivo role of cPLA(2)epsilon, which is highly induced in the keratinocytes of the psoriatic skin, promotes the biosynthesis of NAE-related lipids, and contributes to limiting psoriatic inflammation.	[Liang, Luyiyun; Takamiya, Rina; Miki, Yoshimi; Taketomi, Yoshitaka; Sugimoto, Nao; Murakami, Makoto] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan; [Heike, Kanako; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Tokyo, Japan; [Yamaguchi, Midori; Shitara, Hiroshi; Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Lab Transgen Technol, Tokyo, Japan; [Hirabayashi, Tetsuya] Tokyo Metropolitan Inst Med Sci, Dept Basic Med Sci, Lab Biomembrane, Tokyo, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED, CREST, Tokyo, Japan	University of Tokyo; Ochanomizu University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Lab Microenvironm & Metab Hlth Sci,Bunkyo Ku, Tokyo 1138655, Japan.	makmurak@m.u-tokyo.ac.jp		Miki, Yoshimi/0000-0002-8587-0333	Japan Agency for Medical Research and Development (AMED) [18gm0710006, 20gm1210013, 20gm4010005, 20ek0410052, 20gm0910002]; MEXT \ Japan Society for the Promotion of Science (JSPS) [JP15H05905, JP16H02613, JP20H04939, JP20H05691, JP19K08597, JP19K07042, JP18K06624, JP21K08315]; Hoyu Science Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hoyu Science Foundation	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 18gm0710006, 20gm1210013, 20gm4010005, 20ek0410052 and 20gm0910002; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP15H05905, JP16H02613, JP20H04939, JP20H05691, JP19K08597, JP19K07042, JP18K06624 and JP21K08315; Hoyu Science Foundation	Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Bandyopadhyay M, 2020, IMMUNITY, V53, P16, DOI 10.1016/j.immuni.2020.06.015; Biro T, 2009, TRENDS PHARMACOL SCI, V30, P411, DOI 10.1016/j.tips.2009.05.004; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chiba H, 2004, J BIOL CHEM, V279, P12890, DOI 10.1074/jbc.M305801200; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Everard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08051-7; Gaire BP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081753; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Ghafouri N, 2013, PAIN, V154, P1649, DOI 10.1016/j.pain.2013.05.002; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Greenberg R, 2021, J AM ACAD DERMATOL, V84, P639, DOI 10.1016/j.jaad.2020.03.112; Gruber F, 2019, FREE RADICAL BIO MED, V144, P256, DOI 10.1016/j.freeradbiomed.2019.04.019; Guo YM, 2021, MOLECULES, V26, DOI 10.3390/molecules26175213; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Hirabayashi T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14609; Honda T, 2019, INT IMMUNOL, V31, P589, DOI 10.1093/intimm/dxy087; Hussain Z, 2017, BBA-MOL CELL BIOL L, V1862, P1546, DOI 10.1016/j.bbalip.2017.08.006; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IMOKAWA G, 1994, J CLIN INVEST, V94, P89, DOI 10.1172/JCI117352; Inoue M, 2017, J BIOCHEM, V162, P449, DOI 10.1093/jb/mvx054; Kang H, 2017, BRIT J DERMATOL, V176, P713, DOI 10.1111/bjd.15008; Kemeny L, 2007, SKIN PHARMACOL PHYS, V20, P155, DOI 10.1159/000098702; Kendall AC, 2016, BRIT J DERMATOL, V175, P163, DOI 10.1111/bjd.14521; Kiezel-Tsugunova M, 2018, BIOCHEM SOC T, V46, P119, DOI 10.1042/BST20160469; Kim HJ, 2015, INT J DERMATOL, V54, pE401, DOI 10.1111/ijd.12841; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Laleh P, 2019, J CELL PHYSIOL, V234, P7893, DOI 10.1002/jcp.27913; Lebrero P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080799; Lee HC, 2015, BIOCHEMISTRY-US, V54, P2539, DOI 10.1021/acs.biochem.5b00207; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002; Miki Y, 2016, J BIOL CHEM, V291, P15588, DOI 10.1074/jbc.M116.734624; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Murakami M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101457; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Mustafiz SSB, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158515; Ogura Y, 2016, NAT CHEM BIOL, V12, P669, DOI 10.1038/nchembio.2127; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Omland SH, 2017, J EUR ACAD DERMATOL, V31, P1161, DOI 10.1111/jdv.14128; Park KD, 2021, INT IMMUNOPHARMACOL, V98, DOI 10.1016/j.intimp.2021.107883; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Perez-Gonzalez M, 2020, PROG NEUROBIOL, V191, DOI 10.1016/j.pneurobio.2020.101818; Pohla L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59996-z; Prinz I, 2020, J EXP MED, V217, DOI 10.1084/jem.20191397; Rastelli M, 2020, AM J PHYSIOL-ENDOC M, V319, pE647, DOI 10.1152/ajpendo.00146.2020; Saito-Sasaki N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23623-9; Sasso O, 2018, J INVEST DERMATOL, V138, P562, DOI 10.1016/j.jid.2017.07.853; Sawada Y, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.623052; Sawada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30373-1; Schlosburg JE, 2009, J PHARMACOL EXP THER, V329, P314, DOI 10.1124/jpet.108.150136; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shao S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.151911; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Sorokin AV, 2018, J CLIN LIPIDOL, V12, P1047, DOI 10.1016/j.jacl.2018.03.091; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Sumitomo A, 2019, J INVEST DERMATOL, V139, P1010, DOI 10.1016/j.jid.2018.10.034; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Takeichi T, 2020, J CLIN INVEST, V130, P890, DOI 10.1172/JCI130675; Trinchese G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00032; Tronino D, 2016, COLLOID SURFACE B, V141, P311, DOI 10.1016/j.colsurfb.2016.01.058; Tronino D, 2015, MOL PHARMACEUT, V12, P3369, DOI 10.1021/acs.molpharmaceut.5b00397; Tsuboi K, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158972; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; Ueda N, 2005, LIFE SCI, V77, P1750, DOI 10.1016/j.lfs.2005.05.018; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamamoto K, 2017, METHOD ENZYMOL, V583, P101, DOI 10.1016/bs.mie.2016.09.007; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamashita A, 2009, BBA-MOL CELL BIOL L, V1791, P1011, DOI 10.1016/j.bbalip.2009.05.008; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	80	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22301	10.1096/fj.202101958R	http://dx.doi.org/10.1096/fj.202101958R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1E1JF	35478358				2022-12-28	WOS:000794251300001
J	Shan, XS; Zhang, JX; Wei, X; Tao, WH; Peng, K; Liu, HY; Wang, YQ; Liu, H; Meng, XW; Ji, FH				Shan, Xisheng; Zhang, Jiaxin; Wei, Xiang; Tao, Wenhui; Peng, Ke; Liu, Huayue; Wang, Yiqing; Liu, Hong; Meng, Xiaowen; Ji, Fuhai			Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via alpha(2) adrenoreceptors in renal microvascular endothelial cells	FASEB JOURNAL			English	Article						dexmedetomidine; endothelial nitric oxide synthase; microvascular endothelial cell; PI3K/Akt; renal ischemia and reperfusion injury; alpha(2) adrenoreceptors	MYOCARDIAL-ISCHEMIA; DYSFUNCTION; APOPTOSIS; PATHWAY; INFLAMMATION; RATS	Renal microvascular endothelial cells (RMECs), which are closely related to regulation of vascular reactivity and modulation of inflammation, play a crucial role in the process of renal ischemia and reperfusion (I/R) injury. Previous studies have reported the protective effects of dexmedetomidine (DEX) against renal I/R injury, but little is known about the role of DEX on RMECs. This study aimed to investigate whether DEX alleviated renal I/R injury via acting on the RMECs. Mice underwent bilateral renal artery clamping for 45 min followed by reperfusion for 48 h, and the cultured neonatal mice RMECs were subjected to hypoxia for 1 h followed by reoxygenation (H/R) for 24 h. The results suggest that DEX alleviated renal I/R injury in vivo and improved cell viability of RMECs during H/R injury in vitro. Gene sequencing revealed that the PI3K/Akt was the top enriched signaling pathway and the endothelial cells were widely involved in renal I/R injury. DEX activated phosphorylation of PI3K and Akt, increased eNOS expression, and attenuated inflammatory responses. In addition, the results confirmed the distribution of alpha(2) adrenoreceptor (alpha(2)-AR) in RMECs. Furthermore, the protective effects of DEX against renal I/R injury were abolished by alpha(2)-AR antagonist (atipamezole), which was partly reversed by the PI3K agonist (740 Y-P). These findings indicated that DEX protects against renal I/R injury by activating the PI3K/Akt-eNOS pathway and inhibiting inflammation responses via alpha(2)-AR in RMECs.	[Shan, Xisheng; Zhang, Jiaxin; Wei, Xiang; Tao, Wenhui; Peng, Ke; Liu, Huayue; Meng, Xiaowen; Ji, Fuhai] Soochow Univ, Dept Anesthesiol, Affiliated Hosp 1, 888 Pinghai Rd, Suzhou, Jiangsu, Peoples R China; [Shan, Xisheng; Peng, Ke; Liu, Huayue; Meng, Xiaowen; Ji, Fuhai] Soochow Univ, Inst Anesthesiol, Suzhou, Peoples R China; [Wang, Yiqing] Soochow Univ, Dept Neurol, Affiliated Hosp 1, Suzhou, Peoples R China; [Liu, Hong] Univ Calif Davis Hlth, Dept Anesthesiol & Pain Med, Sacramento, CA USA	Soochow University - China; Soochow University - China; Soochow University - China	Meng, XW; Ji, FH (corresponding author), Soochow Univ, Dept Anesthesiol, Affiliated Hosp 1, 888 Pinghai Rd, Suzhou, Jiangsu, Peoples R China.	lingximxw@163.com; jifuhaisuda@163.com		liu, huayue/0000-0002-1504-1310	National Natural Science Foundation of China (NSFC) [82072130, 81873925]; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) [BK20191171]; Six Talent Peaks Project in Jiangsu Province (Jiangsu Province Six-Category Talent Program) [WSN-022]; Clinical Trial Project of Science and Technology Development Plan in Suzhou city [SLT201909]; 333 High-level Talent Training Project in Jiangsu Province [BRA2020089]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [22KJD320002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)(Natural Science Foundation of Jiangsu Province); Six Talent Peaks Project in Jiangsu Province (Jiangsu Province Six-Category Talent Program); Clinical Trial Project of Science and Technology Development Plan in Suzhou city; 333 High-level Talent Training Project in Jiangsu Province; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82072130 and 81873925; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), Grant/Award Number: BK20191171; Six Talent Peaks Project in Jiangsu Province (Jiangsu Province Six-Category Talent Program), Grant/Award Number: WSN-022; Clinical Trial Project of Science and Technology Development Plan in Suzhou city, Grant/Award Number: SLT201909; 333 High-level Talent Training Project in Jiangsu Province, Grant/Award Number: BRA2020089; Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Grant/Award Number: 22KJD320002	Agrawal M, 2000, AM FAM PHYSICIAN, V61, P2077; Mendoza MGA, 2008, NEPHROLOGY, V13, P218, DOI 10.1111/j.1440-1797.2007.00897.x; Balasubramanian G, 2011, AM J KIDNEY DIS, V57, P228, DOI 10.1053/j.ajkd.2010.08.026; Cao G., 2014, CURR PROTOC TOXICOL, V61, P21; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Cho JS, 2016, KIDNEY INT, V89, P693, DOI 10.1038/ki.2015.306; Dong FY, 2021, FUND CLIN PHARMACOL, V35, P321, DOI 10.1111/fcp.12622; Frumento RJ, 2006, J CLIN ANESTH, V18, P422, DOI 10.1016/j.jclinane.2006.02.005; Gazzaniga S, 2004, IN VITRO CELL DEV-AN, V40, P82; Gerlach AT, 2009, ANN PHARMACOTHER, V43, P2064, DOI 10.1345/aph.1M310; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Gu LJ, 2018, INT UROL NEPHROL, V50, P2027, DOI 10.1007/s11255-018-1918-6; Gumbert SD, 2020, ANESTHESIOLOGY, V132, P180, DOI 10.1097/ALN.0000000000002968; Han SJ, 2019, KIDNEY RES CLIN PRAC, V38, P427, DOI 10.23876/j.krcp.19.062; Jourde-Chiche N, 2019, NAT REV NEPHROL, V15, P87, DOI 10.1038/s41581-018-0098-z; LEFER AM, 1991, BASIC RES CARDIOL, V86, P109; Li BY, 2020, EUR REV MED PHARMACO, V24, P12400, DOI 10.26355/eurrev_202012_24035; Li JJ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1455-1; Liang S, 2019, EUR REV MED PHARMACO, V23, P370, DOI 10.26355/eurrev_201901_16785; Liu B, 2020, MOL MED REP, V22, P4655, DOI 10.3892/mmr.2020.11554; Liu C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.540479; Lv ZQ, 2020, EUR REV MED PHARMACO, V24, P5192, DOI 10.26355/eurrev_202005_21296; Ma JB, 2020, ANESTH ANALG, V130, P1054, DOI 10.1213/ANE.0000000000003820; Mahfoudh-Boussaid A, 2014, RENAL FAILURE, V36, P1436, DOI 10.3109/0886022X.2014.949765; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Molitoris BA, 2011, CONTRIB NEPHROL, V174, P108, DOI 10.1159/000329248; Nakagawa T, 2011, CONTRIB NEPHROL, V170, P93, DOI 10.1159/000324954; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Nong LD, 2016, KOREAN J PHYSIOL PHA, V20, P441, DOI 10.4196/kjpp.2016.20.5.441; Pefanis A, 2019, KIDNEY INT, V96, P291, DOI 10.1016/j.kint.2019.02.009; Pei YH, 2020, NANOTOXICOLOGY, V14, P638, DOI 10.1080/17435390.2020.1731857; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Shan XS, 2021, J CLIN ANESTH, V75, DOI 10.1016/j.jclinane.2021.110498; Shao QB, 2021, MICROCIRCULATION, V28, DOI 10.1111/micc.12675; Si YN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-141; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Soh S., 2020, BRIT J ANAESTH, V29; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tan XH, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00556; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Vinas JL, 2006, FREE RADICAL BIO MED, V40, P992, DOI 10.1016/j.freeradbiomed.2005.10.046; Wei QJ, 2019, GENE, V708, P14, DOI 10.1016/j.gene.2019.05.023; Wen ZM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8678267; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Yu TY, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109231; Yu YW, 2016, MOL MED REP, V13, P1353, DOI 10.3892/mmr.2015.4660; Yuan M, 2019, DRUG DES DEV THER, V13, P3137, DOI 10.2147/DDDT.S219533; Zhan QH, 2020, MICROVASC RES, V128, DOI 10.1016/j.mvr.2019.103941; Zheng Z, 2019, INFLAMMATION, V42, P606, DOI 10.1007/s10753-018-0918-0; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	50	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22608	10.1096/fj.202101626RR	http://dx.doi.org/10.1096/fj.202101626RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0XN	36250975				2022-12-28	WOS:000868770600001
J	Zhao, AN; Yang, Z; Wang, DD; Shi, B; Zhang, H; Bai, Y; Yan, BW; Zhang, Y; Wen, JK; Wang, XL; Qu, CB				Zhao, An-Ning; Yang, Zhan; Wang, Dan-Dan; Shi, Bei; Zhang, Hong; Bai, Yang; Yan, Bo-Wen; Zhang, Yong; Wen, Jin-Kun; Wang, Xiao-Lu; Qu, Chang-Bao			Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor-promoted inflammatory responses and prostate cancer progression	FASEB JOURNAL			English	Article						acetylation; androgen receptor; inflammasome; KAT2B; NLRP3; prostate cancer	CIRCULAR RNAS; ABLATION; COACTIVATORS; MODULATION; ACTIVATION; CROSSTALK; OUTCOMES; ANALOGS; GROWTH; P300	Chronic inflammation is one of the definite factors leading to the occurrence and development of tumors, including prostate cancer (PCa). The androgen receptor (AR) pathway is essential for PCa tumorigenesis and inflammatory response. However, little is known about the AR-regulated NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome pathway in human PCa. In this study, we explored the expression of inflammatory cytokine and AR in high-grade PCa and observed that NLRP3 inflammasome-associated genes were upregulated in high-grade PCa compared with that in low-grade PCa and benign prostatic hyperplasia and were associated with AR expression. In addition, we identified circAR-3-a circRNA derived from the AR gene-which is involved in the AR-regulated inflammatory response and cell proliferation by activating the NLRP3 inflammatory pathway. While circAR-3 overexpression promoted cell proliferation and the inflammatory response, its depletion induced opposite effects. Mechanistically, we noted that circAR-3 mediated the acetylation modification of NLRP3 by KAT2B and then promoted NLRP3 inflammasome complex subcellular distribution and assembly. Disturbing NLRP3 acetylation or blocking inflammasome assembly with an inhibitor suppressed the progression of PCa xenograft tumors. Our findings provide the first evidence that targeting NLRP3 acetylation or inflammasome assembly may be effective in inhibiting PCa progression.	[Zhao, An-Ning; Yang, Zhan; Wang, Dan-Dan; Shi, Bei; Zhang, Hong; Yan, Bo-Wen; Wang, Xiao-Lu; Qu, Chang-Bao] Hebei Med Univ, Dept Urol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Yang, Zhan] Hebei Med Univ, Talent & Acad Exchange Ctr, Mol Biol Lab, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Bai, Yang; Wen, Jin-Kun] Hebei Med Univ, Dept Biochem & Mol Biol, Minist Educ China, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yong] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Urol, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Ministry of Education, China; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wang, XL; Qu, CB (corresponding author), Hebei Med Univ, Dept Urol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.	wxlurology@163.com; changbao_qu@126.com			Excellent Youth Science Foundation of Hebei Province [H2019206536]; Key Research Project of Hebei Natural Science Foundation [H2019206698]; National Natural Science Foundation of China (NSFC) [81672555, 81970216, 81972411]; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation) [H2020206601]	Excellent Youth Science Foundation of Hebei Province; Key Research Project of Hebei Natural Science Foundation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation)	Excellent Youth Science Foundation of Hebei Province, Grant/Award Number: H2019206536; Key Research Project of Hebei Natural Science Foundation, Grant/Award Number: H2019206698; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81672555, 81970216 and 81972411; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation), Grant/Award Number: H2020206601	Akins EJ, 2010, CANCER RES, V70, P3473, DOI 10.1158/0008-5472.CAN-09-2490; Alpsoy A, 2021, CANCER RES, V81, P820, DOI 10.1158/0008-5472.CAN-20-1417; Archer M, 2020, CANCERS, V12, DOI 10.3390/cancers12102984; Aurilio G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122653; Becerra-Diaz M, 2018, J IMMUNOL, V201, P2923, DOI 10.4049/jimmunol.1800352; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Cai T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153833; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Cho YS, 2010, J MED CHEM, V53, P2952, DOI 10.1021/jm100007m; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Crawford ED, 2019, PROSTATE CANCER P D, V22, P24, DOI 10.1038/s41391-018-0079-0; Culig Z, 2016, J CELL PHYSIOL, V231, P270, DOI 10.1002/jcp.25099; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Dong XY, 2021, AGING CELL, V20, DOI 10.1111/acel.13430; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; Fang LY, 2013, CANCER RES, V73, P5633, DOI 10.1158/0008-5472.CAN-12-3228; Fournier M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13227; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Golias Ch., 2009, Experimental Oncology, V31, P3; Gong J, 2006, ONCOGENE, V25, P2011, DOI 10.1038/sj.onc.1209231; Izumi Kouji, 2014, Clin Investig (Lond), V4, P935, DOI 10.4155/cli.14.77; Izumi K, 2013, EMBO MOL MED, V5, P1383, DOI 10.1002/emmm.201202367; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Khurana N, 2018, CANCERS, V10, DOI 10.3390/cancers10100352; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; Komura K, 2018, INT J UROL, V25, P220, DOI 10.1111/iju.13512; Kori M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200717; Kumar R, 1998, ARCH ENVIRON CON TOX, V35, P674, DOI 10.1007/s002449900430; Larsson R, 2011, CURR MED CHEM, V18, P4440, DOI 10.2174/092986711797287539; Lee YH, 2012, INT J MOL MED, V30, P69, DOI 10.3892/ijmm.2012.966; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Lin TH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.270; Liu QP, 2019, INT J CANCER, V145, P415, DOI 10.1002/ijc.32118; Ma Y, 2021, AGING-US, V13, P11610, DOI 10.18632/aging.202855; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Malinen M, 2017, NUCLEIC ACIDS RES, V45, P619, DOI 10.1093/nar/gkw855; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McGuire BB, 2012, BJU INT, V109, P1764, DOI 10.1111/j.1464-410X.2011.10628.x; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Merriel SWD, 2018, ADV THER, V35, P1285, DOI 10.1007/s12325-018-0766-1; Nematollahi A, 2016, MOLECULES, V21, DOI 10.3390/molecules21070856; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Qi JC, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-020-01814-5; Rani A, 2019, AM J PATHOL, V189, P2119, DOI 10.1016/j.ajpath.2019.07.007; Ren LX, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02020-9; Ren LX., 2021, FRONT ONCOL, V11; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Santoni M, 2016, EUR UROL, V69, P186, DOI 10.1016/j.eururo.2015.05.041; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Teo MY, 2019, ANNU REV MED, V70, P479, DOI 10.1146/annurev-med-051517-011947; Trembley JH, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020089; vom Steeg LG, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008506; Wang Y, 2020, ACTA PHARMACOL SIN B, V10, P207, DOI 10.1016/j.apsb.2019.08.001; Welti J, 2021, CANCER DISCOV, V11, P1118, DOI 10.1158/2159-8290.CD-20-0751; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang Z, 2019, ONCOGENE, V38, P2516, DOI 10.1038/s41388-018-0602-8; Yang Z, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0649-3; Zeng QZ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00072; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhao J, 2020, CANCER SCI, V111, P369, DOI 10.1111/cas.14280; Zhu HC, 2019, J CANCER, V10, P2464, DOI 10.7150/jca.29648	69	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22602	10.1096/fj.202200673RRR	http://dx.doi.org/10.1096/fj.202200673RRR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5J0WV	36250925				2022-12-28	WOS:000868768800001
J	Chen, H; Gao, XY; Zhao, SY; Bao, CY; Ming, X; Qian, YJ; Zhou, Y; Jung, YS				Chen, Huan; Gao, Xiaoyu; Zhao, Shiying; Bao, Chenyi; Ming, Xin; Qian, Yingjuan; Zhou, Yan; Jung, Yong-Sam			Pirh2 restricts influenza A virus replication by modulating short-chain ubiquitination of its nucleoprotein	FASEB JOURNAL			English	Article						influenza A virus; NP; Pirh2; short-chain ubiquitination	E3 LIGASE PIRH2; VIRAL NUCLEOPROTEIN; ORF3 PROTEIN; RNA; ADAPTATION; BINDING; PB2; MONOUBIQUITINATION; INFECTION; TRANSPORT	Influenza A viruses (IAVs) rely on viral ribonucleoprotein (vRNP) complexes to control transcription and replication. Each vRNP consists of one viral genomic RNA segment associated with multiple nucleoproteins (NP) and a trimeric IAV RNA polymerase complex. Previous studies showed that post-translational modifications of vRNP components, such as NP, by host factors would in turn affect the IAV life cycle or modulate host anti-viral response. In this study, we found host E3 ubiquitin ligase Pirh2 interacted with NP and mediated short-chain ubiquitination of NP at lysine 351, which suppressed NP-PB2 interaction and vRNP formation. In addition, we showed that knockdown of Pirh2 promoted IAV replication, whereas overexpression of Pirh2 inhibited IAV replication. However, Pirh2-Delta RING lacking E3 ligase activity failed to inhibit IAV infection. Moreover, we showed that Pirh2 had no effect on the replication of a rescued virus, WSN-K351R, carrying lysine-to-arginine substitution at residue 351. Interestingly, by analyzing human and avian IAVs from 2011 to 2020 in influenza research databases, we found that 99.18% of 26 977 human IAVs encode lysine, but 95.3% of 9956 avian IAVs encode arginine at residue 351 of NP protein. Consistently, knockdown of Pirh2 failed to promote propagation of two avian-like influenza viruses, H9N2-W1 and H9N2-C1, which naturally encode arginine at residue 351 of NP. Taken together, we demonstrated that Pirh2 is a host factor restricting IAV infection by modulating short-chain ubiquitination of NP. Meanwhile, it is noteworthy that residue 351 of NP targeted by Pirh2 may associate with the evasion of human anti-viral response against avian-like influenza viruses.	[Chen, Huan; Gao, Xiaoyu; Zhao, Shiying; Bao, Chenyi; Ming, Xin; Qian, Yingjuan; Jung, Yong-Sam] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Jiangsu Foreign Expert Workshop, Nanjing, Jiangsu, Peoples R China; [Qian, Yingjuan] Jiangsu Agrianim Husb Vocat Coll, Jiangsu Key Lab High Tech Res & Dev Vet Biopharma, Vet Biopharmaceut, Taizhou, Peoples R China; [Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Zhou, Yan] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada	Nanjing Agricultural University; Jiangsu Agri-animal Husbandry Vocational College; University of Saskatchewan; University of Saskatchewan	Jung, YS (corresponding author), Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Jiangsu Foreign Expert Workshop, Nanjing, Jiangsu, Peoples R China.	ysjung@njau.edu.cn		, Yan/0000-0002-4706-1543	National Natural Science Foundation of China [31900141]; Fundamental Research Funds for the Central Universities [KJQN202022]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Ministry of Agriculture; Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Innovation Saskatchewan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Innovation Saskatchewan	National Natural Science Foundation of China, Grant/Award Number: 31900141; Fundamental Research Funds for the Central Universities, Grant/Award Number: KJQN202022; Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Innovation Saskatchewan and the Ministry of Agriculture; Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada	Ahmed F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071415; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2019, J VIROL, V93, DOI 10.1128/JVI.01896-18; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; Cianci Christopher, 2013, Antiviral Chemistry & Chemotherapy, V23, P77, DOI 10.3851/IMP2235; Cui L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01816; Danzy S, 2014, J VIROL, V88, P13436, DOI 10.1128/JVI.01093-14; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Dong LL, 2015, VIRUSES-BASEL, V7, P1668, DOI 10.3390/v7041668; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Giese S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01112-3; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Halaby MJ, 2013, CELL CYCLE, V12, P2733, DOI 10.4161/cc.25785; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008; Hu J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.517461; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; Ikeda F, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202008031; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Jung YS, 2011, J BIOL CHEM, V286, P35388, DOI 10.1074/jbc.M111.261537; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Karuppannan AK, 2010, VIROLOGY, V398, P1, DOI 10.1016/j.virol.2009.11.028; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Lin YC, 2017, MBIO, V8, DOI 10.1128/mBio.00597-17; Liu J, 2007, J VIROL, V81, P9560, DOI 10.1128/JVI.00681-07; Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1257, DOI 10.1038/aps.2013.121; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Min JY, 2013, J VIROL, V87, P10884, DOI 10.1128/JVI.01016-13; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Patil G, 2018, J VIROL, V92, DOI 10.1128/JVI.00905-18; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shao WH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081650; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vijaykrishna D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004902; Villalon-Letelier F, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120376; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WHO, 2014, INFL SEAS; Wu XW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00344; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yip TF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01547; Zhao MM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081673; Zheng WN, 2021, SCI CHINA LIFE SCI, V64, P633, DOI 10.1007/s11427-020-1727-y; Zheng WJ, 2013, FEBS LETT, V587, P1206, DOI 10.1016/j.febslet.2013.02.048	61	0	0	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22537	10.1096/fj.202200473R	http://dx.doi.org/10.1096/fj.202200473R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5BC	36070077				2022-12-28	WOS:000850591200001
J	Yin, Z; Zhang, JS; Xu, SW; Liu, JF; Xu, Y; Yu, JP; Zhao, MM; Pan, W; Wang, ML; Wan, J				Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun			The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers	FASEB JOURNAL			English	Review						axonal guidance molecule; cardiovascular diseases; neuropilin; plexin; semaphorin	HOSPITAL CARDIAC-ARREST; MYOCARDIAL-INFARCTION; GENETIC-VARIANTS; SYMPATHETIC DENERVATION; DILATED CARDIOMYOPATHY; VIRAL MYOCARDITIS; KAWASAKI-DISEASE; CELL-ADHESION; T-CELLS; HEART	Semaphorins (Semas), which belongs to the axonal guidance molecules, include 8 classes and could affect axon growth in the nervous system. Recently, semaphorins were found to regulate other pathophysiological processes, such as immune response, oncogenesis, tumor angiogenesis, and bone homeostasis, through binding with their plexin and neuropilin receptors. In this review, we summarized the detailed role of semaphorins and their receptors in the pathological progression of various cardiovascular diseases (CVDs), highlighting that semaphorins may be potential therapeutic targets and novel biomarkers for CVDs.	[Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun] Wuhan Univ, Dept Cardiol, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Peoples R China; [Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Peoples R China; [Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun] Hubei Key Lab Cardiol, Wuhan, Peoples R China	Wuhan University; Wuhan University	Wang, ML; Wan, J (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Peoples R China.	whuwangmenglong@163.com; wanjun@whu.edu.cn			National Natural Science Foundation of China [82100292, 82070436]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 82100292 and 82070436	Luque MCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075772; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Boczek NJ, 2014, CIRC RES, V115, P460, DOI 10.1161/CIRCRESAHA.115.303657; Brugada Ramon, 2014, Methodist Debakey Cardiovasc J, V10, P25; Campuzano O, 2019, HUM MUTAT, V40, P749, DOI 10.1002/humu.23730; Can V, 2021, BIOMARKERS, V26, P468, DOI 10.1080/1354750X.2021.1917664; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Carvalheiro T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186965; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Chen RH, 2013, J CELL MOL MED, V17, P608, DOI 10.1111/jcmm.12035; CINCA J, 1994, CARDIOVASC RES, V28, P1018, DOI 10.1093/cvr/28.7.1018; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Coute RA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005239; CRICK SJ, 1994, CIRCULATION, V89, P1697, DOI 10.1161/01.CIR.89.4.1697; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Dhillon OS, 2010, CLIN SCI, V118, P249, DOI 10.1042/CS20090226; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Epstein JA, 2015, CELL METAB, V21, P163, DOI 10.1016/j.cmet.2014.12.015; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fairweather D, 2012, CURR OPIN RHEUMATOL, V24, P401, DOI 10.1097/BOR.0b013e328353372d; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fiore R, 2003, FRONT BIOSCI-LANDMRK, V8, pS484, DOI 10.2741/1080; Fujimaki T, 2010, ATHEROSCLEROSIS, V210, P468, DOI 10.1016/j.atherosclerosis.2009.11.050; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Gong H, 2019, LIFE SCI, V219, P329, DOI 10.1016/j.lfs.2019.01.021; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; He L, 2022, PHARMACOL THERAPEUT, V235, DOI 10.1016/j.pharmthera.2022.108152; Hong L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02818-x; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Hu HS, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0192-8; Hu SH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01718; Hu SH, 2018, ARTERIOSCL THROM VAS, V38, P335, DOI 10.1161/ATVBAHA.117.310491; Huang JH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6663291; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; INOUE H, 1987, CIRCULATION, V75, P877, DOI 10.1161/01.CIR.75.4.877; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jongbloets BC, 2013, SEMIN CELL DEV BIOL, V24, P129, DOI 10.1016/j.semcdb.2013.01.002; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; KODAMA M, 1994, CIRC RES, V75, P278, DOI 10.1161/01.RES.75.2.278; Kohler D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14958-x; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kwon YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184248; Li Y, 2021, BMC IMMUNOL, V22, DOI 10.1186/s12865-021-00406-y; Liao SY, 2015, EUROPACE, V17, P1875, DOI 10.1093/europace/euu409; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lu N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03128-9; Lu QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064265; Luque MCA, 2015, MOL IMMUNOL, V67, P559, DOI 10.1016/j.molimm.2015.07.028; Makino N, 2008, FEBS LETT, V582, P3935, DOI 10.1016/j.febslet.2008.10.040; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Mehta V, 2020, NATURE, V578, P290, DOI 10.1038/s41586-020-1979-4; Michel JB, 2014, ATHEROSCLEROSIS, V234, P311, DOI 10.1016/j.atherosclerosis.2014.03.020; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Nakano Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003364; Neufeld G, 2016, DRUG RESIST UPDATE, V29, P1, DOI 10.1016/j.drup.2016.08.001; Nishide M, 2017, ANN RHEUM DIS, V76, P1440, DOI 10.1136/annrheumdis-2016-210706; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Oh YS, 2006, HEART RHYTHM, V3, P728, DOI 10.1016/j.hrthm.2006.02.005; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Peng Q, 2016, EUR J PEDIATR, V175, P705, DOI 10.1007/s00431-016-2696-8; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; RANDALL WC, 1968, CIRC RES, V22, P315, DOI 10.1161/01.RES.22.3.315; Reichert S, 2019, INFLAMMATION, V42, P1252, DOI 10.1007/s10753-019-00985-4; Rienks M, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0630-5; ROSE NR, 1988, IMMUNOL TODAY, V9, P117, DOI 10.1016/0167-5699(88)91282-0; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Sarquella-Brugada G, 2016, GENET MED, V18, P3, DOI 10.1038/gim.2015.35; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Schwartz S M, 2000, Curr Atheroscler Rep, V2, P422, DOI 10.1007/s11883-000-0081-5; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Shi ZF, 2016, GENET TEST MOL BIOMA, V20, P55, DOI 10.1089/gtmb.2015.0264; Siebold C, 2013, SEMIN CELL DEV BIOL, V24, P139, DOI 10.1016/j.semcdb.2012.11.003; Song XY, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10876; Song Y, 2021, J CELL PHYSIOL, V236, P6235, DOI 10.1002/jcp.30340; Souilhol C, 2018, CARDIOVASC RES, V114, P565, DOI 10.1093/cvr/cvx253; STANTON MS, 1989, J AM COLL CARDIOL, V14, P1519, DOI 10.1016/0735-1097(89)90391-4; Sun SQ, 2011, CHINESE MED J-PEKING, V124, P2173, DOI 10.3760/cmaj.issn.0366-6999.2011.14.017; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; VRACKO R, 1991, HUM PATHOL, V22, P138, DOI 10.1016/0046-8177(91)90035-N; Vreeken D, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.633609; Wang HM, 2020, IMMUNOLOGY, V160, P209, DOI 10.1111/imm.13189; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Wesseling M, 2018, VASC PHARMACOL, V106, P1, DOI 10.1016/j.vph.2018.02.006; Willner N, 2018, ESC HEART FAIL, V5, P603, DOI 10.1002/ehf2.12275; Wu JH, 2019, EBIOMEDICINE, V39, P95, DOI 10.1016/j.ebiom.2018.12.023; Wu JH, 2017, CARDIOVASC RES, V113, P1763, DOI 10.1093/cvr/cvx190; Wu XJ, 2018, J MOL CELL CARDIOL, V114, P48, DOI 10.1016/j.yjmcc.2017.11.001; Xiang L, 2015, MED SCI MONITOR, V21, P2912, DOI 10.12659/MSM.895441; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036; Yang LC, 2016, EUROPACE, V18, P1886, DOI 10.1093/europace/euv276; Yang SQ, 2019, J HEPATOL, V71, P685, DOI 10.1016/j.jhep.2019.05.013; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yoshida T, 2010, INT J MOL MED, V25, P607, DOI 10.3892/ijmm_00000383; Yoshida T, 2009, INT J MOL MED, V24, P701, DOI 10.3892/ijmm_00000282; You T, 2019, J CELL MOL MED, V23, P2901, DOI 10.1111/jcmm.14186; Yu R, 2022, TRANSL STROKE RES, V13, P142, DOI 10.1007/s12975-021-00914-4; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432; Zhang HY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041471; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zhou YF, 2019, FASEB J, V33, P4947, DOI 10.1096/fj.201801706RR; Zhou YF, 2018, NEUROBIOL AGING, V70, P102, DOI 10.1016/j.neurobiolaging.2018.06.003; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zhu L, 2009, ARTERIOSCL THROM VAS, V29, P1039, DOI 10.1161/ATVBAHA.109.185405	124	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22509	10.1096/fj.202200844R	http://dx.doi.org/10.1096/fj.202200844R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H4KA	36063107				2022-12-28	WOS:000849848100001
J	Zhang, XD; Jin, XX; Li, YB; Xu, MM; Yao, Y; Liu, KY; Ma, CJ; Zhang, YC; Ru, JJ; He, YF; Gao, JH				Zhang, Xiangdong; Jin, Xiaoxuan; Li, Yibao; Xu, Mimi; Yao, Yao; Liu, Kaiyang; Ma, Chijuan; Zhang, Yuchen; Ru, Jiangjiang; He, Yunfan; Gao, Jianhua			Macrophage-mediated extracellular matrix remodeling after fat grafting in nude mice	FASEB JOURNAL			English	Article						extracellular matrix remodeling; fat grafting; fibroblast; graft retention; macrophage	DECELLULARIZED ADIPOSE-TISSUE; STEM-CELL; TRANSPLANTATION; DEGRADATION; ADIPOCYTES; SCAFFOLD	Clinical unpredictability and variability following fat grafting remain non-negligible problems due to the unknown mechanism of grafted fat retention. The role of the extracellular matrix (ECM), which renders cells with structural and biochemical support, has been ignored. This study aimed to clarify the ECM remodeling process, related cellular events, and the spatiotemporal relationship between ECM remodeling and adipocyte survival and adipogenesis after fat grafting. Labeled Coleman fat by the matrix-tracing technique was grafted in nude mice. The ECM remodeling process and cellular events were assessed in vivo. The related cytokines were evaluated by qRT-PCR. An in vitro cell migration assay was performed to verify the chemotactic effect of M2-like macrophages on fibroblasts. The results demonstrated that in the periphery, most of the adipocytes of the graft survived or regenerated, and the graft-derived ECM was gradually replaced by the newly-formed ECM. In the central parts, most adipocytes in the grafts died shortly after, and a small part of the graft-derived and newly-formed ECM was expressed with irregular morphology. Adipose ECM remodeling is associated with increased infiltration of macrophages and fibroblasts, as well as up-regulated expression of cytokines in the adipose tissue. To sum up, our results describe the various preservation mode of fat grafts after transplantation and underscore the importance of macrophage-mediated ECM remodeling in graft preservation after fat grafting. The appreciation and manipulation of underlying mechanisms that are operant in this setting stand to explore new therapeutic approaches and improve clinical outcomes of fat grafting.	[Zhang, Xiangdong; Jin, Xiaoxuan; Li, Yibao; Xu, Mimi; Yao, Yao; Liu, Kaiyang; Ma, Chijuan; Zhang, Yuchen; Ru, Jiangjiang; He, Yunfan; Gao, Jianhua] Southern Med Univ, Nanfang Hosp, Dept Plast Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China	He, YF; Gao, JH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	doctorheyunfan@hotmail.com; doctorgaojianhua@outlook.com	Zhang, Yuchen/GYI-8858-2022		National Nature Science Foundation of China [81772101, 81801933, 81871573]; Natural Science Foundation of Guangdong Province of China [2017A030313900]; Administrator Foundation of Nanfang Hospital [2016Z010, 2017C008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Administrator Foundation of Nanfang Hospital	This work was supported by the National Nature Science Foundation of China (81772101, 81801933, 81871573), the Natural Science Foundation of Guangdong Province of China (2017A030313900), and the Administrator Foundation of Nanfang Hospital (2016Z010, 2017C008).	Abu-Ghname A, 2019, SEMIN PLAST SURG, V33, P147, DOI 10.1055/s-0039-1693438; Alcorta-Sevillano N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122630; Alharbi Z, 2013, J PLAST RECONSTR AES, V66, P1271, DOI 10.1016/j.bjps.2013.04.015; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bhang SH, 2014, MOL THER, V22, P862, DOI 10.1038/mt.2013.301; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Cai JR, 2017, BIOCHEM BIOPH RES CO, V490, P560, DOI 10.1016/j.bbrc.2017.06.078; Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067; Chung MT, 2014, PLAST RECONSTR SURG, V134, P29, DOI 10.1097/PRS.0000000000000290; Cleveland EC, 2015, PLAST RECONSTR SURG, V136, P706, DOI 10.1097/PRS.0000000000001581; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; DeLeon-Pennell KY, 2020, MATRIX BIOL, V91-92, P1, DOI 10.1016/j.matbio.2020.05.006; Derrick CJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.191320; Doi K, 2015, PLAST RECONSTR SURG, V135, P1607, DOI 10.1097/PRS.0000000000001292; Domingues MJ, 2017, J CELL BIOCHEM, V118, P1984, DOI 10.1002/jcb.25905; Dong ZQ, 2015, PLAST RECONSTR SURG, V135, p556E, DOI 10.1097/PRS.0000000000000965; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Fisher C, 2013, PLAST RECONSTR SURG, V132, P351, DOI 10.1097/PRS.0b013e3182958796; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Jeon EY, 2020, ACTA BIOMATER, V114, P244, DOI 10.1016/j.actbio.2020.07.033; Jin XX, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.722427; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Kurose H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071716; Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Li CX, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189997; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Madsen DH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27127; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Newby AC, 2016, EXP PHYSIOL, V101, P1327, DOI 10.1113/EP085567; Peng Z, 2021, BIOMATERIALS, V268, DOI 10.1016/j.biomaterials.2020.120555; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Phipps KD, 2015, PLAST RECONSTR SURG, V135, P140, DOI 10.1097/PRS.0000000000000793; Pu LLQ, 2012, J PLAST RECONSTR AES, V65, P413, DOI 10.1016/j.bjps.2011.09.033; Sagaradze G, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1479-3; Sainio A, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109487; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shih L, 2020, SEMIN PLAST SURG, V34, P5, DOI 10.1055/s-0039-3402073; Simonacci F, 2016, ANN MED SURG, V12, P94, DOI 10.1016/j.amsu.2016.11.012; Sinno S, 2016, PLAST RECONSTR SURG, V137, P818, DOI 10.1097/01.prs.0000479966.52477.8b; Sobreiro-Almeida R, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202100160; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Sprangers S, 2019, MATRIX BIOL, V75-76, P190, DOI 10.1016/j.matbio.2017.11.008; Sterodimas A, 2011, AESTHET SURG J, V31, P682, DOI 10.1177/1090820X11415976; Strong AL, 2015, PLAST RECONSTR SURG, V136, P897, DOI 10.1097/PRS.0000000000001590; Theocharis AD, 2019, FEBS J, V286, P2830, DOI 10.1111/febs.14818; Ueshima E, 2019, AM J PHYSIOL-RENAL, V317, pF52, DOI 10.1152/ajprenal.00260.2018; Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419; Wolter TP, 2005, ANN PLAS SURG, V55, P408, DOI 10.1097/01.sap.0000181345.56084.7d; Yao Y, 2017, PLAST RECONSTR SURG, V139, P867, DOI 10.1097/PRS.0000000000003214; Yi Y., 2021, CELL TRANSPLANT, V30; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Yu C, 2017, BIOMATERIALS, V120, P66, DOI 10.1016/j.biomaterials.2016.12.017	56	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22550	10.1096/fj.202200037R	http://dx.doi.org/10.1096/fj.202200037R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1TO	36098482				2022-12-28	WOS:000853111200001
J	Lin, CM; Sung, CC; Yang, SS; Chen, YC; Huang, SM; Lin, SH				Lin, Chien-Ming; Sung, Chih-Chien; Yang, Sung-Sen; Chen, Ying-Chuan; Huang, Shih-Ming; Lin, Shih-Hua			Generation and analysis of pseudohypoaldosteronism type II knock-in mice caused by a nonsense KLHL3 mutation in the Kelch domain	FASEB JOURNAL			English	Article						cullin3; Kelch-like 3; nonsense mutation; pseudohypoaldosteronism type II; with-no-lysine kinases	FAMILIAL HYPERKALEMIC HYPERTENSION; DISEASE-CAUSING MUTATIONS; MESSENGER-RNA DECAY; CL-COTRANSPORTER; BLOOD-PRESSURE; ION-TRANSPORT; WNK4; KINASE; UBIQUITINATION; MOUSE	Mutations in the Kelch-like 3 (KLHL3) gene are the most common cause of inherited pseudohypoaldosteronism type II (PHAII) featuring thiazide-sensitive hypertension and hyperkalemic metabolic acidosis. Although Klhl3(R528H)(/+) knock-in (KI) mice carrying a missense mutation in the Kelch repeat domain have been reported, nonsense KLHL3 mutations in the same domain that cause PHAII have not been fully investigated in vivo. We generated and analyzed Klhl3 KI mice harboring a nonsense W523X mutation (corresponding to the human KLHL3 W470X mutation). Both heterozygous and homozygous Klhl3(W523X)(/+) KI mice exhibited typical PHAII with low-renin hypertension, hyperkalemia with reduced renal potassium excretion, and hyperchloremic metabolic acidosis. Their kidney tissues showed the presence of Klhl3 mRNA and increased Klhl3 protein levels along with enhanced downstream Wnk1/4-Spak/Osr1-N(k)cc phosphorylation. Increased protein expression of total Spak, phosphor(p-)Spak, total Ncc, and p-Ncc from urinary extracellular vesicles (uEVs) also confirmed the activation of the Wnk-mediated Ncc pathway. In vitro studies showed that the human KLHL3 W470X mutation resulted in increased KLHL3 protein stability and disrupted its binding affinity for WNK1/4, leading to the attenuated degradation and increased abundance of total WNKs. In conclusion, nonsense Klhl3(W523X)(/+) mice recapitulating PHAII phenotypes exhibit Klhl3 protein stability, abrogating its binding to Wnks, with enhanced Ncc expression in the kidney tissue and even in uEVs. Activation of the WNK-mediated Na+-Cl- co-transporter reiterated the in vivo pathogenic role of nonsense KLHL3 mutations in PHAII.	[Lin, Chien-Ming] Triserv Gen Hosp, Dept Pediat, Natl Def Med Ctr, Taipei, Taiwan; [Sung, Chih-Chien; Yang, Sung-Sen; Lin, Shih-Hua] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan; [Yang, Sung-Sen; Lin, Shih-Hua] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Ying-Chuan] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Lin, SH (corresponding author), Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw			Ministry of Science and Technology [107--2314-B--016--064--MY3, 109--2314--B--016--040-MY3, 110--2314--B--016--016--MY3]; Research Fund of Tri--Service General Hospital [TSGH-E--109204, TSGH-E--111196, TSGH--E--110187]; Teh--Tzer Study Group for Human Medical Research Foundation [B1081003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Research Fund of Tri--Service General Hospital; Teh--Tzer Study Group for Human Medical Research Foundation	Ministry of Science and Technology, Grant/Award Number: 107--2314-B--016--064--MY3, 109--2314--B--016--040-MY3 and 110--2314--B--016--016--MY3; Research Fund of Tri--Service General Hospital, Grant/Award Number: TSGH-E--109204, TSGH--E--110187 and TSGH-E--111196; Teh--Tzer Study Group for Human Medical Research Foundation, Grant/Award Number: B1081003	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Benson KF, 2004, NUCLEIC ACIDS RES, V32, P6327, DOI 10.1093/nar/gkh974; Bergaya S, 2011, HYPERTENSION, V58, P439, DOI 10.1161/HYPERTENSIONAHA.111.172429; Borgatti M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020289; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Chiga M, 2011, J CELL SCI, V124, P1391, DOI 10.1242/jcs.084111; Conde-Vancells J, 2010, PROTEOM CLIN APPL, V4, P416, DOI 10.1002/prca.200900103; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Ellison DH., 2017, PSEUDOHYPOALDOSTERON; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Ishizawa K, 2016, BIOCHEM BIOPH RES CO, V480, P745, DOI 10.1016/j.bbrc.2016.10.127; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Lee D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05573; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin CM, 2019, FASEB J, V33, P1051, DOI 10.1096/fj.201801023R; Lin MY, 2011, J CELL BIOL, V193, P985, DOI 10.1083/jcb.201103015; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Maloy S., 2013, BRENNERS ENCY GENETI, V2nd ed., DOI [10.1016/B978-0-12-374984-0.01483-2, DOI 10.1016/B978-0-12-374984-0.01483-2]; McHugh DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199573; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Pathare G, 2013, AM J PHYSIOL-RENAL, V305, pF1513, DOI 10.1152/ajprenal.00440.2013; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Sasaki E, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00508-16; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Street JM, 2017, ADV CLIN CHEM, V78, P103, DOI 10.1016/bs.acc.2016.07.003; Sung CC, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.679171; Susa K, 2014, HUM MOL GENET, V23, P5052, DOI 10.1093/hmg/ddu217; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Uchida S, 2014, BIOL CELL, V106, P45, DOI 10.1111/boc.201300069; Vidal-Petiot E, 2013, P NATL ACAD SCI USA, V110, P14366, DOI 10.1073/pnas.1304230110; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Wu Q, 2021, J AM SOC NEPHROL, V32, P2195, DOI 10.1681/ASN.2020071035; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Yang SS, 2010, ENDOCRINOLOGY, V151, P1829, DOI 10.1210/en.2009-0951	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22363	10.1096/fj.202101827RR	http://dx.doi.org/10.1096/fj.202101827RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1N4GY	35621709				2022-12-28	WOS:000800617000001
J	Li, HP; Barbour, JA; Zhu, XQ; Wong, JWH				Li, Huaping; Barbour, Jayne A.; Zhu, Xiaoqiang; Wong, Jason W. H.			Gene expression is a poor predictor of steady-state metabolite abundance in cancer cells	FASEB JOURNAL			English	Article						cell line; gene expression; machine learning; metabolite; pan-cancer	HETEROGENEITY; PROTEOMICS	Metabolic reprogramming is a hallmark of cancer characterized by global changes in metabolite levels. However, compared with the study of gene expression, profiling of metabolites in cancer samples remains relatively understudied. We obtained metabolomic profiling and gene expression data from 454 human solid cancer cell lines across 24 cancer types from the Cancer Cell Line Encyclopedia (CCLE) database, to evaluate the feasibility of inferring metabolite levels from gene expression data. For each metabolite, we trained multivariable LASSO regression models to identify gene sets that are most predictive of the level of each metabolite profiled. Even when accounting for cell culture conditions or cell lineage in the model, few metabolites could be accurately predicted. In some cases, the inclusion of the upstream and downstream metabolites improved prediction accuracy, suggesting that gene expression is a poor predictor of steady-state metabolite levels. Our analysis uncovered a single robust relationship between the expression of nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA), however, this relationship could only be validated in cancer samples with high purity, as NNMT is not expressed in immune cells. Together, we have trained models that use gene expression profiles to predict the level of individual metabolites. Our analysis suggests that inferring metabolite levels based on the expression of genes is generally challenging in cancer.	[Li, Huaping; Barbour, Jayne A.; Zhu, Xiaoqiang; Wong, Jason W. H.] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China	University of Hong Kong	Wong, JWH (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Pokfulam, L1-51 Lab Block,21 Sassoon Rd, Hong Kong, Peoples R China.	jwhwong@hku.hk			Research Grants Council [17100920]	Research Grants Council(Hong Kong Research Grants Council)	The project was supported by the Research Grants Council, HK (17100920) to JWHW	Andrejeva G, 2017, CELL METAB, V26, P49, DOI 10.1016/j.cmet.2017.06.004; [Anonymous], 2020, CELL, DOI DOI 10.1016/j.cell.2020.05.032; Ayuso JM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc2331; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Djoumbou-Feunang Y, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-018-0324-5; Eckert MA, 2019, NATURE, V569, P723, DOI 10.1038/s41586-019-1173-8; Edwards NJ, 2015, J PROTEOME RES, V14, P2707, DOI 10.1021/pr501254j; Faubert B, 2020, SCIENCE, V368, P152, DOI 10.1126/science.aaw5473; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Kaushik AK, 2018, BBA-REV CANCER, V1870, P2, DOI 10.1016/j.bbcan.2018.04.009; Kim J, 2019, CELL METAB, V30, P434, DOI 10.1016/j.cmet.2019.08.013; Leeuwenburgh VC, 2021, CANCER METAB, V9, DOI 10.1186/s40170-021-00272-7; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Li JB, 2015, J HEPATOL, V63, P1378, DOI 10.1016/j.jhep.2015.07.039; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lv HW, 2021, CELL METAB, V33, P110, DOI 10.1016/j.cmet.2020.10.021; Martin-Martin N, 2018, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00119; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Neinast M, 2019, ANNU REV PHYSIOL, V81, P139, DOI 10.1146/annurev-physiol-020518-114455; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Ortmayr K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09695-9; Patel CH, 2019, NAT REV DRUG DISCOV, V18, P669, DOI 10.1038/s41573-019-0032-5; Peng XX, 2018, CELL REP, V23, P255, DOI 10.1016/j.celrep.2018.03.077; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Reina-Campos M, 2017, CURR OPIN CELL BIOL, V48, P47, DOI 10.1016/j.ceb.2017.05.006; Sinkala M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0666-1; Sternak M, 2010, PHARMACOL REP, V62, P483, DOI 10.1016/S1734-1140(10)70304-2; Sun HY, 2020, CANCER RES, V80, P1143, DOI 10.1158/0008-5472.CAN-19-3392; Sun HY, 2019, GENOM PROTEOM BIOINF, V17, P273, DOI 10.1016/j.gpb.2018.12.006; T'jollyn H, 2011, DRUG METAB DISPOS, V39, P2066, DOI 10.1124/dmd.111.039982; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Xu K, 2021, SCIENCE, V371, P405, DOI 10.1126/science.abb2683; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209	47	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22296	10.1096/fj.202101921RR	http://dx.doi.org/10.1096/fj.202101921RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E5AZ	35363392				2022-12-28	WOS:000776695600001
J	Jiang, XX; Zhang, K; Gao, CY; Ma, WZ; Liu, MQ; Guo, XY; Bao, GW; Han, B; Hu, H; Zhao, ZH				Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang			Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics	FASEB JOURNAL			English	Article						autophagy; cardiac hypertrophy; FMS-like receptor tyrosine kinase 3; isoprenaline; mitochondrial dynamics	LYSOSOMAL BIOGENESIS; IN-VITRO; FLT3; SIRT1; DEACETYLATION; PROMOTES; HEART; DEGRADATION; EXPRESSION; PROGENITOR	FMS-like receptor tyrosine kinase 3 (Flt3) expression was reported to increase in the heart in response to pathological stress, but the role of Flt3 activation and its underlying mechanisms remain poorly elucidated. This study was designed to investigate the role of Flt3 activation in sympathetic hyperactivity-induced cardiac hypertrophy and its mechanisms through autophagy and mitochondrial dynamics. In vivo, cardiac hypertrophy was established by subcutaneous injection of isoprenaline (6 mg/kg center dot day) in C57BL/6 mice for 7 consecutive days. The Flt3-ligand intervention was launched 2 h prior to isoprenaline each day. In vitro, experiments of cardiomyocyte hypertrophy, autophagy, and mitochondrial dynamics were performed in neonatal rat cardiomyocytes (NRCMs). Our results revealed that the expression level of Flt3 protein was significantly increased in the hypertrophic myocardium provoked by isoprenaline administration. Flt3-ligand intervention alleviated isoprenaline-induced cardiac oxidative stress, hypertrophy, fibrosis, and contractile dysfunction. Isoprenaline stimulation impaired autophagic flux in hypertrophic mouse hearts, supported by the accumulation of LC3II and P62 proteins, while Flt3-ligand restored the impairment of autophagic flux. Flt3 activation normalized the imbalance of mitochondrial fission and fusion in the hearts of mice evoked by isoprenaline as evidenced by the neutralization of elevated mitochondrial fission markers and reduced mitochondrial fusion markers. In NRCMs, Flt3-ligand treatment attenuated isoprenaline-stimulated hypertrophy, which was abolished by a Flt3-specific blocker AC220. Activating Flt3 reversed isoprenaline-induced autophagosome accumulation and impairment of autophagic flux probably by enhancing SIRT1 expression and consequently TFEB nuclear translocation. Flt3 activation improved the imbalance of mitochondrial dynamics induced by isoprenaline in NRCMs through the SIRT1/P53 pathway. Activation of Flt3 mitigated ISO-stimulated hypertrophy probably involves the restoration of autophagic flux and balance of mitochondrial dynamics. Therefore, activation of Flt3 attenuates isoprenaline-induced cardiac hypertrophy in vivo and in vitro, the potential mechanism probably attributes to SIRT1/TFEB-mediated autophagy promotion and SIRT1/P53-mediated mitochondrial dynamics balance. These findings suggest that activation of Flt3 may be a novel target for protection against cardiac remodeling and heart failure during sympathetic hyperactivity.	[Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang] Xi An Jiao Tong Univ, Sch Basic Med Sci, Hlth Sci Ctr, Dept Pharmacol, Xian, Peoples R China; [Zhao, Zhenghang] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian 710061, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhao, ZH (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian 710061, Peoples R China.	zzh@mail.xjtu.edu.cn		zhenghang, Zhao/0000-0003-0421-2046	National Natural Science Foundation of China (NSFC) [81470510, 82270296]; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation) [2020JM-029]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81470510 and 82270296; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation), Grant/Award Number: 2020JM-029	Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Bao JT, 2016, PROTEIN CELL, V7, P417, DOI 10.1007/s13238-016-0269-2; Bertero E, 2018, NAT REV CARDIOL, V15, P457, DOI 10.1038/s41569-018-0044-6; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; DELAPEYRIERE O, 1995, DIFFERENTIATION, V58, P351, DOI 10.1007/s002580050094; Della Verde G, 2021, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101112; Ding W, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587438; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dong FF, 2022, FEBS J, V289, P262, DOI 10.1111/febs.16138; Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003; Forte M, 2021, BRIT J PHARMACOL, V178, P2060, DOI 10.1111/bph.15068; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gyongyosi A, 2019, CURR PHARM DESIGN, V25, P2192, DOI 10.2174/1381612825666190619145025; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li LF, 2016, ACTA BIOCH BIOPH SIN, V48, P491, DOI 10.1093/abbs/gmw025; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li ZH, 2015, INT J BIOL SCI, V11, P672, DOI 10.7150/ijbs.11883; Lin Jianguo, 2022, Front Cardiovasc Med, V9, P917135, DOI 10.3389/fcvm.2022.917135; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020682; Lu G, 2022, MEDCOMM, V3, DOI 10.1002/mco2.150; LYMAN SD, 1994, BLOOD, V83, P2795, DOI 10.1182/blood.V83.10.2795.2795; Ma SX, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.551318; Ma WZ, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13519; Meeran MFN, 2020, FOOD FUNCT, V11, P965, DOI [10.1039/c9fo00530g, 10.1039/C9FO00530G]; Pfister O, 2014, J AM COLL CARDIOL, V63, P1011, DOI 10.1016/j.jacc.2013.08.1647; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Qi J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00176; Ramirez-Sagredo A, 2021, FASEB J, V35, DOI 10.1096/fj.202002598R; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Shah AK, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060931; Takahashi Shinichiro, 2020, Leuk Res Rep, V13, P100187, DOI 10.1016/j.lrr.2019.100187; Tran DT, 2022, AM J TRANSPLANT, V22, P386, DOI 10.1111/ajt.16882; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Wang WC, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04059-y; Wei X, 2015, CIRCULATION, V131, P1506, DOI 10.1161/CIRCULATIONAHA.114.013789; Yu HY, 2011, J CARDIOVASC PHARM T, V16, P205, DOI 10.1177/1074248410385683; Zech ATL, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.01.013; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071; Zhang P, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1121323; Zhang YX, 2017, MOL MED REP, V16, P8253, DOI 10.3892/mmr.2017.7601; Zhang ZL, 2017, BIOMED PHARMACOTHER, V89, P1055, DOI 10.1016/j.biopha.2017.02.103; Zhao JC, 2022, BLOOD REV, V52, DOI 10.1016/j.blre.2021.100905; Zheng YH, 2021, AGING-US, V13, P7096, DOI 10.18632/aging.202566	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22672	10.1096/fj.202200419RR	http://dx.doi.org/10.1096/fj.202200419RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6Q0TP	36440960				2022-12-28	WOS:000891334300001
J	Lv, PW; Shang, Y; Zhang, Y; Wang, WK; Liu, YX; Su, DD; Wang, W; Li, CF; Ma, CQ; Yang, CY				Lv, Peiwen; Shang, Yan; Zhang, Ye; Wang, Wenkai; Liu, Yuanxiang; Su, Dandan; Wang, Wei; Li, Chunfang; Ma, Cuiqing; Yang, Chunyu			Structural basis for the arsenite binding and translocation of Acr3 antiporter with NhaA folding pattern	FASEB JOURNAL			English	Article						antiporter; arsenite; Bacillus subtilis; FRET; site-directed mutagenesis; structural model	TRANSPORT ACTIVITY; NA+/H+ ANTIPORTER; CRYSTAL-STRUCTURE; CATION-BINDING; ARSB PROTEIN; PREDICTION; TOPOLOGY; AS(III)/H+; RESISTANCE; STABILITY	The arsenical resistance-3 (ACR3) family constitutes the most common pathway that confers high-level resistance to toxic metalloids in various microorganisms and lower plants. Based on the structural model constructed by AlphaFold2, the Acr3 antiporter from Bacillus subtilis (Acr3(Bs)) exhibits a typical NhaA structure fold, with two discontinuous helices of transmembrane (TM) segments, TM4 and TM9, interacting with each other and forming an X-shaped structure. As the structural information available for these important arsenite-efflux pumps is limited, we investigated the evolutionary conservation among 300 homolog sequences and identified three conserved motifs in both the discontinuous helices and TM5. Through site-directed mutagenesis, microscale thermophoresis (MST), and fluorescence resonance energy transfer (FRET) analyses, the identified Motif C in TM9 was found to be a critical element for substrate binding, in which N292 and E295 are involved in substrate coordination, while R118 in TM4 and E322 in TM10 is responsible for structural stabilization. In addition, the highly conserved residues on Motif B of TM5 are potentially key factors in the protonation/deprotonation process. These consensus motifs and residues are essential for metalloid compound translocation of Acr3 antiporters, by framing the core domain and the typical X-shaped of NhaA fold.	[Lv, Peiwen; Shang, Yan; Zhang, Ye; Wang, Wenkai; Liu, Yuanxiang; Su, Dandan; Wang, Wei; Li, Chunfang; Ma, Cuiqing; Yang, Chunyu] Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao 266237, Peoples R China	Shandong University	Yang, CY (corresponding author), Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao 266237, Peoples R China.	ycy21th@sdu.edu.cn						Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Calinescu O, 2017, J BIOL CHEM, V292, P7932, DOI 10.1074/jbc.M117.778175; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen QY, 2021, ANNU REV PHARMACOL, V61, P47, DOI 10.1146/annurev-pharmtox-030220-013418; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cramer P, 2021, NAT STRUCT MOL BIOL, V28, P704, DOI 10.1038/s41594-021-00650-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Francisco P, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182212226; DOU DX, 1992, J BIOL CHEM, V267, P25768; Dwivedi M, 2021, BIOCHIMIE, V180, P79, DOI 10.1016/j.biochi.2020.10.017; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Hegedus T, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-021-04112-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hu XM, 2021, CHEMOSPHERE, V274, DOI 10.1016/j.chemosphere.2021.129790; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hallgren J, 2022, bioRxiv, DOI 10.1101/2022.04.08.487609; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kumar R, 2020, CHEMOSPHERE, V239, DOI 10.1016/j.chemosphere.2019.124832; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lu PH, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.166764; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maciaszczyk-Dziubinska E, 2014, BBA-BIOMEMBRANES, V1838, P747, DOI 10.1016/j.bbamem.2013.11.013; Maciaszczyk-Dziubinska E, 2012, INT J MOL SCI, V13, P3527, DOI 10.3390/ijms13033527; Maciaszczyk-Dziubinska E, 2011, BBA-BIOMEMBRANES, V1808, P1855, DOI 10.1016/j.bbamem.2011.03.014; Majumder S, 2019, J ENVIRON MANAGE, V233, P184, DOI 10.1016/j.jenvman.2018.12.034; Markowska K, 2015, MOL MICROBIOL, V98, P162, DOI 10.1111/mmi.13113; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rascol E, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-09217-6; Rimon A, 2018, J MOL BIOL, V430, P867, DOI 10.1016/j.jmb.2018.01.014; Saltikov CW, 2002, APPL ENVIRON MICROB, V68, P280, DOI 10.1128/AEM.68.1.280-288.2002; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Tu YH, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2019.121997; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Villadangos AF, 2012, J BIOL CHEM, V287, P723, DOI 10.1074/jbc.M111.263335; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wawrzycka D, 2017, BBA-BIOMEMBRANES, V1859, P117, DOI 10.1016/j.bbamem.2016.11.004; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yang Z, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00831	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22659	10.1096/fj.202201280R	http://dx.doi.org/10.1096/fj.202201280R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6K1IR	36394534				2022-12-28	WOS:000887265600001
J	Lee, SL; Lee, MHH; Wu, KJ; Chiang, CW; Chang, YX; Fang, JD; Tung, HH; Kuo, LW; Wang, Y				Lee, Sheau-Ling; Lee, Michelle Hui-Hsin; Wu, Kuo-Jen; Chiang, Chia-Wen; Chang, Yun-Xuan; Fang, Jung-Da; Tung, Hsiu-Hui; Kuo, Li-Wei; Wang, Yun			Post-ischemic protection of hepatocyte growth factor requires the type II transmembrane serine protease matriptase-A reciprocal regulation of the two for neuroprotection in stroke brain	FASEB JOURNAL			English	Article						astrogliosis; glia reactivation; inflammatory response; microgliosis; neurotrophic factor	NEURAL STEM/PROGENITOR CELLS; CEREBRAL-ARTERY OCCLUSION; ACTIVATION; MICROGLIA; ISCHEMIA; DIFFERENTIATION; PRECURSOR; SURFACE; FORM	In a rat middle cerebral artery occlusion (MACo) model of ischemic stroke, intracerebroventricular administration of human recombinant hepatocyte growth factor (HGF) mitigated motor impairment and cortical infarction. Recombinant HGF reduced MCAo-induced TNF alpha and IL1 beta expression, and alleviated perilesional reactivation of microglia and astrocyte. All of the aforementioned beneficial effects of HGF were antagonized by an inhibitor to the type II transmembrane serine protease matriptase (MTP). MCAo upregulated MTP mRNA and protein in the lesioned cortex. MTP protein, not the mRNA, was increased further by recombinant HGF but reduced when MTP inhibitor (MTPi) was added to the treatment. Changes of the endogenous active HGF by MCAo, HGF or MTPi paralleled with the changes of MTP protein under the same conditions whilst neither HGF mRNA nor the total endogenous HGF protein were altered. These data showed that the therapeutic effects of HGF in stroke brain is attributed to its proteolytic activation and that MTP is a main protease of the event. MCAo enhanced MTP mRNA and thus protein expression; the initial use of the recombinant active HGF stabilized MCAo-induced MTP protein and subsequent activation of endogenous latent HGF which in turn stabilized further MTP protein. A reciprocal regulation between MTP and HGF appears to be present where MTP promotes HGF activation and the active HGF prevents MTP protein turnover. This study, for the first time, shows that MTP can participate in neural protection in stroke brain through activation of HGF. The cycles of HGF-MTP regulation achieved preservation of the neurological activity.	[Lee, Sheau-Ling; Lee, Michelle Hui-Hsin; Chang, Yun-Xuan; Fang, Jung-Da; Tung, Hsiu-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Lee, Sheau-Ling] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lee, Sheau-Ling] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Wu, Kuo-Jen; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Chiang, Chia-Wen; Kuo, Li-Wei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; National Chung Hsing University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.edu.tw			Central Government ST Grant [06A1-NPSP06-034]; National Health Research Institutes (NHRI) [06A1-CSPP10-014, 07A1-CSPP10-014]	Central Government ST Grant; National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan)	Central Government S&T Grant, Grant/Award Number: 06A1-NPSP06-034; National Health Research Institutes (NHRI), Grant/Award Number: 06A1-CSPP10-014 and 07A1-CSPP10-014	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-018-4040-z; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Date I, 2006, NEUROSCI LETT, V407, P141, DOI 10.1016/j.neulet.2006.08.050; Doeppner TR, 2011, J CEREBR BLOOD F MET, V31, P1251, DOI 10.1038/jcbfm.2010.211; Enyedy IJ, 2001, J MED CHEM, V44, P1349, DOI 10.1021/jm000395x; Fang JD, 2019, FASEB J, V33, P4327, DOI 10.1096/fj.201801307R; Fang JD, 2014, BBA-MOL CELL RES, V1843, P1285, DOI 10.1016/j.bbamcr.2014.03.020; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hayashi T, 1998, BRAIN RES, V799, P311, DOI 10.1016/S0006-8993(98)00391-6; Hung YW, 2020, FASEB J, V34, P6950, DOI 10.1096/fj.201902818R; Ito Y, 2006, GLYCOBIOLOGY, V16, P368, DOI 10.1093/glycob/cwj084; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Lee SL, 2010, MECH DEVELOP, V127, P82, DOI 10.1016/j.mod.2009.10.004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; NAKA D, 1992, J BIOL CHEM, V267, P20114; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shang JW, 2011, J NEUROSCI RES, V89, P86, DOI 10.1002/jnr.22524; Shang JW, 2010, J NEUROSCI RES, V88, P2197, DOI 10.1002/jnr.22373; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tung HH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05131-4; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Yoon JS, 2018, EXP NEUROBIOL, V27, P287, DOI 10.5607/en.2018.27.4.287; Zhang LL, 2000, J NEUROSCI RES, V62, P389, DOI 10.1002/1097-4547(20001101)62:3<389::AID-JNR9>3.0.CO;2-M	50	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22494	10.1096/fj.202200414R	http://dx.doi.org/10.1096/fj.202200414R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3V0FZ	35976173				2022-12-28	WOS:000841340100001
J	Silva, VRR; Molinaro, A; Gaudi, AU; Fryk, E; Sardi, C; Hammarlund, M; Mjornstedt, F; Johansson, ME; Becattini, B; Jansson, PA; Solinas, G				Silva, Vagner Ramon R.; Molinaro, Angela; Gaudi, Andrea Usseglio; Fryk, Emanuel; Sardi, Claudia; Hammarlund, Maria; Mjornstedt, Filip; Johansson, Maria E.; Becattini, Barbara; Jansson, Per-Anders; Solinas, Giovanni			Somatic ablation of IKK beta in liver and leukocytes is not tolerated in obese mice but hepatic IKK beta deletion improves fatty liver and insulin sensitivity	FASEB JOURNAL			English	Article						endoplasmic reticulum stress; immunometabolism; liver; metabolic inflammation	KAPPA-B; GLUCOSE-HOMEOSTASIS; INFLAMMATION; RESISTANCE; LINKS; ACTIVATION; PREVENTION; ASPIRIN; ALPHA; DEATH	The kinase IKK beta controls pro-inflammatory gene expression, and its activity in the liver and leukocytes was shown to drive metabolic inflammation and insulin resistance in obesity. However, it was also proposed that liver IKK beta signaling protects obese mice from insulin resistance and endoplasmic reticulum (ER) stress by increasing XBP1s protein stability. Furthermore, mice lacking IKK beta in leukocytes display increased lethality to lipopolysaccharides. This study aims at improving our understanding of the role of IKK beta signaling in obesity. We induced IKK beta deletion in hematopoietic cells and liver of obese mice by Cre-LoxP recombination, using an INF-inducible system, or a liver-specific IKK beta deletion in obese mice by adenovirus delivery of the Cre recombinase. The histopathological, immune, and metabolic phenotype of the mice was characterized. IKK beta deletion in the liver and hematopoietic cells was not tolerated in mice with established obesity exposed to the TLR3 agonist poly(I:C) and exacerbated liver damage and ER-stress despite elevated XBP1s. By contrast, liver-specific ablation of IKK beta in obese mice reduced steatosis and improved insulin sensitivity in association with increased XBP1s protein abundance and reduced expression of de-novo lipogenesis genes. We conclude that IKK beta blockage in liver and leukocytes is not tolerated in obese mice exposed to TLR3 agonists. However, selective hepatic IKK beta ablation improves fatty liver and insulin sensitivity in association with increased XBP1s protein abundance and reduced expression of lipogenic genes.	[Silva, Vagner Ramon R.; Molinaro, Angela; Gaudi, Andrea Usseglio; Fryk, Emanuel; Sardi, Claudia; Becattini, Barbara; Jansson, Per-Anders; Solinas, Giovanni] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Silva, Vagner Ramon R.; Molinaro, Angela; Gaudi, Andrea Usseglio; Fryk, Emanuel; Sardi, Claudia; Becattini, Barbara; Jansson, Per-Anders; Solinas, Giovanni] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Hammarlund, Maria; Mjornstedt, Filip; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Solinas, G (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.; Solinas, G (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden.	giovanni.solinas@wlab.gu.se			Barndiabetesfonden [DIA 2018-384, DIA2020-564]; Cancerfonden (Swedish Cancer Society) [CAN2017/472]; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond) [DIA 2017-250]; Stiftelsen Svenska Diabetesforbundets Forskningsfond [DIA 2017-250]; European Foundation for the Study of Diabetes (EFSD); Novo Nordisk Fonden (NNF) [NNF19OC0057174, NNF17OC0027458]; Schweizerischer National fonds zur Forderung der Wissenschaftlichen Forschung (SNF) [154499, 152998]; Vetenskapsradet (VR) [2014-3019, 2016-02660]	Barndiabetesfonden; Cancerfonden (Swedish Cancer Society)(Swedish Cancer Society); Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond); Stiftelsen Svenska Diabetesforbundets Forskningsfond; European Foundation for the Study of Diabetes (EFSD); Novo Nordisk Fonden (NNF); Schweizerischer National fonds zur Forderung der Wissenschaftlichen Forschung (SNF); Vetenskapsradet (VR)(Swedish Research Council)	Barndiabetesfonden, Grant/Award Number: DIA 2018-384 and DIA2020-564; Cancerfonden (Swedish Cancer Society), Grant/Award Number: CAN2017/472; 20 0840 PjF; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond), Grant/Award Number: DIA 2017-250; European Foundation for the Study of Diabetes (EFSD), Grant/Award Number: Diabetes and Cancer Programme; Novo Nordisk Fonden (NNF), Grant/Award Number: NNF19OC0057174 and NNF17OC0027458; Schweizerischer National fonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 154499 and 152998; Vetenskapsradet (VR), Grant/Award Number: 2014-3019 and 2016-02660	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hegenbarth S, 2000, HUM GENE THER, V11, P481, DOI 10.1089/10430340050015941; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jiao P, 2012, ENDOCRINOLOGY, V153, P154, DOI 10.1210/en.2011-1346; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Liu JL, 2016, CELL, V167, P1052, DOI 10.1016/j.cell.2016.10.015; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Meng H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20028-z; Molinaro A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68721-9; Molinaro A, 2019, CELL METAB, V29, P1400, DOI 10.1016/j.cmet.2019.03.010; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Solinas G, 2012, OBES REV, V13, P69, DOI 10.1111/j.1467-789X.2012.01047.x; Solinas G, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.001; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	34	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22512	10.1096/fj.202200694R	http://dx.doi.org/10.1096/fj.202200694R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3Y3ZB	36001064				2022-12-28	WOS:000843664600001
J	Al-Shaer, AE; Pal, A; Shi, Q; Carson, MS; Regan, J; Behee, M; Buddenbaum, N; Drawdy, C; Davis, T; Virk, R; Shaikh, SR				Al-Shaer, Abrar E.; Pal, Anandita; Shi, Qing; Carson, Meredith S.; Regan, Jennifer; Behee, Madeline; Buddenbaum, Nicole; Drawdy, Catie; Davis, Traci; Virk, Rafia; Shaikh, Saame Raza			Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass-dependent therapeutic window for resolvin E1	FASEB JOURNAL			English	Article						diversity outbred mice; heterogeneity; obesity; resolvin E1; specialized pro-resolving mediators	INSULIN-RESISTANCE; LIPID MEDIATORS; RESOLUTION; MOUSE; INFLAMMATION; D1; PHAGOCYTOSIS; ADIPOCYTES	Resolvin E1 (RvE1), a specialized pro-resolving mediator (SPM), improves glucose homeostasis in inbred mouse models of obesity. However, an impediment toward translation is that obesity is a highly heterogenous disease in which individuals will respond very differently to interventions such as RvE1. Thus, there is a need to study SPMs in the context of modeling the heterogeneity of obesity that is observed in humans. We investigated how RvE1 controls the concentration of key circulating metabolic biomarkers using diversity outbred (DO) mice, which mimic human heterogeneity. We first demonstrate that weights of DO mice can be classified into distinct distributions of fat mass (i.e., modeling differing classes of obesity) in response to a high-fat diet and in the human population when examining body composition. Next, we show RvE1 administration based on body weight for four consecutive days after giving mice a high-fat diet led to approximately half of the mice responding positively for serum total gastric inhibitory polypeptide (GIP), glucagon, insulin, glucose, leptin, and resistin. Interestingly, RvE1 improved hyperleptinemia most effectively in the lowest class of fat mass despite adjusting the dose of RvE1 with increasing adiposity. Furthermore, leptin levels after RvE1 treatment were the lowest in those mice that were also RvE1 positive responders for insulin and resistin. Collectively, these results suggest a therapeutic fat mass-dependent window for RvE1, which should be considered in future clinical trials. Moreover, the data underscore the importance of studying SPMs with heterogenous mice as a step toward precision SPM administration in humans.	[Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA; [Shaikh, Saame Raza] Univ N Carolina, Sch Med, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Shaikh, SR (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, 170 Rosenau Hall,CB 7400,135 Dauer Dr, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu			NIH [AT008375, P30DK05635]; National Science Foundation Graduate Research Fellowship Program [1650116]; ODS Supplement	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); ODS Supplement	This work was supported by NIH AT008375 (SRS), NIH P30DK05635 (SRS), an ODS Supplement to NIH P30DK05635 (SRS). This material is also based on work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1650116 to AEA. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation	Al-Shaer AE, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158936; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Brennan EP, 2019, CLIN SCI, V133, P2121, DOI 10.1042/CS20190067; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Claria J, 2017, MOL ASPECTS MED, V58, P83, DOI 10.1016/j.mam.2017.03.004; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Crouch MJ, 2019, J LEUKOCYTE BIOL, V106, P241, DOI 10.1002/JLB.3HI1017-405RR; Deb A, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101178; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; English JT, 2017, PROSTAG LEUKOTR ESS, V117, P17, DOI 10.1016/j.plefa.2017.01.004; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Gemperle C, 2021, PROSTAG LEUKOTR ESS, V174, DOI 10.1016/j.plefa.2021.102363; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon-Larsen P, 2021, ADV NUTR, V12, P2023, DOI 10.1093/advances/nmab040; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Herrera BS, 2015, INFECT IMMUN, V83, P792, DOI 10.1128/IAI.02444-14; Jung TW, 2019, CLIN EXP PHARMACOL P, V46, P898, DOI 10.1111/1440-1681.13131; Jung TW, 2018, AM J PHYSIOL-ENDOC M, V315, pE543, DOI 10.1152/ajpendo.00408.2017; Jung TW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01603-9; Lopez-Vicario C, 2019, FASEB J, V33, P7072, DOI 10.1096/fj.201802587R; Lopez-Vicario C, 2016, EUR J PHARMACOL, V785, P133, DOI 10.1016/j.ejphar.2015.03.092; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shimizu T, 2022, FASEB J, V36, DOI 10.1096/fj.202100053R; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Sima C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13185-7; Smallwood TL, 2014, G3-GENES GENOM GENET, V4, P2353, DOI 10.1534/g3.114.014704; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Yaeger MJ, 2021, TOXICOL SCI, V183, P170, DOI 10.1093/toxsci/kfab081	35	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2022	36	6							e22354	10.1096/fj.202200350R	http://dx.doi.org/10.1096/fj.202200350R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1M9AI	35616343				2022-12-28	WOS:000800257100001
J	Darabi, M; Lhomme, M; Dahik, VD; Guillas, I; Frisdal, E; Tubeuf, E; Poupel, L; Patel, M; Gautier, EL; Huby, T; Guerin, M; Rye, KA; Lesnik, P; Le Goff, W; Kontush, A				Darabi, Maryam; Lhomme, Marie; Dahik, Veronica D.; Guillas, Isabelle; Frisdal, Eric; Tubeuf, Emilie; Poupel, Lucie; Patel, Mili; Gautier, Emmanuel L.; Huby, Thierry; Guerin, Maryse; Rye, Kerry-Anne; Lesnik, Philippe; Le Goff, Wilfried; Kontush, Anatol			Phosphatidylserine enhances anti-inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways	FASEB JOURNAL			English	Article						atherosclerosis; inflammation; phospholipids; rHDL	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; APOPTOTIC CELLS; CHOLESTEROL EFFLUX; SR-BI; SCAVENGER RECEPTOR; IMMUNE-RESPONSES; BINDING PROTEIN; GENE-EXPRESSION; LIPOPOLYSACCHARIDE	Phosphatidylserine (PS) is a minor phospholipid constituent of high-density lipoprotein (HDL) that exhibits potent anti-inflammatory activity. It remains indeterminate whether PS incorporation can enhance anti-inflammatory effects of reconstituted HDL (rHDL). Human macrophages were treated with rHDL containing phosphatidylcholine alone (PC-rHDL) or PC and PS (PC/PS-rHDL). Interleukin (IL)-6 secretion and expression was more strongly inhibited by PC/PS-rHDL than PC-rHDL in both tumor necrosis factor (TNF)-alpha- and lipopolysaccharide (LPS)-stimulated macrophages. siRNA experiments revealed that the enhanced anti-inflammatory effects of PC/PS-rHDL required scavenger receptor class B type I (SR-BI). Furthermore, PC/PS-rHDL induced a greater increase in Akt1/2/3 phosphorylation than PC-rHDL. In addition, PC/PS but not PC-rHDL decreased the abundance of plasma membrane lipid rafts and p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation. Finally, when these rHDL formulations were administered to dyslipidemic low-density lipoprotein (LDL)-receptor knockout mice fed a high-cholesterol diet, circulating IL-6 levels were significantly reduced only in PC/PS-rHDL-treated mice. In parallel, enhanced Akt1/2/3 phosphorylation by PC/PS-rHDL was observed in the mouse aortic tissue using immunohistochemistry. We concluded that the incorporation of PS into rHDLs enhanced their anti-inflammatory activity by modulating Akt1/2/3- and p38 MAPK-mediated signaling through SR-BI in stimulated macrophages. These data identify PS as a potent anti-inflammatory component capable of enhancing therapeutic potential of rHDL-based therapy.	[Darabi, Maryam; Dahik, Veronica D.; Guillas, Isabelle; Frisdal, Eric; Tubeuf, Emilie; Poupel, Lucie; Gautier, Emmanuel L.; Huby, Thierry; Guerin, Maryse; Lesnik, Philippe; Le Goff, Wilfried; Kontush, Anatol] Sorbonne Univ, UMR S1166, Inst Cardiometab & Nutr ICAN, INSERM, Paris, France; [Lhomme, Marie] Fdn Innovat Cardiometab & Nutr IHU ICAN, ANR IAHU 05 10, Lipid Core, ICAN Analyt, Paris, France; [Patel, Mili; Rye, Kerry-Anne] Univ New South Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of New South Wales Sydney	Kontush, A (corresponding author), Sorbonne Univ, INSERM UMR S 1166 ICAN, 91 Blvd Hop, F-75013 Paris, France.	anatol.kontush@sorbonne-universite.fr	Gautier, Emmanuel L./E-2259-2017; Lesnik, Philippe/AAD-7393-2020	Gautier, Emmanuel L./0000-0003-2976-7566; Lesnik, Philippe/0000-0002-6909-7715	INSERM; Ville de Paris; SATT-Lutech; Fondation de France; CSL	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ville de Paris; SATT-Lutech; Fondation de France(Fondation de France); CSL	INSERM; Ville de Paris; SATT-Lutech; CSL; Fondation de France	Abeywardena MY, 2009, CURR PHARM DESIGN, V15, P1809, DOI 10.2174/138161209788186290; Augsten M, 2011, PHYSIOL GENOMICS, V43, P1255, DOI 10.1152/physiolgenomics.00109.2011; Barter PJ, 2015, CLIN THER, V37, P2716, DOI 10.1016/j.clinthera.2015.07.021; Camont L, 2013, ARTERIOSCL THROM VAS, V33, P2715, DOI 10.1161/ATVBAHA.113.301468; Cao WM, 2004, J MOL ENDOCRINOL, V32, P497, DOI 10.1677/jme.0.0320497; Davidson M., 2021, THERAPEUTIC LIPIDOLO; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Fluiter K, 1997, BIOCHEM J, V326, P515, DOI 10.1042/bj3260515; Fond AM, 2015, J CLIN INVEST, V125, P2748, DOI 10.1172/JCI80300; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Frisdal E, 2015, DIABETES, V64, P840, DOI 10.2337/db14-0245; Frisdal E, 2011, J BIOL CHEM, V286, P30926, DOI 10.1074/jbc.M111.264325; Fukuda M, 2008, J LIPID RES, V49, P2419, DOI 10.1194/jlr.M800287-JLR200; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Kataoka Y, 2017, CARDIOVASC DIAGN THE, V7, P252, DOI 10.21037/cdt.2017.02.01; Khan R, 2015, ATHEROSCLEROSIS, V240, P497, DOI 10.1016/j.atherosclerosis.2015.04.783; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Kootte RS, 2015, J LIPID RES, V56, P703, DOI 10.1194/jlr.M055665; Kwon JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14470; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Levels JHM, 2005, INFECT IMMUN, V73, P2321, DOI 10.1128/IAI.73.4.2321-2326.2005; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Ma HM, 2011, LAB INVEST, V91, P921, DOI 10.1038/labinvest.2011.54; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Nicholls SJ, 2018, JAMA CARDIOL, V3, P815, DOI 10.1001/jamacardio.2018.2121; Nordestgaard BG, 2011, CURR OPIN LIPIDOL, V22, P113, DOI 10.1097/MOL.0b013e32834477d2; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Rader DJ, 2016, CELL METAB, V23, P405, DOI 10.1016/j.cmet.2016.01.005; Ramos GC, 2007, BRIT J PHARMACOL, V151, P844, DOI 10.1038/sj.bjp.0707302; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Roberts RA, 2015, BIOMATERIALS, V72, P1, DOI 10.1016/j.biomaterials.2015.08.040; Schaefer EJ, 2013, CURR OPIN LIPIDOL, V24, P259, DOI 10.1097/MOL.0b013e3283612454; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Smith CK, 2017, ANN RHEUM DIS, V76, P602, DOI 10.1136/annrheumdis-2016-209683; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tang CR, 2016, J LIPID RES, V57, P848, DOI 10.1194/jlr.M065797; Tao H, 2015, J LIPID RES, V56, P1449, DOI 10.1194/jlr.M056689; Tardy C, 2014, ATHEROSCLEROSIS, V232, P110, DOI 10.1016/j.atherosclerosis.2013.10.018; Thuahnai ST, 2001, J BIOL CHEM, V276, P43801, DOI 10.1074/jbc.M106695200; Treguier M, 2007, BBA-MOL CELL BIOL L, V1771, P129, DOI 10.1016/j.bbalip.2006.12.004; van der Vorst EPC, 2017, CELL METAB, V25, P197, DOI 10.1016/j.cmet.2016.10.013; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zhang J, 2006, J NEUROIMMUNOL, V172, P112, DOI 10.1016/j.jneuroim.2005.11.008; Zhang WY, 2017, ATHEROSCLEROSIS, V259, P83, DOI 10.1016/j.atherosclerosis.2016.09.003	58	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22274	10.1096/fj.201800810R	http://dx.doi.org/10.1096/fj.201800810R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0L8PV	35416331				2022-12-28	WOS:000781730700001
J	Tati, S; Alisaraie, L				Tati, Sayi'Mone; Alisaraie, Laleh			Recruitment of dynein and kinesin to viral particles	FASEB JOURNAL			English	Review						cytoplasmic dynein; immune response; infection; kinesin family; virus life cycle	HEPATITIS-B-VIRUS; CYTOPLASMIC DYNEIN; INTRACELLULAR TRAFFICKING; MITOCHONDRIAL TRANSPORT; CONFORMATIONAL-CHANGES; IMMUNOLOGICAL SYNAPSE; INTERMEDIATE CHAIN; BINDING MOTIF; PROTEIN; MICROTUBULE	Dynein and kinesin are cytoskeletal motor proteins involved in transporting cellular cargos and viruses. Throughout viral infection, they actively participate in the virus life cycle in the cell during entry, genome replication, and departure. Through their retrograde and anterograde transport, dynein and kinesin assist in promoting viral infection as well as the cellular defense response. This review highlights the crucial roles kinesin and dynein play in facilitating viral proliferation and aims to exhibit these proteins as vital targets for drug discovery in exploring strategies for regulating their dual functions concerning involvements in various essential phases of viral infections and host cells' immune response.	[Tati, Sayi'Mone; Alisaraie, Laleh] Mem Univ Newfoundland, Sch Pharm, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada	Memorial University Newfoundland	Alisaraie, L (corresponding author), Mem Univ Newfoundland, Sch Pharm, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	laleh.alisaraie@mun.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [212654]	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 212654	Ali I, 2020, CELL ADHES MIGR, V14, P139, DOI 10.1080/19336918.2020.1810939; Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x; Ayloo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5807; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bauer A, 2015, J VIROL, V89, P9591, DOI 10.1128/JVI.01298-15; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Bhuin T, 2015, INT J MOL CELL MED, V4, P1; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Brault JB, 2011, VIROLOGY, V417, P369, DOI 10.1016/j.virol.2011.06.022; Burrell CJ., 2017, FENNER WHITES MED VI, P27, DOI DOI 10.1016/B978-0-12-375156-0.00003-5; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cao JJ, 2015, J VIROL, V89, P2777, DOI 10.1128/JVI.03117-14; Catarinella M, 2009, ANGEW CHEM INT EDIT, V48, P9072, DOI 10.1002/anie.200904510; Chen XJ, 2014, SCI CHINA LIFE SCI, V57, P372, DOI 10.1007/s11427-014-4639-9; Cho YB, 2020, J CELL MOL MED, V24, P5463, DOI 10.1111/jcmm.15200; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Daniele T, 2011, TRAFFIC, V12, P902, DOI 10.1111/j.1600-0854.2011.01194.x; Dharan A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005700; DiGiuseppe S, 2017, J VIROL, V91, DOI 10.1128/JVI.00537-17; Diwaker D, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008597; DuRaine G, 2018, J VIROL, V92, DOI 10.1128/JVI.01269-18; Elshenawy MM, 2020, NAT CELL BIOL, V22, P570, DOI 10.1038/s41556-020-0501-4; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13; Fehling SK, 2013, CELL MICROBIOL, V15, P315, DOI 10.1111/cmi.12095; Feng JX, 2014, FISH SHELLFISH IMMUN, V39, P407, DOI 10.1016/j.fsi.2014.05.034; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Garcea RL, 2003, J VIROL, V77, P5039, DOI 10.1128/JVI.77.9.5039-5045.2003; Goodson HV, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022608; Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11; Halgand B, 2018, HEPATOLOGY, V67, P86, DOI 10.1002/hep.29463; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; He JL, 2013, J VIROL, V87, P1420, DOI 10.1128/JVI.01443-12; Hirokawa N, 2015, EXP CELL RES, V334, P16, DOI 10.1016/j.yexcr.2015.02.016; Ichinose S, 2015, NEURON, V87, P1022, DOI 10.1016/j.neuron.2015.08.008; Jayappa KD, 2015, J VIROL, V89, P3497, DOI 10.1128/JVI.03347-14; Jespersen NE, 2019, J MOL BIOL, V431, P4959, DOI 10.1016/j.jmb.2019.10.011; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Keller AM, 2007, P NATL ACAD SCI USA, V104, P5989, DOI 10.1073/pnas.0700946104; Khan YA, 2022, CRIT REV BIOCHEM MOL, V57, P156, DOI 10.1080/10409238.2021.1979460; Koniger C, 2014, P NATL ACAD SCI USA, V111, pE4244, DOI 10.1073/pnas.1409986111; Konjikusic MJ, 2021, DEV BIOL, V469, P26, DOI 10.1016/j.ydbio.2020.09.009; Kramer T, 2012, CELL HOST MICROBE, V12, P806, DOI 10.1016/j.chom.2012.10.013; Kramer T, 2012, CELL HOST MICROBE, V11, P504, DOI 10.1016/j.chom.2012.03.005; Kratchmarov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058776; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lee IG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19538-7; Leung Daisy W, 2010, Virulence, V1, P526, DOI 10.4161/viru.1.6.12984; Liang B, 2020, J VIROL, V94, DOI 10.1128/JVI.00175-20; Lim D, 2021, J MICROBIOL, V59, P410, DOI 10.1007/s12275-021-0641-7; Lim WM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35593-z; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Locke J, 2017, P NATL ACAD SCI USA, V114, pE9539, DOI 10.1073/pnas.1712169114; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Luthra P, 2015, J VIROL, V89, P5148, DOI 10.1128/JVI.03652-14; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; MCGEOCH DJ, 1994, J MOL BIOL, V238, P9, DOI 10.1006/jmbi.1994.1264; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Milev M.P., 2018, DYNEINS STRUCTURE BI, V2nd ed., P214; Mills J, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118552; Nath S, 2016, J IMMUNOL, V197, P2090, DOI 10.4049/jimmunol.1600180; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Onnis A, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00110; Opazo T, 2017, J VIROL, V91, DOI 10.1128/JVI.00129-17; Osseman Q, 2018, J HEPATOL, V68, P441, DOI 10.1016/j.jhep.2017.10.032; Papageorgiou N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070772; Pierson TC, 2020, NAT MICROBIOL, V5, P796, DOI 10.1038/s41564-020-0714-0; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; Qi YH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005893; Qian MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000465; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Rabe B, 2006, J VIROL, V80, P5465, DOI 10.1128/JVI.02303-05; Rainey-Barger EK, 2007, J VIROL, V81, P12996, DOI 10.1128/JVI.01037-07; Ramos-Nascimento A, 2017, J CELL SCI, V130, P4038, DOI 10.1242/jcs.210807; Rao P, 2011, J VIROL, V85, P8093, DOI 10.1128/JVI.02689-10; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Ravindran MS, 2018, J VIROL, V92, DOI 10.1128/JVI.00353-18; Ravindran MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15496; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Ryu WS, 2017, MOLECULAR VIROLOGY OF HUMAN PATHOGENIC VIRUSES, P21, DOI 10.1016/B978-0-12-800838-6.00002-3; Ryu WS, 2017, MOLECULAR VIROLOGY OF HUMAN PATHOGENIC VIRUSES, P31, DOI 10.1016/B978-0-12-800838-6.00003-5; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Scherer J, 2020, FEBS LETT, V594, P1838, DOI 10.1002/1873-3468.13777; Scherer J, 2015, J VIROL, V89, P1013, DOI 10.1128/JVI.02889-14; Scherer J, 2014, J CELL BIOL, V205, P163, DOI 10.1083/jcb.201307116; Schmidt H, 2016, BIOPOLYMERS, V105, P557, DOI 10.1002/bip.22856; Schneider MA, 2011, CELL MICROBIOL, V13, P32, DOI 10.1111/j.1462-5822.2010.01515.x; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Schuller AP, 2021, NATURE, V598, P667, DOI 10.1038/s41586-021-03985-3; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shrivastava N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025229; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Steinman JB., 2018, DYNEINS STRUCTURE BI, P172; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; SWEET BH, 1960, P SOC EXP BIOL MED, V105, P420, DOI 10.3181/00379727-105-26128; Takamatsu Y, 2019, MICROSCOPY-JPN, V68, P450, DOI 10.1093/jmicro/dfz034; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Tan R, 2018, DEV CELL, V44, P233, DOI 10.1016/j.devcel.2017.12.023; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Tati S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147704; Theerawatanasirikul S, 2017, ARCH VIROL, V162, P677, DOI 10.1007/s00705-016-3140-0; Tomei EJ, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0107-7; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tuli A, 2013, MOL BIOL CELL, V24, P3721, DOI 10.1091/mbc.E13-05-0259; Valle-Tenney R, 2016, J VIROL, V90, P6896, DOI 10.1128/JVI.00863-16; Walczak CP., 2012, FASEB J, V26, plb108, DOI [10.1096/fasebj.26.1_supplement.lb108, DOI 10.1096/FASEBJ.26.1_SUPPLEMENT.LB108]; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; White MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003206; Wong DM, 2016, CELL REP, V14, P1488, DOI 10.1016/j.celrep.2016.01.012; Wu PH, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01339-9; Xie QL, 2016, EXP THER MED, V12, P59, DOI 10.3892/etm.2016.3283; Xiong R, 2015, J VIROL, V89, P6646, DOI 10.1128/JVI.00214-15; Yi JS, 2013, J CELL BIOL, V202, P779, DOI 10.1083/jcb.201301004; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007055; Zhou JY, 2006, VET RES COMMUN, V30, P205, DOI 10.1007/s11259-006-3203-x; Zila V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096922	133	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22311	10.1096/fj.202101900RR	http://dx.doi.org/10.1096/fj.202101900RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0T9ZN	35471771				2022-12-28	WOS:000787320000001
J	Yu, SQ; Wang, HS; Liu, M; Pei, F; Liu, H; Zhang, JL; Zhang, L; Li, QH; Chen, Z				Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi			Loss of ATG5 in KRT14(+) cells leads to accumulated functional impairments of salivary glands via pyroptosis	FASEB JOURNAL			English	Article						autophagy; pyroptosis; salivary glands; Sjogren's syndrome; xerostomia	SJOGRENS-SYNDROME; AUTOPHAGY; XEROSTOMIA; MICE	Macroautophagy/autophagy is critically involved in the process of salivary gland (SG) diseases such as xerostomia, which has a serious impact on quality of life. KRT14(+) progenitor cells are found to be the main progenitors for maintaining the ductal homeostasis of the submandibular SGs. In this study, we investigated the role of ATG5 in SG KRT14(+) cells in mice and humans. Human labial salivary glands (LSG) from primary Sjogren's syndrome (pSS) and non-pSS patients (normal), and submandibular glands (SMG) from Atg5(flox/flox); Krt14-Cre (cKO) mice were used. ATG5(+)KRT14(+) and p62(+)KRT14(+) cells were detected by immunofluorescence staining in LSG. TUNEL, immunofluorescence, immunohistochemistry, and western blot were performed to detect cell death in SMG. Saliva was collected in 12-week-old (12 W) and 32-week-old (32 W) mice, then the concentration of calcium and buffering capacity were detected to analyze the function of SG. We found that LSG from pSS patients showed increased p62 and decreased ATG5 in KRT14(+) cells. We further revealed that in 32 W, (1) the function of salivary glands was significantly impaired in cKO mice, (2) cell death increased in cKO mice, but cl-Caspase 3 was not significantly changed, and (3) cleaved gasdermin D increased and was highly expressed in KRT14(+) cells of cKO mice. After applying a pyroptosis inhibitor to 32 W mice, the reduced saliva flow rate was rescued. In addition, pyroptosis was also found in KRT14(+) cells of pSS patients. Collectively, our results indicate that Atg5 deficiency would induce pyroptosis in mice SG, which could lead to functional impairments of SG.	[Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China; [Yu, Siqi; Wang, Haisheng; Liu, Ming; Pei, Fei; Liu, Huan; Zhang, Jiali; Zhang, Lu; Li, Qiuhui; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Pei, Fei; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Dept Cariol & Endodont, Wuhan, Peoples R China; [Liu, Huan] Wuhan Univ, Sch & Hosp Stomatol, Dept Periodont, Wuhan, Peoples R China; [Zhang, Jiali] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Li, QH (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.; Li, QH; Chen, Z (corresponding author), Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China.; Li, QH; Chen, Z (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Wuhan, Peoples R China.	qiuhui.li@whu.edu.cn; zhichen@whu.edu.cn			National Natural Science Foundation of China (NSFC) [81800963, 81771066, 81802973]; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) [2020CFB844]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81800963, 81771066 and 81802973; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation), Grant/Award Number: 2020CFB844	Bagavant H, 2018, JOVE-J VIS EXP, DOI 10.3791/57203; Barrera MJ, 2021, RHEUMATOLOGY, V60, P1951, DOI 10.1093/rheumatology/keaa670; Byun YS, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010071; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Emmerson E, 2018, GENESIS, V56, DOI 10.1002/dvg.23211; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Hong SM, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e39; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Hukkanen RR., 2017, COMP ANATOMY HISTOLO, V2nd ed, P135; Imgenberg-Kreuz J, 2021, RHEUMATOLOGY, V60, P2085, DOI 10.1093/rheumatology/key330; Kamiya M, 2015, BIORESEARCH OPEN ACC, V4, P307, DOI 10.1089/biores.2015.0017; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin L, 2022, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.809955; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; Malallah OS, 2018, INT J PHARMACEUT, V541, P157, DOI 10.1016/j.ijpharm.2018.02.004; Maruyama CL, 2019, ORAL DIS, V25, P403, DOI 10.1111/odi.12840; May AJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166363; Mitsias DI, 2006, LUPUS, V15, P255, DOI 10.1191/0961203306lu2290rr; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nandula SR, 2007, ARTHRITIS RHEUM-US, V56, P1798, DOI 10.1002/art.22715; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Parashar K, 2020, FASEB J, V34, P7733, DOI 10.1096/fj.201902196R; Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001; Pei F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.397; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1002/art.39859, 10.1136/annrheumdis-2016-210571]; Sordi MB, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010372; Thalayasingam N, 2021, RHEUMATOLOGY, V60, P53, DOI 10.1093/rheumatology/keab466; Turner M, 2008, J AM DENT ASSOC, V139, P146, DOI 10.14219/jada.archive.2008.0129; Wang B, 2021, BIODRUGS, V35, P593, DOI 10.1007/s40259-021-00505-7; Wang HS, 2019, J DENT RES, V98, P1271, DOI 10.1177/0022034519869580; Xiang RL, 2020, J CELL PHYSIOL, V235, P232, DOI 10.1002/jcp.28962; Zhang CY, 2021, J HAZARD MATER, V416, DOI 10.1016/j.jhazmat.2021.126138; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zheng T, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00320-z	37	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22631	10.1096/fj.202200946R	http://dx.doi.org/10.1096/fj.202200946R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5Y7NH	36342387				2022-12-28	WOS:000879468400001
J	Li, LY; Chen, MY; Liu, WY; Tai, PZ; Liu, XG; Liu, JX				Li, LingYa; Chen, MingYue; Liu, WenYe; Tai, PengZhi; Liu, Xingguo; Liu, Jing-Xia			Zebrafish cox17 modulates primitive erythropoiesis via regulation of mitochondrial metabolism to facilitate hypoxia tolerance	FASEB JOURNAL			English	Article						cox17(-/-); erythrogenesis; mitochondrial metabolism; scl/lmo2; WNT	CYTOCHROME-C-OXIDASE; TRANSCRIPTIONAL RESPONSES; GENE-EXPRESSION; COPPER; SCL; HEMATOPOIESIS; MECHANISMS; MUTATIONS; ABSENCE; STRESS	Cox17 is required in the assembly of mitochondrial intermembrane space (IMS) and Cu metallization of cytochrome C oxidase (CcO) in mitochondria as well as Cu homeostasis in cells. Cox deficiency is associated with hematopoietic diseases such as tubulopathy and leukodystrophy, but whether and how cox17 functions in hematopoiesis are still unknown. Here, we report the effects of zebrafish cox17 deficiency on primitive erythropoiesis, mitochondrial metabolism, and hypoxia tolerance. Cox17(-/-) larvae were sensitive to hypoxia stress, with reduced primitive erythropoiesis. Meanwhile, cox17(-/-) mutants showed a significant reduction in the expression of pivotal transcriptional regulators in erythropoiesis, such as scl, lmo2, and gata1a at 14 h post fertilization (hpf), with expression remaining downregulated for scl but upregulated for lmo2 and gata1a at 24 hpf. Mechanistically, cox17(-/-) mutants showed impaired mitochondrial metabolism, coupled with a significant decrease in the mitochondrial membrane potential, ATP and SAM content, and the ratio of SAM and SAH. Additionally, disrupting mitochondrial metabolism in wild type (WT) larvae treated with carbonyl cyanide 3-chlorophenylhydrazone (CCCP) could mimic the primitive erythropoiesis defects observed in cox17(-/-) mutants. Moreover, cox17(-/-) mutants exhibited significantly downregulated WNT signaling and upregulated ER stress, with a significant reduction of beta-Catenin in gata1a(+) cells and of binding enrichment in both scl and lmo2 promoters of the WNT transcriptional factor TCF4. This is the first report on the novel linkage of cox17 deficiency with defective primitive erythropoiesis and reduced hypoxia tolerance. This study has shed light on the potential mechanism by which Cox deficiency, especially cox17 deficiency, induces Cu homeostasis imbalance, leading to hematopoietic diseases.	[Li, LingYa; Chen, MingYue; Liu, WenYe; Tai, PengZhi; Liu, Jing-Xia] Huazhong Agr Univ, Coll Fisheries, Key Lab Freshwater Anim Breeding, Minist Agr, Wuhan, Peoples R China; [Liu, Xingguo] Guangzhou Med Univ, Joint Sch Life Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol,Chinese Acad Sci, Guangzhou, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University	Liu, JX (corresponding author), Huazhong Agr Univ, Wuhan 430070, Peoples R China.	ichliu@mail.hzau.edu.cn			Knowledge Innovation Program of Wuhan--Basic Research [2022020801010223]; National Key R&D Program of China [2018YFD0900101]; Natural Science Foundation of China [32070807]	Knowledge Innovation Program of Wuhan--Basic Research; National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Knowledge Innovation Program of Wuhan--Basic Research, Grant/Award Number: 2022020801010223; The National Key R&D Program of China, Grant/Award Number: 2018YFD0900101; Natural Science Foundation of China, Grant/Award Number: 32070807	Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; Annesley SJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070680; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Bae S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00289; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baron MH, 2013, STEM CELLS, V31, P849, DOI 10.1002/stem.1342; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bragoszewski P, 2015, P NATL ACAD SCI USA, V112, P7713, DOI 10.1073/pnas.1504615112; Chen MY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02599; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chojnacka M, 2015, J BIOL CHEM, V290, P15304, DOI 10.1074/jbc.M115.645069; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Costa R, 2019, CELL REP, V28, P1949, DOI 10.1016/j.celrep.2019.07.050; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Sa JPM, 2007, APPL STAT USING SPSS; Elefantova K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071985; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; Fu WY, 2000, BIOCHEM BIOPH RES CO, V271, P47, DOI 10.1006/bbrc.2000.2587; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224; Gan ES, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1027851; Garcia L, 2016, PLANT CELL ENVIRON, V39, P628, DOI 10.1111/pce.12647; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Gore AV, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.312; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Gui J. F., 2022, WATER BIOL SECURITY, V1; Guo T, 2020, CELL DEATH DIFFER, V27, P2191, DOI 10.1038/s41418-020-0494-3; HAMMERMUELLER JD, 1987, J NUTR, V117, P894, DOI 10.1093/jn/117.5.894; He JB, 2020, NAT PROTOC, V15, P3361, DOI 10.1038/s41596-020-0376-7; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; HEDERSTEDT L, 1981, MICROBIOL REV, V45, P542, DOI 10.1128/MMBR.45.4.542-555.1981; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jin XD, 2021, FASEB J, V35, DOI 10.1096/fj.202100183R; Kafina MD, 2018, METHODS MOL BIOL, V1698, P11, DOI 10.1007/978-1-4939-7428-3_2; Kulkeaw K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt146; Lee MH, 2014, J AM CHEM SOC, V136, P14136, DOI 10.1021/ja506301n; Lensch MW, 2004, CURR TOP DEV BIOL, V60, P127; Liu JX, 2017, BBA-GENE REGUL MECH, V1860, P1103, DOI 10.1016/j.bbagrm.2017.09.001; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Maxfield AB, 2004, J BIOL CHEM, V279, P5072, DOI 10.1074/jbc.M311772200; Mead PE, 2001, DEVELOPMENT, V128, P2301; Mead PE, 1998, DEVELOPMENT, V125, P2611; Medici V, 2016, EPIGENETICS-US, V11, P804, DOI 10.1080/15592294.2016.1231289; Medici V, 2014, EPIGENETICS-US, V9, P286, DOI 10.4161/epi.27110; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ney PA, 2006, CURR OPIN HEMATOL, V13, P203, DOI 10.1097/01.moh.0000231415.18333.2c; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Papadopoulou LC, 1999, NAT GENET, V23, P333; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Rossmann MP, 2021, SCIENCE, V372, P716, DOI 10.1126/science.aaz2740; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Rydz L, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10111738; Salazar C, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100154; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Singh RP, 2020, CELL STEM CELL, V26, P926, DOI 10.1016/j.stem.2020.04.010; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Sun HJ, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113364; Swenson SA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030579; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Vanisova M, 2019, FOLIA BIOL-PRAGUE, V65, P181; Wang DL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030643; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Xia J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015748118; Xu JP, 2017, AQUAT TOXICOL, V192, P155, DOI 10.1016/j.aquatox.2017.09.018; Xu P, 2019, BLOOD, V133, P2518, DOI 10.1182/blood.2018854604; Xu XH, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108922; Yin XH, 2020, ADV BIOSYST, V4, DOI 10.1002/adbi.201900261; Ying ZF, 2018, CELL METAB, V28, P935, DOI 10.1016/j.cmet.2018.08.001; Zhang JH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000095; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19418; Zhang T, 2015, TOXICOL SCI, V148, P299, DOI 10.1093/toxsci/kfv184; Zhang YJ, 2018, J HAZARD MATER, V344, P1057, DOI 10.1016/j.jhazmat.2017.11.039; Zhao G, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00548-3; Zhou XY, 2016, AQUAT TOXICOL, V175, P1, DOI 10.1016/j.aquatox.2016.03.008; Zhou ZQ, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120229	91	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22596	10.1096/fj.202200829R	http://dx.doi.org/10.1096/fj.202200829R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5D7IT	36208295				2022-12-28	WOS:000865111100001
J	Chu, YJ; Zuo, JX; Zhang, Y; Gao, GQ; Hu, XY; Han, RD; Liu, C; Zhou, HS; Li, M; Peng, W; Wang, Y				Chu, Yijing; Zuo, Jianxin; Zhang, Yan; Gao, Guoqiang; Hu, Xiaoyu; Han, Rendong; Liu, Chong; Zhou, Huansheng; Li, Min; Peng, Wei; Wang, Yan			Co-culture with chorionic villous mesenchymal stem cells promotes endothelial cell proliferation and angiogenesis via ABCA9-AKT pathway	FASEB JOURNAL			English	Article						ABCA9; AKT; CV-MSCs; HUVEC; preeclampsia	AKT; MARKERS; TRANSPLANTATION; INFLAMMATION	Human chorionic villous mesenchymal stem cells (CV-MSCs) are a promising and effective therapeutic option for tissue injury. Vascular dysfunction during pregnancies is significantly involved in the pathogenesis of preeclampsia (PE). This work aims to investigate how CV-MSCs regulate the function of vascular endothelial cells. In this study, RNA-seq analysis was used to examine the changes in HUVECs treated with CV-MSC conditioned medium (CM). We examined the levels of ABCA9 and AKT signaling in human umbilical vein endothelial cells (HUVECs) by immunohistochemistry, western blotting, and qRT-PCR assays. CCK-8, colony formation, and tube formation assays were used to understand the role of ABCA9 in HUVEC proliferation and angiogenesis mediated by CV-MSCs. The CV-MSC treatment significantly enhanced the HUVEC proliferation and angiogenesis. Furthermore, a significant increase in the ABCA9 expression and AKT pathway activation was observed in CV-MSCs -treated HUVECs. Consistent with these findings, ABCA9 overexpression exhibited the same proliferation-and angiogenesis-promoting effect in HUVECs as induced by CV-MSC CM, also accompanied the AKT signaling activation. In addition, inhibition of ABCA9 inactivated the AKT signaling in HUVECs and reduced the HUVEC proliferation and angiogenesis. Importantly, the elevation of proliferation and angiogenesis induced by ABCA9 overexpression in HUVECs could be reversed by AKT pathway inhibition. Our results suggest that ABCA9-dependent AKT signaling activation mediated by CV-MSCs could promote HUVEC proliferation and angiogenesis.	[Chu, Yijing; Zuo, Jianxin; Zhang, Yan; Gao, Guoqiang; Hu, Xiaoyu; Han, Rendong; Liu, Chong; Zhou, Huansheng; Li, Min; Peng, Wei] Qingdao Univ, Affiliated Hosp, Dept Obstet, 16 Jiangsu Rd, Qingdao 266000, Peoples R China; [Wang, Yan] Qingdao Univ, Affiliated Hosp, Dept Spinal Surg, Haier 59, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Peng, W (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Obstet, 16 Jiangsu Rd, Qingdao 266000, Peoples R China.; Wang, Y (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Spinal Surg, Haier 59, Qingdao 266071, Peoples R China.	82791819@163.com; sanwang1986@163.com			Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University	Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University	This study was supported by the Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University.	Abumaree MH, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1153-9; Al-ofi EA, 2017, J REPROD IMMUNOL, V121, P26, DOI 10.1016/j.jri.2017.05.002; Amaral LM, 2015, VASC HEALTH RISK MAN, V11, P403, DOI 10.2147/VHRM.S64798; Anasiz Y, 2017, STEM CELL REV REP, V13, P587, DOI 10.1007/s12015-017-9757-x; Babajani A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00748; Basmaeil YS, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0984-0; Brown D, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109669; Ceserani V, 2016, VASC CELL, V8, DOI 10.1186/s13221-016-0037-3; Chen Y, 2017, ONCOGENE, V36, P2879, DOI 10.1038/onc.2016.442; Chu YJ, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00681-7; Chu YJ, 2020, CELL SIGNAL, V69, DOI 10.1016/j.cellsig.2020.109549; Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Ding HF, 2017, CELL MOL IMMUNOL, V14, P693, DOI 10.1038/cmi.2015.99; Du WJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0297-0; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Gao QQ, 2016, J HYPERTENS, V34, P1380, DOI 10.1097/HJH.0000000000000944; Gentile MT, 2019, JOVE-J VIS EXP, DOI 10.3791/58591; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Hsuan YCY, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.526; Imperio GE, 2019, J CELL MOL MED, V23, P610, DOI 10.1111/jcmm.13966; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Karatza AA, 2020, CURR PEDIATR REV, V16, P194, DOI 10.2174/1573396316666191224092405; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Kim YH, 2012, YONSEI MED J, V53, P1036, DOI 10.3349/ymj.2012.53.5.1036; Konukoglu D, 2017, ADV EXP MED BIOL, V956, P511, DOI 10.1007/5584_2016_90; Li M, 2020, HYPERTENS PREGNANCY, V39, P126, DOI 10.1080/10641955.2020.1744000; Lip SV, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.11.1286; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Ma J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1104-x; MacDonald ES, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00507; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Pecher SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082604; Rempel S, 2019, ANNU REV BIOCHEM, V88, P551, DOI 10.1146/annurev-biochem-013118-111705; Rodriguez-Fuentes DE, 2021, ARCH MED RES, V52, P93, DOI 10.1016/j.arcmed.2020.08.006; Saleh M, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00433-z; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; SandvoSS Mareike, 2017, Reprod Sci, V24, P568, DOI 10.1177/1933719116667216; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Silva-Carvalho AE, 2019, CYTOKINE GROWTH F R, V47, P32, DOI 10.1016/j.cytogfr.2019.05.006; Song M, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00595-w; Tachikawa M, 2008, MICROVASC RES, V75, P68, DOI 10.1016/j.mvr.2007.05.002; Tachikawa M, 2018, ANAT SCI INT, V93, P456, DOI 10.1007/s12565-018-0435-0; van Rijn BB, 2016, HYPERTENSION, V67, P404, DOI 10.1161/HYPERTENSIONAHA.115.06455; Wang ZG, 2017, J CELL MOL MED, V21, P2432, DOI 10.1111/jcmm.13165; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Yetik-Anacak G, 2006, VASC PHARMACOL, V45, P268, DOI 10.1016/j.vph.2006.08.002; Yu HX, 2015, VASC PHARMACOL, V71, P57, DOI 10.1016/j.vph.2015.03.003; Zhang XF, 2017, ACTA BIOMATER, V59, P317, DOI 10.1016/j.actbio.2017.07.001	51	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22568	10.1096/fj.202101316RR	http://dx.doi.org/10.1096/fj.202101316RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1MV	36165221				2022-12-28	WOS:000859930700001
J	Tao, JM; Miao, R; Liu, G; Qiu, XN; Yang, BH; Tan, XZ; Liu, L; Long, J; Tang, W; Jing, W				Tao, Junming; Miao, Rong; Liu, Gang; Qiu, Xiaoning; Yang, Baohua; Tan, Xinzhi; Liu, Lei; Long, Jie; Tang, Wei; Jing, Wei			Spatiotemporal correlation between HIF-1 alpha and bone regeneration	FASEB JOURNAL			English	Review							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED BONE; TRANSCRIPTIONAL ACTIVITY; HIF-1; ANGIOGENESIS; PROGENITOR; ACTIVATION; OSTEOGENESIS; DEFECT	Hypoxia-inducible factors (HIFs) are core regulators of the hypoxia response. HIF signaling is activated in the local physiological and pathological hypoxic environment, acting on downstream target genes to synthesize the corresponding proteins and regulate the hypoxic stress response. HIFs belong to the hypoxia-activated transcription family and contain two heterodimeric transcription factors, HIF-alpha and HIF-beta. Under hypoxia, the dimer formed by HIF-alpha binding to HIF-beta translocates into the nucleus and binds to the hypoxia response element (HRE) to induce transcription of a series of genes. HIF-1 alpha plays an important role in innate bone development and acquired bone regeneration. HIF-1 alpha promotes bone regeneration mainly through the following two pathways: (1) By regulating angiogenesis-osteoblast coupling to promote bone regeneration; and (2) by inducing metabolic reprogramming in osteoblasts, promoting cellular anaerobic glycolysis, ensuring the energy supply of osteoblasts under hypoxic conditions, and further promoting bone regeneration and repair. This article reviews recent basic research on HIF-1 alpha and its role in promoting osteogenesis, discusses the possible molecular mechanisms, introduces the hypoxia-independent role of HIF-1 alpha and reviews the application prospects of HIF-1 alpha in tissue engineering.	[Tao, Junming; Miao, Rong; Liu, Gang; Qiu, Xiaoning; Yang, Baohua; Tan, Xinzhi; Liu, Lei; Long, Jie; Tang, Wei; Jing, Wei] Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, Dept Oral & Maxillofacial Surg,West China Hosp St, Chengdu, Peoples R China	Sichuan University	Jing, W (corresponding author), Sichuan Univ, Dept Oral & Maxillofacial Surg, West China Hosp Stomatol, Chengdu 610041, Peoples R China.	jingwei@scu.edu.cn		Tang, Wei/0000-0001-7568-2884	National Natural Science Foundation of China [81971319]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Science Foundation of China, Grant/Award Number: 81971319, is acknowledged.	Abuna RPF, 2021, J CELL PHYSIOL, V236, P3906, DOI 10.1002/jcp.30131; Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Amin N, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061359; ATSUMI T, 1992, CLIN ORTHOP RELAT R, P22; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68; Bullen JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0583; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Camacho-Cardenosa M, 2020, WORLD J STEM CELLS, V12, P1667, DOI 10.4252/wjsc.v12.i12.1667; Carr AN, 2006, CARDIOVASC RES, V69, P925, DOI 10.1016/j.cardiores.2005.12.005; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Corcoran A, 2013, ACTA PHYSIOL, V208, P298, DOI 10.1111/apha.12117; Costa V, 2017, CYTOTHERAPY, V19, P1412, DOI 10.1016/j.jcyt.2017.09.007; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063628; Duan CM, 2016, AM J PHYSIOL-CELL PH, V310, pC260, DOI 10.1152/ajpcell.00315.2015; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Esser TU, 2019, EXPERT OPIN BIOL TH, V19, P105, DOI 10.1080/14712598.2019.1561855; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Fu WL, 2015, TISSUE ENG PT A, V21, P948, DOI [10.1089/ten.TEA.2014.0267, 10.1089/ten.tea.2014.0267]; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Gonzalez FJ, 2018, NAT REV ENDOCRINOL, V15, P21, DOI 10.1038/s41574-018-0096-z; Guo K, 2020, EXP MOL PATHOL, V114, DOI 10.1016/j.yexmp.2020.104416; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Jadaun PK, 2022, J CELL PHYSIOL, V237, P1440, DOI 10.1002/jcp.30617; Jia P, 2016, J BIOMED MATER RES A, V104, P2515, DOI 10.1002/jbm.a.35793; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kling L, 2021, J LEUKOCYTE BIOL, V110, P61, DOI 10.1002/JLB.4RI0820-535R; Komatsu DE, 2007, J BONE MINER RES, V22, P366, DOI 10.1359/JBMR.061207; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li DH, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aac627; Li J, 2020, CYTOKINE GROWTH F R, V52, P88, DOI 10.1016/j.cytogfr.2020.02.003; Li SJ, 2018, J COMPUT ASSIST TOMO, V42, P588, DOI [10.1097/rct.0000000000000725, 10.1097/RCT.0000000000000725]; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Liu J, 2015, J TISSUE ENG REGEN M, V9, P952, DOI 10.1002/term.1654; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Lu Chuanyong, 2008, Iowa Orthop J, V28, P14; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Maes C, 2012, NAT REV RHEUMATOL, V8, P358, DOI 10.1038/nrrheum.2012.36; Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417; Malekan M, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111873; McGettrick AF, 2020, CELL METAB, V32, P524, DOI 10.1016/j.cmet.2020.08.002; Merceron C, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0045-z; Miclau KR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00045; Mills CN, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-104; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Mukherjee S, 2015, ADV HEALTHC MATER, V4, P1722, DOI 10.1002/adhm.201500155; Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143; Nguyen LK, 2015, J CELL SCI, V128, P422, DOI 10.1242/jcs.167304; Palomaki S, 2013, STEM CELLS, V31, P1902, DOI 10.1002/stem.1435; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Park J, 2015, ACS NANO, V9, P4987, DOI 10.1021/nn507149w; Peng J, 2019, J BIOMED NANOTECHNOL, V15, P742, DOI 10.1166/jbn.2019.2735; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajendran G, 2020, J AM SOC NEPHROL, V31, P501, DOI 10.1681/ASN.2019050523; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Salhotra A, 2020, NAT REV MOL CELL BIO, V21, P696, DOI 10.1038/s41580-020-00279-w; Salman S, 2018, INT J ORAL MAX SURG, V47, P1311, DOI 10.1016/j.ijom.2018.01.010; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shao R, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00148-y; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Stegen S, 2016, BONE, V87, P176, DOI 10.1016/j.bone.2016.03.014; Sugahara M, 2020, J AM SOC NEPHROL, V31, P560, DOI 10.1681/ASN.2019060582; Tang Y, 2019, J CELL PHYSIOL, V234, P11165, DOI 10.1002/jcp.27765; Tolonen JP, 2020, CELL MOL LIFE SCI, V77, P3627, DOI 10.1007/s00018-019-03387-9; Towler DA, 2007, J CLIN INVEST, V117, P1477, DOI 10.1172/JCI32518; Tseng WP, 2010, J CELL PHYSIOL, V223, P810, DOI 10.1002/jcp.22104; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan J, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0399-7; Wang ZY, 2021, NANOSCALE RES LETT, V16, DOI 10.1186/s11671-021-03522-1; Weng TJ, 2014, J BONE MINER RES, V29, P820, DOI 10.1002/jbmr.2087; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042; Wu DL, 2019, NAT CHEM BIOL, V15, P367, DOI 10.1038/s41589-019-0234-5; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Xu HX, 2021, STEM CELL TRANSL MED, V10, P781, DOI 10.1002/sctm.20-0346; Yong JW, 2021, J CELL MOL MED, V25, P9710, DOI 10.1111/jcmm.16920; You L, 2021, MED RES REV, V41, P1622, DOI 10.1002/med.21771; Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609; Yu X, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0191-8; Zhang JK, 2018, INT J BIOL SCI, V14, P449, DOI 10.7150/ijbs.24158; Zhang L, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.582670; Zhang WJ, 2016, ADV HEALTHC MATER, V5, P1299, DOI 10.1002/adhm.201500824; Zhang Y, 2016, J GENE MED, V18, P57, DOI 10.1002/jgm.2876; Zhu DH, 2022, J MOL CELL CARDIOL, V162, P10, DOI 10.1016/j.yjmcc.2021.08.010; Zou DH, 2012, BIOMATERIALS, V33, P2097, DOI 10.1016/j.biomaterials.2011.11.053; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	100	2	2	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22520	10.1096/fj.202200329RR	http://dx.doi.org/10.1096/fj.202200329RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H7GF	36065633				2022-12-28	WOS:000850043900001
J	Tong, WX; Hannou, SA; Wang, Y; Astapova, I; Sargsyan, A; Monn, R; Thiriveedi, V; Li, DN; McCann, JR; Rawls, JF; Roper, J; Zhang, GF; Herman, MA				Tong, Wenxin; Hannou, Sarah A.; Wang, You; Astapova, Inna; Sargsyan, Ashot; Monn, Ruby; Thiriveedi, Venkataramana; Li, Diana; McCann, Jessica R.; Rawls, John F.; Roper, Jatin; Zhang, Guo-fang; Herman, Mark A.			The intestine is a major contributor to circulating succinate in mice	FASEB JOURNAL			English	Article						circulating biomarkers; intestine; succinate; TCA cycle intermediates	RECEPTOR GPR91; ACCUMULATION; GLUCOSE; SIGNAL; MOUSE; REPERFUSION; METABOLISM; MICROBIOTA; FRUCTOSE; MURINE	The tricarboxylic acid (TCA) cycle is the epicenter of cellular aerobic metabolism. TCA cycle intermediates facilitate energy production and provide anabolic precursors, but also function as antra- and extracellular metabolic signals regulating pleiotropic biological processes. Despite the importance of circulating TCA cycle metabolites as signaling molecules, the source of circulating TCA cycle intermediates remains uncertain. We observe that in mice, the concentration of TCA cycle intermediates in the portal blood exceeds that in tail blood indicating that the gut is a major contributor to circulating TCA cycle metabolites. With a focus on succinate as a representative of a TCA cycle intermediate with signaling activities and using a combination of gut microbiota depletion mouse models and isotopomer tracing, we demonstrate that intestinal microbiota is not a major contributor to circulating succinate. Moreover, we demonstrate that endogenous succinate production is markedly higher than intestinal succinate absorption in normal physiological conditions. Altogether, these results indicate that endogenous succinate production within the intestinal tissue is a major physiological source of circulating succinate. These results provide a foundation for an investigation into the role of the intestine in regulating circulating TCA cycle metabolites and their potential signaling effects on health and disease.	[Tong, Wenxin; Roper, Jatin] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27701 USA; [Tong, Wenxin; Hannou, Sarah A.; Wang, You; Astapova, Inna; Sargsyan, Ashot; Monn, Ruby; Zhang, Guo-fang; Herman, Mark A.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Astapova, Inna; Herman, Mark A.] Duke Univ, Div Endocrinol Metab & Nutr, Durham, NC 27701 USA; [Thiriveedi, Venkataramana; Li, Diana; Roper, Jatin] Duke Univ, Div Gastroenterol, Durham, NC 27701 USA; [McCann, Jessica R.; Rawls, John F.] Duke Univ, Duke Microbiome Ctr, Dept Mol Genet & Microbiol, Durham, NC 27701 USA; [Wang, You] Jining Med Univ, Sch Basic Med, Jining, Shandong, Peoples R China; [Astapova, Inna; Herman, Mark A.] Baylor Coll Med, Sect Endocrinol Diabet & Metab, Houston, TX 77030 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Jining Medical University; Baylor College of Medicine	Herman, MA (corresponding author), Duke Univ, 300 N Duke St, Durham, NC 27701 USA.	mark.herman@duke.edu	hannou, sarah/AAT-2902-2020; Tong, Wenxin/GLT-9703-2022	hannou, sarah/0000-0003-4780-5773; Tong, Wenxin/0000-0003-4116-5904	National Institute of Diabetes and Digestive and Kidney Diseases [DK121710, DK124723, DK100425]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases, Grant/ Award Number: DK121710, DK124723 and DK100425	Ahn S, 2016, J BIOL CHEM, V291, P11928, DOI 10.1074/jbc.M115.708149; Al-Jawadi A, 2020, J NUTR, V150, P1722, DOI 10.1093/jn/nxaa113; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Borowy C.S., 2020, STATPEARLS; Bu PC, 2018, CELL METAB, V27, P1249, DOI 10.1016/j.cmet.2018.04.003; Casteleyn C, 2010, LAB ANIM-UK, V44, P176, DOI 10.1258/la.2009.009112; Chan TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199177; Cho EH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00455; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; He WT, 2021, MOL GENET METAB, V134, P257, DOI 10.1016/j.ymgme.2021.09.009; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Herman MA, 2021, CELL METAB, V33, P2329, DOI 10.1016/j.cmet.2021.09.010; Jang C, 2019, CELL METAB, V30, P594, DOI 10.1016/j.cmet.2019.06.002; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Kishida K, 2017, AM J PHYSIOL-GASTR L, V312, pG592, DOI 10.1152/ajpgi.00416.2016; Lai YJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26209-8; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Li XX, 2022, NAT METAB, V4, P141, DOI 10.1038/s42255-021-00517-1; Liu XD, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108908; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mills EL, 2021, NAT METAB, V3, P604, DOI 10.1038/s42255-021-00389-5; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Murashige D, 2020, SCIENCE, V370, P364, DOI 10.1126/science.abc8861; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nilsson R, 2020, MATH BIOSCI, V330, DOI 10.1016/j.mbs.2020.108481; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Reddy A, 2020, CELL, V183, P62, DOI 10.1016/j.cell.2020.08.039; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Serena C, 2018, ISME J, V12, P1642, DOI 10.1038/s41396-018-0068-2; Shree M, 2018, METABOLITES, V8, DOI 10.3390/metabo8040066; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang T, 2021, EMBO REP, V22, DOI 10.15252/embr.202153027; Wijermars LGM, 2016, AM J TRANSPLANT, V16, P2741, DOI 10.1111/ajt.13793; Woting A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060685; Zhang GF, 2021, CELL METAB, V33, P804, DOI 10.1016/j.cmet.2020.11.020; Zhao S, 2020, NATURE, V579, P586, DOI 10.1038/s41586-020-2101-7	49	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22546	10.1096/fj.202200135RR	http://dx.doi.org/10.1096/fj.202200135RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4O2VR	36106538				2022-12-28	WOS:000854562800001
J	Han, JX; Wen, CX; Sun, R; Tang, MY; Li, XM; Lian, H				Han, Jia-Xuan; Wen, Chen-Xi; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming; Lian, Hong			The dorsal hippocampal CA3 regulates spatial reference memory through the CtBP2/GluR2 pathway	FASEB JOURNAL			English	Article						CtBP2; dorsal hippocampal CA3; GluR2; spatial reference memory	PERMEABLE AMPA RECEPTORS; TERMINAL BINDING-PROTEIN; TRANSCRIPTIONAL COREPRESSOR; VENTRAL HIPPOCAMPUS; SYNAPTIC PLASTICITY; SUBUNIT; CTBP2; RECONSOLIDATION; EXPRESSION; RIBBONS	The dorsal hippocampus plays a pivotal role in spatial memory. However, the role of subregion-specific molecular pathways in spatial cognition remains unclear. We observed that the transcriptional coregulator C-terminal binding protein 2 (CtBP2) presented CA3-specific enrichment in expression. RNAi interference of CtBP2 in the dorsal CA3 (dCA3) neurons, but not the ventral CA3 (vCA3), specifically impaired spatial reference memory and reduced the expression of GluR2, the calcium permeability determinant subunit of AMPA receptors. Application of an antagonist for GluR2-absent calcium permeable AMPA receptors rescued spatial memory deficits in dCA3 CtBP2 knockdown animals. Transcriptomic analysis suggest that CtBP2 may regulate GluR2 protein level through post-translational mechanisms, especially by the endocytosis pathway which regulates AMPA receptor sorting. Consistently, CtBP2 deficiency altered the mRNA expression of multiple endocytosis-regulatory genes, and CtBP2 knockdown in primary hippocampal neurons enhanced GluR2-containing AMPA receptor endocytosis. Together, our results provide evidence that the dCA3 regulates spatial reference memory by the CtBP2/GluR2 pathway through the modulation of calcium permeable AMPA receptors.	[Han, Jia-Xuan; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming; Lian, Hong] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Res Bldg A505,866 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Han, Jia-Xuan; Wen, Chen-Xi; Sun, Rui; Tang, Meng-Yu; Li, Xiao-Ming] Zhejiang Univ, Sch Brain Sci & Brain Med, Sch Med,NHC & CAMS Key Lab Med Neurobiol, MOE Frontier Ctr Brain Sci & Brain Machine Integr, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Li, XM; Lian, H (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Res Bldg A505,866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.	lixm@zju.edu.cn; honglian@zju.edu.cn			National Natural Science Foundation of China [32000718, U20A6005]; National Key Research and Development Program of China [SQ2021YFA1100045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 32000718 and U20A6005; National Key Research and Development Program of China, Grant/Award Number: SQ2021YFA1100045	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Bellet MM, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03086-5; Bliss T.V.P., 2018, E NEUROFORUM, V24, pA103, DOI [10.1515/nf-2017-A059, DOI 10.1515/NF-2017-A059]; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chawla MK, 2018, HIPPOCAMPUS, V28, P178, DOI 10.1002/hipo.22820; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coughlan G, 2018, NAT REV NEUROL, V14, P496, DOI 10.1038/s41582-018-0031-x; Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fellini L, 2009, LEARN MEMORY, V16, P387, DOI 10.1101/lm.1433209; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Glikmann-Johnston Y, 2019, NEUROSCI BIOBEHAV R, V98, P194, DOI 10.1016/j.neubiorev.2019.01.015; Glikmann-Johnston Y, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00289; Graham J, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.595049; Gusev PA, 2005, J NEUROSCI, V25, P9384, DOI 10.1523/JNEUROSCI.0832-05.2005; Hauser J, 2020, HIPPOCAMPUS, V30, P938, DOI 10.1002/hipo.23207; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; Hubler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039710; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jin JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08388; Karaca E, 2020, MOL CELL NEUROSCI, V104, DOI 10.1016/j.mcn.2020.103481; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim R, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-9; Konen LM, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-0545-1; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee S, 2011, BBA-MOL CELL RES, V1813, P713, DOI 10.1016/j.bbamcr.2011.01.035; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lester AW, 2017, NEURON, V95, P1019, DOI 10.1016/j.neuron.2017.06.037; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Lv CX, 2016, CELL REP, V15, P2784, DOI 10.1016/j.celrep.2016.05.045; Maxeiner S, 2016, EMBO J, V35, P1098, DOI 10.15252/embj.201592701; Monfort P, 2015, ACS CHEM NEUROSCI, V6, P1420, DOI 10.1021/acschemneuro.5b00096; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Oguro K, 1999, J NEUROSCI, V19, P9218; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Park P, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00042; Park P, 2016, J NEUROSCI, V36, P622, DOI 10.1523/JNEUROSCI.3625-15.2016; Ramos JMJ, 2022, BEHAV BRAIN RES, V417, DOI 10.1016/j.bbr.2021.113620; Rebola N, 2017, NAT REV NEUROSCI, V18, P209, DOI 10.1038/nrn.2017.10; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Shen YG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00707-0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00049; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Stankiewicz Trisha R., 2014, BioMolecular Concepts, V5, P489, DOI 10.1515/bmc-2014-0027; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Torquatto KI, 2019, NEUROPHARMACOLOGY, V144, P312, DOI 10.1016/j.neuropharm.2018.10.030; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang HH, 2019, CELL REP, V27, P2335, DOI 10.1016/j.celrep.2019.04.081; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Zhang GW, 2012, J MOL HISTOL, V43, P327, DOI 10.1007/s10735-012-9399-x; Zou FH, 2013, J MOL NEUROSCI, V49, P395, DOI 10.1007/s12031-012-9906-2	70	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22456	10.1096/fj.202101609RR	http://dx.doi.org/10.1096/fj.202101609RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3T7LE	35969153				2022-12-28	WOS:000840450100001
J	Yan, FZ; Qian, H; Liu, F; Ding, CH; Liu, SQ; Xiao, MC; Chen, SJ; Zhang, X; Luo, C; Xie, WF				Yan, Fang-Zhi; Qian, Hui; Liu, Fang; Ding, Chen-Hong; Liu, Shu-Qing; Xiao, Meng-Chao; Chen, Shi-Jie; Zhang, Xin; Luo, Cheng; Xie, Wei-Fen			Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice	FASEB JOURNAL			English	Article						hepatic stellate cell; inflammation; inhibitor; liver fibrosis; protein arginine methyltransferase 1	METHYLATION; INFLAMMATION; EXPRESSION; MECHANISMS; PRMT1	Protein arginine methyltransferase 1 (PRMT1) has been reported to be involved in various diseases. The expression of PRMT1 was increased in cirrhotic livers from human patients. However, the role of PRMT1 in hepatic fibrogenesis remains largely unexplored. In this study, we investigated the effect of PRMT1 on hepatic fibrogenesis and its underlying mechanism. We found that PRMT1 expression was significantly higher in fibrotic livers of the mice treated with thioacetamide (TAA) or 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Immunofluorescence staining revealed that PRMT1 expression was augmented in both hepatocytes and hepatic stellate cells (HSCs) in the fibrotic livers. Applying a selective inhibitor of PRMT1, PT1001B, significantly suppressed PRMT1 activity and mitigated liver fibrosis in mice. Hepatocyte-specific Prmt1 knockout did not affect liver fibrosis in mice. PRMT1 overexpression promoted the expression of fibrotic genes in the LX-2 cells, whereas knockdown of PRMT1 or treatment with PT1001B exhibited reversal effects, suggesting that PRMT1 plays an important role in HSC activation. Additionally, HSC-specific Prmt1 knockout attenuated HSC activation and liver fibrosis in TAA-induced fibrotic model. RNA-seq analysis revealed that Prmt1 knockout in HSCs significantly suppressed pro-inflammatory NF-kappa B and pro-fibrotic TGF-beta signals, and also downregulated the expression of pro-fibrotic mediators in mouse livers. Moreover, treatment with PT1001B consistently inhibited hepatic inflammatory response in fibrotic model. In conclusion, PRMT1 plays a vital role in HSC activation. Inhibition of PRMT1 mitigates hepatic fibrosis by attenuating HSC activation in mice. Therefore, targeting PRMT1 could be a feasible therapeutic strategy for liver fibrosis.	[Yan, Fang-Zhi; Qian, Hui; Liu, Fang; Ding, Chen-Hong; Liu, Shu-Qing; Zhang, Xin; Xie, Wei-Fen] Naval Med Univ, Changzheng Hosp, Dept Gastroenterol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Xiao, Meng-Chao] Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China; [Chen, Shi-Jie; Luo, Cheng] Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Ctr Chem Biol,Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China	Naval Medical University; Tongji University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Xie, WF (corresponding author), Naval Med Univ, Changzheng Hosp, Dept Gastroenterol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Luo, C (corresponding author), Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Ctr Chem Biol,Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	cluo@simm.ac.cn; weifenxie@medmail.com.cn			National Natural Science Foundation of China (NSFC) [82030021, 82072641, 81802324, 81870419]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82030021, 82072641, 81802324 and 81870419	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Choi D, 2012, HEPATOLOGY, V56, P1546, DOI 10.1002/hep.25809; El Sabeh R, 2021, J INFLAMM RES, V14, P2149, DOI 10.2147/JIR.S306805; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Hashimoto M, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129776; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hu GH, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112152; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Ma YX, 2020, FASEB J, V34, P14863, DOI 10.1096/fj.202001061R; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Sanchez PS, 2021, CANCERS, V13, DOI 10.3390/cancers13205045; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Sun QZ, 2019, J IMMUNOL, V202, P37, DOI 10.4049/jimmunol.1800782; Sun QZ, 2016, CELL SIGNAL, V28, P307, DOI 10.1016/j.cellsig.2016.01.004; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Wang C, 2017, J MED CHEM, V60, P8888, DOI 10.1021/acs.jmedchem.7b01134; Wei H, 2019, NEOPLASMA, V66, P918, DOI 10.4149/neo_2018_181226N999; Weiskirchen S, 2017, METHODS MOL BIOL, V1627, P165, DOI 10.1007/978-1-4939-7113-8_11; Wu M, 2019, FASEB J, V33, P6948, DOI 10.1096/fj.201802585RR; Xie YQ, 2014, ORG BIOMOL CHEM, V12, P9665, DOI 10.1039/c4ob01591f; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YY, 2012, LIVER INT, V32, P48, DOI 10.1111/j.1478-3231.2011.02651.x; Zakrzewicz D, 2015, BBA-MOL BASIS DIS, V1852, P2678, DOI 10.1016/j.bbadis.2015.09.008; Zhang XP, 2018, CELL PHYSIOL BIOCHEM, V47, P1643, DOI 10.1159/000490983; Zhao J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45585-2; Zhao J, 2018, HEPATOLOGY, V67, P1109, DOI 10.1002/hep.29587; Zhong YG, 2015, BIOCHEM BIOPH RES CO, V468, P906, DOI 10.1016/j.bbrc.2015.11.055; Zhu Y, 2020, AM J PHYSIOL-RENAL, V318, pF375, DOI 10.1152/ajprenal.00487.2019	37	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22489	10.1096/fj.202200238R	http://dx.doi.org/10.1096/fj.202200238R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3S4EK	35959865				2022-12-28	WOS:000839550800001
J	Machcinska, S; Walendzik, K; Kopcewicz, M; Wisniewska, J; Rokka, A; Paakkonen, M; Slowinska, M; Gawronska-Kozak, B				Machcinska, Sylwia; Walendzik, Katarzyna; Kopcewicz, Marta; Wisniewska, Joanna; Rokka, Anne; Paakkonen, Mirva; Slowinska, Mariola; Gawronska-Kozak, Barbara			Hypoxia reveals a new function of Foxn1 in the keratinocyte antioxidant defense system	FASEB JOURNAL			English	Article						Ccn; Foxn1; hypoxia; keratinocytes; thioredoxin system	THIOREDOXIN-GLUTATHIONE REDUCTASE; EUKARYOTIC PROMOTER DATABASE; GROWTH-FACTOR PRODUCTION; TRANSCRIPTIONAL CONTROL; EMERGING ROLE; WOUND REPAIR; CCN FAMILY; SKIN; EXPRESSION; OXYGEN	Skin exposed to environmental threats, including injuries and oxidative stress, develops an efficient but not fully recognized system of repair and antioxidant protection. Here, using mass spectrometry analysis (LC-MS/MS), followed by in vitro and in vivo experiments, we provided evidence that Foxn1 in keratinocytes regulates elements of the electron transport chain and participates in the thioredoxin system (Txn2, Txnrd3, and Srxn1) induction, particularly in a hypoxic environment. We first showed that Foxn1 in keratinocytes upregulates glutathione thioredoxin reductase 3 (Txnrd3) protein expression, and high levels of Txnrd3 mRNA were detected in injured skin of Foxn1(+/+) mice. We also showed that Foxn1 strongly downregulated the Ccn2 protein expression, participating in epidermal reconstruction after injury. An in vitro assay revealed that Foxn1 controls keratinocyte migration, stimulating it under normoxia and suppressing it under hypoxia. Keratinocytes overexpressing Foxn1 and exposed to hypoxia displayed a reduced ability to promote angiogenesis by downregulating Vegfa expression. In conclusion, this study showed a new mechanism in which Foxn1, along with hypoxia, participates in the activation of antioxidant defense and controls the functional properties of keratinocytes.	[Machcinska, Sylwia; Walendzik, Katarzyna; Kopcewicz, Marta; Wisniewska, Joanna; Slowinska, Mariola; Gawronska-Kozak, Barbara] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland; [Rokka, Anne; Paakkonen, Mirva] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Rokka, Anne; Paakkonen, Mirva] Abo Akad Univ, Turku, Finland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Turku; Abo Akademi University	Gawronska-Kozak, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland.	b.kozak@pan.olsztyn.pl	KOPCEWICZ, Marta/H-7199-2017	KOPCEWICZ, Marta/0000-0002-9776-4941; MACHCINSKA-ZIELINSKA, Sylwia/0000-0003-3892-4519; Rokka, Anne/0000-0003-1482-9154	National Science Centre Poland [2017/27/B/NZ5/02610]	National Science Centre Poland(National Science Centre, Poland)	National Science Centre Poland, Grant/Award Number: 2017/27/B/NZ5/02610	Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Bellavia G, 2014, J DERMATOL SCI, V73, P3, DOI 10.1016/j.jdermsci.2013.08.007; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Cao XK, 2020, BIOL CHEM, V401, P1215, DOI 10.1515/hsz-2020-0181; Cowburn AS, 2014, J INVEST DERMATOL, V134, P801, DOI 10.1038/jid.2013.395; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Du HY, 2018, BIOCHEM BIOPH RES CO, V505, P966, DOI 10.1016/j.bbrc.2018.09.001; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Gawronska-Kozak B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150635; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He J, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03923-1; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kimmel HM, 2016, WOUNDS, V28, P264; Kiwanuka E, 2013, J SURG RES, V185, pE109, DOI 10.1016/j.jss.2013.05.065; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kopcewicz MM, 2017, WOUND REPAIR REGEN, V25, P248, DOI 10.1111/wrr.12524; Kur-Piotrowska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23794-5; Kur-Piotrowska A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3401-z; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Li J, 2007, DIFFERENTIATION, V75, P694, DOI 10.1111/j.1432-0436.2007.00176.x; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Machcinska S, 2021, FASEB J, V35, DOI 10.1096/fj.202001907R; Mascharak S, 2021, SCIENCE, V372, P362, DOI 10.1126/science.aba2374; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Mori R, 2014, AM J PATHOL, V184, P2465, DOI 10.1016/j.ajpath.2014.05.012; Muri J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04274-w; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Piipponen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228790; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Prowse DM, 1999, DEV BIOL, V212, P54, DOI 10.1006/dbio.1999.9328; Quan TH, 2009, J CELL COMMUN SIGNAL, V3, P19, DOI 10.1007/s12079-009-0044-8; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545; Rittie L, 2011, J CELL COMMUN SIGNAL, V5, P69, DOI 10.1007/s12079-010-0114-y; Ross C, 2011, EXP DERMATOL, V20, P58, DOI 10.1111/j.1600-0625.2010.01190.x; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050212; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0765-9; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43926; Telorack M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005800; Tottoli EM, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080735; Walendzik K, 2020, J INVEST DERMATOL, V140, P1166, DOI 10.1016/j.jid.2019.11.010; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Welsh SJ, 2002, CANCER RES, V62, P5089; Weninger W, 1996, LAB INVEST, V75, P647; Williams DL, 2013, ANTIOXID REDOX SIGN, V19, P735, DOI 10.1089/ars.2012.4670; Wisniewska J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115469; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; Xiao HJ, 2013, INT J MED SCI, V10, P1412, DOI 10.7150/ijms.5630; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	78	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22436	10.1096/fj.202200249RR	http://dx.doi.org/10.1096/fj.202200249RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2R5PZ	35792861	hybrid			2022-12-28	WOS:000821165400001
J	Roy, B; Pan, GD; Giri, S; Thandavarayan, RA; Palaniyandi, SS				Roy, Bipradas; Pan, Guodong; Giri, Shailendra; Thandavarayan, Rajarajan A.; Palaniyandi, Suresh Selvaraj			Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes	FASEB JOURNAL			English	Article						4-hydroxy-2-nonenal; adiponectin; aldehyde dehydrogenase 2; AMP-activated protein kinase; cardioprotection; coronary angiogenesis	HIGH-FAT DIET; PLASMA ADIPONECTIN; SKELETAL-MUSCLE; HEART-FAILURE; ACTIVATION; RESISTANCE; MORTALITY; LEVEL; APPL1; MICE	4-hydroxy-2-nonenal (4HNE), an oxidative stress byproduct, is elevated in diabetes which decreases coronary angiogenesis, and this was rescued by the 4HNE detoxifying enzyme, aldehyde dehydrogenase 2 (ALDH2). Adiponectin (APN), an adipocytokine, has pro-angiogenic properties and its loss of function is critical in diabetes and its complications. Coronary endothelial cell (CEC) damage is the initiating step of diabetes-mediated heart failure with preserved ejection fraction (HFpEF) pathogenesis. Thus, we hypothesize that ALDH2 restores 4HNE-induced downregulation of APN signaling in CECs and subsequent coronary angiogenesis in diabetic HFpEF. Treatment with disulfiram, an ALDH2 inhibitor, exacerbated 4HNE-mediated decreases in APN-induced increased coronary angiogenesis and APN-signaling cascades, whereas pretreatment with alda1, an ALDH2 activator, rescued the effect of 4HNE. We employed control mice (db/m), spontaneous type-2 diabetic mice (db/db), ALDH2*2 knock-in mutant mice with intrinsic low ALDH2 activity (AL), and diabetic mice with intrinsic low ALDH2 activity (AF) mice that were created by crossing db/db and AL mice to test our hypothesis in vivo. AF mice exhibited heart failure with preserved ejection fraction (HFpEF)/severe diastolic dysfunction at 6 months with a preserved systolic function compared with db/db mice as well as 3 months of their age. Decreased APN-mediated coronary angiogenesis, along with increased circulatory APN levels and decreased cardiac APN signaling (index of APN resistance) were higher in AF mice relative to db/db mice. Alda1 treatment improved APN-mediated angiogenesis in AF and db/db mice. In summary, 4HNE-induces APN resistance and a subsequent decrease in coronary angiogenesis in diabetic mouse heart which was rescued by ALDH2.	[Roy, Bipradas; Pan, Guodong; Palaniyandi, Suresh Selvaraj] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Dept Internal Med, Detroit, MI USA; [Roy, Bipradas; Pan, Guodong; Palaniyandi, Suresh Selvaraj] Wayne State Univ, Dept Physiol, Detroit, MI USA; [Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Henry Ford Health System; Henry Ford Hospital; The Methodist Hospital System; The Methodist Hospital - Houston	Palaniyandi, SS (corresponding author), Henry Ford Hlth Syst, Integrat Biosci Ctr IBio, Dept Internal Med, Div Hypertens & Vasc Res, Room 3402,6135 Woodward, Detroit, MI 48202 USA.	spalani2@hfhs.org		Roy, Bipradas/0000-0001-6472-951X	National Heart, Lung, and Blood Institute [1R01HL139877-01A1]; Henry Ford Health System [A10249]; American Heart Association [835 262]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Henry Ford Health System; American Heart Association(American Heart Association)	SSP was supported by a grant from the National Heart, Lung, and Blood Institute 1R01HL139877--01A1 and an internal grant from Henry Ford Health System A10249. BR was supported by a predoctoral fellowship grant from the American Heart Association 835 262.	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Baldasseroni S, 2012, NUTR METAB CARDIOVAS, V22, P292, DOI 10.1016/j.numecd.2011.03.012; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Celik T, 2010, INT J CARDIOL, V144, P319, DOI 10.1016/j.ijcard.2009.03.006; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen KK, 2017, MOL MED REP, V15, P1497, DOI 10.3892/mmr.2017.6193; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cuijpers I, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0798-y; Dham D, 2021, FREE RADICAL RES, V55, P547, DOI 10.1080/10715762.2020.1866756; Gariballa S, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0386-z; Gui C, 2018, CELL PHYSIOL BIOCHEM, V46, P2325, DOI 10.1159/000489622; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Khazaei M, 2013, RES PHARM SCI, V8, P119; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Laoutaris ID, 2010, INT J CARDIOL, V144, P230, DOI 10.1016/j.ijcard.2008.12.126; Lewis JW, 2021, BONE RES, V9, DOI 10.1038/s41413-020-00122-0; Li R, 2010, J MOL CELL CARDIOL, V49, P508, DOI 10.1016/j.yjmcc.2010.03.002; Liu W, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019052; Mali VR, 2014, EXP BIOL MED, V239, P610, DOI 10.1177/1535370213520109; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pan GD, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.021140; Pan GD, 2020, J CELL BIOCHEM, V121, P4887, DOI 10.1002/jcb.29814; Pan GD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195796; Park M, 2013, AM J PHYSIOL-ENDOC M, V305, pE795, DOI 10.1152/ajpendo.00257.2013; Parker-Duffen JL, 2014, J BIOL CHEM, V289, P16200, DOI 10.1074/jbc.M114.548115; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Piao LM, 2018, INT J CARDIOL, V267, P150, DOI 10.1016/j.ijcard.2018.05.089; Raghavan S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011295; Roy B, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00587-4; Roy B, 2021, MICROVASC RES, V135, DOI 10.1016/j.mvr.2021.104133; Roy B, 2020, VASC PHARMACOL, V131, DOI 10.1016/j.vph.2020.106762; Roy B, 2020, CELL BIOCHEM FUNCT, V38, P290, DOI 10.1002/cbf.3468; Shah SJ, 2020, CIRCULATION, V141, P1001, DOI 10.1161/CIRCULATIONAHA.119.041886; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Springer J, 2010, CIRC-HEART FAIL, V3, P181, DOI 10.1161/CIRCHEARTFAILURE.110.945063; Tamura T, 2007, CIRC J, V71, P623, DOI 10.1253/circj.71.623; Van Berendoncks AM, 2010, CIRC-HEART FAIL, V3, P185, DOI 10.1161/CIRCHEARTFAILURE.109.885525; Xi W, 2005, BIOCHEM BIOPH RES CO, V332, P200, DOI 10.1016/j.bbrc.2005.04.111; Zambelli VO, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009539	43	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22440	10.1096/fj.202200498R	http://dx.doi.org/10.1096/fj.202200498R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2T9ZW	35815932				2022-12-28	WOS:000822825500001
J	Toren, E; Liu, YP; Bethea, M; Wade, A; Hunter, CS				Toren, Eliana; Liu, Yanping; Bethea, Maigen; Wade, Alexa; Hunter, Chad S.			The Ldb1 transcriptional co-regulator is required for establishment and maintenance of the pancreatic endocrine lineage	FASEB JOURNAL			English	Article						cell fate; co-regulator; diabetes; endocrine; islets; pancreatic development; transcription; transcription factor	TISSUE-SPECIFIC EXPRESSION; NUCLEAR FACTOR 3-BETA; BETA-CELLS; PROGENITOR CELLS; INSULIN GENE; PDX-1 GENE; IN-VITRO; ISLET; ALPHA; MAFA	Pancreatic islet cell development is regulated by transcription factors (TFs) that mediate embryonic progenitor differentiation toward mature endocrine cells. Prior studies from our lab and others showed that the islet-enriched TF, Islet-1 (Isl1), interacts with the broadly-expressed transcriptional co-regulator, Ldb1, to regulate islet cell maturation and postnhyperatal function (by embryonic day (E)18.5). However, Ldb1 is expressed in the developing pancreas prior to Isl1 expression, notably in multipotent progenitor cells (MPCs) marked by Pdx1 and endocrine progenitors (EPs) expressing Neurogenin-3 (Ngn3). MPCs give rise to the endocrine and exocrine pancreas, while Ngn3(+) EPs specify pancreatic islet endocrine cells. We hypothesized that Ldb1 is required for progenitor identity in MPC and EP populations during development to impact islet appearance and function. To test this, we generated a whole-pancreas Ldb1 knockout, termed Ldb1(Delta Panc), and observed severe developmental and postnatal pancreas defects including disorganized progenitor pools, a significant reduction of Ngn3-expressing EPs, Pdx1(HI) beta-cells, and early hormone(+) cells. Ldb1(Delta Panc) neonates presented with severe hyperglycemia, hypoinsulinemia, and drastically reduced hormone expression in islets, yet no change in total pancreas mass. This supports the endocrine-specific actions of Ldb1. Considering this, we also developed an endocrine-enriched model of Ldb1 loss, termed Ldb1(Delta Endo). We observed similar dysglycemia in this model, as well as a loss of islet identity markers. Through in vitro and in vivo chromatin immunoprecipitation experiments, we found that Ldb1 occupies key Pdx1 and Ngn3 promoter domains. Our findings provide insight into novel regulation of endocrine cell differentiation that may be vital toward improving cell-based diabetes therapies.	[Hunter, Chad S.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA; [Hunter, Chad S.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hunter, CS (corresponding author), Univ Alabama Birmingham, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA.; Hunter, CS (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, 1825 Univ Blvd,SHEL 1211, Birmingham, AL 35294 USA.	huntercs@uab.edu	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022	Toren, Eliana/0000-0002-6827-4521; Hunter, Chad/0000-0002-1644-447X	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK120217, DK111483, DK128132]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK120217, DK111483 and DK128132	Alvarez-Dominguez JR, 2020, CELL STEM CELL, V26, P108, DOI 10.1016/j.stem.2019.11.011; BERTUZZI F, 1995, J ENDOCRINOL, V147, P87, DOI 10.1677/joe.0.1470087; Bethea M, 2019, AM J PHYSIOL-ENDOC M, V316, pE397, DOI 10.1152/ajpendo.00235.2018; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Bourgeois S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010191; Boyer DF, 2006, DEV BIOL, V298, P616, DOI 10.1016/j.ydbio.2006.07.020; Caicedo A, 2013, SEMIN CELL DEV BIOL, V24, P11, DOI 10.1016/j.semcdb.2012.09.007; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cervantes S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11691-2; Cox AR, 2017, DIABETES, V66, P2738, DOI 10.2337/dbi17-0036; Davidson RK., 2021, ENDOCRINOLOGY, V162, P1; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Ediger BN, 2017, J CLIN INVEST, V127, P215, DOI 10.1172/JCI88016; Galloway JR, 2015, MOL ENDOCRINOL, V29, P1774, DOI 10.1210/me.2015-1165; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gerace D, 2015, GENE THER, V22, P1, DOI 10.1038/gt.2014.93; GERMAN MS, 1994, GENOMICS, V24, P403, DOI 10.1006/geno.1994.1639; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gribben C, 2021, CELL STEM CELL, V28, P2000, DOI 10.1016/j.stem.2021.08.003; Gromada J, 2018, NAT REV ENDOCRINOL, V14, P694, DOI 10.1038/s41574-018-0097-y; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Helman A, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a03.5741; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hunter CS, 2013, DIABETES, V62, P875, DOI 10.2337/db12-0952; Iannotti CA, 1997, GENOMICS, V46, P520, DOI 10.1006/geno.1997.5075; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kropp PA, 2019, CELL MOL GASTROENTER, V7, P841, DOI 10.1016/j.jcmgh.2019.02.004; Loyd C, 2017, ENDOCRINOLOGY, V158, P1289, DOI 10.1210/en.2016-1791; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; McKenna B, 2015, CELL REP, V10, P2032, DOI 10.1016/j.celrep.2015.02.054; Melton D, 2021, DIABETOLOGIA, V64, P1030, DOI 10.1007/s00125-020-05367-2; Memon B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020283; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rodriguez-Diaz R, 2018, CELL METAB, V27, P549, DOI 10.1016/j.cmet.2018.01.015; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Scoville DW, 2015, DIABETES, V64, P3772, DOI 10.2337/db15-0281; Sharon N, 2019, CELL, V176, P790, DOI 10.1016/j.cell.2018.12.003; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Spaeth JM, 2016, DIABETES OBES METAB, V18, P123, DOI 10.1111/dom.12730; Spaeth JM, 2019, DIABETES, V68, P1806, DOI 10.2337/db19-0349; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Toren E, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.756548; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; van der Meulen T, 2017, CELL METAB, V25, P911, DOI 10.1016/j.cmet.2017.03.017; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Vanhoose AM, 2008, J BIOL CHEM, V283, P22612, DOI 10.1074/jbc.M802902200; Wade AK, 2019, J BIOL CHEM, V294, P11728, DOI 10.1074/jbc.RA118.006985; Xavier GD, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030054; Yang X, 2021, BIORXIV, DOI 10.16.464644v1; Yang YP, 2017, DEVELOPMENT, V144, P248, DOI 10.1242/dev.143123; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	70	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22460	10.1096/fj.202200410R	http://dx.doi.org/10.1096/fj.202200410R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3E5YA	35881062				2022-12-28	WOS:000830058000001
J	Duan, ZW; Chen, Y; Ye, ML; Xiao, LJ; Chen, YX; Cao, YP; Peng, Y; Zhang, JL; Zhang, Y; Yang, T; Liu, WP; Feng, SY; Hu, JD				Duan, Zhengwei; Chen, Yang; Ye, Minlu; Xiao, Lijing; Chen, Yanxin; Cao, Yingping; Peng, Yi; Zhang, Jingling; Zhang, Yu; Yang, Ting; Liu, Wuping; Feng, Shangyuan; Hu, Jianda			Differentiation and prognostic stratification of acute myeloid leukemia by serum-based spectroscopy coupling with metabolic fingerprints	FASEB JOURNAL			English	Article						acute myeloid leukemia; metabolic profiling; nuclear magnetic resonance; prognosis; surface-enhanced Raman scattering	RAMAN-SPECTROSCOPY; CLASSIFICATION; CARCINOMA; DIAGNOSIS; CANCER	Acute myeloid leukemia (AML) is a heterogeneous disease characterized by complex molecular and cytogenetic abnormalities. New approaches to predict the prognosis of AML have increasingly attracted attention. There were 98 non-M3 AML cases and 48 healthy controls were enrolled in the current work. Clinically routine assays for cytogenetic and molecular genetic analyses were performed on the bone marrow samples of patients with AML. Meanwhile, metabolic profiling of these AML subjects was also performed on the serum samples by combining Ag nanoparticle-based surface-enhanced Raman spectroscopy (SERS) with proton nuclear magnetic resonance (NMR) spectroscopy. Although most of the routine biochemical test showed no significant differences between the M0-M2 and M5 groups, the metabolic profiles were significantly different either between AML subtypes or between prognostic risk subgroups. Specific SERS bands were screened to serve as potential markers for AML subtypes. The results demonstrated that the classification models for M0-M2 and M5 shared two bands (i.e., 1328 and 741 cm(-1)), all came from nucleic acid signals. Furthermore, Metabolic profiles provided various differential metabolites responsible for different AML subtypes, and we found altered pathways mainly included energy metabolism like glycolysis, pyruvate metabolism, and metabolisms of nucleic acid bases as well as specific amino acid metabolisms. It is concluded that integration of SERS and NMR provides the rational and could be reliable to reveal AML differentiation, and meanwhile lay the basis for experimental and clinical practice to monitor disease progression and prognostic evaluation.	[Duan, Zhengwei; Chen, Yang; Ye, Minlu; Xiao, Lijing; Hu, Jianda] Fujian Med Univ, Dept Lab Med, Fuzhou 350004, Peoples R China; [Chen, Yanxin; Zhang, Yu; Yang, Ting; Hu, Jianda] Fujian Med Univ, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, Union Hosp, Fuzhou, Peoples R China; [Cao, Yingping; Zhang, Jingling] Fujian Med Univ, Dept Clin Lab, Union Hosp, Fuzhou, Peoples R China; [Peng, Yi] Fujian Med Univ, Dept Ophthalmol & Optometry, Fuzhou, Peoples R China; [Liu, Wuping] Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, Xiamen, Peoples R China; [Feng, Shangyuan] Fujian Normal Univ, Fujian Prov Key Lab Photon Technol, Key Lab Optoelect Sci & Technol Med, Minist Educ, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Xiamen University; Fujian Normal University	Chen, Y (corresponding author), Fujian Med Univ, Dept Lab Med, Fuzhou 350004, Peoples R China.; Hu, JD (corresponding author), Fujian Med Univ, Union Hosp, Fuzhou 350001, Peoples R China.	chzhy85@fjmu.edu.cn; drjiandahu@163.com	Peng, Yiru/HGE-1178-2022	Duan, Zhengwei/0000-0003-3571-2051	National Natural Science Foundation of China (NSFC) [61975031]; Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation) [2020J01651, 2021J011005]; Joint Funds for the Innovation of Science and Technology of Fujian Province [2020Y9034]; Product-University Cooperation Project of Fujian Province [2020Y4006]; Medical Innovation Project of Fujian Provincial Health Commission [2019-CX-35]; Open Fund of Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance (Xiamen University) [20191203]; Innovation and Entrepreneurship Training Program for Undergraduates of Fujian Medical University [C21134]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation); Joint Funds for the Innovation of Science and Technology of Fujian Province; Product-University Cooperation Project of Fujian Province; Medical Innovation Project of Fujian Provincial Health Commission; Open Fund of Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance (Xiamen University); Innovation and Entrepreneurship Training Program for Undergraduates of Fujian Medical University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 61975031; Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation), Grant/Award Number: 2020J01651 and 2021J011005; Joint Funds for the Innovation of Science and Technology of Fujian Province, Grant/Award Number: 2020Y9034; Product--University Cooperation Project of Fujian Province, Grant/Award Number: 2020Y4006; Medical Innovation Project of Fujian Provincial Health Commission, Grant/Award Number: 2019-CX-35; Open Fund of Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance (Xiamen University), Grant/Award Number: 20191203; Innovation and Entrepreneurship Training Program for Undergraduates of Fujian Medical University, Grant/Award Number: C21134	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Assi SA, 2019, NAT GENET, V51, P151, DOI 10.1038/s41588-018-0270-1; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bonifacio A, 2014, ANAL BIOANAL CHEM, V406, P2355, DOI 10.1007/s00216-014-7622-1; Carrabba MG, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0346-2; Chen Y, 2021, BIOMED OPT EXPRESS, V12, P2221, DOI 10.1364/BOE.419716; Chen Y, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000103; Chen Y, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0759-4; Delgado-Lista J, 2013, NUTR METAB CARDIOVAS, V23, P417, DOI 10.1016/j.numecd.2011.09.008; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Earl DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02470-8; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Fenouille N, 2017, NAT MED, V23, P301, DOI 10.1038/nm.4283; Kohrogi K, 2021, BLOOD ADV, V5, P2305, DOI 10.1182/bloodadvances.2020003521; Leopold N, 2003, J PHYS CHEM B, V107, P5723, DOI 10.1021/jp027460u; Li HM, 2021, BIOSENS BIOELECTRON, V189, DOI 10.1016/j.bios.2021.113315; Lo Presti C, 2021, BLOOD ADV, V5, P156, DOI 10.1182/bloodadvances.2020002981; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Mi JQ, 2012, LEUKEMIA, V26, P1743, DOI 10.1038/leu.2012.57; Musharraf SG, 2017, HEMATOL ONCOL, V35, P769, DOI 10.1002/hon.2313; Musharraf SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep30693; Nguyen CT, 2010, CANCER LETT, V292, P91, DOI 10.1016/j.canlet.2009.11.011; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Peterson JF, 2019, GENE CHROMOSOME CANC, V58, P567, DOI 10.1002/gcc.22741; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Shallis RM, 2019, BLOOD REV, V36, P70, DOI 10.1016/j.blre.2019.04.005; Shlush LI, 2017, NATURE, V547, P104, DOI 10.1038/nature22993; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Tallman MS, 2019, J NATL COMPR CANC NE, V17, P721, DOI 10.6004/jnccn.2019.0028; Wang D, 2019, J PHARMACEUT BIOMED, V166, P357, DOI 10.1016/j.jpba.2019.01.022; Wang YH, 2013, J PROTEOME RES, V12, P4393, DOI 10.1021/pr400403p; Wang YJ, 2019, NANOSCALE, V11, P2460, DOI 10.1039/c8nr06929h; Wang YJ, 2018, ACS APPL MATER INTER, V10, P24999, DOI 10.1021/acsami.8b02917; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wen SP, 2018, BIOSENS BIOELECTRON, V117, P260, DOI 10.1016/j.bios.2018.06.001; Wen XN, 2020, CHEM SCI, V11, P9863, DOI 10.1039/d0sc02221g; Xia L, 2021, NANOMED-NANOTECHNOL, V32, DOI 10.1016/j.nano.2020.102328	38	0	0	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22416	10.1096/fj.202200487R	http://dx.doi.org/10.1096/fj.202200487R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2E6JE	35713583				2022-12-28	WOS:000812332400001
J	Ho, WT; Chang, JS; Chen, TC; Wang, JK; Chang, SW; Yang, MH; Jou, TS; Wang, IJ				Ho, Wei-Ting; Chang, Jung-Shen; Chen, Tsan-Chi; Wang, Jia-Kang; Chang, Shu-Wen; Yang, Muh-Hwa; Jou, Tzuu-Shuh; Wang, I-Jong			Inhibition of Rho-associated protein kinase activity enhances oxidative phosphorylation to support corneal endothelial cell migration	FASEB JOURNAL			English	Article						AMP-activated protein kinase; cell migration; corneal endothelial cell; mitochondria; oxidative phosphorylation; rho-associated protein kinase	ROCK INHIBITOR; DESCEMETORHEXIS; TRANSPLANTATION; LAMELLIPODIUM; KERATOPLASTY; RIPASUDIL; TURNOVER; SURVIVAL; MOTILITY; STRESS	Corneal endothelial cell (CEC) dysfunction causes corneal edema and severe visual impairment that require transplantation to restore vision. To address the unmet need of organ shortage, descemetorhexis without endothelial keratoplasty has been specifically employed to treat early stage Fuchs endothelial corneal dystrophy, which is pathophysiologically related to oxidative stress and exhibits centrally located corneal guttae. After stripping off central Descemet's membrane, rho-associated protein kinase (ROCK) inhibitor has been found to facilitate CEC migration, an energy-demanding task, thereby achieving wound closure. However, the correlation between ROCK inhibition and the change in bioenergetic status of CECs remained to be elucidated. Through transcriptomic profiling, we found that the inhibition of ROCK activity by the selective inhibitor, ripasudil or Y27632, promoted enrichment of oxidative phosphorylation (OXPHOS) gene set in bovine CECs (BCECs). Functional analysis revealed that ripasudil, a clinically approved anti-glaucoma agent, enhanced mitochondrial respiration, increased spare respiratory capacity, and induced overexpression of electron transport chain components through upregulation of AMP-activated protein kinase (AMPK) pathway. Accelerated BCEC migration and in vitro wound healing by ripasudil were diminished by OXPHOS and AMPK inhibition, but not by glycolysis inhibition. Correspondingly, lamellipodial protrusion and actin assembly that were augmented by ripasudil became reduced with additional OXPHOS or AMPK inhibition. These results indicate that ROCK inhibition induces metabolic reprogramming toward OXPHOS to support migration of CECs.	[Ho, Wei-Ting; Chen, Tsan-Chi; Wang, Jia-Kang; Chang, Shu-Wen] Far Eastern Mem Hosp, Dept Ophthalmol, New Taipei, Taiwan; [Ho, Wei-Ting] Natl Yang Ming Chiao Tung Univ, Sch Med, Hsinchu, Taiwan; [Chang, Jung-Shen; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, Jia-Kang] Yuan Ze Univ, Dept Elect Engn, Taoyuan, Taiwan; [Chang, Shu-Wen; Jou, Tzuu-Shuh; Wang, I-Jong] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Hsinchu, Taiwan; [Yang, Muh-Hwa] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan; [Jou, Tzuu-Shuh] Natl Taiwan Univ, Coll Med, Ctr Precis Med, Taipei, Taiwan; [Jou, Tzuu-Shuh] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Yuan Ze University; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University	Jou, TS; Wang, IJ (corresponding author), 7 Chung Shan S Rd, Taipei, Taiwan.	jouts@ntu.edu.tw; ijong@ms8.hinet.net	Chen, Tsan-Chi/E-7758-2010	Chen, Tsan-Chi/0000-0001-5221-9707; JOU, TZUU-SHUH/0000-0003-4341-5137; Wang, I-Jong/0000-0002-3045-0614	Ministry of Science and Technology, Taiwan (MOST) [109-2314-B-418-006-MY3, 110-2634-F-002-044]; Far Eastern Memorial Hospital (FEMH) [109-FTN14, 109DN31, 110DN35]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Far Eastern Memorial Hospital (FEMH)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 109-2314-B-418-006-MY3 and 110-2634-F-002-044; Far Eastern Memorial Hospital (FEMH), Grant/ Award Number: 109-FTN14, 109DN31 and 110DN35	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bhogal M, 2017, INVEST OPHTH VIS SCI, V58, P4249, DOI 10.1167/iovs.17-22106; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Carbognin E, 2016, EMBO J, V35, P618, DOI 10.15252/embj.201592629; Davies E, 2021, CORNEA, V40, P899, DOI 10.1097/ICO.0000000000002691; Denisenko TV, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00355; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Flamholz A, 2014, MOL BIOL CELL, V25, P3497, DOI 10.1091/mbc.E14-09-1347; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Ho WT, 2019, J MOL MED, V97, P1345, DOI 10.1007/s00109-019-01818-5; Huang H, 2018, J CLIN INVEST, V128, P5335, DOI 10.1172/JCI63562; ICHIJIMA H, 1993, INVEST OPHTH VIS SCI, V34, P2803; Joyce NC, 2009, INVEST OPHTH VIS SCI, V50, P2116, DOI 10.1167/iovs.08-3007; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kinoshita S, 2018, NEW ENGL J MED, V378, P995, DOI 10.1056/NEJMoa1712770; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Koenig SB, 2015, CORNEA, V34, P1149, DOI 10.1097/ICO.0000000000000531; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Marchetti P, 2020, FASEB J, V34, P13106, DOI 10.1096/fj.202000767R; Moloney G, 2017, CORNEA, V36, P642, DOI 10.1097/ICO.0000000000001209; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; Nie K, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0231-2; Noda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110446; Numa K, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.14.10; Numa K, 2021, OPHTHALMOLOGY, V128, P504, DOI 10.1016/j.ophtha.2020.09.002; Okumura N, 2016, INVEST OPHTH VIS SCI, V57, P1284, DOI 10.1167/iovs.15-18586; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Price MO, 2021, PROG RETIN EYE RES, V82, DOI 10.1016/j.preteyeres.2020.100904; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schiffmann LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17472-2; Shiraishi T, 2015, ONCOTARGET, V6, P130, DOI 10.18632/oncotarget.2766; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith MB, 2013, BIOPHYS J, V104, P247, DOI 10.1016/j.bpj.2012.11.3819; Soh YQ, 2016, INVEST OPHTH VIS SCI, V57, P338, DOI 10.1167/iovs.15-18300; Street CA, 2011, ANTICANCER RES, V31, P3645; Tsygankov D, 2014, J CELL BIOL, V204, P443, DOI 10.1083/jcb.201306067; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Yamaguchi T, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz5195; Yao CH, 2019, ELIFE, V8, DOI 10.7554/eLife.41351; Zhou XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29669	49	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22397	10.1096/fj.202101442RR	http://dx.doi.org/10.1096/fj.202101442RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1V6ST	35661268				2022-12-28	WOS:000806217800001
J	Dasgupta, S; Saha, A; Ganguly, N; Bhuniya, A; Dhar, S; Guha, I; Ghosh, T; Sarkar, A; Ghosh, S; Roy, K; Das, T; Banerjee, S; Pal, C; Baral, R; Bose, A				Dasgupta, Shayani; Saha, Akata; Ganguly, Nilanjan; Bhuniya, Avishek; Dhar, Sukanya; Guha, Ipsita; Ghosh, Tithi; Sarkar, Anirban; Ghosh, Sarbari; Roy, Kamalika; Das, Tapasi; Banerjee, Saptak; Pal, Chiranjib; Baral, Rathindranath; Bose, Anamika			NLGP regulates RGS5-TGF beta axis to promote pericyte-dependent vascular normalization during restricted tumor growth	FASEB JOURNAL			English	Article						apoptosis; endothelial cells; pericytes; RGS5; TGF beta; tumor-microenvironment	T-CELLS; SUPPRESSION; EXPRESSION	Altered RGS5-associated intracellular pericyte signaling and its abnormal crosstalk with endothelial cells (ECs) result chaotic tumor-vasculature, prevent effective drug delivery, promote immune-evasion and many more to ensure ultimate tumor progression. Moreover, the frequency of lethal-RGS5(high) pericytes within tumor was found to increase with disease progression, which signifies the presence of altered cell death pathway within tumor microenvironment (TME). In this study, we checked whether and how neem leaf glycoprotein (NLGP)-immunotherapy-mediated tumor growth restriction is associated with modification of pericytes' signaling, functions and its interaction with ECs. Analysis of pericytes isolated from tumors of NLGP treated mice suggested that NLGP treatment promotes apoptosis of NG2(+)RGS5(high) -fuctionally altered pericytes by downregulating intra-tumoral TGF beta along with maintenance of more matured RGS5(neg) pericytes. NLGP-mediated inhibition of TGE beta within THE rescues binding of RGS5 with Gal and thereby termination of PI3K-AKT mediated survival signaling by downregulating Bcl2 and initiating pJNK mediated apoptosis. Limited availability of TGFP also prevents complex-formation between RGS5 and Smad2 and rapid RGS5 nuclear translocation to mitigate alternate immunoregulatory functions of RGS5(high) tumor-pericytes. We also observed binding of Ang1 from pericytes with Tie2 on ECs in NLGP-treated tumor, which support re-association of pericytes with endothelium and subsequent vessel stabilization. Furthermore, NLGP-therapy- associated RGS5 deficiency relieved CD4(+) and CD8(+) T cells from anergy by regulating 'alternate-APC-like' immunomodulatory characters of tumor-pericytes. Taken together, present study described the mechanisms of NLGP's effectiveness in normalizing tumor-vasculature by chiefly modulating pericyte-biology and EC-pericyte interactions in tumor-host to further strengthen its translational potential as single modality treatment.	[Dasgupta, Shayani; Saha, Akata; Ganguly, Nilanjan; Bhuniya, Avishek; Dhar, Sukanya; Guha, Ipsita; Ghosh, Tithi; Sarkar, Anirban; Ghosh, Sarbari; Das, Tapasi; Banerjee, Saptak; Baral, Rathindranath; Bose, Anamika] Chittaranjan Natl Canc Inst, Dept Immunoregulat & Immunodiagnost, Kolkata, India; [Roy, Kamalika; Pal, Chiranjib] West Bengal State Univ, Dept Zool, Cellular Immunol & Expt Therapeut Lab, Barasat, India	West Bengal State University	Bose, A (corresponding author), Chittaranjan Natl Canc Inst CNCI, Dept Immunoregulat & Immunodiagnost, 37 SP Mukherjee Rd, Kolkata 700026, India.	anamikabose2@gmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Bhuniya, Avishek/0000-0001-6253-0400; Pal, Chiranjib/0000-0002-0724-5292; Ganguly, Nilanjan/0000-0002-7260-1601	Department of Science and Technology, Government of India, New Delhi [SB/YS/LS-289/2013, SR/WOS-A/LS-152/2017]; Indian Council of Medical Research, New Delhi, India [2019-6410/CMB-BMS]; ICMR [61/1/2018-BMS]; DHR [R-12013/05/2018/HR]	Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); ICMR(Indian Council of Medical Research (ICMR)); DHR	In addition to institutional support, this study was supported by Department of Science and Technology, Government of India, New Delhi; Awards to AB, Grant number: SB/YS/LS-289/2013 and SR/WOS-A/LS-152/2017, Indian Council of Medical Research, New Delhi, India (F. No-2019-6410/CMB-BMS), ICMR grant no. 61/1/2018-BMS and DHR (File no. R-12013/05/2018/HR). These funding agencies had no role in study design, data collection and analysis, decision to publish, or the preparation of this manuscript. Funding includes fellowship to scholars and cost of reagents only	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Banerjee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110040; Barik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066501; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhuniya A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00201; Bose A, 2013, J IMMUNOL, V191, P971, DOI 10.4049/jimmunol.1300280; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Chakraborty T, 2012, INT IMMUNOPHARMACOL, V12, P326, DOI 10.1016/j.intimp.2011.12.002; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Das A, 2014, J IMMUNOTHER, V37, P394, DOI 10.1097/CJI.0000000000000050; Dasgupta S, 2021, CELL DEATH DIFFER, V28, P3052, DOI 10.1038/s41418-021-00801-3; Ghosh S, 2016, IMMUNOL LETT, V175, P31, DOI 10.1016/j.imlet.2016.05.004; Ghosh T, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1349-z; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Goswami KK, 2016, MOL IMMUNOL, V80, P1, DOI [10.1016/j.molimm.2016.10.008, 10.1016/j,molimm.2016.10.008]; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hao F, 2014, BBA-REV CANCER, V1846, P247, DOI 10.1016/j.bbcan.2014.07.002; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Mallick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047434; Manzur M, 2008, CELL CYCLE, V7, P2452, DOI 10.4161/cc.7.16.6451; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Neves KB, 2020, CLIN SCI, V134, P2503, DOI 10.1042/CS20200308; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Roy S, 2013, HUM IMMUNOL, V74, P1015, DOI 10.1016/j.humimm.2013.04.022; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Saha A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00260; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar M, 2021, MELANOMA RES, V31, P130, DOI 10.1097/CMR.0000000000000721; Sarkar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175540; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silini A, 2012, CELL MOL LIFE SCI, V69, P1167, DOI 10.1007/s00018-011-0862-8; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Thijssen VLJL, 2018, J PATHOL, V246, P447, DOI 10.1002/path.5152; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Tsioumpekou M, 2020, THERANOSTICS, V10, P1122, DOI 10.7150/thno.37851; Zhao X, 2011, MOL THER, V19, P805, DOI 10.1038/mt.2010.295; Zonneville J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4587-z	45	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22268	10.1096/fj.202101093R	http://dx.doi.org/10.1096/fj.202101093R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E5BA	35363396				2022-12-28	WOS:000776695700001
J	Chau, DDL; Li, W; Chan, WWR; Sun, JKL; Zhai, YQ; Chow, HM; Lau, KF				Chau, Dennis Dik-Long; Li, Wen; Chan, Wai Wa Ray; Sun, Jacquelyne Ka-Li; Zhai, Yuqi; Chow, Hei-Man; Lau, Kwok-Fai			Insulin stimulates atypical protein kinase C-mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6-Rac1 signaling	FASEB JOURNAL			English	Article						ADP ribosylation factor 6; amyloid-beta A4 precursor protein-binding family B member 1; insulin; neurite outgrowth	AMYLOID PRECURSOR PROTEIN; RIBOSYLATION FACTOR 6; GROWTH-FACTOR EXPRESSION; ALZHEIMERS-DISEASE; CELL-PROLIFERATION; SKELETAL-MUSCLE; FACTOR-I; RAC1; PKC; RESISTANCE	Neurite outgrowth is a fundamental process in neurons that produces extensions and, consequently, neural connectivity. Neurite damage and atrophy are observed in various brain injuries and disorders. Understanding the intrinsic pathways of neurite outgrowth is essential for developing strategies to stimulate neurite regeneration. Insulin is a pivotal hormone in the regulation of glucose homeostasis. There is increasing evidence for the neurotrophic functions of insulin, including the induction of neurite outgrowth. However, the associated mechanism remains elusive. Here, we demonstrate that insulin potentiates neurite outgrowth mediated by the small GTPases ADP-ribosylation factor 6 (ARF6) and Ras-related C3 botulinum toxin substrate 1 (Rac1) through the neuronal adaptor FE65. Moreover, insulin enhances atypical protein kinase C-l/lambda (PKCl/lambda) activation and FE65 phosphorylation at serine 459 (S459) in neurons and mouse brains. In vitro and cellular assays show that PKCl/lambda phosphorylated FE65 at S459. Consistently, insulin potentiates FE65 S459 phosphorylation only in the presence of PKCl/lambda. Phosphomimetic studies show that an FE65 S459E mutant potently activates ARF6, Rac1, and neurite outgrowth. Notably, this phosphomimetic mutation enhances the FE65-ARF6 interaction, a process that promotes ARF6-Rac1-mediated neurite outgrowth. Likewise, insulin treatment and PKCl/lambda overexpression potentiate the FE65-ARF6 interaction. Conversely, PKCl/lambda knockdown suppresses the stimulatory effect of FE65 on ARF6-Rac1-mediated neurite outgrowth. The effect of insulin on neurite outgrowth is also markedly attenuated in PKCl/lambda knockdown neurons, in the presence and absence of FE65. Our findings reveal a novel mechanism linking insulin with ARF6-Rac1-dependent neurite extension through the PKCl/lambda-mediated phosphorylation of FE65.	[Chau, Dennis Dik-Long; Li, Wen; Chan, Wai Wa Ray; Sun, Jacquelyne Ka-Li; Zhai, Yuqi; Chow, Hei-Man; Lau, Kwok-Fai] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China; [Li, Wen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Lab Biomed Opt & Mol Imaging, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Lau, KF (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk		Lau, Kwok-Fai/0000-0002-0193-1152	Faculty of Science, Chinese University of Hong Kong; Health and Medical Research Fund; Research Grants Council, University Grants Committee; TUYF Charitable Trust; United college endowment fund	Faculty of Science, Chinese University of Hong Kong; Health and Medical Research Fund; Research Grants Council, University Grants Committee; TUYF Charitable Trust; United college endowment fund	Faculty of Science, Chinese University of Hong Kong; Health and Medical Research Fund; Research Grants Council, University Grants Committee; TUYF Charitable Trust; United college endowment fund	ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; Agostinone J, 2018, BRAIN, V141, P1963, DOI 10.1093/brain/awy142; Apostolatos AH, 2018, INT J ONCOL, V53, P1836, DOI 10.3892/ijo.2018.4542; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Augustin V, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071599; Bandyopadhyay G, 2004, MOL ENDOCRINOL, V18, P373, DOI 10.1210/me.2003-0087; Bazenet CE, 1998, P NATL ACAD SCI USA, V95, P3984, DOI 10.1073/pnas.95.7.3984; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Chan WWR, 2020, FASEB J, V34, P16397, DOI 10.1096/fj.202001703R; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Chow WNV, 2015, CELL MOL BIOL LETT, V20, P66, DOI 10.1515/cmble-2015-0002; COLEMAN ES, 1994, J MOL NEUROSCI, V5, P39, DOI 10.1007/BF02736693; Doonachar Alana, 2014, Cellbio (Irvine, Calif), V3, P1; Farese RV, 2005, EXP BIOL MED, V230, P593; FERNYHOUGH P, 1989, MOL BRAIN RES, V6, P109, DOI 10.1016/0169-328X(89)90044-2; FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F; Fine JM, 2020, NEUROSCI LETT, V714, DOI 10.1016/j.neulet.2019.134567; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Greer YE, 2013, J BIOL CHEM, V288, P9438, DOI 10.1074/jbc.M112.448282; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hogg E, 2018, J PARKINSON DIS, V8, P259, DOI 10.3233/JPD-181305; Hou YL, 2004, CELL SIGNAL, V16, P1061, DOI 10.1016/j.cellsig.2004.03.002; Jiang H, 2005, NAT NEUROSCI, V8, P544, DOI 10.1038/nn0505-544; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim H, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0284-5; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Langlands H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155056; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Lazar BA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00732; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li W, 2018, J BIOL CHEM, V293, P7674, DOI 10.1074/jbc.RA117.000505; Liu Y, 2013, NEUROSCIENCE, V238, P371, DOI 10.1016/j.neuroscience.2013.01.034; Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Millar CA, 1999, J BIOL CHEM, V274, P17619, DOI 10.1074/jbc.274.25.17619; Moore P, 1998, NEUROSCI LETT, V254, P29, DOI 10.1016/S0304-3940(98)00653-3; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Novak P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214364; Nozaki S, 2013, CELL SIGNAL, V25, P1361, DOI 10.1016/j.cellsig.2013.02.023; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Pang Y, 2016, NEUROSCIENCE, V318, P157, DOI 10.1016/j.neuroscience.2016.01.020; Parker SS, 2013, P NATL ACAD SCI USA, V110, P14450, DOI 10.1073/pnas.1301588110; Pearl LH, 2002, CURR OPIN STRUC BIOL, V12, P761, DOI 10.1016/S0959-440X(02)00386-X; Porton B, 2003, NEUROSIGNALS, V12, P45, DOI 10.1159/000068916; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratnayake WS, 2017, INT J ONCOL, V51, P1370, DOI 10.3892/ijo.2017.4131; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Reina-Campos M, 2019, CANCER CELL, V36, P218, DOI 10.1016/j.ccell.2019.07.010; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salameh TS, 2015, J ALZHEIMERS DIS, V47, P715, DOI 10.3233/JAD-150307; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; Senger DL, 2002, CANCER RES, V62, P2131; Shao CY, 2006, J NEUROPATH EXP NEUR, V65, P327, DOI 10.1097/01.jnen.0000218441.00040.82; Shaughness M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.547175; Shome K, 1997, CURR BIOL, V7, P387, DOI 10.1016/S0960-9822(06)00186-2; Singh Vikash, 2019, Small GTPases, V10, P411, DOI 10.1080/21541248.2017.1329691; Soto M, 2019, P NATL ACAD SCI USA, V116, P6379, DOI 10.1073/pnas.1817391116; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standen CL, 2003, MOL CELL NEUROSCI, V24, P851, DOI 10.1016/j.mcn.2003.07.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Takenaka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215443; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tonucci FM, 2019, CANCER LETT, V461, P65, DOI 10.1016/j.canlet.2019.07.006; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Van Acker T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092209; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Xu QG, 2004, EXP NEUROL, V188, P43, DOI 10.1016/j.expneurol.2004.03.008; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297	84	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22594	10.1096/fj.202200757R	http://dx.doi.org/10.1096/fj.202200757R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5I8EK	36250347				2022-12-28	WOS:000868583200001
J	Bretes, E; Wroblewski, J; Wyszczelska-Rokiel, M; Jakubowski, H				Bretes, Ewa; Wroblewski, Jacek; Wyszczelska-Rokiel, Monika; Jakubowski, Hieronim			Cystathionine beta-synthase gene inactivation dysregulates major urinary protein biogenesis and impairs sexual signaling in mice	FASEB JOURNAL			English	Article							N-HOMOCYSTEINYLATION; EXPRESSION; DEFICIENT; FOLATE; MODELS	Reproductive success in mice depends on sexually dimorphic major urinary proteins (Mup) that facilitate interactions between females and males. Deletion of cystathionine beta-synthase (Cbs) gene, a metabolic gene important for homeostasis of one-carbon metabolism, impairs reproduction by causing female infertility in mice. Here, we examined Mup biogenesis and sexual signaling in Cbs(-/-) versus Cbs(+/-) mice. We found significantly reduced levels of total urinary Mup protein in male and female Cbs(-/-) versus Cbs(+/-) mice. SDS-PAGE/Western blot, ESI-MS, and RT-qPCR analyses of the liver, plasma, and urinary proteins identified a male-specific Mup20 in Cbs(-/-), but not in Cbs(+/-) females. The 18 893 Da Mup20 became the most abundant in urine of Cbs(-/-) females and males. Effects of Cbs genotype on 18 645 Da, 18 693 Da, and 18 709 Da Mup species abundance were Mup- and sex-specific. Cbs genotype-dependent changes in hepatic Mups and Mup20 expression were similar at the protein and mRNA level. Changes in Mups, but not in Mup20, can be explained by downregulation of hepatic Zhx2 and Ghr receptors in Cbs(-/-) mice. Behavioral testing showed that Cbs(+/-) females ignored Cbs(-/-) male urine but were attracted to Cbs(+/-) male urine. Cbs(+/-) males ignored urine of Cbs(-/-) males but countermarked urine of other Cbs(+/-) males and were attracted to urines of Cbs(-/-) as well as Cbs(+/-) females. Cbs(-/-) males did not countermark urine of Cbs(+/-) males but were attracted to urines of Cbs(+/-) females. Taken together, these findings show that Cbs, a metabolic gene, interacts with the processes involved in Mup biogenesis that are essential for the maintenance of sexual dimorphism and signaling and suggest that dysregulation of these interactions impairs reproductive fitness in mice.	[Bretes, Ewa; Wroblewski, Jacek; Jakubowski, Hieronim] Poznan Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland; [Wroblewski, Jacek] Inst Bioorgan Chem, Poznan, Poland; [Wyszczelska-Rokiel, Monika; Jakubowski, Hieronim] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Int Ctr Publ Hlth, Newark, NJ USA	Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wroblewski, J (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Int Ctr Publ & Lealth, 225 Warren St, Newark, NJ 07103 USA.	jakubows@rutgers.edu	Bretes, Ewa/AAN-9419-2021	Bretes, Ewa/0000-0001-9218-385X	Narodowe Centrum Nauki (NCN) [2019/33/B/NZ4/01760, 2018/29/B/NZ4/00771, 2016/23/B/NZ5/00573, 2014/15/N/NZ5/01646]	Narodowe Centrum Nauki (NCN)(National Science Centre, Poland)	Narodowe Centrum Nauki (NCN), Grant/Award Number: 2019/33/B/NZ4/01760, 2018/29/B/NZ4/00771, 2016/23/B/NZ5/00573 and 2014/15/N/NZ5/01646	Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bossenmeyer-Pourie C, 2019, J PATHOL, V248, P291, DOI 10.1002/path.5254; Cavaggioni A, 2003, CHEM SENSES, V28, P791, DOI 10.1093/chemse/bjg073; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Connerney J, 2017, ENDOCRINOLOGY, V158, P1386, DOI 10.1210/en.2017-00060; CONSTANTINE G, 1987, BRIT J OBSTET GYNAEC, V94, P803, DOI 10.1111/j.1471-0528.1987.tb03732.x; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Jakubowski H, 2020, EXPERT REV PROTEOMIC, V17, P751, DOI 10.1080/14789450.2020.1865160; Jakubowski H, 2019, TRENDS CANCER, V5, P7, DOI 10.1016/j.trecan.2018.10.006; Jakubowski H, 2019, PHYSIOL REV, V99, P555, DOI 10.1152/physrev.00003.2018; Jiang JY, 2017, J BIOL CHEM, V292, P6765, DOI 10.1074/jbc.M116.768275; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Lehmann ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069822; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15548; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Martin-Sanchez A, 2015, HORM BEHAV, V68, P65, DOI 10.1016/j.yhbeh.2014.08.007; Mei XY, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201809469; MEJBAUMKATZENELLENBOGEN W, 1955, ACTA BIOCHIM POL, V2, P279; Nuno-Ayala M, 2012, PHYSIOL GENOMICS, V44, P702, DOI 10.1152/physiolgenomics.00189.2010; Penn DJ, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.822073; Perla-Kajan J, 2016, FASEB J, V30, P3810, DOI 10.1096/fj.201600539; Qin WY, 2022, J CLIN LAB ANAL, V36, DOI 10.1002/jcla.24312; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Smith AD, 2021, J INTERN MED, V290, P826, DOI 10.1111/joim.13279; Wang D, 2018, CELL REP, V25, P398, DOI 10.1016/j.celrep.2018.09.022; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wu LL, 2002, CLIN CHIM ACTA, V322, P21, DOI 10.1016/S0009-8981(02)00174-2; Xu QH, 2022, BMC PREGNANCY CHILDB, V22, DOI 10.1186/s12884-022-04491-8	33	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22547	10.1096/fj.202200969R	http://dx.doi.org/10.1096/fj.202200969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M9MT	36098436	Green Submitted			2022-12-28	WOS:000853643000001
J	Hollosi, A; Paszty, K; Bunta, BL; Bozo, T; Kellermayer, M; Debreczeni, ML; Cervenak, L; Baccarini, M; Varga, A				Hollosi, Anna; Paszty, Katalin; Bunta, Balint Levente; Bozo, Tamas; Kellermayer, Miklos; Debreczeni, Marta Lidia; Cervenak, Laszlo; Baccarini, Manuela; Varga, Andrea			BRAF increases endothelial cell stiffness through reorganization of the actin cytoskeleton	FASEB JOURNAL			English	Article						actin cytoskeleton; atomic force microscopy; BRAF RNAi; endothelial monolayer; intercellular gaps; permeability	ATOMIC-FORCE MICROSCOPY; STRESS FIBERS; B-RAF; PERMEABILITY; DYNAMICS; ACTIVATION; MECHANICS; MIGRATION; BINDING; ROLES	The dynamics of the actin cytoskeleton and its connection to endothelial cell-cell junctions determine the barrier function of endothelial cells. The proper regulation of barrier opening/closing is necessary for the normal function of vessels, and its dysregulation can result in chronic and acute inflammation leading to edema formation. By using atomic force microscopy, we show here that thrombin-induced permeability of human umbilical vein endothelial cells, associated with actin stress fiber formation, stiffens the cell center. The depletion of the MEK/ERK kinase BRAF reduces thrombin-induced permeability prevents stress fiber formation and cell stiffening. The peripheral actin ring becomes stabilized by phosphorylated myosin light chain, while cofilin is excluded from the cell periphery. All these changes can be reverted by the inhibition of ROCK, but not of the MEK/ERK module. We propose that the balance between the binding of cofilin and myosin to F-actin in the cell periphery, which is regulated by the activity of ROCK, determines the local dynamics of actin reorganization, ultimately driving or preventing stress fiber formation.	[Hollosi, Anna; Paszty, Katalin; Bunta, Balint Levente; Bozo, Tamas; Kellermayer, Miklos; Varga, Andrea] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Debreczeni, Marta Lidia; Cervenak, Laszlo] Semmelweis Univ, Dept Internal Med & Haematol, Budapest, Hungary; [Baccarini, Manuela] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max Perutz Labs, Vienna, Austria	Semmelweis University; Semmelweis University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Varga, A (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	matkovicsne.andrea@med.semmelweis-univ.hu	Varga, Andrea/B-2759-2019	Varga, Andrea/0000-0002-9076-7007	European Joint Programme on Rare Diseases [PredACTINg EJPRD 19-033]; Hungarian Science Foundation [FK132144, K135360]; Ministry for Innovation and Technology [UNKP19-4]; Hungarian Academy of Sciences; Semmelweis University	European Joint Programme on Rare Diseases; Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministry for Innovation and Technology; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Semmelweis University	European Joint Programme on Rare Diseases, Grant/Award Number: PredACTINg EJPRD 19-033; Hungarian Science Foundation, Grant/Award Number: FK132144 and K135360; Ministry for Innovation and Technology, Grant/Award Number: UNKP19-4 New National Excellence Program; Hungarian Academy of Sciences, Grant/Award Number: Bolyai Janos Fellow ship; Semmelweis University, Grant/Award Number: Start-upgrant	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Bleicher P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62942-8; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Claesson-Welsh L, 2021, TRENDS MOL MED, V27, P314, DOI 10.1016/j.molmed.2020.11.006; Codan B, 2013, MAT SCI ENG C-MATER, V33, P3303, DOI 10.1016/j.msec.2013.04.009; Debreczeni ML, 2021, CLIN REV ALLERG IMMU, V60, P318, DOI 10.1007/s12016-021-08851-8; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dorard C, 2019, FEBS J, V286, P2277, DOI 10.1111/febs.14802; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Gavara N, 2016, BIOMECH MODEL MECHAN, V15, P511, DOI 10.1007/s10237-015-0706-9; Grimm KB, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/21/215101; Gronloh MLB, 2021, J CELL SCI, V134, DOI 10.1242/jcs.255653; Gunduz D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01387; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Hino N, 2020, DEV CELL, V53, P646, DOI 10.1016/j.devcel.2020.05.011; Hirano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20989; Hollosi A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168989; Kassianidou E, 2017, MOL BIOL CELL, V28, P3832, DOI 10.1091/mbc.E17-06-0401; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kazakova OA, 2020, BIOCHIMIE, V168, P83, DOI 10.1016/j.biochi.2019.10.010; Kellermayer MSZ, 2006, BIOPHYS J, V91, P2665, DOI 10.1529/biophysj.106.085456; Kern F, 2013, ONCOGENE, V32, P2483, DOI 10.1038/onc.2012.254; Kim SO, 2017, NANO CONVERG, V4, DOI 10.1186/s40580-017-0099-9; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Schaefer A, 2015, J CELL SCI, V128, P2221, DOI 10.1242/jcs.163055; Schaefer A, 2014, J CELL SCI, V127, P4470, DOI 10.1242/jcs.154708; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Valent ET, 2016, EXP CELL RES, V347, P161, DOI 10.1016/j.yexcr.2016.07.029; van Buul Jaap D, 2016, Small GTPases, V7, P21, DOI 10.1080/21541248.2015.1131802; van Steen ACI, 2020, ATHEROSCLEROSIS, V315, P102, DOI 10.1016/j.atherosclerosis.2020.06.004; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wettschureck N, 2019, PHYSIOL REV, V99, P1467, DOI 10.1152/physrev.00037.2018; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Wimmer R, 2012, DEV CELL, V22, P158, DOI 10.1016/j.devcel.2011.11.012; Yao Z, 2019, NAT MED, V25, P284, DOI 10.1038/s41591-018-0274-5; Zhang P, 2016, J BIOL CHEM, V291, P2087, DOI 10.1074/jbc.M115.696419	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22478	10.1096/fj.202200344R	http://dx.doi.org/10.1096/fj.202200344R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3L4XK	35916021	Green Accepted			2022-12-28	WOS:000834765100001
J	Ma, YX; Zhang, HF; Guo, WY; Yu, L				Ma, Yunxiao; Zhang, Haifeng; Guo, Weiying; Yu, Lu			Potential role of ghrelin in the regulation of inflammation	FASEB JOURNAL			English	Review						disease; ghrelin; GHS-R1a; inflammation; NF-kappa B	INDUCED LUNG INJURY; ACUTE KIDNEY INJURY; DES-ACYL GHRELIN; NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL INJURY; INDUCED APOPTOSIS; RECEPTOR; LIVER; PATHWAY	Several diseases are caused or progress due to inflammation. In the past few years, accumulating evidence suggests that ghrelin, a gastric hormone of 28-amino acid residue length, exerts protective effects against inflammation by modulating the related pathways. This review focuses on ghrelin's anti-inflammatory and potential therapeutic effects in neurological, cardiovascular, respiratory, hepatic, gastrointestinal, and kidney disorders. Ghrelin significantly alleviates excessive inflammation and reduces damage to different target organs mainly by reducing the secretion of inflammatory cytokines, including interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), and tumor necrosis factor-alpha (TNF-alpha), and inhibiting the nuclear factor kappa-B (NF-kappa B) and NLRP3 inflammasome signaling pathways. Ghrelin also regulates inflammation and apoptosis through the p38 MAPK/c-Jun N-terminal kinase (JNK) signaling pathway; restores cerebral microvascular integrity, and attenuates vascular leakage. Ghrelin activates the phosphoInositide-3 kinase (PI3K)/protein kinase B (Akt) pathway and inhibits inflammatory responses in cardiovascular diseases and acute kidney injury. Some studies show that ghrelin exacerbates colonic and intestinal manifestations of colitis. Interestingly, some inflammatory states, such as non-alcoholic steatohepatitis, inflammatory bowel diseases, and chronic kidney disease, are often associated with high ghrelin levels. Thus, ghrelin may be a potential new therapeutic target for inflammation-related diseases.	[Guo, Weiying; Yu, Lu] Jilin Univ, State Key Lab Zoonot Dis, First Hosp Jilin Univ,Inst Zoonosis, Dept Endocrinol,Key Lab Zoonosis Res,Minist Educ, Changchun 130000, Peoples R China; [Guo, Weiying; Yu, Lu] Jilin Univ, State Key Lab Zoonot Dis, First Hosp Jilin Univ,Inst Zoonosis, Key Lab Zoonosis Res,Minist Educ,Dept Intervent T, Changchun 130000, Peoples R China; [Guo, Weiying; Yu, Lu] Jilin Univ, Coll Vet Med, Changchun 130000, Peoples R China	Jilin University; Jilin University; Jilin University	Guo, WY; Yu, L (corresponding author), Jilin Univ, State Key Lab Zoonot Dis, First Hosp Jilin Univ,Inst Zoonosis, Dept Endocrinol,Key Lab Zoonosis Res,Minist Educ, Changchun 130000, Peoples R China.; Guo, WY; Yu, L (corresponding author), Jilin Univ, State Key Lab Zoonot Dis, First Hosp Jilin Univ,Inst Zoonosis, Key Lab Zoonosis Res,Minist Educ,Dept Intervent T, Changchun 130000, Peoples R China.; Guo, WY; Yu, L (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130000, Peoples R China.	guowy@jlu.edu.cn; yu_lu@jlu.edu.cn	ma, yunxiao/GRX-2019-2022		Jilin Scientific and Technological Development Program [20200201306JC]	Jilin Scientific and Technological Development Program	Jilin Scientific and Technological Development Program, Grant/Award Number: 20200201306JC	Al Massadi O, 2019, NEUROPHARMACOLOGY, V148, P131, DOI 10.1016/j.neuropharm.2019.01.001; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Azushima K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42657-1; Baatar D, 2011, MOL CELL ENDOCRINOL, V340, P44, DOI 10.1016/j.mce.2011.04.019; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Barazzoni R, 2014, OBESITY, V22, P170, DOI 10.1002/oby.20454; Beaumont NJ, 2003, J BIOL CHEM, V278, P8877, DOI 10.1074/jbc.C200575200; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; Broom LJ, 2018, POULTRY SCI, V97, P510, DOI 10.3382/ps/pex314; Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Carrero JJ, 2011, KIDNEY INT, V79, P749, DOI 10.1038/ki.2010.487; Chang RJ, 2021, HEPATOB PANCREAT DIS, V20, P366, DOI 10.1016/j.hbpd.2020.05.004; Chen Z, 2019, NAT REV RHEUMATOL, V15, P9, DOI 10.1038/s41584-018-0109-2; CHENG K, 1989, ENDOCRINOLOGY, V124, P2791; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Churm R, 2017, OBES REV, V18, P140, DOI 10.1111/obr.12474; Collden G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040798; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Das UN, 2011, WORLD J DIABETES, V2, P1, DOI 10.4239/wjd.v2.i1.1; De Smet B, 2009, NEUROGASTROENT MOTIL, V21, P59, DOI 10.1111/j.1365-2982.2008.01184.x; Delhanty PJD, 2011, PEPTIDES, V32, P2309, DOI 10.1016/j.peptides.2011.03.001; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; El-Shaer NO, 2021, J PHYSIOL PHARMACOL, V72, P273, DOI 10.26402/jpp.2021.2.12; Ezquerro S, 2019, J CLIN ENDOCR METAB, V104, P21, DOI 10.1210/jc.2018-01171; Fazeli PK, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11585; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Frago LM, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00023, 10.3389/fnmol.2011.00023]; Fu T, 2017, AM J MED SCI, V354, P617, DOI 10.1016/j.amjms.2017.08.022; Fujitsuka N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00271; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Guo L, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00364; Guven B, 2013, KAOHSIUNG J MED SCI, V29, P69, DOI 10.1016/j.kjms.2012.08.011; Han K, 2018, MOL MED REP, V18, P3563, DOI 10.3892/mmr.2018.9381; Heshmati M, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109492; Huang J, 2019, FREE RADICAL BIO MED, V141, P322, DOI 10.1016/j.freeradbiomed.2019.07.001; Jiao Q, 2017, NEUROSCI BIOBEHAV R, V73, P98, DOI 10.1016/j.neubiorev.2016.12.010; Jin L, 2020, EUR REV MED PHARMACO, V24, P11740, DOI 10.26355/eurrev_202011_23825; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Kawaguchi M, 2015, CANCER SCI, V106, P1130, DOI 10.1111/cas.12725; Khowailed A, 2015, CLIN EXP NEPHROL, V19, P419, DOI 10.1007/s10157-014-1006-x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kourtzelis I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00553; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Lee J, 2010, J ENDOCRINOL, V205, P262, DOI 10.1677/JOE-10-0040; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Li B, 2015, ENDOCRINOLOGY, V156, P203, DOI 10.1210/en.2014-1539; Li G, 2017, INT IMMUNOPHARMACOL, V52, P85, DOI 10.1016/j.intimp.2017.08.026; Li L, 2006, ACTA PHARMACOL SIN, V27, P527, DOI 10.1111/j.1745-7254.2006.00319.x; Liu F, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01320; Liu Haiming, 2020, Oncotarget, V11, P3286, DOI 10.18632/oncotarget.27705; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Ma X, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.41; Mafra D, 2011, PEPTIDES, V32, P358, DOI 10.1016/j.peptides.2010.11.023; Mak RH, 2011, KIDNEY INT, V79, P697, DOI 10.1038/ki.2010.520; Mao YJ, 2015, HYPERTENSION, V65, P1238, DOI 10.1161/HYPERTENSIONAHA.114.04864; Mao YJ, 2014, HYPERTENSION, V64, P450, DOI 10.1161/HYPERTENSIONAHA.114.03726; Mao YQ, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S89096; Mao YQ, 2015, INT J MOL SCI, V16, P21911, DOI 10.3390/ijms160921911; Miki K, 2017, CLIN RESPIR J, V11, P496, DOI 10.1111/crj.12364; Moon M, 2009, NEUROTOX RES, V15, P332, DOI 10.1007/s12640-009-9037-x; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Nin N, 2006, CRIT CARE MED, V34, P1093, DOI 10.1097/01.CCM.0000205663.92384.E7; Noh JY, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042219; Nojiri T, 2016, PEPTIDES, V82, P85, DOI 10.1016/j.peptides.2016.06.003; Nunez-Salces M, 2021, ACTA PHYSIOL, V231, DOI 10.1111/apha.13588; Sales KMO, 2019, DIGEST DIS, V37, P226, DOI 10.1159/000494920; Patterson M, 2005, J CLIN ENDOCR METAB, V90, P2205, DOI 10.1210/jc.2004-1641; Poher AL, 2018, PEPTIDES, V100, P236, DOI 10.1016/j.peptides.2017.12.015; Porporato PE, 2013, J CLIN INVEST, V123, P611, DOI 10.1172/JCI39920; Pritchett NR, 2020, INT J CANCER, V146, P2728, DOI 10.1002/ijc.32597; Prodam F, 2014, ARCH IMMUNOL THER EX, V62, P369, DOI 10.1007/s00005-014-0287-9; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Qu RZ, 2019, INFLAMMATION, V42, P1652, DOI 10.1007/s10753-019-01026-w; Quinones M, 2020, REV ENDOCR METAB DIS, V21, P45, DOI 10.1007/s11154-019-09528-6; Rasineni K, 2020, CHEM-BIOL INTERACT, V322, DOI 10.1016/j.cbi.2020.109059; Rasineni K, 2019, AM J PHYSIOL-GASTR L, V316, pG453, DOI 10.1152/ajpgi.00334.2018; Sadjadi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074440; Santos VV, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12476; Shao XF, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106175; Shu ZW, 2013, CARDIOVASC DRUG THER, V27, P309, DOI 10.1007/s10557-013-6453-1; Slomiany BL, 2013, INFLAMMOPHARMACOLOGY, V21, P67, DOI 10.1007/s10787-012-0141-9; Smith RG, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7292; Sominsky L, 2017, ENDOCR REV, V38, P432, DOI 10.1210/er.2016-1133; Song BB, 2021, BIOTECHNOL APPL BIOC, V68, P356, DOI 10.1002/bab.1933; Sovetkina A, 2020, CUREUS, V12, DOI 10.7759/cureus.7941; Sun GX, 2015, J UROLOGY, V193, P2107, DOI 10.1016/j.juro.2014.11.098; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Suzuki H, 2013, PEDIATR NEPHROL, V28, P521, DOI 10.1007/s00467-012-2241-6; Takata A, 2015, ANN SURG, V262, P230, DOI 10.1097/SLA.0000000000000986; Tang XP, 2017, PANCREAS, V46, P1305, DOI 10.1097/MPA.0000000000000946; Tanida R, 2022, BIOCHEM BIOPH RES CO, V589, P260, DOI 10.1016/j.bbrc.2021.12.044; Tasneem S, 2019, PHARMACOL RES, V139, P126, DOI 10.1016/j.phrs.2018.11.001; Thoen LFR, 2012, AUTOPHAGY, V8, P126, DOI 10.4161/auto.8.1.18105; Tian PY, 2020, CELL BIOL INT, V44, P1681, DOI 10.1002/cbin.11362; Tokudome T, 2019, PEPTIDES, V111, P42, DOI 10.1016/j.peptides.2018.05.006; Wang M, 2020, CARDIOVASC RES, V116, P2091, DOI 10.1093/cvr/cvz318; Wang Q, 2017, LIFE SCI, V186, P50, DOI 10.1016/j.lfs.2017.08.004; Wang YY, 2019, J ASSIST REPROD GEN, V36, P2357, DOI 10.1007/s10815-019-01589-5; Warzecha Z, 2010, J PHYSIOL PHARMACOL, V61, P419; Wu CR, 2021, BIOCHEM BIOPH RES CO, V552, P37, DOI 10.1016/j.bbrc.2021.03.032; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yin Y, 2021, J CELL PHYSIOL, V236, P5121, DOI 10.1002/jcp.30218; Yu AP, 2014, ACTA PHYSIOL, V211, P201, DOI 10.1111/apha.12263; Yu M, 2022, ACTA PHARMACOL SIN, V43, P2242, DOI 10.1038/s41401-022-00859-w; Yuan MJ, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20203387; Yuan MJ, 2020, PEPTIDES, V126, DOI 10.1016/j.peptides.2020.170264; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Zhang M, 2015, FRONT BIOSCI-LANDMRK, V20, P604, DOI 10.2741/4325; Zhang SP, 2019, BIOMATERIALS, V200, P35, DOI 10.1016/j.biomaterials.2019.02.006; Zhang WZ, 2016, DNA CELL BIOL, V35, P417, DOI 10.1089/dna.2016.3231; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao DZ, 2006, J CELL BIOCHEM, V97, P1317, DOI 10.1002/jcb.20744; Zheng HC, 2019, AM J PHYSIOL-LUNG C, V317, pL381, DOI 10.1152/ajplung.00253.2018; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200	116	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2022	36	9							e22508	10.1096/fj.202200634R	http://dx.doi.org/10.1096/fj.202200634R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3V6NI	35983825				2022-12-28	WOS:000841777800001
J	Islam, M; Strawn, M; Behura, SK				Islam, Maliha; Strawn, Monica; Behura, Susanta K.			Fetal origin of sex-bias brain aging	FASEB JOURNAL			English	Article						brain aging; developmental aging; epigenetic clock; fetal brain programming; sexual dimorphism	DNA METHYLATION SIGNATURES; GENE-EXPRESSION; EPIGENETIC CLOCK; LIFE-SPAN; AGE; MOUSE; PLACENTA; TISSUES; ALIGNER; STRESS	DNA methylation plays crucial roles during fetal development as well as aging. Whether the aging of the brain is programmed at the fetal stage remains untested. To test this hypothesis, mouse epigenetic clock (epiclock) was profiled in fetal (gestation day 15), postnatal (day 5), and aging (week 70) brain of male and female C57BL/6J inbred mice. Data analysis showed that on week 70, the female brain was epigenetically younger than the male brain. Predictive modeling by neural network identified specific methylations in the brain at the developing stages that were predictive of epigenetic state of the brain during aging. Transcriptomic analysis showed coordinated changes in the expression of epiclock genes in the fetal brain relative to the placenta. Whole-genome bisulfite sequencing identified sites that were methylated both in the placenta and fetal brain in a sex-specific manner. Epiclock genes and genes associated with specific signaling pathways, primarily the gonadotropin-releasing hormone receptor (GnRHR) pathway, were associated with the sex-bias methylations in the placenta as well as the fetal brain. Transcriptional crosstalk among the epiclock and GnRHR pathway genes was evident in the placenta that was maintained in the brain during development as well as aging. Collectively, these findings suggest that sex differences in the aging of the brain are of fetal origin and epigenetically linked to the placenta.	[Islam, Maliha; Strawn, Monica; Behura, Susanta K.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Behura, Susanta K.] Univ Missouri, MU Inst Data Sci & Informat, Columbia, MO 65211 USA; [Behura, Susanta K.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Behura, SK (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	behuras@missouri.edu		behura, Susanta/0000-0003-1057-2435	MU | Office of Research, Graduate Studies and Economic Development, University of Missouri (Office of Research, University of Missouri)	MU | Office of Research, Graduate Studies and Economic Development, University of Missouri (Office of Research, University of Missouri)	MU | Office of Research, Graduate Studies and Economic Development, University of Missouri (Office of Research, University of Missouri)	Aguilaniu Hugo, 2015, Worm, V4, pe1020276, DOI 10.1080/21624054.2015.1020276; Alberry BLJ, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00070; Armstrong NM, 2019, NEUROBIOL AGING, V81, P146, DOI 10.1016/j.neurobiolaging.2019.05.020; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bakker J, 2008, FRONT NEUROENDOCRIN, V29, P1, DOI 10.1016/j.yfrne.2007.06.001; Barker DJP, 2011, PLACENTA, V32, P783, DOI 10.1016/j.placenta.2011.07.031; Behura SK, 2019, PHARMACOL RES, V149, DOI 10.1016/j.phrs.2019.104468; Behura SK, 2019, FASEB J, V33, P4261, DOI 10.1096/fj.201802037R; Bianco-Miotto T, 2017, J DEV ORIG HLTH DIS, V8, P513, DOI 10.1017/S2040174417000733; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Brown JD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095273; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chatterjee A, 2016, G3-GENES GENOM GENET, V6, P1911, DOI 10.1534/g3.116.030379; Chen Yunshun, 2017, F1000Res, V6, P2055, DOI 10.12688/f1000research.13196.2; Chew YC, 2018, FASEB J, V32; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Coninx E, 2020, AGING-US, V12, P20817, DOI 10.18632/aging.104056; Cortes LR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00173; Costantino S, 2020, CARDIOVASC RES, V116, P1246, DOI 10.1093/cvr/cvaa014; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; Dearden L, 2018, MOL METAB, V15, P8, DOI 10.1016/j.molmet.2018.04.007; Decato BE, 2017, MOL BIOL EVOL, V34, P1702, DOI 10.1093/molbev/msx112; Denisova EI, 2020, FEBS OPEN BIO, V10, P96, DOI 10.1002/2211-5463.12757; Dhakal P., 2021, INT J MOL SCI, V22, P9693; Dhakal P, 2017, BIOTECHNIQUES, V62, P232, DOI 10.2144/000114548; DILMAN VM, 1971, LANCET, V1, P1211; Docherty SJ, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-3; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Farrell CM, 2022, GENOME RES, V32, P175, DOI 10.1101/gr.275819.121; Feltes BC, 2015, INTERD T GERONT GERI, V40, P74, DOI 10.1159/000364932; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Fushan AA, 2015, AGING CELL, V14, P352, DOI 10.1111/acel.12283; Gontier G, 2018, CELL REP, V22, P1974, DOI 10.1016/j.celrep.2018.02.001; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; Goyal MS, 2019, P NATL ACAD SCI USA, V116, P3251, DOI 10.1073/pnas.1815917116; Gruzieva O, 2019, EPIGENETICS INSIGHTS, V12, DOI 10.1177/2516865719867090; Guebel DV, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00229; Hagg S, 2021, ELIFE, V10, DOI 10.7554/eLife.63425; Handl L, 2019, BIOINFORMATICS, V35, pI154, DOI 10.1093/bioinformatics/btz338; Hannon E, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009443; Hirabayashi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-82; Horvath S, 2018, AGING-US, V10, P1758, DOI 10.18632/aging.101508; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; HUTCHISON JB, 1995, J STEROID BIOCHEM, V53, P307, DOI 10.1016/0960-0760(95)00068-B; Jansson T, 2013, CLIN OBSTET GYNECOL, V56, P591, DOI 10.1097/GRF.0b013e3182993a2e; Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim H, 2016, BIOCHEM BIOPH RES CO, V471, P437, DOI 10.1016/j.bbrc.2016.02.060; Koukoura O, 2012, MOL MED REP, V5, P883, DOI 10.3892/mmr.2012.763; Kratimenos P, 2019, PEDIATR RES, V86, P157, DOI 10.1038/s41390-019-0405-9; Kreisman MJ, 2017, ENDOCRINOLOGY, V158, P2884, DOI 10.1210/en.2017-00285; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kverkova K, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0280; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laufer B.I., 2021, BIORXIV; Li LL, 2020, EPIGENOMICS-UK, V12, P1053, DOI 10.2217/epi-2019-0319; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181155; Maioli S, 2021, ESSAYS BIOCHEM, V65, P913, DOI 10.1042/EBC20200162; Melamed P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00058; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller HG, 2002, J GERONTOL A-BIOL, V57, pB202, DOI 10.1093/gerona/57.5.B202; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nugent BM, 2015, NAT NEUROSCI, V18, P690, DOI 10.1038/nn.3988; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Pidsley R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0483-2; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rachdaoui N, 2014, INT REV NEUROBIOL, V115, P51, DOI 10.1016/B978-0-12-801311-3.00002-0; Radovic M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1423-9; RATH PC, 1989, FEBS LETT, V244, P193, DOI 10.1016/0014-5793(89)81191-3; Ratnu VS, 2017, J NEUROSCI RES, V95, P301, DOI 10.1002/jnr.23886; RIEDMILLER M, 1994, COMP STAND INTER, V16, P265, DOI 10.1016/0920-5489(94)90017-5; Rothwell ES, 2022, NEUROBIOL AGING, V109, P88, DOI 10.1016/j.neurobiolaging.2021.09.015; Saito K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041091; Sasaki K, 2011, CURR OPIN ENDOCRINOL, V18, P401, DOI 10.1097/MED.0b013e32834cd3b0; Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y; Schroeder DI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005442; Shireby GL, 2020, BRAIN, V143, P3763, DOI 10.1093/brain/awaa334; Sierra MI, 2015, CURR GENOMICS, V16, P435, DOI 10.2174/1389202916666150817203459; Sklias A., 2021, NUCLEIC ACIDS RES, V49, P9738, DOI DOI 10.1093/nar/gkab697; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Steg LC, 2021, MOL BRAIN, V14, DOI 10.1186/s13041-021-00810-w; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Strawn M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092439; Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Teschendorff AE, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02126-9; Tognini P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00331; Tripathi M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051645; Vaiserman A., 2019, EARLY LIFE ORIGINS A; Vidal-Pineiro D, 2021, ELIFE, V10, DOI [10.7554/eLife.69995, 10.7554/eLife.69995.sa1, 10.7554/eLife.69995.sa2]; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhuang XW, 2020, HUM BRAIN MAPP, V41, P3807, DOI 10.1002/hbm.25090	100	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2022	36	8							e22463	10.1096/fj.202200255RR	http://dx.doi.org/10.1096/fj.202200255RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	3D1IB	35869938	Green Submitted			2022-12-28	WOS:000829063100001
J	Xue, J; Zhu, YB; Wei, LY; Huang, HJ; Li, GX; Huang, W; Zhu, H; Duan, RH				Xue, Jin; Zhu, Yingbao; Wei, Liyi; Huang, Hongjing; Li, Guangxu; Huang, Wen; Zhu, Hua; Duan, Ranhui			Loss of Drosophila NUS1 results in cholesterol accumulation and Parkinson's disease-related neurodegeneration	FASEB JOURNAL			English	Article						cholesterol accumulation; Drosophila; neurodegeneration; Parkinson's disease	NOGO-B RECEPTOR; ALPHA-SYNUCLEIN; CONGENITAL DISORDER; MODEL; GLUCOCEREBROSIDASE; BIOSYNTHESIS; MUTATIONS; VARIANTS; PROTEIN; PINK1	NgBR is the Nogo-B receptor, encoded by NUS1 gene. As NgBR contains a C-terminal domain that is similar to cis-isoprenyltransferase (cis-IPTase), NgBR was speculated to stabilize nascent Niemann-Pick type C 2 (NPC2) to facilitate cholesterol transport out of lysosomes. Mutations in the NUS1 were known as risk factors for Parkinson's disease (PD). In our previous study, it was shown that knockdown of Drosophila NUS1 orthologous gene tango14 causes decreased climbing ability, loss of dopaminergic neurons, and decreased dopamine contents. In this study, tango14 mutant flies were generated with a mutation in the C-terminal enzyme activity region using CRISPR/Cas9. Tango14 mutant showed a reduced lifespan with locomotive defects and cholesterol accumulation in Malpighian tubules and brains, especially in dopaminergic neurons. Multilamellar bodies were found in tango14 mutants using electron microscopy. Neurodegenerative-related brain vacuolization was also detected in tango14 knockdown flies in an age-dependent manner. In addition, tango14 knockdown increased alpha-synuclein (alpha-syn) neurotoxicity in alpha-syn-overexpressing flies, with decreased locomotive activities, dopamine contents, and the numbers of dopaminergic neurons in aging flies. Thus, these observations suggest a role of NUS1, the ortholog of tango14, in PD-related pathogenesis.	[Xue, Jin; Zhu, Yingbao; Wei, Liyi; Huang, Hongjing; Li, Guangxu; Huang, Wen; Duan, Ranhui] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China; [Xue, Jin; Zhu, Yingbao; Wei, Liyi; Huang, Hongjing; Li, Guangxu; Huang, Wen; Duan, Ranhui] Cent South Univ, Hunan Key Lab Med Genet, Changsha, Peoples R China; [Zhu, Hua] Jilin Canc Hosp, Dept Clin Lab, Jilin 130012, Jilin, Peoples R China; [Duan, Ranhui] Cent South Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Peoples R China	Central South University; Central South University; Central South University	Duan, RH (corresponding author), Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China.; Zhu, H (corresponding author), Jilin Canc Hosp, Dept Clin Lab, Jilin 130012, Jilin, Peoples R China.	zyf07083842@163.com; duanranhui@sklmg.edu.cn			National Natural Science Foundation of China (NSFC) [81771385, 82071273]; Hunan Science and Technology Major Project of Birth Defect Cooperative Control [2019SK1010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hunan Science and Technology Major Project of Birth Defect Cooperative Control	Human Science and Technology Major Project of Birth Defect Cooperative Control, Grant/Award Number: 2019SK1010; National Natural Science Foundation of China (NSFC), Grant/ Award Number: 81771385 and 82071273	Alcalay RN, 2019, MOVEMENT DISORD, V34, P526, DOI 10.1002/mds.27642; Alecu I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00328; Almeida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026454; Bencheikh BOA, 2018, NEUROBIOL AGING, V72, DOI 10.1016/j.neurobiolaging.2018.06.034; Blumenreich S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144966; Chen J, 2017, FASEB J, V31, P5234, DOI 10.1096/fj.201700011R; Chen X, 2020, NEUROBIOL AGING, V86, DOI 10.1016/j.neurobiolaging.2019.09.002; Chen YP, 2021, MOL NEUROBIOL, V58, P1583, DOI 10.1007/s12035-020-02218-4; Davis MY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005944; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Do J, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0336-2; Dodge JC, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00356; Du TT, 2015, AUTOPHAGY, V11, P1803, DOI 10.1080/15548627.2015.1086055; Megias-Vericat JE, 2017, NEUROL SCI, V38, P727, DOI 10.1007/s10072-017-2833-9; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FRIEND DS, 1981, HISTOCHEM J, V13, P535, DOI 10.1007/BF01002709; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Garcia-Sanz P, 2021, MOVEMENT DISORD, V36, P1070, DOI 10.1002/mds.28396; Gundner AL, 2019, NEUROBIOL DIS, V121, P205, DOI 10.1016/j.nbd.2018.09.015; Guo JF, 2018, P NATL ACAD SCI USA, V115, P11567, DOI 10.1073/pnas.1809969115; Hallett PJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1532-2; Hamdan FF, 2017, AM J HUM GENET, V101, P664, DOI 10.1016/j.ajhg.2017.09.008; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Huang X, 2005, DEVELOPMENT, V132, P5115, DOI 10.1242/dev.02079; Huang X, 2007, DEVELOPMENT, V134, P3733, DOI 10.1242/dev.004572; Jahromi SR, 2015, NEUROSCIENCE, V293, P136, DOI 10.1016/j.neuroscience.2015.02.048; Kalinderi K, 2016, ACTA NEUROL SCAND, V134, P314, DOI 10.1111/ane.12563; Kiechle M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.562241; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lin G, 2019, TRENDS ENDOCRIN MET, V30, P106, DOI 10.1016/j.tem.2018.11.003; Luo J, 2017, TRAFFIC, V18, P209, DOI 10.1111/tra.12471; Martina JA, 2020, CELL, V180, P602, DOI 10.1016/j.cell.2020.01.017; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Niwa R, 2011, CHOLESTEROL, DOI 10.1155/2011/176802; Oji Y, 2020, BRAIN, V143, P1190, DOI 10.1093/brain/awaa064; Palladino MJ, 2002, GENETICS, V161, P1197; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Parkinson WM, 2016, DIS MODEL MECH, V9, P513, DOI 10.1242/dmm.022939; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Robak LA, 2017, BRAIN, V140, P3191, DOI 10.1093/brain/awx285; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P323, DOI 10.1093/jnen/63.4.323; Sardi SP, 2012, NEURODEGENER DIS, V10, P195, DOI 10.1159/000335038; Suzuki M, 2015, HUM MOL GENET, V24, P6675, DOI 10.1093/hmg/ddv372; Ugur B, 2016, DIS MODEL MECH, V9, P235, DOI 10.1242/dmm.023762; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2011, ADV GENET, V73, P1, DOI 10.1016/B978-0-12-380860-8.00001-X; Yaneza MJ., 2020, MOL BASIS DIS, V1, P1866; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ysselstein D, 2019, MOVEMENT DISORD, V34, P614, DOI 10.1002/mds.27631; Yu SH, 2021, GENET MED, V23, P1305, DOI 10.1038/s41436-021-01137-6; Yuan LM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.583182; Zhang R, 2020, J CELL MOL MED, V24, P7697, DOI 10.1111/jcmm.15391	55	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2022	36	7							e22411	10.1096/fj.202200212R	http://dx.doi.org/10.1096/fj.202200212R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	2B3PU	35695805				2022-12-28	WOS:000810104300001
J	Hu, HQ; Zhao, RX; He, Q; Cui, C; Song, J; Guo, XH; Zang, N; Yang, MM; Zou, Y; Yang, JW; Li, JQ; Wang, LM; Xia, LQ; Wang, LS; He, FL; Hou, XG; Yan, F; Chen, L				Hu, Huiqing; Zhao, Ruxing; He, Qin; Cui, Chen; Song, Jia; Guo, Xinghong; Zang, Nan; Yang, Mengmeng; Zou, Ying; Yang, Jingwen; Li, Jinquan; Wang, Liming; Xia, Longqing; Wang, Lingshu; He, Falian; Hou, Xinguo; Yan, Fei; Chen, Li			cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic beta-cells induced by metabolic stress	FASEB JOURNAL			English	Article						cGAS-STING pathway; pancreatic beta cell function; SASP; senescence; type 2 diabetes mellitus	SECRETORY PHENOTYPE; DAMAGE	Type 2 diabetes mellitus (T2DM) is an age-related disease characterized by impaired pancreatic beta cell function and insulin resistance. Recent studies have shown that the accumulation of senescent beta cells under metabolic stress conditions leads to the progression of T2DM, while senolysis can improve the prognosis. However, the specific mechanism of beta cell senescence is still unclear. In this study, we found that the increased load of senescence pancreatic beta cells in both older mice and obese mice induced by high-fat diet (HFD) (DIO mice) was accompanied by activation of the Cyclic GMP-AMP synthase (cGAS) - stimulator of interferon genes (STING) pathway and using cGAS or STING small interfering RNA or STING inhibitor C176 to downregulate this pathway reduced the senescence-associated secretion profile (SASP) and senescence of Min6 cells treated with palmitic acid or hydrogen peroxide. C176 intervention in DIO mice also significantly reduced the inflammation and senescence of the islets, thereby protecting the function of pancreatic beta cell and glucose metabolism. Our study further revealed that mitochondrial DNA (mtDNA) leakage under metabolic stress conditions was critical for the activation of the cGAS-STING pathway, which can be reversed by the mtDNA depleting agent ethidium bromide. Consistently, mtDNA leakage was more severe in older mice and was accelerated by a chronic HFD. In conclusion, we demonstrate that cytoplasmic mtDNA activates the cGAS-STING pathway to mediate SASP during the accelerated senescence of pancreatic beta-cells induced by metabolic stress, and this process can be downregulated by the STING inhibitor C176.	[Hu, Huiqing; Zhao, Ruxing; He, Qin; Cui, Chen; Song, Jia; Guo, Xinghong; Zang, Nan; Yang, Mengmeng; Zou, Ying; Yang, Jingwen; Li, Jinquan; Wang, Liming; Xia, Longqing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Endocrinol, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Univ, Inst Endocrine & Metab Dis, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Prov Med & Hlth, Key Lab Endocrine & Metab Dis, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Jinan Clin Res Ctr Endocrine & Metab Dis, Jinan, Peoples R China; [He, Falian; Chen, Li] Nuolai Biomed Technol Co Ltd, Tai An, Shandong, Peoples R China	Shandong University; Shandong University	Yan, F; Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, 107 Wenhua Xi Rd, Jinan 250012, Peoples R China.	yfddbest@163.com; chenli3@email.sdu.edu.cn			National Natural Science Foundation of China [81670706, 81873632, 81770818, 81800727, 81500591]; Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program [2014ZZCX02201]; National Key R&D Program of China [2016YFC0901204, 2018YFC1311800]; Shandong Provincial Natural Science Foundation [ZR2019BH018]; Taishan Industry Leading Talent Project of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program; National Key R&D Program of China; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Taishan Industry Leading Talent Project of Shandong Province	We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript. This work was supported by the National Natural Science Foundation of China (grant nos. 81670706, 81873632, 81770818, 81800727, and 81500591). This work also received support from the Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program (grant no. 2014ZZCX02201) and the National Key R&D Program of China (grant nos. 2016YFC0901204 and 2018YFC1311800) and the Shandong Provincial Natural Science Foundation (grant no. ZR2019BH018) and the Taishan Industry Leading Talent Project of Shandong Province.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006; Aguayo-Mazzucato C, 2017, CELL METAB, V25, P898, DOI 10.1016/j.cmet.2017.03.015; Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Guevara APH, 2021, METABOLISM, V117, DOI 10.1016/j.metabol.2021.154711; Guo XH, 2021, MOL CELL ENDOCRINOL, V537, DOI 10.1016/j.mce.2021.111425; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Helman A, 2016, DIABETES OBES METAB, V18, P58, DOI 10.1111/dom.12719; Hu HQ, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110890; Jauhari A, 2020, J CLIN INVEST, V130, P3124, DOI 10.1172/JCI135026; Jimenez V, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708791; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kumar V, 2019, J LEUKOCYTE BIOL, V106, P171, DOI 10.1002/JLB.4MIR1018-397RR; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266; Machate DJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114093; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/atvbaha.117.309017, 10.1161/ATVBAHA.117.309017]; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Saul D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010401; Schwingshackl L, 2014, BRIT J NUTR, V111, P2047, DOI 10.1017/S0007114514000464; Tamayo T, 2016, DTSCH ARZTEBL INT, V113, P177, DOI 10.3238/arztebl.2016.0177; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang LS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0640-0; Yan CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040379; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22; Yu GW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246268; Zhang H, 2019, J CELL PHYSIOL, V234, P619, DOI 10.1002/jcp.26816	39	3	3	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22266	10.1096/fj.202101988R	http://dx.doi.org/10.1096/fj.202101988R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0D6DE	35357035				2022-12-28	WOS:000776083000001
J	Wang, JH; Zhang, Q; Chen, EG; Zhao, PQ; Xu, Y				Wang, Jianhui; Zhang, Qi; Chen, Enguang; Zhao, Peiquan; Xu, Yu			Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso-obliteration phase in mouse oxygen-induced retinopathy model	FASEB JOURNAL			English	Article						angiogenesis; Elabela; ferroptosis; OIR; ROP	PREECLAMPSIA; PREMATURITY; MANAGEMENT; DEATH	Retinopathy of prematurity (ROP) is a leading cause of childhood blindness associated with retinal vaso-obliteration in phase 1 and pathological neovascularization (NV) in phase 2; however, effective and safe treatments for ROP definitive treatment are yet to be determined. Anti-vascular endothelial growth factor (VEGF) therapy mainly focuses on reducing abnormal NV in phase 2 but with high risks of late recurrence and systemic side effects. Previous studies have established that the severity of vaso-obliteration in phase 1 largely influences subsequent stages, suggesting that prevention of vessels loss may be a potential therapeutic target for ROP. Herein, the therapeutic potential and safety of early Elabela intervention treatment in treating phase 1 ROP and the possible underlying mechanisms were investigated using an oxygen-induced retinopathy (OIR) mouse model. It was observed that intraperitoneal injection of Elabela remarkably reduced the avascular retinal area and increased the vascular density in phase 1 of OIR mice. Further investigation revealed that mitochondrion-dependent ferroptosis was involved in oxidative stress-mediated vascular protection loss in phase 1 OIR. Furthermore, we demonstrated that Elabela could rescue mitochondria-dependent ferroptosis via mediating the xCT/GPX4 axis. Collectively, our study revealed that ferroptosis may play a significant role in early ROP, while Elabela may be a safe and promising strategy for the early intervention of ROP.	[Wang, Jianhui; Chen, Enguang; Zhao, Peiquan; Xu, Yu] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Zhang, Qi] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Inst Dev & Regenerat Cardiovasc Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, PQ; Xu, Y (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China.	zhaopeiquan@126.com; xuyu01@xinhuamed.com.cn		Wang, Jianhui/0000-0002-4878-5850	Science and Technology Commission of Shanghai Municipality [20Z11900400]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by the Science and Technology Commission of Shanghai Municipality (20Z11900400).	Bai T, 2020, FREE RADICAL BIO MED, V160, P92, DOI 10.1016/j.freeradbiomed.2020.07.026; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Di Fiore JM, 2021, EXP NEUROL, V342, DOI 10.1016/j.expneurol.2021.113753; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Feng H, 2020, CELL REP, V30, P3411, DOI 10.1016/j.celrep.2020.02.049; Fielder AR, 2019, OPHTHALMOLOGY, V126, P652, DOI 10.1016/j.ophtha.2018.12.034; Filippi L, 2020, EXPERT OPIN DRUG SAF, V19, P1409, DOI 10.1080/14740338.2020.1826927; Fu JY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02063-1; Hadian K, 2020, CELL, V181, P1188, DOI 10.1016/j.cell.2020.04.039; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hartnett ME, 2017, SURV OPHTHALMOL, V62, P257, DOI 10.1016/j.survophthal.2016.12.004; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Huang Z, 2019, J CELL PHYSIOL, V234, P61, DOI 10.1002/jcp.27047; Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8; Kajarabille N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194968; Li L, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00610-0; Liet B, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.119065; Liu W, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.07; Ma Z, 2021, HEART FAIL REV, V26, P1249, DOI 10.1007/s10741-020-09957-5; Palmer EA, 2020, OPHTHALMOLOGY, V127, pS84, DOI 10.1016/j.ophtha.2020.01.034; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stone WL, 2016, FRONT BIOSCI-LANDMRK, V21, P165, DOI 10.2741/4382; Tadokoro T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132747; Wang XJ, 2020, CLIN EXP PHARMACOL P, V47, P1953, DOI 10.1111/1440-1681.13382; Xu CM, 2021, J HYPERTENS, V39, P12, DOI 10.1097/HJH.0000000000002591; Xu J, 2018, J CELL PHYSIOL, V233, P6472, DOI 10.1002/jcp.26492; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhou YQ, 2021, FREE RADICAL BIO MED, V171, P55, DOI 10.1016/j.freeradbiomed.2021.05.009; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062	36	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22257	10.1096/fj.202101785RRR	http://dx.doi.org/10.1096/fj.202101785RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0DH	35471770				2022-12-28	WOS:000787329800001
